Citrus Sinensis ID: 010266
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 514 | 2.2.26 [Sep-21-2011] | |||||||
| Q5AP53 | 732 | Serine/threonine-protein | N/A | no | 0.928 | 0.651 | 0.444 | 1e-119 | |
| Q6TGC6 | 507 | Serine/threonine-protein | N/A | no | 0.861 | 0.873 | 0.470 | 1e-118 | |
| Q9Y2H1 | 464 | Serine/threonine-protein | yes | no | 0.848 | 0.939 | 0.484 | 1e-118 | |
| Q5R8M1 | 465 | Serine/threonine-protein | yes | no | 0.856 | 0.946 | 0.477 | 1e-117 | |
| Q15208 | 465 | Serine/threonine-protein | no | no | 0.856 | 0.946 | 0.477 | 1e-117 | |
| A2VDV2 | 465 | Serine/threonine-protein | no | no | 0.856 | 0.946 | 0.479 | 1e-117 | |
| Q9NBK5 | 463 | Serine/threonine-protein | yes | no | 0.854 | 0.948 | 0.477 | 1e-117 | |
| Q7TSE6 | 464 | Serine/threonine-protein | yes | no | 0.848 | 0.939 | 0.477 | 1e-116 | |
| Q6BLJ9 | 716 | Serine/threonine-protein | yes | no | 0.935 | 0.671 | 0.428 | 1e-116 | |
| Q2LZZ7 | 458 | Serine/threonine-protein | yes | no | 0.846 | 0.949 | 0.477 | 1e-116 |
| >sp|Q5AP53|CBK1_CANAL Serine/threonine-protein kinase CBK1 OS=Candida albicans (strain SC5314 / ATCC MYA-2876) GN=CBK1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 430 bits (1106), Expect = e-119, Method: Compositional matrix adjust.
Identities = 225/506 (44%), Positives = 326/506 (64%), Gaps = 29/506 (5%)
Query: 1 MENQNIKVEEQGDD-EGAPMAGEVLEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQE 59
+ NQ++ E D G+ E + + S T ++ A+ K +E++Y + + H E
Sbjct: 225 VANQSVSTEAANSDMTGSNTKYVYFERKPNLLSKTTQDKAASIKLTLENYYTSSVSHAIE 284
Query: 60 RKQRRSVLERKLASSDV--PEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRG 117
R QRR LE K+A+ D+ EE + L++L +KE++++RLKR K++++DF + +IG+G
Sbjct: 285 RNQRRLELENKIANEDIGSSEERKNRQLQNLGKKESQFLRLKRTKLALEDFHTVKVIGKG 344
Query: 118 AFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 177
AFGEVRL Q+K +G IYAMK L KSEM ++ Q+ HV+AER++LA S IV LYYSFQD
Sbjct: 345 AFGEVRLVQKKDTGKIYAMKTLLKSEMFNKDQLAHVKAERDVLAGSDSPWIVALYYSFQD 404
Query: 178 AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNL 237
++YLYLIME+LPGGD+MT+L+R E TE + RFYIA+ VLAIE+IHK +IHRDIKPDN+
Sbjct: 405 SQYLYLIMEFLPGGDLMTMLIRWEVFTEDITRFYIAECVLAIEAIHKLGFIHRDIKPDNI 464
Query: 238 LLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRR---- 293
L+D GH+KLSDFGL T+ S N++L+ E N + + + GR
Sbjct: 465 LIDNRGHVKLSDFGLSTGFHKTHDSNY-YNKLLEKEPSNTHLQPN----QLTSGRNSVMV 519
Query: 294 -----WKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 348
S + +Q W+ +RR +AYSTVGTPDYIAPE+ + +GYG ECDWWSLGAIM+E
Sbjct: 520 DAIHLTMSNRQTMQTWRKSRRLMAYSTVGTPDYIAPEIFIHQGYGQECDWWSLGAIMFEC 579
Query: 349 LVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTL-GSE 407
L+G+PPF S++P T RKI++W+ + PE+ L+PEA+DLI R L E+R+G G+E
Sbjct: 580 LIGWPPFCSENPHDTYRKILNWQESFQIPEDVHLSPEAEDLIKRFLTSAENRIGRYGGAE 639
Query: 408 QIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMML 467
+IK HP+F+ + WD + ++A + P ++ + DT++F D++ S S M + L
Sbjct: 640 EIKQHPFFRGVDWDSIRGVQAPFVPRLSSMTDTRHF-PTDDLASVPDNPAMSKAMEQREL 698
Query: 468 TPK----------DLSFVGYTYKNFE 483
K DL F+GYTY F+
Sbjct: 699 DAKNGGGRKNPKEDLPFIGYTYSRFD 724
|
Serine/threonine-protein kinase required for wild-type hyphal growth and transcriptional regulation of cell-wall-associated genes. Involved in the biofilm formation through phosphorylation of the master regulator of biofilm formation BCR1. Candida albicans (strain SC5314 / ATCC MYA-2876) (taxid: 237561) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q6TGC6|CBK1_PNECA Serine/threonine-protein kinase CBK1 OS=Pneumocystis carinii GN=CBK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 426 bits (1094), Expect = e-118, Method: Compositional matrix adjust.
Identities = 213/453 (47%), Positives = 297/453 (65%), Gaps = 10/453 (2%)
Query: 35 TMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERKETE 94
T ER A+ K +E YK ++ ER QRR E KLA EE + L L +KE++
Sbjct: 53 THERAASVKLKLEHLYKVTVEQTVERNQRRMDFEAKLAQDRGSEERKKRQLNSLGQKESQ 112
Query: 95 YMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
++RL+R K+S++DF + +IG+GAFGEVRL Q+ +G IYAMK L KSEM + Q+ HV+
Sbjct: 113 FLRLRRTKLSLNDFHTVKVIGKGAFGEVRLVQKIDTGKIYAMKTLLKSEMFKKDQLAHVK 172
Query: 155 AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQ 214
AER++LAE S +V LYYSFQD++YLYLIME+LPGGD+MT+L++ +T +E V RFYIA+
Sbjct: 173 AERDVLAESDSPWVVSLYYSFQDSQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYIAE 232
Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDEN 274
+LAIE++HK +IHRDIKPDN+L+D+ GH+KLSDFGL T+ +A + L +
Sbjct: 233 CILAIEAVHKLGFIHRDIKPDNILIDKTGHIKLSDFGLSMGFHKTHDNAYYQR--LFESK 290
Query: 275 LNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM 334
+N S S +++ W+ NRR +AYSTVGTPDYIAPE+ + GYG
Sbjct: 291 INTSTSSTQNSLMVDTISLTMSSKDKIATWKKNRRIMAYSTVGTPDYIAPEIFTQHGYGQ 350
Query: 335 ECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLL 394
ECDWWSLGAIM+E L+G+PPF S++ T RKI++W+ +L FPE+ L+ EA+DLI +LL
Sbjct: 351 ECDWWSLGAIMFECLIGWPPFCSENAHETYRKIINWRENLYFPEDLHLSAEAEDLIRKLL 410
Query: 395 CDVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKFDEVESQTP 454
+ RLG G+ IK HP+F+ + WD + E+ A + P++ + DT F + D + P
Sbjct: 411 TSADQRLGRYGANDIKLHPFFRGVNWDTIREINAPFIPQLKSITDTSYFEEIDTI----P 466
Query: 455 KRTGSGPMRKMMLTPKD----LSFVGYTYKNFE 483
T + P P D L+FVGYTYK F+
Sbjct: 467 NITMNSPPVLQNKIPSDVDQNLAFVGYTYKRFD 499
|
Protein kinase that seems to play a role in signaling pathways necessary for cell growth and mating. Pneumocystis carinii (taxid: 4754) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Y2H1|ST38L_HUMAN Serine/threonine-protein kinase 38-like OS=Homo sapiens GN=STK38L PE=1 SV=3 | Back alignment and function description |
|---|
Score = 424 bits (1089), Expect = e-118, Method: Compositional matrix adjust.
Identities = 220/454 (48%), Positives = 295/454 (64%), Gaps = 18/454 (3%)
Query: 32 SSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERK 91
S+ T ERV AK +E+ Y + +ER+ R+ LE + + +EE+ RK
Sbjct: 14 SNHTRERVTVAKLTLENFYSNLILQHEERETRQKKLEVAMEEEGLADEEKKLRRSQHARK 73
Query: 92 ETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE 151
ETE++RLKR ++ +DDF+ L +IGRGAFGEVRL Q+K +G+IYAMK L+KS+ML + QV
Sbjct: 74 ETEFLRLKRTRLGLDDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKSDMLEKEQVA 133
Query: 152 HVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFY 211
H+RAER++L E +VK++YSFQD LYLIME+LPGGD+MTLLM+++TLTE +FY
Sbjct: 134 HIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY 193
Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD 271
I+++VLAI++IH+ +IHRDIKPDNLLLD GH+KLSDFGL CT L + E
Sbjct: 194 ISETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL-----CTGLKKAHRTEFY- 247
Query: 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331
NL + D F R+ ++ W+ NRR+LAYSTVGTPDYIAPEV ++ G
Sbjct: 248 -RNLTHNPPSDFSFQNMNSKRKAET-------WKKNRRQLAYSTVGTPDYIAPEVFMQTG 299
Query: 332 YGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLIC 391
Y CDWWSLG IMYEML+GYPPF S+ P T RK+++WK L FP E ++ +AKDLI
Sbjct: 300 YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLIL 359
Query: 392 RLLCDVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKFDEVES 451
R D E+R+G G E+IK HP+F+ + W+ + E AA E+ + DT NF F E +
Sbjct: 360 RFCIDSENRIGNSGVEEIKGHPFFEGVDWEHIRERPAAIPIEIKSIDDTSNFDDFPESDI 419
Query: 452 QTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFEAV 485
P + P K KD F+ YTYK FE +
Sbjct: 420 LQPVPNTTEPDYK----SKDWVFLNYTYKRFEGL 449
|
Involved in the regulation of structural processes in differentiating and mature neuronal cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5R8M1|STK38_PONAB Serine/threonine-protein kinase 38 OS=Pongo abelii GN=STK38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 422 bits (1085), Expect = e-117, Method: Compositional matrix adjust.
Identities = 218/457 (47%), Positives = 301/457 (65%), Gaps = 17/457 (3%)
Query: 32 SSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERK 91
S+ T ERV K +E+ Y + +ER+ R+ LE+ + + +EE+ RK
Sbjct: 13 SNHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLRRSAHARK 72
Query: 92 ETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE 151
ETE++RLKR ++ ++DF+ L +IGRGAFGEVRL Q+K +G++YAMK L+K++ML + QV
Sbjct: 73 ETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVG 132
Query: 152 HVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFY 211
H+RAER++L E S +VK++YSFQD LYLIME+LPGGD+MTLLM+++TLTE +FY
Sbjct: 133 HIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY 192
Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD 271
IA++VLAI+SIH+ +IHRDIKPDNLLLD GH+KLSDFGL CT L + E
Sbjct: 193 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL-----CTGLKKAHRTEFY- 246
Query: 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331
NLN S+ D F R+ ++ W+ NRR+LA+STVGTPDYIAPEV ++ G
Sbjct: 247 -RNLNHSLPSDFTFQNMNSKRKAET-------WKRNRRQLAFSTVGTPDYIAPEVFMQTG 298
Query: 332 YGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLIC 391
Y CDWWSLG IMYEML+GYPPF S+ P T +K+++WK L FP E ++ +AKDLI
Sbjct: 299 YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPISEKAKDLIL 358
Query: 392 RLLCDVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKFDEVES 451
R C+ EHR+G G E+IK++ +F+ + W+ + E AA E+ + DT NF +F E +
Sbjct: 359 RFCCEWEHRIGAPGVEEIKSNSFFEGVDWEHIRERPAAISIEIKSIDDTSNFDEFPESDI 418
Query: 452 QTPK-RTGSGPMRKMMLTPKDLSFVGYTYKNFEAVKG 487
P T + P + KD F+ YTYK FE +
Sbjct: 419 LKPTVATSNHP--ETDYKNKDWVFINYTYKRFEGLTA 453
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q15208|STK38_HUMAN Serine/threonine-protein kinase 38 OS=Homo sapiens GN=STK38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 422 bits (1085), Expect = e-117, Method: Compositional matrix adjust.
Identities = 218/457 (47%), Positives = 301/457 (65%), Gaps = 17/457 (3%)
Query: 32 SSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERK 91
S+ T ERV K +E+ Y + +ER+ R+ LE+ + + +EE+ RK
Sbjct: 13 SNHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLRRSAHARK 72
Query: 92 ETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE 151
ETE++RLKR ++ ++DF+ L +IGRGAFGEVRL Q+K +G++YAMK L+K++ML + QV
Sbjct: 73 ETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVG 132
Query: 152 HVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFY 211
H+RAER++L E S +VK++YSFQD LYLIME+LPGGD+MTLLM+++TLTE +FY
Sbjct: 133 HIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY 192
Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD 271
IA++VLAI+SIH+ +IHRDIKPDNLLLD GH+KLSDFGL CT L + E
Sbjct: 193 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL-----CTGLKKAHRTEFY- 246
Query: 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331
NLN S+ D F R+ ++ W+ NRR+LA+STVGTPDYIAPEV ++ G
Sbjct: 247 -RNLNHSLPSDFTFQNMNSKRKAET-------WKRNRRQLAFSTVGTPDYIAPEVFMQTG 298
Query: 332 YGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLIC 391
Y CDWWSLG IMYEML+GYPPF S+ P T +K+++WK L FP E ++ +AKDLI
Sbjct: 299 YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPISEKAKDLIL 358
Query: 392 RLLCDVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKFDEVES 451
R C+ EHR+G G E+IK++ +F+ + W+ + E AA E+ + DT NF +F E +
Sbjct: 359 RFCCEWEHRIGAPGVEEIKSNSFFEGVDWEHIRERPAAISIEIKSIDDTSNFDEFPESDI 418
Query: 452 QTPK-RTGSGPMRKMMLTPKDLSFVGYTYKNFEAVKG 487
P T + P + KD F+ YTYK FE +
Sbjct: 419 LKPTVATSNHP--ETDYKNKDWVFINYTYKRFEGLTA 453
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2VDV2|STK38_BOVIN Serine/threonine-protein kinase 38 OS=Bos taurus GN=STK38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 422 bits (1084), Expect = e-117, Method: Compositional matrix adjust.
Identities = 219/457 (47%), Positives = 299/457 (65%), Gaps = 17/457 (3%)
Query: 32 SSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERK 91
SS T ERV K +E+ Y + +ER+ R+ LE+ + + +EE+ RK
Sbjct: 13 SSHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLRRSAHARK 72
Query: 92 ETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE 151
ETE++RLKR ++ ++DF+ L +IGRGAFGEVRL Q+K +G++YAMK L+K++ML + QV
Sbjct: 73 ETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVG 132
Query: 152 HVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFY 211
H+RAER++L E S +VK++YSFQD LYLIME+LPGGD+MTLLM+++TLTE +FY
Sbjct: 133 HIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY 192
Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD 271
IA++VLAI+SIH+ +IHRDIKPDNLLLD GH+KLSDFGL CT L + E
Sbjct: 193 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL-----CTGLKKAHRTEFY- 246
Query: 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331
NLN S+ D F R+ ++ W+ NRR+LA+STVGTPDYIAPEV ++ G
Sbjct: 247 -RNLNHSLPSDFTFQNMNSKRKAET-------WKRNRRQLAFSTVGTPDYIAPEVFMQTG 298
Query: 332 YGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLIC 391
Y CDWWSLG IMYEML+GYPPF S+ P T +K+++WK L FP E ++ +AKDLI
Sbjct: 299 YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPISEKAKDLIL 358
Query: 392 RLLCDVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKFDEVES 451
R C+ EHR+G G E+IK + +F+ + W+ + E AA E+ + DT NF +F E +
Sbjct: 359 RFCCEWEHRIGAPGVEEIKNNSFFEGVDWEHIRERPAAISIEIKSIDDTSNFDEFPESDI 418
Query: 452 QTPK-RTGSGPMRKMMLTPKDLSFVGYTYKNFEAVKG 487
P T + P KD F+ YTYK FE +
Sbjct: 419 LKPTVATSNHP--DTDYKNKDWVFINYTYKRFEGLTA 453
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9NBK5|TRC_DROME Serine/threonine-protein kinase tricorner OS=Drosophila melanogaster GN=trc PE=1 SV=1 | Back alignment and function description |
|---|
Score = 422 bits (1084), Expect = e-117, Method: Compositional matrix adjust.
Identities = 218/457 (47%), Positives = 298/457 (65%), Gaps = 18/457 (3%)
Query: 32 SSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERK 91
S T+++ AK +E++Y + ERKQR + LE +L + E ++ +K
Sbjct: 17 SDHTLDKATKAKVTLENYYSNLVTQYGERKQRLAKLEAQLKDESLSEAQRQEKRLQHAQK 76
Query: 92 ETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE 151
ETEY+RLKR ++ V+DF+ L +IGRGAFGEVRL Q+K +G++YAMK L+K++ML + QV
Sbjct: 77 ETEYLRLKRLRLGVEDFEALKVIGRGAFGEVRLVQKKDTGHVYAMKVLRKADMLEKEQVA 136
Query: 152 HVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFY 211
HVRAER++L E +VK+YYSFQD LYLIME+LPGGD+MTLLM+++TL+E +FY
Sbjct: 137 HVRAERDVLVEADHQWVVKMYYSFQDPVNLYLIMEFLPGGDMMTLLMKKDTLSEEGTQFY 196
Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD 271
I+++ LAI+SIHK +IHRDIKPDNLLLD GH+KLSDFGL CT L + +
Sbjct: 197 ISETALAIDSIHKLGFIHRDIKPDNLLLDARGHLKLSDFGL-----CTGLKKSHRTDFYR 251
Query: 272 DENLNESMDVDGRFPESGCGRRWKSPLE---QLQHWQINRRKLAYSTVGTPDYIAPEVLL 328
D + + D G C SP++ + + W+ NRR LAYSTVGTPDYIAPEV L
Sbjct: 252 DLSQAKPSDFIGTCASLSC-----SPMDSKRRAESWKRNRRALAYSTVGTPDYIAPEVFL 306
Query: 329 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKD 388
+ GYG CDWWSLG IMYEML+GYPPF SD+P T RK+++W+ L FP E ++ EAK+
Sbjct: 307 QTGYGPACDWWSLGVIMYEMLMGYPPFCSDNPQDTYRKVMNWRETLIFPPEIPISEEAKE 366
Query: 389 LICRLLCDVEHRLGT-LGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKFD 447
I C+ + RLG+ G E +K+ P+F+ + W+ + E AA EV + DT NF +F
Sbjct: 367 TIINFCCEADRRLGSQRGLEDLKSVPFFRGVDWEHIRERPAAIPVEVRSIDDTSNFDEFP 426
Query: 448 EVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFEA 484
+V + P S P+ + KD F+ YTYK FE
Sbjct: 427 DVSLEIP----SAPIPQGGEIAKDWVFINYTYKRFEV 459
|
Has an important role, with fry, in controlling cell structure and proliferation of a variety of polarized outgrowths including epidermal hairs, bristles, arista laterals, and dendrites. Affects cellular morphogenesis by regulating the expression of target genes that encode cytoskeleton-interacting proteins and not via the direct modification of the cytoskeleton. Maintains the integrity of epidermal hairs and is an essential component of the signaling pathway regulating dendritic branching of sensory neurons. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7TSE6|ST38L_MOUSE Serine/threonine-protein kinase 38-like OS=Mus musculus GN=Stk38l PE=1 SV=2 | Back alignment and function description |
|---|
Score = 420 bits (1079), Expect = e-116, Method: Compositional matrix adjust.
Identities = 217/454 (47%), Positives = 293/454 (64%), Gaps = 18/454 (3%)
Query: 32 SSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERK 91
S+ T ERV AK +E+ Y + +ER+ R+ LE + + +EE+ RK
Sbjct: 14 SNHTRERVTVAKLTLENFYSNLILQHEERETRQKKLEVAMEEEGLADEEKKLRRSQHARK 73
Query: 92 ETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE 151
ETE++RLKR ++ +DDF+ L +IGRGAFGEVRL Q+K +G+IYAMK L+K++ML + QV
Sbjct: 74 ETEFLRLKRTRLGLDDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVA 133
Query: 152 HVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFY 211
H+RAER++L E +VK++YSFQD LYLIME+LPGGD+MTLLM+++TLTE +FY
Sbjct: 134 HIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY 193
Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD 271
I+++VLAI++IH+ +IHRD+KPDNLLLD GH+KLSDFGL CT L + E
Sbjct: 194 ISETVLAIDAIHQLGFIHRDVKPDNLLLDAKGHVKLSDFGL-----CTGLKKAHRTEFY- 247
Query: 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331
NL + D F R+ ++ W+ NRR+LAYSTVGTPDYIAPEV ++ G
Sbjct: 248 -RNLTHNPPSDFSFQNMNSKRKAET-------WKKNRRQLAYSTVGTPDYIAPEVFMQTG 299
Query: 332 YGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLIC 391
Y CDWWSLG IMYEML+G+PPF S+ P T RK++ WK L FP E ++ +AKDLI
Sbjct: 300 YNKLCDWWSLGVIMYEMLIGFPPFCSETPQETYRKVMSWKETLAFPPEVPVSEKAKDLIL 359
Query: 392 RLLCDVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKFDEVES 451
R D E+R+G G E+IK HP+F+ + W + E AA E+ + DT NF F E +
Sbjct: 360 RFCTDSENRIGNGGVEEIKGHPFFEGVDWGHIRERPAAIPIEIRSIDDTSNFDDFPESDI 419
Query: 452 QTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFEAV 485
P + P K KD F+ YTYK FE +
Sbjct: 420 LQPVPNTTEPDYK----SKDWVFLNYTYKRFEGL 449
|
Involved in the regulation of structural processes in differentiating and mature neuronal cells. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6BLJ9|CBK1_DEBHA Serine/threonine-protein kinase CBK1 OS=Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / JCM 1990 / NBRC 0083 / IGC 2968) GN=CBK1 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 420 bits (1079), Expect = e-116, Method: Compositional matrix adjust.
Identities = 217/506 (42%), Positives = 331/506 (65%), Gaps = 25/506 (4%)
Query: 1 MENQNIKVEEQGDDEGAPMAGEV-LEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQE 59
+ N NI +D A + + + + + ++ ++ K +E++Y+ + H E
Sbjct: 205 LPNSNIPPAGASNDPNAQKSNYIYFNRQPNSLNKIAQDKASSIKLKLENYYQMSVAHAIE 264
Query: 60 RKQRRSVLERKLAS--SDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRG 117
R QRR LE KL + S EE + L++L +KE++++RL+R K+S++DF+ + +IG+G
Sbjct: 265 RNQRRLDLEHKLLNEESGSSEERKNRQLQNLGKKESQFLRLRRTKLSLEDFNTVKVIGKG 324
Query: 118 AFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 177
AFGEVRL Q++ +G IYAMK L KSEM + Q+ HV+AER++LA S +V LYYSFQD
Sbjct: 325 AFGEVRLVQKRDTGKIYAMKTLLKSEMYKKDQLAHVKAERDVLAGSDSPWVVSLYYSFQD 384
Query: 178 AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNL 237
A+YLYLIME+LPGGD+MT+L+R + TE + RFY+A+ VLAIE+IHK +IHRDIKPDN+
Sbjct: 385 AQYLYLIMEFLPGGDLMTMLIRWQIFTEDITRFYMAECVLAIEAIHKLGFIHRDIKPDNI 444
Query: 238 LLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF--PESGCGRRWK 295
L+D GH+KLSDFGL T+ S + ++L+ EN + + +G P R
Sbjct: 445 LIDIRGHIKLSDFGLSTGFHKTHDSNYYK-KLLEKENPHHTNPQNGNLQAPSMATNNRNS 503
Query: 296 ----------SPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345
S +Q+Q W+ +RR +AYSTVGTPDYIAPE+ + +GYG ECDWWSLGAIM
Sbjct: 504 MMVDAIHLTMSNRQQMQTWRKSRRLMAYSTVGTPDYIAPEIFVHQGYGQECDWWSLGAIM 563
Query: 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTL- 404
+E L+G+PPF S+ P T RKI++W+ L+ P++ L+PE++DLI +LL + E+RLG
Sbjct: 564 FECLIGWPPFCSETPHETYRKILNWQETLQIPDDIHLSPESEDLIRKLLTNAENRLGRYN 623
Query: 405 GSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKFDEVES--QTPKRTGSGPM 462
G++++K+HP+F+ + WD + +++A + P++ + DT+ F DE+E+ +P + +
Sbjct: 624 GADELKSHPFFRGVDWDTIRKVDAPFIPKLRSITDTR-FFPTDELENVPDSPALSKAMEQ 682
Query: 463 RKMML-----TPKDLSFVGYTYKNFE 483
R +L +DL F+GYTY F+
Sbjct: 683 RDQVLQNGGNVKEDLPFIGYTYSRFD 708
|
Protein kinase that seems to play a role in the regulation of cell morphogenesis and proliferation. Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / JCM 1990 / NBRC 0083 / IGC 2968) (taxid: 284592) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2LZZ7|TRC_DROPS Serine/threonine-protein kinase tricorner OS=Drosophila pseudoobscura pseudoobscura GN=trc PE=3 SV=1 | Back alignment and function description |
|---|
Score = 420 bits (1079), Expect = e-116, Method: Compositional matrix adjust.
Identities = 218/457 (47%), Positives = 299/457 (65%), Gaps = 22/457 (4%)
Query: 32 SSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERK 91
S T+++ AK +E++Y + ERKQR + LE +L + E ++ +K
Sbjct: 16 SDHTLDKATKAKVTLENYYSNLVTQYGERKQRLAKLEAQLKDESLTESQRQEKRLQHAQK 75
Query: 92 ETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE 151
ETEY+RLKR ++ V+DF+ L +IGRGAFGEVRL Q+K +G++YAMK L+K++ML + QV
Sbjct: 76 ETEYLRLKRLRLGVEDFEALKVIGRGAFGEVRLVQKKDTGHVYAMKVLRKADMLEKEQVA 135
Query: 152 HVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFY 211
HVRAER++L E +VK+YYSFQD LYLIME+LPGGD+MTLLM+++TL+E +FY
Sbjct: 136 HVRAERDVLVEADHQWVVKMYYSFQDQVNLYLIMEFLPGGDMMTLLMKKDTLSEEGTQFY 195
Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD 271
I+++ LAI+SIHK +IHRDIKPDNLLLD GH+KLSDFGL CT L + +
Sbjct: 196 ISETALAIDSIHKLGFIHRDIKPDNLLLDARGHLKLSDFGL-----CTGLKKSHRTDFYR 250
Query: 272 DENLNESMDVDGRFPESGCGRRWKSPLE---QLQHWQINRRKLAYSTVGTPDYIAPEVLL 328
D + + D G C SP++ + + W+ NRR LAYSTVGTPDYIAPEV L
Sbjct: 251 DLSQAKPSDFIG-----TCA----SPMDSKRRAESWKRNRRALAYSTVGTPDYIAPEVFL 301
Query: 329 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKD 388
+ GYG CDWWSLG IMYEML+GYPPF SD+P T RK+++W+ L FP E ++ EAK+
Sbjct: 302 QTGYGPACDWWSLGVIMYEMLMGYPPFCSDNPQDTYRKVMNWRETLIFPPEIPISEEAKE 361
Query: 389 LICRLLCDVEHRLGT-LGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKFD 447
I + C+ + RLG+ G E +K+ P+F+ + W+ + E AA EV + DT NF +F
Sbjct: 362 TIIKFCCEADRRLGSQRGLEDLKSVPFFRGVDWEHIRERPAAIPVEVRSIDDTSNFDEFP 421
Query: 448 EVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFEA 484
+V + P S P+ + KD F+ YTYK FE
Sbjct: 422 DVSLEIP----SAPIPQGGEIAKDWVFINYTYKRFEV 454
|
Has an important role, with fry, in controlling cell structure and proliferation of a variety of polarized outgrowths including epidermal hairs, bristles, arista laterals, and dendrites. Affects cellular morphogenesis by regulating the expression of target genes that encode cytoskeleton-interacting proteins and not via the direct modification of the cytoskeleton. Maintains the integrity of epidermal hairs and is an essential component of the signaling pathway regulating dendritic branching of sensory neurons. Drosophila pseudoobscura pseudoobscura (taxid: 46245) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 514 | ||||||
| 444436616 | 538 | serine/threonine protein kinase [Carica | 0.922 | 0.881 | 0.880 | 0.0 | |
| 255546075 | 492 | serine/threonine-protein kinase, putativ | 0.904 | 0.945 | 0.880 | 0.0 | |
| 449452743 | 533 | PREDICTED: serine/threonine-protein kina | 0.947 | 0.913 | 0.832 | 0.0 | |
| 356558379 | 519 | PREDICTED: serine/threonine-protein kina | 0.941 | 0.932 | 0.821 | 0.0 | |
| 449500536 | 533 | PREDICTED: LOW QUALITY PROTEIN: serine/t | 0.947 | 0.913 | 0.826 | 0.0 | |
| 224091216 | 486 | predicted protein [Populus trichocarpa] | 0.871 | 0.921 | 0.870 | 0.0 | |
| 255550097 | 623 | serine/threonine-protein kinase, putativ | 0.902 | 0.744 | 0.851 | 0.0 | |
| 356532738 | 511 | PREDICTED: probable serine/threonine-pro | 0.894 | 0.900 | 0.85 | 0.0 | |
| 359476253 | 503 | PREDICTED: serine/threonine-protein kina | 0.910 | 0.930 | 0.837 | 0.0 | |
| 357449949 | 676 | Serine/threonine protein kinase [Medicag | 0.912 | 0.693 | 0.827 | 0.0 |
| >gi|444436616|gb|AGE09676.1| serine/threonine protein kinase [Carica papaya] | Back alignment and taxonomy information |
|---|
Score = 877 bits (2265), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 420/477 (88%), Positives = 447/477 (93%), Gaps = 3/477 (0%)
Query: 18 PMAGEVLEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVP 77
P+A V EEEG++GSSLTMERVAAAKQFIESHYKA MKHIQERK+RRS+LER+ A SDVP
Sbjct: 21 PIA--VDEEEGQVGSSLTMERVAAAKQFIESHYKAHMKHIQERKERRSILERRFACSDVP 78
Query: 78 EEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMK 137
+EEQIN+LKDLERKETEYMRLKRHKI VDDFDLLTIIGRGAFGEVRLC+EKKSGNIYAMK
Sbjct: 79 QEEQINMLKDLERKETEYMRLKRHKICVDDFDLLTIIGRGAFGEVRLCREKKSGNIYAMK 138
Query: 138 KLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL 197
KLKKSEMLSRGQVEHVRAERNLLAEV SHCIVKLYYSFQDA+YLYLIMEYLPGGD+MTLL
Sbjct: 139 KLKKSEMLSRGQVEHVRAERNLLAEVGSHCIVKLYYSFQDADYLYLIMEYLPGGDMMTLL 198
Query: 198 MREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
+REETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD++GHMKLSDFGLCKPLD
Sbjct: 199 IREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKSGHMKLSDFGLCKPLD 258
Query: 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG 317
C NLSAINENE L DENLNESMDVDG P S GRRWKSPLEQLQHWQINRRKLAYSTVG
Sbjct: 259 CRNLSAINENEPLHDENLNESMDVDGSLPGSRGGRRWKSPLEQLQHWQINRRKLAYSTVG 318
Query: 318 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFP 377
TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHW+++LKFP
Sbjct: 319 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWRHYLKFP 378
Query: 378 EEARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGV 437
EEARLTPEAKDLICRLLCDVEHRLGT+G+ QIK HPWFKD+ WDKLYE+EAA+KP+VNG
Sbjct: 379 EEARLTPEAKDLICRLLCDVEHRLGTMGAGQIKVHPWFKDVVWDKLYEIEAAFKPQVNGE 438
Query: 438 LDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFEAVKGMHNRIGM 494
LDTQNFMKFDEVE P RTGSG MRK MLT +DLSFVGYTYKNF+AVKG H+ I +
Sbjct: 439 LDTQNFMKFDEVEPPRPGRTGSGAMRK-MLTSQDLSFVGYTYKNFDAVKGSHHSIDI 494
|
Source: Carica papaya Species: Carica papaya Genus: Carica Family: Caricaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255546075|ref|XP_002514097.1| serine/threonine-protein kinase, putative [Ricinus communis] gi|223546553|gb|EEF48051.1| serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 873 bits (2256), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 411/467 (88%), Positives = 445/467 (95%), Gaps = 2/467 (0%)
Query: 32 SSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERK 91
SSLT+ERVAAAK FIE+HY+AQMKHIQ+RK+RRS L+++LASSDV +EEQ N+LKDLERK
Sbjct: 25 SSLTLERVAAAKLFIENHYRAQMKHIQQRKERRSELQKQLASSDVSQEEQTNLLKDLERK 84
Query: 92 ETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE 151
ETEYMRLKR+KI VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE
Sbjct: 85 ETEYMRLKRNKICVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE 144
Query: 152 HVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFY 211
HV+AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGD+MTLLMREETLTETVARFY
Sbjct: 145 HVKAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDIMTLLMREETLTETVARFY 204
Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD 271
IAQSVLAIESIH+HNYIHRDIKPDNLLLD+NGHMKLSDFGLCKPLDC+NLSAINENEVLD
Sbjct: 205 IAQSVLAIESIHRHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCSNLSAINENEVLD 264
Query: 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331
DENL ESMDV+GRFP++G GRRWKSPLEQLQHWQ+NRR LAYSTVGTPDYIAPEVLLKKG
Sbjct: 265 DENLKESMDVNGRFPDTG-GRRWKSPLEQLQHWQMNRRTLAYSTVGTPDYIAPEVLLKKG 323
Query: 332 YGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLIC 391
YGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHW+NHL FPEE RLTPEAKDLIC
Sbjct: 324 YGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWRNHLNFPEEVRLTPEAKDLIC 383
Query: 392 RLLCDVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKFDEVES 451
RLLCDVEHRLGTLG++QIKAHPWFKD+AWDKLYE+EAA+KP+VNG LDTQNFMKFDEVE
Sbjct: 384 RLLCDVEHRLGTLGADQIKAHPWFKDVAWDKLYEVEAAFKPQVNGELDTQNFMKFDEVEP 443
Query: 452 QTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFEAVKGMHNRIGMGILL 498
+R GSGPMRKMML P+DL+FVGYTYKNF+A+KG+H+ G LL
Sbjct: 444 PRTRR-GSGPMRKMMLNPQDLTFVGYTYKNFDAIKGLHHSFGTRTLL 489
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449452743|ref|XP_004144118.1| PREDICTED: serine/threonine-protein kinase CBK1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 853 bits (2203), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/490 (83%), Positives = 450/490 (91%), Gaps = 3/490 (0%)
Query: 1 MENQNIKVEEQGDDEGAPMAGEVLEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQER 60
MEN +VE + DD+ P E EE G +GSSLT+E+VAAAKQ+IE+HYKAQ KHIQER
Sbjct: 1 MENHQ-EVEGEEDDDMGPTTVEE-EEIGFVGSSLTLEKVAAAKQYIENHYKAQRKHIQER 58
Query: 61 KQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFG 120
K+RRSVLER+LASSDV EEEQIN+LKDLER ET+Y+RLKRHKI V+DF LLTIIGRGAFG
Sbjct: 59 KERRSVLERRLASSDVSEEEQINLLKDLERTETQYIRLKRHKICVEDFYLLTIIGRGAFG 118
Query: 121 EVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180
EVRLC+EKK+GNIYAMKKL+KSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY
Sbjct: 119 EVRLCREKKTGNIYAMKKLRKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 178
Query: 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD 240
LYLIMEYLPGGD+MTLL+REETLTETVARFYIAQSVLAIESIH HNYIHRDIKPDNLLLD
Sbjct: 179 LYLIMEYLPGGDMMTLLIREETLTETVARFYIAQSVLAIESIHIHNYIHRDIKPDNLLLD 238
Query: 241 QNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQ 300
+ GHMKLSDFGLCKPLDCTNLSAINE+EVLDDENLN+++DVD FP GRRWKSPLEQ
Sbjct: 239 KRGHMKLSDFGLCKPLDCTNLSAINEHEVLDDENLNDTVDVDESFPGKKSGRRWKSPLEQ 298
Query: 301 LQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDP 360
LQHWQINRRKLA+STVGTPDYIAPEVLLKKGYG+ECDWWSLGAIMYEMLVGYPPFYSDDP
Sbjct: 299 LQHWQINRRKLAFSTVGTPDYIAPEVLLKKGYGVECDWWSLGAIMYEMLVGYPPFYSDDP 358
Query: 361 VTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFKDIAW 420
VTTCRKIVHWKNHLKFP+E RL+PEAKD+I RLLCDVE RLG+ G +QIK HPWFKD W
Sbjct: 359 VTTCRKIVHWKNHLKFPDEIRLSPEAKDMISRLLCDVESRLGSGGVDQIKTHPWFKDTEW 418
Query: 421 DKLYEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYK 480
+KLY+M+AA+KPEVNG LDTQNFM+FDEV+S P R+GSGP+RKM+LTPKDLSFVGYTYK
Sbjct: 419 EKLYDMDAAFKPEVNGELDTQNFMQFDEVDS-PPTRSGSGPIRKMLLTPKDLSFVGYTYK 477
Query: 481 NFEAVKGMHN 490
NFEAVKG+ +
Sbjct: 478 NFEAVKGLRH 487
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558379|ref|XP_003547484.1| PREDICTED: serine/threonine-protein kinase CBK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 850 bits (2195), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 404/492 (82%), Positives = 446/492 (90%), Gaps = 8/492 (1%)
Query: 1 MENQ----NIKVEEQGDDEGAPMAGEVLEEEGEIGSSLTMERVAAAKQFIESHYKAQMKH 56
MENQ ++ V E+ DD +A E E+ G++GSS+T+ERVAAAK+FIE+HYK+Q KH
Sbjct: 1 MENQKVGESVHVREEEDD----VAVEKEEDHGDVGSSMTLERVAAAKKFIENHYKSQRKH 56
Query: 57 IQERKQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGR 116
IQERK+RR +LE+KLASS PEEEQIN+LKDLE KETEYMRLKRHKI VDDFDLLTIIGR
Sbjct: 57 IQERKERRLMLEKKLASSQAPEEEQINLLKDLELKETEYMRLKRHKICVDDFDLLTIIGR 116
Query: 117 GAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 176
GAFGEVRLC+EKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN+LAEVA CIVKLYYSFQ
Sbjct: 117 GAFGEVRLCREKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNVLAEVACDCIVKLYYSFQ 176
Query: 177 DAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDN 236
DAE+LYLIMEYLPGGD+MTLLMREETLTETVARFY+AQSV+AIESIHKHNYIHRDIKPDN
Sbjct: 177 DAEHLYLIMEYLPGGDIMTLLMREETLTETVARFYVAQSVIAIESIHKHNYIHRDIKPDN 236
Query: 237 LLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKS 296
LLLDQ GHMKLSDFGLCKPLDC++LS+I+ENE+LDDENLN++ DVDG GRRWKS
Sbjct: 237 LLLDQYGHMKLSDFGLCKPLDCSSLSSISENEILDDENLNDTTDVDGALSNGRNGRRWKS 296
Query: 297 PLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 356
PLEQLQHWQINRRKLA+STVGTPDYIAPEVLLKKGYG+ECDWWSLGAIMYEMLVGYPPFY
Sbjct: 297 PLEQLQHWQINRRKLAFSTVGTPDYIAPEVLLKKGYGVECDWWSLGAIMYEMLVGYPPFY 356
Query: 357 SDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFK 416
SDDPV+TCRKIVHWKNHLKFPEEARLTPEAKDLIC+LLC V HRLGT G+E+IKAHPWFK
Sbjct: 357 SDDPVSTCRKIVHWKNHLKFPEEARLTPEAKDLICKLLCGVPHRLGTRGAEEIKAHPWFK 416
Query: 417 DIAWDKLYEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVG 476
D+ WD+LYEMEAA+KP+VNG LDTQNFMKFDEVE R+GSGP RK +LT +DLSFVG
Sbjct: 417 DVMWDRLYEMEAAFKPQVNGELDTQNFMKFDEVEQPKSSRSGSGPFRKKLLTSQDLSFVG 476
Query: 477 YTYKNFEAVKGM 488
YTYKNF AVKGM
Sbjct: 477 YTYKNFAAVKGM 488
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449500536|ref|XP_004161124.1| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase CBK1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 845 bits (2184), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/490 (82%), Positives = 447/490 (91%), Gaps = 3/490 (0%)
Query: 1 MENQNIKVEEQGDDEGAPMAGEVLEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQER 60
MEN +VE + DD+ P E EE G +GSSLT+E+VAAAKQ+IE+HYKAQ KHIQER
Sbjct: 1 MENHQ-EVEGEEDDDMGPTTVEE-EEIGFVGSSLTLEKVAAAKQYIENHYKAQRKHIQER 58
Query: 61 KQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFG 120
K+RRSVLER+LASSDV EEEQIN+LKDLER ET+Y+RLKRHKI V+DF LLTIIGRGAFG
Sbjct: 59 KERRSVLERRLASSDVSEEEQINLLKDLERTETQYIRLKRHKICVEDFYLLTIIGRGAFG 118
Query: 121 EVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180
EVRLC+EKK+GNIYAMKKL+KSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY
Sbjct: 119 EVRLCREKKTGNIYAMKKLRKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 178
Query: 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD 240
LYLIMEYLPGGD+MTLL+REETLTETVARFYIAQSVLAIESIH HNYIHRDIKPDNLLLD
Sbjct: 179 LYLIMEYLPGGDMMTLLIREETLTETVARFYIAQSVLAIESIHIHNYIHRDIKPDNLLLD 238
Query: 241 QNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQ 300
+ GHMKLSDFGLCKPLDCTNLSAINE+EVLDDENLN+++DVD GRRWKSPLEQ
Sbjct: 239 KRGHMKLSDFGLCKPLDCTNLSAINEHEVLDDENLNDTVDVDESXSRXKSGRRWKSPLEQ 298
Query: 301 LQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDP 360
LQHWQINRRKLA+STVGTPDYIAPEVL KKGYG+ECDWWSLGAIMYEMLVGYPPFYSDDP
Sbjct: 299 LQHWQINRRKLAFSTVGTPDYIAPEVLXKKGYGVECDWWSLGAIMYEMLVGYPPFYSDDP 358
Query: 361 VTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFKDIAW 420
VTTCRKIVHWKNHLKFP+E RL+PEAKD+I RLLCDVE RLG+ G +QIK HPWFKD W
Sbjct: 359 VTTCRKIVHWKNHLKFPDEIRLSPEAKDMISRLLCDVESRLGSGGVDQIKTHPWFKDTEW 418
Query: 421 DKLYEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYK 480
+KLY+M+AA+KPEVNG LDTQNFM+FDEV+S P R+GSGP+RKM+LTPKDLSFVGYTYK
Sbjct: 419 EKLYDMDAAFKPEVNGELDTQNFMQFDEVDS-PPTRSGSGPIRKMLLTPKDLSFVGYTYK 477
Query: 481 NFEAVKGMHN 490
NFEAVKG+ +
Sbjct: 478 NFEAVKGLRH 487
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224091216|ref|XP_002309207.1| predicted protein [Populus trichocarpa] gi|222855183|gb|EEE92730.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 844 bits (2181), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 402/462 (87%), Positives = 431/462 (93%), Gaps = 14/462 (3%)
Query: 29 EIGSSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDL 88
++GSSLT+ERVAAAK FIE+HYKAQMKHIQ+RK+RR L+++LASS V EEEQINILKDL
Sbjct: 25 QVGSSLTLERVAAAKIFIENHYKAQMKHIQQRKERRLELKKQLASSQVSEEEQINILKDL 84
Query: 89 ERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRG 148
E KET+YMRLKRHKI VDDFDLLTIIGRGAFGEVRLC+EKKSG+IYAMKKLKKSEMLSRG
Sbjct: 85 EHKETQYMRLKRHKICVDDFDLLTIIGRGAFGEVRLCREKKSGDIYAMKKLKKSEMLSRG 144
Query: 149 QVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVA 208
QVEHV+AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGD+MTLL+REETLTET+A
Sbjct: 145 QVEHVKAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDIMTLLIREETLTETMA 204
Query: 209 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENE 268
RFYI+QSVLAIESIHKHNYIHRDIKPDNLLLD+NGHMKLSDFGLCKPLDCTNLSAINENE
Sbjct: 205 RFYISQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCTNLSAINENE 264
Query: 269 VLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL 328
LDDENL ESMD DG FPE+G GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL
Sbjct: 265 ALDDENLKESMDADGHFPEAG-GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL 323
Query: 329 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKD 388
KKGYG+ECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHW+NHL FPEEARLTPEAKD
Sbjct: 324 KKGYGIECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWRNHLIFPEEARLTPEAKD 383
Query: 389 LICRLLCDVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKFDE 448
LICRLLCDV+HRLGTLG++QIKAHPWFKDI WDKLYEMEAA+KPEVNG LDTQNFMKFDE
Sbjct: 384 LICRLLCDVDHRLGTLGADQIKAHPWFKDIVWDKLYEMEAAFKPEVNGELDTQNFMKFDE 443
Query: 449 VESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFEAVKGMHN 490
V K ML P+DLSFVGYTYKNF+AVKG+H+
Sbjct: 444 VS-------------KTMLNPQDLSFVGYTYKNFDAVKGLHH 472
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255550097|ref|XP_002516099.1| serine/threonine-protein kinase, putative [Ricinus communis] gi|223544585|gb|EEF46101.1| serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 843 bits (2177), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/465 (85%), Positives = 434/465 (93%), Gaps = 1/465 (0%)
Query: 30 IGSSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLE 89
+GSSLTME+VAAAKQFIE+HY+AQMK+IQERK+RR VLERKLASSDVP+EEQI+++KDLE
Sbjct: 14 LGSSLTMEKVAAAKQFIENHYRAQMKNIQERKERRWVLERKLASSDVPKEEQISLIKDLE 73
Query: 90 RKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ 149
RKETE+MRLKRHKI VDDF+LLTIIGRGAFGEVRLC+EKKSGNIYAMKKLKKSEML RGQ
Sbjct: 74 RKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMLMRGQ 133
Query: 150 VEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVAR 209
VEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGD+MTLLMRE+TLTE VAR
Sbjct: 134 VEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDMMTLLMREDTLTENVAR 193
Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEV 269
FYIAQSVLAIESIHKHNYIHRDIKPDNLLLD+NGHMKLSDFGLCKPLDCT LS I EN+
Sbjct: 194 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCTTLSVIPENKT 253
Query: 270 LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK 329
+DD+N NE MD+DG P++ W+SP EQLQHWQ+NRRKLA+STVGTPDYIAPEVLLK
Sbjct: 254 IDDKNSNEPMDIDGGIPDADNKSNWRSPHEQLQHWQMNRRKLAFSTVGTPDYIAPEVLLK 313
Query: 330 KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDL 389
KGYGMECDWWSLGAIMYEMLVGYPPFYSDDP+TTCRKIVHW+NHLKFPE+ARLT EAKDL
Sbjct: 314 KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPITTCRKIVHWRNHLKFPEDARLTFEAKDL 373
Query: 390 ICRLLCDVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKFDEV 449
I RLLCDVEHRLGT G+ QIKAHPWF+D+ WDKLYEMEAA+KPEVNG LDTQNFMKFDE+
Sbjct: 374 IYRLLCDVEHRLGTGGANQIKAHPWFRDVVWDKLYEMEAAFKPEVNGELDTQNFMKFDEL 433
Query: 450 ESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFEAVKGMHNRIGM 494
+ +P RTGSGP RKM+LTPKDLSFVGYTYKNF+AVKG H+ GM
Sbjct: 434 NAPSPSRTGSGPSRKMLLTPKDLSFVGYTYKNFDAVKGQHS-FGM 477
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356532738|ref|XP_003534928.1| PREDICTED: probable serine/threonine-protein kinase ndrB-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 834 bits (2154), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 391/460 (85%), Positives = 429/460 (93%)
Query: 29 EIGSSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDL 88
++GSS+T+ERVAAAK+FIE+HY++Q KHIQERK+RR +LE+KLASS VPE+EQIN+LKDL
Sbjct: 32 DVGSSMTLERVAAAKKFIENHYRSQRKHIQERKERRLMLEKKLASSQVPEDEQINLLKDL 91
Query: 89 ERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRG 148
E KETEYMRLKRHKI VDDFDLLTIIGRGAFGEVRLC+EKKSGNIYAMKKLKKSEMLSRG
Sbjct: 92 ELKETEYMRLKRHKICVDDFDLLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEMLSRG 151
Query: 149 QVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVA 208
QVEHVRAERN+LAEVA IVKLYYSFQDAE+LYLIMEYLPGGD+MTLLMREETLTETVA
Sbjct: 152 QVEHVRAERNVLAEVACDFIVKLYYSFQDAEHLYLIMEYLPGGDIMTLLMREETLTETVA 211
Query: 209 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENE 268
RFYIA+SV+AIESIHKHNYIHRDIKPDNLLLDQ GHMKLSDFGLCKPLDC++LS+I+ENE
Sbjct: 212 RFYIAESVIAIESIHKHNYIHRDIKPDNLLLDQYGHMKLSDFGLCKPLDCSSLSSISENE 271
Query: 269 VLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL 328
+LDDENLN++MDVDG P GRRWKSPLEQLQHWQINRRKLA+STVGTPDYIAPEVLL
Sbjct: 272 ILDDENLNDTMDVDGALPNGRNGRRWKSPLEQLQHWQINRRKLAFSTVGTPDYIAPEVLL 331
Query: 329 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKD 388
KKGYG+ECDWWSLGAIMYEMLVGYPPFYSDDPV+TCRKIVHWKNHLKFPEE RLTPEAKD
Sbjct: 332 KKGYGVECDWWSLGAIMYEMLVGYPPFYSDDPVSTCRKIVHWKNHLKFPEEVRLTPEAKD 391
Query: 389 LICRLLCDVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKFDE 448
LICRLL V HRLGT G+E+IKAHPWFKD+ WD+LYEMEAA+KP+VNG LDTQNFMKFDE
Sbjct: 392 LICRLLSGVPHRLGTRGAEEIKAHPWFKDVMWDRLYEMEAAFKPQVNGELDTQNFMKFDE 451
Query: 449 VESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFEAVKGM 488
VE R+GSGP RK +LT +DLSFVGYTYKNF AVKGM
Sbjct: 452 VEQPKSTRSGSGPFRKKLLTSQDLSFVGYTYKNFAAVKGM 491
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359476253|ref|XP_002280119.2| PREDICTED: serine/threonine-protein kinase CBK1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 830 bits (2143), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/468 (83%), Positives = 431/468 (92%)
Query: 26 EEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINIL 85
EE +GSSLTME+VAAAKQFIE+HY+ QMK IQERK+RR VLER+LASSDVP+EEQIN++
Sbjct: 7 EEEVLGSSLTMEKVAAAKQFIENHYRTQMKTIQERKERRWVLERRLASSDVPKEEQINLI 66
Query: 86 KDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML 145
KDLERKETE+MRLKRHKI VDDF+LLTIIGRGAFGEVRLC+EKKS NIYAMKKLKKSEML
Sbjct: 67 KDLERKETEFMRLKRHKICVDDFELLTIIGRGAFGEVRLCREKKSENIYAMKKLKKSEML 126
Query: 146 SRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTE 205
RGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGD+MTLLMRE+TL+E
Sbjct: 127 IRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDMMTLLMREDTLSE 186
Query: 206 TVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265
+VA+FYIAQSVLAIESIHKHNYIHRDIKPDNLLLD+NGHMKLSDFGLCKPLDC LSA+
Sbjct: 187 SVAKFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDKNGHMKLSDFGLCKPLDCRTLSALK 246
Query: 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPE 325
E+EV+DDEN ESMD+DG FP++ WKSP EQLQHWQ+NRRKLA+STVGTPDYIAPE
Sbjct: 247 EDEVMDDENSRESMDIDGGFPDADNRSSWKSPREQLQHWQMNRRKLAFSTVGTPDYIAPE 306
Query: 326 VLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPE 385
VLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDP+TTCRKIVHWKNHLKFPE+ +LT E
Sbjct: 307 VLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMTTCRKIVHWKNHLKFPEDPKLTAE 366
Query: 386 AKDLICRLLCDVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMK 445
AKDLI RLLCDVEHRLGT G QIKAHPWFKD+ WDKLYEMEAA+KPEVNG LDT+NFMK
Sbjct: 367 AKDLIYRLLCDVEHRLGTGGVGQIKAHPWFKDVVWDKLYEMEAAFKPEVNGELDTRNFMK 426
Query: 446 FDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFEAVKGMHNRIG 493
FDE++ T R+GSGP RKM+LTPKDLSFVGYTYKNF+A+KG+ G
Sbjct: 427 FDELDPPTQARSGSGPSRKMLLTPKDLSFVGYTYKNFDALKGLRPSSG 474
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357449949|ref|XP_003595251.1| Serine/threonine protein kinase [Medicago truncatula] gi|355484299|gb|AES65502.1| Serine/threonine protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 826 bits (2134), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 388/469 (82%), Positives = 432/469 (92%)
Query: 25 EEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINI 84
E++ ++ S+LTMERVAAAK+FIESHYK+QMKHIQERK+RRSVL+++L SS VPEEEQIN+
Sbjct: 183 EDDEDVVSTLTMERVAAAKKFIESHYKSQMKHIQERKERRSVLQKELESSHVPEEEQINL 242
Query: 85 LKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM 144
LKDLE KETEYMRLKRHKI VDDFDLLTIIGRGAFGEVRLC+EKKSGNIYAMKKLKKSEM
Sbjct: 243 LKDLESKETEYMRLKRHKICVDDFDLLTIIGRGAFGEVRLCREKKSGNIYAMKKLKKSEM 302
Query: 145 LSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLT 204
LSRGQVEHVRAERN+LAEVA+ CIVKLYYSFQD E+LYLIMEYLPGGD+MTLLMREETLT
Sbjct: 303 LSRGQVEHVRAERNVLAEVANDCIVKLYYSFQDPEFLYLIMEYLPGGDIMTLLMREETLT 362
Query: 205 ETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264
E+VARFYIAQ+VLAIESIHKHNY+HRDIKPDNLLLD NGHMKLSDFGLCKPL+ +NLS I
Sbjct: 363 ESVARFYIAQTVLAIESIHKHNYVHRDIKPDNLLLDINGHMKLSDFGLCKPLEVSNLSPI 422
Query: 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAP 324
+E E+LDD+NLN++MDVDG +P S GRRWKSPLEQLQHWQ+NRRKLA+STVGTPDYIAP
Sbjct: 423 SEKEILDDDNLNDTMDVDGNYPNSRNGRRWKSPLEQLQHWQMNRRKLAFSTVGTPDYIAP 482
Query: 325 EVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTP 384
EVLLKKGYG+ECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTP
Sbjct: 483 EVLLKKGYGVECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTP 542
Query: 385 EAKDLICRLLCDVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFM 444
EAKDL+ RLL V HRLGT G+ +IK HPWF+D+ WD+LYE EAA+KP V G LDTQNFM
Sbjct: 543 EAKDLMHRLLSGVPHRLGTRGAREIKDHPWFRDVLWDRLYETEAAFKPRVVGELDTQNFM 602
Query: 445 KFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFEAVKGMHNRIG 493
KFDEVE P R+GSGP+RK +LTP+DLSFVGYTYKNF AVKG + +G
Sbjct: 603 KFDEVEQPVPARSGSGPIRKTLLTPQDLSFVGYTYKNFAAVKGKRHSVG 651
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 514 | ||||||
| TAIR|locus:2125894 | 519 | AT4G33080 [Arabidopsis thalian | 0.931 | 0.922 | 0.747 | 2e-198 | |
| TAIR|locus:2047590 | 527 | AT2G19400 [Arabidopsis thalian | 0.941 | 0.918 | 0.717 | 2.3e-190 | |
| TAIR|locus:2090925 | 568 | AT3G23310 [Arabidopsis thalian | 0.941 | 0.852 | 0.642 | 6.4e-170 | |
| TAIR|locus:2129650 | 551 | AT4G14350 [Arabidopsis thalian | 0.865 | 0.807 | 0.685 | 3.2e-168 | |
| TAIR|locus:2054784 | 569 | AT2G20470 [Arabidopsis thalian | 0.902 | 0.815 | 0.644 | 8.1e-163 | |
| TAIR|locus:2024167 | 569 | AT1G03920 [Arabidopsis thalian | 0.910 | 0.822 | 0.644 | 4.5e-162 | |
| TAIR|locus:2178208 | 516 | AT5G09890 [Arabidopsis thalian | 0.906 | 0.903 | 0.594 | 1.8e-151 | |
| TAIR|locus:2204574 | 562 | AT1G30640 [Arabidopsis thalian | 0.881 | 0.806 | 0.620 | 7.6e-151 | |
| CGD|CAL0006211 | 732 | CBK1 [Candida albicans (taxid: | 0.486 | 0.341 | 0.482 | 5.1e-106 | |
| UNIPROTKB|Q5AP53 | 732 | CBK1 "Serine/threonine-protein | 0.486 | 0.341 | 0.482 | 5.1e-106 |
| TAIR|locus:2125894 AT4G33080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1921 (681.3 bits), Expect = 2.0e-198, P = 2.0e-198
Identities = 368/492 (74%), Positives = 416/492 (84%)
Query: 4 QNIKVEEQGDDEGAPMAGEVLEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQERKQR 63
++I+ EE G DE EVL GSSLTME+VAAAKQ+IE+HYKAQ K+IQERK+R
Sbjct: 2 EDIQEEENGTDE------EVL------GSSLTMEKVAAAKQYIENHYKAQNKNIQERKER 49
Query: 64 RSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVR 123
R +LERKLASS VP+EEQIN++KDLERKETE+MRLKR+KISVDDF+LLTIIGRGAFGEVR
Sbjct: 50 RWILERKLASSGVPKEEQINMIKDLERKETEFMRLKRNKISVDDFELLTIIGRGAFGEVR 109
Query: 124 LCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL 183
LC+E+KSGNIYAMKKLKKSEM+ RGQVEHVRAERNLLAEV SH IVKLYYSFQD EYLYL
Sbjct: 110 LCRERKSGNIYAMKKLKKSEMVMRGQVEHVRAERNLLAEVESHYIVKLYYSFQDPEYLYL 169
Query: 184 IMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG 243
IMEYLPGGD+ VARFYIAQSVLAIESIH++NYIHRDIKPDNLLLD++G
Sbjct: 170 IMEYLPGGDMMTLLMREDTLREDVARFYIAQSVLAIESIHRYNYIHRDIKPDNLLLDKDG 229
Query: 244 HMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGCGRRWKSPLEQLQH 303
HMKLSDFGLCKPLDC NL +I MDVD FP++ R W+SP EQLQH
Sbjct: 230 HMKLSDFGLCKPLDCRNLPSIQENRATDDETMSEPMDVDRCFPDTDNKRSWRSPQEQLQH 289
Query: 304 WQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTT 363
WQ+NRRKLA+STVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY+DDP++T
Sbjct: 290 WQMNRRKLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPIST 349
Query: 364 CRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLG-SEQIKAHPWFKDIAWDK 422
CRKIVHW+NHLKFPE+A+ + EAKDLICRLLC+V+HRLGT G ++QIK HPWFKD+ W+K
Sbjct: 350 CRKIVHWRNHLKFPEDAKFSSEAKDLICRLLCNVDHRLGTGGGAQQIKDHPWFKDVVWEK 409
Query: 423 LYEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNF 482
LYEMEAAYKPEVN LDTQNFMKFDEV S P+RT SG RKM+L PKDLSFVGYTYKNF
Sbjct: 410 LYEMEAAYKPEVNDELDTQNFMKFDEVNSPAPERTRSGLSRKMLLAPKDLSFVGYTYKNF 469
Query: 483 EAVKGMHNRIGM 494
+AVKG+ + + M
Sbjct: 470 DAVKGLRHSLEM 481
|
|
| TAIR|locus:2047590 AT2G19400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1845 (654.5 bits), Expect = 2.3e-190, P = 2.3e-190
Identities = 353/492 (71%), Positives = 406/492 (82%)
Query: 8 VEEQGDDEG--APMAGEV---LEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQERKQ 62
+E Q +DE A + EV E+EG + +S T+E+VAAAK++IE+HY +M+HIQ+RK+
Sbjct: 1 MENQEEDEVVLAKVTSEVEDNFEDEGLVSNS-TLEKVAAAKKYIENHYNRRMRHIQQRKE 59
Query: 63 RRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEV 122
RR VLE+K+AS DV E+EQ+ +L+DL+RKETEY RL R+++ VDDFDLL+IIGRGAFGEV
Sbjct: 60 RRWVLEQKIASLDVSEKEQLELLEDLQRKETEYTRLMRNRLCVDDFDLLSIIGRGAFGEV 119
Query: 123 RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182
RLC+EKK+GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS CIVKLYYSFQD EYLY
Sbjct: 120 RLCREKKTGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASDCIVKLYYSFQDPEYLY 179
Query: 183 LIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN 242
LIMEYL GGDV VARFYIAQSVLAIESIHKHNY+HRDIKPDNLLLD+
Sbjct: 180 LIMEYLSGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYVHRDIKPDNLLLDKY 239
Query: 243 GHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGCGRRWKSPLEQLQ 302
GHMKLSDFGLCKPLDC N+SA+ S+D D GRRWKSPLEQLQ
Sbjct: 240 GHMKLSDFGLCKPLDCRNISAMNVNEPLNDENINESIDGDENCSIGRRGRRWKSPLEQLQ 299
Query: 303 HWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVT 362
HWQINRRKLAYSTVGTPDYIAPEVLLKKGYG+ECDWWSLGAIMYEMLVGYPPFYSDDPVT
Sbjct: 300 HWQINRRKLAYSTVGTPDYIAPEVLLKKGYGVECDWWSLGAIMYEMLVGYPPFYSDDPVT 359
Query: 363 TCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGT--LGSEQIKAHPWFKDIAW 420
TCRKIV W+ HL FPE ARLTPEA+DLICRLLCD EHRLG+ G+EQIKAH WFKD+ W
Sbjct: 360 TCRKIVSWRTHLVFPEGARLTPEARDLICRLLCDSEHRLGSHGAGAEQIKAHTWFKDVEW 419
Query: 421 DKLYEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYK 480
+KLYEM+AA+KP VNG LDTQNFMKFDEVE P RTGSGP K+ +TP++++FVGYTY+
Sbjct: 420 EKLYEMDAAFKPVVNGELDTQNFMKFDEVECPKPARTGSGPSWKVSITPQNINFVGYTYR 479
Query: 481 NFEAVKGMHNRI 492
NF+AV+G + +
Sbjct: 480 NFDAVRGSRHSL 491
|
|
| TAIR|locus:2090925 AT3G23310 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1652 (586.6 bits), Expect = 6.4e-170, P = 6.4e-170
Identities = 321/500 (64%), Positives = 392/500 (78%)
Query: 2 ENQNIKVEEQGD-DEGAPMAGEVLEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQER 60
++ N K +G+ EG+ AG EE S++T ++ AAAKQ+IE+HYK Q++ Q+R
Sbjct: 18 KSSNKKETSRGNVKEGSKTAGG---EEAV--SNVTKQKAAAAKQYIENHYKKQVQSQQQR 72
Query: 61 KQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFG 120
K+RR +LE KLA+++V EEEQ N+LKDLE+KETEYMR +RHK+ DDF+ LT+IG+GAFG
Sbjct: 73 KERRDMLENKLAAAEVSEEEQKNLLKDLEKKETEYMRRQRHKMGTDDFEPLTMIGKGAFG 132
Query: 121 EVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180
EVR+C+EK +GN+YAMKKLKKSEML RGQVEHV+AERNLLAEV S+CIVKLY SFQD EY
Sbjct: 133 EVRICREKTTGNVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDEEY 192
Query: 181 LYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD 240
LYLIMEYLPGGD+ ARFY+ ++VLAIESIHKHNYIHRDIKPDNLLLD
Sbjct: 193 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLD 252
Query: 241 QNGHMKLSDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGCGRRWKSPLEQ 300
++GHMKLSDFGLCKPLDC S + ++ DGR P + RR +S +EQ
Sbjct: 253 RSGHMKLSDFGLCKPLDC---SILQEKDFVVAHNLSGALQSDGR-PVAP--RRTRSQMEQ 306
Query: 301 LQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDP 360
LQ+WQ NRR LAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG+PPFYSD+P
Sbjct: 307 LQNWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGFPPFYSDEP 366
Query: 361 VTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFKDIAW 420
+TTCRKIV+WKN+LKFP+E RL+PEAKDLICRLLC+VE R+GT G+ +IK HPWF + W
Sbjct: 367 MTTCRKIVNWKNYLKFPDEVRLSPEAKDLICRLLCNVEQRIGTKGANEIKEHPWFSGVEW 426
Query: 421 DKLYEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYK 480
+KLY+M+AA+ P+VN LDTQNF KF+E + Q PK SGP RKM L+ KD++FVGYTYK
Sbjct: 427 EKLYQMKAAFIPQVNDELDTQNFEKFEETDKQVPKTPKSGPWRKM-LSSKDINFVGYTYK 485
Query: 481 NFEAVKGMHNRI-GMGILLK 499
N E V H+++ G+ L K
Sbjct: 486 NVEIVN--HDQLPGIAELKK 503
|
|
| TAIR|locus:2129650 AT4G14350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1636 (581.0 bits), Expect = 3.2e-168, P = 3.2e-168
Identities = 311/454 (68%), Positives = 368/454 (81%)
Query: 32 SSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERK 91
S++T E+ AAAK +IE+HYK QM+ +QERK+RR +LE+KLA+++V EEEQ N+LKDLE K
Sbjct: 43 SNITKEKAAAAKLYIENHYKMQMQSLQERKERRKMLEKKLAAAEVSEEEQNNLLKDLEMK 102
Query: 92 ETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE 151
ETEYMR +RHK+ DDF+ LT+IG+GAFGEVR+C+EK +GN+YAMKKLKKSEML RGQVE
Sbjct: 103 ETEYMRRQRHKMGADDFEPLTMIGKGAFGEVRICREKGTGNVYAMKKLKKSEMLRRGQVE 162
Query: 152 HVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY 211
HV+AERNLLAEV S+CIVKLY SFQD EYLYLIMEYLPGGD+ ARFY
Sbjct: 163 HVKAERNLLAEVDSNCIVKLYCSFQDEEYLYLIMEYLPGGDMMTLLMRKDTLTEDEARFY 222
Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXX 271
I ++VLAIESIHKHNYIHRDIKPDNLLLD++GHMKLSDFGLCKPLDC+NL
Sbjct: 223 IGETVLAIESIHKHNYIHRDIKPDNLLLDKDGHMKLSDFGLCKPLDCSNLQE---KDFTV 279
Query: 272 XXXXXXSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331
++ DGR P + RR + EQL +WQ NRR LAYSTVGTPDYIAPEVLLKKG
Sbjct: 280 ARNVSGALQSDGR-PVAT--RRTQQ--EQLLNWQRNRRMLAYSTVGTPDYIAPEVLLKKG 334
Query: 332 YGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLIC 391
YGMECDWWSLGAIMYEMLVG+PPFYSDDP+TTCRKIV+W+N+LKFP+E RL+PEAKDLIC
Sbjct: 335 YGMECDWWSLGAIMYEMLVGFPPFYSDDPMTTCRKIVNWRNYLKFPDEVRLSPEAKDLIC 394
Query: 392 RLLCDVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKFDEVES 451
RLLC+VE RLGT G+++IK HPWF+ W KLY+M+AA+ P+VN LDTQNF KF+E +
Sbjct: 395 RLLCNVEQRLGTKGADEIKGHPWFRGTEWGKLYQMKAAFIPQVNDELDTQNFEKFEETDK 454
Query: 452 QTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFEAV 485
Q PK SGP RKM L+ KD++FVGYTYKN E V
Sbjct: 455 QVPKSAKSGPWRKM-LSSKDINFVGYTYKNVEIV 487
|
|
| TAIR|locus:2054784 AT2G20470 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1585 (563.0 bits), Expect = 8.1e-163, P = 8.1e-163
Identities = 307/476 (64%), Positives = 372/476 (78%)
Query: 24 LEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQIN 83
+E + E S+ T ++VAAAKQ+IE+HYK QMK +QERK+RRS+LE+KLA +DV EE+Q N
Sbjct: 40 VETDEEAVSNTTKQKVAAAKQYIENHYKEQMKILQERKERRSMLEQKLADADVSEEDQNN 99
Query: 84 ILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSE 143
+LK LE+KETEYMRL+RHK+ V DFDLLT+IG+GAFGEVR+C+EK +G +YAMKKLKK+E
Sbjct: 100 LLKFLEKKETEYMRLQRHKLGVADFDLLTMIGKGAFGEVRVCREKTTGQVYAMKKLKKAE 159
Query: 144 MLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXX 203
ML RGQVEHVRAERNLLAEV S+ IVKLY SFQD ++LYL+MEYLPGGD+
Sbjct: 160 MLRRGQVEHVRAERNLLAEVDSNYIVKLYCSFQDDDHLYLVMEYLPGGDMMTLLMRKDTL 219
Query: 204 XXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
A+FY+A++VLAIESIH+HNYIHRDIKPDNLLLD+ GH++LSDFGLCKPLDC SA
Sbjct: 220 TEEEAKFYVAETVLAIESIHRHNYIHRDIKPDNLLLDRYGHLRLSDFGLCKPLDC---SA 276
Query: 264 IXXXXXXXXXXXXXSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIA 323
I + P+ ++ EQL+HWQ NRR LAYSTVGTPDYIA
Sbjct: 277 IGENDFSNNSNGSTEQEAGSTAPK-------RTQQEQLEHWQRNRRTLAYSTVGTPDYIA 329
Query: 324 PEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLT 383
PEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDP++TCRKIV+WK+HLKFPEEA L+
Sbjct: 330 PEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWKSHLKFPEEAILS 389
Query: 384 PEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNF 443
EAKDLI LLC V RLG+ G++++KAH WF+ + WD +++M+AA+ PEVN LDTQNF
Sbjct: 390 REAKDLINSLLCSVRRRLGSKGADELKAHTWFETVDWDTIFDMDAAFVPEVNDDLDTQNF 449
Query: 444 MKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFEAVKGMHNRIGMGILLK 499
KFDE ES+T + SGP RKM L+ KD++FVGYTYKNFE V + GM L K
Sbjct: 450 EKFDESESETQTSSKSGPWRKM-LSSKDINFVGYTYKNFEIVND-YQVPGMAELKK 503
|
|
| TAIR|locus:2024167 AT1G03920 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1578 (560.5 bits), Expect = 4.5e-162, P = 4.5e-162
Identities = 308/478 (64%), Positives = 369/478 (77%)
Query: 8 VEEQGDDEGAPMAGEVLEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVL 67
V + G+D L +GE S+ T ++VAAAKQ+IE+HYK QMK++ ERK+RR+ L
Sbjct: 37 VPDGGNDTETATKLPPLGGDGEALSNSTKQKVAAAKQYIENHYKEQMKNLNERKERRTTL 96
Query: 68 ERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQE 127
E+KLA +DV EE+Q N++K LE+KETEYMRL+RHK+ DDF+LLT+IG+GAFGEVR+ +E
Sbjct: 97 EKKLADADVCEEDQTNLMKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVVRE 156
Query: 128 KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY 187
+G+++AMKKLKKSEML RGQVEHVRAERNLLAEV S+CIVKLY SFQD EYLYLIMEY
Sbjct: 157 INTGHVFAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDNEYLYLIMEY 216
Query: 188 LPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKL 247
LPGGD+ A+FYIA+SVLAIESIH NYIHRDIKPDNLLLD+ GH++L
Sbjct: 217 LPGGDMMTLLMRKDTLSEDEAKFYIAESVLAIESIHNRNYIHRDIKPDNLLLDRYGHLRL 276
Query: 248 SDFGLCKPLDCTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGCGRRWKSPLEQLQHWQIN 307
SDFGLCKPLDC S I G ES +S EQL+HWQ N
Sbjct: 277 SDFGLCKPLDC---SVIDGEDFTVGNAGS------GGGSESVSTTPKRSQQEQLEHWQKN 327
Query: 308 RRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKI 367
RR LAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY+DDP++TCRKI
Sbjct: 328 RRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPMSTCRKI 387
Query: 368 VHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFKDIAWDKLYEME 427
V+WK HLKFPEE+RL+ A+DLI +LLC V RLG+ G+ QIKAHPWF+ + W+K+Y+ME
Sbjct: 388 VNWKTHLKFPEESRLSRGARDLIGKLLCSVNQRLGSTGASQIKAHPWFEGVQWEKIYQME 447
Query: 428 AAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFEAV 485
AA+ PEVN LDTQNF KFDE ++QT + +GP RKM L+ KD++FVGYTYKNFE V
Sbjct: 448 AAFIPEVNDDLDTQNFEKFDEEDNQTQAPSRTGPWRKM-LSSKDINFVGYTYKNFEIV 504
|
|
| TAIR|locus:2178208 AT5G09890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1478 (525.3 bits), Expect = 1.8e-151, P = 1.8e-151
Identities = 282/474 (59%), Positives = 353/474 (74%)
Query: 18 PMAGEVLEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVP 77
P G E + + S +T ++ AAAKQFIE+HYK ++ + ER +RR +RK+ + +P
Sbjct: 12 PGRGFETETDVAVSSPVTRQKAAAAKQFIENHYKNYLQGLHERMERRREFQRKVQEAQLP 71
Query: 78 EEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMK 137
EEQ ++++L R+ETEYMRL+R KI +DDF+LLT+IG+GAFGEVRLC+ + + +YAMK
Sbjct: 72 VEEQDEMMRNLARRETEYMRLQRRKIGIDDFELLTVIGKGAFGEVRLCRLRSTSEVYAMK 131
Query: 138 KLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXX 197
KLKK+EMLSRGQVEHVR+ERNLLAEV S IVKL+YSFQD+E LYLIMEYLPGGD+
Sbjct: 132 KLKKTEMLSRGQVEHVRSERNLLAEVDSRYIVKLFYSFQDSECLYLIMEYLPGGDIMTLL 191
Query: 198 XXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
VARFYIA+S+LAI SIH+HNY+HRDIKPDNL+LD++GH+KLSDFGLCKPLD
Sbjct: 192 MREDILSEDVARFYIAESILAIHSIHQHNYVHRDIKPDNLILDKSGHLKLSDFGLCKPLD 251
Query: 258 CTNLSAIXXXXXXXXXXXXXSMDVDGRFPESGCGRR-WKSPLEQLQHWQINRRKLAYSTV 316
S + S D + + +S + W+ P EQL W+ NRR LAYSTV
Sbjct: 252 DKYSSLLLEDDEML------SQDSENQSGKSDADKAPWQMPKEQLLQWKRNRRALAYSTV 305
Query: 317 GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKF 376
GT DY+APEVLLKKGYGMECDWWSLGAI+YEMLVGYPPF SDDP TCRKI++W+ LKF
Sbjct: 306 GTLDYMAPEVLLKKGYGMECDWWSLGAILYEMLVGYPPFCSDDPRITCRKIINWRVCLKF 365
Query: 377 PEEARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNG 436
PEE +++ EA+DLICRLLCDV+ RLGT G E+IK+HPWFK WDKLY+MEAAY+P V+G
Sbjct: 366 PEEPKISDEARDLICRLLCDVDSRLGTRGVEEIKSHPWFKGTPWDKLYDMEAAYRPIVDG 425
Query: 437 VLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFEAVKGMHN 490
LDTQNF KF EVE + GP RKM LT KD +F+G+T+K + + M +
Sbjct: 426 ELDTQNFEKFPEVEGSPSEAPQVGPWRKM-LTSKDTNFIGFTFKKSDITRSMES 478
|
|
| TAIR|locus:2204574 AT1G30640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1472 (523.2 bits), Expect = 7.6e-151, P = 7.6e-151
Identities = 284/458 (62%), Positives = 347/458 (75%)
Query: 32 SSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERK 91
S+ T ++VAAAKQ+IE+HYK Q K +QERK+RRS+LE+ LA +DV E++++ILK+ E+K
Sbjct: 44 SNATKQKVAAAKQYIENHYKIQKKSLQERKERRSILEQNLADADVTVEDKMDILKNFEKK 103
Query: 92 ETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE 151
E EYMRL+R K+ VDDF+LL+IIGRGAFGEVR+C+EK +G++YAMKKLKKSEML RGQVE
Sbjct: 104 EMEYMRLQRQKMGVDDFELLSIIGRGAFGEVRICKEKSTGSVYAMKKLKKSEMLRRGQVE 163
Query: 152 HVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVXXXXXXXXXXXXXVARFY 211
HV+AERN+LAEV S IVKL YSFQD E+LYLIMEYLPGGD+ RFY
Sbjct: 164 HVKAERNVLAEVDSPFIVKLCYSFQDDEHLYLIMEYLPGGDMMTLLMRKDTLREDETRFY 223
Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIXXXXXXX 271
+AQ++LAIESIHKHNY+HRDIKPDNLL+ +NGH+KLSDFGL K L+ N
Sbjct: 224 VAQTILAIESIHKHNYVHRDIKPDNLLITRNGHIKLSDFGLSKSLESKNFPDFKAELVDR 283
Query: 272 XXXXXXSMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331
D + P + RR + EQL HWQ NRR LA+STVGTPDYIAPEVLLKKG
Sbjct: 284 STKPAAEHDRLSKPPSAP--RRTQQ--EQLLHWQQNRRTLAFSTVGTPDYIAPEVLLKKG 339
Query: 332 YGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLIC 391
YGMECDWWSLGAIM+EMLVG+PPFYS++P+ TCRKIV+WK LKFP+EA+L+ E KDLI
Sbjct: 340 YGMECDWWSLGAIMFEMLVGFPPFYSEEPLATCRKIVNWKTCLKFPDEAKLSIEVKDLIR 399
Query: 392 RLLCDVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKFDEVES 451
RLLC+VE RLGT G +IKAHPWF+ + W++LYE A Y P+V LDTQNF KFDEV S
Sbjct: 400 RLLCNVEQRLGTKGVHEIKAHPWFRGVEWERLYESNAPYIPQVKHELDTQNFEKFDEVPS 459
Query: 452 QTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFEAVKGMH 489
+ S P RKM ++ KD +F+GYT+KN E V H
Sbjct: 460 TCQTSSKSSPWRKM-ISSKDANFLGYTFKNLEIVDEHH 496
|
|
| CGD|CAL0006211 CBK1 [Candida albicans (taxid:5476)] | Back alignment and assigned GO terms |
|---|
Score = 607 (218.7 bits), Expect = 5.1e-106, Sum P(2) = 5.1e-106
Identities = 122/253 (48%), Positives = 172/253 (67%)
Query: 3 NQNIKVEEQGDD-EGAPMAGEVLEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQERK 61
NQ++ E D G+ E + + S T ++ A+ K +E++Y + + H ER
Sbjct: 227 NQSVSTEAANSDMTGSNTKYVYFERKPNLLSKTTQDKAASIKLTLENYYTSSVSHAIERN 286
Query: 62 QRRSVLERKLASSDV--PEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAF 119
QRR LE K+A+ D+ EE + L++L +KE++++RLKR K++++DF + +IG+GAF
Sbjct: 287 QRRLELENKIANEDIGSSEERKNRQLQNLGKKESQFLRLKRTKLALEDFHTVKVIGKGAF 346
Query: 120 GEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE 179
GEVRL Q+K +G IYAMK L KSEM ++ Q+ HV+AER++LA S IV LYYSFQD++
Sbjct: 347 GEVRLVQKKDTGKIYAMKTLLKSEMFNKDQLAHVKAERDVLAGSDSPWIVALYYSFQDSQ 406
Query: 180 YLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL 239
YLYLIME+LPGGD+ + RFYIA+ VLAIE+IHK +IHRDIKPDN+L+
Sbjct: 407 YLYLIMEFLPGGDLMTMLIRWEVFTEDITRFYIAECVLAIEAIHKLGFIHRDIKPDNILI 466
Query: 240 DQNGHMKLSDFGL 252
D GH+KLSDFGL
Sbjct: 467 DNRGHVKLSDFGL 479
|
|
| UNIPROTKB|Q5AP53 CBK1 "Serine/threonine-protein kinase CBK1" [Candida albicans SC5314 (taxid:237561)] | Back alignment and assigned GO terms |
|---|
Score = 607 (218.7 bits), Expect = 5.1e-106, Sum P(2) = 5.1e-106
Identities = 122/253 (48%), Positives = 172/253 (67%)
Query: 3 NQNIKVEEQGDD-EGAPMAGEVLEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQERK 61
NQ++ E D G+ E + + S T ++ A+ K +E++Y + + H ER
Sbjct: 227 NQSVSTEAANSDMTGSNTKYVYFERKPNLLSKTTQDKAASIKLTLENYYTSSVSHAIERN 286
Query: 62 QRRSVLERKLASSDV--PEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAF 119
QRR LE K+A+ D+ EE + L++L +KE++++RLKR K++++DF + +IG+GAF
Sbjct: 287 QRRLELENKIANEDIGSSEERKNRQLQNLGKKESQFLRLKRTKLALEDFHTVKVIGKGAF 346
Query: 120 GEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE 179
GEVRL Q+K +G IYAMK L KSEM ++ Q+ HV+AER++LA S IV LYYSFQD++
Sbjct: 347 GEVRLVQKKDTGKIYAMKTLLKSEMFNKDQLAHVKAERDVLAGSDSPWIVALYYSFQDSQ 406
Query: 180 YLYLIMEYLPGGDVXXXXXXXXXXXXXVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL 239
YLYLIME+LPGGD+ + RFYIA+ VLAIE+IHK +IHRDIKPDN+L+
Sbjct: 407 YLYLIMEFLPGGDLMTMLIRWEVFTEDITRFYIAECVLAIEAIHKLGFIHRDIKPDNILI 466
Query: 240 DQNGHMKLSDFGL 252
D GH+KLSDFGL
Sbjct: 467 DNRGHVKLSDFGL 479
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9Y2H1 | ST38L_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.4845 | 0.8482 | 0.9396 | yes | no |
| Q7TSE6 | ST38L_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.4779 | 0.8482 | 0.9396 | yes | no |
| Q5R8M1 | STK38_PONAB | 2, ., 7, ., 1, 1, ., 1 | 0.4770 | 0.8560 | 0.9462 | yes | no |
| Q2L6W9 | SAX1_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.4342 | 0.8813 | 0.9516 | yes | no |
| Q2LZZ7 | TRC_DROPS | 2, ., 7, ., 1, 1, ., 1 | 0.4770 | 0.8463 | 0.9497 | yes | no |
| Q54IH8 | NDRB_DICDI | 2, ., 7, ., 1, 1, ., 1 | 0.4625 | 0.8599 | 0.8154 | yes | no |
| O13310 | ORB6_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.4577 | 0.8540 | 0.9360 | yes | no |
| Q9NBK5 | TRC_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.4770 | 0.8540 | 0.9481 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pm.C_LG_VI000411 | hypothetical protein (486 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 514 | |||
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.0 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-165 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-149 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-132 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-132 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-128 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-115 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-114 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-112 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-111 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-110 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-109 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-105 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-98 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-97 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-93 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-91 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-89 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-88 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-87 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-86 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-81 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-81 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-79 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-77 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-76 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-74 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-74 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-74 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-74 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-68 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-68 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-67 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-67 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-66 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-65 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-64 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-64 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-63 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-63 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-60 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-60 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-59 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-56 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-56 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-55 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-55 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-54 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-54 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-54 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-54 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-53 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-51 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-50 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-50 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-49 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-49 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-48 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-48 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-48 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-48 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-47 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-47 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-45 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-45 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-43 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-41 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-41 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-41 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-40 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-40 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-40 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-39 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-37 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-37 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-36 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-35 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-35 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-35 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-35 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-34 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-34 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-33 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-33 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-31 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-31 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-30 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-29 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-29 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-28 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-28 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-28 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-28 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-28 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-28 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-27 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-27 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-27 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-27 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-26 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-26 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-26 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-26 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-25 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-25 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-25 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-25 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-24 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-24 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-24 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-23 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-23 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-23 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-23 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-23 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-23 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-23 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-23 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-22 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-22 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-22 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-22 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-22 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-21 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-21 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-21 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-21 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-20 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-20 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-20 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-20 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-19 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-19 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-19 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-19 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-19 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-18 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-18 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-18 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-18 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-18 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-18 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-17 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-16 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-16 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-15 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-11 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-11 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-10 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-10 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-10 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-09 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-08 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-07 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-07 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-07 | |
| pfam00433 | 47 | pfam00433, Pkinase_C, Protein kinase C terminal do | 3e-07 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-07 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-07 | |
| smart00133 | 64 | smart00133, S_TK_X, Extension to Ser/Thr-type prot | 1e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-06 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-06 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-06 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-06 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-05 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-05 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-05 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-05 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-05 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-04 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-04 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-04 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-04 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-04 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-04 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.001 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.002 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 0.002 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 0.003 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 0.003 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.004 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 590 bits (1523), Expect = 0.0
Identities = 212/378 (56%), Positives = 267/378 (70%), Gaps = 14/378 (3%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
DDF+ + +IGRGAFGEVRL Q+K +G+IYAMKKL+KSEML + QV HVRAER++LAE +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
+VKLYYSFQD YLYLIMEYLPGGD+MTLLM+++T TE RFYIA+++LAI+SIHK
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
YIHRDIKPDNLLLD GH+KLSDFGLC L ++ + L+ ++ +
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE-------FYRILSHALPSNFLD 173
Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345
S + S + + W+ NRR LAYSTVGTPDYIAPEV L+ GY ECDWWSLG IM
Sbjct: 174 FIS----KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229
Query: 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLG 405
YEMLVGYPPF SD+P T RKI++WK L+FP+E L+PEAKDLI RL C+ E RLG G
Sbjct: 230 YEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNG 289
Query: 406 SEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKM 465
+IK+HP+FK + W+ + E A PE+ + DT NF F+E++ P G +
Sbjct: 290 VNEIKSHPFFKGVDWEHIRERPAPIIPELKSITDTSNFDDFEEIDLDVPTSPG---PPRG 346
Query: 466 MLTPKDLSFVGYTYKNFE 483
+ KDL+F+GYTYK FE
Sbjct: 347 KIKSKDLAFIGYTYKRFE 364
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 471 bits (1215), Expect = e-165
Identities = 190/375 (50%), Positives = 250/375 (66%), Gaps = 25/375 (6%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
DDF+++ +IGRGAFGEV L ++K +G +YAMK L+KS+M+ R Q+ HVRAER++LA+ S
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
IVKLYYSFQD E+LYL+MEY+PGGD+M LL+R++ E ARFYIA+ VLA++S+HK
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
+IHRDIKPDN+L+D +GH+KL+DFGLCK +N+ D + + F
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCK--------KMNKA---KDREYYLNDSHNLLF 169
Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345
++ RR RR A STVGTPDYIAPEVL YG+ECDWWSLG I+
Sbjct: 170 RDNVLVRRR---------DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVIL 220
Query: 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLG 405
YEML G+PPFYSD T KI++WK L+FP + ++PEA DLICRLLCD E RLG+
Sbjct: 221 YEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSF- 279
Query: 406 SEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKM 465
E+IK+HP+FK I W+ L E + + PE++ LDT N FD+ E K
Sbjct: 280 -EEIKSHPFFKGIDWENLRETKPPFVPELSSPLDTSN---FDDFEDDKDLSDYLSQNSKK 335
Query: 466 MLTPKDLSFVGYTYK 480
+ K L+FVG+TYK
Sbjct: 336 LNKGKQLAFVGFTYK 350
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 432 bits (1113), Expect = e-149
Identities = 187/385 (48%), Positives = 264/385 (68%), Gaps = 15/385 (3%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
+DF + +IG+GAFGEVRL Q+K +G IYAMK L KSEM + Q+ HV+AER++LAE S
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
+V LYYSFQDA+YLYLIME+LPGGD+MT+L++ +T +E V RFY+A+ VLAIE++HK
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA-----INENEVLDDENLNESMD 280
+IHRDIKPDN+L+D+ GH+KLSDFGL + SA + + + S+
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180
Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340
VD S +Q+ W+ NRR +AYSTVGTPDYIAPE+ L++GYG ECDWWS
Sbjct: 181 VDSINLTM-------SSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233
Query: 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHR 400
LGAIM+E L+G+PPF S++ T RKI++W+ L FP++ L+ EA+DLI RL+ + E+R
Sbjct: 234 LGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENR 293
Query: 401 LGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKFDEVES--QTPKRTG 458
LG G+ +IK+HP+F+ + WD + ++ A + P++ + DT F DE+E + P
Sbjct: 294 LGRGGAHEIKSHPFFRGVDWDTIRQIRAPFIPQLKSITDTSYF-PTDELEQVPEAPALKQ 352
Query: 459 SGPMRKMMLTPKDLSFVGYTYKNFE 483
+ P ++ DL+F+GYTYK F+
Sbjct: 353 AAPAQQEESVELDLAFIGYTYKRFD 377
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 388 bits (998), Expect = e-132
Identities = 194/378 (51%), Positives = 254/378 (67%), Gaps = 18/378 (4%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
DDF+ L +IGRGAFGEVRL Q+K +G+IYAMK L+K++ML + QV H+RAER++L E
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
+VK++YSFQD LYLIME+LPGGD+MTLLM+++TL+E +FYIA++VLAI++IH+
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
+IHRDIKPDNLLLD GH+KLSDFGL CT L + E NL + D F
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGL-----CTGLKKAHRTEFY--RNLTHNPPSDFSF 173
Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345
R+ ++ W+ NRR+LAYSTVGTPDYIAPEV ++ GY CDWWSLG IM
Sbjct: 174 QNMNSKRKAET-------WKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLG 405
YEML+GYPPF S+ P T RK+++WK L FP E ++ +AKDLI R D E+R+G+ G
Sbjct: 227 YEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNG 286
Query: 406 SEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKM 465
E+IK+HP+F+ + W + E AA E+ + DT NF +F E + P P K
Sbjct: 287 VEEIKSHPFFEGVDWGHIRERPAAIPIEIKSIDDTSNFDEFPESDILQPAENTIEPDYK- 345
Query: 466 MLTPKDLSFVGYTYKNFE 483
KD F+ YTYK FE
Sbjct: 346 ---SKDWVFLNYTYKRFE 360
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 387 bits (996), Expect = e-132
Identities = 193/378 (51%), Positives = 257/378 (67%), Gaps = 15/378 (3%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
+DF+ L +IGRGAFGEVRL Q+K +G++YAMK L+K++ML + QV H+RAER++L E S
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
+VK++YSFQD LYLIME+LPGGD+MTLLM+++TLTE +FYIA++VLAI+SIH+
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
+IHRDIKPDNLLLD GH+KLSDFGL CT L + E NLN S+ D F
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGL-----CTGLKKAHRTEFY--RNLNHSLPSDFTF 173
Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345
R+ ++ W+ NRR+LA+STVGTPDYIAPEV ++ GY CDWWSLG IM
Sbjct: 174 QNMNSKRKAET-------WKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLG 405
YEML+GYPPF S+ P T +K+++WK L FP E ++ +AKDLI R C+ EHR+G G
Sbjct: 227 YEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPG 286
Query: 406 SEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKM 465
E+IK +P+F+ + W+ + E AA E+ + DT NF +F + + P S +
Sbjct: 287 VEEIKTNPFFEGVDWEHIRERPAAIPIEIKSIDDTSNFDEFPDSDILKPTVATSN-HPET 345
Query: 466 MLTPKDLSFVGYTYKNFE 483
KD F+ YTYK FE
Sbjct: 346 DYKNKDWVFINYTYKRFE 363
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 377 bits (971), Expect = e-128
Identities = 171/382 (44%), Positives = 240/382 (62%), Gaps = 16/382 (4%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
F + IG GAFGEV L ++ + +YAMK L+K+++L R Q HV+AER++LAE +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
+VKLYYSFQD + LY +M+Y+PGGD+M+LL+R E +ARFYIA+ AIES+HK +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
IHRDIKPDN+L+D++GH+KL+DFGLC T+ S + D + +SM+ + E
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQK---GDHHRQDSMEPSEEWSE 179
Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 347
R PLE+ + Q ++R LA+S VGTP+YIAPEVLL+ GY CDWWS+G I+YE
Sbjct: 180 I--DRCRLKPLERRRKRQ-HQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236
Query: 348 MLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLGSE 407
MLVG PPF +D P T K+++W+ L P +A+L+ EA DLI RL C E RLG G++
Sbjct: 237 MLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGAD 296
Query: 408 QIKAHPWFKDIAWDKLY-EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMM 466
+IKAHP+FK I + L +A Y P++ DT N FD V+ + + SG
Sbjct: 297 EIKAHPFFKGIDFASLIRRQKAPYIPKITHPTDTSN---FDPVDPEKLRSDDSGESSPDR 353
Query: 467 LTPKDLS------FVGYTYKNF 482
+ F +T++ F
Sbjct: 354 NVKPNNRKRTEHAFYEFTFRRF 375
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 340 bits (875), Expect = e-115
Identities = 128/303 (42%), Positives = 178/303 (58%), Gaps = 54/303 (17%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
+G+G+FG+V L ++K +G +YAMK LKK +++ R +VEH ERN+L+ + IVKL+Y
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIK 233
+FQ E LYL++EY PGG++ + L +E +E ARFY A+ VLA+E +H I+RD+K
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 234 PDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRR 293
P+N+LLD +GH+KL+DFGL K L
Sbjct: 121 PENILLDADGHIKLTDFGLAKEL------------------------------------- 143
Query: 294 WKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 353
+ + GTP+Y+APEVLL KGYG DWWSLG ++YEML G P
Sbjct: 144 ------------SSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKP 191
Query: 354 PFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412
PFY++D KI+ L+FPE L+PEA+DLI LL D RLG+ G+E+IKAH
Sbjct: 192 PFYAEDRKEIYEKILKDP--LRFPE--FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247
Query: 413 PWF 415
P+F
Sbjct: 248 PFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 343 bits (880), Expect = e-114
Identities = 169/354 (47%), Positives = 235/354 (66%), Gaps = 6/354 (1%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
F + +G GAFGEV L + + +YAMK L+K ++L+R QV HV+AER++LAE +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
+VKLYYSFQD + LY +M+Y+PGGD+M+LL+R E E +ARFYIA+ LAIES+HK +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
IHRDIKPDN+L+D +GH+KL+DFGLC T+ S + ++ E D+
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 347
CG R K+ LEQ Q ++R LA+S VGTP+YIAPEVLL+KGY CDWWS+G I++E
Sbjct: 183 CRCGDRLKT-LEQRATKQ-HQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240
Query: 348 MLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLGSE 407
MLVG PPF + P T K+++W+N L P + +L+PEA DLI +L C E RLG G++
Sbjct: 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD 300
Query: 408 QIKAHPWFKDIAWDK-LYEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSG 460
IKAHP+F ++ + + A Y P+++ +DT N FD VE ++P SG
Sbjct: 301 DIKAHPFFSEVDFSSDIRTQPAPYVPKISHPMDTSN---FDPVEEESPWNDASG 351
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 334 bits (859), Expect = e-112
Identities = 137/346 (39%), Positives = 191/346 (55%), Gaps = 61/346 (17%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
DDF+ + +G G+FG V L + K SG YA+K L K++++ QVEHV E+ +L +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
+V LY SFQD LYL+MEY+PGG++ + L + E VARFY AQ VLA+E +H
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
+ ++RD+KP+NLLLD +G++K++DFG K V GR
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAK-------------------------RVKGR- 154
Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345
Y+ GTP+Y+APE++L KGYG DWW+LG ++
Sbjct: 155 --------------------------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILI 188
Query: 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLL-CDVEHRLGTL 404
YEML GYPPF+ D+P+ KI+ + ++FP +P+AKDLI LL D+ RLG L
Sbjct: 189 YEMLAGYPPFFDDNPIQIYEKIL--EGKVRFPSF--FSPDAKDLIRNLLQVDLTKRLGNL 244
Query: 405 --GSEQIKAHPWFKDIAWDKLYEM--EAAYKPEVNGVLDTQNFMKF 446
G IK HPWF I W L + EA + P+V G DT NF +
Sbjct: 245 KNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVKGPGDTSNFDDY 290
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 332 bits (853), Expect = e-111
Identities = 160/382 (41%), Positives = 211/382 (55%), Gaps = 60/382 (15%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
DDF++L +IGRGAFGEV + + K +G +YAMK L K EML R + R ER++L
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHK 224
I L+Y+FQD LYL+M+Y GGD++TLL + E+ L E +ARFY+A+ VLAI+S+H+
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
Y+HRDIKPDN+LLD+NGH++L+DFG C + DG
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCL-----------------------RLLADGT 157
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----KKGYGMECDWW 339
+ VGTPDYI+PE+L K YG ECDWW
Sbjct: 158 VQSN-------------------------VAVGTPDYISPEILQAMEDGKGRYGPECDWW 192
Query: 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPE-AKDLICRLLCDVE 398
SLG MYEML G PFY++ V T KI++ K H +FP + E AKDLI RL+C E
Sbjct: 193 SLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPE 252
Query: 399 HRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTG 458
RLG G + K HP+F+ I WD + A Y PEV+ DT NF +V+ + T
Sbjct: 253 TRLGRNGLQDFKDHPFFEGIDWDNIRNSTAPYVPEVSSPTDTSNF----DVDDDDLRNTE 308
Query: 459 S-GPMRKMMLTPKDLSFVGYTY 479
S P + L FVG+TY
Sbjct: 309 SLPPSSHGAFSGNHLPFVGFTY 330
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 332 bits (854), Expect = e-110
Identities = 163/405 (40%), Positives = 228/405 (56%), Gaps = 60/405 (14%)
Query: 83 NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
NI L R E ++ + ++ +DFD++ +IGRGAFGEV+L + K S +YAMK L K
Sbjct: 20 NIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF 79
Query: 143 EMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREET 202
EM+ R ER+++A S IV+L+Y+FQD +YLY++MEY+PGGD++ LM
Sbjct: 80 EMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYD 138
Query: 203 LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262
+ E ARFY A+ VLA+++IH +IHRD+KPDN+LLD++GH+KL+DFG C
Sbjct: 139 IPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM-------- 190
Query: 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYI 322
MD +G + VGTPDYI
Sbjct: 191 ---------------KMDANGMVRCD-------------------------TAVGTPDYI 210
Query: 323 APEVLLKKG----YGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPE 378
+PEVL +G YG ECDWWS+G +YEMLVG PFY+D V T KI+ KN L FP+
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPD 270
Query: 379 EARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFK--DIAWDKLYEMEAAYKPEVNG 436
+ ++ +AKDLIC L D E RLG G ++IK+HP+FK +D + E A PE++
Sbjct: 271 DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTFDNIRETVAPVVPELSS 330
Query: 437 VLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKN 481
+DT N FD++E K + P+ K L F+G+TY
Sbjct: 331 DIDTSN---FDDIEDDD-KNEETFPLPK-AFAGNQLPFIGFTYSK 370
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 330 bits (848), Expect = e-109
Identities = 164/344 (47%), Positives = 229/344 (66%), Gaps = 9/344 (2%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
F + +G GAFGEV L ++ + +YAMK L+K ++L R QV HV+AER++LAE +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
+V+LYYSFQD + LY +M+Y+PGGD+M+LL+R E +ARFYIA+ A+ES+HK +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
IHRDIKPDN+L+D++GH+KL+DFGLC T+ S ++ D +SMD + +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQS---GDHVRQDSMDFSNEWGD 179
Query: 288 SG---CGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344
CG R K PLE+ Q ++R LA+S VGTP+YIAPEVLL+ GY CDWWS+G I
Sbjct: 180 PANCRCGDRLK-PLERRAARQ-HQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237
Query: 345 MYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTL 404
+YEMLVG PPF + P+ T K+++W+ L P +A+L+PEA DLI +L E RLG
Sbjct: 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKN 297
Query: 405 GSEQIKAHPWFKDIAWDK-LYEMEAAYKPEVNGVLDTQNFMKFD 447
G+++IKAHP+FK I + L + A Y P++ DT NF D
Sbjct: 298 GADEIKAHPFFKTIDFSSDLRQQSAPYIPKITHPTDTSNFDPVD 341
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 314 bits (806), Expect = e-105
Identities = 134/308 (43%), Positives = 184/308 (59%), Gaps = 44/308 (14%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
I +GA+G V L ++K +G+IYA+K +KK++M+ + QV+ V ER++L++ S +VKLYY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIK 233
SFQ + LYL+MEYLPGGD+ +LL +L E VAR YIA+ VLA+E +H + IHRD+K
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 234 PDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRR 293
PDN+L+D NGH+KL+DFGL K G RR
Sbjct: 121 PDNILIDSNGHLKLTDFGLSK---------------------------------VGLVRR 147
Query: 294 WKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 353
Q + K VGTPDYIAPEV+L +G+ DWWSLG I+YE LVG P
Sbjct: 148 --------QINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIP 199
Query: 354 PFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412
PF+ + P + I+ +++PE+ ++ EA DLI +LL D E RLG E+IK H
Sbjct: 200 PFHGETPEEIFQNIL--NGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257
Query: 413 PWFKDIAW 420
P+FK I W
Sbjct: 258 PFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 299 bits (768), Expect = 3e-98
Identities = 145/383 (37%), Positives = 212/383 (55%), Gaps = 63/383 (16%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
DFD+ +++GRG FGEV++ +EK +G+IYAMK +KKS +L++ V ER++L+ S
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHK 224
I +L Y+FQD + LYL+MEY PGGD+++LL R E+ E +A+FY+A+ VLAI S+H+
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
Y+HRDIKP+N+L+D+ GH+KL+DFG L
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLT--------------------------- 153
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL------KKGYGMECDW 338
N+ + VGTPDYIAPEVL K YG+ECDW
Sbjct: 154 ---------------------ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDW 192
Query: 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVE 398
WSLG I YEM+ G PF+ T I++++ LKFPE+ +++ + DLI LLC +
Sbjct: 193 WSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLCGQK 252
Query: 399 HRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTG 458
RLG E + HP+F I W+ + + P + DT N FDE E + +R+
Sbjct: 253 ERLGY---EGLCCHPFFSKIDWNNIRNSLPPFVPTLKSDDDTSN---FDEPEKNSTRRSQ 306
Query: 459 SGP--MRKMMLTPKDLSFVGYTY 479
S ++ + KDL FVG+++
Sbjct: 307 SSTTQLKPNGFSGKDLPFVGFSF 329
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 294 bits (755), Expect = 2e-97
Identities = 112/309 (36%), Positives = 167/309 (54%), Gaps = 56/309 (18%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
+++L +G G+FG+V L ++KK+G + A+K +KK ++ + E + E +L ++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKLKHPN 58
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
IV+LY F+D + LYL+MEY GGD+ LL + L+E ARFY+ Q + A+E +H
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
+HRD+KP+N+LLD++GH+KL+DFGL +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR--------------------------------- 145
Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 347
Q++ + + VGTP+Y+APEVLL KGYG D WSLG I+YE
Sbjct: 146 -----------------QLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYE 188
Query: 348 MLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGS 406
+L G PPF DD + K + P E ++PEAKDLI +LL D E R L +
Sbjct: 189 LLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKR---LTA 245
Query: 407 EQIKAHPWF 415
E+ HP+F
Sbjct: 246 EEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 288 bits (737), Expect = 1e-93
Identities = 162/384 (42%), Positives = 214/384 (55%), Gaps = 64/384 (16%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
DDF+++ +IGRGAFGEV + + K + IYAMK L K EML R + R ERN+L
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHK 224
I L+Y+FQD YLYL+M+Y GGD++TLL + E+ L E +ARFYIA+ VLAI SIH+
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
+Y+HRDIKPDN+LLD NGH++L+DFG C M+ DG
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCL-----------------------KMNQDGT 157
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL--LKKG---YGMECDWW 339
S VGTPDYI+PE+L ++ G YG ECDWW
Sbjct: 158 VQSS-------------------------VAVGTPDYISPEILQAMEDGMGKYGPECDWW 192
Query: 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEE-ARLTPEAKDLICRLLCDVE 398
SLG MYEML G PFY++ V T KI++ + +FP ++ EAKDLI RL+C E
Sbjct: 193 SLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRE 252
Query: 399 HRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKFDEVESQT---PK 455
RLG G E K H +F+ I W+ + +EA Y P+V+ DT NF D+V P
Sbjct: 253 RRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIPDVSSPSDTSNFDVDDDVLRNPEIAPP 312
Query: 456 RTGSGPMRKMMLTPKDLSFVGYTY 479
+ +G + L FVG+TY
Sbjct: 313 SSHTG------FSGLHLPFVGFTY 330
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 281 bits (721), Expect = 8e-91
Identities = 157/403 (38%), Positives = 227/403 (56%), Gaps = 60/403 (14%)
Query: 83 NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
NI L R E ++++ ++ +D+D++ +IGRGAFGEV+L + K S +YAMK L K
Sbjct: 20 NIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKF 79
Query: 143 EMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREET 202
EM+ R ER+++A S +V+L+ +FQD +YLY++MEY+PGGD++ LM
Sbjct: 80 EMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYD 138
Query: 203 LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262
+ E A+FY A+ VLA+++IH IHRD+KPDN+LLD++GH+KL+DFG C +D T +
Sbjct: 139 VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198
Query: 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYI 322
+ + VGTPDYI
Sbjct: 199 RCD------------------------------------------------TAVGTPDYI 210
Query: 323 APEVLLKKG----YGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPE 378
+PEVL +G YG ECDWWS+G ++EMLVG PFY+D V T KI+ KN L FPE
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPE 270
Query: 379 EARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFKDIA--WDKLYEMEAAYKPEVNG 436
+ ++ AK+LIC L D E RLG G E+IK HP+FK+ WD + E A PE++
Sbjct: 271 DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSS 330
Query: 437 VLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTY 479
+D+ N FD++E + P+ K + L F+G+TY
Sbjct: 331 DIDSSN---FDDIEDDKGD-VETFPIPKAFVG-NQLPFIGFTY 368
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 276 bits (707), Expect = 4e-89
Identities = 156/382 (40%), Positives = 216/382 (56%), Gaps = 60/382 (15%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
+DF++L +IGRGAFGEV + + K + ++AMK L K EML R + R ER++L +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHK 224
I L+Y+FQD LYL+M+Y GGD++TLL + E+ L E +ARFY+A+ V+AI+S+H+
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
+Y+HRDIKPDN+L+D NGH++L+DFG C L ++D + S+
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKL-------------MEDGTVQSSV----- 162
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----KKGYGMECDWW 339
VGTPDYI+PE+L K YG ECDWW
Sbjct: 163 ------------------------------AVGTPDYISPEILQAMEDGKGKYGPECDWW 192
Query: 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEAR-LTPEAKDLICRLLCDVE 398
SLG MYEML G PFY++ V T KI++ K +FP + ++ +AKDLI RL+C E
Sbjct: 193 SLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSRE 252
Query: 399 HRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTG 458
HRLG G E K HP+F I WD + EA Y PEV+ DT NF +V+ K +
Sbjct: 253 HRLGQNGIEDFKQHPFFTGIDWDNIRNCEAPYIPEVSSPTDTSNF----DVDDDCLKNSE 308
Query: 459 S-GPMRKMMLTPKDLSFVGYTY 479
+ P + L FVG+TY
Sbjct: 309 TMPPPSHTAFSGHHLPFVGFTY 330
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 274 bits (702), Expect = 5e-88
Identities = 157/403 (38%), Positives = 229/403 (56%), Gaps = 60/403 (14%)
Query: 83 NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
NI L R + +++ ++ +D++++ +IGRGAFGEV+L + K + +YAMK L K
Sbjct: 20 NIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF 79
Query: 143 EMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREET 202
EM+ R ER+++A S +V+L+Y+FQD YLY++MEY+PGGD++ LM
Sbjct: 80 EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYD 138
Query: 203 LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262
+ E ARFY A+ VLA+++IH +IHRD+KPDN+LLD++GH+KL+DFG C
Sbjct: 139 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM-------- 190
Query: 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYI 322
M+ +G + R A T PDYI
Sbjct: 191 ---------------KMNKEG----------------------MVRCDTAVGT---PDYI 210
Query: 323 APEVLLKKG----YGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPE 378
+PEVL +G YG ECDWWS+G +YEMLVG PFY+D V T KI++ KN L FP+
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 270
Query: 379 EARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFKD--IAWDKLYEMEAAYKPEVNG 436
+ ++ EAK+LIC L D E RLG G E+IK H +FK+ AW+ L + A P+++
Sbjct: 271 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSS 330
Query: 437 VLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTY 479
+DT N FD++E + + P+ K + L FVG+TY
Sbjct: 331 DIDTSN---FDDIEEDKGEEE-TFPIPKAFVG-NQLPFVGFTY 368
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 269 bits (691), Expect = 1e-87
Identities = 115/314 (36%), Positives = 160/314 (50%), Gaps = 57/314 (18%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
+G G FG V L + K +A+K +KK ++ GQ EH+ +E+ +L E IVKLY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIK 233
+F+D +Y+Y++MEY GG++ T+L E ARFYIA VLA E +H I+RD+K
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 234 PDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRR 293
P+NLLLD NG++KL DFG K L G++
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKL--------------------------------KSGQK 148
Query: 294 WKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 353
++ GTP+Y+APE++L KGY D+WSLG ++YE+L G P
Sbjct: 149 ------------------TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRP 190
Query: 354 PFYSD--DPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCD-VEHRLGTL--GSEQ 408
PF D DP+ I+ L+FP + AKDLI +LL E RLG L G +
Sbjct: 191 PFGEDDEDPMEIYNDILKGNGKLEFPN--YIDKAAKDLIKQLLRRNPEERLGNLKGGIKD 248
Query: 409 IKAHPWFKDIAWDK 422
IK H WF W+
Sbjct: 249 IKKHKWFNGFDWEG 262
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 265 bits (678), Expect = 9e-86
Identities = 125/312 (40%), Positives = 177/312 (56%), Gaps = 59/312 (18%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAER-NLLAEVASHCIVKLY 172
I +GAFG V L +++ +G+ +A+K LKKS+M+++ QV +V+AER ++ + S + KLY
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 173 YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDI 232
YSFQ +YLYL+MEYL GGD +L+ L E A+ YIA+ VL +E +H+ IHRDI
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123
Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGR 292
KP+NLL+DQ GH+KL+DFG L+ + + +F
Sbjct: 124 KPENLLIDQTGHLKLTDFG-----------------------LSRNGLENKKF------- 153
Query: 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 352
VGTPDY+APE +L G DWWSLG +++E L GY
Sbjct: 154 -----------------------VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGY 190
Query: 353 PPFYSDDPVTTCRKIVHWKNHLKFPEEAR--LTPEAKDLICRLLC-DVEHRLGTLGSEQI 409
PPF+++ P I+ + +PEE + +PEA DLI RLLC D RLG G ++I
Sbjct: 191 PPFHAETPDAVFDNILS--RRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248
Query: 410 KAHPWFKDIAWD 421
K+HP+FK I WD
Sbjct: 249 KSHPFFKSINWD 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 254 bits (650), Expect = 3e-81
Identities = 120/313 (38%), Positives = 179/313 (57%), Gaps = 36/313 (11%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
DDF IIG G+F V L +EK++ YA+K L K +++ +V++V+ E+ +L +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 166 H-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK 224
H I+KLYY+FQD E LY ++EY P G+++ + + +L E RFY A+ +LA+E +H
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
IHRD+KP+N+LLD++ H+K++DFG K VLD + ES D
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAK--------------VLDPNSSPESNKGDAT 166
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344
+S + NRR+ A S VGT +Y++PE+L +K G D W+LG I
Sbjct: 167 NIDS--------------QIEKNRRRFA-SFVGTAEYVSPELLNEKPAGKSSDLWALGCI 211
Query: 345 MYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT 403
+Y+ML G PPF + T +KI+ K FP P+AKDLI +LL D + RLG
Sbjct: 212 IYQMLTGKPPFRGSNEYLTFQKIL--KLEYSFPP--NFPPDAKDLIEKLLVLDPQDRLGV 267
Query: 404 -LGSEQIKAHPWF 415
G +++KAHP+F
Sbjct: 268 NEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 254 bits (650), Expect = 8e-81
Identities = 113/344 (32%), Positives = 171/344 (49%), Gaps = 38/344 (11%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
F + ++G+G G V L + K +G ++A+K L K EM+ R +V+ V E+ +LA +
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREET--LTETVARFYIAQSVLAIESIH 223
+ LY SFQ YL L+M+Y PGG++ LL R+ L+E VARFY A+ +LA+E +H
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDG 283
++RD+KP+N+LL ++GH+ LSDF L K D
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP--------------------- 159
Query: 284 RFPESGCGRRWKSPLEQLQHWQINRRKLAYST------VGTPDYIAPEVLLKKGYGMECD 337
G R S + + VGT +YIAPEV+ G+G D
Sbjct: 160 VSKALRKGSRRSSVNSIP-----SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVD 214
Query: 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-D 396
WW+LG ++YEML G PF + T I+ + FP ++ A+DLI +LL D
Sbjct: 215 WWTLGILLYEMLYGTTPFKGSNRDETFSNILK--KEVTFPGSPPVSSSARDLIRKLLVKD 272
Query: 397 VEHRLGT-LGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLD 439
RLG+ G+ +IK HP+F+ + W + P + +D
Sbjct: 273 PSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPRPDDGID 316
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 248 bits (635), Expect = 6e-79
Identities = 116/343 (33%), Positives = 182/343 (53%), Gaps = 61/343 (17%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
DD + + +G G FG V L +++ S + YA+K + E++ Q +HV E+ +L EV+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
I++L+++ D +LY++MEY+PGG++ + L + + FY ++ V A+E +H
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
++RD+KP+N+LLD+ GH+KL+DFG K ++ D
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAK-------------KLRD-------------- 153
Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345
R W + GTP+Y+APEV+ KG+ DWW+LG ++
Sbjct: 154 ------RTW-------------------TLCGTPEYLAPEVIQSKGHNKAVDWWALGILI 188
Query: 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLL-CDVEHRLGTL 404
YEMLVGYPPF+ D+P KI+ K L+FP L AKDLI +LL D RLG +
Sbjct: 189 YEMLVGYPPFFDDNPFGIYEKILAGK--LEFPRH--LDLYAKDLIKKLLVVDRTRRLGNM 244
Query: 405 --GSEQIKAHPWFKDIAWDKLYEM--EAAYKPEVNGVLDTQNF 443
G++ +K H WFK + WD + + + P+V+ DT NF
Sbjct: 245 KNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVSHDGDTSNF 287
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 243 bits (623), Expect = 8e-77
Identities = 134/380 (35%), Positives = 198/380 (52%), Gaps = 71/380 (18%)
Query: 111 LTIIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVE--HVRAERNLLAEVAS 165
L ++G+G +G+V R +G I+AMK LKK+ + R Q + H +AERN+L V
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKA-TIVRNQKDTAHTKAERNILEAVKH 59
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
IV L Y+FQ LYLI+EYL GG++ L RE E A FY+++ LA+E +H+
Sbjct: 60 PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
I+RD+KP+N+LLD GH+KL+DFGLCK +I+E V
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGLCK-------ESIHEGTV---------------- 156
Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345
++ GT +Y+APE+L++ G+G DWWSLGA+M
Sbjct: 157 --------------------------THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALM 190
Query: 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL 404
Y+ML G PPF +++ T KI+ K L P LTPEA+DL+ +LL + RLG
Sbjct: 191 YDMLTGAPPFTAENRKKTIDKIL--KGKLNLP--PYLTPEARDLLKKLLKRNPSSRLGAG 246
Query: 405 GS--EQIKAHPWFKDIAWDKLY--EMEAAYKPEVNGVLDTQNF-MKFDEVESQTPKRTGS 459
++++HP+F+ + WD L ++E +KP + D F KF QTP +
Sbjct: 247 PGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFDSKFTR---QTPVDS-- 301
Query: 460 GPMRKMMLTPKDLSFVGYTY 479
P + + F+G+TY
Sbjct: 302 -PDDSTLSESANQIFLGFTY 320
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 241 bits (616), Expect = 6e-76
Identities = 120/341 (35%), Positives = 192/341 (56%), Gaps = 40/341 (11%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
+DF+ + +I GA+G V L + K++ +AMKK+ K ++ R Q++ V ER++L +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
+V ++ SF+ +L ++MEY+ GGD TLL L +AR Y A++VLA+E +H +
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNE-SMDVDGR 284
+HRD+KPDNLL+ GH+KL+DFGL K + +L+ NL E ++ D R
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSK-IGLMSLTT----------NLYEGHIEKDTR 169
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344
+ Q+ GTP+YIAPEV+L++GYG DWW++G I
Sbjct: 170 ---------------EFLDKQV---------CGTPEYIAPEVILRQGYGKPVDWWAMGII 205
Query: 345 MYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPE-EARLTPEAKDLICRLL-CDVEHRLG 402
+YE LVG PF+ D P +++ + +++PE + L +A+DLI RLL + RLG
Sbjct: 206 LYEFLVGCVPFFGDTPEELFGQVI--SDDIEWPEGDEALPADAQDLISRLLRQNPLERLG 263
Query: 403 TLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNF 443
T G+ ++K H +F + W+ L +A + P++ DT F
Sbjct: 264 TGGAFEVKQHRFFLGLDWNGLLRQKAEFIPQLESEDDTSYF 304
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 238 bits (609), Expect = 1e-74
Identities = 127/376 (33%), Positives = 188/376 (50%), Gaps = 62/376 (16%)
Query: 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVK 170
+IG+G+FG+V L + K G YA+K L+K +L + + +H+ AERN+L + H +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 171 LYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHR 230
L+YSFQ A+ LY +++Y+ GG++ L RE + E ARFY A+ A+ +H N I+R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGC 290
D+KP+N+LLD GH+ L+DFGLCK E
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK-----------EG----------------------- 146
Query: 291 GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350
I K + GTP+Y+APEVL K+ Y DWW LGA++YEML
Sbjct: 147 ---------------IEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLY 191
Query: 351 GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGS-EQ 408
G PPFYS D I++ LK ++ A+ L+ LL D RLG +
Sbjct: 192 GLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQKDRTKRLGAKDDFLE 247
Query: 409 IKAHPWFKDIAWDKLY--EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGP---MR 463
IK H +F I WD L ++ + P V+G +D ++F + E P G P +
Sbjct: 248 IKNHVFFSSINWDDLVNKKITPPFNPNVSGPMDLKHFDP-EFTEEPVPNSVGKSPDSVLV 306
Query: 464 KMMLTPKDLSFVGYTY 479
+ D +F+G++Y
Sbjct: 307 SASVKEADDAFLGFSY 322
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 238 bits (609), Expect = 1e-74
Identities = 126/368 (34%), Positives = 186/368 (50%), Gaps = 72/368 (19%)
Query: 88 LERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR 147
+ +T +L DF++ +G G+FG VR+ + K +G YA+K LKK E+L
Sbjct: 7 FTKPDTSSWKLS-------DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKM 59
Query: 148 GQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETV 207
QV+HV E+++L E++ IV + SFQD +Y ++E++ GG++ T L + V
Sbjct: 60 KQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDV 119
Query: 208 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINEN 267
A+FY A+ VLA E +H + I+RD+KP+NLLLD GH+K++DFG K
Sbjct: 120 AKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK------------- 166
Query: 268 EVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL 327
+ P+ ++ GTP+Y+APEV+
Sbjct: 167 ----------------KVPDR-----------------------TFTLCGTPEYLAPEVI 187
Query: 328 LKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPE--EARLTPE 385
KG+G DWW++G ++YE + GYPPF+ D P KI+ + LKFP + R
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR--LKFPNWFDGR---- 241
Query: 386 AKDLICRLL-CDVEHRLGTL--GSEQIKAHPWFKDIAWDKLYE--MEAAYKPEVNGVLDT 440
A+DL+ LL D RLGTL G +K HP+F WDKLY A V DT
Sbjct: 242 ARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKSPGDT 301
Query: 441 QNFMKFDE 448
NF K+ +
Sbjct: 302 SNFEKYPD 309
|
Length = 329 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 235 bits (602), Expect = 2e-74
Identities = 105/313 (33%), Positives = 154/313 (49%), Gaps = 58/313 (18%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
++LL +G G+FG V + K +G I A+K LKK S+ R E +L ++
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR-EIRILRRLSHPN 59
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
IV+L +F+D ++LYL+MEY GGD+ L R L+E A+ Q + +E +H +
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
IHRD+KP+N+LLD+NG +K++DFGL K L ++
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSS--------------------------- 152
Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 346
+ VGTP Y+APEVLL GYG + D WSLG I+Y
Sbjct: 153 ----------------------SSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILY 190
Query: 347 EMLVGYPPFYSDDPVT---TCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLG 402
E+L G PPF ++ + R+I+ P+ + + EAKDLI + L D R
Sbjct: 191 ELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKR-- 248
Query: 403 TLGSEQIKAHPWF 415
+E+I HPWF
Sbjct: 249 -PTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 235 bits (602), Expect = 7e-74
Identities = 125/333 (37%), Positives = 187/333 (56%), Gaps = 56/333 (16%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
IG+G+FG+V +++ + IYA+K ++K+ ++SR +V H AER +LA+V IV L +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIK 233
SFQ E LYL++ ++ GG++ L RE + ARFY A+ + A+E++HK N I+RD+K
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 234 PDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRR 293
P+N+LLD GH+ L DFGLCK N+ DD+ N
Sbjct: 121 PENILLDYQGHIALCDFGLCK----LNMK--------DDDKTN----------------- 151
Query: 294 WKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 353
+ GTP+Y+APE+LL GY DWW+LG ++YEML G P
Sbjct: 152 --------------------TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLP 191
Query: 354 PFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412
PFY ++ RKI+ + L+FP+ +AKDL+ LL D RLG G+++IK H
Sbjct: 192 PFYDENVNEMYRKIL--QEPLRFPDGFD--RDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247
Query: 413 PWFKDIAWDKLY--EMEAAYKPEVNGVLDTQNF 443
P+F ++W KL ++ +KP V+ +DT NF
Sbjct: 248 PFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNF 280
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 222 bits (566), Expect = 3e-68
Identities = 119/338 (35%), Positives = 178/338 (52%), Gaps = 60/338 (17%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA---SHCIVK 170
IG+G FG+V ++K + IYAMK L K E++++ +V H ERN+L S IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 171 LYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHR 230
L +SFQ LYL+ +Y+ GG++ L +E +E A+FYIA+ VLA+E +HK++ ++R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGC 290
D+KP+N+LLD GH+ L DFGL K NL+
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKA----NLTD--------------------------- 149
Query: 291 GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEML 349
K + GT +Y+APEVLL +KGY D+WSLG +++EM
Sbjct: 150 ------------------NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMC 191
Query: 350 VGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLG-TLGSE 407
G+ PFY++D R I K ++FP+ L+ E + + LL + +HRLG +
Sbjct: 192 CGWSPFYAEDTQQMYRNIAFGK--VRFPKNV-LSDEGRQFVKGLLNRNPQHRLGAHRDAV 248
Query: 408 QIKAHPWFKDIAWDKLYE--MEAAYKPEVNGVLDTQNF 443
++K HP+F DI WD L + + +KP V+ D NF
Sbjct: 249 ELKEHPFFADIDWDLLSKKQITPPFKPIVDSDEDVSNF 286
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 220 bits (563), Expect = 6e-68
Identities = 135/360 (37%), Positives = 194/360 (53%), Gaps = 66/360 (18%)
Query: 111 LTIIGRGAFGEVRLCQEKK---SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
L ++G+G+FG+V L ++ +G +YAMK LKK+ + R +V + ER++LAEV
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVR-TKMERDILAEVNHPF 59
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
IVKL+Y+FQ LYLI+++L GGD+ T L +E TE +FY+A+ LA++ +H
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
I+RD+KP+N+LLD+ GH+KL+DFGL K E +D E
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSK-------------ESIDHE-------------- 152
Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 347
K AYS GT +Y+APEV+ ++G+ DWWS G +M+E
Sbjct: 153 ----------------------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFE 190
Query: 348 MLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT--L 404
ML G PF D T I+ K L P+ L+PEA+ L+ L + +RLG
Sbjct: 191 MLTGSLPFQGKDRKETMTMIL--KAKLGMPQ--FLSPEAQSLLRALFKRNPANRLGAGPD 246
Query: 405 GSEQIKAHPWFKDIAWDKLY--EMEAAYKPEVNGVLDTQNFMKFD-EVESQTPKRTGSGP 461
G E+IK HP+F I W+KLY E++ +KP V DT FD E S+TPK + P
Sbjct: 247 GVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPDDT---FYFDPEFTSRTPKDSPGIP 303
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 218 bits (558), Expect = 3e-67
Identities = 124/373 (33%), Positives = 190/373 (50%), Gaps = 63/373 (16%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKL 171
++G+G+FG+V L + K + +YA+K LKK +L VE E+ +LA H + +L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
+ FQ + L+ +MEY+ GGD+M + R E ARFY A+ VL ++ +H+ I+RD
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRD 121
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
+K DN+LLD GH+K++DFG+CK E + + G + CG
Sbjct: 122 LKLDNVLLDSEGHIKIADFGMCK------------------EGI-----LGGVTTSTFCG 158
Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 351
TPDYIAPE+L + YG DWW+LG ++YEML G
Sbjct: 159 --------------------------TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAG 192
Query: 352 YPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQ 408
PF DD + I+ + +++P L+ EAK ++ L + E RLG L G +
Sbjct: 193 QSPFEGDDEDELFQSILE--DEVRYPRW--LSKEAKSILKSFLTKNPEKRLGCLPTGEQD 248
Query: 409 IKAHPWFKDIAWDKL--YEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMM 466
IK HP+F++I WDKL E++ +KP++ G D NF DE + P T
Sbjct: 249 IKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNFD--DEFTKEKPVLTPPDEAIIRN 306
Query: 467 LTPKDLSFVGYTY 479
+ ++ F G++Y
Sbjct: 307 IDQEE--FRGFSY 317
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 219 bits (559), Expect = 4e-67
Identities = 127/388 (32%), Positives = 192/388 (49%), Gaps = 81/388 (20%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLL--AEVAS 165
F L ++GRG FG+V L + KK+G +YA+K LKK ++++R +VE + E+ + A
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 166 H-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK 224
H +V L+ FQ +++ +MEY GGD+M + + + +E A FY A VL ++ +H+
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLM-MHIHTDVFSEPRAVFYAACVVLGLQYLHE 119
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESM---DV 281
+ ++RD+K DNLLLD G +K++DFGLCK E M D
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCK----------------------EGMGFGDR 157
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341
F CG TP+++APEVL + Y DWW L
Sbjct: 158 TSTF----CG--------------------------TPEFLAPEVLTETSYTRAVDWWGL 187
Query: 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEAR----LTPEAKDLICRLLC-D 396
G ++YEMLVG PF DD IV+ +E R L+ EA ++ RLL +
Sbjct: 188 GVLIYEMLVGESPFPGDDEEEVFDSIVN--------DEVRYPRFLSREAISIMRRLLRRN 239
Query: 397 VEHRLGT--LGSEQIKAHPWFKDIAWDKLY--EMEAAYKPEVNGVLDTQNFMKFDEVESQ 452
E RLG+ +E +K P+F+DI WD L +++ + P + G D NF +E S+
Sbjct: 240 PERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVSNFD--EEFTSE 297
Query: 453 TPKRTGSGPMRKMMLTPKD-LSFVGYTY 479
P T P +LT ++ F G+ Y
Sbjct: 298 APVLT--PPREPRLLTEEEQELFRGFDY 323
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 1e-66
Identities = 107/314 (34%), Positives = 156/314 (49%), Gaps = 63/314 (20%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
F+LL +IG+GAFG+V + Q++ + ++AMK + K + + +G V +V ER +L E+
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
+V L+YSFQD E +YL+++ L GGD+ L ++ +E +F+I + VLA+E +H
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
IHRDIKPDN+LLD+ GH+ ++DF N++ V D
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDF---------NIATK----VTPDTLTT----------- 157
Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 347
ST GTP Y+APEVL ++GY + DWWSLG YE
Sbjct: 158 --------------------------STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYE 191
Query: 348 MLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTP-----EAKDLICRLL-CDVEHRL 401
L G P+ R I K L P EA D I +LL D + RL
Sbjct: 192 CLRGKRPYRGHS-----RTIRDQIRA-KQETADVLYPATWSTEAIDAINKLLERDPQKRL 245
Query: 402 GTLGSEQIKAHPWF 415
G + +K HP+F
Sbjct: 246 GD-NLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 212 bits (542), Expect = 9e-65
Identities = 122/358 (34%), Positives = 180/358 (50%), Gaps = 67/358 (18%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
++G+G FG+V L +EK +G YAMK LKK ++++ +V H E +L + L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 173 YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDI 232
YSFQ + L +MEY GG++ L RE +E ARFY A+ V A+ +H + ++RD+
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDL 121
Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGR 292
K +NL+LD++GH+K++DFGLCK E ++ DG ++ C
Sbjct: 122 KLENLMLDKDGHIKITDFGLCK------------------EGIS-----DGATMKTFC-- 156
Query: 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 352
GTP+Y+APEVL YG DWW LG +MYEM+ G
Sbjct: 157 ------------------------GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
Query: 353 PPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSE---Q 408
PFY+ D I+ ++FP L+PEAK L+ LL D + RLG G E +
Sbjct: 193 LPFYNQDHEKLFELIL--MEEIRFP--RTLSPEAKSLLAGLLKKDPKQRLGG-GPEDAKE 247
Query: 409 IKAHPWFKDIAWDKLY--EMEAAYKPEVNGVLDTQNFMKFDEVESQT-----PKRTGS 459
I H +F I W + ++E +KP+V DT+ F +E +Q+ P R S
Sbjct: 248 IMEHRFFASINWQDVVQKKLEPPFKPQVTSETDTRYFD--EEFTAQSITITPPDRYDS 303
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 210 bits (536), Expect = 2e-64
Identities = 118/338 (34%), Positives = 179/338 (52%), Gaps = 62/338 (18%)
Query: 107 DFDLLTIIGRGAFGEVRLCQE---KKSGNIYAMKKLKKSEMLSRGQV-EHVRAERNLLAE 162
+F+LL ++G GA+G+V L ++ +G +YAMK LKK+ ++ + + EH R ER +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 163 V-ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES 221
V +V L+Y+FQ L+LI++Y+ GG++ T L + E TE+ R YIA+ VLA++
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
+H+ I+RDIK +N+LLD GH+ L+DFGL K E L E +
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSK------------------EFLAEEEE- 161
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK--GYGMECDWW 339
AYS GT +Y+APEV+ G+ DWW
Sbjct: 162 -----------------------------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWW 192
Query: 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVH--WKNHLKFPEEARLTPEAKDLICRLLC-D 396
SLG + +E+L G PF D + +I K+ FP+ ++ EA+D I +LL D
Sbjct: 193 SLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPK--TMSAEARDFIQKLLEKD 250
Query: 397 VEHRLGTLGSEQIKAHPWFKDIAWDKLYE--MEAAYKP 432
+ RLG G+++IK HP+F+ I WD L + A +KP
Sbjct: 251 PKKRLGANGADEIKNHPFFQGIDWDDLAAKRIPAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 9e-64
Identities = 123/357 (34%), Positives = 189/357 (52%), Gaps = 64/357 (17%)
Query: 99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNI--YAMKKLKKSEMLSRGQVEHVRAE 156
+++K+ +DF+ + +G G+FG V L K+ + A+K+ +KS+++ + QV+HV +E
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILAT-YKNEDFPPVAIKRFEKSKIIKQKQVDHVFSE 81
Query: 157 RNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSV 216
R +L + V LY SF+D YLYL++E++ GG+ T L R + V FY AQ V
Sbjct: 82 RKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIV 141
Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLN 276
L E + N ++RD+KP+NLLLD++G +K++DFG K
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV--------------------- 180
Query: 277 ESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336
VD R Y+ GTP+YIAPE+LL G+G
Sbjct: 181 ----VDTR---------------------------TYTLCGTPEYIAPEILLNVGHGKAA 209
Query: 337 DWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC- 395
DWW+LG +YE+LVG PPFY+++P+ +KI+ + + FP+ L K L+ +LL
Sbjct: 210 DWWTLGIFIYEILVGCPPFYANEPLLIYQKIL--EGIIYFPK--FLDNNCKHLMKKLLSH 265
Query: 396 DVEHRLGTL--GSEQIKAHPWFKDIAWDKLYE--MEAAYKPEVNGVLDTQNFMKFDE 448
D+ R G L G++ +K HPWF +I W L +E YKP+ V D+ NF + E
Sbjct: 266 DLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKNVFDSSNFERVQE 322
|
Length = 340 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 209 bits (533), Expect = 2e-63
Identities = 120/375 (32%), Positives = 187/375 (49%), Gaps = 67/375 (17%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC--IVK 170
++G+G+FG+V L + K + +A+K LKK +L VE ER +LA +A +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLA-LAWEHPFLTH 60
Query: 171 LYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHR 230
L+ +FQ E+L+ +MEYL GGD+M + E ARFY A+ + ++ +HK I+R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGC 290
D+K DN+LLD++GH+K++DFG+CK
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCKE----------------------------------- 145
Query: 291 GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350
+N A + GTPDYIAPE+L + Y DWWS G ++YEML+
Sbjct: 146 --------------NMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLI 191
Query: 351 GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQI 409
G PF+ +D I++ + H FP ++ EAKD + +L D RLG G I
Sbjct: 192 GQSPFHGEDEDELFDSILNDRPH--FPR--WISKEAKDCLSKLFERDPTKRLGVDGD--I 245
Query: 410 KAHPWFKDIAWDKL--YEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMML 467
+ HP+F+ I W++L E+ +KP+V D NF E ++ + + P+ K +L
Sbjct: 246 RQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNFD--REFTNEKVRLS---PVDKKLL 300
Query: 468 TPKDLS-FVGYTYKN 481
D F G+++ N
Sbjct: 301 ASMDQEQFRGFSFTN 315
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 208 bits (531), Expect = 4e-63
Identities = 127/376 (33%), Positives = 179/376 (47%), Gaps = 67/376 (17%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKL 171
+IG+G+FG+V L + K G+ YA+K L+K +L + + H+ AERN+L + H +V L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
+YSFQ AE LY +++Y+ GG++ L RE E ARFY A+ AI +H N I+RD
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRD 121
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
+KP+N+LLD GH+ L+DFGLCK +G PE
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK---------------------------EGVEPEETTS 154
Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 351
+ GTP+Y+APEVL K+ Y DWW LGA++YEML G
Sbjct: 155 ----------------------TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
Query: 352 YPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEH-----RLGTLGS 406
PPFYS D I+H + +L C LL + H RLG
Sbjct: 193 LPPFYSRDVSQMYDNILH--------KPLQLPGGKTVAACDLLVGLLHKDQRRRLGAKAD 244
Query: 407 -EQIKAHPWFKDIAWDKLYEMEAA--YKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMR 463
+IK H +F I WD LY Y P V G D ++F + + G P
Sbjct: 245 FLEIKNHVFFSPINWDDLYHKRITPPYNPNVAGPADLRHFDP-EFTQEAVSSSVGQTPDL 303
Query: 464 KMMLTPKDLSFVGYTY 479
+ +F+G++Y
Sbjct: 304 TASSSSASSAFLGFSY 319
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 200 bits (509), Expect = 8e-60
Identities = 116/348 (33%), Positives = 185/348 (53%), Gaps = 59/348 (16%)
Query: 107 DFDLLTIIGRGAFGEVRLCQE---KKSGNIYAMKKLKKSEMLSRGQ-VEHVRAERNLLAE 162
+F+LL ++G GA+G+V L ++ +G +YAMK L+K+ ++ + + VEH R ERN+L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 163 V-ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES 221
V S +V L+Y+FQ L+LI++Y+ GG++ T L + + +E RFY + +LA+E
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
+HK ++RDIK +N+LLD GH+ L+DFGL K E L +E
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK-------------EFLSEE-------- 159
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECDWWS 340
++ YS GT +Y+APE++ K G+G DWWS
Sbjct: 160 ---------------------------KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWS 192
Query: 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEH 399
LG +++E+L G PF + T ++ P + + PEA+DL+ +LL D +
Sbjct: 193 LGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKK 252
Query: 400 RLGT--LGSEQIKAHPWFKDIAWDKLYE--MEAAYKPEVNGVLDTQNF 443
RLG G+ +IK HP+FK + W+ L + ++P + LD NF
Sbjct: 253 RLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNF 300
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 199 bits (508), Expect = 9e-60
Identities = 116/377 (30%), Positives = 184/377 (48%), Gaps = 65/377 (17%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKL 171
++G+G+FG+V L + K + +YA+K LKK +L V+ E+ +LA A H + L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
+ FQ + L+ +MEY+ GGD+M + R E +RFY A+ LA+ +H+H I+RD
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRD 121
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
+K DN+LLD GH KL+DFG+CK E + +
Sbjct: 122 LKLDNILLDAEGHCKLADFGMCK------------------EGILNGV------------ 151
Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 351
+ GTPDYIAPE+L + YG DWW+LG +MYEM+ G
Sbjct: 152 -------------------TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAG 192
Query: 352 YPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGS---- 406
PPF +D+ I+H + + +P L+ EA ++ + + RLG + S
Sbjct: 193 QPPFEADNEDDLFESILH--DDVLYP--VWLSKEAVSILKAFMTKNPNKRLGCVASQGGE 248
Query: 407 EQIKAHPWFKDIAWDKL--YEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRK 464
+ IK HP+FK+I W L +++ +KP++ D NF + + + P T P
Sbjct: 249 DAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQ--DFTKEEPVLTPVDP--A 304
Query: 465 MMLTPKDLSFVGYTYKN 481
++ F G+++ N
Sbjct: 305 VIKQINQEEFRGFSFFN 321
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 199 bits (508), Expect = 1e-59
Identities = 116/383 (30%), Positives = 186/383 (48%), Gaps = 67/383 (17%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA-EVAS 165
DF+ L ++G+G+FG+V L + K + +YA+K LKK ++ VE E+ +LA
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
+ +L+ FQ + LY +MEY+ GGD+M + + E A FY A+ + + +H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
I+RD+K DN++LD GH+K++DFG+CK EN+ G+
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCK------------------ENIF-----GGKT 157
Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345
+ C GTPDYIAPE++ + YG DWW+ G ++
Sbjct: 158 TRTFC--------------------------GTPDYIAPEIIAYQPYGKSVDWWAFGVLL 191
Query: 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEH---RLG 402
YEML G PPF +D + I+ ++++ +P+ L+ EA + LL +H RLG
Sbjct: 192 YEMLAGQPPFDGEDEDELFQSIM--EHNVSYPKS--LSKEAVSICKGLL--TKHPAKRLG 245
Query: 403 T--LGSEQIKAHPWFKDIAWDKLYEME--AAYKPEVNGVLDTQNFMKFDEVESQTPKRTG 458
G I+ H +F+ I W+KL E +KP+V G +NF KF + P T
Sbjct: 246 CGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRSAENFDKF--FTREPPVLTP 303
Query: 459 SGPMRKMMLTPKDLSFVGYTYKN 481
+ + + F G+++ N
Sbjct: 304 PDKLVIANIDQSE--FQGFSFVN 324
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 1e-56
Identities = 127/374 (33%), Positives = 187/374 (50%), Gaps = 60/374 (16%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKL 171
+IG+G+FG+V L + K G YA+K L+K +L+R + +H+ AERN+L + H +V L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
+YSFQ E LY +++++ GG++ L RE + E ARFY A+ A+ +H N ++RD
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRD 121
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
+KP+N+LLD GH+ L+DFGLCK E + +S D F CG
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK------------------EGIAQS-DTTTTF----CG 158
Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 351
TP+Y+APEV+ K+ Y DWW LGA++YEML G
Sbjct: 159 --------------------------TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
Query: 352 YPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLL-CDVEHRLGTLGS-EQI 409
PPFY D I+H L A LT A ++ LL D + RLG +I
Sbjct: 193 LPPFYCRDVAEMYDNILH--KPLVLRPGASLT--AWSILEELLEKDRQRRLGAKEDFLEI 248
Query: 410 KAHPWFKDIAWDKLYE--MEAAYKPEVNGVLDTQNF-MKFDEVESQTPKRTGSGP-MRKM 465
+ HP+F+ ++W L + + + P V G D NF F E S +
Sbjct: 249 QEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDAVFTEETVPYSVCFSSDYSIVNA 308
Query: 466 MLTPKDLSFVGYTY 479
+ D +FVG++Y
Sbjct: 309 SVLEADDAFVGFSY 322
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 191 bits (486), Expect = 2e-56
Identities = 107/338 (31%), Positives = 172/338 (50%), Gaps = 60/338 (17%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKL 171
++G+G+FG+V L + K+SG +YA+K LKK +L VE E+ +L+ +H + +L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
Y FQ + L+ +ME++ GGD+M + + E ARFY A+ A+ +H I+RD
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRD 121
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
+K DN+LLD GH KL+DFG+CK +G+ + C
Sbjct: 122 LKLDNVLLDHEGHCKLADFGMCKEGIF-----------------------NGKTTSTFC- 157
Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 351
GTPDYIAPE+L + YG DWW++G ++YEML G
Sbjct: 158 -------------------------GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
Query: 352 YPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL---GSE 407
+ PF +++ I+ + + +P L+ +A D++ + + RLG+L G E
Sbjct: 193 HAPFEAENEDDLFEAIL--NDEVVYP--TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEE 248
Query: 408 QIKAHPWFKDIAWDKLY--EMEAAYKPEVNGVLDTQNF 443
I HP+FK++ W+KL ++E ++P + D NF
Sbjct: 249 AILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNF 286
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 188 bits (478), Expect = 2e-55
Identities = 122/375 (32%), Positives = 185/375 (49%), Gaps = 62/375 (16%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKL 171
+IG+G+FG+V L + K YA+K L+K +L + + +H+ +ERN+L + H +V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
++SFQ A+ LY +++Y+ GG++ L RE E ARFY A+ A+ +H N ++RD
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRD 121
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
+KP+N+LLD GH+ L+DFGLCK EN
Sbjct: 122 LKPENILLDSQGHIVLTDFGLCK-----------EN------------------------ 146
Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 351
I + GTP+Y+APEVL K+ Y DWW LGA++YEML G
Sbjct: 147 --------------IEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
Query: 352 YPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGS-EQI 409
PPFYS + I++ LK +T A+ L+ LL D RLG +I
Sbjct: 193 LPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 248
Query: 410 KAHPWFKDIAWDKLY--EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMM- 466
K H +F I WD L ++ + P V+G D ++F + E P G P ++
Sbjct: 249 KNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDP-EFTEEPVPNSIGQSPDSILVT 307
Query: 467 --LTPKDLSFVGYTY 479
+ +F+G++Y
Sbjct: 308 ASVKEAAEAFLGFSY 322
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 7e-55
Identities = 116/346 (33%), Positives = 176/346 (50%), Gaps = 60/346 (17%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
++G+G FG+V L +EK +G YAMK L+K ++++ +V H E +L + L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 173 YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDI 232
Y+FQ + L +MEY GG++ L RE TE ARFY A+ V A+E +H + ++RDI
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 121
Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGR 292
K +NL+LD++GH+K++DFGLCK E + D ++ CG
Sbjct: 122 KLENLMLDKDGHIKITDFGLCK-------------EGISDGATMKTF----------CG- 157
Query: 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 352
TP+Y+APEVL YG DWW LG +MYEM+ G
Sbjct: 158 -------------------------TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
Query: 353 PPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLL-CDVEHRL--GTLGSEQI 409
PFY+ D I+ ++FP L+PEAK L+ LL D + RL G ++++
Sbjct: 193 LPFYNQDHERLFELIL--MEEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 248
Query: 410 KAHPWFKDIAWDKLYE--MEAAYKPEVNGVLDTQNFMKFDEVESQT 453
H +F I W + + + +KP+V +DT+ F DE +Q+
Sbjct: 249 MEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD--DEFTAQS 292
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 3e-54
Identities = 86/307 (28%), Positives = 137/307 (44%), Gaps = 57/307 (18%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
++GRG+FG V L +K +G + A+K ++ S ++E + E +L+ + IV+ Y
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEE-ELEALEREIRILSSLQHPNIVRYY 65
Query: 173 YSFQDAE--YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHR 230
S +D E L + +EY+ GG + +LL + L E V R Y Q + + +H + +HR
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHR 125
Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGC 290
DIK N+L+D +G +KL+DFG K L
Sbjct: 126 DIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT------------------------- 160
Query: 291 GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350
S GTP ++APEV+ + YG D WSLG + EM
Sbjct: 161 ----------------------GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMAT 198
Query: 351 GYPPFY-SDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQ 408
G PP+ +P+ KI + PE L+ EAKD + + L D + R +++
Sbjct: 199 GKPPWSELGNPMAALYKIGSSGEPPEIPEH--LSEEAKDFLRKCLRRDPKKR---PTADE 253
Query: 409 IKAHPWF 415
+ HP+
Sbjct: 254 LLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 3e-54
Identities = 74/148 (50%), Positives = 106/148 (71%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
DF +LT +G+G +G+V L ++K +G I A+K++KKS + +V HV ER++L S
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHN 226
+VKL Y+FQD EYLYL MEY+PGGD TLL L+E ARFY+A+ A++++H+
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 227 YIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
YIHRD+KP+N L+D +GH+KL+DFGL K
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK 149
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 8e-54
Identities = 118/375 (31%), Positives = 184/375 (49%), Gaps = 70/375 (18%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKL 171
++G+G+FG+V L + K + +A+K LKK +L VE E+ +L+ H + L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
Y +FQ E L+ +MEYL GGD+M + A FY A+ + ++ +H ++RD
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRD 121
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
+K DN+LLD +GH+K++DFG+CK E+M D +
Sbjct: 122 LKLDNILLDTDGHIKIADFGMCK----------------------ENMLGDAK------- 152
Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 351
+ GTPDYIAPE+LL + Y DWWS G ++YEML+G
Sbjct: 153 --------------------TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIG 192
Query: 352 YPPFYSDDPVTTCRKIVHWKNHLKFPEEAR-LTPEAKDLICRLLC-DVEHRLGTLGSEQI 409
PF+ D + I + P R LT EAKD++ +L + E RLG G I
Sbjct: 193 QSPFHGHDEEELFQSI-----RMDNPCYPRWLTREAKDILVKLFVREPERRLGVKGD--I 245
Query: 410 KAHPWFKDIAWDKL--YEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMML 467
+ HP+F++I W L E+E +KP+V D NF K E ++ P+ + + +M++
Sbjct: 246 RQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDK--EFLNEKPRLSVT---DRMLI 300
Query: 468 TPKDLSFVGYTYKNF 482
D + ++NF
Sbjct: 301 NSMDQNM----FENF 311
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 9e-54
Identities = 117/340 (34%), Positives = 180/340 (52%), Gaps = 64/340 (18%)
Query: 107 DFDLLTIIGRGAFGEVRLCQE---KKSGNIYAMKKLKKSEMLSRGQV-EHVRAERNLLAE 162
+F+LL ++G GA+G+V L ++ SG +YAMK LKK+ ++ + + EH R ER +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 163 V-ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES 221
+ S +V L+Y+FQ L+LI++Y+ GG++ T L + E E + Y + VLA+E
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
+HK I+RDIK +N+LLD NGH+ L+DFGL K E +DE
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-------------EFHEDEV------- 160
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL--KKGYGMECDWW 339
+ AYS GT +Y+AP+++ G+ DWW
Sbjct: 161 ----------------------------ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWW 192
Query: 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVH--WKNHLKFPEEARLTPEAKDLICRLLC-D 396
S+G +MYE+L G PF D + +I K+ +P+E ++ AKD+I RLL D
Sbjct: 193 SMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE--MSALAKDIIQRLLMKD 250
Query: 397 VEHRLGT--LGSEQIKAHPWFKDIAWDKLY--EMEAAYKP 432
+ RLG +++IK HP+F+ I WD L ++ A +KP
Sbjct: 251 PKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVPAPFKP 290
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 1e-53
Identities = 121/374 (32%), Positives = 183/374 (48%), Gaps = 61/374 (16%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
++G+G FG+V L +EK +G YAMK LKK ++++ +V H E +L + L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 173 YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH-KHNYIHRD 231
YSFQ + L +MEY GG++ L RE +E ARFY A+ V A++ +H + N ++RD
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
+K +NL+LD++GH+K++DFGLCK E + DG ++ C
Sbjct: 122 LKLENLMLDKDGHIKITDFGLCK------------------EGIK-----DGATMKTFC- 157
Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 351
GTP+Y+APEVL YG DWW LG +MYEM+ G
Sbjct: 158 -------------------------GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 192
Query: 352 YPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLL-CDVEHRLGTLGSE--- 407
PFY+ D I+ ++FP L+PEAK L+ LL D + RLG G +
Sbjct: 193 RLPFYNQDHEKLFELIL--MEEIRFPRT--LSPEAKSLLSGLLKKDPKQRLGG-GPDDAK 247
Query: 408 QIKAHPWFKDIAWDKLYE--MEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKM 465
+I H +F I W +YE + +KP+V DT+ F + + T +
Sbjct: 248 EIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMET 307
Query: 466 MLTPKDLSFVGYTY 479
+ + F ++Y
Sbjct: 308 VDNERRPHFPQFSY 321
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 1e-51
Identities = 121/375 (32%), Positives = 186/375 (49%), Gaps = 67/375 (17%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKL 171
++G+G+FG+V L + K G +A+K LKK +L VE E+ +LA + + L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
Y +FQ E+L+ +ME+L GGD+M + + A FY A+ V ++ +H I+RD
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRD 121
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
+K DN++LD++GH+K++DFG+CK EN D+
Sbjct: 122 LKLDNVMLDRDGHIKIADFGMCK-----------ENVFGDNR------------------ 152
Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 351
A + GTPDYIAPE+L Y DWWS G ++YEML+G
Sbjct: 153 --------------------ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIG 192
Query: 352 YPPFYSDDPVTTCRKIVHWKNHLKFPEEAR-LTPEAKDLICRLL-CDVEHRLGTLGSEQI 409
PF+ DD I + P R +T E+KD++ +L D RLG +G+ I
Sbjct: 193 QSPFHGDDEDELFESI-----RVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGN--I 245
Query: 410 KAHPWFKDIAWDKL--YEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMML 467
+ HP+FK I W L E++ +KP+V D NF + E S+ P+ + S K ++
Sbjct: 246 RGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDR--EFLSEKPRLSYS---DKNLI 300
Query: 468 TPKDLS-FVGYTYKN 481
D S F G+++ N
Sbjct: 301 DSMDQSAFAGFSFIN 315
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 174 bits (442), Expect = 4e-50
Identities = 114/346 (32%), Positives = 175/346 (50%), Gaps = 60/346 (17%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
++G+G FG+V L +EK SG YAMK LKK ++++ +V H E +L + L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 173 YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDI 232
YSFQ + L +MEY+ GG++ L RE +E RFY A+ V A++ +H ++RD+
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121
Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGR 292
K +NL+LD++GH+K++DFGLCK E + ++ + ++ CG
Sbjct: 122 KLENLMLDKDGHIKITDFGLCK------------------EGITDAATM-----KTFCG- 157
Query: 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 352
TP+Y+APEVL YG DWW LG +MYEM+ G
Sbjct: 158 -------------------------TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
Query: 353 PPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRL--GTLGSEQI 409
PFY+ D I+ +KFP L+ +AK L+ LL D RL G +++I
Sbjct: 193 LPFYNQDHEKLFELIL--MEDIKFPRT--LSADAKSLLSGLLIKDPNKRLGGGPDDAKEI 248
Query: 410 KAHPWFKDIAWDKLYE--MEAAYKPEVNGVLDTQNFMKFDEVESQT 453
H +F + W +Y+ + +KP+V DT+ F +E +QT
Sbjct: 249 MRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRYFD--EEFTAQT 292
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 4e-50
Identities = 82/238 (34%), Positives = 116/238 (48%), Gaps = 54/238 (22%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
+G G FG V L ++KK+G A+K +KK + S +E + E +L ++ IVKLY
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSL--LEELLREIEILKKLNHPNIVKLYG 58
Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDI 232
F+D +LYL+MEY GG + LL E L+E + Q + +E +H + IHRD+
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 233 KPDNLLLDQ-NGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
KP+N+LLD NG +KL+DFGL K L
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLT---------------------------------- 144
Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEM 348
+ + L + VGTP Y+APEVLL K Y + D WSLG I+YE+
Sbjct: 145 ---------------SDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 4e-49
Identities = 87/314 (27%), Positives = 137/314 (43%), Gaps = 67/314 (21%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
F++L IG+G FGEV + K++G A+K +K + E + E +L +
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK---EKIINEIQILKKCKHP 57
Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGG---DVMTLLMREETLTET-VARFYIAQSVL-AIES 221
IVK Y S+ + L+++ME+ GG D++ + TLTE+ +A Y+ + +L +E
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQ--TLTESQIA--YVCKELLKGLEY 113
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
+H + IHRDIK N+LL +G +KL DFGL
Sbjct: 114 LHSNGIIHRDIKAANILLTSDGEVKLIDFGLSA--------------------------- 146
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341
Q++ K + VGTP ++APEV+ K Y + D WSL
Sbjct: 147 -----------------------QLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSL 183
Query: 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHR 400
G E+ G PP+ P+ KI + + E KD + + L + E R
Sbjct: 184 GITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKR 242
Query: 401 LGTLGSEQIKAHPW 414
+EQ+ HP+
Sbjct: 243 ---PTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 171 bits (434), Expect = 4e-49
Identities = 114/347 (32%), Positives = 176/347 (50%), Gaps = 62/347 (17%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-AS 165
DF+ L ++G+G+FG+V L + K + +YA+K LKK ++ VE E+ +LA
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
+ +L+ FQ + LY +MEY+ GGD+M + + E A FY A+ + + +H+
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
I+RD+K DN++LD GH+K++DFG+CK E M VDG
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCK----------------------EHM-VDGVT 157
Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345
+ C GTPDYIAPE++ + YG DWW+ G ++
Sbjct: 158 TRTFC--------------------------GTPDYIAPEIIAYQPYGKSVDWWAYGVLL 191
Query: 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVE--HRLGT 403
YEML G PPF +D + I+ ++++ +P+ L+ EA IC+ L RLG
Sbjct: 192 YEMLAGQPPFDGEDEDELFQSIM--EHNVSYPKS--LSKEAVS-ICKGLMTKHPSKRLGC 246
Query: 404 --LGSEQIKAHPWFKDIAWDKL--YEMEAAYKPEVNGVLDTQNFMKF 446
G I+ H +F+ I WDKL E++ +KP+V G +NF KF
Sbjct: 247 GPEGERDIREHAFFRRIDWDKLENREIQPPFKPKVCGK-GAENFDKF 292
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 3e-48
Identities = 96/317 (30%), Positives = 155/317 (48%), Gaps = 59/317 (18%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
+G+G FGEV CQ K +G +YA KKL K + R + E+ +L +V+S IV L Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 174 SFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
+F+ + L L+M + GGD+ + + E E A FY AQ + +E +H+ ++RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
+KP+N+LLD +G++++S +L ++++ G G
Sbjct: 121 LKPENVLLDDHGNVRIS-------------------------DLGLAVELKGGKKIKG-- 153
Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 351
GTP Y+APEVL + Y DW++LG +YEM+ G
Sbjct: 154 -----------------------RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAG 190
Query: 352 YPPFYSDDPVTTCRKIVH--WKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLG--S 406
PF ++ + +++P+ + +PEAKDL LL D E RLG G +
Sbjct: 191 RSPFRQRKEKVEKEELKRRTLEMAVEYPD--KFSPEAKDLCEALLQKDPEKRLGCRGGSA 248
Query: 407 EQIKAHPWFKDIAWDKL 423
++++ HP FKD+ W +L
Sbjct: 249 DEVREHPLFKDLNWRRL 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 169 bits (428), Expect = 4e-48
Identities = 120/383 (31%), Positives = 191/383 (49%), Gaps = 68/383 (17%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
DF+ L ++G+G+FG+V L + K + +YA+K LKK ++ VE E+ +LA
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 167 -CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
+ +L+ FQ + LY +MEY+ GGD+M + + E A FY A+ + + +H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
I+RD+K DN++LD GH+K++DFG+CK EN+ DG
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCK------------------ENM-----WDGVT 157
Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345
++ C GTPDYIAPE++ + YG DWW+ G ++
Sbjct: 158 TKTFC--------------------------GTPDYIAPEIIAYQPYGKSVDWWAFGVLL 191
Query: 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEH---RLG 402
YEML G PF +D + I+ ++++ +P+ ++ EA IC+ L +H RLG
Sbjct: 192 YEMLAGQAPFEGEDEDELFQSIM--EHNVAYPKS--MSKEAV-AICKGLM-TKHPGKRLG 245
Query: 403 T--LGSEQIKAHPWFKDIAWDKL--YEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTG 458
G IK H +F+ I W+KL E++ YKP+ G D +NF KF P T
Sbjct: 246 CGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKACG-RDAENFDKF--FTRHPPVLT- 301
Query: 459 SGPMRKMMLTPKDLSFVGYTYKN 481
P +++++ F G++Y N
Sbjct: 302 -PPDQEVIMNLDQSEFEGFSYVN 323
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 169 bits (429), Expect = 4e-48
Identities = 109/346 (31%), Positives = 171/346 (49%), Gaps = 65/346 (18%)
Query: 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVK 170
+IGRG++ +V L + KK+ IYAMK +KK + ++ V+ E+++ ++H +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 171 LYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHR 230
L+ FQ L+ ++E++ GGD+M + R+ L E ARFY A+ LA+ +H+ I+R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGC 290
D+K DN+LLD GH+KL+D+G+CK E + G + C
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCK------------------EGIR-----PGDTTSTFC 157
Query: 291 GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350
GTP+YIAPE+L + YG DWW+LG +M+EM+
Sbjct: 158 --------------------------GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 191
Query: 351 GYPPF----YSDDPVTTCRKI---VHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLG 402
G PF SD+P V + ++ P L+ +A ++ L D + RLG
Sbjct: 192 GRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRS--LSVKASSVLKGFLNKDPKERLG 249
Query: 403 TL---GSEQIKAHPWFKDIAWDKLYEMEAA--YKPEVNGVLDTQNF 443
G IK+HP+F++I WD L + + YKP + D NF
Sbjct: 250 CHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESDRDLDNF 295
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 5e-48
Identities = 79/292 (27%), Positives = 132/292 (45%), Gaps = 57/292 (19%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
++++ IG+G+FG+V L + K G +Y +K++ S M S + E E +L ++
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHP 59
Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL----MREETLTETVARFYIAQSVLAIESI 222
I+K Y SF++ L ++MEY GGD+ + + E + Q LA++ +
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
H +HRDIKP N+ L NG +KL DFG+ K L+ ++D
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISK-------------------VLSSTVD-- 158
Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342
LA + VGTP Y++PE+ K Y + D WSLG
Sbjct: 159 ----------------------------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLG 190
Query: 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLL 394
++YE+ PF ++ + KI+ + P + + E ++L+ LL
Sbjct: 191 CVLYELCTLKHPFEGENLLELALKILK-GQYPPIPS--QYSSELRNLVSSLL 239
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 2e-47
Identities = 71/151 (47%), Positives = 105/151 (69%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
S+++F ++ I RGAFG+V L ++K + +YA+K +KK++M+++ V V+AER+ LA
Sbjct: 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS 61
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH 223
S IV LYYS Q A +YL+MEYL GGDV +LL E +A YI++ LA++ +H
Sbjct: 62 KSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
+H IHRD+KPDN+L+ GH+KL+DFGL K
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 3e-47
Identities = 117/384 (30%), Positives = 184/384 (47%), Gaps = 71/384 (18%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKL 171
+IGRG++ +V L + KK+ IYAMK +KK + ++ V+ E+++ + ++H +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
+ FQ L+ ++EY+ GGD+M + R+ L E ARFY A+ LA+ +H+ I+RD
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 121
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
+K DN+LLD GH+KL+D+G+CK E L D F CG
Sbjct: 122 LKLDNVLLDSEGHIKLTDYGMCK------------------EGLRPG-DTTSTF----CG 158
Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 351
TP+YIAPE+L + YG DWW+LG +M+EM+ G
Sbjct: 159 --------------------------TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 192
Query: 352 YPPF----YSDDPVTTCRKI---VHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTL 404
PF SD+P V + ++ P + A L L D + RLG
Sbjct: 193 RSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA-ASVLKSFLNKDPKERLGCH 251
Query: 405 ---GSEQIKAHPWFKDIAWDKLYEMEAA--YKPEVNGVLDTQNFMKFDEVESQ-TPKRTG 458
G I+ HP+F+++ WD + + + +KP ++G NF ++Q T +
Sbjct: 252 PQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGEFGLDNF------DAQFTNEPVQ 305
Query: 459 SGPMRKMMLTPKDLS-FVGYTYKN 481
P ++ D S F G+ Y N
Sbjct: 306 LTPDDDDIVRKIDQSEFEGFEYIN 329
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 163 bits (412), Expect = 2e-45
Identities = 102/330 (30%), Positives = 148/330 (44%), Gaps = 67/330 (20%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
+ +L +G G+FGEV L +++K + A+K L K +VE E +LA +
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 167 -CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL---MREETLTETVARFYIAQSVLAIESI 222
IVKLY FQD LYL+MEY+ GG + LL R+ L+E+ A F +AQ + A+E +
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 223 HKHNYIHRDIKPDNLLLDQNGHM-KLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
H IHRDIKP+N+LLD++G + KL DFGL K L ++
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSI---------------- 161
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG---YGMECDW 338
L ++VGTP Y+APEVLL D
Sbjct: 162 ---------------------------PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDI 194
Query: 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPE---------EARLTPEAKDL 389
WSLG +YE+L G PPF + + + + L P ++ A DL
Sbjct: 195 WSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDL 254
Query: 390 ICRLL-CDVEHRLGTLGSEQIKAHPWFKDI 418
+ +LL D ++R L S +H +
Sbjct: 255 LKKLLAKDPKNR---LSSSSDLSHDLLAHL 281
|
Length = 384 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 5e-45
Identities = 107/343 (31%), Positives = 173/343 (50%), Gaps = 63/343 (18%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKL 171
+IGRG++ +V L + KK+ IYAMK +KK + ++ V+ E+++ + +S+ +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
+ FQ L+L++EY+ GGD+M + R+ L E ARFY A+ +A+ +H+ I+RD
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRD 121
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
+K DN+LLD +GH+KL+D+G+CK E L G + CG
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCK------------------EGLGP-----GDTTSTFCG 158
Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 351
TP+YIAPE+L + YG DWW+LG +M+EM+ G
Sbjct: 159 --------------------------TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAG 192
Query: 352 YPPF--YSDDPVTTCRKI---VHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLG--- 402
PF +D+P V + ++ P L+ +A ++ L D + RLG
Sbjct: 193 RSPFDIITDNPDMNTEDYLFQVILEKPIRIPRF--LSVKASHVLKGFLNKDPKERLGCQP 250
Query: 403 TLGSEQIKAHPWFKDIAWDKLYEMEAA--YKPEVNGVLDTQNF 443
G IK+H +F+ I WD L + + +KP++ +NF
Sbjct: 251 QTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDDYGLENF 293
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 4e-43
Identities = 65/183 (35%), Positives = 96/183 (52%), Gaps = 17/183 (9%)
Query: 311 LAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHW 370
A S VG+PDY+APEVL KGY D+WSLG ++YE L G+PPF P T + +W
Sbjct: 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213
Query: 371 KNHLKFP----EEARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFKDIAWDKLYEM 426
K L+ P L+ EA DLI +L+ D R G+L E IK HP+FK++ W++L E+
Sbjct: 214 KETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSL--EDIKNHPFFKEVDWNELREL 271
Query: 427 EAAYKPEVNGVLDT---------QNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGY 477
+ + PE+ +DT + K+ +V + G + FVG+
Sbjct: 272 KPPFVPELESEIDTGYFDDFENEDDMAKYKDVHEKKKAAGKGGANGRD--PGNRRKFVGF 329
Query: 478 TYK 480
T++
Sbjct: 330 TFR 332
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 1e-41
Identities = 95/319 (29%), Positives = 151/319 (47%), Gaps = 60/319 (18%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
+G+G FGEV CQ + +G +YA KKL K + R E E+ +LA+V S IV L Y
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 174 SFQDAEYLYLIMEYLPGGDVMTLL--MREET--LTETVARFYIAQSVLAIESIHKHNYIH 229
+FQ L L+M + GGD+ + + EE E A FY AQ + +E +H+ I+
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 230 RDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESG 289
RD+KP+N+LLD +G++++SD GL L DG+ G
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVEL------------------------KDGQSKTKG 156
Query: 290 CGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 349
Y+ GTP ++APE+L + Y D+++LG +YEM+
Sbjct: 157 -----------------------YA--GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMI 191
Query: 350 VGYPPFYSDDPVTTCRKIVH--WKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGS 406
PF + +++ + + +P+ + +P +K LL D E RLG
Sbjct: 192 AARGPFRARGEKVENKELKQRILNDSVTYPD--KFSPASKSFCEALLAKDPEKRLGFRDG 249
Query: 407 --EQIKAHPWFKDIAWDKL 423
+ ++ HP F+D+ W +L
Sbjct: 250 NCDGLRTHPLFRDLNWRQL 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 2e-41
Identities = 94/327 (28%), Positives = 150/327 (45%), Gaps = 67/327 (20%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
F ++G+G FGEV CQ + +G +YA KKL+K + R E+ +L +V S
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVARFYIAQSVLAIESIHKH 225
+V L Y+++ + L L++ + GGD+ + M E A FY A+ +E +H+
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
++RD+KP+N+LLD GH+++SD GL I E E + GR
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLA--------VEIPEGET-----------IRGR- 161
Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345
VGT Y+APEV+ + Y DWW LG ++
Sbjct: 162 ------------------------------VGTVGYMAPEVVKNERYTFSPDWWGLGCLI 191
Query: 346 YEMLVGYPPFYSDDPVTTCRKIVHW----KNHLKFPEE--ARLTPEAKDLICRLLC-DVE 398
YEM+ G PF ++ V + + EE + + A+ + +LL D
Sbjct: 192 YEMIEGKSPFRQR------KEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPG 245
Query: 399 HRLG--TLGSEQIKAHPWFKDIAWDKL 423
RLG G+E++KAHP+F+ + +L
Sbjct: 246 FRLGCRGEGAEEVKAHPFFRTANFKRL 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 2e-41
Identities = 83/310 (26%), Positives = 142/310 (45%), Gaps = 57/310 (18%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
++ L +IGRGAFG V ++G+ A+K++ + + ++ + E +LL +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK-IKEEALKSIMQEIDLLKNLKHP 59
Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHN 226
IVK S + ++ LY+I+EY G + ++ + E++ Y+ Q + + +H+
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 227 YIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFP 286
IHRDIK N+L ++G +KL+DFG+ T L+ +++++
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGV-----ATKLNDVSKDD------------------ 156
Query: 287 ESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 346
S VGTP ++APEV+ G D WSLG +
Sbjct: 157 --------------------------ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVI 190
Query: 347 EMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKD-LICRLLCDVEHRLGTLG 405
E+L G PP+Y +P+ +IV +H PE ++PE KD L+ D R
Sbjct: 191 ELLTGNPPYYDLNPMAALFRIVQ-DDHPPLPE--GISPELKDFLMQCFQKDPNLRPTA-- 245
Query: 406 SEQIKAHPWF 415
+Q+ HPW
Sbjct: 246 -KQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 1e-40
Identities = 87/323 (26%), Positives = 140/323 (43%), Gaps = 81/323 (25%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
+ L IG GA GEV ++ +G A+KK++ L + E + E ++ +
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKHPN 76
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF----------YIAQSVL 217
IV Y S+ + L+++MEY+ GG +LT+ + + Y+ + VL
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGG----------SLTDIITQNFVRMNEPQIAYVCREVL 126
Query: 218 -AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLN 276
+E +H N IHRDIK DN+LL ++G +KL+DFG L+
Sbjct: 127 QGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGF-----AAQLTK------------- 168
Query: 277 ESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336
+ ++R S VGTP ++APEV+ +K YG +
Sbjct: 169 ----------------------------EKSKRN---SVVGTPYWMAPEVIKRKDYGPKV 197
Query: 337 DWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL-KFPEEARLTPEAKDLICRLLC 395
D WSLG + EM G PP+ + P+ I + + +PE KD + + L
Sbjct: 198 DIWSLGIMCIEMAEGEPPYLREPPLRALFLIT--TKGIPPLKNPEKWSPEFKDFLNKCLV 255
Query: 396 -DVEHRLGTLGSEQIKAHPWFKD 417
D E R +E++ HP+ K
Sbjct: 256 KDPEKR---PSAEELLQHPFLKK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 3e-40
Identities = 95/321 (29%), Positives = 156/321 (48%), Gaps = 63/321 (19%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS-HC--IV 169
IIGRG FGEV C++ +G +YAMK L K + + ER +L+ V++ C IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 170 KLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIH 229
+ Y+F + L I++ + GGD+ L + +E RFY A+ +L +E +H ++
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 230 RDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESG 289
RD+KP N+LLD++GH+++SD GL
Sbjct: 121 RDLKPANILLDEHGHVRISDLGL------------------------------------A 144
Query: 290 CGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEM 348
C K P +++VGT Y+APEVL K Y DW+SLG +++++
Sbjct: 145 CDFSKKKP---------------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 189
Query: 349 LVGYPPF--YSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLG 405
L G+ PF + ++ ++ P+ +PE + L+ LL DV RLG LG
Sbjct: 190 LRGHSPFRQHKTKDKHEIDRMTLTMA-VELPDS--FSPELRSLLEGLLQRDVNRRLGCLG 246
Query: 406 --SEQIKAHPWFKDIAWDKLY 424
++++K HP+F+ + W ++
Sbjct: 247 RGAQEVKEHPFFRSLDWQMVF 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 3e-40
Identities = 95/328 (28%), Positives = 156/328 (47%), Gaps = 57/328 (17%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
++G+G FGEV CQ + +G +YA KKL+K + R E+ +L +V S +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66
Query: 173 YSFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVARFYIAQSVLAIESIHKHNYIHR 230
Y+++ + L L++ + GGD+ + M E E A FY A+ +E +H+ ++R
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYR 126
Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGC 290
D+KP+N+LLD +GH+++SD GL ++ E + GR
Sbjct: 127 DLKPENILLDDHGHIRISDLGLAV-------------------HVPEGQTIKGR------ 161
Query: 291 GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350
VGT Y+APEV+ + Y DWW+LG ++YEM+
Sbjct: 162 -------------------------VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA 196
Query: 351 GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLG--SE 407
G PF ++ ++ + +P+A+ L LLC D + RLG G +
Sbjct: 197 GQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAR 256
Query: 408 QIKAHPWFKDIAWDKLYE--MEAAYKPE 433
++K HP FK I + +L +E +KP+
Sbjct: 257 EVKEHPLFKQINFKRLEAGMLEPPFKPD 284
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 7e-39
Identities = 87/306 (28%), Positives = 134/306 (43%), Gaps = 63/306 (20%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMK--KLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKL 171
+G G+FG V G+ +A+K L + V+ + E LL+++ IV+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
+ ++ + LY+ +E +PGG + LL + + E V R Y Q +L +E +H N +HRD
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
IK N+L+D NG +KL+DFG+ K
Sbjct: 128 IKGANILVDTNGVVKLADFGMAK------------------------------------- 150
Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLV 350
Q+ A S G+P ++APEV+ ++G YG+ D WSLG + EM
Sbjct: 151 -------------QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMAT 197
Query: 351 GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC---DVEHRLGTLGSE 407
G PP+ + V KI K P+ L+ EAKD I L C D R +
Sbjct: 198 GKPPWSQLEGVAAVFKIGRSKELPPIPDH--LSDEAKDFI--LKCLQRDPSLR---PTAA 250
Query: 408 QIKAHP 413
++ HP
Sbjct: 251 ELLEHP 256
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 1e-37
Identities = 78/318 (24%), Positives = 128/318 (40%), Gaps = 65/318 (20%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH-VRAERNLLAEVA 164
D + + ++G+G+ G V + K +G IYA+KK+ + + + E L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH---VDGDEEFRKQLLRELKTLRSCE 57
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL-AIESIH 223
S +VK Y +F + +++EY+ GG + LL + + E V YIA+ +L ++ +H
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-YIARQILKGLDYLH 116
Query: 224 -KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
K + IHRDIKP NLL++ G +K++DFG+ K L+ T
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT----------------------- 153
Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342
+ VGT Y++PE + + Y D WSLG
Sbjct: 154 --------------------------LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLG 187
Query: 343 AIMYEMLVGYPPFYSD---DPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVE 398
+ E +G PF + I +PE +D I L D +
Sbjct: 188 LTLLECALGKFPFLPPGQPSFFELMQAIC--DGPPPSLPAEEFSPEFRDFISACLQKDPK 245
Query: 399 HRLGTLGSEQIKAHPWFK 416
R ++ HP+ K
Sbjct: 246 KRPSA---AELLQHPFIK 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 7e-37
Identities = 99/322 (30%), Positives = 157/322 (48%), Gaps = 65/322 (20%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS-HC--IV 169
IIGRG FGEV C++ +G +YAMK L K + + ER +L+ V++ C IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 170 KLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIH 229
+ Y+F + L I++ + GGD+ L + +E RFY + +L +E +H ++
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 230 RDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESG 289
RD+KP N+LLD++GH+++SD GL
Sbjct: 121 RDLKPANILLDEHGHVRISDLGL------------------------------------A 144
Query: 290 CGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEM 348
C K P +++VGT Y+APEVL K Y DW+SLG +++++
Sbjct: 145 CDFSKKKP---------------HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKL 189
Query: 349 LVGYPPFY---SDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL 404
L G+ PF + D R + +++ P+ +PE K L+ LL DV RLG L
Sbjct: 190 LRGHSPFRQHKTKDKHEIDRMTL--TVNVELPDS--FSPELKSLLEGLLQRDVSKRLGCL 245
Query: 405 --GSEQIKAHPWFKDIAWDKLY 424
G++++K H +FK I W ++Y
Sbjct: 246 GRGAQEVKEHVFFKGIDWQQVY 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 91/317 (28%), Positives = 153/317 (48%), Gaps = 57/317 (17%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
++G+G FGEV CQ + +G +YA K+L+K + R E+ +L +V S +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66
Query: 173 YSFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVARFYIAQSVLAIESIHKHNYIHR 230
Y+++ + L L++ + GGD+ + M E A FY A+ + +E +H+ N ++R
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYR 126
Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGC 290
D+KP+N+LLD GH+++SD GL A+ + E + GR
Sbjct: 127 DLKPENILLDDYGHIRISDLGL----------AV---------KIPEGESIRGR------ 161
Query: 291 GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350
VGT Y+APEVL + Y + D+W LG ++YEM+
Sbjct: 162 -------------------------VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIE 196
Query: 351 GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC--DVEHRLGTL--GS 406
G PF ++ + A+ + EAK IC++L D + RLG G+
Sbjct: 197 GQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKS-ICKMLLTKDPKQRLGCQEEGA 255
Query: 407 EQIKAHPWFKDIAWDKL 423
++K HP+F+++ + +L
Sbjct: 256 GEVKRHPFFRNMNFKRL 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 93/323 (28%), Positives = 149/323 (46%), Gaps = 69/323 (21%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
++G+G FGEV CQ + +G +YA KKL+K + R E+ +L +V S +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 173 YSFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVARFYIAQSVLAIESIHKHNYIHR 230
Y+++ + L L++ + GGD+ + M E A FY A+ +E + + ++R
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYR 126
Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGC 290
D+KP+N+LLD GH+++SD GL + E V GR
Sbjct: 127 DLKPENILLDDRGHIRISDLGLAV-------------------QIPEGETVRGR------ 161
Query: 291 GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350
VGT Y+APEV+ + Y DWW LG ++YEM+
Sbjct: 162 -------------------------VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQ 196
Query: 351 GYPPFYSDDPVTTCRKIVHWKN---HLKFPEEA---RLTPEAKDLICRLLC--DVEHRLG 402
G PF ++ V + +K +E + + +AK ICR+L + + RLG
Sbjct: 197 GQSPFRKR------KERVKREEVDRRVKEDQEEYSEKFSEDAKS-ICRMLLTKNPKERLG 249
Query: 403 TLGS--EQIKAHPWFKDIAWDKL 423
G+ +K HP FK+I + +L
Sbjct: 250 CRGNGAAGVKQHPIFKNINFKRL 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 1e-35
Identities = 84/291 (28%), Positives = 126/291 (43%), Gaps = 57/291 (19%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
DF++L IG+G+FG V K +YAMK++ S+M R + E + E +LA++ S
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-EARVLAKLDSS 59
Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL--MREETLTET-VARFYIAQSVLAIESIH 223
I++ Y SF D L ++MEY GD+ LL R L E V RF+I Q +L + +H
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QILLGLAHLH 118
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDG 283
+HRDIK NL LD ++K+ D G+ K L
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN---------------------- 156
Query: 284 RFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 343
A + VGTP Y++PE+ K Y + D W+LG
Sbjct: 157 ---------------------------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGV 189
Query: 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLL 394
++YE G PF +++ KI+ P + + LI + L
Sbjct: 190 VLYECCTGKHPFDANNQGALILKIIRGVFP---PVSQMYSQQLAQLIDQCL 237
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-35
Identities = 73/261 (27%), Positives = 115/261 (44%), Gaps = 61/261 (23%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
D+++L IG+G+FG VR + K G I K++ M + + + + +E N+L E+
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHP 59
Query: 167 CIVKLYYSFQD--AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYI----AQSVLAIE 220
IV+ Y D + LY++MEY GGD+ L+ + + + + +I Q +LA+
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 221 SIH-----KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENL 275
H + +HRD+KP N+ LD N ++KL DFGL K L
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG------------------ 161
Query: 276 NESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME 335
+ A + VGTP Y++PE L Y +
Sbjct: 162 -------------------------------HDSSFAKTYVGTPYYMSPEQLNHMSYDEK 190
Query: 336 CDWWSLGAIMYEMLVGYPPFY 356
D WSLG ++YE+ PPF
Sbjct: 191 SDIWSLGCLIYELCALSPPFT 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 3e-35
Identities = 83/284 (29%), Positives = 128/284 (45%), Gaps = 50/284 (17%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLK--KSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
++G+GAFG V LC + +G A+K++ ++ +V + E LL + IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 171 LYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHR 230
Y +D E L + MEY+PGG V L LTETV R Y Q + +E +H + +HR
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHR 128
Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGC 290
DIK N+L D G++KL DFG K L SG
Sbjct: 129 DIKGANILRDSAGNVKLGDFGASKRLQTICS--------------------------SGT 162
Query: 291 GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350
G + S GTP +++PEV+ +GYG + D WS+G + EML
Sbjct: 163 GMK--------------------SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
Query: 351 GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLL 394
PP+ + + KI + + P ++P+A++ + R
Sbjct: 203 EKPPWAEFEAMAAIFKIATQPTNPQLPSH--VSPDARNFLRRTF 244
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 1e-34
Identities = 81/255 (31%), Positives = 119/255 (46%), Gaps = 57/255 (22%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKK--LKKSEMLSRGQVEHVRAERNLLAEV 163
+ F LL IG+G+FGEV +K++ + A+K L+++E ++E ++ E L++
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE----DEIEDIQQEIQFLSQC 56
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH 223
S I K Y SF L++IMEY GG + LL + L ET F + + +L +E +H
Sbjct: 57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLH 115
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDG 283
+ IHRDIK N+LL + G +KL+DFG V G
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFG-----------------------------VSG 146
Query: 284 RFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 343
QL R + VGTP ++APEV+ + GY + D WSLG
Sbjct: 147 ----------------QLTSTMSKRN----TFVGTPFWMAPEVIKQSGYDEKADIWSLGI 186
Query: 344 IMYEMLVGYPPFYSD 358
E+ G PP SD
Sbjct: 187 TAIELAKGEPP-LSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 8e-34
Identities = 80/291 (27%), Positives = 129/291 (44%), Gaps = 58/291 (19%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
+ FD+L +G G++G V K++G + A+K + ++ + E ++L + S
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKV-----VPVEEDLQEIIKEISILKQCDS 57
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFYIAQSVLAIESIHK 224
IVK Y S+ L+++MEY G V ++ + +TLTE + Q++ +E +H
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS 117
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
+ IHRDIK N+LL++ G KL+DFG+
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGV-------------------------------- 145
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344
SG QL R + +GTP ++APEV+ + GY + D WSLG
Sbjct: 146 ---SG----------QLTDTMAKRN----TVIGTPFWMAPEVIQEIGYNNKADIWSLGIT 188
Query: 345 MYEMLVGYPPFYSDDPVTTCRKIVHWK-NHLKFPEEARLTPEAKDLICRLL 394
EM G PP+ P+ I + L PE + +PE D + + L
Sbjct: 189 AIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPE--KWSPEFNDFVKKCL 237
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 4e-33
Identities = 85/306 (27%), Positives = 127/306 (41%), Gaps = 55/306 (17%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
IG G FG+V +G + A+K+++ + ++ + E +L E+ H + YY
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQD-NDPKTIKEIADEMKVL-ELLKHPNLVKYY 65
Query: 174 SFQ-DAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDI 232
+ E +Y+ MEY GG + LL L E V R Y Q + + +H H +HRDI
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDI 125
Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGR 292
KP N+ LD NG +KL DFG L
Sbjct: 126 KPANIFLDHNGVIKLGDFGCAVKL----------------------------------KN 151
Query: 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAIMYEML 349
+ E++Q GTP Y+APEV+ KG+G D WSLG ++ EM
Sbjct: 152 NTTTMGEEVQSL-----------AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMA 200
Query: 350 VGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICR-LLCDVEHRLGTLGSEQ 408
G P+ D V + P+ +L+PE KD + R L D + R +
Sbjct: 201 TGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTA---SE 257
Query: 409 IKAHPW 414
+ HP+
Sbjct: 258 LLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 7e-33
Identities = 90/333 (27%), Positives = 134/333 (40%), Gaps = 87/333 (26%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN--LLAEVASHCIVKL 171
IG G +G V ++K +G I A+KK+K + A R LL E+ I+KL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRF---ESEGIPKTALREIKLLKELNHPNIIKL 63
Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFYIAQSVLAIESIHKHNYIHR 230
F+ LYL+ E++ D+ L+ R+ L E++ + Y+ Q + + H H +HR
Sbjct: 64 LDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHR 122
Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGC 290
D+KP+NLL++ G +KL+DFGL + S R
Sbjct: 123 DLKPENLLINTEGVLKLADFGLAR-----------------------SFGSPVRPYTHYV 159
Query: 291 GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEML 349
RW Y APE+LL KGY D WS+G I E+L
Sbjct: 160 VTRW--------------------------YRAPELLLGDKGYSTPVDIWSVGCIFAELL 193
Query: 350 VGYPPFYSDDPVTTCRKI---------VHWK--------NHLKFPEEARLT--------- 383
P F + KI W FP++A +
Sbjct: 194 SRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNAS 253
Query: 384 PEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415
P+A DL+ ++L D R + +EQ AHP+F
Sbjct: 254 PQALDLLSQMLHYDPHKR---ITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-31
Identities = 65/254 (25%), Positives = 110/254 (43%), Gaps = 58/254 (22%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
DF +L +G+G++G V + YA+K++ M S+ + E E +LA V
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHP 59
Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETL-----TETVARFYIAQSVLAIES 221
I+ +F D L ++MEY P GD+ + + + + + R +I Q + +++
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QLLRGLQA 118
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
+H+ +HRD+K N+LL N +K+ D G+ K L
Sbjct: 119 LHEQKILHRDLKSANILLVANDLVKIGDLGISKVL------------------------- 153
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341
++ +A + +GTP Y+APEV + Y + D WSL
Sbjct: 154 --------------------------KKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSL 187
Query: 342 GAIMYEMLVGYPPF 355
G ++YEM PPF
Sbjct: 188 GCLLYEMATFAPPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 86/317 (27%), Positives = 142/317 (44%), Gaps = 70/317 (22%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
D IG G+ G V + +K +G A+KK+ + R E + E ++ +
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHP 76
Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL-AIESIHKH 225
IV++Y S+ + L+++ME+L GG + ++ E +A + +VL A+ +H
Sbjct: 77 NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--TVCLAVLKALSFLHAQ 134
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
IHRDIK D++LL +G +KLSDFG C + S +V
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQV---------------------SKEVP--- 170
Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345
RRK S VGTP ++APEV+ + YG E D WSLG ++
Sbjct: 171 ----------------------RRK---SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMV 205
Query: 346 YEMLVGYPPFYSDDPVTTCRKI-----VHWKNHLKFPEEARLTPEAKDLICRLLC-DVEH 399
EM+ G PP++++ P+ ++I KN K ++P + + R+L D
Sbjct: 206 IEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHK------VSPRLRSFLDRMLVRDPAQ 259
Query: 400 RLGTLGSEQIKAHPWFK 416
R + ++ HP+
Sbjct: 260 R---ATAAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 2e-30
Identities = 91/335 (27%), Positives = 136/335 (40%), Gaps = 86/335 (25%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRG-QVEHVRAERNLLAEVASH-CI 168
L +G G +G V ++KK+G I A+KK++ + G +R E +LL E+ H I
Sbjct: 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRL-DNEEEGIPSTALR-EISLLKEL-KHPNI 60
Query: 169 VKLYYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFYIAQSVLAIESIHKHNY 227
VKL LYL+ EY D+ L R L+ + + + Q + + H H
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRI 119
Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
+HRD+KP N+L++++G +KL+DFGL
Sbjct: 120 LHRDLKPQNILINRDGVLKLADFGL----------------------------------- 144
Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 346
R + PL H V T Y APE+LL K Y D WS+G I
Sbjct: 145 ---ARAFGIPLRTYTHE-----------VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFA 190
Query: 347 EMLVGYPPFYSDDPVTTCRKI------------------VHWKNHL-KFPEEA------R 381
EM+ G P F D + KI +K KFP + R
Sbjct: 191 EMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPR 250
Query: 382 LTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415
L PE DL+ ++L + R + +++ HP+F
Sbjct: 251 LDPEGIDLLSKMLQYNPAKR---ISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 80/345 (23%), Positives = 125/345 (36%), Gaps = 96/345 (27%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKK--LKKSEMLSRGQVEHVRA-ERNLLAEV 163
+ +L IG GA G V +++++G A+KK L++ E G + + E L
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE----GGIPNQALREIKALQAC 56
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH 223
+VKL F L+MEY+P L E L E + Y+ + + +H
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDG 283
+ +HRD+KP NLL+ +G +K++DFGL + + +
Sbjct: 117 ANGIMHRDLKPANLLISADGVLKIADFGLARLFS----------------------EEEP 154
Query: 284 RFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLG 342
R RW Y APE+L + Y D W++G
Sbjct: 155 RLYSHQVATRW--------------------------YRAPELLYGARKYDPGVDLWAVG 188
Query: 343 AIMYEMLVGYP--------------------------PFYSDDP-----VTTCRKIVHWK 371
I E+L G P P + P K + +
Sbjct: 189 CIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLE 248
Query: 372 NHLKFPEEARLTPEAKDLICRLL-CDVEHRLGTLGSEQIKAHPWF 415
FP+ +PEA DL+ LL D R L + + HP+F
Sbjct: 249 EI--FPDA---SPEALDLLKGLLVYDPSKR---LSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-29
Identities = 88/307 (28%), Positives = 139/307 (45%), Gaps = 57/307 (18%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLK---KSEMLSRGQVEHVRAERNLLAEVASHCIV 169
++G+GAFG V LC + +G A K+++ +S S+ +V + E LL + IV
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSK-EVSALECEIQLLKNLQHERIV 67
Query: 170 KLYYSFQD--AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
+ Y +D + L + MEY+PGG V L LTE+V R Y Q + + +H +
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127
Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
+HRDIK N+L D G++KL DFG K L +
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICM-------------------------- 161
Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 347
SG G R S GTP +++PEV+ +GYG + D WSLG + E
Sbjct: 162 SGTGIR--------------------SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVE 201
Query: 348 MLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLGSE 407
ML PP+ + + KI + + P + ++ A+D + + + HR +E
Sbjct: 202 MLTEKPPWAEYEAMAAIFKIATQPTNPQLP--SHISEHARDFLGCIFVEARHR---PSAE 256
Query: 408 QIKAHPW 414
++ HP+
Sbjct: 257 ELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 91/317 (28%), Positives = 142/317 (44%), Gaps = 59/317 (18%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
+G+G FGEV Q K +G +YA KKL K + + + E+ +L +V S IV L Y
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVAR--FYIAQSVLAIESIHKHNYIHRD 231
+F+ +L L+M + GGD+ + + R Y AQ I +H + ++RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
+KP+N+LLD D G C+ L D L + DG+
Sbjct: 121 MKPENVLLD--------DQGNCR---------------LSDLGLAVELK-DGK------- 149
Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 351
+ Q GT Y+APE+L ++ Y DW+++G +YEM+ G
Sbjct: 150 -----TITQ--------------RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAG 190
Query: 352 YPPF--YSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC--DVEHRLGTLG-S 406
PF + + K ++ +KF E T E+KD ICRL E RLG+ +
Sbjct: 191 RTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKD-ICRLFLAKKPEDRLGSREKN 248
Query: 407 EQIKAHPWFKDIAWDKL 423
+ + H +FK I + +L
Sbjct: 249 DDPRKHEFFKTINFPRL 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-28
Identities = 80/268 (29%), Positives = 113/268 (42%), Gaps = 63/268 (23%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
+++L ++G G+FG L Q S YAMK+++ + S VE R E LLA++
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHP 58
Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTL--LMREETLTETVARFYIAQSVLAIESIHK 224
IV SF+ +LY++MEY GGD+M L R + E + Q L ++ IH+
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
+HRDIK N+ L QNG +KL DF
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDF---------------------------------- 144
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344
G R SP A + VGTP Y+ PE+ Y + D WSLG I
Sbjct: 145 ----GSARLLTSPG-----------AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCI 189
Query: 345 MYEMLVGYPPFYSDDPVTTCRKIVHWKN 372
+YE+ PF ++ WKN
Sbjct: 190 LYELCTLKHPFQANS----------WKN 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 4e-28
Identities = 74/249 (29%), Positives = 113/249 (45%), Gaps = 49/249 (19%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLK------KSEMLSRGQVEHVRAERNLLAEVASH 166
+IG G+FG V L SG + A+K+++ S+ R ++ + E LL E+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHN 226
IV+ S DA++L + +EY+PGG V LL ET+ R ++ Q + + +H
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126
Query: 227 YIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFP 286
IHRDIK N+L+D G +K+SDFG+ K L+ +LS
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLST----------------------- 163
Query: 287 ESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 346
P S G+ ++APEV+ + Y + D WSLG ++
Sbjct: 164 ----KTNGARP----------------SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVV 203
Query: 347 EMLVGYPPF 355
EML G PF
Sbjct: 204 EMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 87/333 (26%), Positives = 139/333 (41%), Gaps = 86/333 (25%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMK--KLKKSEMLSRGQVEHVRAERNLLAE 162
F+L+ +IG G +G+V + KK+G + A+K + + E E ++ E N+L +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE------EEEIKEEYNILRK 58
Query: 163 VASH-CIVKLYYSF------QDAEYLYLIMEYLPGGDVM----TLLMREETLTETVARFY 211
++H I Y +F + + L+L+ME GG V L + + L E +
Sbjct: 59 YSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI 118
Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD 271
+ +++ + +H++ IHRDIK N+LL +N +KL DFG+ LD T
Sbjct: 119 LRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL----------- 167
Query: 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL---- 327
GRR + +GTP ++APEV+
Sbjct: 168 -------------------GRR-------------------NTFIGTPYWMAPEVIACDE 189
Query: 328 -LKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKN---HLKFPEEARLT 383
Y D WSLG E+ G PP P+ KI +N LK PE +
Sbjct: 190 QPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP--RNPPPTLKSPE--NWS 245
Query: 384 PEAKDLI--CRLLCDVEHRLGTLGSEQIKAHPW 414
+ D I C L+ + E R E++ HP+
Sbjct: 246 KKFNDFISEC-LIKNYEQRPFM---EELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 7e-28
Identities = 66/255 (25%), Positives = 108/255 (42%), Gaps = 51/255 (20%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
DD++L+ +IG GA V + A+K++ + + V+ +R E +++
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCNH 58
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGG---DVMTLLMREETLTETVARFYIAQSVLAIESI 222
+VK Y SF + L+L+M YL GG D+M L E + + + + +E +
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
H + IHRDIK N+LL ++G +K++DFG V
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFG-----------------------------VS 149
Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL-LKKGYGMECDWWSL 341
+ G RK+ + VGTP ++APEV+ GY + D WS
Sbjct: 150 ASLADGGD----------------RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSF 193
Query: 342 GAIMYEMLVGYPPFY 356
G E+ G P+
Sbjct: 194 GITAIELATGAAPYS 208
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 9e-28
Identities = 52/156 (33%), Positives = 86/156 (55%), Gaps = 22/156 (14%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK-----SEMLSRGQVEHVRAERNLLAE 162
+ ++ +G G FG V L + K++G + A+KK+KK E + + V++ L +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECM---NLREVKS----LRK 53
Query: 163 VASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTL--LMREET---LTETVARFYIAQSV 216
+ H IVKL F++ + LY + EY+ G L LM++ +E+V R I Q +
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYMEG----NLYQLMKDRKGKPFSESVIRSIIYQIL 109
Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
+ IHKH + HRD+KP+NLL+ +K++DFGL
Sbjct: 110 QGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGL 145
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 71/255 (27%), Positives = 120/255 (47%), Gaps = 53/255 (20%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
++++ IG G+FG++ L + K +K++ ++M + + E + E LLA++
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEVILLAKMKHPN 60
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKH 225
IV + SFQ+ L+++MEY GGD+M + R+ +E + Q L ++ IH
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 226 NYIHRDIKPDNLLLDQNGHM-KLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
+HRDIK N+ L +NG + KL DFG+ + LN+SM+
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIAR-------------------QLNDSME---- 157
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344
LAY+ VGTP Y++PE+ + Y + D WSLG +
Sbjct: 158 --------------------------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCV 191
Query: 345 MYEMLVGYPPFYSDD 359
+YE+ PF ++
Sbjct: 192 LYELCTLKHPFEGNN 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-27
Identities = 83/282 (29%), Positives = 133/282 (47%), Gaps = 56/282 (19%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
IG G+ G V + +EK SG A+K + + R E + E ++ + +V++Y
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQHQNVVEMYK 85
Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL-AIESIHKHNYIHRDI 232
S+ E L+++ME+L GG + ++ + E +A + +SVL A+ +H IHRDI
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIAT--VCESVLQALCYLHSQGVIHRDI 143
Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGR 292
K D++LL +G +KLSDFG C + S DV R
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQI---------------------SKDVPKR-------- 174
Query: 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 352
S VGTP ++APEV+ + YG E D WSLG ++ EM+ G
Sbjct: 175 --------------------KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214
Query: 353 PPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLL 394
PP++SD PV +++ K +++P +D + R+L
Sbjct: 215 PPYFSDSPVQAMKRLRD-SPPPKLKNAHKISPVLRDFLERML 255
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 71/271 (26%), Positives = 114/271 (42%), Gaps = 55/271 (20%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
+ +F + IG+G F V G + A+KK++ EM+ + E +LL ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM----REETLTETVARFYIAQSVLAIE 220
++K SF + L +++E GD+ ++ ++ + E Y Q A+E
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
+H +HRDIKP N+ + G +KL D GL
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGL---------------------------- 152
Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340
GRF S + A+S VGTP Y++PE + + GY + D WS
Sbjct: 153 --GRFFSS-------------------KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWS 191
Query: 341 LGAIMYEMLVGYPPFYSD--DPVTTCRKIVH 369
LG ++YEM PFY D + + C+KI
Sbjct: 192 LGCLLYEMAALQSPFYGDKMNLYSLCKKIEK 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 89/308 (28%), Positives = 144/308 (46%), Gaps = 66/308 (21%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
IG+GA G V + +G A+K++ + + E + E ++ E IV
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKHPNIVNYLD 83
Query: 174 SFQDAEYLYLIMEYLPGG---DVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHR 230
S+ + L+++MEYL GG DV+T +E V R + + A+E +H + IHR
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR----ECLQALEFLHSNQVIHR 139
Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGC 290
DIK DN+LL +G +KL+DFG C +
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQI---------------------------------- 165
Query: 291 GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350
+P EQ ++R + VGTP ++APEV+ +K YG + D WSLG + EM+
Sbjct: 166 -----TP-EQ------SKRS---TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE 210
Query: 351 GYPPFYSDDPVTTCRKI-VHWKNHLKFPEEARLTPEAKDLICRLL-CDVEHRLGTLGSEQ 408
G PP+ +++P+ I + L+ PE +L+ +D + R L DVE R +++
Sbjct: 211 GEPPYLNENPLRALYLIATNGTPELQNPE--KLSAIFRDFLNRCLEMDVEKR---GSAKE 265
Query: 409 IKAHPWFK 416
+ HP+ K
Sbjct: 266 LLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 67/259 (25%), Positives = 113/259 (43%), Gaps = 56/259 (21%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
+D++L+ IG G +G+V ++ +G + A+K +K E ++ E ++L E
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRH 59
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDV-MTLLMREETLTETVARFYIAQSVLAIESIHK 224
IV + S+ + L+++MEY GG + + L+E + +++ + +H+
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE 119
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
IHRDIK N+LL ++G +KL+DFG+ L T
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT------------------------- 154
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL---LKKGYGMECDWWSL 341
I +RK S +GTP ++APEV K GY +CD W+L
Sbjct: 155 ---------------------IAKRK---SFIGTPYWMAPEVAAVERKGGYDGKCDIWAL 190
Query: 342 GAIMYEMLVGYPPFYSDDP 360
G E+ PP + P
Sbjct: 191 GITAIELAELQPPMFDLHP 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 2e-26
Identities = 81/293 (27%), Positives = 129/293 (44%), Gaps = 54/293 (18%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLK---KSEMLSRGQVEHVRAERNLLAEVASHCIV 169
++G+GAFG V LC + +G A+K+++ +S S+ +V + E LL + IV
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSK-EVNALECEIQLLKNLLHERIV 67
Query: 170 KLYYSFQDA--EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
+ Y +D L + ME++PGG + L LTE V R Y Q + + +H +
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMI 127
Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
+HRDIK N+L D G++KL DFG K L L
Sbjct: 128 VHRDIKGANILRDSVGNVKLGDFGASKRLQTICL-------------------------- 161
Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 347
SG G + S GTP +++PEV+ +GYG + D WS+G + E
Sbjct: 162 SGTGMK--------------------SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVE 201
Query: 348 MLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHR 400
ML PP+ + + KI + P ++ +D + R+ + + R
Sbjct: 202 MLTEKPPWAEFEAMAAIFKIATQPTNPVLP--PHVSDHCRDFLKRIFVEAKLR 252
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 85/319 (26%), Positives = 132/319 (41%), Gaps = 66/319 (20%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV---A 164
+ L +IGRGA+G V + +G + A+K + V ++ E LL+++
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQ 60
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK 224
I K Y S+ L++IMEY GG V TL M+ + E I + ++A++ IHK
Sbjct: 61 PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTL-MKAGPIAEKYISVIIREVLVALKYIHK 119
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
IHRDIK N+L+ G++KL DFG+ L
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALL---------------------------- 151
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYST-VGTPDYIAPEVLLK-KGYGMECDWWSLG 342
N K ST VGTP ++APEV+ + K Y + D WSLG
Sbjct: 152 --------------------NQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLG 189
Query: 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFP--EEARLTPEAKDLICRLLCDVEHR 400
+YEM G PP+ D + + K P E+ + ++ + L +
Sbjct: 190 ITIYEMATGNPPYSDVDAF----RAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKE 245
Query: 401 LGTLGSEQIKAHPWFKDIA 419
L +E++ W K +
Sbjct: 246 --RLSAEELLKSKWIKAHS 262
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 77/254 (30%), Positives = 112/254 (44%), Gaps = 60/254 (23%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRA----ERNLLAEV 163
+++L ++G GA+G V C+ K +G I A+KK K+SE E V+ E +L ++
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE-----DDEDVKKTALREVKVLRQL 57
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREET-LTETVARFYIAQSVLAIESI 222
IV L +F+ LYL+ EY+ ++ LL L R YI Q + AI
Sbjct: 58 RHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
H HN IHRDIKP+N+L+ ++G +KL DFG + L S + +
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA------------- 163
Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSL 341
RW Y APE+L+ YG D W++
Sbjct: 164 ---------TRW--------------------------YRAPELLVGDTNYGKPVDVWAI 188
Query: 342 GAIMYEMLVGYPPF 355
G IM E+L G P F
Sbjct: 189 GCIMAELLDGEPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 85/306 (27%), Positives = 135/306 (44%), Gaps = 57/306 (18%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLK---KSEMLSRGQVEHVRAERNLLAEVASHCIV 169
++GRGAFGEV LC + +G A+K++ S+ S+ +V + E LL + IV
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSK-EVNALECEIQLLKNLRHDRIV 67
Query: 170 KLYYSFQDAEY--LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
+ Y +D E L + +EY+PGG + L LTE V R Y Q + + +H +
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMI 127
Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
+HRDIK N+L D G++KL DFG K + +
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRIQTICM-------------------------- 161
Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 347
SG G + S GTP +++PEV+ +GYG + D WS+ + E
Sbjct: 162 SGTGIK--------------------SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVE 201
Query: 348 MLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLGSE 407
ML PP+ + + KI P+ ++ +D + ++ + E R T +E
Sbjct: 202 MLTEKPPWAEYEAMAAIFKIATQPTKPMLPDG--VSDACRDFLKQIFVE-EKRRPT--AE 256
Query: 408 QIKAHP 413
+ HP
Sbjct: 257 FLLRHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 68/253 (26%), Positives = 115/253 (45%), Gaps = 47/253 (18%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLK---KSEMLSRGQVEHVRAERNLLAEVASHCIV 169
++G+GA+G V C G + A+K+++ + + + + E ++ E +LL + IV
Sbjct: 7 VLGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 170 KLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIH 229
+ + D + + ME++PGG + ++L R L E V Y Q + + +H + +H
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVH 125
Query: 230 RDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESG 289
RDIK +N++L NG +KL DFG + L L + N
Sbjct: 126 RDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSN---------------------- 163
Query: 290 CGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 349
+ S GTP ++APEV+ + GYG + D WS+G ++EM
Sbjct: 164 ---------------------MLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMA 202
Query: 350 VGYPPFYSDDPVT 362
G PP S D +
Sbjct: 203 TGKPPLASMDRLA 215
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 3e-25
Identities = 74/255 (29%), Positives = 120/255 (47%), Gaps = 55/255 (21%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
IG G+ G V + EK +G A+KK+ + R E + E ++ + +V +Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR---ELLFNEVVIMRDYHHENVVDMYN 86
Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL-AIESIHKHNYIHRDI 232
S+ + L+++ME+L GG + ++ E +A + SVL A+ +H IHRDI
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT--VCLSVLRALSYLHNQGVIHRDI 144
Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGR 292
K D++LL +G +KLSDFG C +
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVS----------------------------------- 169
Query: 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 352
++ +RK S VGTP ++APEV+ + YG E D WSLG ++ EM+ G
Sbjct: 170 -----------KEVPKRK---SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215
Query: 353 PPFYSDDPVTTCRKI 367
PP++++ P+ R+I
Sbjct: 216 PPYFNEPPLQAMRRI 230
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 4e-25
Identities = 66/250 (26%), Positives = 109/250 (43%), Gaps = 49/250 (19%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ---VEHVRAERNLLAEVASHCIV 169
+G GAF ++ K+G + A+K++ S Q VE +R E L+A + I+
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 170 KLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIH 229
++ + + + L +E++ GG V LL + E V Y Q + + +H++ IH
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIH 126
Query: 230 RDIKPDNLLLDQNGH-MKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPES 288
RD+K NLL+D G ++++DFG +A L G F
Sbjct: 127 RDVKGANLLIDSTGQRLRIADFG----------AAA---------RLAAKGTGAGEF--- 164
Query: 289 GCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 348
Q Q +GT ++APEVL + YG CD WS+G ++ EM
Sbjct: 165 -----------QGQ------------LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEM 201
Query: 349 LVGYPPFYSD 358
PP+ ++
Sbjct: 202 ATAKPPWNAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (259), Expect = 7e-25
Identities = 97/335 (28%), Positives = 155/335 (46%), Gaps = 72/335 (21%)
Query: 92 ETEYMRLKRHKISVDD----FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR 147
+ E M R +S+ D + IG+GA G V + +G A+K++ + +
Sbjct: 1 DEEIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN---LQKQ 57
Query: 148 GQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG---DVMTLLMREETLT 204
+ E + E ++ E+ + IV SF + L+++MEYL GG DV+T +E
Sbjct: 58 PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQI 117
Query: 205 ETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264
V R + + A+E +H + IHRDIK DN+LL +G +KL+DFG C
Sbjct: 118 AAVCR----ECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCA---------- 163
Query: 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYST-VGTPDYIA 323
QI + ST VGTP ++A
Sbjct: 164 ----------------------------------------QITPEQSKRSTMVGTPYWMA 183
Query: 324 PEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKI-VHWKNHLKFPEEARL 382
PEV+ +K YG + D WSLG + EM+ G PP+ +++P+ I + L+ PE +L
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE--KL 241
Query: 383 TPEAKDLICRLL-CDVEHRLGTLGSEQIKAHPWFK 416
+P +D + R L DVE R G+ ++++ HP+ K
Sbjct: 242 SPIFRDFLNRCLEMDVEKR-GS--AKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 79/284 (27%), Positives = 137/284 (48%), Gaps = 60/284 (21%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
IG G+ G V + K SG + A+KK+ + R E + E ++ + +V++Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHENVVEMYN 84
Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL-AIESIHKHNYIHRDI 232
S+ + L+++ME+L GG + ++ E +A + +VL A+ +H IHRDI
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA--VCLAVLKALSVLHAQGVIHRDI 142
Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGR 292
K D++LL +G +KLSDFG C + +++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFC--------AQVSK-------------------------- 168
Query: 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 352
++ RRK S VGTP ++APE++ + YG E D WSLG ++ EM+ G
Sbjct: 169 ------------EVPRRK---SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213
Query: 353 PPFYSDDPVTTCRKIVHWKNHL--KFPEEARLTPEAKDLICRLL 394
PP++++ P+ + I +++L K +++P K + RLL
Sbjct: 214 PPYFNEPPLKAMKMI---RDNLPPKLKNLHKVSPSLKGFLDRLL 254
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 72/290 (24%), Positives = 133/290 (45%), Gaps = 60/290 (20%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLK-------KSEMLSRGQVEHVRAERNLLAEVAS 165
+IG+G +G V L +G + A+K+++ + + + V+ +R+E L ++
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 166 HCIVKLYYSFQDAE-YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK 224
IV+ Y F+ E YL + +EY+PGG + + L E + RF+ Q + + +H
Sbjct: 68 LNIVQ-YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
+HRD+K DNLL+D +G K+SDFG+ K +++ +D+N++
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGISKK---------SDDIYDNDQNMS-------- 169
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEV--LLKKGYGMECDWWSLG 342
+Q G+ ++APEV +GY + D WSLG
Sbjct: 170 ----------------MQ--------------GSVFWMAPEVIHSYSQGYSAKVDIWSLG 199
Query: 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEE--ARLTPEAKDLI 390
++ EM G P+ ++ + K+ + ++ P + L+P A D +
Sbjct: 200 CVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFL 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 79/330 (23%), Positives = 127/330 (38%), Gaps = 78/330 (23%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAER--NLLAEVASHCIVKL 171
+G G + V ++K++G I A+KK+K E + A R LL E+ I+ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
F + L+ E++ + + LT + Y+ ++ +E +H + +HRD
Sbjct: 68 LDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRD 127
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
+KP+NLL+ +G +KL+DFGL
Sbjct: 128 LKPNNLLIASDGVLKLADFGLA-------------------------------------- 149
Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLV 350
R + SP ++ H V T Y APE+L + YG+ D WS+G I E+L+
Sbjct: 150 RSFGSPNRKMTH-----------QVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL 198
Query: 351 GYPPFYSDDPVTTCRKIVH---------WKNHLKFPEEARLTP---------------EA 386
P D + KI W P+ P +A
Sbjct: 199 RVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDA 258
Query: 387 KDLICRLLCDVEHRLGTLGSEQIKAHPWFK 416
DL+ RLL ++ T + Q HP+F
Sbjct: 259 LDLLQRLLTLNPNKRIT--ARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 7e-24
Identities = 74/284 (26%), Positives = 122/284 (42%), Gaps = 55/284 (19%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
++G+GAFGE L + + ++ K++ + LS + E +L+ + I+ Y
Sbjct: 7 VLGKGAFGEATLYRRTEDDSLVVWKEVNLTR-LSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 173 YSFQDAEYLYLIMEYLPGGDVMTLLMREET--LTETVARFYIAQSVLAIESIHKHNYIHR 230
F D L + MEY GG + ++R++ E + +Y+ Q V A+ IHK +HR
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHR 125
Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGC 290
DIK N+ L + G +KL DFG+ K +L E
Sbjct: 126 DIKTLNIFLTKAGLIKLGDFGISK--------------ILGSEYS--------------- 156
Query: 291 GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350
+A + VGTP Y++PE+ Y + D W+LG ++YE+L
Sbjct: 157 --------------------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT 196
Query: 351 GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLL 394
F + +P+ KIV N+ P + + E L+ LL
Sbjct: 197 LKRTFDATNPLNLVVKIVQ-GNYT--PVVSVYSSELISLVHSLL 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 78/277 (28%), Positives = 121/277 (43%), Gaps = 68/277 (24%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
D ++++ IG+G +G+V KK G++ A+K L + E + AE N+L + +
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD----EEIEAEYNILQSLPN 77
Query: 166 H-CIVKLYYSFQDAEY-----LYLIMEYLPGGDVMTL----LMREETLTETVARFYIAQS 215
H +VK Y F A+ L+L++E GG V L L+ + L E + + + +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENL 275
+L ++ +H + IHRD+K +N+LL G +KL DFG+ L T L
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL-------------- 183
Query: 276 NESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL-----LKK 330
RR ++VGTP ++APEV+
Sbjct: 184 --------------------------------RRN---TSVGTPFWMAPEVIACEQQYDY 208
Query: 331 GYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKI 367
Y CD WSLG E+ G PP + PV T KI
Sbjct: 209 SYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 1e-23
Identities = 64/238 (26%), Positives = 108/238 (45%), Gaps = 52/238 (21%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
IG G+FG+ L + K+ G Y +K++ S+M + + E R E +L+ + IV+
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNMKHPNIVQYQE 66
Query: 174 SFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
SF++ LY++M+Y GGD+ + R E + Q LA++ +H +HRD
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRD 126
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
IK N+ L ++G +KL DFG+ + L+ T
Sbjct: 127 IKSQNIFLTKDGTIKLGDFGIARVLNST-------------------------------- 154
Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 349
+LA + +GTP Y++PE+ + Y + D W+LG ++YEM
Sbjct: 155 -----------------VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMC 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 94/335 (28%), Positives = 152/335 (45%), Gaps = 72/335 (21%)
Query: 92 ETEYMRLKRHKISVDD----FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR 147
+ E + R +SV D + IG+GA G V + +G A+K++ + +
Sbjct: 1 DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK 60
Query: 148 GQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG---DVMTLLMREETLT 204
E + E ++ E + IV S+ + L+++MEYL GG DV+T +E
Sbjct: 61 ---ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 117
Query: 205 ETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264
V R + + A++ +H + IHRDIK DN+LL +G +KL+DFG C
Sbjct: 118 AAVCR----ECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA---------- 163
Query: 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYST-VGTPDYIA 323
QI + ST VGTP ++A
Sbjct: 164 ----------------------------------------QITPEQSKRSTMVGTPYWMA 183
Query: 324 PEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKI-VHWKNHLKFPEEARL 382
PEV+ +K YG + D WSLG + EM+ G PP+ +++P+ I + L+ PE RL
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE--RL 241
Query: 383 TPEAKDLICRLL-CDVEHRLGTLGSEQIKAHPWFK 416
+ +D + R L DV+ R G+ ++++ HP+ K
Sbjct: 242 SAVFRDFLNRCLEMDVDRR-GS--AKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 93/349 (26%), Positives = 143/349 (40%), Gaps = 95/349 (27%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
SVD+++ L I G +G V ++KK+G I A+KKLK + + +R E N+L ++
Sbjct: 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKL 61
Query: 164 ASHCIVKLYY----SFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVARFYIAQSVL 217
IV + S D +Y++MEY+ D+ +L+ M++ L V + + Q +
Sbjct: 62 QHPNIVTVKEVVVGSNLDK--IYMVMEYVEH-DLKSLMETMKQPFLQSEV-KCLMLQLLS 117
Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNE 277
+ +H + +HRD+K NLLL+ G +K+ DFGL
Sbjct: 118 GVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGL------------------------- 152
Query: 278 SMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMEC 336
R + SPL+ V T Y APE+LL K Y
Sbjct: 153 -------------AREYGSPLKPYTQ-----------LVVTLWYRAPELLLGAKEYSTAI 188
Query: 337 DWWSLGAIMYEML---------------------VGYP-----PFYSDDP-VTTCRKIVH 369
D WS+G I E+L +G P P +S+ P +
Sbjct: 189 DMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKY 248
Query: 370 WKNHL--KFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415
N L KFP L+ DL+ RLL D R+ + +K HP+F
Sbjct: 249 PYNQLRKKFP-ALSLSDNGFDLLNRLLTYDPAKRIS--AEDALK-HPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 5e-23
Identities = 67/278 (24%), Positives = 114/278 (41%), Gaps = 59/278 (21%)
Query: 110 LLTIIGRGAFGEVRLCQ-EKKSGNIY---AMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
L +G GAFGEV + + K G A+K LK+ Q+E E ++ ++
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQ--QIEEFLREARIMRKL-D 59
Query: 166 H-CIVKLYYSFQDAEYLYLIMEYLPGGDVMT-LLMREETLTETVARFYIAQSVLAIESIH 223
H +VKL + E LY++MEY+ GGD+++ L L+ + + Q +E +
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDG 283
N+IHRD+ N L+ +N +K+SDFGL + ++ DD+ + G
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSR-------------DLYDDDYYRKR---GG 163
Query: 284 RFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 343
+ P RW +APE L + + + D WS G
Sbjct: 164 KLP-----IRW---------------------------MAPESLKEGKFTSKSDVWSFGV 191
Query: 344 IMYEML-VGYPPFYSDDPVTTCRKIVHWKNHLKFPEEA 380
+++E+ +G P+ + + L P
Sbjct: 192 LLWEIFTLGEQPYPGMSNEEVLEYLKN-GYRLPQPPNC 228
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 7e-23
Identities = 89/318 (27%), Positives = 142/318 (44%), Gaps = 67/318 (21%)
Query: 92 ETEYMRLKRHKISVDD----FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR 147
+ E + R +SV D + IG+GA G V + +G A++++ + +
Sbjct: 2 DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61
Query: 148 GQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG---DVMTLLMREETLT 204
E + E ++ E + IV S+ + L+++MEYL GG DV+T +E
Sbjct: 62 ---ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 118
Query: 205 ETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264
V R + + A+E +H + IHRDIK DN+LL +G +KL+DFG C
Sbjct: 119 AAVCR----ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA---------- 164
Query: 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAP 324
Q+ Q R + VGTP ++AP
Sbjct: 165 -----------------------------------QITPEQSKRSTM----VGTPYWMAP 185
Query: 325 EVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKI-VHWKNHLKFPEEARLT 383
EV+ +K YG + D WSLG + EM+ G PP+ +++P+ I + L+ PE +L+
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE--KLS 243
Query: 384 PEAKDLICRLL-CDVEHR 400
+D + R L DVE R
Sbjct: 244 AIFRDFLNRCLDMDVEKR 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 8e-23
Identities = 72/267 (26%), Positives = 112/267 (41%), Gaps = 55/267 (20%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
+F + IGRG F EV A+KK++ EM+ + E +LL ++
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM----REETLTETVARFYIAQSVLAIESI 222
++K SF + L +++E GD+ ++ ++ + E Y Q A+E +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
H +HRDIKP N+ + G +KL D GL
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGL------------------------------ 152
Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342
GRF S + A+S VGTP Y++PE + + GY + D WSLG
Sbjct: 153 GRFFSS-------------------KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLG 193
Query: 343 AIMYEMLVGYPPFYSD--DPVTTCRKI 367
++YEM PFY D + + C+KI
Sbjct: 194 CLLYEMAALQSPFYGDKMNLFSLCQKI 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 9e-23
Identities = 75/254 (29%), Positives = 113/254 (44%), Gaps = 59/254 (23%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
F L IG+G+FGEV + ++ + A+K + E + ++E ++ E +L++ S
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPY 63
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR---EETLTETVARFYIAQSVLAIESIHK 224
I + Y S+ L++IMEYL GG + LL EET T+ R + + ++ +H
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR----EILKGLDYLHS 119
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
IHRDIK N+LL + G +KL+DFG+
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAG------------------------------ 149
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344
QL QI R VGTP ++APEV+ + Y + D WSLG
Sbjct: 150 ---------------QLTDTQIKRNTF----VGTPFWMAPEVIKQSAYDFKADIWSLGIT 190
Query: 345 MYEMLVGYPPFYSD 358
E+ G PP SD
Sbjct: 191 AIELAKGEPP-NSD 203
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-22
Identities = 75/305 (24%), Positives = 130/305 (42%), Gaps = 74/305 (24%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSG-NIYAMKK-------LKKSEMLSRGQVEHVRAERNL 159
+ +L +G GAFG V ++K +G N+ A+K+ K + + + +E +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 160 LAEVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDV----MTLLMREETLTETVARFYIAQ 214
+ E H IV+ Y +F + + LY++M+ + G + +L +++ TE Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 215 SVLAIESIHKHNYI-HRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDE 273
VLA+ +HK I HRD+ P+N++L ++ + ++DFGL K
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ------------------ 163
Query: 274 NLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG 333
K P +L S VGT Y PE++ + YG
Sbjct: 164 ---------------------KQPESKLT-----------SVVGTILYSCPEIVKNEPYG 191
Query: 334 MECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVH----------WKNHLKFPEEARLT 383
+ D W+ G I+Y+M PPFYS + ++ KIV + + + LT
Sbjct: 192 EKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLT 251
Query: 384 PEAKD 388
P+A+
Sbjct: 252 PDAEA 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 75/265 (28%), Positives = 117/265 (44%), Gaps = 57/265 (21%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSE---MLSRGQVEHVRAERNLLAEVA 164
++ L ++G G++G V C+ K++G I A+KK +SE M+ + + +R +L ++
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIR----MLKQLR 58
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK 224
+V L F+ + LYL+ E++ + L L E+ R Y+ Q + IE H
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
HN IHRDIKP+N+L+ Q+G +KL DFG + L EV D
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-------GEVYTDY----------- 160
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGA 343
RW Y APE+L+ YG D W++G
Sbjct: 161 -----VATRW--------------------------YRAPELLVGDTKYGRAVDIWAVGC 189
Query: 344 IMYEMLVGYPPFYSDDPVTTCRKIV 368
++ EML G P F D + I+
Sbjct: 190 LVTEMLTGEPLFPGDSDIDQLYHII 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (242), Expect = 1e-22
Identities = 69/300 (23%), Positives = 116/300 (38%), Gaps = 63/300 (21%)
Query: 110 LLTIIGRGAFGEVRLCQEKKSGNIY----AMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
L +G GAFGEV K G A+K LK+ + E E +++ +++
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEE--EREEFLEEASIMKKLSH 60
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSV-LAIESIHK 224
IV+L E LY++ EY+PGGD++ L + +A + +E +
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
N++HRD+ N L+ +N +K+SDFGL + ++ +D+ G+
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSR-------------DIYEDDYY--RKRGGGK 165
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344
P +W +APE L + + D WS G +
Sbjct: 166 LP-----IKW---------------------------MAPESLKDGKFTSKSDVWSFGVL 193
Query: 345 MYEML-VGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC---DVEHR 400
++E+ +G P+ + L PE E +L+ L C D E R
Sbjct: 194 LWEIFTLGEQPYPGMSNEEVLELLED-GYRLPRPENC--PDELYELM--LQCWAYDPEDR 248
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 64/266 (24%), Positives = 108/266 (40%), Gaps = 59/266 (22%)
Query: 110 LLTIIGRGAFGEVRLCQ-EKKSGNIY---AMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
L +G GAFGEV + K A+K LK+ Q+E E ++ ++
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQ--QIEEFLREARIMRKL-D 59
Query: 166 H-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF--YIAQSVLAIESI 222
H IVKL + E L ++MEY+PGGD++ L + +++ + Q +E +
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
N+IHRD+ N L+ +N +K+SDFGL + ++ DD+
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSR-------------DLYDDDYYKVK---G 163
Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342
G+ P RW +APE L + + + D WS G
Sbjct: 164 GKLP-----IRW---------------------------MAPESLKEGKFTSKSDVWSFG 191
Query: 343 AIMYEML-VGYPPFYSDDPVTTCRKI 367
+++E+ +G P+ +
Sbjct: 192 VLLWEIFTLGEEPYPGMSNAEVLEYL 217
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 85/340 (25%), Positives = 139/340 (40%), Gaps = 85/340 (25%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
++ + IG G +G+V + KK+G + A+KK++ + +R E LL ++
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKLRHPN 59
Query: 168 IVKLY---YSFQDAEYLYLIMEYLPGGDVMTLLMREET-LTETVARFYIAQSVLAIESIH 223
IV+L S Y++ EY+ D+ LL E TE+ + Y+ Q + ++ +H
Sbjct: 60 IVRLKEIVTSKGKGSI-YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH 117
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDG 283
+ +HRDIK N+L++ +G +KL+DFGL +P N SA N V+
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN-SADYTNRVIT------------ 164
Query: 284 RFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 343
W P E L +G Y PEV D WS+G
Sbjct: 165 ---------LWYRPPELL--------------LGATRY-GPEV----------DMWSVGC 190
Query: 344 IMYEMLVGYPPFYSDDPVTTCRKIVH-----------------WKNHLKFPEEAR----- 381
I+ E+ +G P F + KI W +LK + +
Sbjct: 191 ILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLRE 250
Query: 382 -----LTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415
+ P A DL+ +LL D + R + ++Q H +F
Sbjct: 251 FFKHLIDPSALDLLDKLLTLDPKKR---ISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 4e-22
Identities = 67/263 (25%), Positives = 103/263 (39%), Gaps = 76/263 (28%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA---E 162
DD + L +G G G V + +G I A+K + ++E A + + +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTI---------RLEINEAIQKQILRELD 51
Query: 163 VASHC----IVKLYYSFQDAEYLYLIMEYLPGG--DVMTLLMREETLTETVARFYIAQSV 216
+ C IV Y +F + + + MEY+ GG D + ++ + + IA +V
Sbjct: 52 ILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAV 109
Query: 217 LA--IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDEN 274
L KH IHRD+KP N+L++ G +KL DFG
Sbjct: 110 LKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFG----------------------- 146
Query: 275 LNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM 334
V G+ S LA + VGT Y+APE + Y +
Sbjct: 147 ------VSGQLVNS----------------------LAKTFVGTSSYMAPERIQGNDYSV 178
Query: 335 ECDWWSLGAIMYEMLVG---YPP 354
+ D WSLG + E+ G YPP
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 5e-22
Identities = 72/267 (26%), Positives = 113/267 (42%), Gaps = 55/267 (20%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
+F + IGRG F EV G A+KK++ +++ E +LL ++
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM----REETLTETVARFYIAQSVLAIESI 222
++K Y SF + L +++E GD+ ++ ++ + E Y Q A+E +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
H +HRDIKP N+ + G +KL D GL
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGL------------------------------ 152
Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342
GRF S + A+S VGTP Y++PE + + GY + D WSLG
Sbjct: 153 GRFFSS-------------------KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLG 193
Query: 343 AIMYEMLVGYPPFYSD--DPVTTCRKI 367
++YEM PFY D + + C+KI
Sbjct: 194 CLLYEMAALQSPFYGDKMNLYSLCKKI 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 7e-22
Identities = 70/247 (28%), Positives = 108/247 (43%), Gaps = 52/247 (21%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
F L IG+G+FGEV + ++ + A+K + E + ++E ++ E +L++ S
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPY 63
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
+ K Y S+ L++IMEYL GG + LL R E + + + ++ +H
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILKGLDYLHSEKK 122
Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
IHRDIK N+LL + G +KL+DFG+
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAG--------------------------------- 149
Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 347
QL QI R VGTP ++APEV+ + Y + D WSLG E
Sbjct: 150 ------------QLTDTQIKRNTF----VGTPFWMAPEVIQQSAYDSKADIWSLGITAIE 193
Query: 348 MLVGYPP 354
+ G PP
Sbjct: 194 LAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 75/250 (30%), Positives = 112/250 (44%), Gaps = 49/250 (19%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
+ F++L ++G GA+G V C+ K++ I A+KK K SE + +R E +L +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQ 59
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
IV+L +F+ LYL+ EY+ + L + R YI Q + AI HK+
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN 119
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
+ +HRDIKP+NLL+ N +KL DFG + NLS + + N E +
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFAR-----NLSEGS------NANYTEYV------ 162
Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345
RW Y +PE+LL YG D WS+G I+
Sbjct: 163 -----ATRW--------------------------YRSPELLLGAPYGKAVDMWSVGCIL 191
Query: 346 YEMLVGYPPF 355
E+ G P F
Sbjct: 192 GELSDGQPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 75/277 (27%), Positives = 122/277 (44%), Gaps = 68/277 (24%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
D ++++ IG+G +G+V KK+G+ A+K L + E + AE N+L ++
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID----EEIEAEYNILKALSD 73
Query: 166 H-CIVKLYYSF-----QDAEYLYLIMEYLPGGDVMTL----LMREETLTETVARFYIAQS 215
H +VK Y + ++ + L+L++E GG V L L R E + E + + + ++
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENL 275
++ ++ +H + IHRD+K +N+LL G +KL DFG+ L T L
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL-------------- 179
Query: 276 NESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL-----LKK 330
RR ++VGTP ++APEV+ L
Sbjct: 180 --------------------------------RRN---TSVGTPFWMAPEVIACEQQLDS 204
Query: 331 GYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKI 367
Y CD WSLG E+ G PP P+ KI
Sbjct: 205 TYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI 241
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 5e-21
Identities = 72/254 (28%), Positives = 112/254 (44%), Gaps = 52/254 (20%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
F L IG+G+FGEV + ++ + A+K + E + ++E ++ E +L++ S
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPY 63
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
+ K Y S+ L++IMEYL GG + LL L ET + + + ++ +H
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEKK 122
Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
IHRDIK N+LL ++G +KL+DFG+
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAG--------------------------------- 149
Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 347
QL QI R VGTP ++APEV+ + Y + D WSLG E
Sbjct: 150 ------------QLTDTQIKRNTF----VGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 193
Query: 348 MLVGYPPFYSDDPV 361
+ G PP P+
Sbjct: 194 LAKGEPPHSELHPM 207
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 8e-21
Identities = 70/306 (22%), Positives = 126/306 (41%), Gaps = 79/306 (25%)
Query: 117 GAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCI---VKLYY 173
G +V L + ++ + +K L+KS SR ++ + HC+ V L+
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLT-----------IIPHCVPNMVCLHK 52
Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIK 233
+ ++L++++ GG + + + + + E + + A+ V+A++++H+ + RD+
Sbjct: 53 YIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLN 112
Query: 234 PDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRR 293
P+N+LLD GH++L+ F R
Sbjct: 113 PNNILLDDRGHIQLTYFS-----------------------------------------R 131
Query: 294 WKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 353
W + + Y APEV CDWWSLGAI++E+L G
Sbjct: 132 WSEVEDSCDGEAVENM-----------YCAPEVGGISEETEACDWWSLGAILFELLTG-- 178
Query: 354 PFYSDDPVTTCRKI-VHWKNHLKFPEEARLTPEAKDLICRLL-CDVEHRLGT--LGSEQI 409
+ C ++ L PE ++ EA+ L+ +LL + RLG G E I
Sbjct: 179 -----KTLVECHPSGINTHTTLNIPE--WVSEEARSLLQQLLQFNPTERLGAGVAGVEDI 231
Query: 410 KAHPWF 415
K+HP+F
Sbjct: 232 KSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 8e-21
Identities = 78/293 (26%), Positives = 123/293 (41%), Gaps = 73/293 (24%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC----- 167
++G+G +G V ++ + A+K++ + + R + L E+A H
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---------RYVQPLHEEIALHSYLKHR 65
Query: 168 -IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMRE---ETLTETVARFYIAQSVLAIESIH 223
IV+ S + + + ME +PGG + LL + E FY Q + ++ +H
Sbjct: 66 NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH 125
Query: 224 KHNYIHRDIKPDNLLLDQ-NGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
+ +HRDIK DN+L++ +G +K+SDFG K L+ IN
Sbjct: 126 DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSK-----RLAGIN----------------- 163
Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK--KGYGMECDWWS 340
+ GT Y+APEV+ K +GYG D WS
Sbjct: 164 ---------------------------PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWS 196
Query: 341 LGAIMYEMLVGYPPFYS-DDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICR 392
LG + EM G PPF +P K+ +K H + PE L+ EAK+ I R
Sbjct: 197 LGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPES--LSAEAKNFILR 247
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 1e-20
Identities = 80/350 (22%), Positives = 138/350 (39%), Gaps = 95/350 (27%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN--LLAEVAS 165
++LL IG GA+G V +K++G A+KK+ + ++ R R LL +
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI---SNVFDDLIDAKRILREIKLLRHLRH 58
Query: 166 HCIVKL--------YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL 217
I+ L F D +Y++ E + D+ ++ + LT+ ++++ Q +
Sbjct: 59 ENIIGLLDILRPPSPEDFND---VYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILR 114
Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNE 277
++ +H N IHRD+KP N+L++ N +K+ DFG L+ + + + L E
Sbjct: 115 GLKYLHSANVIHRDLKPSNILVNSNCDLKICDFG---------LARGVDPDEDEKGFLTE 165
Query: 278 SMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMEC 336
RW Y APE+LL Y
Sbjct: 166 -----------YVVTRW--------------------------YRAPELLLSSSRYTKAI 188
Query: 337 DWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVH------WKNHLKFP-EEAR-------- 381
D WS+G I E+L P F D + IV ++ E+AR
Sbjct: 189 DIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPK 248
Query: 382 ------------LTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418
+PEA DL+ ++L D + R + +++ AHP+ +
Sbjct: 249 KPKKPLSKLFPGASPEAIDLLEKMLVFDPKKR---ITADEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 5e-20
Identities = 88/329 (26%), Positives = 130/329 (39%), Gaps = 75/329 (22%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSE--MLSRGQVEHVRAERNLLAEV 163
+ L+ +G GA G V C+ K +G I+A+K + L + Q+ +R E +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQK-QI--LR-ELEINKSC 56
Query: 164 ASHCIVKLYYSFQDAE--YLYLIMEYLPGGDVMTLL--MREET--LTETVARFYIAQSVL 217
S IVK Y +F D + + MEY GG + ++ +++ + E V IA+SVL
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-KIAESVL 115
Query: 218 -AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLN 276
+ +H IHRDIKP N+LL + G +KL DFG
Sbjct: 116 KGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFG------------------------- 150
Query: 277 ESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336
V G S LA + GT Y+APE + K Y +
Sbjct: 151 ----VSGELVNS----------------------LAGTFTGTSFYMAPERIQGKPYSITS 184
Query: 337 DWWSLGAIMYEMLVGYPPFYSDD-----PVTTCRKIVHWKN-HLKFPEEA--RLTPEAKD 388
D WSLG + E+ PF + P+ IV+ N LK + + E KD
Sbjct: 185 DVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKD 244
Query: 389 LICRLLCDVEHRLGTLGSEQIKAHPWFKD 417
I + C + + HPW K
Sbjct: 245 FIKQ--CLEKDPTRRPTPWDMLEHPWIKA 271
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 6e-20
Identities = 85/316 (26%), Positives = 141/316 (44%), Gaps = 63/316 (19%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
+ ++++ +G GAFG+V Q K++G + A K + S ++E E ++LA
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDH 61
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHK 224
IVKL +F L++++E+ GG V +++ E LTE R Q++ A+ +H+
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
+ IHRD+K N+L +G +KL+DFG +SA N
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFG---------VSAKNTR----------------- 155
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----KKGYGMECDWW 339
I RR S +GTP ++APEV++ + Y + D W
Sbjct: 156 --------------------TIQRRD---SFIGTPYWMAPEVVMCETSKDRPYDYKADVW 192
Query: 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLL-CDVE 398
SLG + EM PP + +P+ KI + +R + E KD + + L +V+
Sbjct: 193 SLGITLIEMAQIEPPHHELNPMRVLLKIAK-SEPPTLAQPSRWSSEFKDFLKKCLEKNVD 251
Query: 399 HRLGTLGSEQIKAHPW 414
R T Q+ HP+
Sbjct: 252 ARWTT---TQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 7e-20
Identities = 77/347 (22%), Positives = 127/347 (36%), Gaps = 99/347 (28%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQV--EHVRAERNLLAEVAS 165
++ L IG GA+G V ++ +G A+KK++ LS + +R E LL ++ S
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVP--LSEEGIPLSTLR-EIALLKQLES 57
Query: 166 HC---IVKLYYSFQDAEY-----LYLIMEYLPGGDVMTLLMR--EETLTETVARFYIAQS 215
IV+L L L+ E++ D+ T L + + L + + Q
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQL 116
Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENL 275
+ ++ +H H +HRD+KP N+L+ +G +K++DFGL +
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS------------------ 158
Query: 276 NESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME 335
++ L S V T Y APEVLL+ Y
Sbjct: 159 ------------------FEMALT--------------SVVVTLWYRAPEVLLQSSYATP 186
Query: 336 CDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKI-----------------VHWKNHLKFPE 378
D WS+G I E+ P F KI + + FP
Sbjct: 187 VDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSS---FPS 243
Query: 379 EAR---------LTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415
+ E DL+ ++L + R+ + Q HP+F
Sbjct: 244 YTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ---HPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 7e-20
Identities = 80/317 (25%), Positives = 134/317 (42%), Gaps = 73/317 (23%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
+G GAFG+V Q K++G A K + ++ S ++E E ++L+E IV LY
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILSECKHPNIVGLYE 69
Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDI 232
++ L++++E+ GG + ++++ E LTE R+ Q + A+ +H H IHRD+
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDL 129
Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGR 292
K N+LL +G +KL+DFG +SA N++
Sbjct: 130 KAGNILLTLDGDVKLADFG---------VSAKNKST------------------------ 156
Query: 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYE 347
+ +R + +GTP ++APEV+ Y + D WSLG + E
Sbjct: 157 -------------LQKRD---TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIE 200
Query: 348 MLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTP-----EAKDLICRLLC-DVEHRL 401
+ PP + +P+ KI LK P D + L D + R
Sbjct: 201 LAQMEPPHHELNPMRVLLKI------LKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRP 254
Query: 402 GTLGSEQIKAHPWFKDI 418
++ HP+ D
Sbjct: 255 TA---AELLKHPFVSDQ 268
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 9e-20
Identities = 91/347 (26%), Positives = 153/347 (44%), Gaps = 62/347 (17%)
Query: 95 YMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
Y ++R + ++++ +G GAFG+V + K++G + A K + E S ++E
Sbjct: 1 YEHVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYM 57
Query: 155 AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDV-MTLLMREETLTETVARFYIA 213
E +LA IVKL +F L++++E+ PGG V +L + LTE +
Sbjct: 58 VEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICR 117
Query: 214 QSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDE 273
Q + A++ +H IHRD+K N+LL +G +KL+DFG +SA N
Sbjct: 118 QMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFG---------VSAKN-------- 160
Query: 274 NLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL----- 328
++ LQ RR S +GTP ++APEV++
Sbjct: 161 ------------------------VKTLQ-----RRD---SFIGTPYWMAPEVVMCETMK 188
Query: 329 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKD 388
Y + D WSLG + EM PP + +P+ KI + ++ + E +D
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-SEPPTLSQPSKWSMEFRD 247
Query: 389 LICRLLCDVEHRLGTLGSEQIKAHPWFKDIAWDK-LYEMEAAYKPEV 434
+ L +H + Q+ HP+ + ++ L E+ A K EV
Sbjct: 248 FLKTAL--DKHPETRPSAAQLLEHPFVSSVTSNRPLRELVAEAKAEV 292
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 51/159 (32%), Positives = 85/159 (53%), Gaps = 14/159 (8%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
+ +L IG G F EV Q +K+G YA+K +KK S QV ++R E L ++ H
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKH-FKSLEQVNNLR-EIQALRRLSPHP 58
Query: 168 -IVKLYYSFQDAEY--LYLIMEYLPGGDVMTL--LM--REETLTETVARFYIAQSVLAIE 220
I++L D + L L+ E + M L L+ R+ L E + Y+ Q + +++
Sbjct: 59 NILRLIEVLFDRKTGRLALVFELMD----MNLYELIKGRKRPLPEKRVKSYMYQLLKSLD 114
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259
+H++ HRDIKP+N+L+ + +KL+DFG C+ +
Sbjct: 115 HMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSK 152
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 60/281 (21%), Positives = 106/281 (37%), Gaps = 67/281 (23%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIY---AMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
+G GAFGEV + K A+K LK+ S + + E ++ ++ +V
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA--SEEERKDFLKEARVMKKLGHPNVV 59
Query: 170 KLY-YSFQDAEYLYLIMEYLPGGDVMTLL---------MREETLTETVARFYIAQSVLAI 219
+L ++ E LYL++EY+ GGD++ L + TL+ + Q +
Sbjct: 60 RLLGVCTEE-EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESM 279
E + ++HRD+ N L+ ++ +K+SDFGL + + ++
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV---------------YDDDYYRK 163
Query: 280 DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339
G+ P RW +APE L + + D W
Sbjct: 164 KTGGKLP-----IRW---------------------------MAPESLKDGIFTSKSDVW 191
Query: 340 SLGAIMYEM--LVGYPPFYSDDPVTTCRKIVHWKNHLKFPE 378
S G +++E+ L P Y + + L PE
Sbjct: 192 SFGVLLWEIFTLGATP--YPGLSNEEVLEYLRKGYRLPKPE 230
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 78/258 (30%), Positives = 116/258 (44%), Gaps = 63/258 (24%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN--LLAEVAS 165
+++L +G+GA+G V ++++ + A+KK+ + R + R R L E+
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA---FRNATDAQRTFREIMFLQELGD 65
Query: 166 H-CIVKLYYSFQDAEY---LYLIMEYLPGGDVMTLL---MREETLTETVARFYIAQSVLA 218
H IVKL + AE +YL+ EY+ T L +R L + R+ + Q + A
Sbjct: 66 HPNIVKLLNVIK-AENDKDIYLVFEYME-----TDLHAVIRANILEDVHKRYIMYQLLKA 119
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
++ IH N IHRD+KP N+LL+ + +KL+DFGL + L L EN VL D
Sbjct: 120 LKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE--LEENPENPVLTD------ 171
Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECD 337
Y V T Y APE+LL Y D
Sbjct: 172 ----------------------------------Y--VATRWYRAPEILLGSTRYTKGVD 195
Query: 338 WWSLGAIMYEMLVGYPPF 355
WS+G I+ EML+G P F
Sbjct: 196 MWSVGCILGEMLLGKPLF 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 4e-19
Identities = 44/147 (29%), Positives = 80/147 (54%), Gaps = 4/147 (2%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
++GRGAFG V LC+ K + +K++ +M ++ + + E +L ++ I++ Y
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 173 YSFQDAEYLYLIMEYLPGGDVMTLLM--REETLTETVARFYIAQSVLAIESIHKHNYIHR 230
+F + + L ++MEY PGG + + L E + Q +LA+ +H +HR
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHR 125
Query: 231 DIKPDNLLLDQNGH-MKLSDFGLCKPL 256
D+K N+LLD++ +K+ DFG+ K L
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGISKIL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 5e-19
Identities = 68/289 (23%), Positives = 124/289 (42%), Gaps = 56/289 (19%)
Query: 110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
+ ++G+G++GEV L + + G Y +KKL SR + + E LL+++ IV
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIV 62
Query: 170 KLYYSFQDAE-YLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHN 226
S++ + LY++M + GGD+ L + + L E + Q +A++ +H+ +
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122
Query: 227 YIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFP 286
+HRD+K N+ L + +K+ D G+ + L+
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLE----------------------------- 153
Query: 287 ESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 346
N+ +A + +GTP Y++PE+ K Y + D W+LG +Y
Sbjct: 154 --------------------NQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVY 193
Query: 347 EMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC 395
EM F + D + +I+ K P +PE +LI +L
Sbjct: 194 EMATLKHAFNAKDMNSLVYRIIEGKLP---PMPKDYSPELGELIATMLS 239
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 7e-19
Identities = 74/255 (29%), Positives = 105/255 (41%), Gaps = 63/255 (24%)
Query: 110 LLTIIGR----GAFGEVRLCQEKKSGNIYAMKKLKKSEMLS-RGQVEHVRAERNLLAEVA 164
L T++GR AF R G+ K + K ML+ Q + R+E + LA
Sbjct: 71 LTTLVGRNPTTAAFVATR-------GSDPKEKVVAKFVMLNDERQAAYARSELHCLAACD 123
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGD----VMTLLMREETLTETVARFYIAQSVLAIE 220
IVK + F+ + L LIMEY GGD + L E Q VLA++
Sbjct: 124 HFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALD 183
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
+H +HRD+K N+ L G +KL DFG K ++S+
Sbjct: 184 EVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK-------------------QYSDSVS 224
Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340
+D +A S GTP Y+APE+ +K Y + D WS
Sbjct: 225 LD----------------------------VASSFCGTPYYLAPELWERKRYSKKADMWS 256
Query: 341 LGAIMYEMLVGYPPF 355
LG I+YE+L + PF
Sbjct: 257 LGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 8e-19
Identities = 65/241 (26%), Positives = 104/241 (43%), Gaps = 56/241 (23%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM--LSRGQVEHVRAERNLLAEVASHCIVKL 171
+G+G+FG V L ++KK+ +K LK+ + L+ + E LL+++ IVK
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 172 YYSFQDAEYLYLIMEYLPGGD----VMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
+ SF + + +I EY G D + L +TL+E + Q +L + +H+
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127
Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
+HRD+K N+ L +N +K+ DFG+ R
Sbjct: 128 LHRDLKAKNIFL-KNNLLKIGDFGV------------------------------SRLLM 156
Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 347
C LA + GTP Y++PE L +GY + D WSLG I+YE
Sbjct: 157 GSC-------------------DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYE 197
Query: 348 M 348
M
Sbjct: 198 M 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 73/270 (27%), Positives = 112/270 (41%), Gaps = 71/270 (26%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
F+L+ ++G G +G+V + K+G + A+K + +E + E ++ E N+L + + H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHR 73
Query: 168 IVKLYYSF--------QDAEYLYLIMEYLPGGDVMTLL--MREETLTETVARFYIAQSVL 217
+ YY D + L+L+ME+ G V L+ + L E YI + +L
Sbjct: 74 NIATYYGAFIKKSPPGHDDQ-LWLVMEFCGAGSVTDLVKNTKGNALKEDWIA-YICREIL 131
Query: 218 -AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLN 276
+ +H H IHRDIK N+LL +N +KL DFG+ LD T
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT----------------- 174
Query: 277 ESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----KKG 331
GRR + +GTP ++APEV+
Sbjct: 175 -------------VGRR-------------------NTFIGTPYWMAPEVIACDENPDAT 202
Query: 332 YGMECDWWSLGAIMYEMLVGYPPFYSDDPV 361
Y D WSLG EM G PP P+
Sbjct: 203 YDYRSDIWSLGITAIEMAEGAPPLCDMHPM 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 75/257 (29%), Positives = 104/257 (40%), Gaps = 57/257 (22%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLK-KSEMLSRGQVEHVRAERNLLAEVAS 165
D+ + IG G +G V + KK+G I AMKK++ +SE G E +LL E+
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQH 58
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDV---MTLLMREETLTETVARFYIAQSVLAIESI 222
IV L LYLI E+L D+ + L + + + + + Y+ Q + I
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
H +HRD+KP NLL+D G +KL+DFGL
Sbjct: 118 HSRRVLHRDLKPQNLLIDNKGVIKLADFGL------------------------------ 147
Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSL 341
R + P+ H V T Y APEVLL Y D WS+
Sbjct: 148 --------ARAFGIPVRVYTH-----------EVVTLWYRAPEVLLGSPRYSTPVDIWSI 188
Query: 342 GAIMYEMLVGYPPFYSD 358
G I EM P F+ D
Sbjct: 189 GTIFAEMATKKPLFHGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 73/288 (25%), Positives = 123/288 (42%), Gaps = 52/288 (18%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM-----LSRGQVE----HVRAERNL--LAE 162
+G G +G+V + +G I A+KK+K E+ R V H R L + E
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESI 222
+ I+ L + + +++ L+M+ + D+ ++ R+ LTE+ + + Q + + +
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQILNGLNVL 135
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
HK ++HRD+ P N+ ++ G K++DFGL + S
Sbjct: 136 HKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS-------------------- 175
Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSL 341
S E +Q RR+ S V T Y APE+L+ + Y D WS+
Sbjct: 176 ----------DTLSKDETMQ-----RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSV 220
Query: 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDL 389
G I E+L G P F ++ + +I L P E P+AK L
Sbjct: 221 GCIFAELLTGKPLFPGENEIDQLGRIF---ELLGTPNEDNW-PQAKKL 264
|
Length = 335 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 81/324 (25%), Positives = 131/324 (40%), Gaps = 71/324 (21%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
D+ ++L +G+G +G V + +G AMK+++ L + + E ++L + S
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVS 58
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL---MREETLTETVARFYIAQSVLAIESI 222
IV Y +F +Y+ MEY+ G + L + E + E V R V ++ +
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 223 -HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
+HN IHRD+KP N+L++ NG +KL DFG V
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFG-----------------------------V 149
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG------YGME 335
G S LA + +G Y+APE + G Y ++
Sbjct: 150 SGNLVAS----------------------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQ 187
Query: 336 CDWWSLGAIMYEMLVG---YPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICR 392
D WSLG + EM +G YPP + IV + P + +A+D + +
Sbjct: 188 SDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD-GDPPTLPSG--YSDDAQDFVAK 244
Query: 393 LLCDVEHRLGTLGSEQIKAHPWFK 416
L + +R T Q+ HPW
Sbjct: 245 CLNKIPNRRPTY--AQLLEHPWLV 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 87/336 (25%), Positives = 127/336 (37%), Gaps = 93/336 (27%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
IG G +G V ++K +G I A+KK++ E G E +LL E+ IV+L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRL-ETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 174 SFQDAEYLYLIMEYLPGGDVMTL--LMR---EETLTETVARFYIAQSVLAIESIHKHNYI 228
LYL+ E+L + L M L + + Y+ Q + I H H +
Sbjct: 66 VVHSENKLYLVFEFLD----LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVL 121
Query: 229 HRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPES 288
HRD+KP NLL+D+ G +KL+DFGL
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGL------------------------------------ 145
Query: 289 GCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYE 347
R + P+ H V T Y APE+LL + Y D WS+G I E
Sbjct: 146 --ARAFGVPVRTYTH-----------EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAE 192
Query: 348 MLVGYPPFYSDDPVTTCRKIVH---------W---------KNHLKFPEEAR-------- 381
M+ P F D + +I W K FP+ AR
Sbjct: 193 MVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP--TFPKWARQDLSKVVP 250
Query: 382 -LTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415
L + DL+ ++L D R + ++ HP+F
Sbjct: 251 NLDEDGLDLLSKMLVYDPAKR---ISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 2e-18
Identities = 70/268 (26%), Positives = 114/268 (42%), Gaps = 67/268 (25%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
F+L+ ++G G +G+V + K+G + A+K + ++ + E ++ E N+L + + H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63
Query: 168 IVKLYY-SFQDA------EYLYLIMEYLPGGDVMTLL--MREETLTETVARFYIAQSVLA 218
+ YY +F + L+L+ME+ G V L+ + TL E + + +
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
+ +H+H IHRDIK N+LL +N +KL DFG+ LD T
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT------------------- 164
Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----KKGYG 333
GRR + +GTP ++APEV+ Y
Sbjct: 165 -----------VGRR-------------------NTFIGTPYWMAPEVIACDENPDATYD 194
Query: 334 MECDWWSLGAIMYEMLVGYPPFYSDDPV 361
+ D WSLG EM G PP P+
Sbjct: 195 FKSDLWSLGITAIEMAEGAPPLCDMHPM 222
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-18
Identities = 46/130 (35%), Positives = 70/130 (53%), Gaps = 7/130 (5%)
Query: 316 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLK 375
+GTPDY+APE+LL K +G DWW+LG ++E L G PPF + P + I+ +
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNIL--NRDIP 598
Query: 376 FPE-EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPE 433
+PE E +L+ A++ I LL D R G +++K HP F + W+ L + P+
Sbjct: 599 WPEGEEKLSVNAQNAIEILLTMDPTKRAGL---KELKQHPLFHGVDWENLQNQTMPFIPQ 655
Query: 434 VNGVLDTQNF 443
+ DT F
Sbjct: 656 PDDETDTSYF 665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-18
Identities = 66/260 (25%), Positives = 112/260 (43%), Gaps = 57/260 (21%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ-VEHVRAERNLLAEVA 164
+DF+L+ IG G +G+V + +G + A+K +K L G+ V+ E ++ +
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK----LEPGEDFAVVQQEIIMMKDCK 64
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK 224
IV + S+ + L++ ME+ GG + + L+E+ + +++ + +H
Sbjct: 65 HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHS 124
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
+HRDIK N+LL NGH+KL+DFG+ + T
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT------------------------- 159
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSL 341
I +RK S +GTP ++APEV K GY CD W++
Sbjct: 160 ---------------------IAKRK---SFIGTPYWMAPEVAAVERKGGYNQLCDIWAV 195
Query: 342 GAIMYEMLVGYPPFYSDDPV 361
G E+ PP + P+
Sbjct: 196 GITAIELAELQPPMFDLHPM 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 66/262 (25%), Positives = 109/262 (41%), Gaps = 54/262 (20%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAER--NLLA 161
+ D+++L +G G FGEV ++ K+G + A+KK+ M + + A R +L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKIL---MHNEKDGFPITALREIKILK 62
Query: 162 EVASHCIVKL---YYSFQDAEY-----LYLIMEYLPGGDVMTLLMREE-TLTETVARFYI 212
++ +V L D +Y++ Y+ D+ LL LTE+ + Y+
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSVKLTESQIKCYM 121
Query: 213 AQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDD 272
Q + I +H+++ +HRDIK N+L+D G +K++DFGL +P D
Sbjct: 122 LQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD--------------- 166
Query: 273 ENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKG 331
G K RK + V T Y PE+LL ++
Sbjct: 167 ----------------GPPPNPKGGGGG------GTRKYT-NLVVTRWYRPPELLLGERR 203
Query: 332 YGMECDWWSLGAIMYEMLVGYP 353
Y D W +G + EM P
Sbjct: 204 YTTAVDIWGIGCVFAEMFTRRP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 72/252 (28%), Positives = 106/252 (42%), Gaps = 59/252 (23%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS--RGQVEHVRAERNLLAEV 163
DDF+ L +G G G V + SG I A +KL E+ R Q+ +R E +L E
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMA-RKLIHLEIKPAIRNQI--IR-ELKVLHEC 56
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETV-ARFYIAQSVLAIESI 222
S IV Y +F + + ME++ GG + +L + + E + + IA
Sbjct: 57 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLR 116
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
KH +HRD+KP N+L++ G +KL DFG V
Sbjct: 117 EKHKIMHRDVKPSNILVNSRGEIKLCDFG-----------------------------VS 147
Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342
G+ +S +A S VGT Y++PE L Y ++ D WSLG
Sbjct: 148 GQLIDS----------------------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLG 185
Query: 343 AIMYEMLVG-YP 353
+ EM +G YP
Sbjct: 186 LSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 4e-17
Identities = 48/146 (32%), Positives = 73/146 (50%), Gaps = 22/146 (15%)
Query: 117 GAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCI-------V 169
G FG+V + + K + ++ K +K ++ A E H + +
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKIIKA---------KNFNA-----IEPMVHQLMKDNPNFI 72
Query: 170 KLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIH 229
KLYYS + LIM+Y+ GD+ LL +E L+E + I Q V A+ +HKHN IH
Sbjct: 73 KLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIH 132
Query: 230 RDIKPDNLLLDQN-GHMKLSDFGLCK 254
DIK +N+L D+ + L D+GLCK
Sbjct: 133 NDIKLENVLYDRAKDRIYLCDYGLCK 158
|
Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 8e-17
Identities = 67/254 (26%), Positives = 97/254 (38%), Gaps = 72/254 (28%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
F + IG G +G V + K +G + A+KK++ + + G E +LL E+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 60
Query: 168 IVKLYYSFQDAEYLYLIMEYL-----------PGGDVMTLLMREETLTETVARFYIAQSV 216
IVKL LYL+ E+L P + L++ Y+ Q +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKS----------YLFQLL 110
Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLN 276
+ H H +HRD+KP NLL++ G +KL+DFGL
Sbjct: 111 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL------------------------ 146
Query: 277 ESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGME 335
R + P+ H V T Y APE+LL K Y
Sbjct: 147 --------------ARAFGVPVRTYTH-----------EVVTLWYRAPEILLGCKYYSTA 181
Query: 336 CDWWSLGAIMYEML 349
D WSLG I EM+
Sbjct: 182 VDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 64/259 (24%), Positives = 108/259 (41%), Gaps = 57/259 (22%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ-VEHVRAERNLLAEVAS 165
D++L+ +G G +G+V + +G + A+K +K L G ++ E ++ E
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK----LEPGDDFSLIQQEIFMVKECKH 65
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
IV + S+ E L++ MEY GG + + L+E + +++ + +H
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
+HRDIK N+LL NG +KL+DFG+ + T
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITAT-------------------------- 159
Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK---GYGMECDWWSLG 342
I +RK S +GTP ++APEV + GY CD W++G
Sbjct: 160 --------------------IAKRK---SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVG 196
Query: 343 AIMYEMLVGYPPFYSDDPV 361
E+ PP + P+
Sbjct: 197 ITAIELAELQPPMFDLHPM 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-16
Identities = 79/294 (26%), Positives = 128/294 (43%), Gaps = 69/294 (23%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR--AERNLLAEVAS 165
+D++ +IG+G GEV L + A+KK+++ LS + R E + A++
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIRED--LSENPLLKKRFLREAKIAADLIH 61
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM---REETLTETVARFYIAQSVLA---- 218
IV +Y D + +Y M Y+ G + +LL ++E+L++ +A SV A
Sbjct: 62 PGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELA---EKTSVGAFLSI 118
Query: 219 -------IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD 271
IE +H +HRD+KPDN+LL G + + D+G + E E L
Sbjct: 119 FHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA-------IFKKLEEEDLL 171
Query: 272 DENLNE------SMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPE 325
D +++E SM + G+ VGTPDY+APE
Sbjct: 172 DIDVDERNICYSSMTIPGKI------------------------------VGTPDYMAPE 201
Query: 326 VLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEE 379
LL D ++LG I+Y+ML P+ RKI +++ + P E
Sbjct: 202 RLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG----RKI-SYRDVILSPIE 250
|
Length = 932 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 79/333 (23%), Positives = 133/333 (39%), Gaps = 90/333 (27%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKK-------------LKKSEMLSRGQVEH 152
+ L+ IG GA+G V K +G A+KK L++ ++L R + E+
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 153 VRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYI 212
+ +++ + SF D +Y++ E + D+ L+ + + L+ ++++
Sbjct: 65 IIGILDII-------RPPSFESFND---VYIVQELMET-DLYKLI-KTQHLSNDHIQYFL 112
Query: 213 AQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDD 272
Q + ++ IH N +HRD+KP NLLL+ N +K+ DFGL + A E++
Sbjct: 113 YQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLAR-------IADPEHD---- 161
Query: 273 ENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KG 331
F RW Y APE++L KG
Sbjct: 162 ---------HTGFLTEYVATRW--------------------------YRAPEIMLNSKG 186
Query: 332 YGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLIC 391
Y D WS+G I+ EML P F + + L TP +DL C
Sbjct: 187 YTKAIDIWSVGCILAEMLSNRPLFPGK----------DYLHQLNLILGVLGTPSQEDLNC 236
Query: 392 RLLCDVEHRLGTLGSEQIKAHPWFKDIAWDKLY 424
+ + R IK+ P+ + W+KL+
Sbjct: 237 --IISLRAR------NYIKSLPFKPKVPWNKLF 261
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 74/271 (27%), Positives = 107/271 (39%), Gaps = 74/271 (27%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
D ++ L IG G +G+V ++K +G + A+KK + EM G E +LL + S
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQML-S 58
Query: 166 HC--IVKLYYSFQDAEY---------LYLIMEYLPGGDVMTLLMRE-----ETLTETVAR 209
IV+L D E+ LYL+ EYL D+ + L +
Sbjct: 59 ESIYIVRLL----DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIK 113
Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-QNGHMKLSDFGLCKPLDCTNLSAINENE 268
++ Q + + HKH +HRD+KP NLL+D Q G +K++D GL
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGL---------------- 157
Query: 269 VLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL 328
GR + P++ H + T Y APEVLL
Sbjct: 158 ----------------------GRAFSIPVKSYTH-----------EIVTLWYRAPEVLL 184
Query: 329 -KKGYGMECDWWSLGAIMYEMLVGYPPFYSD 358
Y D WS+G I EM P F D
Sbjct: 185 GSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 2e-15
Identities = 77/307 (25%), Positives = 123/307 (40%), Gaps = 75/307 (24%)
Query: 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKL 171
++G GA G V + G +A+K + E +S +AE L IVK
Sbjct: 38 RVLGSGATGTVLCAKRVSDGEPFAVKVVD-MEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 172 YYSF--------QDAEYLYLIMEYLPGGDVMTLLMREE---------TLTETVARFYIAQ 214
+ F ++ + L+++Y GD +R+E T E A Q
Sbjct: 97 HEDFAKKDPRNPENVLMIALVLDYANAGD-----LRQEIKSRAKTNRTFREHEAGLLFIQ 151
Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDEN 274
+LA+ +H + IHRDIK N+LL NG +KL DFG K + V DD
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK---------MYAATVSDD-- 200
Query: 275 LNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM 334
GR + GTP Y+APE+ +K Y
Sbjct: 201 ---------------VGRTF---------------------CGTPYYVAPEIWRRKPYSK 224
Query: 335 ECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKF-PEEARLTPEAKDLICRL 393
+ D +SLG ++YE+L PF ++ +++H ++ P ++PE ++++ L
Sbjct: 225 KADMFSLGVLLYELLTLKRPFDGEN----MEEVMHKTLAGRYDPLPPSISPEMQEIVTAL 280
Query: 394 LCDVEHR 400
L R
Sbjct: 281 LSSDPKR 287
|
Length = 496 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 47/154 (30%), Positives = 85/154 (55%), Gaps = 7/154 (4%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSE---MLSRGQVEHVRAERNLLAE 162
+ ++ L+ IG G++G V C+ +++G I A+KK +SE ++ + + +R +L +
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIR----MLKQ 56
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESI 222
+ +V L F+ L+L+ EY + L + E + + I Q++ A+
Sbjct: 57 LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
HKHN IHRD+KP+N+L+ + G +KL DFG + L
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARIL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 74/305 (24%), Positives = 125/305 (40%), Gaps = 82/305 (26%)
Query: 108 FDLLTIIGRGAFGEVRLCQ----EKKSGNIYAMKKL----KKSEMLSRGQVE-----HVR 154
++L+ +G+GA+G V C E A+KK+ K + R E H R
Sbjct: 2 YELIKELGQGAYGIV--CSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFR 59
Query: 155 AERNLLAEVASHCIVKL---YYSFQDAEYLYL-IMEYLPGGDVMTLLMREETLTETVARF 210
+N+ C+ + + + YLY +ME D+ ++ + LT+ +
Sbjct: 60 GHKNIT------CLYDMDIVFPGNFNELYLYEELMEA----DLHQIIRSGQPLTDAHFQS 109
Query: 211 YIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270
+I Q + ++ IH N +HRD+KP NLL++ + +K+ DFGL + +EN
Sbjct: 110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR--------GFSENPGE 161
Query: 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK- 329
+ + E + RW Y APE++L
Sbjct: 162 NAGFMTEYV-----------ATRW--------------------------YRAPEIMLSF 184
Query: 330 KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARL----TPE 385
+ Y D WS+G I+ E+L P F D V +I+ L P+E L +P+
Sbjct: 185 QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQ---VLGTPDEETLSRIGSPK 241
Query: 386 AKDLI 390
A++ I
Sbjct: 242 AQNYI 246
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 79/349 (22%), Positives = 132/349 (37%), Gaps = 93/349 (26%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL-----L 160
+ + IG GA+G V + +SG A+KK+ A+R L L
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI------PHAFDVPTLAKRTLRELKIL 58
Query: 161 AEVASHCIVKLYYSFQ----DAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSV 216
I+ + + D + +Y++M+ L D+ ++ ++ LTE R+++ Q +
Sbjct: 59 RHFKHDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLL 117
Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLN 276
++ IH N IHRD+KP NLL++++ +++ DFG+ + L
Sbjct: 118 RGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS------------------- 158
Query: 277 ESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGME 335
SP E V T Y APE+LL Y
Sbjct: 159 ------------------SSPTEHKYFMT--------EYVATRWYRAPELLLSLPEYTTA 192
Query: 336 CDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIV-----------------HWKNHL-KFP 377
D WS+G I EML F + V + I+ + ++ P
Sbjct: 193 IDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLP 252
Query: 378 EEARL---------TPEAKDLICRLL-CDVEHRLGTLGSEQIKAHPWFK 416
+ + +PEA DL+ ++L D E R + EQ HP+
Sbjct: 253 RKQPVPWSKIFPKASPEALDLLSQMLQFDPEER---ITVEQALQHPFLA 298
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 66/256 (25%), Positives = 107/256 (41%), Gaps = 55/256 (21%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
SV +F+ L IG G +G V ++ SG I A+KK++ + +R E LL +
Sbjct: 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNL 63
Query: 164 ASHCIVKLYYSF--QDAEYLYLIMEYLPGGDVMTLLMREET-LTETVARFYIAQSVLAIE 220
IV+L + + ++L+MEY D+ +LL T +E+ + + Q + ++
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQ 122
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
+H++ IHRD+K NLLL G +K++DFGL
Sbjct: 123 YLHENFIIHRDLKVSNLLLTDKGCLKIADFGL---------------------------- 154
Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECDWW 339
R + P + + V T Y APE+LL Y D W
Sbjct: 155 ----------ARTYGLPAKPMT-----------PKVVTLWYRAPELLLGCTTYTTAIDMW 193
Query: 340 SLGAIMYEMLVGYPPF 355
++G I+ E+L P
Sbjct: 194 AVGCILAELLAHKPLL 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 8e-15
Identities = 82/335 (24%), Positives = 120/335 (35%), Gaps = 79/335 (23%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLK-KSEMLSRGQVEHVRAERNLLAEVASH 166
F L +G G + V + + +G I A+K++ +E G E +L+ E+
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHE 58
Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGG--DVMTLLMREETLTETVARFYIAQSVLAIESIHK 224
IV+L+ L L+ EY+ M L + + Q + I H+
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
+ +HRD+KP NLL+++ G +KL+DFGL
Sbjct: 119 NRVLHRDLKPQNLLINKRGELKLADFGL-------------------------------- 146
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGA 343
R + P+ + V T Y AP+VLL + Y D WS+G
Sbjct: 147 ------ARAFGIPVNTFS-----------NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGC 189
Query: 344 IMYEMLVGYPPFYSDDPVTTCRKIVH---------WKNHLKFPEEARLTPEAK--DL--- 389
IM EM+ G P F + KI W + PE P DL
Sbjct: 190 IMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQL 249
Query: 390 ---ICRLLCDVEHRLGTLGSE------QIKAHPWF 415
L D+ HRL L E HPWF
Sbjct: 250 FPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 84/348 (24%), Positives = 126/348 (36%), Gaps = 90/348 (25%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
+D ++ + IG G +G V +++ + A+KK++ E G E +LL E+
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRL-EQEDEGVPSTAIREISLLKEMQ 59
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYL-----PGGDVMTLLMREETLTETVARFYIAQSVLAI 219
IV+L + LYL+ EYL D + L +T Y+ Q + I
Sbjct: 60 HGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKT----YLYQILRGI 115
Query: 220 ESIHKHNYIHRDIKPDNLLLDQ-NGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
H H +HRD+KP NLL+D+ +KL+DFGL
Sbjct: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGL-------------------------- 149
Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECD 337
R + P+ H V T Y APE+LL + Y D
Sbjct: 150 ------------ARAFGIPVRTFTH-----------EVVTLWYRAPEILLGSRHYSTPVD 186
Query: 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVH---------WKNHLKFPEEAR------- 381
WS+G I EM+ P F D + KI W P+
Sbjct: 187 IWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPP 246
Query: 382 ---------LTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIA 419
L P DL+ ++L D R + + H +FKD+
Sbjct: 247 KDLATVVPTLEPAGVDLLSKMLRLDPSKR---ITARAALEHEYFKDLG 291
|
Length = 294 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 72/271 (26%), Positives = 116/271 (42%), Gaps = 66/271 (24%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLK---KSEMLSRGQVEHVRAERN 158
K VD FD++ IG G +G+V ++K +G + A+KK++ + E + ++ R
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62
Query: 159 L-------LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETL---TETVA 208
L L E+ + L + +D YL+ EY+ D+M LL E L +E
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFK-KDKGAFYLVFEYM-DHDLMGLL--ESGLVHFSEDHI 118
Query: 209 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENE 268
+ ++ Q + + HK N++HRDIK N+LL+ G +KL+DFGL
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL---------------- 162
Query: 269 VLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL 328
R S R + + + L W Y PE+LL
Sbjct: 163 --------------ARLYNSEESRPYTNKVITL--W----------------YRPPELLL 190
Query: 329 -KKGYGMECDWWSLGAIMYEMLVGYPPFYSD 358
++ YG D WS G I+ E+ P F ++
Sbjct: 191 GEERYGPAIDVWSCGCILGELFTKKPIFQAN 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 64/262 (24%), Positives = 107/262 (40%), Gaps = 63/262 (24%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKL---KKSEMLSRGQVEHVRAERNL-- 159
V ++ L IG+G FGEV + KK+ I A+KK+ + E + ++ + L
Sbjct: 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKH 70
Query: 160 -----LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIA 213
L E+ C K + YL+ E+ D+ LL + T + + +
Sbjct: 71 ENVVNLIEI---CRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMK 126
Query: 214 QSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDE 273
+ + IH++ +HRD+K N+L+ ++G +KL+DFGL + ++++N
Sbjct: 127 MLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF------SLSKNS----- 175
Query: 274 NLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYST-VGTPDYIAPEVLL-KKG 331
+ NR Y+ V T Y PE+LL ++
Sbjct: 176 -------------------------------KPNR----YTNRVVTLWYRPPELLLGERD 200
Query: 332 YGMECDWWSLGAIMYEMLVGYP 353
YG D W G IM EM P
Sbjct: 201 YGPPIDMWGAGCIMAEMWTRSP 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 61/255 (23%), Positives = 104/255 (40%), Gaps = 62/255 (24%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKL---KKSEMLSRGQVEHVRAERNLLAE 162
+D + ++ +G G G V + +G + A K + KS + R Q+ +R E ++ E
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSV--RKQI--LR-ELQIMHE 59
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLA--IE 220
S IV Y +F + + + ME++ G + + + + + IA +V+
Sbjct: 60 CRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-KIAVAVVEGLTY 118
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
+ H +HRDIKP N+L++ G +KL DFG
Sbjct: 119 LYNVHRIMHRDIKPSNILVNSRGQIKLCDFG----------------------------- 149
Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340
V G S +A + VGT Y++PE + Y ++ D WS
Sbjct: 150 VSGELINS----------------------IADTFVGTSTYMSPERIQGGKYTVKSDVWS 187
Query: 341 LGAIMYEMLVGYPPF 355
LG + E+ +G PF
Sbjct: 188 LGISIIELALGKFPF 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 69/255 (27%), Positives = 107/255 (41%), Gaps = 54/255 (21%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
DDF+ ++ +G G G V Q K SG I A +KL E+ + + +R E +L E S
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMA-RKLIHLEIKPAIRNQIIR-ELQVLHECNS 62
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETV-ARFYIAQSVLAIESIHK 224
IV Y +F + + ME++ GG + +L + + E + + IA K
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
H +HRD+KP N+L++ G +KL DFG V G+
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFG-----------------------------VSGQ 153
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344
+S +A S VGT Y++PE L Y ++ D WS+G
Sbjct: 154 LIDS----------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLS 191
Query: 345 MYEMLVGYPPFYSDD 359
+ E+ +G P D
Sbjct: 192 LVELAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 69/258 (26%), Positives = 108/258 (41%), Gaps = 60/258 (23%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
DDF+ ++ +G G G V K SG I A +KL E+ + + +R E +L E S
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMA-RKLIHLEIKPAIRNQIIR-ELQVLHECNS 62
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESI--- 222
IV Y +F + + ME++ GG + +L + + E + S+ I+ +
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSIAVIKGLTYL 119
Query: 223 -HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
KH +HRD+KP N+L++ G +KL DFG V
Sbjct: 120 REKHKIMHRDVKPSNILVNSRGEIKLCDFG-----------------------------V 150
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341
G+ +S +A S VGT Y++PE L Y ++ D WS+
Sbjct: 151 SGQLIDS----------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSM 188
Query: 342 GAIMYEMLVGYPPFYSDD 359
G + EM +G P D
Sbjct: 189 GLSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 72/281 (25%), Positives = 118/281 (41%), Gaps = 98/281 (34%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-- 163
+D L IGRGAFG V K SG I A+K+++ S + + Q + LL ++
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIR-STVDEKEQ-------KRLLMDLDV 55
Query: 164 ---ASHC--IVKLY---YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETV---ARFYI 212
+S C IVK Y + D ++ ME +M + + + + V + I
Sbjct: 56 VMRSSDCPYIVKFYGALFREGDC---WICME------LMDISL--DKFYKYVYEVLKSVI 104
Query: 213 AQSVLA------IESIH----KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262
+ +L +++++ + IHRD+KP N+LLD+NG++KL DFG+ L
Sbjct: 105 PEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL------ 158
Query: 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYI 322
+++ ++ D GC P Y+
Sbjct: 159 ---------VDSIAKTRDA-------GC-----RP-----------------------YM 174
Query: 323 APEVLL---KKGYGMECDWWSLGAIMYEMLVG---YPPFYS 357
APE + + GY + D WSLG +YE+ G YP + S
Sbjct: 175 APERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS 215
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 84/337 (24%), Positives = 148/337 (43%), Gaps = 98/337 (29%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-- 163
DD +++ +GRGA+G V + +G I A+K++ R V + ++ LL ++
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRI-------RATVN-SQEQKRLLMDLDI 52
Query: 164 ---ASHC--IVKLYYS-FQDAEYLYLIME-------------YLPGGDVMTLLMREETLT 204
+ C V Y + F++ + +++ ME Y G L + E+ L
Sbjct: 53 SMRSVDCPYTVTFYGALFREGD-VWICMEVMDTSLDKFYKKVYDKG-----LTIPEDILG 106
Query: 205 ETVARFYIAQSVL-AIESIH-KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262
+ IA S++ A+E +H K + IHRD+KP N+L+++NG +KL DFG+
Sbjct: 107 K------IAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGI---------- 150
Query: 263 AINENEVLDDENLNESM--DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPD 320
L +S+ +D +GC + +A P+
Sbjct: 151 ---------SGYLVDSVAKTID-----AGC-----------------KPYMA------PE 173
Query: 321 YIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS-DDPVTTCRKIVHWKNHLKFPEE 379
I PE L +KGY ++ D WSLG M E+ G P+ S P +++V + + P E
Sbjct: 174 RINPE-LNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-EPSPQLPAE 231
Query: 380 ARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFK 416
+ +PE +D + + L ++ HP+F+
Sbjct: 232 -KFSPEFQDFVNKCLKKNYKERPNY--PELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 69/258 (26%), Positives = 112/258 (43%), Gaps = 62/258 (24%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKL-KKSEMLSRGQVEHVRAERNLLAE 162
S+ + + + IG GA G V + +G +YA+K + E R Q+ E +L +
Sbjct: 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICR---EIEILRD 128
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESI 222
V +VK + F + +++E++ GG + + +E VAR Q + I +
Sbjct: 129 VNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYL 184
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
H+ + +HRDIKP NLL++ ++K++DFG +S I L ++MD
Sbjct: 185 HRRHIVHRDIKPSNLLINSAKNVKIADFG---------VSRI----------LAQTMD-- 223
Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL---LKKGY--GMECD 337
P C S+VGT Y++PE + L G G D
Sbjct: 224 ---P---CN----------------------SSVGTIAYMSPERINTDLNHGAYDGYAGD 255
Query: 338 WWSLGAIMYEMLVGYPPF 355
WSLG + E +G PF
Sbjct: 256 IWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 7e-13
Identities = 77/336 (22%), Positives = 123/336 (36%), Gaps = 81/336 (24%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
++ L IG G +G V + +++ I A+K+++ + G E LL E+
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKN 60
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
IV+LY + L L+ EY + + + ++ Q + + H HN
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNV 120
Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
+HRD+KP NLL+++NG +KL+DFGL
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGL----------------------------------- 145
Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMY 346
R + P+ V T Y P+VL K Y D WS G I
Sbjct: 146 ---ARAFGIPVRCYSA-----------EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFA 191
Query: 347 EML-VGYPPFYSDDPVTTCRKIVH---------WKNHLKFPEE----------------A 380
E+ G P F +D ++I W K P+
Sbjct: 192 ELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVP 251
Query: 381 RLTPEAKDLICRLL-CDVEHRLGTLGSEQIKAHPWF 415
+L +DL+ LL C+ R + +E+ HP+F
Sbjct: 252 KLNSTGRDLLQNLLVCNPVQR---ISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 9e-13
Identities = 64/271 (23%), Positives = 113/271 (41%), Gaps = 59/271 (21%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
+I + L+ +G G FGEV + S + A+K LK M V+ E NL+
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTM----SVQAFLEEANLMK 56
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF--YIAQSVLAI 219
+ +V+LY E +Y+I EY+ G ++ L +E + + + AQ +
Sbjct: 57 TLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGM 116
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESM 279
I + NYIHRD++ N+L+ ++ K++DFGL + I +NE E
Sbjct: 117 AYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR--------VIEDNEYTAREG----- 163
Query: 280 DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339
+FP +W APE + + ++ D W
Sbjct: 164 ---AKFP-----IKWT---------------------------APEAINFGSFTIKSDVW 188
Query: 340 SLGAIMYEML----VGYPPFYSDDPVTTCRK 366
S G ++YE++ + YP + D ++ ++
Sbjct: 189 SFGILLYEIVTYGKIPYPGMSNSDVMSALQR 219
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 67/269 (24%), Positives = 115/269 (42%), Gaps = 70/269 (26%)
Query: 99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
+++ ++D + L IG G G+V + KK+G++ A+K+++++ + E+ R +
Sbjct: 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG----NKEENKRILMD 63
Query: 159 LLAEVASH-C--IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQ- 214
L + SH C IVK Y F +++ ME L + LL R + + + +
Sbjct: 64 LDVVLKSHDCPYIVKCYGYFITDSDVFICME-LMSTCLDKLLKR---IQGPIPEDILGKM 119
Query: 215 SVLAIESIH----KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270
+V ++++H KH IHRD+KP N+LLD +G++KL DFG
Sbjct: 120 TVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFG------------------- 160
Query: 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL--- 327
+ GR +S R + G Y+APE +
Sbjct: 161 ----------ISGRLVDSKAKTR---------------------SAGCAAYMAPERIDPP 189
Query: 328 -LKKGYGMECDWWSLGAIMYEMLVGYPPF 355
Y + D WSLG + E+ G P+
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQFPY 218
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 9e-12
Identities = 63/266 (23%), Positives = 102/266 (38%), Gaps = 62/266 (23%)
Query: 109 DLLTIIGRGAFGE--VRLCQEKKSGNIYAMKKL----KKSEMLSRGQVEHVRAERNLLAE 162
+LLT+IG+ V L + K + + A+KK+ E L Q E + R L
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQE-IITSRQL--- 56
Query: 163 VASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMRE---ETLTETVARFYIAQSVLA 218
H I+ SF LY++ + G L++ E L E F + + A
Sbjct: 57 --QHPNILPYVTSFIVDSELYVVSPLMAYGSC-EDLLKTHFPEGLPELAIAFILKDVLNA 113
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
++ IH +IHR +K ++LL +G + LS + + V+ D
Sbjct: 114 LDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSM----IKHGKRQRVVHD------ 163
Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK--KGYGMEC 336
FP+S + W ++PEVL + +GY +
Sbjct: 164 ------FPKSS---------VKNLPW-----------------LSPEVLQQNLQGYNEKS 191
Query: 337 DWWSLGAIMYEMLVGYPPFYSDDPVT 362
D +S+G E+ G+ PF D P T
Sbjct: 192 DIYSVGITACELANGHVPF-KDMPAT 216
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 58/247 (23%), Positives = 96/247 (38%), Gaps = 54/247 (21%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
I D L +G G FG V+ + + ++ A+K +K+ M +E + L E
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIEEAKVMMKLSHE 59
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL-AIES 221
+V+LY +Y++ EY+ G ++ L + + + V +
Sbjct: 60 K----LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAY 115
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
+ +IHRD+ N L+D G +K+SDFGL + VLDDE + V
Sbjct: 116 LESKQFIHRDLAARNCLVDDQGCVKVSDFGLSR-------------YVLDDEYTSS---V 159
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341
+FP RW PEVLL + + D W+
Sbjct: 160 GSKFPV-----RWS---------------------------PPEVLLYSKFSSKSDVWAF 187
Query: 342 GAIMYEM 348
G +M+E+
Sbjct: 188 GVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 6/143 (4%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
+G G +GEV KK A+K LK+ M +VE E ++ E+ +V+L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMR--EETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
Y+I E++ G+++ L + + V + Q A+E + K N+IHRD
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129
Query: 232 IKPDNLLLDQNGHMKLSDFGLCK 254
+ N L+ +N +K++DFGL +
Sbjct: 130 LAARNCLVGENHLVKVADFGLSR 152
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 42/151 (27%), Positives = 71/151 (47%), Gaps = 3/151 (1%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
F L IG G+FG V ++ ++ + A+KK+ S S + + + E L ++
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
++ + +L+MEY G L + ++ L E ++ + +H H
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER 136
Query: 228 IHRDIKPDNLLLDQNGHMKLSDFG---LCKP 255
IHRDIK N+LL + G +KL+DFG L P
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSASLVSP 167
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 76/307 (24%), Positives = 123/307 (40%), Gaps = 77/307 (25%)
Query: 114 IGRGAFGEVRLCQE-KKSGNIYAMKKLK---KSEMLSRGQVEHVRAERNLLAEVASH-CI 168
IG GA+G+V ++ K G A+K+++ E + + V R+L E H +
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL--ETFEHPNV 66
Query: 169 VKLY----YSFQDAEY-LYLIMEYLPGGDVMTLLMREE---TLTETVARFYIAQSVLAIE 220
V+L+ S D E L L+ E++ D+ T L + TET+ + Q + ++
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDM-MFQLLRGLD 124
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
+H H +HRD+KP N+L+ +G +KL+DFG
Sbjct: 125 FLHSHRVVHRDLKPQNILVTSSGQIKLADFG----------------------------- 155
Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340
L ++ +Q+ S V T Y APEVLL+ Y D WS
Sbjct: 156 -----------------LARIYSFQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWS 194
Query: 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIV---------HWKNHLKFPEEARLTPEAKDLIC 391
+G I EM P F V KI+ W + P +A ++ I
Sbjct: 195 VGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA-FHSKSAQPIE 253
Query: 392 RLLCDVE 398
+ + D++
Sbjct: 254 KFVTDID 260
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 70/284 (24%), Positives = 110/284 (38%), Gaps = 78/284 (27%)
Query: 114 IGRGAFGEV-----RLCQE----KKSGNIY-----AMKKLKKSEMLSRGQVEHVRAERNL 159
IGRGA+G V E KK N + A + L++ ++L E+V A +++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAI 219
+ +F D +Y +M+ D+ ++ +TL++ ++++ Q + +
Sbjct: 73 MPPPHRE-------AFNDVYIVYELMD----TDLHQIIRSSQTLSDDHCQYFLYQLLRGL 121
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESM 279
+ IH N +HRD+KP NLLL+ N +K+ DFGL + + E V
Sbjct: 122 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVVT--------- 171
Query: 280 DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDW 338
RW Y APE+LL Y D
Sbjct: 172 -------------RW--------------------------YRAPELLLNCSEYTTAIDV 192
Query: 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARL 382
WS+G I E+L P F D V + I L P E L
Sbjct: 193 WSVGCIFAELLGRKPLFPGKDYVHQLKLIT---ELLGSPSEEDL 233
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 48/175 (27%), Positives = 80/175 (45%), Gaps = 5/175 (2%)
Query: 77 PEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAM 136
P + LKD E E + + K+ D L IG G+FG V ++ ++ + A+
Sbjct: 1 PSTSRAGSLKDPEIAEL-FFKEDPEKLFTD----LREIGHGSFGAVYFARDVRTNEVVAI 55
Query: 137 KKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTL 196
KK+ S S + + + E L + ++ + +L+MEY G L
Sbjct: 56 KKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLL 115
Query: 197 LMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
+ ++ L E ++ + +H HN IHRDIK N+LL + G +KL+DFG
Sbjct: 116 EVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFG 170
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-11
Identities = 46/164 (28%), Positives = 82/164 (50%), Gaps = 8/164 (4%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
++ + L+ +G G FGEV + + A+K LK+ M E AE NL+
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKV-AIKSLKQGSM----SPEAFLAEANLMK 56
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF--YIAQSVLAI 219
++ +V+LY + E +Y+I EY+ G ++ L E + T+ + AQ +
Sbjct: 57 QLQHPRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGM 115
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
I + NYIHRD++ N+L+ + K++DFGL + ++ +A
Sbjct: 116 AFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 47/156 (30%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 111 LTIIGRGAFGEVRLCQ----EKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
+ +G+G FG V LC+ + +G + A+KKL+ S + + E +L +
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHD 65
Query: 167 CIVK---LYYSFQDAEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESI 222
IVK + YS L L+MEYLP G + L + E L Y +Q +E +
Sbjct: 66 NIVKYKGVCYSAGRRN-LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL 124
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258
Y+HRD+ N+L++ +K+ DFGL K L
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 7e-11
Identities = 60/260 (23%), Positives = 103/260 (39%), Gaps = 68/260 (26%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
I+ + L IG+G FG+V L + G A+K LK + A + LAE
Sbjct: 3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLK----------DDSTAAQAFLAE 50
Query: 163 VA-----SH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFYIAQS 215
+ H +V+L LY++ EY+ G ++ L R + + A
Sbjct: 51 ASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALD 110
Query: 216 VL-AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDEN 274
V +E + + N++HRD+ N+L+ ++ K+SDFGL K + +
Sbjct: 111 VCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-----------------EAS 153
Query: 275 LNESMDVDGRFPESGCGRRWKSPLEQLQH----------------WQINRRKLAYSTVGT 318
+ G+ P +W +P E L+ W+I ++ V
Sbjct: 154 QGQDS---GKLP-----VKWTAP-EALREKKFSTKSDVWSFGILLWEI----YSFGRVPY 200
Query: 319 PDYIAPEVL--LKKGYGMEC 336
P +V+ ++KGY ME
Sbjct: 201 PRIPLKDVVPHVEKGYRMEA 220
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 8e-11
Identities = 46/156 (29%), Positives = 80/156 (51%), Gaps = 15/156 (9%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK---SEMLSRGQVEHVRAERNLLAEVASHC 167
L +G GA+G V ++++G A+KKL + SE+ ++ +R LL +
Sbjct: 20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELR----LLKHMKHEN 75
Query: 168 IVKLYYSFQDAEYL------YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES 221
++ L F L YL+M ++ G + LM+ E L+E +F + Q + ++
Sbjct: 76 VIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKY 133
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
IH IHRD+KP NL ++++ +K+ DFGL + D
Sbjct: 134 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 40/144 (27%), Positives = 69/144 (47%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
F L IG G+FG V ++ ++ + A+KK+ S S + + + E L ++
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
++ + +L+MEY G L + ++ L E ++ + +H HN
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 228 IHRDIKPDNLLLDQNGHMKLSDFG 251
IHRD+K N+LL + G +KL DFG
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFG 160
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 1e-10
Identities = 63/271 (23%), Positives = 120/271 (44%), Gaps = 57/271 (21%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
+++++++ IG G FGEV L + K++ + K + + R + + V E N++ E+
Sbjct: 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV-IEVNVMRELK 70
Query: 165 SHCIVKLYYSFQDA--EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIA----QSVLA 218
IV+ F + + LY++ME+ GD+ + + + + I Q + A
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130
Query: 219 IESIHK-------HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD 271
+ H +HRD+KP N+ L T + I +
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLS------------------TGIRHIGKITA-- 170
Query: 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINR----RKLAYSTVGTPDYIAPEVL 327
++ +++GR P+ ++ + +++ +A+S VGTP Y +PE+L
Sbjct: 171 -----QANNLNGR------------PIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELL 213
Query: 328 L--KKGYGMECDWWSLGAIMYEMLVGYPPFY 356
L K Y + D W+LG I+YE+ G PF+
Sbjct: 214 LHETKSYDDKSDMWALGCIIYELCSGKTPFH 244
|
Length = 1021 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 53/244 (21%), Positives = 96/244 (39%), Gaps = 56/244 (22%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
+ L +G G FG V L + + ++ A+K +++ M +E + L SH
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDV-AIKMIREGAMSEDDFIEEAKVMMKL-----SH 58
Query: 167 C-IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL-AIESIHK 224
+V+LY ++++ EY+ G ++ L + T + V A+E +
Sbjct: 59 PNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES 118
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
+ +IHRD+ N L+ ++ +K+SDFGL + VLDD+ + +
Sbjct: 119 NGFIHRDLAARNCLVGEDNVVKVSDFGLAR-------------YVLDDQ---YTSSQGTK 162
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344
FP +W PEV + + D WS G +
Sbjct: 163 FP-----VKWA---------------------------PPEVFDYSRFSSKSDVWSFGVL 190
Query: 345 MYEM 348
M+E+
Sbjct: 191 MWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 47/155 (30%), Positives = 69/155 (44%), Gaps = 23/155 (14%)
Query: 114 IGRGAFGEVRLC----QEKKSGNIYAMKKLKKSEMLSRGQVEHVRA----ERNLLAEVAS 165
+G G FG+V LC +G A+K L S E R+ E +L +
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS------GEEQHRSDFEREIEILRTLDH 65
Query: 166 HCIVKLYYSFQDAEY--LYLIMEYLPGGDVMTLL--MREETLTETVARF--YIAQSVLAI 219
IVK + L LIMEYLP G + L R++ + + F I + + +
Sbjct: 66 ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYL 125
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
S YIHRD+ N+L++ +K+SDFGL K
Sbjct: 126 GSQR---YIHRDLAARNILVESEDLVKISDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 47/161 (29%), Positives = 80/161 (49%), Gaps = 26/161 (16%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK---SEMLSRGQVEHVRAERNL--LAEVAS 165
L +G GA+G V +K++G A+KKL + SE+ ++ RA R L L +
Sbjct: 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAK------RAYRELTLLKHMQH 73
Query: 166 HCIVKL---------YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSV 216
++ L FQD YL+M Y+ D+ ++ L+E ++ + Q +
Sbjct: 74 ENVIGLLDVFTSAVSGDEFQD---FYLVMPYMQT-DLQKIMGHP--LSEDKVQYLVYQML 127
Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
++ IH IHRD+KP NL ++++ +K+ DFGL + D
Sbjct: 128 CGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 10/148 (6%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKK---SEMLSRGQVEHVRAERNLLAEVASHCIVK 170
+G GAFG V +++ +G A+KK+ K + +L++ E LL + I+
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAK----RTYRELKLLKHLRHENIIS 73
Query: 171 LYYSF-QDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIH 229
L F E +Y + E L G D+ LL L + ++++ Q + ++ +H +H
Sbjct: 74 LSDIFISPLEDIYFVTELL-GTDLHRLL-TSRPLEKQFIQYFLYQILRGLKYVHSAGVVH 131
Query: 230 RDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
RD+KP N+L+++N +K+ DFGL + D
Sbjct: 132 RDLKPSNILINENCDLKICDFGLARIQD 159
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 57/240 (23%), Positives = 92/240 (38%), Gaps = 61/240 (25%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
IG+G FG+V K + + A+K + L E +L + IVKL
Sbjct: 3 IGKGNFGDVYKGVLKGNTEV-AVKTCR--STLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREE------TLTETVARFYIAQSVLAIESIHKHNY 227
+ +Y++ME +PGG ++T L +++ L + A + +ES N
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLD--AAAGMEYLES---KNC 114
Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
IHRD+ N L+ +N +K+SDFG+ S + +G
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGM-------------------------SREEEGGIYT 149
Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 347
G + QI + + APE L Y E D WS G +++E
Sbjct: 150 VSDGLK-----------QIPIK-----------WTAPEALNYGRYTSESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 43/156 (27%), Positives = 80/156 (51%), Gaps = 15/156 (9%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK---SEMLSRGQVEHVRAERNLLAEVASHC 167
L+ +G GA+G+V + K+G A+KKL + S + ++ +R LL +
Sbjct: 20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELR----LLKHMDHEN 75
Query: 168 IVKLYYSFQDAEYL------YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES 221
++ L F A L YL+ L G D+ +++ + L++ +F + Q + ++
Sbjct: 76 VIGLLDVFTPASSLEDFQDVYLVTH-LMGADLNN-IVKCQKLSDDHIQFLVYQILRGLKY 133
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
IH IHRD+KP N+ ++++ +K+ DFGL + D
Sbjct: 134 IHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 38/138 (27%), Positives = 65/138 (47%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
IG G+FG V + + A+KK+ S + + + + E L ++ ++
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIK 233
+ +L+MEY G L + ++ L E ++ + +H HN IHRDIK
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 148
Query: 234 PDNLLLDQNGHMKLSDFG 251
N+LL + G +KL+DFG
Sbjct: 149 AGNILLTEPGQVKLADFG 166
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 4e-10
Identities = 43/161 (26%), Positives = 74/161 (45%), Gaps = 2/161 (1%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
D ++ L +G G++ V + K +G + A+K ++ E G E +LL +
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLKH 62
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
IV L+ E L L+ EY+ + L + ++ Q + + IH+
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE 266
+HRD+KP NLL+ G +KL+DFGL + + + NE
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNE 163
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 76/279 (27%), Positives = 110/279 (39%), Gaps = 78/279 (27%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKL------KKSEMLSRGQVEHVRAERNLLA 161
+ L IIG G+FG V + A+KK+ K E+L + H+ N++
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHI----NII- 122
Query: 162 EVASHCIVKLYY---SFQDAE---YLYLIMEYLPGG--DVMTLLMRE-ETLTETVARFYI 212
+K YY F+ E +L ++ME++P M R L + + Y
Sbjct: 123 ------FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYS 176
Query: 213 AQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH-MKLSDFGLCKPLDCTNLSAINENEVLD 271
Q A+ IH HRD+KP NLL+D N H +KL DFG K NL A
Sbjct: 177 YQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK-----NLLA-------- 223
Query: 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KK 330
G+R + S + + Y APE++L
Sbjct: 224 -------------------GQR------------------SVSYICSRFYRAPELMLGAT 246
Query: 331 GYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVH 369
Y D WSLG I+ EM++GYP F V +I+
Sbjct: 247 NYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285
|
Length = 440 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 6e-10
Identities = 61/245 (24%), Positives = 97/245 (39%), Gaps = 59/245 (24%)
Query: 114 IGRGAFGEVRLC----QEKKSGNIYAMKKLKKSEMLSRG-QVEHVRAERNLLAEVASHCI 168
+G G FG+V LC + +G A+K LK S G + ++ E +L + I
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE---SGGNHIADLKKEIEILRNLYHENI 68
Query: 169 VKLYYSFQDAEY---LYLIMEYLPGGDVMTLLMREETLTETVARF-YIAQSVLAIESIHK 224
VK Y + + LIME+LP G + L R + + Y Q ++ +
Sbjct: 69 VK-YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
Y+HRD+ N+L++ +K+ DFGL K ++ D E D+D
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET------------DKEYYTVKDDLD-- 173
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344
SP+ W APE L++ + + D WS G
Sbjct: 174 -----------SPV----FW-----------------YAPECLIQSKFYIASDVWSFGVT 201
Query: 345 MYEML 349
+YE+L
Sbjct: 202 LYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 6e-10
Identities = 68/265 (25%), Positives = 107/265 (40%), Gaps = 74/265 (27%)
Query: 113 IIGRGAFGEVRLCQEKK-----SGNI-YAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
+G GAFGEV SG I A+K L+K + E + E +L++
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFL-KEAHLMSNFNHP 59
Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE---------TLTETVAR-FYIAQSV 216
IVKL E Y+IME + GGD+++ L TL E + +A+
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGH-----MKLSDFGLCKPLDCTNLSAINENEVLD 271
+ +E +H +IHRD+ N L+ + G+ +K+ DFGL + I +++
Sbjct: 120 VYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD--------IYKSDYYR 168
Query: 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331
E +G P RW +APE LL
Sbjct: 169 KEG-------EGLLPV-----RW---------------------------MAPESLLDGK 189
Query: 332 YGMECDWWSLGAIMYEML-VGYPPF 355
+ + D WS G +M+E+L +G P+
Sbjct: 190 FTTQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 8e-10
Identities = 61/257 (23%), Positives = 97/257 (37%), Gaps = 56/257 (21%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
+G G + V + K + N+ A+K+++ G E +LL + IV L+
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIK 233
L L+ EYL L ++ + ++ Q + + HK +HRD+K
Sbjct: 71 IIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLK 130
Query: 234 PDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRR 293
P NLL+++ G +KL+DFGL + + NE L
Sbjct: 131 PQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTL----------------------- 167
Query: 294 WKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGY 352
W P P+VLL Y D W +G I+YEM G
Sbjct: 168 WYRP--------------------------PDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
Query: 353 PPFYSDDPVTTCRKIVH 369
P F P +T ++ +H
Sbjct: 202 PMF----PGSTVKEELH 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 55/246 (22%), Positives = 98/246 (39%), Gaps = 55/246 (22%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
+G G FG V L + + + A+K + + M +E E ++ +++ +V+LY
Sbjct: 12 LGSGQFGVVHLGKWRAQIKV-AIKAINEGAMSEEDFIE----EAKVMMKLSHPKLVQLYG 66
Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL-AIESIHKHNYIHRDI 232
+ LY++ E++ G ++ L + + + Q V +E + ++++IHRD+
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDL 126
Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGR 292
N L+ G +K+SDFG+ + VLDDE + S +FP
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTR-------------YVLDDEYTSSS---GAKFPVKWS-- 168
Query: 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-G 351
PEV Y + D WS G +M+E+ G
Sbjct: 169 ------------------------------PPEVFNFSKYSSKSDVWSFGVLMWEVFTEG 198
Query: 352 YPPFYS 357
PF
Sbjct: 199 KMPFEK 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 62/250 (24%), Positives = 105/250 (42%), Gaps = 63/250 (25%)
Query: 113 IIGRGAFGEVR--LCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
++G+G FGEV ++K + K+ E+ + +E +L + IVK
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-----FLSEARILKQYDHPNIVK 56
Query: 171 LYYSFQDAEYLYLIMEYLPGGDVMTLLMR--EETLTETVARFYI--AQSVLAIESIHKHN 226
L + +Y++ME +PGGD ++ L + +E T+ + +F + A + +ES N
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLES---KN 113
Query: 227 YIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFP 286
IHRD+ N L+ +N +K+SDFG+ + D DG +
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQED------------------------DGIYS 149
Query: 287 ESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 346
SG L+Q+ + APE L Y E D WS G +++
Sbjct: 150 SSG--------LKQI----------------PIKWTAPEALNYGRYSSESDVWSYGILLW 185
Query: 347 EML-VGYPPF 355
E +G P+
Sbjct: 186 ETFSLGVCPY 195
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 64/269 (23%), Positives = 106/269 (39%), Gaps = 60/269 (22%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
+ + L+ +G GA+G V + K+G A+KKL + S + E LL +
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKH 75
Query: 166 HCIVKLYYSFQDAEYL------YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAI 219
++ L F A L YL+ +L G D+ ++ + + LT+ +F I Q + +
Sbjct: 76 ENVIGLLDVFTPARSLEEFNDVYLVT-HLMGADLNNIV-KCQKLTDDHVQFLIYQILRGL 133
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESM 279
+ IH + IHRD+KP NL ++++ +K+ DFGL + D + M
Sbjct: 134 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------------------DEM 174
Query: 280 DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339
RW E + +W Y D W
Sbjct: 175 -------TGYVATRWYRAPEIMLNWM-------------------------HYNQTVDIW 202
Query: 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIV 368
S+G IM E+L G F D + + I+
Sbjct: 203 SVGCIMAELLTGRTLFPGTDHIDQLKLIL 231
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 40/146 (27%), Positives = 74/146 (50%), Gaps = 6/146 (4%)
Query: 114 IGRGAFGEVR--LCQEKKSGNI-YAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
+G G FG V + K + A+K LK+ + + G+ E +R E +++A++ CIV+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAA-GKKEFLR-EASVMAQLDHPCIVR 60
Query: 171 LYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHR 230
L + E L L+ME P G ++ L + + + + Q + + + +++HR
Sbjct: 61 LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119
Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPL 256
D+ N+LL K+SDFG+ + L
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRAL 145
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 60/261 (22%), Positives = 100/261 (38%), Gaps = 56/261 (21%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
L +G G + V + K + N+ A+K+++ G E +LL ++ IV
Sbjct: 11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVT 68
Query: 171 LYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHR 230
L+ + L L+ EYL L ++ + ++ Q + + H+ +HR
Sbjct: 69 LHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHR 128
Query: 231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGC 290
D+KP NLL+++ G +KL+DFGL + + NE L
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTL-------------------- 168
Query: 291 GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEML 349
W P P++LL Y + D W +G I YEM
Sbjct: 169 ---WYRP--------------------------PDILLGSTDYSTQIDMWGVGCIFYEMS 199
Query: 350 VGYPPFYSDDPVTTCRKIVHW 370
G P F P +T + +H+
Sbjct: 200 TGRPLF----PGSTVEEQLHF 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 42/146 (28%), Positives = 76/146 (52%), Gaps = 8/146 (5%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
+G G FGEV + K + A+K +K M VE AE N++ + +VKL+
Sbjct: 14 LGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLH- 67
Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF--YIAQSVLAIESIHKHNYIHRD 231
+ E +Y+I E++ G ++ L +E + + + + AQ + I + NYIHRD
Sbjct: 68 AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 127
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLD 257
++ N+L+ + K++DFGL + ++
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIE 153
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 40/159 (25%), Positives = 74/159 (46%), Gaps = 18/159 (11%)
Query: 111 LTIIGRGAFGEVRLCQEKKS--GNIYAMKKLKKSEMLSRGQVEHV----RAERNLLAEVA 164
+T +GRG FGEV L + K + +K L + + E++ R E ++ +++
Sbjct: 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVK---ALQKTKDENLQSEFRRELDMFRKLS 66
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM----REETL----TETVARFYIA-QS 215
+V+L ++AE Y+I+EY GD+ L ++E L T + + Q
Sbjct: 67 HKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
L ++ + ++HRD+ N L+ +K+S L K
Sbjct: 127 ALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 58/255 (22%), Positives = 96/255 (37%), Gaps = 70/255 (27%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
L +G G + V + K + N+ A+K+++ G E +LL ++ IV
Sbjct: 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVT 68
Query: 171 LYYSFQDAEYLYLIMEYLPG---------GDVMTLLMREETLTETVARFYIAQSVLAIES 221
L+ + L L+ EYL G++M++ + ++ Q + +
Sbjct: 69 LHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSM---------HNVKIFLYQILRGLAY 119
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
H+ +HRD+KP NLL+++ G +KL+DFGL + + NE L
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTL----------- 168
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG-YGMECDWWS 340
W P P+VLL Y + D W
Sbjct: 169 ------------WYRP--------------------------PDVLLGSSEYSTQIDMWG 190
Query: 341 LGAIMYEMLVGYPPF 355
+G I +EM G P F
Sbjct: 191 VGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 6e-09
Identities = 48/148 (32%), Positives = 74/148 (50%), Gaps = 11/148 (7%)
Query: 114 IGRGAFGEVRL-CQEKK---SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
+G G FG+V L C + +G + A+K LK+ + + E N+L + IV
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE--CGQQNTSGWKKEINILKTLYHENIV 69
Query: 170 KLY--YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL-AIESIHKHN 226
K S Q + L LIMEY+P G + L + + + F AQ + + +H +
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLF--AQQICEGMAYLHSQH 127
Query: 227 YIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
YIHRD+ N+LLD + +K+ DFGL K
Sbjct: 128 YIHRDLAARNVLLDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 70/291 (24%), Positives = 107/291 (36%), Gaps = 64/291 (21%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL--LAEVAS 165
+ L IG GA G V + G A+KKL + + Q RA R L L V
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP---FQNQTHAKRAYRELVLLKCVNH 79
Query: 166 HCIVKLYYSF------QDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAI 219
I+ L F ++ + +YL+ME + + M L + + Q + I
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME---LDHERMSYLLYQMLCGI 136
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESM 279
+ +H IHRD+KP N+++ + +K+ DFGL + CTN
Sbjct: 137 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-CTNF------------------ 177
Query: 280 DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339
+ V T Y APEV+L GY D W
Sbjct: 178 -------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIW 206
Query: 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLI 390
S+G IM E++ G F D + K++ RL P ++ +
Sbjct: 207 SVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYV 257
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 43/162 (26%), Positives = 79/162 (48%), Gaps = 25/162 (15%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA--- 164
+ + +IG+G++G V + +G A+KK+ EHV +L E+
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-------NDVFEHVSDATRILREIKLLR 54
Query: 165 --SHC-IVKLYY--------SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIA 213
H IV++ + F+D +Y++ E L D+ ++ + LT +F++
Sbjct: 55 LLRHPDIVEIKHIMLPPSRREFKD---IYVVFE-LMESDLHQVIKANDDLTPEHHQFFLY 110
Query: 214 QSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255
Q + A++ IH N HRD+KP N+L + + +K+ DFGL +
Sbjct: 111 QLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 68/324 (20%), Positives = 116/324 (35%), Gaps = 102/324 (31%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKL--------------KKSEMLSRGQVEHVRAERNL 159
IG GAFG V + + G A+KK+ ++ +ML + ++V + ++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAI 219
L E +Y++ E L D+ +++ + L+ + ++ Q + +
Sbjct: 68 LQPPHIDPF----------EEIYVVTE-LMQSDLHKIIVSPQPLSSDHVKVFLYQILRGL 116
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESM 279
+ +H +HRDIKP NLL++ N +K+ DFGL +
Sbjct: 117 KYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARV------------------------ 152
Query: 280 DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECDW 338
+ + K V T Y APE+L+ + Y D
Sbjct: 153 ------------------------EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDI 188
Query: 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHW----------------KNHL-----KFP 377
WS+G I E+L F + P+ I + H+ K P
Sbjct: 189 WSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPP 248
Query: 378 EEARL-------TPEAKDLICRLL 394
L T EA L+CR+L
Sbjct: 249 SLPVLYTLSSQATHEAVHLLCRML 272
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 8e-09
Identities = 49/169 (28%), Positives = 80/169 (47%), Gaps = 23/169 (13%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSG--NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
+D +IG G FG+V + KK G A+K++K E S+ E +L ++
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKL 64
Query: 164 ASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES- 221
H I+ L + + YLYL +EY P G+++ L R+ + ET F IA S + S
Sbjct: 65 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSS 123
Query: 222 ----------------IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
+ + +IHRD+ N+L+ +N K++DFGL +
Sbjct: 124 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 20/153 (13%)
Query: 114 IGRGAFGEVR--LCQEKKSGNIYAMKKLK--------KSEMLSRGQVEHVRAERNLLAEV 163
+G G FG V+ + + KKS A+K LK K E+L E N++ ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELL---------REANVMQQL 53
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH 223
+ IV++ +AE L+ME G + L + + +TE + Q + ++ +
Sbjct: 54 DNPYIVRMI-GICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE 112
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
+ N++HRD+ N+LL + K+SDFGL K L
Sbjct: 113 ETNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 145
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 2e-08
Identities = 71/290 (24%), Positives = 120/290 (41%), Gaps = 80/290 (27%)
Query: 98 LKRHKISVDDFDLLTIIGRGAFGEV------RLCQEKKSGNIYAMKKLKKSEMLSRGQVE 151
+KRH I L +G GAFG+V LC E+ + A+K LK + +R
Sbjct: 2 IKRHNIV-----LKRELGEGAFGKVFLAECYNLCPEQDK-ILVAVKTLKDASDNARKDF- 54
Query: 152 HVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVM---------TLLMRE-- 200
H AE LL + IVK Y + + L ++ EY+ GD+ +LM E
Sbjct: 55 HREAE--LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGN 112
Query: 201 --ETLTETVARFYIAQSVLA-IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
LT++ +IAQ + A + + +++HRD+ N L+ +N +K+ DFG+ + +
Sbjct: 113 RPAELTQS-QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVY 171
Query: 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG 317
T+ + + +L RW
Sbjct: 172 STDYYRVGGHTMLP--------------------IRW----------------------- 188
Query: 318 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFY--SDDPVTTC 364
+ PE ++ + + E D WSLG +++E+ G P+Y S++ V C
Sbjct: 189 ----MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 50/203 (24%), Positives = 71/203 (34%), Gaps = 54/203 (26%)
Query: 156 ERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQS 215
E +LL + IV L+ E L + EY+ ++ L R ++ Q
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQL 112
Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC--KPLDCTNLSAINENEVLDDE 273
+ + IH + +HRD+KP NLL+ G +KL+DFGL K + S+
Sbjct: 113 LRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS---------- 162
Query: 274 NLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGY 332
E + W Y P+VLL Y
Sbjct: 163 -------------------------EVVTLW----------------YRPPDVLLGATDY 181
Query: 333 GMECDWWSLGAIMYEMLVGYPPF 355
D W G I EML G P F
Sbjct: 182 SSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 45/169 (26%), Positives = 77/169 (45%), Gaps = 23/169 (13%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIY--AMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
+D +IG G FG+V KK G A+K LK E S E +L ++
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK--EFASENDHRDFAGELEVLCKL 59
Query: 164 ASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF------------ 210
H I+ L + ++ YLY+ +EY P G+++ L R+ + ET F
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTASTLTS 118
Query: 211 -----YIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
+ + ++ + + +IHRD+ N+L+ +N K++DFGL +
Sbjct: 119 QQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 5e-08
Identities = 29/101 (28%), Positives = 49/101 (48%), Gaps = 3/101 (2%)
Query: 317 GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKF 376
GT DY +PE + Y + DWW++G + YE+L G PF D+ + + + K
Sbjct: 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKL 227
Query: 377 PEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFK 416
P ++ A D + +L ++ +RL +I HP+ K
Sbjct: 228 PFIKNVSKNANDFVQSMLKYNINYRLTNY--NEIIKHPFLK 266
|
Length = 267 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 41/150 (27%), Positives = 60/150 (40%), Gaps = 51/150 (34%)
Query: 212 IAQSVL-AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG-LCKPLDCTNLSAINENEV 269
I +SVL AI+ +H++ IHRDIK +N+ ++ G + L DFG C P+D IN N+
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVD------INANKY 240
Query: 270 LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK 329
Y GT APE+L +
Sbjct: 241 -------------------------------------------YGWAGTIATNAPELLAR 257
Query: 330 KGYGMECDWWSLGAIMYEMLVGYPPFYSDD 359
YG D WS G +++EM + + D
Sbjct: 258 DPYGPAVDIWSAGIVLFEMATCHDSLFEKD 287
|
Length = 391 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 45/157 (28%), Positives = 76/157 (48%), Gaps = 17/157 (10%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
I + L +G G FGEV + + + A+K LK M E E ++ +
Sbjct: 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKV-AVKTLKPGTM----SPEAFLQEAQIMKK 57
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-------MREETLTETVARFYIAQS 215
+ +V+LY + E +Y++ EY+ G ++ L +R L + A+ IA+
Sbjct: 58 LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQ--IAEG 115
Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
+ +ES NYIHRD+ N+L+ +N K++DFGL
Sbjct: 116 MAYLES---RNYIHRDLAARNILVGENLVCKIADFGL 149
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 58/264 (21%), Positives = 102/264 (38%), Gaps = 60/264 (22%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
LT +G GA+G V + + A+KKL + S E LL + ++
Sbjct: 20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRP-FQSLIHARRTYRELRLLKHMKHENVIG 78
Query: 171 LY------YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK 224
L S ++ +YL+ L G D+ ++ + + L++ +F I Q + ++ IH
Sbjct: 79 LLDVFTPATSIENFNEVYLVTN-LMGADLNNIV-KCQKLSDEHVQFLIYQLLRGLKYIHS 136
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
IHRD+KP N+ ++++ +++ DFGL + D + M
Sbjct: 137 AGIIHRDLKPSNVAVNEDCELRILDFGLARQAD-------------------DEM----- 172
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344
RW E + +W Y D WS+G I
Sbjct: 173 --TGYVATRWYRAPEIMLNWM-------------------------HYNQTVDIWSVGCI 205
Query: 345 MYEMLVGYPPFYSDDPVTTCRKIV 368
M E+L G F +D + ++I+
Sbjct: 206 MAELLKGKALFPGNDYIDQLKRIM 229
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 41/148 (27%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 114 IGRGAFGEVR---LCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
+G G FG V+ KK ++ A+K LK + + + E ++ ++ + IV+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDV-AIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 171 LYYSFQDAEYLYLIMEYLPGGDVMTLLM--REETLTETVARFYIAQSVLAIESIHKHNYI 228
+ +AE L L+ME GG + L ++E V + Q + ++ + N++
Sbjct: 60 MI-GVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVEL-MHQVSMGMKYLEGKNFV 117
Query: 229 HRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
HRD+ N+LL + K+SDFGL K L
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKAL 145
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 56/244 (22%), Positives = 97/244 (39%), Gaps = 51/244 (20%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
IGRG FGEV + + A+K + E L E +L + + IV+L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLA-IESIHKHNYIHRDI 232
+ +Y++ME + GGD +T L E + + ++ A +E + + IHRD+
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGR 292
N L+ + +K+SDFG+ + + DG + +G +
Sbjct: 121 AARNCLVTEKNVLKISDFGMSRE------------------------EEDGVYASTGGMK 156
Query: 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VG 351
+ P++ + APE L Y E D WS G +++E +G
Sbjct: 157 --QIPVK---------------------WTAPEALNYGRYSSESDVWSFGILLWEAFSLG 193
Query: 352 YPPF 355
P+
Sbjct: 194 AVPY 197
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 41/155 (26%), Positives = 73/155 (47%), Gaps = 8/155 (5%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
+I + L+ +G G FGEV + + + A+K LK M +E E ++
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTMSPESFLE----EAQIMK 56
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF--YIAQSVLAI 219
++ +V+LY + E +Y++ EY+ G ++ L E + AQ +
Sbjct: 57 KLRHDKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGM 115
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
I + NYIHRD++ N+L+ K++DFGL +
Sbjct: 116 AYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 44/160 (27%), Positives = 73/160 (45%), Gaps = 19/160 (11%)
Query: 113 IIGRGAFGEVRLCQEKKSG-NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVK 170
+IG G FG+V + KK G + A K K E S+ E +L ++ H I+
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 171 LYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTE--TVARFYIAQSVLA---------- 218
L + + YLYL +EY P G+++ L + L A S L+
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 219 ----IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
++ + + +IHRD+ N+L+ +N K++DFGL +
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 41/169 (24%), Positives = 66/169 (39%), Gaps = 21/169 (12%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRL--CQEKKSGN---IYAMKKLKKSEMLSRGQVEHVRAER 157
+ D L +G GAFG+V L C + N + A+K LK E S + E
Sbjct: 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLK--ETASNDARKDFEREA 59
Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR--------------EETL 203
LL IVK Y + + ++ EY+ GD+ L L
Sbjct: 60 ELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119
Query: 204 TETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
T + Q + + +++HRD+ N L+ + +K+ DFG+
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGM 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 62/255 (24%), Positives = 101/255 (39%), Gaps = 65/255 (25%)
Query: 113 IIGRGAFGEVRLCQEKKSGN---IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
+IG G FGEV K G A+K LK + Q + +E +++ + + H I+
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEASIMGQFSHHNII 69
Query: 170 KLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESI------- 222
+L + +I EY+ G + ++ L + F Q V + I
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGAL------DKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
NY+HRD+ N+L++ N K+SDFGL + VL+D D +
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSR--------------VLED-------DPE 162
Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342
G + SG K P+ + APE + + + D WS G
Sbjct: 163 GTYTTSG----GKIPIR---------------------WTAPEAIAYRKFTSASDVWSFG 197
Query: 343 AIMYE-MLVGYPPFY 356
+M+E M G P++
Sbjct: 198 IVMWEVMSFGERPYW 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 42/164 (25%), Positives = 81/164 (49%), Gaps = 10/164 (6%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
+++ + LL IG+G FG+V L + GN A+K +K + AE +++ +
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQ 55
Query: 163 VASHCIVKLY-YSFQDAEYLYLIMEYLPGGDVMTLLM-REETLTETVARFYIAQSVL-AI 219
+ +V+L ++ LY++ EY+ G ++ L R ++ + V A+
Sbjct: 56 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
E + +N++HRD+ N+L+ ++ K+SDFGL K T +
Sbjct: 116 EYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 159
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 53/254 (20%), Positives = 96/254 (37%), Gaps = 62/254 (24%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
+++L+ + G+ GEV +C K G+ K + K+ + + + + SH
Sbjct: 94 YNILSSLTPGSEGEVFVCT--KHGDEQRKKVIVKAVTGGKTPGREIDILKTI-----SHR 146
Query: 168 -IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLT-ETVARFYIAQSVL-AIESIHK 224
I+ L ++++ + ++M D+ T + R L E I + +L A+ +H
Sbjct: 147 AIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQA--ITIQRRLLEALAYLHG 203
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFG-LCKPLDCTNLSAINENEVLDDENLNESMDVDG 283
IHRD+K +N+ LD+ + L DFG CK +
Sbjct: 204 RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD----------------------- 240
Query: 284 RFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 343
+P Y GT + +PE+L Y + D WS G
Sbjct: 241 ------------TP-------------QCYGWSGTLETNSPELLALDPYCAKTDIWSAGL 275
Query: 344 IMYEMLVGYPPFYS 357
+++EM V +
Sbjct: 276 VLFEMSVKNVTLFG 289
|
Length = 392 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 7/159 (4%)
Query: 103 ISVDDFDLLTIIGRGAFGEVR--LCQEKKSGNI-YAMKKLKKSEMLSRGQVEHVRAERNL 159
I +D L IG G FG+V + ++ I A+K K S E E +
Sbjct: 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR--EKFLQEAYI 60
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDV-MTLLMREETLTETVARFYIAQSVLA 218
+ + IVKL + ++++ME P G++ L + + +L Y Q A
Sbjct: 61 MRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTA 119
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
+ + ++HRDI N+L+ +KL DFGL + L+
Sbjct: 120 LAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|215917 pfam00433, Pkinase_C, Protein kinase C terminal domain | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 3e-07
Identities = 16/51 (31%), Positives = 25/51 (49%), Gaps = 4/51 (7%)
Query: 433 EVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFE 483
+V DT NF E S+ PK + P +++ + L F G++Y N E
Sbjct: 1 KVKSPTDTSNFDP--EFTSEPPKLSP--PDSEVLSSIDQLEFRGFSYVNPE 47
|
Length = 47 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 14/155 (9%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
+G+G FGEV + + + A+K LK M ++ + + L E +V+LY
Sbjct: 14 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQEAQVMKKLRHEK----LVQLYA 68
Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF-----YIAQSVLAIESIHKHNYI 228
+ E +Y++ EY+ G ++ L E R AQ + + + NY+
Sbjct: 69 VVSE-EPIYIVTEYMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMNYV 124
Query: 229 HRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
HRD++ N+L+ +N K++DFGL + ++ +A
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 48/254 (18%), Positives = 85/254 (33%), Gaps = 62/254 (24%)
Query: 144 MLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETL 203
+L GQ E LL V ++++ + +++ + D+ T L +
Sbjct: 95 VLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRP 153
Query: 204 TETVARFYIAQSVL-AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262
I + +L + +H IHRD+K +N+ ++ + + D G +
Sbjct: 154 LPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQ-------- 205
Query: 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYI 322
+ GT +
Sbjct: 206 ----------FPVVAPAF--------------------------------LGLAGTVETN 223
Query: 323 APEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIV-HWKNHLK------ 375
APEVL + Y + D WS G +++EML YP +DP +T + V +HL
Sbjct: 224 APEVLARDKYNSKADIWSAGIVLFEML-AYPSTIFEDPPSTPEEYVKSCHSHLLKIISTL 282
Query: 376 --FPEEARLTPEAK 387
PEE P ++
Sbjct: 283 KVHPEEFPRDPGSR 296
|
Length = 357 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 44/165 (26%), Positives = 74/165 (44%), Gaps = 12/165 (7%)
Query: 103 ISVDDFDLLTIIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL 159
I + +IG G FGEV RL K A+K LK S Q E ++
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASI 58
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE---TLTETVARFY-IAQS 215
+ + I++L + + +I EY+ G + L + T+ + V IA
Sbjct: 59 MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIAS- 117
Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
++ + + NY+HRD+ N+L++ N K+SDFGL + L+ +
Sbjct: 118 --GMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|214529 smart00133, S_TK_X, Extension to Ser/Thr-type protein kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 1e-06
Identities = 21/71 (29%), Positives = 30/71 (42%), Gaps = 12/71 (16%)
Query: 416 KDIAWDKLY--EMEAAYKPEVNGVLDTQNFMKFDEVE-SQTPKRT--GSGPMRKMMLTPK 470
+ I WDKL E+E + P++ DT N FD +TP T S + P
Sbjct: 1 RGIDWDKLENKEIEPPFVPKIKSPTDTSN---FDPEFTEETPVLTPVDSPLSGGIQQEP- 56
Query: 471 DLSFVGYTYKN 481
F G++Y
Sbjct: 57 ---FRGFSYVF 64
|
Length = 64 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 43/177 (24%), Positives = 70/177 (39%), Gaps = 50/177 (28%)
Query: 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD 240
+Y++ EY+ + ++ + L+E AR ++ Q + ++ IH N +HRD+KP N+ ++
Sbjct: 91 VYIVQEYMETD--LANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN 148
Query: 241 QNGHM-KLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLE 299
+ K+ DFGL + VD + G
Sbjct: 149 TEDLVLKIGDFGLARI-------------------------VDPHYSHKG---------- 173
Query: 300 QLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPF 355
L+ V T Y +P +LL Y D W+ G I EML G P F
Sbjct: 174 ----------YLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 37/152 (24%), Positives = 76/152 (50%), Gaps = 8/152 (5%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
+G+G FGEV + + + A+K LK M+ ++ E ++ ++ +V LY
Sbjct: 14 LGQGCFGEVWMGTWNGTTKV-AIKTLKPGTMMPEAFLQ----EAQIMKKLRHDKLVPLYA 68
Query: 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLA--IESIHKHNYIHRD 231
+ E +Y++ E++ G ++ L + + + + +A + I + NYIHRD
Sbjct: 69 VVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
++ N+L+ N K++DFGL + ++ +A
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTA 159
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 60/258 (23%), Positives = 99/258 (38%), Gaps = 71/258 (27%)
Query: 113 IIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
+IG G FGEV RL K A+K LK Q +E +++ + I+
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNII 68
Query: 170 KLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESI------- 222
L ++ + ++ EY+ G + L + + +F + Q V + I
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD------GQFTVIQLVGMLRGIASGMKYL 122
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
Y+HRD+ N+L++ N K+SDFGL + VL+D+
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSR--------------VLEDD--------- 159
Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTP---DYIAPEVLLKKGYGMECDWW 339
PE+ AY+T G + APE + + + D W
Sbjct: 160 ---PEA-----------------------AYTTRGGKIPIRWTAPEAIAYRKFTSASDVW 193
Query: 340 SLGAIMYE-MLVGYPPFY 356
S G +M+E M G P++
Sbjct: 194 SYGIVMWEVMSYGERPYW 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 27/83 (32%), Positives = 42/83 (50%), Gaps = 3/83 (3%)
Query: 312 AYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWK 371
AY+ VGTP YI+PE+ K Y + D W+LG ++YE+ F + + KI+
Sbjct: 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT 217
Query: 372 NHLKFPEEARLTPEAKDLICRLL 394
P R +P+ + LI +L
Sbjct: 218 FA---PISDRYSPDLRQLILSML 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 40/156 (25%), Positives = 69/156 (44%), Gaps = 11/156 (7%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
I LL +G G FGEV + + A+K LK M + AE ++ +
Sbjct: 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPV-AVKTLKPGTM----DPKDFLAEAQIMKK 57
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE----TLTETVARFYIAQSVLA 218
+ +++LY E +Y++ E + G ++ L L + + AQ
Sbjct: 58 LRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLID--MAAQVASG 115
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
+ + NYIHRD+ N+L+ +N K++DFGL +
Sbjct: 116 MAYLEAQNYIHRDLAARNVLVGENNICKVADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 47/163 (28%), Positives = 77/163 (47%), Gaps = 18/163 (11%)
Query: 108 FDLLTIIGRGAFGEVR---LCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
F L ++G+G FG VR L E S A+K LK +++ S +E E + E
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLK-ADIFSSSDIEEFLREAACMKEFD 59
Query: 165 SHCIVKLY------YSFQDAEYLYLIMEYLPGGDVMTLLMR----EETLT---ETVARFY 211
++KL + +I+ ++ GD+ T L+ EE T +T+ RF
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
I +E + N+IHRD+ N +L++N + ++DFGL K
Sbjct: 120 I-DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 41/182 (22%), Positives = 76/182 (41%), Gaps = 40/182 (21%)
Query: 109 DLLTI---IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ--------VEHVRAER 157
LT +G G FGEV LC+ + M+K + V+ +R +
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAE------GMEKFMDKDFSLDVSGNQPVLVAVKMLREDA 58
Query: 158 N------------LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE---- 201
N +++ + I++L ++ L +I EY+ GD+ L R E
Sbjct: 59 NKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEA 118
Query: 202 -------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
T++ + F Q ++ + N++HRD+ N L+ +N +K++DFG+ +
Sbjct: 119 AEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
Query: 255 PL 256
L
Sbjct: 179 NL 180
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 51/211 (24%), Positives = 76/211 (36%), Gaps = 50/211 (23%)
Query: 149 QVEHVRAERNLLAEVASHCIVKLYYSFQ-DAEYLYLIMEYLPGGDVMTLLMREETLT--E 205
Q R E L A + IV L S + L+ + EY+PG + +L + L E
Sbjct: 21 QRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGE 80
Query: 206 TVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG---HMKLSDFGLCKPLDCTNLS 262
T + Q + A+ H +HRD+KP N+++ Q G H K+ DFG+ T L
Sbjct: 81 TGR--LMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGI-----GTLLP 133
Query: 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYI 322
+ + +V +GTP Y
Sbjct: 134 GVRDADVA-------------------------------------TLTRTTEVLGTPTYC 156
Query: 323 APEVLLKKGYGMECDWWSLGAIMYEMLVGYP 353
APE L + D ++ G I E L G
Sbjct: 157 APEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 45/156 (28%), Positives = 76/156 (48%), Gaps = 14/156 (8%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLK---KSEMLSRGQVEHVRAERNLLAEVASH-CIV 169
IG GA+G V ++ SG+ A+K ++ + L V V + L E H IV
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRL--EAFDHPNIV 65
Query: 170 KLY----YSFQDAEY-LYLIMEYLPGGDVMTLLMREET--LTETVARFYIAQSVLAIESI 222
+L S D E + L+ E++ D+ T L + L + + Q + ++ +
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258
H + +HRD+KP+N+L+ G +KL+DFGL + C
Sbjct: 125 HANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 60/259 (23%), Positives = 100/259 (38%), Gaps = 71/259 (27%)
Query: 113 IIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR----AERNLLAEVAS 165
+IG G FGEV RL K A+K LK G E R +E +++ +
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKS------GYTEKQRRDFLSEASIMGQFDH 64
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESI--- 222
I+ L + + +I E++ G + + L + + +F + Q V + I
Sbjct: 65 PNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQND------GQFTVIQLVGMLRGIAAG 118
Query: 223 ----HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
+ NY+HRD+ N+L++ N K+SDFGL + L+ D + +
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE------------DDTSDPTYT 166
Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
+ G+ P RW APE + + + D
Sbjct: 167 SSLGGKIP-----IRWT---------------------------APEAIAYRKFTSASDV 194
Query: 339 WSLGAIMYE-MLVGYPPFY 356
WS G +M+E M G P++
Sbjct: 195 WSYGIVMWEVMSYGERPYW 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 6e-06
Identities = 67/276 (24%), Positives = 106/276 (38%), Gaps = 89/276 (32%)
Query: 108 FDLLTIIGRGAFGEVRLCQEK--KSGNIYAMKKLK--KSEM--LSRGQVEHVRAERNL-- 159
+++ IGRG +G V + K K G YA+KK K K + +S+ + R L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 160 -----LAEV-ASHCIVKLYYSFQDAEY-LYLIMEY--------LPGGDVMTLLMREETLT 204
L EV H +Y F AE+ L+ I+++ +P V +LL
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW------ 115
Query: 205 ETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL----DQNGHMKLSDFGLCKPLDCTN 260
Q + + +H + +HRD+KP N+L+ + G +K+ D GL
Sbjct: 116 ---------QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL-------- 158
Query: 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPD 320
R + +PL+ L ++ V T
Sbjct: 159 ------------------------------ARLFNAPLKPLAD--LDP------VVVTIW 180
Query: 321 YIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPF 355
Y APE+LL + Y D W++G I E+L P F
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 46/155 (29%), Positives = 76/155 (49%), Gaps = 24/155 (15%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR--GQVEHV-RAERNL-LAEVASH 166
L IG GA G V + +G A+KKL SR V H RA R L L ++ +H
Sbjct: 21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKL------SRPFQNVTHAKRAYRELVLMKLVNH 74
Query: 167 -CIVKLYYSF------QDAEYLYLIMEYLPGG--DVMTLLMREETLTETVARFYIAQSVL 217
I+ L F ++ + +YL+ME + V+ + + E ++ + + Q +
Sbjct: 75 KNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQMLC 129
Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
I+ +H IHRD+KP N+++ + +K+ DFGL
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 164
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 9e-06
Identities = 39/141 (27%), Positives = 52/141 (36%), Gaps = 48/141 (34%)
Query: 209 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENE 268
R + Q + A+E IH IHRDIK +N+ L+ +G + L DFG P + E E
Sbjct: 270 RAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFE-------KERE 322
Query: 269 VLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL 328
D Y VGT +PE+L
Sbjct: 323 AFD-----------------------------------------YGWVGTVATNSPEILA 341
Query: 329 KKGYGMECDWWSLGAIMYEML 349
GY D WS G I+ +ML
Sbjct: 342 GDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 44/167 (26%), Positives = 76/167 (45%), Gaps = 40/167 (23%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH--------VRAE 156
++ + L +G G++ V + K +G + A+K+++ +EH +R E
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIR---------LEHEEGAPFTAIR-E 53
Query: 157 RNLLAEVASHCIVKLYYSFQDAEYLYLIMEYL-----------PGGDVMTLLMREETLTE 205
+LL ++ IV L+ + L L+ EYL GG L M
Sbjct: 54 ASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGG----LSMHN----- 104
Query: 206 TVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
R ++ Q + + H+ +HRD+KP NLL+ + G +KL+DFGL
Sbjct: 105 --VRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGL 149
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 62/266 (23%), Positives = 101/266 (37%), Gaps = 64/266 (24%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL-LAEVASH-CI 168
L IG GA G V + A+KKL + + Q RA R L L + +H I
Sbjct: 29 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRP---FQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 169 VKLY------YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESI 222
+ L S ++ + +Y++ME + + M L + + Q + I+ +
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIKHL 142
Query: 223 HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
H IHRD+KP N+++ + +K+ DFGL + S + V+
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVT----------- 188
Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342
R +++P EV+L GY D WS+G
Sbjct: 189 ---------RYYRAP---------------------------EVILGMGYKENVDIWSVG 212
Query: 343 AIMYEMLVGYPPFYSDDPVTTCRKIV 368
IM EM+ G F D + K++
Sbjct: 213 CIMGEMIKGGVLFPGTDHIDQWNKVI 238
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 64/270 (23%)
Query: 109 DLLTIIGRG--AFGEVRLCQEKKSGNIYAMKKLK----KSEMLSRGQVE-HVRAERNLLA 161
+LLT+IGRG V L + K +G ++++ +EM++ Q E HV +
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHV-------S 53
Query: 162 EVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVL- 217
++ +H IV +F L+++ ++ G L+ + ++E +A YI Q VL
Sbjct: 54 KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSE-LAIAYILQGVLK 112
Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNE 277
A++ IH Y+HR +K ++L+ +G + LS GL +NLS IN + L
Sbjct: 113 ALDYIHHMGYVHRSVKASHILISVDGKVYLS--GL-----RSNLSMINHGQRL------- 158
Query: 278 SMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK--KGYGME 335
V FP+ YS P +++PEVL + +GY +
Sbjct: 159 --RVVHDFPK-------------------------YSVKVLP-WLSPEVLQQNLQGYDAK 190
Query: 336 CDWWSLGAIMYEMLVGYPPFYSDDPVTTCR 365
D +S+G E+ G+ PF D P T
Sbjct: 191 SDIYSVGITACELANGHVPF-KDMPATQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 61/274 (22%), Positives = 106/274 (38%), Gaps = 81/274 (29%)
Query: 114 IGRGAFGEVRLCQEKKSG-------NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
IG+GAFG R+ Q + G + A+K LK+ E + Q + R E L+AE
Sbjct: 13 IGQGAFG--RVFQARAPGLLPYEPFTMVAVKMLKE-EASADMQADFQR-EAALMAEFDHP 68
Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR-----EETLTETVAR------------ 209
IVKL + + L+ EY+ GD+ L + +L+ + +
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 210 ----FYIAQSVLA-IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264
IA+ V A + + + ++HRD+ N L+ +N +K++DFGL + + +
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAP 324
+EN+ + RW + P
Sbjct: 189 SENDAIP--------------------IRW---------------------------MPP 201
Query: 325 EVLLKKGYGMECDWWSLGAIMYEML-VGYPPFYS 357
E + Y E D W+ G +++E+ G P+Y
Sbjct: 202 ESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 41/181 (22%), Positives = 77/181 (42%), Gaps = 24/181 (13%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAE-----RN-------LLA 161
+G G FGEV LC+ + + V+ +RA+ RN +++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTE--------TVARFYIA 213
+ + I++L + L +I EY+ GD+ L + E + +V+ +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 214 QSVLAIESIHKH----NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEV 269
+ I S K+ N++HRD+ N L+ + +K++DFG+ + L + I V
Sbjct: 133 YMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAV 192
Query: 270 L 270
L
Sbjct: 193 L 193
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 41/153 (26%), Positives = 54/153 (35%), Gaps = 55/153 (35%)
Query: 207 VARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE 266
VAR Q + AI+ IH IHRDIK +N+L++ + L DFG
Sbjct: 265 VAR----QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFG--------------- 305
Query: 267 NEVLDDENLNESMDVDGRFPESGCGRR--WKSPLEQLQHWQINRRKLAYSTVGTPDYIAP 324
+ C R W +P Y GT D AP
Sbjct: 306 ---------------------AACFARGSWSTPFH-------------YGIAGTVDTNAP 331
Query: 325 EVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 357
EVL Y D WS G +++E V +S
Sbjct: 332 EVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFS 364
|
Length = 461 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 66/269 (24%), Positives = 102/269 (37%), Gaps = 66/269 (24%)
Query: 110 LLTIIGRGAFGEV------RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
L +G G FG+V RL + + A+K LK++ S ++ + +E NLL +V
Sbjct: 4 LGKTLGEGEFGKVVKATAFRL-KGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQV 60
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR------------------------ 199
++KLY + L LI+EY G + + L
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 200 EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259
E LT + Q ++ + + +HRD+ N+L+ + MK+SDFGL + +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV--- 177
Query: 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQH--------WQINRRKL 311
+D + S GR P +W + H W
Sbjct: 178 ---------YEEDSYVKRS---KGRIPV-----KWMAIESLFDHIYTTQSDVWSFGVLLW 220
Query: 312 AYSTVGTPDY--IAPE---VLLKKGYGME 335
T+G Y IAPE LLK GY ME
Sbjct: 221 EIVTLGGNPYPGIAPERLFNLLKTGYRME 249
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 38/152 (25%), Positives = 67/152 (44%), Gaps = 10/152 (6%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMK--KLKKSEMLSRGQVEHVRAERNLLAEVA 164
D I+G G G V + I A+K L + L + + +E +L +
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQK----QIMSELEILYKCD 57
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK 224
S I+ Y +F + + E++ GG +L + + + R +A V + +
Sbjct: 58 SPYIIGFYGAFFVENRISICTEFMDGG---SLDVYRKIPEHVLGRIAVA-VVKGLTYLWS 113
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
+HRD+KP N+L++ G +KL DFG+ L
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL 145
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 58/272 (21%), Positives = 101/272 (37%), Gaps = 78/272 (28%)
Query: 114 IGRGAFGEVRLCQ-----EKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCI 168
+G GAFG+V L + K + A+K LK + +R + E LL + I
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLTNLQHEHI 69
Query: 169 VKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR------------------EETLTETV-AR 209
VK Y D + L ++ EY+ GD+ L E L++ +
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEV 269
IA ++ + S H ++HRD+ N L+ N +K+ DFG+ + + T+ + + +
Sbjct: 130 SQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 270 LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK 329
L RW + PE ++
Sbjct: 187 LP--------------------IRW---------------------------MPPESIMY 199
Query: 330 KGYGMECDWWSLGAIMYEMLV-GYPPFYSDDP 360
+ + E D WS G I++E+ G P++
Sbjct: 200 RKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 63/283 (22%), Positives = 109/283 (38%), Gaps = 78/283 (27%)
Query: 100 RHKISVDDFDLLTIIGRGAFGEVRLCQ-------EKKSGNIYAMKKLKKSEMLSRGQVEH 152
R + S D L +G G FG+V + + + K A+K LK + +
Sbjct: 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSD 66
Query: 153 VRAERNLLAEVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-------------- 197
+ +E ++ + H I+ L + LY+I+EY G++ L
Sbjct: 67 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 126
Query: 198 --MREETLT--ETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253
+ +E +T + V+ Y Q +E + IHRD+ N+L+ +N MK++DFGL
Sbjct: 127 ARVPDEQMTFKDLVSCTY--QVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 184
Query: 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAY 313
+ D N+ + +GR P +W
Sbjct: 185 R--DVNNIDYYKKT-------------TNGRLPV-----KW------------------- 205
Query: 314 STVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPPF 355
+APE L + Y + D WS G +M+E+ +G P+
Sbjct: 206 --------MAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 22/113 (19%), Positives = 44/113 (38%), Gaps = 12/113 (10%)
Query: 146 SRGQVEHVRAERNLLAEVASHCIV--KLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETL 203
SR + E +L +A + K+ S + + YL+ME++ G L
Sbjct: 31 SREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG----ETLDEVSEE 86
Query: 204 TETVARFYIAQSVLAIESIHKHNY---IHRDIKPDNLLLDQNGHMKLSDFGLC 253
+ +A+ + +H+ H D+ P N+L+D + + D+
Sbjct: 87 EKEDIAEQLAE---LLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 57/267 (21%), Positives = 105/267 (39%), Gaps = 77/267 (28%)
Query: 114 IGRGAFGEVRLCQ-----EKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCI 168
+G GAFG+V L + ++ + A+K LK++ +R + + E LL + I
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR---QDFQREAELLTVLQHQHI 69
Query: 169 VKLYYSFQDAEYLYLIMEYLPGGDVMTLL-----------------MREETLTETVA-RF 210
V+ Y + L ++ EY+ GD+ L + TL + +A
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 211 YIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270
IA ++ + S+H ++HRD+ N L+ Q +K+ DFG+ + + T+ +
Sbjct: 130 QIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV------ 180
Query: 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK 330
G R P+ ++ PE +L +
Sbjct: 181 --------------------GGRTMLPIR---------------------WMPPESILYR 199
Query: 331 GYGMECDWWSLGAIMYEMLV-GYPPFY 356
+ E D WS G +++E+ G P+Y
Sbjct: 200 KFTTESDIWSFGVVLWEIFTYGKQPWY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 60/289 (20%), Positives = 110/289 (38%), Gaps = 75/289 (25%)
Query: 114 IGRGAFGEVRLCQ------EKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH- 166
+G G FG+V + + +K + + K+ K + + + V +E ++ + H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLV-SEMEMMKMIGKHK 78
Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL----------------MREETLT--ETVA 208
I+ L + LY+++EY G++ L + EE LT + V+
Sbjct: 79 NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138
Query: 209 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENE 268
Y Q +E + IHRD+ N+L+ ++ MK++DFGL + D N+ +
Sbjct: 139 CAY--QVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLAR--DVHNIDYYKKT- 193
Query: 269 VLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL 328
+GR P +W +APE L
Sbjct: 194 ------------TNGRLPV-----KW---------------------------MAPEALF 209
Query: 329 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFP 377
+ Y + D WS G +++E+ Y PV K++ + + P
Sbjct: 210 DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP 258
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 42/151 (27%), Positives = 69/151 (45%), Gaps = 12/151 (7%)
Query: 113 IIGRGAFGEVR------LCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
+G GAFG+V L + + A+K LK + S + E + +E +++ + +H
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKV-AVKMLKPTAHSS--EREALMSELKIMSHLGNH 98
Query: 167 C-IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR--EETLTETVARFYIAQSVLAIESIH 223
IV L + + +I EY GD++ L R E LT + Q + +
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
N IHRD+ N+LL +K+ DFGL +
Sbjct: 159 SKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 40/163 (24%), Positives = 77/163 (47%), Gaps = 18/163 (11%)
Query: 108 FDLLTIIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
L I+G G FG V +L Q+ S A+K +K ++ + ++E +E + +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMK-LDIHTYSEIEEFLSEAACMKDFD 59
Query: 165 SHCIVKLY-YSFQDAEYLYL-----IMEYLPGGDVMTLL--MREETL-----TETVARFY 211
++KL F+ + + I+ ++ GD+ + L R L +T+ +F
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF- 118
Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
+ L +E + N+IHRD+ N +L ++ + ++DFGL K
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 47/172 (27%), Positives = 79/172 (45%), Gaps = 23/172 (13%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQ-----EKKSGNIYAMKKLKKSEMLSRGQVEHVRAE 156
+I + L +G GAFG+V + E+ S A+K LK++ + R E
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQE 58
Query: 157 RNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMRE--------ETLTETVA 208
L++++ IV L + ++ EYL GD+ L+R E+ ETV
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 209 R-------FYIAQSVLA-IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
+IA + A +E + H+++HRD+ N L+ + +K+SDFGL
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGL 170
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 6e-05
Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 21/180 (11%)
Query: 83 NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
N +E ++ + LKR++ L IG GA G V + A+KKL +
Sbjct: 1 NQFYSVEVGDSTFTVLKRYQN-------LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP 53
Query: 143 EMLSRGQVEHVRAERNL-LAEVASH-CIVKLYYSF------QDAEYLYLIMEYLPGGDVM 194
+ Q RA R L L + +H I+ L F ++ + +YL+ME +
Sbjct: 54 ---FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQ 110
Query: 195 TLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
+ M L + + Q + I+ +H IHRD+KP N+++ + +K+ DFGL +
Sbjct: 111 VIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 7e-05
Identities = 43/170 (25%), Positives = 73/170 (42%), Gaps = 29/170 (17%)
Query: 114 IGRGAFGEVRLCQ----------------EKKSGNIYAMKKLKKSEMLSRGQVEHVRAER 157
+G G FGEV LC+ + + A+K L+ S E E
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEV 70
Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVA--RFYIAQS 215
+L+ ++ I +L L +IMEY+ GD+ L + T +A ++ S
Sbjct: 71 KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130
Query: 216 VL-----AIESIHKH----NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
L I S ++ N++HRD+ N L+ +N +K++DFG+ + L
Sbjct: 131 TLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 37/148 (25%), Positives = 67/148 (45%), Gaps = 6/148 (4%)
Query: 114 IGRGAFGEVRLCQEKKSGN--IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKL 171
+G G+FG VR + SG I K KS+ LS + ++ E ++ + +++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLK-EAAIMHSLDHENLIRL 61
Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF--YIAQSVLAIESIHKHNYIH 229
Y L ++ E P G ++ L ++ ++ Y Q + + +IH
Sbjct: 62 YGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIH 120
Query: 230 RDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
RD+ N+LL + +K+ DFGL + L
Sbjct: 121 RDLAARNILLASDDKVKIGDFGLMRALP 148
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 49/214 (22%), Positives = 93/214 (43%), Gaps = 53/214 (24%)
Query: 151 EHVRAERNLLAEVASHC-----IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR--EETL 203
EH++A +N V SH I+ + F +L++I ++ G +LL E +
Sbjct: 41 EHLKALQN--EVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGM 98
Query: 204 TETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
+E + + ++ + +H++ YIHR+IK ++L+ +G + LS GL ++L +
Sbjct: 99 SEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLS--GL------SHLYS 150
Query: 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIA 323
+ N + V FP+ +ST P +++
Sbjct: 151 LVRN--------GQKAKVVYDFPQ-------------------------FSTSVLP-WLS 176
Query: 324 PEVLLKK--GYGMECDWWSLGAIMYEMLVGYPPF 355
PE+L + GY ++ D +S+G E+ G PF
Sbjct: 177 PELLRQDLYGYNVKSDIYSVGITACELATGRVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 20/66 (30%), Positives = 37/66 (56%)
Query: 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHM 245
E++ G + M ++ V + + Q + + +H+ +HRDIKP+NLL+ +G +
Sbjct: 289 EFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQV 348
Query: 246 KLSDFG 251
K+ DFG
Sbjct: 349 KIIDFG 354
|
Length = 507 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 46/173 (26%), Positives = 74/173 (42%), Gaps = 27/173 (15%)
Query: 102 KISVDDFDLLTIIGRGAFGEV-----RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAE 156
++ D LL +G GAFGEV R A+K L E S E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL--PESCSEQDESDFLME 59
Query: 157 RNLLAEVASHCIVKLY-YSFQDAEYLYLIMEYLPGGDVMTLLMREE----------TLTE 205
++++ IV+L SF+ ++++E + GGD+ + L RE T+ +
Sbjct: 60 ALIMSKFNHQNIVRLIGVSFERLPR-FILLELMAGGDLKSFL-RENRPRPERPSSLTMKD 117
Query: 206 TV-ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH---MKLSDFGLCK 254
+ +A+ +E H +IHRDI N LL G K++DFG+ +
Sbjct: 118 LLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 42/151 (27%), Positives = 73/151 (48%), Gaps = 8/151 (5%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ-VEHVRAERNLLAEVAS 165
+F L +G G FGEV K + A+K LK ++L + + V+A + L +
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVRV-AIKILKSDDLLKQQDFQKEVQALKRLRHK--- 62
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF-YIAQSVL-AIESIH 223
H ++ L+ E +Y+I E + G ++ L E VA +A V + +
Sbjct: 63 H-LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
+ N IHRD+ N+L+ ++ K++DFGL +
Sbjct: 122 EQNSIHRDLAARNILVGEDLVCKVADFGLAR 152
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 55/249 (22%), Positives = 94/249 (37%), Gaps = 58/249 (23%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRL--CQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLL 160
I + L+ IG G FG V L EK+ I +++ SE E E ++
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-------EDFIEEAQVM 53
Query: 161 AEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL-AI 219
+++ +V+LY + + L+ E++ G + L + + V +
Sbjct: 54 MKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGM 113
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESM 279
+ N IHRD+ N L+ +N +K+SDFG+ + VLDD+ + +
Sbjct: 114 AYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTR-------------FVLDDQYTSST- 159
Query: 280 DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339
+FP +W S PEV Y + D W
Sbjct: 160 --GTKFPV-----KWSS---------------------------PEVFSFSKYSSKSDVW 185
Query: 340 SLGAIMYEM 348
S G +M+E+
Sbjct: 186 SFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 47/157 (29%), Positives = 67/157 (42%), Gaps = 31/157 (19%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYA---MKKLKKS-------EMLSRGQVEHVRAERNLLAEV 163
IG G FG+V L E SG A +K+L+ S + L Q NLL +
Sbjct: 3 IGNGWFGKVIL-GEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL-QC 60
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL--------MREETLTETVARFYIAQS 215
C + YL L+ME+ P GD+ L M + T IA
Sbjct: 61 LGQCT-------EVTPYL-LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALG 112
Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
+L +HK+N+IH D+ N LL + +K+ D+GL
Sbjct: 113 LL---HLHKNNFIHSDLALRNCLLTADLTVKIGDYGL 146
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 58/254 (22%), Positives = 110/254 (43%), Gaps = 43/254 (16%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR-GQVEHVRAERNLLA 161
+S F +L+++G G FG+V ++K A+K ++ +R ++E E+ A
Sbjct: 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQA 185
Query: 162 EVASH-CIVKLYYSFQ-DAEYLYLIM-EYLPGGDVMTLLMREETLTETVARFYIAQSVLA 218
+ A ++K+ FQ + ++ ++M +Y P ++ +M+ + I Q+ +A
Sbjct: 186 DPADRFPLMKIQRYFQNETGHMCIVMPKYGPC--LLDWIMKHGPFSHRHLAQIIFQTGVA 243
Query: 219 IESIHKH-NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNE 277
++ H + +H D+KP+N+L M+ SD T + + + D
Sbjct: 244 LDYFHTELHLMHTDLKPENIL------METSD---------TVVDPVTNRALPPDPCRVR 288
Query: 278 SMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
D+ GC + R + V T Y +PEV+L G+ D
Sbjct: 289 ICDL------GGC---------------CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTD 327
Query: 338 WWSLGAIMYEMLVG 351
WS+G I+YE+ G
Sbjct: 328 MWSMGCIIYELYTG 341
|
Length = 467 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 54/265 (20%), Positives = 104/265 (39%), Gaps = 71/265 (26%)
Query: 114 IGRGAFGEVRLCQEKKSG----NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
+G AFG++ G + A+K LK ++ + Q + E +L+AE+ IV
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLK--DINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 170 KLYYSFQDAEYLYLIMEYLPGGDVMT-LLMR------------EETLTETVAR---FYIA 213
L + + ++ EYL GD+ L+MR + T+ ++ +IA
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 214 QSVLA-IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDD 272
+ A +E + H ++H+D+ N+L+ + H+K+SD GL + + + + +L
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP- 189
Query: 273 ENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY 332
RW + PE ++ +
Sbjct: 190 -------------------IRW---------------------------MPPEAIMYGKF 203
Query: 333 GMECDWWSLGAIMYEML-VGYPPFY 356
+ D WS G +++E+ G P+Y
Sbjct: 204 SSDSDIWSFGVVLWEIFSFGLQPYY 228
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 30/122 (24%), Positives = 50/122 (40%), Gaps = 30/122 (24%)
Query: 321 YIAPEVLLKKG-YGMECDWWSLGAIMYEMLVGYPPFYSDDPV---------------TTC 364
Y APE LL G YG + D W++G + +E+L +P F + +
Sbjct: 164 YRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVL 223
Query: 365 RKIVHW-KNHLKFPEEA---------RLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHP 413
+K + FP + + E DL+ +LL D + R + ++Q HP
Sbjct: 224 KKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDER---ITAKQALRHP 280
Query: 414 WF 415
+F
Sbjct: 281 YF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 6e-04
Identities = 55/255 (21%), Positives = 100/255 (39%), Gaps = 55/255 (21%)
Query: 113 IIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
+IG+G FG V L A+K L + L +VE E ++ + + ++
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL--EEVEQFLKEGIIMKDFSHPNVL 59
Query: 170 KLYYSFQDAEYLYLI-MEYLPGGDVMTLLMREETLTETVARF--YIAQSVLAIESIHKHN 226
L +E L+ + Y+ GD+ + R ET TV + Q +E +
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFI-RSETHNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 227 YIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFP 286
++HRD+ N +LD++ +K++DFGL + ++ D E + + P
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLAR-------------DIYDKEYYSVHNHTGAKLP 165
Query: 287 ESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 346
+W + LE LQ + + + D WS G +++
Sbjct: 166 V-----KWMA-LESLQ--------------------------TQKFTTKSDVWSFGVLLW 193
Query: 347 EMLV-GYPPFYSDDP 360
E++ G PP+ D
Sbjct: 194 ELMTRGAPPYPDVDS 208
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 9e-04
Identities = 60/301 (19%), Positives = 111/301 (36%), Gaps = 82/301 (27%)
Query: 103 ISVDDFDLLTIIGRGAFGEVR--LCQEKKSGNIY---AMKKLKKSEMLSRGQVEHVRAER 157
+ + L+ +G+G+FG V L + G A+K + +E S + E
Sbjct: 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTV--NENASMRERIEFLNEA 60
Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL---MREETLTE-----TVAR 209
+++ E H +V+L + ++ME + GD+ + L E T+ +
Sbjct: 61 SVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQK 120
Query: 210 FY-----IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264
F IA + + + ++HRD+ N ++ ++ +K+ DFG+ + I
Sbjct: 121 FIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRD--------I 169
Query: 265 NENEVLDDENLNESMDVDGRFPESGCGR---RWKSPLEQLQHWQINRRKLAYSTVGTPDY 321
E + + + G G RW
Sbjct: 170 YETDY---------------YRKGGKGLLPVRW--------------------------- 187
Query: 322 IAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPPF--YSDDPVTTCRKIVHWKNHLKFPE 378
+APE L + + D WS G +++EM + P+ S++ V K V HL PE
Sbjct: 188 MAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL---KFVIDGGHLDLPE 244
Query: 379 E 379
Sbjct: 245 N 245
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 59/258 (22%), Positives = 104/258 (40%), Gaps = 64/258 (24%)
Query: 114 IGRGAFGEVRLCQEK--KSGNIYAMKKLKKS--EMLSRGQVEHVRAERN-----LLAEVA 164
+GRG +G V + K K YA+K+++ + M + ++ +R ++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 165 SHCIVKLYYSFQDAEY-LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH 223
SH K++ F AE+ L+ I+++ M+ L ++ + + Q + I +H
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQ---LPRSMVKSLLYQILDGIHYLH 125
Query: 224 KHNYIHRDIKPDNLLL----DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESM 279
+ +HRD+KP N+L+ + G +K++D G
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGF--------------------------- 158
Query: 280 DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECDW 338
R + SPL+ L V T Y APE+LL + Y D
Sbjct: 159 -----------ARLFNSPLKPLADLD--------PVVVTFWYRAPELLLGARHYTKAIDI 199
Query: 339 WSLGAIMYEMLVGYPPFY 356
W++G I E+L P F+
Sbjct: 200 WAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 23/53 (43%), Positives = 28/53 (52%)
Query: 316 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIV 368
V T Y APEV+L GY D WS+G IM EM+ G F D + KI+
Sbjct: 178 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKII 230
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 22/66 (33%), Positives = 33/66 (50%), Gaps = 7/66 (10%)
Query: 311 LAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG---YPPFYSDD----PVTT 363
+A + VGT Y+APE + + YG+ D WSLG E+ +G YP + P+
Sbjct: 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL 208
Query: 364 CRKIVH 369
+ IV
Sbjct: 209 LQCIVD 214
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 35/157 (22%), Positives = 72/157 (45%), Gaps = 15/157 (9%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMK-KLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
+G G FG V Q + +I + K K + +R ++E +E + E +++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 173 -YSFQDAE-----YLYLIMEYLPGGDVMTLLMREET-------LTETVARFYIAQSVLAI 219
Q E +I+ ++ GD+ + L+ T+ + +F + +
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKF-MTDIASGM 125
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
E + ++IHRD+ N +L++N ++ ++DFGL K +
Sbjct: 126 EYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI 162
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 22/76 (28%), Positives = 40/76 (52%), Gaps = 2/76 (2%)
Query: 181 LYLIMEYLPGGDVMTLL-MREETLTETVARFYIAQSVL-AIESIHKHNYIHRDIKPDNLL 238
LY++ME + G+++ L R L + + V +E + +HRD+ N+L
Sbjct: 73 LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNIL 132
Query: 239 LDQNGHMKLSDFGLCK 254
+ ++G K+SDFGL +
Sbjct: 133 VSEDGVAKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.004
Identities = 58/258 (22%), Positives = 102/258 (39%), Gaps = 64/258 (24%)
Query: 114 IGRGAFGEVRLCQEK--KSGNIYAMKKLKKS--EMLSRGQVEHVRAER-----NLLAEVA 164
+GRG +G V + K K YA+K+++ + M + ++ +R + +L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 165 SHCIVKLYYSFQDAEY-LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH 223
SH K++ F AE+ L+ I+++ + L + + + Q + I +H
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANK---KPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 224 KHNYIHRDIKPDNLLL----DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESM 279
+ +HRD+KP N+L+ + G +K++D G
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGF--------------------------- 158
Query: 280 DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECDW 338
R + SPL+ L V T Y APE+LL + Y D
Sbjct: 159 -----------ARLFNSPLKPLADLD--------PVVVTFWYRAPELLLGARHYTKAIDI 199
Query: 339 WSLGAIMYEMLVGYPPFY 356
W++G I E+L P F+
Sbjct: 200 WAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 40/176 (22%), Positives = 75/176 (42%), Gaps = 33/176 (18%)
Query: 114 IGRGAFGEVRLCQEKKSGNI------YAMKK----LKKSEMLSRGQVEHVRA----ERNL 159
+G G FGEV LC+ ++ + ++K L ++L ++ R E +
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTE-------------- 205
L+ + I++L D + L +I EY+ GD+ L +
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 206 -TVARFYIAQSVLAIESIHKH----NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
++ + L I S K+ N++HRD+ N L+ +N +K++DFG+ + L
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 514 | |||
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.84 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.79 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.63 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.6 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.57 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.53 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.49 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.46 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.43 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.33 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.29 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.27 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.2 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.15 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.11 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.98 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.98 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.97 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.79 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.79 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.68 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.64 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.5 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.49 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.47 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.47 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.46 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.4 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.28 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.24 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.2 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.16 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.15 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.03 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.96 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.96 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.96 | |
| smart00133 | 64 | S_TK_X Extension to Ser/Thr-type protein kinases. | 97.93 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.83 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.79 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.66 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.66 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.49 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.49 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.48 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.48 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.44 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.19 | |
| PLN02236 | 344 | choline kinase | 97.1 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.03 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.99 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.88 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.82 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.73 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.65 | |
| PF00433 | 48 | Pkinase_C: Protein kinase C terminal domain; Inter | 96.58 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.55 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.53 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.18 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.09 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.0 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.75 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.49 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.41 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.09 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.06 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.22 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 94.15 |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-111 Score=857.20 Aligned_cols=464 Identities=62% Similarity=0.985 Sum_probs=418.6
Q ss_pred ccccCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHhhcCCCC
Q 010266 25 EEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKIS 104 (514)
Q Consensus 25 ~~~~~~~s~~t~~~~~~~~~~~~~~~~~~~~~~~~r~~r~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~ 104 (514)
++.+...|+.|+++++++|.+++++|..++...++|++|+..+++.++..+++++++.+.++.+..++++|+|+++.++.
T Consensus 60 ~~~~~~~s~~T~~k~~~~k~~ien~Y~~~~~~~~~R~er~~~le~~l~~~~~s~~~~~~~~~~~~~kEte~lR~~R~r~~ 139 (550)
T KOG0605|consen 60 SEYEFLVSNKTKRKVAAAKQYIENHYSSQIKYLNERKERRKELEEKLASEDVSEEEQNELLKSLLSKETEYLRLRRTRLS 139 (550)
T ss_pred cccccccCchhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccccHHHHHHHHHHHhhHHHHHHHhccccCC
Confidence 56677889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.+||+++++||+||||.||+|+.+.||++||||+++|+.+..+++++|++.|++||...++||||+|||+|||.++||||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
|||+||||++++|++.+.|+|..++||++|+++||+.||++|||||||||+|+|||..|||||+|||||+.+...+....
T Consensus 220 MEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~ 299 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIES 299 (550)
T ss_pred EEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999988776554332
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 344 (514)
.......+..... .....++.....+++.+...++.+|+.+++..+++++|||+||||||+.+++|+..|||||||||
T Consensus 300 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 300 YRLDEQMQINLSE--AKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI 377 (550)
T ss_pred hcchhhhhhhhcc--CCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence 1100000000000 01111221122345666788999999999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhccCccccCCCCCHhHHhcCCccccCCccccc
Q 010266 345 MYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFKDIAWDKLY 424 (514)
Q Consensus 345 lyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~Hpff~~i~w~~l~ 424 (514)
|||||+|+|||+++++.+++.+|++|...+.+|....+|++|+|||.+|||||.+|+|..|++||++||||++|+|+.|+
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~v~W~~l~ 457 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKGVDWDHLR 457 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCccccCCcchhh
Confidence 99999999999999999999999999999999999999999999999999999999998899999999999999999999
Q ss_pred cccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCcccccc------CCCCCCcccCeeeecCcccccccc
Q 010266 425 EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMM------LTPKDLSFVGYTYKNFEAVKGMHN 490 (514)
Q Consensus 425 ~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~f~~f~~~~~~~~~~~~~ 490 (514)
++.|||+|.++++.|++|||+|++++...+.....++.+++. .+..+.+|+||||++++..++-..
T Consensus 458 ~~~apfvP~v~~~~DT~yFddF~e~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~FvgfTyk~~~~~~~~~~ 529 (550)
T KOG0605|consen 458 EMPAPFVPQVNSELDTQYFDDFPEEDSMTPTADKSGPSRKMLSMVDTNNSSKDINFVGFTYKNFDGLNKANS 529 (550)
T ss_pred cCCCCCCCCCCCcccccccccCcccccCcccccccccchhhhhcccccCCcccccccceeeecccccccccc
Confidence 999999999999999999999999887777666665555442 235678999999999999866543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-87 Score=685.66 Aligned_cols=438 Identities=43% Similarity=0.751 Sum_probs=388.3
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHhhcCCCCCCCeeEEeeeeecCc
Q 010266 40 AAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAF 119 (514)
Q Consensus 40 ~~~~~~~~~~~~~~~~~~~~r~~r~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~LG~G~f 119 (514)
.+-|.|+|+|..+.++..++|..|+..||..+.+..+++..+.+..+-+.++|+.|.|+++.++..+-|..++.||-|+|
T Consensus 563 qafkFfMEQHVEnvlksyqqr~~Rk~QLEkEM~kagLpd~~q~qMrkmL~QKESnYiRLkRaKMdKSmFvkik~iGvGAF 642 (1034)
T KOG0608|consen 563 QAFKFFMEQHVENVLKSYQQREKRKKQLEKEMVKAGLPDIMQNQMRKMLQQKESNYIRLKRAKMDKSMFVKIKTIGVGAF 642 (1034)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHHHHHHHHHHHhhhhhHHHHHHhhccccceEEEeeeccccc
Confidence 35678899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecCCCCHHHHHhh
Q 010266 120 GEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR 199 (514)
Q Consensus 120 G~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~l~~ 199 (514)
|+|.||+..+|...||||.++|.+++.++++.|+++|++||+..+++|||+||++|||.++||+||+|++|||++++|++
T Consensus 643 GeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIr 722 (1034)
T KOG0608|consen 643 GEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR 722 (1034)
T ss_pred ceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccccccccccccccccC
Q 010266 200 EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESM 279 (514)
Q Consensus 200 ~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (514)
.+.|.|+.||||++++.+|++++|+.|+|||||||+|||||.+|||||+|||||..+.+.+.+..+.. +++...+++
T Consensus 723 mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~---gdH~RqDSm 799 (1034)
T KOG0608|consen 723 MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQE---GDHHRQDSM 799 (1034)
T ss_pred hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccC---CCccccccC
Confidence 99999999999999999999999999999999999999999999999999999999999888776652 455555666
Q ss_pred CCCCCCCCCCCCCCCCCchHHHH--HHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhhCCCCCCC
Q 010266 280 DVDGRFPESGCGRRWKSPLEQLQ--HWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 357 (514)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemltG~~PF~~ 357 (514)
.....+.+.+. ....+. ..+..++..+.+.|||+.|+||||+...+|+..|||||.|||||||+.|++||..
T Consensus 800 ep~~e~~d~~~------~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~ 873 (1034)
T KOG0608|consen 800 EPSPEWADISK------CLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLA 873 (1034)
T ss_pred CCchhhccccc------cchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccC
Confidence 65544443221 122232 2345567788999999999999999999999999999999999999999999999
Q ss_pred CChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhccCccccCCCCCHhHHhcCCccccCCccccccccCCCCCcCCCC
Q 010266 358 DDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGV 437 (514)
Q Consensus 358 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~Hpff~~i~w~~l~~~~~p~~p~~~~~ 437 (514)
+++-++..+|++|...+.+|....+|++|.+||.+|+|+++.|+|..+++||++||||++|||..|++..+||+|.++-+
T Consensus 874 ~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDfsslRkq~ApYIP~ItHp 953 (1034)
T KOG0608|consen 874 DTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDFSSLRKQRAPYIPRITHP 953 (1034)
T ss_pred CCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccchHhhhhccCCcCccccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeeecCccccc
Q 010266 438 LDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFEAVKG 487 (514)
Q Consensus 438 ~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~~~~ 487 (514)
.||+|||.++++..-.... .+..............|..|||.+|=..++
T Consensus 954 tDTSNFdpvdpeklwndds-es~~~~~~~nkhpehaFyEFTfRrFFDdng 1002 (1034)
T KOG0608|consen 954 TDTSNFDPVDPEKLWNDDS-ESPNVRDTLNKHPEHAFYEFTFRRFFDDNG 1002 (1034)
T ss_pred CccccCCcCCccccccccc-cCCCcccccccCCccceeEeeeehhccCCC
Confidence 9999999988754211111 111111010112246899999998754444
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-84 Score=631.11 Aligned_cols=329 Identities=44% Similarity=0.773 Sum_probs=288.5
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 181 (514)
.+.+++|+++++||+|+||+|++|++++|++.||||+|+|..+..++.++++++|+.||..++||+||+|+++||+.+++
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 56789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
|||+||++||+|+.+|++.+.|+|..++||++||++||.|||++|||||||||||||||.+|||+|||||||+......
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~- 179 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG- 179 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999532210
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
..+.++|||+.|||||++.+.+|+.+||||||
T Consensus 180 ------------------------------------------------~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsL 211 (357)
T KOG0598|consen 180 ------------------------------------------------DATRTFCGTPEYMAPEILLGKGYDKAVDWWSL 211 (357)
T ss_pred ------------------------------------------------CccccccCCccccChHHHhcCCCCcccchHhH
Confidence 12347899999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCC-CCHhHHhcCCccccCC
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT-LGSEQIKAHPWFKDIA 419 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~-~~~~eil~Hpff~~i~ 419 (514)
||++||||+|.+||.+.+...++.+|+..+ +..|+ ..+|.+++|||++||. ||.+|+|. .++++|++||||++||
T Consensus 212 GillYeML~G~pPF~~~~~~~~~~~I~~~k--~~~~p-~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 212 GILLYEMLTGKPPFYAEDVKKMYDKILKGK--LPLPP-GYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred HHHHHHHhhCCCCCcCccHHHHHHHHhcCc--CCCCC-ccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence 999999999999999999999999999743 33343 2599999999999999 99999973 3899999999999999
Q ss_pred ccccc--cccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCcc---ccccCCCCCCcccCeeeecC
Q 010266 420 WDKLY--EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPM---RKMMLTPKDLSFVGYTYKNF 482 (514)
Q Consensus 420 w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~f~~f~~~~~ 482 (514)
|+.+. ++.|||+|.+.+..|+++||..+...........+.+. ...........|.||||...
T Consensus 289 W~~l~~k~l~PpF~P~~~~~~~~~~Fd~eft~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~gft~~~~ 356 (357)
T KOG0598|consen 289 WEKLLAKKLSPPFKPNVTGLEDTSNFDNEFTSYTVDYSPVDSSPDMSAFTAFSRTYNKIFPGFTYVAS 356 (357)
T ss_pred HHHHHhcCCCCCeecCCCCccccccccHHHHhccccCCccccCcccccccccccccccccCCccccCC
Confidence 99986 68999999999999999999754443322222211111 11112234567999999754
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-81 Score=679.39 Aligned_cols=334 Identities=48% Similarity=0.839 Sum_probs=300.0
Q ss_pred HhhcCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE
Q 010266 97 RLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 176 (514)
Q Consensus 97 ~~~~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 176 (514)
.++..++..+||.++++||+|+||.|.+|+++.|+++||||+++|-.+.++.....++.|++||...+++|||.|+++||
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 34556778899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccC
Q 010266 177 DAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256 (514)
Q Consensus 177 ~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~ 256 (514)
|+.+||||||||+||||.+++.+.+++||..|+||+++|+.||+.||++|+|||||||+|||||..|||||+|||.|-.+
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm 225 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKM 225 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-----CC
Q 010266 257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-----KG 331 (514)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-----~~ 331 (514)
...+. ....+.||||+|++||++.. +.
T Consensus 226 ~~dG~------------------------------------------------V~s~~aVGTPDYISPEvLqs~~~~~g~ 257 (1317)
T KOG0612|consen 226 DADGT------------------------------------------------VRSSVAVGTPDYISPEVLQSQGDGKGE 257 (1317)
T ss_pred CCCCc------------------------------------------------EEeccccCCCCccCHHHHHhhcCCccc
Confidence 53311 12346799999999999973 45
Q ss_pred CCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhccCccccCCCCCHhHHhc
Q 010266 332 YGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLGSEQIKA 411 (514)
Q Consensus 332 y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~ 411 (514)
||..||||||||++||||+|.+||+.++..+||.+|++.++.+.||+...+|++++|||.+|||+|+.|+|+.|+++|+.
T Consensus 258 yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 258 YGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLCDREVRLGRNGIEDIKN 337 (1317)
T ss_pred cCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhcChhhhcccccHHHHHh
Confidence 89999999999999999999999999999999999999999999998788999999999999999999999999999999
Q ss_pred CCccccCCccccccccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeeec
Q 010266 412 HPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKN 481 (514)
Q Consensus 412 Hpff~~i~w~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~ 481 (514)
||||.+++|+.|++..|||+|.++++.||+|||................+ ...++.+.+|+||||..
T Consensus 338 HpFF~g~~W~~iR~~~pP~vPevssd~DTsnFd~~~dd~~~~e~~p~~~~---~~f~Gn~LPFIGfTy~~ 404 (1317)
T KOG0612|consen 338 HPFFEGIDWDNIRESVPPVVPEVSSDDDTSNFDVDEDDLRDAETFPPRIP---KAFSGNHLPFIGFTYTH 404 (1317)
T ss_pred CccccCCChhhhhhcCCCCCCcCCCCCccccccccccccchhhccCCCCC---CCCcCCcCCeeeeeecc
Confidence 99999999999999999999999999999999643322211111110001 11457889999999995
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-80 Score=584.61 Aligned_cols=293 Identities=45% Similarity=0.911 Sum_probs=279.9
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
...+||+.++.||.|+||+|.+|+++.+|..||||++.|..++.-.|++|+.+|+.||+.+.||++++|+++|+|.+++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 77899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
|||||++||.|+++|++.++|++..||||++||++||+|||+++|+||||||||||||.+||+||+|||+|+....
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---- 196 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---- 196 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999997541
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
.+++.||||+|+|||++..++|+.++||||||
T Consensus 197 ------------------------------------------------rT~TlCGTPeYLAPEii~sk~ynkavDWWalG 228 (355)
T KOG0616|consen 197 ------------------------------------------------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALG 228 (355)
T ss_pred ------------------------------------------------cEEEecCCccccChHHhhcCCCCcchhHHHHH
Confidence 25689999999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CHhHHhcCCccccCC
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHPWFKDIA 419 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~Hpff~~i~ 419 (514)
|++|||+.|++||++.++..++++|+. ..+.||. .+|++++|||++||+ |-.+|.|+. +.++|+.||||++++
T Consensus 229 VLIYEMlaG~pPF~~~~~~~iY~KI~~--~~v~fP~--~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 229 VLIYEMLAGYPPFYDDNPIQIYEKILE--GKVKFPS--YFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD 304 (355)
T ss_pred HHHHHHHcCCCCCcCCChHHHHHHHHh--CcccCCc--ccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence 999999999999999999999999998 6789997 799999999999999 999999874 889999999999999
Q ss_pred ccccc--cccCCCCC-cCCCCCCCCCCCCCCcccC
Q 010266 420 WDKLY--EMEAAYKP-EVNGVLDTQNFMKFDEVES 451 (514)
Q Consensus 420 w~~l~--~~~~p~~p-~~~~~~d~~~f~~~~~~~~ 451 (514)
|..+. .++|||+| .+.++.|++|||...+++.
T Consensus 305 W~~i~~r~ie~P~~pp~~~~~gdtsnfd~y~e~~~ 339 (355)
T KOG0616|consen 305 WEAILQRKIEPPFEPPNIHGPGDTSNFDDYEEEDT 339 (355)
T ss_pred HHHHhhccccCCCCCccccCCcccccccccccccc
Confidence 99996 68999998 8999999999999877753
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-78 Score=629.23 Aligned_cols=325 Identities=37% Similarity=0.688 Sum_probs=295.5
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEEEcCC
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAE 179 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~ 179 (514)
..+..++|.++++||+|+||+|++|..+.+++.||||+++|..++.+++++.++.|+.|+..+. ||++++|+.+||+.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 4788999999999999999999999999999999999999999999999999999999999885 999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
++|+||||+.||| +.+++..+.|++..|+||+|+|++||.|||++||||||||.+|||||.+||+||+||||||..-..
T Consensus 443 ~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 443 HLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred eEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 9999999999999 566667789999999999999999999999999999999999999999999999999999964321
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
...|+|+||||+|||||++.++.|+.+||||
T Consensus 522 -------------------------------------------------g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW 552 (694)
T KOG0694|consen 522 -------------------------------------------------GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWW 552 (694)
T ss_pred -------------------------------------------------CCccccccCChhhcChhhhccCcccchhhHH
Confidence 1245699999999999999999999999999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CHhHHhcCCccc
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHPWFK 416 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~Hpff~ 416 (514)
||||+|||||+|.+||.|++..+.+..|++ ....+|. ++|.++.+++++||. +|++|+|.. ++++|++||||+
T Consensus 553 ~lGVLlyeML~Gq~PF~gddEee~FdsI~~--d~~~yP~--~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr 628 (694)
T KOG0694|consen 553 GLGVLLYEMLVGESPFPGDDEEEVFDSIVN--DEVRYPR--FLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFR 628 (694)
T ss_pred HHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--CCCCCCC--cccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccc
Confidence 999999999999999999999999999998 6778886 799999999999999 999999973 799999999999
Q ss_pred cCCccccc--cccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeeecCc
Q 010266 417 DIAWDKLY--EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFE 483 (514)
Q Consensus 417 ~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~ 483 (514)
.|||+.|. +++|||+|.++++.|.+|||..++.+.+..++...... ....+..|.||+|.+..
T Consensus 629 ~i~w~~L~~r~i~PPf~P~i~~~~D~snFd~eFt~e~p~Lt~~~~~~l----~~~~q~~F~~Fs~~~~~ 693 (694)
T KOG0694|consen 629 SIDWDDLLNRRIKPPFVPTIKGPEDVSNFDEEFTSEKPALTPSDPRPL----TEEEQEAFRDFSFVAEW 693 (694)
T ss_pred cCCHHHHhhccCCCCCCcccCChhhhcccchhhhcCCCccCCCCcccc----chhhHHHhcCccccCCC
Confidence 99999996 68999999999999999999876666665544332222 23467899999998754
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-75 Score=556.41 Aligned_cols=340 Identities=36% Similarity=0.674 Sum_probs=301.5
Q ss_pred hhcCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc
Q 010266 98 LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 177 (514)
Q Consensus 98 ~~~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 177 (514)
..+.++..++|..+++||+|.||+|.+|+.+.|++.||||+++|..++.++++.|...|-.+|+..+||++..|-|+||+
T Consensus 160 ~~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt 239 (516)
T KOG0690|consen 160 KRKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT 239 (516)
T ss_pred cccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc
Confidence 34667899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 178 AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 178 ~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
.+.+|+||||+.||+|+.+|.+.+.|+|..+|||-++|++||.|||+++||+||||.+|+|+|.+|||||+|||||+...
T Consensus 240 ~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 240 QDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred CceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999643
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
... ..+.++||||.|+|||++....|+.++|
T Consensus 320 ~~g-------------------------------------------------~t~kTFCGTPEYLAPEVleDnDYgraVD 350 (516)
T KOG0690|consen 320 KYG-------------------------------------------------DTTKTFCGTPEYLAPEVLEDNDYGRAVD 350 (516)
T ss_pred ccc-------------------------------------------------ceeccccCChhhcCchhhccccccceee
Confidence 211 1244899999999999999999999999
Q ss_pred hhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CHhHHhcCCc
Q 010266 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHPW 414 (514)
Q Consensus 338 iWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~Hpf 414 (514)
||.+||+||||++|+.||+..+....+..|+. ..+.||. .+|++|+.|+..||. ||.+|+|.. ++.||..|+|
T Consensus 351 WWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~--ed~kFPr--~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~F 426 (516)
T KOG0690|consen 351 WWGVGVVMYEMMCGRLPFYNKDHEKLFELILM--EDLKFPR--TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRF 426 (516)
T ss_pred hhhhhHHHHHHHhccCcccccchhHHHHHHHh--hhccCCc--cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhh
Confidence 99999999999999999999999999999987 7899997 799999999999998 999999975 7899999999
Q ss_pred cccCCccccc--cccCCCCCcCCCCCCCCCCCCCCccc-CCCCCCCCCCccccccCCCCCCcccCeeeecCcc-cccccc
Q 010266 415 FKDIAWDKLY--EMEAAYKPEVNGVLDTQNFMKFDEVE-SQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFEA-VKGMHN 490 (514)
Q Consensus 415 f~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~-~~~~~~ 490 (514)
|.+|||+... ++.|||+|++.++.|+++||+.+... ....++...++... .....+..|..|+|..... ++..+.
T Consensus 427 F~~v~W~~~~~Kki~PPfKPqVtSetDTryFD~EFT~q~v~lTPP~r~~~~~~-~~~e~~~~FpQFsy~~~~~s~~r~~~ 505 (516)
T KOG0690|consen 427 FASVDWEATYRKKIEPPFKPQVTSETDTRYFDEEFTSQPVTLTPPDRYGSTVD-EDEERRPHFPQFSYSASMGSINRIHE 505 (516)
T ss_pred hccCCHHHHHHhccCCCCCCCcccccchhhhhhhhhcceeEecCCCCCCcccc-hhhhhccCCcceeeecchhhhhchhh
Confidence 9999999985 69999999999999999999754443 33222333333211 1344578999999986543 244443
Q ss_pred c
Q 010266 491 R 491 (514)
Q Consensus 491 ~ 491 (514)
+
T Consensus 506 ~ 506 (516)
T KOG0690|consen 506 A 506 (516)
T ss_pred c
Confidence 3
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-72 Score=552.20 Aligned_cols=337 Identities=33% Similarity=0.568 Sum_probs=274.4
Q ss_pred hcCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC
Q 010266 99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA 178 (514)
Q Consensus 99 ~~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 178 (514)
+...+..++|++++.||+|.-|+||||+.+.++..+|||+|.|..+..++...++..|++||+.++||+++.||..|+++
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 44667889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~ 256 (514)
.+.|+|||||+||||..+++++ +.|++..+|||+++++.||+|||.+||||||||||||||.++|||.|+||.||...
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 9999999999999999999875 68999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCccccccccccccccccccCCC-CCCCCCCCCCCCCCC---chHH----HHHH-hhhccccccccccCCCcCCcccc
Q 010266 257 DCTNLSAINENEVLDDENLNESMDV-DGRFPESGCGRRWKS---PLEQ----LQHW-QINRRKLAYSTVGTPDYIAPEVL 327 (514)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~----~~~~-~~~~~~~~~s~~GT~~Y~APEvl 327 (514)
..... .+.......+......... ...+. ..+...... .... ++-. -........++|||-+|+|||++
T Consensus 230 ~~~Pt-~~~s~~~~~~~~~~~~~~~~~s~f~-~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI 307 (459)
T KOG0610|consen 230 PVSPT-LVKSSSPRSSGSQPSCRSRQPSCFS-PRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI 307 (459)
T ss_pred CCCCe-eeccCCCCCCCCCcccccccccccc-cchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence 32111 0000000000000000000 00000 000000000 0000 0000 00012346799999999999999
Q ss_pred ccCCCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC-C
Q 010266 328 LKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL-G 405 (514)
Q Consensus 328 ~~~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~-~ 405 (514)
.+.+++.+||||+|||+|||||+|.+||.|.+..+++.+|+. ..+.||....+|..|+|||++||. ||.+|+|+. +
T Consensus 308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~--~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rG 385 (459)
T KOG0610|consen 308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG--QPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRG 385 (459)
T ss_pred ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc--CCCcCCCCCcchhHHHHHHHHHhccChhhhhccccc
Confidence 999999999999999999999999999999999999999997 788999988999999999999998 999999864 8
Q ss_pred HhHHhcCCccccCCccccccccCCCCCcCCCCCC
Q 010266 406 SEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLD 439 (514)
Q Consensus 406 ~~eil~Hpff~~i~w~~l~~~~~p~~p~~~~~~d 439 (514)
|.||+.||||++++|.-++...||++|.......
T Consensus 386 A~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~~~ 419 (459)
T KOG0610|consen 386 AAEIKRHPFFEGVNWALIRCARPPEIPKPVDGGL 419 (459)
T ss_pred hHHhhcCccccCCChhheeccCCCcCCCccccCc
Confidence 9999999999999999888999999998765543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-73 Score=555.13 Aligned_cols=331 Identities=36% Similarity=0.664 Sum_probs=302.3
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcC
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDA 178 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~ 178 (514)
+..+...||.++.+||+|+||+|.++..+.|.+.||||+++|+.++..+.++..+.|..+|+.. +.|++|+|+.+||+-
T Consensus 343 ~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm 422 (683)
T KOG0696|consen 343 RDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM 422 (683)
T ss_pred ccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence 3456778999999999999999999999999999999999999999999999999999999987 578999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
+.+|+||||+.||||+.++++.++|.|..|.||+++|+.||-+||++|||+||||.+|||+|++|||||+|||+|+.-..
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999986321
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
. ...+.++||||+|+|||++..++|+.++||
T Consensus 503 ~-------------------------------------------------~~TTkTFCGTPdYiAPEIi~YqPYgksvDW 533 (683)
T KOG0696|consen 503 D-------------------------------------------------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDW 533 (683)
T ss_pred C-------------------------------------------------CcceeeecCCCcccccceEEecccccchhH
Confidence 1 123558999999999999999999999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CHhHHhcCCcc
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHPWF 415 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~Hpff 415 (514)
||+||+|||||.|++||.|++..+.++.|.. ....+|. .+|.+|.++++.+|. .|.+|+|+. +-.+|..||||
T Consensus 534 Wa~GVLLyEmlaGQpPFdGeDE~elF~aI~e--hnvsyPK--slSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FF 609 (683)
T KOG0696|consen 534 WAFGVLLYEMLAGQPPFDGEDEDELFQAIME--HNVSYPK--SLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFF 609 (683)
T ss_pred HHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH--ccCcCcc--cccHHHHHHHHHHhhcCCccccCCCCccccchhhCcch
Confidence 9999999999999999999999999999997 6788886 799999999999998 999999975 56799999999
Q ss_pred ccCCccccc--cccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeeecCccccc
Q 010266 416 KDIAWDKLY--EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFEAVKG 487 (514)
Q Consensus 416 ~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~~~~ 487 (514)
+.|||+++. +++|||+|.++-..|.+|||+++..+.+..++++. ..+.+.++..|.||||.|++.+..
T Consensus 610 R~iDWek~E~~eiqPPfkPk~k~~r~~eNFD~~Ft~~~~~lTPpD~----~v~~nldq~eF~gFsfvNpefv~~ 679 (683)
T KOG0696|consen 610 RRIDWEKLERREIQPPFKPKIKCGRDAENFDKFFTREPTDLTPPDK----LVMMNLDQSEFEGFSFVNPEFVKP 679 (683)
T ss_pred hhccHHHHhhccCCCCCCCccccCCchhhhhHHHhcCCCCCCCchH----HHHhcCchhhcCceeeeChhhcCC
Confidence 999999995 79999999999999999999988887665554432 223567889999999999988754
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-68 Score=542.64 Aligned_cols=285 Identities=40% Similarity=0.715 Sum_probs=258.1
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCe
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~ 180 (514)
+...+||.+.+.||.|+|++|++|+++.|++.||||++.|..++..+.++-+..|+++|..+ .||.||+||..|||+..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 55679999999999999999999999999999999999999999999999999999999999 89999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
||+|+||+++|+|.++|.+.+.|++..+|+|++||+.||+|||++|||||||||||||||.|||+||+|||.|+.+....
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999876543
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 340 (514)
.+.-. ..+.... .....++|||..|.+||++.+...++.+|+|+
T Consensus 229 ~~~~~--------------~~~~~~a----------------------~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWA 272 (604)
T KOG0592|consen 229 KSQEN--------------PVDPNQA----------------------SSRRSSFVGTAEYVSPELLNDSPAGPSSDLWA 272 (604)
T ss_pred ccccC--------------ccCcccc----------------------cCcccceeeeecccCHHHhcCCCCCcccchHH
Confidence 22100 0000000 00124899999999999999999999999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCC
Q 010266 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIA 419 (514)
Q Consensus 341 lGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~ 419 (514)
||||||+|+.|.|||.+.++.-++++|+. -...||+ .+++.++|||++||. ||.+|+ |++||++||||.+||
T Consensus 273 lGCilyQmlaG~PPFra~NeyliFqkI~~--l~y~fp~--~fp~~a~dLv~KLLv~dp~~Rl---t~~qIk~HpFF~~Vd 345 (604)
T KOG0592|consen 273 LGCILYQMLAGQPPFRAANEYLIFQKIQA--LDYEFPE--GFPEDARDLIKKLLVRDPSDRL---TSQQIKAHPFFEGVD 345 (604)
T ss_pred HHHHHHHHhcCCCCCccccHHHHHHHHHH--hcccCCC--CCCHHHHHHHHHHHccCccccc---cHHHHhhCcccccCC
Confidence 99999999999999999999999999997 4567776 789999999999998 999999 899999999999999
Q ss_pred ccccccccCC
Q 010266 420 WDKLYEMEAA 429 (514)
Q Consensus 420 w~~l~~~~~p 429 (514)
|+.|.+..||
T Consensus 346 w~nlw~~~PP 355 (604)
T KOG0592|consen 346 WENLWQQTPP 355 (604)
T ss_pred hhhhhhcCCC
Confidence 9999976654
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-67 Score=502.25 Aligned_cols=329 Identities=33% Similarity=0.625 Sum_probs=287.8
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcC
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDA 178 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~ 178 (514)
...+...||.++++||+|+|++|.+|+.+.|.+.||||+++|.-+.....++.++.|..+.... +||++|.|+.+||++
T Consensus 244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte 323 (593)
T KOG0695|consen 244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE 323 (593)
T ss_pred ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence 3567889999999999999999999999999999999999998777788899999999999876 799999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
..+++|.||++||||+.++++++.++|+.||||.++|++||+|||++|||+||||.+|+|||+.|||||+|+|+|+..-.
T Consensus 324 srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999986432
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
.. ..+.++||||.|+|||++++..|+.++||
T Consensus 404 ~g-------------------------------------------------d~tstfcgtpnyiapeilrgeeygfsvdw 434 (593)
T KOG0695|consen 404 PG-------------------------------------------------DTTSTFCGTPNYIAPEILRGEEYGFSVDW 434 (593)
T ss_pred CC-------------------------------------------------cccccccCCCcccchhhhcccccCceehH
Confidence 11 13458999999999999999999999999
Q ss_pred hhhhHHHHHHhhCCCCCCC---C-----ChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC---CH
Q 010266 339 WSLGAIMYEMLVGYPPFYS---D-----DPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL---GS 406 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~---~-----~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~---~~ 406 (514)
|+|||+||||+.|+.||.- + +..-.++-|+. ..+.+|. .+|-.|..+++.+|. ||.+|+|+. ++
T Consensus 435 walgvlmfemmagrspfdivgm~n~d~ntedylfqvile--kqiripr--slsvkas~vlkgflnkdp~erlgc~~~~g~ 510 (593)
T KOG0695|consen 435 WALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE--KQIRIPR--SLSVKASHVLKGFLNKDPKERLGCRPQTGF 510 (593)
T ss_pred HHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh--hcccccc--eeehhhHHHHHHhhcCCcHHhcCCCcccch
Confidence 9999999999999999962 1 12233555665 6678886 789999999999998 999999975 88
Q ss_pred hHHhcCCccccCCccccc--cccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeeecCcc
Q 010266 407 EQIKAHPWFKDIAWDKLY--EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFEA 484 (514)
Q Consensus 407 ~eil~Hpff~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~ 484 (514)
.+|+.||||+.|||+.+. ++.|||.|.+.+..+..|||.-++.+....++......++ ..+..|.||.|.|+-.
T Consensus 511 ~dik~h~ffr~idwd~leqk~v~ppf~p~i~~d~~l~~fd~qft~e~~qltpdd~d~i~r----idqsefegfeyinpl~ 586 (593)
T KOG0695|consen 511 SDIKSHAFFRSIDWDLLEQKQVLPPFQPQITDDYGLDNFDTQFTSEPVQLTPDDEDAIKR----IDQSEFEGFEYINPLL 586 (593)
T ss_pred hhhhcchhhhhCCHHHHhhcccCCCCCCccccccCccccccccccCCcccCCCCHHHHHh----cchhhcCcceecchhh
Confidence 999999999999999996 5889999999999999999985555544444433333332 3677999999998754
Q ss_pred c
Q 010266 485 V 485 (514)
Q Consensus 485 ~ 485 (514)
+
T Consensus 587 m 587 (593)
T KOG0695|consen 587 M 587 (593)
T ss_pred c
Confidence 3
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-63 Score=513.28 Aligned_cols=362 Identities=52% Similarity=0.928 Sum_probs=294.5
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++++.||+|+||+||+|+++.+++.||||++.+..........++..|+.++..++||+|++++++|++...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 48999999999999999999999999999999998876666667788999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
||++||+|.+++.+.+.+++..++.+++|++.||+|||++||+||||||+|||++.+|++||+|||+|+.+.........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999999998899999999999999999999999999999999999999999999999999999865432111100
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 345 (514)
... ......+..+. ..........|+.++.....+.+||+.|+|||++.+.+|+.++|||||||++
T Consensus 161 ~~~-------~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 226 (363)
T cd05628 161 RNL-------NHSLPSDFTFQ-------NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (363)
T ss_pred ccc-------ccccccccccc-------ccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence 000 00000000000 0000111122333344445578999999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhccCccccCCCCCHhHHhcCCccccCCcccccc
Q 010266 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFKDIAWDKLYE 425 (514)
Q Consensus 346 yemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~Hpff~~i~w~~l~~ 425 (514)
|||++|.+||.+.+..+.+.+|..+...+.+|+...+|+++++||.+|+++|.+|+++.+++||++||||++++|+.+.+
T Consensus 227 ~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~~~~~~ 306 (363)
T cd05628 227 YEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWEHIRE 306 (363)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCHHHHHh
Confidence 99999999999999999999999888888888877799999999999999999998888999999999999999999987
Q ss_pred ccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeeecC
Q 010266 426 MEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNF 482 (514)
Q Consensus 426 ~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~ 482 (514)
..++..+.+.+..|+++|+.+.......+....+. .........+..|.||||+.+
T Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 362 (363)
T cd05628 307 RPAAIPIEIKSIDDTSNFDEFPDSDILKPTVATSN-HPETDYKNKDWVFINYTYKRF 362 (363)
T ss_pred CCCCCCccCCCcchhhccCCCCccccccccccccC-CcccccCcCCcccCCceeecC
Confidence 77777778889999999998876654433222211 111223345678999999855
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-66 Score=518.91 Aligned_cols=299 Identities=37% Similarity=0.702 Sum_probs=282.4
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
..+...+++.+..||-||||.|-+|+.+.....+|+|+++|..+....|.+|+..|++||..+++|+||+||..|.|..+
T Consensus 415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence 35667899999999999999999999877666799999999999999999999999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
+||+||-|-||+|.+.|..++.|++..++||+++++.|++|||++|||+|||||||.|+|.+|.+||.|||+|+.+..+
T Consensus 495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g- 573 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG- 573 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999987533
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 340 (514)
..++++||||+|.|||++.+++++.++|+||
T Consensus 574 -------------------------------------------------~KTwTFcGTpEYVAPEIILnKGHD~avDyWa 604 (732)
T KOG0614|consen 574 -------------------------------------------------RKTWTFCGTPEYVAPEIILNKGHDRAVDYWA 604 (732)
T ss_pred -------------------------------------------------CceeeecCCcccccchhhhccCcchhhHHHH
Confidence 2467999999999999999999999999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCC--CCCHhHHhcCCcccc
Q 010266 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLG--TLGSEQIKAHPWFKD 417 (514)
Q Consensus 341 lGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~--~~~~~eil~Hpff~~ 417 (514)
||+++||||+|.|||.+.++..+++.|+.+-..+.+|. .++..+.+||++|.. +|.+|+| ..++.+|++|-||.+
T Consensus 605 LGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr--~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 605 LGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPR--RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred HHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhccc--ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 99999999999999999999999999999888889995 799999999999987 9999999 569999999999999
Q ss_pred CCccccc--cccCCCCCcCCCCCCCCCCCCCCcccC
Q 010266 418 IAWDKLY--EMEAAYKPEVNGVLDTQNFMKFDEVES 451 (514)
Q Consensus 418 i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~ 451 (514)
+||+.|+ .++|||+|.+.++.|++|||.|+....
T Consensus 683 fdweglr~~~L~pPi~~~va~ptD~s~Fd~~p~dnd 718 (732)
T KOG0614|consen 683 FDWEGLRSRTLPPPIIPSVANPTDVSNFDNFPPDND 718 (732)
T ss_pred CChhhhhhccCCCCccccCCCcccchhccCCCcccC
Confidence 9999997 589999999999999999999876643
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-62 Score=507.04 Aligned_cols=364 Identities=58% Similarity=1.023 Sum_probs=300.6
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++++.||+|+||+||+|+++.+|+.||||++.+..........++.+|+.+|..++||||++++++|++.+++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 58999999999999999999999999999999998876666677788999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|++||+|||+++.+.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999999876433211110
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 345 (514)
.... .. .....+. ..............|...++....+.+||+.|+|||++.+.+|+.++|||||||++
T Consensus 161 ~~~~-------~~--~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 229 (364)
T cd05599 161 RILS-------HA--LPSNFLD--FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229 (364)
T ss_pred cccc-------cc--ccccccc--cccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHH
Confidence 0000 00 0000000 00000111122334555555556678999999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhccCccccCCCCCHhHHhcCCccccCCcccccc
Q 010266 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFKDIAWDKLYE 425 (514)
Q Consensus 346 yemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~Hpff~~i~w~~l~~ 425 (514)
|||++|.+||.+.+..+.+.++..|...+.+|....+|+++++||.+||++|.+|+++.++++++.||||++++|+.+..
T Consensus 230 ~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~~~~~~~ 309 (364)
T cd05599 230 YEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVDWEHIRE 309 (364)
T ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCCHHHHhh
Confidence 99999999999999999999999888888888877889999999999999999999666799999999999999999998
Q ss_pred ccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeeecCc
Q 010266 426 MEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFE 483 (514)
Q Consensus 426 ~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~ 483 (514)
..+|+.|.+.+..|.++|+.+++.+...+...... ......++..|.||+|++++
T Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 364 (364)
T cd05599 310 RPAPIIPELKSITDTSNFDDFEEIDLDVPTSPGPP---RGKIKSKDLAFIGYTYKRFE 364 (364)
T ss_pred cCCCCCCCCCCchhhhhccccccccccccCCCccc---cccccccCCCCCCCeeeCCC
Confidence 89999999999999999998877665443322111 11134678999999999875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-63 Score=490.06 Aligned_cols=264 Identities=33% Similarity=0.570 Sum_probs=236.5
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccC----hhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS----RGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE 179 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~----~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 179 (514)
..+.|.+.+.||+|+||.|.+|..+.||+.||||+++|..... ......+.+|.+||++++||+||+++++|..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3467889999999999999999999999999999999876554 224455789999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCC---CcEEEccccccccC
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN---GHMKLSDFGLCKPL 256 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~---g~iKL~DFGla~~~ 256 (514)
+.||||||+.||+|++.+...+.+.|...+.|+.|++.||.|||++||+||||||||||+..+ .++||+|||+||..
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 999999999999999999999999999999999999999999999999999999999999866 89999999999976
Q ss_pred CCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCC---C
Q 010266 257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY---G 333 (514)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y---~ 333 (514)
+.. ....++||||.|.|||++.++++ .
T Consensus 330 g~~--------------------------------------------------sfm~TlCGTpsYvAPEVl~~kg~~~~~ 359 (475)
T KOG0615|consen 330 GEG--------------------------------------------------SFMKTLCGTPSYVAPEVLASKGVEYYP 359 (475)
T ss_pred ccc--------------------------------------------------eehhhhcCCccccChhheecCCeeccc
Confidence 422 12348999999999999998764 4
Q ss_pred cccchhhhhHHHHHHhhCCCCCCCCChhH-HHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 334 MECDWWSLGAIMYEMLVGYPPFYSDDPVT-TCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 334 ~~~DiWSlGvilyemltG~~PF~~~~~~~-~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
.+||+|||||+||-||+|++||.+..... ..+.|..++..+.-|.|..+|++++|||.+||. ||++|+ +++|+++
T Consensus 360 ~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~---s~~eaL~ 436 (475)
T KOG0615|consen 360 SKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRP---SADEALN 436 (475)
T ss_pred chheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCc---CHHHHhc
Confidence 57899999999999999999999876665 788888876666666778899999999999999 999999 9999999
Q ss_pred CCccccCCc
Q 010266 412 HPWFKDIAW 420 (514)
Q Consensus 412 Hpff~~i~w 420 (514)
||||+.++-
T Consensus 437 hpW~~~~~~ 445 (475)
T KOG0615|consen 437 HPWFKDAPC 445 (475)
T ss_pred Chhhhcccc
Confidence 999998753
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-61 Score=502.42 Aligned_cols=376 Identities=48% Similarity=0.891 Sum_probs=294.3
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|.+++.||+|+||+||+|+++.+++.||||++.+..........++.+|+++|..++|||||+++++|++..++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999998876656667788999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
||++||+|..++...+.+++..+++++.|++.||+|||++||+||||||+|||++.+|++||+|||+|+...........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999999754322111000
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 345 (514)
.. ..................... .............|..++.....+.+||+.|+|||++.+..|+.++|||||||++
T Consensus 161 ~~-~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 161 QK-LLQGKSNKNRIDNRNSVAVDS-INLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cc-ccccccccccccccccccccc-ccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 00 000000000000000000000 0000111122233444444444567999999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhccCccccCCCCCHhHHhcCCccccCCcccccc
Q 010266 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFKDIAWDKLYE 425 (514)
Q Consensus 346 yemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~Hpff~~i~w~~l~~ 425 (514)
|||++|.+||.+.+..+.+.++..|...+.+|....+|+++++||.+||++|.+|+++.++.|++.||||++++|+.+..
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~~~~~~~~ 318 (377)
T cd05629 239 FECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQ 318 (377)
T ss_pred hhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCCCHHHHcc
Confidence 99999999999999888899999888888888876789999999999999999999888999999999999999999999
Q ss_pred ccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCC-CccccccCCCCCCcccCeeeecCc
Q 010266 426 MEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGS-GPMRKMMLTPKDLSFVGYTYKNFE 483 (514)
Q Consensus 426 ~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~f~~f~~~~~~ 483 (514)
+.+|+.|.+....|+.+|........+..+.... .+.........+.+|.||||++|+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (377)
T cd05629 319 IRAPFIPQLKSITDTSYFPTDELEQVPEAPALKQAAPAQQEESVELDLAFIGYTYKRFD 377 (377)
T ss_pred CCCCcccCCCCccccccCCccccccCccccccccccccccccccccCcccccceecCCC
Confidence 9999999999999999887544433222111111 010111123457899999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-63 Score=493.55 Aligned_cols=296 Identities=34% Similarity=0.662 Sum_probs=264.0
Q ss_pred HHhhcCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEE
Q 010266 96 MRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSF 175 (514)
Q Consensus 96 ~~~~~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 175 (514)
..+....++.+.|...++||+||||.|+-|+.+.||+.||+|.+.|..+..+....-..+|+.||..+++++||.|-|+|
T Consensus 175 K~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf 254 (591)
T KOG0986|consen 175 KWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF 254 (591)
T ss_pred HHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee
Confidence 33455778899999999999999999999999999999999999998887777778889999999999999999999999
Q ss_pred EcCCeEEEEEeecCCCCHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccc
Q 010266 176 QDAEYLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253 (514)
Q Consensus 176 ~~~~~l~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla 253 (514)
++.+.+||||..|+||||..+|...+ .|+|..++||++||++||++||+.+||+|||||+|||+|+.||+.|+|.|||
T Consensus 255 eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLA 334 (591)
T KOG0986|consen 255 ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLA 334 (591)
T ss_pred cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceE
Confidence 99999999999999999999998766 8999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCC
Q 010266 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG 333 (514)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 333 (514)
..+.... ...+.+||.+|||||++.+..|+
T Consensus 335 vei~~g~--------------------------------------------------~~~~rvGT~GYMAPEvl~ne~Y~ 364 (591)
T KOG0986|consen 335 VEIPEGK--------------------------------------------------PIRGRVGTVGYMAPEVLQNEVYD 364 (591)
T ss_pred EecCCCC--------------------------------------------------ccccccCcccccCHHHHcCCccc
Confidence 8765321 11245899999999999999999
Q ss_pred cccchhhhhHHHHHHhhCCCCCCCCC----hhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CH
Q 010266 334 MECDWWSLGAIMYEMLVGYPPFYSDD----PVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GS 406 (514)
Q Consensus 334 ~~~DiWSlGvilyemltG~~PF~~~~----~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~ 406 (514)
.++|||||||+||||+.|+.||.... ..+.-+.++. ....+|+ .+|+++++|++.||+ ||.+|+|+. ++
T Consensus 365 ~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~--~~~ey~~--kFS~eakslc~~LL~Kdp~~RLGcrg~ga 440 (591)
T KOG0986|consen 365 FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE--DPEEYSD--KFSEEAKSLCEGLLTKDPEKRLGCRGEGA 440 (591)
T ss_pred CCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc--chhhccc--ccCHHHHHHHHHHHccCHHHhccCCCcCc
Confidence 99999999999999999999997543 2355566665 5567775 799999999999999 999999975 89
Q ss_pred hHHhcCCccccCCccccc--cccCCCCCcCC-----CCCCCCCCCC
Q 010266 407 EQIKAHPWFKDIAWDKLY--EMEAAYKPEVN-----GVLDTQNFMK 445 (514)
Q Consensus 407 ~eil~Hpff~~i~w~~l~--~~~~p~~p~~~-----~~~d~~~f~~ 445 (514)
+++++||||+++||.++. .++|||+|... +..|..+|++
T Consensus 441 ~evk~HpfFk~lnw~rleagml~PPfiPdp~aVyakDv~DIeqFs~ 486 (591)
T KOG0986|consen 441 QEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAKDVLDIEQFST 486 (591)
T ss_pred chhhhCcccccCCHhHHhccCCCCCCCCCccccchhhhhhhhhccc
Confidence 999999999999999997 58999999874 5567777763
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-61 Score=500.09 Aligned_cols=360 Identities=53% Similarity=0.938 Sum_probs=293.2
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++++.||+|+||+||+|+++.+++.||||++++..........++..|+.++..++||+|++++++|++.+++|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999998876666677888999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
||++||+|.+++.+.+.+++..++++++|++.||+|||++||+||||||+|||++.+|++||+|||+|+.+.........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999999865432211100
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 345 (514)
..... .... +..+ ...........|..++...+.+.+||+.|+|||++.+.+|+.++|||||||++
T Consensus 161 ~~~~~-----~~~~--~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil 226 (360)
T cd05627 161 RNLTH-----NPPS--DFSF-------QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (360)
T ss_pred ccccc-----CCcc--cccc-------cccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence 00000 0000 0000 00000011112333344455678999999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhccCccccCCCCCHhHHhcCCccccCCcccccc
Q 010266 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFKDIAWDKLYE 425 (514)
Q Consensus 346 yemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~Hpff~~i~w~~l~~ 425 (514)
|||++|.+||.+.++...+.++..|...+.+|....+|+++++||.+|+.||.+|+++.++++|++||||++++|..+..
T Consensus 227 yel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~ 306 (360)
T cd05627 227 YEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDWGHIRE 306 (360)
T ss_pred eecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCCHHHHhc
Confidence 99999999999999999999999887778888766789999999999877999999888899999999999999999987
Q ss_pred ccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeeecCc
Q 010266 426 MEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFE 483 (514)
Q Consensus 426 ~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~ 483 (514)
..++..+.+.+..|+++|+.+++.....+......+ ....++..|.+|+|++++
T Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 360 (360)
T cd05627 307 RPAAIPIEIKSIDDTSNFDEFPESDILQPAENTIEP----DYKSKDWVFLNYTYKRFE 360 (360)
T ss_pred CCCCCCccCCCcchhhhcCCCCcccccCCCcccccc----ccCcCCcccCCceeecCC
Confidence 666666678889999999987766543332222111 134577889999999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-61 Score=499.50 Aligned_cols=372 Identities=45% Similarity=0.809 Sum_probs=288.9
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++++.||+|+||+||+|+++.+++.||||++.+.......+..++.+|+.+|+.++|||||+++++|++.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999998877666777889999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
|||+||+|.+++.+.+.+++..++++++||+.||+|||++||+||||||+|||++.+|++||+|||+|..+.........
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999998755322111110
Q ss_pred cccccccccccccCCCCCCCCC---CCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 266 ENEVLDDENLNESMDVDGRFPE---SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
.. .+.........+..... ..++.... ....... .........+.+||+.|+|||++.+.+|+.++||||||
T Consensus 161 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 161 QS---GDHVRQDSMDFSNEWGDPANCRCGDRLK-PLERRAA-RQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cc---cccccccccccccccccccccccccccc-chhhhhc-cccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 00 00000000000000000 00000000 0000000 01112234467999999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhccCccccCCCCCHhHHhcCCccccCCccc
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFKDIAWDK 422 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~Hpff~~i~w~~ 422 (514)
|++|||++|.+||.+.++.+...++..|...+.+|....+|+++++||.+|+.+|.+|+++.++++|+.||||++++|..
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~ 315 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFSS 315 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcChHH
Confidence 99999999999999999988999999888888888777899999999999877999999877899999999999999987
Q ss_pred -cccccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCC---CCcccc--ccCCCCCCcccCeeeecC
Q 010266 423 -LYEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTG---SGPMRK--MMLTPKDLSFVGYTYKNF 482 (514)
Q Consensus 423 -l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~---~~~~~~--~~~~~~~~~f~~f~~~~~ 482 (514)
+.+..+|+.|.+..+.|+++|+.++..+........ ...... .........|.||||+++
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (382)
T cd05625 316 DLRQQSAPYIPKITHPTDTSNFDPVDPDKLWSDDDKEGNVNDTLNGWYKNGKHPEHAFYEFTFRRF 381 (382)
T ss_pred HHhcCCCCccCcCCCcchhhhcCCCCccccccccccccccccccccccccccccCcccccceeccc
Confidence 457889999999999999999876654321110000 000000 012345689999999854
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-60 Score=494.90 Aligned_cols=374 Identities=44% Similarity=0.781 Sum_probs=284.6
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
..|++++.||+|+||+||+|+++.+++.||||++.+..........++..|+.+|..++|||||+++++|.+.+++|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36999999999999999999999999999999999877777777889999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
||++||+|.+++.+.+.+++..++++++||+.||+|||+.||+||||||+||||+.+|++||+|||+|+.+.........
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999998765322111100
Q ss_pred ccc-ccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHH
Q 010266 266 ENE-VLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344 (514)
Q Consensus 266 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 344 (514)
... ........... .........++..... .............+.+.+||+.|+|||++.+.+|+.++|||||||+
T Consensus 161 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 161 QKGSHIRQDSMEPSD-LWDDVSNCRCGDRLKT--LEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred cccccccccccCccc-ccccccccccccccch--hhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 000 00000000000 0000000000000000 0000000111223456799999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhccCccccCCCCCHhHHhcCCccccCCcccc-
Q 010266 345 MYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFKDIAWDKL- 423 (514)
Q Consensus 345 lyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~Hpff~~i~w~~l- 423 (514)
+|||++|.+||.+.+..+...++..|...+.+|....+|+++++||.+|||.+.+|.+|.++++|++||||.+++|...
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~~~~ 317 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSSDI 317 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChhHHh
Confidence 9999999999999888888888888877788887778999999999999986666666679999999999999999875
Q ss_pred ccccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCc-c---ccccCCCCCCcccCeeeecC
Q 010266 424 YEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGP-M---RKMMLTPKDLSFVGYTYKNF 482 (514)
Q Consensus 424 ~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~-~---~~~~~~~~~~~f~~f~~~~~ 482 (514)
....+|+.|.+..+.|+++|+...+..........+.. . ...........|.||||+++
T Consensus 318 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (381)
T cd05626 318 RTQPAPYVPKISHPMDTSNFDPVEEESPWNDASGDSTRTWDTLCSPNGKHPEHAFYEFTFRRF 380 (381)
T ss_pred hcCCCCccCcCCCcchhhhcCCCCcccccccCCccchhhhccccCcccccccccccccEeecc
Confidence 46778999999999999999876544321110111000 0 00101123679999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-61 Score=495.24 Aligned_cols=255 Identities=36% Similarity=0.609 Sum_probs=242.2
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
.+|...+.||+|||++||.+++..+|+.||+|++.|..+.+..+.+.+.+|++|.+.++|||||++|.+|+|.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 56999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
|+|..|+|+.++.+.+.++|.+||+|+.||+.||.|||++||||||||..|++|+++.++||+|||||..+....
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~----- 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG----- 172 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999998765221
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 345 (514)
+...+.||||.|+||||+.+.+++..|||||+||||
T Consensus 173 --------------------------------------------Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvm 208 (592)
T KOG0575|consen 173 --------------------------------------------ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVM 208 (592)
T ss_pred --------------------------------------------cccceecCCCcccChhHhccCCCCCchhhhhhhhHH
Confidence 123489999999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccc
Q 010266 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFK 416 (514)
Q Consensus 346 yemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~ 416 (514)
|-||+|+|||...+-.+++.+|.. ....+|. .+|.+|+|||.+||. ||.+|+ ++++|+.|+||+
T Consensus 209 YtLL~G~PPFetk~vkety~~Ik~--~~Y~~P~--~ls~~A~dLI~~lL~~~P~~Rp---sl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 209 YTLLVGRPPFETKTVKETYNKIKL--NEYSMPS--HLSAEAKDLIRKLLRPNPSERP---SLDEVLDHPFFK 273 (592)
T ss_pred HhhhhCCCCcccchHHHHHHHHHh--cCccccc--ccCHHHHHHHHHHhcCCcccCC---CHHHHhcCHhhh
Confidence 999999999999999999999987 5677786 799999999999999 999999 999999999993
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-58 Score=475.69 Aligned_cols=329 Identities=45% Similarity=0.858 Sum_probs=277.2
Q ss_pred hcCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC
Q 010266 99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA 178 (514)
Q Consensus 99 ~~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 178 (514)
....+..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||++++++|.++
T Consensus 36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 44556678999999999999999999999999999999999876655556667788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
..+|+||||++||+|.+++.. ..+++..+++++.||+.||+|||++||+||||||+|||++.+|++||+|||+|.....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 999999999999999998854 4689999999999999999999999999999999999999999999999999976532
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCC----CCc
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG----YGM 334 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~----y~~ 334 (514)
... ....+.+||+.|+|||++.+.+ ++.
T Consensus 195 ~~~------------------------------------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~ 226 (370)
T cd05621 195 TGM------------------------------------------------VRCDTAVGTPDYISPEVLKSQGGDGYYGR 226 (370)
T ss_pred CCc------------------------------------------------eecccCCCCcccCCHHHHhccCCCCCCCc
Confidence 100 0112568999999999997643 789
Q ss_pred ccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhccCccccCCCCCHhHHhcCCc
Q 010266 335 ECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPW 414 (514)
Q Consensus 335 ~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~Hpf 414 (514)
++|||||||++|||++|.+||.+.+....+.+|+.....+.+|....+|+.+++||.+||+++..|++|.+++|+++|||
T Consensus 227 ~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 227 ECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF 306 (370)
T ss_pred ccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence 99999999999999999999999998889999987666677887777899999999999998788888889999999999
Q ss_pred cccCCc--cccccccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeeec
Q 010266 415 FKDIAW--DKLYEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKN 481 (514)
Q Consensus 415 f~~i~w--~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~ 481 (514)
|++.+| ..+....+|+.|.+.+..|.++|+.............. + +... ..+..|.||+|.+
T Consensus 307 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~--~~~~-~~~~~~~~~~~~~ 370 (370)
T cd05621 307 FKNDQWNWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETFPI--P--KAFV-GNQLPFIGFTYYR 370 (370)
T ss_pred cCCCCcChHhcCCCCCCcCCCCCCcchhhhcCCccccccccccCCC--C--cccc-ccccccCCCEecC
Confidence 998655 45567889999999999999999865544322211111 1 1111 2358999999963
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-58 Score=473.49 Aligned_cols=349 Identities=54% Similarity=0.956 Sum_probs=286.5
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|.+++.||+|+||+||+|+++.+|+.||||++++...........+..|+.+|..++||||++++++|++.+++|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999999877666677788999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
||++||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||++............
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999999876533211100
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 345 (514)
.... ..... .... .................+||+.|+|||++.+..++.++|+|||||++
T Consensus 161 ~~~~-----~~~~~-~~~~--------------~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 220 (350)
T cd05573 161 LNDS-----HNLLF-RDNV--------------LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVIL 220 (350)
T ss_pred cccc-----ccccc-cccc--------------cccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhh
Confidence 0000 00000 0000 00000000011223457899999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhccCccccCCCCC-HhHHhcCCccccCCccccc
Q 010266 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLG-SEQIKAHPWFKDIAWDKLY 424 (514)
Q Consensus 346 yemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~-~~eil~Hpff~~i~w~~l~ 424 (514)
|||++|.+||.+.+..+.+.++..|...+.+|....+++++++||.+||+||.+|+ + ++++++||||++++|+.+.
T Consensus 221 ~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~---~s~~~ll~hp~~~~~~~~~~~ 297 (350)
T cd05573 221 YEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRL---GSFEEIKSHPFFKGIDWENLR 297 (350)
T ss_pred hhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcC---CCHHHHhcCCCcCCCCHHHHh
Confidence 99999999999999999999999888888888877789999999999999999999 6 9999999999999999999
Q ss_pred cccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeee
Q 010266 425 EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYK 480 (514)
Q Consensus 425 ~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~ 480 (514)
...||++|.+.+..|+++|+............... .+........+|.||+|+
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 350 (350)
T cd05573 298 ETKPPFVPELSSPLDTSNFDDFEDDKDLSDYLSQN---SKKLNKGKQLAFVGFTYK 350 (350)
T ss_pred hCCCCcCCCCCCchhhhhcCCCCcccccccccccc---cccccccccCccCCCccC
Confidence 88999999999999999998876654322211111 111133467899999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-58 Score=477.32 Aligned_cols=370 Identities=45% Similarity=0.818 Sum_probs=285.8
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++++.||+|+||.||+|+++.+++.||+|++.+..........++.+|+++|..++||||+++++.|++.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998776656667788999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|..+.........
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999998755322111100
Q ss_pred cccccccccccccCCCCCCCCC-CCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPE-SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 344 (514)
... ................ ..+.. ..... ............+.+||+.|||||++.+..++.++|||||||+
T Consensus 161 ~~~---~~~~~~~~~~~~~~~~~~~~~~---~~~~~-~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 161 QKG---DHHRQDSMEPSEEWSEIDRCRL---KPLER-RRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred ccc---cccccccccccccccccccccc---cchhh-hhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 000 0000000000000000 00000 00000 0000001122336789999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhccCccccCCCCCHhHHhcCCccccCCcccc-
Q 010266 345 MYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFKDIAWDKL- 423 (514)
Q Consensus 345 lyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~Hpff~~i~w~~l- 423 (514)
+|||++|.+||.+.++.+....+..|...+.+|....+|+++.+||.+|+++|.+|++..+++++++||||++++|..+
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~~~~~~ 313 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGIDFASLI 313 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCCHHHHh
Confidence 9999999999999998888888888877777777667999999999998889999998778999999999999999988
Q ss_pred ccccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCC---ccccccCCCCCCcccCeeeecC
Q 010266 424 YEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSG---PMRKMMLTPKDLSFVGYTYKNF 482 (514)
Q Consensus 424 ~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~f~~f~~~~~ 482 (514)
....+|+.|.+..+.|+++|+....+........... .............|.-|+|.+|
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (376)
T cd05598 314 RRQKAPYIPKITHPTDTSNFDPVDPEKLRSDDSGESSPDRNVKPNNRKRTEHAFYEFTFRRF 375 (376)
T ss_pred hcCCCCCCCcCCCcchhhhcCCCCcccccccccccccccccccccccccCCcccccceeccc
Confidence 4678999999999999999987655432221111110 0011112334568888888875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-57 Score=469.74 Aligned_cols=330 Identities=45% Similarity=0.853 Sum_probs=278.3
Q ss_pred hhcCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc
Q 010266 98 LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 177 (514)
Q Consensus 98 ~~~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 177 (514)
.+...+..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+..|+.++..++||||++++++|++
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 34456677999999999999999999999999999999999987665555666778899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 178 AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 178 ~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
..++|+||||++||+|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 9999999999999999998855 468999999999999999999999999999999999999999999999999987653
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCC----CC
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG----YG 333 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~----y~ 333 (514)
.... ....+.+||+.|+|||++.+.+ ++
T Consensus 194 ~~~~------------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~ 225 (371)
T cd05622 194 KEGM------------------------------------------------VRCDTAVGTPDYISPEVLKSQGGDGYYG 225 (371)
T ss_pred cCCc------------------------------------------------ccccCcccCccccCHHHHhccCCCccCC
Confidence 2100 0112568999999999997643 78
Q ss_pred cccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhccCccccCCCCCHhHHhcCC
Q 010266 334 MECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHP 413 (514)
Q Consensus 334 ~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~Hp 413 (514)
.++|||||||++|||++|.+||.+.+....+.+|......+.+|....+|+++++||.+||.+|..|+++.++++|++||
T Consensus 226 ~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 226 RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 99999999999999999999999999989999998766667788777899999999999999888888888999999999
Q ss_pred ccccCC--ccccccccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeeec
Q 010266 414 WFKDIA--WDKLYEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKN 481 (514)
Q Consensus 414 ff~~i~--w~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~ 481 (514)
||++.+ |..++...+|++|.+.+..++++|++............. + .. ....+..|.||+|.+
T Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~--~~-~~~~~~~~~~~~~~~ 370 (371)
T cd05622 306 FFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDIEEDKGEEETFPI--P--KA-FVGNQLPFVGFTYYS 370 (371)
T ss_pred ccCCCChhHHhcCCCCCCCCCCCCCcchhhhcCCCcccccccccCCC--C--cc-ccccccccCCCeecC
Confidence 999854 566778889999999999999999865443321111111 1 11 112358999999974
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-57 Score=463.98 Aligned_cols=316 Identities=36% Similarity=0.669 Sum_probs=267.4
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecCCC
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG 191 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg 191 (514)
+.||+|+||.||+|+++.+|+.||||++++..........++..|..+|..++||||++++++|++.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998876666667778889999999999999999999999999999999999999
Q ss_pred CHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccccccccc
Q 010266 192 DVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD 271 (514)
Q Consensus 192 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~ 271 (514)
+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~----------- 149 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG----------- 149 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-----------
Confidence 999999988999999999999999999999999999999999999999999999999999987432110
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhhC
Q 010266 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 351 (514)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemltG 351 (514)
......+||+.|+|||++.+..|+.++|+|||||++|||++|
T Consensus 150 --------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg 191 (323)
T cd05571 150 --------------------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191 (323)
T ss_pred --------------------------------------CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcC
Confidence 011256899999999999999999999999999999999999
Q ss_pred CCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CHhHHhcCCccccCCccccc--cc
Q 010266 352 YPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHPWFKDIAWDKLY--EM 426 (514)
Q Consensus 352 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~Hpff~~i~w~~l~--~~ 426 (514)
.+||.+.+.......+.. ....+|. .+++++.+||.+||+ ||.+|++.. ++.++++||||.+++|..+. .+
T Consensus 192 ~~Pf~~~~~~~~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~~~~ 267 (323)
T cd05571 192 RLPFYNQDHEKLFELILM--EEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKL 267 (323)
T ss_pred CCCCCCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCC
Confidence 999999888888777765 4456664 689999999999999 999999643 69999999999999999986 57
Q ss_pred cCCCCCcCCCCCCCCCCCC-CCcccCCCCCCCCCCccccccCCCCCCcccCeeeec
Q 010266 427 EAAYKPEVNGVLDTQNFMK-FDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKN 481 (514)
Q Consensus 427 ~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~ 481 (514)
.||+.|.+.+..|+++|+. +........++....+ ..+........|.+|+|..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~ 322 (323)
T cd05571 268 EPPFKPQVTSETDTRYFDEEFTAQSITITPPDRYDS-LGLLQLEERPHFPQFSYSA 322 (323)
T ss_pred CCCcCCCCCCcchhhhcCcccccCCcccCCCCcccc-cccccccccccCCCCeeeC
Confidence 8999999999999999975 3332222221111111 1111234567899999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-56 Score=466.23 Aligned_cols=328 Identities=46% Similarity=0.865 Sum_probs=274.2
Q ss_pred hcCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC
Q 010266 99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA 178 (514)
Q Consensus 99 ~~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 178 (514)
....+..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+..|+.+++.++||||++++++|.+.
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~ 115 (370)
T cd05596 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD 115 (370)
T ss_pred ccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 34556778999999999999999999999999999999999876655556667788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
..+|+||||++||+|..++.. ..+++..++.++.|++.||+|||+.||+||||||+|||++.+|++||+|||++.....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999999998854 4689999999999999999999999999999999999999999999999999875432
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC----CCCc
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK----GYGM 334 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~----~y~~ 334 (514)
... ....+.+||+.|+|||++.+. .++.
T Consensus 195 ~~~------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 226 (370)
T cd05596 195 NGM------------------------------------------------VRCDTAVGTPDYISPEVLKSQGGDGYYGR 226 (370)
T ss_pred CCc------------------------------------------------ccCCCCCCCcCeECHHHhccCCCCCCCCC
Confidence 100 011256899999999999754 3789
Q ss_pred ccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhccCccccCCCCCHhHHhcCCc
Q 010266 335 ECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPW 414 (514)
Q Consensus 335 ~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~Hpf 414 (514)
++|||||||++|||++|.+||.+.+....+.+|......+.+|....+|.++++||.+||.++.+|++|.++++++.|||
T Consensus 227 ~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~ 306 (370)
T cd05596 227 ECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF 306 (370)
T ss_pred ceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence 99999999999999999999999999889999987666678887777899999999999994446666669999999999
Q ss_pred cccCCccc--cccccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeee
Q 010266 415 FKDIAWDK--LYEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYK 480 (514)
Q Consensus 415 f~~i~w~~--l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~ 480 (514)
|++.+|.. ++...+|+.|.+.+..|+++|++....+........ + .. ....+..|.||+|.
T Consensus 307 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~--~~~~~~~~~~~~~~ 369 (370)
T cd05596 307 FKNDQWTFDNIRETVAPVVPELSSDIDTSNFDDIEDDDKNEETFPL--P-KA--FAGNQLPFIGFTYS 369 (370)
T ss_pred cCCCChhhHHhcCCCcCccCcCCCcchhhhcCCccccccccccCCC--c-cc--cccccCccCCCeec
Confidence 99988864 456788999999999999999876554422111111 1 00 11235569999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-57 Score=461.44 Aligned_cols=293 Identities=41% Similarity=0.788 Sum_probs=263.5
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
.....++|++.+.||+|+||.||+|+++.+++.||+|++.+.........+++.+|..+|..++||||++++++|.+.+.
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 92 (329)
T PTZ00263 13 SSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR 92 (329)
T ss_pred CCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE
Confidence 44567899999999999999999999999999999999988766555667889999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
+|+||||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 9999999999999999998889999999999999999999999999999999999999999999999999998754311
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 340 (514)
..+.+||+.|+|||++.+..++.++||||
T Consensus 172 ---------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Diws 200 (329)
T PTZ00263 172 ---------------------------------------------------TFTLCGTPEYLAPEVIQSKGHGKAVDWWT 200 (329)
T ss_pred ---------------------------------------------------cceecCChhhcCHHHHcCCCCCCcceeec
Confidence 12467999999999999999999999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCC--CCHhHHhcCCcccc
Q 010266 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT--LGSEQIKAHPWFKD 417 (514)
Q Consensus 341 lGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~Hpff~~ 417 (514)
|||++|||++|.+||.+.+..+.+..+.. ..+.+|. .+++.+++||.+||. ||.+|++. .++++|+.||||++
T Consensus 201 lG~il~elltg~~pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 201 MGVLLYEFIAGYPPFFDDTPFRIYEKILA--GRLKFPN--WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred hHHHHHHHHcCCCCCCCCCHHHHHHHHhc--CCcCCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 99999999999999999988888888876 3456664 589999999999999 99999964 35899999999999
Q ss_pred CCccccc--cccCCCCCcCCCCCCCCCCCCCCcc
Q 010266 418 IAWDKLY--EMEAAYKPEVNGVLDTQNFMKFDEV 449 (514)
Q Consensus 418 i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~ 449 (514)
++|+.+. ...+|+.|.+....++++|+.+++.
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 310 (329)
T PTZ00263 277 ANWDKLYARYYPAPIPVRVKSPGDTSNFEKYPDS 310 (329)
T ss_pred CCHHHHHhCCCCCCcCCCCCCcccchhccCCccc
Confidence 9999885 4678888888888999999877554
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-57 Score=460.56 Aligned_cols=323 Identities=43% Similarity=0.808 Sum_probs=275.6
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++.+.||+|+||+||+|+++.+|+.||+|++++...........+..|+.++..++||+|++++++|.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998876555566777889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 186 EYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
||++||+|.+++.+. ..+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|..+.....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~--- 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM--- 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc---
Confidence 999999999999876 7899999999999999999999999999999999999999999999999999976532110
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc------cCCCCcccch
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL------KKGYGMECDW 338 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~------~~~y~~~~Di 338 (514)
......+||+.|+|||++. +..++.++||
T Consensus 158 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di 192 (330)
T cd05601 158 ---------------------------------------------VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDW 192 (330)
T ss_pred ---------------------------------------------eeeecccCCccccCHHHhccccccccCCCCCccee
Confidence 0011357999999999987 4567899999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhccCccccCCCCCHhHHhcCCccccC
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
|||||++|||++|..||.+.+....+.++......+.+|....+++++++||.+||++|.+|+ +++++++||||..+
T Consensus 193 wslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~~p~~R~---t~~~l~~h~~~~~~ 269 (330)
T cd05601 193 WSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLCGQKERL---GYEGLCCHPFFSKI 269 (330)
T ss_pred ecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccChhhCC---CHHHHhCCCCcCCC
Confidence 999999999999999999988888899998876677788777799999999999999999999 99999999999999
Q ss_pred CccccccccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeee
Q 010266 419 AWDKLYEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYK 480 (514)
Q Consensus 419 ~w~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~ 480 (514)
+|+.+....||+.|.+....|+++|+................ ....-.+.++..|+||+|.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 330 (330)
T cd05601 270 DWNNIRNSLPPFVPTLKSDDDTSNFDEPEKNSTRRSQSSTTQ-LKPNGFSGKDLPFVGFSFI 330 (330)
T ss_pred CHHHHhhCCCCccCcCCCcchhhhcCCCcccccccccccccc-CCCcCCCCCCCCccCceeC
Confidence 999999888999999999999999976443322111110100 0111134578899999983
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-56 Score=460.54 Aligned_cols=294 Identities=41% Similarity=0.818 Sum_probs=262.8
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCC-CEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSG-NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA 178 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~-~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 178 (514)
...+..++|++++.||+|+||.||+|+++.++ ..||+|++.+.........+.+.+|..++..++|||||+++++|++.
T Consensus 24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 103 (340)
T PTZ00426 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103 (340)
T ss_pred CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence 35567789999999999999999999877655 68999999887666666778889999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
..+|+||||++||+|.+++.+...+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999875431
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
. ..+.+||+.|+|||++.+..++.++||
T Consensus 184 ~----------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di 211 (340)
T PTZ00426 184 R----------------------------------------------------TYTLCGTPEYIAPEILLNVGHGKAADW 211 (340)
T ss_pred C----------------------------------------------------cceecCChhhcCHHHHhCCCCCccccc
Confidence 1 125689999999999999999999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCC--CCHhHHhcCCcc
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT--LGSEQIKAHPWF 415 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~Hpff 415 (514)
|||||++|||++|.+||.+.++...+..+.. ....+|. .+++++++||++||. ||.+|++. .+++++++||||
T Consensus 212 wSlGvil~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f 287 (340)
T PTZ00426 212 WTLGIFIYEILVGCPPFYANEPLLIYQKILE--GIIYFPK--FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287 (340)
T ss_pred cchhhHHHHHhcCCCCCCCCCHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCc
Confidence 9999999999999999999998888888876 3445664 689999999999999 99999864 389999999999
Q ss_pred ccCCccccc--cccCCCCCcCCCCCCCCCCCCCCcc
Q 010266 416 KDIAWDKLY--EMEAAYKPEVNGVLDTQNFMKFDEV 449 (514)
Q Consensus 416 ~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~ 449 (514)
++++|..+. .+.+|++|......+.++|....+.
T Consensus 288 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 323 (340)
T PTZ00426 288 GNIDWVSLLHKNVEVPYKPKYKNVFDSSNFERVQED 323 (340)
T ss_pred CCCCHHHHHhCCCCCCcCCCCCCCcchhhcCCCccc
Confidence 999999875 5789999999999999998765444
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-56 Score=455.82 Aligned_cols=324 Identities=48% Similarity=0.858 Sum_probs=272.6
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++++.||+|+||+||+|+++.+++.||+|++.+...........+..|+.++..++||+|++++++|.+.+++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 57999999999999999999999999999999998766666667778899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 186 EYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 186 Ey~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|..+.....
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--- 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT--- 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC---
Confidence 99999999999976 46799999999999999999999999999999999999999999999999999875432110
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-----CCCCcccchh
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-----KGYGMECDWW 339 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-----~~y~~~~DiW 339 (514)
......+||+.|+|||++.+ ..++.++|||
T Consensus 158 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diw 192 (331)
T cd05597 158 ---------------------------------------------VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWW 192 (331)
T ss_pred ---------------------------------------------ccccceeccccccCHHHHhhccccccCCCCcceee
Confidence 00113479999999999973 4578899999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcC-cCCChhHHHHHhhhccCccccCCCCCHhHHhcCCccccC
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEE-ARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~-~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
||||++|+|++|..||.+.+..+.+..+......+.+|.. ..+|+++++||++||+.|.+|+++.++++++.||||.++
T Consensus 193 slG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 193 SLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred hhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 9999999999999999999888888888876555555542 358999999999999988888888899999999999999
Q ss_pred CccccccccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeee
Q 010266 419 AWDKLYEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYK 480 (514)
Q Consensus 419 ~w~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~ 480 (514)
+|..+....+|+.|...+..++++|+..+............. ....+....++.||+|.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 331 (331)
T cd05597 273 DWDNIRNSTAPYVPEVSSPTDTSNFDVDDDDLRNTESLPPSS---HGAFSGNHLPFVGFTYT 331 (331)
T ss_pred CHHHHhhCCCCccCcCCCcchhhhcCCcccccccccccCCCC---cCcCCcCCCCCCceeeC
Confidence 999999889999999999999999975443321111111110 01123456789999984
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-56 Score=455.26 Aligned_cols=323 Identities=47% Similarity=0.855 Sum_probs=271.3
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++++.||+|+||.||+++.+.+++.||+|++.+...........+..|+.++..++||+|++++++|++.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999998766555566677889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 186 EYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 186 Ey~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|..+.....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~--- 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT--- 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc---
Confidence 99999999999977 46799999999999999999999999999999999999999999999999999875432100
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc-----cCCCCcccchh
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----KKGYGMECDWW 339 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~DiW 339 (514)
......+||+.|+|||++. ...++.++|||
T Consensus 158 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Dvw 192 (332)
T cd05623 158 ---------------------------------------------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWW 192 (332)
T ss_pred ---------------------------------------------ceecccccCccccCHHHHhccccCCCCCCCcCCEE
Confidence 0011357999999999986 34689999999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcC-cCCChhHHHHHhhhccCccccCCCCCHhHHhcCCccccC
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEE-ARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~-~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
||||++|||++|.+||.+.+..+.+.++......+.+|.. ..+|+++++||++||+.+.+|+++.+++++++||||.++
T Consensus 193 SlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 193 SLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred eeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 9999999999999999999999999998875555556643 358999999999999977788888899999999999999
Q ss_pred CccccccccCCCCCcCCCCCCCCCCCCCCcccCCCC-CCCCCCccccccCCCCCCcccCeeee
Q 010266 419 AWDKLYEMEAAYKPEVNGVLDTQNFMKFDEVESQTP-KRTGSGPMRKMMLTPKDLSFVGYTYK 480 (514)
Q Consensus 419 ~w~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~f~~f~~~ 480 (514)
+|+.+....+|+.|...++.++++++...+-..... .+..+.. ..+.....|.||||.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~ 331 (332)
T cd05623 273 DWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPPPSHT----AFSGHHLPFVGFTYT 331 (332)
T ss_pred CHHHHhhCCCCccCCCCCCcccccCCCCcccccccCCCCCCCcc----ccccCCCCcCCeeec
Confidence 999999999999999999999998864332221111 1111110 123457799999986
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-56 Score=455.76 Aligned_cols=294 Identities=50% Similarity=0.898 Sum_probs=259.0
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++++.||+|+||.||+|+++.+++.||+|++.+...........+..|..++..++||+|++++++|++.+++|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999998765555566677889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 186 EYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 186 Ey~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
||++||+|..++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~--- 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT--- 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc---
Confidence 99999999999987 46899999999999999999999999999999999999999999999999999876432110
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-----CCCCcccchh
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-----KGYGMECDWW 339 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-----~~y~~~~DiW 339 (514)
......+||+.|+|||++.+ ..++.++|||
T Consensus 158 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diw 192 (331)
T cd05624 158 ---------------------------------------------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWW 192 (331)
T ss_pred ---------------------------------------------eeeccccCCcccCCHHHHhccccCCCCCCCcccEE
Confidence 00113579999999999976 4688999999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcC-cCCChhHHHHHhhhccCccccCCCCCHhHHhcCCccccC
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEE-ARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~-~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
||||++|||++|.+||.+.+..+.+.++......+.+|.. ..+++++++||.+||+.+.+|+++.+++++++||||+++
T Consensus 193 SlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 193 SLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred eeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 9999999999999999999888888888875555556642 357899999999999976788877899999999999999
Q ss_pred CccccccccCCCCCcCCCCCCCCCCCCCC
Q 010266 419 AWDKLYEMEAAYKPEVNGVLDTQNFMKFD 447 (514)
Q Consensus 419 ~w~~l~~~~~p~~p~~~~~~d~~~f~~~~ 447 (514)
+|+.++...+|+.|...++.+.++|+..+
T Consensus 273 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 301 (331)
T cd05624 273 DWENIRNLEAPYIPDVSSPSDTSNFDVDD 301 (331)
T ss_pred CHHHHhhCCCCccCCCCCcchhhhcCCcc
Confidence 99999999999999999999999887543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-56 Score=453.00 Aligned_cols=317 Identities=34% Similarity=0.652 Sum_probs=269.0
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCeEEEEE
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
+|++++.||+|+||+||+|+++.+++.||||++.+..............|..++..+ +||+|++++++|++.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 689999999999999999999999999999999887655555667778888888877 5899999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
||++||+|..++...+.+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~----- 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG----- 155 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-----
Confidence 999999999999888899999999999999999999999999999999999999999999999999987432110
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 345 (514)
......+||+.|+|||++.+..++.++|||||||++
T Consensus 156 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 191 (323)
T cd05616 156 --------------------------------------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 191 (323)
T ss_pred --------------------------------------------CccccCCCChhhcCHHHhcCCCCCCccchhchhHHH
Confidence 011256899999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CHhHHhcCCccccCCccc
Q 010266 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHPWFKDIAWDK 422 (514)
Q Consensus 346 yemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~Hpff~~i~w~~ 422 (514)
|||++|.+||.+.+.......|.. ....+|. .+++++.+||.+||. ||.+|++.. +..+++.||||+.++|+.
T Consensus 192 ~elltg~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~ 267 (323)
T cd05616 192 YEMLAGQAPFEGEDEDELFQSIME--HNVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 267 (323)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCC--cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 999999999999988888888876 4455664 689999999999999 999999642 568999999999999999
Q ss_pred cc--cccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeeec
Q 010266 423 LY--EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKN 481 (514)
Q Consensus 423 l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~ 481 (514)
+. ...||+.|... ..|.++|+.+.....+..++.. +.......+..|.||+|.+
T Consensus 268 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 323 (323)
T cd05616 268 LERKEVQPPYKPKAC-GRDAENFDKFFTRHPPVLTPPD----QEVIMNLDQSEFEGFSYVN 323 (323)
T ss_pred HHhCCCCCCcCCcCC-CchhhhcCchhccCCccCCCCC----ccccccccccccCCCcccC
Confidence 86 57899999875 4788899887765433322222 1122333457899999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-57 Score=444.57 Aligned_cols=259 Identities=33% Similarity=0.589 Sum_probs=236.0
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 183 (514)
...+|.+.+.||.|+||+||+++++.++..||||.+.+..+ .++.++.+..|+.||+.++|||||.|++++.+++++||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 45899999999999999999999999999999999998865 56677889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCC------CcEEEccccccccCC
Q 010266 184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN------GHMKLSDFGLCKPLD 257 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~------g~iKL~DFGla~~~~ 257 (514)
|||||.||||..+|++.+.++|..++.++.|++.||++||+++||||||||+||||+.. -.+||+|||+|+.+.
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 99999999999999999999999999999999999999999999999999999999864 468999999999875
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
.. ..+.+.||||-||||||+..+.|+.++|
T Consensus 167 ~~--------------------------------------------------~~a~tlcGSplYMAPEV~~~~~YdAKAD 196 (429)
T KOG0595|consen 167 PG--------------------------------------------------SMAETLCGSPLYMAPEVIMSQQYDAKAD 196 (429)
T ss_pred ch--------------------------------------------------hHHHHhhCCccccCHHHHHhccccchhh
Confidence 32 2344889999999999999999999999
Q ss_pred hhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccc
Q 010266 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFK 416 (514)
Q Consensus 338 iWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~ 416 (514)
+||+|+|||+|++|++||...++.+.+..+.........++ ..+|+...+|+..+|+ ++.+|. +.++-..|||..
T Consensus 197 LWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~-~~~s~~~~~Ll~~ll~~~~~~~~---~~~~~~~~~~l~ 272 (429)
T KOG0595|consen 197 LWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP-AELSNPLRELLISLLQRNPKDRI---SFEDFFDHPFLA 272 (429)
T ss_pred HHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh-hhccCchhhhhhHHHhcCccccC---chHHhhhhhhcc
Confidence 99999999999999999999999999998887666555554 3678888899999998 999998 788888898886
Q ss_pred c
Q 010266 417 D 417 (514)
Q Consensus 417 ~ 417 (514)
.
T Consensus 273 ~ 273 (429)
T KOG0595|consen 273 A 273 (429)
T ss_pred c
Confidence 4
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-56 Score=452.21 Aligned_cols=318 Identities=35% Similarity=0.674 Sum_probs=269.9
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCC-ceeeEEEEEEcCCeEEEEE
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp-~Iv~l~~~f~~~~~l~lVm 185 (514)
+|++++.||+|+||.||+|+++.+++.||||++.+.........+.+..|..++..+.|+ +|+.++++|.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 689999999999999999999999999999999887655566677888999999999765 6889999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~----- 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----- 155 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-----
Confidence 999999999999888899999999999999999999999999999999999999999999999999986432110
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 345 (514)
......+||+.|+|||++.+..++.++|||||||++
T Consensus 156 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil 191 (324)
T cd05587 156 --------------------------------------------KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 191 (324)
T ss_pred --------------------------------------------CceeeecCCccccChhhhcCCCCCcccchhhhHHHH
Confidence 011256899999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCC--CCHhHHhcCCccccCCccc
Q 010266 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT--LGSEQIKAHPWFKDIAWDK 422 (514)
Q Consensus 346 yemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~Hpff~~i~w~~ 422 (514)
|||++|.+||.+.+..+.+..+.. ....+|. .+++++.+||.+||. ||.+|++. ...+++++||||+.++|..
T Consensus 192 ~elltG~~pf~~~~~~~~~~~i~~--~~~~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~ 267 (324)
T cd05587 192 YEMLAGQPPFDGEDEDELFQSIME--HNVSYPK--SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEK 267 (324)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 999999999999998888888876 3345554 689999999999999 99999954 2458999999999999998
Q ss_pred cc--cccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeeec
Q 010266 423 LY--EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKN 481 (514)
Q Consensus 423 l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~ 481 (514)
+. ...+|+.|.+....+.++|+.+.........+.. .....+..+..|.+|+|.|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 324 (324)
T cd05587 268 LERREIQPPFKPKVKGRRSAENFDKFFTREPPVLTPPD----KLVIANIDQSEFQGFSFVN 324 (324)
T ss_pred HHhCCCCCCccCcCCCcchhhhcCcccccCccccCCCC----ccccccccccccCCCcccC
Confidence 85 5788999999999999999987554433222211 1112344567899999864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-56 Score=454.42 Aligned_cols=290 Identities=45% Similarity=0.830 Sum_probs=261.6
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++++.||+|+||.||+|+++.+++.||+|++.+..........++..|+.+|..++||||++++++|++.+++|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998876555566778899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|.....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~------- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT------- 153 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-------
Confidence 9999999999998888999999999999999999999999999999999999999999999999999875431
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 345 (514)
...+.+||+.|+|||++.+..++.++|||||||++
T Consensus 154 ---------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il 188 (333)
T cd05600 154 ---------------------------------------------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCML 188 (333)
T ss_pred ---------------------------------------------ccCCcccCccccChhHhcCCCCCCccceecchHHH
Confidence 01256899999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCc----CCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCc
Q 010266 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEA----RLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAW 420 (514)
Q Consensus 346 yemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~----~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w 420 (514)
|||++|.+||.+.+..+.+..+..|...+..|... .+|+++++||.+||. +|.+|+ +++++++||||++++|
T Consensus 189 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~---s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 189 YEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFG---SLEDIKNHPFFKEVDW 265 (333)
T ss_pred hhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcC---CHHHHHhCcccCCCCH
Confidence 99999999999999988888888876666555432 569999999999999 677777 8999999999999999
Q ss_pred cccccccCCCCCcCCCCCCCCCCCCCCccc
Q 010266 421 DKLYEMEAAYKPEVNGVLDTQNFMKFDEVE 450 (514)
Q Consensus 421 ~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~ 450 (514)
+.+....||+.|.+....|..+|+.+...+
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (333)
T cd05600 266 NELRELKPPFVPELESEIDTGYFDDFENED 295 (333)
T ss_pred HHHhhCCCCCCCCCCCcchhhhccCCCCcc
Confidence 999999999999999999998887654443
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-57 Score=440.67 Aligned_cols=260 Identities=30% Similarity=0.502 Sum_probs=235.3
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe-
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY- 180 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~- 180 (514)
.+..++.+.++.||+|+.|+||+|+|+.|++.||+|++.- .......+++.+|.+||..++||+||.+|++|.+...
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~--~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL--NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc--cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 3566789999999999999999999999999999999943 2456667889999999999999999999999999995
Q ss_pred EEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
++++||||.||+|..++...++++|.....++.+|+.||.|||. ++||||||||+|||+++.|.|||||||.++.+..+
T Consensus 153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 99999999999999999999999999999999999999999995 99999999999999999999999999999876422
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
.+++++||..|||||-+.+..|+.++|||
T Consensus 233 ---------------------------------------------------~a~tfvGT~~YMsPERi~g~~Ys~~sDIW 261 (364)
T KOG0581|consen 233 ---------------------------------------------------IANTFVGTSAYMSPERISGESYSVKSDIW 261 (364)
T ss_pred ---------------------------------------------------hcccccccccccChhhhcCCcCCccccee
Confidence 35689999999999999999999999999
Q ss_pred hhhHHHHHHhhCCCCCCCC-----ChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCC
Q 010266 340 SLGAIMYEMLVGYPPFYSD-----DPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHP 413 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~-----~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hp 413 (514)
|||+.++||.+|+.||... +..+.+..|+.. ....+|.. .+|+++++||..||. ||.+|. ++.|+++||
T Consensus 262 SLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~-ppP~lP~~-~fS~ef~~FV~~CL~Kdp~~R~---s~~qLl~Hp 336 (364)
T KOG0581|consen 262 SLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE-PPPRLPEG-EFSPEFRSFVSCCLRKDPSERP---SAKQLLQHP 336 (364)
T ss_pred cccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC-CCCCCCcc-cCCHHHHHHHHHHhcCCcccCC---CHHHHhcCH
Confidence 9999999999999999875 667788888863 34566653 599999999999999 999999 999999999
Q ss_pred ccccCC
Q 010266 414 WFKDIA 419 (514)
Q Consensus 414 ff~~i~ 419 (514)
|++...
T Consensus 337 fi~~~~ 342 (364)
T KOG0581|consen 337 FIKKFE 342 (364)
T ss_pred HHhhcc
Confidence 998643
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-56 Score=450.75 Aligned_cols=312 Identities=35% Similarity=0.655 Sum_probs=262.5
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCeEEEEEeecCC
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLIMEYLPG 190 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lVmEy~~g 190 (514)
+.||+|+||+||+|+++.+++.||+|++.+...........+..|..++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999877655556677788898998876 699999999999999999999999999
Q ss_pred CCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccccccc
Q 010266 191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270 (514)
Q Consensus 191 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~ 270 (514)
|+|..++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~---------- 150 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG---------- 150 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987532110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhh
Q 010266 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350 (514)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt 350 (514)
......+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 151 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 191 (320)
T cd05590 151 ---------------------------------------KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLC 191 (320)
T ss_pred ---------------------------------------CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhh
Confidence 01124679999999999999999999999999999999999
Q ss_pred CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC---CHhHHhcCCccccCCccccc--
Q 010266 351 GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL---GSEQIKAHPWFKDIAWDKLY-- 424 (514)
Q Consensus 351 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~---~~~eil~Hpff~~i~w~~l~-- 424 (514)
|.+||.+.+..+.+..+.. ....+|. .+++++++||.+||+ ||.+|++.. +.++++.||||.+++|+.+.
T Consensus 192 g~~Pf~~~~~~~~~~~i~~--~~~~~~~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~~ 267 (320)
T cd05590 192 GHAPFEAENEDDLFEAILN--DEVVYPT--WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRR 267 (320)
T ss_pred CCCCCCCCCHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHHhC
Confidence 9999999998888888876 3445554 689999999999999 999999542 24999999999999999885
Q ss_pred cccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeee
Q 010266 425 EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYK 480 (514)
Q Consensus 425 ~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~ 480 (514)
.+.|||.|.+.+..|.++|+.....+.+.......... .......|.||+|.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 319 (320)
T cd05590 268 QIEPPFRPRIKSREDVSNFDPDFIKEDPVLTPIEESLL----PMINQDEFRNFSYT 319 (320)
T ss_pred CCCCCcCCCCCCcchhhhcCcccccCCccCCCCccccc----ccccccCcCCCccc
Confidence 57899999999999999998644443222211111111 12345688888874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-56 Score=448.19 Aligned_cols=309 Identities=40% Similarity=0.768 Sum_probs=264.1
Q ss_pred eeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecCCCCH
Q 010266 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDV 193 (514)
Q Consensus 114 LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~L 193 (514)
||+|+||.||+|+++.+++.||+|++.+..........++..|..+|..++||||++++++|.+.+.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999877666666778889999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccccccccccc
Q 010266 194 MTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDE 273 (514)
Q Consensus 194 ~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~ 273 (514)
..++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~------------- 147 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD------------- 147 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-------------
Confidence 9999888899999999999999999999999999999999999999999999999999987532110
Q ss_pred cccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhhCCC
Q 010266 274 NLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 353 (514)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemltG~~ 353 (514)
......+||+.|+|||++.+..|+.++|+|||||++|||++|.+
T Consensus 148 ------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~ 191 (312)
T cd05585 148 ------------------------------------DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLP 191 (312)
T ss_pred ------------------------------------CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCC
Confidence 01125689999999999999999999999999999999999999
Q ss_pred CCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCccccc--cccCCC
Q 010266 354 PFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLY--EMEAAY 430 (514)
Q Consensus 354 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~l~--~~~~p~ 430 (514)
||.+.+..+.+..+.. ..+.+|. .+++++++||.+||. ||.+|++..++.+++.||||..++|..+. ...+|+
T Consensus 192 pf~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~~~~~~~~~~~~~ 267 (312)
T cd05585 192 PFYDENVNEMYRKILQ--EPLRFPD--GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPF 267 (312)
T ss_pred CcCCCCHHHHHHHHHc--CCCCCCC--cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCc
Confidence 9999888888888875 4456664 689999999999999 99999977789999999999999998774 578999
Q ss_pred CCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeee
Q 010266 431 KPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTY 479 (514)
Q Consensus 431 ~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~ 479 (514)
.|.+.+..|+++|+.......+.......... ....+..|.||+|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 312 (312)
T cd05585 268 KPAVSSAIDTSNFDEEFTREKPIDSVVDDSHL----SETVQQQFGGWSY 312 (312)
T ss_pred CCCCCCccchhhcCccccccccccCCCccccc----cchhccccCCCCC
Confidence 99999999999997543332221111111111 1234678889887
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-55 Score=447.45 Aligned_cols=312 Identities=35% Similarity=0.664 Sum_probs=263.7
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCeEEEEEeecCC
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLIMEYLPG 190 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lVmEy~~g 190 (514)
++||+|+||.||+|+++.+++.||||++.+...........+..|..++..+ +||+|++++++|++.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999887655566677788899999866 799999999999999999999999999
Q ss_pred CCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccccccc
Q 010266 191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270 (514)
Q Consensus 191 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~ 270 (514)
|+|..++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|.......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~---------- 150 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG---------- 150 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987432110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhh
Q 010266 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350 (514)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt 350 (514)
......+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 151 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t 191 (321)
T cd05591 151 ---------------------------------------VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMA 191 (321)
T ss_pred ---------------------------------------ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhc
Confidence 01124679999999999999999999999999999999999
Q ss_pred CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC----CHhHHhcCCccccCCccccc-
Q 010266 351 GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL----GSEQIKAHPWFKDIAWDKLY- 424 (514)
Q Consensus 351 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~----~~~eil~Hpff~~i~w~~l~- 424 (514)
|.+||.+.+..+.+..+.. ....+|. .+++++.+||.+||. ||.+|++.. +++++++||||.+++|..+.
T Consensus 192 g~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~ 267 (321)
T cd05591 192 GQPPFEADNEDDLFESILH--DDVLYPV--WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQ 267 (321)
T ss_pred CCCCCCCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHh
Confidence 9999999999888888876 3445554 689999999999999 999999653 78999999999999999885
Q ss_pred -cccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeee
Q 010266 425 -EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYK 480 (514)
Q Consensus 425 -~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~ 480 (514)
...+||.|.+....+.++|+.....+.+..++.... ......+..|.||+|.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 320 (321)
T cd05591 268 RKIKPPFKPKIKTKRDVNNFDQDFTKEEPVLTPVDPA----VIKQINQEEFRGFSFF 320 (321)
T ss_pred CCCCCCCCCCCCCcchhhhcCCccccCccccCCCCcc----ccccccccccCCCccc
Confidence 467899999988888888875433332222222111 1123456789999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-56 Score=443.93 Aligned_cols=285 Identities=40% Similarity=0.819 Sum_probs=257.2
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++++.||+|+||.||+|.++.+++.||+|++.+.......+.+.+.+|..+|..++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999998765555556778899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~------ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR------ 154 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC------
Confidence 99999999999998889999999999999999999999999999999999999999999999999998754211
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 345 (514)
..+.+||+.|+|||++.+..++.++|||||||++
T Consensus 155 ----------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 188 (291)
T cd05612 155 ----------------------------------------------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILI 188 (291)
T ss_pred ----------------------------------------------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHH
Confidence 1145799999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CHhHHhcCCccccCCccc
Q 010266 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHPWFKDIAWDK 422 (514)
Q Consensus 346 yemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~Hpff~~i~w~~ 422 (514)
|+|++|..||.+.+..+.+..+.. ..+.+|. .+++.+++||++||. ||.+|++.. ++++++.||||..++|..
T Consensus 189 ~~l~~g~~pf~~~~~~~~~~~i~~--~~~~~~~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~ 264 (291)
T cd05612 189 YEMLVGYPPFFDDNPFGIYEKILA--GKLEFPR--HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDD 264 (291)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHh--CCcCCCc--cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHH
Confidence 999999999999988888888876 3455664 579999999999999 999999543 699999999999999998
Q ss_pred cc--cccCCCCCcCCCCCCCCCCCCC
Q 010266 423 LY--EMEAAYKPEVNGVLDTQNFMKF 446 (514)
Q Consensus 423 l~--~~~~p~~p~~~~~~d~~~f~~~ 446 (514)
+. ...||+.|.+....|+.||+..
T Consensus 265 ~~~~~~~~~~~p~~~~~~~~~~~~~~ 290 (291)
T cd05612 265 VPQRKLKPPIVPKVSHDGDTSNFDDY 290 (291)
T ss_pred HhcCCCCCCEeCCCCCccccccccCC
Confidence 75 5788999999999999999864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-55 Score=444.72 Aligned_cols=317 Identities=35% Similarity=0.667 Sum_probs=266.7
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEEEcCCeEEEEE
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l~lVm 185 (514)
+|++.+.||+|+||+||+|+++.+|+.||||++.+...........+..|..++..+. ||+|++++++|++.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 5889999999999999999999999999999998876555566777888999998886 578889999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
||++||+|..++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~----- 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----- 155 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-----
Confidence 999999999999888899999999999999999999999999999999999999999999999999987532110
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 345 (514)
......+||+.|+|||++.+..++.++|||||||++
T Consensus 156 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil 191 (323)
T cd05615 156 --------------------------------------------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLL 191 (323)
T ss_pred --------------------------------------------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHH
Confidence 011256799999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CHhHHhcCCccccCCccc
Q 010266 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHPWFKDIAWDK 422 (514)
Q Consensus 346 yemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~Hpff~~i~w~~ 422 (514)
|||++|.+||.+.+.......+.. ....+|. .+++++.+||.+||. +|.+|++.. ..+++++||||+.++|..
T Consensus 192 ~elltG~~pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~ 267 (323)
T cd05615 192 YEMLAGQPPFDGEDEDELFQSIME--HNVSYPK--SLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDK 267 (323)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCc--cCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHH
Confidence 999999999999988888888876 4455664 689999999999999 999999643 468999999999999998
Q ss_pred cc--cccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeeec
Q 010266 423 LY--EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKN 481 (514)
Q Consensus 423 l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~ 481 (514)
+. ...+|+.|.... .+.++|+.+.....+....+.+ ....+....-|.||+|.+
T Consensus 268 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 323 (323)
T cd05615 268 LENREIQPPFKPKVCG-KGAENFDKFFTRGQPVLTPPDQ----LVIANIDQADFEGFSYVN 323 (323)
T ss_pred HhcCCCCcCccCccCC-CchhhcCccccccCCCCCCCcc----cccccccccccCCCcccC
Confidence 86 467999998765 4588898876654333222111 111233456899999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-55 Score=445.51 Aligned_cols=318 Identities=36% Similarity=0.657 Sum_probs=266.1
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecCCC
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG 191 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg 191 (514)
+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|..+|+.++||||++++++|++.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998876666667788889999999999999999999999999999999999999
Q ss_pred CHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccccccccc
Q 010266 192 DVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD 271 (514)
Q Consensus 192 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~ 271 (514)
+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~----------- 149 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA----------- 149 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-----------
Confidence 999999888899999999999999999999999999999999999999999999999999987532110
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhhC
Q 010266 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 351 (514)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemltG 351 (514)
......+||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 150 --------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG 191 (328)
T cd05593 150 --------------------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191 (328)
T ss_pred --------------------------------------cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhC
Confidence 011246899999999999999999999999999999999999
Q ss_pred CCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCC--CCHhHHhcCCccccCCccccc--cc
Q 010266 352 YPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT--LGSEQIKAHPWFKDIAWDKLY--EM 426 (514)
Q Consensus 352 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~Hpff~~i~w~~l~--~~ 426 (514)
.+||.+.+..+....+.. ....+|. .+++++.+||.+||. ||.+|++. .++++|++||||.+++|..+. .+
T Consensus 192 ~~Pf~~~~~~~~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~ 267 (328)
T cd05593 192 RLPFYNQDHEKLFELILM--EDIKFPR--TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKL 267 (328)
T ss_pred CCCCCCCCHHHHHHHhcc--CCccCCC--CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCC
Confidence 999998888777777764 4455664 689999999999999 99999864 389999999999999999875 46
Q ss_pred cCCCCCcCCCCCCCCCCCCCCcccCCC-CCCCC--CCccccccCCCCCCcccCeeeecCc
Q 010266 427 EAAYKPEVNGVLDTQNFMKFDEVESQT-PKRTG--SGPMRKMMLTPKDLSFVGYTYKNFE 483 (514)
Q Consensus 427 ~~p~~p~~~~~~d~~~f~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~f~~f~~~~~~ 483 (514)
.||+.|.+.+..++++|+.....+... ..... ......+ .......|.+|+|....
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 326 (328)
T cd05593 268 VPPFKPQVTSETDTRYFDEEFTAQTITITPPEKYDEDGMDCM-DNERRPHFPQFSYSASG 326 (328)
T ss_pred CCCcCCcCCCcchhhhcCcccccCCcccCCcccccccccccc-ccccccccCCceeeCCC
Confidence 889999999999999998533332211 11111 1111111 23345789999997543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-55 Score=444.04 Aligned_cols=312 Identities=36% Similarity=0.663 Sum_probs=262.6
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCeEEEEEeecCC
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLIMEYLPG 190 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lVmEy~~g 190 (514)
++||+|+||+||+|+++.+++.||+|++++..............|+.++... +||||++++++|.+...+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876554555566667788888754 899999999999999999999999999
Q ss_pred CCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccccccc
Q 010266 191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270 (514)
Q Consensus 191 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~ 270 (514)
|+|..++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---------- 150 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---------- 150 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987532110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhh
Q 010266 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350 (514)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt 350 (514)
......+||+.|+|||++.+..++.++|+|||||++|||++
T Consensus 151 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~ 191 (316)
T cd05592 151 ---------------------------------------GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLI 191 (316)
T ss_pred ---------------------------------------CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHh
Confidence 01125689999999999999999999999999999999999
Q ss_pred CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCccccc--ccc
Q 010266 351 GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLY--EME 427 (514)
Q Consensus 351 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~l~--~~~ 427 (514)
|..||.+.+..+.+..+.. ....+|. .+++++.+||.+||. ||.+|++ ...+++.||||+.++|..+. ...
T Consensus 192 G~~Pf~~~~~~~~~~~i~~--~~~~~~~--~~~~~~~~ll~~~l~~~P~~R~~--~~~~l~~h~~~~~~~~~~~~~~~~~ 265 (316)
T cd05592 192 GQSPFHGEDEDELFDSILN--DRPHFPR--WISKEAKDCLSKLFERDPTKRLG--VDGDIRQHPFFRGIDWERLEKREIP 265 (316)
T ss_pred CCCCCCCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHccCCHHHcCC--ChHHHHcCcccCCCCHHHHHhCCCC
Confidence 9999999988888887765 3334453 689999999999999 9999993 24689999999999999875 578
Q ss_pred CCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeeecC
Q 010266 428 AAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNF 482 (514)
Q Consensus 428 ~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~ 482 (514)
||+.|......+.++|+.....+.....+..... ..+..+..|.||.|.++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 316 (316)
T cd05592 266 PPFKPKVKSPSDASNFDREFTNEKVRLSPVDKKL----LASMDQEQFRGFSFTNP 316 (316)
T ss_pred CCcCCCCCCcchhhhcCcccccccccCCCccccc----cccccccccCCCcccCc
Confidence 8999999999999999865555443332222222 23346789999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-55 Score=445.57 Aligned_cols=313 Identities=34% Similarity=0.626 Sum_probs=258.0
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCeEEEEEeecCC
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLIMEYLPG 190 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lVmEy~~g 190 (514)
+.||+|+||+||+|+.+.+++.||+|++++...........+..|..++..+ +||+|+.++++|++.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999987655566677889999999888 699999999999999999999999999
Q ss_pred CCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccccccc
Q 010266 191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270 (514)
Q Consensus 191 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~ 270 (514)
|+|..++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---------- 150 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG---------- 150 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987432110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhh
Q 010266 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350 (514)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt 350 (514)
....+.+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 151 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~ 191 (327)
T cd05617 151 ---------------------------------------DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMA 191 (327)
T ss_pred ---------------------------------------CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHh
Confidence 01125689999999999999999999999999999999999
Q ss_pred CCCCCCCCC-------hhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCC---CCHhHHhcCCccccCC
Q 010266 351 GYPPFYSDD-------PVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT---LGSEQIKAHPWFKDIA 419 (514)
Q Consensus 351 G~~PF~~~~-------~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~---~~~~eil~Hpff~~i~ 419 (514)
|.+||.... .......+.. ....+|. .+|..+++||.+||. ||.+|++. .++++|++||||++++
T Consensus 192 g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 192 GRSPFDIITDNPDMNTEDYLFQVILE--KPIRIPR--FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred CCCCCCccCCCcccccHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 999996421 2233344433 3445664 689999999999999 99999964 2678999999999999
Q ss_pred ccccc--cccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeeec
Q 010266 420 WDKLY--EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKN 481 (514)
Q Consensus 420 w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~ 481 (514)
|+.+. ...|||.|.+.+..+.++|+.....+....++......++ ..+..|.||.|.|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 327 (327)
T cd05617 268 WDLLEKKQVTPPFKPQITDDYGLENFDTQFTSEPVQLTPDDEDVIKR----IDQSEFEGFEYIN 327 (327)
T ss_pred HHHHHhCCCCCCccCCCCCCcchhhcCCccccCcccCCCCCcccccc----ccccccCCCcCCC
Confidence 99885 5788999999999999999864433322222222212221 2456888998864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-55 Score=444.47 Aligned_cols=316 Identities=36% Similarity=0.683 Sum_probs=265.1
Q ss_pred eeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHH---HcCCCceeeEEEEEEcCCeEEEE
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA---EVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~---~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
|++++.||+|+||.||+|.++.+++.||||++++.........+.+..|+.++. .++||||++++++|.+.+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 788999999999999999999999999999998876555666777888887764 55799999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
|||++||+|..++. .+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 81 ~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~---- 155 (324)
T cd05589 81 MEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG---- 155 (324)
T ss_pred EcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC----
Confidence 99999999998875 4579999999999999999999999999999999999999999999999999987432110
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 344 (514)
....+.+||+.|+|||++.+..++.++|||||||+
T Consensus 156 ---------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~i 190 (324)
T cd05589 156 ---------------------------------------------DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVL 190 (324)
T ss_pred ---------------------------------------------CcccccccCccccCHhHhcCCCCCcccchhhHHHH
Confidence 01125689999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CHhHHhcCCccccCCcc
Q 010266 345 MYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHPWFKDIAWD 421 (514)
Q Consensus 345 lyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~Hpff~~i~w~ 421 (514)
+|||++|.+||.+.+..+....+.. ....+|. .+++++.+||.+||. ||.+|++.. +++++++||||++++|.
T Consensus 191 l~el~~G~~pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~ 266 (324)
T cd05589 191 IYEMLVGESPFPGDDEEEVFDSIVN--DEVRYPR--FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWD 266 (324)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHH
Confidence 9999999999999988888888876 3345554 689999999999999 999998643 68999999999999999
Q ss_pred ccc--cccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeee
Q 010266 422 KLY--EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYK 480 (514)
Q Consensus 422 ~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~ 480 (514)
.+. ...||+.|.+....|.++|+.-.....+..++.. +.+ ...+..+..|.+|+|.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~ 324 (324)
T cd05589 267 DLLARKIKPPFVPTIKGPEDVSNFDEEFTSEAPVLTPPR--EPR-LLTEEEQELFRGFDYV 324 (324)
T ss_pred HHHhCCCCcCccCCCCCcchhhhcCccccccccccCCCc--ccc-ccchhhhcccCCcccC
Confidence 874 5789999999999999998754333332222211 111 1244578899999884
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-55 Score=444.25 Aligned_cols=315 Identities=36% Similarity=0.668 Sum_probs=263.5
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecCCC
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG 191 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg 191 (514)
+.||+|+||.||+|+++.+|+.||+|++.+..........++..|..++..++||||++++++|.+.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998876656667778889999999999999999999999999999999999999
Q ss_pred CHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccccccccc
Q 010266 192 DVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD 271 (514)
Q Consensus 192 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~ 271 (514)
+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~----------- 149 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG----------- 149 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-----------
Confidence 999999888899999999999999999999999999999999999999999999999999987432110
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhhC
Q 010266 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 351 (514)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemltG 351 (514)
......+||+.|+|||++.+..++.++|+|||||++|||++|
T Consensus 150 --------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g 191 (323)
T cd05595 150 --------------------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191 (323)
T ss_pred --------------------------------------CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhC
Confidence 001246799999999999999999999999999999999999
Q ss_pred CCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCC--CCHhHHhcCCccccCCccccc--cc
Q 010266 352 YPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT--LGSEQIKAHPWFKDIAWDKLY--EM 426 (514)
Q Consensus 352 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~Hpff~~i~w~~l~--~~ 426 (514)
..||.+.+.......+.. ....+|. .+++++++||.+||+ ||.+|++. .++.++++||||.+++|..+. .+
T Consensus 192 ~~Pf~~~~~~~~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~ 267 (323)
T cd05595 192 RLPFYNQDHERLFELILM--EEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL 267 (323)
T ss_pred CCCCCCCCHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHHhCCC
Confidence 999999888887777765 4455664 689999999999999 99999854 379999999999999999875 46
Q ss_pred cCCCCCcCCCCCCCCCCCCCCcccCC-CCCCCCCCccccccCCCCCCcccCeeee
Q 010266 427 EAAYKPEVNGVLDTQNFMKFDEVESQ-TPKRTGSGPMRKMMLTPKDLSFVGYTYK 480 (514)
Q Consensus 427 ~~p~~p~~~~~~d~~~f~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~f~~f~~~ 480 (514)
.||+.|.+.+..+++.|+........ .+++....+.. ......-..|.+|||.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 321 (323)
T cd05595 268 LPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLG-LLELDQRTHFPQFSYS 321 (323)
T ss_pred CCCcCCCCCChhhhhhcCcccccCCccCCCCccccccc-ccccccccccCCCccc
Confidence 78999999999999999864333322 11111111111 1011223588999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-54 Score=443.98 Aligned_cols=313 Identities=34% Similarity=0.624 Sum_probs=256.9
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCeEEEEEeecCC
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLIMEYLPG 190 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lVmEy~~g 190 (514)
++||+|+||.||+|+++.+++.||+|++++...........+..|..++..+ +||||++++++|.+...+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999887655556677888999999988 799999999999999999999999999
Q ss_pred CCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccccccc
Q 010266 191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270 (514)
Q Consensus 191 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~ 270 (514)
|+|..++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~---------- 150 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG---------- 150 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987422110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhh
Q 010266 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350 (514)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt 350 (514)
....+.+||+.|+|||++.+..++.++|+|||||++|+|++
T Consensus 151 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~ 191 (329)
T cd05588 151 ---------------------------------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 191 (329)
T ss_pred ---------------------------------------CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHH
Confidence 01125689999999999999999999999999999999999
Q ss_pred CCCCCCCCC---------hhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCC---CCHhHHhcCCcccc
Q 010266 351 GYPPFYSDD---------PVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT---LGSEQIKAHPWFKD 417 (514)
Q Consensus 351 G~~PF~~~~---------~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~---~~~~eil~Hpff~~ 417 (514)
|..||.... .......+.. ..+.+|. .+++++.+||.+||. ||.+|++. .+++++++||||+.
T Consensus 192 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 192 GRSPFDIVGMSDNPDQNTEDYLFQVILE--KQIRIPR--SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred CCCCcccccccccccccchHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999996321 1223344443 3455664 689999999999999 99999953 25899999999999
Q ss_pred CCccccc--cccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeeec
Q 010266 418 IAWDKLY--EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKN 481 (514)
Q Consensus 418 i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~ 481 (514)
++|+.+. +..||+.|.+....+..+|+.....+.....+...... ....+..|.||.|.|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~----~~~~~~~~~~~~~~~ 329 (329)
T cd05588 268 IDWDLLEQKQVLPPYKPNIESDRDLDNFDPQFTDEPVQLTPDDPDVI----ARIDQSEFEGFEYIN 329 (329)
T ss_pred CCHHHHHhCCCCCCccccCCCcchhhhcCCccccCccccCCCCcccc----ccccccccCCCcccC
Confidence 9999885 46788999998888888998644433222211111111 223457899998864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-54 Score=441.43 Aligned_cols=310 Identities=35% Similarity=0.653 Sum_probs=259.1
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCeEEEEEeecCC
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLIMEYLPG 190 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lVmEy~~g 190 (514)
+.||+|+||.||+|+++.+|+.||+|++++..............|..++... +||+|++++++|++.+++|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999999876544445566677888888765 899999999999999999999999999
Q ss_pred CCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccccccc
Q 010266 191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270 (514)
Q Consensus 191 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~ 270 (514)
|+|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|++||+|||+++......
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---------- 150 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD---------- 150 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999986421110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhh
Q 010266 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350 (514)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt 350 (514)
......+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 151 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~ 191 (316)
T cd05620 151 ---------------------------------------NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLI 191 (316)
T ss_pred ---------------------------------------CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHh
Confidence 01125689999999999999999999999999999999999
Q ss_pred CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCH-hHHhcCCccccCCccccc--cc
Q 010266 351 GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGS-EQIKAHPWFKDIAWDKLY--EM 426 (514)
Q Consensus 351 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~-~eil~Hpff~~i~w~~l~--~~ 426 (514)
|..||.+.+..+....+.. ....+|. .++.++++||.+||. ||.+|+ ++ +++++||||++++|..+. ..
T Consensus 192 g~~Pf~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~dP~~R~---~~~~~~~~h~~f~~~~~~~~~~~~~ 264 (316)
T cd05620 192 GQSPFHGDDEDELFESIRV--DTPHYPR--WITKESKDILEKLFERDPTRRL---GVVGNIRGHPFFKTINWTALEKREL 264 (316)
T ss_pred CCCCCCCCCHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHHHccCCHHHcC---CChHHHHcCCCcCCCCHHHHHhCCC
Confidence 9999999888888877764 3344554 689999999999998 999999 55 689999999999999875 57
Q ss_pred cCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeeec
Q 010266 427 EAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKN 481 (514)
Q Consensus 427 ~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~ 481 (514)
.+|+.|....+.+.++|+.-...+.+....... ....+..+..|.||+|-+
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 315 (316)
T cd05620 265 DPPFKPKVKSPSDYSNFDREFLSEKPRLSYSDK----NLIDSMDQSAFAGFSFIN 315 (316)
T ss_pred CCCcCCCCCCcchhhhcCccccccCcccCCCcc----cccccccccCcCCCcccC
Confidence 799999999999999998643333222211111 111234567999999865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-55 Score=448.88 Aligned_cols=260 Identities=36% Similarity=0.653 Sum_probs=235.2
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccCh--hhHHHHHHHHHHHHHcC-CCceeeEEEEEEcCC
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR--GQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAE 179 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~--~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~ 179 (514)
...+.|.+.+.||.|+||+|++|++..+|..||+|++.+...... ...+++.+|+.+++.+. ||||++++.++.+..
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 456899999999999999999999999999999998877633322 34567789999999999 999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCC-CcEEEccccccccCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPLDC 258 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~-g~iKL~DFGla~~~~~ 258 (514)
.+|+||||+.||+|++++...+++.|..+++|+.|++.||+|||++||+||||||||||+|.+ +++||+|||++.....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 999999999999999999999999999999999999999999999999999999999999999 9999999999986520
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCC-C-Cccc
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG-Y-GMEC 336 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~-y-~~~~ 336 (514)
. .....+.||||.|+|||++.+.+ | +.++
T Consensus 174 ~-------------------------------------------------~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~a 204 (370)
T KOG0583|consen 174 E-------------------------------------------------DGLLKTFCGSPAYAAPEVLSGKGTYSGKAA 204 (370)
T ss_pred C-------------------------------------------------CCcccCCCCCcccCCHHHhCCCCCcCCchh
Confidence 0 11233789999999999999988 8 5899
Q ss_pred chhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCC-ChhHHHHHhhhcc-CccccCCCCCHhHHhcCCc
Q 010266 337 DWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARL-TPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPW 414 (514)
Q Consensus 337 DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~-s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpf 414 (514)
|+||+||+||.|++|+.||...+...++.+|.. ..+.+|. .+ |+++++||++||. ||.+|+ ++.+|+.|||
T Consensus 205 DvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~--~~~~~p~--~~~S~~~~~Li~~mL~~~P~~R~---t~~~i~~h~w 277 (370)
T KOG0583|consen 205 DVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK--GEFKIPS--YLLSPEARSLIEKMLVPDPSTRI---TLLEILEHPW 277 (370)
T ss_pred hhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc--CCccCCC--CcCCHHHHHHHHHHcCCCcccCC---CHHHHhhChh
Confidence 999999999999999999999999999999876 6788887 46 9999999999999 999998 9999999999
Q ss_pred cccC
Q 010266 415 FKDI 418 (514)
Q Consensus 415 f~~i 418 (514)
|+.-
T Consensus 278 ~~~~ 281 (370)
T KOG0583|consen 278 FQKE 281 (370)
T ss_pred hccC
Confidence 9863
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-54 Score=440.64 Aligned_cols=309 Identities=37% Similarity=0.696 Sum_probs=262.2
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCeEEEEEeecCC
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLIMEYLPG 190 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lVmEy~~g 190 (514)
+.||+|+||+||+|+++.+++.||+|++++...........+..|..++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999987665566677788899999887 699999999999999999999999999
Q ss_pred CCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccccccc
Q 010266 191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270 (514)
Q Consensus 191 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~ 270 (514)
|+|..++.+.+.+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---------- 150 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---------- 150 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999986422110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhh
Q 010266 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350 (514)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt 350 (514)
......+||+.|+|||++.+..++.++|+|||||++|+|++
T Consensus 151 ---------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~ 191 (318)
T cd05570 151 ---------------------------------------VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLA 191 (318)
T ss_pred ---------------------------------------CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhh
Confidence 01124679999999999999999999999999999999999
Q ss_pred CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCH-----hHHhcCCccccCCccccc
Q 010266 351 GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGS-----EQIKAHPWFKDIAWDKLY 424 (514)
Q Consensus 351 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~-----~eil~Hpff~~i~w~~l~ 424 (514)
|..||.+.+.......+.. ....+|. .+++++.+||.+||. ||.+|+ ++ .+++.||||+.++|..+.
T Consensus 192 G~~pf~~~~~~~~~~~i~~--~~~~~~~--~~~~~~~~li~~~l~~dP~~R~---s~~~~~~~~ll~~~~~~~~~~~~~~ 264 (318)
T cd05570 192 GQSPFEGDDEDELFQSILE--DEVRYPR--WLSKEAKSILKSFLTKNPEKRL---GCLPTGEQDIKGHPFFREIDWDKLE 264 (318)
T ss_pred CCCCCCCCCHHHHHHHHHc--CCCCCCC--cCCHHHHHHHHHHccCCHHHcC---CCCCCCHHHHhcCCCcCCCCHHHHH
Confidence 9999999888888877765 3445554 689999999999999 999999 66 999999999999998765
Q ss_pred --cccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeee
Q 010266 425 --EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYK 480 (514)
Q Consensus 425 --~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~ 480 (514)
...||+.|.+.+..+.++|+.-...+.+..++.... .+.+..+..|.||+|.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 318 (318)
T cd05570 265 RKEIKPPFKPKIKGRFDVSNFDDEFTKEKPVLTPPDEA----IIRNIDQEEFRGFSYI 318 (318)
T ss_pred hCCCCCCcCCCCCCcchhhhcCchhccCcccCCCCccc----ccccccccccCCCCCC
Confidence 578999999999999999985333322222221111 1234466899999983
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-54 Score=439.32 Aligned_cols=310 Identities=36% Similarity=0.654 Sum_probs=259.3
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCeEEEEEeecCC
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLIMEYLPG 190 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lVmEy~~g 190 (514)
+.||+|+||+||+|+++.+++.||||++++..............|..++... +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876544445556677788888764 899999999999999999999999999
Q ss_pred CCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccccccc
Q 010266 191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270 (514)
Q Consensus 191 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~ 270 (514)
|+|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+++......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~---------- 150 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---------- 150 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC----------
Confidence 9999999888889999999999999999999999999999999999999999999999999987432110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhh
Q 010266 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350 (514)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt 350 (514)
....+.+||+.|+|||++.+..++.++|+|||||++|||++
T Consensus 151 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~ 191 (316)
T cd05619 151 ---------------------------------------AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLI 191 (316)
T ss_pred ---------------------------------------CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHh
Confidence 01125679999999999999999999999999999999999
Q ss_pred CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHh-HHhcCCccccCCccccc--cc
Q 010266 351 GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSE-QIKAHPWFKDIAWDKLY--EM 426 (514)
Q Consensus 351 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~-eil~Hpff~~i~w~~l~--~~ 426 (514)
|..||.+.+..+....+... ...+|. .++.++++||.+||+ ||.+|+ ++. +++.||||+.++|..+. ..
T Consensus 192 G~~pf~~~~~~~~~~~i~~~--~~~~~~--~~~~~~~~li~~~l~~~P~~R~---~~~~~l~~h~~~~~~~~~~~~~~~~ 264 (316)
T cd05619 192 GQSPFHGHDEEELFQSIRMD--NPCYPR--WLTREAKDILVKLFVREPERRL---GVKGDIRQHPFFREIDWSALEEREI 264 (316)
T ss_pred CCCCCCCCCHHHHHHHHHhC--CCCCCc--cCCHHHHHHHHHHhccCHhhcC---CChHHHHcCcccCCCCHHHHHhCCC
Confidence 99999998888887777642 334554 689999999999999 999999 664 99999999999999875 57
Q ss_pred cCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeeec
Q 010266 427 EAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKN 481 (514)
Q Consensus 427 ~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~ 481 (514)
+||+.|...+..|.++|+.....+.+...... .....+..+..|.||+|-+
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 315 (316)
T cd05619 265 EPPFKPKVKSANDCSNFDKEFLNEKPRLSVTD----RMLINSMDQNMFENFSFIN 315 (316)
T ss_pred CCCcCCCCCCccchhhcChhhhcCCcccCCCc----ccccccccccccCCCcccC
Confidence 89999999999999999875444332221111 1111233456799998864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-54 Score=440.67 Aligned_cols=316 Identities=38% Similarity=0.695 Sum_probs=259.9
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHH-HHHcCCCceeeEEEEEEcCCeEEEEEeecCC
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL-LAEVASHCIVKLYYSFQDAEYLYLIMEYLPG 190 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~i-L~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~g 190 (514)
+.||+|+||+||+|+++.+|+.||+|++.+..........++..|+.+ ++.++||||+++++.|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 479999999999999999999999999987655455555666666664 5778999999999999999999999999999
Q ss_pred CCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccccccc
Q 010266 191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270 (514)
Q Consensus 191 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~ 270 (514)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~---------- 150 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS---------- 150 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC----------
Confidence 9999999988899999999999999999999999999999999999999999999999999987432110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhh
Q 010266 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350 (514)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt 350 (514)
......+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 151 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~ 191 (323)
T cd05575 151 ---------------------------------------KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLY 191 (323)
T ss_pred ---------------------------------------CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhc
Confidence 01124679999999999999999999999999999999999
Q ss_pred CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC-CHhHHhcCCccccCCccccc--cc
Q 010266 351 GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL-GSEQIKAHPWFKDIAWDKLY--EM 426 (514)
Q Consensus 351 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~-~~~eil~Hpff~~i~w~~l~--~~ 426 (514)
|.+||.+.+..+.+..+.. ..+.++. .+++++.+||.+||+ ||.+|++.. .+.+++.||||..++|..+. ++
T Consensus 192 g~~pf~~~~~~~~~~~i~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~~~~~ 267 (323)
T cd05575 192 GLPPFYSRDTAEMYDNILN--KPLRLKP--NISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKI 267 (323)
T ss_pred CCCCCCCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHhhccC
Confidence 9999999988888888876 3344443 579999999999999 999999542 45799999999999999885 57
Q ss_pred cCCCCCcCCCCCCCCCCCCCCc-ccCCCCCCCCCCcc-ccccCCCCCCcccCeeee
Q 010266 427 EAAYKPEVNGVLDTQNFMKFDE-VESQTPKRTGSGPM-RKMMLTPKDLSFVGYTYK 480 (514)
Q Consensus 427 ~~p~~p~~~~~~d~~~f~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~f~~f~~~ 480 (514)
.+|+.|.+....+.++|+.... ...+........+. ........+..|.||+|.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (323)
T cd05575 268 TPPFNPNVSGPMDLKHFDPEFTEEPVPNSVGKSPDSVLVSASVKEADDAFLGFSYA 323 (323)
T ss_pred CCCcCCCCCCcchhhhcCccccccccccccCCCcccccccccccccccccCCCccC
Confidence 8999999999999999876333 22221111111111 011133467899999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-54 Score=440.03 Aligned_cols=317 Identities=37% Similarity=0.662 Sum_probs=260.8
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHH-HHHcCCCceeeEEEEEEcCCeEEEEEeecCC
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL-LAEVASHCIVKLYYSFQDAEYLYLIMEYLPG 190 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~i-L~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~g 190 (514)
+.||+|+||+||+|+++.+|+.||+|++.+...........+..|+.+ ++.++||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999999999999999999987655445555666667654 6778999999999999999999999999999
Q ss_pred CCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccccccc
Q 010266 191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270 (514)
Q Consensus 191 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~ 270 (514)
|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~---------- 150 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS---------- 150 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987432110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhh
Q 010266 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350 (514)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt 350 (514)
......+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 151 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~ 191 (325)
T cd05604 151 ---------------------------------------DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLY 191 (325)
T ss_pred ---------------------------------------CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhc
Confidence 01125689999999999999999999999999999999999
Q ss_pred CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCC-CCHhHHhcCCccccCCccccc--cc
Q 010266 351 GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT-LGSEQIKAHPWFKDIAWDKLY--EM 426 (514)
Q Consensus 351 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~-~~~~eil~Hpff~~i~w~~l~--~~ 426 (514)
|.+||.+.+..+.+.++... .+.++. .++.++.++|.+||. +|.+|++. .++.+++.||||++++|..+. .+
T Consensus 192 G~~pf~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~~~~~~ 267 (325)
T cd05604 192 GLPPFYCRDVAEMYDNILHK--PLVLRP--GASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKI 267 (325)
T ss_pred CCCCCCCCCHHHHHHHHHcC--CccCCC--CCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHHHHHhCCC
Confidence 99999999888888888763 334443 589999999999999 99999964 366899999999999999875 46
Q ss_pred cCCCCCcCCCCCCCCCCCCC-CcccCCCCCCCCCCcc-ccccCCCCCCcccCeeeec
Q 010266 427 EAAYKPEVNGVLDTQNFMKF-DEVESQTPKRTGSGPM-RKMMLTPKDLSFVGYTYKN 481 (514)
Q Consensus 427 ~~p~~p~~~~~~d~~~f~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~f~~f~~~~ 481 (514)
.+|+.|.+.+..|.++|+.. .++..+......+++. ........+.+|.||+|..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (325)
T cd05604 268 PPPFNPNVEGPDDISNFDAVFTEETVPYSVCFSSDYSIVNASVLEADDAFVGFSYAP 324 (325)
T ss_pred CCCcCCcCCCcchhhhcCCccccCCcccCcccccccccccccccccccccCCCEecC
Confidence 78999999999999999863 3333222211111110 0001223578999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-54 Score=438.56 Aligned_cols=313 Identities=33% Similarity=0.627 Sum_probs=254.7
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCeEEEEEeecCC
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLIMEYLPG 190 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lVmEy~~g 190 (514)
+.||+|+||+||+|+++.+++.||+|++++...........+..|..++..+ +||||++++++|++.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999887655556677788899998876 799999999999999999999999999
Q ss_pred CCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccccccc
Q 010266 191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270 (514)
Q Consensus 191 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~ 270 (514)
|+|..++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~---------- 150 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---------- 150 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987432110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhh
Q 010266 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350 (514)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt 350 (514)
......+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 151 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 191 (329)
T cd05618 151 ---------------------------------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 191 (329)
T ss_pred ---------------------------------------CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhh
Confidence 01125689999999999999999999999999999999999
Q ss_pred CCCCCCCC---------ChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCC---CCHhHHhcCCcccc
Q 010266 351 GYPPFYSD---------DPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT---LGSEQIKAHPWFKD 417 (514)
Q Consensus 351 G~~PF~~~---------~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~---~~~~eil~Hpff~~ 417 (514)
|.+||... ........+.. ....+|. .++.++.+||.+||. ||.+|++. .+++++++||||++
T Consensus 192 g~~Pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 192 GRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred CCCCCccCCCcCCcccccHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 99999521 11223334443 4455664 689999999999999 99999953 24789999999999
Q ss_pred CCccccc--cccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeeec
Q 010266 418 IAWDKLY--EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKN 481 (514)
Q Consensus 418 i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~ 481 (514)
++|+.+. +..||+.|.+.+..+..+|+.....+.....+...... .......|.||.|.|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~ 329 (329)
T cd05618 268 VDWDLMEQKQVVPPFKPNISGEFGLDNFDAQFTNEPVQLTPDDDDIV----RKIDQSEFEGFEYIN 329 (329)
T ss_pred CCHHHHHcCCCCcCccCCCCCcccchhcCcccccCCccCCCCccccc----ccccccccCCCcccC
Confidence 9999875 57899999998888888887533332211111111111 112456889998864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-54 Score=436.41 Aligned_cols=283 Identities=40% Similarity=0.726 Sum_probs=250.2
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecCCC
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG 191 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg 191 (514)
+.||+|+||+||+|+++.+|+.||+|++.+...........+..|..++..++||||++++++|.+.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998876555666777888999999999999999999999999999999999999
Q ss_pred CHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccccccc
Q 010266 192 DVMTLLMREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270 (514)
Q Consensus 192 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~ 270 (514)
+|..++...+.+++..++.++.||+.||.|||+ .||+||||||+|||++.+|.+||+|||+|+......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~---------- 150 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG---------- 150 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC----------
Confidence 999999888899999999999999999999997 799999999999999999999999999987432110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhh
Q 010266 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350 (514)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt 350 (514)
......+||+.|+|||++.+..++.++|+|||||++|+|++
T Consensus 151 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t 191 (325)
T cd05594 151 ---------------------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 191 (325)
T ss_pred ---------------------------------------cccccccCCcccCCHHHHccCCCCCccccccccceeeeecc
Confidence 00124579999999999999999999999999999999999
Q ss_pred CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCC--CCHhHHhcCCccccCCccccc--c
Q 010266 351 GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT--LGSEQIKAHPWFKDIAWDKLY--E 425 (514)
Q Consensus 351 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~Hpff~~i~w~~l~--~ 425 (514)
|..||.+.+.......+.. ....+|. .+++++.+||.+||+ ||.+|++. .++.++++||||.+++|..+. .
T Consensus 192 G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~ 267 (325)
T cd05594 192 GRLPFYNQDHEKLFELILM--EEIRFPR--TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKK 267 (325)
T ss_pred CCCCCCCCCHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHHhCC
Confidence 9999999888777777765 4456664 689999999999999 99999854 379999999999999999875 4
Q ss_pred ccCCCCCcCCCCCCCCCCCCCC
Q 010266 426 MEAAYKPEVNGVLDTQNFMKFD 447 (514)
Q Consensus 426 ~~~p~~p~~~~~~d~~~f~~~~ 447 (514)
..||+.|...+..++.+|+...
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~ 289 (325)
T cd05594 268 LVPPFKPQVTSETDTRYFDEEF 289 (325)
T ss_pred CCCCcCCcCCCcchhhhcCchh
Confidence 6789999999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-53 Score=435.95 Aligned_cols=316 Identities=38% Similarity=0.715 Sum_probs=255.4
Q ss_pred CeeEEeeeeecCceEEEEEEEc---cCCCEEEEEEeecccccC-hhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCeE
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEK---KSGNIYAMKKLKKSEMLS-RGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~---~t~~~~AiK~l~k~~~~~-~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l 181 (514)
+|++++.||+|+||.||+|++. .+++.||+|++.+..... ....+++..|..+|..+ +||+|++++++|.+.+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999864 578999999998764432 23456788899999999 599999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
|+||||++||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~- 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE- 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC-
Confidence 9999999999999999888899999999999999999999999999999999999999999999999999987543210
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-CCCcccchhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWWS 340 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWS 340 (514)
...+.+.+||+.|+|||++.+. .++.++||||
T Consensus 160 -----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws 192 (332)
T cd05614 160 -----------------------------------------------KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWS 192 (332)
T ss_pred -----------------------------------------------CCccccccCCccccCHHHhcCCCCCCCcccccc
Confidence 0012256899999999999875 4789999999
Q ss_pred hhHHHHHHhhCCCCCCCCCh----hHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CHhHHhcCC
Q 010266 341 LGAIMYEMLVGYPPFYSDDP----VTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHP 413 (514)
Q Consensus 341 lGvilyemltG~~PF~~~~~----~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~Hp 413 (514)
|||++|||++|..||..... ......+.. ....+|. .+++.+++||.+||. ||.+|++.. +++++++||
T Consensus 193 lG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 193 LGILIFELLTGASPFTLEGERNTQSEVSRRILK--CDPPFPS--FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred chhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 99999999999999975432 233334443 2233443 689999999999999 999999765 889999999
Q ss_pred ccccCCccccc--cccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeeec
Q 010266 414 WFKDIAWDKLY--EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKN 481 (514)
Q Consensus 414 ff~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~ 481 (514)
||++++|..+. ...+|+.|......|.++|........+...+... ..+....|.||+|..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~ 331 (332)
T cd05614 269 FFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEFTNLEPVYSPAGT-------PPSGARVFQGYSFVA 331 (332)
T ss_pred CcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCCcccCCCCC-------CcccccccCCceecC
Confidence 99999999875 57899999999888888886422221111111111 113456899999873
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-55 Score=405.13 Aligned_cols=259 Identities=38% Similarity=0.613 Sum_probs=240.3
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
...++++|++.+.||+|-||.||+|+.+.++-.||+|++-|+.+....-..++++|++|-+.++||||.++|++|.|...
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 45678999999999999999999999999999999999999988777777889999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 181 LYLIMEYLPGGDVMTLLM--REETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
+||++||.++|+|...|. ....|++..+..|+.|++.||.|+|..+||||||||+|+|++..|.+||+|||-+....+
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 999999999999999998 667899999999999999999999999999999999999999999999999998764321
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
. ...+.|||.+|++||++.+.+++..||+
T Consensus 177 ~---------------------------------------------------kR~tlcgt~dyl~pEmv~~~~hd~~Vd~ 205 (281)
T KOG0580|consen 177 N---------------------------------------------------KRKTLCGTLDYLPPEMVEGRGHDKFVDL 205 (281)
T ss_pred C---------------------------------------------------CceeeecccccCCHhhcCCCCccchhhH
Confidence 1 1237899999999999999999999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
||+|++.||+|+|.+||.+.+..+++++|.. -.+.+|. .+|.+|+|||.+||. +|.+|+ ...|++.|||...
T Consensus 206 w~lgvl~yeflvg~ppFes~~~~etYkrI~k--~~~~~p~--~is~~a~dlI~~ll~~~p~~r~---~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 206 WSLGVLCYEFLVGLPPFESQSHSETYKRIRK--VDLKFPS--TISGGAADLISRLLVKNPIERL---ALTEVMDHPWIVA 278 (281)
T ss_pred HHHHHHHHHHHhcCCchhhhhhHHHHHHHHH--ccccCCc--ccChhHHHHHHHHhccCccccc---cHHHHhhhHHHHh
Confidence 9999999999999999999999999999987 5677774 899999999999998 999999 8999999999854
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-54 Score=444.81 Aligned_cols=261 Identities=31% Similarity=0.574 Sum_probs=241.7
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
-.++-|++.+.||.|+-|.|.+|++..||+..|||++.+.......+...+.+|+-||+.+.||||+.||+++.+..++|
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ly 88 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLY 88 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEE
Confidence 34577999999999999999999999999999999999986667777788999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
+|+||++||.|+++|.+.++++|..++.|+.||+.|+.|+|..+|+||||||||+|||..++|||+|||+|.....+
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--- 165 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--- 165 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999753311
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCC-Ccccchhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSL 341 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWSl 341 (514)
.+.-+-||+|.|.|||++.|.+| |.++||||.
T Consensus 166 -----------------------------------------------klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSC 198 (786)
T KOG0588|consen 166 -----------------------------------------------KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSC 198 (786)
T ss_pred -----------------------------------------------ccccccCCCcccCCchhhcCCCCCCCccccchh
Confidence 12337799999999999999999 789999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCc
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAW 420 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w 420 (514)
|||||.||||..||.+++...++.++.. +.+..|. .+|++|+|||++||. ||..|+ +.+||++|||+.+..=
T Consensus 199 GVILfALLtG~LPFdDdNir~LLlKV~~--G~f~MPs--~Is~eaQdLLr~ml~VDp~~Ri---T~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 199 GVILFALLTGKLPFDDDNIRVLLLKVQR--GVFEMPS--NISSEAQDLLRRMLDVDPSTRI---TTEEILKHPFLSGYTS 271 (786)
T ss_pred HHHHHHHHhCCCCCCCccHHHHHHHHHc--CcccCCC--cCCHHHHHHHHHHhccCccccc---cHHHHhhCchhhcCCC
Confidence 9999999999999999999999999987 6678885 799999999999999 999999 9999999999988643
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-53 Score=432.75 Aligned_cols=317 Identities=37% Similarity=0.687 Sum_probs=256.9
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHH-HHHHcCCCceeeEEEEEEcCCeEEEEEeecCC
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN-LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPG 190 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~-iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~g 190 (514)
+.||+|+||+||+|+++.+++.||+|++.+..........++..|.. +++.++||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999998765444444455555554 46778999999999999999999999999999
Q ss_pred CCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccccccc
Q 010266 191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270 (514)
Q Consensus 191 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~ 270 (514)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~---------- 150 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN---------- 150 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987432110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhh
Q 010266 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350 (514)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt 350 (514)
......+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 151 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 191 (325)
T cd05602 151 ---------------------------------------GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY 191 (325)
T ss_pred ---------------------------------------CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhc
Confidence 01125689999999999999999999999999999999999
Q ss_pred CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC-CHhHHhcCCccccCCccccc--cc
Q 010266 351 GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL-GSEQIKAHPWFKDIAWDKLY--EM 426 (514)
Q Consensus 351 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~-~~~eil~Hpff~~i~w~~l~--~~ 426 (514)
|.+||.+.+..+.+..+.. ....++. .+++++++||.+||. ||.+|++.. .+.++++||||..++|+.+. ..
T Consensus 192 g~~pf~~~~~~~~~~~i~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 267 (325)
T cd05602 192 GLPPFYSRNTAEMYDNILN--KPLQLKP--NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKI 267 (325)
T ss_pred CCCCCCCCCHHHHHHHHHh--CCcCCCC--CCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHHHHhCCC
Confidence 9999999988888888876 3334443 689999999999999 999999643 45699999999999999986 46
Q ss_pred cCCCCCcCCCCCCCCCCCC-CCcccCCCCCCCCCCcc-ccccCCCCCCcccCeeeec
Q 010266 427 EAAYKPEVNGVLDTQNFMK-FDEVESQTPKRTGSGPM-RKMMLTPKDLSFVGYTYKN 481 (514)
Q Consensus 427 ~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~f~~f~~~~ 481 (514)
.+|+.|.+.++.++.+|+. +..+............. ..........+|.||+|..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~ 324 (325)
T cd05602 268 TPPFNPNVSGPNDLRHFDPEFTEEPVPNSIGQSPDSILVTASVKEAAEAFLGFSYAP 324 (325)
T ss_pred CcCcCCCCCCcchhhhcCCccccCCcccccCCCchhhhhcccccccccccCCCccCC
Confidence 7899999999888888874 33222211110010000 0011223456799999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-53 Score=431.24 Aligned_cols=313 Identities=39% Similarity=0.741 Sum_probs=258.9
Q ss_pred EeeeeecCceEEEEEEEc---cCCCEEEEEEeeccccc-ChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 111 LTIIGRGAFGEVRLCQEK---KSGNIYAMKKLKKSEML-SRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 111 ~~~LG~G~fG~V~l~~~~---~t~~~~AiK~l~k~~~~-~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
++.||+|+||.||+|++. .+++.||+|++++.... ......++..|+.+|..++||||+++++.|.+++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999864 57899999999876543 22345677889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccc
Q 010266 187 YLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE 266 (514)
Q Consensus 187 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~ 266 (514)
|++||+|..++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~------ 154 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG------ 154 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC------
Confidence 99999999999988899999999999999999999999999999999999999999999999999987432110
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHH
Q 010266 267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 346 (514)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 346 (514)
......+||+.|+|||++.+..++.++|+|||||++|
T Consensus 155 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 191 (323)
T cd05584 155 -------------------------------------------TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMY 191 (323)
T ss_pred -------------------------------------------CcccccCCCccccChhhccCCCCCCcceecccHHHHH
Confidence 0112467999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCC--CCHhHHhcCCccccCCcccc
Q 010266 347 EMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT--LGSEQIKAHPWFKDIAWDKL 423 (514)
Q Consensus 347 emltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~Hpff~~i~w~~l 423 (514)
||++|.+||.+.+.......+.. ....+|. .+++++++||.+||. ||.+|++. .++++++.||||+..+|+.+
T Consensus 192 ell~G~~pf~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~ 267 (323)
T cd05584 192 DMLTGAPPFTAENRKKTIDKILK--GKLNLPP--YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDL 267 (323)
T ss_pred HHhcCCCCCCCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 99999999999888888888876 3445554 689999999999999 99999853 27899999999999999988
Q ss_pred c--cccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeeec
Q 010266 424 Y--EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKN 481 (514)
Q Consensus 424 ~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~ 481 (514)
. ...+|+.|...+..|.+.|+.-.....+...+.+.. ........|.||+|..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~ 322 (323)
T cd05584 268 LARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDST-----LSESANQIFLGFTYVA 322 (323)
T ss_pred hcCCCCCCcCCCCCCcchhhhcCchhcccccccCccccc-----cccccccCcCCCeecC
Confidence 5 467889998888888888875322222111111111 1223457899999964
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-53 Score=424.42 Aligned_cols=275 Identities=31% Similarity=0.621 Sum_probs=233.8
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
.|++++.||+|+||+||+|.++.+|+.||+|++.+...........+.+|..+|..++||+|++++++|.+.+.+|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 38899999999999999999999999999999987655444455567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 187 YLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 187 y~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
|++||+|..++... ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC----
Confidence 99999999887543 468999999999999999999999999999999999999999999999999987542110
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 344 (514)
.....+||+.|+|||++.+..|+.++|||||||+
T Consensus 157 ----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvi 190 (285)
T cd05631 157 ----------------------------------------------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCL 190 (285)
T ss_pred ----------------------------------------------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHH
Confidence 0114579999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHhhh--cCcccCCcCcCCChhHHHHHhhhcc-CccccCCC--CCHhHHhcCCccccCC
Q 010266 345 MYEMLVGYPPFYSDDPVTTCRKIVHW--KNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT--LGSEQIKAHPWFKDIA 419 (514)
Q Consensus 345 lyemltG~~PF~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~Hpff~~i~ 419 (514)
+|||++|.+||.+.+.......+... .....+| ..+|+++.+||++||. ||.+|++. .+++++++||||.+++
T Consensus 191 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 191 IYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYS--EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred HHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCC--ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 99999999999876553332222211 1222333 3689999999999999 99999953 2589999999999999
Q ss_pred ccccc--cccCCCCCc
Q 010266 420 WDKLY--EMEAAYKPE 433 (514)
Q Consensus 420 w~~l~--~~~~p~~p~ 433 (514)
|+.+. ..+|||+|.
T Consensus 269 ~~~~~~~~~~~~~~~~ 284 (285)
T cd05631 269 FKRLEANMLEPPFCPD 284 (285)
T ss_pred HHHHHhCcCCcCCCCC
Confidence 99997 468999995
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-53 Score=430.32 Aligned_cols=284 Identities=43% Similarity=0.756 Sum_probs=246.1
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHH-HHHHcCCCceeeEEEEEEcCCeEEEEEeecCC
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN-LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPG 190 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~-iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~g 190 (514)
++||+|+||.||+|+++.+++.||+|++.+..........++..|+. +++.++|||||+++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999998765544445555666655 57889999999999999999999999999999
Q ss_pred CCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccccccc
Q 010266 191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270 (514)
Q Consensus 191 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~ 270 (514)
|+|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---------- 150 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE---------- 150 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987432110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhh
Q 010266 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350 (514)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt 350 (514)
......+||+.|+|||++.+..++.++|+|||||++|||++
T Consensus 151 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 191 (321)
T cd05603 151 ---------------------------------------ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLY 191 (321)
T ss_pred ---------------------------------------CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhc
Confidence 01124679999999999999999999999999999999999
Q ss_pred CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC-CHhHHhcCCccccCCccccc--cc
Q 010266 351 GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL-GSEQIKAHPWFKDIAWDKLY--EM 426 (514)
Q Consensus 351 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~-~~~eil~Hpff~~i~w~~l~--~~ 426 (514)
|.+||.+.+....+..+.. ..+.+|. ..+.++.++|.+||. ||.+|++.. ++.++++||||..++|..+. ..
T Consensus 192 g~~pf~~~~~~~~~~~i~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T cd05603 192 GLPPFYSRDVSQMYDNILH--KPLQLPG--GKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRI 267 (321)
T ss_pred CCCCCCCCCHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHHHhcCCC
Confidence 9999999988888888876 3455554 578999999999999 999999643 66799999999999999875 47
Q ss_pred cCCCCCcCCCCCCCCCCCCCCc
Q 010266 427 EAAYKPEVNGVLDTQNFMKFDE 448 (514)
Q Consensus 427 ~~p~~p~~~~~~d~~~f~~~~~ 448 (514)
.||+.|...+..+...|+....
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~ 289 (321)
T cd05603 268 TPPYNPNVAGPADLRHFDPEFT 289 (321)
T ss_pred CCCcCCCCCCcchhhhcCCccc
Confidence 7899999988888888875433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-54 Score=431.26 Aligned_cols=268 Identities=37% Similarity=0.643 Sum_probs=232.2
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccC-----------hhhHHHHHHHHHHHHHcCCCcee
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS-----------RGQVEHVRAERNLLAEVASHCIV 169 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~-----------~~~~~~~~~E~~iL~~l~hp~Iv 169 (514)
....+++|++++.||+|.||+|.||++..+++.||||++.|..... ...++.+++|+.||++++|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 4567799999999999999999999999999999999998875432 12357899999999999999999
Q ss_pred eEEEEEEcC--CeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEE
Q 010266 170 KLYYSFQDA--EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKL 247 (514)
Q Consensus 170 ~l~~~f~~~--~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL 247 (514)
+|+.+..|. +++|||+|||..|.+...=.....+++..||.|+..++.||+|||.+|||||||||+|+||+++|++||
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence 999998764 689999999999988765433333999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccc
Q 010266 248 SDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL 327 (514)
Q Consensus 248 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl 327 (514)
+|||.|-....+.... .... ....+|||.|||||.+
T Consensus 252 sDFGVs~~~~~~~~~~---------------------------------~d~~-----------L~~tvGTPAF~APE~c 287 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEG---------------------------------SDDQ-----------LSRTVGTPAFFAPELC 287 (576)
T ss_pred eccceeeecccCCccc---------------------------------cHHH-----------HhhcCCCccccchHhh
Confidence 9999987654321110 0011 1147999999999999
Q ss_pred ccC---CC-CcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCC
Q 010266 328 LKK---GY-GMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLG 402 (514)
Q Consensus 328 ~~~---~y-~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~ 402 (514)
.+. .| +.+.|||||||.||.|++|..||.++...+++.+|++ ..+.||....+.++++|||.+||+ ||..|+
T Consensus 288 ~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn--~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri- 364 (576)
T KOG0585|consen 288 SGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN--DPLEFPENPEINEDLKDLIKRLLEKDPEQRI- 364 (576)
T ss_pred cCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc--CcccCCCcccccHHHHHHHHHHhhcChhhee-
Confidence 873 23 7899999999999999999999999999999999998 789999877899999999999999 999999
Q ss_pred CCCHhHHhcCCcccc
Q 010266 403 TLGSEQIKAHPWFKD 417 (514)
Q Consensus 403 ~~~~~eil~Hpff~~ 417 (514)
++.+|+.|||...
T Consensus 365 --~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 365 --TLPDIKLHPWVTR 377 (576)
T ss_pred --ehhhheecceecc
Confidence 9999999999853
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-53 Score=435.99 Aligned_cols=280 Identities=41% Similarity=0.766 Sum_probs=244.8
Q ss_pred eeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc---CCCceeeEEEEEEcCCeEEEEEeecCC
Q 010266 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV---ASHCIVKLYYSFQDAEYLYLIMEYLPG 190 (514)
Q Consensus 114 LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~~~~~l~lVmEy~~g 190 (514)
||+|+||+||+|+++.+++.||+|++.+..........+...|..++... +||+|++++..|.+...+|+||||++|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999876655555666677788888765 699999999999999999999999999
Q ss_pred CCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccccccc
Q 010266 191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270 (514)
Q Consensus 191 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~ 270 (514)
|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~---------- 150 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN---------- 150 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC----------
Confidence 9999999988999999999999999999999999999999999999999999999999999987532110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-CCCcccchhhhhHHHHHHh
Q 010266 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEML 349 (514)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvilyeml 349 (514)
......+||+.|+|||++.+. .++.++|+|||||++|+|+
T Consensus 151 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell 191 (330)
T cd05586 151 ---------------------------------------KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMC 191 (330)
T ss_pred ---------------------------------------CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEec
Confidence 011256899999999999764 5899999999999999999
Q ss_pred hCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC-CHhHHhcCCccccCCccccc--c
Q 010266 350 VGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL-GSEQIKAHPWFKDIAWDKLY--E 425 (514)
Q Consensus 350 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~-~~~eil~Hpff~~i~w~~l~--~ 425 (514)
+|..||.+.+..+.+.++.. ....+|. ..+++++++||.+||+ ||.+|++.. ++++++.||||.+++|+.+. .
T Consensus 192 tG~~Pf~~~~~~~~~~~i~~--~~~~~~~-~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~~~~~~ 268 (330)
T cd05586 192 CGWSPFYAEDTQQMYRNIAF--GKVRFPK-NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQ 268 (330)
T ss_pred cCCCCCCCCCHHHHHHHHHc--CCCCCCC-ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHHHHHhCC
Confidence 99999999988888888765 3445554 2589999999999999 999998653 78999999999999999875 4
Q ss_pred ccCCCCCcCCCCCCCCCCCC
Q 010266 426 MEAAYKPEVNGVLDTQNFMK 445 (514)
Q Consensus 426 ~~~p~~p~~~~~~d~~~f~~ 445 (514)
+.+|+.|.+....+.++|+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~ 288 (330)
T cd05586 269 ITPPFKPIVDSDEDVSNFDP 288 (330)
T ss_pred CCCCccCCCCCCcchhhcCc
Confidence 78899999998899988874
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-54 Score=441.44 Aligned_cols=254 Identities=31% Similarity=0.586 Sum_probs=234.3
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|.+.+.||+|+||.||+++.|.|.+.||||.+.|..- ...++..+++|.+|++.++|||||.++.+|++..++++|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 678899999999999999999999999999999988753 4567888999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
||+.| +|+.+|...+.++|+.++.++.+++.||.|||+++|+|||+||.|||++..|++|+||||+|+.....
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~------ 153 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN------ 153 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC------
Confidence 99987 99999999999999999999999999999999999999999999999999999999999999875421
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 345 (514)
.....++.|||.|||||++.+++|+..+|.||||||+
T Consensus 154 -------------------------------------------t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcil 190 (808)
T KOG0597|consen 154 -------------------------------------------TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCIL 190 (808)
T ss_pred -------------------------------------------ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHH
Confidence 1123377899999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 346 yemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
|||.+|+|||+..+..+....|.. ++...|. .+|.++..||.+||. ||..|+ +..+++.|||.++
T Consensus 191 YE~~~G~PPF~a~si~~Lv~~I~~--d~v~~p~--~~S~~f~nfl~gLL~kdP~~Rl---tW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 191 YELYVGQPPFYARSITQLVKSILK--DPVKPPS--TASSSFVNFLQGLLIKDPAQRL---TWTDLLGHPFWKG 256 (808)
T ss_pred HHHhcCCCCchHHHHHHHHHHHhc--CCCCCcc--cccHHHHHHHHHHhhcChhhcc---cHHHHhcChHHhh
Confidence 999999999999998888888886 5556665 799999999999998 999999 9999999999875
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-55 Score=407.87 Aligned_cols=260 Identities=33% Similarity=0.593 Sum_probs=236.8
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.+.|++-++||+|+|+.|+.|.+..||+.||+|++.-..+... ..+.+.+|..|-+.++|||||+|..+++.....|||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3668888899999999999999999999999999987665444 677899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCC---CcEEEccccccccCCCCCc
Q 010266 185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN---GHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~---g~iKL~DFGla~~~~~~~~ 261 (514)
+|+|.||+|..-|-.+..++|..+..|+.||+.||.|+|.+||||||+||+|+|+.+. --+||+|||+|..+..+
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g-- 166 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG-- 166 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc--
Confidence 9999999999888777889999999999999999999999999999999999999643 45999999999876521
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
..+..++|||.|||||++...+|+..+|+|+-
T Consensus 167 ------------------------------------------------~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~c 198 (355)
T KOG0033|consen 167 ------------------------------------------------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWAC 198 (355)
T ss_pred ------------------------------------------------cccccccCCCcccCHHHhhcCCCCCcchhhhh
Confidence 12347899999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
|||||-+|.|++||.+.+....++.|....-...-|.+..+|++|++||++||. ||.+|+ |+.|.++|||.++-
T Consensus 199 GViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRI---ta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 199 GVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRI---TADEALKHPWICNR 273 (355)
T ss_pred hHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhc---cHHHHhCCchhcch
Confidence 999999999999999999999999999876666666788999999999999999 999999 99999999999863
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-52 Score=424.53 Aligned_cols=310 Identities=40% Similarity=0.688 Sum_probs=254.4
Q ss_pred EeeeeecCceEEEEEEE---ccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEee
Q 010266 111 LTIIGRGAFGEVRLCQE---KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY 187 (514)
Q Consensus 111 ~~~LG~G~fG~V~l~~~---~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy 187 (514)
++.||+|+||.||+|++ +.+|+.||+|++.+... .......+..|+.+|..++||||++++++|.+...+|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 36799999999999986 35789999999987543 223345577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccccc
Q 010266 188 LPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINEN 267 (514)
Q Consensus 188 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~ 267 (514)
++||+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~------- 152 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE------- 152 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-------
Confidence 9999999999888889999999999999999999999999999999999999999999999999987542110
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHH
Q 010266 268 EVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 347 (514)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilye 347 (514)
....+.+||+.|+|||++.+..++.++|+|||||++||
T Consensus 153 ------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~e 190 (318)
T cd05582 153 ------------------------------------------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFE 190 (318)
T ss_pred ------------------------------------------CceecccCChhhcCHHHHcCCCCCCccceeccceEeee
Confidence 01225689999999999999999999999999999999
Q ss_pred HhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCC--HhHHhcCCccccCCccccc
Q 010266 348 MLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLG--SEQIKAHPWFKDIAWDKLY 424 (514)
Q Consensus 348 mltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~--~~eil~Hpff~~i~w~~l~ 424 (514)
|++|..||.+.+..+....+.. ....+|. .+++++++||.+||. ||.+|+.... +++++.||||..++|..+.
T Consensus 191 l~tg~~p~~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T cd05582 191 MLTGSLPFQGKDRKETMTMILK--AKLGMPQ--FLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLY 266 (318)
T ss_pred eccCCCCCCCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHHH
Confidence 9999999999888888887765 3445564 689999999999998 9999995432 7889999999999999875
Q ss_pred --cccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeee
Q 010266 425 --EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYK 480 (514)
Q Consensus 425 --~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~ 480 (514)
+..||+.|......+..+|+.......+.+.. ..+. ....+..|.||+|.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~----s~~~~~~~~~~~~~ 318 (318)
T cd05582 267 RREIKPPFKPAVGRPDDTFYFDPEFTSRTPKDSP--GIPP----SANAHQLFRGFSFV 318 (318)
T ss_pred hcCCCCCcCCCCCCcchhhhcCcccccCccccCC--CCcc----ccccccccCCCEeC
Confidence 46788999887777777766432222111111 1111 12345678899873
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-54 Score=409.31 Aligned_cols=250 Identities=33% Similarity=0.571 Sum_probs=222.4
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEE-EEEcCC
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY-SFQDAE 179 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~-~f~~~~ 179 (514)
...+..+|+++++||+|+||+||+|++..+|..+|.|.++- .+......+.+..|+.+|++++|||||+.|+ .|..+.
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f-~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQF-GMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcch-hhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 34556789999999999999999999999999999999984 4556667788889999999999999999998 777666
Q ss_pred e-EEEEEeecCCCCHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHh--CC--eEEcCCCCCCccccCCCcEEEccc
Q 010266 180 Y-LYLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHK--HN--YIHRDIKPDNLLLDQNGHMKLSDF 250 (514)
Q Consensus 180 ~-l~lVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~--~g--iiHrDLKpeNILld~~g~iKL~DF 250 (514)
. +++|||||.+|||..+++. .+.++|..++.|+.|++.||.++|+ .. |+||||||.||+|+.+|.+||+||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 5 9999999999999999864 4679999999999999999999998 44 999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC
Q 010266 251 GLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK 330 (514)
Q Consensus 251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~ 330 (514)
||++.+.+. ...+.+.||||.||+||++.+.
T Consensus 173 GL~r~l~s~-------------------------------------------------~tfA~S~VGTPyYMSPE~i~~~ 203 (375)
T KOG0591|consen 173 GLGRFLSSK-------------------------------------------------TTFAHSLVGTPYYMSPERIHES 203 (375)
T ss_pred hhHhHhcch-------------------------------------------------hHHHHhhcCCCcccCHHHHhcC
Confidence 999987532 1235589999999999999999
Q ss_pred CCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCC
Q 010266 331 GYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLG 402 (514)
Q Consensus 331 ~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~ 402 (514)
+|+.++|||||||++|||+.-++||+|++-.+.+.+|.++ +....|. ...|.++..||..||+ ||..||+
T Consensus 204 ~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d~~~~p~-~~YS~~l~~li~~ci~vd~~~RP~ 274 (375)
T KOG0591|consen 204 GYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-DYPPLPD-EHYSTDLRELINMCIAVDPEQRPD 274 (375)
T ss_pred CCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-CCCCCcH-HHhhhHHHHHHHHHccCCcccCCC
Confidence 9999999999999999999999999999999999999874 2223453 3689999999999999 9999995
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-52 Score=426.53 Aligned_cols=260 Identities=36% Similarity=0.614 Sum_probs=239.3
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEEEcCCeEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l~l 183 (514)
...|++.+.||+|.||.||+|+++.||+.||+|++.|..+........+.+|+.||+.+. |||||.++++|.+...+|+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 357999999999999999999999999999999999988776667788999999999998 9999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCC----CcEEEccccccccCCCC
Q 010266 184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN----GHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~----g~iKL~DFGla~~~~~~ 259 (514)
|||+|.||+|++.+... .++|..+..++.|++.|+.|||+.||+||||||||+|+... +.+|++|||+|......
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~ 192 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG 192 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC
Confidence 99999999999999877 49999999999999999999999999999999999999643 58999999999875421
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
......||||.|+|||++...+|+..+|+|
T Consensus 193 --------------------------------------------------~~~~~~~Gtp~y~APEvl~~~~y~~~~DiW 222 (382)
T KOG0032|consen 193 --------------------------------------------------ERLHTIVGTPEYVAPEVLGGRPYGDEVDVW 222 (382)
T ss_pred --------------------------------------------------ceEeeecCCccccCchhhcCCCCCcccchh
Confidence 123478999999999999999999999999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
|+||++|.|++|.+||.+.+...++.+|......+..+.+..+|..|+|||++||. ||..|+ ++.++++|||+++.
T Consensus 223 S~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~---ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 223 SIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRL---TAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCC---CHHHHhcCccccCC
Confidence 99999999999999999999999999999876666777778899999999999999 999999 99999999998764
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-53 Score=402.41 Aligned_cols=259 Identities=31% Similarity=0.488 Sum_probs=220.7
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
+.|+.+.++|+|+||.|++|++++||+.||||++..++- .+.-.+-..+|+.+|++++|||+|.|..+|.....++||+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 568889999999999999999999999999999875531 2333455789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
|||...=|..+=.-...++++.++.|+.|++.|+.|+|++++||||||||||||+.+|.+||||||+|+.+...+.
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd---- 156 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD---- 156 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc----
Confidence 9997644444434457899999999999999999999999999999999999999999999999999997753210
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchhhhhHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAI 344 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvi 344 (514)
.-..+|.|.+|.|||.+.+ ..|+.+|||||+||+
T Consensus 157 ---------------------------------------------~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv 191 (396)
T KOG0593|consen 157 ---------------------------------------------NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCV 191 (396)
T ss_pred ---------------------------------------------hhhhhhhhhhccChhhhcccCcCCCcccchhhhHH
Confidence 0115789999999999998 889999999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHhhhcC-----------------cccCCcC----------cCCChhHHHHHhhhcc-C
Q 010266 345 MYEMLVGYPPFYSDDPVTTCRKIVHWKN-----------------HLKFPEE----------ARLTPEAKDLICRLLC-D 396 (514)
Q Consensus 345 lyemltG~~PF~~~~~~~~~~~i~~~~~-----------------~~~~p~~----------~~~s~~~~dLI~~lL~-d 396 (514)
+.||++|.|.|.|.+..++...|...-+ .+.+|.. +.+|.-+.||+++||. |
T Consensus 192 ~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~d 271 (396)
T KOG0593|consen 192 FAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMD 271 (396)
T ss_pred HHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCC
Confidence 9999999999999998888777753111 1233321 3578899999999999 9
Q ss_pred ccccCCCCCHhHHhcCCcccc
Q 010266 397 VEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 397 p~~Rl~~~~~~eil~Hpff~~ 417 (514)
|.+|+ +.+|++.||||.+
T Consensus 272 P~~R~---sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 272 PDDRL---SCEQLLHHPYFDG 289 (396)
T ss_pred ccccc---cHHHHhcChHHHH
Confidence 99999 8999999999954
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-53 Score=399.28 Aligned_cols=269 Identities=33% Similarity=0.591 Sum_probs=238.5
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeeccccc-----ChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCC
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML-----SRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAE 179 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~-----~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~ 179 (514)
..|.--+.||+|..+.|..|.++.||+.+|+|++.-.... ...-.+..+.|..||+++ .||+|++|.++|+++.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 3566677899999999999999999999999998643221 122345667899999988 5999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
.+++|+|.|+.|.|+++|...-.++|..++.++.|++.|++|||.++||||||||+|||+|++-+|||+|||+|..+..+
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999876532
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc------cCCCC
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL------KKGYG 333 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~------~~~y~ 333 (514)
+.....||||+|+|||.+. ..+|+
T Consensus 177 --------------------------------------------------ekLrelCGTPgYLAPEtikC~m~e~~pGYs 206 (411)
T KOG0599|consen 177 --------------------------------------------------EKLRELCGTPGYLAPETIKCSMYENHPGYS 206 (411)
T ss_pred --------------------------------------------------hhHHHhcCCCcccChhheeeecccCCCCcc
Confidence 1223679999999999986 36799
Q ss_pred cccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 334 MECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 334 ~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
..+|.||+|||||-+|.|.+||......-+...|+.++..+..|+|..+|..++|||++||. ||.+|+ |++|+++|
T Consensus 207 ~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ri---take~LaH 283 (411)
T KOG0599|consen 207 KEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRI---TAKEALAH 283 (411)
T ss_pred chhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcc---cHHHHhcC
Confidence 99999999999999999999999998889999999988889999999999999999999999 999999 99999999
Q ss_pred CccccCCcccccccc
Q 010266 413 PWFKDIAWDKLYEME 427 (514)
Q Consensus 413 pff~~i~w~~l~~~~ 427 (514)
|||..+--...+++.
T Consensus 284 pff~q~~~~~~r~ms 298 (411)
T KOG0599|consen 284 PFFIQIAQQQARQMS 298 (411)
T ss_pred hHHHHHHHhcccccC
Confidence 999776444334333
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-51 Score=415.36 Aligned_cols=262 Identities=30% Similarity=0.477 Sum_probs=227.7
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC--C
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA--E 179 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~--~ 179 (514)
....+.|+.++.||+|+||.||+|++..||+.||+|+++.... .........+|+.||++++||||++|.+...+. .
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~ 191 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG 191 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence 3456789999999999999999999999999999999987643 344556678899999999999999999988766 6
Q ss_pred eEEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
.+|||+|||+. ||..++... -.|++.+++.|+.|++.||+|+|++||+|||||.+|||||.+|.+||+|||||+....
T Consensus 192 siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 192 SIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred eEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 89999999975 999999774 4899999999999999999999999999999999999999999999999999997653
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccc
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECD 337 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~D 337 (514)
.... ...+.|-|.+|.|||+++| ..|+.++|
T Consensus 271 ~~~~------------------------------------------------~~T~rVvTLWYRpPELLLG~t~Yg~aVD 302 (560)
T KOG0600|consen 271 SGSA------------------------------------------------PYTSRVVTLWYRPPELLLGATSYGTAVD 302 (560)
T ss_pred CCCc------------------------------------------------ccccceEEeeccChHHhcCCccccccee
Confidence 3211 1125688999999999997 57999999
Q ss_pred hhhhhHHHHHHhhCCCCCCCCChhHHHHHHhh---------hcCcccCCc-----------------CcCCChhHHHHHh
Q 010266 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVH---------WKNHLKFPE-----------------EARLTPEAKDLIC 391 (514)
Q Consensus 338 iWSlGvilyemltG~~PF~~~~~~~~~~~i~~---------~~~~~~~p~-----------------~~~~s~~~~dLI~ 391 (514)
+||+||||.||++|+|.|.|.+..++..+|.. |. ...+|. ...+++.+.+|+.
T Consensus 303 lWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~ 381 (560)
T KOG0600|consen 303 LWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLE 381 (560)
T ss_pred ehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccCCcccccCCCCcccchHHHHhccCCHHHHHHHH
Confidence 99999999999999999999999999999975 43 223331 1236899999999
Q ss_pred hhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 392 RLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 392 ~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
.||+ ||.+|. ||.+++.|+||..
T Consensus 382 ~lL~ldP~kR~---tA~~aL~seyF~t 405 (560)
T KOG0600|consen 382 KLLSLDPDKRG---TASSALQSEYFTT 405 (560)
T ss_pred HHhccCccccc---cHHHHhcCccccc
Confidence 9999 999999 9999999999943
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-52 Score=424.39 Aligned_cols=255 Identities=30% Similarity=0.551 Sum_probs=228.4
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
...|.....||+|+-|.||.|+...+++.||+|.|...... ..+-+.+|+.||+..+|+|||.++.+|--.+.+++|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~---~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP---KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC---chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 45688889999999999999999999999999999876533 334588999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
||||+||+|.+++.. -.++|..++.++.+++.||+|||.+||||||||.+|||++.+|.+||+|||+|..+.....
T Consensus 349 MEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--- 424 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--- 424 (550)
T ss_pred EeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC---
Confidence 999999999888744 4599999999999999999999999999999999999999999999999999987653210
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 344 (514)
...+.+|||+|||||++.+..|++++||||||+|
T Consensus 425 ----------------------------------------------KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIM 458 (550)
T KOG0578|consen 425 ----------------------------------------------KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIM 458 (550)
T ss_pred ----------------------------------------------ccccccCCCCccchhhhhhcccCccccchhhhhH
Confidence 1237899999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccc
Q 010266 345 MYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFK 416 (514)
Q Consensus 345 lyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~ 416 (514)
++||+-|.|||..+++......|.. .+.+.+.....+|++++|||.+||+ |+.+|. +|.|+|.||||+
T Consensus 459 aIEMveGEPPYlnE~PlrAlyLIa~-ng~P~lk~~~klS~~~kdFL~~cL~~dv~~Ra---sA~eLL~HpFl~ 527 (550)
T KOG0578|consen 459 AIEMVEGEPPYLNENPLRALYLIAT-NGTPKLKNPEKLSPELKDFLDRCLVVDVEQRA---SAKELLEHPFLK 527 (550)
T ss_pred HHHHhcCCCCccCCChHHHHHHHhh-cCCCCcCCccccCHHHHHHHHHHhhcchhcCC---CHHHHhcChhhh
Confidence 9999999999999999888877765 3445555556899999999999999 999999 999999999995
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-50 Score=402.88 Aligned_cols=275 Identities=32% Similarity=0.636 Sum_probs=233.9
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
.|++++.||+|+||+||++.+..+++.||+|++.+...........+.+|+.+++.++||+|+++++.|.+.+.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48899999999999999999999999999999987654444444567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 187 YLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 187 y~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
|++||+|..++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.+++++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC----
Confidence 99999999888653 468999999999999999999999999999999999999999999999999987542110
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 344 (514)
.....+||+.|+|||++.+..++.++|+||+||+
T Consensus 157 ----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~ 190 (285)
T cd05605 157 ----------------------------------------------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCL 190 (285)
T ss_pred ----------------------------------------------ccccccCCCCccCcHHhcCCCCCccccchhHHHH
Confidence 0114579999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHhhh--cCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CHhHHhcCCccccCC
Q 010266 345 MYEMLVGYPPFYSDDPVTTCRKIVHW--KNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHPWFKDIA 419 (514)
Q Consensus 345 lyemltG~~PF~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~Hpff~~i~ 419 (514)
+|||++|..||.+.+.......+... .....+| ..+++.+++||.+||. ||.+|++.. ++++++.||||...+
T Consensus 191 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05605 191 IYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYS--EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN 268 (285)
T ss_pred HHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccC--cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence 99999999999887654443333221 1222333 3589999999999998 999999766 889999999999999
Q ss_pred ccccc--cccCCCCCc
Q 010266 420 WDKLY--EMEAAYKPE 433 (514)
Q Consensus 420 w~~l~--~~~~p~~p~ 433 (514)
|+.+. .+.|||.|.
T Consensus 269 ~~~~~~~~~~~~~~~~ 284 (285)
T cd05605 269 FKRLEAGMLEPPFCPD 284 (285)
T ss_pred HHHHhhCCCCCCCCCC
Confidence 99986 467899884
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-51 Score=405.38 Aligned_cols=260 Identities=34% Similarity=0.560 Sum_probs=220.4
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC--eEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE--YLY 182 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~--~l~ 182 (514)
..++...+.||+|+||.||++.++.+|..+|+|.+.... ....+.+.+|..+|..++||+||+.++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 356788899999999999999999999999999987652 222677899999999999999999999755544 699
Q ss_pred EEEeecCCCCHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC-CCcEEEccccccccCCCCC
Q 010266 183 LIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ-NGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~-~g~iKL~DFGla~~~~~~~ 260 (514)
+.|||++||+|.+++.+.+ .++|..++.|..|++.||.|||++|||||||||+|||++. +|.+||+|||+++......
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999999877 8999999999999999999999999999999999999999 7999999999998765210
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCC-CCcccchh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG-YGMECDWW 339 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~-y~~~~DiW 339 (514)
.. .....+..|||.|||||++.+.. -+.++|+|
T Consensus 173 ~~----------------------------------------------~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiW 206 (313)
T KOG0198|consen 173 TK----------------------------------------------SDSELSVQGTPNYMAPEVIRNGEVARRESDIW 206 (313)
T ss_pred cc----------------------------------------------ccccccccCCccccCchhhcCCCcCCccchhh
Confidence 00 00122678999999999999622 23499999
Q ss_pred hhhHHHHHHhhCCCCCCC-CChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 340 SLGAIMYEMLVGYPPFYS-DDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 340 SlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
||||++.||+||.+||.. ....+....|........+|+ .+|++++|||.+|+. +|.+|+ ||++++.|||.+.
T Consensus 207 SlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~--~ls~~a~~Fl~~C~~~~p~~Rp---ta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 207 SLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPD--SLSDEAKDFLRKCFKRDPEKRP---TAEELLEHPFLKQ 281 (313)
T ss_pred hcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCc--ccCHHHHHHHHHHhhcCcccCc---CHHHHhhChhhhc
Confidence 999999999999999987 455555666655443446665 699999999999998 999999 9999999999976
Q ss_pred C
Q 010266 418 I 418 (514)
Q Consensus 418 i 418 (514)
.
T Consensus 282 ~ 282 (313)
T KOG0198|consen 282 N 282 (313)
T ss_pred c
Confidence 4
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-50 Score=399.51 Aligned_cols=285 Identities=47% Similarity=0.918 Sum_probs=256.9
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|..+|+.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998876666667788999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
||++||+|.+++...+.+++..+..++.|++.||.|||+.||+||||+|+|||++.+|.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~------ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------ 154 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC------
Confidence 99999999999998899999999999999999999999999999999999999999999999999998754311
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 345 (514)
....+||+.|+|||.+.+..++.++|+||||+++
T Consensus 155 ----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 188 (290)
T cd05580 155 ----------------------------------------------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILI 188 (290)
T ss_pred ----------------------------------------------CCCCCCCccccChhhhcCCCCCccccHHHHHHHH
Confidence 1145799999999999988899999999999999
Q ss_pred HHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CHhHHhcCCccccCCccc
Q 010266 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHPWFKDIAWDK 422 (514)
Q Consensus 346 yemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~Hpff~~i~w~~ 422 (514)
|+|++|.+||...+......++.. ....+|. .+++.++++|.+||+ ||.+|++.. +++|++.||||+.++|..
T Consensus 189 ~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~--~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~ 264 (290)
T cd05580 189 YEMLAGYPPFFDDNPIQIYEKILE--GKVRFPS--FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIA 264 (290)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHhc--CCccCCc--cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHH
Confidence 999999999998887777777764 3445554 578999999999998 999998765 899999999999999999
Q ss_pred cc--cccCCCCCcCCCCCCCCCCCCC
Q 010266 423 LY--EMEAAYKPEVNGVLDTQNFMKF 446 (514)
Q Consensus 423 l~--~~~~p~~p~~~~~~d~~~f~~~ 446 (514)
+. .+.+|+.|....+.|++.|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (290)
T cd05580 265 LLQRKIEAPFIPKVKGPGDTSNFDDY 290 (290)
T ss_pred HhhccCCCCccCCCCCccccccccCC
Confidence 86 5789999999999999988753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-50 Score=401.10 Aligned_cols=266 Identities=34% Similarity=0.659 Sum_probs=225.5
Q ss_pred eeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecCCCCH
Q 010266 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDV 193 (514)
Q Consensus 114 LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~L 193 (514)
||+|+||+||+|.++.+++.||+|++.+...........+..|..+|+.++||+|++++++|.+...+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999876554455556778899999999999999999999999999999999999999
Q ss_pred HHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccccccc
Q 010266 194 MTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEV 269 (514)
Q Consensus 194 ~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~ 269 (514)
..++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++..+.....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-------- 152 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-------- 152 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--------
Confidence 888743 35689999999999999999999999999999999999999999999999999875432100
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHh
Q 010266 270 LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 349 (514)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 349 (514)
......||+.|+|||++.+..++.++|+|||||++|||+
T Consensus 153 -----------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~ 191 (280)
T cd05608 153 -----------------------------------------KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMI 191 (280)
T ss_pred -----------------------------------------cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHH
Confidence 011457999999999999999999999999999999999
Q ss_pred hCCCCCCCCChh----HHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCC--CCHhHHhcCCccccCCccc
Q 010266 350 VGYPPFYSDDPV----TTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT--LGSEQIKAHPWFKDIAWDK 422 (514)
Q Consensus 350 tG~~PF~~~~~~----~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~Hpff~~i~w~~ 422 (514)
+|..||...+.. .....+.. ....+|. .+|+++.+||.+||. ||.+|++. .+++++++||||++++|..
T Consensus 192 ~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~ 267 (280)
T cd05608 192 AARGPFRARGEKVENKELKQRILN--DSVTYPD--KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQ 267 (280)
T ss_pred hCCCCCCCCCcchhHHHHHHhhcc--cCCCCcc--cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhH
Confidence 999999865432 22233322 2334443 689999999999998 99999953 2789999999999999998
Q ss_pred ccc--ccCCCCC
Q 010266 423 LYE--MEAAYKP 432 (514)
Q Consensus 423 l~~--~~~p~~p 432 (514)
+.. ..+||.|
T Consensus 268 ~~~~~~~~~~~~ 279 (280)
T cd05608 268 LEAGMLPPPFVP 279 (280)
T ss_pred HhhccCCCCCCC
Confidence 853 6678876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-51 Score=402.18 Aligned_cols=252 Identities=32% Similarity=0.600 Sum_probs=232.5
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
.+|++.+.||+|.||+|-+|.....|+.||||.++|+.+......-|+++|++||+.++||+|+.+|.+|...+.+.+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 57999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
||..||+|.+++...+.++|..+|.++.||+.|+.|+|+++++|||||.+|||+|.++++||+||||+..+...
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~------ 206 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK------ 206 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc------
Confidence 99999999999999999999999999999999999999999999999999999999999999999998755321
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCC-CcccchhhhhHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAI 344 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWSlGvi 344 (514)
....++||+|-|.+||++.+.+| ++.+|.|||||+
T Consensus 207 --------------------------------------------kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvL 242 (668)
T KOG0611|consen 207 --------------------------------------------KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVL 242 (668)
T ss_pred --------------------------------------------cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHH
Confidence 12338999999999999999999 789999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 345 MYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 345 lyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
||-|+.|..||.|.+...+..+|..+ ...-|. -+.+|.-||+.||. +|+.|- |+++|-.|=|.
T Consensus 243 LYtLVyGtMPFDG~Dhk~lvrQIs~G--aYrEP~---~PSdA~gLIRwmLmVNP~RRA---TieDiAsHWWv 306 (668)
T KOG0611|consen 243 LYTLVYGTMPFDGRDHKRLVRQISRG--AYREPE---TPSDASGLIRWMLMVNPERRA---TIEDIASHWWV 306 (668)
T ss_pred HHHHhhcccccCCchHHHHHHHhhcc--cccCCC---CCchHHHHHHHHHhcCcccch---hHHHHhhhhee
Confidence 99999999999999999999888763 233332 35688999999998 999998 99999999775
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-50 Score=388.31 Aligned_cols=261 Identities=29% Similarity=0.471 Sum_probs=222.4
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE--cCCeE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ--DAEYL 181 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~--~~~~l 181 (514)
++++|+.+..|+.|+||.||.|+++.|+++||+|.++.+.-...--+ ...+|+.+|.+++|||||.+-.+.. +-+.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPI-tsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPI-TSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcc-hhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 45789999999999999999999999999999999976542111122 2467999999999999999988765 45679
Q ss_pred EEEEeecCCCCHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 182 YLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
|||||||+. ||.+++..-+ +|.+.+++.++.|++.||.|||.+.|+||||||+|+|++..|.+||+|||||+.+.++.
T Consensus 153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 999999974 9999998754 89999999999999999999999999999999999999999999999999999876431
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWW 339 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiW 339 (514)
. .....|-|.+|.|||++.+ ..|+.++|+|
T Consensus 232 k-------------------------------------------------~~T~lVVTLWYRaPELLLG~~tyst~iDMW 262 (419)
T KOG0663|consen 232 K-------------------------------------------------PYTPLVVTLWYRAPELLLGAKTYSTAVDMW 262 (419)
T ss_pred c-------------------------------------------------cCcceEEEeeecCHHHhcCCcccCcchhhh
Confidence 0 1125789999999999998 5699999999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhHHHHHHhh---------hcCcccCC--------cC-----------cCCChhHHHHHh
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVH---------WKNHLKFP--------EE-----------ARLTPEAKDLIC 391 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~~~~~~i~~---------~~~~~~~p--------~~-----------~~~s~~~~dLI~ 391 (514)
|+|||+.||+++.|.|.|.+..++..+|.. |.+...+| .. ..+|+.+.||+.
T Consensus 263 SvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln 342 (419)
T KOG0663|consen 263 SVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLN 342 (419)
T ss_pred hHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHH
Confidence 999999999999999999999999999875 32222222 10 126799999999
Q ss_pred hhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 392 RLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 392 ~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
.||+ ||.+|. ||+|.++|+||+..
T Consensus 343 ~llt~dP~kR~---tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 343 KLLTYDPGKRI---TAEDGLKHEYFRET 367 (419)
T ss_pred HHhccCccccc---cHHHhhcccccccC
Confidence 9999 999999 99999999999874
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-50 Score=377.04 Aligned_cols=259 Identities=29% Similarity=0.536 Sum_probs=224.1
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|..++.||+|.||.||+|++..||+.||||+++.... ...-.....+|+..|+.++||||+.|.++|.+.+++.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~-kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA-KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc-ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 467888999999999999999999999999999987743 2333345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 186 EYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
|||+ .||...+... ..++...++.|+.+++.||+|||++.|+||||||.|+||+++|.+||+|||||+.+.+.+..
T Consensus 81 Efm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~-- 157 (318)
T KOG0659|consen 81 EFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI-- 157 (318)
T ss_pred Eecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc--
Confidence 9997 5999998764 57999999999999999999999999999999999999999999999999999987643211
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchhhhhH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 343 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGv 343 (514)
.+ ..|-|.+|.|||.+.| ..|+..+|+||+||
T Consensus 158 ----------------------------------------------~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGC 190 (318)
T KOG0659|consen 158 ----------------------------------------------QT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGC 190 (318)
T ss_pred ----------------------------------------------cc-cceeeeeccChHHhccchhcCCcchhhhHHH
Confidence 11 2378999999999987 57999999999999
Q ss_pred HHHHHhhCCCCCCCCChhHHHHHHhh---------hcCcccCCcC---------------cCCChhHHHHHhhhcc-Ccc
Q 010266 344 IMYEMLVGYPPFYSDDPVTTCRKIVH---------WKNHLKFPEE---------------ARLTPEAKDLICRLLC-DVE 398 (514)
Q Consensus 344 ilyemltG~~PF~~~~~~~~~~~i~~---------~~~~~~~p~~---------------~~~s~~~~dLI~~lL~-dp~ 398 (514)
|+.||+-|.|-|.|++..++...|.. |++-..+|+. ...|+++.||+.+||. ||.
T Consensus 191 I~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~ 270 (318)
T KOG0659|consen 191 IFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPK 270 (318)
T ss_pred HHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCch
Confidence 99999999999999999999888874 3332222221 2357899999999999 999
Q ss_pred ccCCCCCHhHHhcCCccccC
Q 010266 399 HRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 399 ~Rl~~~~~~eil~Hpff~~i 418 (514)
+|+ ++.|+++||||+..
T Consensus 271 ~Ri---ta~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 271 KRI---TASQALKHPYFKSL 287 (318)
T ss_pred hcc---cHHHHhcchhhhcC
Confidence 999 99999999999863
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=396.62 Aligned_cols=275 Identities=33% Similarity=0.668 Sum_probs=230.4
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
.|++.+.||+|+||.||+|.++.+++.||+|.+.+...........+..|..+++.++|++|+.+++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999987655444445667789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 187 YLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 187 y~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
|++||+|..++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---- 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc----
Confidence 99999999988543 368999999999999999999999999999999999999999999999999986532110
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 344 (514)
.....+||+.|+|||++.+..++.++|+|||||+
T Consensus 157 ----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~ 190 (285)
T cd05630 157 ----------------------------------------------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCL 190 (285)
T ss_pred ----------------------------------------------cccCCCCCccccChHHHcCCCCCCccccHHHHHH
Confidence 0113479999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCChh---HHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CHhHHhcCCccccC
Q 010266 345 MYEMLVGYPPFYSDDPV---TTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHPWFKDI 418 (514)
Q Consensus 345 lyemltG~~PF~~~~~~---~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~Hpff~~i 418 (514)
+|+|++|.+||.+.... .....+... ....++ ..+++++++||.+||+ ||.+|++.. +++|+++||||+.+
T Consensus 191 l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 191 LYEMIAGQSPFQQRKKKIKREEVERLVKE-VQEEYS--EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred HHHHHhCCCCCCCCCccchHHHHHhhhhh-hhhhcC--ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 99999999999875432 122222211 112233 3578999999999999 999999321 38999999999999
Q ss_pred Cccccc--cccCCCCCcC
Q 010266 419 AWDKLY--EMEAAYKPEV 434 (514)
Q Consensus 419 ~w~~l~--~~~~p~~p~~ 434 (514)
+|..+. +..|||+|.+
T Consensus 268 ~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05630 268 NFKRLEAGMLEPPFKPDP 285 (285)
T ss_pred CHHHHhcCCCCCCCCCCC
Confidence 999886 4778999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-51 Score=409.70 Aligned_cols=258 Identities=31% Similarity=0.539 Sum_probs=222.9
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEEEcCC-eE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAE-YL 181 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~-~l 181 (514)
..++|.+++.||.|+||.||+|+.+.+|..||||.|++.- ....+.- -.+|+.-|++++ |||||+|..++.+.+ .+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf-~s~ee~~-nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKF-YSWEECM-NLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhh-ccHHHHH-HHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 3478999999999999999999999999999999998763 3333333 346888899998 999999999999888 99
Q ss_pred EEEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 182 YLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
|+|||||. .+|.+++.. .+.|++..++.|+.||++||+|+|++|+.||||||||||+.....|||+|||||+.+.+..
T Consensus 86 ~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 86 YFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP 164 (538)
T ss_pred eeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCC
Confidence 99999995 689999865 4679999999999999999999999999999999999999999999999999999876432
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-CCCcccchh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWW 339 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiW 339 (514)
.. ..+|.|.+|.|||++.+. -|+.++|+|
T Consensus 165 PY--------------------------------------------------TeYVSTRWYRAPEvLLrs~~Ys~pvD~w 194 (538)
T KOG0661|consen 165 PY--------------------------------------------------TEYVSTRWYRAPEVLLRSGYYSSPVDMW 194 (538)
T ss_pred Cc--------------------------------------------------chhhhcccccchHHhhhccccCCchHHH
Confidence 11 157899999999999875 579999999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhHHHHHHhh---------h--------cCcccCCcC---------cCCChhHHHHHhhh
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVH---------W--------KNHLKFPEE---------ARLTPEAKDLICRL 393 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~~~~~~i~~---------~--------~~~~~~p~~---------~~~s~~~~dLI~~l 393 (514)
|+|||++|+.+-+|.|.|.+..+++.+|.. | .-.+.+|.- ...|+++.+||.+|
T Consensus 195 A~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~l 274 (538)
T KOG0661|consen 195 AVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERL 274 (538)
T ss_pred HHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHH
Confidence 999999999999999999999999888864 1 112344431 23689999999999
Q ss_pred cc-CccccCCCCCHhHHhcCCcccc
Q 010266 394 LC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 394 L~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
|. ||.+|+ +|+|+++||||+.
T Consensus 275 l~WDP~kRp---TA~~al~~pffq~ 296 (538)
T KOG0661|consen 275 LAWDPDKRP---TASQALQHPFFQV 296 (538)
T ss_pred hcCCCccCc---cHHHHhcCccccc
Confidence 99 999999 9999999999975
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-49 Score=392.42 Aligned_cols=264 Identities=33% Similarity=0.582 Sum_probs=221.9
Q ss_pred eeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecCCCCH
Q 010266 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDV 193 (514)
Q Consensus 114 LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~L 193 (514)
||+|+||.||+|+.+.+|+.||+|++.+...........+..|+++|..++||||++++++|.+..++|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999876554444455567799999999999999999999999999999999999999
Q ss_pred HHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccccccccc
Q 010266 194 MTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD 271 (514)
Q Consensus 194 ~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~ 271 (514)
..++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~----------- 149 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----------- 149 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-----------
Confidence 9888654 358888899999999999999999999999999999999999999999999987543210
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhhC
Q 010266 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 351 (514)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemltG 351 (514)
......||+.|+|||++.+..++.++|+|||||++|||++|
T Consensus 150 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g 190 (277)
T cd05607 150 ---------------------------------------TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAG 190 (277)
T ss_pred ---------------------------------------eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhC
Confidence 00134699999999999998899999999999999999999
Q ss_pred CCCCCCCCh----hHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCH----hHHhcCCccccCCccc
Q 010266 352 YPPFYSDDP----VTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGS----EQIKAHPWFKDIAWDK 422 (514)
Q Consensus 352 ~~PF~~~~~----~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~----~eil~Hpff~~i~w~~ 422 (514)
.+||.+... .+....+.. ..+.++. ..+++++++||.+||. ||.+|+ ++ ++++.||||++++|..
T Consensus 191 ~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~-~~~~~~~~~li~~~L~~~P~~R~---~~~~~~~~~~~h~~f~~~~~~~ 264 (277)
T cd05607 191 RTPFKDHKEKVAKEELKRRTLE--DEVKFEH-QNFTEESKDICRLFLAKKPEDRL---GSREKNDDPRKHEFFKTINFPR 264 (277)
T ss_pred CCCCCCCcchhhHHHHHHHhhc--ccccccc-ccCCHHHHHHHHHHhccCHhhCC---CCccchhhhhcChhhcCCCHHH
Confidence 999976533 223333332 2222322 3689999999999999 999999 55 7888999999999999
Q ss_pred cc--cccCCCCCc
Q 010266 423 LY--EMEAAYKPE 433 (514)
Q Consensus 423 l~--~~~~p~~p~ 433 (514)
+. ..+|||+|.
T Consensus 265 ~~~~~~~~~~~~~ 277 (277)
T cd05607 265 LEAGLIPPPFVPD 277 (277)
T ss_pred HhcCcCCCCCCCC
Confidence 87 467888773
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=389.15 Aligned_cols=261 Identities=32% Similarity=0.509 Sum_probs=222.3
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc-----CCe
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-----AEY 180 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~-----~~~ 180 (514)
..|..++.||+|+||.|+.|.++.||+.||||++... +...-..++..+|..+|+.++|+||+.+++.+.. -+.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 4566689999999999999999999999999998632 3345566788999999999999999999999865 356
Q ss_pred EEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
+|+|+|+| +.||...+..+..+++.++++++.|++.||.|+|+.||+||||||.|+|++.+..+||||||||+......
T Consensus 101 vYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 99999999 67999999888889999999999999999999999999999999999999999999999999999764320
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWW 339 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiW 339 (514)
. .......+-|.+|.|||++.. ..|+.++|||
T Consensus 180 -----~------------------------------------------~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiW 212 (359)
T KOG0660|consen 180 -----E------------------------------------------DGFMTEYVATRWYRAPELLLNSSEYTKAIDIW 212 (359)
T ss_pred -----c------------------------------------------ccchhcceeeeeecCHHHHhccccccchhhhh
Confidence 0 001125789999999999875 7899999999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcC---------------------cccCCc------CcCCChhHHHHHhh
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKN---------------------HLKFPE------EARLTPEAKDLICR 392 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~~~~~~i~~~~~---------------------~~~~p~------~~~~s~~~~dLI~~ 392 (514)
|+|||+.|||+|++.|.|.+...++..|+.--+ ....|. .+..++.|.||+.+
T Consensus 213 SvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlek 292 (359)
T KOG0660|consen 213 SVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEK 292 (359)
T ss_pred hhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHH
Confidence 999999999999999999998888777763111 011111 13578999999999
Q ss_pred hcc-CccccCCCCCHhHHhcCCccccC
Q 010266 393 LLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 393 lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
||. ||.+|+ |++|+++||||...
T Consensus 293 mL~fdP~kRi---ta~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 293 MLVFDPKKRI---TAEEALAHPYLAPY 316 (359)
T ss_pred HhccCccccC---CHHHHhcChhhhhh
Confidence 999 999999 99999999999864
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=390.81 Aligned_cols=303 Identities=39% Similarity=0.720 Sum_probs=254.4
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++++.||+|+||.||++.++.+++.||+|.+.+...........+.+|++++..++||||++++++|.+.+++|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999998765544556677889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
||++||+|..++...+.+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++...........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998743211100000
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 345 (514)
.... ... ..........|++.|+|||.+.+..++.++|+|||||++
T Consensus 161 ~~~~----------~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl 206 (305)
T cd05609 161 EGHI----------EKD------------------------TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIIL 206 (305)
T ss_pred cccc----------ccc------------------------hhhccccCCccCccccCchhccCCCCCchhhHHHHHHHH
Confidence 0000 000 000011135689999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcC-cCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCcccc
Q 010266 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEE-ARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKL 423 (514)
Q Consensus 346 yemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~-~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~l 423 (514)
|||++|..||.+.+..+....+... ....|.. ..++++++++|.+||. +|.+|+...++.++++||||...+|..+
T Consensus 207 ~el~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~ 284 (305)
T cd05609 207 YEFLVGCVPFFGDTPEELFGQVISD--DIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGL 284 (305)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHhc--ccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHH
Confidence 9999999999998888777777653 2333332 2578999999999999 9999997767999999999999999998
Q ss_pred ccccCCCCCcCCCCCCCCCCC
Q 010266 424 YEMEAAYKPEVNGVLDTQNFM 444 (514)
Q Consensus 424 ~~~~~p~~p~~~~~~d~~~f~ 444 (514)
.....+++|.+....|++|||
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~ 305 (305)
T cd05609 285 LRQKAEFIPQLESEDDTSYFD 305 (305)
T ss_pred hhcCCCCCCCCCCccccccCC
Confidence 877789999999988988875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-49 Score=390.47 Aligned_cols=268 Identities=25% Similarity=0.467 Sum_probs=230.5
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE 179 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 179 (514)
...+..++|++..+||.|+-++||+|+...++.+||||++.-.... +..+.+++|...|+.++||||++.+.+|..+.
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~--~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN--NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS 97 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh--hhHHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence 4567789999999999999999999999999999999999876543 34788999999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
.+|+||.||.+|++.+++... ..++|..++.++.+++.||.|||++|.||||||+.||||+.+|.|||+|||.+..+.
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 999999999999999999763 569999999999999999999999999999999999999999999999999876553
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc--CCCCcc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK--KGYGME 335 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~ 335 (514)
..+.. .+-+. .+++|||.|||||++.. .+|+.+
T Consensus 178 ~~G~R--------------------------------------------~~~rf-~tfvgtp~wmAPEvl~q~~~GYdfK 212 (516)
T KOG0582|consen 178 DSGDR--------------------------------------------QVTRF-NTFVGTPCWMAPEVLMQQLHGYDFK 212 (516)
T ss_pred ccCce--------------------------------------------eeEee-ccccCcccccChHHhhhcccCccch
Confidence 22100 00011 47899999999999664 689999
Q ss_pred cchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCccc--------CCcCcCCChhHHHHHhhhcc-CccccCCCCCH
Q 010266 336 CDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLK--------FPEEARLTPEAKDLICRLLC-DVEHRLGTLGS 406 (514)
Q Consensus 336 ~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~--------~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~ 406 (514)
+||||||+...||.+|..||..-.+.++...-++ +.+. ......++..++.+|..||. ||.+|+ ++
T Consensus 213 aDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq--n~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRp---tA 287 (516)
T KOG0582|consen 213 ADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ--NDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRP---TA 287 (516)
T ss_pred hhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--CCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCC---CH
Confidence 9999999999999999999998877776655554 2222 11234567889999999998 999999 99
Q ss_pred hHHhcCCccccCC
Q 010266 407 EQIKAHPWFKDIA 419 (514)
Q Consensus 407 ~eil~Hpff~~i~ 419 (514)
+++++||||+..-
T Consensus 288 skLlkh~FFk~~k 300 (516)
T KOG0582|consen 288 SKLLKHAFFKKAK 300 (516)
T ss_pred HHHhccHHHhhcc
Confidence 9999999998753
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=400.50 Aligned_cols=258 Identities=33% Similarity=0.552 Sum_probs=233.7
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
.-|.+-+.||+|.|+.|-+|++--||..||||++.|..+ ..-...|+.+|...|+.++|||||+||.+..+...+|||+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl-D~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc-chhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 458888999999999999999999999999999999876 3445678999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCcccc-CCCcEEEccccccccCCCCCccc
Q 010266 186 EYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-QNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld-~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
|.=.||||+++|++. ..+.|+.++.|++||+.|+.|+|+..+||||||||||++- .-|-+||+|||++..+..+
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG---- 172 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG---- 172 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc----
Confidence 999999999999875 5799999999999999999999999999999999999875 6699999999998765432
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCC-cccchhhhh
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG-MECDWWSLG 342 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~-~~~DiWSlG 342 (514)
....+.||+..|-|||++.+..|+ ++|||||||
T Consensus 173 ----------------------------------------------~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLG 206 (864)
T KOG4717|consen 173 ----------------------------------------------KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLG 206 (864)
T ss_pred ----------------------------------------------chhhcccchhhccCchhhhcCccCCcchhhhHHH
Confidence 123378999999999999999996 689999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCcc
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWD 421 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~ 421 (514)
||||-|++|++||...+..+++..|+..+ ...|. .+|.+|+|||.+||. ||.+|- ++++|..|+|++.+|-.
T Consensus 207 VILyMLVCGq~PFqeANDSETLTmImDCK--YtvPs--hvS~eCrdLI~sMLvRdPkkRA---slEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 207 VILYMLVCGQPPFQEANDSETLTMIMDCK--YTVPS--HVSKECRDLIQSMLVRDPKKRA---SLEEIVSTSWLQAGDRG 279 (864)
T ss_pred HHHHHHHhCCCccccccchhhhhhhhccc--ccCch--hhhHHHHHHHHHHHhcCchhhc---cHHHHhccccccCCCCC
Confidence 99999999999999999999999999754 34554 799999999999998 999998 99999999999998854
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=388.85 Aligned_cols=258 Identities=33% Similarity=0.486 Sum_probs=216.9
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++++.||+|+||.||+|+++.+++.||+|++..... .......+.+|..++..++||||++++++|.+++.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999976533 2344567788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
||++++.+..+......+++..++.++.|++.||.|||+.||+||||||+||+++.+|.+||+|||+|........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---- 155 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN---- 155 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc----
Confidence 9999887776655567899999999999999999999999999999999999999999999999999886532100
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 345 (514)
......+||+.|+|||++.+..++.++|+|||||++
T Consensus 156 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil 191 (287)
T cd07848 156 --------------------------------------------ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCIL 191 (287)
T ss_pred --------------------------------------------ccccccccccccCCcHHHcCCCCCCchhHHhHHHHH
Confidence 001145799999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChhHHHHHHhhhcCc-----------------ccCCcC-----------cCCChhHHHHHhhhcc-C
Q 010266 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNH-----------------LKFPEE-----------ARLTPEAKDLICRLLC-D 396 (514)
Q Consensus 346 yemltG~~PF~~~~~~~~~~~i~~~~~~-----------------~~~p~~-----------~~~s~~~~dLI~~lL~-d 396 (514)
|||++|.+||.+.+..+....+...... ..+|.. ..+|+++.|||.+||. |
T Consensus 192 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~ 271 (287)
T cd07848 192 GELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLN 271 (287)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCC
Confidence 9999999999987765554444321110 111110 1368899999999999 9
Q ss_pred ccccCCCCCHhHHhcCCcc
Q 010266 397 VEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 397 p~~Rl~~~~~~eil~Hpff 415 (514)
|.+|+ +++++++||||
T Consensus 272 P~~R~---s~~~~l~hp~f 287 (287)
T cd07848 272 PTDRY---LTEQCLNHPAF 287 (287)
T ss_pred cccCC---CHHHHhcCCCC
Confidence 99999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=389.78 Aligned_cols=256 Identities=28% Similarity=0.466 Sum_probs=215.5
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.++|++++.||.|+||.||+|+++.+++.||+|+++... .......+.+|..+++.++||||+++++++.+...+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc--cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 578999999999999999999999999999999997543 222344577899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 185 MEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
|||++| +|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-- 158 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-- 158 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--
Confidence 999975 899988664 4578999999999999999999999999999999999999999999999999875431100
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchhhhh
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 342 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlG 342 (514)
.....+||+.|+|||++.+ ..++.++|+||||
T Consensus 159 -----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 191 (288)
T cd07871 159 -----------------------------------------------TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVG 191 (288)
T ss_pred -----------------------------------------------cccCceecccccChHHhcCCcccCcHHHHHHHH
Confidence 0114578999999999876 5689999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcC-----------------cccCCc---------CcCCChhHHHHHhhhcc-
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKN-----------------HLKFPE---------EARLTPEAKDLICRLLC- 395 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~-----------------~~~~p~---------~~~~s~~~~dLI~~lL~- 395 (514)
|++|+|++|.+||.+.+..+....+..... ...+|. ...++++++|||++||+
T Consensus 192 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~ 271 (288)
T cd07871 192 CILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLY 271 (288)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCc
Confidence 999999999999999887776665543110 011221 12478999999999999
Q ss_pred CccccCCCCCHhHHhcCCcc
Q 010266 396 DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 396 dp~~Rl~~~~~~eil~Hpff 415 (514)
||.+|+ |++|+++||||
T Consensus 272 dp~~R~---t~~~~l~hp~f 288 (288)
T cd07871 272 ETKSRI---SAEAALRHSYF 288 (288)
T ss_pred CcccCC---CHHHHhcCCCC
Confidence 999999 99999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=391.73 Aligned_cols=261 Identities=27% Similarity=0.422 Sum_probs=212.3
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.++|++++.||.|+||.||+|+++.+++.||+|++.+... ......+.+|..+++.++||||+++++++.+...+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999976532 22234567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 185 MEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 185 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
|||++ ++|.+++.. .+.+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+|+......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 157 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--- 157 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC---
Confidence 99995 678777765 3678999999999999999999999999999999999999999999999999987432110
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchhhhh
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 342 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlG 342 (514)
....+.+||+.|+|||++.+ ..++.++||||||
T Consensus 158 ----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 191 (303)
T cd07869 158 ----------------------------------------------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVG 191 (303)
T ss_pred ----------------------------------------------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHH
Confidence 00114578999999999876 4589999999999
Q ss_pred HHHHHHhhCCCCCCCCCh-hHHHHHHhhh---------cCccc------------CCc-------CcCCChhHHHHHhhh
Q 010266 343 AIMYEMLVGYPPFYSDDP-VTTCRKIVHW---------KNHLK------------FPE-------EARLTPEAKDLICRL 393 (514)
Q Consensus 343 vilyemltG~~PF~~~~~-~~~~~~i~~~---------~~~~~------------~p~-------~~~~s~~~~dLI~~l 393 (514)
|++|+|++|.+||.+... .+....+... ..... .|. ....+++++|||.+|
T Consensus 192 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m 271 (303)
T cd07869 192 CIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKL 271 (303)
T ss_pred HHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHH
Confidence 999999999999987543 2333333210 00000 000 012457899999999
Q ss_pred cc-CccccCCCCCHhHHhcCCccccCCc
Q 010266 394 LC-DVEHRLGTLGSEQIKAHPWFKDIAW 420 (514)
Q Consensus 394 L~-dp~~Rl~~~~~~eil~Hpff~~i~w 420 (514)
|+ ||.+|+ |++|+++||||+++++
T Consensus 272 L~~dp~~R~---s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 272 LQCFPKNRL---SAQAALSHEYFSDLPP 296 (303)
T ss_pred hccCchhcc---CHHHHhcCcccccCCh
Confidence 99 999999 9999999999998874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=386.99 Aligned_cols=275 Identities=32% Similarity=0.627 Sum_probs=232.5
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
.|+..+.||+|+||+||++.+..+++.||+|++.+...........+..|+++|..++|++|+.++++|.+++.+|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 37888999999999999999999999999999987655444445567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 187 YLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 187 y~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
|++||+|..++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---- 156 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---- 156 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC----
Confidence 99999999888653 469999999999999999999999999999999999999999999999999986532110
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 344 (514)
......||+.|+|||++.+..++.++|+|||||+
T Consensus 157 ----------------------------------------------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~ 190 (285)
T cd05632 157 ----------------------------------------------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCL 190 (285)
T ss_pred ----------------------------------------------cccCCCCCcCccChHHhcCCCCCcccchHHHHHH
Confidence 0114579999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHhhhc--CcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CHhHHhcCCccccCC
Q 010266 345 MYEMLVGYPPFYSDDPVTTCRKIVHWK--NHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHPWFKDIA 419 (514)
Q Consensus 345 lyemltG~~PF~~~~~~~~~~~i~~~~--~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~Hpff~~i~ 419 (514)
+|+|++|.+||.+.........+.... ....++ ..+++++.+||.+||. ||.+|++.. ++.+++.||||+.++
T Consensus 191 l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 191 IYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYS--AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccC--ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence 999999999998876654444433211 112233 3578999999999999 999999431 388999999999999
Q ss_pred ccccc--cccCCCCCc
Q 010266 420 WDKLY--EMEAAYKPE 433 (514)
Q Consensus 420 w~~l~--~~~~p~~p~ 433 (514)
|+.+. ++.|||+|.
T Consensus 269 ~~~~~~~~~~~~~~~~ 284 (285)
T cd05632 269 FKRLEAGMLDPPFVPD 284 (285)
T ss_pred HHHHhcCcCCCCCCCC
Confidence 99875 578999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-48 Score=389.60 Aligned_cols=305 Identities=36% Similarity=0.657 Sum_probs=249.1
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+..|..+|..++||+|+++++.+.+....|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998876555556778899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 186 EYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
||+.|++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.+|.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998754 579999999999999999999999999999999999999999999999999988654321110
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchH-HHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLE-QLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
........ ...+... ................+||..|+|||++.+..++.++||||||
T Consensus 161 ~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG 219 (316)
T cd05574 161 SKALRKGS---------------------RRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLG 219 (316)
T ss_pred cccccccc---------------------ccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHH
Confidence 00000000 0000000 0000000011123356899999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCC----HhHHhcCCcccc
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLG----SEQIKAHPWFKD 417 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~----~~eil~Hpff~~ 417 (514)
|++|+|++|..||.+.+....+.++.. ....+|....++++++++|.+||+ +|.+|+ + +++++.||||++
T Consensus 220 ~ll~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~---s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 220 ILLYEMLYGTTPFKGSNRDETFSNILK--KEVTFPGSPPVSSSARDLIRKLLVKDPSKRL---GSKRGAAEIKQHPFFRG 294 (316)
T ss_pred HHHHHHhhCCCCCCCCchHHHHHHHhc--CCccCCCccccCHHHHHHHHHHccCCHhHCC---CchhhHHHHHcCchhhc
Confidence 999999999999999888888877764 445566554589999999999998 999999 7 999999999999
Q ss_pred CCccccccccCCCCCcCCC
Q 010266 418 IAWDKLYEMEAAYKPEVNG 436 (514)
Q Consensus 418 i~w~~l~~~~~p~~p~~~~ 436 (514)
++|..+....||-.|.+..
T Consensus 295 ~~~~~~~~~~~~~~~~~~~ 313 (316)
T cd05574 295 VNWALIRHTTPPIIPRPDD 313 (316)
T ss_pred CChhhcccCCCCCCCCccc
Confidence 9999999888888887654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-48 Score=379.61 Aligned_cols=261 Identities=29% Similarity=0.524 Sum_probs=220.8
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCc-eeeEEEEEEcCC----
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDAE---- 179 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~-Iv~l~~~f~~~~---- 179 (514)
...|+.++.||.|+||+||.|+.+.+|+.||+|+++-..-. +.--....+|+.+|..++|+| ||.|++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 35677788899999999999999999999999999765321 223344678999999999999 999999999888
Q ss_pred --eEEEEEeecCCCCHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccc
Q 010266 180 --YLYLIMEYLPGGDVMTLLMREE----TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253 (514)
Q Consensus 180 --~l~lVmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla 253 (514)
.+|||+||+. -||..++.... .++...++.++.||+.||+|||++||+||||||.||||+.+|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 8999999995 59999997654 5788899999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-CC
Q 010266 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GY 332 (514)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y 332 (514)
+...-+. +...+-++|.+|.|||++.+. .|
T Consensus 168 ra~~ip~-------------------------------------------------~~yt~evvTlWYRaPEvLlGs~~Y 198 (323)
T KOG0594|consen 168 RAFSIPM-------------------------------------------------RTYTPEVVTLWYRAPEVLLGSTSY 198 (323)
T ss_pred HHhcCCc-------------------------------------------------ccccccEEEeeccCHHHhcCCCcC
Confidence 8543211 011256899999999999986 79
Q ss_pred CcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhh---------hcCcccCCc-------C----------cCCChhH
Q 010266 333 GMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVH---------WKNHLKFPE-------E----------ARLTPEA 386 (514)
Q Consensus 333 ~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~---------~~~~~~~p~-------~----------~~~s~~~ 386 (514)
+..+|+||+|||++||+++.+.|.|.+..++..+|.. |+....+|. + ..+++++
T Consensus 199 s~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~ 278 (323)
T KOG0594|consen 199 STSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDG 278 (323)
T ss_pred CCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccH
Confidence 9999999999999999999999999999888888864 433332222 1 1234699
Q ss_pred HHHHhhhcc-CccccCCCCCHhHHhcCCccccCC
Q 010266 387 KDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIA 419 (514)
Q Consensus 387 ~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~ 419 (514)
.||+.+||+ +|.+|. +++.++.||||..++
T Consensus 279 ~dll~~~L~y~p~~R~---Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 279 IELLSKLLQYDPAKRI---SAKGALTHPYFSELP 309 (323)
T ss_pred HHHHHHHhccCcccCc---CHHHHhcChhhcccc
Confidence 999999999 999999 999999999998863
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-49 Score=374.58 Aligned_cols=252 Identities=35% Similarity=0.580 Sum_probs=217.0
Q ss_pred CCCeeEE-eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEE----EcC
Q 010266 105 VDDFDLL-TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSF----QDA 178 (514)
Q Consensus 105 ~~~f~~~-~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f----~~~ 178 (514)
.+||.+- ++||-|-.|+|..|.++.||+.||+|++..+ ...++|.++.-.. .|||||.++++| +..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 4677765 5899999999999999999999999998644 2356777775444 699999999876 456
Q ss_pred CeEEEEEeecCCCCHHHHHhhccC--CCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC---CCcEEEcccccc
Q 010266 179 EYLYLIMEYLPGGDVMTLLMREET--LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ---NGHMKLSDFGLC 253 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~---~g~iKL~DFGla 253 (514)
..|.+|||.|+||+|++.++.++. |+|..|..++.||..|+.|||+.+|.||||||||+|... +..+||+|||+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 789999999999999999988765 999999999999999999999999999999999999974 457999999999
Q ss_pred ccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCC
Q 010266 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG 333 (514)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 333 (514)
+...... ...+.|-||.|.|||++...+|+
T Consensus 212 K~t~~~~--------------------------------------------------~L~TPc~TPyYvaPevlg~eKyd 241 (400)
T KOG0604|consen 212 KETQEPG--------------------------------------------------DLMTPCFTPYYVAPEVLGPEKYD 241 (400)
T ss_pred cccCCCc--------------------------------------------------cccCCcccccccCHHHhCchhcC
Confidence 9654211 12277999999999999999999
Q ss_pred cccchhhhhHHHHHHhhCCCCCCCCCh----hHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhH
Q 010266 334 MECDWWSLGAIMYEMLVGYPPFYSDDP----VTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQ 408 (514)
Q Consensus 334 ~~~DiWSlGvilyemltG~~PF~~~~~----~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~e 408 (514)
..||+||+|||||-||+|+|||++... ..+..+|......+.-|+|..+|++++|+|+.||. +|.+|+ ++++
T Consensus 242 kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRl---TI~~ 318 (400)
T KOG0604|consen 242 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERL---TIEE 318 (400)
T ss_pred CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhhe---eHHH
Confidence 999999999999999999999997643 45677888755555555677899999999999998 999999 9999
Q ss_pred HhcCCcccc
Q 010266 409 IKAHPWFKD 417 (514)
Q Consensus 409 il~Hpff~~ 417 (514)
+++|||..+
T Consensus 319 ~m~hpwi~~ 327 (400)
T KOG0604|consen 319 VMDHPWINQ 327 (400)
T ss_pred hhcCchhcc
Confidence 999999976
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=388.70 Aligned_cols=263 Identities=27% Similarity=0.416 Sum_probs=213.3
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC-----CeE
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA-----EYL 181 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~-----~~l 181 (514)
+|++.+.||+|+||.||+|+++.+|+.||||++.... ........+.+|..+|+.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 5899999999999999999999999999999987532 2233445678899999999999999999887543 358
Q ss_pred EEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
|+||||+ +++|..++.....+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 80 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 9999999 479999998888899999999999999999999999999999999999999999999999999875421100
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc--CCCCcccchh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK--KGYGMECDWW 339 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiW 339 (514)
. .......+||+.|+|||++.+ ..++.++|||
T Consensus 159 ~----------------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~Dvw 192 (338)
T cd07859 159 T----------------------------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIW 192 (338)
T ss_pred c----------------------------------------------cccccCCCCCCCcCCHHHHhccccccCchhHHH
Confidence 0 000124679999999999876 6789999999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhHHHHHHhhhc--------------------------CcccCC-cCcCCChhHHHHHhh
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWK--------------------------NHLKFP-EEARLTPEAKDLICR 392 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~~~~~~i~~~~--------------------------~~~~~p-~~~~~s~~~~dLI~~ 392 (514)
||||++|||++|.+||.+.+.......+.... ....++ ....+++++.+||.+
T Consensus 193 SlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 272 (338)
T cd07859 193 SIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLER 272 (338)
T ss_pred HHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHH
Confidence 99999999999999998876544332221100 000000 012467889999999
Q ss_pred hcc-CccccCCCCCHhHHhcCCccccCCc
Q 010266 393 LLC-DVEHRLGTLGSEQIKAHPWFKDIAW 420 (514)
Q Consensus 393 lL~-dp~~Rl~~~~~~eil~Hpff~~i~w 420 (514)
||+ ||.+|+ +++|+++||||+++..
T Consensus 273 ~l~~~P~~Rp---t~~e~l~hp~f~~~~~ 298 (338)
T cd07859 273 LLAFDPKDRP---TAEEALADPYFKGLAK 298 (338)
T ss_pred HcCcCcccCC---CHHHHhcCchhhhcCc
Confidence 999 999999 9999999999987654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=403.03 Aligned_cols=258 Identities=29% Similarity=0.458 Sum_probs=211.5
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC----
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA---- 178 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~---- 178 (514)
....+|++++.||+|+||.||+|.+..+++.||||++.+.. ....+|..+|+.++|||||+++++|.+.
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK 135 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence 34578999999999999999999999999999999886532 1234699999999999999998877432
Q ss_pred ----CeEEEEEeecCCCCHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC-cEEEcc
Q 010266 179 ----EYLYLIMEYLPGGDVMTLLM----REETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG-HMKLSD 249 (514)
Q Consensus 179 ----~~l~lVmEy~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g-~iKL~D 249 (514)
..+|+||||+++ +|..++. ....+++..++.|+.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeec
Confidence 358899999975 6666654 346799999999999999999999999999999999999999765 699999
Q ss_pred ccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc
Q 010266 250 FGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK 329 (514)
Q Consensus 250 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~ 329 (514)
||+|+.+.... ...+.+||+.|+|||++.+
T Consensus 215 FGla~~~~~~~--------------------------------------------------~~~~~~~t~~y~aPE~~~~ 244 (440)
T PTZ00036 215 FGSAKNLLAGQ--------------------------------------------------RSVSYICSRFYRAPELMLG 244 (440)
T ss_pred cccchhccCCC--------------------------------------------------CcccCCCCcCccCHHHhcC
Confidence 99998653210 1124679999999999876
Q ss_pred -CCCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcC---------------cccCCc----------CcCCC
Q 010266 330 -KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKN---------------HLKFPE----------EARLT 383 (514)
Q Consensus 330 -~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s 383 (514)
..|+.++|||||||++|||++|.+||.+.+..+...+++.... .+.+|. +...+
T Consensus 245 ~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~ 324 (440)
T PTZ00036 245 ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTP 324 (440)
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCC
Confidence 4699999999999999999999999999887777766654211 111221 11467
Q ss_pred hhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCcc
Q 010266 384 PEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWD 421 (514)
Q Consensus 384 ~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~ 421 (514)
+++++||.+||+ ||.+|+ ++.|+++||||..+.+.
T Consensus 325 ~~~~~li~~~L~~dP~~R~---ta~e~l~hp~f~~~~~~ 360 (440)
T PTZ00036 325 DDAINFISQFLKYEPLKRL---NPIEALADPFFDDLRDP 360 (440)
T ss_pred HHHHHHHHHHCCCChhHCc---CHHHHhCChhHHhhhcc
Confidence 899999999999 999999 99999999999887543
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-47 Score=386.12 Aligned_cols=261 Identities=26% Similarity=0.416 Sum_probs=221.1
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
+..++|++++.||+|+||.||+|+++.++..||+|++.... .......+.+|.++|..++||||+++++++.+++.+|
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 44689999999999999999999999999999999987542 3344567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC-CeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
+||||++||+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.+|++||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 9999999999999998888899999999999999999999986 6999999999999999999999999998754211
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
.....+||+.|+|||++.+..++.++|+|||
T Consensus 158 -------------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 188 (331)
T cd06649 158 -------------------------------------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSM 188 (331)
T ss_pred -------------------------------------------------ccccCCCCcCcCCHhHhcCCCCCchHhHHHH
Confidence 0124579999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhh------------------------------------------h---cCcccC
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVH------------------------------------------W---KNHLKF 376 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~------------------------------------------~---~~~~~~ 376 (514)
||++|||++|..||...+..+....+.. + ......
T Consensus 189 G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (331)
T cd06649 189 GLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKL 268 (331)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCC
Confidence 9999999999999987655443221110 0 000111
Q ss_pred CcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCc
Q 010266 377 PEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAW 420 (514)
Q Consensus 377 p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w 420 (514)
|. ..+++++++||.+||. ||++|+ ++++|++||||+....
T Consensus 269 ~~-~~~~~~l~~li~~~L~~~P~~Rp---t~~ell~h~~~~~~~~ 309 (331)
T cd06649 269 PN-GVFTPDFQEFVNKCLIKNPAERA---DLKMLMNHTFIKRSEV 309 (331)
T ss_pred CC-ccccHHHHHHHHHHccCCcccCC---CHHHHhcChHHhhccc
Confidence 11 2468899999999999 999999 9999999999987543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=374.31 Aligned_cols=281 Identities=30% Similarity=0.535 Sum_probs=229.3
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCeEEEEEeecCC
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLIMEYLPG 190 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lVmEy~~g 190 (514)
+.||.|+||.|--|....||..||||++.|.. .....++.+|.+++... .|+||++|+.+|+|+.+.|||||-|.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 47999999999999999999999999998863 34556789999999988 599999999999999999999999999
Q ss_pred CCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCc---EEEccccccccCCCCCccccccc
Q 010266 191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH---MKLSDFGLCKPLDCTNLSAINEN 267 (514)
Q Consensus 191 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~---iKL~DFGla~~~~~~~~~~~~~~ 267 (514)
|.|..+|++...|+|.+|..++.+|+.||+|||.+||.||||||||||...-.+ +|||||.|...+...+.-.
T Consensus 161 GplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s---- 236 (463)
T KOG0607|consen 161 GPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS---- 236 (463)
T ss_pred chHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC----
Confidence 999999999999999999999999999999999999999999999999976654 7999999987654322110
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc-----cCCCCcccchhhhh
Q 010266 268 EVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLG 342 (514)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~DiWSlG 342 (514)
|. . .....+.||+.+|||||++. ..-|+..||.||||
T Consensus 237 ------------------pa------s--------------tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLG 278 (463)
T KOG0607|consen 237 ------------------PA------S--------------TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLG 278 (463)
T ss_pred ------------------CC------C--------------CccccCcccchhhcchhHHhhhccccccccccccHHHHH
Confidence 00 0 00123789999999999975 24589999999999
Q ss_pred HHHHHHhhCCCCCCCCC---------------hhHHHHHHhhhcCcccCCc--CcCCChhHHHHHhhhcc-CccccCCCC
Q 010266 343 AIMYEMLVGYPPFYSDD---------------PVTTCRKIVHWKNHLKFPE--EARLTPEAKDLICRLLC-DVEHRLGTL 404 (514)
Q Consensus 343 vilyemltG~~PF~~~~---------------~~~~~~~i~~~~~~~~~p~--~~~~s~~~~dLI~~lL~-dp~~Rl~~~ 404 (514)
||||-||.|++||.|.- ....+..|.. +...||+ |..+|.+++|||+.||. |+.+|+
T Consensus 279 vIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQE--GkYeFPdkdWahIS~eakdlisnLlvrda~~rl--- 353 (463)
T KOG0607|consen 279 VILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQE--GKYEFPDKDWAHISSEAKDLISNLLVRDAKQRL--- 353 (463)
T ss_pred HHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhc--cCCcCChhhhHHhhHHHHHHHHHHHhccHHhhh---
Confidence 99999999999997531 3455677776 5567775 66799999999999998 999999
Q ss_pred CHhHHhcCCccccCCccccccccCCCCCcCCCCCCCCCC
Q 010266 405 GSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNF 443 (514)
Q Consensus 405 ~~~eil~Hpff~~i~w~~l~~~~~p~~p~~~~~~d~~~f 443 (514)
++.+++.|||++.+.-++-.. .|+.+-...+-.|.+.|
T Consensus 354 sa~~vlnhPw~~~~~~ekalp-tp~v~~r~~s~~~lslf 391 (463)
T KOG0607|consen 354 SAAQVLNHPWVQRCAPEKALP-TPQVLQRNSSTMDLSLF 391 (463)
T ss_pred hhhhccCCccccccchhccCC-CCcccccCccchhhHHH
Confidence 899999999999876543221 22333333333455555
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-48 Score=377.39 Aligned_cols=252 Identities=31% Similarity=0.549 Sum_probs=214.0
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC-----Ce
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA-----EY 180 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~-----~~ 180 (514)
-.|.-.+++|.|+||.||.+....+++.||||.+..+.-. -.+|..||..++|||||+|.++|... -+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 3588899999999999999999999999999988665322 23689999999999999999998632 26
Q ss_pred EEEEEeecCCCCHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCC-CcEEEcccccccc
Q 010266 181 LYLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKP 255 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~-g~iKL~DFGla~~ 255 (514)
+.|||||||. +|...+.. +..++.-.++.|+.||+.||.|||+.||+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 7799999985 88888864 5789999999999999999999999999999999999999976 9999999999998
Q ss_pred CCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCc
Q 010266 256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGM 334 (514)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~ 334 (514)
+.... ...+..-|..|.|||.+.+ ..|+.
T Consensus 176 L~~~e--------------------------------------------------pniSYicSRyYRaPELifga~~Yt~ 205 (364)
T KOG0658|consen 176 LVKGE--------------------------------------------------PNISYICSRYYRAPELIFGATEYTT 205 (364)
T ss_pred eccCC--------------------------------------------------CceeEEEeccccCHHHHcCccccCc
Confidence 75331 1126778999999999987 67999
Q ss_pred ccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhc---------------CcccCCc----------CcCCChhHHHH
Q 010266 335 ECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWK---------------NHLKFPE----------EARLTPEAKDL 389 (514)
Q Consensus 335 ~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~---------------~~~~~p~----------~~~~s~~~~dL 389 (514)
++|+||.||++.||+-|++-|.|++...+...|+..- ....+|. ...+++++.||
T Consensus 206 ~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dl 285 (364)
T KOG0658|consen 206 SIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDL 285 (364)
T ss_pred eeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHH
Confidence 9999999999999999999999999888887776411 1122232 12468999999
Q ss_pred Hhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 390 ICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 390 I~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
+.++|. +|.+|+ ++.|++.||||...
T Consensus 286 l~~~L~Y~P~~R~---~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 286 LSKLLQYSPSKRL---SALEALAHPFFDEL 312 (364)
T ss_pred HHHHhccChhhcC---CHHHHhcchhhHHh
Confidence 999999 999999 99999999999764
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-47 Score=391.65 Aligned_cols=261 Identities=27% Similarity=0.424 Sum_probs=218.2
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC-----eE
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE-----YL 181 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~-----~l 181 (514)
+|++++.||+|+||.||+|.+..+|+.||||++.+.. ........+.+|..+|..++||||+++++++.+.. .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 5889999999999999999999999999999986532 22334567889999999999999999999998877 89
Q ss_pred EEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
|+||||+. ++|...+.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 99999996 68999988888999999999999999999999999999999999999999999999999999875432100
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-CCCcccchhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWWS 340 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWS 340 (514)
......+||+.|+|||++.+. .|+.++||||
T Consensus 159 ------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws 190 (372)
T cd07853 159 ------------------------------------------------KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWS 190 (372)
T ss_pred ------------------------------------------------ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHh
Confidence 001134789999999999874 4799999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhHHHHHHhhhcC---------------------cccCC-------cCcCCChhHHHHHhh
Q 010266 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKN---------------------HLKFP-------EEARLTPEAKDLICR 392 (514)
Q Consensus 341 lGvilyemltG~~PF~~~~~~~~~~~i~~~~~---------------------~~~~p-------~~~~~s~~~~dLI~~ 392 (514)
|||++|||++|.+||.+.++......|..... ....| .....++++.+||.+
T Consensus 191 lG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 270 (372)
T cd07853 191 VGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCR 270 (372)
T ss_pred HHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHH
Confidence 99999999999999998887766665543111 00111 112458899999999
Q ss_pred hcc-CccccCCCCCHhHHhcCCccccCCc
Q 010266 393 LLC-DVEHRLGTLGSEQIKAHPWFKDIAW 420 (514)
Q Consensus 393 lL~-dp~~Rl~~~~~~eil~Hpff~~i~w 420 (514)
||+ ||.+|+ +++|++.||||++..+
T Consensus 271 mL~~dP~~R~---t~~e~l~hp~~~~~~~ 296 (372)
T cd07853 271 MLVFDPDKRI---SAADALAHPYLDEGRL 296 (372)
T ss_pred hCCCChhhCc---CHHHHhcCHhhCCCcc
Confidence 999 999999 9999999999998654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-48 Score=392.42 Aligned_cols=257 Identities=30% Similarity=0.507 Sum_probs=233.1
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe-EEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY-LYL 183 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~-l~l 183 (514)
.++|..+++||+|+||.+++++++..++.||+|.+.-.....+. ......|..+++++.|||||..+++|..++. +|+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 47899999999999999999999999999999999877665443 3467889999999999999999999998887 999
Q ss_pred EEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 184 IMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
||+||+||+|...|.+. ..|+|+.+..|+.|++.||.|||+++|+|||||+.||+++.++.|||+|||+|+.+...
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~-- 159 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE-- 159 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc--
Confidence 99999999999999764 47999999999999999999999999999999999999999999999999999987532
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
...+.+.+|||.||.||++.+.+|+.++|+|||
T Consensus 160 -----------------------------------------------~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsL 192 (426)
T KOG0589|consen 160 -----------------------------------------------DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSL 192 (426)
T ss_pred -----------------------------------------------hhhhheecCCCcccCHHHhCCCCCCccCcchhh
Confidence 113458899999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
||++|||++-+++|.+.+......+|.... ..|-+...|.+++.||+.||. +|+.|| ++.+++.+|....
T Consensus 193 GC~~yEm~~lk~aF~a~~m~~Li~ki~~~~---~~Plp~~ys~el~~lv~~~l~~~P~~RP---sa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 193 GCCLYEMCTLKPAFKASNMSELILKINRGL---YSPLPSMYSSELRSLVKSMLRKNPEHRP---SALELLRRPHLLR 263 (426)
T ss_pred cchHHHHHhcccccCccchHHHHHHHhhcc---CCCCCccccHHHHHHHHHHhhcCCccCC---CHHHHhhChhhhh
Confidence 999999999999999999999999998633 445455789999999999998 999999 9999999998874
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=393.59 Aligned_cols=257 Identities=25% Similarity=0.377 Sum_probs=211.4
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
..+...+|++++.||+|+||.||+|.+..+++.||+|+... ..+.+|+.+|+.++|||||+++++|.....
T Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 157 (391)
T PHA03212 87 AGIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKF 157 (391)
T ss_pred cccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCe
Confidence 34566789999999999999999999999999999996532 236789999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
.|+|||++. ++|..++.....+++..++.++.|++.||.|||++|||||||||+|||++.+|.+||+|||+|+......
T Consensus 158 ~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 158 TCLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred eEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 999999995 7999999888889999999999999999999999999999999999999999999999999986432110
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 340 (514)
.......+||+.|+|||++.+..|+.++||||
T Consensus 237 ------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 268 (391)
T PHA03212 237 ------------------------------------------------ANKYYGWAGTIATNAPELLARDPYGPAVDIWS 268 (391)
T ss_pred ------------------------------------------------ccccccccCccCCCChhhhcCCCCCcHHHHHH
Confidence 00112568999999999999999999999999
Q ss_pred hhHHHHHHhhCCCCCCCCC-------hhHHHHHHhhhcC------------------------ccc----CCc---CcCC
Q 010266 341 LGAIMYEMLVGYPPFYSDD-------PVTTCRKIVHWKN------------------------HLK----FPE---EARL 382 (514)
Q Consensus 341 lGvilyemltG~~PF~~~~-------~~~~~~~i~~~~~------------------------~~~----~p~---~~~~ 382 (514)
|||++|||++|..||...+ .......++.... ... .|. ...+
T Consensus 269 lGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (391)
T PHA03212 269 AGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYEL 348 (391)
T ss_pred HHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhh
Confidence 9999999999998886432 1112222211000 000 010 0134
Q ss_pred ChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 383 TPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 383 s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
+.++.+||.+||+ ||.+|+ +++|+++||||+.+
T Consensus 349 ~~~l~~Li~~mL~~dP~~Rp---ta~elL~hp~f~~~ 382 (391)
T PHA03212 349 PIDLEYLICKMLAFDAHHRP---SAEALLDFAAFQDI 382 (391)
T ss_pred hhhHHHHHHHHhcCChhhCC---CHHHHhcChhhccC
Confidence 6789999999999 999999 99999999999874
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-49 Score=390.90 Aligned_cols=257 Identities=31% Similarity=0.509 Sum_probs=227.0
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
...|..+..||+|+||.||++.+..|++.||+|++.-.. ...+++.+.+|+.+|+.++++||.+.|++|..+..++++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 356888899999999999999999999999999998664 466788999999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
||||.||++.++|.....++|..+..++.+++.||.|||..+.+|||||+.|||+..+|.+||+|||++..+....
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~---- 165 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV---- 165 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh----
Confidence 9999999999999888888999999999999999999999999999999999999999999999999987654221
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 344 (514)
....+++|||.||||||+.+.+|+.++||||||++
T Consensus 166 ---------------------------------------------~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGIT 200 (467)
T KOG0201|consen 166 ---------------------------------------------KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGIT 200 (467)
T ss_pred ---------------------------------------------hccccccccccccchhhhccccccchhhhhhhhHH
Confidence 11258999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 345 MYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 345 lyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
.+||++|.||+....+......|-. ..+..+. ...|+.+++||..||. ||+.|+ +|.++++|+|.+..
T Consensus 201 aiEla~GePP~s~~hPmrvlflIpk-~~PP~L~--~~~S~~~kEFV~~CL~k~P~~Rp---sA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 201 AIELAKGEPPHSKLHPMRVLFLIPK-SAPPRLD--GDFSPPFKEFVEACLDKNPEFRP---SAKELLKHKFIKRA 269 (467)
T ss_pred HHHHhcCCCCCcccCcceEEEeccC-CCCCccc--cccCHHHHHHHHHHhhcCcccCc---CHHHHhhhHHHHhc
Confidence 9999999999998877444333322 1111222 2689999999999998 999999 99999999999874
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=412.73 Aligned_cols=152 Identities=46% Similarity=0.785 Sum_probs=144.1
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
+++|.+++.||+|+||+||+|++..+++.||||++++...........+..|+.++..++||+|+++++++.+..++|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999999887766666778899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccC
Q 010266 185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~ 256 (514)
|||++||+|..++...+.+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+++..
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~ 154 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccc
Confidence 999999999999988888999999999999999999999999999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=372.83 Aligned_cols=255 Identities=27% Similarity=0.455 Sum_probs=209.7
Q ss_pred CCeeEEeeeeecCceEEEEEEEcc-CCCEEEEEEeecccccChhhHHHHHHHHHHHHHc---CCCceeeEEEEEE-----
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKK-SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV---ASHCIVKLYYSFQ----- 176 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~-t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~----- 176 (514)
.+|++++.||+|+||+||+|++.. +++.||+|+++.... .........+|..++..+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC-CCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999854 568899999876432 222334456677777765 6999999999885
Q ss_pred cCCeEEEEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccc
Q 010266 177 DAEYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254 (514)
Q Consensus 177 ~~~~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~ 254 (514)
....+|+||||++ ++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3467999999996 6899988653 458999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCc
Q 010266 255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM 334 (514)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~ 334 (514)
..... .......||+.|+|||++.+..++.
T Consensus 159 ~~~~~--------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~ 188 (290)
T cd07862 159 IYSFQ--------------------------------------------------MALTSVVVTLWYRAPEVLLQSSYAT 188 (290)
T ss_pred eccCC--------------------------------------------------cccccccccccccChHHHhCCCCCC
Confidence 54311 0112457999999999999999999
Q ss_pred ccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcC---------cccCCc--------------CcCCChhHHHHHh
Q 010266 335 ECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKN---------HLKFPE--------------EARLTPEAKDLIC 391 (514)
Q Consensus 335 ~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~---------~~~~p~--------------~~~~s~~~~dLI~ 391 (514)
++|+|||||++|||++|.+||.+.+..+....|+.... ...++. ...+++.+++||.
T Consensus 189 ~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 268 (290)
T cd07862 189 PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL 268 (290)
T ss_pred ccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHH
Confidence 99999999999999999999999888888777764321 111110 0246788999999
Q ss_pred hhcc-CccccCCCCCHhHHhcCCcc
Q 010266 392 RLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 392 ~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
+||+ ||++|+ ++.|+++||||
T Consensus 269 ~~l~~~P~~R~---s~~~~l~hp~f 290 (290)
T cd07862 269 KCLTFNPAKRI---SAYSALSHPYF 290 (290)
T ss_pred HHhccCchhcC---CHHHHhcCCCC
Confidence 9999 999999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=382.74 Aligned_cols=253 Identities=28% Similarity=0.453 Sum_probs=218.1
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCCCE-EEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC-
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNI-YAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE- 179 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~-~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~- 179 (514)
.+...++.+.+.||.|+||+||.+.++ |+. ||+|++......... .+.+.+|..+|.+++|||||++++++.+..
T Consensus 37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 37 EIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPG 113 (362)
T ss_pred ecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 344556667777999999999988776 445 999999876654444 778999999999999999999999999887
Q ss_pred eEEEEEeecCCCCHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC-eEEcCCCCCCccccCCC-cEEEcccccccc
Q 010266 180 YLYLIMEYLPGGDVMTLLMR--EETLTETVARFYIAQSVLAIESIHKHN-YIHRDIKPDNLLLDQNG-HMKLSDFGLCKP 255 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g-iiHrDLKpeNILld~~g-~iKL~DFGla~~ 255 (514)
.+++|||||++|+|..+|.. ...++...+..++.+|+.||+|||+++ ||||||||+|||++.++ ++||+|||+++.
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 79999999999999999988 689999999999999999999999999 99999999999999998 999999999986
Q ss_pred CCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc--cCCCC
Q 010266 256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL--KKGYG 333 (514)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~--~~~y~ 333 (514)
...... ...+..||+.|||||++. ...|+
T Consensus 194 ~~~~~~-------------------------------------------------~~~~~~GT~~wMAPEv~~~~~~~~~ 224 (362)
T KOG0192|consen 194 KVISKT-------------------------------------------------SMTSVAGTYRWMAPEVLRGEKSPYT 224 (362)
T ss_pred eccccc-------------------------------------------------cccCCCCCccccChhhhcCCCCcCC
Confidence 542210 011367999999999999 56999
Q ss_pred cccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 334 MECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 334 ~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
.++||||||++||||+||..||.+....+....+......+.+|. ..++.+..||.+|+. ||..|+ ++.+|..
T Consensus 225 ~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~--~~~~~l~~l~~~CW~~dp~~RP---~f~ei~~ 298 (362)
T KOG0192|consen 225 EKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPK--ECPPHLSSLMERCWLVDPSRRP---SFLEIVS 298 (362)
T ss_pred ccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCc--cCCHHHHHHHHHhCCCCCCcCC---CHHHHHH
Confidence 999999999999999999999999988777777776555666665 488999999999998 999999 7777653
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=371.40 Aligned_cols=268 Identities=36% Similarity=0.684 Sum_probs=224.2
Q ss_pred eeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecCCCCH
Q 010266 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDV 193 (514)
Q Consensus 114 LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~L 193 (514)
||+|+||+||+|.++.+|+.||+|++.+...........+..|..+|+.++||+|++++++|.+.+..|+||||++|++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999876554444555667899999999999999999999999999999999999999
Q ss_pred HHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccccccccc
Q 010266 194 MTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD 271 (514)
Q Consensus 194 ~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~ 271 (514)
.+++.+.. .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~----------- 149 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK----------- 149 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC-----------
Confidence 99997765 79999999999999999999999999999999999999999999999999987542110
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhhC
Q 010266 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 351 (514)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemltG 351 (514)
......|+..|+|||++.+..++.++|+|||||++|+|++|
T Consensus 150 ---------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g 190 (277)
T cd05577 150 ---------------------------------------KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAG 190 (277)
T ss_pred ---------------------------------------ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhC
Confidence 01134688999999999988899999999999999999999
Q ss_pred CCCCCCCChhHHHHHHhhh--cCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CHhHHhcCCccccCCccccc--
Q 010266 352 YPPFYSDDPVTTCRKIVHW--KNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHPWFKDIAWDKLY-- 424 (514)
Q Consensus 352 ~~PF~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~Hpff~~i~w~~l~-- 424 (514)
..||.+.+.......+... .....+| ..+++++.++|.+||. +|.+|++.. ++.+++.||||+.++|..+.
T Consensus 191 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~~ 268 (277)
T cd05577 191 RSPFRQRKEKVEKEELKRRTLEMAVEYP--DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAG 268 (277)
T ss_pred CCCCCCCcccccHHHHHhccccccccCC--ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhhhcC
Confidence 9999876542222222221 1122333 3579999999999998 999999532 67889999999999999886
Q ss_pred cccCCCCCc
Q 010266 425 EMEAAYKPE 433 (514)
Q Consensus 425 ~~~~p~~p~ 433 (514)
...|||.|.
T Consensus 269 ~~~~~~~~~ 277 (277)
T cd05577 269 MLEPPFIPD 277 (277)
T ss_pred CCCCCCCCC
Confidence 467888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=370.64 Aligned_cols=254 Identities=27% Similarity=0.446 Sum_probs=208.7
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc---CCCceeeEEEEEEc-----C
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV---ASHCIVKLYYSFQD-----A 178 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~~-----~ 178 (514)
+|++++.||+|+||+||+|+++.+++.||+|.++.... .......+..|..++..+ +||||++++++|.+ .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN-EDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcC-CCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 58999999999999999999999999999999876432 222223455677777655 79999999998864 3
Q ss_pred CeEEEEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~ 256 (514)
..+++||||++ ++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++...
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 56899999997 4898888653 35899999999999999999999999999999999999999999999999998754
Q ss_pred CCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCccc
Q 010266 257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336 (514)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 336 (514)
.... .....+||+.|+|||++.+..++.++
T Consensus 159 ~~~~--------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~ 188 (288)
T cd07863 159 SCQM--------------------------------------------------ALTPVVVTLWYRAPEVLLQSTYATPV 188 (288)
T ss_pred cCcc--------------------------------------------------cCCCccccccccCchHhhCCCCCCcc
Confidence 3210 01145789999999999999999999
Q ss_pred chhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhc---------CcccCCc--------------CcCCChhHHHHHhhh
Q 010266 337 DWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWK---------NHLKFPE--------------EARLTPEAKDLICRL 393 (514)
Q Consensus 337 DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~---------~~~~~p~--------------~~~~s~~~~dLI~~l 393 (514)
|||||||++|+|++|.+||.+.+......++.... .....+. ...++..+++||.+|
T Consensus 189 DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 268 (288)
T cd07863 189 DMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEM 268 (288)
T ss_pred hhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHH
Confidence 99999999999999999999887777766665421 1111110 024678899999999
Q ss_pred cc-CccccCCCCCHhHHhcCCcc
Q 010266 394 LC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 394 L~-dp~~Rl~~~~~~eil~Hpff 415 (514)
|+ ||.+|+ ++.|++.||||
T Consensus 269 L~~dP~~R~---t~~~~l~hp~f 288 (288)
T cd07863 269 LTFNPHKRI---SAFRALQHPFF 288 (288)
T ss_pred hccCcccCC---CHHHHhcCCCC
Confidence 99 999999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=366.05 Aligned_cols=255 Identities=48% Similarity=0.881 Sum_probs=221.0
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHH-HcCCCceeeEEEEEEcCCeEEEEEeecCC
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA-EVASHCIVKLYYSFQDAEYLYLIMEYLPG 190 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~-~l~hp~Iv~l~~~f~~~~~l~lVmEy~~g 190 (514)
+.||.|+||.||+|.+..+++.||+|++.+...........+..|..++. ..+||||++++++|.+.+.+|+||||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999999999999999998765544444455566666554 45899999999999999999999999999
Q ss_pred CCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccccccc
Q 010266 191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270 (514)
Q Consensus 191 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~ 270 (514)
|+|.+++...+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.+||+|||+++....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------------ 149 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------------ 149 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------------
Confidence 99999998888899999999999999999999999999999999999999999999999999864321
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhh
Q 010266 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350 (514)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt 350 (514)
.....|++.|+|||++.+..++.++||||||+++|+|++
T Consensus 150 -----------------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~ 188 (260)
T cd05611 150 -----------------------------------------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLF 188 (260)
T ss_pred -----------------------------------------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHH
Confidence 013568999999999998889999999999999999999
Q ss_pred CCCCCCCCChhHHHHHHhhhcCcccCCc--CcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCcc
Q 010266 351 GYPPFYSDDPVTTCRKIVHWKNHLKFPE--EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWD 421 (514)
Q Consensus 351 G~~PF~~~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~ 421 (514)
|.+||...+....+..+... ...++. ...+++++.++|.+||. +|.+|++..+++|+++||||++++|+
T Consensus 189 g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 189 GYPPFHAETPDAVFDNILSR--RINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260 (260)
T ss_pred CCCCCCCCCHHHHHHHHHhc--ccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence 99999988887777776542 222332 22578999999999998 99999987788999999999999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=398.45 Aligned_cols=255 Identities=25% Similarity=0.440 Sum_probs=207.2
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCC------CceeeEEEEEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS------HCIVKLYYSFQ 176 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h------p~Iv~l~~~f~ 176 (514)
+..++|++++.||+|+||+||+|.+..+++.||||++++.. ........|+.++..+.| +++++++.+|.
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34578999999999999999999999999999999996532 223345667777777654 45899999988
Q ss_pred cC-CeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCCccccCCC-----------
Q 010266 177 DA-EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNG----------- 243 (514)
Q Consensus 177 ~~-~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKpeNILld~~g----------- 243 (514)
+. .++|+|||++ |++|.+++.+.+.+++..++.++.||+.||+|||+ .|||||||||+|||++.+|
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 65 5799999998 78999999888899999999999999999999997 6999999999999998776
Q ss_pred -----cEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccC
Q 010266 244 -----HMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGT 318 (514)
Q Consensus 244 -----~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT 318 (514)
.+||+|||++..... .....+||
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~----------------------------------------------------~~~~~~gt 308 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERH----------------------------------------------------SRTAIVST 308 (467)
T ss_pred CCCCceEEECCCCccccCcc----------------------------------------------------ccccccCC
Confidence 499999998753211 01256899
Q ss_pred CCcCCccccccCCCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCccc-----------------------
Q 010266 319 PDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLK----------------------- 375 (514)
Q Consensus 319 ~~Y~APEvl~~~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~----------------------- 375 (514)
+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+....+......+.
T Consensus 309 ~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 388 (467)
T PTZ00284 309 RHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLR 388 (467)
T ss_pred ccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhccccc
Confidence 999999999999999999999999999999999999998877665554432111000
Q ss_pred ---CCc------------CcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 376 ---FPE------------EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 376 ---~p~------------~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
.|. ...-++.+.|||.+||+ ||.+|+ +++|+++||||..
T Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~---ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 389 PCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL---NARQMTTHPYVLK 443 (467)
T ss_pred ccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC---CHHHHhcCccccc
Confidence 000 00114567899999999 999999 9999999999975
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-46 Score=369.40 Aligned_cols=266 Identities=35% Similarity=0.668 Sum_probs=214.7
Q ss_pred eeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHH---cCCCceeeEEEEEEcCCeEEEEEeecC
Q 010266 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE---VASHCIVKLYYSFQDAEYLYLIMEYLP 189 (514)
Q Consensus 113 ~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~---l~hp~Iv~l~~~f~~~~~l~lVmEy~~ 189 (514)
.||+|+||.||+|.+..+++.||+|.+.+..............|..++.. .+||+|+.++++|.+.+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999999999999999987654433333334445544443 479999999999999999999999999
Q ss_pred CCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccccccc
Q 010266 190 GGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEV 269 (514)
Q Consensus 190 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~ 269 (514)
||+|..++...+.+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--------- 151 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--------- 151 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---------
Confidence 99999999888899999999999999999999999999999999999999999999999999986432110
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc-cCCCCcccchhhhhHHHHHH
Q 010266 270 LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEM 348 (514)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-~~~y~~~~DiWSlGvilyem 348 (514)
.....||+.|+|||++. +..++.++|+||+||++|+|
T Consensus 152 ------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l 189 (279)
T cd05633 152 ------------------------------------------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKL 189 (279)
T ss_pred ------------------------------------------ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHH
Confidence 01346999999999987 46689999999999999999
Q ss_pred hhCCCCCCCCChhH--HHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CHhHHhcCCccccCCcccc
Q 010266 349 LVGYPPFYSDDPVT--TCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHPWFKDIAWDKL 423 (514)
Q Consensus 349 ltG~~PF~~~~~~~--~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~Hpff~~i~w~~l 423 (514)
++|..||....... ...... ......+|. .++++++++|.+||. ||.+|+++. +++++++||||++++|...
T Consensus 190 ~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~ 266 (279)
T cd05633 190 LRGHSPFRQHKTKDKHEIDRMT-LTVNVELPD--SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQV 266 (279)
T ss_pred HhCCCCcCCCCCcCHHHHHHHh-hcCCcCCcc--ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHH
Confidence 99999997643221 111111 112233443 588999999999999 999999543 7999999999999999887
Q ss_pred c--cccCCCCC
Q 010266 424 Y--EMEAAYKP 432 (514)
Q Consensus 424 ~--~~~~p~~p 432 (514)
. ...+|.+|
T Consensus 267 ~~~~~~~~~~~ 277 (279)
T cd05633 267 YLQKYPPPLIP 277 (279)
T ss_pred hcCCCCCCCCC
Confidence 5 34455444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=381.56 Aligned_cols=256 Identities=28% Similarity=0.457 Sum_probs=209.9
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC-----
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE----- 179 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~----- 179 (514)
.++|++++.||+|+||.||+|.++.+|+.||+|++.+.. ........+.+|..++..++||||++++++|....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 578999999999999999999999999999999997653 23344566788999999999999999999987543
Q ss_pred -eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 180 -YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 180 -~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
.+|+||||+.+ +|...+. ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 57999999975 5666653 3588999999999999999999999999999999999999999999999999874321
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
.. .....+||+.|+|||++.+..++.++|+
T Consensus 176 ~~--------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di 205 (359)
T cd07876 176 NF--------------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDI 205 (359)
T ss_pred Cc--------------------------------------------------cCCCCcccCCCCCchhccCCCCCcchhh
Confidence 10 0124579999999999999999999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhc--------------------Cccc--------------CCc----Cc
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWK--------------------NHLK--------------FPE----EA 380 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--------------------~~~~--------------~p~----~~ 380 (514)
|||||++|+|++|.+||.+.+....+..+.... .... +|. ..
T Consensus 206 wSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (359)
T cd07876 206 WSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDK 285 (359)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhcccccccccccccc
Confidence 999999999999999999877654443332110 0000 110 11
Q ss_pred CCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 381 RLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 381 ~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
..++++++||.+||+ ||.+|+ |++|++.||||..
T Consensus 286 ~~~~~~~~li~~mL~~dP~~R~---t~~e~l~hp~~~~ 320 (359)
T cd07876 286 LKTSQARDLLSKMLVIDPDKRI---SVDEALRHPYITV 320 (359)
T ss_pred ccchhHHHHHHHHhccCcccCC---CHHHHhcCchhhh
Confidence 246789999999999 999999 9999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=383.29 Aligned_cols=255 Identities=26% Similarity=0.388 Sum_probs=208.5
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
...++|+.++.||+|+||.||+|+++.+++.||||++.+.. .......+.+|..+|+.++||||++++++|.+.+.+|
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence 34578889999999999999999999999999999986542 2344567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
+||||++||+|... ...++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+....
T Consensus 149 lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-- 222 (353)
T PLN00034 149 VLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-- 222 (353)
T ss_pred EEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--
Confidence 99999999998653 345677888899999999999999999999999999999999999999999987643210
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-----CCCCcccc
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-----KGYGMECD 337 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-----~~y~~~~D 337 (514)
......+||+.|+|||++.. ..++.++|
T Consensus 223 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~D 255 (353)
T PLN00034 223 -----------------------------------------------DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGD 255 (353)
T ss_pred -----------------------------------------------ccccccccCccccCccccccccccCcCCCcchh
Confidence 00124579999999999853 23457899
Q ss_pred hhhhhHHHHHHhhCCCCCCCCChhHH---HHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCC
Q 010266 338 WWSLGAIMYEMLVGYPPFYSDDPVTT---CRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHP 413 (514)
Q Consensus 338 iWSlGvilyemltG~~PF~~~~~~~~---~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hp 413 (514)
||||||++|||++|..||......+. ...+.. ......+ ..+++++++||.+||. ||.+|+ ++.||++||
T Consensus 256 vwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~l~~li~~~l~~~P~~Rp---t~~ell~hp 329 (353)
T PLN00034 256 IWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM-SQPPEAP--ATASREFRHFISCCLQREPAKRW---SAMQLLQHP 329 (353)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc-cCCCCCC--CccCHHHHHHHHHHccCChhhCc---CHHHHhcCc
Confidence 99999999999999999974332222 122211 1122222 3678999999999998 999999 999999999
Q ss_pred ccccC
Q 010266 414 WFKDI 418 (514)
Q Consensus 414 ff~~i 418 (514)
||.+-
T Consensus 330 ~~~~~ 334 (353)
T PLN00034 330 FILRA 334 (353)
T ss_pred ccccC
Confidence 99863
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=378.45 Aligned_cols=258 Identities=27% Similarity=0.419 Sum_probs=217.7
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
+..++|++++.||.|+||.||+|.++.++..+|+|++.... .......+.+|..+|..++|||||+++++|.+.+.+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 34589999999999999999999999999999999987542 3344567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC-CeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
+||||++||+|.+++...+.+++..+..++.+++.||.|||+. +|+||||||+|||++.+|.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 9999999999999998888899999999999999999999975 7999999999999999999999999998654211
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
.....+||+.|+|||++.+..++.++|+|||
T Consensus 158 -------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 188 (333)
T cd06650 158 -------------------------------------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSM 188 (333)
T ss_pred -------------------------------------------------ccccCCCCccccCHHHhcCCCCCcHHHHHHH
Confidence 0114579999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHH--------------------------------------------hhhcCcccCC
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKI--------------------------------------------VHWKNHLKFP 377 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i--------------------------------------------~~~~~~~~~p 377 (514)
||++|+|++|..||...+.......+ .. .....++
T Consensus 189 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 267 (333)
T cd06650 189 GLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVN-EPPPKLP 267 (333)
T ss_pred HHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhc-CCCccCC
Confidence 99999999999999865443322111 00 0001111
Q ss_pred cCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 378 EEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 378 ~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
. ..+++++++||.+||. ||.+|+ +++|++.||||+..
T Consensus 268 ~-~~~~~~~~~li~~~L~~~P~~Rp---t~~ell~h~~~~~~ 305 (333)
T cd06650 268 S-GVFGAEFQDFVNKCLIKNPAERA---DLKQLMVHAFIKRS 305 (333)
T ss_pred C-CCcCHHHHHHHHHhccCCcccCc---CHHHHhhCHHHhcC
Confidence 1 1367899999999999 999999 99999999999863
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-46 Score=382.92 Aligned_cols=256 Identities=27% Similarity=0.443 Sum_probs=212.4
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC------
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA------ 178 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~------ 178 (514)
.++|++++.||+|+||.||+|.+..+++.||||++.+.. ........+.+|..+++.++||||++++++|...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 579999999999999999999999999999999997643 2334456678899999999999999999988644
Q ss_pred CeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
..+|+||||+++ +|...+.. .+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 357999999965 67777643 578899999999999999999999999999999999999999999999999875431
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
.. .....+||+.|+|||++.+..++.++|+
T Consensus 179 ~~--------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di 208 (364)
T cd07875 179 SF--------------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDI 208 (364)
T ss_pred CC--------------------------------------------------cccCCcccCCcCCHHHHhCCCCCchhhH
Confidence 10 0124579999999999999999999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCc----------------------------------ccCCc----Cc
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNH----------------------------------LKFPE----EA 380 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~----------------------------------~~~p~----~~ 380 (514)
|||||++|+|++|..||.+.+..+.+.+++..... ..+|. ..
T Consensus 209 wSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (364)
T cd07875 209 WSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNK 288 (364)
T ss_pred HhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccc
Confidence 99999999999999999998877776666531110 00110 01
Q ss_pred CCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 381 RLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 381 ~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
..+.+++|||.+||+ ||.+|+ |++|++.||||..
T Consensus 289 ~~~~~~~dll~~mL~~dP~~R~---t~~e~L~hp~~~~ 323 (364)
T cd07875 289 LKASQARDLLSKMLVIDASKRI---SVDEALQHPYINV 323 (364)
T ss_pred cccHHHHHHHHHhcCcCcccCC---CHHHHhcCccccc
Confidence 135689999999999 999999 9999999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=361.57 Aligned_cols=259 Identities=32% Similarity=0.549 Sum_probs=224.8
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeeccccc--ChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML--SRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 183 (514)
++|++.+.||.|+||.||.|.+..+++.||||.+...... ...+...+.+|..++..++||||+++++++.+...+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999999999999999998765432 22345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
||||++|++|.+++...+.+++..++.++.|++.||.|||+.||+||||||+||+++.+|.++|+|||+++........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~- 160 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS- 160 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc-
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998754321000
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhH
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 343 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 343 (514)
........|++.|+|||++.+..++.++|+|||||
T Consensus 161 ---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 195 (263)
T cd06625 161 ---------------------------------------------GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGC 195 (263)
T ss_pred ---------------------------------------------cccccCCCcCccccCcceeccCCCCchhhhHHHHH
Confidence 00001456899999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 344 ilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
++|||++|.+||...+......++........+|. .++.++.+||.+||. +|.+|+ ++.++++||||
T Consensus 196 il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp---t~~~ll~~~~~ 263 (263)
T cd06625 196 TVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPS--HVSPDARNFLRRTFVENAKKRP---SAEELLRHFFV 263 (263)
T ss_pred HHHHHHhCCCCccccchHHHHHHHhccCCCCCCCc--cCCHHHHHHHHHHhhcCcccCC---CHHHHhhCCCC
Confidence 99999999999988777666666665444445554 688999999999999 999999 99999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=366.45 Aligned_cols=259 Identities=35% Similarity=0.670 Sum_probs=214.1
Q ss_pred eeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHH---HHHcCCCceeeEEEEEEcCCeEEEEEeecC
Q 010266 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL---LAEVASHCIVKLYYSFQDAEYLYLIMEYLP 189 (514)
Q Consensus 113 ~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~i---L~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~ 189 (514)
+||+|+||.||+|++..+++.||+|++.+..............|..+ +....||+|+.+++.|.+.+.+|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999987654333322333444444 344579999999999999999999999999
Q ss_pred CCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccccccc
Q 010266 190 GGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEV 269 (514)
Q Consensus 190 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~ 269 (514)
||+|..++...+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---------- 150 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---------- 150 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----------
Confidence 9999999988888999999999999999999999999999999999999999999999999998754211
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchhhhhHHHHHH
Q 010266 270 LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEM 348 (514)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyem 348 (514)
.....+||+.|+|||++.+ ..++.++|+||+||++|+|
T Consensus 151 -----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l 189 (278)
T cd05606 151 -----------------------------------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 189 (278)
T ss_pred -----------------------------------------CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHH
Confidence 0114579999999999975 4689999999999999999
Q ss_pred hhCCCCCCCCC---hhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CHhHHhcCCccccCCccc
Q 010266 349 LVGYPPFYSDD---PVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHPWFKDIAWDK 422 (514)
Q Consensus 349 ltG~~PF~~~~---~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~Hpff~~i~w~~ 422 (514)
++|..||.+.. .......+.. ....+|. .+|+++.++|.+||. +|.+|+... +++++++||||++++|+.
T Consensus 190 ~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~--~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~ 265 (278)
T cd05606 190 LRGHSPFRQHKTKDKHEIDRMTLT--MAVELPD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQM 265 (278)
T ss_pred HhCCCCCCCCCccchHHHHHHhhc--cCCCCCC--cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchH
Confidence 99999998763 2222222221 2334443 578999999999998 999999765 899999999999999999
Q ss_pred cccc
Q 010266 423 LYEM 426 (514)
Q Consensus 423 l~~~ 426 (514)
+...
T Consensus 266 ~~~~ 269 (278)
T cd05606 266 VFLQ 269 (278)
T ss_pred hhhc
Confidence 8643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=373.69 Aligned_cols=259 Identities=26% Similarity=0.462 Sum_probs=214.9
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.++|.+++.||+|+||.||+|+++.+++.||+|+++.... ......+.+|..+++.++||||+++++++.+++..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 5789999999999999999999999999999999975532 22334567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 185 MEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
|||+++ +|..++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 159 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-- 159 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--
Confidence 999975 888887654 4588999999999999999999999999999999999999999999999999875321100
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchhhhh
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 342 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlG 342 (514)
.....+||+.|+|||++.+ ..++.++|+||||
T Consensus 160 -----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 192 (309)
T cd07872 160 -----------------------------------------------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVG 192 (309)
T ss_pred -----------------------------------------------ccccccccccccCCHHHhCCCCCCcHHHHHHHH
Confidence 0113468999999999875 4689999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcC-----------------cccCCc---------CcCCChhHHHHHhhhcc-
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKN-----------------HLKFPE---------EARLTPEAKDLICRLLC- 395 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~-----------------~~~~p~---------~~~~s~~~~dLI~~lL~- 395 (514)
|++|+|++|.+||.+.+..+....+..... ...+|. ...+++++++||.+||+
T Consensus 193 ~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 272 (309)
T cd07872 193 CIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQY 272 (309)
T ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccC
Confidence 999999999999998877665555432100 011111 12478999999999999
Q ss_pred CccccCCCCCHhHHhcCCccccC
Q 010266 396 DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 396 dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
||.+|+ +++|++.||||+.+
T Consensus 273 dp~~R~---t~~e~l~h~~~~~~ 292 (309)
T cd07872 273 ESKKRI---SAEEAMKHAYFRSL 292 (309)
T ss_pred ChhhCC---CHHHHhcChhhhhc
Confidence 999999 99999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=395.39 Aligned_cols=257 Identities=29% Similarity=0.430 Sum_probs=221.9
Q ss_pred CCeeEEeeeeecCceEEEEEEEccC-CCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKS-GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t-~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
..|.+.+.||+|+||.||+|....+ +..||+|.+... .......++.|+.+|+.++|||||+++++|.+.+++|||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 4599999999999999999998877 788999976543 344556788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 185 MEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 185 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
|||++||+|.++|.. ...+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.+....
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999999988753 3568999999999999999999999999999999999999999999999999998653210
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 340 (514)
. .....+.+||+.|+|||++.+..++.++||||
T Consensus 224 ~-----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s 256 (478)
T PTZ00267 224 S-----------------------------------------------LDVASSFCGTPYYLAPELWERKRYSKKADMWS 256 (478)
T ss_pred c-----------------------------------------------cccccccCCCccccCHhHhCCCCCCcHHhHHH
Confidence 0 00122578999999999999999999999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 341 lGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
|||++|||++|.+||.+.+..+....+.... ...+| ..+++++++||.+||. ||..|+ ++++++.|||++.+
T Consensus 257 lG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~-~~~~~--~~~s~~~~~li~~~L~~dP~~Rp---s~~~~l~~~~~~~~ 329 (478)
T PTZ00267 257 LGVILYELLTLHRPFKGPSQREIMQQVLYGK-YDPFP--CPVSSGMKALLDPLLSKNPALRP---TTQQLLHTEFLKYV 329 (478)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCC--ccCCHHHHHHHHHHhccChhhCc---CHHHHHhCHHHHHH
Confidence 9999999999999999988888887776532 12233 3689999999999999 999999 99999999999754
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=395.83 Aligned_cols=262 Identities=29% Similarity=0.460 Sum_probs=224.5
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC---
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE--- 179 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~--- 179 (514)
...++|.+.+.||+|+||+||+|++..+|+.||||++..... .......+.+|..+|..++|++|++++..|...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 445799999999999999999999999999999999977643 4455667888999999999999999998775432
Q ss_pred -----eEEEEEeecCCCCHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccc
Q 010266 180 -----YLYLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDF 250 (514)
Q Consensus 180 -----~l~lVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DF 250 (514)
.+++||||++||+|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+|||++.+|++||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 47899999999999999864 247899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC
Q 010266 251 GLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK 330 (514)
Q Consensus 251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~ 330 (514)
|+++........ ....+.+||+.|+|||++.+.
T Consensus 188 Gls~~~~~~~~~-----------------------------------------------~~~~~~~Gt~~Y~aPE~~~~~ 220 (496)
T PTZ00283 188 GFSKMYAATVSD-----------------------------------------------DVGRTFCGTPYYVAPEIWRRK 220 (496)
T ss_pred ccCeeccccccc-----------------------------------------------cccccccCCcceeCHHHhCCC
Confidence 999865321000 011256899999999999999
Q ss_pred CCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHH
Q 010266 331 GYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQI 409 (514)
Q Consensus 331 ~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ei 409 (514)
.|+.++|||||||++|||++|..||.+.+..+....+..... ..+| ..+++++.+||.+||+ ||.+|+ ++.++
T Consensus 221 ~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~-~~~~--~~~~~~l~~li~~~L~~dP~~RP---s~~el 294 (496)
T PTZ00283 221 PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY-DPLP--PSISPEMQEIVTALLSSDPKRRP---SSSKL 294 (496)
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC-CCCC--CCCCHHHHHHHHHHcccChhhCc---CHHHH
Confidence 999999999999999999999999999888888877765322 2233 3689999999999999 999999 99999
Q ss_pred hcCCccccC
Q 010266 410 KAHPWFKDI 418 (514)
Q Consensus 410 l~Hpff~~i 418 (514)
+.|||++..
T Consensus 295 l~~p~~~~~ 303 (496)
T PTZ00283 295 LNMPICKLF 303 (496)
T ss_pred HhCHHHHHh
Confidence 999999764
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=361.91 Aligned_cols=257 Identities=44% Similarity=0.819 Sum_probs=226.5
Q ss_pred eeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecCCCCH
Q 010266 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDV 193 (514)
Q Consensus 114 LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~L 193 (514)
||.|+||.||+|++..+++.||+|++.+.........+.+..|+.+++.++||||+++++.+.++..+|+||||++||+|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999887665556677899999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccccccccccc
Q 010266 194 MTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDE 273 (514)
Q Consensus 194 ~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~ 273 (514)
.+++.+...+++..+..++.|++.||.|||+.|++|+||||+||+++.+|.++|+|||++.......
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~------------- 147 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ------------- 147 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-------------
Confidence 9999888889999999999999999999999999999999999999999999999999987653210
Q ss_pred cccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhhCCC
Q 010266 274 NLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 353 (514)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemltG~~ 353 (514)
.....+|++.|+|||++.+..++.++|+|||||++|+|++|.+
T Consensus 148 -------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~ 190 (262)
T cd05572 148 -------------------------------------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRP 190 (262)
T ss_pred -------------------------------------ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCC
Confidence 0124578999999999998889999999999999999999999
Q ss_pred CCCCCC--hhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCC--CCHhHHhcCCccccCCccc
Q 010266 354 PFYSDD--PVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT--LGSEQIKAHPWFKDIAWDK 422 (514)
Q Consensus 354 PF~~~~--~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~Hpff~~i~w~~ 422 (514)
||...+ +......+........+|. ..+++++++|.+||+ +|.+|++. .+++|+++||||++.+|+.
T Consensus 191 p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~ 262 (262)
T cd05572 191 PFGEDDEDPMEIYNDILKGNGKLEFPN--YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWEG 262 (262)
T ss_pred CcCCCCCCHHHHHHHHhccCCCCCCCc--ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCCC
Confidence 998776 6666777765445566665 458999999999998 99999931 1399999999999999973
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=360.38 Aligned_cols=255 Identities=37% Similarity=0.616 Sum_probs=214.0
Q ss_pred eeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEee
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY 187 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy 187 (514)
|++++.||+|+||+||+|+++.+++.||+|++........ .......|..++..++||+|+++++++.+...+|+||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccccccccccccccccccccccccccc
Confidence 7899999999999999999999999999999987754222 223345599999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccccc
Q 010266 188 LPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINEN 267 (514)
Q Consensus 188 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~ 267 (514)
+++++|.+++.....+++..+..++.|++.||.+||+.||+||||||+||+++.+|.++|+|||++.......
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~------- 152 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN------- 152 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------
Confidence 9999999999988899999999999999999999999999999999999999999999999999987531100
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc-cCCCCcccchhhhhHHHH
Q 010266 268 EVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMY 346 (514)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-~~~y~~~~DiWSlGvily 346 (514)
......+||+.|+|||++. +..++.++|+||||+++|
T Consensus 153 ------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~ 190 (260)
T PF00069_consen 153 ------------------------------------------ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILY 190 (260)
T ss_dssp ------------------------------------------SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHH
T ss_pred ------------------------------------------cccccccccccccccccccccccccccccccccccccc
Confidence 0122567999999999998 788999999999999999
Q ss_pred HHhhCCCCCCCCC---hhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 347 EMLVGYPPFYSDD---PVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 347 emltG~~PF~~~~---~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
+|++|..||...+ ......+................++++.+||.+||. ||.+|+ +++++++||||
T Consensus 191 ~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~---~~~~l~~~~~~ 260 (260)
T PF00069_consen 191 ELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRP---SAEELLKHPWF 260 (260)
T ss_dssp HHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGST---THHHHHTSGGG
T ss_pred cccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCc---CHHHHhcCCCC
Confidence 9999999999873 333333333211111122111234899999999999 999999 99999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=385.23 Aligned_cols=263 Identities=24% Similarity=0.379 Sum_probs=216.2
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEc--cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEK--KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~--~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 181 (514)
...+|.+++.||.|+||.||+|... .++..||+|.+.+.. ...+|+.+|+.++|||||+++++|.....+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 3467999999999999999999764 356789999886542 245799999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
|+|||++. ++|..++.....+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||++........
T Consensus 162 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred EEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 99999995 68999997778899999999999999999999999999999999999999999999999999876432110
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
. ......+||+.|+|||++.+..|+.++|||||
T Consensus 241 ~-----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 273 (392)
T PHA03207 241 T-----------------------------------------------PQCYGWSGTLETNSPELLALDPYCAKTDIWSA 273 (392)
T ss_pred c-----------------------------------------------ccccccccccCccCHhHhcCCCCCchhhHHHH
Confidence 0 01225689999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChh---HHHHHHhhhc--CcccC-------------------------Cc---CcCCChhHHH
Q 010266 342 GAIMYEMLVGYPPFYSDDPV---TTCRKIVHWK--NHLKF-------------------------PE---EARLTPEAKD 388 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~---~~~~~i~~~~--~~~~~-------------------------p~---~~~~s~~~~d 388 (514)
||++|||++|..||.+.... ..+..++... ....+ |. ...++.++.+
T Consensus 274 Gvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (392)
T PHA03207 274 GLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEY 353 (392)
T ss_pred HHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHH
Confidence 99999999999999875432 2222222100 01111 11 1235678999
Q ss_pred HHhhhcc-CccccCCCCCHhHHhcCCccccCCcccccc
Q 010266 389 LICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLYE 425 (514)
Q Consensus 389 LI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~l~~ 425 (514)
||.+||+ ||.+|+ ++.|++.||||...+|+.+..
T Consensus 354 li~~ml~~dp~~Rp---sa~e~l~~p~f~~~~~~~~~~ 388 (392)
T PHA03207 354 LIAKMLTFDQEFRP---SAQDILSLPLFTKEPINLLNI 388 (392)
T ss_pred HHHHHhccChhhCC---CHHHHhhCchhhccchhhhcC
Confidence 9999999 999999 999999999999999988764
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=375.33 Aligned_cols=256 Identities=23% Similarity=0.337 Sum_probs=207.8
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEc-----cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSF 175 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f 175 (514)
.+..++|++.+.||+|+||.||+|.+. .++..||||+++... .......+..|..+|..+ +|||||+++++|
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 456689999999999999999999752 456789999987542 334456788999999999 899999999988
Q ss_pred EcC-CeEEEEEeecCCCCHHHHHhhc------------------------------------------------------
Q 010266 176 QDA-EYLYLIMEYLPGGDVMTLLMRE------------------------------------------------------ 200 (514)
Q Consensus 176 ~~~-~~l~lVmEy~~gg~L~~~l~~~------------------------------------------------------ 200 (514)
.+. ..+|+||||++||+|.+++...
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 764 4689999999999999998642
Q ss_pred --------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccccccccc
Q 010266 201 --------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDD 272 (514)
Q Consensus 201 --------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~ 272 (514)
..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++........
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~---------- 230 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---------- 230 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcch----------
Confidence 23777888899999999999999999999999999999999999999999998754321000
Q ss_pred ccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhh-C
Q 010266 273 ENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-G 351 (514)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt-G 351 (514)
....+..||+.|+|||++.+..|+.++|||||||++|||++ |
T Consensus 231 -------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g 273 (338)
T cd05102 231 -------------------------------------VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLG 273 (338)
T ss_pred -------------------------------------hcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCC
Confidence 00113457789999999999999999999999999999997 9
Q ss_pred CCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 352 YPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 352 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
.+||.+....+.+...+........| ..+++++.+||.+||. ||.+|+ ++.+|++
T Consensus 274 ~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~RP---s~~el~~ 329 (338)
T cd05102 274 ASPYPGVQINEEFCQRLKDGTRMRAP--ENATPEIYRIMLACWQGDPKERP---TFSALVE 329 (338)
T ss_pred CCCCCCCCccHHHHHHHhcCCCCCCC--CCCCHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 99998866544444444322333333 3678999999999998 999999 8888875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=364.65 Aligned_cols=265 Identities=29% Similarity=0.470 Sum_probs=225.3
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.+.|++++.||+|+||.||+|++..+++.||+|++... .......+..|..+++.++||||++++++|..+..+|+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 46699999999999999999999999999999998754 345567788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 185 MEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 185 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
|||++|++|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++.......
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--- 164 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--- 164 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc---
Confidence 999999999888754 4678999999999999999999999999999999999999999999999999986432110
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc-----cCCCCcccch
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----KKGYGMECDW 338 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~Di 338 (514)
.......|++.|+|||++. ...++.++|+
T Consensus 165 ----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv 198 (292)
T cd06644 165 ----------------------------------------------QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADI 198 (292)
T ss_pred ----------------------------------------------cccceecCCccccCceeeccccccCCCCCchhhh
Confidence 0011456899999999985 3457889999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
|||||++|+|++|.+||...+......++..... ...+....++.++.+||.+||. +|.+|+ +++++++||||..
T Consensus 199 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~ 274 (292)
T cd06644 199 WSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP-PTLSQPSKWSMEFRDFLKTALDKHPETRP---SAAQLLEHPFVSS 274 (292)
T ss_pred HhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCC-ccCCCCcccCHHHHHHHHHHhcCCcccCc---CHHHHhcCccccc
Confidence 9999999999999999988777666666543221 1222234678999999999998 999999 9999999999999
Q ss_pred CCcccccc
Q 010266 418 IAWDKLYE 425 (514)
Q Consensus 418 i~w~~l~~ 425 (514)
++|.+..+
T Consensus 275 ~~~~~~~~ 282 (292)
T cd06644 275 VTSNRPLR 282 (292)
T ss_pred cccchhHH
Confidence 99998653
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=377.16 Aligned_cols=256 Identities=28% Similarity=0.475 Sum_probs=212.1
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC------
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA------ 178 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~------ 178 (514)
.++|++++.||+|+||+||+|.+..+++.||+|++.+... .......+.+|..+|+.++||||++++++|.+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 3689999999999999999999999999999999876432 223445677899999999999999999988643
Q ss_pred CeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
...|++||++ |++|..++. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 4579999998 789988774 46799999999999999999999999999999999999999999999999999875431
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccc
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECD 337 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~D 337 (514)
. ..+.+||+.|+|||++.+ ..++.++|
T Consensus 171 ~----------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~D 198 (343)
T cd07878 171 E----------------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVD 198 (343)
T ss_pred C----------------------------------------------------cCCccccccccCchHhcCCccCCchhh
Confidence 1 114579999999999987 56899999
Q ss_pred hhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcc---------------------cCCc------CcCCChhHHHHH
Q 010266 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL---------------------KFPE------EARLTPEAKDLI 390 (514)
Q Consensus 338 iWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---------------------~~p~------~~~~s~~~~dLI 390 (514)
||||||++|+|++|.+||.+.+..+....+....... ..|. ....++.+.+||
T Consensus 199 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 278 (343)
T cd07878 199 IWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLL 278 (343)
T ss_pred hHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHH
Confidence 9999999999999999998877665555544311100 0111 013567899999
Q ss_pred hhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 391 CRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 391 ~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
.+||. ||.+|+ ++.|++.||||...
T Consensus 279 ~~mL~~dp~~R~---s~~ell~hp~~~~~ 304 (343)
T cd07878 279 EKMLVLDSDKRI---SASEALAHPYFSQY 304 (343)
T ss_pred HHHcCCChhhCC---CHHHHhcCcchhcc
Confidence 99999 999999 99999999999764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=376.15 Aligned_cols=256 Identities=27% Similarity=0.436 Sum_probs=209.9
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC------
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA------ 178 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~------ 178 (514)
.++|++++.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|..+++.++||||++++++|...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 478999999999999999999999999999999987543 2334456677899999999999999999998654
Q ss_pred CeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
..+|+||||+++ +|...+.. .+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+|+....
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 357999999965 67666643 588999999999999999999999999999999999999999999999999875432
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
.. .....+||+.|+|||++.+..++.++|+
T Consensus 172 ~~--------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di 201 (355)
T cd07874 172 SF--------------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDI 201 (355)
T ss_pred cc--------------------------------------------------ccCCccccCCccCHHHHcCCCCCchhhH
Confidence 10 0124579999999999999999999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcC-------------------------cccCC---------c----Cc
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKN-------------------------HLKFP---------E----EA 380 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-------------------------~~~~p---------~----~~ 380 (514)
|||||++|+|++|..||.+.+..+.+..++..-. .+.+| . ..
T Consensus 202 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (355)
T cd07874 202 WSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 281 (355)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhcccccccccccccc
Confidence 9999999999999999998776555444332100 00001 0 11
Q ss_pred CCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 381 RLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 381 ~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
..+.++++||.+||. ||.+|+ |++|+++||||..
T Consensus 282 ~~~~~~~~li~~mL~~dP~~Rp---s~~ell~hp~~~~ 316 (355)
T cd07874 282 LKASQARDLLSKMLVIDPAKRI---SVDEALQHPYINV 316 (355)
T ss_pred ccchHHHHHHHHHhcCCchhcC---CHHHHhcCcchhc
Confidence 245788999999999 999999 9999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-46 Score=383.02 Aligned_cols=259 Identities=30% Similarity=0.543 Sum_probs=234.9
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
.......|.+++.||+|.|++|.++++..|+..||||++.|+.+... ..+++.+|.++|..++|||||+||.+..+...
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSLNHPNIVKLFSVIETEAT 129 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-HHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence 34556889999999999999999999999999999999999876443 44558899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
+|+||||+.||+++++|.+.++..+..++.++.|++.|++|||+++|||||||++||||+.+-++||+|||++..+....
T Consensus 130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL 209 (596)
T ss_pred eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998765321
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCC-Ccccchh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDWW 339 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiW 339 (514)
...++||+|.|.|||++.+..| ++.+|+|
T Consensus 210 --------------------------------------------------~lqt~cgsppyAaPEl~~g~~y~gpe~D~W 239 (596)
T KOG0586|consen 210 --------------------------------------------------MLQTFCGSPPYAAPELFNGKKYDGPEVDIW 239 (596)
T ss_pred --------------------------------------------------cccccCCCCCccChHhhcCcccCCcceehh
Confidence 1237899999999999999988 7899999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
|||++||-|+.|..||.|.+..+...+.+.. .+.+|. .+|-++++||+++|. +|.+|. +.++|++|+|...
T Consensus 240 slgvvly~LV~GsLPFDG~~lk~Lr~rvl~g--k~rIp~--~ms~dce~lLrk~lvl~Pskr~---~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 240 SLGVVLYALVEGSLPFDGQNLKELRPRVLRG--KYRIPF--YMSCDCEDLLRKFLVLNPSKRG---PCDQIMKDRWRND 311 (596)
T ss_pred hhhhhheeeeecccccCCcccccccchheee--eecccc--eeechhHHHHHHhhccCccccC---CHHHhhhhcccch
Confidence 9999999999999999999988888888764 445554 589999999999998 999998 9999999999864
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=384.09 Aligned_cols=252 Identities=27% Similarity=0.429 Sum_probs=215.5
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-C-----CceeeEEEEEEcCCe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-S-----HCIVKLYYSFQDAEY 180 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-h-----p~Iv~l~~~f~~~~~ 180 (514)
+|.++++||+|+||.|-+|.+..|++.||||+++.. +.-..+...|+.||..++ | -|+|+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 789999999999999999999999999999999865 344556778999999986 3 389999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCC--CcEEEccccccccC
Q 010266 181 LYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN--GHMKLSDFGLCKPL 256 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~--g~iKL~DFGla~~~ 256 (514)
+|||+|.+ +-+|.++|... ..|+...+|.++.||+.||.+||++||||.|||||||||..- ..|||+|||.|...
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999999 57999999765 478999999999999999999999999999999999999744 47999999998754
Q ss_pred CCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCccc
Q 010266 257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336 (514)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 336 (514)
.. ..++.+-+..|.|||||.|.+|+.+.
T Consensus 342 ~q----------------------------------------------------~vytYiQSRfYRAPEVILGlpY~~~I 369 (586)
T KOG0667|consen 342 SQ----------------------------------------------------RVYTYIQSRFYRAPEVILGLPYDTAI 369 (586)
T ss_pred CC----------------------------------------------------cceeeeeccccccchhhccCCCCCcc
Confidence 31 12377899999999999999999999
Q ss_pred chhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhc---------------------------------------------
Q 010266 337 DWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWK--------------------------------------------- 371 (514)
Q Consensus 337 DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--------------------------------------------- 371 (514)
|+||||||++||++|.|.|.|++..+++..|+.-.
T Consensus 370 DmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~ 449 (586)
T KOG0667|consen 370 DMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKY 449 (586)
T ss_pred ceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhh
Confidence 99999999999999999999999999988886400
Q ss_pred -----CcccCC-cCc--------CCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 372 -----NHLKFP-EEA--------RLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 372 -----~~~~~p-~~~--------~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
.....| ... .-...+.|||.+||. ||..|+ ++.++++||||.+.
T Consensus 450 ~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~---tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 450 YRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI---TPAQALNHPFLTGT 508 (586)
T ss_pred hhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC---CHHHHhcCcccccc
Confidence 000122 000 012456899999999 999998 99999999999864
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=365.00 Aligned_cols=261 Identities=26% Similarity=0.471 Sum_probs=216.6
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 183 (514)
..++|++++.||.|+||.||+|+++.+++.||+|.+..... ......+.+|..+++.++||||+++++++.+...+|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 35789999999999999999999999999999999875432 2233456789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 184 IMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
||||++ ++|..++.. ...+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 999997 589888865 35689999999999999999999999999999999999999999999999999875321100
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSL 341 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSl 341 (514)
......||+.|+|||++.+ ..++.++|+|||
T Consensus 160 ------------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl 191 (301)
T cd07873 160 ------------------------------------------------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGV 191 (301)
T ss_pred ------------------------------------------------cccccceeecccCcHHHhCCCCCccHHHHHHH
Confidence 0113468999999999876 457899999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcC-----------------cccCCc---------CcCCChhHHHHHhhhcc
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKN-----------------HLKFPE---------EARLTPEAKDLICRLLC 395 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~-----------------~~~~p~---------~~~~s~~~~dLI~~lL~ 395 (514)
||++|+|++|.+||.+.+..+....+..... ...+|. ...+++++++||.+||+
T Consensus 192 G~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~ 271 (301)
T cd07873 192 GCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQ 271 (301)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhc
Confidence 9999999999999998877666555433110 111221 12478899999999999
Q ss_pred -CccccCCCCCHhHHhcCCccccCC
Q 010266 396 -DVEHRLGTLGSEQIKAHPWFKDIA 419 (514)
Q Consensus 396 -dp~~Rl~~~~~~eil~Hpff~~i~ 419 (514)
||.+|+ +++|++.||||+.+-
T Consensus 272 ~dp~~R~---t~~eil~h~~f~~~~ 293 (301)
T cd07873 272 FEGRKRI---SAEEAMKHPYFHCLG 293 (301)
T ss_pred CCcccCc---CHHHHhcCccccccc
Confidence 999999 999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=354.76 Aligned_cols=260 Identities=30% Similarity=0.529 Sum_probs=219.5
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccc--cChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC--CeE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM--LSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA--EYL 181 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~--~~l 181 (514)
++|++.+.||+|+||.||++.++.++..||||.+..... ....+...+.+|..+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 689999999999999999999999999999999864321 1234567888999999999999999999998764 578
Q ss_pred EEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
|+||||++||+|.+++.+...+++..+..++.|++.||.|||+.||+|+||||+||+++.+|.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999875432100
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
.. .......||..|+|||++.+..++.++|+|||
T Consensus 162 ~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 195 (265)
T cd06652 162 SG----------------------------------------------TGMKSVTGTPYWMSPEVISGEGYGRKADIWSV 195 (265)
T ss_pred cc----------------------------------------------cccccCCCCccccChhhhcCCCCCcchhHHHH
Confidence 00 00114569999999999998889999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhccCccccCCCCCHhHHhcCCccc
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFK 416 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~Hpff~ 416 (514)
||++|+|++|.+||...+.......+.........|. .++..+.++|.+|+.+|.+|+ ++++|+.|||++
T Consensus 196 G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~~l~~p~~Rp---~~~~il~~~~~~ 265 (265)
T cd06652 196 GCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPP--HVSDHCRDFLKRIFVEAKLRP---SADELLRHTFVH 265 (265)
T ss_pred HHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCch--hhCHHHHHHHHHHhcChhhCC---CHHHHhcCcccC
Confidence 9999999999999987766666555543322233343 578899999999998999999 999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-47 Score=387.65 Aligned_cols=261 Identities=29% Similarity=0.478 Sum_probs=229.7
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
+.++++..||.|+||+||+|..+.++-..|.|+|.- .....++.+..|++||+.++||+||+|+++|..++.++++.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 457889999999999999999999999999998853 35677889999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 186 EYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 186 Ey~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
|||+||-...++.. ...+++..++.+++|++.||.|||+++|||||||..|||++-+|.|+|+|||.+......
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t----- 183 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST----- 183 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH-----
Confidence 99999999888755 568999999999999999999999999999999999999999999999999997643211
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc-----cCCCCcccchh
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----KKGYGMECDWW 339 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~DiW 339 (514)
+....++.|||+||||||+. ..+|++++|||
T Consensus 184 --------------------------------------------~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiW 219 (1187)
T KOG0579|consen 184 --------------------------------------------RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIW 219 (1187)
T ss_pred --------------------------------------------HhhhccccCCcccccchheeeccccCCCchhhhhHH
Confidence 11223899999999999986 57899999999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
|||+.|.||..+.||-..-++...+.+|..- .+..+-.+..+|..++||+.+||. ||..|+ ++.++++||||.++
T Consensus 220 SlGITLIEMAqiEPPHhelnpMRVllKiaKS-ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp---~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 220 SLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRP---PAAQLLKHPFVQNA 295 (1187)
T ss_pred hhhhHHHHHhccCCCccccchHHHHHHHhhc-CCCcccCcchhhhHHHHHHHHHHhcCCccCC---CHHHHhhCcccccC
Confidence 9999999999999999999998888888753 333333345789999999999998 999999 99999999999988
Q ss_pred Cccc
Q 010266 419 AWDK 422 (514)
Q Consensus 419 ~w~~ 422 (514)
+-++
T Consensus 296 ~SnK 299 (1187)
T KOG0579|consen 296 PSNK 299 (1187)
T ss_pred Ccch
Confidence 7654
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=364.71 Aligned_cols=255 Identities=28% Similarity=0.425 Sum_probs=216.1
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++.+.||+|+||.||++++..++..||+|.+.... .......+.+|++++..++||||++++++|.+++.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 47999999999999999999999999999999987542 3344566888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
||++||+|.+++.+.+.+++..++.++.|++.||.|||+ .||+||||||+|||++.+|.+||+|||++......
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----- 153 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----- 153 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-----
Confidence 999999999999888899999999999999999999997 69999999999999999999999999998643211
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 344 (514)
...+.+|++.|+|||++.+..++.++|+|||||+
T Consensus 154 ----------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~ 187 (308)
T cd06615 154 ----------------------------------------------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLS 187 (308)
T ss_pred ----------------------------------------------ccccCCCCcCccChhHhcCCCCCccchHHHHHHH
Confidence 0124579999999999988889999999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHhhhc-----------------------------------CcccCCcCcCCChhHHHH
Q 010266 345 MYEMLVGYPPFYSDDPVTTCRKIVHWK-----------------------------------NHLKFPEEARLTPEAKDL 389 (514)
Q Consensus 345 lyemltG~~PF~~~~~~~~~~~i~~~~-----------------------------------~~~~~p~~~~~s~~~~dL 389 (514)
+|+|++|..||...+.......+.... .....|. ..+++++++|
T Consensus 188 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l 266 (308)
T cd06615 188 LVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPS-GAFSDEFQDF 266 (308)
T ss_pred HHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcC-cccCHHHHHH
Confidence 999999999998665433322221100 0011111 1367899999
Q ss_pred Hhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 390 ICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 390 I~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
|.+||. +|.+|+ ++++|+.||||.+
T Consensus 267 i~~~l~~~P~~Rp---t~~~ll~~~~~~~ 292 (308)
T cd06615 267 VDKCLKKNPKERA---DLKELTKHPFIKR 292 (308)
T ss_pred HHHHccCChhhCc---CHHHHhcChhhhh
Confidence 999998 999999 9999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=359.11 Aligned_cols=252 Identities=24% Similarity=0.405 Sum_probs=211.7
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++++.||+|+||.||+|++..+++.||+|++.+.. .......+..|..+|..++||||++++++|.+.+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 47889999999999999999999999999999987642 2344566889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
||++||+|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.+|.+||+|||++......
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~------ 148 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS------ 148 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc------
Confidence 99999998654 35789999999999999999999999999999999999999999999999998754311
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 345 (514)
.....+||+.|+|||++.+..++.++|+|||||++
T Consensus 149 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l 183 (279)
T cd06619 149 ---------------------------------------------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISF 183 (279)
T ss_pred ---------------------------------------------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHH
Confidence 01145799999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChh-------HHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 346 YEMLVGYPPFYSDDPV-------TTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 346 yemltG~~PF~~~~~~-------~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
|+|++|..||...... .....+.. ......|. ...++++++||.+||+ +|.+|+ ++++++.||||..
T Consensus 184 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp---~~~eil~~~~~~~ 258 (279)
T cd06619 184 MELALGRFPYPQIQKNQGSLMPLQLLQCIVD-EDPPVLPV-GQFSEKFVHFITQCMRKQPKERP---APENLMDHPFIVQ 258 (279)
T ss_pred HHHHhCCCCchhhcccccccchHHHHHHHhc-cCCCCCCC-CcCCHHHHHHHHHHhhCChhhCC---CHHHHhcCccccc
Confidence 9999999999753221 22222221 11112222 3578899999999998 999999 9999999999986
Q ss_pred CC
Q 010266 418 IA 419 (514)
Q Consensus 418 i~ 419 (514)
.+
T Consensus 259 ~~ 260 (279)
T cd06619 259 YN 260 (279)
T ss_pred cc
Confidence 54
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=377.38 Aligned_cols=257 Identities=34% Similarity=0.618 Sum_probs=223.5
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecCCC
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG 191 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg 191 (514)
++||.|-||+||-++++.||+.||||++.|..+- .++...+++|..||+.++||.||.|-..|++.+.+++|||-+. |
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp-~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFP-TKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCC-CchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 5899999999999999999999999999988764 4555889999999999999999999999999999999999995 5
Q ss_pred CHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCC---CcEEEccccccccCCCCCcccccc
Q 010266 192 DVMTLLMR--EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN---GHMKLSDFGLCKPLDCTNLSAINE 266 (514)
Q Consensus 192 ~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~---g~iKL~DFGla~~~~~~~~~~~~~ 266 (514)
|+...|.. .+++++..++|.+.||+.||.|||-+||+|.||||||||+.+. -.+||||||+|+.+....
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks------ 721 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS------ 721 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh------
Confidence 77776643 5899999999999999999999999999999999999999754 479999999999875321
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHH
Q 010266 267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 346 (514)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 346 (514)
...+.+|||.|+|||++++++|+.+-|+||+|||+|
T Consensus 722 --------------------------------------------FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiY 757 (888)
T KOG4236|consen 722 --------------------------------------------FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIY 757 (888)
T ss_pred --------------------------------------------hhhhhcCCccccCHHHHhhccccccccceeeeEEEE
Confidence 123789999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCChhHHHHHHhhhcCcccCCc--CcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC-Cccc
Q 010266 347 EMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPE--EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI-AWDK 422 (514)
Q Consensus 347 emltG~~PF~~~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i-~w~~ 422 (514)
--|.|..||..+ +++-.+|.+ ..+-+|+ |..+|++|.|||..||+ .-.+|. +++..+.|||+++. -|-.
T Consensus 758 VsLSGTFPFNEd--EdIndQIQN--AaFMyPp~PW~eis~~AidlIn~LLqVkm~kRy---svdk~lsh~Wlq~yq~w~D 830 (888)
T KOG4236|consen 758 VSLSGTFPFNED--EDINDQIQN--AAFMYPPNPWSEISPEAIDLINNLLQVKMRKRY---SVDKSLSHPWLQDYQTWLD 830 (888)
T ss_pred EEecccccCCCc--cchhHHhhc--cccccCCCchhhcCHHHHHHHHHHHHHHHHHhc---chHhhccchhhhcchHHHH
Confidence 999999999643 334455554 3455564 55799999999999998 888888 99999999999986 5888
Q ss_pred ccccc
Q 010266 423 LYEME 427 (514)
Q Consensus 423 l~~~~ 427 (514)
|++++
T Consensus 831 LRelE 835 (888)
T KOG4236|consen 831 LRELE 835 (888)
T ss_pred HHHHH
Confidence 88644
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=361.19 Aligned_cols=276 Identities=41% Similarity=0.748 Sum_probs=225.3
Q ss_pred CeeEEeeeeecCceEEEEEEEc---cCCCEEEEEEeecccccC-hhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCeE
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEK---KSGNIYAMKKLKKSEMLS-RGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~---~t~~~~AiK~l~k~~~~~-~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l 181 (514)
+|++.+.||.|+||.||+|++. .+|+.||+|++++..... ....+++..|+.+|..+ +||+|++++++|+.+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999875 478999999998654332 23456788899999999 599999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
|+||||++||+|.+++.....+++..+..++.|++.||.|||+.|++||||||+|||++.+|++||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999875432100
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc--CCCCcccchh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK--KGYGMECDWW 339 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiW 339 (514)
......+|++.|+|||++.+ ..++.++|+|
T Consensus 161 ------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~ 192 (290)
T cd05613 161 ------------------------------------------------ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWW 192 (290)
T ss_pred ------------------------------------------------cccccccCCcccCChhhccCCCCCCCccccHH
Confidence 01124579999999999875 3578899999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhHHHHHHhhh--cCcccCCcCcCCChhHHHHHhhhcc-CccccCCC--CCHhHHhcCCc
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHW--KNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT--LGSEQIKAHPW 414 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~Hpf 414 (514)
||||++|+|++|..||...+.......+... .....+| ..+++.+.+||.+||. ||.+|++. .++++++.|||
T Consensus 193 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~ 270 (290)
T cd05613 193 SMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPF 270 (290)
T ss_pred HHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCC--ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcc
Confidence 9999999999999999754332222222211 1122333 3578999999999999 99999854 38899999999
Q ss_pred cccCCccccc--cccCCCCC
Q 010266 415 FKDIAWDKLY--EMEAAYKP 432 (514)
Q Consensus 415 f~~i~w~~l~--~~~~p~~p 432 (514)
|..++|+.+. ..++||.|
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~ 290 (290)
T cd05613 271 FQKINWDDLAAKKVPAPFKP 290 (290)
T ss_pred cccCCHHHHhhccCCCCCCC
Confidence 9999998874 34555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-45 Score=367.98 Aligned_cols=250 Identities=26% Similarity=0.443 Sum_probs=194.4
Q ss_pred EeeeeecCceEEEEEEEcc--CCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc--CCeEEEEEe
Q 010266 111 LTIIGRGAFGEVRLCQEKK--SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--AEYLYLIME 186 (514)
Q Consensus 111 ~~~LG~G~fG~V~l~~~~~--t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~--~~~l~lVmE 186 (514)
.+.||+|+||+||+|+++. +++.||+|.+..... ...+.+|..+|+.++||||++++++|.+ ...+|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 3589999999999999763 678999999875432 2346789999999999999999999854 567999999
Q ss_pred ecCCCCHHHHHhhc---------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccc----cCCCcEEEcccccc
Q 010266 187 YLPGGDVMTLLMRE---------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL----DQNGHMKLSDFGLC 253 (514)
Q Consensus 187 y~~gg~L~~~l~~~---------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILl----d~~g~iKL~DFGla 253 (514)
|+. ++|..++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.+|.+||+|||+|
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 995 5888877532 258999999999999999999999999999999999999 46689999999999
Q ss_pred ccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCC
Q 010266 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGY 332 (514)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y 332 (514)
+........ .......+||+.|+|||++.+ ..|
T Consensus 160 ~~~~~~~~~----------------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~ 193 (317)
T cd07868 160 RLFNSPLKP----------------------------------------------LADLDPVVVTFWYRAPELLLGARHY 193 (317)
T ss_pred eccCCCCcc----------------------------------------------ccccCCccccccccCCHHHcCCCCc
Confidence 765321100 001124679999999999987 458
Q ss_pred CcccchhhhhHHHHHHhhCCCCCCCCCh---------hHHHHHHhh---------hcCcccCCc----------------
Q 010266 333 GMECDWWSLGAIMYEMLVGYPPFYSDDP---------VTTCRKIVH---------WKNHLKFPE---------------- 378 (514)
Q Consensus 333 ~~~~DiWSlGvilyemltG~~PF~~~~~---------~~~~~~i~~---------~~~~~~~p~---------------- 378 (514)
+.++|+|||||++|||++|.+||.+... .....++.. |......|.
T Consensus 194 ~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (317)
T cd07868 194 TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNC 273 (317)
T ss_pred CchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcc
Confidence 9999999999999999999999975432 122222221 000000000
Q ss_pred ---------CcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 379 ---------EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 379 ---------~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
....+.++.|||.+||+ ||.+|+ |++|+++||||
T Consensus 274 ~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~---t~~e~l~hp~f 317 (317)
T cd07868 274 SLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI---TSEQAMQDPYF 317 (317)
T ss_pred cccchHHhcCCCCChHHHHHHHHHhccCcccCC---CHHHHhcCCCC
Confidence 01235679999999999 999999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=354.55 Aligned_cols=264 Identities=50% Similarity=0.889 Sum_probs=227.1
Q ss_pred eeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecCCCCH
Q 010266 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDV 193 (514)
Q Consensus 114 LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~L 193 (514)
||.|+||.||+|++..+|+.||+|++.+...........+.+|.+++..++||||+++++.+.+....|+||||++|++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999999877655556778899999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccccccccccc
Q 010266 194 MTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDE 273 (514)
Q Consensus 194 ~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~ 273 (514)
.+++.+.+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++............
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-------- 152 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN-------- 152 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc--------
Confidence 999988789999999999999999999999999999999999999999999999999998754321100000
Q ss_pred cccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhhCCC
Q 010266 274 NLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 353 (514)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemltG~~ 353 (514)
.........+|++.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus 153 ---------------------------------~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 199 (265)
T cd05579 153 ---------------------------------DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIP 199 (265)
T ss_pred ---------------------------------cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 00001124578999999999998889999999999999999999999
Q ss_pred CCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCc
Q 010266 354 PFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAW 420 (514)
Q Consensus 354 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w 420 (514)
||...+..+.+..+.. ....+|....+++.+.+||.+||+ +|.+|+...++.++++||||++++|
T Consensus 200 p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 200 PFHGETPEEIFQNILN--GKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred CCCCCCHHHHHHHHhc--CCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 9998888888777765 345556544468999999999999 9999995555599999999999999
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=353.09 Aligned_cols=260 Identities=32% Similarity=0.551 Sum_probs=218.2
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeeccccc--ChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc--CCeE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML--SRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--AEYL 181 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~--~~~l 181 (514)
.+|++.+.||+|+||.||+|.+..++..||+|++...... .......+.+|..+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 5799999999999999999999999999999998754321 23455678899999999999999999999875 4678
Q ss_pred EEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
|+||||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++++||+|||++..+.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999876532100
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
.. .......|+..|+|||++.+..++.++|+|||
T Consensus 162 ~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 195 (266)
T cd06651 162 SG----------------------------------------------TGIRSVTGTPYWMSPEVISGEGYGRKADVWSL 195 (266)
T ss_pred cC----------------------------------------------CccccCCccccccCHHHhCCCCCCchhhhHHH
Confidence 00 00113468999999999999889999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhccCccccCCCCCHhHHhcCCccc
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFK 416 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~Hpff~ 416 (514)
||++|||++|.+||...+.......+........+|. .+++.+++||+.|+.+|.+|+ +++||+.||||+
T Consensus 196 G~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~~~~p~~Rp---~~~eil~hp~~~ 265 (266)
T cd06651 196 GCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPS--HISEHARDFLGCIFVEARHRP---SAEELLRHPFAQ 265 (266)
T ss_pred HHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCch--hcCHHHHHHHHHhcCChhhCc---CHHHHhcCcccc
Confidence 9999999999999988776666655554333344443 578999999954434999999 999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=360.23 Aligned_cols=274 Identities=42% Similarity=0.760 Sum_probs=225.9
Q ss_pred CeeEEeeeeecCceEEEEEEEc---cCCCEEEEEEeecccccC-hhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCeE
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEK---KSGNIYAMKKLKKSEMLS-RGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~---~t~~~~AiK~l~k~~~~~-~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l 181 (514)
+|++.+.||+|+||.||+|+.. .+++.||||++++..... .....++..|..++..+ +||+|+++++.|.+...+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 5889999999999999999864 467899999998654432 23446678899999999 599999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
|+||||++||+|..++.....+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..+.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999875432100
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCC--CCcccchh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG--YGMECDWW 339 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~--y~~~~DiW 339 (514)
......+|++.|+|||++.+.. ++.++|+|
T Consensus 161 ------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~ 192 (288)
T cd05583 161 ------------------------------------------------ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWW 192 (288)
T ss_pred ------------------------------------------------cccccccCCccccCHHHhcCCCCCCcchhhhH
Confidence 0112457999999999987654 78899999
Q ss_pred hhhHHHHHHhhCCCCCCCCChh----HHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCc
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPV----TTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPW 414 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~----~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpf 414 (514)
|||+++|+|++|..||...+.. +....+.. .....| ..++++++++|.+||. +|++|+...++.++++|||
T Consensus 193 slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~--~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~ 268 (288)
T cd05583 193 SLGVLTFELLTGASPFTVDGEQNSQSEISRRILK--SKPPFP--KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268 (288)
T ss_pred HHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc--cCCCCC--cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence 9999999999999999654322 22233332 222233 3578999999999998 9999996667889999999
Q ss_pred cccCCccccc--cccCCCCC
Q 010266 415 FKDIAWDKLY--EMEAAYKP 432 (514)
Q Consensus 415 f~~i~w~~l~--~~~~p~~p 432 (514)
|++++|+.+. +..|||.|
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~ 288 (288)
T cd05583 269 FQGIDWDDLAAKRIPAPFKP 288 (288)
T ss_pred cccCCHHHHhhhccCCCCCC
Confidence 9999999885 45666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=356.29 Aligned_cols=255 Identities=26% Similarity=0.481 Sum_probs=214.0
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.++|.+.+.||+|+||.||+|++..+++.||+|+++... ......+.+|..+++.++||||+++++++.+.+.+|+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 457888999999999999999999999999999987542 23345677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
|||+++|+|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++........
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~--- 161 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA--- 161 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc---
Confidence 99999999999998888999999999999999999999999999999999999999999999999999875431100
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc---cCCCCcccchhhh
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSL 341 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiWSl 341 (514)
.....+||+.|+|||++. ...++.++|+|||
T Consensus 162 ----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSl 195 (267)
T cd06645 162 ----------------------------------------------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAV 195 (267)
T ss_pred ----------------------------------------------ccccccCcccccChhhhccccCCCCCchhhhHHH
Confidence 011457999999999985 4568899999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCc-ccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCc
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNH-LKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPW 414 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~-~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpf 414 (514)
||++|+|++|.+||....+......+...... ...+....++..+.+||.+||. +|++|+ ++++|+.|||
T Consensus 196 G~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~---~~~~ll~~~~ 267 (267)
T cd06645 196 GITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRP---TAEKLLQHPF 267 (267)
T ss_pred HHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCc---CHHHHhcCCC
Confidence 99999999999999876654443333221111 1111123577899999999998 999999 9999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=348.69 Aligned_cols=253 Identities=28% Similarity=0.534 Sum_probs=216.7
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc-CCeEEEEE
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-AEYLYLIM 185 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~-~~~l~lVm 185 (514)
+|++++.||+|+||.||+|.++.+++.||+|.+..... .....+.+..|..+++.++||+++++++.+.. +..+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 58999999999999999999999999999999976432 34456678889999999999999999998874 45789999
Q ss_pred eecCCCCHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 186 EYLPGGDVMTLLMR--EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 186 Ey~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
||++|++|.+++.. ...+++..+..++.+++.||.+||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--- 156 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--- 156 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC---
Confidence 99999999999875 3468999999999999999999999999999999999999999999999999987543210
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhH
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 343 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 343 (514)
.......|++.|+|||++.+..++.++|+|||||
T Consensus 157 ----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 190 (257)
T cd08223 157 ----------------------------------------------DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGC 190 (257)
T ss_pred ----------------------------------------------CccccccCCcCccChhHhcCCCCCchhhhHHHHH
Confidence 0011457899999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 344 ilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
++|+|++|..||.+.+.......+.... ....| ..+++++.+||.+||+ +|.+|+ ++.++++||||
T Consensus 191 il~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~~l~~~~~ 257 (257)
T cd08223 191 CVYEMATLKHAFNAKDMNSLVYRIIEGK-LPPMP--KDYSPELGELIATMLSKRPEKRP---SVKSILRQPYI 257 (257)
T ss_pred HHHHHHcCCCCCCCCCHHHHHHHHHhcC-CCCCc--cccCHHHHHHHHHHhccCcccCC---CHHHHhcCCCC
Confidence 9999999999999887766666655421 11222 3688999999999999 999999 99999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=400.34 Aligned_cols=264 Identities=27% Similarity=0.449 Sum_probs=219.7
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc--
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-- 177 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~-- 177 (514)
......++|++++.||+|+||+||+|+++.++..||+|++..... .......+..|+.+|..++|||||+++++|.+
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 455667899999999999999999999999999999999976543 34456778899999999999999999999864
Q ss_pred CCeEEEEEeecCCCCHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC-------CeEEcCCCCCCccccC-----
Q 010266 178 AEYLYLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKH-------NYIHRDIKPDNLLLDQ----- 241 (514)
Q Consensus 178 ~~~l~lVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~-------giiHrDLKpeNILld~----- 241 (514)
...+||||||+++|+|..+|.. .+.+++..++.++.||+.||.|||+. +||||||||+||||+.
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 4679999999999999999865 35799999999999999999999985 4999999999999964
Q ss_pred ------------CCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhcc
Q 010266 242 ------------NGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRR 309 (514)
Q Consensus 242 ------------~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (514)
.+.+||+|||++..+....
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s------------------------------------------------- 196 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIES------------------------------------------------- 196 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccc-------------------------------------------------
Confidence 3459999999987543110
Q ss_pred ccccccccCCCcCCcccccc--CCCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHH
Q 010266 310 KLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAK 387 (514)
Q Consensus 310 ~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~ 387 (514)
.....+||+.|+|||++.+ ..++.++||||||||||||++|.+||...+.......++.. ...+|. ...++++.
T Consensus 197 -~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~--~p~lpi-~~~S~eL~ 272 (1021)
T PTZ00266 197 -MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKR--GPDLPI-KGKSKELN 272 (1021)
T ss_pred -cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhc--CCCCCc-CCCCHHHH
Confidence 1124579999999999965 45899999999999999999999999876655444444432 222332 25789999
Q ss_pred HHHhhhcc-CccccCCCCCHhHHhcCCccccCCc
Q 010266 388 DLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAW 420 (514)
Q Consensus 388 dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w 420 (514)
+||.+||. +|.+|+ ++.|++.||||+.+..
T Consensus 273 dLI~~~L~~dPeeRP---Sa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 273 ILIKNLLNLSAKERP---SALQCLGYQIIKNVGP 303 (1021)
T ss_pred HHHHHHhcCChhHCc---CHHHHhccHHHhhcCC
Confidence 99999999 999999 9999999999987754
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=355.06 Aligned_cols=255 Identities=32% Similarity=0.494 Sum_probs=209.8
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
+|++++.||.|+||.||+|.++.+++.||||++..... .......+.+|..++..++||||+++++++.++..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 68999999999999999999999999999999875432 23344567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 187 YLPGGDVMTLLMRE---ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 187 y~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
|++ |+|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++........
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-- 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--
Confidence 997 5888887542 5689999999999999999999999999999999999999999999999999875431100
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchhhhh
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 342 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlG 342 (514)
......|++.|+|||++.+ ..++.++|+||||
T Consensus 157 -----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 189 (285)
T cd07861 157 -----------------------------------------------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIG 189 (285)
T ss_pred -----------------------------------------------cccCCcccccccChHHhcCCCCcCcHHHHHHHH
Confidence 0113468899999999875 4578999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcCc----------------ccCC---------cCcCCChhHHHHHhhhcc-C
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNH----------------LKFP---------EEARLTPEAKDLICRLLC-D 396 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~~----------------~~~p---------~~~~~s~~~~dLI~~lL~-d 396 (514)
|++|+|++|.+||.+.+.......+...... ..++ ....+|+++++||.+||+ |
T Consensus 190 ~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 269 (285)
T cd07861 190 TIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYD 269 (285)
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCC
Confidence 9999999999999887654443333211000 0000 012478999999999999 9
Q ss_pred ccccCCCCCHhHHhcCCcc
Q 010266 397 VEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 397 p~~Rl~~~~~~eil~Hpff 415 (514)
|.+|+ ++++|+.||||
T Consensus 270 P~~Rp---t~~~ll~~~~~ 285 (285)
T cd07861 270 PAKRI---SAKKALNHPYF 285 (285)
T ss_pred hhhCC---CHHHHhcCCCC
Confidence 99999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=352.95 Aligned_cols=252 Identities=40% Similarity=0.761 Sum_probs=220.1
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|..+++.++||||++++++|.+...+|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999999999999999988766565677889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccc
Q 010266 187 YLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE 266 (514)
Q Consensus 187 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~ 266 (514)
|++|++|..++.....+++..+..++.|++.||.|||++||+|+||||+||+++.+|.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~------ 154 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT------ 154 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc------
Confidence 99999999999887899999999999999999999999999999999999999999999999999987543210
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHH
Q 010266 267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 346 (514)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 346 (514)
......|+..|+|||++.+..++.++|+|||||++|
T Consensus 155 --------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~ 190 (258)
T cd05578 155 --------------------------------------------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAY 190 (258)
T ss_pred --------------------------------------------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHH
Confidence 011346889999999999988999999999999999
Q ss_pred HHhhCCCCCCCCCh---hHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCH--hHHhcCCcc
Q 010266 347 EMLVGYPPFYSDDP---VTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGS--EQIKAHPWF 415 (514)
Q Consensus 347 emltG~~PF~~~~~---~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~--~eil~Hpff 415 (514)
+|++|..||...+. ......+.. ....+|. .++.++.++|.+||. ||.+|+ ++ +|+++||||
T Consensus 191 ~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~~i~~~l~~~p~~R~---~~~~~~l~~~~~~ 258 (258)
T cd05578 191 ECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPA--TWSTEAIDAINKLLERDPQKRL---GDNLKDLKNHPYF 258 (258)
T ss_pred HHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcc--cCcHHHHHHHHHHccCChhHcC---CccHHHHhcCCCC
Confidence 99999999987764 333222221 2233443 578999999999999 999999 66 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=353.21 Aligned_cols=256 Identities=25% Similarity=0.453 Sum_probs=214.6
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 183 (514)
..++|++++.||+|+||.||+|+++.+++.||+|++.... ......+.+|..++..++||+|+++++++.+...+|+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 3468999999999999999999999999999999987542 2344568889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
||||+++|+|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++........
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-- 161 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-- 161 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc--
Confidence 999999999999998888899999999999999999999999999999999999999999999999999876531100
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc---cCCCCcccchhh
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---KKGYGMECDWWS 340 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiWS 340 (514)
......|++.|+|||++. ...++.++|+||
T Consensus 162 -----------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws 194 (267)
T cd06646 162 -----------------------------------------------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWA 194 (267)
T ss_pred -----------------------------------------------ccCccccCccccCHhHcccccCCCCcchhhHHH
Confidence 011457999999999985 455788999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhHHHHHHhhhcC-cccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCc
Q 010266 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKN-HLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPW 414 (514)
Q Consensus 341 lGvilyemltG~~PF~~~~~~~~~~~i~~~~~-~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpf 414 (514)
|||++|||++|.+||...++......+..... ....+....++..+.+||++||+ +|.+|+ ++++|++|+|
T Consensus 195 ~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---~~~~il~~l~ 267 (267)
T cd06646 195 VGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRP---TAERLLTHLF 267 (267)
T ss_pred HHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCc---CHHHHhcCCC
Confidence 99999999999999976655444333322111 11111223578999999999998 999999 9999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=356.44 Aligned_cols=260 Identities=28% Similarity=0.482 Sum_probs=221.7
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.++|++++.||.|+||.||+|.+..++..||+|++... .....+.+..|..+++.++||+|+++++.|.+...+|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 36799999999999999999999889999999998644 345567788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 185 MEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
|||++||+|..++... ..+++..++.++.|++.||.|||+.||+||||||+||+++.+|.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--- 157 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--- 157 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc---
Confidence 9999999999998764 579999999999999999999999999999999999999999999999999876542110
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc-----cCCCCcccch
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----KKGYGMECDW 338 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~Di 338 (514)
.......||+.|+|||++. ...++.++|+
T Consensus 158 ----------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi 191 (280)
T cd06611 158 ----------------------------------------------QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADI 191 (280)
T ss_pred ----------------------------------------------cccceeecchhhcCHHHHhhcccCCCCCCccccH
Confidence 0011457999999999985 3457789999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
|||||++|+|++|.+||.+.+......++.... ...++....++.++.+||.+||. +|.+|+ +++++++||||.+
T Consensus 192 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~~~~~ 267 (280)
T cd06611 192 WSLGITLIELAQMEPPHHELNPMRVLLKILKSE-PPTLDQPSKWSSSFNDFLKSCLVKDPDDRP---TAAELLKHPFVSD 267 (280)
T ss_pred HHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC-CCCcCCcccCCHHHHHHHHHHhccChhhCc---CHHHHhcChhhcc
Confidence 999999999999999999887777666665421 12222234688999999999998 999999 9999999999987
Q ss_pred CCc
Q 010266 418 IAW 420 (514)
Q Consensus 418 i~w 420 (514)
..+
T Consensus 268 ~~~ 270 (280)
T cd06611 268 QSD 270 (280)
T ss_pred cch
Confidence 643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=357.53 Aligned_cols=248 Identities=21% Similarity=0.250 Sum_probs=213.5
Q ss_pred CCCeeEE--eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc----C
Q 010266 105 VDDFDLL--TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD----A 178 (514)
Q Consensus 105 ~~~f~~~--~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~----~ 178 (514)
.++++.. ..||+|++|.||++.. +|+.||||++++.........+.+.+|..+|.+++|||||+++++|.+ .
T Consensus 17 ~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 17 SDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred HHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 3444444 6799999999999976 688999999987654444446778899999999999999999999877 4
Q ss_pred CeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
..+++||||++||+|.+++.....++...+..++.+++.||.|||+ .|++||||||+|||++.+|.+||+|||+++...
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~ 174 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS 174 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence 5799999999999999999888889999999999999999999998 599999999999999999999999999987543
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc--CCCCcc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK--KGYGME 335 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~ 335 (514)
.. ....+||+.|+|||++.+ ..|+.+
T Consensus 175 ~~----------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~k 202 (283)
T PHA02988 175 SP----------------------------------------------------PFKNVNFMVYFSYKMLNDIFSEYTIK 202 (283)
T ss_pred cc----------------------------------------------------cccccCcccccCHHHhhhccccccch
Confidence 11 013468999999999976 689999
Q ss_pred cchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 336 CDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 336 ~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
+|||||||++|||++|..||.+.+..+.+..+......+.+|. ..++++++||.+||. ||.+|+ ++++|+.
T Consensus 203 ~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~~l~~li~~cl~~dp~~Rp---s~~ell~ 274 (283)
T PHA02988 203 DDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPL--DCPLEIKCIVEACTSHDSIKRP---NIKEILY 274 (283)
T ss_pred hhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCC--cCcHHHHHHHHHHhcCCcccCc---CHHHHHH
Confidence 9999999999999999999999888888888876544555553 578999999999999 999999 8998874
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=353.97 Aligned_cols=255 Identities=31% Similarity=0.513 Sum_probs=216.8
Q ss_pred eeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEee
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY 187 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy 187 (514)
|++++.||.|+||.||++++..++..+|+|.+... .......+.+|..+++.++||||++++++|......|+||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 57788999999999999999999999999998654 234566788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccc
Q 010266 188 LPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE 266 (514)
Q Consensus 188 ~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~ 266 (514)
++||+|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++.......
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~------ 157 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI------ 157 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc------
Confidence 999999988765 4679999999999999999999999999999999999999999999999999987542110
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc-----cCCCCcccchhhh
Q 010266 267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSL 341 (514)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~DiWSl 341 (514)
.......||+.|+|||++. +..++.++|+|||
T Consensus 158 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl 194 (282)
T cd06643 158 -------------------------------------------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSL 194 (282)
T ss_pred -------------------------------------------cccccccccccccCHhhccccCCCCCCCCccchhhhH
Confidence 0011457999999999984 4557889999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
||++|+|++|.+||...+..+....+..... ...+.+..++.++++||.+||. +|.+|+ +++++++||||+..
T Consensus 195 Gvil~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~ 268 (282)
T cd06643 195 GITLIEMAQIEPPHHELNPMRVLLKIAKSEP-PTLAQPSRWSSEFKDFLKKCLEKNVDARW---TTTQLLQHPFVTVN 268 (282)
T ss_pred HHHHHHHccCCCCccccCHHHHHHHHhhcCC-CCCCCccccCHHHHHHHHHHccCChhhCc---CHHHHhcCCCEecc
Confidence 9999999999999998877776666654221 1222233678999999999998 999999 99999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=364.34 Aligned_cols=264 Identities=20% Similarity=0.348 Sum_probs=209.7
Q ss_pred EEeeeeec--CceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEee
Q 010266 110 LLTIIGRG--AFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY 187 (514)
Q Consensus 110 ~~~~LG~G--~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy 187 (514)
++++||+| +||+||++.++.+|+.||+|++..... .......+..|..+++.++|||||+++++|.+++.+|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 789999999999999999999876532 344556788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 188 LPGGDVMTLLMR--EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 188 ~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
+++|+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.++++|||.+...........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~- 159 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR- 159 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc-
Confidence 999999999865 34689999999999999999999999999999999999999999999999987654321100000
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc--CCCCcccchhhhhH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGA 343 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiWSlGv 343 (514)
... ......+|+..|+|||++.+ .+|+.++|+|||||
T Consensus 160 ---------------~~~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~ 198 (327)
T cd08227 160 ---------------VVH--------------------------DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI 198 (327)
T ss_pred ---------------ccc--------------------------cccccccceecccChHHhhcccCCCCchhhHHHHHH
Confidence 000 00113467888999999976 46899999999999
Q ss_pred HHHHHhhCCCCCCCCChhHHHHHHhhhcCc------------------------------------------ccCCcCcC
Q 010266 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKNH------------------------------------------LKFPEEAR 381 (514)
Q Consensus 344 ilyemltG~~PF~~~~~~~~~~~i~~~~~~------------------------------------------~~~p~~~~ 381 (514)
++|||++|.+||.................. ...|....
T Consensus 199 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (327)
T cd08227 199 TACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRT 278 (327)
T ss_pred HHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccc
Confidence 999999999999865544333322211000 00011123
Q ss_pred CChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCC
Q 010266 382 LTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIA 419 (514)
Q Consensus 382 ~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~ 419 (514)
+++++.+||.+||+ ||.+|+ |++|+++||||+.+.
T Consensus 279 ~~~~~~~li~~~l~~dP~~Rp---t~~ell~~p~f~~~~ 314 (327)
T cd08227 279 FSPHFHHFVEQCLQRNPDARP---SASTLLNHSFFKQIK 314 (327)
T ss_pred cCHHHHHHHHHHHhhCchhcC---CHHHHhcChhhhhcc
Confidence 57889999999999 999999 999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=369.34 Aligned_cols=252 Identities=21% Similarity=0.330 Sum_probs=203.2
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 183 (514)
...+|++++.||+|+||.||+|++..+++.||+|+..+.. ...|..+|..++|||||+++++|.+....|+
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 3467999999999999999999999999999999865432 3468999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 184 IMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
||||+. |+|..++.. ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++.....
T Consensus 135 v~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 210 (357)
T PHA03209 135 VLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--- 210 (357)
T ss_pred EEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC---
Confidence 999995 588888765 467999999999999999999999999999999999999999999999999998642211
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
....+..||+.|+|||++.+..|+.++||||||
T Consensus 211 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 243 (357)
T PHA03209 211 -----------------------------------------------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAG 243 (357)
T ss_pred -----------------------------------------------cccccccccccccCCeecCCCCCCchhhHHHHH
Confidence 011245799999999999999999999999999
Q ss_pred HHHHHHhhCCCCC-CCCChh---------HHHHHHhhhc--CcccCC----------------------------cCcCC
Q 010266 343 AIMYEMLVGYPPF-YSDDPV---------TTCRKIVHWK--NHLKFP----------------------------EEARL 382 (514)
Q Consensus 343 vilyemltG~~PF-~~~~~~---------~~~~~i~~~~--~~~~~p----------------------------~~~~~ 382 (514)
|++|||+++..|+ ...... .....++... ....+| ....+
T Consensus 244 vvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (357)
T PHA03209 244 IVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNL 323 (357)
T ss_pred HHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCC
Confidence 9999999855444 332111 1111111100 001111 01246
Q ss_pred ChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 383 TPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 383 s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
+.++.+||.+||+ ||.+|+ +++|+++||||+.+
T Consensus 324 ~~~~~~li~~mL~~dP~~Rp---ta~e~l~hp~f~~~ 357 (357)
T PHA03209 324 PIDGEFLVHKMLTFDAAMRP---SAEEILNYPMFAQL 357 (357)
T ss_pred CchHHHHHHHHHcCCcccCc---CHHHHhcCchhccC
Confidence 7888999999999 999999 99999999999864
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=356.16 Aligned_cols=255 Identities=29% Similarity=0.518 Sum_probs=214.5
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++++.||+|+||.||+|++..+++.||+|.+... ........+.+|..++..++||||++++++|.....+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 4789999999999999999999999999999998653 23344567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 186 EYLPGGDVMTLLMRE---ETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
||++|++|..++... ..+++..++.++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 999999999888663 378999999999999999999996 69999999999999999999999999998754211
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC------CCCcc
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK------GYGME 335 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~------~y~~~ 335 (514)
.....+|++.|+|||++.+. .++.+
T Consensus 157 -------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~ 187 (286)
T cd06622 157 -------------------------------------------------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQ 187 (286)
T ss_pred -------------------------------------------------ccccCCCccCccCcchhcCCCCCccCCCCcc
Confidence 01134689999999998643 35889
Q ss_pred cchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhh--cCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 336 CDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHW--KNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 336 ~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
+|+|||||++|+|++|..||...+.......+... .....+|. .+++++.+||.+||. +|.+|+ ++++++.|
T Consensus 188 ~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~~ 262 (286)
T cd06622 188 SDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPS--GYSDDAQDFVAKCLNKIPNRRP---TYAQLLEH 262 (286)
T ss_pred cchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCc--ccCHHHHHHHHHHcccCcccCC---CHHHHhcC
Confidence 99999999999999999999876555444332221 12233443 489999999999998 999999 99999999
Q ss_pred CccccC
Q 010266 413 PWFKDI 418 (514)
Q Consensus 413 pff~~i 418 (514)
|||...
T Consensus 263 ~~~~~~ 268 (286)
T cd06622 263 PWLVKY 268 (286)
T ss_pred hhhhhc
Confidence 999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=347.61 Aligned_cols=259 Identities=27% Similarity=0.491 Sum_probs=220.8
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++.+.||.|+||+||+|....++..+|+|++.+..... ....+.+|..+|+.++||+|+++++.+.+.+..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 57999999999999999999998899999999997654322 6677899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 186 EYLPGGDVMTLLMRE---ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
||++|++|.+++... ..+++..++.++.|++.||.+||+.||+||||||+||+++.++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999999764 46899999999999999999999999999999999999999999999999998765422100
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-CCCcccchhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSL 341 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSl 341 (514)
. .......+|++.|+|||++... .++.++|+|||
T Consensus 159 ~---------------------------------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~sl 193 (267)
T cd06610 159 T---------------------------------------------RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSF 193 (267)
T ss_pred c---------------------------------------------ccccccccCChhhcChHHHccccCcCcccchHhH
Confidence 0 0011245799999999999876 78999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcC---cCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEE---ARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~---~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
||++|+|++|..||...+....+.++... ....++.. ..+++++.+||.+||+ ||.+|+ ++++|+.||||
T Consensus 194 G~i~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~ll~~p~~ 267 (267)
T cd06610 194 GITAIELATGAAPYSKYPPMKVLMLTLQN-DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRP---TAEELLKHKFF 267 (267)
T ss_pred hHHHHHHHhCCCCccccChhhhHHHHhcC-CCCCcCCccccccccHHHHHHHHHHcCCChhhCc---CHHHHhhCCCC
Confidence 99999999999999888776666666542 12222221 2578999999999999 999999 99999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=348.12 Aligned_cols=260 Identities=31% Similarity=0.506 Sum_probs=219.3
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccCh------hhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR------GQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~------~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
.|.+...||.|+||.||+|.+..+++.||+|.+........ ...+.+..|..+++.++||+|+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 36778899999999999999999999999999876543221 234678899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
.++||||++|++|..++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999998654211
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 340 (514)
.... .........|++.|+|||++.+..++.++|+||
T Consensus 161 ~~~~-------------------------------------------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~s 197 (267)
T cd06628 161 LSTK-------------------------------------------TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWS 197 (267)
T ss_pred ccCC-------------------------------------------ccccccccCCCcCccChhHhccCCCCchhhhHH
Confidence 0000 000011456999999999999989999999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 341 lGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
|||++|+|++|..||.+.+......++... ....+|. .++.++.+||.+||. ||.+|+ ++.+|+.||||
T Consensus 198 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~ 267 (267)
T cd06628 198 LGCLVVEMLTGKHPFPDCTQLQAIFKIGEN-ASPEIPS--NISSEAIDFLEKTFEIDHNKRP---TAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHhhCCCCCCCccHHHHHHHHhcc-CCCcCCc--ccCHHHHHHHHHHccCCchhCc---CHHHHhhCCCC
Confidence 999999999999999887665555555442 1223333 578999999999999 999999 99999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=344.42 Aligned_cols=253 Identities=32% Similarity=0.523 Sum_probs=220.0
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
+|.+.+.||+|+||.||+|..+.+++.||+|.+..... .......+..|..+++.++||||+++++++.+....|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 58899999999999999999999999999999976543 34456678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 187 YLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 187 y~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
|++|++|.+++... ..+++..+..++.+++.||.|||+.||+||||||+||+++.++++||+|||+++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~--- 156 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--- 156 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc---
Confidence 99999999999764 5788999999999999999999999999999999999999999999999999876532100
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 344 (514)
.....+|++.|+|||++.+..++.++|+|||||+
T Consensus 157 ----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 190 (256)
T cd08529 157 ----------------------------------------------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVV 190 (256)
T ss_pred ----------------------------------------------hhhccccCccccCHHHhcCCCCCCccchHHHHHH
Confidence 0114578999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 345 MYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 345 lyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
+|+|++|..||...+.......+.... ...++. .++.++.++|.+||+ +|++|+ ++.+++.|||+
T Consensus 191 l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~i~~~l~~~p~~Rp---~~~~ll~~~~~ 256 (256)
T cd08529 191 LYECCTGKHPFDANNQGALILKIIRGV-FPPVSQ--MYSQQLAQLIDQCLTKDYRQRP---DTFQLLRNPSL 256 (256)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCcc--ccCHHHHHHHHHHccCCcccCc---CHHHHhhCCCC
Confidence 999999999999888777666665421 112222 678999999999998 999999 99999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=351.90 Aligned_cols=247 Identities=30% Similarity=0.559 Sum_probs=202.4
Q ss_pred CCeeEEeee--eecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCeEE
Q 010266 106 DDFDLLTII--GRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 106 ~~f~~~~~L--G~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~ 182 (514)
++|++.+.+ |.|+||.||+|+++.++..||+|++.+..... .|..+...+ +||+|++++++|.+.+.+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 456666665 99999999999999999999999987653211 122222222 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC-cEEEccccccccCCCCCc
Q 010266 183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG-HMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g-~iKL~DFGla~~~~~~~~ 261 (514)
+||||++||+|..++.....+++..++.++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++......
T Consensus 86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-- 163 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-- 163 (267)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--
Confidence 9999999999999998888999999999999999999999999999999999999999998 9999999998754311
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
....||+.|+|||++.+..++.++|||||
T Consensus 164 ---------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 192 (267)
T PHA03390 164 ---------------------------------------------------SCYDGTLDYFSPEKIKGHNYDVSFDWWAV 192 (267)
T ss_pred ---------------------------------------------------ccCCCCCcccChhhhcCCCCCchhhHHHH
Confidence 13468999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHH-HHHhh-hcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTC-RKIVH-WKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~-~~i~~-~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
||++|+|++|..||......... ..+.. .......+ ..+|+.+.+||.+||+ +|.+|+. +++++++||||++
T Consensus 193 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~--~~~~~l~h~~~~~ 267 (267)
T PHA03390 193 GVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFI--KNVSKNANDFVQSMLKYNINYRLT--NYNEIIKHPFLKI 267 (267)
T ss_pred HHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcc--cccCHHHHHHHHHHhccChhhCCc--hHHHHhcCCcccC
Confidence 99999999999999865443321 11111 11222223 3689999999999999 9999983 3699999999974
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=352.05 Aligned_cols=257 Identities=33% Similarity=0.549 Sum_probs=222.0
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++++.||.|+||.||+|++..+++.||+|++.... .......+.+|..+++.++||||++++++|.++..+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 46889999999999999999999999999999987653 2345567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
||++|++|.+++... .+++..+..++.|++.||.|||+.||+||||+|+||+++.+|.++|+|||+++.......
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~---- 153 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS---- 153 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc----
Confidence 999999999998765 889999999999999999999999999999999999999999999999999886542200
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 345 (514)
.....+||+.|+|||++.+..++.++|+|||||++
T Consensus 154 ---------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il 188 (274)
T cd06609 154 ---------------------------------------------KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITA 188 (274)
T ss_pred ---------------------------------------------ccccccCCccccChhhhccCCCCchhhHHHHHHHH
Confidence 01245799999999999998899999999999999
Q ss_pred HHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCC
Q 010266 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIA 419 (514)
Q Consensus 346 yemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~ 419 (514)
|+|++|.+||.+.++......+... .....+. ..+++++.++|.+||+ +|.+|+ +++++++||||.+..
T Consensus 189 ~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~l~~~l~~~p~~Rp---t~~~il~~~~~~~~~ 258 (274)
T cd06609 189 IELAKGEPPLSDLHPMRVLFLIPKN-NPPSLEG-NKFSKPFKDFVSLCLNKDPKERP---SAKELLKHKFIKKAK 258 (274)
T ss_pred HHHHhCCCCcccCchHHHHHHhhhc-CCCCCcc-cccCHHHHHHHHHHhhCChhhCc---CHHHHhhChhhcCCC
Confidence 9999999999887776666555542 1222232 2278899999999998 999999 999999999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=348.53 Aligned_cols=260 Identities=29% Similarity=0.493 Sum_probs=217.6
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccc---cChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEE
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM---LSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~---~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 183 (514)
+|++.+.||+|+||.||+|.. .+++.+|+|.+..... ........+.+|+++|+.++|+||++++++|.+...+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 578889999999999999975 5788999999875421 223445678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
||||++||+|.+++.+...+++..+..++.|++.||.|||+.||+|+||||+||+++.+|.++|+|||++..........
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999987643211000
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhH
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 343 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 343 (514)
. .........||+.|+|||++.+..++.++|+|||||
T Consensus 160 ~-------------------------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~ 196 (265)
T cd06631 160 T-------------------------------------------HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGC 196 (265)
T ss_pred c-------------------------------------------ccccccccCCCccccChhhhcCCCCcchhhHHHHHH
Confidence 0 000112457999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCChhHHHHHHhhhcCc-ccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKNH-LKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 344 ilyemltG~~PF~~~~~~~~~~~i~~~~~~-~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
++|+|++|.+||...+.......+...... ...| ..++.++.+||.+||. +|.+|+ ++.+++.||||
T Consensus 197 ~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp---~~~~~l~~~~~ 265 (265)
T cd06631 197 TVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLP--DSFSAAAIDFVTSCLTRDQHERP---SALQLLRHDFL 265 (265)
T ss_pred HHHHHHhCCCccccCChHHHHHHhhhccCCCCCCC--CCCCHHHHHHHHHHhcCCcccCC---CHHHHhcCCCC
Confidence 999999999999887666555555432111 1233 3578999999999998 999999 99999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=351.04 Aligned_cols=252 Identities=30% Similarity=0.513 Sum_probs=210.5
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEc------C
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQD------A 178 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~------~ 178 (514)
+.|++.+.||+|+||.||+|..+.+++.||+|++.... .....+..|..++..+ +||||++++++|.+ .
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 56888899999999999999999999999999987542 2345678899999988 69999999999875 3
Q ss_pred CeEEEEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~ 256 (514)
..+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 5689999999999999998763 46899999999999999999999999999999999999999999999999998754
Q ss_pred CCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc-----cCC
Q 010266 257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----KKG 331 (514)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~ 331 (514)
.... .......||+.|+|||++. +..
T Consensus 162 ~~~~-------------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~ 192 (272)
T cd06637 162 DRTV-------------------------------------------------GRRNTFIGTPYWMAPEVIACDENPDAT 192 (272)
T ss_pred cccc-------------------------------------------------ccCCcccccccccCHhHhccccCcCCC
Confidence 3110 0012467999999999986 346
Q ss_pred CCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHh
Q 010266 332 YGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIK 410 (514)
Q Consensus 332 y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 410 (514)
|+.++|+|||||++|||++|..||....+......+.. ..........++.++.+||.+||. +|.+|+ ++.+|+
T Consensus 193 ~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~il 267 (272)
T cd06637 193 YDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR--NPAPRLKSKKWSKKFQSFIESCLVKNHSQRP---TTEQLM 267 (272)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc--CCCCCCCCCCcCHHHHHHHHHHcCCChhhCC---CHHHHh
Confidence 88899999999999999999999987665554444432 211222223578999999999998 999999 999999
Q ss_pred cCCcc
Q 010266 411 AHPWF 415 (514)
Q Consensus 411 ~Hpff 415 (514)
.||||
T Consensus 268 ~~~~~ 272 (272)
T cd06637 268 KHPFI 272 (272)
T ss_pred hCCCC
Confidence 99998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=351.31 Aligned_cols=257 Identities=30% Similarity=0.468 Sum_probs=214.8
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++++.||+|+||.||+|+++.+|+.||+|++.+... .....+.+.+|+.++..++||||++++++|.+...+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 479999999999999999999999999999999875532 2223345778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
||++++.|..++.....+++..++.++.|++.||.|||+.||+||||||+||+++.+|++||+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---- 155 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD---- 155 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc----
Confidence 9999998888887777899999999999999999999999999999999999999999999999999876532210
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchhhhhHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAI 344 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvi 344 (514)
......|+..|+|||++.+ ..++.++|+|||||+
T Consensus 156 ---------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i 190 (286)
T cd07847 156 ---------------------------------------------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCV 190 (286)
T ss_pred ---------------------------------------------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHH
Confidence 0113468899999999876 557899999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHhhhcC-----------------cccCCc----------CcCCChhHHHHHhhhcc-C
Q 010266 345 MYEMLVGYPPFYSDDPVTTCRKIVHWKN-----------------HLKFPE----------EARLTPEAKDLICRLLC-D 396 (514)
Q Consensus 345 lyemltG~~PF~~~~~~~~~~~i~~~~~-----------------~~~~p~----------~~~~s~~~~dLI~~lL~-d 396 (514)
+|+|++|.+||.+.+..+....+..... ....|. ...++..+.+||.+||+ +
T Consensus 191 ~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 270 (286)
T cd07847 191 FAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMD 270 (286)
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCC
Confidence 9999999999998776555444332100 111111 12468899999999999 9
Q ss_pred ccccCCCCCHhHHhcCCcc
Q 010266 397 VEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 397 p~~Rl~~~~~~eil~Hpff 415 (514)
|.+|+ ++.|++.||||
T Consensus 271 p~~Rp---~~~eil~~~~f 286 (286)
T cd07847 271 PTERL---SCEELLEHPYF 286 (286)
T ss_pred ccccC---CHHHHhcCCCC
Confidence 99999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=355.43 Aligned_cols=255 Identities=27% Similarity=0.480 Sum_probs=208.3
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
+|++++.||+|+||.||+|+++.+|+.||+|++..... .......+..|+.+++.++||||+++++++.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 48899999999999999999999999999999976432 22334557789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 187 YLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 187 y~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
|++ ++|..++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~---- 154 (284)
T cd07839 80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR---- 154 (284)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC----
Confidence 996 578887765 56799999999999999999999999999999999999999999999999999875432100
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-CCCcccchhhhhHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAI 344 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvi 344 (514)
......||+.|+|||++.+. .++.++|+|||||+
T Consensus 155 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i 189 (284)
T cd07839 155 ---------------------------------------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCI 189 (284)
T ss_pred ---------------------------------------------CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHH
Confidence 01134688999999998774 47999999999999
Q ss_pred HHHHhhCCCCC-CCCChhHHHHHHhhhc---------------CcccCCc----------CcCCChhHHHHHhhhcc-Cc
Q 010266 345 MYEMLVGYPPF-YSDDPVTTCRKIVHWK---------------NHLKFPE----------EARLTPEAKDLICRLLC-DV 397 (514)
Q Consensus 345 lyemltG~~PF-~~~~~~~~~~~i~~~~---------------~~~~~p~----------~~~~s~~~~dLI~~lL~-dp 397 (514)
+|+|++|..|| .+.+..+.+..+.... ....++. ...+|+++++||.+||. ||
T Consensus 190 l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 269 (284)
T cd07839 190 FAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNP 269 (284)
T ss_pred HHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCCh
Confidence 99999988875 4455444444442210 0000110 12478999999999999 99
Q ss_pred cccCCCCCHhHHhcCCcc
Q 010266 398 EHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 398 ~~Rl~~~~~~eil~Hpff 415 (514)
.+|+ |+++++.||||
T Consensus 270 ~~R~---t~~~il~h~~f 284 (284)
T cd07839 270 VQRI---SAEEALQHPYF 284 (284)
T ss_pred hhcC---CHHHHhcCCCC
Confidence 9999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=352.61 Aligned_cols=264 Identities=19% Similarity=0.312 Sum_probs=217.2
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEcc-----CCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKK-----SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 176 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~-----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 176 (514)
.+..++|++.+.||+|+||.||+|..+. .+..||+|.+.... .......+.+|..+++.++||+|+++++++.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 3556889999999999999999997653 34579999886543 2233445778999999999999999999999
Q ss_pred cCCeEEEEEeecCCCCHHHHHhhcc----------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEE
Q 010266 177 DAEYLYLIMEYLPGGDVMTLLMREE----------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMK 246 (514)
Q Consensus 177 ~~~~l~lVmEy~~gg~L~~~l~~~~----------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iK 246 (514)
+....|+||||++||+|.+++.... .++...+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 9999999999999999999996532 245567888999999999999999999999999999999999999
Q ss_pred EccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccc
Q 010266 247 LSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEV 326 (514)
Q Consensus 247 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEv 326 (514)
|+|||+++........ .......++..|+|||.
T Consensus 160 L~Dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y~~pE~ 192 (288)
T cd05061 160 IGDFGMTRDIYETDYY-----------------------------------------------RKGGKGLLPVRWMAPES 192 (288)
T ss_pred ECcCCccccccccccc-----------------------------------------------cccCCCcccccccCHHH
Confidence 9999998754321100 00012346788999999
Q ss_pred cccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC
Q 010266 327 LLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL 404 (514)
Q Consensus 327 l~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~ 404 (514)
+.+..++.++|+|||||++|||++ |.+||.+.+..+....+... .....|. ..++.++++|.+||+ ||.+|+
T Consensus 193 ~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp--- 266 (288)
T cd05061 193 LKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG-GYLDQPD--NCPERVTDLMRMCWQFNPKMRP--- 266 (288)
T ss_pred hccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCC--CCCHHHHHHHHHHcCCChhHCc---
Confidence 999999999999999999999998 89999988777766666542 2233333 567899999999999 999999
Q ss_pred CHhHHhc------CCccccCCc
Q 010266 405 GSEQIKA------HPWFKDIAW 420 (514)
Q Consensus 405 ~~~eil~------Hpff~~i~w 420 (514)
++.++++ ||||+++||
T Consensus 267 s~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 267 TFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred CHHHHHHHHHhhcCCCCCCCCC
Confidence 8888876 999999999
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=348.57 Aligned_cols=260 Identities=28% Similarity=0.490 Sum_probs=216.8
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccC---hhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEE
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS---RGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~---~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 183 (514)
+|+..+.||+|+||.||++.+..+++.||+|++.+..... ......+..|..+|+.++||+|+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4778899999999999999999999999999997654222 2235678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC-cEEEccccccccCCCCCcc
Q 010266 184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG-HMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g-~iKL~DFGla~~~~~~~~~ 262 (514)
||||++|++|.+++.+.+.+++..+..++.|++.||.|||++|++||||||+||+++.+| .+||+|||++.........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998888899999999999999999999999999999999999998877 5999999998765422100
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
. .......+||..|+|||++.+..++.++|+||||
T Consensus 161 ~---------------------------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG 195 (268)
T cd06630 161 A---------------------------------------------GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVG 195 (268)
T ss_pred C---------------------------------------------CccccccccccceeCHhHhccCCCCcccchHHHH
Confidence 0 0001145799999999999988999999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhh---cCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccc
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHW---KNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFK 416 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~---~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~ 416 (514)
|++|+|++|..||...+.......+... .....+| ..+++++.++|.+||. +|.+|+ ++.++++||||+
T Consensus 196 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~---~~~~ll~~~~~~ 268 (268)
T cd06630 196 CVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIP--EHLSPGLRDVTLRCLELQPEDRP---PSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCc--hhhCHHHHHHHHHHcCCCcccCc---CHHHHhcCcccC
Confidence 9999999999999765543333333221 1222233 2578999999999998 999999 999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=351.66 Aligned_cols=257 Identities=31% Similarity=0.536 Sum_probs=219.9
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
..+|++++.||.|+||.||++.+..+++.||+|.+.... ......+.+|..+++.++||||++++++|.+...+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 467999999999999999999999999999999987543 23456688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
|||++||+|..++.. ..+++..+..++.+++.||.|||+.|++||||||+||+++.+|.+||+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--- 170 (296)
T cd06655 95 MEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--- 170 (296)
T ss_pred EEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc---
Confidence 999999999998854 4689999999999999999999999999999999999999999999999999875432100
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 344 (514)
.....+|++.|+|||++.+..++.++|+|||||+
T Consensus 171 ----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvi 204 (296)
T cd06655 171 ----------------------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM 204 (296)
T ss_pred ----------------------------------------------cCCCcCCCccccCcchhcCCCCCchhhHHHHHHH
Confidence 0113469999999999999889999999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 345 MYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 345 lyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
+|+|++|.+||.+.++......+... ....++....+++.+++||.+||. ||.+|+ ++.+|+.||||+..
T Consensus 205 l~~lltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---t~~~il~~~~~~~~ 275 (296)
T cd06655 205 AIEMVEGEPPYLNENPLRALYLIATN-GTPELQNPEKLSPIFRDFLNRCLEMDVEKRG---SAKELLQHPFLKLA 275 (296)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhc-CCcccCCcccCCHHHHHHHHHHhhcChhhCC---CHHHHhhChHhhhc
Confidence 99999999999988776555554431 111222234688999999999998 999999 99999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=352.56 Aligned_cols=257 Identities=29% Similarity=0.509 Sum_probs=218.1
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 183 (514)
...+|++++.||+|+||.||++.++.+++.||+|.+..... .....+..|..++..++||||+++++.|.+....|+
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l 94 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence 34789999999999999999999999999999999876542 234668889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
||||++||+|..++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 95 v~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-- 171 (296)
T cd06654 95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 171 (296)
T ss_pred eecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--
Confidence 9999999999998854 5689999999999999999999999999999999999999999999999999875421100
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhH
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 343 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 343 (514)
......|++.|+|||++.+..++.++|+|||||
T Consensus 172 -----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gv 204 (296)
T cd06654 172 -----------------------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204 (296)
T ss_pred -----------------------------------------------ccCcccCCccccCHHHHcCCCCCccchHHHHHH
Confidence 011347999999999999988999999999999
Q ss_pred HHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 344 ilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
++|+|++|.+||...++......+... .....+....+++.+.+||.+||. +|.+|+ ++++|+.||||..
T Consensus 205 il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~eil~~~~~~~ 275 (296)
T cd06654 205 MAIEMIEGEPPYLNENPLRALYLIATN-GTPELQNPEKLSAIFRDFLNRCLDMDVEKRG---SAKELLQHQFLKI 275 (296)
T ss_pred HHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCCCCCccccCHHHHHHHHHHCcCCcccCc---CHHHHhhChhhhc
Confidence 999999999999887765544333321 111222223688999999999998 999999 9999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=362.17 Aligned_cols=262 Identities=28% Similarity=0.468 Sum_probs=214.2
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC------
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA------ 178 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~------ 178 (514)
.++|++++.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+.++..++||||++++++|...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 478999999999999999999999999999999986542 2333455677899999999999999999998644
Q ss_pred CeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
...|+||||+. ++|...+... +++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 35799999996 5888887544 89999999999999999999999999999999999999999999999999875432
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
.. ......||+.|+|||++.+..++.++|+
T Consensus 171 ~~--------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 200 (353)
T cd07850 171 SF--------------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDI 200 (353)
T ss_pred CC--------------------------------------------------CCCCCcccccccCHHHHhCCCCCCchhh
Confidence 10 0114568999999999999999999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCc----------------------------------ccCCc-----C
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNH----------------------------------LKFPE-----E 379 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~----------------------------------~~~p~-----~ 379 (514)
|||||++|+|++|..||.+.+....+.+++..... ..+|. .
T Consensus 201 wslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (353)
T cd07850 201 WSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHN 280 (353)
T ss_pred HhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCccccccc
Confidence 99999999999999999988766655555321100 00110 1
Q ss_pred cCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCcccccc
Q 010266 380 ARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLYE 425 (514)
Q Consensus 380 ~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~l~~ 425 (514)
...++.+++||.+||+ ||.+|+ ++.|++.||||+. |-....
T Consensus 281 ~~~~~~~~~li~~~L~~dP~~R~---t~~eiL~~~~~~~--~~~~~~ 322 (353)
T cd07850 281 KLKASQARDLLSKMLVIDPEKRI---SVDDALQHPYINV--WYDPSE 322 (353)
T ss_pred ccchhHHHHHHHHHcCCChhhCc---CHHHHhcChhHhh--ccCCcc
Confidence 1245678999999999 999999 9999999999983 444443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=385.66 Aligned_cols=305 Identities=34% Similarity=0.590 Sum_probs=263.9
Q ss_pred eeeecCceEEEEEEEc---cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEEEcCCeEEEEEeec
Q 010266 113 IIGRGAFGEVRLCQEK---KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYLYLIMEYL 188 (514)
Q Consensus 113 ~LG~G~fG~V~l~~~~---~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l~lVmEy~ 188 (514)
++|+|+||.|++|+.. +.|..||||+++|.....+... +...|+.++..++ ||++|++++.|+++..+|++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 4799999999998753 5678999999998876655555 8889999999997 999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccccc
Q 010266 189 PGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENE 268 (514)
Q Consensus 189 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~ 268 (514)
.||+|...+.....+++...++|.+++++|++++|+.||+|||+|++||+++.+||+|++|||+++......
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-------- 151 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-------- 151 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh--------
Confidence 999999999999999999999999999999999999999999999999999999999999999998653210
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHH
Q 010266 269 VLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 348 (514)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyem 348 (514)
..|||..|||||++. ++..++||||+|+++|||
T Consensus 152 ---------------------------------------------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~fel 184 (612)
T KOG0603|consen 152 ---------------------------------------------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFEL 184 (612)
T ss_pred ---------------------------------------------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHH
Confidence 228999999999998 789999999999999999
Q ss_pred hhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CHhHHhcCCccccCCccccc-
Q 010266 349 LVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHPWFKDIAWDKLY- 424 (514)
Q Consensus 349 ltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~Hpff~~i~w~~l~- 424 (514)
++|..||.+ ++..+|+. ..+.+|. .++..+++++..|+. +|.+|+|.. ++.||++|+||..|+|+.+.
T Consensus 185 ltg~~pf~~----~~~~~Il~--~~~~~p~--~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~ 256 (612)
T KOG0603|consen 185 LTGTLPFGG----DTMKRILK--AELEMPR--ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEA 256 (612)
T ss_pred hhCCCCCch----HHHHHHhh--hccCCch--hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhh
Confidence 999999988 67777775 3456664 789999999999998 999999984 89999999999999999875
Q ss_pred -cccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeeecCccccc
Q 010266 425 -EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFEAVKG 487 (514)
Q Consensus 425 -~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~~~~ 487 (514)
+..|||+|.+..+.|+.+||.......+...+....+ ...+.-|.||+|..+....+
T Consensus 257 r~~~~~fkp~~~~e~~~~~fd~eft~~~P~dsp~~~~~------~s~~~if~g~sfva~~il~~ 314 (612)
T KOG0603|consen 257 RSRPPPFKPGSITERDVAQFDPEFTSQVPADSPLLSAS------GSDHTIFSGPSFVAPGVLED 314 (612)
T ss_pred cCCCCCCCCcccchhhhhhcCchhccCCcccCCCCCCC------ccccchhcCCCccChHHhhc
Confidence 6899999999999999999986666544432222221 13447899999998776644
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=356.85 Aligned_cols=274 Identities=29% Similarity=0.466 Sum_probs=228.6
Q ss_pred HhhcCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeeccccc----ChhhHHHHHHHHHHHHHcCCCceeeEE
Q 010266 97 RLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML----SRGQVEHVRAERNLLAEVASHCIVKLY 172 (514)
Q Consensus 97 ~~~~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~----~~~~~~~~~~E~~iL~~l~hp~Iv~l~ 172 (514)
.+..+..-.++|-++..||+|||+.||+|.+....+.||+|+-.-..-+ +.+..+|..+|.+|.+.++||.||++|
T Consensus 454 QFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlY 533 (775)
T KOG1151|consen 454 QFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLY 533 (775)
T ss_pred hhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeee
Confidence 3455666778899999999999999999999988999999986543322 234568899999999999999999999
Q ss_pred EEEE-cCCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC--CeEEcCCCCCCcccc---CCCcEE
Q 010266 173 YSFQ-DAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH--NYIHRDIKPDNLLLD---QNGHMK 246 (514)
Q Consensus 173 ~~f~-~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~--giiHrDLKpeNILld---~~g~iK 246 (514)
++|. |.+.+|-|+|||+|.||..+|.....++|..||.++.||+.||.||... .|||-||||.|||+- ..|.||
T Consensus 534 DyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 534 DYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred eeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeE
Confidence 9996 6678999999999999999999999999999999999999999999975 699999999999995 458899
Q ss_pred EccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccc
Q 010266 247 LSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEV 326 (514)
Q Consensus 247 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEv 326 (514)
|+||||++.+........ ....++....||.+|++||.
T Consensus 614 ITDFGLSKIMdddSy~~v------------------------------------------dGmeLTSQgAGTYWYLPPEc 651 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNSV------------------------------------------DGMELTSQGAGTYWYLPPEC 651 (775)
T ss_pred eeecchhhhccCCccCcc------------------------------------------cceeeecccCceeeecCcce
Confidence 999999998754321110 01234557889999999999
Q ss_pred ccc----CCCCcccchhhhhHHHHHHhhCCCCCCCCChhH-H--HHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-Ccc
Q 010266 327 LLK----KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVT-T--CRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVE 398 (514)
Q Consensus 327 l~~----~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~-~--~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~ 398 (514)
+.- ...+.+|||||+|||+|.+|+|+.||..+..+. + ...|+. ...+.||..+.+|++|++||++||. .-+
T Consensus 652 FvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlk-AtEVqFP~KPvVsseAkaFIRRCLaYRKe 730 (775)
T KOG1151|consen 652 FVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILK-ATEVQFPPKPVVSSEAKAFIRRCLAYRKE 730 (775)
T ss_pred eecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhc-ceeccCCCCCccCHHHHHHHHHHHHhhhh
Confidence 863 346899999999999999999999997654322 1 122333 3567899989999999999999998 778
Q ss_pred ccCCCCCHhHHhcCCccc
Q 010266 399 HRLGTLGSEQIKAHPWFK 416 (514)
Q Consensus 399 ~Rl~~~~~~eil~Hpff~ 416 (514)
+|. ++.++-.||||.
T Consensus 731 DR~---DV~qLA~dpyll 745 (775)
T KOG1151|consen 731 DRI---DVQQLACDPYLL 745 (775)
T ss_pred hhh---hHHHHccCcccc
Confidence 888 999999999996
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=368.13 Aligned_cols=256 Identities=23% Similarity=0.306 Sum_probs=209.8
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccC-----CCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKS-----GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSF 175 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t-----~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f 175 (514)
.+..++|++.+.||+|+||.||+|++..+ +..||+|+++... .......+..|..+|+.+ +|||||+++++|
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 45567899999999999999999986544 3579999997653 234456788999999999 899999999999
Q ss_pred EcCCeEEEEEeecCCCCHHHHHhhc-------------------------------------------------------
Q 010266 176 QDAEYLYLIMEYLPGGDVMTLLMRE------------------------------------------------------- 200 (514)
Q Consensus 176 ~~~~~l~lVmEy~~gg~L~~~l~~~------------------------------------------------------- 200 (514)
.+...+|+||||+++|+|.+++...
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 9999999999999999999998542
Q ss_pred ---------------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 201 ---------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 201 ---------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
.++++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|+........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~--- 268 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY--- 268 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce---
Confidence 24678889999999999999999999999999999999999999999999998754321000
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 345 (514)
....+..+++.|||||++.+..|+.++|||||||++
T Consensus 269 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil 304 (374)
T cd05106 269 --------------------------------------------VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 304 (374)
T ss_pred --------------------------------------------eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHH
Confidence 001123466789999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 346 YEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 346 yemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|||++ |.+||...........+.........| ..++++++++|.+||+ ||.+|+ ++++|.+
T Consensus 305 ~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~RP---s~~~l~~ 367 (374)
T cd05106 305 WEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRP--DFAPPEIYSIMKMCWNLEPTERP---TFSQISQ 367 (374)
T ss_pred HHHHhCCCCCCccccccHHHHHHHHcccCccCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 99997 999998776555554554432223333 3578999999999999 999999 8888864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=346.59 Aligned_cols=259 Identities=27% Similarity=0.507 Sum_probs=216.0
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeeccccc-------ChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML-------SRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE 179 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~-------~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 179 (514)
+|.+.+.||.|+||.||++....+|+.||+|.++..... .....+.+..|..+++.++||+|+++++++.+.+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999999999999999988643211 1123456788999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
..++||||++||+|.+++...+.+++..++.++.|++.||.|||+.|++||||||+||+++.+|.++|+|||+++.....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999998754311
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCC--CCcccc
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG--YGMECD 337 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~--y~~~~D 337 (514)
.. ........|+..|+|||++.... ++.++|
T Consensus 162 ~~-----------------------------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~D 194 (272)
T cd06629 162 YD-----------------------------------------------NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVD 194 (272)
T ss_pred cc-----------------------------------------------ccccccccCCccccCHHHhccccCCCCccch
Confidence 00 00012456899999999998754 899999
Q ss_pred hhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcC--cCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCc
Q 010266 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEE--ARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPW 414 (514)
Q Consensus 338 iWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~--~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpf 414 (514)
+|||||++|+|++|..||...+..+....+........+|.. ..++.++++||.+||. +|..|+ ++++|++|||
T Consensus 195 v~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~~ 271 (272)
T cd06629 195 IWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRP---TARELLQHPF 271 (272)
T ss_pred hHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCC---CHHHHhhCCC
Confidence 999999999999999999776655555444332223334432 2468999999999998 999999 8999999999
Q ss_pred c
Q 010266 415 F 415 (514)
Q Consensus 415 f 415 (514)
|
T Consensus 272 ~ 272 (272)
T cd06629 272 I 272 (272)
T ss_pred C
Confidence 7
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=374.05 Aligned_cols=253 Identities=24% Similarity=0.289 Sum_probs=205.5
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
...|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|.++|+.++|||||++++++......|+|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4579999999999999999999999999999996432 2256799999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 185 MEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
||++. |+|..++... ..+++..++.++.|++.||.|||++|||||||||+||||+.++.+||+|||+++........
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~- 316 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST- 316 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc-
Confidence 99995 6888887654 57999999999999999999999999999999999999999999999999998754311000
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhH
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 343 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 343 (514)
......+||+.|+|||++.+..++.++|||||||
T Consensus 317 ----------------------------------------------~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGv 350 (461)
T PHA03211 317 ----------------------------------------------PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGL 350 (461)
T ss_pred ----------------------------------------------ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHH
Confidence 0112467999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCCh-------hHHHHHHhhhcCc--ccCC-----------------------------cCcCCChh
Q 010266 344 IMYEMLVGYPPFYSDDP-------VTTCRKIVHWKNH--LKFP-----------------------------EEARLTPE 385 (514)
Q Consensus 344 ilyemltG~~PF~~~~~-------~~~~~~i~~~~~~--~~~p-----------------------------~~~~~s~~ 385 (514)
+||||++|..|+.+... .....+++..... ..+| ....++.+
T Consensus 351 iL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (461)
T PHA03211 351 VIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLD 430 (461)
T ss_pred HHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccch
Confidence 99999998876643221 1222233221110 0111 11135678
Q ss_pred HHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 386 AKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 386 ~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
+.+||.+||. ||.+|+ +++|+++||||+.
T Consensus 431 ~~dli~~mL~~DP~~RP---sa~elL~hp~f~~ 460 (461)
T PHA03211 431 VEYLVCRALTFDGARRP---SAAELLRLPLFQS 460 (461)
T ss_pred HHHHHHHHcccChhhCc---CHHHHhhCcccCC
Confidence 9999999999 999999 9999999999964
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=341.13 Aligned_cols=253 Identities=30% Similarity=0.522 Sum_probs=221.0
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
+|++++.||.|+||.|++++...+++.+|+|.+..... .......+.+|.++|+.++|+||++++++|.+...+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 58999999999999999999999999999999876543 34456678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 187 YLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 187 y~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
|++||+|.+++.+. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--- 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--- 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc---
Confidence 99999999999764 5689999999999999999999999999999999999999999999999999875432100
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 344 (514)
......||+.|+|||++.+..++.++|+|||||+
T Consensus 157 ----------------------------------------------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i 190 (256)
T cd08221 157 ----------------------------------------------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCV 190 (256)
T ss_pred ----------------------------------------------cccccCCCccccCHhhcCCCCCCCcchhHHHHHH
Confidence 0114579999999999998889999999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 345 MYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 345 lyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
+|+|++|..||.+.+..+....+.... .. +....++.++.++|.+||+ +|.+|+ +++++++|||+
T Consensus 191 ~~~l~~g~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~i~~~l~~~p~~R~---s~~~ll~~~~l 256 (256)
T cd08221 191 LYELLTLKRTFDATNPLNLVVKIVQGN--YT-PVVSVYSSELISLVHSLLQQDPEKRP---TADEVLDQPLL 256 (256)
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHcCC--CC-CCccccCHHHHHHHHHHcccCcccCC---CHHHHhhCcCC
Confidence 999999999999988888887776522 11 1124678999999999998 999998 99999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=342.73 Aligned_cols=259 Identities=31% Similarity=0.537 Sum_probs=219.8
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeeccc--ccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC--CeE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSE--MLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA--EYL 181 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~--~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~--~~l 181 (514)
.+|++.+.||+|+||.||++.++.+++.||+|++.... .........+.+|+.+++.++||+|+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 58999999999999999999999999999999986432 12234556788999999999999999999998764 568
Q ss_pred EEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
++||||++|++|.+++...+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 99999999999999998878899999999999999999999999999999999999999999999999999886532100
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
. ........||+.|+|||++.+..++.++|+|||
T Consensus 162 ~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 195 (264)
T cd06653 162 S----------------------------------------------GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSV 195 (264)
T ss_pred c----------------------------------------------CccccccCCcccccCHhhhcCCCCCccccHHHH
Confidence 0 000114569999999999999889999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhccCccccCCCCCHhHHhcCCcc
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~Hpff 415 (514)
||++|+|++|.+||..........++........+|. .+++++.++|.+||.+|..|+ ++.+++.|||.
T Consensus 196 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~~i~~~l~~~~~r~---~~~~~~~~~~~ 264 (264)
T cd06653 196 ACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPD--GVSDACRDFLKQIFVEEKRRP---TAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCc--ccCHHHHHHHHHHhcCcccCc---cHHHHhcCCCC
Confidence 9999999999999988776666666554333344554 689999999999999888888 99999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=384.24 Aligned_cols=287 Identities=24% Similarity=0.344 Sum_probs=212.9
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCC-CEEEEE--------------EeecccccChhhHHHHHHHHHHHHHcCCCce
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSG-NIYAMK--------------KLKKSEMLSRGQVEHVRAERNLLAEVASHCI 168 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~-~~~AiK--------------~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~I 168 (514)
..++|++++.||+|+||+||+|..+... ...+.| ++.+...........+.+|+.+|..++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3578999999999999999998765432 222222 1111111122344567899999999999999
Q ss_pred eeEEEEEEcCCeEEEEEeecCCCCHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC
Q 010266 169 VKLYYSFQDAEYLYLIMEYLPGGDVMTLLMRE-----ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG 243 (514)
Q Consensus 169 v~l~~~f~~~~~l~lVmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g 243 (514)
|++++++.+.+..|+|||++. ++|..++... .......++.++.||+.||.|||++|||||||||+|||++.+|
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 999999999999999999995 5777776432 2334667888999999999999999999999999999999999
Q ss_pred cEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCC
Q 010266 244 HMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIA 323 (514)
Q Consensus 244 ~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~A 323 (514)
.+||+|||+|+.+..... ....+.+||+.|+|
T Consensus 305 ~vkL~DFGla~~~~~~~~------------------------------------------------~~~~~~~gt~~y~a 336 (501)
T PHA03210 305 KIVLGDFGTAMPFEKERE------------------------------------------------AFDYGWVGTVATNS 336 (501)
T ss_pred CEEEEeCCCceecCcccc------------------------------------------------cccccccCCcCCCC
Confidence 999999999976532100 01125689999999
Q ss_pred ccccccCCCCcccchhhhhHHHHHHhhCCCCCCC-C--ChhHHHHHHhhhcC--cccCCc--------------------
Q 010266 324 PEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS-D--DPVTTCRKIVHWKN--HLKFPE-------------------- 378 (514)
Q Consensus 324 PEvl~~~~y~~~~DiWSlGvilyemltG~~PF~~-~--~~~~~~~~i~~~~~--~~~~p~-------------------- 378 (514)
||++.+..|+.++|||||||++|||++|..|+.+ . ++.....+++.... ...+|.
T Consensus 337 PE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~ 416 (501)
T PHA03210 337 PEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHS 416 (501)
T ss_pred chhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccc
Confidence 9999999999999999999999999998755432 2 22233333222100 001110
Q ss_pred ------CcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCcccccc---------ccCCCCCcCCCCCCCCC
Q 010266 379 ------EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLYE---------MEAAYKPEVNGVLDTQN 442 (514)
Q Consensus 379 ------~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~l~~---------~~~p~~p~~~~~~d~~~ 442 (514)
...++.++.++|.+||+ ||.+|+ ++.|++.||||...+++.+.- --.|+.|.+....|+..
T Consensus 417 ~~~~~~~~~~~~~~~~li~kmL~~DP~~Rp---sa~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 493 (501)
T PHA03210 417 VPPLIRNLGLPADFEYPLVKMLTFDWHLRP---GAAELLALPLFSAEEEEEILFIHGLKSGAAHFKPIKPACRIESDTAA 493 (501)
T ss_pred hhhHHHhcCCChHHHHHHHHHhccCcccCc---CHHHHhhChhhhcCCchHHHHHHhhhccccccccCCchheecccccc
Confidence 12356788899999999 999999 999999999999988776531 23467777666555543
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=342.43 Aligned_cols=255 Identities=29% Similarity=0.519 Sum_probs=217.5
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.++|++.+.||.|+||.||+|.+..+++.+|+|++.... ......+..|..+++.++||+|+++++++.+...+|+|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 368999999999999999999999999999999997653 23567788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 185 MEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
|||++|++|..++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--- 155 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--- 155 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh---
Confidence 9999999999998776 789999999999999999999999999999999999999999999999999987543210
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC---CCCcccchhh
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK---GYGMECDWWS 340 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~---~y~~~~DiWS 340 (514)
......+|++.|+|||++.+. .++.++|+||
T Consensus 156 ----------------------------------------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~s 189 (262)
T cd06613 156 ----------------------------------------------AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWA 189 (262)
T ss_pred ----------------------------------------------hccccccCCccccCchhhcccccCCcCchhhhHH
Confidence 001145789999999999877 8899999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhHHHHHHhhhc-CcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCc
Q 010266 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVHWK-NHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPW 414 (514)
Q Consensus 341 lGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpf 414 (514)
|||++|+|++|.+||.+.++......+.... ..........++.++.+||.+||+ +|..|+ ++++|+.|||
T Consensus 190 lG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~il~~~~ 262 (262)
T cd06613 190 LGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRP---TATKLLQHPF 262 (262)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCC---CHHHHhcCCC
Confidence 9999999999999998877665554444321 011111122467889999999998 999999 9999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=353.61 Aligned_cols=256 Identities=30% Similarity=0.520 Sum_probs=216.5
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
..+|++++.||.|+||.||+|.+..+++.||+|.+..... ...+.+..|..+++.++||||++++++|.+....|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 3789999999999999999999999999999999875432 3345678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
|||++|++|..++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|.++|+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--- 170 (297)
T cd06656 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--- 170 (297)
T ss_pred ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc---
Confidence 999999999999854 5688999999999999999999999999999999999999999999999999875432100
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 344 (514)
......|++.|+|||.+.+..++.++|+|||||+
T Consensus 171 ----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvi 204 (297)
T cd06656 171 ----------------------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM 204 (297)
T ss_pred ----------------------------------------------CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHH
Confidence 0113468999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 345 MYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 345 lyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
+|+|++|.+||.+.++......+... ..........+++.+++||.+||. +|.+|+ ++++|+.||||+.
T Consensus 205 l~~l~tg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~~~~~ 274 (297)
T cd06656 205 AIEMVEGEPPYLNENPLRALYLIATN-GTPELQNPERLSAVFRDFLNRCLEMDVDRRG---SAKELLQHPFLKL 274 (297)
T ss_pred HHHHHhCCCCCCCCCcchheeeeccC-CCCCCCCccccCHHHHHHHHHHccCChhhCc---CHHHHhcCchhcc
Confidence 99999999999887664443333221 111111223678899999999998 999999 9999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=352.53 Aligned_cols=261 Identities=28% Similarity=0.446 Sum_probs=215.9
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC--CeE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA--EYL 181 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~--~~l 181 (514)
..++|++++.||+|+||.||+|.++.+|+.||+|++..... .......+.+|..++..++||+|+++++++.+. +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 46899999999999999999999999999999999875432 222233456799999999999999999999765 579
Q ss_pred EEEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 182 YLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
|+||||+. ++|.+++.. ...+++..+..++.|++.||.|||+.|++||||||+||+++.+|.+||+|||++.......
T Consensus 84 ~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 99999996 488888765 4678999999999999999999999999999999999999999999999999987653210
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWW 339 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiW 339 (514)
. ......+++.|+|||++.+ ..++.++|+|
T Consensus 163 ~-------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvw 193 (309)
T cd07845 163 K-------------------------------------------------PMTPKVVTLWYRAPELLLGCTTYTTAIDMW 193 (309)
T ss_pred C-------------------------------------------------CCCcccccccccChhhhcCCCCcCchHHHH
Confidence 0 0012356889999999876 5689999999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcC-----------------cccCCcC---------cCCChhHHHHHhhh
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKN-----------------HLKFPEE---------ARLTPEAKDLICRL 393 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-----------------~~~~p~~---------~~~s~~~~dLI~~l 393 (514)
||||++|||++|.+||.+.+..+.+..+..... .+.++.. ..+++++.+||.+|
T Consensus 194 slG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~m 273 (309)
T cd07845 194 AVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFL 273 (309)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHH
Confidence 999999999999999999888888777765211 0111110 13589999999999
Q ss_pred cc-CccccCCCCCHhHHhcCCccccC
Q 010266 394 LC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 394 L~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
|+ ||.+|+ ++++++.||||++.
T Consensus 274 l~~dp~~R~---t~~~il~h~~f~~~ 296 (309)
T cd07845 274 LMYDPKKRA---TAEEALESSYFKEK 296 (309)
T ss_pred hcCChhhCc---CHHHHhcChhhccC
Confidence 99 999999 99999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=340.95 Aligned_cols=260 Identities=31% Similarity=0.499 Sum_probs=221.3
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
+|++.+.||+|+||.||++....+++.||+|+++.... .......+..|..+++.++||+|+++++.+.+.+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc-chHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 58899999999999999999988999999999987643 24577889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccc
Q 010266 187 YLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE 266 (514)
Q Consensus 187 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~ 266 (514)
|+++++|.+++.....+++..++.++.+++.||.|||+.||+||||+|+||+++.++.+||+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~--- 156 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM--- 156 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc---
Confidence 99999999999888789999999999999999999999999999999999999999999999999988654321100
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCC---CCcccchhhhhH
Q 010266 267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG---YGMECDWWSLGA 343 (514)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~---y~~~~DiWSlGv 343 (514)
........|++.|+|||++.+.. ++.++|+|||||
T Consensus 157 ------------------------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~ 194 (264)
T cd06626 157 ------------------------------------------GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGC 194 (264)
T ss_pred ------------------------------------------cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHH
Confidence 00011356899999999998766 899999999999
Q ss_pred HHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 344 ilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
++|+|++|..||...+........+.......+|....+++.+.+||.+||. +|.+|+ ++++++.|||+
T Consensus 195 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~---~~~~i~~~~~~ 264 (264)
T cd06626 195 VVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRP---TASELLQHPFV 264 (264)
T ss_pred HHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCC---CHHHHhcCCCC
Confidence 9999999999997654333322222223445666655679999999999998 999999 99999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=354.72 Aligned_cols=249 Identities=25% Similarity=0.442 Sum_probs=192.2
Q ss_pred eeeeecCceEEEEEEEcc--CCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE--cCCeEEEEEee
Q 010266 112 TIIGRGAFGEVRLCQEKK--SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ--DAEYLYLIMEY 187 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~--t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~--~~~~l~lVmEy 187 (514)
..||+|+||+||+|+.+. ++..||+|.+..... ...+.+|..+|+.++||||++++++|. ++..+|+||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 579999999999999764 568899999875432 234678999999999999999999885 46789999999
Q ss_pred cCCCCHHHHHhh---------ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccc----cCCCcEEEccccccc
Q 010266 188 LPGGDVMTLLMR---------EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL----DQNGHMKLSDFGLCK 254 (514)
Q Consensus 188 ~~gg~L~~~l~~---------~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILl----d~~g~iKL~DFGla~ 254 (514)
++ ++|..++.. ...+++..++.++.|++.||.|||+.||+||||||+|||+ +.+|.+||+|||+|+
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 96 577777642 1358899999999999999999999999999999999999 567899999999998
Q ss_pred cCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCC
Q 010266 255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYG 333 (514)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~ 333 (514)
........ .......+||+.|+|||++.+ ..++
T Consensus 161 ~~~~~~~~----------------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~ 194 (317)
T cd07867 161 LFNSPLKP----------------------------------------------LADLDPVVVTFWYRAPELLLGARHYT 194 (317)
T ss_pred ccCCCccc----------------------------------------------ccccCcceecccccCcHHhcCCCccC
Confidence 65422100 000124679999999999977 4589
Q ss_pred cccchhhhhHHHHHHhhCCCCCCCCChh---------HHHHHHhh---------hcC---cccCC---------------
Q 010266 334 MECDWWSLGAIMYEMLVGYPPFYSDDPV---------TTCRKIVH---------WKN---HLKFP--------------- 377 (514)
Q Consensus 334 ~~~DiWSlGvilyemltG~~PF~~~~~~---------~~~~~i~~---------~~~---~~~~p--------------- 377 (514)
.++|||||||++|||++|.+||.+.... .....+.. |.. ...++
T Consensus 195 ~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (317)
T cd07867 195 KAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSS 274 (317)
T ss_pred cHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCch
Confidence 9999999999999999999999754321 11111110 000 00000
Q ss_pred -------cCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 378 -------EEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 378 -------~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
.....+..+.+||.+||+ ||.+|+ |++|+++||||
T Consensus 275 ~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~---t~~e~l~hp~f 317 (317)
T cd07867 275 LIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRI---TSEQALQDPYF 317 (317)
T ss_pred hhhhhhcccCCCChHHHHHHHHHhccCccccc---CHHHHhcCCCC
Confidence 011245678999999999 999999 99999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=346.53 Aligned_cols=258 Identities=27% Similarity=0.480 Sum_probs=208.9
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHH-HHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL-LAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~i-L~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
++|++++.||+|+||.||+|+++.+|+.||+|++++... ...+. .+..|..+ ++..+||||+++++++.++..+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~-~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQEQK-RLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC-cHHHH-HHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 589999999999999999999999999999999976532 22333 34445554 6667899999999999999999999
Q ss_pred EeecCCCCHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC-CeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 185 MEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 185 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
|||++ |+|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99996 678777653 34789999999999999999999997 9999999999999999999999999998754211
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc----CCCCcc
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK----KGYGME 335 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~----~~y~~~ 335 (514)
. ......||+.|+|||++.+ .+++.+
T Consensus 158 ~--------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 187 (283)
T cd06617 158 V--------------------------------------------------AKTIDAGCKPYMAPERINPELNQKGYDVK 187 (283)
T ss_pred c--------------------------------------------------ccccccCCccccChhhcCCcccccccCcc
Confidence 0 0013468999999999865 567899
Q ss_pred cchhhhhHHHHHHhhCCCCCCCC-ChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCC
Q 010266 336 CDWWSLGAIMYEMLVGYPPFYSD-DPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHP 413 (514)
Q Consensus 336 ~DiWSlGvilyemltG~~PF~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hp 413 (514)
+|+|||||++|+|++|..||... ...+....+.. .....+|. ..+|.++.+||.+||. +|.+|+ ++++|+.||
T Consensus 188 ~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rp---~~~~il~~~ 262 (283)
T cd06617 188 SDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-EPSPQLPA-EKFSPEFQDFVNKCLKKNYKERP---NYPELLQHP 262 (283)
T ss_pred ccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh-cCCCCCCc-cccCHHHHHHHHHHccCChhhCc---CHHHHhcCc
Confidence 99999999999999999999653 23333334432 12233443 2578999999999998 999999 999999999
Q ss_pred ccccCCcc
Q 010266 414 WFKDIAWD 421 (514)
Q Consensus 414 ff~~i~w~ 421 (514)
||+...+.
T Consensus 263 ~~~~~~~~ 270 (283)
T cd06617 263 FFELHLSK 270 (283)
T ss_pred hhhhcccc
Confidence 99986654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=350.99 Aligned_cols=257 Identities=33% Similarity=0.523 Sum_probs=215.9
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++++.||+|+||.||+|.++.+++.||+|++.+.... ....+.+.+|.++|+.++||||++++++|.+....|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 4799999999999999999999999999999998765432 234456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
||+++++|..+......+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~---- 155 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---- 155 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc----
Confidence 9999999988877767799999999999999999999999999999999999999999999999999876432110
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchhhhhHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAI 344 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvi 344 (514)
.....+|++.|+|||++.+ ..++.++|+|||||+
T Consensus 156 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~ 190 (286)
T cd07846 156 ---------------------------------------------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCL 190 (286)
T ss_pred ---------------------------------------------ccCcccceeeccCcHHhccccccCchHhHHHHHHH
Confidence 0113568999999999876 457889999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHhhhcCcc-----------------cCCc----------CcCCChhHHHHHhhhcc-C
Q 010266 345 MYEMLVGYPPFYSDDPVTTCRKIVHWKNHL-----------------KFPE----------EARLTPEAKDLICRLLC-D 396 (514)
Q Consensus 345 lyemltG~~PF~~~~~~~~~~~i~~~~~~~-----------------~~p~----------~~~~s~~~~dLI~~lL~-d 396 (514)
+|||++|.+||.+.+..+....+..+...+ ..|. ...++..+.+||.+||. +
T Consensus 191 l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 270 (286)
T cd07846 191 VTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRID 270 (286)
T ss_pred HHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCC
Confidence 999999999998877655555544321111 1111 12568899999999998 9
Q ss_pred ccccCCCCCHhHHhcCCcc
Q 010266 397 VEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 397 p~~Rl~~~~~~eil~Hpff 415 (514)
|.+|+ ++.+|+.||||
T Consensus 271 P~~Rp---~~~~il~~~~~ 286 (286)
T cd07846 271 PDDRP---SSSQLLHHEFF 286 (286)
T ss_pred cccch---hHHHHhcCCCC
Confidence 99999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=350.33 Aligned_cols=256 Identities=25% Similarity=0.414 Sum_probs=216.7
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 183 (514)
..++|++++.||+|+||+||++.+..+++.||+|++.... .......+.+|.+++..++||||+++++++.+...+|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 4578999999999999999999999999999999987542 23345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
||||++||+|..++...+.+++..++.++.+++.||.|||+ .|++||||||+||+++.++.++|+|||++......
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--- 157 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--- 157 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence 99999999999999888889999999999999999999997 69999999999999999999999999998643211
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
.....+||..|+|||++.+..++.++|+||||
T Consensus 158 ------------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG 189 (284)
T cd06620 158 ------------------------------------------------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLG 189 (284)
T ss_pred ------------------------------------------------ccCccccCcccCCHHHHccCCCCccchHHHHH
Confidence 01145799999999999888999999999999
Q ss_pred HHHHHHhhCCCCCCCCChh-----------HHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHh
Q 010266 343 AIMYEMLVGYPPFYSDDPV-----------TTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIK 410 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~-----------~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 410 (514)
|++|+|++|..||...+.. +....+... ....+|. ..++.++.+||.+||. ||.+|+ +++|++
T Consensus 190 ~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~li~~~l~~dp~~Rp---t~~e~~ 264 (284)
T cd06620 190 ISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-PPPRLPS-SDFPEDLRDFVDACLLKDPTERP---TPQQLC 264 (284)
T ss_pred HHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-cCCCCCc-hhcCHHHHHHHHHHhcCCcccCc---CHHHHh
Confidence 9999999999999865542 222333221 1122222 2367899999999998 999999 999999
Q ss_pred cCCcccc
Q 010266 411 AHPWFKD 417 (514)
Q Consensus 411 ~Hpff~~ 417 (514)
+||||..
T Consensus 265 ~~~~~~~ 271 (284)
T cd06620 265 AMPPFIQ 271 (284)
T ss_pred cCccccc
Confidence 9999953
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=347.03 Aligned_cols=257 Identities=30% Similarity=0.514 Sum_probs=216.0
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
+|++.+.||.|+||.||+|.++.+|+.||+|++..... .......+.+|..+++.++||||+++++++.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 58999999999999999999999999999999986543 23445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 187 YLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 187 y~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
|+ |++|.+++.. ...+++..++.++.|++.||.|||+.||+|+||||+||+++.+|.++|+|||++........
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~---- 154 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP---- 154 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC----
Confidence 99 9999999865 46789999999999999999999999999999999999999999999999999876542210
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-CCCcccchhhhhHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAI 344 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvi 344 (514)
.......||+.|+|||++.+. .++.++|||||||+
T Consensus 155 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~ 190 (286)
T cd07832 155 --------------------------------------------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCI 190 (286)
T ss_pred --------------------------------------------CccccccCcccccCceeeeccccCCchhHHHHHHHH
Confidence 001135799999999998764 46899999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHhhhcC-----------------cccCCcC---------cCCChhHHHHHhhhcc-Cc
Q 010266 345 MYEMLVGYPPFYSDDPVTTCRKIVHWKN-----------------HLKFPEE---------ARLTPEAKDLICRLLC-DV 397 (514)
Q Consensus 345 lyemltG~~PF~~~~~~~~~~~i~~~~~-----------------~~~~p~~---------~~~s~~~~dLI~~lL~-dp 397 (514)
+|+|++|.+||.+.+....+..++.... ...++.. ...+.++.+||.+||. +|
T Consensus 191 l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 270 (286)
T cd07832 191 FAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDP 270 (286)
T ss_pred HHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccCh
Confidence 9999999999988877666665543111 1111111 1357899999999999 99
Q ss_pred cccCCCCCHhHHhcCCccc
Q 010266 398 EHRLGTLGSEQIKAHPWFK 416 (514)
Q Consensus 398 ~~Rl~~~~~~eil~Hpff~ 416 (514)
.+|+ ++++++.||||.
T Consensus 271 ~~R~---~~~~~l~h~~~~ 286 (286)
T cd07832 271 SKRL---SAAEALRHPYFT 286 (286)
T ss_pred hhCC---CHHHHhhCcCcC
Confidence 9999 999999999993
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=346.78 Aligned_cols=274 Identities=41% Similarity=0.741 Sum_probs=228.6
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEEEcCCeEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l~lV 184 (514)
++|.+.+.||+|+||.||+|....+++.||+|++.+..+........+..|..++..+. ||||++++++|.+.+.+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998866655566677889999999998 99999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
|||++|++|.+++.+.+.+++..+..++.|++.||.+||+.|++|+||||+||+++.+|+++|+|||++...........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 99999999999999888999999999999999999999999999999999999999999999999999886543211100
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 344 (514)
..... . ...... . ..........|++.|+|||++.+..++.++|+|||||+
T Consensus 161 ~~~~~---------~-----~~~~~~-~--------------~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~ 211 (280)
T cd05581 161 NKGDA---------T-----NIDSQI-E--------------KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCI 211 (280)
T ss_pred CCCCC---------c-----cccccc-c--------------ccccccccccCCccccCHHHhCCCCCChhhhHHHHHHH
Confidence 00000 0 000000 0 00011235679999999999998889999999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCH----hHHhcCCcc
Q 010266 345 MYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGS----EQIKAHPWF 415 (514)
Q Consensus 345 lyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~----~eil~Hpff 415 (514)
+|+|++|.+||...+....+..+.. ....+|. .+++.+.+||.+||. +|.+|+ ++ +++++||||
T Consensus 212 l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~R~---~~~~~~~~ll~~~~~ 280 (280)
T cd05581 212 IYQMLTGKPPFRGSNEYLTFQKILK--LEYSFPP--NFPPDAKDLIEKLLVLDPQDRL---GVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHHhCCCCCCCccHHHHHHHHHh--cCCCCCC--ccCHHHHHHHHHHhcCCHhhCC---CcccCHHHHhcCCCC
Confidence 9999999999998887777777653 3344553 678999999999998 999999 88 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=350.76 Aligned_cols=259 Identities=29% Similarity=0.473 Sum_probs=215.9
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccC--hhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS--RGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~--~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
+|++++.||.|+||.||+|.++.+++.||+|.+....... ......+..|..+++.++||||+++++++.+...+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4889999999999999999999999999999998765431 22345567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 185 MEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
|||+ +|+|..++.... .+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-- 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-- 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc--
Confidence 9999 899999997766 899999999999999999999999999999999999999999999999999876532110
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchhhhh
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 342 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlG 342 (514)
......+++.|+|||++.+ ..++.++|+||||
T Consensus 158 -----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 190 (298)
T cd07841 158 -----------------------------------------------KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVG 190 (298)
T ss_pred -----------------------------------------------cccccccceeeeCHHHHhCCCCCCcHHHHHHHH
Confidence 0113357889999999865 4678999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcCcc---------cC---------Cc------CcCCChhHHHHHhhhcc-Cc
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL---------KF---------PE------EARLTPEAKDLICRLLC-DV 397 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~~~---------~~---------p~------~~~~s~~~~dLI~~lL~-dp 397 (514)
|++|||++|.+||.+.+..+...++....... .. +. ....+.++.+||.+||. +|
T Consensus 191 ~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 270 (298)
T cd07841 191 CIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNP 270 (298)
T ss_pred HHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCc
Confidence 99999999999998887766665554311000 00 00 12357899999999999 99
Q ss_pred cccCCCCCHhHHhcCCccccC
Q 010266 398 EHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 398 ~~Rl~~~~~~eil~Hpff~~i 418 (514)
.+|+ +++|++.||||++.
T Consensus 271 ~~R~---s~~e~l~~~~~~~~ 288 (298)
T cd07841 271 NKRI---TARQALEHPYFSND 288 (298)
T ss_pred ccCc---CHHHHhhCccccCC
Confidence 9999 99999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=341.93 Aligned_cols=253 Identities=32% Similarity=0.536 Sum_probs=217.0
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.++|++.+.||.|+||.||+|..+.+++.||+|.+.... ..+.+.+|.++++.++||||+++++.+.+...+|+|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 368999999999999999999999889999999987542 256788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 185 MEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 185 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
|||++|++|.+++.. ...+++..++.++.|++.||.|||+.||+||||+|+||+++.+|.+||+|||++........
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 999999999999875 46789999999999999999999999999999999999999999999999999886532110
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhH
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 343 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 343 (514)
......|++.|+|||++.+..++.++|+|||||
T Consensus 155 -----------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~ 187 (256)
T cd06612 155 -----------------------------------------------KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGI 187 (256)
T ss_pred -----------------------------------------------ccccccCCccccCHHHHhcCCCCchhhHHHHHH
Confidence 011346899999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 344 ilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
++|+|++|.+||...++......+.... ...+.....++.++.++|.+||. +|.+|+ +++||+.||||
T Consensus 188 il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp---s~~~il~~~~~ 256 (256)
T cd06612 188 TAIEMAEGKPPYSDIHPMRAIFMIPNKP-PPTLSDPEKWSPEFNDFVKKCLVKDPEERP---SAIQLLQHPFI 256 (256)
T ss_pred HHHHHHhCCCCCCCcchhhhhhhhccCC-CCCCCchhhcCHHHHHHHHHHHhcChhhCc---CHHHHhcCCCC
Confidence 9999999999998776655444443311 11222223578899999999998 999999 99999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=346.96 Aligned_cols=255 Identities=29% Similarity=0.488 Sum_probs=211.6
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEE-----
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQ----- 176 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~----- 176 (514)
...+.|++.+.||.|+||.||+|+++.+++.||+|++... ......+..|..++..+ +||||++++++|.
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 3457899999999999999999999999999999998654 23445678899999988 7999999999985
Q ss_pred -cCCeEEEEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccc
Q 010266 177 -DAEYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253 (514)
Q Consensus 177 -~~~~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla 253 (514)
....+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 356899999999999999998653 45888889999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc-----
Q 010266 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL----- 328 (514)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~----- 328 (514)
....... ......+|++.|+|||++.
T Consensus 169 ~~~~~~~-------------------------------------------------~~~~~~~~~~~y~aPE~l~~~~~~ 199 (282)
T cd06636 169 AQLDRTV-------------------------------------------------GRRNTFIGTPYWMAPEVIACDENP 199 (282)
T ss_pred hhhhccc-------------------------------------------------cCCCcccccccccCHhhcCcccCc
Confidence 7542110 0012467999999999986
Q ss_pred cCCCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHh
Q 010266 329 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSE 407 (514)
Q Consensus 329 ~~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ 407 (514)
+..++.++|+|||||++|||++|.+||....+......+... ...... ...++.++.+||.+||. ||.+|+ ++.
T Consensus 200 ~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~cl~~~p~~Rp---~~~ 274 (282)
T cd06636 200 DATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PPPKLK-SKKWSKKFIDFIEGCLVKNYLSRP---STE 274 (282)
T ss_pred CcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC-CCCCCc-ccccCHHHHHHHHHHhCCChhhCc---CHH
Confidence 356888999999999999999999999877665554444321 111111 23578999999999998 999999 999
Q ss_pred HHhcCCcc
Q 010266 408 QIKAHPWF 415 (514)
Q Consensus 408 eil~Hpff 415 (514)
||+.||||
T Consensus 275 ell~~~~~ 282 (282)
T cd06636 275 QLLKHPFI 282 (282)
T ss_pred HHhcCCCC
Confidence 99999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=347.94 Aligned_cols=255 Identities=23% Similarity=0.383 Sum_probs=215.2
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCC-----CEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSG-----NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 177 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~-----~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 177 (514)
+..++|++++.||+|+||.||+|.....+ ..||+|.+.... .......+.+|..++..++||+|+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 45678999999999999999999876655 679999987542 33445668899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHhhc----------------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC
Q 010266 178 AEYLYLIMEYLPGGDVMTLLMRE----------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ 241 (514)
Q Consensus 178 ~~~l~lVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~ 241 (514)
....|++|||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 99999999999999999999764 45788889999999999999999999999999999999999
Q ss_pred CCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCc
Q 010266 242 NGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDY 321 (514)
Q Consensus 242 ~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y 321 (514)
++.+||+|||+++........ .......+|+.|
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y 192 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYY-----------------------------------------------RVQSKSLLPVRW 192 (283)
T ss_pred CCcEEECCCcceeeccccccc-----------------------------------------------cccCCCcccccc
Confidence 999999999998754321100 011134678999
Q ss_pred CCccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-Cccc
Q 010266 322 IAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEH 399 (514)
Q Consensus 322 ~APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~ 399 (514)
+|||++.+..++.++|+|||||++|||++ |..||.+.+..+....+.... ....| ..+++++.+|+.+||. ||.+
T Consensus 193 ~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~~~~l~~~c~~~~p~~ 269 (283)
T cd05048 193 MPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ-LLPCP--EDCPARVYALMIECWNEIPAR 269 (283)
T ss_pred cCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-cCCCc--ccCCHHHHHHHHHHccCChhh
Confidence 99999998899999999999999999998 999999988887777765421 22233 3688999999999999 9999
Q ss_pred cCCCCCHhHHhcC
Q 010266 400 RLGTLGSEQIKAH 412 (514)
Q Consensus 400 Rl~~~~~~eil~H 412 (514)
|+ ++.+|++|
T Consensus 270 Rp---~~~~i~~~ 279 (283)
T cd05048 270 RP---RFKDIHTR 279 (283)
T ss_pred Cc---CHHHHHHH
Confidence 99 99999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=353.74 Aligned_cols=255 Identities=29% Similarity=0.500 Sum_probs=219.9
Q ss_pred eeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEee
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY 187 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy 187 (514)
|.++..||.|+||.||+|.++.+|+++|||.+.-. ..++.+..|+.||+++++|++|+.|++|.-...+++||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 66788999999999999999999999999987643 4677889999999999999999999999989999999999
Q ss_pred cCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccc
Q 010266 188 LPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE 266 (514)
Q Consensus 188 ~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~ 266 (514)
|..|+..+++.. +.+++|.++..++...+.||+|||...-||||||..|||++.+||.||+|||.|..+...
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT------- 182 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT------- 182 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh-------
Confidence 999999999864 578999999999999999999999999999999999999999999999999998765421
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHH
Q 010266 267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 346 (514)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 346 (514)
....++..|||.|||||++..-+|+..+||||||+...
T Consensus 183 ------------------------------------------MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaI 220 (502)
T KOG0574|consen 183 ------------------------------------------MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAI 220 (502)
T ss_pred ------------------------------------------HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhh
Confidence 01224789999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCc
Q 010266 347 EMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAW 420 (514)
Q Consensus 347 emltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w 420 (514)
||..|+|||..-.+....--|-. ..+..|-.+..+|.++.|||++||. .|++|. ++.++++|||.++..-
T Consensus 221 EMAEG~PPYsDIHPMRAIFMIPT-~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~---TA~~L~~H~FiknA~g 291 (502)
T KOG0574|consen 221 EMAEGRPPYSDIHPMRAIFMIPT-KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERK---TALRLCEHTFIKNAPG 291 (502)
T ss_pred hhhcCCCCcccccccceeEeccC-CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHH---HHHHHhhhhhhcCCCc
Confidence 99999999987666433322211 1222232334679999999999998 999998 9999999999997544
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=339.39 Aligned_cols=253 Identities=28% Similarity=0.507 Sum_probs=219.4
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
+|++++.||+|+||.||+++...+|+.||+|.+..... .......+.+|..+++.++||+|++++++|.+.++.|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 58999999999999999999999999999999876543 33445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 187 YLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 187 y~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
|++|++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--- 156 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--- 156 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh---
Confidence 99999999998754 3578999999999999999999999999999999999999999999999999875432100
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 344 (514)
......|++.|+|||++.+..++.++|+|||||+
T Consensus 157 ----------------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i 190 (256)
T cd08218 157 ----------------------------------------------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCV 190 (256)
T ss_pred ----------------------------------------------hhhhccCCccccCHHHhCCCCCCCccchhHHHHH
Confidence 0113468999999999998889999999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 345 MYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 345 lyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
+|+|++|..||...+..+....++... ....| ..++.++.++|.+||. +|.+|+ ++.+|+.||||
T Consensus 191 ~~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~vl~~~~~ 256 (256)
T cd08218 191 LYEMCTLKHAFEAGNMKNLVLKIIRGS-YPPVS--SHYSYDLRNLVSQLFKRNPRDRP---SVNSILEKNFI 256 (256)
T ss_pred HHHHHcCCCCccCCCHHHHHHHHhcCC-CCCCc--ccCCHHHHHHHHHHhhCChhhCc---CHHHHhhCcCC
Confidence 999999999999888877777776422 12233 3678999999999998 999999 99999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=339.73 Aligned_cols=254 Identities=33% Similarity=0.574 Sum_probs=217.7
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccc--cChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM--LSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
+|+..+.||+|+||+||+|..+.+++.||+|.+..... ........+.+|..+++.++||+|+++++++.+...+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 36777899999999999999988999999999876432 2234567788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
|||++|++|.+++.+...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc----
Confidence 9999999999999888889999999999999999999999999999999999999999999999999987543210
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCC-CCcccchhhhhH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGA 343 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~-y~~~~DiWSlGv 343 (514)
......|++.|+|||.+.... ++.++|+|||||
T Consensus 157 ----------------------------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~ 190 (258)
T cd06632 157 ----------------------------------------------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGC 190 (258)
T ss_pred ----------------------------------------------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHH
Confidence 011456899999999998776 899999999999
Q ss_pred HHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 344 ilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
++|+|++|.+||...........+........+|. .+++++.+||.+||. +|.+|+ ++++++.|||+
T Consensus 191 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp---~~~~~l~~~~~ 258 (258)
T cd06632 191 TVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPD--HLSDEAKDFILKCLQRDPSLRP---TAAELLEHPFV 258 (258)
T ss_pred HHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCC--CcCHHHHHHHHHHhhcCcccCc---CHHHHhcCCCC
Confidence 99999999999987665555555443222333443 578999999999998 999999 99999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=346.05 Aligned_cols=257 Identities=30% Similarity=0.511 Sum_probs=211.0
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEE-----
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSF----- 175 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f----- 175 (514)
....++|++++.||+|+||.||+|.++.+++.||+|++.+.. .....+.+|..++..+ +||||+++++++
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 345689999999999999999999999999999999876532 2234577899999998 699999999987
Q ss_pred EcCCeEEEEEeecCCCCHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccc
Q 010266 176 QDAEYLYLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251 (514)
Q Consensus 176 ~~~~~l~lVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFG 251 (514)
++...+|+||||++||+|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.+|.+||+|||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence 355689999999999999988752 3568899999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc--
Q 010266 252 LCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-- 329 (514)
Q Consensus 252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-- 329 (514)
++........ .....+||+.|+|||++..
T Consensus 170 ~~~~~~~~~~-------------------------------------------------~~~~~~~~~~y~aPE~~~~~~ 200 (286)
T cd06638 170 VSAQLTSTRL-------------------------------------------------RRNTSVGTPFWMAPEVIACEQ 200 (286)
T ss_pred ceeecccCCC-------------------------------------------------ccccccCCCcccChhhhchhh
Confidence 9875432100 0114469999999999853
Q ss_pred ---CCCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCC
Q 010266 330 ---KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLG 405 (514)
Q Consensus 330 ---~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~ 405 (514)
..++.++|||||||++|||++|.+||...+......++.... ....+.....+..+.+||.+||. ||.+|+ +
T Consensus 201 ~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s 276 (286)
T cd06638 201 QLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP-PPTLHQPELWSNEFNDFIRKCLTKDYEKRP---T 276 (286)
T ss_pred hccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC-CCcccCCCCcCHHHHHHHHHHccCCcccCC---C
Confidence 457899999999999999999999998776655444443221 11111222467899999999998 999999 9
Q ss_pred HhHHhcCCcc
Q 010266 406 SEQIKAHPWF 415 (514)
Q Consensus 406 ~~eil~Hpff 415 (514)
+.||+.||||
T Consensus 277 ~~ell~~~~~ 286 (286)
T cd06638 277 VSDLLQHVFI 286 (286)
T ss_pred HHHHhhcccC
Confidence 9999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=346.40 Aligned_cols=256 Identities=28% Similarity=0.483 Sum_probs=207.1
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.++|++++.||.|+||.||+|.++.+++.||+|.+..... ......+.+|..+++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 5789999999999999999999998999999999875431 22234466899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 185 MEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
|||+++ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++.......
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-- 158 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-- 158 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--
Confidence 999975 999988664 4689999999999999999999999999999999999999999999999999865321100
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchhhhh
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 342 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlG 342 (514)
......+++.|+|||++.+ ..++.++||||||
T Consensus 159 -----------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG 191 (291)
T cd07844 159 -----------------------------------------------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVG 191 (291)
T ss_pred -----------------------------------------------cccccccccccCCcHHhhcCcccCcHHHHHHHH
Confidence 0012357889999999876 5589999999999
Q ss_pred HHHHHHhhCCCCCCCCC-hhHHHHHHhhhcC-----------------cccC----Cc-----CcCCC--hhHHHHHhhh
Q 010266 343 AIMYEMLVGYPPFYSDD-PVTTCRKIVHWKN-----------------HLKF----PE-----EARLT--PEAKDLICRL 393 (514)
Q Consensus 343 vilyemltG~~PF~~~~-~~~~~~~i~~~~~-----------------~~~~----p~-----~~~~s--~~~~dLI~~l 393 (514)
|++|+|++|.+||.+.+ ..+....+..... ...+ +. ...++ .++.++|.+|
T Consensus 192 ~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 271 (291)
T cd07844 192 CIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKF 271 (291)
T ss_pred HHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHH
Confidence 99999999999997665 3333322221000 0000 00 01244 8899999999
Q ss_pred cc-CccccCCCCCHhHHhcCCcc
Q 010266 394 LC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 394 L~-dp~~Rl~~~~~~eil~Hpff 415 (514)
|+ +|.+|+ ++.+++.||||
T Consensus 272 L~~~p~~Rp---s~~e~l~~~~f 291 (291)
T cd07844 272 LQYEPKKRI---SAAEAMKHPYF 291 (291)
T ss_pred hccCccccc---CHHHHhcCCCC
Confidence 99 999999 99999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=349.73 Aligned_cols=256 Identities=20% Similarity=0.327 Sum_probs=206.3
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEcc----------------CCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCC
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKK----------------SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~----------------t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp 166 (514)
+..++|.+.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|..+|..++||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ 79 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDP 79 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCC
Confidence 345789999999999999999998532 34579999987642 344566788999999999999
Q ss_pred ceeeEEEEEEcCCeEEEEEeecCCCCHHHHHhhcc-------------------CCCHHHHHHHHHHHHHHHHHHHhCCe
Q 010266 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE-------------------TLTETVARFYIAQSVLAIESIHKHNY 227 (514)
Q Consensus 167 ~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~l~~~~-------------------~l~e~~~~~~~~qi~~aL~~LH~~gi 227 (514)
||++++++|.+.+..|+||||+++|+|.+++.... .++...+..++.|++.||.|||+.||
T Consensus 80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 159 (304)
T cd05096 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159 (304)
T ss_pred CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 99999999999999999999999999999986532 35667788999999999999999999
Q ss_pred EEcCCCCCCccccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhh
Q 010266 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQIN 307 (514)
Q Consensus 228 iHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (514)
+||||||+|||++.+|.+||+|||+++........
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~--------------------------------------------- 194 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY--------------------------------------------- 194 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCcee---------------------------------------------
Confidence 99999999999999999999999998764322100
Q ss_pred ccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhh--CCCCCCCCChhHHHHHHhhhc----CcccCCcCcC
Q 010266 308 RRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV--GYPPFYSDDPVTTCRKIVHWK----NHLKFPEEAR 381 (514)
Q Consensus 308 ~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt--G~~PF~~~~~~~~~~~i~~~~----~~~~~p~~~~ 381 (514)
.......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.... ..........
T Consensus 195 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (304)
T cd05096 195 --RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPP 272 (304)
T ss_pred --EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCC
Confidence 00113457889999999998899999999999999999986 678898776666555443211 1111111235
Q ss_pred CChhHHHHHhhhcc-CccccCCCCCHhHHh
Q 010266 382 LTPEAKDLICRLLC-DVEHRLGTLGSEQIK 410 (514)
Q Consensus 382 ~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 410 (514)
.+..+.+||.+||. ||.+|+ ++++|.
T Consensus 273 ~~~~~~~li~~cl~~~p~~RP---s~~~i~ 299 (304)
T cd05096 273 CPQGLYELMLQCWSRDCRERP---SFSDIH 299 (304)
T ss_pred CCHHHHHHHHHHccCCchhCc---CHHHHH
Confidence 78899999999999 999999 899984
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=364.18 Aligned_cols=256 Identities=23% Similarity=0.303 Sum_probs=208.0
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEE-----ccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQE-----KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSF 175 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~-----~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f 175 (514)
.+..++|++.+.||+|+||.||+|.. ..++..||+|+++... .....+.+.+|+.+|..+ +|||||+++++|
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 44556899999999999999999974 3567789999987543 233456788899999999 899999999999
Q ss_pred EcCCeEEEEEeecCCCCHHHHHhhcc------------------------------------------------------
Q 010266 176 QDAEYLYLIMEYLPGGDVMTLLMREE------------------------------------------------------ 201 (514)
Q Consensus 176 ~~~~~l~lVmEy~~gg~L~~~l~~~~------------------------------------------------------ 201 (514)
.+.+..|+|||||+||+|.+++....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 99999999999999999999986432
Q ss_pred ---------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 202 ---------------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 202 ---------------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 46778888999999999999999999999999999999999999999999987653211
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 340 (514)
.. ....+..+++.|+|||++.+..++.++||||
T Consensus 269 ~~-----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~s 301 (375)
T cd05104 269 NY-----------------------------------------------VVKGNARLPVKWMAPESIFNCVYTFESDVWS 301 (375)
T ss_pred cc-----------------------------------------------cccCCCCCCcceeChhHhcCCCCCCCCCHHH
Confidence 00 0001234677899999999999999999999
Q ss_pred hhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 341 LGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 341 lGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|||++|||++ |.+||.+........+++........| ...+.++++||.+||. ||.+|+ ++.+|++
T Consensus 302 lG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RP---s~~eil~ 369 (375)
T cd05104 302 YGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSP--ECAPSEMYDIMKSCWDADPLKRP---TFKQIVQ 369 (375)
T ss_pred HHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCC--CCCCHHHHHHHHHHccCChhHCc---CHHHHHH
Confidence 9999999998 999998765544444444322222223 3567899999999999 999999 8999875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=338.00 Aligned_cols=252 Identities=30% Similarity=0.556 Sum_probs=218.6
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
+|++++.||+|+||.||+|....+++.+|+|.+..... .......+..|..+|+.++||+|+++++.+...+.+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 58999999999999999999999999999999987643 34456778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC-cEEEccccccccCCCCCccc
Q 010266 187 YLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG-HMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 187 y~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g-~iKL~DFGla~~~~~~~~~~ 263 (514)
|++|++|.+++... ..+++..+..++.+++.||.|||++||+||||||+||+++.++ .+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--- 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS--- 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc---
Confidence 99999999999764 3589999999999999999999999999999999999998654 58999999987653210
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhH
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 343 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 343 (514)
.....+|++.|+|||++.+..++.++|+|||||
T Consensus 157 -----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 189 (256)
T cd08220 157 -----------------------------------------------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGC 189 (256)
T ss_pred -----------------------------------------------cccccccCCcccCchhccCCCCCcccchHHHHH
Confidence 011356899999999999888999999999999
Q ss_pred HHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 344 ilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
++|+|++|..||.+.+.......+... ....+| ..++++++++|.+||. +|.+|+ ++.|+++||||
T Consensus 190 ~l~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---t~~~ll~~p~~ 256 (256)
T cd08220 190 VLYELASLKRAFEAANLPALVLKIMSG-TFAPIS--DRYSPDLRQLILSMLNLDPSKRP---QLSQIMAQPIC 256 (256)
T ss_pred HHHHHHhCCCCcccCchHHHHHHHHhc-CCCCCC--CCcCHHHHHHHHHHccCChhhCC---CHHHHhhCCCC
Confidence 999999999999988877777666542 122333 3588999999999998 999999 99999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=344.53 Aligned_cols=257 Identities=32% Similarity=0.546 Sum_probs=213.2
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcC---
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDA--- 178 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~--- 178 (514)
...++|.+.+.||+|+||.||+|..+.+++.||+|++.+.. .....+..|..++..+ +||||++++++|...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 34688999999999999999999999999999999986542 2234567889999988 799999999998753
Q ss_pred --CeEEEEEeecCCCCHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccc
Q 010266 179 --EYLYLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252 (514)
Q Consensus 179 --~~l~lVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGl 252 (514)
...|+||||++||+|.+++.. ...+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeeccc
Confidence 468999999999999998753 45789999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC--
Q 010266 253 CKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-- 330 (514)
Q Consensus 253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-- 330 (514)
+........ .....+|++.|+|||++...
T Consensus 175 ~~~~~~~~~-------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~ 205 (291)
T cd06639 175 SAQLTSTRL-------------------------------------------------RRNTSVGTPFWMAPEVIACEQQ 205 (291)
T ss_pred chhcccccc-------------------------------------------------cccCccCCccccChhhhcCCCC
Confidence 876432100 01134689999999998643
Q ss_pred ---CCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCH
Q 010266 331 ---GYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGS 406 (514)
Q Consensus 331 ---~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~ 406 (514)
.++.++|+|||||++|||++|.+||...+.......+..+.. ..+.....++.++.+||.+||. +|.+|+ ++
T Consensus 206 ~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~ 281 (291)
T cd06639 206 YDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP-PTLLHPEKWCRSFNHFISQCLIKDFEARP---SV 281 (291)
T ss_pred cccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCC-CCCCcccccCHHHHHHHHHHhhcChhhCc---CH
Confidence 368899999999999999999999988777666655544321 1222223567889999999998 999999 99
Q ss_pred hHHhcCCccc
Q 010266 407 EQIKAHPWFK 416 (514)
Q Consensus 407 ~eil~Hpff~ 416 (514)
.+|+.||||+
T Consensus 282 ~~il~~~~~~ 291 (291)
T cd06639 282 THLLEHPFIK 291 (291)
T ss_pred HHHhcCcccC
Confidence 9999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=340.23 Aligned_cols=257 Identities=30% Similarity=0.517 Sum_probs=221.5
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++.+.||.|++|.||+|++..+++.||+|++..... ......+..|..++..++||+|+++++++.+...+|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 479999999999999999999999999999999876532 145677889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
||++|++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||+++.+|.++|+|||++........
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~--- 155 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD--- 155 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC---
Confidence 999999999999888899999999999999999999999 9999999999999999999999999999876532110
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 344 (514)
......|+..|+|||++.+..++.++|+||||++
T Consensus 156 ----------------------------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~i 189 (264)
T cd06623 156 ----------------------------------------------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLT 189 (264)
T ss_pred ----------------------------------------------cccceeecccccCHhhhCCCCCCchhhHHHHHHH
Confidence 0114568999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCC---hhHHHHHHhhhcCcccCCcCcC-CChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCC
Q 010266 345 MYEMLVGYPPFYSDD---PVTTCRKIVHWKNHLKFPEEAR-LTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIA 419 (514)
Q Consensus 345 lyemltG~~PF~~~~---~~~~~~~i~~~~~~~~~p~~~~-~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~ 419 (514)
+|+|++|.+||...+ ..+....+.. ......+ .. ++..+.++|.+||. +|.+|+ ++++++.||||+.++
T Consensus 190 l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~l~~li~~~l~~~p~~R~---~~~~ll~~~~~~~~~ 263 (264)
T cd06623 190 LLECALGKFPFLPPGQPSFFELMQAICD-GPPPSLP--AEEFSPEFRDFISACLQKDPKKRP---SAAELLQHPFIKKAD 263 (264)
T ss_pred HHHHHhCCCCCccccccCHHHHHHHHhc-CCCCCCC--cccCCHHHHHHHHHHccCChhhCC---CHHHHHhCHHHHhcc
Confidence 999999999998764 3444444442 1122222 23 78999999999998 999999 999999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=347.46 Aligned_cols=255 Identities=30% Similarity=0.500 Sum_probs=211.7
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
+|++++.||.|+||.||+|+++.+++.||||.+..... .......+..|.++++.++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 58999999999999999999999999999999875432 23344568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 187 YLPGGDVMTLLMR--EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 187 y~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
|++ ++|..++.. ...+++..++.++.|++.||+|||+.|++||||+|+||+++.+|.+||+|||++........
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--- 155 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--- 155 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc---
Confidence 996 689888865 35789999999999999999999999999999999999999999999999999875432100
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCC-CCcccchhhhhH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGA 343 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~-y~~~~DiWSlGv 343 (514)
......|++.|+|||++.+.. ++.++|+|||||
T Consensus 156 ----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 189 (284)
T cd07860 156 ----------------------------------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGC 189 (284)
T ss_pred ----------------------------------------------ccccccccccccCCeEEecCCCCCcHHHHHHHHH
Confidence 011345789999999987644 688999999999
Q ss_pred HHHHHhhCCCCCCCCChhHHHHHHhhhcCcc----------------cCCc---------CcCCChhHHHHHhhhcc-Cc
Q 010266 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL----------------KFPE---------EARLTPEAKDLICRLLC-DV 397 (514)
Q Consensus 344 ilyemltG~~PF~~~~~~~~~~~i~~~~~~~----------------~~p~---------~~~~s~~~~dLI~~lL~-dp 397 (514)
++|+|++|..||.+.+......++....... .+|. ...+++++++||.+||+ ||
T Consensus 190 il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 269 (284)
T cd07860 190 IFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDP 269 (284)
T ss_pred HHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCc
Confidence 9999999999999877665555544321110 1111 12478899999999999 99
Q ss_pred cccCCCCCHhHHhcCCcc
Q 010266 398 EHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 398 ~~Rl~~~~~~eil~Hpff 415 (514)
.+|+ +++++++||||
T Consensus 270 ~~Rp---t~~~~l~~~~f 284 (284)
T cd07860 270 NKRI---SAKAALAHPFF 284 (284)
T ss_pred ccCC---CHHHHhcCCCC
Confidence 9999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=339.07 Aligned_cols=249 Identities=32% Similarity=0.533 Sum_probs=214.7
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
+|++.+.||.|+||.||+|+++.+++.||+|.++... .....+.+..|..+++.++||||++++++|.+...+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 5899999999999999999999999999999987543 23456678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 187 YLPGGDVMTLLMR--EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 187 y~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
|++||+|..++.. ...+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--- 155 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--- 155 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc---
Confidence 9999999998864 34689999999999999999999999999999999999999999999999999875432100
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 344 (514)
......|++.|+|||++.+..++.++|+||||++
T Consensus 156 ----------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i 189 (255)
T cd08219 156 ----------------------------------------------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCI 189 (255)
T ss_pred ----------------------------------------------ccccccCCccccCHHHHccCCcCchhhhhhhchh
Confidence 0114579999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 345 MYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 345 lyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
+|+|++|.+||...+.......+.... ....| ..++..+++||.+||. ||.+|+ ++.+|+.-
T Consensus 190 ~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~P~~Rp---~~~~il~~ 252 (255)
T cd08219 190 LYELCTLKHPFQANSWKNLILKVCQGS-YKPLP--SHYSYELRSLIKQMFKRNPRSRP---SATTILSR 252 (255)
T ss_pred heehhhccCCCCCCCHHHHHHHHhcCC-CCCCC--cccCHHHHHHHHHHHhCCcccCC---CHHHHhhc
Confidence 999999999999888777766665421 11233 3678999999999998 999999 99998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=371.50 Aligned_cols=243 Identities=33% Similarity=0.611 Sum_probs=210.2
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCeEE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~ 182 (514)
...+|.+...+|.|+||.|..|.++.+++.+|+|++.+.. ....+|..++... +||||++++..+.+..+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence 3578999999999999999999999999999999998762 1234566666554 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccc-cCCCcEEEccccccccCCCCCc
Q 010266 183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL-DQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILl-d~~g~iKL~DFGla~~~~~~~~ 261 (514)
+|||.+.||.+.+.+.....+. ..+..|++||+.|+.|||.+|||||||||+|||+ ++.|+++|||||.++.....
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999999999998887766665 7888899999999999999999999999999999 69999999999998865421
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
..+.|-|..|.|||++...+|+.+||||||
T Consensus 470 --------------------------------------------------~~tp~~t~~y~APEvl~~~~yt~acD~WSL 499 (612)
T KOG0603|consen 470 --------------------------------------------------CDTPALTLQYVAPEVLAIQEYTEACDWWSL 499 (612)
T ss_pred --------------------------------------------------hcccchhhcccChhhhccCCCCcchhhHHH
Confidence 125578999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChh-HHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 342 GAIMYEMLVGYPPFYSDDPV-TTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~-~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
|++||+||+|++||.+.... ++..+|.. ..+. ..+|++|+|||++||+ ||.+|+ ++.++..||||
T Consensus 500 GvlLy~ML~G~tp~~~~P~~~ei~~~i~~----~~~s--~~vS~~AKdLl~~LL~~dP~~Rl---~~~~i~~h~w~ 566 (612)
T KOG0603|consen 500 GVLLYEMLTGRTLFAAHPAGIEIHTRIQM----PKFS--ECVSDEAKDLLQQLLQVDPALRL---GADEIGAHPWF 566 (612)
T ss_pred HHHHHHHHhCCCccccCCchHHHHHhhcC----Cccc--cccCHHHHHHHHHhccCChhhCc---ChhhhccCcch
Confidence 99999999999999875544 55555532 2222 4799999999999999 999999 99999999999
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=342.42 Aligned_cols=253 Identities=18% Similarity=0.271 Sum_probs=211.8
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEc---cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEK---KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE 179 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~---~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 179 (514)
+..++|++.+.||+|+||.||++..+ ..+..||+|+++... .......+.+|..+|..++||||+++++++.+.+
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 34578999999999999999999765 346789999987642 3344567889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
.+|+||||++||+|.+++... ..+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999999998764 5789999999999999999999999999999999999999999999999998654321
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
... .......+|+.|+|||++.+..++.++|+
T Consensus 160 ~~~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 191 (266)
T cd05064 160 EAI------------------------------------------------YTTMSGKSPVLWAAPEAIQYHHFSSASDV 191 (266)
T ss_pred cch------------------------------------------------hcccCCCCceeecCHHHHhhCCccchhHH
Confidence 100 00112346788999999999999999999
Q ss_pred hhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 339 WSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 339 WSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|||||++|||++ |.+||.+.+..+....+... ...|....++..+.+++.+|+. +|.+|+ ++++|++
T Consensus 192 ~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~c~~~~p~~RP---~~~~i~~ 260 (266)
T cd05064 192 WSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG---FRLPAPRNCPNLLHQLMLDCWQKERGERP---RFSQIHS 260 (266)
T ss_pred HHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC---CCCCCCCCCCHHHHHHHHHHcCCCchhCC---CHHHHHH
Confidence 999999999775 99999988877777766542 2233334678999999999998 999999 8888865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=346.64 Aligned_cols=260 Identities=30% Similarity=0.488 Sum_probs=213.1
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++.+.||+|++|.||++.++.+|+.||+|.+..... .......+.+|..+++.++||||+++++++.+..+.|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 689999999999999999999999999999999876532 2234456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC-CCcEEEccccccccCCCCCcc
Q 010266 186 EYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ-NGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~-~g~iKL~DFGla~~~~~~~~~ 262 (514)
||++ ++|..++.... .+++..++.++.||+.||+|||++||+||||||+||+++. ++.+||+|||++........
T Consensus 81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~- 158 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR- 158 (294)
T ss_pred eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc-
Confidence 9996 58888876543 3578888999999999999999999999999999999985 56799999999875431100
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSL 341 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSl 341 (514)
......|++.|+|||++.+ ..++.++|||||
T Consensus 159 ------------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl 190 (294)
T PLN00009 159 ------------------------------------------------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSV 190 (294)
T ss_pred ------------------------------------------------ccccCceeecccCHHHHhCCCCCCcHHHHHHH
Confidence 0113468999999999876 457899999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcc-------------------cCCc------CcCCChhHHHHHhhhcc-
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL-------------------KFPE------EARLTPEAKDLICRLLC- 395 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~~-------------------~~p~------~~~~s~~~~dLI~~lL~- 395 (514)
||++|+|++|.+||.+.+..+...++....... .++. ...++++++++|.+||.
T Consensus 191 G~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 270 (294)
T PLN00009 191 GCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRL 270 (294)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccC
Confidence 999999999999999887766666554311100 0000 12478999999999998
Q ss_pred CccccCCCCCHhHHhcCCccccCC
Q 010266 396 DVEHRLGTLGSEQIKAHPWFKDIA 419 (514)
Q Consensus 396 dp~~Rl~~~~~~eil~Hpff~~i~ 419 (514)
+|.+|+ ++++++.||||++++
T Consensus 271 ~P~~Rp---s~~~~l~~~~~~~~~ 291 (294)
T PLN00009 271 DPSKRI---TARAALEHEYFKDLG 291 (294)
T ss_pred ChhhCc---CHHHHhcCchHhHHh
Confidence 999999 999999999998764
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=348.58 Aligned_cols=256 Identities=25% Similarity=0.396 Sum_probs=217.0
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
.....|++++.||+|+||.||+|.++.+++.||+|++.............+.+|+.+++.++||||++++++|.+.+..|
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 34467999999999999999999999999999999997665545556677889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 183 LIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
+||||++ |+|.+++.. ...+++..+..++.|++.||.|||+.||+||||+|+||+++.+|.+||+|||++......
T Consensus 92 lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 92 LVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred EEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 9999997 567676653 567899999999999999999999999999999999999999999999999998643211
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc---cCCCCcccch
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---KKGYGMECDW 338 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~~~Di 338 (514)
....|++.|+|||++. ...++.++|+
T Consensus 169 ---------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv 197 (307)
T cd06607 169 ---------------------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDV 197 (307)
T ss_pred ---------------------------------------------------CCccCCccccCceeeeccCCCCCCcccch
Confidence 1346889999999985 3568899999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
|||||++|||++|.+||.+.+.......+... .....+. ..++.++++||.+||. +|.+|+ ++.+|+.||||..
T Consensus 198 ~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~ 272 (307)
T cd06607 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSPTLSS-NDWSDYFRNFVDSCLQKIPQDRP---SSEELLKHRFVLR 272 (307)
T ss_pred HHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC-CCCCCCc-hhhCHHHHHHHHHHhcCChhhCc---CHHHHhcChhhcc
Confidence 99999999999999999888776655555432 2222222 2468899999999998 999999 9999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=346.02 Aligned_cols=257 Identities=31% Similarity=0.504 Sum_probs=210.3
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEEEcCCe----
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEY---- 180 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~---- 180 (514)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|..+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 47999999999999999999999999999999986542 22334456788999999995 6999999999987766
Q ss_pred -EEEEEeecCCCCHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC-CCcEEEcccccc
Q 010266 181 -LYLIMEYLPGGDVMTLLMRE-----ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ-NGHMKLSDFGLC 253 (514)
Q Consensus 181 -l~lVmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~-~g~iKL~DFGla 253 (514)
+|+||||+++ +|..++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999985 888887643 35799999999999999999999999999999999999998 899999999998
Q ss_pred ccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCC
Q 010266 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGY 332 (514)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y 332 (514)
........ ......+++.|+|||++.+ ..+
T Consensus 159 ~~~~~~~~-------------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~ 189 (295)
T cd07837 159 RAFSIPVK-------------------------------------------------SYTHEIVTLWYRAPEVLLGSTHY 189 (295)
T ss_pred eecCCCcc-------------------------------------------------ccCCcccccCCCChHHhhCCCCC
Confidence 75431100 0113367899999999865 457
Q ss_pred CcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcc---------------cCCc---------CcCCChhHHH
Q 010266 333 GMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL---------------KFPE---------EARLTPEAKD 388 (514)
Q Consensus 333 ~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---------------~~p~---------~~~~s~~~~d 388 (514)
+.++|+|||||++|+|++|.+||.+.+......++....... .+|. ...+++++.+
T Consensus 190 ~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (295)
T cd07837 190 STPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLD 269 (295)
T ss_pred CchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHH
Confidence 999999999999999999999999887776665554321100 0110 0247899999
Q ss_pred HHhhhcc-CccccCCCCCHhHHhcCCccc
Q 010266 389 LICRLLC-DVEHRLGTLGSEQIKAHPWFK 416 (514)
Q Consensus 389 LI~~lL~-dp~~Rl~~~~~~eil~Hpff~ 416 (514)
||.+||. ||.+|+ +++|++.||||+
T Consensus 270 ~i~~~l~~~P~~R~---~~~eil~~~~~~ 295 (295)
T cd07837 270 LLQKMLRYDPAKRI---SAKAALTHPYFD 295 (295)
T ss_pred HHHHHccCChhhcC---CHHHHhcCCCcC
Confidence 9999999 999999 999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=344.43 Aligned_cols=258 Identities=34% Similarity=0.551 Sum_probs=215.8
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++.+.||+|+||.||+|.++.+++.||+|+++.... .......+..|..+++.++||||++++++|.+.+.+|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 479999999999999999999999999999999876432 3334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
||++++.+..++.+...+++..+..++.+++.||.|||+.||+||||+|+||+++.+|.+||+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~---- 155 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA---- 155 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc----
Confidence 9999888877776677899999999999999999999999999999999999999999999999999876542210
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-CCCcccchhhhhHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAI 344 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvi 344 (514)
......+|++.|+|||++.+. .++.++|+|||||+
T Consensus 156 --------------------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~ 191 (288)
T cd07833 156 --------------------------------------------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCI 191 (288)
T ss_pred --------------------------------------------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHH
Confidence 001145789999999999887 88999999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHhhhcCc-----------------ccCCc-----------CcCCChhHHHHHhhhcc-
Q 010266 345 MYEMLVGYPPFYSDDPVTTCRKIVHWKNH-----------------LKFPE-----------EARLTPEAKDLICRLLC- 395 (514)
Q Consensus 345 lyemltG~~PF~~~~~~~~~~~i~~~~~~-----------------~~~p~-----------~~~~s~~~~dLI~~lL~- 395 (514)
+|+|++|.+||.+.+..+....+...... ..+++ ...+++++++||.+||.
T Consensus 192 l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 271 (288)
T cd07833 192 MAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRM 271 (288)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhcc
Confidence 99999999999877665544433221000 01110 11348899999999998
Q ss_pred CccccCCCCCHhHHhcCCcc
Q 010266 396 DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 396 dp~~Rl~~~~~~eil~Hpff 415 (514)
+|.+|+ +++++++||||
T Consensus 272 ~p~~Rp---s~~~il~~~~f 288 (288)
T cd07833 272 DPKERL---TCDELLQHPYF 288 (288)
T ss_pred Cchhcc---cHHHHhcCCCC
Confidence 999999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=344.05 Aligned_cols=254 Identities=28% Similarity=0.504 Sum_probs=216.9
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++.+.||.|+||.||+|.++.+++.+|+|.+.+.. .......+.+|.++++.++||||+++++.+.+...+|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 46888999999999999999999999999999997653 2344567888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 186 EYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
||++|++|.+++... ..+++..+..++.|++.||.|||+ .|++||||||+||+++.+|.++|+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~---- 154 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---- 154 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH----
Confidence 999999999999776 789999999999999999999999 99999999999999999999999999998654211
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhH
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 343 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 343 (514)
......|++.|+|||++.+..++.++|+|||||
T Consensus 155 -----------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ 187 (265)
T cd06605 155 -----------------------------------------------LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGL 187 (265)
T ss_pred -----------------------------------------------HhhcccCChhccCHHHHcCCCCCchhhHHHHHH
Confidence 001257899999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCC-----hhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 344 IMYEMLVGYPPFYSDD-----PVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 344 ilyemltG~~PF~~~~-----~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
++|+|++|..||...+ ..+....+... .....|.. .++++++++|.+||. +|.+|+ ++.+++.||||+.
T Consensus 188 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~li~~~l~~~p~~Rp---t~~~ll~~~~~~~ 262 (265)
T cd06605 188 SLIELATGRFPYPPENDPPDGIFELLQYIVNE-PPPRLPSG-KFSPDFQDFVNLCLIKDPRERP---SYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHhCCCCCCccccccccHHHHHHHHhcC-CCCCCChh-hcCHHHHHHHHHHcCCCchhCc---CHHHHhhCchhhc
Confidence 9999999999997642 23333444332 22233332 278999999999998 999999 9999999999965
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=337.19 Aligned_cols=253 Identities=33% Similarity=0.596 Sum_probs=217.2
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc--CCeEEEE
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--AEYLYLI 184 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~--~~~l~lV 184 (514)
+|++++.||.|+||.||+|.+..+++.||+|++..... .....+.+..|..+++.++||+|+++++.+.+ ...+|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58999999999999999999999999999999976544 44556778889999999999999999987753 4578999
Q ss_pred EeecCCCCHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHH-----hCCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 185 MEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIH-----KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 185 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH-----~~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
|||+++++|.+++.. ...+++..+..++.|++.||.||| +.+|+||||||+||+++.+|++||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999865 367899999999999999999999 89999999999999999999999999999886
Q ss_pred CCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcc
Q 010266 256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME 335 (514)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~ 335 (514)
...... ......|++.|+|||++.+..++.+
T Consensus 160 ~~~~~~-------------------------------------------------~~~~~~~~~~~~~pE~~~~~~~~~~ 190 (265)
T cd08217 160 LGHDSS-------------------------------------------------FAKTYVGTPYYMSPEQLNHMSYDEK 190 (265)
T ss_pred ccCCcc-------------------------------------------------cccccccCCCccChhhhcCCCCCch
Confidence 532110 0114579999999999998889999
Q ss_pred cchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCc
Q 010266 336 CDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPW 414 (514)
Q Consensus 336 ~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpf 414 (514)
+|+|||||++|+|++|..||...+.......+... ....+| ..++.++.+|+.+||. +|.+|+ ++++|++|||
T Consensus 191 ~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~l~~~~l~~~p~~Rp---~~~~il~~~~ 264 (265)
T cd08217 191 SDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG-KFRRIP--YRYSSELNEVIKSMLNVDPDKRP---STEELLQLPL 264 (265)
T ss_pred hHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC-CCCCCc--cccCHHHHHHHHHHccCCcccCC---CHHHHhhCCC
Confidence 99999999999999999999988766666665542 122233 3678999999999998 999999 9999999999
Q ss_pred c
Q 010266 415 F 415 (514)
Q Consensus 415 f 415 (514)
+
T Consensus 265 ~ 265 (265)
T cd08217 265 I 265 (265)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=347.73 Aligned_cols=263 Identities=27% Similarity=0.430 Sum_probs=211.9
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEEEcCCeEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l~l 183 (514)
.++|+..+.||+|+||.||++.+..+++.||+|.+.+... ......+..|..++.++. ||||+++++++.++...++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 3567778899999999999999999999999999876532 244566788999999996 9999999999999999999
Q ss_pred EEeecCCCCHHHHH---h--hccCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 184 IMEYLPGGDVMTLL---M--REETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 184 VmEy~~gg~L~~~l---~--~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
||||+.+ ++.++. . ....+++..+..++.+++.||+|||+ .||+||||||+||+++.+|.+||+|||++....
T Consensus 81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9999864 554432 2 24679999999999999999999997 599999999999999999999999999987543
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC---CCCc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK---GYGM 334 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~---~y~~ 334 (514)
... ......||+.|+|||++.+. .++.
T Consensus 160 ~~~--------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~ 189 (288)
T cd06616 160 DSI--------------------------------------------------AKTRDAGCRPYMAPERIDPSARDGYDV 189 (288)
T ss_pred cCC--------------------------------------------------ccccccCccCccCHHHhccccccCCcc
Confidence 210 01134689999999999876 6899
Q ss_pred ccchhhhhHHHHHHhhCCCCCCCCCh-hHHHHHHhhhcCcccCCc--CcCCChhHHHHHhhhcc-CccccCCCCCHhHHh
Q 010266 335 ECDWWSLGAIMYEMLVGYPPFYSDDP-VTTCRKIVHWKNHLKFPE--EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIK 410 (514)
Q Consensus 335 ~~DiWSlGvilyemltG~~PF~~~~~-~~~~~~i~~~~~~~~~p~--~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 410 (514)
++|+|||||++|+|++|.+||...+. .+....+... ....++. ...++.++.+||.+||. +|.+|+ ++++|+
T Consensus 190 ~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~i~ 265 (288)
T cd06616 190 RSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKG-DPPILSNSEEREFSPSFVNFINLCLIKDESKRP---KYKELL 265 (288)
T ss_pred hhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCC-CCCcCCCcCCCccCHHHHHHHHHHccCChhhCc---CHHHHh
Confidence 99999999999999999999976542 1222222221 1112221 23578999999999998 999999 999999
Q ss_pred cCCccccCCccccc
Q 010266 411 AHPWFKDIAWDKLY 424 (514)
Q Consensus 411 ~Hpff~~i~w~~l~ 424 (514)
.||||+...|.+..
T Consensus 266 ~~~~~~~~~~~~~~ 279 (288)
T cd06616 266 EHPFIKDYEERNVD 279 (288)
T ss_pred cChhhhchhhcchh
Confidence 99999988776653
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=349.47 Aligned_cols=259 Identities=26% Similarity=0.439 Sum_probs=207.3
Q ss_pred CeeEEeeeeecCceEEEEEEEcc--CCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC--CeEE
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKK--SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA--EYLY 182 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~--t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~--~~l~ 182 (514)
.|++++.||+|+||.||+|.++. +++.||+|.+.+...........+.+|+.++..++||||++++++|.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999988 8999999999875433344456678899999999999999999999988 8899
Q ss_pred EEEeecCCCCHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC----CCcEEEcccccc
Q 010266 183 LIMEYLPGGDVMTLLMRE-----ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ----NGHMKLSDFGLC 253 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~----~g~iKL~DFGla 253 (514)
+||||+++ +|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++. +|.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999964 777766432 36899999999999999999999999999999999999999 999999999998
Q ss_pred ccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCC
Q 010266 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGY 332 (514)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y 332 (514)
.......... ......+||+.|+|||++.+ ..+
T Consensus 160 ~~~~~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~ 193 (316)
T cd07842 160 RLFNAPLKPL----------------------------------------------ADLDPVVVTIWYRAPELLLGARHY 193 (316)
T ss_pred cccCCCcccc----------------------------------------------cccCCccccccccCHHHHhCCCCC
Confidence 8654221000 00124578999999998876 458
Q ss_pred CcccchhhhhHHHHHHhhCCCCCCCCChhH---------HHHHHhh------------------------hcCcccCCc-
Q 010266 333 GMECDWWSLGAIMYEMLVGYPPFYSDDPVT---------TCRKIVH------------------------WKNHLKFPE- 378 (514)
Q Consensus 333 ~~~~DiWSlGvilyemltG~~PF~~~~~~~---------~~~~i~~------------------------~~~~~~~p~- 378 (514)
+.++|+|||||++|+|++|.+||.+.+... ....++. ......++.
T Consensus 194 ~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (316)
T cd07842 194 TKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSN 273 (316)
T ss_pred CcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCc
Confidence 999999999999999999999998655432 1111110 000011110
Q ss_pred --------CcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 379 --------EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 379 --------~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
....+.++.++|.+||. ||++|+ ++.|++.||||
T Consensus 274 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp---s~~eil~~~~f 316 (316)
T cd07842 274 SLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRI---TAEEALEHPYF 316 (316)
T ss_pred cHHHHHHhccCCCHHHHHHHHHHhcCCcccCc---CHHHHhcCCCC
Confidence 01467889999999999 999999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=349.10 Aligned_cols=253 Identities=25% Similarity=0.387 Sum_probs=210.1
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCCCE--EEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcC
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNI--YAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDA 178 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~--~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~ 178 (514)
.+..++|++.+.||+|+||.||+|.++.++.. +|+|.++. .........+.+|..++..+ +||||+++++++.+.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~ 80 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 80 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence 35568999999999999999999999888765 46666543 23445566788899999999 899999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhcc----------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMREE----------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN 242 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~ 242 (514)
+..|+||||++||+|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 160 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence 99999999999999999997543 57889999999999999999999999999999999999999
Q ss_pred CcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcC
Q 010266 243 GHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYI 322 (514)
Q Consensus 243 g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~ 322 (514)
+.+||+|||++....... ......+++.|+
T Consensus 161 ~~~kl~dfg~~~~~~~~~--------------------------------------------------~~~~~~~~~~y~ 190 (303)
T cd05088 161 YVAKIADFGLSRGQEVYV--------------------------------------------------KKTMGRLPVRWM 190 (303)
T ss_pred CcEEeCccccCcccchhh--------------------------------------------------hcccCCCccccc
Confidence 999999999986321000 000123567899
Q ss_pred CccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-Ccccc
Q 010266 323 APEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHR 400 (514)
Q Consensus 323 APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R 400 (514)
|||++.+..++.++|+|||||++|||++ |.+||.+.+..+....+... .....| ..+++++.+||.+||. +|.+|
T Consensus 191 aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~R 267 (303)
T cd05088 191 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKP--LNCDDEVYDLMRQCWREKPYER 267 (303)
T ss_pred CHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC-CcCCCC--CCCCHHHHHHHHHHcCCChhhC
Confidence 9999988889999999999999999998 99999988777766665431 112223 3578999999999999 99999
Q ss_pred CCCCCHhHHhcC
Q 010266 401 LGTLGSEQIKAH 412 (514)
Q Consensus 401 l~~~~~~eil~H 412 (514)
+ ++++++.+
T Consensus 268 p---~~~~il~~ 276 (303)
T cd05088 268 P---SFAQILVS 276 (303)
T ss_pred c---CHHHHHHH
Confidence 9 89999876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=340.78 Aligned_cols=255 Identities=30% Similarity=0.507 Sum_probs=212.9
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCC---
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAE--- 179 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~--- 179 (514)
..++|++.+.||.|+||.||+|.++.+++.||+|++.... .....+..|..++..+ +||||++++++|.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 3478999999999999999999999899999999987653 2345688999999998 7999999999997544
Q ss_pred ---eEEEEEeecCCCCHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccc
Q 010266 180 ---YLYLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252 (514)
Q Consensus 180 ---~l~lVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGl 252 (514)
.+|+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++||||+|+||+++.+|.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 59999999999999998865 35789999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc---
Q 010266 253 CKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK--- 329 (514)
Q Consensus 253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--- 329 (514)
+....... .......||+.|+|||++..
T Consensus 160 ~~~~~~~~-------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~ 190 (275)
T cd06608 160 SAQLDSTL-------------------------------------------------GRRNTFIGTPYWMAPEVIACDEQ 190 (275)
T ss_pred ceecccch-------------------------------------------------hhhcCccccccccCHhHhccccc
Confidence 87543210 00114569999999999864
Q ss_pred --CCCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCH
Q 010266 330 --KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGS 406 (514)
Q Consensus 330 --~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~ 406 (514)
..++.++|+|||||+||+|++|.+||...+.......+.... ....+....++.++++||.+||. ||.+|+ ++
T Consensus 191 ~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---t~ 266 (275)
T cd06608 191 PDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP-PPTLKSPENWSKKFNDFISECLIKNYEQRP---FM 266 (275)
T ss_pred ccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC-CCCCCchhhcCHHHHHHHHHHhhcChhhCc---CH
Confidence 346889999999999999999999998776665555554321 11222223478899999999998 999999 99
Q ss_pred hHHhcCCcc
Q 010266 407 EQIKAHPWF 415 (514)
Q Consensus 407 ~eil~Hpff 415 (514)
+++++|||+
T Consensus 267 ~~ll~~~~~ 275 (275)
T cd06608 267 EELLEHPFI 275 (275)
T ss_pred HHHhcCCCC
Confidence 999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=354.26 Aligned_cols=256 Identities=31% Similarity=0.510 Sum_probs=213.1
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC-----
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE----- 179 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~----- 179 (514)
.++|++++.||+|+||.||+|.+..++..||||++.+.. ........+..|..+|+.++||||++++++|.++.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 467999999999999999999999999999999986542 23334456788999999999999999999998664
Q ss_pred -eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 180 -YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 180 -~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
..|+||||+ |++|..++. ...+++..++.++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++.....
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 459999999 789988875 46799999999999999999999999999999999999999999999999999875421
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccc
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECD 337 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~D 337 (514)
. .....||+.|+|||++.+ ..++.++|
T Consensus 171 ~----------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~D 198 (343)
T cd07880 171 E----------------------------------------------------MTGYVVTRWYRAPEVILNWMHYTQTVD 198 (343)
T ss_pred C----------------------------------------------------ccccccCCcccCHHHHhCCCCCCcHHH
Confidence 1 013468999999999876 45889999
Q ss_pred hhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcc------------------cCCc---------CcCCChhHHHHH
Q 010266 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL------------------KFPE---------EARLTPEAKDLI 390 (514)
Q Consensus 338 iWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~------------------~~p~---------~~~~s~~~~dLI 390 (514)
+|||||++|+|++|.+||.+.+.......+....... ..|. ...+++++.++|
T Consensus 199 i~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 278 (343)
T cd07880 199 IWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVL 278 (343)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHH
Confidence 9999999999999999999877666555554321110 0000 125788999999
Q ss_pred hhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 391 CRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 391 ~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
.+||+ ||.+|+ ++.+++.||||+..
T Consensus 279 ~~~l~~dP~~R~---t~~~~l~~~~~~~~ 304 (343)
T cd07880 279 EKMLVLDAESRI---TAAEALAHPYFEEF 304 (343)
T ss_pred HHHcCCChhhCC---CHHHHhcCccHhhh
Confidence 99999 999999 99999999999875
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=359.57 Aligned_cols=262 Identities=29% Similarity=0.501 Sum_probs=212.3
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEEEcCCe
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEY 180 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~ 180 (514)
.+....|++++.||+||-++||+|...+ .+.||+|.+.-. ......+.-++.|+.+|.+++ |.+||+||++-..+++
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 4556789999999999999999998644 456777765432 234556788999999999995 8999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhccCC-CHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMREETL-TETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~~l-~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
+||||||= ..||..+|.+.... +...+++|..||++|+.++|+.||||-||||.|+|+ -.|.+||+|||+|+.+...
T Consensus 435 lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 435 LYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPD 512 (677)
T ss_pred EEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCcc
Confidence 99999975 57999999876544 446899999999999999999999999999999999 4799999999999987644
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCC--------
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG-------- 331 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~-------- 331 (514)
..+.+ ..+.|||+.||+||.+....
T Consensus 513 TTsI~-----------------------------------------------kdsQvGT~NYMsPEAl~~~~s~~~~~~~ 545 (677)
T KOG0596|consen 513 TTSIV-----------------------------------------------KDSQVGTVNYMSPEALTDMSSSRENGKS 545 (677)
T ss_pred cccee-----------------------------------------------eccccCcccccCHHHHhhccccccCCCc
Confidence 32211 12679999999999997533
Q ss_pred ---CCcccchhhhhHHHHHHhhCCCCCCCCC-hhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCH
Q 010266 332 ---YGMECDWWSLGAIMYEMLVGYPPFYSDD-PVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGS 406 (514)
Q Consensus 332 ---y~~~~DiWSlGvilyemltG~~PF~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~ 406 (514)
.+.++||||||||||+|+.|++||..-. ...-+..|..-...+.||.... ..++.++++.||. ||.+|+ ++
T Consensus 546 k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~-~~~li~~mK~CL~rdPkkR~---si 621 (677)
T KOG0596|consen 546 KIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPE-NDELIDVMKCCLARDPKKRW---SI 621 (677)
T ss_pred ceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCC-chHHHHHHHHHHhcCcccCC---Cc
Confidence 4578999999999999999999996532 3344455555444567775321 2349999999999 999999 99
Q ss_pred hHHhcCCccccC
Q 010266 407 EQIKAHPWFKDI 418 (514)
Q Consensus 407 ~eil~Hpff~~i 418 (514)
.++|+|||+..+
T Consensus 622 ~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 622 PELLQHPFLQIQ 633 (677)
T ss_pred HHHhcCcccccc
Confidence 999999999753
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=349.94 Aligned_cols=255 Identities=29% Similarity=0.531 Sum_probs=215.7
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
.|.....||.|+||.||++.+..++..||||.+.... ....+.+.+|..++..++||||+++++.|...+..|+|||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 3444567999999999999999999999999986532 3345668889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccc
Q 010266 187 YLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE 266 (514)
Q Consensus 187 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~ 266 (514)
|++|++|.+++. .+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 100 ~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~------ 172 (292)
T cd06658 100 FLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV------ 172 (292)
T ss_pred CCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc------
Confidence 999999999874 4568999999999999999999999999999999999999999999999999986532110
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHH
Q 010266 267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 346 (514)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 346 (514)
......+||+.|+|||++.+..++.++|+|||||++|
T Consensus 173 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~ 209 (292)
T cd06658 173 -------------------------------------------PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVI 209 (292)
T ss_pred -------------------------------------------ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHH
Confidence 0012457999999999999889999999999999999
Q ss_pred HHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 347 EMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 347 emltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
||++|..||.+.+.......+... .....+....++..+.+||.+||+ ||.+|+ +++++++||||+..
T Consensus 210 el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---t~~~il~~~~~~~~ 278 (292)
T cd06658 210 EMIDGEPPYFNEPPLQAMRRIRDN-LPPRVKDSHKVSSVLRGFLDLMLVREPSQRA---TAQELLQHPFLKLA 278 (292)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhc-CCCccccccccCHHHHHHHHHHccCChhHCc---CHHHHhhChhhhcc
Confidence 999999999988776665555432 112223333578999999999999 999999 99999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=343.36 Aligned_cols=256 Identities=28% Similarity=0.415 Sum_probs=205.0
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.++|.+++.||+|+||.||+|.+..+|+.||+|++..... ......+.+|..+|+.++|+||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999875532 22233567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 185 MEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 185 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
|||+. ++|...+.. ...+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++.......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-- 158 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-- 158 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC--
Confidence 99996 677766654 45688889999999999999999999999999999999999999999999999875321100
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchhhhh
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 342 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlG 342 (514)
.....+|++.|+|||++.+ ..++.++|+||||
T Consensus 159 -----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 191 (291)
T cd07870 159 -----------------------------------------------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAG 191 (291)
T ss_pred -----------------------------------------------CCCCccccccccCCceeecCCCCCcHHHHHHHH
Confidence 0113468999999999876 4578999999999
Q ss_pred HHHHHHhhCCCCCCCCChh-HHHHHHhhhcC------------------c---ccCCc-------CcCCChhHHHHHhhh
Q 010266 343 AIMYEMLVGYPPFYSDDPV-TTCRKIVHWKN------------------H---LKFPE-------EARLTPEAKDLICRL 393 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~-~~~~~i~~~~~------------------~---~~~p~-------~~~~s~~~~dLI~~l 393 (514)
|++|+|++|.+||.+.+.. +....+..... . ...+. ....++++.+||.+|
T Consensus 192 ~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 271 (291)
T cd07870 192 CIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQM 271 (291)
T ss_pred HHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHH
Confidence 9999999999999865432 22222211000 0 00000 012357899999999
Q ss_pred cc-CccccCCCCCHhHHhcCCcc
Q 010266 394 LC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 394 L~-dp~~Rl~~~~~~eil~Hpff 415 (514)
|. ||.+|+ +++|++.||||
T Consensus 272 l~~dp~~R~---t~~~~l~h~~~ 291 (291)
T cd07870 272 LMMFPKDRI---SAQDALLHPYF 291 (291)
T ss_pred hCcCcccCc---CHHHHhcCCCC
Confidence 99 999999 99999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=342.37 Aligned_cols=255 Identities=20% Similarity=0.368 Sum_probs=212.1
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEc----cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEK----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA 178 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 178 (514)
+..++|++.+.||+|+||+||+|... .++..||+|.+.... .......+.+|..+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 45678999999999999999999853 456789999987532 344556788899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhc-----------------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMRE-----------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ 241 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~-----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~ 241 (514)
...|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 9999999999999999998532 24778888999999999999999999999999999999999
Q ss_pred CCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCc
Q 010266 242 NGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDY 321 (514)
Q Consensus 242 ~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y 321 (514)
++.+||+|||+++........ ....+..++..|
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y 192 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYY-----------------------------------------------RVQPKSLLPIRW 192 (283)
T ss_pred CCcEEeccccccccccCCcce-----------------------------------------------ecccCCCcccee
Confidence 999999999999865322100 001134577889
Q ss_pred CCccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-Cccc
Q 010266 322 IAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEH 399 (514)
Q Consensus 322 ~APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~ 399 (514)
+|||++.+..++.++|+|||||++|||++ |.+||.+.+.......+... ..+..| ..+++.++++|.+||+ ||.+
T Consensus 193 ~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~cl~~~p~~ 269 (283)
T cd05090 193 MPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR-QLLPCS--EDCPPRMYSLMTECWQEGPSR 269 (283)
T ss_pred cChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcccCccc
Confidence 99999998889999999999999999998 99999988776666555432 222233 4678999999999999 9999
Q ss_pred cCCCCCHhHHhcC
Q 010266 400 RLGTLGSEQIKAH 412 (514)
Q Consensus 400 Rl~~~~~~eil~H 412 (514)
|+ ++.+|+++
T Consensus 270 Rp---~~~~i~~~ 279 (283)
T cd05090 270 RP---RFKDIHTR 279 (283)
T ss_pred Cc---CHHHHHHH
Confidence 99 88888764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=342.27 Aligned_cols=254 Identities=30% Similarity=0.498 Sum_probs=212.0
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
+|++++.||.|++|.||+|+++.+|+.||+|+++.... ......+..|..+++.++||||++++++|.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999999976532 2334557789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 187 YLPGGDVMTLLMRE---ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 187 y~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
|++| +|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.+|.++|+|||++........
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 155 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-- 155 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--
Confidence 9985 888887653 3689999999999999999999999999999999999999999999999999875432100
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchhhhh
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 342 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlG 342 (514)
.....+||+.|+|||++.+ ..++.++|+||||
T Consensus 156 -----------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG 188 (284)
T cd07836 156 -----------------------------------------------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVG 188 (284)
T ss_pred -----------------------------------------------ccccccccccccChHHhcCCCCCCcHHHHHHHH
Confidence 0113468999999999876 4578999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcCc----------------ccCCc---------CcCCChhHHHHHhhhcc-C
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNH----------------LKFPE---------EARLTPEAKDLICRLLC-D 396 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~~----------------~~~p~---------~~~~s~~~~dLI~~lL~-d 396 (514)
|++|+|++|.+||.+.+..+....+...... ..+|. ...+++.++++|.+||+ |
T Consensus 189 ~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 268 (284)
T cd07836 189 CIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLN 268 (284)
T ss_pred HHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCC
Confidence 9999999999999988877766665432100 00110 01457899999999998 9
Q ss_pred ccccCCCCCHhHHhcCCcc
Q 010266 397 VEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 397 p~~Rl~~~~~~eil~Hpff 415 (514)
|.+|+ +++++++||||
T Consensus 269 p~~R~---~~~~~l~~~~f 284 (284)
T cd07836 269 PELRI---SAHDALQHPWF 284 (284)
T ss_pred cccCC---CHHHHhcCCCC
Confidence 99999 99999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=342.02 Aligned_cols=255 Identities=29% Similarity=0.539 Sum_probs=217.7
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
.|...+.||.|++|.||++.++.+++.+|+|++... .....+.+.+|..++..++||+|++++++|...+..|+|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 455567999999999999999999999999988643 23345568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccc
Q 010266 187 YLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE 266 (514)
Q Consensus 187 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~ 266 (514)
|++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||+|+||+++.+|.++|+|||++.......
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~------ 169 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV------ 169 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC------
Confidence 9999999999876 678999999999999999999999999999999999999999999999999876432110
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHH
Q 010266 267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 346 (514)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 346 (514)
.......|++.|+|||++.+..++.++|+|||||++|
T Consensus 170 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ 206 (285)
T cd06648 170 -------------------------------------------PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVI 206 (285)
T ss_pred -------------------------------------------cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHH
Confidence 0011456999999999999888999999999999999
Q ss_pred HHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 347 EMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 347 emltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
+|++|..||...++......+... .....+....++..+.+||.+||. +|.+|+ ++.+++.||||+..
T Consensus 207 ell~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~il~~~~~~~~ 275 (285)
T cd06648 207 EMVDGEPPYFNEPPLQAMKRIRDN-LPPKLKNLHKVSPRLRSFLDRMLVRDPAQRA---TAAELLNHPFLAKA 275 (285)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHhc-CCCCCcccccCCHHHHHHHHHHcccChhhCc---CHHHHccCcccccC
Confidence 999999999988887777766543 112222223478999999999999 999999 99999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=354.11 Aligned_cols=263 Identities=28% Similarity=0.457 Sum_probs=214.8
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE----cCCeE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ----DAEYL 181 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~----~~~~l 181 (514)
++|++.+.||.|+||.||+|.++.+|+.||+|++.+... .......+..|..+|..++||||++++++|. +...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 689999999999999999999999999999999976432 2334566778999999999999999998886 34579
Q ss_pred EEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
|+||||+. |+|..++.....+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++........
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999995 68999998888899999999999999999999999999999999999999999999999999876432210
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWS 340 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWS 340 (514)
.. .......+||+.|+|||++.+ ..++.++|+||
T Consensus 163 ~~---------------------------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~s 197 (334)
T cd07855 163 EH---------------------------------------------KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWS 197 (334)
T ss_pred CC---------------------------------------------CcccccccccccccChHHhcCCcccccccchHH
Confidence 00 001124579999999999876 46899999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhHHHHHHhhhcC------------------------cccCCc---CcCCChhHHHHHhhh
Q 010266 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKN------------------------HLKFPE---EARLTPEAKDLICRL 393 (514)
Q Consensus 341 lGvilyemltG~~PF~~~~~~~~~~~i~~~~~------------------------~~~~p~---~~~~s~~~~dLI~~l 393 (514)
|||++|||++|.+||.+.+.......+..... ....+. ...++++++++|.+|
T Consensus 198 lG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 277 (334)
T cd07855 198 VGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQM 277 (334)
T ss_pred HHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHH
Confidence 99999999999999988766544433332100 000110 124689999999999
Q ss_pred cc-CccccCCCCCHhHHhcCCccccC
Q 010266 394 LC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 394 L~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
|+ +|.+|+ ++++++.||||.+.
T Consensus 278 l~~~P~~Rp---t~~~~l~~~~~~~~ 300 (334)
T cd07855 278 LQFDPEERI---TVEQALQHPFLAQY 300 (334)
T ss_pred ccCChhhCc---CHHHHHhChhhhhc
Confidence 99 999999 99999999999854
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=342.82 Aligned_cols=252 Identities=25% Similarity=0.410 Sum_probs=212.0
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEc-----cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA 178 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 178 (514)
..++|.+.+.||+|+||+||+|... .++..||+|.+.+. .......+..|..++..++||+|+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 4468999999999999999999853 34567999988754 244566788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhcc-------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcE
Q 010266 179 EYLYLIMEYLPGGDVMTLLMREE-------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHM 245 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~~-------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~i 245 (514)
+.+|+||||+++|+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.+|++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999999999999999986543 48999999999999999999999999999999999999999999
Q ss_pred EEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcc
Q 010266 246 KLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPE 325 (514)
Q Consensus 246 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APE 325 (514)
||+|||+++........ .......|++.|+|||
T Consensus 160 kl~dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y~aPE 192 (288)
T cd05093 160 KIGDFGMSRDVYSTDYY-----------------------------------------------RVGGHTMLPIRWMPPE 192 (288)
T ss_pred EeccCCccccccCCcee-----------------------------------------------ecCCCCCccccccCHH
Confidence 99999998754321100 0011345788999999
Q ss_pred ccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCC
Q 010266 326 VLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT 403 (514)
Q Consensus 326 vl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~ 403 (514)
++.+..++.++|+|||||++|+|++ |.+||.+.+..+....+.... ....| ...++++.+||.+||. ||.+|+
T Consensus 193 ~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rp-- 267 (288)
T cd05093 193 SIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR-VLQRP--RTCPKEVYDLMLGCWQREPHMRL-- 267 (288)
T ss_pred HhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHccCChhhCC--
Confidence 9999999999999999999999998 999999888877777776532 12223 3578999999999999 999999
Q ss_pred CCHhHHhc
Q 010266 404 LGSEQIKA 411 (514)
Q Consensus 404 ~~~~eil~ 411 (514)
+++++.+
T Consensus 268 -t~~~v~~ 274 (288)
T cd05093 268 -NIKEIHS 274 (288)
T ss_pred -CHHHHHH
Confidence 8888854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=342.48 Aligned_cols=253 Identities=23% Similarity=0.371 Sum_probs=212.1
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEcc-----CCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKK-----SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA 178 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~-----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 178 (514)
..++|.+++.||+|+||.||+|.... ++..||+|++++.. .......+.+|..+|..++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 35678999999999999999998753 46789999987542 233457789999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhc--------------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCc
Q 010266 179 EYLYLIMEYLPGGDVMTLLMRE--------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH 244 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~--------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~ 244 (514)
...|+||||++||+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 9999999999999999999754 34788889999999999999999999999999999999999999
Q ss_pred EEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCc
Q 010266 245 MKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAP 324 (514)
Q Consensus 245 iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~AP 324 (514)
+||+|||++......... .......+++.|+||
T Consensus 161 ~kl~d~g~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y~aP 193 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYY-----------------------------------------------RVGGHTMLPIRWMPP 193 (280)
T ss_pred EEECCcccceecccCcce-----------------------------------------------ecCCCCcccceecCh
Confidence 999999998754221100 000134578899999
Q ss_pred cccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCC
Q 010266 325 EVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLG 402 (514)
Q Consensus 325 Evl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~ 402 (514)
|++.+..++.++|||||||++|||++ |..||.+.+..+....+... ....+ ...++..+++||.+||+ ||.+|+
T Consensus 194 E~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp- 269 (280)
T cd05049 194 ESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG--RLLQR-PRTCPSEVYDIMLGCWKRDPQQRI- 269 (280)
T ss_pred hhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CcCCC-CCCCCHHHHHHHHHHcCCCcccCC-
Confidence 99999999999999999999999998 99999988877777776642 22222 23688999999999999 999999
Q ss_pred CCCHhHHhc
Q 010266 403 TLGSEQIKA 411 (514)
Q Consensus 403 ~~~~~eil~ 411 (514)
+++||+.
T Consensus 270 --~~~eil~ 276 (280)
T cd05049 270 --NIKDIHE 276 (280)
T ss_pred --CHHHHHH
Confidence 8999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=352.67 Aligned_cols=261 Identities=29% Similarity=0.467 Sum_probs=208.7
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC-----C
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA-----E 179 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~-----~ 179 (514)
.++|++.+.||+|+||.||+|.++.+|+.||+|++.... .......+..|..++..++||||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 368999999999999999999999999999999986432 233445677899999999999999999876544 4
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
.+|+||||+. ++|..++ ....+++..++.++.|++.||.|||+.||+||||||+|||++.+|++||+|||++......
T Consensus 82 ~~~lv~e~~~-~~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 82 DVYIVQELME-TDLYKLI-KTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred eEEEEehhcc-cCHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 6899999996 5888877 4467999999999999999999999999999999999999999999999999998764321
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccch
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDW 338 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~Di 338 (514)
... .......+||+.|+|||++.+ ..++.++|+
T Consensus 160 ~~~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 193 (336)
T cd07849 160 HDH----------------------------------------------TGFLTEYVATRWYRAPEIMLNSKGYTKAIDI 193 (336)
T ss_pred ccc----------------------------------------------cCCcCCcCcCCCccChHHhhCCCCCCcHHHH
Confidence 100 000114579999999998765 568999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcC--------------------ccc----CC---cCcCCChhHHHHHh
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKN--------------------HLK----FP---EEARLTPEAKDLIC 391 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~--------------------~~~----~p---~~~~~s~~~~dLI~ 391 (514)
|||||++|+|++|++||.+.+.......+..... .+. .+ ....+++++.+||.
T Consensus 194 wslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 273 (336)
T cd07849 194 WSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLD 273 (336)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHH
Confidence 9999999999999999987665443332221000 000 00 01246889999999
Q ss_pred hhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 392 RLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 392 ~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
+||+ +|.+|+ ++.|++.||||+..
T Consensus 274 ~~l~~dP~~Rp---t~~e~l~hp~~~~~ 298 (336)
T cd07849 274 KMLTFNPHKRI---TVEEALAHPYLEQY 298 (336)
T ss_pred HHcCCChhhCc---CHHHHhcCcccccc
Confidence 9999 999999 99999999999854
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=344.81 Aligned_cols=261 Identities=28% Similarity=0.429 Sum_probs=208.1
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC-----
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE----- 179 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~----- 179 (514)
.++|++++.||+|+||.||+|.++.+++.||||++..... .......+.+|..+++.++||+|+++++++.+..
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 4689999999999999999999999999999999865432 2223345667999999999999999999887654
Q ss_pred ---eEEEEEeecCCCCHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 180 ---YLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 180 ---~l~lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
..|+||||+. ++|..++.... .+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++..
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 4599999996 58888876543 789999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-CCCc
Q 010266 256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGM 334 (514)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~ 334 (514)
........ .......+|++.|+|||++.+. .++.
T Consensus 169 ~~~~~~~~---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~ 203 (310)
T cd07865 169 FSLSKNSK---------------------------------------------PNRYTNRVVTLWYRPPELLLGERDYGP 203 (310)
T ss_pred ccCCcccC---------------------------------------------CCCccCcccCccccCcHHhcCCcccCc
Confidence 54221000 0001135689999999998764 4789
Q ss_pred ccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCc-----------------ccCCcC-----------cCCChhH
Q 010266 335 ECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNH-----------------LKFPEE-----------ARLTPEA 386 (514)
Q Consensus 335 ~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-----------------~~~p~~-----------~~~s~~~ 386 (514)
++|+|||||++|||++|.+||.+.+.......+...... +.+|.. ...++.+
T Consensus 204 ~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 283 (310)
T cd07865 204 PIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHA 283 (310)
T ss_pred hhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHH
Confidence 999999999999999999999887765544433321110 111110 1135788
Q ss_pred HHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 387 KDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 387 ~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
.+||.+||+ ||.+|+ +++++++||||
T Consensus 284 ~dli~~~l~~~P~~R~---t~~e~l~h~~f 310 (310)
T cd07865 284 LDLIDKLLVLDPAKRI---DADTALNHDFF 310 (310)
T ss_pred HHHHHHHhcCChhhcc---CHHHHhcCCCC
Confidence 999999999 999999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=381.58 Aligned_cols=272 Identities=24% Similarity=0.362 Sum_probs=209.0
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
+++|++++.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|..+++.++|||||++++++.+.+..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 36899999999999999999999999999999999865433444556788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccc
Q 010266 185 MEYLPGGDVMTLLMRE-----------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~-----------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla 253 (514)
|||++||+|.+++... ..++...+..++.|++.||+|||+.||+||||||+|||++.+|.+||+|||+|
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999998642 22445566788999999999999999999999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCC
Q 010266 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG 333 (514)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 333 (514)
+............ .....+.. .+........+||+.|||||++.+..++
T Consensus 161 k~i~~~~~~~~~l-----------~~~~~~s~--------------------~s~~t~~g~~vGT~~YmAPE~l~g~~~S 209 (932)
T PRK13184 161 IFKKLEEEDLLDI-----------DVDERNIC--------------------YSSMTIPGKIVGTPDYMAPERLLGVPAS 209 (932)
T ss_pred eeccccccccccc-----------cccccccc--------------------ccccccCCCCCCCCCCCCHHHhcCCCCC
Confidence 8653211000000 00000000 0000111246899999999999999999
Q ss_pred cccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHh
Q 010266 334 MECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIK 410 (514)
Q Consensus 334 ~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 410 (514)
.++|||||||++|||++|.+||.+.+.......... ......++...+++.+.+++.+||. ||.+|++ ++++++
T Consensus 210 ~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i-~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~s--s~eeLl 284 (932)
T PRK13184 210 ESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVI-LSPIEVAPYREIPPFLSQIAMKALAVDPAERYS--SVQELK 284 (932)
T ss_pred cHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhc-cChhhccccccCCHHHHHHHHHHccCChhhCcC--HHHHHH
Confidence 999999999999999999999987654433222111 1112222234678999999999999 9999984 444444
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=336.60 Aligned_cols=255 Identities=31% Similarity=0.510 Sum_probs=209.2
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 183 (514)
..+.+.....||+|+||.||++.+..++..||+|.+.... ....+.+.+|..+++.++||||+++++++.+.+..|+
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3455555678999999999999999999999999887542 3455678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhc-cCC--CHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC-CCcEEEccccccccCCCC
Q 010266 184 IMEYLPGGDVMTLLMRE-ETL--TETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ-NGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~~-~~l--~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~-~g~iKL~DFGla~~~~~~ 259 (514)
||||++|++|.+++... ..+ ++..+.+++.|++.||.|||+.||+||||||+||+++. ++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 99999999999998764 455 88889999999999999999999999999999999986 689999999998754321
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC--CCCcccc
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK--GYGMECD 337 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~--~y~~~~D 337 (514)
+. ......|++.|+|||++.+. .++.++|
T Consensus 163 ~~-------------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~D 193 (268)
T cd06624 163 NP-------------------------------------------------CTETFTGTLQYMAPEVIDKGPRGYGAPAD 193 (268)
T ss_pred CC-------------------------------------------------ccccCCCCccccChhhhccccccCCchhh
Confidence 10 01134589999999998764 3789999
Q ss_pred hhhhhHHHHHHhhCCCCCCCCChh-HHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 338 WWSLGAIMYEMLVGYPPFYSDDPV-TTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 338 iWSlGvilyemltG~~PF~~~~~~-~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
+|||||++|+|++|.+||...... .....+........+|. .+++++++||.+||. +|.+|+ ++++++.||||
T Consensus 194 v~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp---t~~~ll~~~~~ 268 (268)
T cd06624 194 IWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPE--SLSAEAKNFILRCFEPDPDKRA---SAHDLLQDPFL 268 (268)
T ss_pred hHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCc--ccCHHHHHHHHHHcCCCchhCC---CHHHHHhCCCC
Confidence 999999999999999999764332 22222211122233443 578999999999998 999999 99999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=341.00 Aligned_cols=256 Identities=31% Similarity=0.531 Sum_probs=215.5
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC---CCceeeEEEEEEcCCeEEE
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA---SHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~~~f~~~~~l~l 183 (514)
.|++++.||+|+||.||+|.+..+++.||+|.+.... .......+.+|..+++.+. ||++++++++|.+....|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5788899999999999999999999999999987542 3445667888999999986 9999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
||||++|++|.+++.. +.+++..+..++.+++.||.|||+.||+||||+|+||+++.+|.++|+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-- 156 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc--
Confidence 9999999999999855 5789999999999999999999999999999999999999999999999999876532210
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchhhhh
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 342 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlG 342 (514)
.....+|++.|+|||++.+ ..++.++|+||||
T Consensus 157 -----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 189 (277)
T cd06917 157 -----------------------------------------------KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLG 189 (277)
T ss_pred -----------------------------------------------ccccccCCcceeCHHHhccCCccccchhHHHHH
Confidence 0114579999999999875 4578999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCC
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIA 419 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~ 419 (514)
|++|+|++|.+||.+.+.......+... ....++. ...+.++.++|.+||. ||.+|+ ++.+++.||||+...
T Consensus 190 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~---~~~~il~~~~~~~~~ 262 (277)
T cd06917 190 ITIYEMATGNPPYSDVDAFRAMMLIPKS-KPPRLED-NGYSKLLREFVAACLDEEPKERL---SAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHHHHhCCCCCCCCChhhhhhccccC-CCCCCCc-ccCCHHHHHHHHHHcCCCcccCc---CHHHHhhChHhhccc
Confidence 9999999999999887665544433221 1122222 1378899999999998 999999 999999999998754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=336.52 Aligned_cols=252 Identities=23% Similarity=0.365 Sum_probs=214.1
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 181 (514)
.+...+|.+.+.||.|+||.||+|..+.+++.||+|++.+.. .....+.+|..+|..++||+|+++++++..+..+
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 355678999999999999999999999999999999987542 2345688899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 182 YLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
|+||||+++|+|.+++... ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 9999999999999998653 36889999999999999999999999999999999999999999999999998765321
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
... ......+++.|+|||++.+..++.++|+|
T Consensus 158 ~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 189 (263)
T cd05052 158 TYT------------------------------------------------AHAGAKFPIKWTAPESLAYNKFSIKSDVW 189 (263)
T ss_pred eee------------------------------------------------ccCCCCCccccCCHHHhccCCCCchhHHH
Confidence 100 00122356789999999999999999999
Q ss_pred hhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 340 SLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 340 SlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
||||++|||++ |.+||.+.+..+....+... .....| ..+++++.+||.+||. +|.+|+ ++.++.+
T Consensus 190 slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~cl~~~p~~Rp---~~~~l~~ 257 (263)
T cd05052 190 AFGVLLWEIATYGMSPYPGIDLSQVYELLEKG-YRMERP--EGCPPKVYELMRACWQWNPSDRP---SFAEIHQ 257 (263)
T ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CCCCCC--CCCCHHHHHHHHHHccCCcccCC---CHHHHHH
Confidence 99999999998 99999988887777776542 122333 3688999999999999 999999 8888865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=331.10 Aligned_cols=262 Identities=24% Similarity=0.443 Sum_probs=222.7
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcC
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDA 178 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~ 178 (514)
+....+++.+.+..||.|+-|.||+++.+.+|...|||.|.+.. ++.+.+++....+++... ++|+||+.|++|..+
T Consensus 86 r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n 163 (391)
T KOG0983|consen 86 RYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN 163 (391)
T ss_pred ccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC
Confidence 34556778888999999999999999999999999999999875 455667777777777666 499999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCCccccCCCcEEEccccccccC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKpeNILld~~g~iKL~DFGla~~~ 256 (514)
..+++.||.| +..+..+|.+ .++++|..+-.+...++.||.||.. +||||||+||+|||+|..|+|||||||++-.+
T Consensus 164 ~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 164 TDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRL 242 (391)
T ss_pred chHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccccee
Confidence 9999999998 4466666654 5789999999999999999999985 69999999999999999999999999998765
Q ss_pred CCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc---CCCC
Q 010266 257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK---KGYG 333 (514)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~y~ 333 (514)
..+.. ...-.|-+.|||||-+.- ..|+
T Consensus 243 vdSkA--------------------------------------------------htrsAGC~~YMaPERidp~~~~kYD 272 (391)
T KOG0983|consen 243 VDSKA--------------------------------------------------HTRSAGCAAYMAPERIDPPDKPKYD 272 (391)
T ss_pred ecccc--------------------------------------------------cccccCCccccCccccCCCCCCccc
Confidence 43210 012369999999999863 5799
Q ss_pred cccchhhhhHHHHHHhhCCCCCCCC-ChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 334 MECDWWSLGAIMYEMLVGYPPFYSD-DPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 334 ~~~DiWSlGvilyemltG~~PF~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
..+||||||+.|+||.||..||.+. ..-++..+|++ .++..+|....+|+++.+|+..||+ |+.+|+ .-.++++
T Consensus 273 iRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP---~Y~~Ll~ 348 (391)
T KOG0983|consen 273 IRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRP---KYNKLLE 348 (391)
T ss_pred hhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCcccCcCHHHHHHHHHHhhcCcccCc---chHHHhc
Confidence 9999999999999999999999885 45677788887 4556777777799999999999999 999999 7789999
Q ss_pred CCccccC
Q 010266 412 HPWFKDI 418 (514)
Q Consensus 412 Hpff~~i 418 (514)
|||.+..
T Consensus 349 h~Fi~~y 355 (391)
T KOG0983|consen 349 HPFIKRY 355 (391)
T ss_pred Ccceeec
Confidence 9999763
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=342.32 Aligned_cols=256 Identities=30% Similarity=0.483 Sum_probs=218.4
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
..|+.++.||.|+||.||+|.++.++..||+|++.... .......+.+|..+++.++||+|+++++++.+....|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35778899999999999999999999999999987543 2345677889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
||++||+|.+++.. +.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---- 156 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI---- 156 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc----
Confidence 99999999998854 6789999999999999999999999999999999999999999999999999875432100
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 345 (514)
......||..|+|||++.+..++.++|+|||||++
T Consensus 157 ---------------------------------------------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il 191 (277)
T cd06640 157 ---------------------------------------------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITA 191 (277)
T ss_pred ---------------------------------------------ccccccCcccccCHhHhccCCCccHHHHHHHHHHH
Confidence 01134689999999999988899999999999999
Q ss_pred HHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCC
Q 010266 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIA 419 (514)
Q Consensus 346 yemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~ 419 (514)
|||++|.+||...++......+... ....++ ..++..+.++|.+||. +|.+|+ ++++++.||||....
T Consensus 192 ~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~~ 260 (277)
T cd06640 192 IELAKGEPPNSDMHPMRVLFLIPKN-NPPTLT--GEFSKPFKEFIDACLNKDPSFRP---TAKELLKHKFIVKNA 260 (277)
T ss_pred HHHHHCCCCCCCcChHhHhhhhhcC-CCCCCc--hhhhHHHHHHHHHHcccCcccCc---CHHHHHhChHhhhcc
Confidence 9999999999887766655544321 111222 2467899999999998 999999 999999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=336.76 Aligned_cols=252 Identities=29% Similarity=0.499 Sum_probs=212.4
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++.+.||+|+||.||+|+.+.+++.||||.+.............+..|..+++.++||||+++++++.+.+..|+||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 68999999999999999999999999999999988765556666677889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 186 EYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 186 Ey~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~- 160 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh-
Confidence 99999999988853 3458899999999999999999999999999999999999999999999999987643210
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
.......|++.|+|||++.+..++.++|+|||
T Consensus 161 ------------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~sl 192 (267)
T cd08228 161 ------------------------------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSL 192 (267)
T ss_pred ------------------------------------------------HHHhcCCCCccccChhhhccCCCCchhhHHHH
Confidence 00114568999999999999889999999999
Q ss_pred hHHHHHHhhCCCCCCCCCh--hHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 342 GAIMYEMLVGYPPFYSDDP--VTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~--~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
||++|||++|..||..... ......+... .....|. ...+..+.+||.+||+ +|.+|+ ++++|++
T Consensus 193 G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rp---~~~~vl~ 260 (267)
T cd08228 193 GCLLYEMAALQSPFYGDKMNLFSLCQKIEQC-DYPPLPT-EHYSEKLRELVSMCIYPDPDQRP---DIGYVHQ 260 (267)
T ss_pred HHHHHHHhcCCCCCccccccHHHHHHHHhcC-CCCCCCh-hhcCHHHHHHHHHHCCCCcccCc---CHHHHHH
Confidence 9999999999999976532 3333333221 1111121 2467889999999999 999999 8999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=340.52 Aligned_cols=251 Identities=30% Similarity=0.507 Sum_probs=205.7
Q ss_pred eeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEEEcC--CeEEEE
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDA--EYLYLI 184 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~--~~l~lV 184 (514)
|++++.||+|+||.||+|.++.+++.||+|++++... .... .....|..++..+. ||||+++++++.+. +.+|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6789999999999999999999999999999876432 2222 23446888888885 99999999999988 899999
Q ss_pred EeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 185 MEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 185 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
|||++ |+|.+.+.. ...+++..++.++.|++.||.|||+.||+||||||+||+++. |.+||+|||+++.......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-- 154 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-- 154 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC--
Confidence 99997 578887765 457899999999999999999999999999999999999999 9999999999876532100
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchhhhh
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 342 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlG 342 (514)
.....||+.|+|||++.. ..++.++|+||||
T Consensus 155 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG 186 (282)
T cd07831 155 ------------------------------------------------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVG 186 (282)
T ss_pred ------------------------------------------------cCCCCCCcccCChhHhhcCCCCCcchhHHHHH
Confidence 013468999999998754 4568999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhc----------------CcccCCc---------CcCCChhHHHHHhhhcc-C
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWK----------------NHLKFPE---------EARLTPEAKDLICRLLC-D 396 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~----------------~~~~~p~---------~~~~s~~~~dLI~~lL~-d 396 (514)
|++|||++|.+||.+.+..+....+.... ....+|. ...+|.++.+||.+||. +
T Consensus 187 v~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 266 (282)
T cd07831 187 CVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYD 266 (282)
T ss_pred HHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccC
Confidence 99999999999999887766655554311 1112221 12468999999999999 9
Q ss_pred ccccCCCCCHhHHhcCCcc
Q 010266 397 VEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 397 p~~Rl~~~~~~eil~Hpff 415 (514)
|.+|+ ++++++.||||
T Consensus 267 P~~R~---~~~~~l~~~~~ 282 (282)
T cd07831 267 PDERI---TAKQALRHPYF 282 (282)
T ss_pred ccccc---CHHHHhhCCCC
Confidence 99999 99999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=347.48 Aligned_cols=253 Identities=31% Similarity=0.559 Sum_probs=214.0
Q ss_pred eeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEee
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY 187 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy 187 (514)
|.....||+|+||.||+|.+..+++.||+|++..... .....+.+|+.++..++||||++++++|...+..|+||||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 4445579999999999999999999999999865432 2345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccccc
Q 010266 188 LPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINEN 267 (514)
Q Consensus 188 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~ 267 (514)
++|++|..++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++........
T Consensus 100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~------ 172 (297)
T cd06659 100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP------ 172 (297)
T ss_pred CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc------
Confidence 999999987744 5789999999999999999999999999999999999999999999999999875432100
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHH
Q 010266 268 EVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 347 (514)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilye 347 (514)
.....+|++.|+|||++.+..++.++|+|||||++||
T Consensus 173 -------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e 209 (297)
T cd06659 173 -------------------------------------------KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIE 209 (297)
T ss_pred -------------------------------------------cccceecCccccCHHHHccCCCCchhhHHHHHHHHHH
Confidence 0114579999999999999899999999999999999
Q ss_pred HhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 348 MLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 348 mltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
|++|.+||...+..+....+.... .........+++.+.++|.+||+ +|.+|+ +++++++||||..
T Consensus 210 l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rp---s~~~ll~~~~~~~ 276 (297)
T cd06659 210 MVDGEPPYFSDSPVQAMKRLRDSP-PPKLKNAHKISPVLRDFLERMLTREPQERA---TAQELLDHPFLLQ 276 (297)
T ss_pred HHhCCCCCCCCCHHHHHHHHhccC-CCCccccCCCCHHHHHHHHHHhcCCcccCc---CHHHHhhChhhcc
Confidence 999999999877766665554321 11122223578899999999999 999999 9999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=339.51 Aligned_cols=255 Identities=17% Similarity=0.258 Sum_probs=209.9
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEc-----cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 177 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 177 (514)
+..++|++.+.||+|+||.||++.++ .++..||+|++.... .......+.+|..+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 45678999999999999999998864 245679999986542 22344567889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHhhcc----------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEE
Q 010266 178 AEYLYLIMEYLPGGDVMTLLMREE----------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKL 247 (514)
Q Consensus 178 ~~~l~lVmEy~~gg~L~~~l~~~~----------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL 247 (514)
....|+||||+++|+|.+++.+.. .++...+..++.|++.||.|||+.|++||||||+|||++.++.+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999999986532 3566778889999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccc
Q 010266 248 SDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL 327 (514)
Q Consensus 248 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl 327 (514)
+|||+++......... ......+++.|+|||++
T Consensus 161 ~dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y~aPE~~ 193 (277)
T cd05062 161 GDFGMTRDIYETDYYR-----------------------------------------------KGGKGLLPVRWMSPESL 193 (277)
T ss_pred CCCCCccccCCcceee-----------------------------------------------cCCCCccCHhhcChhHh
Confidence 9999987543211000 00123568899999999
Q ss_pred ccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCC
Q 010266 328 LKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLG 405 (514)
Q Consensus 328 ~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~ 405 (514)
.+..++.++|+|||||++|||++ |.+||.+.+..+....+... .....| ...++.++++|.+||+ +|.+|+ +
T Consensus 194 ~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s 267 (277)
T cd05062 194 KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG-GLLDKP--DNCPDMLFELMRMCWQYNPKMRP---S 267 (277)
T ss_pred hcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcCCChhhCc---C
Confidence 99999999999999999999999 79999988877776666542 222333 3678899999999999 999999 8
Q ss_pred HhHHhcC
Q 010266 406 SEQIKAH 412 (514)
Q Consensus 406 ~~eil~H 412 (514)
+.|++++
T Consensus 268 ~~e~l~~ 274 (277)
T cd05062 268 FLEIISS 274 (277)
T ss_pred HHHHHHH
Confidence 9998764
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=352.13 Aligned_cols=259 Identities=27% Similarity=0.439 Sum_probs=213.5
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC-----Ce
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA-----EY 180 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~-----~~ 180 (514)
++|.+++.||+|+||+||+|++..+++.||||.+.+... .......+..|..+|..++||||+++++++.+. ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 579999999999999999999999999999999875422 333445677899999999999999999988654 35
Q ss_pred EEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
+|+||||+. ++|..++...+.+++..+..++.|++.||.|||++|++||||||+||+++.+|.+||+|||+++......
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 899999995 7899999888899999999999999999999999999999999999999999999999999987543210
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWW 339 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiW 339 (514)
......+||..|+|||++.+ ..++.++|+|
T Consensus 163 -------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diw 193 (337)
T cd07858 163 -------------------------------------------------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVW 193 (337)
T ss_pred -------------------------------------------------ccccccccccCccChHHHhcCCCCCCcccHH
Confidence 00114568999999999875 4689999999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCc--------------------c---cCC----cCcCCChhHHHHHhh
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNH--------------------L---KFP----EEARLTPEAKDLICR 392 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~--------------------~---~~p----~~~~~s~~~~dLI~~ 392 (514)
||||++|+|++|.+||.+.+.......+...... + ..+ ....+++++++||.+
T Consensus 194 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 273 (337)
T cd07858 194 SVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEK 273 (337)
T ss_pred HHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHH
Confidence 9999999999999999887655444433321000 0 000 012578999999999
Q ss_pred hcc-CccccCCCCCHhHHhcCCccccC
Q 010266 393 LLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 393 lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
||+ +|.+|+ +++++++||||+.+
T Consensus 274 ~l~~~P~~Rp---s~~ell~h~~~~~~ 297 (337)
T cd07858 274 MLVFDPSKRI---TVEEALAHPYLASL 297 (337)
T ss_pred HhcCChhhcc---CHHHHHcCcchhhh
Confidence 999 999999 99999999999865
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=335.27 Aligned_cols=251 Identities=23% Similarity=0.392 Sum_probs=212.2
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 181 (514)
.+..++|++++.||+|+||.||+|... ++..||+|.+.... ...+.+..|..+++.++||||+++++.+.+.+..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI 76 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 356789999999999999999999864 56679999886542 2356788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 182 YLIMEYLPGGDVMTLLMR--EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
|+||||++||+|.+++.+ ...++...+..++.|++.||.|||+.|++||||||+||+++.+|.+||+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 999999999999999865 356888889999999999999999999999999999999999999999999999764321
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
... ......++..|+|||++.+..++.++|+|
T Consensus 157 ~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 188 (261)
T cd05072 157 EYT------------------------------------------------AREGAKFPIKWTAPEAINFGSFTIKSDVW 188 (261)
T ss_pred cee------------------------------------------------ccCCCccceecCCHHHhccCCCChhhhhh
Confidence 000 00123467789999999988899999999
Q ss_pred hhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 340 SLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 340 SlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
||||++|+|++ |..||.+.+.......+.. ....|....++.++.++|.+||. +|.+|+ ++++|.+
T Consensus 189 slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~ 256 (261)
T cd05072 189 SFGILLYEIVTYGKIPYPGMSNSDVMSALQR---GYRMPRMENCPDELYDIMKTCWKEKAEERP---TFDYLQS 256 (261)
T ss_pred hhHHHHHHHHccCCCCCCCCCHHHHHHHHHc---CCCCCCCCCCCHHHHHHHHHHccCCcccCc---CHHHHHH
Confidence 99999999998 9999998877777766653 23344444688999999999998 999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=365.58 Aligned_cols=249 Identities=31% Similarity=0.549 Sum_probs=217.0
Q ss_pred eeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecCCCC
Q 010266 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGD 192 (514)
Q Consensus 113 ~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~ 192 (514)
+||+|.||+||.++++.|....|||.+... .....+-+..|+.+.+.++|.|||+.++++...+++-+.||-+|||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 799999999999999999999999998654 23456678899999999999999999999999999999999999999
Q ss_pred HHHHHhh-ccCC--CHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCcccc-CCCcEEEccccccccCCCCCcccccccc
Q 010266 193 VMTLLMR-EETL--TETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-QNGHMKLSDFGLCKPLDCTNLSAINENE 268 (514)
Q Consensus 193 L~~~l~~-~~~l--~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld-~~g~iKL~DFGla~~~~~~~~~~~~~~~ 268 (514)
|.++|.. .+++ .|...-||..||+.||.|||.+.|||||||-+||||+ -.|.+||+|||-||.+..-+
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-------- 730 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-------- 730 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCC--------
Confidence 9999975 5787 7889999999999999999999999999999999997 57999999999999764211
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc--CCCCcccchhhhhHHHH
Q 010266 269 VLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMY 346 (514)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvily 346 (514)
..+-++.||..|||||++.. .+|+.++|||||||.+.
T Consensus 731 -----------------------------------------P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~v 769 (1226)
T KOG4279|consen 731 -----------------------------------------PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMV 769 (1226)
T ss_pred -----------------------------------------ccccccccchhhhChHhhccCCcCCCchhhhhhccceeE
Confidence 12347899999999999985 57999999999999999
Q ss_pred HHhhCCCCCCCC-ChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 347 EMLVGYPPFYSD-DPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 347 emltG~~PF~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
||.||+|||..- +++...-++--.+....+|. .+|.+|+.||.+|.. ||.+|+ +|.+++..||++.-
T Consensus 770 EMATGrPPF~ElgspqAAMFkVGmyKvHP~iPe--elsaeak~FilrcFepd~~~R~---sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 770 EMATGRPPFVELGSPQAAMFKVGMYKVHPPIPE--ELSAEAKNFILRCFEPDPCDRP---SAKDLLQDPFLQHN 838 (1226)
T ss_pred eeccCCCCeeecCChhHhhhhhcceecCCCCcH--HHHHHHHHHHHHHcCCCcccCc---cHHHhccCcccccC
Confidence 999999999743 34444445544455666675 799999999999998 999999 99999999999764
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=343.21 Aligned_cols=256 Identities=31% Similarity=0.491 Sum_probs=212.5
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC--CeEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA--EYLY 182 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~--~~l~ 182 (514)
.++|++.+.||.|+||.||+|.++.+++.+|+|.++..... ......+.+|..++..++||||+++++++.+. ..+|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 36799999999999999999999999999999999765432 23334567899999999999999999999877 8999
Q ss_pred EEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 183 LIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
+||||++ ++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++........
T Consensus 83 lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred EEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 9999997 4999988764 4589999999999999999999999999999999999999999999999999876542100
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-CCCcccchhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWWS 340 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWS 340 (514)
......|++.|+|||++.+. .++.++|+||
T Consensus 162 -------------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s 192 (293)
T cd07843 162 -------------------------------------------------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWS 192 (293)
T ss_pred -------------------------------------------------ccccccccccccCchhhcCCccccchhhHHH
Confidence 01134688999999998764 4689999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCc-----------------------------ccCCcCcCCChhHHHHHh
Q 010266 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNH-----------------------------LKFPEEARLTPEAKDLIC 391 (514)
Q Consensus 341 lGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-----------------------------~~~p~~~~~s~~~~dLI~ 391 (514)
|||++|+|++|.+||.+.+......++...... -.+|. ..+++.+++||.
T Consensus 193 lG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~ 271 (293)
T cd07843 193 VGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPA-LSLSDNGFDLLN 271 (293)
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccc-cCCChHHHHHHH
Confidence 999999999999999988777666655431100 01111 115889999999
Q ss_pred hhcc-CccccCCCCCHhHHhcCCcc
Q 010266 392 RLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 392 ~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
+||+ +|++|+ +++|++.||||
T Consensus 272 ~~l~~~p~~R~---t~~ell~~~~f 293 (293)
T cd07843 272 RLLTYDPAKRI---SAEDALKHPYF 293 (293)
T ss_pred HHhccCccccC---CHHHHhcCCCC
Confidence 9999 999999 99999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=339.43 Aligned_cols=257 Identities=30% Similarity=0.466 Sum_probs=212.4
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC--CeEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA--EYLYL 183 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~--~~l~l 183 (514)
++|+.++.||.|++|.||+|.+..+++.||+|.+.+.. .......+.+|.++++.++||||++++++|.+. ..+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 47999999999999999999999999999999987653 224456688899999999999999999988654 47999
Q ss_pred EEeecCCCCHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 184 IMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
||||++|++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999888653 356889999999999999999999999999999999999999999999999998654211
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
. .....|+..|+|||.+.+..++.++|+|
T Consensus 159 ~---------------------------------------------------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~ 187 (287)
T cd06621 159 L---------------------------------------------------AGTFTGTSFYMAPERIQGKPYSITSDVW 187 (287)
T ss_pred c---------------------------------------------------cccccCCccccCHHHhcCCCCCchhhHH
Confidence 0 0134578899999999999999999999
Q ss_pred hhhHHHHHHhhCCCCCCCCC-----hhHHHHHHhhhcCcccCCc----CcCCChhHHHHHhhhcc-CccccCCCCCHhHH
Q 010266 340 SLGAIMYEMLVGYPPFYSDD-----PVTTCRKIVHWKNHLKFPE----EARLTPEAKDLICRLLC-DVEHRLGTLGSEQI 409 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~-----~~~~~~~i~~~~~~~~~p~----~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ei 409 (514)
||||++|+|++|..||.... ..+....+.... ...++. ...+++++.+||.+||. +|.+|+ ++.||
T Consensus 188 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~ei 263 (287)
T cd06621 188 SLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP-NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRP---TPWDM 263 (287)
T ss_pred HHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC-chhhccCCCCCCchHHHHHHHHHHHcCCCcccCC---CHHHH
Confidence 99999999999999998652 233344433321 112221 12356789999999998 999999 99999
Q ss_pred hcCCccccCC
Q 010266 410 KAHPWFKDIA 419 (514)
Q Consensus 410 l~Hpff~~i~ 419 (514)
+.||||+...
T Consensus 264 l~~~~~~~~~ 273 (287)
T cd06621 264 LEHPWIKAQM 273 (287)
T ss_pred HhCccccccc
Confidence 9999997643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=344.53 Aligned_cols=257 Identities=30% Similarity=0.518 Sum_probs=217.6
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.++|.+++.||.|+||.||++.+..+++.||+|.+.... ....+.+..|..+++.++||||++++++|.+.+..|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 478999999999999999999998899999999986442 23346688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
+||++||+|..++.+ ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--- 170 (293)
T cd06647 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--- 170 (293)
T ss_pred EecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc---
Confidence 999999999999864 4678999999999999999999999999999999999999999999999999875432100
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 344 (514)
......|++.|+|||++.+..++.++|+|||||+
T Consensus 171 ----------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~l 204 (293)
T cd06647 171 ----------------------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM 204 (293)
T ss_pred ----------------------------------------------ccccccCChhhcCchhhccCCCCchhhHHHHHHH
Confidence 0113469999999999998889999999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 345 MYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 345 lyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
+|+|++|.+||...+.......+..+ ....++....++..+++||.+||. +|.+|+ ++++++.||||+..
T Consensus 205 l~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---~~~~il~h~~~~~~ 275 (293)
T cd06647 205 AIEMVEGEPPYLNENPLRALYLIATN-GTPELQNPEKLSAIFRDFLNRCLEMDVEKRG---SAKELLQHPFLKIA 275 (293)
T ss_pred HHHHHhCCCCCCCCChhhheeehhcC-CCCCCCCccccCHHHHHHHHHHccCChhhCc---CHHHHhcCHHHhcC
Confidence 99999999999877665443333221 222333334578899999999998 999998 99999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=333.24 Aligned_cols=249 Identities=20% Similarity=0.345 Sum_probs=209.8
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 183 (514)
..++|++++.||+|+||.||++..+. +..+|+|.+.+... ....+..|..+|+.++||||++++++|.+...+|+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 76 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI 76 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence 45789999999999999999998754 56799998875432 23457889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 184 IMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
||||++||+|.+++.. .+.+++..+..++.+++.||.|||++||+||||||+||+++.++.+||+|||+++........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 9999999999999875 356899999999999999999999999999999999999999999999999998754321000
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
......++..|+|||++.+..++.++|+||||
T Consensus 157 ------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G 188 (256)
T cd05114 157 ------------------------------------------------SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFG 188 (256)
T ss_pred ------------------------------------------------ccCCCCCchhhCChhhcccCccchhhhhHHHH
Confidence 00123466789999999988999999999999
Q ss_pred HHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 343 AIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 343 vilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|++|||++ |.+||...+..+....+.... ....| ...+.++.+||.+|++ +|.+|+ ++++++.
T Consensus 189 ~~l~el~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~~~~li~~c~~~~p~~Rp---s~~~l~~ 253 (256)
T cd05114 189 VLMWEVFTEGKMPFEKKSNYEVVEMISRGF-RLYRP--KLASMTVYEVMYSCWHEKPEGRP---TFAELLR 253 (256)
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-CCCCC--CCCCHHHHHHHHHHccCCcccCc---CHHHHHH
Confidence 99999999 999999888888877776532 22233 3568899999999999 999999 8998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=334.02 Aligned_cols=253 Identities=30% Similarity=0.564 Sum_probs=215.9
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
+|.+.+.||+|+||.||+|..+.+|..||+|.+..... .....+.+.+|+.+++.++||||+++++.+.+....|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 58899999999999999999999999999999876543 22345667889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCc-EEEccccccccCCCCCccc
Q 010266 187 YLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH-MKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 187 y~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~-iKL~DFGla~~~~~~~~~~ 263 (514)
|++|++|.+++.... .+++..+..++.|++.||.|||+.||+|+||||+||+++.++. +||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--- 156 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM--- 156 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc---
Confidence 999999999987643 5789999999999999999999999999999999999998865 6999999987543210
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhH
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 343 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 343 (514)
.......|++.|+|||++.+..++.++|+|||||
T Consensus 157 ----------------------------------------------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~ 190 (257)
T cd08225 157 ----------------------------------------------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGC 190 (257)
T ss_pred ----------------------------------------------ccccccCCCccccCHHHHcCCCCCchhhHHHHHH
Confidence 0011346899999999998888999999999999
Q ss_pred HHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 344 ilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
++|+|++|..||.+.+..+....+.... + .+....++.+++++|.+||. +|.+|+ ++++|++||||
T Consensus 191 il~~l~~g~~p~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~i~~~l~~~p~~Rp---t~~~ll~~~~~ 257 (257)
T cd08225 191 VLYELCTLKHPFEGNNLHQLVLKICQGY--F-APISPNFSRDLRSLISQLFKVSPRDRP---SITSILKRPFL 257 (257)
T ss_pred HHHHHHhCCCCCCCccHHHHHHHHhccc--C-CCCCCCCCHHHHHHHHHHhccChhhCc---CHHHHhhCCCC
Confidence 9999999999998877766666555321 1 11223578899999999998 999999 99999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=352.21 Aligned_cols=257 Identities=24% Similarity=0.329 Sum_probs=208.2
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEcc-----CCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKK-----SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSF 175 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~-----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f 175 (514)
.+..++|++.+.||.|+||.||+|+... +++.||+|+++... .......+..|..++..+ +||||++++++|
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 4556789999999999999999997543 45789999987542 234456678899999999 899999999987
Q ss_pred Ec-CCeEEEEEeecCCCCHHHHHhhc------------------------------------------------------
Q 010266 176 QD-AEYLYLIMEYLPGGDVMTLLMRE------------------------------------------------------ 200 (514)
Q Consensus 176 ~~-~~~l~lVmEy~~gg~L~~~l~~~------------------------------------------------------ 200 (514)
.+ +..+|+||||++||+|.+++...
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 64 46799999999999999998542
Q ss_pred -------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccccccccccc
Q 010266 201 -------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDE 273 (514)
Q Consensus 201 -------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~ 273 (514)
..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+......
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~----------- 229 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY----------- 229 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcch-----------
Confidence 25788889999999999999999999999999999999999999999999999865321000
Q ss_pred cccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhh-CC
Q 010266 274 NLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GY 352 (514)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt-G~ 352 (514)
....+..|++.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 230 ------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~ 273 (337)
T cd05054 230 ------------------------------------VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGA 273 (337)
T ss_pred ------------------------------------hhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCC
Confidence 00113456788999999999999999999999999999998 99
Q ss_pred CCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 353 PPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 353 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
+||.+....+.....+........| ...++++.+++.+||+ +|++|+ ++++|++|
T Consensus 274 ~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~cl~~~p~~RP---s~~ell~~ 329 (337)
T cd05054 274 SPYPGVQIDEEFCRRLKEGTRMRAP--EYATPEIYSIMLDCWHNNPEDRP---TFSELVEI 329 (337)
T ss_pred CCCCCCCccHHHHHHHhccCCCCCC--ccCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 9998765544444444322223333 3578999999999999 999999 99999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=341.06 Aligned_cols=256 Identities=21% Similarity=0.368 Sum_probs=213.6
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCC----------------CEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCc
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSG----------------NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~----------------~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~ 167 (514)
..++|++++.||+|+||.||+|....++ ..||+|.+.+.. .....+.+.+|.+++..++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCC
Confidence 4578999999999999999999876544 568999987653 2355677889999999999999
Q ss_pred eeeEEEEEEcCCeEEEEEeecCCCCHHHHHhhcc-----------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCC
Q 010266 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE-----------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDN 236 (514)
Q Consensus 168 Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~l~~~~-----------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeN 236 (514)
|++++++|.++...++||||+++++|..++.... .+++..+..++.|++.||.|||+.||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999997765 68999999999999999999999999999999999
Q ss_pred ccccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccc
Q 010266 237 LLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTV 316 (514)
Q Consensus 237 ILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 316 (514)
|+++.++.++|+|||++......... ....+..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~ 193 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYY-----------------------------------------------RVQGRAP 193 (296)
T ss_pred eeecCCCceEEccccceeecccCcce-----------------------------------------------eecCcCC
Confidence 99999999999999998754321100 0111446
Q ss_pred cCCCcCCccccccCCCCcccchhhhhHHHHHHhh--CCCCCCCCChhHHHHHHhhh----cCcccCCcCcCCChhHHHHH
Q 010266 317 GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV--GYPPFYSDDPVTTCRKIVHW----KNHLKFPEEARLTPEAKDLI 390 (514)
Q Consensus 317 GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt--G~~PF~~~~~~~~~~~i~~~----~~~~~~p~~~~~s~~~~dLI 390 (514)
+|+.|+|||++.+..++.++|+|||||++|||++ |..||...+.......+... ......+.....++++.+||
T Consensus 194 ~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 273 (296)
T cd05051 194 LPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELM 273 (296)
T ss_pred CCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHH
Confidence 7889999999998889999999999999999998 78999887777776666543 11222333345779999999
Q ss_pred hhhcc-CccccCCCCCHhHHhc
Q 010266 391 CRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 391 ~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
.+||. ||.+|+ ++.+|..
T Consensus 274 ~~cl~~~p~~Rp---t~~el~~ 292 (296)
T cd05051 274 LECWRRDEEDRP---TFREIHL 292 (296)
T ss_pred HHHhccChhcCC---CHHHHHH
Confidence 99998 999999 8999854
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=337.71 Aligned_cols=253 Identities=30% Similarity=0.488 Sum_probs=216.1
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
-|++++.||.|+||.||++.+..++..||+|++.... .......+.+|+.++..++||||++++++|.+....|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 3678889999999999999998999999999986543 23455678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccc
Q 010266 187 YLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE 266 (514)
Q Consensus 187 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~ 266 (514)
|++||+|..++.. ..+++..+..++.|++.||.+||+.|++|+||||+||+++.+|.++|+|||++..+.....
T Consensus 83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~----- 156 (277)
T cd06641 83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI----- 156 (277)
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-----
Confidence 9999999998854 5689999999999999999999999999999999999999999999999999875432100
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHH
Q 010266 267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 346 (514)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 346 (514)
......|+..|+|||++.+..++.++|+|||||++|
T Consensus 157 --------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~ 192 (277)
T cd06641 157 --------------------------------------------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 192 (277)
T ss_pred --------------------------------------------hhccccCCccccChhhhccCCCCchhhHHHHHHHHH
Confidence 011456899999999998888899999999999999
Q ss_pred HHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 347 EMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 347 emltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
+|++|.+||...+.......+... ....++ ..++.++.++|.+||. +|.+|+ ++.+++.||||..
T Consensus 193 ~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp---~~~~~l~~~~~~~ 258 (277)
T cd06641 193 ELAKGEPPHSELHPMKVLFLIPKN-NPPTLE--GNYSKPLKEFVEACLNKEPSFRP---TAKELLKHKFIVR 258 (277)
T ss_pred HHHcCCCCCCccchHHHHHHHhcC-CCCCCC--cccCHHHHHHHHHHccCChhhCc---CHHHHHhCHHHhh
Confidence 999999999887766655555332 122222 2578899999999998 999999 9999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=350.31 Aligned_cols=257 Identities=31% Similarity=0.516 Sum_probs=211.2
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC------C
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA------E 179 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~------~ 179 (514)
++|.+.+.||+|+||.||+|+++.+|+.||+|++.+... .......+.+|..+++.++||||++++++|.+. .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 689999999999999999999999999999999876432 233345678899999999999999999998754 3
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
..|+||||+. ++|..++ ...+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++.....
T Consensus 94 ~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~ 170 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE 170 (342)
T ss_pred eEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC
Confidence 5699999996 4777665 346899999999999999999999999999999999999999999999999998753211
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccch
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDW 338 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~Di 338 (514)
....+||+.|+|||++.+ ..++.++|+
T Consensus 171 ----------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 198 (342)
T cd07879 171 ----------------------------------------------------MTGYVVTRWYRAPEVILNWMHYNQTVDI 198 (342)
T ss_pred ----------------------------------------------------CCCceeeecccChhhhcCccccCchHHH
Confidence 013578999999999876 468999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCc---------------------ccCCc------CcCCChhHHHHHh
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNH---------------------LKFPE------EARLTPEAKDLIC 391 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~---------------------~~~p~------~~~~s~~~~dLI~ 391 (514)
|||||++|||++|+.||.+.+.......+...... ..+|. ....++++.+||.
T Consensus 199 ~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 278 (342)
T cd07879 199 WSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLE 278 (342)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHH
Confidence 99999999999999999988766655554431100 00111 1246788999999
Q ss_pred hhcc-CccccCCCCCHhHHhcCCccccCCcc
Q 010266 392 RLLC-DVEHRLGTLGSEQIKAHPWFKDIAWD 421 (514)
Q Consensus 392 ~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~ 421 (514)
+||+ ||.+|+ ++++++.||||+.+.+.
T Consensus 279 ~~l~~dP~~R~---~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 279 KMLELDVDKRL---TATEALEHPYFDSFRDA 306 (342)
T ss_pred HHcCCChhhCc---CHHHHhcCcchhhcccc
Confidence 9999 999999 99999999999987543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=349.16 Aligned_cols=261 Identities=28% Similarity=0.468 Sum_probs=220.0
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC-----eE
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE-----YL 181 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~-----~l 181 (514)
+|++.+.||.|+||.||+|++..+++.||+|++.+.. ......+.+..|..+++.++||+|+++++++.+.. .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5899999999999999999999999999999987642 22345567889999999999999999999998875 89
Q ss_pred EEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
|+||||++ ++|..++.+...+++..++.++.|++.||.+||+.||+||||||+|||++.+|+++|+|||++........
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 99999997 58999998878999999999999999999999999999999999999999999999999999886542210
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-CCCcccchhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWWS 340 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWS 340 (514)
. ........||+.|+|||++.+. .++.++|+||
T Consensus 159 ~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~s 192 (330)
T cd07834 159 E----------------------------------------------KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWS 192 (330)
T ss_pred c----------------------------------------------cccccccccccCcCCceeeecccCCCcchhHHH
Confidence 0 0011245789999999999887 8899999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccC------------------Cc---------CcCCChhHHHHHhhh
Q 010266 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKF------------------PE---------EARLTPEAKDLICRL 393 (514)
Q Consensus 341 lGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~------------------p~---------~~~~s~~~~dLI~~l 393 (514)
|||++|+|++|.+||.+.+..+.+..+......... +. ...+++++.+||.+|
T Consensus 193 lG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 272 (330)
T cd07834 193 VGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKM 272 (330)
T ss_pred HHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHH
Confidence 999999999999999998887777766652211100 00 123688999999999
Q ss_pred cc-CccccCCCCCHhHHhcCCccccC
Q 010266 394 LC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 394 L~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
|+ +|.+|+ ++++++.||||+++
T Consensus 273 l~~~P~~Rp---t~~~ll~~~~~~~~ 295 (330)
T cd07834 273 LVFDPKKRI---TADEALAHPYLAQL 295 (330)
T ss_pred ccCChhhCC---CHHHHHhCccHHhh
Confidence 99 999999 99999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=332.94 Aligned_cols=249 Identities=51% Similarity=0.934 Sum_probs=219.3
Q ss_pred eeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecCCCCH
Q 010266 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDV 193 (514)
Q Consensus 114 LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~L 193 (514)
||.|+||.||+|.+..+++.||+|++.+...........+..|+.+++.++||+|+++++.+.+....|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999889999999999887766666778899999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccccccccccc
Q 010266 194 MTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDE 273 (514)
Q Consensus 194 ~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~ 273 (514)
.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~------------- 147 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG------------- 147 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-------------
Confidence 9999888889999999999999999999999999999999999999999999999999987643210
Q ss_pred cccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhhCCC
Q 010266 274 NLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 353 (514)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemltG~~ 353 (514)
.......|+..|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 148 ------------------------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~ 191 (250)
T cd05123 148 ------------------------------------SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKP 191 (250)
T ss_pred ------------------------------------CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 01124568999999999998889999999999999999999999
Q ss_pred CCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 354 PFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 354 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
||...+.......+.. ..+.+|. .++..+.++|.+||+ ||.+|+....++++++||||
T Consensus 192 p~~~~~~~~~~~~~~~--~~~~~~~--~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 192 PFYAEDRKEIYEKILK--DPLRFPE--FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred CCCCCCHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 9988887777777765 3445554 578999999999998 99999932222999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=343.68 Aligned_cols=257 Identities=29% Similarity=0.481 Sum_probs=216.4
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
.|+.++.||+|+||.||++.+..++..||+|.+.... .......+..|..+++.++||||++++++|.+....|+|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 4666778999999999999999999999999987543 23455678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccc
Q 010266 187 YLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE 266 (514)
Q Consensus 187 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~ 266 (514)
|++||+|..++. .+.+++..++.++.+++.||.|||++|++|+||+|+||+++.+|.++|+|||++..+.....
T Consensus 83 ~~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~----- 156 (277)
T cd06642 83 YLGGGSALDLLK-PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI----- 156 (277)
T ss_pred ccCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch-----
Confidence 999999999885 46789999999999999999999999999999999999999999999999999875432100
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHH
Q 010266 267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 346 (514)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 346 (514)
......|+..|+|||++.+..++.++|+|||||++|
T Consensus 157 --------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ 192 (277)
T cd06642 157 --------------------------------------------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAI 192 (277)
T ss_pred --------------------------------------------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHH
Confidence 011346899999999999999999999999999999
Q ss_pred HHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCcc
Q 010266 347 EMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWD 421 (514)
Q Consensus 347 emltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~ 421 (514)
||++|.+||....+......+... ....++ ..++.++.++|.+||. +|.+|+ ++.++++||||....+.
T Consensus 193 el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~~~~ 262 (277)
T cd06642 193 ELAKGEPPNSDLHPMRVLFLIPKN-SPPTLE--GQYSKPFKEFVEACLNKDPRFRP---TAKELLKHKFITRYTKK 262 (277)
T ss_pred HHHhCCCCCcccchhhHHhhhhcC-CCCCCC--cccCHHHHHHHHHHccCCcccCc---CHHHHHHhHHHHHHhhh
Confidence 999999999876655544443321 111222 2467899999999998 999999 99999999999875543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=343.33 Aligned_cols=253 Identities=26% Similarity=0.405 Sum_probs=215.9
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
..|..++.||+|+||.||++++..++..||+|++.+...........+..|..+++.++|||++++++++.++...|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 44888899999999999999999999999999998765545556677889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 186 EYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 186 Ey~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
||++| +|.+++.. ...+++..+..++.+++.||.|||+.||+||||+|+||+++.+|++||+|||++......
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~----- 178 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----- 178 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc-----
Confidence 99975 77777654 567899999999999999999999999999999999999999999999999987643211
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc---cCCCCcccchhhh
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSL 341 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiWSl 341 (514)
....|++.|+|||++. ...++.++|+|||
T Consensus 179 ------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~sl 210 (317)
T cd06635 179 ------------------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 210 (317)
T ss_pred ------------------------------------------------ccccCCccccChhhhhcCCCCCCCccccHHHH
Confidence 1346899999999984 4568899999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
||++|||++|.+||.+.+.......+..... ..+....+++.+++||.+||. +|.+|+ ++.+|+.|||+..
T Consensus 211 Gvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~il~~~~~~~ 282 (317)
T cd06635 211 GITCIELAERKPPLFNMNAMSALYHIAQNES--PTLQSNEWSDYFRNFVDSCLQKIPQDRP---TSEELLKHMFVLR 282 (317)
T ss_pred HHHHHHHHhCCCCCCCccHHHHHHHHHhccC--CCCCCccccHHHHHHHHHHccCCcccCc---CHHHHHhChhhhc
Confidence 9999999999999988877776666654221 112223578899999999998 999999 9999999999954
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=337.13 Aligned_cols=261 Identities=31% Similarity=0.534 Sum_probs=224.2
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 183 (514)
..+.|++.+.||.|+||.||+|.+..++..||+|++..... ....+..|.+++..++||||++++++|.+....|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 45679999999999999999999998899999999976532 45667889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 184 IMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
|+||++|++|.+++.... .++...+..++.+++.||.|||+.||+|+||+|+||+++.+|+++|+|||++........
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 999999999999998876 899999999999999999999999999999999999999999999999999765431100
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
......|++.|+|||++.+..++.++|+||||
T Consensus 172 ------------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG 203 (286)
T cd06614 172 ------------------------------------------------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLG 203 (286)
T ss_pred ------------------------------------------------hhccccCCcccCCHhHhcCCCCCCccccHHHH
Confidence 01134688999999999988899999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCcc
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWD 421 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~ 421 (514)
|++|+|++|..||...++......+... .....+....++.++++||.+||+ +|..|+ ++.+|+.||||....|.
T Consensus 204 vil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~il~~~~~~~~~~~ 279 (286)
T cd06614 204 IMCIEMAEGEPPYLREPPLRALFLITTK-GIPPLKNPEKWSPEFKDFLNKCLVKDPEKRP---SAEELLQHPFLKKACPK 279 (286)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCCCcchhhCCHHHHHHHHHHhccChhhCc---CHHHHhhChHhhccCch
Confidence 9999999999999987776665555432 222333333478999999999999 999999 99999999999986554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=350.55 Aligned_cols=260 Identities=21% Similarity=0.360 Sum_probs=206.4
Q ss_pred eeeec--CceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecCC
Q 010266 113 IIGRG--AFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPG 190 (514)
Q Consensus 113 ~LG~G--~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~g 190 (514)
.||+| +||+||+|+++.+|+.||+|++..... .....+.+.+|..+++.++||||++++++|++.+.+|+||||+++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 46666 999999999999999999999876533 334567888999999999999999999999999999999999999
Q ss_pred CCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccccc
Q 010266 191 GDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENE 268 (514)
Q Consensus 191 g~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~ 268 (514)
|+|..++.+. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+|++|||.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~----- 158 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA----- 158 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc-----
Confidence 9999998764 458999999999999999999999999999999999999999999999998754322110000
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc--CCCCcccchhhhhHHHH
Q 010266 269 VLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMY 346 (514)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvily 346 (514)
... ........++..|+|||++.+ .+++.++|+|||||++|
T Consensus 159 ---------------~~~----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~ 201 (328)
T cd08226 159 ---------------KVV----------------------YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITAC 201 (328)
T ss_pred ---------------ccc----------------------ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHH
Confidence 000 000012246678999999976 45789999999999999
Q ss_pred HHhhCCCCCCCCChhHHHHHHhhhcC-------------------------------------------cccCCcCcCCC
Q 010266 347 EMLVGYPPFYSDDPVTTCRKIVHWKN-------------------------------------------HLKFPEEARLT 383 (514)
Q Consensus 347 emltG~~PF~~~~~~~~~~~i~~~~~-------------------------------------------~~~~p~~~~~s 383 (514)
+|++|.+||.+.........++.... .+..|.....+
T Consensus 202 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (328)
T cd08226 202 ELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFS 281 (328)
T ss_pred HHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhh
Confidence 99999999987766555444432110 00111122357
Q ss_pred hhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 384 PEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 384 ~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
+.+.+||++||+ ||.+|+ +++|+++||||+++
T Consensus 282 ~~~~~li~~~l~~dP~~Rp---ta~e~l~~~~~~~~ 314 (328)
T cd08226 282 PAFQNLVELCLQQDPEKRP---SASSLLSHAFFKQV 314 (328)
T ss_pred HHHHHHHHHHccCCcccCC---CHHHHhhCHHHHHH
Confidence 789999999999 999999 99999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=356.41 Aligned_cols=258 Identities=24% Similarity=0.321 Sum_probs=209.3
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccC-----CCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEE
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKS-----GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYY 173 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t-----~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~ 173 (514)
+..+..++|++++.||+|+||.||+|.+... +..||||++.+.. .....+.+.+|..+|..+. |||||++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 5566778999999999999999999986433 3469999997542 3344567889999999996 999999999
Q ss_pred EEEcCCeEEEEEeecCCCCHHHHHhhc-----------------------------------------------------
Q 010266 174 SFQDAEYLYLIMEYLPGGDVMTLLMRE----------------------------------------------------- 200 (514)
Q Consensus 174 ~f~~~~~l~lVmEy~~gg~L~~~l~~~----------------------------------------------------- 200 (514)
+|++...+|||||||+||+|.++|...
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 999999999999999999999988642
Q ss_pred -------------------------------------------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCc
Q 010266 201 -------------------------------------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNL 237 (514)
Q Consensus 201 -------------------------------------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNI 237 (514)
..+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 2367778889999999999999999999999999999
Q ss_pred cccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhcccccccccc
Q 010266 238 LLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG 317 (514)
Q Consensus 238 Lld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~G 317 (514)
|++.++.+||+|||+++........ ....+..|
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~-----------------------------------------------~~~~~~~~ 301 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNY-----------------------------------------------VSKGSTFL 301 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccc-----------------------------------------------cccCCcCC
Confidence 9999999999999998754321000 01114568
Q ss_pred CCCcCCccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-
Q 010266 318 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC- 395 (514)
Q Consensus 318 T~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~- 395 (514)
++.|+|||++.+..++.++|||||||++|||++ |..||.+..........+.... ..+....++.++.++|.+||.
T Consensus 302 ~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~ 379 (400)
T cd05105 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGY--RMAKPDHATQEVYDIMVKCWNS 379 (400)
T ss_pred CcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCC--CCCCCccCCHHHHHHHHHHCcc
Confidence 889999999999999999999999999999997 9999987655444433333222 223334678999999999998
Q ss_pred CccccCCCCCHhHHhc
Q 010266 396 DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 396 dp~~Rl~~~~~~eil~ 411 (514)
+|.+|+ ++.+|.+
T Consensus 380 dP~~RP---t~~~l~~ 392 (400)
T cd05105 380 EPEKRP---SFLHLSD 392 (400)
T ss_pred CHhHCc---CHHHHHH
Confidence 999999 7777654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=344.12 Aligned_cols=254 Identities=20% Similarity=0.330 Sum_probs=208.9
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCE----EEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNI----YAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA 178 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~----~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 178 (514)
+...+|++++.||+|+||.||+|++..++.. ||+|+++... .....+.+..|..+++.++||||+++++++.+.
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 4557899999999999999999998766664 8999986432 334456788899999999999999999998764
Q ss_pred CeEEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
..++|+||+++|+|.+++... ..++...+..++.||+.||+|||+.||+||||||+|||++.++++||+|||+++...
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 578999999999999999764 468888999999999999999999999999999999999999999999999998654
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
..... .......+|+.|+|||++.+..++.++|
T Consensus 161 ~~~~~-----------------------------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~D 193 (316)
T cd05108 161 ADEKE-----------------------------------------------YHAEGGKVPIKWMALESILHRIYTHQSD 193 (316)
T ss_pred CCCcc-----------------------------------------------eeccCCccceeecChHHhccCCCCchhh
Confidence 22100 0001234577899999999999999999
Q ss_pred hhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 338 WWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 338 iWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
||||||++|||++ |.+||.+....+.. .+.... ...|.....+.++.++|.+||. +|.+|+ ++.+++.+
T Consensus 194 i~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---s~~~l~~~ 264 (316)
T cd05108 194 VWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKG--ERLPQPPICTIDVYMIMVKCWMIDADSRP---KFRELIIE 264 (316)
T ss_pred hHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCC--CCCCCCCCCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 9999999999997 99999887655543 444422 2334334678899999999998 999999 89999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=341.42 Aligned_cols=253 Identities=26% Similarity=0.406 Sum_probs=213.9
Q ss_pred eeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEee
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY 187 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy 187 (514)
|..++.||+|+||+||+|++..+++.||+|++.............+..|..+++.++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999999999999999999876554555667788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccc
Q 010266 188 LPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE 266 (514)
Q Consensus 188 ~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~ 266 (514)
++ |+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-------- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-------- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC--------
Confidence 96 577777654 45789999999999999999999999999999999999999999999999998753210
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc---cCCCCcccchhhhhH
Q 010266 267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGA 343 (514)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiWSlGv 343 (514)
.....|++.|+|||++. +..++.++|+|||||
T Consensus 174 ---------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGv 208 (313)
T cd06633 174 ---------------------------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 208 (313)
T ss_pred ---------------------------------------------CCCccccccccChhhccccCCCCCCchhhHHHHHH
Confidence 11457899999999985 356888999999999
Q ss_pred HHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCC
Q 010266 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIA 419 (514)
Q Consensus 344 ilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~ 419 (514)
++|+|++|.+||.+.+.......+.... ....+ ...++..+++||.+||. +|.+|+ ++.+++.||||+..+
T Consensus 209 il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~l~~li~~~l~~~P~~Rp---~~~~~l~~~~~~~~~ 280 (313)
T cd06633 209 TCIELAERKPPLFNMNAMSALYHIAQND-SPTLQ-SNEWTDSFRGFVDYCLQKIPQERP---ASAELLRHDFVRRDR 280 (313)
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHhcC-CCCCC-ccccCHHHHHHHHHHccCChhhCc---CHHHHhcCcccCCCc
Confidence 9999999999998877766665554321 11111 23467889999999998 999999 999999999998644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=338.47 Aligned_cols=254 Identities=31% Similarity=0.506 Sum_probs=211.3
Q ss_pred eeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEee
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY 187 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy 187 (514)
|++++.||.|++|.||+|.++.+|..||+|++..... .......+.+|.++++.++||+|+++++++.+....|+||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 6788999999999999999999999999999976532 233445678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 188 LPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 188 ~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
++ ++|..++.... .+++..+..++.|++.||.|||+.|++||||+|+||+++.+|.++|+|||++........
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---- 154 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR---- 154 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc----
Confidence 95 68999987765 789999999999999999999999999999999999999999999999999875431100
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-CCCcccchhhhhHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAI 344 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvi 344 (514)
......|++.|+|||++.+. .++.++|+|||||+
T Consensus 155 ---------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~ 189 (283)
T cd07835 155 ---------------------------------------------TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCI 189 (283)
T ss_pred ---------------------------------------------ccCccccccCCCCCceeecCcccCcHHHHHHHHHH
Confidence 00133578999999988764 57899999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHhhhcCcc----------------cCC---------cCcCCChhHHHHHhhhcc-Ccc
Q 010266 345 MYEMLVGYPPFYSDDPVTTCRKIVHWKNHL----------------KFP---------EEARLTPEAKDLICRLLC-DVE 398 (514)
Q Consensus 345 lyemltG~~PF~~~~~~~~~~~i~~~~~~~----------------~~p---------~~~~~s~~~~dLI~~lL~-dp~ 398 (514)
+|+|++|.+||.+.+......++..+.... .+| ....++.++.+||.+||+ +|.
T Consensus 190 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 269 (283)
T cd07835 190 FAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPA 269 (283)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChh
Confidence 999999999999887765555544321100 011 013577899999999999 999
Q ss_pred ccCCCCCHhHHhcCCcc
Q 010266 399 HRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 399 ~Rl~~~~~~eil~Hpff 415 (514)
+|+ +++|++.||||
T Consensus 270 ~Rp---t~~~il~~~~~ 283 (283)
T cd07835 270 KRI---SAKAALQHPYF 283 (283)
T ss_pred hCc---CHHHHhcCCCC
Confidence 999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=335.17 Aligned_cols=255 Identities=19% Similarity=0.304 Sum_probs=213.3
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccC-----CCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKS-----GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 176 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t-----~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 176 (514)
.+..++|++.+.||+|+||.||++..+.. +..||+|.+.... .......+.+|..+|..++||+|+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 34567999999999999999999988654 3789999986543 2344567888999999999999999999999
Q ss_pred cCCeEEEEEeecCCCCHHHHHhhcc----------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEE
Q 010266 177 DAEYLYLIMEYLPGGDVMTLLMREE----------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMK 246 (514)
Q Consensus 177 ~~~~l~lVmEy~~gg~L~~~l~~~~----------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iK 246 (514)
+....|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+|
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 9999999999999999999986532 367778899999999999999999999999999999999999999
Q ss_pred EccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccc
Q 010266 247 LSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEV 326 (514)
Q Consensus 247 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEv 326 (514)
|+|||+++........ .......||+.|+|||+
T Consensus 160 l~dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y~aPE~ 192 (277)
T cd05032 160 IGDFGMTRDIYETDYY-----------------------------------------------RKGGKGLLPVRWMAPES 192 (277)
T ss_pred ECCcccchhhccCccc-----------------------------------------------ccCCCCCccccccCHHH
Confidence 9999998754321100 00113457889999999
Q ss_pred cccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC
Q 010266 327 LLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL 404 (514)
Q Consensus 327 l~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~ 404 (514)
+.+..++.++|+|||||++|||++ |.+||.+.+..+....+.. .....+|. ..+.++.+||.+||+ +|.+|+
T Consensus 193 ~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp--- 266 (277)
T cd05032 193 LKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID-GGHLDLPE--NCPDKLLELMRMCWQYNPKMRP--- 266 (277)
T ss_pred HhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc-CCCCCCCC--CCCHHHHHHHHHHcCCChhhCC---
Confidence 998889999999999999999998 9999998887777766653 33344454 568999999999999 999999
Q ss_pred CHhHHhc
Q 010266 405 GSEQIKA 411 (514)
Q Consensus 405 ~~~eil~ 411 (514)
++.+|++
T Consensus 267 t~~~l~~ 273 (277)
T cd05032 267 TFLEIVS 273 (277)
T ss_pred CHHHHHH
Confidence 8999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=336.38 Aligned_cols=255 Identities=22% Similarity=0.327 Sum_probs=211.8
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEcc-----CCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKK-----SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 177 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~-----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 177 (514)
+..++|.+.+.||+|+||.||+|.++. ++..||+|.+.... .......+..|..+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 345789999999999999999999987 77889999886432 23344568889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC---cEEE
Q 010266 178 AEYLYLIMEYLPGGDVMTLLMREE-------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG---HMKL 247 (514)
Q Consensus 178 ~~~l~lVmEy~~gg~L~~~l~~~~-------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g---~iKL 247 (514)
....|+||||++||+|.+++...+ .+++..+..++.||+.||.|||++|++||||||+|||++.+| .+||
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 999999999999999999987653 488899999999999999999999999999999999998765 6999
Q ss_pred ccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccc
Q 010266 248 SDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL 327 (514)
Q Consensus 248 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl 327 (514)
+|||+++......... ......+++.|+|||++
T Consensus 161 ~dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y~aPE~~ 193 (277)
T cd05036 161 ADFGMARDIYRASYYR-----------------------------------------------KGGRAMLPIKWMPPEAF 193 (277)
T ss_pred ccCccccccCCcccee-----------------------------------------------cCCCCCccHhhCCHHHH
Confidence 9999998653211000 00122345789999999
Q ss_pred ccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCC
Q 010266 328 LKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLG 405 (514)
Q Consensus 328 ~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~ 405 (514)
.+..++.++|+|||||++|||++ |..||.+.+..+....+... ....+| ..++..+.++|.+||+ +|.+|+ +
T Consensus 194 ~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~i~~cl~~~p~~Rp---s 267 (277)
T cd05036 194 LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-GRLDPP--KGCPGPVYRIMTDCWQHTPEDRP---N 267 (277)
T ss_pred hcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcCCCcccCc---C
Confidence 99899999999999999999997 99999988777766655432 223333 3678999999999998 999999 9
Q ss_pred HhHHhcC
Q 010266 406 SEQIKAH 412 (514)
Q Consensus 406 ~~eil~H 412 (514)
+.+|++|
T Consensus 268 ~~~vl~~ 274 (277)
T cd05036 268 FATILER 274 (277)
T ss_pred HHHHHHH
Confidence 9999876
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=335.84 Aligned_cols=252 Identities=29% Similarity=0.506 Sum_probs=212.0
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++.+.||+|+||.||+|+.+.+++.||||.+.+...........+.+|..+++.++||||++++++|.+.+..|+||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57899999999999999999999999999999988766555666678889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 186 EYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 186 Ey~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
||++|++|.+++.. ...+++..+..++.|++.||.|||++|++|+||||+||+++.+|.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC-
Confidence 99999999998863 3568999999999999999999999999999999999999999999999999987543210
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
......+|++.|+|||++.+..++.++|+|||
T Consensus 161 ------------------------------------------------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~sl 192 (267)
T cd08229 161 ------------------------------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSL 192 (267)
T ss_pred ------------------------------------------------cccccccCCcCccCHHHhcCCCccchhhHHHH
Confidence 00114579999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCCh--hHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 342 GAIMYEMLVGYPPFYSDDP--VTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~--~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
||++|+|++|..||.+... ......+... .....| ...+++++++||.+||. +|.+|+ ++++|..
T Consensus 193 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp---t~~~i~~ 260 (267)
T cd08229 193 GCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-DYPPLP-SDHYSEELRQLVNMCINPDPEKRP---DITYVYD 260 (267)
T ss_pred HHHHHHHHhCCCCcccccchHHHHhhhhhcC-CCCCCC-cccccHHHHHHHHHhcCCCcccCC---CHHHHHH
Confidence 9999999999999976543 2333333321 111122 13578899999999998 999999 8887653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=391.67 Aligned_cols=258 Identities=31% Similarity=0.486 Sum_probs=222.7
Q ss_pred eeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEee
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY 187 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy 187 (514)
++-...||.|.||.||-|.+.+||...|||-++-.... ......+.+|..+|..++|||+|+.|+.=.+.+.+|+.|||
T Consensus 1237 Wqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 34455799999999999999999999999988765543 45566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccccc
Q 010266 188 LPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINEN 267 (514)
Q Consensus 188 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~ 267 (514)
|.||+|.+++...+..+|...+.|..|++.|+.|||+.|||||||||+||+|+.+|.||++|||.|..+.... .++.
T Consensus 1316 C~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~-~~~~-- 1392 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA-QTMP-- 1392 (1509)
T ss_pred hccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCch-hcCC--
Confidence 9999999999999999999999999999999999999999999999999999999999999999998765331 0000
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc---CCCCcccchhhhhHH
Q 010266 268 EVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAI 344 (514)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~y~~~~DiWSlGvi 344 (514)
......+|||.|||||++.+ .+.+-+.|||||||+
T Consensus 1393 ------------------------------------------~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCV 1430 (1509)
T KOG4645|consen 1393 ------------------------------------------GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCV 1430 (1509)
T ss_pred ------------------------------------------HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccce
Confidence 01226799999999999985 567889999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccc
Q 010266 345 MYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFK 416 (514)
Q Consensus 345 lyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~ 416 (514)
+.||+||+.||..-+..-.+.--+.....+++|. .+|.+.+|||.+||. ||+.|. ++.||+.|.|-+
T Consensus 1431 VlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~--~ls~~g~dFle~Cl~~dP~~Rw---~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1431 VLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPE--RLSSEGRDFLEHCLEQDPKMRW---TASQLLEHAFGK 1498 (1509)
T ss_pred EEEeecCCCchhhccchhHHHhHHhccCCCCCch--hhhHhHHHHHHHHHhcCchhhh---HHHHHHHhhccc
Confidence 9999999999987555444333334456778887 599999999999998 999998 899999999865
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=334.93 Aligned_cols=253 Identities=28% Similarity=0.455 Sum_probs=209.9
Q ss_pred eeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc---CCCceeeEEEEEEcCCe----
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV---ASHCIVKLYYSFQDAEY---- 180 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~~~~~---- 180 (514)
|++++.||+|+||.||+|+++.+++.||+|+++.... .......+..|..++..+ +||||++++++|.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 6789999999999999999998999999999975532 222334566788777666 59999999999998877
Q ss_pred -EEEEEeecCCCCHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 181 -LYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 181 -l~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
+|+||||+++ +|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++++||+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999974 8988886643 58999999999999999999999999999999999999999999999999987643
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
... ......|++.|+|||++.+..++.++|
T Consensus 159 ~~~--------------------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~D 188 (287)
T cd07838 159 FEM--------------------------------------------------ALTSVVVTLWYRAPEVLLQSSYATPVD 188 (287)
T ss_pred CCc--------------------------------------------------ccccccccccccChHHhccCCCCCcch
Confidence 210 011345889999999999999999999
Q ss_pred hhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcC---cccCC-----------c---------CcCCChhHHHHHhhhc
Q 010266 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKN---HLKFP-----------E---------EARLTPEAKDLICRLL 394 (514)
Q Consensus 338 iWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~---~~~~p-----------~---------~~~~s~~~~dLI~~lL 394 (514)
+|||||++|+|++|.+||.+.+..+...++..... ...+| . ...+++.+.+||.+||
T Consensus 189 i~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 268 (287)
T cd07838 189 MWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKML 268 (287)
T ss_pred hhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHh
Confidence 99999999999999999999888877777754211 00111 0 0135688999999999
Q ss_pred c-CccccCCCCCHhHHhcCCcc
Q 010266 395 C-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 395 ~-dp~~Rl~~~~~~eil~Hpff 415 (514)
+ ||.+|+ ++++++.||||
T Consensus 269 ~~dp~~Rp---~~~~il~~~~~ 287 (287)
T cd07838 269 TFNPHKRI---SAFEALQHPYF 287 (287)
T ss_pred ccCCccCC---CHHHHhcCcCC
Confidence 8 999999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=330.00 Aligned_cols=252 Identities=30% Similarity=0.516 Sum_probs=212.9
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++.+.||+|+||.||+|....+|+.||+|.++............+.+|..+++.++|++|++++++|.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999999999999998766656666778999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 186 EYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 186 Ey~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
||++||+|..++.. ...+++..+..++.+++.||.|||+.||+||||||+||+++.+|.++|+|||++..+....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~- 160 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC-
Confidence 99999999999864 3458999999999999999999999999999999999999999999999999987543210
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
.......|++.|+|||++.+..++.++|+|||
T Consensus 161 ------------------------------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 192 (267)
T cd08224 161 ------------------------------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSL 192 (267)
T ss_pred ------------------------------------------------cccceecCCccccCHHHhccCCCCchhcHHHH
Confidence 00124578999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCCh--hHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 342 GAIMYEMLVGYPPFYSDDP--VTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~--~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
||++|+|++|..||..... ......+... .....|. ..++.++.++|.+||. +|.+|+ ++.+|+.
T Consensus 193 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~i~~cl~~~p~~Rp---~~~~il~ 260 (267)
T cd08224 193 GCLLYEMAALQSPFYGDKMNLYSLCKKIEKC-DYPPLPA-DHYSEELRDLVSRCINPDPEKRP---DISYVLQ 260 (267)
T ss_pred HHHHHHHHHCCCCcccCCccHHHHHhhhhcC-CCCCCCh-hhcCHHHHHHHHHHcCCCcccCC---CHHHHHH
Confidence 9999999999999976532 2333333321 1112222 2578899999999998 999999 8888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=339.95 Aligned_cols=257 Identities=22% Similarity=0.309 Sum_probs=212.5
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEE-----ccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEE
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQE-----KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYS 174 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~-----~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 174 (514)
..+..++|.+.+.||+|+||.||++.+ ..++..||+|++++.. .....+.+..|..+++.+ +||||++++++
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 345667899999999999999999975 2355689999987543 234456788999999999 79999999999
Q ss_pred EEcCCeEEEEEeecCCCCHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccc
Q 010266 175 FQDAEYLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252 (514)
Q Consensus 175 f~~~~~l~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGl 252 (514)
+.+.+.+|+||||++||+|.+++.... .+++..+..++.+++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999999997543 389999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCC
Q 010266 253 CKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY 332 (514)
Q Consensus 253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y 332 (514)
++........ .......+++.|+|||++.+..+
T Consensus 188 ~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~ 220 (302)
T cd05055 188 ARDIMNDSNY-----------------------------------------------VVKGNARLPVKWMAPESIFNCVY 220 (302)
T ss_pred cccccCCCce-----------------------------------------------eecCCCCcccccCCHhhhccCCC
Confidence 8754321100 00112357889999999999999
Q ss_pred CcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHh
Q 010266 333 GMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIK 410 (514)
Q Consensus 333 ~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 410 (514)
+.++|+|||||++|||++ |.+||.+....+.+.+..... ...+.....++++.+||.+||. +|++|+ ++.|++
T Consensus 221 ~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---t~~ell 295 (302)
T cd05055 221 TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG--YRMAQPEHAPAEIYDIMKTCWDADPLKRP---TFKQIV 295 (302)
T ss_pred CcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC--CcCCCCCCCCHHHHHHHHHHcCCCchhCc---CHHHHH
Confidence 999999999999999998 999998877666655554422 2222223678999999999998 999999 888887
Q ss_pred c
Q 010266 411 A 411 (514)
Q Consensus 411 ~ 411 (514)
.
T Consensus 296 ~ 296 (302)
T cd05055 296 Q 296 (302)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=326.75 Aligned_cols=253 Identities=32% Similarity=0.584 Sum_probs=221.0
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
+|++.+.||+|++|.||++.++.+++.||+|.+.+... .......+..|.+++..++||+++++++++.+....|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 58899999999999999999999999999999987643 33566789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccc
Q 010266 187 YLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE 266 (514)
Q Consensus 187 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~ 266 (514)
|++|++|.+++.....+++..+..++.|++.||.+||+.||+||||||+||+++.+|.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~----- 154 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK----- 154 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-----
Confidence 999999999998888999999999999999999999999999999999999999999999999999986542210
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHH
Q 010266 267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 346 (514)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 346 (514)
......|++.|+|||.+.+..++.++|+||||+++|
T Consensus 155 --------------------------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~ 190 (254)
T cd06627 155 --------------------------------------------DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVI 190 (254)
T ss_pred --------------------------------------------cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHH
Confidence 011456899999999998888999999999999999
Q ss_pred HHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 347 EMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 347 emltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
+|++|.+||...+......++... ....+| ..+++.+.++|.+||. +|++|+ ++++++.||||
T Consensus 191 ~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~---~~~~~l~~~~~ 254 (254)
T cd06627 191 ELLTGNPPYYDLNPMAALFRIVQD-DHPPLP--EGISPELKDFLMQCFQKDPNLRP---TAKQLLKHPWI 254 (254)
T ss_pred HHHhCCCCCCCccHHHHHHHHhcc-CCCCCC--CCCCHHHHHHHHHHHhCChhhCc---CHHHHhcCCCC
Confidence 999999999877665555554432 222333 3678999999999998 999999 99999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=330.20 Aligned_cols=245 Identities=24% Similarity=0.343 Sum_probs=203.6
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecCCC
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG 191 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg 191 (514)
+.||+|+||.||+|.++.+++.||+|.+.+. ........+.+|..+|+.++||||+++++++.+...+|+||||++|+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 3699999999999999999999999988643 23445567889999999999999999999999999999999999999
Q ss_pred CHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccccccc
Q 010266 192 DVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270 (514)
Q Consensus 192 ~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~ 270 (514)
+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++++||+|||++..........
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~------- 151 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS------- 151 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccc-------
Confidence 999999764 468999999999999999999999999999999999999999999999999987543110000
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhh
Q 010266 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350 (514)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt 350 (514)
......++..|+|||.+.+..++.++|+|||||++|||++
T Consensus 152 ----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~ 191 (252)
T cd05084 152 ----------------------------------------TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS 191 (252)
T ss_pred ----------------------------------------cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHh
Confidence 0001123567999999999899999999999999999997
Q ss_pred -CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 351 -GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 351 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|.+||...+.......+... .....| ...+..+.+||.+||+ +|.+|+ ++.++++
T Consensus 192 ~~~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~~~~ 248 (252)
T cd05084 192 LGAVPYANLSNQQTREAIEQG-VRLPCP--ELCPDAVYRLMERCWEYDPGQRP---SFSTVHQ 248 (252)
T ss_pred CCCCCccccCHHHHHHHHHcC-CCCCCc--ccCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 99999877766655555432 222333 3678999999999999 999999 8888864
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=334.39 Aligned_cols=253 Identities=20% Similarity=0.311 Sum_probs=208.9
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCC----EEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGN----IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA 178 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~----~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 178 (514)
+..++|++++.||+|+||+||+|.+..+++ .||+|+++... .......+.+|..++..++||||+++++.+.+
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~- 80 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT- 80 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-
Confidence 456899999999999999999999877776 48999986542 34445678889999999999999999999875
Q ss_pred CeEEEEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
...+++|||+++|+|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+|||++.++++||+|||+++...
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 457899999999999999976 4578999999999999999999999999999999999999999999999999998654
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
..... .......+++.|+|||++.+..++.++|
T Consensus 161 ~~~~~-----------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~D 193 (279)
T cd05109 161 IDETE-----------------------------------------------YHADGGKVPIKWMALESILHRRFTHQSD 193 (279)
T ss_pred cccce-----------------------------------------------eecCCCccchhhCCHHHhccCCCCchhH
Confidence 21100 0001224577899999999999999999
Q ss_pred hhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 338 WWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 338 iWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
||||||++|||++ |.+||...........+... ... |.....++++.++|.+||. ||..|+ ++.+++.
T Consensus 194 i~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~li~~~l~~dp~~Rp---~~~~l~~ 263 (279)
T cd05109 194 VWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG-ERL--PQPPICTIDVYMIMVKCWMIDSECRP---RFRELVD 263 (279)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CcC--CCCccCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 9999999999998 99999877666555544432 222 2234678999999999998 999999 8999884
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=331.56 Aligned_cols=254 Identities=22% Similarity=0.313 Sum_probs=213.2
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccC---CCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKS---GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t---~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
..++|++.+.||+|+||.||+|..+.+ ...||+|+++... .......+..|..++..++||||+++++++.+...
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP 79 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence 457899999999999999999998654 4579999987543 34455678889999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
.|+||||++||+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999998764 47899999999999999999999999999999999999999999999999999865411
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
... .......+++.|+|||.+.+..++.++|+|
T Consensus 160 ~~~-----------------------------------------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~ 192 (266)
T cd05033 160 EAT-----------------------------------------------YTTKGGKIPIRWTAPEAIAYRKFTSASDVW 192 (266)
T ss_pred ccc-----------------------------------------------eeccCCCCCccccChhhhccCCCccccchH
Confidence 000 000123457789999999999999999999
Q ss_pred hhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 340 SLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 340 SlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
||||++|+|++ |..||......+....+... ...|.....++.+.+|+.+||. +|.+|+ ++++|++|
T Consensus 193 slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~~p~~Rp---~~~ei~~~ 261 (266)
T cd05033 193 SFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG---YRLPPPMDCPSALYQLMLDCWQKDRNERP---TFSQIVST 261 (266)
T ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHcCCCcccCc---CHHHHHHH
Confidence 99999999998 99999887777766666542 2223334678999999999998 999999 89998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=357.29 Aligned_cols=251 Identities=27% Similarity=0.417 Sum_probs=219.9
Q ss_pred eeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEee
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY 187 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy 187 (514)
|.-++.||.|+||.||-|++..|.++||||+|.-+.-.....-..+..|+.+|..+.|||+|..-++|-.+...+|||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 55567899999999999999999999999999876655556667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccc
Q 010266 188 LPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE 266 (514)
Q Consensus 188 ~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~ 266 (514)
|-| +-.++|.- ..++.|..+..+..+.+.||.|||+.+.||||||..|||++..|.|||+|||.|....
T Consensus 108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~--------- 177 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA--------- 177 (948)
T ss_pred Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC---------
Confidence 964 66666643 4678899999999999999999999999999999999999999999999999886543
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc---CCCCcccchhhhhH
Q 010266 267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGA 343 (514)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~y~~~~DiWSlGv 343 (514)
.+++++|||.|||||||.. +.|+-+|||||||+
T Consensus 178 --------------------------------------------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGI 213 (948)
T KOG0577|consen 178 --------------------------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 213 (948)
T ss_pred --------------------------------------------chhcccCCccccchhHheeccccccCCccceeeccc
Confidence 2458999999999999973 67999999999999
Q ss_pred HHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 344 ilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
...|+.-.+||...-+....+..|... ..+.++. ..+|..++.||..||. -|.+|+ |.++++.|+|...
T Consensus 214 TCIELAERkPPlFnMNAMSALYHIAQN-esPtLqs-~eWS~~F~~Fvd~CLqKipqeRp---tse~ll~H~fv~R 283 (948)
T KOG0577|consen 214 TCIELAERKPPLFNMNAMSALYHIAQN-ESPTLQS-NEWSDYFRNFVDSCLQKIPQERP---TSEELLKHRFVLR 283 (948)
T ss_pred hhhhhhhcCCCccCchHHHHHHHHHhc-CCCCCCC-chhHHHHHHHHHHHHhhCcccCC---cHHHHhhcchhcc
Confidence 999999999999988887777777652 3334443 3679999999999998 899999 9999999999864
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=324.34 Aligned_cols=251 Identities=34% Similarity=0.551 Sum_probs=217.1
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
+|++.+.||+|++|.||+|.+..+++.||+|++..... .....+.+|..+++.++||+|+++++.|.+....|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 58899999999999999999988999999999976543 456678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 187 YLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 187 y~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
|++|++|.+++... ..+++..+..++.+++.||.+||+.|++||||+|+||+++.+|.++|+|||++........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---- 153 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---- 153 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc----
Confidence 99999999998776 6899999999999999999999999999999999999999999999999999876532100
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 345 (514)
.....|+..|+|||++.+..++.++|+||||+++
T Consensus 154 ----------------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il 187 (253)
T cd05122 154 ----------------------------------------------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITA 187 (253)
T ss_pred ----------------------------------------------ccceecCCcccCHHHHcCCCCCccccHHHHHHHH
Confidence 1145789999999999988899999999999999
Q ss_pred HHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCc
Q 010266 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPW 414 (514)
Q Consensus 346 yemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpf 414 (514)
|+|++|.+||...+.......+.. ......+....++..+.++|.+||. ||.+|+ ++.+++.|||
T Consensus 188 ~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~---t~~~~l~~~~ 253 (253)
T cd05122 188 IELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRP---TAEQLLKHPF 253 (253)
T ss_pred HHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHHccCChhhCC---CHHHHhcCCC
Confidence 999999999988765554444432 2223344433458999999999998 999999 9999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=331.90 Aligned_cols=250 Identities=20% Similarity=0.331 Sum_probs=208.6
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 183 (514)
...+|++.+.||+|+||.||+++++ ++..+|+|++.+... ....+..|..+++.++||||+++++++.+.+..|+
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFI 76 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEE
Confidence 3467899999999999999999876 466899999875533 22356779999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 184 IMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
||||++|++|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+||+++.+|++||+|||+++........
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 77 VTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred EEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 9999999999999875 357899999999999999999999999999999999999999999999999998754311000
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
......++..|+|||++.+..++.++|+||||
T Consensus 157 ------------------------------------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG 188 (256)
T cd05059 157 ------------------------------------------------SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFG 188 (256)
T ss_pred ------------------------------------------------ccCCCCCCccccCHHHhccCCCCchhhHHHHH
Confidence 00012345689999999999999999999999
Q ss_pred HHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 343 AIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 343 vilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
|++|+|++ |.+||.+.+..+....+... .....| ...++++.+++.+||+ +|++|+ +++++++.
T Consensus 189 ~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~cl~~~p~~Rp---t~~~~l~~ 254 (256)
T cd05059 189 VLMWEVFSEGKMPYERFSNSEVVESVSAG-YRLYRP--KLAPTEVYTIMYSCWHEKPEDRP---AFKKLLSQ 254 (256)
T ss_pred HHHHHHhccCCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHhcCChhhCc---CHHHHHHH
Confidence 99999999 89999888777777666532 122333 3578999999999998 999999 89998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=339.02 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=207.0
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCC--EEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCeEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGN--IYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~--~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~ 182 (514)
++|++.+.||+|+||.||+|..+.++. .+|+|.++.. ......+.+..|..++.++ +||+|+++++++.+...+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 689999999999999999999887765 4688877632 2344456788899999999 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcc----------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEE
Q 010266 183 LIMEYLPGGDVMTLLMREE----------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMK 246 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iK 246 (514)
+||||+++|+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999996532 478889999999999999999999999999999999999999999
Q ss_pred EccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccc
Q 010266 247 LSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEV 326 (514)
Q Consensus 247 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEv 326 (514)
|+|||++....... ......++..|+|||+
T Consensus 160 l~dfg~~~~~~~~~--------------------------------------------------~~~~~~~~~~y~aPE~ 189 (297)
T cd05089 160 IADFGLSRGEEVYV--------------------------------------------------KKTMGRLPVRWMAIES 189 (297)
T ss_pred ECCcCCCcccccee--------------------------------------------------ccCCCCcCccccCchh
Confidence 99999986321100 0001123457999999
Q ss_pred cccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC
Q 010266 327 LLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL 404 (514)
Q Consensus 327 l~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~ 404 (514)
+.+..++.++|||||||++|||++ |.+||.+.+..+....+... ...+....+++++++||.+||. +|.+|+
T Consensus 190 ~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp--- 263 (297)
T cd05089 190 LNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRMEKPRNCDDEVYELMRQCWRDRPYERP--- 263 (297)
T ss_pred hccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC---CCCCCCCCCCHHHHHHHHHHcCCChhhCc---
Confidence 999999999999999999999997 99999998887777776542 2222223688999999999999 999999
Q ss_pred CHhHHhcC
Q 010266 405 GSEQIKAH 412 (514)
Q Consensus 405 ~~~eil~H 412 (514)
++++|...
T Consensus 264 ~~~~i~~~ 271 (297)
T cd05089 264 PFAQISVQ 271 (297)
T ss_pred CHHHHHHH
Confidence 89998654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=336.96 Aligned_cols=257 Identities=23% Similarity=0.353 Sum_probs=214.0
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCC-----CEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEE
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSG-----NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYS 174 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~-----~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 174 (514)
..+..++|++.+.||+|+||.||++..+..+ ..+|+|.+.... .......+.+|.+++..+ +||||++++++
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 4566688999999999999999999876443 689999987542 234556788999999999 79999999999
Q ss_pred EEcCCeEEEEEeecCCCCHHHHHhh----------------ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCcc
Q 010266 175 FQDAEYLYLIMEYLPGGDVMTLLMR----------------EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLL 238 (514)
Q Consensus 175 f~~~~~l~lVmEy~~gg~L~~~l~~----------------~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNIL 238 (514)
+.+...+|+||||+++|+|..++.. ...+++..+..++.|++.||.|||+.||+||||||+|||
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 9999999999999999999999854 246888899999999999999999999999999999999
Q ss_pred ccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccC
Q 010266 239 LDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGT 318 (514)
Q Consensus 239 ld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT 318 (514)
++.++.+||+|||+++......... ......++
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~-----------------------------------------------~~~~~~~~ 197 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYR-----------------------------------------------KTTNGRLP 197 (293)
T ss_pred EcCCCeEEeCcccccccccccccee-----------------------------------------------ccCCCCCC
Confidence 9999999999999998654221000 00122356
Q ss_pred CCcCCccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-C
Q 010266 319 PDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-D 396 (514)
Q Consensus 319 ~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-d 396 (514)
+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.+..+... .....| ...+.++.+||.+||. +
T Consensus 198 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~ 274 (293)
T cd05053 198 VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG-YRMEKP--QNCTQELYHLMRDCWHEV 274 (293)
T ss_pred ccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcccC
Confidence 78999999999999999999999999999997 99999988877777766542 222333 3678999999999998 9
Q ss_pred ccccCCCCCHhHHhcC
Q 010266 397 VEHRLGTLGSEQIKAH 412 (514)
Q Consensus 397 p~~Rl~~~~~~eil~H 412 (514)
|.+|+ ++++++++
T Consensus 275 p~~Rp---s~~eil~~ 287 (293)
T cd05053 275 PSQRP---TFKQLVED 287 (293)
T ss_pred cccCc---CHHHHHHH
Confidence 99999 99998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=349.02 Aligned_cols=255 Identities=29% Similarity=0.497 Sum_probs=214.1
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe----
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY---- 180 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~---- 180 (514)
.++|++++.||.|+||.||+|++..+++.||+|++.... ........+.+|..+++.++||||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 578999999999999999999999999999999987542 223345667789999999999999999988876655
Q ss_pred --EEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 181 --LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 181 --l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
+|+|+||+ |++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++.....
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 99999999 6799998865 5799999999999999999999999999999999999999999999999999875421
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccc
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECD 337 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~D 337 (514)
. ....+||+.|+|||++.+ ..++.++|
T Consensus 171 ~----------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~D 198 (343)
T cd07851 171 E----------------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVD 198 (343)
T ss_pred c----------------------------------------------------ccCCcccccccCHHHHhCCCCCCchHh
Confidence 1 114468999999999875 46789999
Q ss_pred hhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCccc--------------------------CCc-CcCCChhHHHHH
Q 010266 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLK--------------------------FPE-EARLTPEAKDLI 390 (514)
Q Consensus 338 iWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~--------------------------~p~-~~~~s~~~~dLI 390 (514)
+|||||++|+|++|.+||.+.+.......+........ ++. ...+|+++.+||
T Consensus 199 vwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli 278 (343)
T cd07851 199 IWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLL 278 (343)
T ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHH
Confidence 99999999999999999998887776666654211100 000 124689999999
Q ss_pred hhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 391 CRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 391 ~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
.+||+ +|.+|+ ++.+|+.||||..
T Consensus 279 ~~~l~~~P~~Rp---t~~ell~h~~~~~ 303 (343)
T cd07851 279 EKMLVLDPDKRI---TAAEALAHPYLAE 303 (343)
T ss_pred HHhCCCChhhCC---CHHHHhcCCCccc
Confidence 99999 999999 9999999999985
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=325.94 Aligned_cols=253 Identities=34% Similarity=0.604 Sum_probs=220.6
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
+|.+.+.||.|+||.||+|.+..+++.||+|++..... .......+..|.++++.++||+++++++.+.+....++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 58899999999999999999999999999999976543 33455678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 187 YLPGGDVMTLLMRE----ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 187 y~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
|++|++|..++... ..+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 99999999999764 789999999999999999999999999999999999999999999999999987543210
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
......+|++.|+|||.+.+..++.++|+||||
T Consensus 158 -----------------------------------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG 190 (258)
T cd08215 158 -----------------------------------------------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLG 190 (258)
T ss_pred -----------------------------------------------ceecceeeeecccChhHhccCCCCccccHHHHH
Confidence 011245799999999999998999999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
+++|+|++|..||...+..+....+... ....+|. .++.++.++|.+||. +|.+|+ ++.+++.||||
T Consensus 191 ~~~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~i~~~l~~~p~~Rp---~~~~ll~~~~~ 258 (258)
T cd08215 191 CVLYELCTLKHPFEGENLLELALKILKG-QYPPIPS--QYSSELRNLVSSLLQKDPEERP---SIAQILQSPFI 258 (258)
T ss_pred HHHHHHHcCCCCCCCCcHHHHHHHHhcC-CCCCCCC--CCCHHHHHHHHHHcCCChhhCc---CHHHHhcCCCC
Confidence 9999999999999888777666666542 1223332 678999999999999 999999 99999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=335.73 Aligned_cols=253 Identities=24% Similarity=0.403 Sum_probs=211.6
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEc-----cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 177 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 177 (514)
+...+|.+.++||+|+||.||+|... .++..+|+|.+.+. .......+.+|.+++..++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTE 78 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence 34568899999999999999999753 35678999988654 34456678999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHhhcc---------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCC
Q 010266 178 AEYLYLIMEYLPGGDVMTLLMREE---------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN 242 (514)
Q Consensus 178 ~~~l~lVmEy~~gg~L~~~l~~~~---------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~ 242 (514)
....|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG 158 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence 999999999999999999987643 47889999999999999999999999999999999999999
Q ss_pred CcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcC
Q 010266 243 GHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYI 322 (514)
Q Consensus 243 g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~ 322 (514)
+++||+|||++......... .......+++.|+
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y~ 191 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYY-----------------------------------------------RVGGRTMLPIRWM 191 (280)
T ss_pred CCEEECCCCceeEcCCCcee-----------------------------------------------ecCCCcccccccc
Confidence 99999999998754321000 0011345678999
Q ss_pred CccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-Ccccc
Q 010266 323 APEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHR 400 (514)
Q Consensus 323 APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R 400 (514)
|||++.+..++.++|+|||||++|||++ |.+||...+..+....+..+. ....| ..+++.+.+||.+||+ ||.+|
T Consensus 192 aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~cl~~~P~~R 268 (280)
T cd05092 192 PPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR-ELERP--RTCPPEVYAIMQGCWQREPQQR 268 (280)
T ss_pred CHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc-cCCCC--CCCCHHHHHHHHHHccCChhhC
Confidence 9999999999999999999999999998 999998877777777766532 22333 3678999999999999 99999
Q ss_pred CCCCCHhHHhc
Q 010266 401 LGTLGSEQIKA 411 (514)
Q Consensus 401 l~~~~~~eil~ 411 (514)
+ ++++|+.
T Consensus 269 p---~~~~l~~ 276 (280)
T cd05092 269 M---VIKDIHS 276 (280)
T ss_pred C---CHHHHHH
Confidence 9 8888864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=334.29 Aligned_cols=255 Identities=31% Similarity=0.528 Sum_probs=212.5
Q ss_pred eeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC--CeEEEEE
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA--EYLYLIM 185 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~--~~l~lVm 185 (514)
|++++.||.|+||.||+|....+++.||+|++.+.. ........+.+|..+++.++||+++++++++.+. ..+|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 678999999999999999999999999999998764 2334456678899999999999999999999988 8999999
Q ss_pred eecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 186 EYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
||+++ +|..++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+|.+||+|||++.........
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-- 156 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-- 156 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc--
Confidence 99974 899888765 58999999999999999999999999999999999999999999999999998765422100
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchhhhhH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 343 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGv 343 (514)
......+++.|+|||++.+ ..++.++|+|||||
T Consensus 157 ----------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~ 190 (287)
T cd07840 157 ----------------------------------------------DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGC 190 (287)
T ss_pred ----------------------------------------------cccccccccccCCceeeEccccCChHHHHHHHHH
Confidence 0112357889999998765 46799999999999
Q ss_pred HHHHHhhCCCCCCCCChhHHHHHHhhhcCcc---cCCcC-----------------------cC-CChhHHHHHhhhcc-
Q 010266 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL---KFPEE-----------------------AR-LTPEAKDLICRLLC- 395 (514)
Q Consensus 344 ilyemltG~~PF~~~~~~~~~~~i~~~~~~~---~~p~~-----------------------~~-~s~~~~dLI~~lL~- 395 (514)
++|||++|.+||...+.......+....... .+|.. .. .++++.++|.+||+
T Consensus 191 ~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 270 (287)
T cd07840 191 ILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTL 270 (287)
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCC
Confidence 9999999999999888776666655321110 01100 11 38899999999999
Q ss_pred CccccCCCCCHhHHhcCCcc
Q 010266 396 DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 396 dp~~Rl~~~~~~eil~Hpff 415 (514)
+|.+|+ ++++++.||||
T Consensus 271 ~P~~Rp---~~~~~l~~~~~ 287 (287)
T cd07840 271 DPKKRI---SADQALQHEYF 287 (287)
T ss_pred ChhhCc---CHHHHhhCcCC
Confidence 999999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=344.10 Aligned_cols=274 Identities=25% Similarity=0.439 Sum_probs=216.4
Q ss_pred CCeeE-EeeeeecCceEEEEEEEccCCCEEEEEEeecccccChh-----------hHHHHHHHHHHHHHcCCCceeeEEE
Q 010266 106 DDFDL-LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRG-----------QVEHVRAERNLLAEVASHCIVKLYY 173 (514)
Q Consensus 106 ~~f~~-~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~-----------~~~~~~~E~~iL~~l~hp~Iv~l~~ 173 (514)
++|.. .+.||.|+||+||+|.++.+++.||+|++.+....... ....+.+|..++..++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45554 47799999999999999999999999999765432211 0124678999999999999999999
Q ss_pred EEEcCCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccc
Q 010266 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253 (514)
Q Consensus 174 ~f~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla 253 (514)
+|...+..|+||||+. |+|.+++.....+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence 9999999999999996 699999988888999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-CC
Q 010266 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GY 332 (514)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y 332 (514)
............... ... ..+.......+++.|+|||++.+. .+
T Consensus 167 ~~~~~~~~~~~~~~~--------------~~~---------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~ 211 (335)
T PTZ00024 167 RRYGYPPYSDTLSKD--------------ETM---------------------QRREEMTSKVVTLWYRAPELLMGAEKY 211 (335)
T ss_pred eeccccccccccccc--------------ccc---------------------cccccccccccccCCCCChhcccCCCC
Confidence 865422111000000 000 000011244689999999999764 46
Q ss_pred CcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCccc---CCc---------------------CcCCChhHHH
Q 010266 333 GMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLK---FPE---------------------EARLTPEAKD 388 (514)
Q Consensus 333 ~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~---~p~---------------------~~~~s~~~~d 388 (514)
+.++|+|||||++|||++|.+||.+.+..+....+........ +|. ....+.++.+
T Consensus 212 ~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (335)
T PTZ00024 212 HFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAID 291 (335)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHH
Confidence 8999999999999999999999999888777766654211110 110 1235788999
Q ss_pred HHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 389 LICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 389 LI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
||.+||. +|.+|+ +++|++.||||++.
T Consensus 292 li~~~l~~~P~~R~---s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 292 LLQSLLKLNPLERI---SAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHcCCCchhcc---CHHHHhcCcccCCC
Confidence 9999999 999999 99999999999853
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=339.92 Aligned_cols=268 Identities=28% Similarity=0.488 Sum_probs=211.1
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc-------
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------- 177 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~------- 177 (514)
.++|++++.||.|+||.||+|.++.+++.||+|++..... .......+.+|..+++.++||+|+++++.+.+
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE-KDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC-CCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 5899999999999999999999999999999999876532 22223456789999999999999999988743
Q ss_pred -CCeEEEEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 178 -AEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 178 -~~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
...+|+||||+.+ +|...+.. ...+++..++.++.|++.||.|||++||+||||||+||+++.+|++||+|||++..
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 3457999999964 77777765 45799999999999999999999999999999999999999999999999999976
Q ss_pred CCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCc
Q 010266 256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGM 334 (514)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~ 334 (514)
........... . . .......+.+||+.|+|||++.+ ..++.
T Consensus 165 ~~~~~~~~~~~--------------------~-~-----------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 206 (311)
T cd07866 165 YDGPPPNPKGG--------------------G-G-----------------GGTRKYTNLVVTRWYRPPELLLGERRYTT 206 (311)
T ss_pred ccCCCcccccC--------------------C-c-----------------ccccccccceeccCcCChHHhhCCCccCc
Confidence 54221100000 0 0 00011225679999999998875 45899
Q ss_pred ccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcc---------------------cCCc-----CcCCChhHHH
Q 010266 335 ECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL---------------------KFPE-----EARLTPEAKD 388 (514)
Q Consensus 335 ~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---------------------~~p~-----~~~~s~~~~d 388 (514)
++|+|||||++|||++|.+||.+.+.......+....... ..|. ...+++++.+
T Consensus 207 ~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (311)
T cd07866 207 AVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLD 286 (311)
T ss_pred hhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHH
Confidence 9999999999999999999999888776666654321110 0000 0235578899
Q ss_pred HHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 389 LICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 389 LI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
||.+||. ||.+|+ ++.+++.||||
T Consensus 287 ~i~~~l~~~p~~R~---t~~ell~~~~f 311 (311)
T cd07866 287 LLSKLLSLDPYKRL---TASDALEHPYF 311 (311)
T ss_pred HHHHHcccCcccCc---CHHHHhcCCCC
Confidence 9999999 999999 99999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=328.87 Aligned_cols=251 Identities=23% Similarity=0.338 Sum_probs=210.6
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 181 (514)
.+..++|++.+.||+|+||.||+|... +++.||+|.++.... ..+.+.+|..+++.++||||+++++++...+.+
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPI 76 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCe
Confidence 355678999999999999999999865 456899999876532 235578899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 182 YLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
|+||||++|++|.+++.... .++...+..++.|++.||.+||+.||+||||||+||+++.+|.+||+|||+++.....
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 99999999999999997644 6899999999999999999999999999999999999999999999999999865411
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
... ......++..|+|||++.+..++.++|+|
T Consensus 157 ~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 188 (261)
T cd05068 157 IYE------------------------------------------------AREGAKFPIKWTAPEAALYNRFSIKSDVW 188 (261)
T ss_pred ccc------------------------------------------------ccCCCcCceeccCccccccCCCCchhhHH
Confidence 000 00012234689999999999999999999
Q ss_pred hhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 340 SLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 340 SlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
||||++|||++ |.+||.+.+.......+... ...|.....+..+.++|.+||. +|.+|+ ++++|..
T Consensus 189 slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---~~~~l~~ 256 (261)
T cd05068 189 SFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG---YRMPCPPGCPKELYDIMLDCWKEDPDDRP---TFETLQW 256 (261)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---CCCCCCCcCCHHHHHHHHHHhhcCcccCC---CHHHHHH
Confidence 99999999999 99999988877777766542 2223334678999999999998 999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=345.21 Aligned_cols=255 Identities=30% Similarity=0.483 Sum_probs=210.1
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC------
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA------ 178 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~------ 178 (514)
.++|++++.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|..++..++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 478999999999999999999999999999999987642 2233345677899999999999999999988643
Q ss_pred CeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
...|+|++++ |++|..++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++.....
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 4578999987 7899887754 4689999999999999999999999999999999999999999999999999875321
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccc
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECD 337 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~D 337 (514)
. .....||+.|+|||++.+ ..++.++|
T Consensus 173 ~----------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~D 200 (345)
T cd07877 173 E----------------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVD 200 (345)
T ss_pred c----------------------------------------------------ccccccCCCccCHHHHhCccCCCchhh
Confidence 0 113568999999999876 56899999
Q ss_pred hhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCc---------------------ccCCc------CcCCChhHHHHH
Q 010266 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNH---------------------LKFPE------EARLTPEAKDLI 390 (514)
Q Consensus 338 iWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~---------------------~~~p~------~~~~s~~~~dLI 390 (514)
+|||||++|+|++|.+||.+.+.......++..... ...|. ....++++.+||
T Consensus 201 vwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 280 (345)
T cd07877 201 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 280 (345)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHH
Confidence 999999999999999999887765555544331110 01111 113578999999
Q ss_pred hhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 391 CRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 391 ~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
.+||+ ||.+|+ ++.+++.||||+.
T Consensus 281 ~~~L~~dp~~R~---t~~e~l~h~~f~~ 305 (345)
T cd07877 281 EKMLVLDSDKRI---TAAQALAHAYFAQ 305 (345)
T ss_pred HHHcCCChhhcC---CHHHHhcChhhhh
Confidence 99999 999999 9999999999986
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=329.70 Aligned_cols=245 Identities=26% Similarity=0.373 Sum_probs=204.2
Q ss_pred eeeecCceEEEEEEE--ccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecCC
Q 010266 113 IIGRGAFGEVRLCQE--KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPG 190 (514)
Q Consensus 113 ~LG~G~fG~V~l~~~--~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~g 190 (514)
.||+|+||.||+|.. +.+++.+|+|+++... ......+.+..|..+++.++||||+++++.+. .+..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999999999864 4678899999986543 23445677889999999999999999999876 4567999999999
Q ss_pred CCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccccccc
Q 010266 191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270 (514)
Q Consensus 191 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~ 270 (514)
|+|.+++.....+++..+..++.|++.||.|||++||+||||||.|||++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~------- 152 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY------- 152 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee-------
Confidence 9999999888889999999999999999999999999999999999999999999999999987653221000
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhh
Q 010266 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350 (514)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt 350 (514)
.......+++.|+|||++.+..++.++|+|||||++|||++
T Consensus 153 ---------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t 193 (257)
T cd05116 153 ---------------------------------------KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193 (257)
T ss_pred ---------------------------------------eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHh
Confidence 00012345789999999988889999999999999999998
Q ss_pred -CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 351 -GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 351 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|.+||.+.+..+....+... .....|. .+++++++||.+||+ ||.+|| ++++|..
T Consensus 194 ~g~~p~~~~~~~~~~~~i~~~-~~~~~~~--~~~~~l~~li~~~~~~~p~~Rp---~~~~i~~ 250 (257)
T cd05116 194 YGQKPYKGMKGNEVTQMIESG-ERMECPQ--RCPPEMYDLMKLCWTYGVDERP---GFAVVEL 250 (257)
T ss_pred CCCCCCCCCCHHHHHHHHHCC-CCCCCCC--CCCHHHHHHHHHHhccCchhCc---CHHHHHH
Confidence 99999988777777766543 2234443 689999999999998 999999 7777753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=324.69 Aligned_cols=256 Identities=34% Similarity=0.555 Sum_probs=219.2
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC--CeEEEE
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA--EYLYLI 184 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~--~~l~lV 184 (514)
+|.+.+.||+|++|.||+|.+..+++.|++|++..... .....+.+.+|..+++.++||+|+++++.+.+. ..+|+|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 57889999999999999999998999999999976543 245677889999999999999999999999988 899999
Q ss_pred EeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
|||++|++|.+++.....+++..+..++.+++.||.|||+.|++|+||+|+||+++.+|.++|+|||.+.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 157 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG-- 157 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc--
Confidence 999999999999988889999999999999999999999999999999999999999999999999998765432100
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 344 (514)
.......|++.|+|||++.+..++.++|+||||++
T Consensus 158 ---------------------------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~i 192 (260)
T cd06606 158 ---------------------------------------------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCT 192 (260)
T ss_pred ---------------------------------------------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHH
Confidence 00113568999999999998889999999999999
Q ss_pred HHHHhhCCCCCCCCC-hhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 345 MYEMLVGYPPFYSDD-PVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 345 lyemltG~~PF~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
+|+|++|..||...+ .......+........+|. .++..+++||.+||. +|.+|+ ++.+++.||||
T Consensus 193 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~~i~~~l~~~p~~Rp---~~~~ll~~~~~ 260 (260)
T cd06606 193 VIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPE--HLSEEAKDFLRKCLRRDPKKRP---TADELLQHPFL 260 (260)
T ss_pred HHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCc--ccCHHHHHHHHHhCcCChhhCC---CHHHHhhCCCC
Confidence 999999999998765 3333333332223334443 568999999999998 999999 99999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=330.95 Aligned_cols=251 Identities=23% Similarity=0.342 Sum_probs=207.4
Q ss_pred eeEEeeeeecCceEEEEEEEccC---CCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe----
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKS---GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY---- 180 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t---~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~---- 180 (514)
|.+.+.||+|+||.||.|....+ +..||+|.++... ........+..|..+|+.++||||+++++.+.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 56788999999999999987653 4789999987543 334556778999999999999999999988765443
Q ss_pred --EEEEEeecCCCCHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccc
Q 010266 181 --LYLIMEYLPGGDVMTLLMRE------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252 (514)
Q Consensus 181 --l~lVmEy~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGl 252 (514)
.++||||+++|+|..++... ..+++..+..++.|++.||.|||+.||+||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 89999999999999988542 3688999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCC
Q 010266 253 CKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY 332 (514)
Q Consensus 253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y 332 (514)
++........ .......+++.|+|||++.+..+
T Consensus 160 ~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~~pe~~~~~~~ 192 (273)
T cd05035 160 SKKIYSGDYY-----------------------------------------------RQGRIAKMPVKWIAIESLADRVY 192 (273)
T ss_pred eeeccccccc-----------------------------------------------cccccccCCccccCHhhcccCCC
Confidence 8765321100 00012235678999999998999
Q ss_pred CcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHh
Q 010266 333 GMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIK 410 (514)
Q Consensus 333 ~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 410 (514)
+.++|||||||++|||++ |.+||.+.+..+....+... .....| ...++++.++|.+||. ||.+|+ ++.+++
T Consensus 193 ~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~e~~ 266 (273)
T cd05035 193 TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG-NRLKQP--EDCLDELYDLMYSCWRADPKDRP---TFTKLR 266 (273)
T ss_pred CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--cCCCHHHHHHHHHHcCCChhhCc---CHHHHH
Confidence 999999999999999999 99999988877777766643 233344 3688999999999999 999999 888887
Q ss_pred cC
Q 010266 411 AH 412 (514)
Q Consensus 411 ~H 412 (514)
++
T Consensus 267 ~~ 268 (273)
T cd05035 267 EV 268 (273)
T ss_pred HH
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=338.90 Aligned_cols=258 Identities=22% Similarity=0.339 Sum_probs=211.0
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEcc-------CCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeE
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKK-------SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKL 171 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~-------t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l 171 (514)
+..+..++|.+.+.||+|+||.||+|++.. +...+|+|.+.+.. .......+..|..++..+ +||+|+++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 445566899999999999999999998643 23579999987542 234456688899999999 79999999
Q ss_pred EEEEEcCCeEEEEEeecCCCCHHHHHhhc----------------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCC
Q 010266 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMRE----------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPD 235 (514)
Q Consensus 172 ~~~f~~~~~l~lVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpe 235 (514)
++++.+...+|+||||+++|+|.+++... ..++...+..++.|++.||+|||++|++||||||+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 169 (307)
T cd05098 90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169 (307)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence 99999999999999999999999999754 24778889999999999999999999999999999
Q ss_pred CccccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhcccccccc
Q 010266 236 NLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYST 315 (514)
Q Consensus 236 NILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 315 (514)
|||++.++++||+|||+++........ ......
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~-----------------------------------------------~~~~~~ 202 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYY-----------------------------------------------KKTTNG 202 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchh-----------------------------------------------hccccC
Confidence 999999999999999998754321000 000112
Q ss_pred ccCCCcCCccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhc
Q 010266 316 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLL 394 (514)
Q Consensus 316 ~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL 394 (514)
.+++.|+|||++.+..++.++|+|||||++|||++ |.+||.+.+..+....+.. ......| ..++.++++||.+||
T Consensus 203 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~li~~~l 279 (307)
T cd05098 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE-GHRMDKP--SNCTNELYMMMRDCW 279 (307)
T ss_pred CCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHc-CCCCCCC--CcCCHHHHHHHHHHc
Confidence 35678999999999899999999999999999998 8999988777666666543 2222333 367899999999999
Q ss_pred c-CccccCCCCCHhHHhcC
Q 010266 395 C-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 395 ~-dp~~Rl~~~~~~eil~H 412 (514)
. +|.+|+ ++.+|+++
T Consensus 280 ~~~p~~Rp---s~~evl~~ 295 (307)
T cd05098 280 HAVPSQRP---TFKQLVED 295 (307)
T ss_pred ccChhhCc---CHHHHHHH
Confidence 8 999999 88888753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=345.73 Aligned_cols=259 Identities=26% Similarity=0.429 Sum_probs=209.2
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC-------
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA------- 178 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~------- 178 (514)
.+|.+.+.||.|+||.||+|.++.+|+.||+|++..... ...+.+.+|..+|+.++||||+++++++.+.
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 689999999999999999999999999999999876532 4556788899999999999999999776543
Q ss_pred -------CeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC-CCcEEEccc
Q 010266 179 -------EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ-NGHMKLSDF 250 (514)
Q Consensus 179 -------~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~-~g~iKL~DF 250 (514)
..+|+||||++ ++|..++. .+.+++..++.++.|++.||.|||+.||+||||||+||+++. ++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 46899999997 58888774 457899999999999999999999999999999999999984 567899999
Q ss_pred cccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-
Q 010266 251 GLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK- 329 (514)
Q Consensus 251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~- 329 (514)
|++..+...... .......+||+.|+|||++.+
T Consensus 160 g~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~ 193 (342)
T cd07854 160 GLARIVDPHYSH----------------------------------------------KGYLSEGLVTKWYRSPRLLLSP 193 (342)
T ss_pred ccceecCCcccc----------------------------------------------ccccccccccccccCHHHHhCc
Confidence 998754321000 000112368999999998764
Q ss_pred CCCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhc-----------------------CcccCCc---CcCCC
Q 010266 330 KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWK-----------------------NHLKFPE---EARLT 383 (514)
Q Consensus 330 ~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-----------------------~~~~~p~---~~~~s 383 (514)
..++.++|+|||||++|+|++|..||.+.++.+....+.... .....|. ...++
T Consensus 194 ~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (342)
T cd07854 194 NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVN 273 (342)
T ss_pred cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCC
Confidence 568899999999999999999999998877666555543210 0000000 12478
Q ss_pred hhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 384 PEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 384 ~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
.++.+||.+||+ ||.+|+ ++++++.||||+.+
T Consensus 274 ~~~~~li~~~L~~dP~~R~---t~~ell~h~~~~~~ 306 (342)
T cd07854 274 PEALDFLEQILTFNPMDRL---TAEEALMHPYMSCY 306 (342)
T ss_pred HHHHHHHHHHhCCCchhcc---CHHHHhCCCccccc
Confidence 899999999999 999999 99999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=330.34 Aligned_cols=254 Identities=22% Similarity=0.332 Sum_probs=212.0
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCC---EEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGN---IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~---~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
...+|++.+.||+|+||.||+|.++.++. .+|+|.++... .......+..|..+|..++||||+++++++.+.+.
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP 79 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 34689999999999999999999875543 79999986542 23445678889999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
.|+||||++||+|.+++... ..++...+..++.|++.||.|||++||+||||||+|||++.++++||+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999999764 46899999999999999999999999999999999999999999999999998865321
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
.... .......+++.|+|||++.+..++.++|+|
T Consensus 160 ~~~~----------------------------------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~ 193 (267)
T cd05066 160 PEAA----------------------------------------------YTTRGGKIPIRWTAPEAIAYRKFTSASDVW 193 (267)
T ss_pred ccee----------------------------------------------eecCCCccceeecCHhHhccCccCchhhhH
Confidence 1000 000122346789999999998999999999
Q ss_pred hhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 340 SLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 340 SlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
||||++|||++ |..||...+..+....+... ...|....+++.+.+++.+||+ +|.+|+ ++.++++
T Consensus 194 slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~ 261 (267)
T cd05066 194 SYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG---YRLPAPMDCPAALHQLMLDCWQKDRNERP---KFEQIVS 261 (267)
T ss_pred HHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC---CcCCCCCCCCHHHHHHHHHHcccCchhCC---CHHHHHH
Confidence 99999999886 99999888777777666542 2344444678999999999998 999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=327.53 Aligned_cols=246 Identities=24% Similarity=0.358 Sum_probs=212.5
Q ss_pred eeeeecCceEEEEEEEccC---CCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeec
Q 010266 112 TIIGRGAFGEVRLCQEKKS---GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYL 188 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t---~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~ 188 (514)
+.||+|+||.||+|..... +..||+|++..... ....+.+..|..++..++||+|+++++++.+...+|+||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc--hhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999998865 88999999976543 225678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhc---------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 189 PGGDVMTLLMRE---------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 189 ~gg~L~~~l~~~---------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
+||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 78999999999999999999999999999999999999999999999999999865422
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
... .......+++.|+|||.+.+..++.++|+|
T Consensus 159 ~~~-----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 191 (262)
T cd00192 159 DYY-----------------------------------------------RKKTGGKLPIRWMAPESLKDGIFTSKSDVW 191 (262)
T ss_pred ccc-----------------------------------------------ccccCCCcCccccCHHHhccCCcchhhccH
Confidence 100 011245688999999999988999999999
Q ss_pred hhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 340 SLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 340 SlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
||||++|+|++ |..||.+.+..+....+... .....| ..+|+++.++|.+||+ +|.+|+ +++++++|
T Consensus 192 slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~l~~~ 260 (262)
T cd00192 192 SFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG-YRLPKP--EYCPDELYELMLSCWQLDPEDRP---TFSELVER 260 (262)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCC--ccCChHHHHHHHHHccCCcccCc---CHHHHHHh
Confidence 99999999999 69999998887777777652 233334 3679999999999999 999999 99999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=348.84 Aligned_cols=251 Identities=26% Similarity=0.424 Sum_probs=212.3
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
..+....+.+++.||+|-||.||++..+.+ ..||+|.++...+ ..+.+.+|+.||.+++|++||+|++++..++.
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p 275 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSM----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEP 275 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEecccc----ChhHHHHHHHHHHhCcccCeEEEEEEEecCCc
Confidence 344455677788999999999999998643 3699999986543 23457799999999999999999999999889
Q ss_pred EEEEEeecCCCCHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMR--EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
+|||||||+.|+|.++|.. ...+.......+++||+.|++||+++++|||||...||||++++.+||+|||||+....
T Consensus 276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCC
Confidence 9999999999999999987 56788889999999999999999999999999999999999999999999999995443
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
...... .++. --..|.|||.+....++.++||
T Consensus 356 ~~Y~~~----------------~~~k--------------------------------fPIkWtAPEa~~~~~FS~kSDV 387 (468)
T KOG0197|consen 356 DEYTAS----------------EGGK--------------------------------FPIKWTAPEALNYGKFSSKSDV 387 (468)
T ss_pred Cceeec----------------CCCC--------------------------------CCceecCHHHHhhCCcccccce
Confidence 211110 0011 1236999999999999999999
Q ss_pred hhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHh
Q 010266 339 WSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIK 410 (514)
Q Consensus 339 WSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 410 (514)
|||||+||||+| |+.|+.+.+..+....+-++ ...|.+...+++..+++..|.. +|++|| |++.+.
T Consensus 388 WSFGVlL~E~fT~G~~py~~msn~ev~~~le~G---yRlp~P~~CP~~vY~lM~~CW~~~P~~RP---tF~~L~ 455 (468)
T KOG0197|consen 388 WSFGVLLWELFTYGRVPYPGMSNEEVLELLERG---YRLPRPEGCPDEVYELMKSCWHEDPEDRP---TFETLR 455 (468)
T ss_pred eehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc---CcCCCCCCCCHHHHHHHHHHhhCCcccCC---CHHHHH
Confidence 999999999998 99999999999999888753 4555556899999999999998 999999 776543
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=340.07 Aligned_cols=256 Identities=30% Similarity=0.483 Sum_probs=210.8
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc-CCeEE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-AEYLY 182 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~-~~~l~ 182 (514)
..++|++++.||.|+||.||+|.++.+++.||+|++.+.. .......++..|..++..++||||++++++|.. ....|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 4578999999999999999999999999999999987643 233445678889999999999999999999976 56899
Q ss_pred EEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
+||||+ +++|..++. ...+++..+..++.|++.||.|||+.||+||||||+|||++.+|++||+|||++......
T Consensus 87 lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--- 161 (328)
T cd07856 87 FVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--- 161 (328)
T ss_pred EEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC---
Confidence 999998 568888775 456889999999999999999999999999999999999999999999999998743210
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSL 341 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSl 341 (514)
..+.+|++.|+|||++.+ ..++.++|+|||
T Consensus 162 -------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 192 (328)
T cd07856 162 -------------------------------------------------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSA 192 (328)
T ss_pred -------------------------------------------------cCCCcccccccCceeeeccCCcCcHHHHHHH
Confidence 013468899999999876 578999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcC------------------------cccCCc---CcCCChhHHHHHhhhc
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKN------------------------HLKFPE---EARLTPEAKDLICRLL 394 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~------------------------~~~~p~---~~~~s~~~~dLI~~lL 394 (514)
||++|+|++|.+||.+.+.......+...-. ....|. ...++++++++|.+||
T Consensus 193 G~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 272 (328)
T cd07856 193 GCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKML 272 (328)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHc
Confidence 9999999999999988765443332221100 001111 1246789999999999
Q ss_pred c-CccccCCCCCHhHHhcCCcccc
Q 010266 395 C-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 395 ~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
+ +|.+|+ ++++++.||||..
T Consensus 273 ~~~P~~R~---t~~ell~~~~~~~ 293 (328)
T cd07856 273 VFDPQKRI---SAAEALAHPYLAP 293 (328)
T ss_pred CCChhhCC---CHHHHhcCCcccc
Confidence 8 999999 9999999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=336.93 Aligned_cols=254 Identities=20% Similarity=0.304 Sum_probs=211.8
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccC-----CCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKS-----GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 177 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t-----~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 177 (514)
+...+|++++.||+|+||.||++....+ ++.||||+++... .....+.+..|..++..++||||+++++++.+
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 79 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK 79 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 3456788899999999999999987543 5789999987542 23345668889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHhhc----------------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC
Q 010266 178 AEYLYLIMEYLPGGDVMTLLMRE----------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ 241 (514)
Q Consensus 178 ~~~l~lVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~ 241 (514)
...+++++||+++++|..++... ..+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 99999999999999999998532 34788889999999999999999999999999999999999
Q ss_pred CCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCc
Q 010266 242 NGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDY 321 (514)
Q Consensus 242 ~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y 321 (514)
++.+||+|||+++........ .......+|+.|
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y 192 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYY-----------------------------------------------KLMGNSLLPIRW 192 (283)
T ss_pred CCceEecccccccccccchhe-----------------------------------------------eeccCccCCccc
Confidence 999999999998865321100 011134578899
Q ss_pred CCccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-Cccc
Q 010266 322 IAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEH 399 (514)
Q Consensus 322 ~APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~ 399 (514)
+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+.... ....| ...+..+.+||.+||. +|.+
T Consensus 193 ~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~~~~li~~cl~~~p~~ 269 (283)
T cd05091 193 MSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ-VLPCP--DDCPAWVYTLMLECWNEFPSR 269 (283)
T ss_pred cCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHhCCCccc
Confidence 99999998889999999999999999998 899999888887777776532 22233 3678999999999998 9999
Q ss_pred cCCCCCHhHHhc
Q 010266 400 RLGTLGSEQIKA 411 (514)
Q Consensus 400 Rl~~~~~~eil~ 411 (514)
|+ ++++|+.
T Consensus 270 RP---~~~~i~~ 278 (283)
T cd05091 270 RP---RFKDIHS 278 (283)
T ss_pred CC---CHHHHHH
Confidence 99 8999876
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=335.47 Aligned_cols=260 Identities=25% Similarity=0.439 Sum_probs=211.1
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCC
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAE 179 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~ 179 (514)
..+..++|++.+.||+|+||.||+|.++.+++.||||.+++... ......+..|..++... .||||++++++|.+..
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 87 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS 87 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence 35667899999999999999999999999999999999976532 22334455677666666 4999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
.+|+||||++ ++|.+++.. ...+++..+..++.|++.||.|||+ .||+||||+|+||+++.++.+||+|||++..+.
T Consensus 88 ~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 88 DVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 9999999985 577777755 4578999999999999999999997 699999999999999999999999999987543
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCC----CC
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG----YG 333 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~----y~ 333 (514)
.... .....|++.|+|||++.+.. ++
T Consensus 167 ~~~~--------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~ 196 (296)
T cd06618 167 DSKA--------------------------------------------------KTRSAGCAAYMAPERIDPPDPNPKYD 196 (296)
T ss_pred CCCc--------------------------------------------------ccCCCCCccccCHhhcCCCCCccccc
Confidence 2100 01235889999999997653 78
Q ss_pred cccchhhhhHHHHHHhhCCCCCCCCCh-hHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 334 MECDWWSLGAIMYEMLVGYPPFYSDDP-VTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 334 ~~~DiWSlGvilyemltG~~PF~~~~~-~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
.++|+|||||++|+|++|..||..... .+....+... .....|....++.++.+||.+||. ||.+|+ ++++++.
T Consensus 197 ~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---~~~~il~ 272 (296)
T cd06618 197 IRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE-EPPSLPPNEGFSPDFCSFVDLCLTKDHRKRP---KYRELLQ 272 (296)
T ss_pred cchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC-CCCCCCCCCCCCHHHHHHHHHHccCChhhCC---CHHHHhc
Confidence 999999999999999999999976433 3444444432 222334333578899999999998 999999 9999999
Q ss_pred CCcccc
Q 010266 412 HPWFKD 417 (514)
Q Consensus 412 Hpff~~ 417 (514)
||||..
T Consensus 273 ~~~~~~ 278 (296)
T cd06618 273 HPFIRR 278 (296)
T ss_pred Chhhhc
Confidence 999974
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=329.13 Aligned_cols=231 Identities=28% Similarity=0.504 Sum_probs=194.9
Q ss_pred cCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecCCCCHHHH
Q 010266 117 GAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTL 196 (514)
Q Consensus 117 G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~ 196 (514)
|+||+||+|+++.+++.||+|++++... ...|...+....||||+++++++++.+..|+||||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8999999999999999999999976531 23455555566799999999999999999999999999999999
Q ss_pred HhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccccccccccccc
Q 010266 197 LMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLN 276 (514)
Q Consensus 197 l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~ 276 (514)
+.+...+++..+..++.|++.||.|||++||+||||||+||+++.+|.++|+|||++......
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----------------- 138 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----------------- 138 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----------------
Confidence 988888999999999999999999999999999999999999999999999999987654311
Q ss_pred ccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhhCCCCCC
Q 010266 277 ESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 356 (514)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemltG~~PF~ 356 (514)
..+..+++.|+|||++.+..++.++|+||+||++|||++|..||.
T Consensus 139 -----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~ 183 (237)
T cd05576 139 -----------------------------------CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE 183 (237)
T ss_pred -----------------------------------cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence 013456788999999988889999999999999999999999986
Q ss_pred CCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCC--CCHhHHhcCCcc
Q 010266 357 SDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT--LGSEQIKAHPWF 415 (514)
Q Consensus 357 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~Hpff 415 (514)
..... ......+.+|. .+++.+++||.+||+ ||.+|++. .+++++++||||
T Consensus 184 ~~~~~------~~~~~~~~~~~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 184 CHPSG------INTHTTLNIPE--WVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cCchh------cccccccCCcc--cCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 43211 11112234553 689999999999998 99999953 246999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=340.77 Aligned_cols=261 Identities=28% Similarity=0.422 Sum_probs=209.7
Q ss_pred CeeEEeeeeecCceEEEEEEEccC--CCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEE----cCC
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKS--GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQ----DAE 179 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t--~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~----~~~ 179 (514)
+|++.+.||+|+||.||+|++..+ +..||+|++.... ........+.+|..++..+ +||||+++++.+. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 588999999999999999999888 8999999986432 2223345677899999998 5999999998643 235
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
.+|++|||+. ++|..++.....+++..++.++.|++.||.|||+.||+||||||+||+++.+|++||+|||+|+.+...
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 6899999985 699999988889999999999999999999999999999999999999999999999999999865422
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccch
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDW 338 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~Di 338 (514)
.... .......+||+.|+|||++.+ ..++.++|+
T Consensus 159 ~~~~---------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di 193 (332)
T cd07857 159 PGEN---------------------------------------------AGFMTEYVATRWYRAPEIMLSFQSYTKAIDV 193 (332)
T ss_pred cccc---------------------------------------------cccccCcccCccccCcHHHhCCCCCCcHHHH
Confidence 1000 001124679999999998765 578999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcC--------------------------cccCCc-CcCCChhHHHHHh
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKN--------------------------HLKFPE-EARLTPEAKDLIC 391 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~--------------------------~~~~p~-~~~~s~~~~dLI~ 391 (514)
|||||++|+|++|.+||.+.+.......++.... ...++. ....+..+.+||.
T Consensus 194 ~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 273 (332)
T cd07857 194 WSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLE 273 (332)
T ss_pred HHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHH
Confidence 9999999999999999988765544443332110 001111 1235789999999
Q ss_pred hhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 392 RLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 392 ~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
+||+ ||.+|+ ++++++.||||+.
T Consensus 274 ~~l~~~P~~R~---t~~~ll~~~~~~~ 297 (332)
T cd07857 274 KLLAFDPTKRI---SVEEALEHPYLAI 297 (332)
T ss_pred HHccCCcccCC---CHHHHhcChhhhh
Confidence 9999 999999 9999999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=338.34 Aligned_cols=254 Identities=26% Similarity=0.398 Sum_probs=213.0
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
..|..++.||+|+||.||+|+++.+++.+|+|.+.............+..|..+++.++||+++++++++.+....|+||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 44777889999999999999999999999999987654444455667888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 186 EYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 186 Ey~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
||+. |+|..++.. ...+++..+..++.|++.||.|||+.|++||||||+|||++.+|.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~----- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----- 168 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-----
Confidence 9996 577777643 456899999999999999999999999999999999999999999999999998653211
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc---cCCCCcccchhhh
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSL 341 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiWSl 341 (514)
....||+.|+|||++. ...++.++|||||
T Consensus 169 ------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~sl 200 (308)
T cd06634 169 ------------------------------------------------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 200 (308)
T ss_pred ------------------------------------------------ccccCCccccCHHHHhhcccCCCCcccchHHH
Confidence 1346899999999985 3457889999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
||++|+|++|..||...+.......+.... ....+ ...++..+++||.+||. +|.+|+ ++++++.|||+...
T Consensus 201 G~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~li~~cl~~~P~~Rp---~~~~ll~~~~~~~~ 273 (308)
T cd06634 201 GITCIELAERKPPLFNMNAMSALYHIAQNE-SPALQ-SGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHHHHcCCCCCccccHHHHHHHHhhcC-CCCcC-cccccHHHHHHHHHHhhCCcccCC---CHHHHhhCcccccc
Confidence 999999999999998776655555444321 11111 23578899999999998 999999 99999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=330.27 Aligned_cols=251 Identities=21% Similarity=0.322 Sum_probs=205.8
Q ss_pred eeEEeeeeecCceEEEEEEEccCCC--EEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc------CC
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSGN--IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------AE 179 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~~--~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~------~~ 179 (514)
|.+.+.||+|+||.||+|+...++. .+|+|.++... ......+.+..|..+++.++||||+++++.+.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3467899999999999999887775 58999887642 345567788899999999999999999987632 23
Q ss_pred eEEEEEeecCCCCHHHHHhh------ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccc
Q 010266 180 YLYLIMEYLPGGDVMTLLMR------EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~------~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla 253 (514)
..++||||+++|+|..++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++++||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57999999999999988742 235789999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCC
Q 010266 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG 333 (514)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 333 (514)
+........ .......+++.|+|||++.+..++
T Consensus 160 ~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~~pe~~~~~~~~ 192 (272)
T cd05075 160 KKIYNGDYY-----------------------------------------------RQGRIAKMPVKWIAIESLADRVYT 192 (272)
T ss_pred cccCcccce-----------------------------------------------ecCCcccCCcccCCHHHccCCCcC
Confidence 865322100 000123467889999999999999
Q ss_pred cccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 334 MECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 334 ~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
.++|||||||++|||++ |.+||.+.+..+....+.... ....+ ..++..++++|.+||+ ||.+|+ ++++|++
T Consensus 193 ~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~l~~ 266 (272)
T cd05075 193 TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN-RLKQP--PDCLDGLYSLMSSCWLLNPKDRP---SFETLRC 266 (272)
T ss_pred hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHcCCCcccCc---CHHHHHH
Confidence 99999999999999999 899999887777777766532 22333 3678999999999999 999999 8999876
Q ss_pred C
Q 010266 412 H 412 (514)
Q Consensus 412 H 412 (514)
+
T Consensus 267 ~ 267 (272)
T cd05075 267 E 267 (272)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=333.96 Aligned_cols=253 Identities=24% Similarity=0.394 Sum_probs=209.6
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEcc-----CCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKK-----SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 177 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~-----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 177 (514)
+...+|.+.+.||+|+||.||+|+... ++..+|+|.+.... ......+.+|..+++.++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGD 78 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence 345689999999999999999998543 45679999886442 3344568889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHhhc----------------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC
Q 010266 178 AEYLYLIMEYLPGGDVMTLLMRE----------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ 241 (514)
Q Consensus 178 ~~~l~lVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~ 241 (514)
....++||||++||+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 158 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 99999999999999999998653 23788999999999999999999999999999999999999
Q ss_pred CCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCc
Q 010266 242 NGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDY 321 (514)
Q Consensus 242 ~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y 321 (514)
++.+||+|||++......... .......|++.|
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y 191 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYY-----------------------------------------------RVGGHTMLPIRW 191 (291)
T ss_pred CCcEEECCCCcccccCCCcee-----------------------------------------------ecCCCCCcceee
Confidence 999999999998754321100 001134678999
Q ss_pred CCccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-Cccc
Q 010266 322 IAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEH 399 (514)
Q Consensus 322 ~APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~ 399 (514)
+|||++.+..++.++|+|||||++|||++ |.+||...+..+....+.... ....+ ...+..+.+||.+||. +|.+
T Consensus 192 ~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~P~~ 268 (291)
T cd05094 192 MPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR-VLERP--RVCPKEVYDIMLGCWQREPQQ 268 (291)
T ss_pred cChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCC-CCCCC--ccCCHHHHHHHHHHcccChhh
Confidence 99999999999999999999999999998 999998887777666654421 11222 3568899999999999 9999
Q ss_pred cCCCCCHhHHhc
Q 010266 400 RLGTLGSEQIKA 411 (514)
Q Consensus 400 Rl~~~~~~eil~ 411 (514)
|+ ++.+|++
T Consensus 269 Rp---t~~~v~~ 277 (291)
T cd05094 269 RL---NIKEIYK 277 (291)
T ss_pred Cc---CHHHHHH
Confidence 99 8888864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=328.12 Aligned_cols=255 Identities=22% Similarity=0.330 Sum_probs=212.8
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCC---EEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGN---IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE 179 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~---~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 179 (514)
+..++|+..+.||+|+||.||+|..+.++. .+|+|.+.... .....+.+..|..++..++||||+++++++.+.+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 456789999999999999999999876665 79999886542 2344567889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
..|+||||+++|+|..++... +.+++..+..++.+++.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999999998764 5789999999999999999999999999999999999999999999999999875432
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
..... .......+++.|+|||++.+..++.++||
T Consensus 160 ~~~~~----------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv 193 (268)
T cd05063 160 DPEGT----------------------------------------------YTTSGGKIPIRWTAPEAIAYRKFTSASDV 193 (268)
T ss_pred ccccc----------------------------------------------eeccCCCcCceecCHHHhhcCCcChHhHH
Confidence 11000 00001234567999999998889999999
Q ss_pred hhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 339 WSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 339 WSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|||||++|||++ |..||...+..+....+.. ....|.....+.++.+||.+|+. +|.+|+ ++.+|++
T Consensus 194 ~slG~il~ell~~g~~p~~~~~~~~~~~~i~~---~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp---~~~~i~~ 262 (268)
T cd05063 194 WSFGIVMWEVMSFGERPYWDMSNHEVMKAIND---GFRLPAPMDCPSAVYQLMLQCWQQDRARRP---RFVDIVN 262 (268)
T ss_pred HHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc---CCCCCCCCCCCHHHHHHHHHHcCCCcccCc---CHHHHHH
Confidence 999999999997 9999988877777777654 23444444678999999999998 999999 8888864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=340.56 Aligned_cols=260 Identities=23% Similarity=0.330 Sum_probs=204.9
Q ss_pred eeeec--CceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecCC
Q 010266 113 IIGRG--AFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPG 190 (514)
Q Consensus 113 ~LG~G--~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~g 190 (514)
+||+| ++|.||+++.+.+++.||||++.+.. ........+..|..+++.++||||++++++|.+.+..|++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 44544 55677777888899999999998753 2445677899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccccc
Q 010266 191 GDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENE 268 (514)
Q Consensus 191 g~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~ 268 (514)
|+|.+++... ..+++..++.++.|++.||.|||+.||+||||||+||+++.+|.+||+|||.+............
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~--- 160 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV--- 160 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc---
Confidence 9999999753 56899999999999999999999999999999999999999999999999998754321100000
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc--CCCCcccchhhhhHHHH
Q 010266 269 VLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMY 346 (514)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvily 346 (514)
.........++..|+|||++.+ ..|+.++|+|||||++|
T Consensus 161 ---------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~ 201 (314)
T cd08216 161 ---------------------------------------VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITAC 201 (314)
T ss_pred ---------------------------------------cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHH
Confidence 0001124568899999999976 46899999999999999
Q ss_pred HHhhCCCCCCCCChhHHHHHHhhhcC------------------------------cccCCcCcCCChhHHHHHhhhcc-
Q 010266 347 EMLVGYPPFYSDDPVTTCRKIVHWKN------------------------------HLKFPEEARLTPEAKDLICRLLC- 395 (514)
Q Consensus 347 emltG~~PF~~~~~~~~~~~i~~~~~------------------------------~~~~p~~~~~s~~~~dLI~~lL~- 395 (514)
||++|.+||...+............. ....+....+++++.+||.+||+
T Consensus 202 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 281 (314)
T cd08216 202 ELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQR 281 (314)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhc
Confidence 99999999987654433221111000 00000112345789999999999
Q ss_pred CccccCCCCCHhHHhcCCccccC
Q 010266 396 DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 396 dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
||.+|+ +++++++||||+.+
T Consensus 282 ~P~~Rp---t~~~ll~~p~~~~~ 301 (314)
T cd08216 282 DPESRP---SASQLLNHSFFKQC 301 (314)
T ss_pred CCCcCc---CHHHHhcCchHhhh
Confidence 999999 99999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=336.54 Aligned_cols=251 Identities=30% Similarity=0.541 Sum_probs=211.8
Q ss_pred EeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecCC
Q 010266 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPG 190 (514)
Q Consensus 111 ~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~g 190 (514)
...||+|+||.||++..+.+++.||+|++... .......+.+|..+++.++||+|+++++.|.+.++.|+||||+++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 46799999999999999999999999987533 233456688899999999999999999999999999999999999
Q ss_pred CCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccccccc
Q 010266 191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270 (514)
Q Consensus 191 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~ 270 (514)
++|.+++. ...+++..++.++.|++.||.|||+.||+||||||+||+++.+|+++|+|||++........
T Consensus 102 ~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--------- 171 (292)
T cd06657 102 GALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--------- 171 (292)
T ss_pred CcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc---------
Confidence 99998774 45789999999999999999999999999999999999999999999999998765421100
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhh
Q 010266 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350 (514)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt 350 (514)
.....+||+.|+|||++.+..++.++|+||+||++|+|++
T Consensus 172 ----------------------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~t 211 (292)
T cd06657 172 ----------------------------------------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVD 211 (292)
T ss_pred ----------------------------------------cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh
Confidence 0114578999999999988889999999999999999999
Q ss_pred CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 351 GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 351 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
|.+||.+.+..+....+... ....++....+++.+.++|.+||. +|.+|+ ++.+++.||||...
T Consensus 212 g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~---~~~~ll~~~~~~~~ 276 (292)
T cd06657 212 GEPPYFNEPPLKAMKMIRDN-LPPKLKNLHKVSPSLKGFLDRLLVRDPAQRA---TAAELLKHPFLAKA 276 (292)
T ss_pred CCCCCCCCCHHHHHHHHHhh-CCcccCCcccCCHHHHHHHHHHHhCCcccCc---CHHHHhcChHHhcc
Confidence 99999987766555544321 112222233578999999999999 999999 99999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=327.12 Aligned_cols=250 Identities=21% Similarity=0.357 Sum_probs=209.6
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 183 (514)
..++|++++.||+|+||.||++.... +..+|+|.+..... ....+.+|..++..++||||+++++++.+...+|+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI 76 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence 45789999999999999999997654 44699999875432 23457889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 184 IMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++........
T Consensus 77 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 99999999999998763 47899999999999999999999999999999999999999999999999998754321000
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
......|+..|+|||++.+..++.++|+||||
T Consensus 157 ------------------------------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG 188 (256)
T cd05113 157 ------------------------------------------------SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFG 188 (256)
T ss_pred ------------------------------------------------ecCCCccChhhCCHHHHhcCcccchhHHHHHH
Confidence 00122366789999999988899999999999
Q ss_pred HHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 343 AIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 343 vilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
|++|+|++ |..||...+..+....+.+... ...| ...++.++++|.+||. +|.+|+ ++.+|+.+
T Consensus 189 ~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~li~~cl~~~p~~Rp---~~~~ll~~ 254 (256)
T cd05113 189 VLMWEVYSLGKMPYERFNNSETVEKVSQGLR-LYRP--HLASEKVYAIMYSCWHEKAEERP---TFQQLLSS 254 (256)
T ss_pred HHHHHHhcCCCCCcCcCCHHHHHHHHhcCCC-CCCC--CCCCHHHHHHHHHHcCCCcccCC---CHHHHHHh
Confidence 99999998 9999988877777777765322 2222 3568999999999998 999999 89998864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=335.50 Aligned_cols=260 Identities=30% Similarity=0.494 Sum_probs=211.9
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC---
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE--- 179 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~--- 179 (514)
...++|++.+.||.|+||.||+|.++.+|+.||+|+++.... .......+..|..+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 446789999999999999999999999999999999976532 2233455678999999999999999999987655
Q ss_pred -------eEEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccc
Q 010266 180 -------YLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251 (514)
Q Consensus 180 -------~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFG 251 (514)
.+|+||||+++ ++...+... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 89999999976 677776553 578999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-C
Q 010266 252 LCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-K 330 (514)
Q Consensus 252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~ 330 (514)
++......... ......+++.|+|||++.+ .
T Consensus 162 ~~~~~~~~~~~------------------------------------------------~~~~~~~~~~y~~PE~~~~~~ 193 (302)
T cd07864 162 LARLYNSEESR------------------------------------------------PYTNKVITLWYRPPELLLGEE 193 (302)
T ss_pred ccccccCCccc------------------------------------------------ccccceeccCccChHHhcCCC
Confidence 98765322100 0012357889999998865 4
Q ss_pred CCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcc---cCC-----------------------cCcCCCh
Q 010266 331 GYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL---KFP-----------------------EEARLTP 384 (514)
Q Consensus 331 ~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---~~p-----------------------~~~~~s~ 384 (514)
.++.++|+|||||++|||++|++||...+..+....+....... .+| ....+++
T Consensus 194 ~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (302)
T cd07864 194 RYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPT 273 (302)
T ss_pred CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCH
Confidence 57899999999999999999999999877766665554421110 010 1124689
Q ss_pred hHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 385 EAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 385 ~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
.+.+||.+||. +|.+|+ ++++|+.||||
T Consensus 274 ~~~~li~~~l~~~P~~Rp---~~~~il~~~~~ 302 (302)
T cd07864 274 PALDLLDHMLTLDPSKRC---TAEEALNSPWL 302 (302)
T ss_pred HHHHHHHHHccCChhhCC---CHHHHhcCCCC
Confidence 99999999999 999999 99999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=303.06 Aligned_cols=258 Identities=29% Similarity=0.513 Sum_probs=218.1
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
.|.-.+.||+|.||+|++++.+.|++.||+|.++-++- ...--....+|+-+|+.++|.|||+|++....+..+-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 45667789999999999999999999999999986542 23334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 187 YLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 187 y~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
||. .+|..+... ++.++.+.++.++.|++.||.++|++++.||||||.|.||+.+|.+||+|||+++.+..+..
T Consensus 82 ~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvr---- 156 (292)
T KOG0662|consen 82 FCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR---- 156 (292)
T ss_pred Hhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE----
Confidence 995 588888765 57899999999999999999999999999999999999999999999999999987653210
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-CCCcccchhhhhHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAI 344 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvi 344 (514)
.-..-+-|.+|.+|.++.+. -|+.+.|+||.|||
T Consensus 157 ---------------------------------------------cysaevvtlwyrppdvlfgakly~tsidmwsagci 191 (292)
T KOG0662|consen 157 ---------------------------------------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCI 191 (292)
T ss_pred ---------------------------------------------eeeceeeeeeccCcceeeeeehhccchHhhhcchH
Confidence 01134789999999999884 58999999999999
Q ss_pred HHHHhh-CCCCCCCCChhHHHHHHhh---------hcCcccCCcC----------------cCCChhHHHHHhhhcc-Cc
Q 010266 345 MYEMLV-GYPPFYSDDPVTTCRKIVH---------WKNHLKFPEE----------------ARLTPEAKDLICRLLC-DV 397 (514)
Q Consensus 345 lyemlt-G~~PF~~~~~~~~~~~i~~---------~~~~~~~p~~----------------~~~s~~~~dLI~~lL~-dp 397 (514)
+.|+.. |+|.|.|.+..++..+|.. |+..-.+|+. +.++...+||+++||. +|
T Consensus 192 faelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp 271 (292)
T KOG0662|consen 192 FAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNP 271 (292)
T ss_pred HHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCc
Confidence 999985 8999999999999988864 3322222221 2356778999999995 99
Q ss_pred cccCCCCCHhHHhcCCccccC
Q 010266 398 EHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 398 ~~Rl~~~~~~eil~Hpff~~i 418 (514)
..|+ ++++.++||||.+.
T Consensus 272 ~qri---saeaalqhpyf~d~ 289 (292)
T KOG0662|consen 272 AQRI---SAEAALQHPYFSDF 289 (292)
T ss_pred cccc---CHHHHhcCcccccc
Confidence 9998 99999999999764
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=330.13 Aligned_cols=254 Identities=22% Similarity=0.389 Sum_probs=212.5
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEcc-----CCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKK-----SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA 178 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~-----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 178 (514)
..++|++++.||.|+||.||+|+.+. +.+.||+|.+.... .......+.+|..+|+.++||+|+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 44789999999999999999999764 34679999876532 223456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcc
Q 010266 179 EYLYLIMEYLPGGDVMTLLMREE---------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSD 249 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~D 249 (514)
...|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.+++++|+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999999997655 689999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc
Q 010266 250 FGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK 329 (514)
Q Consensus 250 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~ 329 (514)
||+++....... .......+++.|+|||.+.+
T Consensus 161 ~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~y~~PE~~~~ 192 (275)
T cd05046 161 LSLSKDVYNSEY------------------------------------------------YKLRNALIPLRWLAPEAVQE 192 (275)
T ss_pred cccccccCcccc------------------------------------------------cccCCceeEEeecChhhhcc
Confidence 999874321100 00113467888999999988
Q ss_pred CCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHh
Q 010266 330 KGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSE 407 (514)
Q Consensus 330 ~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ 407 (514)
..++.++|||||||++|+|++ |..||...+.......+... .+.++....++..+.++|.+||+ +|.+|+ ++.
T Consensus 193 ~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp---~~~ 267 (275)
T cd05046 193 DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG--KLELPVPEGCPSRLYKLMTRCWAVNPKDRP---SFS 267 (275)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC--CcCCCCCCCCCHHHHHHHHHHcCCCcccCC---CHH
Confidence 889999999999999999998 89999877766666666542 23333334678999999999998 999998 999
Q ss_pred HHhcC
Q 010266 408 QIKAH 412 (514)
Q Consensus 408 eil~H 412 (514)
+++++
T Consensus 268 ~~l~~ 272 (275)
T cd05046 268 ELVSA 272 (275)
T ss_pred HHHHH
Confidence 98863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=330.41 Aligned_cols=248 Identities=22% Similarity=0.348 Sum_probs=212.5
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
..+|++++.||.|+||.||+|..+. +..+|+|++.+... .....+..|..+++.++||||+++++++.+....|+|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 4578999999999999999999877 88999999876532 2345688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 185 MEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
|||+++|+|.+++.+. ..++...+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~- 159 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY- 159 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence 9999999999999753 4689999999999999999999999999999999999999999999999999875432100
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
...+..+++.|+|||++.+..++.++|+||||
T Consensus 160 ------------------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG 191 (261)
T cd05148 160 ------------------------------------------------LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFG 191 (261)
T ss_pred ------------------------------------------------cccCCCCceEecCHHHHccCCCCchhhHHHHH
Confidence 00123467789999999988999999999999
Q ss_pred HHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 343 AIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 343 vilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|++|+|++ |..||.+.+..+.+..+... ...|.....++++.++|.+||+ ||.+|+ ++.+|.+
T Consensus 192 ~~l~~l~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp---t~~~l~~ 256 (261)
T cd05148 192 ILLYEMFTYGQVPYPGMNNHEVYDQITAG---YRMPCPAKCPQEIYKIMLECWAAEPEDRP---SFKALRE 256 (261)
T ss_pred HHHHHHHcCCCCCCCcCCHHHHHHHHHhC---CcCCCCCCCCHHHHHHHHHHcCCCchhCc---CHHHHHH
Confidence 99999998 89999988888888777642 2333334788999999999998 999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=325.68 Aligned_cols=251 Identities=29% Similarity=0.489 Sum_probs=217.6
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
+|++.+.||.|+||.||+|+++.+++.||+|.+.+... .......+..|..+++.++||+|+++++++.+....|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 58999999999999999999999999999999987654 33455667789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 187 YLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 187 y~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
|++|++|..++.+ ...+++..+..++.+++.||.|||+.|++||||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999999866 357899999999999999999999999999999999999999999999999998754321
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
......|++.|+|||.+.+..++.++|+||||
T Consensus 157 ------------------------------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG 188 (256)
T cd08530 157 ------------------------------------------------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLG 188 (256)
T ss_pred ------------------------------------------------CcccccCCccccCHHHHCCCCCCchhhHHHHH
Confidence 01134688999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
+++|+|++|.+||...+..+....+... .....+ ..++.+++++|.+||. +|.+|+ ++.++++||+.
T Consensus 189 ~~~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~~l~~p~~ 256 (256)
T cd08530 189 CLLYEMATFAPPFEARSMQDLRYKVQRG-KYPPIP--PIYSQDLQNFIRSMLQVKPKLRP---NCDKILASPAV 256 (256)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCCc--hhhCHHHHHHHHHHcCCCcccCC---CHHHHhcCCCC
Confidence 9999999999999988876666655431 111222 2678999999999998 999999 99999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=328.06 Aligned_cols=249 Identities=24% Similarity=0.394 Sum_probs=206.8
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
+..++|++.+.||+|+||.||+|++..++ .||+|++.+... ..+.+.+|..++..++||||+++++.+. ....|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence 45578999999999999999999886654 599999976432 2345788999999999999999998875 45689
Q ss_pred EEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 183 LIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
+||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 999999999999999753 457889999999999999999999999999999999999999999999999987553211
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 340 (514)
.. ......|+..|+|||++.+..++.++|+||
T Consensus 157 ~~------------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dvws 188 (262)
T cd05071 157 YT------------------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188 (262)
T ss_pred cc------------------------------------------------cccCCcccceecCHhHhccCCCCchhhHHH
Confidence 00 011335778899999999889999999999
Q ss_pred hhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 341 LGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 341 lGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|||++|+|++ |.+||.+....+....+... ...|....++..+.+||.+||. +|.+|+ +++++++
T Consensus 189 lG~~l~ellt~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---~~~~~~~ 255 (262)
T cd05071 189 FGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLHDLMCQCWRKEPEERP---TFEYLQA 255 (262)
T ss_pred HHHHHHHHHcCCCCCCCCCChHHHHHHHhcC---CCCCCccccCHHHHHHHHHHccCCcccCC---CHHHHHH
Confidence 9999999999 89999888777777766542 1223234678999999999998 999999 8887764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=336.19 Aligned_cols=255 Identities=23% Similarity=0.325 Sum_probs=211.0
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEcc-------CCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKK-------SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYY 173 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~-------t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 173 (514)
.+..++|.+.+.||+|+||.||+|++.. ....+|+|.+++.. .......+..|+.++..+ +||||+++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 4556789999999999999999998642 34579999987542 344567788999999999 6999999999
Q ss_pred EEEcCCeEEEEEeecCCCCHHHHHhhc----------------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCc
Q 010266 174 SFQDAEYLYLIMEYLPGGDVMTLLMRE----------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNL 237 (514)
Q Consensus 174 ~f~~~~~l~lVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNI 237 (514)
++.+...+|+||||+++|+|.+++... ..++...+..++.|++.||.|||++||+||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 999999999999999999999999653 3478888899999999999999999999999999999
Q ss_pred cccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhcccccccccc
Q 010266 238 LLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG 317 (514)
Q Consensus 238 Lld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~G 317 (514)
|++.+|++||+|||+++........ .......+
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~ 198 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYY-----------------------------------------------KKTSNGRL 198 (314)
T ss_pred EEcCCCcEEEccccccccccccccc-----------------------------------------------cccccCCC
Confidence 9999999999999999865321100 00012235
Q ss_pred CCCcCCccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-
Q 010266 318 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC- 395 (514)
Q Consensus 318 T~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~- 395 (514)
++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.+..+.... ....| ..++.++++||.+||.
T Consensus 199 ~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~cl~~ 275 (314)
T cd05099 199 PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGH-RMDKP--SNCTHELYMLMRECWHA 275 (314)
T ss_pred CccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHcCC
Confidence 568999999999999999999999999999999 999999888877777766532 22333 3578899999999998
Q ss_pred CccccCCCCCHhHHhc
Q 010266 396 DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 396 dp~~Rl~~~~~~eil~ 411 (514)
+|.+|+ ++.++++
T Consensus 276 ~p~~Rp---s~~~ll~ 288 (314)
T cd05099 276 VPTQRP---TFKQLVE 288 (314)
T ss_pred CcccCc---CHHHHHH
Confidence 999999 8888875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=334.53 Aligned_cols=258 Identities=24% Similarity=0.360 Sum_probs=213.6
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEc-------cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeE
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEK-------KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKL 171 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~-------~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l 171 (514)
+..+..++|.+.+.||+|+||.||+|+.. .++..||+|.+... ........+.+|..++..+ +||||+++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~ 86 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINL 86 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc--cchHHHHHHHHHHHHHHhhccCCCchhe
Confidence 34566789999999999999999999753 23457999988754 2344567788999999999 89999999
Q ss_pred EEEEEcCCeEEEEEeecCCCCHHHHHhhc----------------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCC
Q 010266 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMRE----------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPD 235 (514)
Q Consensus 172 ~~~f~~~~~l~lVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpe 235 (514)
++++.+...+|+||||+++|+|.+++.+. ..++...+..++.|++.||.|||++||+||||||+
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 166 (304)
T cd05101 87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166 (304)
T ss_pred eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence 99999999999999999999999999764 24667778889999999999999999999999999
Q ss_pred CccccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhcccccccc
Q 010266 236 NLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYST 315 (514)
Q Consensus 236 NILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 315 (514)
|||++.+|.+||+|||+++........ ..+...
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~-----------------------------------------------~~~~~~ 199 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYY-----------------------------------------------KKTTNG 199 (304)
T ss_pred eEEEcCCCcEEECCCccceeccccccc-----------------------------------------------ccccCC
Confidence 999999999999999999865322100 001123
Q ss_pred ccCCCcCCccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhc
Q 010266 316 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLL 394 (514)
Q Consensus 316 ~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL 394 (514)
.+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.... ....| ...+.++++||.+||
T Consensus 200 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~cl 276 (304)
T cd05101 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH-RMDKP--ANCTNELYMMMRDCW 276 (304)
T ss_pred CCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHc
Confidence 56788999999999999999999999999999998 899999888888777775432 22233 367899999999999
Q ss_pred c-CccccCCCCCHhHHhcC
Q 010266 395 C-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 395 ~-dp~~Rl~~~~~~eil~H 412 (514)
. +|.+|+ ++.+|++.
T Consensus 277 ~~~p~~Rp---s~~e~l~~ 292 (304)
T cd05101 277 HAIPSHRP---TFKQLVED 292 (304)
T ss_pred ccChhhCC---CHHHHHHH
Confidence 8 999999 88888763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=341.18 Aligned_cols=264 Identities=29% Similarity=0.486 Sum_probs=213.1
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcC--CeE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDA--EYL 181 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~--~~l 181 (514)
.++|++.+.||+|+||.||+|.+..+|+.+|+|++.+.. ........+..|..+++.+ +||||++++++|... ..+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 468999999999999999999999899999999986542 2333445677899999999 999999999998653 478
Q ss_pred EEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
|+||||++ ++|..++... .+++..++.++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++........
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred EEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 99999997 5999888665 788999999999999999999999999999999999999999999999999886542210
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWS 340 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWS 340 (514)
.. ........+||+.|+|||++.+ ..++.++|+||
T Consensus 163 ~~--------------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~s 198 (337)
T cd07852 163 NP--------------------------------------------ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWS 198 (337)
T ss_pred cc--------------------------------------------cCcchhcccccccccCceeeeccccccccchHHH
Confidence 00 0001124579999999998865 55789999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCc-----------------------ccC---Cc-CcCCChhHHHHHhhh
Q 010266 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNH-----------------------LKF---PE-EARLTPEAKDLICRL 393 (514)
Q Consensus 341 lGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-----------------------~~~---p~-~~~~s~~~~dLI~~l 393 (514)
|||++|+|++|++||.+.+.......+...... ... .. ...++.++.+||.+|
T Consensus 199 lG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 278 (337)
T cd07852 199 VGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKL 278 (337)
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHh
Confidence 999999999999999887766555544332110 000 00 123688999999999
Q ss_pred cc-CccccCCCCCHhHHhcCCccccC
Q 010266 394 LC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 394 L~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
|. +|.+|+ ++.+++.||||+.+
T Consensus 279 l~~~P~~Rp---s~~~il~~~~~~~~ 301 (337)
T cd07852 279 LVFNPNKRL---TAEEALEHPYVAQF 301 (337)
T ss_pred ccCCccccc---CHHHHhhChhhhhh
Confidence 99 999999 99999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=325.30 Aligned_cols=249 Identities=24% Similarity=0.387 Sum_probs=207.6
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
+..++|+++++||+|+||.||+|..+ +++.||+|.+.+... ....+..|..+++.++||||+++++++. .+..|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 45678999999999999999999864 567899999876542 2356788999999999999999998874 56799
Q ss_pred EEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 183 LIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
+||||+++|+|.+++... ..++...+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 999999999999998653 468889999999999999999999999999999999999999999999999987643210
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 340 (514)
.. ......++..|+|||++.+..++.++|+||
T Consensus 157 ~~------------------------------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~s 188 (260)
T cd05067 157 YT------------------------------------------------AREGAKFPIKWTAPEAINYGTFTIKSDVWS 188 (260)
T ss_pred cc------------------------------------------------cccCCcccccccCHHHhccCCcCcccchHH
Confidence 00 001335678899999999888999999999
Q ss_pred hhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 341 LGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 341 lGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|||++|||++ |.+||.+.+..+....+... ...|.....+.++.++|.+||. +|.+|+ +++++..
T Consensus 189 lG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~ 255 (260)
T cd05067 189 FGILLTEIVTYGRIPYPGMTNPEVIQNLERG---YRMPRPDNCPEELYELMRLCWKEKPEERP---TFEYLRS 255 (260)
T ss_pred HHHHHHHHHhCCCCCCCCCChHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHccCChhhCC---CHHHHHH
Confidence 9999999998 99999988777666665432 2223334678899999999998 999999 8888865
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=326.80 Aligned_cols=256 Identities=22% Similarity=0.349 Sum_probs=212.2
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCC---EEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGN---IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~---~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
...+|++.+.||+|+||.||+|..+.+++ .||+|++.+. ........+..|..+++.++||||+++++++.+...
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 79 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP 79 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence 35679999999999999999999887665 6999998754 235556788999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
.|+||||++||+|.+++.. .+.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999999999875 456899999999999999999999999999999999999999999999999998754321
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
.... .+ .......++..|+|||++.+..++.++|+|
T Consensus 160 ~~~~--------------------~~------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dvw 195 (269)
T cd05065 160 TSDP--------------------TY------------------------TSSLGGKIPIRWTAPEAIAYRKFTSASDVW 195 (269)
T ss_pred cccc--------------------cc------------------------ccccCCCcceeecCHhHhccCcccchhhhh
Confidence 1000 00 000011234679999999999999999999
Q ss_pred hhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 340 SLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 340 SlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
||||++|||++ |.+||...+.......+.. ....|....++..+.+++.+||. +|.+|+ ++++|+.
T Consensus 196 slG~~l~e~l~~g~~p~~~~~~~~~~~~i~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~ 263 (269)
T cd05065 196 SYGIVMWEVMSYGERPYWDMSNQDVINAIEQ---DYRLPPPMDCPTALHQLMLDCWQKDRNARP---KFGQIVS 263 (269)
T ss_pred hhHHHHHHHhcCCCCCCCCCCHHHHHHHHHc---CCcCCCcccCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 99999999886 9999998877777766643 23334334678899999999998 999999 8888875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=351.47 Aligned_cols=244 Identities=25% Similarity=0.375 Sum_probs=208.0
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 181 (514)
+|..+...-++-||.|+.|.||+++.+ ++.||||+++.- +. .++.-|++++||||+.+.++|.....+
T Consensus 120 eiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el---kE-------TdIKHLRkLkH~NII~FkGVCtqsPcy 187 (904)
T KOG4721|consen 120 EIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL---KE-------TDIKHLRKLKHPNIITFKGVCTQSPCY 187 (904)
T ss_pred cCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhh---hh-------hhHHHHHhccCcceeeEeeeecCCcee
Confidence 344444455677999999999999754 678999977532 12 345557899999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
|+|||||+.|.|..+|...+.++......|..+|+.|++|||.+.|||||||.-||||..+..|||+|||-++.+...
T Consensus 188 CIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-- 265 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-- 265 (904)
T ss_pred EEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999998865321
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
....+++||..|||||||.+.+.+.+||||||
T Consensus 266 ------------------------------------------------STkMSFaGTVaWMAPEvIrnePcsEKVDIwSf 297 (904)
T KOG4721|consen 266 ------------------------------------------------STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSF 297 (904)
T ss_pred ------------------------------------------------hhhhhhhhhHhhhCHHHhhcCCcccccceehh
Confidence 11238999999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
||+|||||||..||...+...++--+- .+.+.+|-+...++-++-||++|+. .|.+|+ ++.+|+.|
T Consensus 298 GVVLWEmLT~EiPYkdVdssAIIwGVG--sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRP---SFrqil~H 364 (904)
T KOG4721|consen 298 GVVLWEMLTGEIPYKDVDSSAIIWGVG--SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRP---SFRQILLH 364 (904)
T ss_pred HHHHHHHHhcCCCccccchheeEEecc--CCcccccCcccCchHHHHHHHHHHhcCCCCCc---cHHHHHHH
Confidence 999999999999998776654433222 2456666656788999999999998 999999 89999988
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=325.69 Aligned_cols=249 Identities=23% Similarity=0.390 Sum_probs=207.0
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
+..++|++++.||+|+||.||+|... ++..+|+|.+..... ..+.+.+|..+++.++||+|+++++.+. ....|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 45678999999999999999999865 556799999876533 2345888999999999999999998875 45689
Q ss_pred EEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 183 LIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
+||||+++|+|.+++... ..+++..++.++.+++.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999999999998753 458999999999999999999999999999999999999999999999999987543210
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 340 (514)
.. ......|+..|+|||++.+..++.++|+||
T Consensus 157 ~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 188 (260)
T cd05070 157 YT------------------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188 (260)
T ss_pred cc------------------------------------------------cccCCCCCccccChHHHhcCCCcchhhhHH
Confidence 00 001234667899999998888999999999
Q ss_pred hhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 341 LGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 341 lGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|||++|+|++ |.+||.+.+..+....+... ...|.....+.++.+||.+||. +|.+|+ +++++.+
T Consensus 189 lG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~l~~ 255 (260)
T cd05070 189 FGILLTELVTKGRVPYPGMNNREVLEQVERG---YRMPCPQDCPISLHELMLQCWKKDPEERP---TFEYLQS 255 (260)
T ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---CCCCCCCcCCHHHHHHHHHHcccCcccCc---CHHHHHH
Confidence 9999999999 99999988877777766532 2233334678999999999998 999999 8888763
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=323.98 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=211.0
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
+..++|++.+.||.|+||.||+|..+ .+..||||.+..... ....+.+|..+++.++||+|+++++++.+...+|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 56689999999999999999999875 457799999876532 2356888999999999999999999999989999
Q ss_pred EEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 183 LIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
+||||++|++|.+++... ..++...+..++.+++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 999999999999999764 368999999999999999999999999999999999999999999999999987653210
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 340 (514)
.. ......++..|+|||.+.+..++.++|+||
T Consensus 158 ~~------------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s 189 (261)
T cd05034 158 YT------------------------------------------------AREGAKFPIKWTAPEAANYGRFTIKSDVWS 189 (261)
T ss_pred hh------------------------------------------------hhhccCCCccccCHHHhccCCcCchhHHHH
Confidence 00 000223567899999999989999999999
Q ss_pred hhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 341 LGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 341 lGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|||++|+|++ |..||.+.+.......+.. ....|.....+.++.+++.+||+ +|.+|+ +++++..
T Consensus 190 lG~il~~l~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp---~~~~l~~ 256 (261)
T cd05034 190 FGILLTEIVTYGRVPYPGMTNREVLEQVER---GYRMPRPPNCPEELYDLMLQCWDKDPEERP---TFEYLQS 256 (261)
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCCCCCCCCCCHHHHHHHHHHcccCcccCC---CHHHHHH
Confidence 9999999998 9999998887777777654 22233333568899999999999 999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=330.58 Aligned_cols=254 Identities=23% Similarity=0.349 Sum_probs=210.0
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEcc-----CCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKK-----SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 177 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~-----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 177 (514)
+..++|++++.||+|+||.||+|.++. ++..||+|++.... .......+.+|+.+++.++||+|+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 345789999999999999999998753 67899999987542 23345668889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHhhcc----------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCC
Q 010266 178 AEYLYLIMEYLPGGDVMTLLMREE----------------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPD 235 (514)
Q Consensus 178 ~~~l~lVmEy~~gg~L~~~l~~~~----------------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpe 235 (514)
+..+|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++|++||||||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ 159 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR 159 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence 999999999999999999996432 3677888999999999999999999999999999
Q ss_pred CccccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhcccccccc
Q 010266 236 NLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYST 315 (514)
Q Consensus 236 NILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 315 (514)
||+++.+|.+||+|||++......... ......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~-----------------------------------------------~~~~~~ 192 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYY-----------------------------------------------KASEND 192 (288)
T ss_pred heEecCCCceEECccccceecccCccc-----------------------------------------------cccCCC
Confidence 999999999999999998754321100 000122
Q ss_pred ccCCCcCCccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhc
Q 010266 316 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLL 394 (514)
Q Consensus 316 ~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL 394 (514)
.+++.|+|||++.+..++.++|+|||||++|||++ |..||.+.+..+....+... .....| ..++.++.+||.+||
T Consensus 193 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l 269 (288)
T cd05050 193 AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDG-NVLSCP--DNCPLELYNLMRLCW 269 (288)
T ss_pred ccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CCCCCC--CCCCHHHHHHHHHHc
Confidence 35678999999999999999999999999999997 88999988887777666542 222223 357899999999999
Q ss_pred c-CccccCCCCCHhHHhc
Q 010266 395 C-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 395 ~-dp~~Rl~~~~~~eil~ 411 (514)
+ +|.+|+ +++||++
T Consensus 270 ~~~p~~Rp---t~~el~~ 284 (288)
T cd05050 270 SKLPSDRP---SFASINR 284 (288)
T ss_pred ccCcccCC---CHHHHHH
Confidence 9 999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=342.32 Aligned_cols=257 Identities=22% Similarity=0.336 Sum_probs=205.4
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEE-----ccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQE-----KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSF 175 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~-----~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f 175 (514)
.+..++|++.+.||+|+||.||+|++ ..+++.||||+++... .......+..|..+|..+ +||||+++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 34567899999999999999999984 3467899999997542 234456788999999999 689999999887
Q ss_pred Ec-CCeEEEEEeecCCCCHHHHHhhc------------------------------------------------------
Q 010266 176 QD-AEYLYLIMEYLPGGDVMTLLMRE------------------------------------------------------ 200 (514)
Q Consensus 176 ~~-~~~l~lVmEy~~gg~L~~~l~~~------------------------------------------------------ 200 (514)
.. ...+|+||||++||+|.+++...
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 64 45789999999999999998642
Q ss_pred -------------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccccc
Q 010266 201 -------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINEN 267 (514)
Q Consensus 201 -------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~ 267 (514)
..++...+..++.|++.||.|||++||+||||||+|||++.++++||+|||++.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~----- 235 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY----- 235 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch-----
Confidence 23567778889999999999999999999999999999999999999999998754211000
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHH
Q 010266 268 EVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 347 (514)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilye 347 (514)
.......+++.|+|||++.+..++.++|+|||||++|+
T Consensus 236 ------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~e 273 (343)
T cd05103 236 ------------------------------------------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 273 (343)
T ss_pred ------------------------------------------hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHH
Confidence 00112346778999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 348 MLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 348 mlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
|++ |..||.+..........+........| ...++++.+++.+||. +|.+|+ ++.+|++|
T Consensus 274 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~cl~~~p~~Rp---s~~eil~~ 335 (343)
T cd05103 274 IFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRP---TFSELVEH 335 (343)
T ss_pred HHHCCCCCCCCccccHHHHHHHhccCCCCCC--CCCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 996 999998765443333333222223333 3578899999999998 999999 99999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=323.71 Aligned_cols=244 Identities=24% Similarity=0.421 Sum_probs=204.9
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEE-EcCCeE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSF-QDAEYL 181 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f-~~~~~l 181 (514)
+..++|++.+.||+|+||.||++... |..||+|.++.. ...+.+..|..+++.++||+++++++++ .+....
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 45678999999999999999998654 778999988643 2345688899999999999999999865 566789
Q ss_pred EEEEeecCCCCHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 182 YLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999999987643 4788999999999999999999999999999999999999999999999998754211
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
..+..++..|+|||++.+..++.++|+|
T Consensus 156 ----------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 183 (256)
T cd05082 156 ----------------------------------------------------QDTGKLPVKWTAPEALREKKFSTKSDVW 183 (256)
T ss_pred ----------------------------------------------------CCCCccceeecCHHHHccCCCCchhhhH
Confidence 0123456789999999999999999999
Q ss_pred hhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 340 SLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 340 SlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
||||++|+|++ |.+||...+..+....+... .....+ ..+++.+.++|.+||+ +|.+|+ ++.++.+
T Consensus 184 slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---t~~~l~~ 251 (256)
T cd05082 184 SFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAP--DGCPPVVYDVMKQCWHLDAATRP---SFLQLRE 251 (256)
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CCCCCC--CCCCHHHHHHHHHHhcCChhhCc---CHHHHHH
Confidence 99999999997 99999887777666666432 122223 3678999999999999 999999 8888875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=332.36 Aligned_cols=256 Identities=20% Similarity=0.353 Sum_probs=206.6
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCC--------------CEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCcee
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSG--------------NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~--------------~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv 169 (514)
..++|++.+.||+|+||.||+|++..++ ..||+|+++.. ........+.+|.++|..++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD--VTKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC--CCHHHHHHHHHHHHHHHhCCCCCcC
Confidence 3468999999999999999999875432 35899998754 2344556788999999999999999
Q ss_pred eEEEEEEcCCeEEEEEeecCCCCHHHHHhhcc------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCc
Q 010266 170 KLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNL 237 (514)
Q Consensus 170 ~l~~~f~~~~~l~lVmEy~~gg~L~~~l~~~~------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNI 237 (514)
++++++.+....|+||||++|++|.+++.... .+++..+..++.+++.||.|||+.|++||||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999986532 367788889999999999999999999999999999
Q ss_pred cccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhcccccccccc
Q 010266 238 LLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG 317 (514)
Q Consensus 238 Lld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~G 317 (514)
|++.++.+||+|||++......... .......+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~ 193 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYY-----------------------------------------------RIQGRAVL 193 (295)
T ss_pred EEcCCCcEEecccccccccccCcce-----------------------------------------------eccCcCcC
Confidence 9999999999999998754321000 00113356
Q ss_pred CCCcCCccccccCCCCcccchhhhhHHHHHHhh--CCCCCCCCChhHHHHHHhhhc----CcccCCcCcCCChhHHHHHh
Q 010266 318 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV--GYPPFYSDDPVTTCRKIVHWK----NHLKFPEEARLTPEAKDLIC 391 (514)
Q Consensus 318 T~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt--G~~PF~~~~~~~~~~~i~~~~----~~~~~p~~~~~s~~~~dLI~ 391 (514)
++.|+|||++.+..++.++|+|||||++|+|++ |..||...+..+....+.... .....+.....++.+.+||.
T Consensus 194 ~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 273 (295)
T cd05097 194 PIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMM 273 (295)
T ss_pred ceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHH
Confidence 789999999999999999999999999999988 778998877666555543210 11112222357889999999
Q ss_pred hhcc-CccccCCCCCHhHHhc
Q 010266 392 RLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 392 ~lL~-dp~~Rl~~~~~~eil~ 411 (514)
+||. +|.+|+ ++++|++
T Consensus 274 ~~l~~~p~~RP---s~~~i~~ 291 (295)
T cd05097 274 RCWSRDIKDRP---TFNKIHH 291 (295)
T ss_pred HHcCCCchhCc---CHHHHHH
Confidence 9999 999999 8888854
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=323.10 Aligned_cols=245 Identities=21% Similarity=0.319 Sum_probs=202.8
Q ss_pred eeeeecCceEEEEEEEccCC---CEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeec
Q 010266 112 TIIGRGAFGEVRLCQEKKSG---NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYL 188 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~---~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~ 188 (514)
+.||+|+||.||+|....++ ..||+|.+...... ...+.+..|..+++.++||+||++++++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 46999999999999876554 78999999866442 44567888999999999999999999876 45689999999
Q ss_pred CCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccccc
Q 010266 189 PGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENE 268 (514)
Q Consensus 189 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~ 268 (514)
++|+|.+++.....+++..+..++.|++.||.|||..||+||||||+|||++.++.+||+|||+++.........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~----- 152 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY----- 152 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc-----
Confidence 999999999888889999999999999999999999999999999999999999999999999987653211000
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHH
Q 010266 269 VLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 348 (514)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyem 348 (514)
.......++..|+|||.+.+..++.++|+|||||++|+|
T Consensus 153 -----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~ 191 (257)
T cd05060 153 -----------------------------------------RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEA 191 (257)
T ss_pred -----------------------------------------ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHH
Confidence 000012356789999999999999999999999999999
Q ss_pred hh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 349 LV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 349 lt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
++ |.+||...+..+....+... .....| ..+++.++++|.+||. +|.+|+ ++.++.+
T Consensus 192 ~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~cl~~~p~~Rp---~~~~l~~ 250 (257)
T cd05060 192 FSYGAKPYGEMKGAEVIAMLESG-ERLPRP--EECPQEIYSIMLSCWKYRPEDRP---TFSELES 250 (257)
T ss_pred HcCCCCCcccCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHhcCChhhCc---CHHHHHH
Confidence 98 99999887776666665442 222333 4678999999999999 999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=347.81 Aligned_cols=258 Identities=22% Similarity=0.316 Sum_probs=210.2
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEc-----cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEE
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYS 174 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~ 174 (514)
..+..++|.+.+.||+|+||.||+|++. .+++.||+|+++... .....+.+..|..+|..+. |||||+++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 4566678999999999999999999854 345689999997542 3334556889999999997 9999999999
Q ss_pred EEcCCeEEEEEeecCCCCHHHHHhhcc-----------------------------------------------------
Q 010266 175 FQDAEYLYLIMEYLPGGDVMTLLMREE----------------------------------------------------- 201 (514)
Q Consensus 175 f~~~~~l~lVmEy~~gg~L~~~l~~~~----------------------------------------------------- 201 (514)
+++...+|+||||++||+|.+++.+.+
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 999999999999999999999986432
Q ss_pred ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCC
Q 010266 202 ---------------------------------------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDN 236 (514)
Q Consensus 202 ---------------------------------------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeN 236 (514)
.++...+..++.|++.||.|||+.||+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 24566678889999999999999999999999999
Q ss_pred ccccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccc
Q 010266 237 LLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTV 316 (514)
Q Consensus 237 ILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 316 (514)
||++.++.+||+|||+++........ ....+.+
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~-----------------------------------------------~~~~~~~ 302 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNY-----------------------------------------------ISKGSTF 302 (401)
T ss_pred EEEeCCCEEEEEecCcceeccccccc-----------------------------------------------ccCCCcC
Confidence 99999999999999998754211000 0011346
Q ss_pred cCCCcCCccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc
Q 010266 317 GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC 395 (514)
Q Consensus 317 GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~ 395 (514)
|++.|+|||++.+..++.++|||||||++|||++ |..||......+.....+.....+..| ..++.++.+||.+|++
T Consensus 303 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~l~~li~~cl~ 380 (401)
T cd05107 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKP--AHASDEIYEIMQKCWE 380 (401)
T ss_pred CCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCC--CCCCHHHHHHHHHHcC
Confidence 8899999999999889999999999999999998 899998766555544444322233334 3578999999999999
Q ss_pred -CccccCCCCCHhHHhcC
Q 010266 396 -DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 396 -dp~~Rl~~~~~~eil~H 412 (514)
+|..|+ ++.+|+..
T Consensus 381 ~~P~~RP---s~~ell~~ 395 (401)
T cd05107 381 EKFEIRP---DFSQLVHL 395 (401)
T ss_pred CChhHCc---CHHHHHHH
Confidence 999999 89998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=326.44 Aligned_cols=262 Identities=27% Similarity=0.448 Sum_probs=209.8
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCC----EEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc-CCe
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGN----IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-AEY 180 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~----~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~-~~~ 180 (514)
..|++++.||+|+||.||+|..+.++. .||||.++...- ...--....+|+.+++.++||||+.|..+|.. +..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 468899999999999999997665543 699999875421 11222346689999999999999999999877 889
Q ss_pred EEEEEeecCCCCHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCC----CcEEEcccc
Q 010266 181 LYLIMEYLPGGDVMTLLMR-----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN----GHMKLSDFG 251 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~----g~iKL~DFG 251 (514)
++|++||.+. ||..+|.- ...++...++.++.||+.|+.|||++-|+||||||.|||+..+ |.+||+|||
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999999974 99988853 3568999999999999999999999999999999999999888 999999999
Q ss_pred ccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-C
Q 010266 252 LCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-K 330 (514)
Q Consensus 252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~ 330 (514)
+++.+...-..-. .....|-|.+|.|||.+.+ .
T Consensus 182 laR~~~~plkpl~----------------------------------------------s~d~VVVTiWYRAPELLLGa~ 215 (438)
T KOG0666|consen 182 LARLFNNPLKPLA----------------------------------------------SLDPVVVTIWYRAPELLLGAR 215 (438)
T ss_pred HHHHhhccccccc----------------------------------------------cCCceEEEEEecChHHhcccc
Confidence 9998754311100 0125688999999999998 5
Q ss_pred CCCcccchhhhhHHHHHHhhCCCCCCCCCh---------hHHHHHHhh---------hcCcccCCcC-------------
Q 010266 331 GYGMECDWWSLGAIMYEMLVGYPPFYSDDP---------VTTCRKIVH---------WKNHLKFPEE------------- 379 (514)
Q Consensus 331 ~y~~~~DiWSlGvilyemltG~~PF~~~~~---------~~~~~~i~~---------~~~~~~~p~~------------- 379 (514)
.|+.++|+||.|||+.|||+-.|.|.+... .....+|.+ |..--.+|+.
T Consensus 216 hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~ 295 (438)
T KOG0666|consen 216 HYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYD 295 (438)
T ss_pred cccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcC
Confidence 689999999999999999999999987521 244555653 3222233322
Q ss_pred -----------cCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 380 -----------ARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 380 -----------~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
..-++.+.+|+.+||+ ||.+|. +++++++|+||..-
T Consensus 296 n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRI---ta~qAleh~yF~~d 343 (438)
T KOG0666|consen 296 NVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRI---TAEQALEHPYFTED 343 (438)
T ss_pred cchHHHHHHHhcCCCchHHHHHHHHhccCchhhc---cHHHHhcccccccC
Confidence 0125779999999999 999999 99999999999864
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=330.42 Aligned_cols=255 Identities=21% Similarity=0.375 Sum_probs=206.3
Q ss_pred CCCeeEEeeeeecCceEEEEEEEcc----------------CCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCce
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKK----------------SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCI 168 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~----------------t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~I 168 (514)
.++|++.+.||+|+||.||+|++.. ++..||+|++.... .......+..|+.+|..++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 4679999999999999999986542 34579999987542 33445678899999999999999
Q ss_pred eeEEEEEEcCCeEEEEEeecCCCCHHHHHhhcc-----------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCc
Q 010266 169 VKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE-----------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNL 237 (514)
Q Consensus 169 v~l~~~f~~~~~l~lVmEy~~gg~L~~~l~~~~-----------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNI 237 (514)
+++++++.+.+..|+||||++||+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999987643 366778999999999999999999999999999999
Q ss_pred cccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhcccccccccc
Q 010266 238 LLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG 317 (514)
Q Consensus 238 Lld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~G 317 (514)
|++.++.++|+|||+++.+...... .......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~ 194 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYY-----------------------------------------------RIQGRAVL 194 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcce-----------------------------------------------eccCcCcC
Confidence 9999999999999998765321100 00112345
Q ss_pred CCCcCCccccccCCCCcccchhhhhHHHHHHhh--CCCCCCCCChhHHHHHHhhh----cCcccCCcCcCCChhHHHHHh
Q 010266 318 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV--GYPPFYSDDPVTTCRKIVHW----KNHLKFPEEARLTPEAKDLIC 391 (514)
Q Consensus 318 T~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt--G~~PF~~~~~~~~~~~i~~~----~~~~~~p~~~~~s~~~~dLI~ 391 (514)
++.|+|||+..+..++.++|+|||||++|||++ |..||...+..+...+...+ .....+|.....++.+.+||.
T Consensus 195 ~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 274 (296)
T cd05095 195 PIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLML 274 (296)
T ss_pred ccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHH
Confidence 788999999988889999999999999999998 78999877666555443221 112233444467899999999
Q ss_pred hhcc-CccccCCCCCHhHHhc
Q 010266 392 RLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 392 ~lL~-dp~~Rl~~~~~~eil~ 411 (514)
+||. ||.+|+ ++.+|.+
T Consensus 275 ~cl~~~p~~Rp---~~~~i~~ 292 (296)
T cd05095 275 SCWRRNAKERP---SFQEIHA 292 (296)
T ss_pred HHcCCCcccCC---CHHHHHH
Confidence 9999 999999 8888753
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=326.50 Aligned_cols=253 Identities=28% Similarity=0.465 Sum_probs=212.1
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeeccccc--ChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML--SRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
+|.+.+.||+|+||.||+|.+..++..+++|+++..... ......++..|..+++.++||||+++++++.+....|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 488999999999999999999888888888887654322 223445567789999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 185 MEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 185 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
|||+++++|..++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++. +.+||+|||+++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999988853 457899999999999999999999999999999999999974 679999999987643210
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 340 (514)
. ......|++.|+|||.+.+..++.++|+||
T Consensus 160 ~-------------------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~s 190 (260)
T cd08222 160 D-------------------------------------------------LATTFTGTPYYMSPEALKHQGYDSKSDIWS 190 (260)
T ss_pred c-------------------------------------------------cccCCCCCcCccCHHHHccCCCCchhhHHH
Confidence 0 011456899999999998888999999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 341 lGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
||+++|+|++|..||.+.+.......+... ....+| ..++.++.++|.+||. +|.+|+ ++++|+.||||
T Consensus 191 lG~~~~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~ 260 (260)
T cd08222 191 LGCILYEMCCLAHAFEGQNFLSVVLRIVEG-PTPSLP--ETYSRQLNSIMQSMLNKDPSLRP---SAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHHhCCCCCCCccHHHHHHHHHcC-CCCCCc--chhcHHHHHHHHHHhcCChhhCc---CHHHHhhCCCC
Confidence 999999999999999887776666666542 122223 3578999999999998 999999 99999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=321.28 Aligned_cols=245 Identities=24% Similarity=0.380 Sum_probs=209.5
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
+..++|++.+.||.|+||.||+|... |+.||+|.+..... ..+++.+|..++..++||||+++++.+.+....|
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 45678999999999999999999764 78999999875532 5677889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 183 LIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
+||||+++++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||+++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999999999999997765 78999999999999999999999999999999999999999999999999987542110
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 340 (514)
....++..|+|||++.+..++.++|+||
T Consensus 157 ----------------------------------------------------~~~~~~~~~~ape~~~~~~~~~~~Di~s 184 (256)
T cd05039 157 ----------------------------------------------------DSGKLPVKWTAPEALREKKFSTKSDVWS 184 (256)
T ss_pred ----------------------------------------------------ccCCCcccccCchhhcCCcCCcHHHHHH
Confidence 0123456799999998888999999999
Q ss_pred hhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 341 LGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 341 lGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|||++|+|++ |..||...+.......+... .....| ..+++++.++|.+||. +|.+|+ +++++++
T Consensus 185 lG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~ 251 (256)
T cd05039 185 FGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-YRMEAP--EGCPPEVYKVMKDCWELDPAKRP---TFKQLRE 251 (256)
T ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC-CCCCCc--cCCCHHHHHHHHHHhccChhhCc---CHHHHHH
Confidence 9999999997 99999888776666555432 122333 3578999999999998 999999 8888875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=360.49 Aligned_cols=267 Identities=25% Similarity=0.384 Sum_probs=216.1
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEEEc--
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQD-- 177 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~-- 177 (514)
-.+...+.++.++|.+|||+.||+|+....|..||+|.+--. .....+.+++|+++|+.+. |+|||.++++...
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~ 108 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR 108 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence 345556788999999999999999999888899999988643 5677888999999999997 9999999994321
Q ss_pred -----CCeEEEEEeecCCCCHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC--eEEcCCCCCCccccCCCcEEEc
Q 010266 178 -----AEYLYLIMEYLPGGDVMTLLMR--EETLTETVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLDQNGHMKLS 248 (514)
Q Consensus 178 -----~~~l~lVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKpeNILld~~g~iKL~ 248 (514)
.-.++|.||||.||.|-+++.. ...|+|.++..|+++++.|+.+||.+. |||||||-|||||+.+|+.|||
T Consensus 109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeC
Confidence 2357899999999999999974 456999999999999999999999987 9999999999999999999999
Q ss_pred cccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc
Q 010266 249 DFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL 328 (514)
Q Consensus 249 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~ 328 (514)
|||.|........+. ....-...+ -...-||.|.|||++.
T Consensus 189 DFGSatt~~~~~~~~-----------------------------------~e~~~ve~e-----I~k~TTp~YRsPEMID 228 (738)
T KOG1989|consen 189 DFGSATTKILSPTSA-----------------------------------QEVNYVEEE-----IEKYTTPQYRSPEMID 228 (738)
T ss_pred cccccccccCCCccH-----------------------------------HHHHHHHHH-----HHhhCCccccChHHHh
Confidence 999987432111000 000000000 0224699999999985
Q ss_pred ---cCCCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC
Q 010266 329 ---KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL 404 (514)
Q Consensus 329 ---~~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~ 404 (514)
+.+.+.++|||+|||+||-|++...||..... ..|++ ..+.||+....|..+++||+.||. ||.+|+
T Consensus 229 lysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----laIln--g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RP--- 299 (738)
T KOG1989|consen 229 LYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LAILN--GNYSFPPFPNYSDRLKDLIRTMLQPNPDERP--- 299 (738)
T ss_pred hhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEe--ccccCCCCccHHHHHHHHHHHHhccCcccCC---
Confidence 67889999999999999999999999976533 34555 567888877899999999999999 999999
Q ss_pred CHhHHhc--------CCccccCC
Q 010266 405 GSEQIKA--------HPWFKDIA 419 (514)
Q Consensus 405 ~~~eil~--------Hpff~~i~ 419 (514)
++-|++. ++++.++.
T Consensus 300 nI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 300 NIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred CHHHHHHHHHHHhcCCCCccccc
Confidence 8877774 56666554
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=329.35 Aligned_cols=254 Identities=32% Similarity=0.537 Sum_probs=213.0
Q ss_pred eeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEee
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY 187 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy 187 (514)
|++.+.||+|+||.||+|+...+++.||+|++.+.. ........+..|..+++.++||+|+++++++.+...+|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 677889999999999999999999999999998764 2333456677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccc
Q 010266 188 LPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE 266 (514)
Q Consensus 188 ~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~ 266 (514)
++ ++|.+++.+. ..+++..+..++.+++.||.+||++||+||||+|+||+++.+|.+||+|||+++.......
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----- 153 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR----- 153 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-----
Confidence 97 5899999876 5899999999999999999999999999999999999999999999999999876532110
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-CCCcccchhhhhHHH
Q 010266 267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIM 345 (514)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil 345 (514)
......+++.|+|||++.+. .++.++|+|||||++
T Consensus 154 --------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l 189 (282)
T cd07829 154 --------------------------------------------TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIF 189 (282)
T ss_pred --------------------------------------------ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHH
Confidence 00133567889999999876 789999999999999
Q ss_pred HHHhhCCCCCCCCChhHHHHHHhhhcC----------------cccCCc---------CcCCChhHHHHHhhhcc-Cccc
Q 010266 346 YEMLVGYPPFYSDDPVTTCRKIVHWKN----------------HLKFPE---------EARLTPEAKDLICRLLC-DVEH 399 (514)
Q Consensus 346 yemltG~~PF~~~~~~~~~~~i~~~~~----------------~~~~p~---------~~~~s~~~~dLI~~lL~-dp~~ 399 (514)
|||++|.+||.+.+..+...++..... ...+|. ...++.++.++|.+||. +|.+
T Consensus 190 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~ 269 (282)
T cd07829 190 AEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAK 269 (282)
T ss_pred HHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCccc
Confidence 999999999998877666655543110 001111 11357899999999998 9999
Q ss_pred cCCCCCHhHHhcCCcc
Q 010266 400 RLGTLGSEQIKAHPWF 415 (514)
Q Consensus 400 Rl~~~~~~eil~Hpff 415 (514)
|+ ++++++.||||
T Consensus 270 Rp---~~~~~l~~p~~ 282 (282)
T cd07829 270 RI---SAKEALKHPYF 282 (282)
T ss_pred CC---CHHHHhhCcCC
Confidence 99 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=351.33 Aligned_cols=253 Identities=25% Similarity=0.448 Sum_probs=221.4
Q ss_pred eEEeeeeecCceEEEEEEEccCCCEEEEEEeeccccc-ChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe--EEEEE
Q 010266 109 DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML-SRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY--LYLIM 185 (514)
Q Consensus 109 ~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~-~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~--l~lVm 185 (514)
+...+||+|+|-+||+|.+..+|-.||--.++-.++. .....+++..|+.+|+.++|||||++|+++.+..+ +-+|.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 4556899999999999999999998887665544433 45567899999999999999999999999998776 88999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC--CeEEcCCCCCCccccCC-CcEEEccccccccCCCCCcc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH--NYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~--giiHrDLKpeNILld~~-g~iKL~DFGla~~~~~~~~~ 262 (514)
|.+.+|+|..++.+.+..+...++.|+.||+.||.|||++ .|||||||-+||+|+.+ |.|||+|+|||+....+
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s--- 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS--- 199 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc---
Confidence 9999999999999999999999999999999999999987 59999999999999855 99999999999865422
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
.+.+.+|||.|||||+.. ..|+..+||||||
T Consensus 200 ------------------------------------------------~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFG 230 (632)
T KOG0584|consen 200 ------------------------------------------------HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFG 230 (632)
T ss_pred ------------------------------------------------ccceeccCccccChHHHh-hhcchhhhhhhhh
Confidence 233689999999999996 8899999999999
Q ss_pred HHHHHHhhCCCCCC-CCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhccCccccCCCCCHhHHhcCCccccC
Q 010266 343 AIMYEMLVGYPPFY-SDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 343 vilyemltG~~PF~-~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
.+|.||+|+..||. +.++.++|.++..+..+-.|-. .-.+++++||.+||.-..+|+ ++.|+|.||||..-
T Consensus 231 MCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~k--V~dPevr~fIekCl~~~~~R~---sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 231 MCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSK--VKDPEVREFIEKCLATKSERL---SAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhc--cCCHHHHHHHHHHhcCchhcc---CHHHHhhChhhccc
Confidence 99999999999996 6788999999988655444432 236899999999998788898 99999999999863
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=324.64 Aligned_cols=242 Identities=25% Similarity=0.392 Sum_probs=200.0
Q ss_pred eeeeecCceEEEEEEEccCCCE--EEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCeEEEEEeec
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNI--YAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLIMEYL 188 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~--~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lVmEy~ 188 (514)
+.||+|+||.||+|+.+.++.. +|+|.++.. ........+..|..++..+ +||||++++++|.....+|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 3689999999999999888764 588877642 2344556788999999999 7999999999999999999999999
Q ss_pred CCCCHHHHHhhcc----------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccc
Q 010266 189 PGGDVMTLLMREE----------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252 (514)
Q Consensus 189 ~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGl 252 (514)
++|+|.+++.... .+++..++.++.|++.||+|||+.|++||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999987543 478889999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCC
Q 010266 253 CKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY 332 (514)
Q Consensus 253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y 332 (514)
+....... ......+++.|+|||++.+..+
T Consensus 159 ~~~~~~~~--------------------------------------------------~~~~~~~~~~y~apE~~~~~~~ 188 (270)
T cd05047 159 SRGQEVYV--------------------------------------------------KKTMGRLPVRWMAIESLNYSVY 188 (270)
T ss_pred ccccchhh--------------------------------------------------hccCCCCccccCChHHHccCCC
Confidence 75321000 0001234667999999998999
Q ss_pred CcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHh
Q 010266 333 GMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIK 410 (514)
Q Consensus 333 ~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 410 (514)
+.++|+|||||++|||++ |.+||.+.+..+....+... .....| ..++.++.+||.+|+. +|.+|+ ++++++
T Consensus 189 ~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~il 262 (270)
T cd05047 189 TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKP--LNCDDEVYDLMRQCWREKPYERP---SFAQIL 262 (270)
T ss_pred CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC-CCCCCC--CcCCHHHHHHHHHHcccChhhCC---CHHHHH
Confidence 999999999999999997 99999888777766666431 122223 3578899999999999 999999 888887
Q ss_pred c
Q 010266 411 A 411 (514)
Q Consensus 411 ~ 411 (514)
.
T Consensus 263 ~ 263 (270)
T cd05047 263 V 263 (270)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=336.00 Aligned_cols=257 Identities=21% Similarity=0.325 Sum_probs=210.8
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccC-------CCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEE
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKS-------GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLY 172 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t-------~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~ 172 (514)
..+...+|++.+.||+|+||.||+|++... +..||+|+++.. ........+..|+.++..+ +||||++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 445557899999999999999999986432 236899988743 2344567788999999999 799999999
Q ss_pred EEEEcCCeEEEEEeecCCCCHHHHHhhcc----------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCC
Q 010266 173 YSFQDAEYLYLIMEYLPGGDVMTLLMREE----------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDN 236 (514)
Q Consensus 173 ~~f~~~~~l~lVmEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeN 236 (514)
++|.+...+|+||||+++|+|.+++.+.. .++...+..++.|++.||.|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 164 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN 164 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence 99999999999999999999999987532 36667788899999999999999999999999999
Q ss_pred ccccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccc
Q 010266 237 LLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTV 316 (514)
Q Consensus 237 ILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 316 (514)
||++.++.+||+|||+++........ .......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~ 197 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYY-----------------------------------------------KKTTNGR 197 (334)
T ss_pred EEEcCCCcEEECCcccceeccccccc-----------------------------------------------ccccCCC
Confidence 99999999999999998764321000 0011223
Q ss_pred cCCCcCCccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc
Q 010266 317 GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC 395 (514)
Q Consensus 317 GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~ 395 (514)
+++.|+|||++.+..++.++|+|||||++|||++ |.+||.+.+..+....+... .....| ...+.++.+||.+||.
T Consensus 198 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~cl~ 274 (334)
T cd05100 198 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG-HRMDKP--ANCTHELYMIMRECWH 274 (334)
T ss_pred cCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcc
Confidence 5678999999999999999999999999999998 89999988877777766542 122233 3578899999999998
Q ss_pred -CccccCCCCCHhHHhcC
Q 010266 396 -DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 396 -dp~~Rl~~~~~~eil~H 412 (514)
+|.+|+ ++.+++.+
T Consensus 275 ~~p~~Rp---s~~ell~~ 289 (334)
T cd05100 275 AVPSQRP---TFKQLVED 289 (334)
T ss_pred cChhhCc---CHHHHHHH
Confidence 999999 89999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=328.28 Aligned_cols=250 Identities=23% Similarity=0.328 Sum_probs=206.5
Q ss_pred CeeEEeeeeecCceEEEEEEEcc-----CCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeE
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKK-----SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~-----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 181 (514)
+|++.+.||+|+||.||+|.... ....+|+|.+.+.. .......+..|..+++.++||||+++++.|...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 57889999999999999998753 23578999886542 234456788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhc------------------------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCc
Q 010266 182 YLIMEYLPGGDVMTLLMRE------------------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNL 237 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~------------------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNI 237 (514)
|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999998642 2477888899999999999999999999999999999
Q ss_pred cccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhcccccccccc
Q 010266 238 LLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG 317 (514)
Q Consensus 238 Lld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~G 317 (514)
|++.++.+||+|||+++........ .......+
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~ 191 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSY-----------------------------------------------VKRSKGRI 191 (290)
T ss_pred EEcCCCcEEeccccccccccCccch-----------------------------------------------hcccCCCC
Confidence 9999999999999998754321100 00012346
Q ss_pred CCCcCCccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-
Q 010266 318 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC- 395 (514)
Q Consensus 318 T~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~- 395 (514)
+..|+|||++.+..++.++|+|||||++|||++ |.+||.+..+......+.. ....+....++.++.+||.+||.
T Consensus 192 ~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~cl~~ 268 (290)
T cd05045 192 PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKT---GYRMERPENCSEEMYNLMLTCWKQ 268 (290)
T ss_pred CccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC---CCCCCCCCCCCHHHHHHHHHHccC
Confidence 778999999998899999999999999999998 9999998887776665543 22333334688999999999998
Q ss_pred CccccCCCCCHhHHhc
Q 010266 396 DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 396 dp~~Rl~~~~~~eil~ 411 (514)
+|.+|+ ++.+|++
T Consensus 269 ~P~~Rp---~~~~i~~ 281 (290)
T cd05045 269 EPDKRP---TFADISK 281 (290)
T ss_pred CcccCC---CHHHHHH
Confidence 999999 8888865
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=321.55 Aligned_cols=249 Identities=23% Similarity=0.357 Sum_probs=205.5
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
+..++|++...||+|+||.||+|....++ .+|+|.+..... ..+.+.+|+.+++.++||+++++++++. ....|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY 76 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence 44578999999999999999999876554 589998865432 2345778999999999999999998875 46789
Q ss_pred EEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 183 LIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
+||||+++|+|.+++... ..++...+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 999999999999999764 347888899999999999999999999999999999999999999999999987543210
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 340 (514)
.. ......++..|+|||++.+..++.++|+||
T Consensus 157 ~~------------------------------------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~s 188 (260)
T cd05069 157 YT------------------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188 (260)
T ss_pred cc------------------------------------------------ccCCCccchhhCCHHHhccCCcChHHHHHH
Confidence 00 001234678899999999888999999999
Q ss_pred hhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 341 LGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 341 lGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|||++|+|++ |.+||.+....+....+... ...|....++..++++|.+||. +|.+|+ ++++|++
T Consensus 189 lG~~l~el~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~ 255 (260)
T cd05069 189 FGILLTELVTKGRVPYPGMVNREVLEQVERG---YRMPCPQGCPESLHELMKLCWKKDPDERP---TFEYIQS 255 (260)
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCcccCHHHHHHHHHHccCCcccCc---CHHHHHH
Confidence 9999999999 99999988877777666542 2222223678999999999999 999999 8888864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=325.61 Aligned_cols=253 Identities=19% Similarity=0.298 Sum_probs=203.6
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCE----EEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNI----YAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA 178 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~----~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 178 (514)
+..++|++++.||+|+||+||+|....+++. +|+|.+... ........+..|..++..++||||+++++++. .
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 3457899999999999999999998877774 566665422 12233456777888889999999999999875 4
Q ss_pred CeEEEEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
...++||||+++|+|.+++.. .+.+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 568899999999999999976 4578999999999999999999999999999999999999999999999999987543
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
..... .......|+..|+|||++.+..++.++|
T Consensus 161 ~~~~~-----------------------------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~D 193 (279)
T cd05111 161 PDDKK-----------------------------------------------YFYSEHKTPIKWMALESILFGRYTHQSD 193 (279)
T ss_pred CCCcc-----------------------------------------------cccCCCCCcccccCHHHhccCCcCchhh
Confidence 21100 0011345778899999999889999999
Q ss_pred hhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 338 WWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 338 iWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
+|||||++|||++ |..||.+.........+.. ...+..| ...+.++.+++.+|+. +|..|+ ++.|+++
T Consensus 194 v~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~li~~c~~~~p~~Rp---s~~el~~ 263 (279)
T cd05111 194 VWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK-GERLAQP--QICTIDVYMVMVKCWMIDENVRP---TFKELAN 263 (279)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCcCCCC--CCCCHHHHHHHHHHcCCCcccCc---CHHHHHH
Confidence 9999999999998 9999988776655444432 2222222 3467789999999998 999999 8999865
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=323.71 Aligned_cols=253 Identities=21% Similarity=0.323 Sum_probs=211.0
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCC----EEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGN----IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA 178 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~----~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 178 (514)
+...+|++++.||+|+||.||+|..+.+|. .+|+|.+.+.. .......+.+|..++..++||||+++++++.+
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 345789999999999999999999877765 58999887653 24455678889999999999999999999987
Q ss_pred CeEEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
...++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 7899999999999999998764 578999999999999999999999999999999999999999999999999998654
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
...... ......+++.|+|||.+....++.++|
T Consensus 161 ~~~~~~-----------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~D 193 (279)
T cd05057 161 VDEKEY-----------------------------------------------HAEGGKVPIKWMALESILHRIYTHKSD 193 (279)
T ss_pred Ccccce-----------------------------------------------ecCCCcccccccCHHHhhcCCcCchhh
Confidence 211000 000123467899999998889999999
Q ss_pred hhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 338 WWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 338 iWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
+|||||++||+++ |.+||.+.+..+....+... ..+..| ...+.++.++|.+||. +|..|+ ++.++++
T Consensus 194 i~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~l~~~p~~Rp---~~~~l~~ 263 (279)
T cd05057 194 VWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG-ERLPQP--PICTIDVYMVLVKCWMIDAESRP---TFKELIN 263 (279)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC-CCCCCC--CCCCHHHHHHHHHHcCCChhhCC---CHHHHHH
Confidence 9999999999998 99999998877777666642 223333 3578899999999998 999999 7777754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=320.76 Aligned_cols=246 Identities=20% Similarity=0.337 Sum_probs=206.5
Q ss_pred eeeeecCceEEEEEEEcc-CCC--EEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeec
Q 010266 112 TIIGRGAFGEVRLCQEKK-SGN--IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYL 188 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~-t~~--~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~ 188 (514)
+.||+|+||.||+|.+.. .++ .||+|.+.+.... ...+.+..|..+++.++||||+++++.+.+ ..+++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 333 6999999876542 566788899999999999999999999988 8999999999
Q ss_pred CCCCHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccc
Q 010266 189 PGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE 266 (514)
Q Consensus 189 ~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~ 266 (514)
++|+|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.+.......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~--- 154 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY--- 154 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccce---
Confidence 9999999997754 68999999999999999999999999999999999999999999999999998654221000
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHH
Q 010266 267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 346 (514)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 346 (514)
.......|+..|+|||++.+..++.++|+|||||++|
T Consensus 155 -------------------------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~ 191 (257)
T cd05040 155 -------------------------------------------VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLW 191 (257)
T ss_pred -------------------------------------------ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHH
Confidence 0001345788999999999999999999999999999
Q ss_pred HHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 347 EMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 347 emlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
||++ |.+||.+.+..+....+.........| ...+..+.++|.+||+ +|.+|+ ++.++..
T Consensus 192 el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~~~~ 253 (257)
T cd05040 192 EMFTYGEEPWAGLSGSQILKKIDKEGERLERP--EACPQDIYNVMLQCWAHNPADRP---TFAALRE 253 (257)
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCC--ccCCHHHHHHHHHHCCCCcccCC---CHHHHHH
Confidence 9998 999998888777777666422233333 3578999999999999 999999 8888864
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=318.66 Aligned_cols=250 Identities=21% Similarity=0.296 Sum_probs=208.6
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 183 (514)
...+|++.+.||+|+||.||++.+. ++..+|+|.+.+... ....+..|..++..++||+|+++++++.+....|+
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICL 76 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEE
Confidence 3568999999999999999999875 467899999875533 12457789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 184 IMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
||||++||+|.+++... +.+++..++.++.+++.||.+||+.|++||||||+||+++.++++||+|||++.........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999999999998764 56899999999999999999999999999999999999999999999999998754211000
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
......++..|+|||++.+..++.++|+||||
T Consensus 157 ------------------------------------------------~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG 188 (256)
T cd05112 157 ------------------------------------------------SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFG 188 (256)
T ss_pred ------------------------------------------------ccCCCccchhhcCHhHhccCCcChHHHHHHHH
Confidence 00123456789999999988999999999999
Q ss_pred HHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 343 AIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 343 vilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
|++|||++ |.+||...+.......+.... ....| ...+..+.+|+.+||. +|.+|+ ++++++++
T Consensus 189 ~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~l~~~~l~~~p~~Rp---~~~~~l~~ 254 (256)
T cd05112 189 VLMWEVFSEGKTPYENRSNSEVVETINAGF-RLYKP--RLASQSVYELMQHCWKERPEDRP---SFSLLLHQ 254 (256)
T ss_pred HHHHHHHcCCCCCCCcCCHHHHHHHHhCCC-CCCCC--CCCCHHHHHHHHHHcccChhhCC---CHHHHHHh
Confidence 99999998 999998877777666664321 12223 3568999999999998 999999 89998763
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=326.48 Aligned_cols=252 Identities=33% Similarity=0.545 Sum_probs=207.8
Q ss_pred eeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEEEcCCeEEEEEe
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
|++.+.||+|+||+||+|....+++.||||.+.+... . .......+|...+..++ ||+|+++++.+.+.+..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY-S-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc-c-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 6788999999999999999999999999999876432 1 12223446888999998 9999999999999999999999
Q ss_pred ecCCCCHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 187 YLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 187 y~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
|+ +|+|..++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||+++......
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---- 153 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---- 153 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC----
Confidence 99 789999887764 78999999999999999999999999999999999999999999999999987543210
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchhhhhH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 343 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGv 343 (514)
......||..|+|||++.+ ..++.++|+|||||
T Consensus 154 ----------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~ 187 (283)
T cd07830 154 ----------------------------------------------PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGC 187 (283)
T ss_pred ----------------------------------------------CcCCCCCcccccCceeeecCcCcCCccchhhHHH
Confidence 0013468999999998854 55799999999999
Q ss_pred HHHHHhhCCCCCCCCChhHHHHHHhhhcCcc-----------------cCCc---------CcCCChhHHHHHhhhcc-C
Q 010266 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL-----------------KFPE---------EARLTPEAKDLICRLLC-D 396 (514)
Q Consensus 344 ilyemltG~~PF~~~~~~~~~~~i~~~~~~~-----------------~~p~---------~~~~s~~~~dLI~~lL~-d 396 (514)
++|||++|.+||.+.+..+...++....... .+|. ....++++.+||.+||+ +
T Consensus 188 ~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~ 267 (283)
T cd07830 188 IMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWD 267 (283)
T ss_pred HHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccC
Confidence 9999999999998887766665554321110 0000 01236889999999998 9
Q ss_pred ccccCCCCCHhHHhcCCcc
Q 010266 397 VEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 397 p~~Rl~~~~~~eil~Hpff 415 (514)
|.+|+ +++|++.||||
T Consensus 268 p~~Rp---t~~ei~~~~~~ 283 (283)
T cd07830 268 PKKRP---TASQALQHPYF 283 (283)
T ss_pred cccCC---CHHHHhhCCCC
Confidence 99999 99999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=324.74 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=197.5
Q ss_pred eeEEeeeeecCceEEEEEEE----ccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc--CCeE
Q 010266 108 FDLLTIIGRGAFGEVRLCQE----KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--AEYL 181 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~----~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~--~~~l 181 (514)
|++++.||+|+||+||++.. ..++..||+|+++... .......+.+|+++|+.++||||+++++++.. ...+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 38999999999999988653 3578899999987542 22345667889999999999999999998765 3468
Q ss_pred EEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
|+||||+++|+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred EEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 999999999999999865 4699999999999999999999999999999999999999999999999999876542110
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
.. .......++..|+|||++.+..++.++|||||
T Consensus 163 ~~----------------------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~sl 196 (283)
T cd05080 163 YY----------------------------------------------RVREDGDSPVFWYAVECLKENKFSYASDVWSF 196 (283)
T ss_pred hh----------------------------------------------ccCCCCCCCceeeCHhHhcccCCCcccccHHH
Confidence 00 00012245677999999998889999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhH--------------HHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCH
Q 010266 342 GAIMYEMLVGYPPFYSDDPVT--------------TCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGS 406 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~--------------~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~ 406 (514)
||++|||++|..||....... ......... ...|.....+.++.+++.+||. +|.+|+ ++
T Consensus 197 G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---s~ 271 (283)
T cd05080 197 GVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG--MRLPCPKNCPQEVYILMKNCWETEAKFRP---TF 271 (283)
T ss_pred HHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC--CCCCCCCCCCHHHHHHHHHHhccChhhCC---CH
Confidence 999999999999986533210 011111111 1222223578999999999999 999999 88
Q ss_pred hHHhc
Q 010266 407 EQIKA 411 (514)
Q Consensus 407 ~eil~ 411 (514)
++|+.
T Consensus 272 ~~i~~ 276 (283)
T cd05080 272 RSLIP 276 (283)
T ss_pred HHHHH
Confidence 88874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=323.47 Aligned_cols=254 Identities=21% Similarity=0.315 Sum_probs=210.9
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEcc----CCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc-
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKK----SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD- 177 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~- 177 (514)
+..++|++.+.||+|+||.||.|.+.. ++..||+|++... ....+...+.+|..+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 456889999999999999999999876 3578999988643 345667888999999999999999999997654
Q ss_pred CCeEEEEEeecCCCCHHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcc
Q 010266 178 AEYLYLIMEYLPGGDVMTLLMRE--------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSD 249 (514)
Q Consensus 178 ~~~l~lVmEy~~gg~L~~~l~~~--------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~D 249 (514)
....++++||+++|+|..++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 57899999999999999998653 4588999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc
Q 010266 250 FGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK 329 (514)
Q Consensus 250 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~ 329 (514)
||+++.+....... ......|+..|+|||++.+
T Consensus 161 ~g~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y~apE~~~~ 193 (280)
T cd05043 161 NALSRDLFPMDYHC-----------------------------------------------LGDNENRPVKWMALESLVN 193 (280)
T ss_pred CCCcccccCCceEE-----------------------------------------------eCCCCCcchhccCHHHHhc
Confidence 99998653221000 0002346778999999999
Q ss_pred CCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHh
Q 010266 330 KGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSE 407 (514)
Q Consensus 330 ~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ 407 (514)
..++.++|+|||||++||+++ |.+||...++.+....+.. ...++....+++++.++|.+|++ ||.+|+ ++.
T Consensus 194 ~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~ 267 (280)
T cd05043 194 KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD---GYRLAQPINCPDELFAVMACCWALDPEERP---SFS 267 (280)
T ss_pred CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc---CCCCCCCCcCCHHHHHHHHHHcCCChhhCC---CHH
Confidence 999999999999999999999 9999998877766655543 22333334578999999999999 999999 888
Q ss_pred HHhc
Q 010266 408 QIKA 411 (514)
Q Consensus 408 eil~ 411 (514)
+++.
T Consensus 268 ~~~~ 271 (280)
T cd05043 268 QLVQ 271 (280)
T ss_pred HHHH
Confidence 8874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=318.36 Aligned_cols=244 Identities=25% Similarity=0.345 Sum_probs=204.5
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecCCC
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG 191 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg 191 (514)
+.||+|+||.||+|.+.. ++.||+|++..... ......+..|.++++.++||+|+++++++.+....|+||||++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 469999999999999877 99999999876533 245567889999999999999999999999999999999999999
Q ss_pred CHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccccccc
Q 010266 192 DVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270 (514)
Q Consensus 192 ~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~ 270 (514)
+|.+++.. ...+++..+..++.+++.||.|||++|++||||||+|||++.++++||+|||++..........
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~------- 150 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV------- 150 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCccee-------
Confidence 99999865 4568889999999999999999999999999999999999999999999999987543110000
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhh
Q 010266 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350 (514)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt 350 (514)
......++..|+|||++.+..++.++|+|||||++|||++
T Consensus 151 ----------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t 190 (251)
T cd05041 151 ----------------------------------------SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFS 190 (251)
T ss_pred ----------------------------------------ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHh
Confidence 0002234678999999998899999999999999999999
Q ss_pred -CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 351 -GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 351 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|..||.+.+.......+... ...+....++.++.++|.+||+ +|.+|+ +++|++.
T Consensus 191 ~~~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~ell~ 247 (251)
T cd05041 191 LGDTPYPGMSNQQTRERIESG---YRMPAPQLCPEEIYRLMLQCWAYDPENRP---SFSEIYN 247 (251)
T ss_pred ccCCCCccCCHHHHHHHHhcC---CCCCCCccCCHHHHHHHHHHhccChhhCc---CHHHHHH
Confidence 89999888776666665431 2222234678999999999998 999999 9999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=320.09 Aligned_cols=244 Identities=25% Similarity=0.351 Sum_probs=199.6
Q ss_pred eeeecCceEEEEEEEc--cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecCC
Q 010266 113 IIGRGAFGEVRLCQEK--KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPG 190 (514)
Q Consensus 113 ~LG~G~fG~V~l~~~~--~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~g 190 (514)
.||+|+||.||++... .++..||+|++.... .....+.+.+|..+++.++||||++++++++. ...|+||||++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 4899999999998765 445679999986542 34445678899999999999999999998864 578999999999
Q ss_pred CCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccccccc
Q 010266 191 GDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEV 269 (514)
Q Consensus 191 g~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~ 269 (514)
|+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++..........
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~------ 152 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY------ 152 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccce------
Confidence 999999875 4578999999999999999999999999999999999999999999999999987543221000
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHh
Q 010266 270 LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 349 (514)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 349 (514)
.......+++.|+|||++.+..++.++|+|||||++|||+
T Consensus 153 ----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 192 (257)
T cd05115 153 ----------------------------------------KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAF 192 (257)
T ss_pred ----------------------------------------eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHh
Confidence 0000123467899999999888999999999999999999
Q ss_pred h-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 350 V-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 350 t-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
+ |.+||.+....+....+... ....+| ...++++.++|.+|+. +|.+|+ ++.+|.+
T Consensus 193 ~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~c~~~~~~~Rp---~~~~i~~ 250 (257)
T cd05115 193 SYGQKPYKKMKGPEVMSFIEQG-KRLDCP--AECPPEMYALMKDCWIYKWEDRP---NFAKVEE 250 (257)
T ss_pred cCCCCCcCcCCHHHHHHHHHCC-CCCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 6 99999988777766666543 223344 3678999999999999 999999 7777654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=318.39 Aligned_cols=248 Identities=27% Similarity=0.387 Sum_probs=211.4
Q ss_pred eeEEeeeeecCceEEEEEEEccCC----CEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEE
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSG----NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~----~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 183 (514)
|++.+.||.|+||.||+|++..++ ..||+|++.... .......+..|..++..++||+|+++++.+.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 467889999999999999998766 899999996553 22366788999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccC--CCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 184 IMEYLPGGDVMTLLMREET--LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
||||++|++|.+++..... +++..+..++.|++.||.+||+.|++||||||+||+++.+|+++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999976554 99999999999999999999999999999999999999999999999999876532200
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
.. .....|++.|+|||.+.+..++.++|+|||
T Consensus 159 ~~------------------------------------------------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~sl 190 (258)
T smart00219 159 YK------------------------------------------------KKGGKLPIRWMAPESLKDGKFTSKSDVWSF 190 (258)
T ss_pred cc------------------------------------------------cccCCCcccccChHHhccCCCCcchhHHHH
Confidence 00 001237889999999988889999999999
Q ss_pred hHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 342 GAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 342 Gvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
||++|+|++ |.+||.+.+.......+.... ....| ...+.++.++|.+||. +|.+|+ ++.|+++
T Consensus 191 G~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp---t~~~ll~ 256 (258)
T smart00219 191 GVLLWEIFTLGESPYPGMSNEEVLEYLKKGY-RLPKP--ENCPPEIYKLMLQCWAEDPEDRP---TFSELVE 256 (258)
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCCCC--CcCCHHHHHHHHHHCcCChhhCc---CHHHHHh
Confidence 999999998 899999888877777776532 22333 3578999999999999 999999 9999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=318.88 Aligned_cols=250 Identities=24% Similarity=0.375 Sum_probs=207.1
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 181 (514)
.+..++|++.+.||+|+||.||++... .+..+|+|.+.+.. ...+.+.+|..+++.++|++|+++++.+.+ ...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence 356689999999999999999999754 45679999887542 234668889999999999999999999987 788
Q ss_pred EEEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 182 YLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
|+||||+++|+|.+++.+. ..++...+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++..+...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 9999999999999999763 45778888999999999999999999999999999999999999999999998754321
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
.. .......|+..|+|||++....++.++|+|
T Consensus 156 ~~------------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~ 187 (260)
T cd05073 156 EY------------------------------------------------TAREGAKFPIKWTAPEAINFGSFTIKSDVW 187 (260)
T ss_pred Cc------------------------------------------------ccccCCcccccccCHhHhccCCcCccccch
Confidence 00 000123466789999999988899999999
Q ss_pred hhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 340 SLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 340 SlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
||||++|+|++ |.+||.+.+.......+.. ....+.....+.++.+++.+||+ +|.+|+ ++.++++
T Consensus 188 slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp---~~~~l~~ 255 (260)
T cd05073 188 SFGILLMEIVTYGRIPYPGMSNPEVIRALER---GYRMPRPENCPEELYNIMMRCWKNRPEERP---TFEYIQS 255 (260)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC---CCCCCCcccCCHHHHHHHHHHcccCcccCc---CHHHHHH
Confidence 99999999998 9999998877666666543 22233334688999999999999 999999 7777653
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=325.72 Aligned_cols=254 Identities=23% Similarity=0.381 Sum_probs=202.8
Q ss_pred CCeeEEeeeeecCceEEEEEEE----ccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC--C
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQE----KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA--E 179 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~----~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~--~ 179 (514)
.-|++++.||+|+||.||+|+. +.++..||+|.++... .......+.+|..+|+.++||||+++++++.+. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 3478999999999999999974 4678899999986542 344456788999999999999999999998875 6
Q ss_pred eEEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
..|+||||++|++|.+++.+. ..+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||++..+..
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 789999999999999998664 4689999999999999999999999999999999999999999999999999886532
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
.... ........|+..|+|||++.+..++.++|+
T Consensus 162 ~~~~----------------------------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di 195 (284)
T cd05079 162 DKEY----------------------------------------------YTVKDDLDSPVFWYAPECLIQSKFYIASDV 195 (284)
T ss_pred Cccc----------------------------------------------eeecCCCCCCccccCHHHhccCCCCccccc
Confidence 2100 000113457888999999998899999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCCh--------------hHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCC
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDP--------------VTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT 403 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~--------------~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~ 403 (514)
|||||++|||++|..|+..... ......... .....|....++..+.+||.+||+ +|.+|+
T Consensus 196 ~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-- 271 (284)
T cd05079 196 WSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE--EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRT-- 271 (284)
T ss_pred hhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH--cCccCCCCCCCCHHHHHHHHHHccCCcccCc--
Confidence 9999999999998877643211 111111111 112233334688999999999998 999999
Q ss_pred CCHhHHhcC
Q 010266 404 LGSEQIKAH 412 (514)
Q Consensus 404 ~~~~eil~H 412 (514)
++++++.+
T Consensus 272 -t~~~il~~ 279 (284)
T cd05079 272 -TFQNLIEG 279 (284)
T ss_pred -CHHHHHHH
Confidence 89998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=326.07 Aligned_cols=254 Identities=34% Similarity=0.550 Sum_probs=212.4
Q ss_pred eeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEee
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY 187 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy 187 (514)
|++++.||.|++|.||+|.+..+++.+|+|.+..... .......+..|..+|+.++||+|+++++.+.+...+|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 5778899999999999999999999999999876543 223456677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccc
Q 010266 188 LPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE 266 (514)
Q Consensus 188 ~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~ 266 (514)
+++ +|..++.. ...+++..+..++.|++.||.|||+.||+|+||||+||+++.++.+||+|||.+........
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~----- 153 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR----- 153 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-----
Confidence 975 88888766 46889999999999999999999999999999999999999999999999999876542210
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-CCCcccchhhhhHHH
Q 010266 267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIM 345 (514)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil 345 (514)
......|+..|+|||++.+. .++.++|+|||||++
T Consensus 154 --------------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l 189 (283)
T cd05118 154 --------------------------------------------PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIF 189 (283)
T ss_pred --------------------------------------------cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHH
Confidence 00134588999999999876 789999999999999
Q ss_pred HHHhhCCCCCCCCChhHHHHHHhhhcCc-----------------ccCCc---------CcCCChhHHHHHhhhcc-Ccc
Q 010266 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNH-----------------LKFPE---------EARLTPEAKDLICRLLC-DVE 398 (514)
Q Consensus 346 yemltG~~PF~~~~~~~~~~~i~~~~~~-----------------~~~p~---------~~~~s~~~~dLI~~lL~-dp~ 398 (514)
|+|++|++||.+.+..+...++...... ..+|. ...++.++.+||.+||. ||.
T Consensus 190 ~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~ 269 (283)
T cd05118 190 AELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPH 269 (283)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcc
Confidence 9999999999888776666555431110 01111 12367899999999999 999
Q ss_pred ccCCCCCHhHHhcCCcc
Q 010266 399 HRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 399 ~Rl~~~~~~eil~Hpff 415 (514)
+|+ ++.+++.||||
T Consensus 270 ~Rp---~~~~ll~~~~~ 283 (283)
T cd05118 270 KRI---TAEQALAHPYF 283 (283)
T ss_pred cCc---CHHHHhhCCCC
Confidence 999 99999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=320.88 Aligned_cols=247 Identities=22% Similarity=0.288 Sum_probs=194.5
Q ss_pred eeeeecCceEEEEEEEc--cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecC
Q 010266 112 TIIGRGAFGEVRLCQEK--KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLP 189 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~--~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~ 189 (514)
+.||+|+||.||+|... .++..+|+|.++... .......+.+|..++..++||||+++++++.+...+|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 36899999999999764 355789999886543 22334568889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 190 GGDVMTLLMREE-----TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 190 gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
||+|.+++.... ..++..++.++.|++.||+|||+.|++||||||+||+++.++++||+|||+++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~-- 156 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY-- 156 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee--
Confidence 999999986532 3566778889999999999999999999999999999999999999999998643211000
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-------CCCcccc
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-------GYGMECD 337 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-------~y~~~~D 337 (514)
.......|++.|+|||++.+. .++.++|
T Consensus 157 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~D 191 (269)
T cd05087 157 ---------------------------------------------VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESN 191 (269)
T ss_pred ---------------------------------------------ecCCCcCCcccccCHhHhccccccccccCCCccch
Confidence 001134688999999998642 3578999
Q ss_pred hhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcC---cCCChhHHHHHhhhccCccccCCCCCHhHHhc
Q 010266 338 WWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEE---ARLTPEAKDLICRLLCDVEHRLGTLGSEQIKA 411 (514)
Q Consensus 338 iWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~---~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~ 411 (514)
+|||||++|||++ |.+||...+..+........ ....++.. ...++.+.+++.+|+.+|.+|+ ++++|..
T Consensus 192 iwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~Rp---t~~~l~~ 265 (269)
T cd05087 192 VWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE-QQLKLPKPRLKLPLSDRWYEVMQFCWLQPEQRP---SAEEVHL 265 (269)
T ss_pred hHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhc-ccCCCCCCccCCCCChHHHHHHHHHhcCcccCC---CHHHHHH
Confidence 9999999999996 99999876665554433321 12222221 2467889999999988999999 8888863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=311.90 Aligned_cols=262 Identities=25% Similarity=0.397 Sum_probs=212.9
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC---
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE--- 179 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~--- 179 (514)
+..++|++.+.||.|||+.|++|+...+++.||+|.+... +..+++..++|++.-++++||||++++++...+.
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 5668899999999999999999999999999999998755 3567888999999999999999999987764433
Q ss_pred --eEEEEEeecCCCCHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC--eEEcCCCCCCccccCCCcEEEcccc
Q 010266 180 --YLYLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLDQNGHMKLSDFG 251 (514)
Q Consensus 180 --~l~lVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKpeNILld~~g~iKL~DFG 251 (514)
..|++++|...|+|.+.+.. ...++|..+..|+.+++.||++||... ++||||||.|||+.++|.++|.|||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence 49999999999999998864 347999999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCC
Q 010266 252 LCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331 (514)
Q Consensus 252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~ 331 (514)
.+....-.-. .+...-.+..|-.. .-|..|.|||.+.-+.
T Consensus 175 S~~~a~i~i~--------------------------------~~~~a~~lQe~a~e--------~Ct~pyRAPELf~vk~ 214 (302)
T KOG2345|consen 175 SATQAPIQIE--------------------------------GSRQALRLQEWAEE--------RCTIPYRAPELFNVKS 214 (302)
T ss_pred CccccceEee--------------------------------chHHHHHHHHHHHH--------hCCCcccCchheeccc
Confidence 9875432100 01112233344322 3578899999997443
Q ss_pred ---CCcccchhhhhHHHHHHhhCCCCCCCCChh--HHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCC
Q 010266 332 ---YGMECDWWSLGAIMYEMLVGYPPFYSDDPV--TTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLG 405 (514)
Q Consensus 332 ---y~~~~DiWSlGvilyemltG~~PF~~~~~~--~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~ 405 (514)
.+.++|||||||+||+|++|..||...-.. ...-.+.+ ..+.+|+....|+.+..||+.||+ ||.+|| +
T Consensus 215 ~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n--~q~s~P~~~~yse~l~~lik~mlqvdP~qRP---~ 289 (302)
T KOG2345|consen 215 HCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQN--AQISIPNSSRYSEALHQLIKSMLQVDPNQRP---T 289 (302)
T ss_pred CcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeec--cccccCCCCCccHHHHHHHHHHhcCCcccCC---C
Confidence 488999999999999999999999532111 01112222 467889888899999999999999 999999 8
Q ss_pred HhHHhcC
Q 010266 406 SEQIKAH 412 (514)
Q Consensus 406 ~~eil~H 412 (514)
+.+++.+
T Consensus 290 i~~ll~~ 296 (302)
T KOG2345|consen 290 IPELLSK 296 (302)
T ss_pred HHHHHHH
Confidence 8888764
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=315.22 Aligned_cols=243 Identities=23% Similarity=0.359 Sum_probs=202.0
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecCCC
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG 191 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg 191 (514)
++||+|+||.||++... ++..||+|++.... .......+.+|.++++.++||||+++++.+.+....|+||||++||
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 36999999999999854 68899999987542 2334456888999999999999999999999999999999999999
Q ss_pred CHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccccccc
Q 010266 192 DVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270 (514)
Q Consensus 192 ~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~ 270 (514)
+|.+++... ..+++..+..++.+++.||.|||++|++||||||+||+++.++.+||+|||++.........
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-------- 149 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-------- 149 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccc--------
Confidence 999998653 46789999999999999999999999999999999999999999999999998643211000
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhh
Q 010266 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350 (514)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt 350 (514)
......+++.|+|||++.+..++.++|+|||||++|+|++
T Consensus 150 ----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~ 189 (250)
T cd05085 150 ----------------------------------------SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFS 189 (250)
T ss_pred ----------------------------------------cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhc
Confidence 0001235678999999998889999999999999999998
Q ss_pred -CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 351 -GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 351 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|..||.+.+.......+... .....| ..++.++.+||.+||. +|.+|+ ++.++.+
T Consensus 190 ~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~ 246 (250)
T cd05085 190 LGVCPYPGMTNQQAREQVEKG-YRMSCP--QKCPDDVYKVMQRCWDYKPENRP---KFSELQK 246 (250)
T ss_pred CCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcccCcccCC---CHHHHHH
Confidence 99999988777766666532 222333 3578999999999998 999999 8888865
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=328.16 Aligned_cols=254 Identities=18% Similarity=0.299 Sum_probs=206.0
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCC----EEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGN----IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA 178 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~----~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 178 (514)
+..++|+.++.||+|+||.||+|.+..+|. .+|+|.+.... .......+..|..+++.++||||+++++.+.+.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 345789999999999999999999887776 46888876542 233344678899999999999999999998754
Q ss_pred CeEEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
..++|+||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence 578999999999999998764 368899999999999999999999999999999999999999999999999998653
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
..... .......+++.|+|||++.+..++.++|
T Consensus 161 ~~~~~-----------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~D 193 (303)
T cd05110 161 GDEKE-----------------------------------------------YNADGGKMPIKWMALECIHYRKFTHQSD 193 (303)
T ss_pred Ccccc-----------------------------------------------cccCCCccccccCCHHHhccCCCChHHH
Confidence 21100 0011234678999999999999999999
Q ss_pred hhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 338 WWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 338 iWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
+|||||++|||++ |..||.+.........+ .... .+|.....+..+.++|.+|+. +|.+|+ +++++++.
T Consensus 194 iwslG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~li~~c~~~~p~~Rp---~~~~l~~~ 264 (303)
T cd05110 194 VWSYGVTIWELMTFGGKPYDGIPTREIPDLL-EKGE--RLPQPPICTIDVYMVMVKCWMIDADSRP---KFKELAAE 264 (303)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCCC--CCCCCCCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 9999999999997 99999887655544433 3222 233334578899999999998 999999 88998763
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=320.08 Aligned_cols=252 Identities=25% Similarity=0.359 Sum_probs=208.0
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccC---CCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKS---GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE 179 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t---~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 179 (514)
+..++|.+.+.||+|+||.||+|.+..+ ...||+|...... .....+.+.+|..+++.++||||+++++++.+ .
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 4457899999999999999999987654 3468999886542 24456678899999999999999999998876 4
Q ss_pred eEEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
..|+||||+++|+|.+++... ..+++..+..++.+++.||.|||+.|++||||||+||+++.++.+||+|||+++....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 578999999999999999764 4689999999999999999999999999999999999999999999999999875432
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
.... ......+++.|+|||++....++.++|+
T Consensus 160 ~~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di 191 (270)
T cd05056 160 ESYY------------------------------------------------KASKGKLPIKWMAPESINFRRFTSASDV 191 (270)
T ss_pred ccce------------------------------------------------ecCCCCccccccChhhhccCCCCchhhh
Confidence 1000 0002235678999999998899999999
Q ss_pred hhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 339 WSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 339 WSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|||||++|||++ |.+||.+.+..+....+... ..+..| ..++++++++|.+|+. +|.+|+ ++.+++.
T Consensus 192 ~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~P~~Rp---t~~~~~~ 260 (270)
T cd05056 192 WMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG-ERLPMP--PNCPPTLYSLMTKCWAYDPSKRP---RFTELKA 260 (270)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 999999999996 99999888777666665432 223333 3678999999999998 999999 8888875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=321.46 Aligned_cols=252 Identities=25% Similarity=0.410 Sum_probs=200.9
Q ss_pred CCeeEEeeeeecCceEEEEEEE----ccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE--cCC
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQE----KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ--DAE 179 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~----~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~--~~~ 179 (514)
.+|++++.||+|+||.||+|.. ..++..||+|.+... .......+..|..+|..++||||+++++++. +..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 5899999999999999999974 457889999998654 3455677889999999999999999998764 345
Q ss_pred eEEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
.+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++++||+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 789999999999999999764 5689999999999999999999999999999999999999999999999999986532
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
..... .......++..|+|||++.+..++.++|+
T Consensus 161 ~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 194 (284)
T cd05081 161 DKEYY----------------------------------------------KVREPGESPIFWYAPESLTESKFSVASDV 194 (284)
T ss_pred CCcce----------------------------------------------eecCCCCCceEeeCHHHhccCCcChHHHH
Confidence 21000 00001234456999999998899999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhH---------------HHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCC
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVT---------------TCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLG 402 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~---------------~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~ 402 (514)
|||||++|||++|..|+....... ....++. ....+|....++.++.+||.+||. +|.+|+
T Consensus 195 ~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp- 271 (284)
T cd05081 195 WSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK--NNGRLPAPPGCPAEIYAIMKECWNNDPSQRP- 271 (284)
T ss_pred HHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh--cCCcCCCCCCCCHHHHHHHHHHccCChhhCC-
Confidence 999999999999988765432110 0111111 122333334678999999999998 999999
Q ss_pred CCCHhHHhc
Q 010266 403 TLGSEQIKA 411 (514)
Q Consensus 403 ~~~~~eil~ 411 (514)
++++|++
T Consensus 272 --t~~ei~~ 278 (284)
T cd05081 272 --SFSELAL 278 (284)
T ss_pred --CHHHHHH
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=323.50 Aligned_cols=236 Identities=19% Similarity=0.281 Sum_probs=193.7
Q ss_pred eeeeecCceEEEEEEEccCCC-------EEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 112 TIIGRGAFGEVRLCQEKKSGN-------IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~-------~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
+.||+|+||.||+|.++.++. .+|+|.+.+.. ....+.+..|..+++.++||||+++++++.++...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 369999999999999866544 38888876442 34456678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCc--------EEEcccccccc
Q 010266 185 MEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH--------MKLSDFGLCKP 255 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~--------iKL~DFGla~~ 255 (514)
|||+++|+|..++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999997644 5899999999999999999999999999999999999988775 68999998754
Q ss_pred CCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCc
Q 010266 256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGM 334 (514)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~ 334 (514)
.... ....||+.|+|||++.+ ..++.
T Consensus 158 ~~~~-----------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~ 184 (258)
T cd05078 158 VLPK-----------------------------------------------------EILLERIPWVPPECIENPQNLSL 184 (258)
T ss_pred cCCc-----------------------------------------------------hhccccCCccCchhccCCCCCCc
Confidence 3210 13568899999999987 45899
Q ss_pred ccchhhhhHHHHHHhhC-CCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 335 ECDWWSLGAIMYEMLVG-YPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 335 ~~DiWSlGvilyemltG-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
++|+|||||++|+|++| .+||...++..... +.. ....+|. ..+.++.+||.+||. +|.+|+ ++++|++
T Consensus 185 ~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp---s~~~il~ 255 (258)
T cd05078 185 AADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYE--DRHQLPA--PKWTELANLINQCMDYEPDFRP---SFRAIIR 255 (258)
T ss_pred hhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHH--ccccCCC--CCcHHHHHHHHHHhccChhhCC---CHHHHHH
Confidence 99999999999999998 57776655544332 222 2334554 467899999999999 999999 9999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=319.19 Aligned_cols=247 Identities=19% Similarity=0.287 Sum_probs=193.8
Q ss_pred eeeeecCceEEEEEEEcc--CCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecC
Q 010266 112 TIIGRGAFGEVRLCQEKK--SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLP 189 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~--t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~ 189 (514)
+.||+|+||.||++.... ....+|+|.+.... .......+.+|..+++.++||||+++++++.+...+|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999996543 34578888775432 23344567789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 190 GGDVMTLLMREE-----TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 190 gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
+|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-- 156 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY-- 156 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe--
Confidence 999999986642 3467788899999999999999999999999999999999999999999998643211000
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-------CCCCcccc
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-------KGYGMECD 337 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-------~~y~~~~D 337 (514)
.......+++.|+|||++.. ..++.++|
T Consensus 157 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~D 191 (269)
T cd05042 157 ---------------------------------------------ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSN 191 (269)
T ss_pred ---------------------------------------------eccCCCCCcccccCHHHHhhccccccccccchhhH
Confidence 00013457788999999753 45688999
Q ss_pred hhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCc---CcCCChhHHHHHhhhccCccccCCCCCHhHHhc
Q 010266 338 WWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPE---EARLTPEAKDLICRLLCDVEHRLGTLGSEQIKA 411 (514)
Q Consensus 338 iWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~---~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~ 411 (514)
||||||++|||++ |.+||......+....+... ....+|. ...+++...+++..|+.||.+|+ ++++|+.
T Consensus 192 iwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~dp~~Rp---t~~~v~~ 265 (269)
T cd05042 192 IWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE-QDIKLPKPQLDLKYSDRWYEVMQFCWLDPETRP---TAEEVHE 265 (269)
T ss_pred HHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhc-cCccCCCCcccccCCHHHHHHHHHHhcCccccc---CHHHHHH
Confidence 9999999999999 88999887766666555442 2222222 23578888999988877999999 7887764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=316.48 Aligned_cols=242 Identities=20% Similarity=0.338 Sum_probs=202.8
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 183 (514)
..++|++.+.||+|+||.||++. .+++.||+|++.... ....+..|..++..++||||+++++++... ..|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 45789999999999999999875 578899999986432 235688899999999999999999998764 5799
Q ss_pred EEeecCCCCHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 184 IMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
||||++||+|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.+|.+||+|||++.......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 999999999999997643 57899999999999999999999999999999999999999999999999987432110
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
....++..|+|||++.+..++.++|+|||
T Consensus 155 ---------------------------------------------------~~~~~~~~y~~pe~~~~~~~~~~~Dv~sl 183 (254)
T cd05083 155 ---------------------------------------------------DNSKLPVKWTAPEALKHKKFSSKSDVWSY 183 (254)
T ss_pred ---------------------------------------------------CCCCCCceecCHHHhccCCcCchhhHHHH
Confidence 01234567999999998899999999999
Q ss_pred hHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 342 GAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 342 Gvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
||++|+|++ |.+||.+.+..+....+... ...+....+++.+.+||.+||. +|..|+ ++++|+.
T Consensus 184 G~~l~el~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~ 249 (254)
T cd05083 184 GVLLWEVFSYGRAPYPKMSLKEVKECVEKG---YRMEPPEGCPADVYVLMTSCWETEPKKRP---SFHKLRE 249 (254)
T ss_pred HHHHHHHHhCCCCCCccCCHHHHHHHHhCC---CCCCCCCcCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 999999997 99999988877666665432 2222223678999999999998 999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=317.76 Aligned_cols=248 Identities=34% Similarity=0.472 Sum_probs=203.2
Q ss_pred eEEeeeeecCceEEEEEEEc----cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 109 DLLTIIGRGAFGEVRLCQEK----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 109 ~~~~~LG~G~fG~V~l~~~~----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.+.+.||.|+||.||.|... ..+..||||+++.. ......+.+.+|.+++..++||||+++++++...+.+++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 46789999999999999988 34678999999542 2444578899999999999999999999999988889999
Q ss_pred EeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 185 MEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
|||+++|+|.++|... ..++......++.|++.||.|||+++|+|+||+|+|||++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999886 78999999999999999999999999999999999999999999999999998865211100
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
.......+...|+|||++.+..++.++||||||
T Consensus 160 -----------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG 192 (259)
T PF07714_consen 160 -----------------------------------------------KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFG 192 (259)
T ss_dssp -----------------------------------------------EESTTSESGGGGS-HHHHHHSEESHHHHHHHHH
T ss_pred -----------------------------------------------ccccccccccccccccccccccccccccccccc
Confidence 001134567789999999999899999999999
Q ss_pred HHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 343 AIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 343 vilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
+++|||++ |..||...+..+...++... ..+..| ..++..+.++|.+|+. +|.+|| ++.+|++
T Consensus 193 ~~l~ei~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~C~~~~p~~RP---s~~~i~~ 257 (259)
T PF07714_consen 193 MLLYEILTLGKFPFSDYDNEEIIEKLKQG-QRLPIP--DNCPKDIYSLIQQCWSHDPEKRP---SFQEILQ 257 (259)
T ss_dssp HHHHHHHTTSSGTTTTSCHHHHHHHHHTT-EETTSB--TTSBHHHHHHHHHHT-SSGGGS-----HHHHHH
T ss_pred ccccccccccccccccccccccccccccc-ccceec--cchhHHHHHHHHHHcCCChhhCc---CHHHHHh
Confidence 99999999 78999988888877777442 233333 3688999999999998 999999 9998864
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=315.83 Aligned_cols=247 Identities=19% Similarity=0.292 Sum_probs=197.1
Q ss_pred eeeeecCceEEEEEEEcc---CCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE-cCCeEEEEEee
Q 010266 112 TIIGRGAFGEVRLCQEKK---SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ-DAEYLYLIMEY 187 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~---t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~-~~~~l~lVmEy 187 (514)
+.||+|+||.||+|.... .+..+|+|.+... ........+..|..+++.++||||+++++.+. .+...|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 368999999999998654 3457999987542 23345667888999999999999999999765 55678999999
Q ss_pred cCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccc
Q 010266 188 LPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE 266 (514)
Q Consensus 188 ~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~ 266 (514)
+++|+|.+++.+. ..++...+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++..........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~-- 156 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV-- 156 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee--
Confidence 9999999998764 4466777788899999999999999999999999999999999999999999875432110000
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHH
Q 010266 267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 346 (514)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 346 (514)
.......+++.|+|||++.+..++.++|||||||++|
T Consensus 157 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 193 (262)
T cd05058 157 -------------------------------------------HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 193 (262)
T ss_pred -------------------------------------------cccccCcCCccccChhHhccCccchHHHHHHHHHHHH
Confidence 0011335678999999999899999999999999999
Q ss_pred HHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 347 EMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 347 emlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
||++ |.+||...+..+....+..+ .....| ..+++.+.+++.+||. +|++|+ ++.+|+.
T Consensus 194 el~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~cl~~~p~~Rp---~~~~il~ 254 (262)
T cd05058 194 ELMTRGAPPYPDVDSFDITVYLLQG-RRLLQP--EYCPDPLYEVMLSCWHPKPEMRP---TFSELVS 254 (262)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHhcC-CCCCCC--CcCCHHHHHHHHHHcCCChhhCC---CHHHHHH
Confidence 9999 57788777776666655542 222223 3578899999999998 999999 8888875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=319.11 Aligned_cols=245 Identities=24% Similarity=0.361 Sum_probs=201.9
Q ss_pred eeeeecCceEEEEEEEccCC------CEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 112 TIIGRGAFGEVRLCQEKKSG------NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~------~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
+.||+|+||.||+++.+... ..+|+|.+.+.. .......+.+|..+|+.++||+|+++++++.+....|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999987544 689999886542 2334556788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC-----cEEEcccccc
Q 010266 186 EYLPGGDVMTLLMRE-------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG-----HMKLSDFGLC 253 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g-----~iKL~DFGla 253 (514)
||++||+|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999998642 3477888899999999999999999999999999999999888 8999999998
Q ss_pred ccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCC
Q 010266 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG 333 (514)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 333 (514)
+......... ......+++.|+|||++.+..++
T Consensus 159 ~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~ 191 (269)
T cd05044 159 RDIYKSDYYR-----------------------------------------------KEGEGLLPVRWMAPESLLDGKFT 191 (269)
T ss_pred cccccccccc-----------------------------------------------cCcccCCCccccCHHHHccCCcc
Confidence 7543211000 00123567889999999999999
Q ss_pred cccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 334 MECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 334 ~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
.++|+|||||++|||++ |..||...+..+....+... ..+..| ..+++.+++||.+||+ +|.+|+ ++++|++
T Consensus 192 ~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~ 265 (269)
T cd05044 192 TQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-GRLQKP--ENCPDKIYQLMTNCWAQDPSERP---TFDRIQE 265 (269)
T ss_pred cchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-CccCCc--ccchHHHHHHHHHHcCCCcccCC---CHHHHHH
Confidence 99999999999999998 99999887777666665431 223333 3678999999999998 999999 8888864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=327.51 Aligned_cols=258 Identities=24% Similarity=0.425 Sum_probs=210.6
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCC--C----ceeeEEEE
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS--H----CIVKLYYS 174 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h--p----~Iv~l~~~ 174 (514)
...-.++|.++..+|+|+||+|..|.+..++..||||+++.- ....+..+.|+++|.++.+ | .+|.+.++
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 334468899999999999999999999999999999998743 2234456779999999842 2 48899999
Q ss_pred EEcCCeEEEEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC-----------
Q 010266 175 FQDAEYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ----------- 241 (514)
Q Consensus 175 f~~~~~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~----------- 241 (514)
|.-.++.|+|+|.+ |-++.++|..+ .+|+-..++.+.+|++.++.+||+++++|-||||||||+.+
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCC
Confidence 99999999999988 77999999764 47999999999999999999999999999999999999842
Q ss_pred ---------CCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccc
Q 010266 242 ---------NGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLA 312 (514)
Q Consensus 242 ---------~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (514)
+-+|||+|||.|+..... .
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~----------------------------------------------------h 266 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEH----------------------------------------------------H 266 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccC----------------------------------------------------c
Confidence 346899999988754322 1
Q ss_pred cccccCCCcCCccccccCCCCcccchhhhhHHHHHHhhCCCCCCCCChhH---HHHHHhh----------------hcCc
Q 010266 313 YSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVT---TCRKIVH----------------WKNH 373 (514)
Q Consensus 313 ~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~---~~~~i~~----------------~~~~ 373 (514)
+++|.|..|.||||+.+-+++..||+||+||||+|+.+|...|.+.+..+ +.++|+. ..+.
T Consensus 267 s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~r 346 (415)
T KOG0671|consen 267 STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGR 346 (415)
T ss_pred ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhccc
Confidence 26789999999999999999999999999999999999999999877544 4555542 0011
Q ss_pred ccCCcCc--------------------CC---ChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 374 LKFPEEA--------------------RL---TPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 374 ~~~p~~~--------------------~~---s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
+.+|+.. .. -.++-|||++||. ||.+|+ |+.|++.||||+..
T Consensus 347 ldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri---Tl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 347 LDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI---TLREALSHPFFARL 412 (415)
T ss_pred ccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc---cHHHHhcCHHhhcC
Confidence 2222100 00 1457899999999 999999 99999999999864
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=338.30 Aligned_cols=257 Identities=26% Similarity=0.376 Sum_probs=218.5
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCC---E-EEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEE
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGN---I-YAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSF 175 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~---~-~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 175 (514)
.+.+.-++-.+.++||+|+||.||+++.+..+. . ||+|..+.+....+.++..+..|.++|+.++|||||++|++.
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344555677778999999999999999875432 3 899998875666788999999999999999999999999999
Q ss_pred EcCCeEEEEEeecCCCCHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccc
Q 010266 176 QDAEYLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254 (514)
Q Consensus 176 ~~~~~l~lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~ 254 (514)
.+...+|+|||+|+||+|.++|.+.+ .++......++.+.+.||+|||++++|||||-..|+|++.++.+||+|||||+
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence 99999999999999999999999876 59999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhcccccccc-ccCCCcCCccccccCCCC
Q 010266 255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYST-VGTPDYIAPEVLLKKGYG 333 (514)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-~GT~~Y~APEvl~~~~y~ 333 (514)
....-.. .... .--..|+|||.+...-|+
T Consensus 311 ~~~~~~~--------------------------------------------------~~~~~klPirWLAPEtl~~~~~s 340 (474)
T KOG0194|consen 311 AGSQYVM--------------------------------------------------KKFLKKLPIRWLAPETLNTGIFS 340 (474)
T ss_pred CCcceee--------------------------------------------------ccccccCcceecChhhhccCccc
Confidence 5421000 0001 123479999999999999
Q ss_pred cccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 334 MECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 334 ~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
.++|||||||++||+++ |..||.+....+...+|.........|. ..+.+...++.+|.. +|++|+ ++.++.+
T Consensus 341 ~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~--~~p~~~~~~~~~c~~~~p~~R~---tm~~i~~ 415 (474)
T KOG0194|consen 341 FKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS--KTPKELAKVMKQCWKKDPEDRP---TMSTIKK 415 (474)
T ss_pred cccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC--CCHHHHHHHHHHhccCChhhcc---CHHHHHH
Confidence 99999999999999998 8999999999999999965334444443 677888999999888 999999 7777764
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=316.47 Aligned_cols=237 Identities=20% Similarity=0.241 Sum_probs=190.8
Q ss_pred eeeeecCceEEEEEEEccC------------CCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC
Q 010266 112 TIIGRGAFGEVRLCQEKKS------------GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE 179 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t------------~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 179 (514)
+.||+|+||.||++..... ...+|+|++.... ......+..|..++..++||||+++++++.+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 3689999999999975322 2358888876542 334456778889999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCc-------EEEcccc
Q 010266 180 YLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH-------MKLSDFG 251 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~-------iKL~DFG 251 (514)
..++||||+++|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|. +|++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999988865 457899999999999999999999999999999999999987664 8999999
Q ss_pred ccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc-cC
Q 010266 252 LCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KK 330 (514)
Q Consensus 252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-~~ 330 (514)
++...... ...+||+.|+|||++. +.
T Consensus 158 ~~~~~~~~-----------------------------------------------------~~~~~~~~y~aPE~~~~~~ 184 (262)
T cd05077 158 IPITVLSR-----------------------------------------------------QECVERIPWIAPECVEDSK 184 (262)
T ss_pred CCccccCc-----------------------------------------------------ccccccccccChhhhcCCC
Confidence 98643211 1346888999999987 46
Q ss_pred CCCcccchhhhhHHHHHHh-hCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhH
Q 010266 331 GYGMECDWWSLGAIMYEML-VGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQ 408 (514)
Q Consensus 331 ~y~~~~DiWSlGvilyeml-tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~e 408 (514)
.++.++|||||||++|||+ .|.+||......+.. .+.. ...... ...++++.+||.+||. ||.+|+ ++.+
T Consensus 185 ~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~--~~~~~~--~~~~~~~~~li~~cl~~dp~~Rp---~~~~ 256 (262)
T cd05077 185 NLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYE--GQCMLV--TPSCKELADLMTHCMNYDPNQRP---FFRA 256 (262)
T ss_pred CCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHh--cCccCC--CCChHHHHHHHHHHcCCChhhCc---CHHH
Confidence 7899999999999999998 589998776544332 2222 112222 2356889999999999 999999 8999
Q ss_pred HhcC
Q 010266 409 IKAH 412 (514)
Q Consensus 409 il~H 412 (514)
|+.+
T Consensus 257 il~~ 260 (262)
T cd05077 257 IMRD 260 (262)
T ss_pred HHHh
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=315.42 Aligned_cols=251 Identities=29% Similarity=0.497 Sum_probs=208.0
Q ss_pred CeeEEeeeeecCceEEEEEEEcc-CCCEEEEEEeecccc-------cChhhHHHHHHHHHHHHH-cCCCceeeEEEEEEc
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKK-SGNIYAMKKLKKSEM-------LSRGQVEHVRAERNLLAE-VASHCIVKLYYSFQD 177 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~-t~~~~AiK~l~k~~~-------~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~f~~ 177 (514)
+|++.+.||+|+||.||+|.++. +++.+|+|.+..... ........+..|..++.. ++||||+++++.|.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999987 788999999864321 223345567778888865 799999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCCccccCCCcEEEccccc
Q 010266 178 AEYLYLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252 (514)
Q Consensus 178 ~~~l~lVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKpeNILld~~g~iKL~DFGl 252 (514)
.+..|+||||++|++|.+++.. ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988743 3568999999999999999999996 7899999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCC
Q 010266 253 CKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY 332 (514)
Q Consensus 253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y 332 (514)
+....... ......|+..|+|||++.+..+
T Consensus 161 ~~~~~~~~--------------------------------------------------~~~~~~~~~~~~~Pe~~~~~~~ 190 (269)
T cd08528 161 AKQKQPES--------------------------------------------------KLTSVVGTILYSCPEIVKNEPY 190 (269)
T ss_pred eeeccccc--------------------------------------------------ccccccCcccCcChhhhcCCCC
Confidence 87543210 0114568999999999998889
Q ss_pred CcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 333 GMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 333 ~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
+.++|+|||||++|+|++|.+||...+.......+..... ..+.....++++.++|.+||. ||.+|+ ++.|+..
T Consensus 191 ~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rp---~~~e~~~ 265 (269)
T cd08528 191 GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVY--EPLPEGMYSEDVTDVITSCLTPDAEARP---DIIQVSA 265 (269)
T ss_pred chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccC--CcCCcccCCHHHHHHHHHHCCCCCccCC---CHHHHHH
Confidence 9999999999999999999999988777666666654221 111222578999999999998 999999 8888765
Q ss_pred C
Q 010266 412 H 412 (514)
Q Consensus 412 H 412 (514)
+
T Consensus 266 ~ 266 (269)
T cd08528 266 M 266 (269)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=360.51 Aligned_cols=268 Identities=38% Similarity=0.688 Sum_probs=223.4
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 181 (514)
.-..++|+.|+.|..|+||.||+++++.|.+.+|+ .++|..++.+ +||....+|++|
T Consensus 79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~lilR----------nilt~a~npfvv------------ 135 (1205)
T KOG0606|consen 79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLILR----------NILTFAGNPFVV------------ 135 (1205)
T ss_pred CCCccccceeEeeccCCCCceeeeeccccccchhh-cccccchhhh----------ccccccCCccee------------
Confidence 34568999999999999999999999999999999 5555544322 277777888887
Q ss_pred EEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
||-..++..-+.++... +.|++|||+-||+|||+||+|.||..-||+|++||||++...-...
T Consensus 136 ---------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 77788887767776544 8899999999999999999999999999999999999986543221
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
..+++..+. . ..+.-.....||||.|+||||+..++|+..||||++
T Consensus 199 tnl~eg~I~-----------------------------k-----~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwam 244 (1205)
T KOG0606|consen 199 TNLKEGHIE-----------------------------K-----DTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAM 244 (1205)
T ss_pred chhhhcchH-----------------------------H-----HHHHhhhccccCCccccChhhhhhhccCCCccHHHH
Confidence 111111100 0 001111235799999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcC-cCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCC
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEE-ARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIA 419 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~-~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~ 419 (514)
|+|+||.+.|..||.++++++.+..++. ..+.+|+. ..+.++++|+|.+||. +|..|+|..++-+++.|+||+.+|
T Consensus 245 GiIlyeFLVgcvpffGdtpeelfg~vis--d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LD 322 (1205)
T KOG0606|consen 245 GIILYEFLVGCVPFFGDTPEELFGQVIS--DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLD 322 (1205)
T ss_pred HHHHHHHheeeeeccCCCHHHHHhhhhh--hhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecc
Confidence 9999999999999999999999999887 55667753 3578999999999998 999999999999999999999999
Q ss_pred ccccccccCCCCCcCCCCCCCCCCCC
Q 010266 420 WDKLYEMEAAYKPEVNGVLDTQNFMK 445 (514)
Q Consensus 420 w~~l~~~~~p~~p~~~~~~d~~~f~~ 445 (514)
|..|...+++|+|.+....|++|||+
T Consensus 323 w~~llRqkaefvpql~~eddtsyfdT 348 (1205)
T KOG0606|consen 323 WKSLLRQKAEFVPQLESEDDTSYFDT 348 (1205)
T ss_pred cchhhhhhccccccccccccchhhcc
Confidence 99999999999999999999999985
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=317.88 Aligned_cols=236 Identities=19% Similarity=0.229 Sum_probs=191.3
Q ss_pred eeeecCceEEEEEEEccC------------------------CCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCce
Q 010266 113 IIGRGAFGEVRLCQEKKS------------------------GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCI 168 (514)
Q Consensus 113 ~LG~G~fG~V~l~~~~~t------------------------~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~I 168 (514)
.||+|+||.||++....+ ...+|+|++.... ......+..|..+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 599999999999875322 2358899886542 2334567788999999999999
Q ss_pred eeEEEEEEcCCeEEEEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC----
Q 010266 169 VKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG---- 243 (514)
Q Consensus 169 v~l~~~f~~~~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g---- 243 (514)
+++++++.+....|+||||++||+|..++.. .+.+++..+..++.|++.||+|||+.||+||||||+|||++..|
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999999865 46789999999999999999999999999999999999998654
Q ss_pred ---cEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCC
Q 010266 244 ---HMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPD 320 (514)
Q Consensus 244 ---~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~ 320 (514)
.+||+|||++...... ....|++.
T Consensus 159 ~~~~~kl~d~g~~~~~~~~-----------------------------------------------------~~~~~~~~ 185 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR-----------------------------------------------------EERVERIP 185 (274)
T ss_pred ccceeeecCCccccccccc-----------------------------------------------------cccccCCc
Confidence 4899999987532110 02357888
Q ss_pred cCCcccccc-CCCCcccchhhhhHHHHHHh-hCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-Cc
Q 010266 321 YIAPEVLLK-KGYGMECDWWSLGAIMYEML-VGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DV 397 (514)
Q Consensus 321 Y~APEvl~~-~~y~~~~DiWSlGvilyeml-tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp 397 (514)
|+|||++.+ ..++.++|+|||||++|||+ +|.+||.+..+.+.... .. ....+|. ..++++.++|.+||+ +|
T Consensus 186 ~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~--~~~~~~~--~~~~~~~~li~~cl~~~p 260 (274)
T cd05076 186 WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF-YE--KKHRLPE--PSCKELATLISQCLTYEP 260 (274)
T ss_pred ccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH-HH--hccCCCC--CCChHHHHHHHHHcccCh
Confidence 999999876 56899999999999999985 79999988766544332 22 2233443 356789999999999 99
Q ss_pred cccCCCCCHhHHhcC
Q 010266 398 EHRLGTLGSEQIKAH 412 (514)
Q Consensus 398 ~~Rl~~~~~~eil~H 412 (514)
.+|+ ++++|+++
T Consensus 261 ~~Rp---s~~~il~~ 272 (274)
T cd05076 261 TQRP---SFRTILRD 272 (274)
T ss_pred hhCc---CHHHHHHh
Confidence 9999 99999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=316.31 Aligned_cols=254 Identities=24% Similarity=0.360 Sum_probs=205.1
Q ss_pred CCCeeEEeeeeecCceEEEEEEEc----cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc--C
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEK----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--A 178 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~--~ 178 (514)
..+|++++.||+|+||.||+|... .+++.||+|++.+.... .....+..|..+++.+.||+|+++++++.+ .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 357889999999999999999864 35889999999765321 356778999999999999999999999887 6
Q ss_pred CeEEEEEeecCCCCHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
...|+||||+++|+|.+++.... .++...+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 68999999999999999997654 68999999999999999999999999999999999999999999999999988654
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
...... .......++..|+|||.+.+..++.++|
T Consensus 161 ~~~~~~----------------------------------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D 194 (284)
T cd05038 161 EDKDYY----------------------------------------------YVKEPGESPIFWYAPECLRTSKFSSASD 194 (284)
T ss_pred cCCcce----------------------------------------------eccCCCCCcccccCcHHHccCCCCcccc
Confidence 211000 0000223556799999999889999999
Q ss_pred hhhhhHHHHHHhhCCCCCCCCChhH--------------HHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCC
Q 010266 338 WWSLGAIMYEMLVGYPPFYSDDPVT--------------TCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLG 402 (514)
Q Consensus 338 iWSlGvilyemltG~~PF~~~~~~~--------------~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~ 402 (514)
+|||||++|||++|..||....... ....++. .....+.....+.++.+|+.+||. +|.+|+
T Consensus 195 i~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp- 271 (284)
T cd05038 195 VWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK--EGERLPRPPSCPDEVYDLMKLCWEAEPQDRP- 271 (284)
T ss_pred hHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH--cCCcCCCCccCCHHHHHHHHHHhccChhhCC-
Confidence 9999999999999999997643221 1122222 222333334567899999999998 999999
Q ss_pred CCCHhHHhc
Q 010266 403 TLGSEQIKA 411 (514)
Q Consensus 403 ~~~~~eil~ 411 (514)
++.||+.
T Consensus 272 --t~~ei~~ 278 (284)
T cd05038 272 --SFADLIL 278 (284)
T ss_pred --CHHHHHH
Confidence 8988875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=314.81 Aligned_cols=250 Identities=24% Similarity=0.387 Sum_probs=204.4
Q ss_pred eeEEeeeeecCceEEEEEEEc---cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC-----
Q 010266 108 FDLLTIIGRGAFGEVRLCQEK---KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE----- 179 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~---~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~----- 179 (514)
|.+.++||+|+||.||+|..+ .+++.||||++.... ......+.+.+|..+|+.++||+|+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 567889999999999999865 357899999996543 34455677889999999999999999999886432
Q ss_pred -eEEEEEeecCCCCHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccc
Q 010266 180 -YLYLIMEYLPGGDVMTLLMRE------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252 (514)
Q Consensus 180 -~l~lVmEy~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGl 252 (514)
..++++||+++|+|..++... ..++...+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 347899999999998887432 2578889999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCC
Q 010266 253 CKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY 332 (514)
Q Consensus 253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y 332 (514)
++........ .......+++.|++||.+.+..+
T Consensus 160 ~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~~pe~~~~~~~ 192 (273)
T cd05074 160 SKKIYSGDYY-----------------------------------------------RQGCASKLPVKWLALESLADNVY 192 (273)
T ss_pred cccccCCcce-----------------------------------------------ecCCCccCchhhcCHhHHhcCcc
Confidence 8865321100 00112346778999999999999
Q ss_pred CcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHh
Q 010266 333 GMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIK 410 (514)
Q Consensus 333 ~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 410 (514)
+.++|+|||||++|+|++ |.+||.+.+..+....+..+. .+..+ ...++.+.+++.+||. +|.+|+ ++.+++
T Consensus 193 ~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~l~~~~l~~~p~~Rp---s~~~~~ 266 (273)
T cd05074 193 TTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-RLKQP--PDCLEDVYELMCQCWSPEPKCRP---SFQHLR 266 (273)
T ss_pred chhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHH
Confidence 999999999999999999 999999888877777766532 22333 3578899999999998 999999 888887
Q ss_pred c
Q 010266 411 A 411 (514)
Q Consensus 411 ~ 411 (514)
.
T Consensus 267 ~ 267 (273)
T cd05074 267 D 267 (273)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=318.59 Aligned_cols=258 Identities=17% Similarity=0.162 Sum_probs=191.2
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccC---CCEEEEEEeecccccChhhH--------HHHHHHHHHHHHcCCCceeeE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKS---GNIYAMKKLKKSEMLSRGQV--------EHVRAERNLLAEVASHCIVKL 171 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t---~~~~AiK~l~k~~~~~~~~~--------~~~~~E~~iL~~l~hp~Iv~l 171 (514)
+..++|++.+.||+|+||+||+|++..+ +..+|+|+..........+. .....+...+..++|++|+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 4457899999999999999999998877 67788886432221100010 011122334456689999999
Q ss_pred EEEEEcCC----eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEE
Q 010266 172 YYSFQDAE----YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKL 247 (514)
Q Consensus 172 ~~~f~~~~----~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL 247 (514)
++++.... ..|++||++. .++...+.....+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 98765443 4578899874 467777766666789999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccc
Q 010266 248 SDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL 327 (514)
Q Consensus 248 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl 327 (514)
+|||+|+.+......... .........||+.|+|||++
T Consensus 168 ~DFGla~~~~~~~~~~~~------------------------------------------~~~~~~~~~gt~~y~ape~~ 205 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEY------------------------------------------SKEQKDLHRGTLYYAGLDAH 205 (294)
T ss_pred EEcCCceeeccCCccccc------------------------------------------ccccccccCCCccccCHHHh
Confidence 999999865422100000 00011245799999999999
Q ss_pred ccCCCCcccchhhhhHHHHHHhhCCCCCCCCChhHH-H--------HHHhhhcCcccCCcCcCCChhHHHHHhhhcc-Cc
Q 010266 328 LKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTT-C--------RKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DV 397 (514)
Q Consensus 328 ~~~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~-~--------~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp 397 (514)
.+..|+.++|||||||++|||++|.+||.+.+.... . .++.. ..+.++ ..++++.+++..|+. +|
T Consensus 206 ~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~---~~~~~~~~~~~~~~~~~~ 280 (294)
T PHA02882 206 NGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHE--GKIKIK---NANKFIYDFIECVTKLSY 280 (294)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhh--hhhccC---CCCHHHHHHHHHHHhCCC
Confidence 999999999999999999999999999987633221 1 12211 112222 457899999999998 99
Q ss_pred cccCCCCCHhHHhc
Q 010266 398 EHRLGTLGSEQIKA 411 (514)
Q Consensus 398 ~~Rl~~~~~~eil~ 411 (514)
++|| +.++|++
T Consensus 281 ~~rp---~~~~l~~ 291 (294)
T PHA02882 281 EEKP---DYDALIK 291 (294)
T ss_pred CCCC---CHHHHHH
Confidence 9999 8888864
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=312.82 Aligned_cols=247 Identities=18% Similarity=0.261 Sum_probs=193.0
Q ss_pred eeeecCceEEEEEEEccCC--CEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecCC
Q 010266 113 IIGRGAFGEVRLCQEKKSG--NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPG 190 (514)
Q Consensus 113 ~LG~G~fG~V~l~~~~~t~--~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~g 190 (514)
.||+|+||.||+++...++ ..+++|.+.... .......+.+|..+++.++||||+++++.|.+....|+||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 5999999999999754332 345666655432 233456788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccc
Q 010266 191 GDVMTLLMRE----ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE 266 (514)
Q Consensus 191 g~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~ 266 (514)
|+|.+++.+. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++++||+|||++........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~----- 154 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY----- 154 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh-----
Confidence 9999999753 3456677888999999999999999999999999999999999999999999764221100
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-------CCCCcccchh
Q 010266 267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-------KGYGMECDWW 339 (514)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-------~~y~~~~DiW 339 (514)
.......+|++.|+|||++.. ..++.++|||
T Consensus 155 ------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diw 192 (268)
T cd05086 155 ------------------------------------------IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVW 192 (268)
T ss_pred ------------------------------------------hhcccCCcCcccccCchhcccccCccccCCCCCcchhH
Confidence 000114578999999999853 2457899999
Q ss_pred hhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcC-cccCCc-CcCCChhHHHHHhhhccCccccCCCCCHhHHhc
Q 010266 340 SLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKN-HLKFPE-EARLTPEAKDLICRLLCDVEHRLGTLGSEQIKA 411 (514)
Q Consensus 340 SlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~-~~~~p~-~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~ 411 (514)
||||++|||++ |.+||...+..+.+..+..... .+..|. ...+++.+.++|..|+.+|.+|+ ++++|++
T Consensus 193 slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~Rp---~~~~i~~ 264 (268)
T cd05086 193 ALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCWLSPEKRA---TAEEVHR 264 (268)
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHhhCcccCC---CHHHHHH
Confidence 99999999997 5789987777777766654221 111121 12478899999999988999999 8998864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=312.05 Aligned_cols=234 Identities=21% Similarity=0.260 Sum_probs=192.5
Q ss_pred eeeeecCceEEEEEEEccCC----------CEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeE
Q 010266 112 TIIGRGAFGEVRLCQEKKSG----------NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~----------~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 181 (514)
+.||+|+||.||++.++.++ ..+|+|++..... ....+.+|..+|+.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 36899999999999998777 3477887654421 15667889999999999999999999988 778
Q ss_pred EEEEeecCCCCHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC-------cEEEcccccc
Q 010266 182 YLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG-------HMKLSDFGLC 253 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g-------~iKL~DFGla 253 (514)
|+||||+++|+|.+++.... .++...+..++.|++.||.|||++||+||||||+|||++.++ ++||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998765 789999999999999999999999999999999999999888 8999999998
Q ss_pred ccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC--C
Q 010266 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK--G 331 (514)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~--~ 331 (514)
...... ...+|++.|+|||++.+. .
T Consensus 156 ~~~~~~-----------------------------------------------------~~~~~~~~y~aPE~~~~~~~~ 182 (259)
T cd05037 156 ITVLSR-----------------------------------------------------EERVERIPWIAPECIRNGQAS 182 (259)
T ss_pred cccccc-----------------------------------------------------cccccCCCccChhhhcCCCCC
Confidence 754310 034577889999999876 7
Q ss_pred CCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHH
Q 010266 332 YGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQI 409 (514)
Q Consensus 332 y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ei 409 (514)
++.++|+|||||++|+|++ |..||...+..+...... +......| .+..+.++|.+||. +|.+|+ ++.+|
T Consensus 183 ~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~li~~~l~~~p~~Rp---t~~~i 254 (259)
T cd05037 183 LTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMP----DCAELANLINQCWTYDPTKRP---SFRAI 254 (259)
T ss_pred cchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCC----CchHHHHHHHHHhccChhhCC---CHHHH
Confidence 8999999999999999999 688887765443333222 22222222 24899999999998 999999 88888
Q ss_pred hc
Q 010266 410 KA 411 (514)
Q Consensus 410 l~ 411 (514)
++
T Consensus 255 l~ 256 (259)
T cd05037 255 LR 256 (259)
T ss_pred HH
Confidence 74
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=314.12 Aligned_cols=262 Identities=27% Similarity=0.423 Sum_probs=210.4
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE--------c
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ--------D 177 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~--------~ 177 (514)
+.|+-+..||+|.||.||+|+.+.+|+.||+|++--..- +..--....+|+.||..++|+|++.|...+. +
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 556677789999999999999999999999986533211 1122234567999999999999988876553 2
Q ss_pred CCeEEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccC
Q 010266 178 AEYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256 (514)
Q Consensus 178 ~~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~ 256 (514)
...+||||.+|+ .||..+|... .+|+..+++.++.++..||.|+|++.|+|||+||+|+||+.+|.+||+|||+++.+
T Consensus 96 r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 96 RATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred cceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence 345899999996 4999999765 68999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcc
Q 010266 257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGME 335 (514)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~ 335 (514)
..+.....+ . -...+-|.+|.+||.+.+ ..|+++
T Consensus 175 s~~~n~~kp--------------------------------------------r-ytnrvvTLwYrppEllLG~r~yg~~ 209 (376)
T KOG0669|consen 175 STSKNVVKP--------------------------------------------R-YTNRVVTLWYRPPELLLGDREYGPP 209 (376)
T ss_pred ecccccCCC--------------------------------------------C-cccceeeeecCCHHHhhcccccCCc
Confidence 533211000 0 113467999999999987 569999
Q ss_pred cchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhh---------hcCcccCC-----------cC-----------cCCCh
Q 010266 336 CDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVH---------WKNHLKFP-----------EE-----------ARLTP 384 (514)
Q Consensus 336 ~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~---------~~~~~~~p-----------~~-----------~~~s~ 384 (514)
.|+|..||||.||.+|.+-|.+++...+...|.. |++...+| .. ..-++
T Consensus 210 iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~ 289 (376)
T KOG0669|consen 210 IDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDD 289 (376)
T ss_pred chhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCCh
Confidence 9999999999999999999999999888887753 22211111 10 01246
Q ss_pred hHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 385 EAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 385 ~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
++.||+.+||. ||.+|+ ++++++.|.||..
T Consensus 290 ~a~dLle~ll~~DP~kR~---~ad~alnh~~F~k 320 (376)
T KOG0669|consen 290 EALDLLEKLLKLDPTKRI---DADQALNHDFFWK 320 (376)
T ss_pred hHHHHHHHHhccCcccCc---chHhhhchhhhhc
Confidence 89999999999 999999 9999999999953
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=313.57 Aligned_cols=268 Identities=28% Similarity=0.460 Sum_probs=221.7
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC------
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA------ 178 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~------ 178 (514)
..+|.-++.+|.|+- .|..|-+.-+++.||+|++... ........+..+|..++..+.|+||++++.+|.-.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 467888999999999 7888888889999999988765 33444456778899999999999999999999644
Q ss_pred CeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
...|+|||||. ++|...+. -.++-..++++..|+++|+.|||+.||+||||||+||++..++.+||.|||+|+....
T Consensus 94 ~e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 94 QEVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred HhHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc
Confidence 35799999995 68888876 4578889999999999999999999999999999999999999999999999985431
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
. -+...++.|..|.|||++.+.+|...+||
T Consensus 171 ~--------------------------------------------------~~mtpyVvtRyyrapevil~~~~ke~vdi 200 (369)
T KOG0665|consen 171 D--------------------------------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDI 200 (369)
T ss_pred c--------------------------------------------------cccCchhheeeccCchheeccCCcccchh
Confidence 1 01225789999999999999999999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCc-----------------------------ccCCcC---------c
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNH-----------------------------LKFPEE---------A 380 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-----------------------------~~~p~~---------~ 380 (514)
||+|||+.||++|...|.|.+..+.+.+|...-++ -.||+. .
T Consensus 201 wSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~ 280 (369)
T KOG0665|consen 201 WSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSK 280 (369)
T ss_pred hhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCc
Confidence 99999999999999999999988888887631110 012211 1
Q ss_pred CCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCccccccccCCCCC
Q 010266 381 RLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKP 432 (514)
Q Consensus 381 ~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~l~~~~~p~~p 432 (514)
.-+..|+||+.+||. ||++|. +++++|.||||+ -|-.-.+.++|..|
T Consensus 281 ~~~~~ardll~~MLvi~pe~Ri---sv~daL~HPY~~--vw~~~~ev~ap~pe 328 (369)
T KOG0665|consen 281 LDCSLARDLLSKMLVIDPEKRI---SVDDALRHPYIK--VWYDPDEVEAPPPE 328 (369)
T ss_pred cchHHHHHHHHHhhccChhhcc---cHHHHhcCCeee--eecccccccCCCCc
Confidence 124679999999998 999999 999999999999 57655666666555
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=342.33 Aligned_cols=198 Identities=32% Similarity=0.535 Sum_probs=172.0
Q ss_pred eeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC------eE
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE------YL 181 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~------~l 181 (514)
+..-+.||+||||.||.++++.||+.||||.+++.. .....+...+|++||++++|||||+++++=.+.. .-
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 455678999999999999999999999999998764 3445566778999999999999999998765443 46
Q ss_pred EEEEeecCCCCHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCcccc--CCCc--EEEccccccc
Q 010266 182 YLIMEYLPGGDVMTLLMRE---ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD--QNGH--MKLSDFGLCK 254 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld--~~g~--iKL~DFGla~ 254 (514)
.+|||||+||||+..|.+. ..++|.....++..++.||.|||++|||||||||+||++- .+|. -||||||.|+
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 7999999999999999764 5799999999999999999999999999999999999985 3343 5999999999
Q ss_pred cCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCC
Q 010266 255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYG 333 (514)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~ 333 (514)
.+..+ ....+++||+.|+|||+..+ +.|+
T Consensus 173 el~d~--------------------------------------------------s~~~S~vGT~~YLhPel~E~q~~y~ 202 (732)
T KOG4250|consen 173 ELDDN--------------------------------------------------SLFTSLVGTEEYLHPELYERQKKYT 202 (732)
T ss_pred cCCCC--------------------------------------------------CeeeeecCchhhcChHHHhhccCcC
Confidence 87532 12348999999999999995 8899
Q ss_pred cccchhhhhHHHHHHhhCCCCCCC
Q 010266 334 MECDWWSLGAIMYEMLVGYPPFYS 357 (514)
Q Consensus 334 ~~~DiWSlGvilyemltG~~PF~~ 357 (514)
..||.||+||++|++.||..||-.
T Consensus 203 ~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 203 ATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred ceeehhhhhhHHHHHhccCCCCCc
Confidence 999999999999999999999953
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=344.87 Aligned_cols=264 Identities=20% Similarity=0.326 Sum_probs=185.0
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccC----CCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEE-
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKS----GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYS- 174 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t----~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~- 174 (514)
+.....++|++.+.||+|+||.||+|++..+ +..||+|++.... ..+....+ .+....+..++.+...
T Consensus 126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~~~~e--~l~~~~~~~~~~~~~~~ 198 (566)
T PLN03225 126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----AVEIWMNE--RVRRACPNSCADFVYGF 198 (566)
T ss_pred CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----hhHHHHHH--HHHhhchhhHHHHHHhh
Confidence 4556789999999999999999999999988 8999999876432 11111111 1122222222222222
Q ss_pred -----EEcCCeEEEEEeecCCCCHHHHHhhccC--------------------CCHHHHHHHHHHHHHHHHHHHhCCeEE
Q 010266 175 -----FQDAEYLYLIMEYLPGGDVMTLLMREET--------------------LTETVARFYIAQSVLAIESIHKHNYIH 229 (514)
Q Consensus 175 -----f~~~~~l~lVmEy~~gg~L~~~l~~~~~--------------------l~e~~~~~~~~qi~~aL~~LH~~giiH 229 (514)
..+...+++||||+++|+|.+++..... ..+..++.++.|++.||.|||++||||
T Consensus 199 ~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiH 278 (566)
T PLN03225 199 LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVH 278 (566)
T ss_pred hcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence 2456789999999999999999865321 123446678999999999999999999
Q ss_pred cCCCCCCccccC-CCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhc
Q 010266 230 RDIKPDNLLLDQ-NGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINR 308 (514)
Q Consensus 230 rDLKpeNILld~-~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (514)
|||||+|||++. ++++||+|||+|+.+.....
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~----------------------------------------------- 311 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN----------------------------------------------- 311 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCccccccccc-----------------------------------------------
Confidence 999999999985 68999999999975432100
Q ss_pred cccccccccCCCcCCccccccC----------------------CCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHH
Q 010266 309 RKLAYSTVGTPDYIAPEVLLKK----------------------GYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRK 366 (514)
Q Consensus 309 ~~~~~s~~GT~~Y~APEvl~~~----------------------~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~ 366 (514)
.....++||+.|||||.+... .++.++|||||||+||||+++..|+. +....+..
T Consensus 312 -~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~--~~~~~~~~ 388 (566)
T PLN03225 312 -YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSD--SNLIQFNR 388 (566)
T ss_pred -cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCc--hHHHHHHH
Confidence 011256899999999976432 23456799999999999999766643 33333333
Q ss_pred Hhh--------hcCccc--CC-c-------CcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCcccc
Q 010266 367 IVH--------WKNHLK--FP-E-------EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKL 423 (514)
Q Consensus 367 i~~--------~~~~~~--~p-~-------~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~l 423 (514)
++. |..... .+ . ....+..++|||.+||+ ||.+|+ +++|+++||||.+.+|..+
T Consensus 389 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~---ta~e~L~Hpff~~~~~~~~ 461 (566)
T PLN03225 389 QLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI---SAKAALAHPYFDREGLLGL 461 (566)
T ss_pred HHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCC---CHHHHhCCcCcCCCCcccc
Confidence 221 111000 00 0 00123456799999999 999999 9999999999999887644
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=354.60 Aligned_cols=271 Identities=28% Similarity=0.431 Sum_probs=202.7
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc-------
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------- 177 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~------- 177 (514)
.+||+.+..||+||||.||+|+++-+|..||||+|.-.. .......+.+|+.+|++++|||||+.|.++..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 368999999999999999999999999999999997654 55666778999999999999999999976500
Q ss_pred --------------------------------------------------------------------------------
Q 010266 178 -------------------------------------------------------------------------------- 177 (514)
Q Consensus 178 -------------------------------------------------------------------------------- 177 (514)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C--------CeEEEEEeecCCCCHHHHHhhccCC-CHHHHHHHHHHHHHHHHHHHh
Q 010266 178 ------------------------A--------EYLYLIMEYLPGGDVMTLLMREETL-TETVARFYIAQSVLAIESIHK 224 (514)
Q Consensus 178 ------------------------~--------~~l~lVmEy~~gg~L~~~l~~~~~l-~e~~~~~~~~qi~~aL~~LH~ 224 (514)
. ..+|+-||||+...|.+++.++... ....++.+++||+.||.|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 0 2479999999876666666554443 477888999999999999999
Q ss_pred CCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHH
Q 010266 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHW 304 (514)
Q Consensus 225 ~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (514)
+|||||||||.||++|++++|||+|||+|+......... ..... ..+......
T Consensus 716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~------d~~~~------~~~~~~g~~--------------- 768 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESI------DQDLS------FSTNRAGSN--------------- 768 (1351)
T ss_pred CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhH------hhccC------ccccccCCC---------------
Confidence 999999999999999999999999999998632100000 00000 000000000
Q ss_pred hhhccccccccccCCCcCCccccccCC---CCcccchhhhhHHHHHHhhCCCCCCCCC-hhHHHHHHhhhcCcccCCcC-
Q 010266 305 QINRRKLAYSTVGTPDYIAPEVLLKKG---YGMECDWWSLGAIMYEMLVGYPPFYSDD-PVTTCRKIVHWKNHLKFPEE- 379 (514)
Q Consensus 305 ~~~~~~~~~s~~GT~~Y~APEvl~~~~---y~~~~DiWSlGvilyemltG~~PF~~~~-~~~~~~~i~~~~~~~~~p~~- 379 (514)
..-..+.+||.-|+|||++.+.. |+.++|+||||||+|||+. ||...- ...+..++. ...+++|..
T Consensus 769 ----~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR--~g~iP~~~~f 839 (1351)
T KOG1035|consen 769 ----DGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR--KGSIPEPADF 839 (1351)
T ss_pred ----CcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc--cCCCCCCccc
Confidence 00122679999999999998754 9999999999999999984 575432 223333332 233333310
Q ss_pred -cCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccc
Q 010266 380 -ARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFK 416 (514)
Q Consensus 380 -~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~ 416 (514)
..--+....+|+.||. ||.+|| ||.|+|++.||-
T Consensus 840 ~~~~~~~e~slI~~Ll~hdP~kRP---tA~eLL~s~llp 875 (1351)
T KOG1035|consen 840 FDPEHPEEASLIRWLLSHDPSKRP---TATELLNSELLP 875 (1351)
T ss_pred ccccchHHHHHHHHHhcCCCccCC---CHHHHhhccCCC
Confidence 1123566789999999 999999 999999999997
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=344.11 Aligned_cols=256 Identities=25% Similarity=0.416 Sum_probs=218.6
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEc-----cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEE
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYS 174 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 174 (514)
...+...+-++.+.||+|+||+||+++.- .....||||.++... ......++++|+++|+.++|||||+|++.
T Consensus 480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGV 557 (774)
T KOG1026|consen 480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGV 557 (774)
T ss_pred eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 34567788999999999999999999853 234679999998653 34467889999999999999999999999
Q ss_pred EEcCCeEEEEEeecCCCCHHHHHhhc----------c----CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCcccc
Q 010266 175 FQDAEYLYLIMEYLPGGDVMTLLMRE----------E----TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD 240 (514)
Q Consensus 175 f~~~~~l~lVmEy~~gg~L~~~l~~~----------~----~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld 240 (514)
+..++.+|||+|||..|||..+|... . .++..+...++.||+.|++||-++.+|||||-..|+||.
T Consensus 558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG 637 (774)
T ss_pred EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec
Confidence 99999999999999999999999642 1 277778888999999999999999999999999999999
Q ss_pred CCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCC
Q 010266 241 QNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPD 320 (514)
Q Consensus 241 ~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~ 320 (514)
++..|||+||||++..-+.++..... ...--..
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~-----------------------------------------------~t~lPIR 670 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRG-----------------------------------------------NTLLPIR 670 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccC-----------------------------------------------Cceeeee
Confidence 99999999999999765443321110 0112347
Q ss_pred cCCccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-Ccc
Q 010266 321 YIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVE 398 (514)
Q Consensus 321 Y~APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~ 398 (514)
|||||.|...+|+.++||||+||+|||+++ |..|+++-+.++....|.+..- +.-| ...+.++.+|+.+|.. .|.
T Consensus 671 WMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L~~P--e~CP~~vY~LM~~CW~~~P~ 747 (774)
T KOG1026|consen 671 WMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-LSCP--ENCPTEVYSLMLECWNENPK 747 (774)
T ss_pred cCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc-ccCC--CCCCHHHHHHHHHHhhcCcc
Confidence 999999999999999999999999999997 9999999999999999987543 4555 4789999999999998 999
Q ss_pred ccCCCCCHhHHh
Q 010266 399 HRLGTLGSEQIK 410 (514)
Q Consensus 399 ~Rl~~~~~~eil 410 (514)
+|+ ++.||-
T Consensus 748 ~RP---sF~eI~ 756 (774)
T KOG1026|consen 748 RRP---SFKEIH 756 (774)
T ss_pred cCC---CHHHHH
Confidence 999 777774
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=337.19 Aligned_cols=261 Identities=30% Similarity=0.515 Sum_probs=221.9
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEE--
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQ-- 176 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~-- 176 (514)
......+-|+++.+||+|.+|+||+++++.+++..|+|++.... +..+.+..|.+||... +|||++.+|++|.
T Consensus 13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 34455678999999999999999999999999999999986543 3345577899999877 6999999999885
Q ss_pred ---cCCeEEEEEeecCCCCHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccc
Q 010266 177 ---DAEYLYLIMEYLPGGDVMTLLMR--EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251 (514)
Q Consensus 177 ---~~~~l~lVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFG 251 (514)
.++.|+||||||.||+.-+++.. ..++.|+.+..++.+++.||.+||.+.+||||||-.|||++.+|.+||+|||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeee
Confidence 46789999999999999999864 5689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc--
Q 010266 252 LCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-- 329 (514)
Q Consensus 252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-- 329 (514)
++..++.. +...++.+|||.|||||++..
T Consensus 169 vSaQldsT-------------------------------------------------~grRnT~iGtP~WMAPEViac~e 199 (953)
T KOG0587|consen 169 VSAQLDST-------------------------------------------------VGRRNTFIGTPYWMAPEVIACDE 199 (953)
T ss_pred eeeeeecc-------------------------------------------------cccccCcCCCcccccceeeeccc
Confidence 99876532 112358899999999999974
Q ss_pred ---CCCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCC
Q 010266 330 ---KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLG 405 (514)
Q Consensus 330 ---~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~ 405 (514)
..|+..+|+||||++..||--|.||+....+...+-.|-.. .++.+-.+..+|.++-|||..||. |-++|+ +
T Consensus 200 ~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN-PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP---~ 275 (953)
T KOG0587|consen 200 SPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PPPKLKRPKKWSKKFNDFISTCLVKDYEQRP---S 275 (953)
T ss_pred CCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCC-CCccccchhhHHHHHHHHHHHHHhhccccCc---c
Confidence 34788999999999999999999999988887666666432 222232344689999999999998 888998 8
Q ss_pred HhHHhcCCcccc
Q 010266 406 SEQIKAHPWFKD 417 (514)
Q Consensus 406 ~~eil~Hpff~~ 417 (514)
..+++.|||...
T Consensus 276 ~~~ll~hpFi~e 287 (953)
T KOG0587|consen 276 TEELLKHPFITE 287 (953)
T ss_pred hhhhccCCcccc
Confidence 999999999984
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=332.04 Aligned_cols=255 Identities=21% Similarity=0.290 Sum_probs=209.4
Q ss_pred hcCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC
Q 010266 99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA 178 (514)
Q Consensus 99 ~~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 178 (514)
..+.+..+++.+...||+|.||+||.+++-. .||||+++-... ...+.+.++.|+.+|++.+|.||+-+.+++..+
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 3466778889999999999999999988753 599999987765 556899999999999999999999999999887
Q ss_pred CeEEEEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
.. .+|..+|.|.+|..+|+- ...|+...++.++.|+++|+.|||.++|||||||..||+|.+++.|||+||||+..-.
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 77 999999999999999975 4579999999999999999999999999999999999999999999999999986421
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc---CCCCc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK---KGYGM 334 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~y~~ 334 (514)
.- +.........|...|||||+++. .+|++
T Consensus 540 ~w-----------------------------------------------~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~ 572 (678)
T KOG0193|consen 540 RW-----------------------------------------------SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSF 572 (678)
T ss_pred ee-----------------------------------------------ccccccCCCccchhhhcHHHHhhcccCCCCc
Confidence 10 00001123458889999999974 57999
Q ss_pred ccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCc----CcCCChhHHHHHhhhcc-CccccCCCCCHhHH
Q 010266 335 ECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPE----EARLTPEAKDLICRLLC-DVEHRLGTLGSEQI 409 (514)
Q Consensus 335 ~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~----~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ei 409 (514)
.+|||||||++|||++|..||...+..+++-.+-.+ . -.|+ ......++++|+..|+. ++++|+ .+.+|
T Consensus 573 qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG--~-l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP---~F~~i 646 (678)
T KOG0193|consen 573 QSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRG--Y-LMPDLSKIRSNCPKAMKRLLSDCWKFDREERP---LFPQL 646 (678)
T ss_pred ccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccc--c-cCccchhhhccCHHHHHHHHHHHHhcCcccCc---cHHHH
Confidence 999999999999999999999966665544333322 1 1121 12344689999999998 999999 77787
Q ss_pred hc
Q 010266 410 KA 411 (514)
Q Consensus 410 l~ 411 (514)
+.
T Consensus 647 l~ 648 (678)
T KOG0193|consen 647 LS 648 (678)
T ss_pred HH
Confidence 74
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=320.39 Aligned_cols=199 Identities=27% Similarity=0.382 Sum_probs=171.9
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC-eEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE-YLYLI 184 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~-~l~lV 184 (514)
++|.--..||+|+||.||++...+ |..||||.+....... ...+.+|+.+|..++|||+|+|+++|.+.+ ..+||
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV 150 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV 150 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence 788888999999999999998644 4899999776543211 445999999999999999999999999988 59999
Q ss_pred EeecCCCCHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---eEEcCCCCCCccccCCCcEEEccccccccCCC-
Q 010266 185 MEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHN---YIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC- 258 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKpeNILld~~g~iKL~DFGla~~~~~- 258 (514)
+|||++|+|.++|.... .++......++.+++.||+|||... ||||||||+|||||.++.+||+|||||+....
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG 230 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence 99999999999998765 8888888899999999999999853 99999999999999999999999999965432
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhcccccccc-ccCCCcCCccccccCCCCcccc
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYST-VGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-~GT~~Y~APEvl~~~~y~~~~D 337 (514)
.. ...+. .||.+|+|||++..+..+.++|
T Consensus 231 ~~--------------------------------------------------~~~~~~~gt~gY~~PEy~~~g~lt~KsD 260 (361)
T KOG1187|consen 231 DT--------------------------------------------------SVSTTVMGTFGYLAPEYASTGKLTEKSD 260 (361)
T ss_pred cc--------------------------------------------------ceeeecCCCCccCChhhhccCCcCcccc
Confidence 10 00122 7999999999999988999999
Q ss_pred hhhhhHHHHHHhhCCCCCCCC
Q 010266 338 WWSLGAIMYEMLVGYPPFYSD 358 (514)
Q Consensus 338 iWSlGvilyemltG~~PF~~~ 358 (514)
||||||+|.|+++|+.|....
T Consensus 261 VySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 261 VYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred cccchHHHHHHHhCCcccCCC
Confidence 999999999999999988753
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=294.70 Aligned_cols=253 Identities=29% Similarity=0.513 Sum_probs=208.1
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEEEcCC--e
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAE--Y 180 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~--~ 180 (514)
..++|++++.+|+|-|++|+.+.+..+++.++||+++.- ..+.+.+|+.||..+. ||||++|++...|.. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 468999999999999999999999899999999998643 2345889999999997 999999999998764 4
Q ss_pred EEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCC-CcEEEccccccccCCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~-g~iKL~DFGla~~~~~~ 259 (514)
..||+||+.+.|+..+. ..++...+++|+.|++.||+|+|++||+|||+||.|++||.. -.++|+|+|||......
T Consensus 110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 67999999998887765 567888999999999999999999999999999999999954 67999999999876543
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccch
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDW 338 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~Di 338 (514)
.. -+-.+.+..|--||.+.. +-|+.+-|+
T Consensus 187 ~e--------------------------------------------------YnVRVASRyfKGPELLVdy~~YDYSLD~ 216 (338)
T KOG0668|consen 187 KE--------------------------------------------------YNVRVASRYFKGPELLVDYQMYDYSLDM 216 (338)
T ss_pred ce--------------------------------------------------eeeeeehhhcCCchheeechhccccHHH
Confidence 11 113467778899999986 668999999
Q ss_pred hhhhHHHHHHhhCCCCCC-CCChhHHHHHHhh---------------------------------hcCcccCCcCcCCCh
Q 010266 339 WSLGAIMYEMLVGYPPFY-SDDPVTTCRKIVH---------------------------------WKNHLKFPEEARLTP 384 (514)
Q Consensus 339 WSlGvilyemltG~~PF~-~~~~~~~~~~i~~---------------------------------~~~~~~~p~~~~~s~ 384 (514)
|||||+|..|++.+-||. |.+..++.-+|.. |...+.-....-+++
T Consensus 217 WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~p 296 (338)
T KOG0668|consen 217 WSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSP 296 (338)
T ss_pred HHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCCh
Confidence 999999999999988874 5565555555532 111111111123579
Q ss_pred hHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 385 EAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 385 ~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
++.|||.+||. |-.+|+ |+.|++.||||..+
T Consensus 297 eaiDlldklLrYDHqeRl---TakEam~HpyF~~~ 328 (338)
T KOG0668|consen 297 EAIDLLDKLLRYDHQERL---TAKEAMAHPYFAPV 328 (338)
T ss_pred HHHHHHHHHHhhcccccc---chHHHhcCchHHHH
Confidence 99999999999 999999 99999999999754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=328.08 Aligned_cols=269 Identities=22% Similarity=0.308 Sum_probs=189.5
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEc----------------cCCCEEEEEEeecccccC-----------hhhHHHH
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEK----------------KSGNIYAMKKLKKSEMLS-----------RGQVEHV 153 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~----------------~t~~~~AiK~l~k~~~~~-----------~~~~~~~ 153 (514)
.++..++|++.++||+|+||.||++... ..++.||||.+....... ....+..
T Consensus 140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~ 219 (507)
T PLN03224 140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG 219 (507)
T ss_pred CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence 4567889999999999999999998642 345679999986432110 0111223
Q ss_pred HHHHHHHHHcCCCce-----eeEEEEEE--------cCCeEEEEEeecCCCCHHHHHhhc--------------------
Q 010266 154 RAERNLLAEVASHCI-----VKLYYSFQ--------DAEYLYLIMEYLPGGDVMTLLMRE-------------------- 200 (514)
Q Consensus 154 ~~E~~iL~~l~hp~I-----v~l~~~f~--------~~~~l~lVmEy~~gg~L~~~l~~~-------------------- 200 (514)
..|..++..++|+++ ++++++|. +....+|||||+++|+|.++|...
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 346667777766554 56666553 245689999999999999988642
Q ss_pred ----cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccccccccccccc
Q 010266 201 ----ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLN 276 (514)
Q Consensus 201 ----~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~ 276 (514)
..++...++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~--------------- 364 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN--------------- 364 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc---------------
Confidence 1234567888999999999999999999999999999999999999999999865431100
Q ss_pred ccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCC--------------------CC--c
Q 010266 277 ESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG--------------------YG--M 334 (514)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~--------------------y~--~ 334 (514)
.......+||.|+|||++.... |+ .
T Consensus 365 ---------------------------------~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~ 411 (507)
T PLN03224 365 ---------------------------------FNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPD 411 (507)
T ss_pred ---------------------------------cCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCC
Confidence 0001234689999999986432 22 2
Q ss_pred ccchhhhhHHHHHHhhCCC-CCCCCChh----HHHHHH-hhh----cCcccCCcCcCCChhHHHHHhhhcc-CccccCCC
Q 010266 335 ECDWWSLGAIMYEMLVGYP-PFYSDDPV----TTCRKI-VHW----KNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT 403 (514)
Q Consensus 335 ~~DiWSlGvilyemltG~~-PF~~~~~~----~~~~~i-~~~----~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~ 403 (514)
.+|+||+||++|+|++|.. ||.+.... ..+... ..| .....++.....|+.++|||.+||+ +|.++.+|
T Consensus 412 ~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~R 491 (507)
T PLN03224 412 LFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGR 491 (507)
T ss_pred ccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccC
Confidence 4799999999999999985 77542111 111111 111 1234455555789999999999998 66432233
Q ss_pred CCHhHHhcCCcccc
Q 010266 404 LGSEQIKAHPWFKD 417 (514)
Q Consensus 404 ~~~~eil~Hpff~~ 417 (514)
+|++|+++||||..
T Consensus 492 lSa~eaL~Hp~f~~ 505 (507)
T PLN03224 492 LSVGQALSHRFFLP 505 (507)
T ss_pred CCHHHHhCCCCcCC
Confidence 39999999999953
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=305.93 Aligned_cols=262 Identities=27% Similarity=0.455 Sum_probs=209.0
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHH-HHHcCCCceeeEEEEEEcCC
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL-LAEVASHCIVKLYYSFQDAE 179 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~i-L~~l~hp~Iv~l~~~f~~~~ 179 (514)
+.+..++.+-+..||.|+||+|++..++.+|+..|||.++.... ..+..+++.|.+. ++.-+.|+||++|++...+.
T Consensus 59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG 136 (361)
T KOG1006|consen 59 HTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG 136 (361)
T ss_pred cccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC
Confidence 34556677778899999999999999999999999999986643 3444556667665 45568999999999998899
Q ss_pred eEEEEEeecCCCCHHHHHh-----hccCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCCccccCCCcEEEcccccc
Q 010266 180 YLYLIMEYLPGGDVMTLLM-----REETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~-----~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKpeNILld~~g~iKL~DFGla 253 (514)
-.++.||.|. .+|..+.. +...++|...-.+....+.||+||.. ..|||||+||+|||+|..|.+||||||+|
T Consensus 137 dcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIc 215 (361)
T KOG1006|consen 137 DCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGIC 215 (361)
T ss_pred ceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccch
Confidence 9999999994 56655432 35689999999999999999999985 68999999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc--cCC
Q 010266 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL--KKG 331 (514)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~--~~~ 331 (514)
..+..+-. ..--+|-..|||||-+. +.+
T Consensus 216 GqLv~SiA--------------------------------------------------kT~daGCrpYmAPERi~p~~~g 245 (361)
T KOG1006|consen 216 GQLVDSIA--------------------------------------------------KTVDAGCRPYMAPERIDPSDKG 245 (361)
T ss_pred HhHHHHHH--------------------------------------------------hhhccCCccccChhccCCccCC
Confidence 76542210 00236888999999997 457
Q ss_pred CCcccchhhhhHHHHHHhhCCCCCCCCCh-hHHHHHHhhhcCc-ccCCc-CcCCChhHHHHHhhhcc-CccccCCCCCHh
Q 010266 332 YGMECDWWSLGAIMYEMLVGYPPFYSDDP-VTTCRKIVHWKNH-LKFPE-EARLTPEAKDLICRLLC-DVEHRLGTLGSE 407 (514)
Q Consensus 332 y~~~~DiWSlGvilyemltG~~PF~~~~~-~~~~~~i~~~~~~-~~~p~-~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ 407 (514)
|+.++|+||||+.|||+.||..|+.+-+. -++...++.+..+ +.++. ....|..+..+|.-||. |-..|+ ...
T Consensus 246 yDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rp---ky~ 322 (361)
T KOG1006|consen 246 YDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRP---KYD 322 (361)
T ss_pred cchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCc---chh
Confidence 99999999999999999999999987654 3334444443222 22332 24589999999999998 888888 889
Q ss_pred HHhcCCccccC
Q 010266 408 QIKAHPWFKDI 418 (514)
Q Consensus 408 eil~Hpff~~i 418 (514)
++++|||++..
T Consensus 323 ~Lk~~~fyr~y 333 (361)
T KOG1006|consen 323 DLKKFPFYRMY 333 (361)
T ss_pred hhhcCchhhhh
Confidence 99999999753
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=339.72 Aligned_cols=254 Identities=23% Similarity=0.378 Sum_probs=215.2
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCC-----EEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGN-----IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 177 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~-----~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 177 (514)
+....-++.+.||+|+||.||.+....-.. .||||.+++. .+..++..+.+|..+|+.++|||||+|.+.+.+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 446778899999999999999998765322 3899998764 467788899999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccc
Q 010266 178 AEYLYLIMEYLPGGDVMTLLMRE-------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDF 250 (514)
Q Consensus 178 ~~~l~lVmEy~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DF 250 (514)
....++++|||.||||..+|+.. ..++......++.+|+.|++||+++++|||||...|+||+....+||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999865 35788888999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC
Q 010266 251 GLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK 330 (514)
Q Consensus 251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~ 330 (514)
|||+.+......... + ...--..|||||.+...
T Consensus 847 GlArDiy~~~yyr~~-----------------------~------------------------~a~lPvkWm~PEsl~d~ 879 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKH-----------------------G------------------------EAMLPVKWMPPESLKDG 879 (1025)
T ss_pred chhHhhhhchheecc-----------------------C------------------------ccccceecCCHHHHhhc
Confidence 999954322111000 0 00112379999999999
Q ss_pred CCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhH
Q 010266 331 GYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQ 408 (514)
Q Consensus 331 ~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~e 408 (514)
.++.++|||||||+|||+++ |.+||.+.+..+...-.+... .+..| ...++...+++..|+. +|++|+ ++..
T Consensus 880 iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~~P--~~CP~~ly~lM~~CW~~~pe~RP---~F~~ 953 (1025)
T KOG1095|consen 880 IFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLDPP--SYCPEKLYQLMLQCWKHDPEDRP---SFRT 953 (1025)
T ss_pred ccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccCCC--CCCChHHHHHHHHHccCChhhCc---cHHH
Confidence 99999999999999999998 999999999988888777643 44444 5789999999999998 999999 7777
Q ss_pred Hhc
Q 010266 409 IKA 411 (514)
Q Consensus 409 il~ 411 (514)
|++
T Consensus 954 i~~ 956 (1025)
T KOG1095|consen 954 IVE 956 (1025)
T ss_pred HHh
Confidence 775
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=321.22 Aligned_cols=262 Identities=26% Similarity=0.458 Sum_probs=217.0
Q ss_pred HHHhhcCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC------CCce
Q 010266 95 YMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA------SHCI 168 (514)
Q Consensus 95 ~~~~~~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~------hp~I 168 (514)
|.++....+--++|.+....|+|-||+|..|.+..-|+.||||+|...++..+. =+.|.+||.+++ --++
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~Kt----Gl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKT----GLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhh----hhHHHHHHHHhhccCchhhhHH
Confidence 555566667778999999999999999999999999999999999887654333 356899999885 2378
Q ss_pred eeEEEEEEcCCeEEEEEeecCCCCHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCC-Cc
Q 010266 169 VKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE---TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-GH 244 (514)
Q Consensus 169 v~l~~~f~~~~~l~lVmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~-g~ 244 (514)
+.|+..|...++||||+|-+ .-+|..+|.+.+ .|....++.|+.|++.||..|..+||+|.||||+|||++.. ..
T Consensus 497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcce
Confidence 99999999999999999988 569999998764 58888999999999999999999999999999999999965 56
Q ss_pred EEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCc
Q 010266 245 MKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAP 324 (514)
Q Consensus 245 iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~AP 324 (514)
+||||||.|........ ..+.-+..|.||
T Consensus 576 LKLCDfGSA~~~~enei---------------------------------------------------tPYLVSRFYRaP 604 (752)
T KOG0670|consen 576 LKLCDFGSASFASENEI---------------------------------------------------TPYLVSRFYRAP 604 (752)
T ss_pred eeeccCccccccccccc---------------------------------------------------cHHHHHHhccCc
Confidence 89999999876543211 133455679999
Q ss_pred cccccCCCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCc--------------------------
Q 010266 325 EVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPE-------------------------- 378 (514)
Q Consensus 325 Evl~~~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~-------------------------- 378 (514)
|++.|.+|++..|+||+||+|||+.||+..|.|.+...++...+..++ .||.
T Consensus 605 EIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG--k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~ 682 (752)
T KOG0670|consen 605 EIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG--KFPNKMLRKGQFKDQHFDQDLNFLYIEVDK 682 (752)
T ss_pred ceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC--CCcHHHhhhcchhhhhcccccceEEEeccc
Confidence 999999999999999999999999999999999988887766553221 1111
Q ss_pred -------------------------------C-cCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 379 -------------------------------E-ARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 379 -------------------------------~-~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
. ..+-.+++|||.+||. ||++|+ ++.++|+||||..
T Consensus 683 vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi---t~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 683 VTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI---TVNQALKHPFITE 751 (752)
T ss_pred cccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC---CHHHHhcCCcccC
Confidence 0 0012568999999999 999999 9999999999964
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=287.81 Aligned_cols=241 Identities=46% Similarity=0.805 Sum_probs=205.1
Q ss_pred CceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecCCCCHHHHH
Q 010266 118 AFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL 197 (514)
Q Consensus 118 ~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~l 197 (514)
+||.||+|....+|+.+|+|++........ ...+..|..+++.++|++|+++++.+.+....++||||+++++|..++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 689999999998999999999976543221 577889999999999999999999999999999999999999999999
Q ss_pred hhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccccccccccccccc
Q 010266 198 MREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNE 277 (514)
Q Consensus 198 ~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~ 277 (514)
.....++...+..++.+++.+|.+||+.||+|+||+|+||+++.+|.++|+|||++.......
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----------------- 141 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----------------- 141 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-----------------
Confidence 877668999999999999999999999999999999999999999999999999987654221
Q ss_pred cCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhhCCCCCCC
Q 010266 278 SMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 357 (514)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemltG~~PF~~ 357 (514)
......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..
T Consensus 142 ---------------------------------~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 142 ---------------------------------LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred ---------------------------------ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 01145689999999999988899999999999999999999999987
Q ss_pred -CChhHHHHHHhhhcCcccCCcCcC-CChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 358 -DDPVTTCRKIVHWKNHLKFPEEAR-LTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 358 -~~~~~~~~~i~~~~~~~~~p~~~~-~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
.+.......+... ....+.... ++.++.+++.+||. +|.+|+ ++.++++||||
T Consensus 189 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp---~~~~~~~~~~~ 244 (244)
T smart00220 189 DDQLLELFKKIGKP--KPPFPPPEWKISPEAKDLIRKLLVKDPEKRL---TAEEALQHPFF 244 (244)
T ss_pred CCcHHHHHHHHhcc--CCCCccccccCCHHHHHHHHHHccCCchhcc---CHHHHhhCCCC
Confidence 4444444444331 122221111 78899999999998 999999 99999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=316.75 Aligned_cols=202 Identities=33% Similarity=0.546 Sum_probs=182.8
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChh-----hHHHHHHHHHHHHHcC---CCceeeEEEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRG-----QVEHVRAERNLLAEVA---SHCIVKLYYSFQ 176 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~-----~~~~~~~E~~iL~~l~---hp~Iv~l~~~f~ 176 (514)
..+|..++.+|.|+||+|++|.++.+...|+||.+.|..+.-.. ....+-.|+.||+.++ |+||++++.+|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 46899999999999999999999999999999999998765433 3344667999999997 999999999999
Q ss_pred cCCeEEEEEeec-CCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 177 DAEYLYLIMEYL-PGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 177 ~~~~l~lVmEy~-~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
++++.||+||-. +|-||+++|.....++|.+++.++.|++.|+++||+.||||||||-|||.++.+|-+||+|||.|..
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence 999999999985 4679999999999999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCC-Cc
Q 010266 256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GM 334 (514)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~ 334 (514)
..++. -..++||.+|.|||++.+.+| +.
T Consensus 720 ~ksgp---------------------------------------------------fd~f~gtv~~aapevl~g~~y~gk 748 (772)
T KOG1152|consen 720 TKSGP---------------------------------------------------FDVFVGTVDYAAPEVLGGEKYLGK 748 (772)
T ss_pred hcCCC---------------------------------------------------cceeeeeccccchhhhCCCccCCC
Confidence 54321 127899999999999999998 88
Q ss_pred ccchhhhhHHHHHHhhCCCCCCC
Q 010266 335 ECDWWSLGAIMYEMLVGYPPFYS 357 (514)
Q Consensus 335 ~~DiWSlGvilyemltG~~PF~~ 357 (514)
.-|||+||++||-+++...||+.
T Consensus 749 ~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 749 PQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cchhhhhhheeeEEEeccCCCcC
Confidence 99999999999999999999975
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=290.14 Aligned_cols=261 Identities=28% Similarity=0.465 Sum_probs=212.4
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC-----e
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE-----Y 180 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~-----~ 180 (514)
-|.+--+.||.|+||.||.|.+..+|+.||+|++..- ..+--.-+.+.+|..+|...+|.|+..+++..|-.. .
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 3555567899999999999999999999999988642 222233467889999999999999999988877543 4
Q ss_pred EEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
+|+|.|.|. .||..++-....++.+.++.+++||+.||.|||+.||.||||||.|.|++++..+|||||||++......
T Consensus 132 iYV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 132 LYVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 789999995 5999999999999999999999999999999999999999999999999999999999999998654221
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWW 339 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiW 339 (514)
. +.+ ..-+-|-.|.|||++.+ ..|+.++|||
T Consensus 211 ~-----------------------------------------------~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiW 242 (449)
T KOG0664|consen 211 R-----------------------------------------------LNM-THEVVTQYYRAPELLMGARRYTGAVDIW 242 (449)
T ss_pred h-----------------------------------------------hhh-HHHHHHHHhccHHHhhcchhhcCcccee
Confidence 0 001 13467889999999998 5689999999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhHHHHHHhhh---------------------cCcccCCcC---------cCCChhHHHH
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHW---------------------KNHLKFPEE---------ARLTPEAKDL 389 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~~~~~~i~~~---------------------~~~~~~p~~---------~~~s~~~~dL 389 (514)
|+|||+.|+|..+..|...++.+..+.|... .....-|.. ..-..++.++
T Consensus 243 SVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~ 322 (449)
T KOG0664|consen 243 SVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDL 322 (449)
T ss_pred hhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHH
Confidence 9999999999999999999998888777531 111122211 1223578889
Q ss_pred Hhhhcc-CccccCCCCCHhHHhcCCccccCC
Q 010266 390 ICRLLC-DVEHRLGTLGSEQIKAHPWFKDIA 419 (514)
Q Consensus 390 I~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~ 419 (514)
+..+|. ||..|. +.++.+.|++.....
T Consensus 323 ~~~~l~~d~dkri---s~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 323 LQKLLHFDPDKRI---SVEEALQHRYLEEGR 350 (449)
T ss_pred HHHHhCCCCcccc---cHhhhcccccccccc
Confidence 999998 999998 899999999987643
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=269.79 Aligned_cols=223 Identities=28% Similarity=0.479 Sum_probs=183.0
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHH-cCCCceeeEEEEEEcCC
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE-VASHCIVKLYYSFQDAE 179 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~f~~~~ 179 (514)
..+..++...+..||+|+||.|-+.++..+|...|+|.++... .....++...|.++... ..+|++|.+|+.+.+..
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 4455667777889999999999999999999999999997553 34455667778887654 57999999999999999
Q ss_pred eEEEEEeecCCCCHHHH----HhhccCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCCccccCCCcEEEccccccc
Q 010266 180 YLYLIMEYLPGGDVMTL----LMREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~----l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKpeNILld~~g~iKL~DFGla~ 254 (514)
.+++.||.|. .+|..+ +.+.+.++|..+-.++..++.||.|||+ +.+||||+||+||||+.+|++|+||||+|-
T Consensus 119 dvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 119 DVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred cEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 9999999994 466654 4456789999999999999999999996 499999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccc-cccCCCcCCcccccc----
Q 010266 255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYS-TVGTPDYIAPEVLLK---- 329 (514)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s-~~GT~~Y~APEvl~~---- 329 (514)
.+..+- +.+ -.|--.|||||.+..
T Consensus 198 ~L~dSi---------------------------------------------------Akt~daGCkpYmaPEri~~e~n~ 226 (282)
T KOG0984|consen 198 YLVDSI---------------------------------------------------AKTMDAGCKPYMAPERINPELNQ 226 (282)
T ss_pred eehhhh---------------------------------------------------HHHHhcCCCccCChhhcCcccCc
Confidence 654321 112 458889999999863
Q ss_pred CCCCcccchhhhhHHHHHHhhCCCCCCC-CChhHHHHHHhhhcCcccCCc
Q 010266 330 KGYGMECDWWSLGAIMYEMLVGYPPFYS-DDPVTTCRKIVHWKNHLKFPE 378 (514)
Q Consensus 330 ~~y~~~~DiWSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~~~~~p~ 378 (514)
.+|+.++|+||||+.++||.+++.||.. .++-+++..++.. ....+|.
T Consensus 227 ~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee-p~P~Lp~ 275 (282)
T KOG0984|consen 227 KGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE-PSPQLPA 275 (282)
T ss_pred ccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC-CCCCCcc
Confidence 5899999999999999999999999975 4667777777752 2334443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=290.87 Aligned_cols=142 Identities=23% Similarity=0.426 Sum_probs=119.9
Q ss_pred HHHhhcCCCCC-CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-----CC--
Q 010266 95 YMRLKRHKISV-DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-----SH-- 166 (514)
Q Consensus 95 ~~~~~~~~~~~-~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-----hp-- 166 (514)
|-.+..+.+.. .+|.++++||+|.|++||||.+..+.+.||||+.+.... ..+....|+.+|++++ |+
T Consensus 66 YHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh----YtEaAlDEIklL~~v~~~Dp~~~~~ 141 (590)
T KOG1290|consen 66 YHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH----YTEAALDEIKLLQQVREGDPNDPGK 141 (590)
T ss_pred CceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH----HHHHHHHHHHHHHHHHhcCCCCCCC
Confidence 34444444444 899999999999999999999999999999999976533 3445678999998873 33
Q ss_pred -ceeeEEEEEE----cCCeEEEEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCCcc
Q 010266 167 -CIVKLYYSFQ----DAEYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLL 238 (514)
Q Consensus 167 -~Iv~l~~~f~----~~~~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKpeNIL 238 (514)
+||+|++.|. ...++|||+|++ |.+|..+|... +.++...++.++.||+.||.|||. +||||-||||||||
T Consensus 142 ~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvL 220 (590)
T KOG1290|consen 142 KCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVL 220 (590)
T ss_pred ceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceee
Confidence 6999999996 467999999999 88999999764 679999999999999999999995 69999999999999
Q ss_pred ccC
Q 010266 239 LDQ 241 (514)
Q Consensus 239 ld~ 241 (514)
+..
T Consensus 221 l~~ 223 (590)
T KOG1290|consen 221 LCS 223 (590)
T ss_pred eec
Confidence 953
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=300.29 Aligned_cols=255 Identities=21% Similarity=0.341 Sum_probs=207.4
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
+..+...+.+.||+|-||.|.+|.-. .+..||+|+++... ..+....+..|+.+|.+++|||||.|+++|..++.+|
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEec-CceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 44566778899999999999999854 36899999998764 3455678999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 183 LIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
+|||||+.|||.+++.... .........++.||+.|+.||.+.++|||||.+.|+|+|.++++||+|||+++.+-++.
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 9999999999999998763 22333445589999999999999999999999999999999999999999999765543
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 340 (514)
...++. ..+-...|||||.+.-+++++++|+|+
T Consensus 692 yy~vqg-----------------------------------------------r~vlpiRwmawEsillgkFttaSDvWa 724 (807)
T KOG1094|consen 692 YYRVQG-----------------------------------------------RAVLPIRWMAWESILLGKFTTASDVWA 724 (807)
T ss_pred ceeeec-----------------------------------------------ceeeeeeehhHHHHHhccccchhhhhh
Confidence 222111 234556899999999999999999999
Q ss_pred hhHHHHHHhh--CCCCCCCCChhHHHHHHhhh---c-CcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHh
Q 010266 341 LGAIMYEMLV--GYPPFYSDDPVTTCRKIVHW---K-NHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIK 410 (514)
Q Consensus 341 lGvilyemlt--G~~PF~~~~~~~~~~~i~~~---~-~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 410 (514)
|||.|||+++ ...||...+..+...+.... . .....+.+.-.+..+..||.+|.. +..+|+ +++++-
T Consensus 725 fgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RP---sFe~lh 798 (807)
T KOG1094|consen 725 FGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRP---SFEQLH 798 (807)
T ss_pred hHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCC---CHHHHH
Confidence 9999999765 78999877666665554321 1 111222334567888999999998 999999 899884
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=331.38 Aligned_cols=238 Identities=19% Similarity=0.256 Sum_probs=185.0
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
.|....+||+|+||.||+|+.+.++..||+|.+...... ...|..+++.++|||||++++++.+....|+|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 455667899999999999999999999999998654321 1245788999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 187 YLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH---KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 187 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
|++||+|.+++. .++...+..++.+++.||+||| +.+|+||||||+||+++.++..++. ||.+.....
T Consensus 764 y~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----- 834 (968)
T PLN00113 764 YIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----- 834 (968)
T ss_pred CCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence 999999999995 3788889999999999999999 6799999999999999999888875 665432110
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhH
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 343 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 343 (514)
..+.+||+.|||||++.+..|+.++|||||||
T Consensus 835 ------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gv 866 (968)
T PLN00113 835 ------------------------------------------------DTKCFISSAYVAPETRETKDITEKSDIYGFGL 866 (968)
T ss_pred ------------------------------------------------CCCccccccccCcccccCCCCCcccchhhHHH
Confidence 01336899999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCChh--HH--HHH-Hh------hhcCccc---CCcCcCCChhHHHHHhhhcc-CccccCCCCCHhH
Q 010266 344 IMYEMLVGYPPFYSDDPV--TT--CRK-IV------HWKNHLK---FPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQ 408 (514)
Q Consensus 344 ilyemltG~~PF~~~~~~--~~--~~~-i~------~~~~~~~---~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~e 408 (514)
++|||++|+.||...... .. +.+ .. .|..... .+.......++.+++.+|+. ||.+|+ +++|
T Consensus 867 vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP---t~~e 943 (968)
T PLN00113 867 ILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP---CAND 943 (968)
T ss_pred HHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCc---CHHH
Confidence 999999999999542211 01 000 00 0000000 00000112356789999998 999999 8999
Q ss_pred Hhc
Q 010266 409 IKA 411 (514)
Q Consensus 409 il~ 411 (514)
|++
T Consensus 944 vl~ 946 (968)
T PLN00113 944 VLK 946 (968)
T ss_pred HHH
Confidence 876
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.41 Aligned_cols=247 Identities=29% Similarity=0.416 Sum_probs=193.7
Q ss_pred eeEEeeeeecCceE-EEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCeEEEEE
Q 010266 108 FDLLTIIGRGAFGE-VRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 108 f~~~~~LG~G~fG~-V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
|.--+++|.|+-|+ ||.+. -.|+.||||.+-.. -...+.+|+..|+.. +|||||+.|+.=++...+|++.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGV--YEGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEe--eCCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 33446799999985 56554 45789999977533 334578899999988 4999999999999999999999
Q ss_pred eecCCCCHHHHHhhccC----CCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC---CC--cEEEccccccccC
Q 010266 186 EYLPGGDVMTLLMREET----LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ---NG--HMKLSDFGLCKPL 256 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~----l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~---~g--~iKL~DFGla~~~ 256 (514)
|.|. .+|.+++..... ......+..+.|++.||.+||+.+||||||||.||||+. +| .++|+|||+|+.+
T Consensus 583 ELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 9995 699999976311 111345778899999999999999999999999999986 34 6899999999987
Q ss_pred CCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCccc
Q 010266 257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336 (514)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 336 (514)
.....+- +...+..||-+|+|||++....-+.++
T Consensus 662 ~~~~sS~----------------------------------------------~r~s~~sGt~GW~APE~L~~~~~~~av 695 (903)
T KOG1027|consen 662 AGGKSSF----------------------------------------------SRLSGGSGTSGWQAPEQLREDRKTQAV 695 (903)
T ss_pred CCCcchh----------------------------------------------hcccCCCCcccccCHHHHhccccCccc
Confidence 6432110 013366799999999999998888999
Q ss_pred chhhhhHHHHHHhhC-CCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCc
Q 010266 337 DWWSLGAIMYEMLVG-YPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPW 414 (514)
Q Consensus 337 DiWSlGvilyemltG-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpf 414 (514)
|++||||++|..++| ..||... .+...+|+.....+.--.. ....+|+|||.+||. +|..|+ +|.+|+.|||
T Consensus 696 DiFslGCvfyYvltgG~HpFGd~--~~R~~NIl~~~~~L~~L~~-~~d~eA~dLI~~ml~~dP~~RP---sa~~VL~HPl 769 (903)
T KOG1027|consen 696 DIFSLGCVFYYVLTGGSHPFGDS--LERQANILTGNYTLVHLEP-LPDCEAKDLISRMLNPDPQLRP---SATDVLNHPL 769 (903)
T ss_pred chhhcCceEEEEecCCccCCCch--HHhhhhhhcCccceeeecc-CchHHHHHHHHHhcCCCcccCC---CHHHHhCCCc
Confidence 999999999999996 8999654 3344567664433321110 111299999999999 999999 9999999999
Q ss_pred c
Q 010266 415 F 415 (514)
Q Consensus 415 f 415 (514)
|
T Consensus 770 F 770 (903)
T KOG1027|consen 770 F 770 (903)
T ss_pred c
Confidence 9
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=295.98 Aligned_cols=252 Identities=21% Similarity=0.339 Sum_probs=211.7
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEcc-CCC--EEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKK-SGN--IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~-t~~--~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
..++..+.+.||+|+||.|+.+.+.. +|+ .||||+++...... ....+++|..+|.+++||++++||+...+ ..
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence 34566677899999999999998864 344 48999998665432 66789999999999999999999999987 78
Q ss_pred EEEEEeecCCCCHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMR--EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
+.||||.+++|+|.+.|.+ ...|.......|+.||+.|+.||.++++|||||-..|+|+-.--.||||||||.+.+..
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 8999999999999999987 45788888999999999999999999999999999999999999999999999998764
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
...... ++-...--..|+|||.+....++.++|+
T Consensus 265 ned~Yv----------------------------------------------m~p~rkvPfAWCaPEsLrh~kFShaSDv 298 (1039)
T KOG0199|consen 265 NEDMYV----------------------------------------------MAPQRKVPFAWCAPESLRHRKFSHASDV 298 (1039)
T ss_pred CCcceE----------------------------------------------ecCCCcCcccccCHhHhccccccccchh
Confidence 321100 0000112236999999999999999999
Q ss_pred hhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHh
Q 010266 339 WSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIK 410 (514)
Q Consensus 339 WSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 410 (514)
|++||.+|||++ |.-||.|.....++++|- ..+.+.-| ...|.++.+++.+|+. +|.+|+ ++..|.
T Consensus 299 WmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRP--k~csedIY~imk~cWah~paDRp---tFsair 366 (1039)
T KOG0199|consen 299 WMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRP--KYCSEDIYQIMKNCWAHNPADRP---TFSAIR 366 (1039)
T ss_pred hhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCC--CCChHHHHHHHHHhccCCccccc---cHHHHH
Confidence 999999999997 899999999999999987 34555555 4789999999999999 999999 776665
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=291.44 Aligned_cols=243 Identities=23% Similarity=0.366 Sum_probs=200.9
Q ss_pred CCeeEEeeeeecCceEEEEEEEccC----CCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKS----GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t----~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 181 (514)
....+.+.||.|-||.||.+..... .--||||..+++. ..+..+.+..|.-+|+.++||+||+|++.+.+ ...
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~ 465 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM 465 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence 3344456899999999999876432 2348999987754 34457889999999999999999999999874 568
Q ss_pred EEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 182 YLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
++|||.++-|.|..+|+.+ ..++......|+.||+.||.|||+..+|||||...|||+.+...+||+||||++.+....
T Consensus 466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 9999999999999999864 578888999999999999999999999999999999999999999999999999775432
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 340 (514)
... +....-...|||||.+.-..++.++|+|.
T Consensus 546 yYk------------------------------------------------aS~~kLPIKWmaPESINfRrFTtASDVWM 577 (974)
T KOG4257|consen 546 YYK------------------------------------------------ASRGKLPIKWMAPESINFRRFTTASDVWM 577 (974)
T ss_pred hhh------------------------------------------------ccccccceeecCccccchhcccchhhHHH
Confidence 110 00111234799999999999999999999
Q ss_pred hhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCC
Q 010266 341 LGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLG 402 (514)
Q Consensus 341 lGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~ 402 (514)
|||+|||+|. |..||.+-...+.+..|-++ ..+..| ...++.+..|+.+|+. +|.+|+.
T Consensus 578 FgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG-eRlP~P--~nCPp~LYslmskcWayeP~kRPr 638 (974)
T KOG4257|consen 578 FGVCMWEILSLGVKPFQGVKNSDVIGHIENG-ERLPCP--PNCPPALYSLMSKCWAYEPSKRPR 638 (974)
T ss_pred HHHHHHHHHHhcCCccccccccceEEEecCC-CCCCCC--CCCChHHHHHHHHHhccCcccCCc
Confidence 9999999886 99999998777776666543 334444 4789999999999999 9999993
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=283.24 Aligned_cols=298 Identities=22% Similarity=0.396 Sum_probs=206.8
Q ss_pred CCCeeEEeeeeecCceEEEEEEEcc---CCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEEEcCCe
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKK---SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEY 180 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~---t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~ 180 (514)
.+.|.++..||.|+|+.||++.+.. .++.||+|.+.... ....+.+|.++|..+. +.||+++.++|...+.
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 3678899999999999999998877 78899999886543 3345889999999984 8899999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC-CCcEEEccccccccCCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ-NGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~-~g~iKL~DFGla~~~~~~ 259 (514)
.++||||++..+..+++.. ++-..++.|+.+++.||.++|++|||||||||.|+|.+. .++-.|+|||||......
T Consensus 110 v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred eEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 9999999999998888744 567889999999999999999999999999999999984 588999999999742111
Q ss_pred CccccccccccccccccccCCCCCCCC-CCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCC-CCcccc
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFP-ESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG-YGMECD 337 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~-y~~~~D 337 (514)
....-... ...+..... .|... ...+.. ...+..-....+..++.......|||+|.|||++.+.+ .+.++|
T Consensus 187 ~~~~~s~~--~~~~~~~~~---~g~~~~~~~~~~-~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 187 QQTEHSRS--YSGRHATPA---MGKDVHCQSVAT-ASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred hhhhhhhh--hhcccCCcc---ccCccccccccc-ccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 00000000 000000000 00000 000000 00000000000111233445678999999999998744 589999
Q ss_pred hhhhhHHHHHHhhCCCCCCCCC-hhHHHHHHh-------------------hhc--------------Cccc----CC--
Q 010266 338 WWSLGAIMYEMLVGYPPFYSDD-PVTTCRKIV-------------------HWK--------------NHLK----FP-- 377 (514)
Q Consensus 338 iWSlGvilyemltG~~PF~~~~-~~~~~~~i~-------------------~~~--------------~~~~----~p-- 377 (514)
+||.|||+.-++++..||.... .......|. -|. ..+. .+
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 9999999999999999996432 111111110 111 0000 00
Q ss_pred --------cCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCC
Q 010266 378 --------EEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIA 419 (514)
Q Consensus 378 --------~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~ 419 (514)
.....+..+.||+.+||. ||.+|. |++++|+||||...+
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRi---tAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRI---TAEDALKHPFFDEAD 388 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcc---cHHHHhcCcCCcchh
Confidence 001234589999999999 999999 999999999998543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.91 Aligned_cols=261 Identities=26% Similarity=0.474 Sum_probs=224.4
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
-..+||+++.++|.|+||.||+++++.+++..|+|+++-. ..+...-+++|+-+++..+|||||.+++++.-.+.++
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 3458999999999999999999999999999999999754 4456677888999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
++||||.||+|.+.-+--++++|.++.+...+.+.||+|||+.|=+|||||-.|||+++.|.+||+|||.+..+...-
T Consensus 89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati-- 166 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-- 166 (829)
T ss_pred EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh--
Confidence 999999999999998888999999999999999999999999999999999999999999999999999987654221
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc---cCCCCcccchh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---KKGYGMECDWW 339 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiW 339 (514)
....++.|||.||||||-. ..+|+..||+|
T Consensus 167 -----------------------------------------------~KrksfiGtpywmapEvaaverkggynqlcdiw 199 (829)
T KOG0576|consen 167 -----------------------------------------------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIW 199 (829)
T ss_pred -----------------------------------------------hhhhcccCCccccchhHHHHHhccccccccccc
Confidence 0123789999999999864 67899999999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhHHHHHHhh-hcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVH-WKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~~~~~~i~~-~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
++|+...|+---++|-....+......... ....+.+-+....++.+-+|++..|. +|++|+ +++-++.|||...
T Consensus 200 a~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRp---taeklL~h~fvs~ 276 (829)
T KOG0576|consen 200 ALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRP---TAEKLLQHPFVSQ 276 (829)
T ss_pred ccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCC---Chhhheeceeecc
Confidence 999999999999999877666544333321 12223333445789999999999998 999999 9999999999975
Q ss_pred C
Q 010266 418 I 418 (514)
Q Consensus 418 i 418 (514)
-
T Consensus 277 ~ 277 (829)
T KOG0576|consen 277 T 277 (829)
T ss_pred c
Confidence 3
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.59 Aligned_cols=256 Identities=24% Similarity=0.381 Sum_probs=222.1
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCC---EEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGN---IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 176 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~---~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 176 (514)
..++..+...+-++||.|.||.|+.++.+..|+ .||||.++.. ....+...+..|..||-+.+||||++|-++..
T Consensus 623 akEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT 700 (996)
T KOG0196|consen 623 AKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT 700 (996)
T ss_pred hhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence 356778889999999999999999999887664 6999999865 35778888999999999999999999999999
Q ss_pred cCCeEEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 177 DAEYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 177 ~~~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
....+.+|.|||++|+|..+|..+ +.|+..+..-++.-|+.|+.||-++|+|||||...|||++++-.+|++||||++.
T Consensus 701 ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 701 KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceee
Confidence 999999999999999999999764 6788888888999999999999999999999999999999999999999999997
Q ss_pred CCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhcccccccccc---CCCcCCccccccCCC
Q 010266 256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG---TPDYIAPEVLLKKGY 332 (514)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~G---T~~Y~APEvl~~~~y 332 (514)
+..... .+++..| ...|.|||.|...++
T Consensus 781 ledd~~-------------------------------------------------~~ytt~GGKIPiRWTAPEAIa~RKF 811 (996)
T KOG0196|consen 781 LEDDPE-------------------------------------------------AAYTTLGGKIPIRWTAPEAIAYRKF 811 (996)
T ss_pred cccCCC-------------------------------------------------ccccccCCccceeecChhHhhhccc
Confidence 643210 0112222 247999999999999
Q ss_pred CcccchhhhhHHHHHHh-hCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHh
Q 010266 333 GMECDWWSLGAIMYEML-VGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIK 410 (514)
Q Consensus 333 ~~~~DiWSlGvilyeml-tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 410 (514)
+.++|+||+||+|||.+ +|..||..-+.++.+..|-. ...+|++...+..+..|+..|.+ |-.+|+ .+.||.
T Consensus 812 TsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~---gyRLPpPmDCP~aL~qLMldCWqkdR~~RP---~F~qiV 885 (996)
T KOG0196|consen 812 TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQ---GYRLPPPMDCPAALYQLMLDCWQKDRNRRP---KFAQIV 885 (996)
T ss_pred CchhhccccceEEEEecccCCCcccccchHHHHHHHHh---ccCCCCCCCCcHHHHHHHHHHHHHHhhcCC---CHHHHH
Confidence 99999999999999966 59999999999999888874 56778777889999999999998 777887 888887
Q ss_pred cC
Q 010266 411 AH 412 (514)
Q Consensus 411 ~H 412 (514)
++
T Consensus 886 ~~ 887 (996)
T KOG0196|consen 886 ST 887 (996)
T ss_pred HH
Confidence 63
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=285.44 Aligned_cols=251 Identities=23% Similarity=0.358 Sum_probs=211.3
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
+.+...+......||-|-||.||.+.++...-.||||.++.+. ..++.+..|..||+.++|||+|+|+++|..+..
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 4455567778889999999999999999888899999997654 367889999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
+|+|.|||..|+|.++|...+ .++.-....++.||..|++||..+++|||||...|+|+..+..+|++||||++.+..
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 999999999999999998754 355556666777999999999999999999999999999999999999999998754
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
.....-. ...-...|.|||-+....++.++||
T Consensus 418 DTYTAHA------------------------------------------------GAKFPIKWTAPEsLAyNtFSiKSDV 449 (1157)
T KOG4278|consen 418 DTYTAHA------------------------------------------------GAKFPIKWTAPESLAYNTFSIKSDV 449 (1157)
T ss_pred Cceeccc------------------------------------------------CccCcccccCcccccccccccchhh
Confidence 3211100 0112346999999999999999999
Q ss_pred hhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHH
Q 010266 339 WSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQI 409 (514)
Q Consensus 339 WSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ei 409 (514)
|+|||+|||+.| |-.||.|.+..+.|..+-+. ....-| ...++....|++.|+. .|.+|+ ++.||
T Consensus 450 WAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg-yRM~~P--eGCPpkVYeLMraCW~WsPsDRP---sFaei 516 (1157)
T KOG4278|consen 450 WAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG-YRMDGP--EGCPPKVYELMRACWNWSPSDRP---SFAEI 516 (1157)
T ss_pred HHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc-ccccCC--CCCCHHHHHHHHHHhcCCcccCc---cHHHH
Confidence 999999999987 99999999988887766432 233344 4789999999999999 999999 66665
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-31 Score=253.29 Aligned_cols=212 Identities=42% Similarity=0.664 Sum_probs=182.5
Q ss_pred eeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEee
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY 187 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy 187 (514)
|.+.+.||.|++|.||++....+++.+|+|.+...... .....+..|...+..++|++++++++++......++|+||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 56788999999999999999988999999999865432 2567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccC-CCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccc
Q 010266 188 LPGGDVMTLLMREET-LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE 266 (514)
Q Consensus 188 ~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~ 266 (514)
+++++|.+++..... +++..+..++.+++.+|.+||+.|++|+||+|.||+++.++.++|+|||++........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~----- 153 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA----- 153 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-----
Confidence 999999999987766 89999999999999999999999999999999999999999999999999876542210
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccc-ccCCCCcccchhhhhHHH
Q 010266 267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL-LKKGYGMECDWWSLGAIM 345 (514)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl-~~~~y~~~~DiWSlGvil 345 (514)
.......|+..|++||++ ....++.++|+||||+++
T Consensus 154 -------------------------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~ 190 (225)
T smart00221 154 -------------------------------------------ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVIL 190 (225)
T ss_pred -------------------------------------------ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHH
Confidence 001145788999999999 667788899999999999
Q ss_pred HHHhhCCCCCCC-CCh-hHHHHHHhh
Q 010266 346 YEMLVGYPPFYS-DDP-VTTCRKIVH 369 (514)
Q Consensus 346 yemltG~~PF~~-~~~-~~~~~~i~~ 369 (514)
|+|++|++||.+ .+. ....+.|..
T Consensus 191 ~~l~~g~~pf~~~~~~~~~~~~~~~~ 216 (225)
T smart00221 191 YELLWGPEPFSGEGEFTSLLSDVWSF 216 (225)
T ss_pred HHHHHCCCCccccchhHHHHHHHHhc
Confidence 999999999987 444 455555554
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=290.09 Aligned_cols=259 Identities=26% Similarity=0.391 Sum_probs=210.1
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEcc---C----CCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEE
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKK---S----GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLY 172 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~---t----~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~ 172 (514)
..+..++..+.+.||.|+||+|+++.-+. . ...||||.++... ...+.+.+..|..+|..+ .||||+.|.
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~--~~~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA--SSSEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc--CcHHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 44555666777799999999999987441 1 3469999987654 336778899999999988 599999999
Q ss_pred EEEEcCCeEEEEEeecCCCCHHHHHhhcc----------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCC
Q 010266 173 YSFQDAEYLYLIMEYLPGGDVMTLLMREE----------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDN 236 (514)
Q Consensus 173 ~~f~~~~~l~lVmEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeN 236 (514)
+++.....+++|+||+..|+|..+|...+ .++......++.||+.|++||++.++|||||-..|
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN 448 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence 99999999999999999999999997765 47888889999999999999999999999999999
Q ss_pred ccccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccc
Q 010266 237 LLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTV 316 (514)
Q Consensus 237 ILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 316 (514)
||+..+..+||+|||||+.......... ....
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~------------------------------------------------~~~~ 480 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRT------------------------------------------------KSSA 480 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEe------------------------------------------------cCCC
Confidence 9999999999999999986443211100 0112
Q ss_pred cCC--CcCCccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCC-hhHHHHHHhhhcCcccCCcCcCCChhHHHHHhh
Q 010266 317 GTP--DYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDD-PVTTCRKIVHWKNHLKFPEEARLTPEAKDLICR 392 (514)
Q Consensus 317 GT~--~Y~APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~ 392 (514)
||. .|||||.+....|+.++|+||+||+||||++ |.+|+.+-. ..+.+..+.. ...+..|. ..+++..++++.
T Consensus 481 ~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~-G~r~~~P~--~c~~eiY~iM~~ 557 (609)
T KOG0200|consen 481 GTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKE-GNRMEQPE--HCSDEIYDLMKS 557 (609)
T ss_pred CccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhc-CCCCCCCC--CCCHHHHHHHHH
Confidence 222 4999999999999999999999999999998 999999855 4555554443 33455564 679999999999
Q ss_pred hcc-CccccCCCCCHhHHhcCCcccc
Q 010266 393 LLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 393 lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
|.. +|++|+ ++.++.. +|..
T Consensus 558 CW~~~p~~RP---~F~~~~~--~~~~ 578 (609)
T KOG0200|consen 558 CWNADPEDRP---TFSECVE--FFEK 578 (609)
T ss_pred HhCCCcccCC---CHHHHHH--HHHH
Confidence 998 999999 8888765 4443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=269.55 Aligned_cols=243 Identities=24% Similarity=0.329 Sum_probs=191.8
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc--CCCceeeEEEEEEcCC---
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV--ASHCIVKLYYSFQDAE--- 179 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l--~hp~Iv~l~~~f~~~~--- 179 (514)
....+++.+||+|.||.||+|+. +++.||||++.. .+.+.+.+|++|.+.. .|+||++++++-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 46677888999999999999875 468999999863 4567789999998864 7999999998766444
Q ss_pred -eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---------CCeEEcCCCCCCccccCCCcEEEcc
Q 010266 180 -YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK---------HNYIHRDIKPDNLLLDQNGHMKLSD 249 (514)
Q Consensus 180 -~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~---------~giiHrDLKpeNILld~~g~iKL~D 249 (514)
.+.||++|.+.|+|.++|.. ..++......++.-|+.||.|||+ .+|+|||||..||||.+|+...|+|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred cceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 78999999999999999954 578899999999999999999995 3699999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc
Q 010266 250 FGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK 329 (514)
Q Consensus 250 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~ 329 (514)
||||..+...... .-+...|||..|||||++.+
T Consensus 360 FGLAl~~~p~~~~-----------------------------------------------~d~~~qVGT~RYMAPEvLEg 392 (534)
T KOG3653|consen 360 FGLALRLEPGKPQ-----------------------------------------------GDTHGQVGTRRYMAPEVLEG 392 (534)
T ss_pred cceeEEecCCCCC-----------------------------------------------cchhhhhhhhhhcCHHHHhh
Confidence 9999877532100 01224699999999999976
Q ss_pred CC-CC-----cccchhhhhHHHHHHhhCCC------------CCC-----CCChhHHHHHHhhhcCcccCCcCcC---CC
Q 010266 330 KG-YG-----MECDWWSLGAIMYEMLVGYP------------PFY-----SDDPVTTCRKIVHWKNHLKFPEEAR---LT 383 (514)
Q Consensus 330 ~~-y~-----~~~DiWSlGvilyemltG~~------------PF~-----~~~~~~~~~~i~~~~~~~~~p~~~~---~s 383 (514)
.- .. ...||||+|.+||||++... ||. ..+-.++...+++.+....+|+... --
T Consensus 393 ainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~ 472 (534)
T KOG3653|consen 393 AINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGM 472 (534)
T ss_pred hcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccH
Confidence 32 22 36899999999999998643 343 2234566667777777778886321 12
Q ss_pred hhHHHHHhhhcc-CccccCCC
Q 010266 384 PEAKDLICRLLC-DVEHRLGT 403 (514)
Q Consensus 384 ~~~~dLI~~lL~-dp~~Rl~~ 403 (514)
..+++.|..|.. |++.|+..
T Consensus 473 ~~l~et~EeCWDhDaeARLTA 493 (534)
T KOG3653|consen 473 AVLCETIEECWDHDAEARLTA 493 (534)
T ss_pred HHHHHHHHHHcCCchhhhhhh
Confidence 456777788887 99999943
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=242.25 Aligned_cols=211 Identities=44% Similarity=0.706 Sum_probs=185.7
Q ss_pred eeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecCCCCH
Q 010266 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDV 193 (514)
Q Consensus 114 LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~L 193 (514)
||.|++|.||+|....+++.+++|++....... ....+.+|..++..+.|++|+++++++......++||||++|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999987653211 356788999999999999999999999999999999999999999
Q ss_pred HHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC-CCcEEEccccccccCCCCCccccccccccc
Q 010266 194 MTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ-NGHMKLSDFGLCKPLDCTNLSAINENEVLD 271 (514)
Q Consensus 194 ~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~-~g~iKL~DFGla~~~~~~~~~~~~~~~~~~ 271 (514)
..++... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. +++++|+|||.+........
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---------- 148 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---------- 148 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----------
Confidence 9999775 57899999999999999999999999999999999999999 89999999999876532210
Q ss_pred cccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-CCCcccchhhhhHHHHHHhh
Q 010266 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLV 350 (514)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvilyemlt 350 (514)
......++..|++||.+... .++.+.|+||||+++++|
T Consensus 149 ---------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-- 187 (215)
T cd00180 149 ---------------------------------------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-- 187 (215)
T ss_pred ---------------------------------------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--
Confidence 01134688899999999877 889999999999999999
Q ss_pred CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCC
Q 010266 351 GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHP 413 (514)
Q Consensus 351 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hp 413 (514)
+.+.+++.+||+ +|.+|+ +++++++||
T Consensus 188 ---------------------------------~~~~~~l~~~l~~~p~~R~---~~~~l~~~~ 215 (215)
T cd00180 188 ---------------------------------PELKDLIRKMLQKDPEKRP---SAKEILEHL 215 (215)
T ss_pred ---------------------------------HHHHHHHHHHhhCCcccCc---CHHHHhhCC
Confidence 578899999998 999999 999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=279.74 Aligned_cols=246 Identities=20% Similarity=0.273 Sum_probs=201.2
Q ss_pred eeEEeeeeecCceEEEEEEEccCCC----EEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEE
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSGN----IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~~----~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 183 (514)
....++||.|+||+||++.+-..|+ +||+|++.... .......+..|.-+|.+++|||+++|+++++... +-|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 3346799999999999998865554 58999887653 3444567889999999999999999999998776 889
Q ss_pred EEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 184 IMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
|++|||+|.|.++++. ++.+-......|..||+.|+.|||.+++|||||-..|||+.+-.|+|++|||+++.+......
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 9999999999999976 467888888999999999999999999999999999999999999999999999987643221
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
.. +....--+.|||-|.+....|++++||||+|
T Consensus 855 y~-----------------------------------------------~~~gK~pikwmale~i~~~~~thqSDVWsfG 887 (1177)
T KOG1025|consen 855 YS-----------------------------------------------APGGKVPIKWMALESIRIRKYTHQSDVWSFG 887 (1177)
T ss_pred cc-----------------------------------------------ccccccCcHHHHHHHhhccCCCchhhhhhhh
Confidence 10 0011234579999999999999999999999
Q ss_pred HHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHH
Q 010266 343 AIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQI 409 (514)
Q Consensus 343 vilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ei 409 (514)
|.+||++| |..|+.+....++- +++...+.+.-|+ ..+-+..-++.+|+. |+..|+ +++++
T Consensus 888 VtiWElmTFGa~Py~gi~~~eI~-dlle~geRLsqPp--iCtiDVy~~mvkCwmid~~~rp---~fkel 950 (1177)
T KOG1025|consen 888 VTIWELMTFGAKPYDGIPAEEIP-DLLEKGERLSQPP--ICTIDVYMVMVKCWMIDADSRP---TFKEL 950 (1177)
T ss_pred hhHHHHHhcCCCccCCCCHHHhh-HHHhccccCCCCC--CccHHHHHHHHHHhccCcccCc---cHHHH
Confidence 99999997 99999988666554 4444444455554 678899999999998 888888 55444
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=260.44 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=185.6
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHH--cCCCceeeEEEEEEcC---
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE--VASHCIVKLYYSFQDA--- 178 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~--l~hp~Iv~l~~~f~~~--- 178 (514)
...+..+++.||+|-||.||.+++. |+.||||++...+ ...-.+|.+|.+. ++|+||..++++=..+
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred hhheeEEEEEecCccccceeecccc--CCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 3467899999999999999988765 8899999986442 2345678888875 4899999998875433
Q ss_pred -CeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh--------CCeEEcCCCCCCccccCCCcEEEcc
Q 010266 179 -EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK--------HNYIHRDIKPDNLLLDQNGHMKLSD 249 (514)
Q Consensus 179 -~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~--------~giiHrDLKpeNILld~~g~iKL~D 249 (514)
..++||.+|.+.|+|+++|.+ ..++.+....++.-++.||.|||. -.|.|||||..|||+.++|...|+|
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 369999999999999999977 788889999999999999999994 2599999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc
Q 010266 250 FGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK 329 (514)
Q Consensus 250 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~ 329 (514)
+|||-........ .+. ..+..|||..|||||++..
T Consensus 360 LGLAv~h~~~t~~----------------idi-----------------------------~~N~rVGTKRYMAPEvLde 394 (513)
T KOG2052|consen 360 LGLAVRHDSDTDT----------------IDI-----------------------------PPNPRVGTKRYMAPEVLDE 394 (513)
T ss_pred ceeeEEecccCCc----------------ccC-----------------------------CCCCccceeeccChHHhhh
Confidence 9999865433110 000 1125699999999999975
Q ss_pred CC----C--CcccchhhhhHHHHHHhhC----------CCCCCCC----ChhHHHHHHhh-hcCcccCCcCcCCChhHHH
Q 010266 330 KG----Y--GMECDWWSLGAIMYEMLVG----------YPPFYSD----DPVTTCRKIVH-WKNHLKFPEEARLTPEAKD 388 (514)
Q Consensus 330 ~~----y--~~~~DiWSlGvilyemltG----------~~PF~~~----~~~~~~~~i~~-~~~~~~~p~~~~~s~~~~d 388 (514)
.- + =..+||||||.++||+... .+||++- ...+...+++- .+-.+.+|+. +-|.++..
T Consensus 395 tin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnr-W~s~~~l~ 473 (513)
T KOG2052|consen 395 TINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNR-WKSDPALR 473 (513)
T ss_pred hcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcc-cccCHHHH
Confidence 32 1 1358999999999998863 6899752 22333344432 2233445543 34444433
Q ss_pred ----HHhhhcc-CccccCCCCCHhHHhc
Q 010266 389 ----LICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 389 ----LI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|++.|.. +|..|+ ++--|++
T Consensus 474 ~m~klMkeCW~~Np~aRl---tALriKK 498 (513)
T KOG2052|consen 474 VMAKLMKECWYANPAARL---TALRIKK 498 (513)
T ss_pred HHHHHHHHhhcCCchhhh---HHHHHHH
Confidence 4555555 899999 6555543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=250.56 Aligned_cols=253 Identities=22% Similarity=0.368 Sum_probs=193.2
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEE-EEEcCCeEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYY-SFQDAEYLYL 183 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~-~f~~~~~l~l 183 (514)
+.|.+.+.||.|-||++.||+++.++..+|+|.+.+... .+..+.+|..---.+ .|.+|+.-|. .||+.+...+
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 679999999999999999999999999999999887532 345566676654444 4889998875 6999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCcccc-CC-CcEEEccccccccCCCCCc
Q 010266 184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-QN-GHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld-~~-g~iKL~DFGla~~~~~~~~ 261 (514)
+|||+|-|||.+-+.. ..+.|.-.+.+++|++.||+|+|+.++||||||.|||||- .| -.|||||||+++..+..-
T Consensus 100 ~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV- 177 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV- 177 (378)
T ss_pred eeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee-
Confidence 9999999999988855 4578999999999999999999999999999999999984 33 579999999987543210
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc---CC--CCccc
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK---KG--YGMEC 336 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~--y~~~~ 336 (514)
.-.--+..|.|||++.. .. ..+..
T Consensus 178 ---------------------------------------------------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~ 206 (378)
T KOG1345|consen 178 ---------------------------------------------------KYLEYVNNYHAPELCDTVVNEKLVVNPST 206 (378)
T ss_pred ---------------------------------------------------hhhhhhcccCCcHHHhhccccceEecccc
Confidence 01124567899998763 33 37889
Q ss_pred chhhhhHHHHHHhhCCCCCCCCC-hhHHHHHHhhhcC--cccCCc-CcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 337 DWWSLGAIMYEMLVGYPPFYSDD-PVTTCRKIVHWKN--HLKFPE-EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 337 DiWSlGvilyemltG~~PF~~~~-~~~~~~~i~~~~~--~~~~p~-~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|+|.||+++|.+|||.+||.... ...-+-+...|.. ....|. ...+|+.+..+.++.|. ++++|-.--++.....
T Consensus 207 D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 207 DIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred cchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 99999999999999999997432 2233444444433 234453 24689999999999998 8888731114444444
Q ss_pred CCcc
Q 010266 412 HPWF 415 (514)
Q Consensus 412 Hpff 415 (514)
.-|.
T Consensus 287 ~~w~ 290 (378)
T KOG1345|consen 287 CLWK 290 (378)
T ss_pred HHHH
Confidence 4443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=287.91 Aligned_cols=324 Identities=31% Similarity=0.518 Sum_probs=269.2
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 181 (514)
..+.++|.+++-+-+|++|.++.+....+|...+.|+..+...+..++.+.++.+..++....+|.++...+.|.-...+
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 46789999999999999999999998899999999999998888888888899999999989999999999998888999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC-
Q 010266 182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN- 260 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~- 260 (514)
+|||+|+.||+|...|+..+..+++-++.++..+++++++||...++|||++|.|+|+..+||.+++|||+........
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999655432211
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 340 (514)
...... .... ....++... .................+||+.|.|||.+.+...+..+|||+
T Consensus 960 ~~~~sg----~~~~-----~~~~~~~~~----------~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~ 1020 (1205)
T KOG0606|consen 960 TTDLSG----PSSS-----GTPRRLSRS----------ERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWS 1020 (1205)
T ss_pred cCCccc----cccc-----Ccccccccc----------ccccccccchhhccccccCCCcccCCcccccccCCCcchhhh
Confidence 000000 0000 000000000 000000000112234689999999999999999999999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCc-CcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPE-EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 341 lGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
+|++++|.++|.+||....++..+++|.. ....+|. ....++++++++.++|. ++.+|+|..++.+++.||||+++
T Consensus 1021 ~g~~l~e~l~g~pp~na~tpq~~f~ni~~--~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1021 SGVCLFEVLTGIPPFNAETPQQIFENILN--RDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred hhhhhhhhhcCCCCCCCcchhhhhhcccc--CCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence 99999999999999999999999999987 4455554 23578999999999998 99999988888899999999999
Q ss_pred CccccccccCCCCCcCCCCCCCCCCCCC
Q 010266 419 AWDKLYEMEAAYKPEVNGVLDTQNFMKF 446 (514)
Q Consensus 419 ~w~~l~~~~~p~~p~~~~~~d~~~f~~~ 446 (514)
+|+.|....++|+|.+.+..|+++|..-
T Consensus 1099 ~~~~l~~q~~~~~p~~~s~~dtS~~~~r 1126 (1205)
T KOG0606|consen 1099 DWENLALQKAEFVPQPESTQDTSYFESR 1126 (1205)
T ss_pred CccccccccCccCCCCCCCCccchhhcc
Confidence 9999999999999999999999999763
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=297.11 Aligned_cols=223 Identities=14% Similarity=0.182 Sum_probs=155.2
Q ss_pred CceeeEEEEE-------EcCCeEEEEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCc
Q 010266 166 HCIVKLYYSF-------QDAEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNL 237 (514)
Q Consensus 166 p~Iv~l~~~f-------~~~~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNI 237 (514)
+||++++++| .....++++|||+ +++|..+|.. ...+++..++.++.||+.||+|||++|||||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 4777788877 3345788899988 6699999965 45699999999999999999999999999999999999
Q ss_pred cccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCC----CchHHHHHHh-hhccccc
Q 010266 238 LLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWK----SPLEQLQHWQ-INRRKLA 312 (514)
Q Consensus 238 Lld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~-~~~~~~~ 312 (514)
||+..|.+|++|||+|............ ..+.|..+... .......... .......
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~k-------------------i~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTK-------------------SREIGSSRREEILSERRIEKLEEVKKQPFPMKQ 172 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCccc-------------------ccccccccccccccccchhhhhccccCCCcccc
Confidence 9999899999999988654321110000 00001000000 0000000000 0000011
Q ss_pred cccccCCCcCCccccccCCCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCc-CcCCChhHHHHHh
Q 010266 313 YSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPE-EARLTPEAKDLIC 391 (514)
Q Consensus 313 ~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~dLI~ 391 (514)
...+||+.|||||++.+..|+.++|||||||+||||++|.+||.... .....+... .+|+ ...-.+.+.+++.
T Consensus 173 ~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 246 (793)
T PLN00181 173 ILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHR----VLPPQILLNWPKEASFCL 246 (793)
T ss_pred cccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHh----hcChhhhhcCHHHHHHHH
Confidence 23579999999999999999999999999999999999999986432 222222211 1121 1122466789999
Q ss_pred hhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 392 RLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 392 ~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
+||. +|.+|+ ++.||+.||||..
T Consensus 247 ~~L~~~P~~Rp---s~~eil~h~~~~~ 270 (793)
T PLN00181 247 WLLHPEPSCRP---SMSELLQSEFINE 270 (793)
T ss_pred HhCCCChhhCc---ChHHHhhchhhhh
Confidence 9999 999999 9999999999975
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-27 Score=233.57 Aligned_cols=262 Identities=39% Similarity=0.606 Sum_probs=207.5
Q ss_pred eeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCC-ceeeEEEEEEcCCeEEEEEe
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp-~Iv~l~~~f~~~~~l~lVmE 186 (514)
|.+.+.||.|+||.||++.+. ..+|+|.+.+...........+.+|..++..+.|+ +|++++..+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999887 78999999877654444577788999999999988 79999999988888999999
Q ss_pred ecCCCCHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC-cEEEccccccccCCCCCcc
Q 010266 187 YLPGGDVMTLLMREE---TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG-HMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 187 y~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g-~iKL~DFGla~~~~~~~~~ 262 (514)
++.|+++..++.... .+++..+..++.|++.++.|+|+.|++||||||+||+++..+ .++++|||+++........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999997776654 799999999999999999999999999999999999999998 7999999998744322100
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc---CCCCcccchh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK---KGYGMECDWW 339 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~y~~~~DiW 339 (514)
... .......+||+.|+|||.+.+ ..++...|+|
T Consensus 159 ~~~-------------------------------------------~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~ 195 (384)
T COG0515 159 SSI-------------------------------------------PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIW 195 (384)
T ss_pred ccc-------------------------------------------cccccccccccccCCHHHhcCCCCCCCCchHhHH
Confidence 000 001236789999999999988 5789999999
Q ss_pred hhhHHHHHHhhCCCCCCCCCh----hHHHHHHhhhcCc-ccCCcCcCC----ChhHHHHHhhhcc-CccccCCCCCHhHH
Q 010266 340 SLGAIMYEMLVGYPPFYSDDP----VTTCRKIVHWKNH-LKFPEEARL----TPEAKDLICRLLC-DVEHRLGTLGSEQI 409 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~----~~~~~~i~~~~~~-~~~p~~~~~----s~~~~dLI~~lL~-dp~~Rl~~~~~~ei 409 (514)
|+|++++++++|..||..... ......+...... ...+..... +..+.+++.+++. +|..|. +..+.
T Consensus 196 s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~---~~~~~ 272 (384)
T COG0515 196 SLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRL---SSSSD 272 (384)
T ss_pred HHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcC---CHHHH
Confidence 999999999999999887763 3444444332211 111111111 2578999999998 899998 66777
Q ss_pred hcCCccccC
Q 010266 410 KAHPWFKDI 418 (514)
Q Consensus 410 l~Hpff~~i 418 (514)
..++|....
T Consensus 273 ~~~~~~~~~ 281 (384)
T COG0515 273 LSHDLLAHL 281 (384)
T ss_pred hhchHhhCc
Confidence 777665543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=226.57 Aligned_cols=161 Identities=20% Similarity=0.219 Sum_probs=129.7
Q ss_pred CCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccccccc
Q 010266 191 GDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEV 269 (514)
Q Consensus 191 g~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~ 269 (514)
|+|.+++.. ...+++..++.++.|++.||.|||+.| ||+|||++.+|++|+ ||+++.....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~---------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE---------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----------
Confidence 789999976 456999999999999999999999999 999999999999999 9998754211
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHh
Q 010266 270 LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 349 (514)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 349 (514)
...||+.|||||++.+..|+.++|||||||++|||+
T Consensus 63 --------------------------------------------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 98 (176)
T smart00750 63 --------------------------------------------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEAL 98 (176)
T ss_pred --------------------------------------------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHH
Confidence 226899999999999999999999999999999999
Q ss_pred hCCCCCCCCChh-HHHHHHhhhcCccc---CCcCcCCCh--hHHHHHhhhcc-CccccCCCCCHhHHhcCCccc
Q 010266 350 VGYPPFYSDDPV-TTCRKIVHWKNHLK---FPEEARLTP--EAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFK 416 (514)
Q Consensus 350 tG~~PF~~~~~~-~~~~~i~~~~~~~~---~p~~~~~s~--~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~ 416 (514)
+|.+||...... .....+........ .+....++. ++++||.+||. +|.+|+ ++.+++.|+|+.
T Consensus 99 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp---~~~~ll~~~~~~ 169 (176)
T smart00750 99 DYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRRE---AANHYLAHCRAL 169 (176)
T ss_pred hCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhccccccc---CHHHHHHHHHHH
Confidence 999999765442 33333332111110 011123344 69999999998 999999 999999999985
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-29 Score=272.47 Aligned_cols=263 Identities=26% Similarity=0.397 Sum_probs=202.9
Q ss_pred eEEeeeeecCceEEEEEEEccCCCEEEEEEeecc---cccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 109 DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS---EMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 109 ~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~---~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
....++|.|++|.|+.+......+.++.|..+.. ..........+..|.-+-..+.||+++.....+++....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567899999999999888777777777765521 1111112222555666666789999988777776666666669
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
|||++ ||+.++...+.++...+..++.|++.||.|+|+.||.||||||+|+|+..+|.+||+|||.+..+......
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~--- 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK--- 476 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcch---
Confidence 99999 99999998889999999999999999999999999999999999999999999999999998765432110
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCc-ccchhhhhHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM-ECDWWSLGAI 344 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~-~~DiWSlGvi 344 (514)
.......++|+..|+|||++.+..|.+ .+|+||.|++
T Consensus 477 ------------------------------------------~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii 514 (601)
T KOG0590|consen 477 ------------------------------------------NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGII 514 (601)
T ss_pred ------------------------------------------hhhhhcCcccCCcCcCcccccccccCcchhhhhhccce
Confidence 001234789999999999999999965 7999999999
Q ss_pred HHHHhhCCCCCCCCChhHHH---HHHhhhcCcccCC--cCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 345 MYEMLVGYPPFYSDDPVTTC---RKIVHWKNHLKFP--EEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 345 lyemltG~~PF~~~~~~~~~---~~i~~~~~~~~~p--~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
+..|++|+.||......+.. .+-..|.....-| -...++...+.+|.+||. +|.+|. ++++|++.+||+.|
T Consensus 515 ~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~---ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 515 YICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRI---TIEQILNDEWIRSI 591 (601)
T ss_pred EEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhhee---cHHHHhhChHhhhc
Confidence 99999999999765443321 1111111111111 123578899999999999 999999 99999999999987
Q ss_pred Cc
Q 010266 419 AW 420 (514)
Q Consensus 419 ~w 420 (514)
+=
T Consensus 592 ~~ 593 (601)
T KOG0590|consen 592 EC 593 (601)
T ss_pred ce
Confidence 63
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=242.53 Aligned_cols=146 Identities=16% Similarity=0.165 Sum_probs=118.0
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEcc-CCCEEEEEEeecccc--cChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKK-SGNIYAMKKLKKSEM--LSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA 178 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~-t~~~~AiK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 178 (514)
....++|.+.+.||+|+||+||+|+++. +++.+|||++..... ........+.+|..+|..++|++|+..+..+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 3456889999999999999999999876 788889998753311 1233456689999999999999998533322
Q ss_pred CeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCC-CCCCccccCCCcEEEccccccccCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDI-KPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDL-KpeNILld~~g~iKL~DFGla~~~~ 257 (514)
...|+||||++|++|.. +... . ...++.+++.||.|||+.||+|||| ||+|||++.+|.+||+|||+|+.+.
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~~~---~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-ARPH---G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred CCcEEEEEccCCCCHHH-hCcc---c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 45899999999999963 2111 1 1457889999999999999999999 9999999999999999999998764
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-26 Score=223.85 Aligned_cols=259 Identities=21% Similarity=0.280 Sum_probs=207.6
Q ss_pred HhhcCCCCCCCeeEEeeeeecCceEEEEEEEccCC-----CEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeE
Q 010266 97 RLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSG-----NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKL 171 (514)
Q Consensus 97 ~~~~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~-----~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l 171 (514)
|.....+..+++++...+-+|.||.||.+.+.+.. +.+-+|.++.. .+.-|+..+..|.-.|..+.|||+...
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V 352 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSV 352 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccce
Confidence 34455566778999999999999999999765432 33556666533 356677888999999999999999998
Q ss_pred EEEEE-cCCeEEEEEeecCCCCHHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCC
Q 010266 172 YYSFQ-DAEYLYLIMEYLPGGDVMTLLMRE--------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN 242 (514)
Q Consensus 172 ~~~f~-~~~~l~lVmEy~~gg~L~~~l~~~--------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~ 242 (514)
.+... +.+..++++.++.-|+|..+|... +.++......++.|+..|++|||+.||||.||...|++||+.
T Consensus 353 ~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 353 LGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred eEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh
Confidence 87654 556778888999899999999732 245566677788999999999999999999999999999999
Q ss_pred CcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcC
Q 010266 243 GHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYI 322 (514)
Q Consensus 243 g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~ 322 (514)
-.+||+|=.|++.+-..+...+..+ --....||
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDn-----------------------------------------------EnRPvkWM 465 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDN-----------------------------------------------ENRPVKWM 465 (563)
T ss_pred eeEEeccchhccccCcccccccCCC-----------------------------------------------CCCccccc
Confidence 9999999999987654432221110 01224699
Q ss_pred CccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-Ccccc
Q 010266 323 APEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHR 400 (514)
Q Consensus 323 APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R 400 (514)
+||.+.+..|+.++|+|||||+||||+| |+.|+..-++.++..-+..+. .+.-| .+.++++-.++.-|+. +|++|
T Consensus 466 slEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy-RlaQP--~NCPDeLf~vMacCWallpeeR 542 (563)
T KOG1024|consen 466 SLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY-RLAQP--FNCPDELFTVMACCWALLPEER 542 (563)
T ss_pred CHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc-eecCC--CCCcHHHHHHHHHHHhcCcccC
Confidence 9999999999999999999999999998 999999999999998887642 34444 4788999999998888 99999
Q ss_pred CCCCCHhHHh
Q 010266 401 LGTLGSEQIK 410 (514)
Q Consensus 401 l~~~~~~eil 410 (514)
+ +.+|+.
T Consensus 543 P---sf~Qlv 549 (563)
T KOG1024|consen 543 P---SFSQLV 549 (563)
T ss_pred C---CHHHHH
Confidence 9 888775
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-25 Score=224.86 Aligned_cols=212 Identities=27% Similarity=0.338 Sum_probs=170.2
Q ss_pred CeeEEeeeeecCceEEEEEEEccCC-CEEEEEEeecccccChhhHHHHHHHHHHHHHcC----CCceeeEEEEE-EcCCe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSG-NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA----SHCIVKLYYSF-QDAEY 180 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~-~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~----hp~Iv~l~~~f-~~~~~ 180 (514)
+|.+.+.||+|+||.||+|.+..++ ..+|+|+.......... .+..|..+|..+. .++++.++..+ .+..+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~---~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS---VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc---cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999987764 67999987765322211 4677899998886 36899999999 58889
Q ss_pred EEEEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCC-----CcEEEcccccc
Q 010266 181 LYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-----GHMKLSDFGLC 253 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~-----g~iKL~DFGla 253 (514)
-|+||+.+ |-+|.++.... +.|+...+..++.|++.||++||+.|+|||||||+|+++... -.+.|.|||+|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999988 88999988543 689999999999999999999999999999999999999865 36999999999
Q ss_pred ccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCC
Q 010266 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG 333 (514)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 333 (514)
+......... .. .+ ..+.....+.||..|+++.+..+...+
T Consensus 175 r~~~~~~~~~--------------------~~-----~~--------------~~r~~~~~~rGT~ry~S~~~H~~~e~~ 215 (322)
T KOG1164|consen 175 RRFKYVGDSG--------------------GN-----LR--------------PPRPQKGLFRGTLRYASINVHLGIEQG 215 (322)
T ss_pred ccccccCCCC--------------------cc-----cc--------------cCCCCccCCCCccccccHHHhCCCccC
Confidence 8432110000 00 00 000111246799999999999999999
Q ss_pred cccchhhhhHHHHHHhhCCCCCCCCChh
Q 010266 334 MECDWWSLGAIMYEMLVGYPPFYSDDPV 361 (514)
Q Consensus 334 ~~~DiWSlGvilyemltG~~PF~~~~~~ 361 (514)
...|+||++.++.||+.|..||.+....
T Consensus 216 r~DDles~~Y~l~el~~g~LPW~~~~~~ 243 (322)
T KOG1164|consen 216 RRDDLESLFYMLLELLKGSLPWEALEMT 243 (322)
T ss_pred CchhhhhHHHHHHHHhcCCCCCcccccc
Confidence 9999999999999999999999776543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-25 Score=207.67 Aligned_cols=143 Identities=19% Similarity=0.210 Sum_probs=113.4
Q ss_pred EeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhh-----------------------HHHHHHHHHHHHHcCCCc
Q 010266 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ-----------------------VEHVRAERNLLAEVASHC 167 (514)
Q Consensus 111 ~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~-----------------------~~~~~~E~~iL~~l~hp~ 167 (514)
...||+|+||.||+|... +|+.||||++++........ ......|..+|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999986 89999999998753211110 123345999999998777
Q ss_pred eeeEEEEEEcCCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHH-HhCCeEEcCCCCCCccccCCCcEE
Q 010266 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESI-HKHNYIHRDIKPDNLLLDQNGHMK 246 (514)
Q Consensus 168 Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~L-H~~giiHrDLKpeNILld~~g~iK 246 (514)
+........ .. .+|||||++|+++...+.....+++..+..++.|++.+|.+| |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~-~~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILL-KS-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEe-cC-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 644332222 22 389999999988776655567899999999999999999999 799999999999999998 58999
Q ss_pred EccccccccCC
Q 010266 247 LSDFGLCKPLD 257 (514)
Q Consensus 247 L~DFGla~~~~ 257 (514)
|+|||+|....
T Consensus 158 LiDFG~a~~~~ 168 (190)
T cd05147 158 IIDVSQSVEHD 168 (190)
T ss_pred EEEccccccCC
Confidence 99999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=201.42 Aligned_cols=221 Identities=25% Similarity=0.313 Sum_probs=179.0
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEEEcCCeE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l 181 (514)
+..+.|.+++.||.|+||.+|++....+|..||||+=.+.. ...++.-|..+...++ .+.|+.+..++....+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 45689999999999999999999999999999999865442 1234677888888886 57899999999999999
Q ss_pred EEEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC---cEEEccccccccCC
Q 010266 182 YLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG---HMKLSDFGLCKPLD 257 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g---~iKL~DFGla~~~~ 257 (514)
.|||+.+ |-+|.+++.- .+.|+...+.-.+-|++.-++|+|.+++|||||||+|+|..-+- .+.|+|||||+...
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999998 8899999864 57899999999999999999999999999999999999987554 47899999999764
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
..... .+ .| -+.-....||..|.+--...+...+..-|
T Consensus 166 d~~t~-----~H---------------Ip----------------------yre~r~ltGTaRYASinAh~g~eqSRRDD 203 (341)
T KOG1163|consen 166 DIRTR-----QH---------------IP----------------------YREDRNLTGTARYASINAHLGIEQSRRDD 203 (341)
T ss_pred ccccc-----cc---------------Cc----------------------cccCCccceeeeehhhhhhhhhhhhhhhh
Confidence 32100 00 00 00112567999999988777777788999
Q ss_pred hhhhhHHHHHHhhCCCCCCCC---ChhHHHHHHhhhc
Q 010266 338 WWSLGAIMYEMLVGYPPFYSD---DPVTTCRKIVHWK 371 (514)
Q Consensus 338 iWSlGvilyemltG~~PF~~~---~~~~~~~~i~~~~ 371 (514)
+=|+|.+|..+.-|..||.+- +..+-+.+|...+
T Consensus 204 meSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK 240 (341)
T KOG1163|consen 204 MESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK 240 (341)
T ss_pred hhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence 999999999999999999875 4455677777643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=208.09 Aligned_cols=141 Identities=16% Similarity=0.210 Sum_probs=116.1
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHH------HHHHHHHHHHcCCCceeeEEEEEEcC
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH------VRAERNLLAEVASHCIVKLYYSFQDA 178 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~------~~~E~~iL~~l~hp~Iv~l~~~f~~~ 178 (514)
.++|+++++||.|+||.||++.. ++..||+|++.......+..... +.+|...+.++.||+|+.+..++.+.
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 48999999999999999999754 46689999997665433333334 56888899999999999998887644
Q ss_pred --------CeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccc
Q 010266 179 --------EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDF 250 (514)
Q Consensus 179 --------~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DF 250 (514)
...+|||||++|.+|.++. .+++. ...+++.+|..+|+.|++||||||+||+++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 3589999999999998773 23332 356999999999999999999999999999999 999999
Q ss_pred cccccC
Q 010266 251 GLCKPL 256 (514)
Q Consensus 251 Gla~~~ 256 (514)
|.++..
T Consensus 179 g~~~~~ 184 (232)
T PRK10359 179 SGKRCT 184 (232)
T ss_pred CCcccc
Confidence 987643
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.5e-24 Score=198.82 Aligned_cols=204 Identities=17% Similarity=0.201 Sum_probs=146.0
Q ss_pred eeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhh-HHHHHHHHHHHHHcC-CCceeeEEEEEEcCCeEEEEE
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ-VEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~-~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l~lVm 185 (514)
+.+...||+|+||+|+++.. .+..++.+.+.-.......- ...+.+|.++|+.+. |++|++++++ ...|+||
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34667899999999998764 67778877776554332222 124788999999995 5789999875 4579999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCC-CCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDI-KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDL-KpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
||+.|.+|...+.. . ...++.|++.+|.++|++||+|||| ||+|||++.+|+++|+|||+|.........
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~-- 148 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW-- 148 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH--
Confidence 99999998754321 1 1346789999999999999999999 799999999999999999999854321100
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc--CCCCcccchhhhh
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLG 342 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiWSlG 342 (514)
. .+ ...+.+.+...- -..++|+|++|+--.- ..--...+|.+.|
T Consensus 149 ~--r~--------------------------L~~rDl~~llk~------~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g 194 (218)
T PRK12274 149 M--RL--------------------------LAREDLRHLLKH------KRMYCPAALTPVERRVLKRTSWIRELWFATG 194 (218)
T ss_pred H--HH--------------------------HHHHHHHHHHHH------HHhcCCCCCCHHHHhhhccchhHHHHHHHhc
Confidence 0 00 000111111111 1237899999986432 2223678999999
Q ss_pred HHHHHHhhCCCCCCCCCh
Q 010266 343 AIMYEMLVGYPPFYSDDP 360 (514)
Q Consensus 343 vilyemltG~~PF~~~~~ 360 (514)
+.+|.|+||..|+.+++.
T Consensus 195 ~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 195 KPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred chHHHHHhccCCccccCC
Confidence 999999999999987653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.2e-24 Score=199.57 Aligned_cols=144 Identities=18% Similarity=0.168 Sum_probs=114.9
Q ss_pred EeeeeecCceEEEEEEEccCCCEEEEEEeecccccChh-----------------------hHHHHHHHHHHHHHcCCCc
Q 010266 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRG-----------------------QVEHVRAERNLLAEVASHC 167 (514)
Q Consensus 111 ~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~-----------------------~~~~~~~E~~iL~~l~hp~ 167 (514)
.+.||+|+||.||+|.+. +|+.||||++++....... .......|...+..+.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 8999999999876321100 0123457889999999998
Q ss_pred eeeEEEEEEcCCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCCccccCCCcEE
Q 010266 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMK 246 (514)
Q Consensus 168 Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKpeNILld~~g~iK 246 (514)
|.......... .||||||++|+++.........+++..+..++.|++.+|.++|+ .||+||||||+|||++ +|.++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 75443333222 48999999988665544455678888999999999999999999 9999999999999999 89999
Q ss_pred EccccccccCCC
Q 010266 247 LSDFGLCKPLDC 258 (514)
Q Consensus 247 L~DFGla~~~~~ 258 (514)
|+|||+|+....
T Consensus 158 liDFG~a~~~~~ 169 (190)
T cd05145 158 IIDVSQAVELDH 169 (190)
T ss_pred EEEcccceecCC
Confidence 999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-24 Score=205.38 Aligned_cols=217 Identities=24% Similarity=0.351 Sum_probs=178.8
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCeEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~l 183 (514)
--+|.+.+.||.|+||..+++...-+++.||||.=... ...-+++.|....+.+ ..+.|+..|++-+..-+-.|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 35799999999999999999999999999999975432 2334577788777776 47899999999999999999
Q ss_pred EEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC-----cEEEccccccccCC
Q 010266 184 IMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG-----HMKLSDFGLCKPLD 257 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g-----~iKL~DFGla~~~~ 257 (514)
|||.+ |-+|.+++.- .+.|+...+..++.||+.-++|+|++.+|+|||||+|+||..-| .|-++|||+|+...
T Consensus 102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 99998 8899999864 46899999999999999999999999999999999999997543 58999999999764
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
..... ..+ .-+...+..||..||+-.-..+...+..-|
T Consensus 181 Dp~Tk--------------qHI----------------------------PYrE~KSLsGTARYMSINTHlGrEQSRRDD 218 (449)
T KOG1165|consen 181 DPKTK--------------QHI----------------------------PYREHKSLSGTARYMSINTHLGREQSRRDD 218 (449)
T ss_pred Ccccc--------------ccC----------------------------ccccccccccceeeeEeeccccchhhhhhh
Confidence 33110 000 001123678999999999888888999999
Q ss_pred hhhhhHHHHHHhhCCCCCCC---CChhHHHHHHhh
Q 010266 338 WWSLGAIMYEMLVGYPPFYS---DDPVTTCRKIVH 369 (514)
Q Consensus 338 iWSlGvilyemltG~~PF~~---~~~~~~~~~i~~ 369 (514)
+=|||-++...|-|..||.| ++..+-+++|-.
T Consensus 219 LEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe 253 (449)
T KOG1165|consen 219 LEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE 253 (449)
T ss_pred HHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence 99999999999999999976 455666777754
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.1e-23 Score=201.67 Aligned_cols=233 Identities=24% Similarity=0.350 Sum_probs=150.2
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCC-----------CceeeEEE--
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS-----------HCIVKLYY-- 173 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-----------p~Iv~l~~-- 173 (514)
.......||.|++|.||.|.+..||+.+|+|+..-.........+.+++|.-....+.+ ..++.+--
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 34567899999999999999999999999999876554445566777666543333221 12222111
Q ss_pred ------EEEcC---C-----eEEEEEeecCCCCHHHHHh---hccCC---CHHHHHHHH-HHHHHHHHHHHhCCeEEcCC
Q 010266 174 ------SFQDA---E-----YLYLIMEYLPGGDVMTLLM---REETL---TETVARFYI-AQSVLAIESIHKHNYIHRDI 232 (514)
Q Consensus 174 ------~f~~~---~-----~l~lVmEy~~gg~L~~~l~---~~~~l---~e~~~~~~~-~qi~~aL~~LH~~giiHrDL 232 (514)
++... . +.+++|+-+ -+||..++. ..... ....++.++ .|++..+++||+.|+||+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11111 1 347888877 468887753 22222 233444444 89999999999999999999
Q ss_pred CCCCccccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccc
Q 010266 233 KPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLA 312 (514)
Q Consensus 233 KpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (514)
||+|++++.+|.++|+||+.....+.. .
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~----------------------------------------------------~ 199 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTR----------------------------------------------------Y 199 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEE----------------------------------------------------E
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCce----------------------------------------------------e
Confidence 999999999999999999977643211 0
Q ss_pred cccccCCCcCCcccccc--------CCCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCCh
Q 010266 313 YSTVGTPDYIAPEVLLK--------KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTP 384 (514)
Q Consensus 313 ~s~~GT~~Y~APEvl~~--------~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~ 384 (514)
.....+..|.+||.... -.++.+.|.|+||+++|.|.+|..||....+...... .|-....+++
T Consensus 200 ~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~--------~f~~C~~~Pe 271 (288)
T PF14531_consen 200 RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW--------DFSRCRDMPE 271 (288)
T ss_dssp EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG--------GGTTSS---H
T ss_pred eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc--------cchhcCCcCH
Confidence 01234577899998754 2478899999999999999999999986544322111 2223336789
Q ss_pred hHHHHHhhhcc-Ccccc
Q 010266 385 EAKDLICRLLC-DVEHR 400 (514)
Q Consensus 385 ~~~dLI~~lL~-dp~~R 400 (514)
..++||.+||. +|.+|
T Consensus 272 ~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 272 PVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHccCCcccC
Confidence 99999999998 88877
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=200.68 Aligned_cols=270 Identities=25% Similarity=0.369 Sum_probs=180.0
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCC-----------------------------------EEEEEEeecccc
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGN-----------------------------------IYAMKKLKKSEM 144 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~-----------------------------------~~AiK~l~k~~~ 144 (514)
..++.+++|++...||+|.-..||.|..+.+|. +.|||.|-.-+.
T Consensus 151 dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~ 230 (598)
T KOG4158|consen 151 DSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEH 230 (598)
T ss_pred hcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccccc
Confidence 456788999999999999999999887554221 346665543222
Q ss_pred cChh--hHHHHHHHH------HHH----------------HHcCCCceeeEEEEEEc-----------------------
Q 010266 145 LSRG--QVEHVRAER------NLL----------------AEVASHCIVKLYYSFQD----------------------- 177 (514)
Q Consensus 145 ~~~~--~~~~~~~E~------~iL----------------~~l~hp~Iv~l~~~f~~----------------------- 177 (514)
.+.. ..+.+-+|. ..+ ....|||||+++.+|.|
T Consensus 231 ~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~ 310 (598)
T KOG4158|consen 231 DSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPS 310 (598)
T ss_pred CCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccc
Confidence 1111 011111121 011 11369999999998854
Q ss_pred ----CCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCcccc--CCC--cEEEcc
Q 010266 178 ----AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD--QNG--HMKLSD 249 (514)
Q Consensus 178 ----~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld--~~g--~iKL~D 249 (514)
...+|+||.-.+ .+|+.++..+ ..+....+.+++|++.|+.|||++||.|||||.+||||. .|+ .+.|+|
T Consensus 311 g~g~~~tlylvMkrY~-~tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaD 388 (598)
T KOG4158|consen 311 GAGEPKTLYLVMKRYR-QTLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVAD 388 (598)
T ss_pred ccCCCceEEEehhcch-hhHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcc
Confidence 245899999885 4899998654 456778888999999999999999999999999999984 444 478999
Q ss_pred ccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc
Q 010266 250 FGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK 329 (514)
Q Consensus 250 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~ 329 (514)
||.|-.-+..+..-.+. +|. -..-|...-||||+...
T Consensus 389 FGCcLAd~~hGlqlpy~------------------------------------S~~-------Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 389 FGCCLADDNHGLQLPYE------------------------------------SDE-------VDLGGNAKLMAPEIATA 425 (598)
T ss_pred cceeeeccccccccccc------------------------------------ccc-------ccCCCcceecchhhhhc
Confidence 99886432211110000 000 02236677899999875
Q ss_pred CCC------CcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCC
Q 010266 330 KGY------GMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLG 402 (514)
Q Consensus 330 ~~y------~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~ 402 (514)
.+- -.++|.|+.|.+.||++....||++......-.+-.+...-...|+ .+++.+++|+..+|. ||.+|..
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~--~vpp~~rqlV~~lL~r~pskRvs 503 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPS--RVPPVARQLVFDLLKRDPSKRVS 503 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcc--cCChHHHHHHHHHhcCCccccCC
Confidence 331 2378999999999999999999998443222111111112223443 689999999999999 9999996
Q ss_pred CCCHhHHhcCCccc
Q 010266 403 TLGSEQIKAHPWFK 416 (514)
Q Consensus 403 ~~~~~eil~Hpff~ 416 (514)
..=+..+++---|.
T Consensus 504 p~iAANvl~LsLw~ 517 (598)
T KOG4158|consen 504 PNIAANVLNLSLWR 517 (598)
T ss_pred ccHHHhHHHHHHhc
Confidence 43345555433333
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.7e-22 Score=187.17 Aligned_cols=135 Identities=15% Similarity=0.199 Sum_probs=108.9
Q ss_pred EeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-----CCCceeeEEEEEEcCC---eEE
Q 010266 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-----ASHCIVKLYYSFQDAE---YLY 182 (514)
Q Consensus 111 ~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-----~hp~Iv~l~~~f~~~~---~l~ 182 (514)
.+.||+|+||.||. +..++.. +||++.... ....+.+.+|+.++..+ +||||+++|++++++. .++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 46899999999994 7777665 699887643 22446689999999999 5799999999999874 444
Q ss_pred -EEEee--cCCCCHHHHHhhccCCCHHHHHHHHHHHHHHH-HHHHhCCeEEcCCCCCCccccC----CCcEEEccccccc
Q 010266 183 -LIMEY--LPGGDVMTLLMREETLTETVARFYIAQSVLAI-ESIHKHNYIHRDIKPDNLLLDQ----NGHMKLSDFGLCK 254 (514)
Q Consensus 183 -lVmEy--~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL-~~LH~~giiHrDLKpeNILld~----~g~iKL~DFGla~ 254 (514)
+|||| +++|+|.+++.+ ..+++. ..++.+++.++ +|||++|||||||||+|||++. ++.++|+||+-+.
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 78999 568999999965 457666 35678888888 9999999999999999999974 3489999955444
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-22 Score=221.29 Aligned_cols=243 Identities=22% Similarity=0.306 Sum_probs=181.1
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeeccc-ccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSE-MLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~-~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
+|...+.||.+-|=+|.+|++. .| .|++|++-+.. ...-....+...|.. ....++||.+.+.-.-.++...|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 7888999999999999988764 34 59999986654 333333333333444 66678999999887777888999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
+|+. .+|.+.|..+.-+...+.++|+.|++.||.-+|..||+|+|||.|||||++-.-+.|+||..-|..--+.+.+..
T Consensus 101 qyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 101 QYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 9995 589999988888888899999999999999999999999999999999999999999999977653222111100
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCC-----------CCc
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG-----------YGM 334 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~-----------y~~ 334 (514)
-... +| +----..|+|||-+.... .++
T Consensus 180 f~fF-----------FD-------------------------------TSrRRtCYiAPERFv~~~~~~~~~q~~~~L~p 217 (1431)
T KOG1240|consen 180 FTFF-----------FD-------------------------------TSRRRTCYIAPERFVSALGKTSVGQDAPLLTP 217 (1431)
T ss_pred ceEE-----------Ee-------------------------------cCCceeeecChHhhhccccccccCCcccccCh
Confidence 0000 00 000113699999886422 567
Q ss_pred ccchhhhhHHHHHHhh-CCCCCCC-----------CChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccC
Q 010266 335 ECDWWSLGAIMYEMLV-GYPPFYS-----------DDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRL 401 (514)
Q Consensus 335 ~~DiWSlGvilyemlt-G~~PF~~-----------~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl 401 (514)
+.||+|+||+++|+++ |+|||.- .+++....+| + +...+.||..||. ||.+|+
T Consensus 218 aMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~I---------e-----d~~~Rnlil~Mi~rdPs~Rl 283 (1431)
T KOG1240|consen 218 AMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLEKI---------E-----DVSLRNLILSMIQRDPSKRL 283 (1431)
T ss_pred hhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHHhC---------c-----CccHHHHHHHHHccCchhcc
Confidence 8999999999999987 7999941 1122222222 1 3578999999999 999999
Q ss_pred CCCCHhHHhcC
Q 010266 402 GTLGSEQIKAH 412 (514)
Q Consensus 402 ~~~~~~eil~H 412 (514)
+|++.++-
T Consensus 284 ---SAedyL~~ 291 (1431)
T KOG1240|consen 284 ---SAEDYLQK 291 (1431)
T ss_pred ---CHHHHHHh
Confidence 99999874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.7e-23 Score=224.16 Aligned_cols=262 Identities=25% Similarity=0.421 Sum_probs=212.6
Q ss_pred CCCeeEEeeeeecCceEEEEEEEc-cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEEEcCCeEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEK-KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~-~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l~ 182 (514)
...|.+.+.||+|+|+.|-++... .+...+|+|.+.... .......++..|..+-..+. |+|++.+++...+.+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 567899999999999999988764 445567888776543 34455667777888887776 999999999999999999
Q ss_pred EEEeecCCCCHHHHH-hhcc-CCCHHHHHHHHHHHHHHHHHHH-hCCeEEcCCCCCCccccCCC-cEEEccccccccCCC
Q 010266 183 LIMEYLPGGDVMTLL-MREE-TLTETVARFYIAQSVLAIESIH-KHNYIHRDIKPDNLLLDQNG-HMKLSDFGLCKPLDC 258 (514)
Q Consensus 183 lVmEy~~gg~L~~~l-~~~~-~l~e~~~~~~~~qi~~aL~~LH-~~giiHrDLKpeNILld~~g-~iKL~DFGla~~~~~ 258 (514)
++++|..||+++..+ .... ..+...+.+|+.|+..++.|+| ..|+.||||||+|.+++..| .+|++|||+|.....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999998 5554 7788899999999999999999 99999999999999999999 999999999986543
Q ss_pred -CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhcccccccccc-CCCcCCccccccCCC-Ccc
Q 010266 259 -TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG-TPDYIAPEVLLKKGY-GME 335 (514)
Q Consensus 259 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~G-T~~Y~APEvl~~~~y-~~~ 335 (514)
.+. .......+| ++.|+|||...+..| +..
T Consensus 178 ~~g~-----------------------------------------------~~~~~~~~g~s~~y~a~E~~~~~~~~~~~ 210 (601)
T KOG0590|consen 178 KNGA-----------------------------------------------ERSLKDRCGSSPPYGAPEHLSGKAYRGPS 210 (601)
T ss_pred cCCc-----------------------------------------------ceeeecccCCCCCCCCcccccchhhcCCC
Confidence 110 112235678 999999999998655 789
Q ss_pred cchhhhhHHHHHHhhCCCCCCCCChhHH-HHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCC
Q 010266 336 CDWWSLGAIMYEMLVGYPPFYSDDPVTT-CRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHP 413 (514)
Q Consensus 336 ~DiWSlGvilyemltG~~PF~~~~~~~~-~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hp 413 (514)
.|+||.|+++.-|++|..|+........ +.........+....+..++..+.+++.++|+ +|..|. +.+++..+|
T Consensus 211 ~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~---s~~~~~~d~ 287 (601)
T KOG0590|consen 211 VDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRL---SIEELKLDN 287 (601)
T ss_pred cccccccccccccccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhcc---ccccccccc
Confidence 9999999999999999999976544332 12222212222344456899999999999997 999998 899999999
Q ss_pred cccc
Q 010266 414 WFKD 417 (514)
Q Consensus 414 ff~~ 417 (514)
|+..
T Consensus 288 ~~~~ 291 (601)
T KOG0590|consen 288 WLSS 291 (601)
T ss_pred cccc
Confidence 9987
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.5e-21 Score=185.96 Aligned_cols=146 Identities=16% Similarity=0.134 Sum_probs=116.6
Q ss_pred CeeEEeeeeecCceEEEEEE-EccCCCEEEEEEeecccccCh-------------------h--hHHHHHHHHHHHHHcC
Q 010266 107 DFDLLTIIGRGAFGEVRLCQ-EKKSGNIYAMKKLKKSEMLSR-------------------G--QVEHVRAERNLLAEVA 164 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~-~~~t~~~~AiK~l~k~~~~~~-------------------~--~~~~~~~E~~iL~~l~ 164 (514)
.|.+.+.||+|+||.||+|. +..+|+.||||+++....... . ....+..|..++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 57888999999999999998 667899999999976432100 0 1123568999999997
Q ss_pred CCc--eeeEEEEEEcCCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC-eEEcCCCCCCccccC
Q 010266 165 SHC--IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHN-YIHRDIKPDNLLLDQ 241 (514)
Q Consensus 165 hp~--Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~g-iiHrDLKpeNILld~ 241 (514)
+.+ +++.+.. ...|+||||++|++|.........+....++.++.|++.+|.+||+.| |+||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 533 4455542 234899999999888776655556777778889999999999999999 99999999999999
Q ss_pred CCcEEEccccccccCC
Q 010266 242 NGHMKLSDFGLCKPLD 257 (514)
Q Consensus 242 ~g~iKL~DFGla~~~~ 257 (514)
++.++|+|||+|....
T Consensus 184 ~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCCEEEEEChhhhccC
Confidence 8999999999988654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.5e-21 Score=215.07 Aligned_cols=198 Identities=22% Similarity=0.325 Sum_probs=158.6
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC---CCceeeEEEEEEc
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA---SHCIVKLYYSFQD 177 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~~~f~~ 177 (514)
-.+....|.|-+.||+|+||+||.|...+ |+.||+|+-+....+. +.--.+++.+++ -|.|..+..++.-
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE------fYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE------FYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee------eeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 34566789999999999999999999877 9999999877654332 222233334443 2445556555555
Q ss_pred CCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC-------CCcEEEccc
Q 010266 178 AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ-------NGHMKLSDF 250 (514)
Q Consensus 178 ~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~-------~g~iKL~DF 250 (514)
.+..+||+||.+-|+|.+++...+.+++..+.+++.||+.-|++||..||||+||||+|+||.. .--++|+||
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 6677899999999999999998899999999999999999999999999999999999999952 235899999
Q ss_pred cccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC
Q 010266 251 GLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK 330 (514)
Q Consensus 251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~ 330 (514)
|-|-.+...... ..-...++|-.+-.+|+..|.
T Consensus 846 G~siDm~lfp~~-----------------------------------------------~~F~~~~~td~f~C~EM~~gr 878 (974)
T KOG1166|consen 846 GRSIDMKLFPDG-----------------------------------------------TKFKAVWHTDLFDCIEMREGR 878 (974)
T ss_pred ccceeeeEcCCC-----------------------------------------------cEEeeeeccccchhHHHhcCC
Confidence 988654321100 012256789999999999999
Q ss_pred CCCcccchhhhhHHHHHHhhCC
Q 010266 331 GYGMECDWWSLGAIMYEMLVGY 352 (514)
Q Consensus 331 ~y~~~~DiWSlGvilyemltG~ 352 (514)
++++.+|.|.|..+++-||+|.
T Consensus 879 pWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 879 PWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred CCchhhhhHHHHHHHHHHHHHH
Confidence 9999999999999999999996
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=178.99 Aligned_cols=137 Identities=23% Similarity=0.283 Sum_probs=114.0
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccccCh-----hhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR-----GQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~-----~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
+.||+|++|.||++.. +|..+++|+......... .....+.+|..++..+.|++|+....++.+.+..++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999976 677899998654322111 123457789999999999988777777777788999999
Q ss_pred ecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 187 YLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 187 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
|++|++|.+++..... ....++.+++.+|.++|+.|++|||++|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999865432 6778889999999999999999999999999999 89999999999874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.4e-20 Score=172.64 Aligned_cols=133 Identities=21% Similarity=0.278 Sum_probs=107.1
Q ss_pred eeeecCceEEEEEEEccCCCEEEEEEeecccccC-----hhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEee
Q 010266 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS-----RGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY 187 (514)
Q Consensus 113 ~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~-----~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy 187 (514)
.||+|+||.||++. .+|..+++|+........ .....++.+|..++..+.|+++......+.+.+..++||||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 48999999999998 457789999865432211 11235677899999999888655444445566778999999
Q ss_pred cCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 188 LPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 188 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
++|++|..++..... .++.+++.+|.+||+.|++|||++|+||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999988754321 6788999999999999999999999999999 89999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.5e-19 Score=171.19 Aligned_cols=140 Identities=21% Similarity=0.185 Sum_probs=109.5
Q ss_pred eeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccCh-------------------hhHHHHHHHHHHHHHcCCC--
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR-------------------GQVEHVRAERNLLAEVASH-- 166 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~-------------------~~~~~~~~E~~iL~~l~hp-- 166 (514)
|.+.+.||.|+||.||++... +|+.||||+++....... ........|..++..+.|+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 777889999999999999864 799999999875431000 0112356788888888777
Q ss_pred ceeeEEEEEEcCCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEE
Q 010266 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMK 246 (514)
Q Consensus 167 ~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iK 246 (514)
.++..+. ....|+||||++|++|..+... ..+..++.+++.++.++|+.||+||||||+||+++.++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 4455543 2455899999999998776431 34556788999999999999999999999999999999999
Q ss_pred EccccccccCCC
Q 010266 247 LSDFGLCKPLDC 258 (514)
Q Consensus 247 L~DFGla~~~~~ 258 (514)
|+|||+|.....
T Consensus 166 liDfg~~~~~~~ 177 (198)
T cd05144 166 IIDWPQMVSTDH 177 (198)
T ss_pred EEECCccccCCC
Confidence 999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.5e-19 Score=166.59 Aligned_cols=140 Identities=18% Similarity=0.217 Sum_probs=101.3
Q ss_pred EeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHH---------------------HHHHHHHHHHcCCCc--
Q 010266 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---------------------VRAERNLLAEVASHC-- 167 (514)
Q Consensus 111 ~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~---------------------~~~E~~iL~~l~hp~-- 167 (514)
.+.||+|+||+||+|.+. +++.||||+++............ ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999876 79999999987643221111111 135566666664442
Q ss_pred eeeEEEEEEcCCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCCccccCCCcEE
Q 010266 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMK 246 (514)
Q Consensus 168 Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKpeNILld~~g~iK 246 (514)
++++++. ...++||||++|+.+........... ..++.++.+++.++.++|. .||+||||||+||+++ ++.++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~ 154 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVY 154 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEE
Confidence 4455543 24689999999965432211111111 6678889999999999999 9999999999999999 99999
Q ss_pred EccccccccCC
Q 010266 247 LSDFGLCKPLD 257 (514)
Q Consensus 247 L~DFGla~~~~ 257 (514)
|+|||.|....
T Consensus 155 liDfg~a~~~~ 165 (187)
T cd05119 155 IIDVPQAVEID 165 (187)
T ss_pred EEECccccccc
Confidence 99999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.3e-20 Score=172.44 Aligned_cols=240 Identities=19% Similarity=0.267 Sum_probs=191.9
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
..+..++..++.+|.....|+.|.+++. |..++.|++.-.+...+ .-..+..|.-.|+...||||+.++++++...+
T Consensus 185 ~gid~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~r-isrdfneefp~lrifshpnilpvlgacnsppn 261 (448)
T KOG0195|consen 185 TGIDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTAR-ISRDFNEEFPALRIFSHPNILPVLGACNSPPN 261 (448)
T ss_pred cCcchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcchh-hcchhhhhCcceeeecCCchhhhhhhccCCCC
Confidence 3466777888899999999999988765 45677788876554332 33457778888888999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC-eE-EcCCCCCCccccCCCcEEEc--cccccc
Q 010266 181 LYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHN-YI-HRDIKPDNLLLDQNGHMKLS--DFGLCK 254 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~g-ii-HrDLKpeNILld~~g~iKL~--DFGla~ 254 (514)
+.++..|||-|+|+.+|.... ..+..++..++..++.|+.|||+.. +| ---|....++||++-..+|+ |--++.
T Consensus 262 lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf 341 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF 341 (448)
T ss_pred ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee
Confidence 999999999999999997654 4567788888999999999999974 33 34678888999988777663 322211
Q ss_pred cCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCC--
Q 010266 255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-- 332 (514)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-- 332 (514)
.. ....-.|.||+||.+.+.+-
T Consensus 342 qe--------------------------------------------------------~gr~y~pawmspealqrkped~ 365 (448)
T KOG0195|consen 342 QE--------------------------------------------------------VGRAYSPAWMSPEALQRKPEDL 365 (448)
T ss_pred ec--------------------------------------------------------cccccCcccCCHHHHhcCchhc
Confidence 10 02235689999999988765
Q ss_pred -CcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccC
Q 010266 333 -GMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRL 401 (514)
Q Consensus 333 -~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl 401 (514)
-.++|+|||.+++||+.|...||..-++.+.-.+|.-..-...+|+ .+|+....|+.-|+. ||-+|+
T Consensus 366 n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ipp--gis~hm~klm~icmnedpgkrp 434 (448)
T KOG0195|consen 366 NIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPP--GISRHMNKLMNICMNEDPGKRP 434 (448)
T ss_pred chhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCC--CccHHHHHHHHHHhcCCCCcCC
Confidence 3589999999999999999999999999888888876445566775 899999999999998 999998
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=189.66 Aligned_cols=138 Identities=23% Similarity=0.268 Sum_probs=111.4
Q ss_pred eeEEeeeeecCceEEEEEEEccCCCEEEEEEeeccccc-----ChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML-----SRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~-----~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
|...+.||+|+||+||++.... ..+++|+....... .....+.+.+|..++..++|++++....++.+....+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 3457899999999999987643 34455543222111 1123456889999999999999988877777777889
Q ss_pred EEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccC
Q 010266 183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~ 256 (514)
+||||++|++|.+++. ....++.+++.+|.+||+.||+||||||+|||+ .++.++|+|||+|+..
T Consensus 413 lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999999999885 346688999999999999999999999999999 6889999999999864
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.7e-17 Score=159.36 Aligned_cols=138 Identities=20% Similarity=0.290 Sum_probs=106.2
Q ss_pred eeee-ecCceEEEEEEEccCCCEEEEEEeeccccc----------ChhhHHHHHHHHHHHHHcCCCce--eeEEEEEEcC
Q 010266 112 TIIG-RGAFGEVRLCQEKKSGNIYAMKKLKKSEML----------SRGQVEHVRAERNLLAEVASHCI--VKLYYSFQDA 178 (514)
Q Consensus 112 ~~LG-~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~----------~~~~~~~~~~E~~iL~~l~hp~I--v~l~~~f~~~ 178 (514)
..|| .||.|+||.+... +..+|||.+.+..+. .......+.+|..++..+.|++| +..++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 3677 8888899988653 778999988653321 11234567889999999988774 6666654332
Q ss_pred -Ce---EEEEEeecCC-CCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccc
Q 010266 179 -EY---LYLIMEYLPG-GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253 (514)
Q Consensus 179 -~~---l~lVmEy~~g-g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla 253 (514)
.. .++|||+++| .+|..++.. ..+++.. +.+++.+|.+||+.||+||||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 22 3599999998 688888754 4566543 568999999999999999999999999999999999999998
Q ss_pred ccC
Q 010266 254 KPL 256 (514)
Q Consensus 254 ~~~ 256 (514)
...
T Consensus 190 ~~~ 192 (239)
T PRK01723 190 ELR 192 (239)
T ss_pred ccC
Confidence 753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.7e-18 Score=178.12 Aligned_cols=181 Identities=27% Similarity=0.384 Sum_probs=135.6
Q ss_pred CeEEEEEeecCCCCHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 179 EYLYLIMEYLPGGDVMTLLMREE---TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
.++|+.|++|.-.+|.++|.... ..+......++.|+..|++| +|.+|||+||.||....++.+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 46999999999999999997543 34556777888999999999 9999999999999999999999999999875
Q ss_pred CCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcc
Q 010266 256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME 335 (514)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~ 335 (514)
....... .| .......-+||+.||+||.|.++.|+.+
T Consensus 406 ~~~~~~~--------------------------~~-----------------~~a~~t~~~gt~~YmsPEQi~g~~y~~k 442 (516)
T KOG1033|consen 406 QDKDETV--------------------------AP-----------------AAASHTQQVGTLLYMSPEQIRGQQYSEK 442 (516)
T ss_pred cccCCcc--------------------------cc-----------------hhhhhhhcccccccCCHHHHhhhhhhhh
Confidence 4322100 00 0001124589999999999999999999
Q ss_pred cchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcC-CChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 336 CDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEAR-LTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 336 ~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~-~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
+||||||+||||+++ -..+|.. ..++..|. ...+|+... =-++..+|+.+||. .|.+|| ++.+.--|
T Consensus 443 vdIyaLGlil~EL~~~f~T~~er---~~t~~d~r----~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP---~~~~~~~~ 512 (516)
T KOG1033|consen 443 VDIYALGLILAELLIQFSTQFER---IATLTDIR----DGIIPPEFLQDYPEEYTLLQQLLSPSPEERP---SAIEVALH 512 (516)
T ss_pred cchhhHHHHHHHHHHHhccHHHH---HHhhhhhh----cCCCChHHhhcCcHHHHHHHHhcCCCcccCc---hHHHHhhh
Confidence 999999999999997 4444422 22233332 234453211 13566799999998 999999 77777777
Q ss_pred Ccc
Q 010266 413 PWF 415 (514)
Q Consensus 413 pff 415 (514)
+|.
T Consensus 513 ~~~ 515 (516)
T KOG1033|consen 513 EFL 515 (516)
T ss_pred hhc
Confidence 764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.8e-17 Score=144.37 Aligned_cols=133 Identities=20% Similarity=0.254 Sum_probs=112.6
Q ss_pred EEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCC--CceeeEEEEEEcCCeEEEEEee
Q 010266 110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS--HCIVKLYYSFQDAEYLYLIMEY 187 (514)
Q Consensus 110 ~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~f~~~~~l~lVmEy 187 (514)
+++.||.|+++.||++.... ..+++|...+... ...+..|..++..+.+ +.+++++.++...+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 45789999999999998643 6899999865432 4568889999999976 5899999998888899999999
Q ss_pred cCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeEEcCCCCCCccccCCCcEEEccccccccC
Q 010266 188 LPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH---NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256 (514)
Q Consensus 188 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKpeNILld~~g~iKL~DFGla~~~ 256 (514)
++|+.+..+ +......++.+++.+|..||.. +++|+||+|+||+++..+.++++|||++...
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 999877654 4455667788999999999985 7999999999999999999999999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.1e-15 Score=160.04 Aligned_cols=201 Identities=26% Similarity=0.298 Sum_probs=150.5
Q ss_pred HHHcCCCceeeEEEEEEcCCeEEEEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCe-EEcCCCCCCc
Q 010266 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNY-IHRDIKPDNL 237 (514)
Q Consensus 160 L~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~gi-iHrDLKpeNI 237 (514)
|+.+.|.|+.++++.+.++...+.|.+||.-|+|.+.+.. .-.++..-....+.+++.||.|||.-.| .|+.|++.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 3467899999999999999999999999999999999977 3456666667778999999999998755 9999999999
Q ss_pred cccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhcccccccccc
Q 010266 238 LLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG 317 (514)
Q Consensus 238 Lld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~G 317 (514)
++|....+||+|||+.......... . ......-
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~---~--------------------------------------------~~~~~~~ 113 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEP---E--------------------------------------------AHHPIRK 113 (484)
T ss_pred eeeeeEEEEechhhhcccccccccc---c--------------------------------------------ccchhHH
Confidence 9999999999999997654320000 0 0000112
Q ss_pred CCCcCCccccccCC-------CCcccchhhhhHHHHHHhhCCCCCCCC----ChhHHHHHHhhhcCcccCCcC---cCCC
Q 010266 318 TPDYIAPEVLLKKG-------YGMECDWWSLGAIMYEMLVGYPPFYSD----DPVTTCRKIVHWKNHLKFPEE---ARLT 383 (514)
Q Consensus 318 T~~Y~APEvl~~~~-------y~~~~DiWSlGvilyemltG~~PF~~~----~~~~~~~~i~~~~~~~~~p~~---~~~s 383 (514)
..-|.|||.+.+.. -+.+.|+||+|++++|+++..-||... ++.+....+.........|.- ..+.
T Consensus 114 ~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~ 193 (484)
T KOG1023|consen 114 ALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELP 193 (484)
T ss_pred HHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcc
Confidence 23589999998632 366799999999999999999999753 233455555442233333321 1345
Q ss_pred hhHHHHHhhhcc-CccccCCCCCHhHHh
Q 010266 384 PEAKDLICRLLC-DVEHRLGTLGSEQIK 410 (514)
Q Consensus 384 ~~~~dLI~~lL~-dp~~Rl~~~~~~eil 410 (514)
++...++.+|.. +|..|+ ++++|.
T Consensus 194 ~~l~~l~~~cw~e~P~~rP---s~~~i~ 218 (484)
T KOG1023|consen 194 PELLLLVARCWEEIPEKRP---SIEQIR 218 (484)
T ss_pred hHHHHHHHHhcccChhhCc---cHHHHH
Confidence 678999999998 999999 666654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.5e-16 Score=165.41 Aligned_cols=143 Identities=22% Similarity=0.368 Sum_probs=99.0
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeeccccc--------------------------C-----hhhHHHHH
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML--------------------------S-----RGQVEHVR 154 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~--------------------------~-----~~~~~~~~ 154 (514)
.+|+. +.||.|++|.||.|+.+.+|+.||||++++.... . ....+.+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45776 7899999999999999888999999999764200 0 01123344
Q ss_pred HHHHHHHHcCCCceeeEEEEEEc-------------CCeEEEEEeecCCCCHHHH--Hhhcc----CCCHHHHHHHHHHH
Q 010266 155 AERNLLAEVASHCIVKLYYSFQD-------------AEYLYLIMEYLPGGDVMTL--LMREE----TLTETVARFYIAQS 215 (514)
Q Consensus 155 ~E~~iL~~l~hp~Iv~l~~~f~~-------------~~~l~lVmEy~~gg~L~~~--l~~~~----~l~e~~~~~~~~qi 215 (514)
+|.++.... .|+.++...|.+ ...-+|||||+.|+++.++ +...+ .+.+..+..++.|+
T Consensus 199 ~ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 199 DELDLMREA--ANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HhhCHHHHH--HHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 555554443 122222222222 2345699999999999764 33333 34455555566665
Q ss_pred HHHHHHHHhCCeEEcCCCCCCccccCCC----cEEEccccccccCCC
Q 010266 216 VLAIESIHKHNYIHRDIKPDNLLLDQNG----HMKLSDFGLCKPLDC 258 (514)
Q Consensus 216 ~~aL~~LH~~giiHrDLKpeNILld~~g----~iKL~DFGla~~~~~ 258 (514)
+ ..|++|+|+||.||+++.+| .++++|||++..++.
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4 58999999999999999988 999999999987653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.3e-15 Score=157.75 Aligned_cols=262 Identities=19% Similarity=0.232 Sum_probs=192.9
Q ss_pred CCeeEEeeeee--cCceEEEEEEE--ccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEEEcCCe
Q 010266 106 DDFDLLTIIGR--GAFGEVRLCQE--KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEY 180 (514)
Q Consensus 106 ~~f~~~~~LG~--G~fG~V~l~~~--~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~ 180 (514)
..|.+.+.+|. |.+|.||.+.. ..++..+|+|.-+.. ......-.+-.+|..-...++ |++.|+.+..+.+.+.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p-~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP-FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCC-CCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 45778889999 99999999998 888999999974321 111122222334555555554 8899999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhccC-CCHHHHHHHHHHHHH----HHHHHHhCCeEEcCCCCCCccccCC-CcEEEccccccc
Q 010266 181 LYLIMEYLPGGDVMTLLMREET-LTETVARFYIAQSVL----AIESIHKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCK 254 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~----aL~~LH~~giiHrDLKpeNILld~~-g~iKL~DFGla~ 254 (514)
+|+-+|+| |.+|..+...... +++..++.+..+... ||.++|+.+++|-|+||+||.+..+ ...+++|||+..
T Consensus 193 lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred ceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 99999998 5788887766544 888899999999998 9999999999999999999999999 889999999999
Q ss_pred cCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCc
Q 010266 255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM 334 (514)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~ 334 (514)
.+...+....... ....-|-.-|++||++. .-++.
T Consensus 272 ~i~~~~~~~~~~~--------------------------------------------~~r~~~~~~Y~~ke~~~-~l~~~ 306 (524)
T KOG0601|consen 272 KISDGNFSSVFKV--------------------------------------------SKRPEGDCIYAAKELLN-GLATF 306 (524)
T ss_pred EccCCccccceee--------------------------------------------eecCCCCceEeChhhhc-cccch
Confidence 8775543221110 01234777899999874 55899
Q ss_pred ccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCC
Q 010266 335 ECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHP 413 (514)
Q Consensus 335 ~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hp 413 (514)
..|++|||.+..+-.+|..++...- ...+..+-++..+..+- ...|.+....+..++. ++..|+ +++.+++|+
T Consensus 307 ~~di~sl~ev~l~~~l~~~~~~~g~-~~~W~~~r~~~ip~e~~--~~~s~~l~~~~~~~~d~~~~~~~---~~q~~~~l~ 380 (524)
T KOG0601|consen 307 ASDIFSLGEVILEAILGSHLPSVGK-NSSWSQLRQGYIPLEFC--EGGSSSLRSVTSQMLDEDPRLRL---TAQILTALN 380 (524)
T ss_pred HhhhcchhhhhHhhHhhcccccCCC-CCCccccccccCchhhh--cCcchhhhhHHHHhcCcchhhhh---HHHHHhccc
Confidence 9999999999999999877765430 01111222211111222 2456677778888887 777777 899999999
Q ss_pred ccccCCc
Q 010266 414 WFKDIAW 420 (514)
Q Consensus 414 ff~~i~w 420 (514)
+.+....
T Consensus 381 ~i~s~~~ 387 (524)
T KOG0601|consen 381 VIHSKLF 387 (524)
T ss_pred cccchhh
Confidence 9986543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.6e-14 Score=149.24 Aligned_cols=140 Identities=16% Similarity=0.281 Sum_probs=95.1
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccccC--------------------------h-h----hHH------HHH
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS--------------------------R-G----QVE------HVR 154 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~--------------------------~-~----~~~------~~~ 154 (514)
+.||.|++|.||+|+. .+|+.||||+.+...... . . -.. .+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5799999999999986 478999999986542000 0 0 001 133
Q ss_pred HHHHHHHHc-----CCCc--eeeEEEEEEcCCeEEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHH-HHHHHHhC
Q 010266 155 AERNLLAEV-----ASHC--IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVL-AIESIHKH 225 (514)
Q Consensus 155 ~E~~iL~~l-----~hp~--Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~-aL~~LH~~ 225 (514)
.|...+..+ ++++ |++.|..+ ...-+|||||++|++|.++.... ...+ ...++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~--~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR--TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh--cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence 344444443 2343 33444333 33468999999999998876432 1222 1223444444 46788999
Q ss_pred CeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 226 giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
|++|+|+||.||+++.+|.++|+|||++..+.
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999998765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.49 E-value=7.6e-14 Score=128.05 Aligned_cols=128 Identities=20% Similarity=0.242 Sum_probs=96.0
Q ss_pred EeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCc-eeeEEEEEEcCCeEEEEEeecC
Q 010266 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDAEYLYLIMEYLP 189 (514)
Q Consensus 111 ~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~-Iv~l~~~f~~~~~l~lVmEy~~ 189 (514)
++.|+.|.++.||.++.. +..|++|+...... .......|..++..+.+.. ++++++... ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 567899999999998753 77899998765421 1123567888888886544 445555443 33579999999
Q ss_pred CCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCe-----EEcCCCCCCccccCCCcEEEcccccccc
Q 010266 190 GGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY-----IHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 190 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~gi-----iHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
|.++... ......++.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.|..
T Consensus 75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 9887643 11123456789999999999885 9999999999999 77899999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.46 E-value=8.8e-13 Score=123.78 Aligned_cols=141 Identities=14% Similarity=0.137 Sum_probs=103.3
Q ss_pred eeeeecCceEEEEEEEcc------CCCEEEEEEeecccc-------------------cChhhHHHH----HHHHHHHHH
Q 010266 112 TIIGRGAFGEVRLCQEKK------SGNIYAMKKLKKSEM-------------------LSRGQVEHV----RAERNLLAE 162 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~------t~~~~AiK~l~k~~~-------------------~~~~~~~~~----~~E~~iL~~ 162 (514)
..||.|-=+.||.|.... .+..+|||+.+-+.. ...+....+ .+|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 478999999999997543 357899999763210 011222233 389999988
Q ss_pred cCC--CceeeEEEEEEcCCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHH-HhCCeEEcCCCCCCccc
Q 010266 163 VAS--HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESI-HKHNYIHRDIKPDNLLL 239 (514)
Q Consensus 163 l~h--p~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~L-H~~giiHrDLKpeNILl 239 (514)
+.. -.++.+++. ..-+|||||+.|+.+..-..+...+++..+..+..+++.+|..| |+.||||+||+|.|||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~ 158 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW 158 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 853 466677654 45679999997755543333334566666777789999999999 89999999999999999
Q ss_pred cCCCcEEEccccccccCC
Q 010266 240 DQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 240 d~~g~iKL~DFGla~~~~ 257 (514)
+ +|.+.|+|||.|....
T Consensus 159 ~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 159 H-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred E-CCcEEEEECCCceeCC
Confidence 6 5889999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=9.9e-14 Score=145.57 Aligned_cols=252 Identities=23% Similarity=0.248 Sum_probs=184.6
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEc-cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcC
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEK-KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDA 178 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~-~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~ 178 (514)
......+|..+..||.|.|+.|+.+... .++..||+|-+.+.......++.. ..|.-+...+ .|.+++..+..|...
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~s-l~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFS-LGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcc-hhhhhHhhHhhcccccCCCCCCcccc
Confidence 3445689999999999999999998866 678899999887765444444433 3466666655 589999999999888
Q ss_pred CeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCC-CcEEEccccccccCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPLD 257 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~-g~iKL~DFGla~~~~ 257 (514)
++.|+=.|||.|+++...+.-...+++...+...+|++.|+.++|+..++|+|+||+||++..+ +..++.|||..+.+.
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 9999999999999887776556678888899999999999999999999999999999999886 788999999886532
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcC--CccccccCCCCcc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYI--APEVLLKKGYGME 335 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~--APEvl~~~~y~~~ 335 (514)
... ....++-.++ +|.......+..+
T Consensus 419 ~~~----------------------------------------------------~~~~~~~r~~p~~~~~~e~~~~~~~ 446 (524)
T KOG0601|consen 419 FSS----------------------------------------------------GVFHHIDRLYPIAEILLEDYPHLSK 446 (524)
T ss_pred eec----------------------------------------------------ccccccccccccchhhccccccccc
Confidence 110 0112233334 5555556778999
Q ss_pred cchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCc
Q 010266 336 CDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPW 414 (514)
Q Consensus 336 ~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpf 414 (514)
+|++|||.-+.+.++|.+--...+ ....|.. + ..|.....+.++..+.+.++. ++..|+ .+.++..|+=
T Consensus 447 ~~~~sl~~~~~e~~~~~~ls~~~~---~~~~i~~--~--~~p~~~~~~~~~q~~~kv~~~~~~~~~~---l~~~l~~~~~ 516 (524)
T KOG0601|consen 447 ADIFSLGLSVDEAITGSPLSESGV---QSLTIRS--G--DTPNLPGLKLQLQVLLKVMINPDRKRRP---SAVELSLHSE 516 (524)
T ss_pred cccccccccccccccCcccCcccc---cceeeec--c--cccCCCchHHhhhhhhhhhcCCccccch---hhhhhcccch
Confidence 999999999999999875432211 1222222 1 223222445777888888776 666665 6666666654
Q ss_pred c
Q 010266 415 F 415 (514)
Q Consensus 415 f 415 (514)
|
T Consensus 517 ~ 517 (524)
T KOG0601|consen 517 F 517 (524)
T ss_pred h
Confidence 4
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.7e-11 Score=130.10 Aligned_cols=125 Identities=18% Similarity=0.227 Sum_probs=104.3
Q ss_pred EEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecCCCCHHHHHhhccCC
Q 010266 124 LCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETL 203 (514)
Q Consensus 124 l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~l~~~~~l 203 (514)
.+..+.++.++.+.+.+.+. ......+.+-..-|+.++||+|++++.++..+..+|||.|-+. .|..++...+
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~---~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-- 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSN---GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-- 102 (690)
T ss_pred ccceeccCCceEEEEEeCCC---chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH--
Confidence 34556788899999887553 2345556777888999999999999999999999999999984 6777776544
Q ss_pred CHHHHHHHHHHHHHHHHHHH-hCCeEEcCCCCCCccccCCCcEEEccccccccC
Q 010266 204 TETVARFYIAQSVLAIESIH-KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256 (514)
Q Consensus 204 ~e~~~~~~~~qi~~aL~~LH-~~giiHrDLKpeNILld~~g~iKL~DFGla~~~ 256 (514)
......-+.||+.||.||| +.+++|++|.-+.|.++..|+.||.+|-++...
T Consensus 103 -~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~ 155 (690)
T KOG1243|consen 103 -KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKA 155 (690)
T ss_pred -HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence 6667777899999999997 679999999999999999999999999987643
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.7e-11 Score=110.50 Aligned_cols=134 Identities=20% Similarity=0.231 Sum_probs=98.8
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccccChh-----hHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRG-----QVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~-----~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
..|++|+=+.++.+... |..+.+|.=.++....+. ...+..+|..+|..+.--.|.-.+-++.|.....++||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999988653 444666643222211111 23456778889998876666555556677888889999
Q ss_pred ecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 187 YLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 187 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
|++|-.|.+.+... . ..++.++-.-+.-||..||||+||.++||++..++ +.++||||+..
T Consensus 80 ~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99998888888665 1 34566777778889999999999999999997554 99999999874
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.4e-11 Score=116.15 Aligned_cols=140 Identities=17% Similarity=0.230 Sum_probs=103.2
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCC--CceeeEEEEEEcC---CeEEEEEe
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS--HCIVKLYYSFQDA---EYLYLIME 186 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~f~~~---~~l~lVmE 186 (514)
+.||.|..+.||++.... |+.|++|+....... .....+..|..++..+.+ ..+++++.+.... +..|+|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 578999999999998643 678999997654321 123457889999999875 3467777766553 26789999
Q ss_pred ecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 010266 187 YLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK------------------------------------------ 224 (514)
Q Consensus 187 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~------------------------------------------ 224 (514)
|++|+++...+.. ..+++.....++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999887765432 345555555566666666666662
Q ss_pred --------------CCeEEcCCCCCCccccC--CCcEEEcccccccc
Q 010266 225 --------------HNYIHRDIKPDNLLLDQ--NGHMKLSDFGLCKP 255 (514)
Q Consensus 225 --------------~giiHrDLKpeNILld~--~g~iKL~DFGla~~ 255 (514)
..++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 35799999999999998 67789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=3.3e-11 Score=117.78 Aligned_cols=216 Identities=21% Similarity=0.279 Sum_probs=152.6
Q ss_pred HHHHHHHHHHcCCCceeeEEEEEEcCC-----eEEEEEeecCCCCHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHH
Q 010266 153 VRAERNLLAEVASHCIVKLYYSFQDAE-----YLYLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIH 223 (514)
Q Consensus 153 ~~~E~~iL~~l~hp~Iv~l~~~f~~~~-----~l~lVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH 223 (514)
.+.-.+-|-.+.|.|||+++.++.+.. ...++.|||..|+|..+|++ ...+....-+.|+-||+.||.|||
T Consensus 114 ~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh 193 (458)
T KOG1266|consen 114 RRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH 193 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh
Confidence 333445566677999999998886544 48899999999999999975 346778888899999999999999
Q ss_pred hC--CeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHH
Q 010266 224 KH--NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQL 301 (514)
Q Consensus 224 ~~--giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (514)
+. -|+|+++.-+-|.+..+|-||+.- +.. +..+.+.
T Consensus 194 s~~PpiihgnlTc~tifiq~ngLIkig~---~ap-~s~h~s~-------------------------------------- 231 (458)
T KOG1266|consen 194 SCDPPIIHGNLTCDTIFIQHNGLIKIGS---VAP-DSTHPSV-------------------------------------- 231 (458)
T ss_pred ccCCccccCCcchhheeecCCceEEecc---cCc-cccchhh--------------------------------------
Confidence 87 599999999999999999999842 110 0000000
Q ss_pred HHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhhCCCC-CCCCChhHHHHHHhhhcCcccCCcCc
Q 010266 302 QHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP-FYSDDPVTTCRKIVHWKNHLKFPEEA 380 (514)
Q Consensus 302 ~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemltG~~P-F~~~~~~~~~~~i~~~~~~~~~p~~~ 380 (514)
+..+...+..-.|-++|.|||.=.....+.++|||++|.+..||..|..- =.+.+..+.-.+|.+- .+...
T Consensus 232 ---~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~--i~~le--- 303 (458)
T KOG1266|consen 232 ---NSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANV--IIGLE--- 303 (458)
T ss_pred ---hhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhh--eeecc---
Confidence 00000011123477899999987666778899999999999999988654 3333333333333321 11111
Q ss_pred CCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCcccc
Q 010266 381 RLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKL 423 (514)
Q Consensus 381 ~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~l 423 (514)
.+--+++|.+||. .|..|+ ++.+++-||-.-++.-.++
T Consensus 304 --n~lqr~~i~kcl~~eP~~rp---~ar~llfHpllfeVhslkl 342 (458)
T KOG1266|consen 304 --NGLQRGSITKCLEGEPNGRP---DARLLLFHPLLFEVHSLKL 342 (458)
T ss_pred --CccccCcCcccccCCCCCCc---chhhhhcCceeeecchHHH
Confidence 1233678999999 999998 9999999999877765444
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.1e-10 Score=102.44 Aligned_cols=144 Identities=24% Similarity=0.277 Sum_probs=104.5
Q ss_pred EEeeeeecCceEEEEEEEccCCCEEEEEEee-cc----cccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLK-KS----EMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 110 ~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~-k~----~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.+..|-+|+=+.|+.+. ..|+.+.||.=. |. .+..+-...+..+|..+|.++.--.|.-..-+|.|...-+++
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 67789999999999775 568888888532 21 111122245678899999888644554444467777788899
Q ss_pred EeecCC-CCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCc---EEEcccccccc
Q 010266 185 MEYLPG-GDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH---MKLSDFGLCKP 255 (514)
Q Consensus 185 mEy~~g-g~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~---iKL~DFGla~~ 255 (514)
|||++| -++.+++... .........-.+..+-..|.-||.++|||+||..+||++..+|. +.|+||||+..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999987 4677776543 22223333567788888999999999999999999999987763 58999999764
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.7e-09 Score=111.95 Aligned_cols=210 Identities=17% Similarity=0.240 Sum_probs=152.1
Q ss_pred ceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE----cCCeEEEEEeecCC-CCH
Q 010266 119 FGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ----DAEYLYLIMEYLPG-GDV 193 (514)
Q Consensus 119 fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~----~~~~l~lVmEy~~g-g~L 193 (514)
-.+.|+|..+.+|..|++|.+.-......+. ...-.+.++++.|+|||++..+|. ++..++||++|.|+ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk---~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNK---DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCccc---chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 3578999999999999999995443333332 223467899999999999999997 45679999999987 577
Q ss_pred HHHHh---------------hccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 194 MTLLM---------------REETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 194 ~~~l~---------------~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
.++.- .....+|..++.|+.|+..||.++|+.|+.-+-|-|.+||++.+-.|+|+.-|....+..
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 76542 223577899999999999999999999999999999999999888899987666543322
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
.. | |-+.. -.+-|.
T Consensus 446 d~--------------------------------------------------------~-------~~le~---~Qq~D~ 459 (655)
T KOG3741|consen 446 DP--------------------------------------------------------T-------EPLES---QQQNDL 459 (655)
T ss_pred CC--------------------------------------------------------C-------cchhH---HhhhhH
Confidence 10 0 01111 124688
Q ss_pred hhhhHHHHHHhhCCCCC-CCCChhHH-HHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 339 WSLGAIMYEMLVGYPPF-YSDDPVTT-CRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 339 WSlGvilyemltG~~PF-~~~~~~~~-~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
=.||.+++.|.||..-= ..+...+. ...|- ...|.+++++|.-|.. .+.++ ++++++.|
T Consensus 460 ~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-----------~~yS~D~rn~v~yl~s~~~~~k----sI~~llp~ 521 (655)
T KOG3741|consen 460 RDLGLLLLALATGTENSNRTDSTQSSHLTRIT-----------TTYSTDLRNVVEYLESLNFREK----SIQDLLPM 521 (655)
T ss_pred HHHHHHHHHHhhcccccccccchHHHHHHHhh-----------hhhhHHHHHHHHHHHhcCcccc----cHHHHHHH
Confidence 89999999999996442 22222222 22222 2578899999988876 55543 67777755
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.98 E-value=6.9e-09 Score=102.62 Aligned_cols=126 Identities=13% Similarity=0.114 Sum_probs=89.3
Q ss_pred CCCEEEEEEeecccc---cCh-----hhHHHHHHHHHHHHHcCCC--ceeeEEEEEEc-----CCeEEEEEeecCCC-CH
Q 010266 130 SGNIYAMKKLKKSEM---LSR-----GQVEHVRAERNLLAEVASH--CIVKLYYSFQD-----AEYLYLIMEYLPGG-DV 193 (514)
Q Consensus 130 t~~~~AiK~l~k~~~---~~~-----~~~~~~~~E~~iL~~l~hp--~Iv~l~~~f~~-----~~~l~lVmEy~~gg-~L 193 (514)
.|+.|.||....... ... .-.....+|...+..+..- .++.+.+++.. ...-+||||+++|. +|
T Consensus 44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL 123 (268)
T PRK15123 44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISL 123 (268)
T ss_pred CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccH
Confidence 466788886643221 000 1112367888888777432 23334444432 23578999999886 78
Q ss_pred HHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC-------CCcEEEcccccccc
Q 010266 194 MTLLMR--EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ-------NGHMKLSDFGLCKP 255 (514)
Q Consensus 194 ~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~-------~g~iKL~DFGla~~ 255 (514)
.+++.. ....++.....++.+++..+.-||..||+|+||+|.|||++. ++.+.|+||+.+..
T Consensus 124 ~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 124 EDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 888754 345566777888999999999999999999999999999985 46899999998853
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.5e-09 Score=99.01 Aligned_cols=129 Identities=20% Similarity=0.228 Sum_probs=82.1
Q ss_pred EEEEEEEccCCCEEEEEEeeccccc-----------------------ChhhHHHHHHHHHHHHHcCCC--ceeeEEEEE
Q 010266 121 EVRLCQEKKSGNIYAMKKLKKSEML-----------------------SRGQVEHVRAERNLLAEVASH--CIVKLYYSF 175 (514)
Q Consensus 121 ~V~l~~~~~t~~~~AiK~l~k~~~~-----------------------~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~f 175 (514)
.||.|.. ..|..+|||+.+..... ..-......+|...|..+..- ++++++.+-
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888875 56779999997643110 001134577899999999765 466666442
Q ss_pred EcCCeEEEEEeecC--CCCHHHHHhhccCCCHHHHHHHHHHHHHHHHH-HHhCCeEEcCCCCCCccccCCCcEEEccccc
Q 010266 176 QDAEYLYLIMEYLP--GGDVMTLLMREETLTETVARFYIAQSVLAIES-IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252 (514)
Q Consensus 176 ~~~~~l~lVmEy~~--gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~-LH~~giiHrDLKpeNILld~~g~iKL~DFGl 252 (514)
.-+|||||++ |..+..+.... ++......++.+++..+.. +|..||||+||.+.|||++.+ .+.|+|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 2369999998 65554433221 2244455667777775555 589999999999999999876 999999999
Q ss_pred cccCC
Q 010266 253 CKPLD 257 (514)
Q Consensus 253 a~~~~ 257 (514)
|....
T Consensus 153 av~~~ 157 (188)
T PF01163_consen 153 AVDSS 157 (188)
T ss_dssp EEETT
T ss_pred ceecC
Confidence 87543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.6e-10 Score=120.60 Aligned_cols=168 Identities=21% Similarity=0.332 Sum_probs=119.5
Q ss_pred HHHHHHHHHHh-CCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCC
Q 010266 214 QSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGR 292 (514)
Q Consensus 214 qi~~aL~~LH~-~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (514)
+++.|+.|+|. .++||+.|-|++|.++.+|..||+.|+.|............. .+...
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~--------------yd~~l------- 165 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSE--------------YDPPL------- 165 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCcccccc--------------CCCCC-------
Confidence 44489999996 599999999999999999999999999987543321110000 00000
Q ss_pred CCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHh-hCCCCCCCCChhHHHHHHhhhc
Q 010266 293 RWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPPFYSDDPVTTCRKIVHWK 371 (514)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml-tG~~PF~~~~~~~~~~~i~~~~ 371 (514)
.....-...|.|||++.+...+.++|++||||++|-+. .|..-|.+.+....+..-....
T Consensus 166 -------------------p~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~ 226 (700)
T KOG2137|consen 166 -------------------PLLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLL 226 (700)
T ss_pred -------------------ChhhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccc
Confidence 01223456899999999988899999999999999999 5666666554443333322211
Q ss_pred CcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCccccc
Q 010266 372 NHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLY 424 (514)
Q Consensus 372 ~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~l~ 424 (514)
+.-.+-....++.+.++=|.++|. ++.-|+ ++.+++.-|||.+.--..|+
T Consensus 227 ~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp---~~~~l~~~~ff~D~~~~aLr 277 (700)
T KOG2137|consen 227 NAGAFGYSNNLPSELRESLKKLLNGDSAVRP---TLDLLLSIPFFSDPGLKALR 277 (700)
T ss_pred ccccccccccCcHHHHHHHHHHhcCCcccCc---chhhhhcccccCCchhhhhh
Confidence 111122224688999999999998 999998 88999999999986655554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.79 E-value=5.2e-08 Score=92.89 Aligned_cols=127 Identities=23% Similarity=0.241 Sum_probs=92.1
Q ss_pred CCCEEEEEEeeccc----ccChhhHHHHHHHHHHHHHcCCC--ceeeEEEEEEcC----CeEEEEEeecCCC-CHHHHHh
Q 010266 130 SGNIYAMKKLKKSE----MLSRGQVEHVRAERNLLAEVASH--CIVKLYYSFQDA----EYLYLIMEYLPGG-DVMTLLM 198 (514)
Q Consensus 130 t~~~~AiK~l~k~~----~~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~f~~~----~~l~lVmEy~~gg-~L~~~l~ 198 (514)
.++.|-+|.+...- +...-......+|...+..+..- .+++.+++.... ...+||+|+++|. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 45566666543221 11112334567787777766432 234444444432 3468999999985 8999998
Q ss_pred hccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC---cEEEccccccccC
Q 010266 199 REETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG---HMKLSDFGLCKPL 256 (514)
Q Consensus 199 ~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g---~iKL~DFGla~~~ 256 (514)
.....+......++.++...+.-||..||+|+|++|.|||++.++ .+.|+||+.++..
T Consensus 111 ~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 755577778888999999999999999999999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1e-09 Score=116.03 Aligned_cols=188 Identities=21% Similarity=0.268 Sum_probs=136.6
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCc-eeeEEEEEEcCCeEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~-Iv~l~~~f~~~~~l~lV 184 (514)
.-+....-+++|+++++++.+...+.... .+.+... ...+-++++|.+++||+ .+.-+..++.+.++.++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 34556667899999999987765554444 5555432 33566899999999999 77777788888999999
Q ss_pred EeecCCC-CHHHH-HhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 185 MEYLPGG-DVMTL-LMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 185 mEy~~gg-~L~~~-l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
|+++.+| +-... ....-.+.+.........-..++++||+.-=+||| |||.. ++..|+.||+....+...
T Consensus 313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~--- 384 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRT--- 384 (829)
T ss_pred hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCcc---
Confidence 9999887 21111 11111222333333445566789999988778998 88775 488899999987655321
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
....+..||+.++|||+.....+....|.||+|
T Consensus 385 -----------------------------------------------~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~ 417 (829)
T KOG0576|consen 385 -----------------------------------------------MKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLA 417 (829)
T ss_pred -----------------------------------------------cccccCCCCCCCCCchhhcccccccCCCccCCC
Confidence 012367899999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCC
Q 010266 343 AIMYEMLVGYPPFYS 357 (514)
Q Consensus 343 vilyemltG~~PF~~ 357 (514)
+--.+|--|-+|-..
T Consensus 418 ~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 418 VSAIQMAPGLPPRSS 432 (829)
T ss_pred cchhhcCCCCCCCCC
Confidence 988888888887654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=3.7e-07 Score=92.75 Aligned_cols=230 Identities=15% Similarity=0.196 Sum_probs=144.3
Q ss_pred EEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceee--------EEEEEEcCCe
Q 010266 110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVK--------LYYSFQDAEY 180 (514)
Q Consensus 110 ~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~--------l~~~f~~~~~ 180 (514)
..+.||+|+-+.+|-+-.- + -.+.|+..+...-.. ..-+..|... .||-+-. |++. .....
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~-d~VAKIYh~Pppa~~------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~ 84 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--R-DQVAKIYHAPPPAAQ------AQKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKV 84 (637)
T ss_pred CCccccCCccceeeecchh--h-chhheeecCCCchHH------HHHHHHhccCCCCcchhhhhcccHHHhhCC-Cccce
Confidence 3467999999999965432 2 235588766532211 1123334443 4553322 1211 12233
Q ss_pred EEEEEeecCCCCH-HHHHh---hc---cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccc
Q 010266 181 LYLIMEYLPGGDV-MTLLM---RE---ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253 (514)
Q Consensus 181 l~lVmEy~~gg~L-~~~l~---~~---~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla 253 (514)
+-+.|..++|-.- ..++. +. ..+...-+.....+++.|...||..|.+-+|+.++|+|+++++.+.|.|=..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 7788998887522 22221 12 23445566677889999999999999999999999999999999999873321
Q ss_pred ccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc-----
Q 010266 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL----- 328 (514)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~----- 328 (514)
..... .......+|.++|.+||.-.
T Consensus 165 qi~~n--------------------------------------------------g~~~~cpVg~~eftPPElQ~~~sf~ 194 (637)
T COG4248 165 QINAN--------------------------------------------------GTLHLCPVGVSEFTPPELQTLPSFV 194 (637)
T ss_pred eeccC--------------------------------------------------CceEecccCccccCCHHHhcccccc
Confidence 11000 00112568999999999865
Q ss_pred cCCCCcccchhhhhHHHHHHhhC-CCCCCCC-------ChhHHHHHHhhh---------cC---cccCCcCcCCChhHHH
Q 010266 329 KKGYGMECDWWSLGAIMYEMLVG-YPPFYSD-------DPVTTCRKIVHW---------KN---HLKFPEEARLTPEAKD 388 (514)
Q Consensus 329 ~~~y~~~~DiWSlGvilyemltG-~~PF~~~-------~~~~~~~~i~~~---------~~---~~~~p~~~~~s~~~~d 388 (514)
+..-+...|-+.|||++|++|.| +.||.|. ++-++ .|.++ .. ...-++..-+.++...
T Consensus 195 g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~--~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqA 272 (637)
T COG4248 195 GFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET--DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQA 272 (637)
T ss_pred ccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh--hhhcceeeechhccCCCCCCCCCCChhhcCHHHHH
Confidence 33446789999999999999987 9999763 22221 23221 01 1111122347899999
Q ss_pred HHhhhccC---ccccC
Q 010266 389 LICRLLCD---VEHRL 401 (514)
Q Consensus 389 LI~~lL~d---p~~Rl 401 (514)
|..++..+ +.-|+
T Consensus 273 lF~qaF~~~~~~~~RP 288 (637)
T COG4248 273 LFQQAFTESGVATPRP 288 (637)
T ss_pred HHHHHhcccCCCCCCC
Confidence 99999874 44666
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.64 E-value=3.3e-07 Score=86.93 Aligned_cols=140 Identities=20% Similarity=0.329 Sum_probs=91.2
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHH------HHHHHHHHHHcCC---CceeeEEE-
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH------VRAERNLLAEVAS---HCIVKLYY- 173 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~------~~~E~~iL~~l~h---p~Iv~l~~- 173 (514)
..++|.+++++-......|.+.. .+|+.|.+|..+............ ..++...+..+.. ..++.++.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 34789999999998888888765 457889999876543221111111 1222333333321 12222222
Q ss_pred ----EEEcCCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcc
Q 010266 174 ----SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSD 249 (514)
Q Consensus 174 ----~f~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~D 249 (514)
.+.-....+|||||++|..|.++.. +++. +...++.++.-||+.|+.|+|..|.|++++.+| ++++|
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID 177 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIID 177 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh----cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEE
Confidence 2222345578999999988766532 3332 335677789999999999999999999998555 99999
Q ss_pred ccccc
Q 010266 250 FGLCK 254 (514)
Q Consensus 250 FGla~ 254 (514)
|+..+
T Consensus 178 ~~~k~ 182 (229)
T PF06176_consen 178 TQGKR 182 (229)
T ss_pred Ccccc
Confidence 98654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=6e-07 Score=87.02 Aligned_cols=138 Identities=17% Similarity=0.205 Sum_probs=97.9
Q ss_pred EEeeeeecCceEEEEEEEccCCCEEEEEEeecccc-----------------cCh--hhHHHHHHHHHHHHHcCCC--ce
Q 010266 110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM-----------------LSR--GQVEHVRAERNLLAEVASH--CI 168 (514)
Q Consensus 110 ~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~-----------------~~~--~~~~~~~~E~~iL~~l~hp--~I 168 (514)
+...||-|-=|.||.|... .|..+|||.=+-... .+. -......+|.++|..+... .|
T Consensus 95 iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4578999999999999864 688999996432210 000 0123456788889988655 56
Q ss_pred eeEEEEEEcCCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEc
Q 010266 169 VKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLS 248 (514)
Q Consensus 169 v~l~~~f~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~ 248 (514)
++.++ .+.-.+||||+.|-.|...-. +.+.+..++..|+.-+.-+-..||||+|+.+=|||++.+|.+.++
T Consensus 174 P~P~~----~nRHaVvMe~ieG~eL~~~r~-----~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vI 244 (304)
T COG0478 174 PKPIA----WNRHAVVMEYIEGVELYRLRL-----DVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVI 244 (304)
T ss_pred CCccc----cccceeeeehcccceeecccC-----cccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEE
Confidence 66654 356689999999977655431 233344444555555555558999999999999999999999999
Q ss_pred cccccccCC
Q 010266 249 DFGLCKPLD 257 (514)
Q Consensus 249 DFGla~~~~ 257 (514)
||--|....
T Consensus 245 DwPQ~v~~~ 253 (304)
T COG0478 245 DWPQAVPIS 253 (304)
T ss_pred eCcccccCC
Confidence 999876543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.4e-06 Score=82.34 Aligned_cols=139 Identities=13% Similarity=0.180 Sum_probs=100.5
Q ss_pred eecCceEEEEEEEccCCCEEEEEEeecc---cccChhhHHHHHHHHHHHHHcCCC--ceeeEEEEEEc----CCeEEEEE
Q 010266 115 GRGAFGEVRLCQEKKSGNIYAMKKLKKS---EMLSRGQVEHVRAERNLLAEVASH--CIVKLYYSFQD----AEYLYLIM 185 (514)
Q Consensus 115 G~G~fG~V~l~~~~~t~~~~AiK~l~k~---~~~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~f~~----~~~l~lVm 185 (514)
|+||-+.|+.... .|+.|-+|..... .+.-+.-..-+.+|...|..+..- .++++.+.-.. .-.-+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 6789999997654 3446888876411 111133456688999999887532 24454422211 22478999
Q ss_pred eecCC-CCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCc--EEEcccccccc
Q 010266 186 EYLPG-GDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH--MKLSDFGLCKP 255 (514)
Q Consensus 186 Ey~~g-g~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~--iKL~DFGla~~ 255 (514)
|-++| -||.+++... .+.++..-+.++.++..+|.-||+.|+.|+|+-+.||+++.+|. ++++||--++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98865 4888887653 34567777788999999999999999999999999999997777 99999987664
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.47 E-value=2e-06 Score=83.14 Aligned_cols=133 Identities=20% Similarity=0.167 Sum_probs=84.6
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCc--eeeEEEEEEcCCeEEEEEeecC
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC--IVKLYYSFQDAEYLYLIMEYLP 189 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~--Iv~l~~~f~~~~~l~lVmEy~~ 189 (514)
..||.|..+.||++ .+..+++|...... ....+.+|.+++..+..-. +++.+++..+.+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999973 24567889876422 2344788999999886433 5677777777888899999999
Q ss_pred CCC-HHHHH---------------------hhc--c--CCCHHHHHHHHH----------HHHH-HHHHHH----hCCeE
Q 010266 190 GGD-VMTLL---------------------MRE--E--TLTETVARFYIA----------QSVL-AIESIH----KHNYI 228 (514)
Q Consensus 190 gg~-L~~~l---------------------~~~--~--~l~e~~~~~~~~----------qi~~-aL~~LH----~~gii 228 (514)
|.+ +...+ +.- . .++.... .+.. .+.. ...+|. ...++
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~-~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKE-KIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHH-HHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 864 11111 110 0 0111110 0100 0111 122222 12578
Q ss_pred EcCCCCCCccccCCCcEEEcccccccc
Q 010266 229 HRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 229 HrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
|+|+.|.||+++.+| +.++||+.+..
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999999888 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=7.8e-07 Score=95.32 Aligned_cols=142 Identities=19% Similarity=0.315 Sum_probs=90.3
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccc--------------------cC-------hhh----HHHH------H
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM--------------------LS-------RGQ----VEHV------R 154 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~--------------------~~-------~~~----~~~~------~ 154 (514)
..|+.++-|.||.|+.+ +|+.||||+.+..-. .. ... .+.+ .
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 57999999999999975 499999999875410 00 000 1122 2
Q ss_pred HHHHHHHHc-----CCCc--eeeEEEEEEcCCeEEEEEeecCCCCHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhCC
Q 010266 155 AERNLLAEV-----ASHC--IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM-REETLTETVARFYIAQSVLAIESIHKHN 226 (514)
Q Consensus 155 ~E~~iL~~l-----~hp~--Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~g 226 (514)
.|..-+.++ +.|+ |++.|--+ ...-.|+|||+.|-.+.+... +...++...+.....++. +.-+=..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~--t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dg 285 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEY--TTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhc--cCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcC
Confidence 333333333 2343 34444333 344579999999988888742 224444333222222221 22233489
Q ss_pred eEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 227 YIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 227 iiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
++|.|..|.||+++.+|++.+.|||+...+..
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999877653
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.7e-06 Score=81.52 Aligned_cols=138 Identities=20% Similarity=0.328 Sum_probs=83.5
Q ss_pred EeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCC--ceeeEEEEEE---cCCeEEEEE
Q 010266 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH--CIVKLYYSFQ---DAEYLYLIM 185 (514)
Q Consensus 111 ~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~f~---~~~~l~lVm 185 (514)
++.|+.|..+.||.+.... ..|++|..... .....+..|..++..+... .++.++.... .....+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 5789999999999988654 48999986543 3456677888898887533 3566665432 334579999
Q ss_pred eecCCCCHHH----------------HHh---hc----cCCCHHH---HH---HH---------------HHHHHH-HHH
Q 010266 186 EYLPGGDVMT----------------LLM---RE----ETLTETV---AR---FY---------------IAQSVL-AIE 220 (514)
Q Consensus 186 Ey~~gg~L~~----------------~l~---~~----~~l~e~~---~~---~~---------------~~qi~~-aL~ 220 (514)
++++|..+.. .+. .. ..+.... .. .. ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987777 111 11 0011000 00 00 111222 233
Q ss_pred HHH-------hCCeEEcCCCCCCcccc-CCCcEEEcccccccc
Q 010266 221 SIH-------KHNYIHRDIKPDNLLLD-QNGHMKLSDFGLCKP 255 (514)
Q Consensus 221 ~LH-------~~giiHrDLKpeNILld-~~g~iKL~DFGla~~ 255 (514)
.++ ..+++|+|+.|.|||++ .+|.+-|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 333 24699999999999999 777788999998753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.40 E-value=3.3e-06 Score=81.13 Aligned_cols=140 Identities=19% Similarity=0.199 Sum_probs=97.1
Q ss_pred EeeeeecCceEEEEEEEccCCCEEEEEEeecccccCh-------------------hh--HHHHHHHHHHHHHcC--CCc
Q 010266 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR-------------------GQ--VEHVRAERNLLAEVA--SHC 167 (514)
Q Consensus 111 ~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~-------------------~~--~~~~~~E~~iL~~l~--hp~ 167 (514)
...|+.|-=+.||+|.. .++..+|+|+.+.....-+ .+ ......|..-|.++. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 33677788889999874 5688999999875422111 11 234556777777763 445
Q ss_pred eeeEEEEEEcCCeEEEEEeecCCCCH-HHHHhhccCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCCccccCCCcE
Q 010266 168 IVKLYYSFQDAEYLYLIMEYLPGGDV-MTLLMREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHM 245 (514)
Q Consensus 168 Iv~l~~~f~~~~~l~lVmEy~~gg~L-~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKpeNILld~~g~i 245 (514)
+++.+.++. -.|||||+..... .-.| +.-.+..+.+..+..+++..+.-|-. .|+||+||..=|||+. +|.+
T Consensus 132 vP~Pi~~~~----nVLvMEfIg~~g~pAP~L-kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 132 VPEPIAFRN----NVLVMEFIGDDGLPAPRL-KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCCceeecC----CeEEEEeccCCCCCCCCc-ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 666666553 3599999954311 1112 12223333677788889998888876 8999999999999998 9999
Q ss_pred EEccccccccCC
Q 010266 246 KLSDFGLCKPLD 257 (514)
Q Consensus 246 KL~DFGla~~~~ 257 (514)
.++|||-|....
T Consensus 206 ~iID~~QaV~~~ 217 (268)
T COG1718 206 YIIDVSQAVTID 217 (268)
T ss_pred EEEECccccccC
Confidence 999999987654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.2e-05 Score=75.44 Aligned_cols=128 Identities=23% Similarity=0.345 Sum_probs=88.8
Q ss_pred CCeeEEeeeeecCc-eEEEEEEEccCCCEEEEEEeecccccCh------------------hhHHHHHHHHHHHHHc---
Q 010266 106 DDFDLLTIIGRGAF-GEVRLCQEKKSGNIYAMKKLKKSEMLSR------------------GQVEHVRAERNLLAEV--- 163 (514)
Q Consensus 106 ~~f~~~~~LG~G~f-G~V~l~~~~~t~~~~AiK~l~k~~~~~~------------------~~~~~~~~E~~iL~~l--- 163 (514)
.+++.++.||.|+- |.||+++. .|+.||+|+.+.-..... ....-+..|-+...++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 79999999999999 99998864 578999999432111100 1223455666665554
Q ss_pred CCCce--eeEEEEEEcC------------------CeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH
Q 010266 164 ASHCI--VKLYYSFQDA------------------EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH 223 (514)
Q Consensus 164 ~hp~I--v~l~~~f~~~------------------~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH 223 (514)
.+..+ |+.++++.-. ....+|.||++... .+... -+.+|..-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHHH
Confidence 44444 9999887311 12467888887643 22222 3567888889999
Q ss_pred hCCeEEcCCCCCCccccCCCcEEEcccccc
Q 010266 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253 (514)
Q Consensus 224 ~~giiHrDLKpeNILld~~g~iKL~DFGla 253 (514)
+.||+-+|+|+.|.. .-||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999986 2388999964
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.24 E-value=5.4e-06 Score=93.69 Aligned_cols=203 Identities=18% Similarity=0.231 Sum_probs=144.8
Q ss_pred hhHHHHHHHHHHHHHcCCCceeeEEEEEEcC---C-eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH
Q 010266 148 GQVEHVRAERNLLAEVASHCIVKLYYSFQDA---E-YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH 223 (514)
Q Consensus 148 ~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~---~-~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH 223 (514)
.++.....|...+..+.|+|++..+.+-... + .+.+..++|.+-+++..++..+..+...++.+..+.+.||.++|
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence 3445555677778888999999987654322 2 34456689999999999999999999999999999999999999
Q ss_pred hCCeEEcCCCCC---CccccCCCcEEEc--cccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCch
Q 010266 224 KHNYIHRDIKPD---NLLLDQNGHMKLS--DFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPL 298 (514)
Q Consensus 224 ~~giiHrDLKpe---NILld~~g~iKL~--DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (514)
+....|.-|-.. +-..+..++..++ ||+.++.+.....
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~------------------------------------- 346 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK------------------------------------- 346 (1351)
T ss_pred HhccceeEEecccccccccCccceeecchhhhcccccCCCccc-------------------------------------
Confidence 986666655554 5555667777777 8888776542211
Q ss_pred HHHHHHhhhccccccccccCCCcCCccccccCCCCcc--cchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccC
Q 010266 299 EQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME--CDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKF 376 (514)
Q Consensus 299 ~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~--~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~ 376 (514)
..+..-+..+.|||......+..+ .|+|++|..+..+..|..+-.-. .+...++
T Consensus 347 -------------~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~---~~~~~~l-------- 402 (1351)
T KOG1035|consen 347 -------------SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKS---AVPVSLL-------- 402 (1351)
T ss_pred -------------chhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccc---cchhhhh--------
Confidence 012344566788888877666554 69999999999999886553211 1111111
Q ss_pred CcCcCCCh-hHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 377 PEEARLTP-EAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 377 p~~~~~s~-~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
+ ..+. ...+++.+|+. ++++|+ ++.+++.|||.+-
T Consensus 403 ~---~~~~~~~~d~~~~~~~~~~~~Rl---~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 403 D---VLSTSELLDALPKCLDEDSEERL---SALELLTHPFLRF 439 (1351)
T ss_pred c---cccchhhhhhhhhhcchhhhhcc---chhhhhhchhccc
Confidence 1 1121 67788888886 899999 8999999999874
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.3e-05 Score=78.13 Aligned_cols=135 Identities=16% Similarity=0.093 Sum_probs=84.0
Q ss_pred eeeecCc-eEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEEEcCCeEEEEEeecCC
Q 010266 113 IIGRGAF-GEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYLYLIMEYLPG 190 (514)
Q Consensus 113 ~LG~G~f-G~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l~lVmEy~~g 190 (514)
.|-.|.. +.||.+... +..+.+|+..... ...+.+|..++..+. +--+++++++..+.+..++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 3445555 789988643 4678888875432 234667888888774 34466788877777778999999999
Q ss_pred CCHHHHH-------------------hhcc----CCCHH------HHHHH-------------------HHHHHHHHHHH
Q 010266 191 GDVMTLL-------------------MREE----TLTET------VARFY-------------------IAQSVLAIESI 222 (514)
Q Consensus 191 g~L~~~l-------------------~~~~----~l~e~------~~~~~-------------------~~qi~~aL~~L 222 (514)
..|.... +.-. .+... ..... ..++...|...
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 7766431 0000 11100 00000 01111111111
Q ss_pred ----HhCCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 223 ----HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 223 ----H~~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
....++|+|+.|.|||++.++.+.|+||+.|..
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 124599999999999999988889999998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.3e-05 Score=85.78 Aligned_cols=142 Identities=20% Similarity=0.285 Sum_probs=89.5
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeeccccc----------------------------ChhhHHHHHHHHHHHHHc
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML----------------------------SRGQVEHVRAERNLLAEV 163 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~----------------------------~~~~~~~~~~E~~iL~~l 163 (514)
+.||.-+.|.|+.|+.+. |+.||||+-+..--. -+.-.+.+..|.+.+...
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 469999999999999766 999999997654100 001112233344433322
Q ss_pred ----------CCCc------eeeEEEEEEcCCeEEEEEeecCCCCHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhCC
Q 010266 164 ----------ASHC------IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM-REETLTETVARFYIAQSVLAIESIHKHN 226 (514)
Q Consensus 164 ----------~hp~------Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~g 226 (514)
.|-. |+++|..+. ..-.|+||||+|..+.++-. ....++...+...+.+... +-+=..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcC
Confidence 2333 566655553 34579999999986665531 2233444433332222221 1122468
Q ss_pred eEEcCCCCCCccccC----CCcEEEccccccccCCC
Q 010266 227 YIHRDIKPDNLLLDQ----NGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 227 iiHrDLKpeNILld~----~g~iKL~DFGla~~~~~ 258 (514)
++|.|-.|.||+++. ++.+.+-|||+...+..
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 999999999999994 67899999999987653
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.5e-05 Score=89.59 Aligned_cols=81 Identities=25% Similarity=0.374 Sum_probs=57.9
Q ss_pred EEeeeeecCceEEEEEEEccCC--CEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCce--eeEEEEEEcC---CeE
Q 010266 110 LLTIIGRGAFGEVRLCQEKKSG--NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCI--VKLYYSFQDA---EYL 181 (514)
Q Consensus 110 ~~~~LG~G~fG~V~l~~~~~t~--~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~I--v~l~~~f~~~---~~l 181 (514)
.++.|+.|.++.+|++.....+ ..|++|+........ ....+.+|..+|..+. |++| ++++..+.+. ...
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3678899999999998764432 467888765433221 1235778999999985 6654 7778777764 467
Q ss_pred EEEEeecCCCC
Q 010266 182 YLIMEYLPGGD 192 (514)
Q Consensus 182 ~lVmEy~~gg~ 192 (514)
|+||||++|..
T Consensus 120 flVME~v~G~~ 130 (822)
T PLN02876 120 FYIMEYLEGRI 130 (822)
T ss_pred eEEEEecCCcc
Confidence 89999999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.03 E-value=2.1e-05 Score=71.84 Aligned_cols=130 Identities=16% Similarity=0.221 Sum_probs=92.1
Q ss_pred eEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeec
Q 010266 109 DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYL 188 (514)
Q Consensus 109 ~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~ 188 (514)
++.+.||+|.+|.||++.+. |..+|+|+-+.+ .....+..|..+|..+..-++..=.+.+- .-+++|||+
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d-----s~r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me~i 94 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD-----SPRRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRMEYI 94 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecCC-----cchhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhhhh
Confidence 34567999999999999764 668999987644 33456888999999998776654433332 223559999
Q ss_pred CCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCC-CCCccccCCCcEEEcccccccc
Q 010266 189 PGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIK-PDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 189 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLK-peNILld~~g~iKL~DFGla~~ 255 (514)
.|-.|..+-... + +.-+..++.+---|-..||-|..|. |..++|-.++.+.|+||..|+.
T Consensus 95 ~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 95 DGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 998888775322 1 2223345555445667899999994 6666666677999999999874
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.96 E-value=7.6e-07 Score=102.14 Aligned_cols=201 Identities=15% Similarity=0.100 Sum_probs=140.9
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeeccccc--ChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc--CCe
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML--SRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--AEY 180 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~--~~~ 180 (514)
..++++.--+|.|.+++--..+.+.. -+-+|+.+..+.. .+-..+-...|++-++...|++++.-+.-..+ ...
T Consensus 1228 ~e~~EV~l~i~~~~~~R~k~Lr~kid--~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~e 1305 (2724)
T KOG1826|consen 1228 MEHSEVNLGISNHFHFRNKWLRSKID--WFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTE 1305 (2724)
T ss_pred hhhhheeeecccceeeccchHhhhhc--eeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChH
Confidence 35667766777777775543332322 2445555433221 22334556677787788899988776554432 345
Q ss_pred EEEEEeecCCCCHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhC-----CeEEcCCCCCCccccCCCcEEEcccc
Q 010266 181 LYLIMEYLPGGDVMTLLMRE----ETLTETVARFYIAQSVLAIESIHKH-----NYIHRDIKPDNLLLDQNGHMKLSDFG 251 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~-----giiHrDLKpeNILld~~g~iKL~DFG 251 (514)
.|.+++|+.+|++++.|.+. ..+++.-+-....+.+++..-+|+. -.+|++||+-|.+|..+-.+|+.++|
T Consensus 1306 e~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~g 1385 (2724)
T KOG1826|consen 1306 EYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGG 1385 (2724)
T ss_pred HHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccc
Confidence 78999999999999999764 2233333333333447777777753 27899999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCC
Q 010266 252 LCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331 (514)
Q Consensus 252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~ 331 (514)
+.+..... .......+++|.|++|++...-.
T Consensus 1386 LdKIknp~-------------------------------------------------~sf~Gl~l~sp~~v~qli~N~ik 1416 (2724)
T KOG1826|consen 1386 LDKIKNPV-------------------------------------------------LSFFGLELCSPIYVLQLIKNEIK 1416 (2724)
T ss_pred cccccCch-------------------------------------------------HhhhhhhhCCHHHHHHHHHHHHh
Confidence 98832211 01122678999999999999999
Q ss_pred CCcccchhhhhHHHHHHhhCCCCCC
Q 010266 332 YGMECDWWSLGAIMYEMLVGYPPFY 356 (514)
Q Consensus 332 y~~~~DiWSlGvilyemltG~~PF~ 356 (514)
++.+.|+|+.|+-+|+.--|.+||-
T Consensus 1417 ~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1417 FTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred hhhHHHHHHHHHHHHHHhcccHHHH
Confidence 9999999999999999999998884
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.96 E-value=3.9e-05 Score=74.50 Aligned_cols=74 Identities=15% Similarity=0.227 Sum_probs=46.3
Q ss_pred EeeeeecCce-EEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCC---ceeeEEEEEEcC---CeEEE
Q 010266 111 LTIIGRGAFG-EVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH---CIVKLYYSFQDA---EYLYL 183 (514)
Q Consensus 111 ~~~LG~G~fG-~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp---~Iv~l~~~f~~~---~~l~l 183 (514)
+..|+.|+.. .||.+ +..+++|+.... .....+..|..+|..+... -++..++..... ...|+
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 3567777776 59976 235778865432 1234688899999887532 344444443332 24589
Q ss_pred EEeecCCCCHH
Q 010266 184 IMEYLPGGDVM 194 (514)
Q Consensus 184 VmEy~~gg~L~ 194 (514)
||++++|.++.
T Consensus 72 l~~~i~G~~l~ 82 (235)
T cd05155 72 VYRWLEGETAT 82 (235)
T ss_pred EEEeecCCCCC
Confidence 99999996653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00015 Score=68.55 Aligned_cols=130 Identities=19% Similarity=0.267 Sum_probs=90.4
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccc-------------cChhhHHHHHHHHHHHHHcC------CCceeeEE
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM-------------LSRGQVEHVRAERNLLAEVA------SHCIVKLY 172 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~-------------~~~~~~~~~~~E~~iL~~l~------hp~Iv~l~ 172 (514)
..||+|+.=.|| .+..+ ....||++..... .........++|..-...+. +.+|.++|
T Consensus 7 ~~i~~G~~R~cy--~HP~d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCY--QHPDD-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEE--ECCCC-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 479999999999 44443 3467899987651 01112344556665555444 77899999
Q ss_pred EEEEcCCeEEEEEeecCCC------CHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCC--C-
Q 010266 173 YSFQDAEYLYLIMEYLPGG------DVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN--G- 243 (514)
Q Consensus 173 ~~f~~~~~l~lVmEy~~gg------~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~--g- 243 (514)
+..+++--+-+|+|.+... +|.+++ +.+.+++ ..+. .+-.-..+|-+.+|+.+||+|.||++... |
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l-~~~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYL-KEGGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHH-HcCCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 9999999999999987542 566776 4445665 3322 33344577888999999999999999633 3
Q ss_pred -cEEEcc
Q 010266 244 -HMKLSD 249 (514)
Q Consensus 244 -~iKL~D 249 (514)
.+.|+|
T Consensus 159 ~~lvlID 165 (199)
T PF10707_consen 159 FRLVLID 165 (199)
T ss_pred eEEEEEe
Confidence 577887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >smart00133 S_TK_X Extension to Ser/Thr-type protein kinases | Back alignment and domain information |
|---|
Probab=97.93 E-value=6.2e-06 Score=62.86 Aligned_cols=60 Identities=30% Similarity=0.515 Sum_probs=40.3
Q ss_pred ccCCccccc--cccCCCCCcCCCCCCCCCCCC-CCcccCCCCCCCCCCccccccCCCCCCcccCeeee
Q 010266 416 KDIAWDKLY--EMEAAYKPEVNGVLDTQNFMK-FDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYK 480 (514)
Q Consensus 416 ~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~ 480 (514)
++|||+.|. ++.|||+|.+.+..|+++|+. +........ ..... +.....+..|.||||.
T Consensus 1 ~~idW~~l~~r~~~pP~~P~~~~~~d~s~fd~~~~~~~~~~s-~~~~~----~~~~~~~~~F~gfsy~ 63 (64)
T smart00133 1 RGIDWDKLENKEIEPPFVPKIKSPTDTSNFDDEFTEETPVLT-PVDSP----ASGGSQQEPFRGFSYV 63 (64)
T ss_pred CCCCHHHHHhCCCCCCcccccCCccHHhHcCCcCCCCCCCCC-CCCcc----ccccccccccCCCccc
Confidence 479999995 789999999999999999997 444432211 11110 0011124689999996
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00062 Score=71.10 Aligned_cols=82 Identities=21% Similarity=0.190 Sum_probs=56.1
Q ss_pred eEEeeeeecCceEEEEEEEccCCCEEEEEEeeccccc-C---hhhHHHHHHHHHHHHHcC---CCceeeEEEEEEcCCeE
Q 010266 109 DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML-S---RGQVEHVRAERNLLAEVA---SHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 109 ~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~-~---~~~~~~~~~E~~iL~~l~---hp~Iv~l~~~f~~~~~l 181 (514)
.-.+.||.|.+..||.+.....++.++||.-....-. . +-..++...|.+.|..+. ...+++++.+ +.+..
T Consensus 29 ~~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~ 106 (401)
T PRK09550 29 LTAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELA 106 (401)
T ss_pred ceeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCC
Confidence 3457899999999999987543358999975321110 0 123456777888888753 3457777766 45667
Q ss_pred EEEEeecCCCC
Q 010266 182 YLIMEYLPGGD 192 (514)
Q Consensus 182 ~lVmEy~~gg~ 192 (514)
++||||+++..
T Consensus 107 ~lVME~L~~~~ 117 (401)
T PRK09550 107 VTVMEDLSDHK 117 (401)
T ss_pred EEEEecCCCcc
Confidence 89999998743
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00018 Score=69.54 Aligned_cols=137 Identities=15% Similarity=0.198 Sum_probs=81.6
Q ss_pred EeeeeecCceEEEEEEEcc-CCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCC-CceeeEEEEEEcCCeEEEEEeec
Q 010266 111 LTIIGRGAFGEVRLCQEKK-SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS-HCIVKLYYSFQDAEYLYLIMEYL 188 (514)
Q Consensus 111 ~~~LG~G~fG~V~l~~~~~-t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~f~~~~~l~lVmEy~ 188 (514)
++.|..|-...||++.... .++.|++|+...... . .....+|..++..+.. ...+++++.+.+ .+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---L-IIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---c-eecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEee
Confidence 5678888899999986443 356899997654311 1 1123468888888843 345556555432 3799999
Q ss_pred CCCCHHHH--------------Hh---hcc-CC----------C-HHHHHHHHHH----------------------HH-
Q 010266 189 PGGDVMTL--------------LM---REE-TL----------T-ETVARFYIAQ----------------------SV- 216 (514)
Q Consensus 189 ~gg~L~~~--------------l~---~~~-~l----------~-e~~~~~~~~q----------------------i~- 216 (514)
+|..+... |. ... .. . ...+..|... +.
T Consensus 75 ~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 154 (235)
T cd05157 75 PGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRD 154 (235)
T ss_pred CCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHH
Confidence 98665211 11 100 01 0 0111122111 11
Q ss_pred --HHHH-HHH----hCCeEEcCCCCCCccccC-CCcEEEcccccccc
Q 010266 217 --LAIE-SIH----KHNYIHRDIKPDNLLLDQ-NGHMKLSDFGLCKP 255 (514)
Q Consensus 217 --~aL~-~LH----~~giiHrDLKpeNILld~-~g~iKL~DFGla~~ 255 (514)
..|. .+- ..+++|+|+.|.|||++. ++.+.|+||..|..
T Consensus 155 ~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 155 EISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 1111 111 246999999999999998 58899999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00065 Score=68.51 Aligned_cols=77 Identities=16% Similarity=0.060 Sum_probs=54.4
Q ss_pred EEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCC---CceeeEEEEEEc---CCeEEE
Q 010266 110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS---HCIVKLYYSFQD---AEYLYL 183 (514)
Q Consensus 110 ~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h---p~Iv~l~~~f~~---~~~l~l 183 (514)
-++.||.|..+.||.+.. ++..+.+|..+ .. .....+..|...|+.+.. -.++++++.+.+ .+.-+|
T Consensus 18 ~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~-~~----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 18 RVECISEQPYAALWALYD--SQGNPMPLMAR-SF----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeeecCCccceeEEEEEc--CCCCEEEEEec-cc----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 356899999999998753 22346777743 21 112357889999988853 367888887754 366899
Q ss_pred EEeecCCCCH
Q 010266 184 IMEYLPGGDV 193 (514)
Q Consensus 184 VmEy~~gg~L 193 (514)
|||+++|+.+
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998754
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00018 Score=70.76 Aligned_cols=133 Identities=17% Similarity=0.230 Sum_probs=77.9
Q ss_pred eeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCc-eeeEEEEEEcCCeEEEEEeecCCC
Q 010266 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDAEYLYLIMEYLPGG 191 (514)
Q Consensus 113 ~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~-Iv~l~~~f~~~~~l~lVmEy~~gg 191 (514)
.+..|-.+.+|++. .+++.|++|........- .+ ...+|..+|..+.... .+++++.+. -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~--~~-~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL--GV-DRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc--cC-cHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 35568888999886 456788899754431110 01 2467888888886432 345555442 26899999986
Q ss_pred CHHH--------------HHh---hcc----CCC-HHHHHHHHHHH---------HHHHHHHH--------hCCeEEcCC
Q 010266 192 DVMT--------------LLM---REE----TLT-ETVARFYIAQS---------VLAIESIH--------KHNYIHRDI 232 (514)
Q Consensus 192 ~L~~--------------~l~---~~~----~l~-e~~~~~~~~qi---------~~aL~~LH--------~~giiHrDL 232 (514)
.+.. .+. ... +++ ...+..|..++ ...+..+- ...++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 5431 111 111 111 11222222111 11122221 125899999
Q ss_pred CCCCccccCCCcEEEcccccccc
Q 010266 233 KPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 233 KpeNILld~~g~iKL~DFGla~~ 255 (514)
.|.|||++.+| +.|+||..|..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999887 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00058 Score=68.78 Aligned_cols=76 Identities=17% Similarity=0.152 Sum_probs=50.3
Q ss_pred EeeeeecCceEEEEEEEcc------CCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCC-ceeeEEEEEEcCCeEEE
Q 010266 111 LTIIGRGAFGEVRLCQEKK------SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 111 ~~~LG~G~fG~V~l~~~~~------t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp-~Iv~l~~~f~~~~~l~l 183 (514)
++.|..|--..||++.... +++.|++|+..... .......+|..++..+... ..+++++++.+ .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 4567777778999887543 25789999965432 1123456788888887532 34566666653 25
Q ss_pred EEeecCCCCHH
Q 010266 184 IMEYLPGGDVM 194 (514)
Q Consensus 184 VmEy~~gg~L~ 194 (514)
|+||++|..+.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 89999987653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0011 Score=66.99 Aligned_cols=143 Identities=20% Similarity=0.178 Sum_probs=84.8
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCC--ceeeEEEEE------Ec
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH--CIVKLYYSF------QD 177 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~f------~~ 177 (514)
+....++.++.|.-..||++.. . +..|++|+..... ....+..|..++..+... .+++.+..- ..
T Consensus 22 ~~~~~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~ 94 (307)
T TIGR00938 22 GELLSLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTL 94 (307)
T ss_pred CCceeccccCCccccceEEEEe-C-CCcEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhc
Confidence 4455677888888899998863 3 3468889775421 123455667777766322 244444321 22
Q ss_pred CCeEEEEEeecCCCCHH-----------HH---Hhh-ccCCC---------HH----HHH----------HHHHHHHHHH
Q 010266 178 AEYLYLIMEYLPGGDVM-----------TL---LMR-EETLT---------ET----VAR----------FYIAQSVLAI 219 (514)
Q Consensus 178 ~~~l~lVmEy~~gg~L~-----------~~---l~~-~~~l~---------e~----~~~----------~~~~qi~~aL 219 (514)
.+..++||+|++|..+. .. ++. ...++ .. ... .....+..++
T Consensus 95 ~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~ 174 (307)
T TIGR00938 95 AGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKEL 174 (307)
T ss_pred CCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHH
Confidence 45678999999985432 11 111 00110 00 000 0011223345
Q ss_pred HHHH-------hCCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 220 ESIH-------KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 220 ~~LH-------~~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
+++. ..+++|+|+.+.||+++.++.+.|+||+.|..
T Consensus 175 ~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 175 DYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 5553 36899999999999999988778999998763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.001 Score=66.71 Aligned_cols=140 Identities=17% Similarity=0.141 Sum_probs=84.3
Q ss_pred eeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCC--ceeeEEEE------EEcCC
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH--CIVKLYYS------FQDAE 179 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~------f~~~~ 179 (514)
..-++.|..|.-..||++.. ++..+++|+.... ....+..|..++..+.+. .+++++.. ....+
T Consensus 16 ~~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~ 87 (296)
T cd05153 16 LLSFEGISAGIENTNYFVTT--DSGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG 87 (296)
T ss_pred hhheecccCccccceEEEEe--CCCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence 33466788888899998853 3457899987541 123466677777776422 24454432 23345
Q ss_pred eEEEEEeecCCCCHHH-----------HH---hhc-cCCCH--------HHHH------------HHHHHHHHHHHHHHh
Q 010266 180 YLYLIMEYLPGGDVMT-----------LL---MRE-ETLTE--------TVAR------------FYIAQSVLAIESIHK 224 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~-----------~l---~~~-~~l~e--------~~~~------------~~~~qi~~aL~~LH~ 224 (514)
..++|++|++|..+.. .| +.. ..+.. .... .....+..++.++.+
T Consensus 88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~ 167 (296)
T cd05153 88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA 167 (296)
T ss_pred ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence 6789999999876421 01 100 00000 0000 011112233444442
Q ss_pred -------CCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 225 -------HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 225 -------~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
.+++|+|+.|.|||++.++.+.|+||+.|..
T Consensus 168 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 168 FDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999887789999998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00037 Score=65.34 Aligned_cols=98 Identities=20% Similarity=0.221 Sum_probs=76.5
Q ss_pred HHHHHHHHcCC-CceeeEEEEEEcCCeEEEEEeecCCCCHHHH---HhhccCCCHHHHHHHHHHHHHHHHHHHh---CCe
Q 010266 155 AERNLLAEVAS-HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTL---LMREETLTETVARFYIAQSVLAIESIHK---HNY 227 (514)
Q Consensus 155 ~E~~iL~~l~h-p~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~---l~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gi 227 (514)
.|.-+|+.+.+ ++++++++++-+ ++|.||++.+++... +......+......++.+++..+++|+. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 47778888865 699999999842 568899987766421 2222344677777899999999999997 347
Q ss_pred EEcCCCCCCccccCCCcEEEccccccccC
Q 010266 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256 (514)
Q Consensus 228 iHrDLKpeNILld~~g~iKL~DFGla~~~ 256 (514)
.-.|++|+|+.++++|++|++|...+...
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 77999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0017 Score=66.00 Aligned_cols=137 Identities=16% Similarity=0.132 Sum_probs=75.3
Q ss_pred EeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCC--ceeeEEEE------EEcCCeEE
Q 010266 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH--CIVKLYYS------FQDAEYLY 182 (514)
Q Consensus 111 ~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~------f~~~~~l~ 182 (514)
++.|+.|....+|.+... +..|++|++.. ... ..+..|..++..+... .+++.+.+ ....+..+
T Consensus 27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~~---~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT--QGEYVLTLFER---LTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred cchhccccccceEEEEeC--CCcEEEEEecc---CCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 456778888899988642 33689998751 122 2233455555554211 13333321 22355679
Q ss_pred EEEeecCCCCHH-----------HHH---hh-ccCCC----------H--HHHH-----------HHHHH-HHHHHHHHH
Q 010266 183 LIMEYLPGGDVM-----------TLL---MR-EETLT----------E--TVAR-----------FYIAQ-SVLAIESIH 223 (514)
Q Consensus 183 lVmEy~~gg~L~-----------~~l---~~-~~~l~----------e--~~~~-----------~~~~q-i~~aL~~LH 223 (514)
++|+|++|..+. ..| +. ...++ . .... ..+.+ +-..++.+.
T Consensus 99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (319)
T PRK05231 99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA 178 (319)
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence 999999987431 111 11 00010 0 0000 01111 111222332
Q ss_pred -------hCCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 224 -------KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 224 -------~~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
..|+||+|+.|.|||++.+...-|+||+.|..
T Consensus 179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 24899999999999998665568999998763
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0024 Score=64.82 Aligned_cols=144 Identities=21% Similarity=0.241 Sum_probs=96.3
Q ss_pred EEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChh---------------------h--HHHHHHHHHHHHHcCCC
Q 010266 110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRG---------------------Q--VEHVRAERNLLAEVASH 166 (514)
Q Consensus 110 ~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~---------------------~--~~~~~~E~~iL~~l~hp 166 (514)
+-..|..|-=+-||.|.. .+|..+|||+++-+-+.-++ . .-....|..-|.+++.-
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 445788899999999874 67888999998755332111 1 12234456667776543
Q ss_pred ceeeEEEEEEcCCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH-hCCeEEcCCCCCCccccCCCcE
Q 010266 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH-KHNYIHRDIKPDNLLLDQNGHM 245 (514)
Q Consensus 167 ~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH-~~giiHrDLKpeNILld~~g~i 245 (514)
.|+..--.. -..-.|||+|+.+.....=..+.-.++...++.+-.+++.-+.-|- .++.||.||.-=|+|+ .+|++
T Consensus 227 GIP~PePIl--Lk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~l 303 (520)
T KOG2270|consen 227 GIPCPEPIL--LKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKL 303 (520)
T ss_pred CCCCCCcee--eecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEE
Confidence 332211111 0234699999954332222334456777788888888888887774 6799999999999999 58999
Q ss_pred EEccccccccCC
Q 010266 246 KLSDFGLCKPLD 257 (514)
Q Consensus 246 KL~DFGla~~~~ 257 (514)
.++|.+-+....
T Consensus 304 yiIDVSQSVE~D 315 (520)
T KOG2270|consen 304 YIIDVSQSVEHD 315 (520)
T ss_pred EEEEccccccCC
Confidence 999999876543
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0041 Score=64.05 Aligned_cols=141 Identities=11% Similarity=0.156 Sum_probs=83.1
Q ss_pred CCeeEEeeeeecCceEEEEEEEcc----CCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCC-ceeeEEEEEEcCCe
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKK----SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDAEY 180 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp-~Iv~l~~~f~~~~~ 180 (514)
+...+ ..|-.|-...+|++.... +++.|++|+..... ...+. ..+|..++..+..- .-+++++.|...
T Consensus 37 ~~~~i-~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g-- 109 (344)
T PLN02236 37 EALQV-IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG-- 109 (344)
T ss_pred CcEEE-EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc--
Confidence 34444 455558889999987432 34689999876532 12222 25688888887543 344666777543
Q ss_pred EEEEEeecCCCCHHHH--------------H---hhcc----C-CC-HHHHHHHHHHH-----------------HHHHH
Q 010266 181 LYLIMEYLPGGDVMTL--------------L---MREE----T-LT-ETVARFYIAQS-----------------VLAIE 220 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~--------------l---~~~~----~-l~-e~~~~~~~~qi-----------------~~aL~ 220 (514)
.|.+|++|..|... + +... . +. ...+..+..++ ...+.
T Consensus 110 --~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~ 187 (344)
T PLN02236 110 --RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEIN 187 (344)
T ss_pred --eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHH
Confidence 58999987665311 1 1101 0 11 11222222111 11111
Q ss_pred HH--------HhCCeEEcCCCCCCccccC-CCcEEEcccccccc
Q 010266 221 SI--------HKHNYIHRDIKPDNLLLDQ-NGHMKLSDFGLCKP 255 (514)
Q Consensus 221 ~L--------H~~giiHrDLKpeNILld~-~g~iKL~DFGla~~ 255 (514)
.| +...++|+|+++.|||++. ++.+.|+||..|..
T Consensus 188 ~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 188 LLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11 2336999999999999986 47899999998864
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0051 Score=63.17 Aligned_cols=84 Identities=15% Similarity=0.112 Sum_probs=52.9
Q ss_pred eeeecCceEEEEEEEccCCCEEEEEEeecccc----cChhhHHHHHHHHHHHHHcC--CC-ceeeEEEEEEcCCeEEEEE
Q 010266 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM----LSRGQVEHVRAERNLLAEVA--SH-CIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 113 ~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~----~~~~~~~~~~~E~~iL~~l~--hp-~Iv~l~~~f~~~~~l~lVm 185 (514)
.||.|-...||.+.....++-++||.-..-.- .-+-...+...|...|.... .| .++++|+ .|++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 57999999999998754336799996432111 11234556677888887653 34 4555543 3455667999
Q ss_pred eecCCC-CHHHHHh
Q 010266 186 EYLPGG-DVMTLLM 198 (514)
Q Consensus 186 Ey~~gg-~L~~~l~ 198 (514)
|+++.. .|...|.
T Consensus 80 EdL~~~~ilR~~Li 93 (370)
T TIGR01767 80 EDLSHHKIARKGLI 93 (370)
T ss_pred hhCccchHHHHHHH
Confidence 999653 3444443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.012 Score=59.31 Aligned_cols=30 Identities=27% Similarity=0.562 Sum_probs=26.6
Q ss_pred CCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 225 ~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
.+++|+|+.+.|||++. +.+.|+||+.|..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 58999999999999987 7789999997753
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.01 Score=59.10 Aligned_cols=31 Identities=26% Similarity=0.480 Sum_probs=26.3
Q ss_pred CeEEcCCCCCCccccCCCc-EEEccccccccC
Q 010266 226 NYIHRDIKPDNLLLDQNGH-MKLSDFGLCKPL 256 (514)
Q Consensus 226 giiHrDLKpeNILld~~g~-iKL~DFGla~~~ 256 (514)
.++|+|+.|.|||++.+|. .-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 5899999999999997565 469999988754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.00081 Score=67.15 Aligned_cols=138 Identities=16% Similarity=0.171 Sum_probs=92.1
Q ss_pred eeEEeeeeecCceEEEEEEEccCCCEEEEEEeeccccc-----------------ChhhHH--HHHHHHHHHHHcC-CCc
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML-----------------SRGQVE--HVRAERNLLAEVA-SHC 167 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~-----------------~~~~~~--~~~~E~~iL~~l~-hp~ 167 (514)
+.+...||-|-=+-||.+-+ ..|+.+++|.-+-.... +.-.+. ...+|...|+.+. |-+
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 55778999999999999875 46889999964322110 000111 2345777777764 333
Q ss_pred -eeeEEEEEEcCCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEE
Q 010266 168 -IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMK 246 (514)
Q Consensus 168 -Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iK 246 (514)
+++.+ |.+.-|+|||++.|-.|...-.-. +.. .+...+..-+--|-..|+||+|..-=||+++.+++++
T Consensus 173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v~---d~~---~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPI----DHNRHCVVMELVDGYPLRQVRHVE---DPP---TLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCcc----cccceeeHHHhhcccceeeeeecC---ChH---HHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 33333 345678999999998776553211 112 2233444455667889999999999999999999999
Q ss_pred EccccccccC
Q 010266 247 LSDFGLCKPL 256 (514)
Q Consensus 247 L~DFGla~~~ 256 (514)
++||--+-..
T Consensus 243 vIDFPQmvS~ 252 (465)
T KOG2268|consen 243 VIDFPQMVST 252 (465)
T ss_pred EeechHhhcc
Confidence 9999876543
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.0092 Score=61.09 Aligned_cols=142 Identities=16% Similarity=0.180 Sum_probs=81.2
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccC---CCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCce-eeEEEEEEcCCe
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKS---GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCI-VKLYYSFQDAEY 180 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t---~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~I-v~l~~~f~~~~~ 180 (514)
.++..+..+ ..|--..+|++..... +..|++|+..... . ..-.-.+|..++..+..-.+ +++++++...
T Consensus 14 ~~~i~i~~l-~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G-- 86 (330)
T PLN02421 14 DSDFSVERI-SGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---D-YVIDRERELQAIKYLSAAGFGAKLLGVFGNG-- 86 (330)
T ss_pred cCceEEEEe-CCcccceEEEEEecCCCCCCceEEEEEecCCc---C-eEechHHHHHHHHHHHhcCCCCceeEEeCCc--
Confidence 345555544 4488889998865432 3478999875431 1 11123468888888864443 5666666432
Q ss_pred EEEEEeecCCCCHHH--------------HH---hhcc-C----CC-HHHHHHHHHHH----------------------
Q 010266 181 LYLIMEYLPGGDVMT--------------LL---MREE-T----LT-ETVARFYIAQS---------------------- 215 (514)
Q Consensus 181 l~lVmEy~~gg~L~~--------------~l---~~~~-~----l~-e~~~~~~~~qi---------------------- 215 (514)
+|.+|++|-.|.. .+ +... + ++ -..+..|..++
T Consensus 87 --~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l 164 (330)
T PLN02421 87 --MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEEL 164 (330)
T ss_pred --EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHH
Confidence 5899998765421 11 1111 0 11 11222222221
Q ss_pred HHHHHH---HH-hC----CeEEcCCCCCCccccC-CCcEEEcccccccc
Q 010266 216 VLAIES---IH-KH----NYIHRDIKPDNLLLDQ-NGHMKLSDFGLCKP 255 (514)
Q Consensus 216 ~~aL~~---LH-~~----giiHrDLKpeNILld~-~g~iKL~DFGla~~ 255 (514)
..-+.. +. .. -++|.||-|.|||++. ++.++++||..|..
T Consensus 165 ~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 165 RDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 111221 21 12 3899999999999974 57899999998864
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.025 Score=59.12 Aligned_cols=77 Identities=17% Similarity=0.156 Sum_probs=52.0
Q ss_pred EEeeeeecCceEEEEEEEccCCCEEEEEEeeccccc-Ch---hhHHHHHHHHHHHHHcC---CCceeeEEEEEEcCCeEE
Q 010266 110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML-SR---GQVEHVRAERNLLAEVA---SHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 110 ~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~-~~---~~~~~~~~E~~iL~~l~---hp~Iv~l~~~f~~~~~l~ 182 (514)
..+.||.|--..||++.. .+..|+||.-...... .. ....+...|...|..+. ...++++|.+.. +.-+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 467899999999999886 3456889975422111 11 13445556677776653 247888887766 4467
Q ss_pred EEEeecCC
Q 010266 183 LIMEYLPG 190 (514)
Q Consensus 183 lVmEy~~g 190 (514)
+||||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 89999987
|
|
| >PF00433 Pkinase_C: Protein kinase C terminal domain; InterPro: IPR017892 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.00077 Score=48.24 Aligned_cols=47 Identities=26% Similarity=0.292 Sum_probs=24.2
Q ss_pred cCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeeecC
Q 010266 433 EVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNF 482 (514)
Q Consensus 433 ~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~ 482 (514)
.|+++.|++|||..+..+.+..+... .. ..+....+..|.||||+++
T Consensus 1 ~v~~~~DtsnFD~eFt~~~~~~t~~~-~~--~~~~~~~~~~F~GFTy~~~ 47 (48)
T PF00433_consen 1 KVKSETDTSNFDPEFTEEPPVDTPPS-DP--SPLSSSMQENFQGFTYVNP 47 (48)
T ss_dssp S-SSTT-GTTSCHHHHTSSSSS--S---H--HHHCTSSGGGGTT-CEETC
T ss_pred CCCchhhhhhcCcccccCCCCCCCcc-cC--CcccccccCcCCCCeecCC
Confidence 36789999999984444333222210 00 1112334556999999976
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This domain is found in a large variety of protein kinases with different functions and dependencies. Protein kinase C, for example, is a calcium-activated, phospholipid-dependent serine- and threonine-specific enzyme. It is activated by diacylglycerol which, in turn, phosphorylates a range of cellular proteins. This domain is most often found associated with IPR000719 from INTERPRO.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3E8D_A 1MRV_A 3E88_A 1GZO_A 1GZK_A 2JDO_A 2JDR_A 1MRY_A 1GZN_A 1O6L_A .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.019 Score=58.07 Aligned_cols=30 Identities=13% Similarity=0.190 Sum_probs=28.0
Q ss_pred CeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 226 giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
|++|+|+.+.|||++.+|.+-++||..|..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.022 Score=57.66 Aligned_cols=148 Identities=14% Similarity=0.172 Sum_probs=85.5
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCC--CceeeEEEEEEcCC--eE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS--HCIVKLYYSFQDAE--YL 181 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~f~~~~--~l 181 (514)
....++..+-.|.--.+|... .+++.+++. ... ............+|..+++.+.- .-+...++.+.++. ..
T Consensus 25 ~~~~~v~~~~~G~sn~t~~~~--~~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~p 100 (321)
T COG3173 25 AGLLIVEEISGGWSNDTFRLG--DTGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTP 100 (321)
T ss_pred CCCceeeeccCCcccceEEEe--cCCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCc
Confidence 344555666444444555443 337888888 332 22233445556778888887743 23445566666655 67
Q ss_pred EEEEeecCCCCHHH------------------HHhhc--------------cCCCHHHHHHHHHHH--------------
Q 010266 182 YLIMEYLPGGDVMT------------------LLMRE--------------ETLTETVARFYIAQS-------------- 215 (514)
Q Consensus 182 ~lVmEy~~gg~L~~------------------~l~~~--------------~~l~e~~~~~~~~qi-------------- 215 (514)
|.||+|+.|..+.+ .|..- +.+.......+..+.
T Consensus 101 f~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 101 FYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred eEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 99999999832211 11100 000111111122222
Q ss_pred HHHHHHHHh--------CCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 216 VLAIESIHK--------HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 216 ~~aL~~LH~--------~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
..-..+|+. -.++|+|+.+.||+++.++-+=+.||+++...+
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 122344443 259999999999999999889999999987644
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.068 Score=53.57 Aligned_cols=75 Identities=19% Similarity=0.211 Sum_probs=47.6
Q ss_pred eEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC---CCceeeEEEEEEcCCeEEEEE
Q 010266 109 DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA---SHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 109 ~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~~~f~~~~~l~lVm 185 (514)
+-.+.||.|....+|.+. .+++.|.+|+-... ....+..|..-|+.+. .-.+++.+.+....+.-||||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 345678999999999876 77889999987632 1234677888888773 346778888887777779999
Q ss_pred eecCCC
Q 010266 186 EYLPGG 191 (514)
Q Consensus 186 Ey~~gg 191 (514)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.035 Score=57.83 Aligned_cols=86 Identities=19% Similarity=0.191 Sum_probs=56.6
Q ss_pred EeeeeecCceEEEEEEEccCCCEEEEEEeeccccc---ChhhHHHHHHHHHHHHHcC--CC-ceeeEEEEEEcCCeEEEE
Q 010266 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML---SRGQVEHVRAERNLLAEVA--SH-CIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 111 ~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~---~~~~~~~~~~E~~iL~~l~--hp-~Iv~l~~~f~~~~~l~lV 184 (514)
++.||-|--.-||.|.....++-++||.-..-.-. -+-..++.+.|.++|+... .| .++++|+ .|.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 77899999999999987433567889864321111 1234567788888888763 34 4556653 355667799
Q ss_pred EeecCCC-CHHHHHh
Q 010266 185 MEYLPGG-DVMTLLM 198 (514)
Q Consensus 185 mEy~~gg-~L~~~l~ 198 (514)
||+++.. .|...|.
T Consensus 112 MEdL~~~~ilR~~Li 126 (409)
T PRK12396 112 MEDLSDHTILRTALI 126 (409)
T ss_pred HHhCcccHHHHHHHH
Confidence 9999653 3444443
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.049 Score=56.88 Aligned_cols=85 Identities=15% Similarity=0.170 Sum_probs=47.8
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccC-CCEEEEEE-eecccccChhhHHHHHHHHHHHHHcCC-CceeeEEEEEEcCCeE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKS-GNIYAMKK-LKKSEMLSRGQVEHVRAERNLLAEVAS-HCIVKLYYSFQDAEYL 181 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t-~~~~AiK~-l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~f~~~~~l 181 (514)
.++..+ +.|..|--+.+|+|..... +..+.+|. +....-......-.-.+|..++..+.. -.-+++++.|..
T Consensus 50 ~~~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~---- 124 (383)
T PTZ00384 50 PEFIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD---- 124 (383)
T ss_pred cccEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----
Confidence 344554 4555588899999875432 22333332 111100011111123468888888864 455677777753
Q ss_pred EEEEeecCCCCHH
Q 010266 182 YLIMEYLPGGDVM 194 (514)
Q Consensus 182 ~lVmEy~~gg~L~ 194 (514)
++|.||++|-.|.
T Consensus 125 g~l~efIeGr~l~ 137 (383)
T PTZ00384 125 FTIQEWVEGNTMG 137 (383)
T ss_pred EEEEEEeccccCC
Confidence 5999999987553
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.015 Score=59.24 Aligned_cols=73 Identities=23% Similarity=0.483 Sum_probs=51.2
Q ss_pred cCCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 177 DAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 177 ~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
...++|++|++- |+.+... +... -+++..++.+.+.-++-+.. ..+-||||.-+||||+ +|+|-|+||-+|+.
T Consensus 297 e~~y~yl~~kdh-gt~is~i--k~~~--~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISII--KADR--SEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred CceEEEEEEecC-Cceeeee--eccc--HHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 445788999986 5555322 1222 33344445555555555554 3799999999999999 99999999999984
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.49 E-value=0.058 Score=51.46 Aligned_cols=101 Identities=19% Similarity=0.208 Sum_probs=65.9
Q ss_pred EEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHH
Q 010266 133 IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYI 212 (514)
Q Consensus 133 ~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~ 212 (514)
...+|+++...+.- ....++.+.+|++++. .|++|..- +.-..-+++|+|---. .. ..-++.
T Consensus 87 ~L~lKKi~slp~~~--~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~---------i~---~~N~i~ 148 (308)
T PF07387_consen 87 PLFLKKIRSLPCCI--NDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK---------IN---FSNFIT 148 (308)
T ss_pred hhhhhhccCCCccc--chhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc---------cc---hhHHHH
Confidence 34566665443321 1233577888888874 68888732 3445678899984211 11 111222
Q ss_pred HHHHHHHHHHHh--CCeEEcCCCCCCccccCCCcEEEccccc
Q 010266 213 AQSVLAIESIHK--HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252 (514)
Q Consensus 213 ~qi~~aL~~LH~--~giiHrDLKpeNILld~~g~iKL~DFGl 252 (514)
.-+.+|.-.|+ .+.+|+|-.|+||+-|+.|.+||.|=+.
T Consensus 149 -agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 149 -AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred -HhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 22467788894 4799999999999999999999999774
|
The function of this family is unknown. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.33 Score=57.24 Aligned_cols=31 Identities=32% Similarity=0.505 Sum_probs=26.7
Q ss_pred CCeEEcCCCCCCccccCCC--cEE-Ecccccccc
Q 010266 225 HNYIHRDIKPDNLLLDQNG--HMK-LSDFGLCKP 255 (514)
Q Consensus 225 ~giiHrDLKpeNILld~~g--~iK-L~DFGla~~ 255 (514)
.++||.|+.++|||++.++ ++. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 5799999999999999876 665 999998753
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.09 E-value=0.08 Score=50.26 Aligned_cols=31 Identities=32% Similarity=0.674 Sum_probs=22.4
Q ss_pred CCeEEcCCCCCCccc-cCCCcEEEcccccccc
Q 010266 225 HNYIHRDIKPDNLLL-DQNGHMKLSDFGLCKP 255 (514)
Q Consensus 225 ~giiHrDLKpeNILl-d~~g~iKL~DFGla~~ 255 (514)
..++|.||.|.|||+ +.++.++|+||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 469999999999999 8899999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.33 Score=49.64 Aligned_cols=135 Identities=22% Similarity=0.258 Sum_probs=78.8
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC---CCc---eeeEEE----EEEcCCeE
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA---SHC---IVKLYY----SFQDAEYL 181 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~---hp~---Iv~l~~----~f~~~~~l 181 (514)
..|+. .-..||++... .| .+++|+.... ... ..+..|..+|..+. .|- +..+-+ .+....+.
T Consensus 32 ~~l~s-~eN~~f~~~~~-~g-~~iLki~~~~--~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~ 103 (331)
T COG2334 32 RGLNS-EENSNFRVQTE-DG-RYILKIYRPG--WTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRP 103 (331)
T ss_pred ccccc-ccCceEEEEec-CC-CeEEEEecCC--CCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCcee
Confidence 34554 55678987643 33 4599988765 233 33556777776663 222 222222 22223478
Q ss_pred EEEEeecCCCCHHH-----HH----------hh-ccCCC---------------HHHHH---------HHHHHHHHHHHH
Q 010266 182 YLIMEYLPGGDVMT-----LL----------MR-EETLT---------------ETVAR---------FYIAQSVLAIES 221 (514)
Q Consensus 182 ~lVmEy~~gg~L~~-----~l----------~~-~~~l~---------------e~~~~---------~~~~qi~~aL~~ 221 (514)
+-|.+|++|..+.. .+ +. ...++ ..... ...+++...++.
T Consensus 104 a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~ 183 (331)
T COG2334 104 AALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDR 183 (331)
T ss_pred EEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHH
Confidence 88999999987762 11 10 00111 01111 122344445555
Q ss_pred HHh--------CC--eEEcCCCCCCccccCCCc-EEEccccccc
Q 010266 222 IHK--------HN--YIHRDIKPDNLLLDQNGH-MKLSDFGLCK 254 (514)
Q Consensus 222 LH~--------~g--iiHrDLKpeNILld~~g~-iKL~DFGla~ 254 (514)
+.+ .| +||.|+.|+|||++.+.. +.++|||-|.
T Consensus 184 ~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 184 LLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 543 34 999999999999998885 8999999876
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.22 E-value=1.6 Score=44.47 Aligned_cols=70 Identities=11% Similarity=0.078 Sum_probs=41.9
Q ss_pred cCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC---CCceeeEE---E--EEEcCCeEEEEEeec
Q 010266 117 GAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA---SHCIVKLY---Y--SFQDAEYLYLIMEYL 188 (514)
Q Consensus 117 G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~---~--~f~~~~~l~lVmEy~ 188 (514)
|.-..||.+.. .+|..|++|+.+... .....+..|.+++..+. -| ++... + ....++..+.|++++
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~----~~~~~i~~E~~~l~~L~~~gip-v~~p~~~~G~~~~~~~g~~~~l~~~~ 109 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPER----WSDAQILEEHAFALELAEAEIP-VVAPLAFNGQTLHEHQGFRFALFPRR 109 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCccc----CCHHHHHHHHHHHHHHHHCCCC-CCCCccCCCCEEEEECCEEEEEEeee
Confidence 45567998864 456789999876432 12344666777776653 22 22211 1 122346778899999
Q ss_pred CCCC
Q 010266 189 PGGD 192 (514)
Q Consensus 189 ~gg~ 192 (514)
+|..
T Consensus 110 ~G~~ 113 (325)
T PRK11768 110 GGRA 113 (325)
T ss_pred CCCC
Confidence 8864
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.15 E-value=0.044 Score=55.11 Aligned_cols=50 Identities=30% Similarity=0.479 Sum_probs=34.4
Q ss_pred HHHHHHHHHHHHHHHHHH----hCCeEEcCCCCCCccccCCC------------------cEEEcccccccc
Q 010266 206 TVARFYIAQSVLAIESIH----KHNYIHRDIKPDNLLLDQNG------------------HMKLSDFGLCKP 255 (514)
Q Consensus 206 ~~~~~~~~qi~~aL~~LH----~~giiHrDLKpeNILld~~g------------------~iKL~DFGla~~ 255 (514)
+-+++++.||++-.-.+- ..+++|-||||+|||+-.+. .++|.||.+|..
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 350 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQV 350 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHH
Confidence 446778888876543332 34799999999999984322 246678877764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 514 | ||||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-73 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-71 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-69 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-69 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-69 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-67 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-67 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-67 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-58 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-58 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-57 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-57 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-57 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-57 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-57 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-57 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-57 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-57 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-57 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-57 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-57 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-57 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-57 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-57 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-57 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-57 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-57 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-57 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-57 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-57 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-57 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-57 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-57 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-57 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-57 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-57 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-57 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-57 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-56 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-56 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-56 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-56 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-56 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-56 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-56 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-56 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-56 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-56 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-56 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-56 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-56 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-56 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-56 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-56 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-56 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-56 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-56 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-56 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-56 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-55 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-51 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-48 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-48 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-47 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-47 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-47 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-46 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-46 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-46 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-46 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-46 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-46 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-46 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-46 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-46 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-46 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-46 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-46 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-45 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-45 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-45 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-45 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-43 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-42 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-42 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-41 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-41 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-41 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-40 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-40 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-40 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-40 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-40 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-40 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-40 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-40 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-40 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-40 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-40 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-40 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-40 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-39 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-39 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-39 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-39 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-39 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-39 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-39 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-39 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-39 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-38 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-37 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-33 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-33 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-33 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-32 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-32 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-32 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-32 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-31 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-31 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-30 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-30 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-30 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-30 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-30 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-30 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-30 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-29 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-29 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-29 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-29 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-29 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-29 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-29 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-29 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-29 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-29 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-29 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-29 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-29 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-29 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-28 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-28 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-28 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-28 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-28 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-28 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-28 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-28 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-28 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-28 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-28 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-28 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-28 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-28 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-28 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-28 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-28 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-28 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-28 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-28 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-28 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-28 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-28 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-28 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-28 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-27 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-27 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-27 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-27 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-27 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-27 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-27 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-27 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-27 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-27 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-26 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-26 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-26 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-26 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-26 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-26 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-26 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-25 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-25 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-25 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-25 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-25 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-25 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-25 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-25 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-24 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-24 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-24 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-24 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-24 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-24 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-24 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-24 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-24 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-24 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-23 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-23 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-23 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-23 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-23 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-23 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-23 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-23 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-23 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-23 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-22 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-22 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-22 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-22 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-22 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-22 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-22 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-22 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-22 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-22 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-22 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-22 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-22 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-22 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-22 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-22 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-22 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-22 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-21 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-21 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-21 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-21 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-21 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-21 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-21 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-21 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-21 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-21 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-21 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-21 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-21 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-21 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-21 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-21 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-21 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-21 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-21 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-21 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-21 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-21 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-21 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-21 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-21 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-21 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-20 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-20 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-20 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-20 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-20 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-20 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-20 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-20 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-20 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-20 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-20 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-20 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-20 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-20 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-20 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-20 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-20 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-20 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-20 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-19 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-19 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-19 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-19 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-19 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-19 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-19 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-18 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-18 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-18 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-18 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-18 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-18 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-18 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-18 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-18 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-18 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-18 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-18 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-18 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-18 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-18 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-18 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-18 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-18 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-18 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-18 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-18 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-18 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-18 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-18 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-18 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-17 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-17 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-16 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-15 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-14 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-14 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-14 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-14 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-13 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-13 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-13 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-13 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-13 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-12 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-12 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-12 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-12 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-11 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-11 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-11 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 9e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-10 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-10 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-10 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-10 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-10 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-10 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-10 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-10 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 9e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-08 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-08 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-07 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-07 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-07 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-07 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-07 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-07 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-07 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-07 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-07 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-07 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-07 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-07 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-07 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-07 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 6e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-07 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 6e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-07 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-07 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-07 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-07 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 8e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-07 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 8e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-06 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-06 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-06 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-06 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-06 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-06 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-06 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-06 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-06 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-06 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-06 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-05 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-05 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-05 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-05 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-05 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-05 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-05 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-05 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-05 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-05 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-05 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-05 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-05 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-05 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-05 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-05 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-05 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-05 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 7e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-05 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-04 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-04 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-04 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-04 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-04 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-04 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-04 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-04 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 2e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-04 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-04 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-04 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-04 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-04 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-04 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-04 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 3e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-04 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 5e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 5e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-04 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 5e-04 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 5e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-04 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 6e-04 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 6e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-04 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 7e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-04 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-04 |
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 475 bits (1224), Expect = e-166
Identities = 151/429 (35%), Positives = 224/429 (52%), Gaps = 61/429 (14%)
Query: 66 VLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLC 125
+ ++L +S++ +++ + L+ E +RLK ++ DDF++L +IGRGAF EV +
Sbjct: 23 GVHQELGASELAQDK--YVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVV 80
Query: 126 QEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185
+ K++G +YAMK + K +ML RG+V R ER++L I +L+++FQD YLYL+M
Sbjct: 81 KMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM 140
Query: 186 EYLPGGDVMTLLMREET-LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH 244
EY GGD++TLL + + +ARFY+A+ V+AI+S+H+ Y+HRDIKPDN+LLD+ GH
Sbjct: 141 EYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH 200
Query: 245 MKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHW 304
++L+DFG C L
Sbjct: 201 IRLADFGSCLKLR----------------------------------------------- 213
Query: 305 QINRRKLAYSTVGTPDYIAPEVLLKKG-------YGMECDWWSLGAIMYEMLVGYPPFYS 357
+ + VGTPDY++PE+L G YG ECDWW+LG YEM G PFY+
Sbjct: 214 -ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA 272
Query: 358 DDPVTTCRKIVHWKNHLKFPEEAR-LTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFK 416
D T KIVH+K HL P + EA+D I RLLC E RLG G+ + HP+F
Sbjct: 273 DSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFF 332
Query: 417 DIAWDKLYEMEAAYKPEVNGVLDTQNFMKFDEVES--QTPKRTGSGPMRKMMLTPKDLSF 474
+ WD L + + P+ G DT NF ++ + + +R+ L F
Sbjct: 333 GLDWDGLRDSVPPFTPDFEGATDTCNFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPF 392
Query: 475 VGYTYKNFE 483
VGY+Y
Sbjct: 393 VGYSYSCMA 401
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 464 bits (1195), Expect = e-161
Identities = 161/425 (37%), Positives = 230/425 (54%), Gaps = 58/425 (13%)
Query: 73 SSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGN 132
++ P + NIL+ LE + ++K+ ++ +DF++L +IGRGAFGEV + + K +
Sbjct: 41 CNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADK 100
Query: 133 IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGD 192
++AMK L K EML R + R ER++L S I L+Y+FQD LYL+M+Y GGD
Sbjct: 101 VFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGD 160
Query: 193 VMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
++TLL + E+ L E +ARFY+A+ V+AI+S+H+ +Y+HRDIKPDN+L+D NGH++L+DFG
Sbjct: 161 LLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFG 220
Query: 252 LCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKL 311
C ++++D +
Sbjct: 221 SCL-------------KLMEDGTVQ----------------------------------- 232
Query: 312 AYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRK 366
+ VGTPDYI+PE+L K YG ECDWWSLG MYEML G PFY++ V T K
Sbjct: 233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 292
Query: 367 IVHWKNHLKFPEE-ARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFKDIAWDKLYE 425
I++ K +FP + ++ AKDLI RL+C EHRLG G E K HP+F I WD +
Sbjct: 293 IMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRN 352
Query: 426 MEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFEAV 485
EA Y PEV+ DT N FD + P + L FVG+TY + +
Sbjct: 353 CEAPYIPEVSSPTDTSN---FDVDDDCLKNSETMPPPTHTAFSGHHLPFVGFTYTSSCVL 409
Query: 486 KGMHN 490
Sbjct: 410 SDRSC 414
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 462 bits (1190), Expect = e-161
Identities = 149/411 (36%), Positives = 221/411 (53%), Gaps = 60/411 (14%)
Query: 77 PEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAM 136
+ NI L R + +++ ++ +D++++ +IGRGAFGEV+L + K + +YAM
Sbjct: 40 ALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAM 99
Query: 137 KKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTL 196
K L K EM+ R ER+++A S +V+L+Y+FQD YLY++MEY+PGGD++ L
Sbjct: 100 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNL 159
Query: 197 LMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256
+ + + E ARFY A+ VLA+++IH +IHRD+KPDN+LLD++GH+KL+DFG C +
Sbjct: 160 MSNYD-VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218
Query: 257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTV 316
+ + V
Sbjct: 219 N------------------------------------------------KEGMVRCDTAV 230
Query: 317 GTPDYIAPEVLLKKG----YGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKN 372
GTPDYI+PEVL +G YG ECDWWS+G +YEMLVG PFY+D V T KI++ KN
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN 290
Query: 373 HLKFPEEARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAHPWFKDIAWDKLY--EMEAAY 430
L FP++ ++ EAK+LIC L D E RLG G E+IK H +FK+ W + A
Sbjct: 291 SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPV 350
Query: 431 KPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKN 481
P+++ +DT NF +E + + L FVG+TY +
Sbjct: 351 VPDLSSDIDTSNFDDLEEDKGEE-----ETFPIPKAFVGNQLPFVGFTYYS 396
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 379 bits (976), Expect = e-130
Identities = 133/371 (35%), Positives = 198/371 (53%), Gaps = 65/371 (17%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
K S+ DF +L +G G+FG V L + + +G YAMK LKK ++ QVEH ER +L+
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES 221
V I++++ +FQDA+ +++IM+Y+ GG++ +LL + + VA+FY A+ LA+E
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL-DCTNLSAINENEVLDDENLNESMD 280
+H + I+RD+KP+N+LLD+NGH+K++DFG K + D T
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-------------------- 161
Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340
+ CG TPDYIAPEV+ K Y DWWS
Sbjct: 162 -------TLCG--------------------------TPDYIAPEVVSTKPYNKSIDWWS 188
Query: 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEH 399
G ++YEML GY PFY + + T KI++ + L+FP + KDL+ RL+ D+
Sbjct: 189 FGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFP--PFFNEDVKDLLSRLITRDLSQ 244
Query: 400 RLGTL--GSEQIKAHPWFKDIAWDKLY--EMEAAYKPEV-NGVLDTQNFMKFDEVESQTP 454
RLG L G+E +K HPWFK++ W+KL +E Y+P + G DT F K+ E E
Sbjct: 245 RLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKYPE-EDINY 303
Query: 455 KRTGSGPMRKM 465
G P +
Sbjct: 304 GVQGEDPYADL 314
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 377 bits (970), Expect = e-128
Identities = 129/391 (32%), Positives = 199/391 (50%), Gaps = 65/391 (16%)
Query: 72 ASSDVPEEEQINILKDLERKE--TEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKK 129
A+ E+E + +++ ++ ++ +D FD + +G G+FG V L + K+
Sbjct: 5 AAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE 64
Query: 130 SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLP 189
SGN YAMK L K +++ Q+EH E+ +L V +VKL +SF+D LY++MEY+
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 190 GGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSD 249
GG++ + L R +E ARFY AQ VL E +H + I+RD+KP+NLL+DQ G+++++D
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTD 184
Query: 250 FGLCKPL-DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINR 308
FG K + T + CG
Sbjct: 185 FGFAKRVKGRTW---------------------------TLCG----------------- 200
Query: 309 RKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIV 368
TP+ +APE++L KGY DWW+LG ++YEM GYPPF++D P+ KIV
Sbjct: 201 ---------TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251
Query: 369 HWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHPWFKDIAWDKLY- 424
K ++FP + + + KDL+ LL D+ R G L G IK H WF W +Y
Sbjct: 252 SGK--VRFP--SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQ 307
Query: 425 -EMEAAYKPEVNGVLDTQNFMKFDEVESQTP 454
++EA + P+ G DT NF ++E E +
Sbjct: 308 RKVEAPFIPKFKGPGDTSNFDDYEEEEIRVS 338
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 371 bits (956), Expect = e-126
Identities = 122/419 (29%), Positives = 195/419 (46%), Gaps = 61/419 (14%)
Query: 71 LASSDVPEEEQINILKD-LERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKK 129
++ PE N ++ DF L +IG+G+FG+V L + K
Sbjct: 2 ISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKA 61
Query: 130 SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDAEYLYLIMEYL 188
YA+K L+K +L + + +H+ +ERN+L + H +V L++SFQ A+ LY +++Y+
Sbjct: 62 EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 121
Query: 189 PGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLS 248
GG++ L RE E ARFY A+ A+ +H N ++RD+KP+N+LLD GH+ L+
Sbjct: 122 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLT 181
Query: 249 DFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINR 308
DFGLCK E+++ +
Sbjct: 182 DFGLCK----------------------ENIEHNST------------------------ 195
Query: 309 RKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIV 368
+ GTP+Y+APEVL K+ Y DWW LGA++YEML G PPFYS + I+
Sbjct: 196 ---TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 252
Query: 369 HWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL-GSEQIKAHPWFKDIAWDKLY-- 424
+ L+ +T A+ L+ LL D RLG +IK+H +F I WD L
Sbjct: 253 NKP--LQLKPN--ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINK 308
Query: 425 EMEAAYKPEVNGVLDTQNFMKF--DEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKN 481
++ + P V+G D ++F +E + + + +F+G++Y
Sbjct: 309 KITPPFNPNVSGPNDLRHFDPEFTEEPVPNAIGKAPDSVLVTASVKEAAEAFLGFSYAP 367
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 366 bits (942), Expect = e-125
Identities = 98/341 (28%), Positives = 167/341 (48%), Gaps = 55/341 (16%)
Query: 92 ETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE 151
+ + K +DF I+G G+F V L +E + YA+K L+K ++ +V
Sbjct: 16 QHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVP 75
Query: 152 HVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFY 211
+V ER++++ + VKLY++FQD E LY + Y G+++ + + + ET RFY
Sbjct: 76 YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY 135
Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD 271
A+ V A+E +H IHRD+KP+N+LL+++ H++++DFG K +
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK-------------VLSP 182
Query: 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331
+ + A S VGT Y++PE+L +K
Sbjct: 183 ESK----------------------------------QARANSFVGTAQYVSPELLTEKS 208
Query: 332 YGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLIC 391
D W+LG I+Y+++ G PPF + + +KI+ + FPE+ P+A+DL+
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--YDFPEK--FFPKARDLVE 264
Query: 392 RLLC-DVEHRLGTL---GSEQIKAHPWFKDIAWDKLYEMEA 428
+LL D RLG G +KAHP+F+ + W+ L++
Sbjct: 265 KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 305
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 362 bits (932), Expect = e-123
Identities = 117/388 (30%), Positives = 194/388 (50%), Gaps = 65/388 (16%)
Query: 99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
+ K+ ++DF L ++G+G+FG+V L + KK+ +A+K LKK +L VE E+
Sbjct: 10 LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR 69
Query: 159 LLAEVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL 217
+L+ H + ++ +FQ E L+ +MEYL GGD+M + + A FY A+ +L
Sbjct: 70 VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL 129
Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNE 277
++ +H ++RD+K DN+LLD++GH+K++DFG+CK E
Sbjct: 130 GLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK----------------------E 167
Query: 278 SMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
+M D + + GTPDYIAPE+LL + Y D
Sbjct: 168 NMLGDAK---------------------------TNTFCGTPDYIAPEILLGQKYNHSVD 200
Query: 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-D 396
WWS G ++YEML+G PF+ D I ++ +P L EAKDL+ +L +
Sbjct: 201 WWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNPFYPRW--LEKEAKDLLVKLFVRE 256
Query: 397 VEHRLGTLGSEQIKAHPWFKDIAWDKLY--EMEAAYKPEVNGVLDTQNFMKFDEVESQTP 454
E RLG I+ HP F++I W++L E++ ++P+V D NF K E ++ P
Sbjct: 257 PEKRLG--VRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDK--EFLNEKP 312
Query: 455 KRTGSGPMRKMMLTPKDLS-FVGYTYKN 481
+ + + ++ D + F +++ N
Sbjct: 313 RLS---FADRALINSMDQNMFRNFSFMN 337
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 361 bits (929), Expect = e-122
Identities = 121/362 (33%), Positives = 186/362 (51%), Gaps = 62/362 (17%)
Query: 91 KETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQE---KKSGNIYAMKKLKKSEMLSR 147
+ KI + F+LL ++G+G +G+V ++ +G I+AMK LKK+ ++
Sbjct: 2 SSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN 61
Query: 148 G-QVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTET 206
H +AERN+L EV IV L Y+FQ LYLI+EYL GG++ L RE E
Sbjct: 62 AKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED 121
Query: 207 VARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE 266
A FY+A+ +A+ +H+ I+RD+KP+N++L+ GH+KL+DFGLCK
Sbjct: 122 TACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK------------ 169
Query: 267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEV 326
ES+ ++ GT +Y+APE+
Sbjct: 170 ----------ESIHDGTV---------------------------THTFCGTIEYMAPEI 192
Query: 327 LLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEA 386
L++ G+ DWWSLGA+MY+ML G PPF ++ T KI+ K L P LT EA
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK--LNLPPY--LTQEA 248
Query: 387 KDLICRLLC-DVEHRLGTL--GSEQIKAHPWFKDIAWDKLY--EMEAAYKPEVNGVLDTQ 441
+DL+ +LL + RLG + +++AHP+F+ I W++L ++E +KP + D
Sbjct: 249 RDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVS 308
Query: 442 NF 443
F
Sbjct: 309 QF 310
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 361 bits (928), Expect = e-122
Identities = 110/404 (27%), Positives = 193/404 (47%), Gaps = 66/404 (16%)
Query: 86 KDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML 145
K+ ++ +++ +D+F+ + ++G+G+FG+V L + K++G++YA+K LKK +L
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL 62
Query: 146 SRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLT 204
VE E+ +L+ +H + +L+ FQ + L+ +ME++ GGD+M + +
Sbjct: 63 QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD 122
Query: 205 ETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264
E ARFY A+ + A+ +H I+RD+K DN+LLD GH KL+DFG+CK
Sbjct: 123 EARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK---------- 172
Query: 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAP 324
E + + GTPDYIAP
Sbjct: 173 ------------EGICNGVT---------------------------TATFCGTPDYIAP 193
Query: 325 EVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTP 384
E+L + YG DWW++G ++YEML G+ PF +++ I++ + + +P L
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN--DEVVYPTW--LHE 249
Query: 385 EAKDLICRLLC-DVEHRLG---TLGSEQIKAHPWFKDIAWDKLY--EMEAAYKPEVNGVL 438
+A ++ + + RLG G I HP+FK+I W +L ++E ++P +
Sbjct: 250 DATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSRE 309
Query: 439 DTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLS-FVGYTYKN 481
D NF + + P T P+ + L + F + Y +
Sbjct: 310 DVSNFDP--DFIKEEPVLT---PIDEGHLPMINQDEFRNFEYVS 348
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 358 bits (920), Expect = e-121
Identities = 121/388 (31%), Positives = 190/388 (48%), Gaps = 61/388 (15%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
K++++DFD L ++G+G FG+V L +EK +G YAMK L+K ++++ +V H E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES 221
+ L Y+FQ + L +MEY GG++ L RE TE ARFY A+ V A+E
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
+H + ++RDIK +NL+LD++GH+K++DFGLCK E +
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK----------------------EGISD 158
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341
+ GTP+Y+APEVL YG DWW L
Sbjct: 159 GAT---------------------------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHR 400
G +MYEM+ G PFY+ D I+ + ++FP L+PEAK L+ LL D + R
Sbjct: 192 GVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRT--LSPEAKSLLAGLLKKDPKQR 247
Query: 401 LG--TLGSEQIKAHPWFKDIAWDKLY--EMEAAYKPEVNGVLDTQNF-MKF-DEVESQTP 454
LG ++++ H +F I W + ++ +KP+V +DT+ F +F + + TP
Sbjct: 248 LGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITP 307
Query: 455 KRTGSGPMRKMMLTPKDLS-FVGYTYKN 481
+ ++ F + Y
Sbjct: 308 PDRYDSLGLLELDQREEQEMFEDFDYIA 335
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 356 bits (916), Expect = e-121
Identities = 131/371 (35%), Positives = 195/371 (52%), Gaps = 64/371 (17%)
Query: 93 TEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQE---KKSGNIYAMKKLKKSEMLSRGQ 149
T +++ K F+LL ++G+G+FG+V L ++ + +YAMK LKK+ + R +
Sbjct: 11 THHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR 70
Query: 150 VEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVAR 209
V + ER++L EV IVKL+Y+FQ LYLI+++L GGD+ T L +E TE +
Sbjct: 71 V-RTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK 129
Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEV 269
FY+A+ LA++ +H I+RD+KP+N+LLD+ GH+KL+DFGL K
Sbjct: 130 FYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--------------- 174
Query: 270 LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK 329
ES+D + + AYS GT +Y+APEV+ +
Sbjct: 175 -------ESIDHEKK---------------------------AYSFCGTVEYMAPEVVNR 200
Query: 330 KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDL 389
+G+ DWWS G +M+EML G PF D T I+ K L P+ L+PEA+ L
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--LGMPQF--LSPEAQSL 256
Query: 390 ICRLLC-DVEHRLGTL--GSEQIKAHPWFKDIAWDKLY--EMEAAYKPEVNGVLDTQNFM 444
+ L + +RLG G E+IK H +F I W+KLY E+ +KP DT F
Sbjct: 257 LRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKPATGRPEDTFYFD 316
Query: 445 KFDEVESQTPK 455
E ++TPK
Sbjct: 317 P--EFTAKTPK 325
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 356 bits (917), Expect = e-120
Identities = 126/405 (31%), Positives = 200/405 (49%), Gaps = 69/405 (17%)
Query: 55 KHIQERKQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTII 114
H ++ S S+D + + + E + K+ +++F+LL ++
Sbjct: 4 HHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTG-HAEKVGIENFELLKVL 62
Query: 115 GRGAFGEVRLCQE---KKSGNIYAMKKLKKSEMLSRG-QVEHVRAERNLLAEVASHC-IV 169
G GA+G+V L ++ +G +YAMK LKK+ ++ + EH R ER +L + +V
Sbjct: 63 GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLV 122
Query: 170 KLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIH 229
L+Y+FQ L+LI++Y+ GG++ T L + E TE + Y+ + VLA+E +HK I+
Sbjct: 123 TLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIY 182
Query: 230 RDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESG 289
RDIK +N+LLD NGH+ L+DFGL K E + DE
Sbjct: 183 RDIKLENILLDSNGHVVLTDFGLSK-------------EFVADET--------------- 214
Query: 290 CGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL--KKGYGMECDWWSLGAIMYE 347
+ AY GT +Y+AP+++ G+ DWWSLG +MYE
Sbjct: 215 --------------------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 254
Query: 348 MLVGYPPFYSDDPVTTC----RKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLG 402
+L G PF D + R+I+ + +P+E ++ AKDLI RLL D + RLG
Sbjct: 255 LLTGASPFTVDGEKNSQAEISRRILKSE--PPYPQE--MSALAKDLIQRLLMKDPKKRLG 310
Query: 403 TL--GSEQIKAHPWFKDIAWDKLY--EMEAAYKPEVNGVLDTQNF 443
+++IK H +F+ I WD L ++ A +KP + LD NF
Sbjct: 311 CGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDVSNF 355
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 356 bits (915), Expect = e-120
Identities = 112/399 (28%), Positives = 187/399 (46%), Gaps = 66/399 (16%)
Query: 99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
R ++ + DF+ L ++G+G+FG+V L + K + +YA+K LKK ++ VE E+
Sbjct: 13 NRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR 72
Query: 159 LLAEVASHC-IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL 217
+LA + +L+ FQ + LY +MEY+ GGD+M + + E A FY A+ +
Sbjct: 73 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI 132
Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNE 277
+ + I+RD+K DN++LD GH+K++DFG+CK E
Sbjct: 133 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK----------------------E 170
Query: 278 SMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
++ + GTPDYIAPE++ + YG D
Sbjct: 171 NIWDGVT---------------------------TKTFCGTPDYIAPEIIAYQPYGKSVD 203
Query: 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-D 396
WW+ G ++YEML G PF +D + I+ +++ +P+ ++ EA + L+
Sbjct: 204 WWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKS--MSKEAVAICKGLMTKH 259
Query: 397 VEHRLGTL--GSEQIKAHPWFKDIAWDKLY--EMEAAYKPEVNGVLDTQNFMKFDEVESQ 452
RLG G IK H +F+ I W+KL E++ YKP+ G + +NF +
Sbjct: 260 PGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACG-RNAENFDR--FFTRH 316
Query: 453 TPKRTGSGPMRKMMLTPKD-LSFVGYTYKNFEAVKGMHN 490
P T P + ++ D F G+++ N E +K
Sbjct: 317 PPVLT---PPDQEVIRNIDQSEFEGFSFVNSEFLKPEVK 352
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 353 bits (907), Expect = e-118
Identities = 85/354 (24%), Positives = 152/354 (42%), Gaps = 69/354 (19%)
Query: 99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
+ ++ D F++L IG+G+FG+V + Q+ + +YAMK + K + + R +V +V E
Sbjct: 8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQ 67
Query: 159 LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLA 218
++ + +V L+YSFQD E ++++++ L GGD+ L + E + +I + V+A
Sbjct: 68 IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA 127
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
++ + IHRD+KPDN+LLD++GH+ ++DF +
Sbjct: 128 LDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA------------------------ 163
Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK---GYGME 335
+ R + GT Y+APE+ + GY
Sbjct: 164 --------------------------MLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFA 197
Query: 336 CDWWSLGAIMYEMLVGYPPFY---SDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICR 392
DWWSLG YE+L G P++ S + +P + E L+ +
Sbjct: 198 VDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV--VTYPSA--WSQEMVSLLKK 253
Query: 393 LLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLY--EMEAAYKPEVNGVLDTQNF 443
LL + + R ++ P+ DI WD ++ + + P N
Sbjct: 254 LLEPNPDQRFS--QLSDVQNFPYMNDINWDAVFQKRLIPGFIPNK----GRLNC 301
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 347 bits (892), Expect = e-117
Identities = 114/397 (28%), Positives = 190/397 (47%), Gaps = 75/397 (18%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
+ + DFDLL +IGRG++ +V L + KK+ IYAMK +KK + ++ V+ E+++
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE 64
Query: 162 EVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIE 220
+ ++H +V L+ FQ L+ ++EY+ GGD+M + R+ L E ARFY A+ LA+
Sbjct: 65 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 124
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
+H+ I+RD+K DN+LLD GH+KL+D+G+CK E +
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK----------------------EGLR 162
Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340
+ GTP+YIAPE+L + YG DWW+
Sbjct: 163 PGDT---------------------------TSTFCGTPNYIAPEILRGEDYGFSVDWWA 195
Query: 341 LGAIMYEMLVGYPPF---------YSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLIC 391
LG +M+EM+ G PF + + I+ ++ P L+ +A ++
Sbjct: 196 LGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPRS--LSVKAASVLK 251
Query: 392 RLLC-DVEHRLG---TLGSEQIKAHPWFKDIAWDKLY--EMEAAYKPEVNGVLDTQNFMK 445
L D + RLG G I+ HP+F+++ WD + ++ +KP ++G NF
Sbjct: 252 SFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDS 311
Query: 446 FDEVESQTPKRTGSGPMRKMMLTPKDLS-FVGYTYKN 481
+ ++ + T P ++ D S F G+ Y N
Sbjct: 312 --QFTNEPVQLT---PDDDDIVRKIDQSEFEGFEYIN 343
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 345 bits (886), Expect = e-115
Identities = 118/434 (27%), Positives = 198/434 (45%), Gaps = 83/434 (19%)
Query: 73 SSDVPEEEQINILKDL--------ERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRL 124
D+P E + + E T + + DFDLL +IGRG++ +V L
Sbjct: 11 DYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLL 70
Query: 125 CQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDAEYLYL 183
+ KK+ IYAM+ +KK + ++ V+ E+++ + ++H +V L+ FQ L+
Sbjct: 71 VRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130
Query: 184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG 243
++EY+ GGD+M + R+ L E ARFY A+ LA+ +H+ I+RD+K DN+LLD G
Sbjct: 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG 190
Query: 244 HMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQH 303
H+KL+D+G+CK E +
Sbjct: 191 HIKLTDYGMCK----------------------EGLRPGDT------------------- 209
Query: 304 WQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF-------- 355
+ GTP+YIAPE+L + YG DWW+LG +M+EM+ G PF
Sbjct: 210 --------TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 261
Query: 356 -YSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLG---TLGSEQIK 410
+ + I+ ++ P L+ +A ++ L D + RLG G I+
Sbjct: 262 PDQNTEDYLFQVILE--KQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQ 317
Query: 411 AHPWFKDIAWDKLY--EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLT 468
HP+F+++ WD + ++ +KP ++G NF + ++ + T P ++
Sbjct: 318 GHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDS--QFTNEPVQLT---PDDDDIVR 372
Query: 469 PKDLS-FVGYTYKN 481
D S F G+ Y N
Sbjct: 373 KIDQSEFEGFEYIN 386
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 342 bits (880), Expect = e-114
Identities = 116/351 (33%), Positives = 181/351 (51%), Gaps = 59/351 (16%)
Query: 99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
+H++++++F+ L ++G+G FG+V L +EK +G YAMK LKK ++++ +V H E
Sbjct: 141 PKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 200
Query: 159 LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLA 218
+L + L YSFQ + L +MEY GG++ L RE +E ARFY A+ V A
Sbjct: 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA 260
Query: 219 IESIH-KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNE 277
++ +H + N ++RD+K +NL+LD++GH+K++DFGLCK E
Sbjct: 261 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK----------------------E 298
Query: 278 SMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
+ + GTP+Y+APEVL YG D
Sbjct: 299 GIKDGAT---------------------------MKTFCGTPEYLAPEVLEDNDYGRAVD 331
Query: 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-D 396
WW LG +MYEM+ G PFY+ D I+ + ++FP L PEAK L+ LL D
Sbjct: 332 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPRT--LGPEAKSLLSGLLKKD 387
Query: 397 VEHRLG--TLGSEQIKAHPWFKDIAWDKLY--EMEAAYKPEVNGVLDTQNF 443
+ RLG + +++I H +F I W +Y ++ +KP+V DT+ F
Sbjct: 388 PKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYF 438
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 347 bits (892), Expect = e-112
Identities = 112/416 (26%), Positives = 189/416 (45%), Gaps = 66/416 (15%)
Query: 73 SSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGN 132
+ + + + K R ++ + DF+ L ++G+G+FG+V L + K +
Sbjct: 308 RAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDE 367
Query: 133 IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDAEYLYLIMEYLPGG 191
+YA+K LKK ++ VE E+ +LA + +L+ FQ + LY +MEY+ GG
Sbjct: 368 LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 427
Query: 192 DVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251
D+M + + E A FY A+ + + + I+RD+K DN++LD GH+K++DFG
Sbjct: 428 DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 487
Query: 252 LCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKL 311
+CK E++
Sbjct: 488 MCK----------------------ENIWDGVT--------------------------- 498
Query: 312 AYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWK 371
+ GTPDYIAPE++ + YG DWW+ G ++YEML G PF +D + I+
Sbjct: 499 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 558
Query: 372 NHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHPWFKDIAWDKLY--EM 426
+ +P+ ++ EA + L+ RLG G IK H +F+ I W+KL E+
Sbjct: 559 --VAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEI 614
Query: 427 EAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLS-FVGYTYKN 481
+ YKP+ +G + +NF + P T P + ++ D S F G+++ N
Sbjct: 615 QPPYKPKASG-RNAENFDR--FFTRHPPVLT---PPDQEVIRNIDQSEFEGFSFVN 664
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 338 bits (868), Expect = e-110
Identities = 106/459 (23%), Positives = 183/459 (39%), Gaps = 91/459 (19%)
Query: 22 EVLEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQ 81
+ ++ R A+ ++ + Q + +V + + D +
Sbjct: 96 DTADDA---------LRPQKAQALRAAYLEPQAQLFCSFLDAETVARARAGAGDGLFQPL 146
Query: 82 INILKDLERKE--------------TEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQE 127
+ + + ++ L+ + D F ++GRG FGEV CQ
Sbjct: 147 LRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQM 206
Query: 128 KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY 187
K +G +YA KKL K + R + E+ +LA+V S IV L Y+F+ L L+M
Sbjct: 207 KATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTI 266
Query: 188 LPGGDVM----TLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG 243
+ GGD+ + E A FY AQ V +E +H+ N I+RD+KP+N+LLD +G
Sbjct: 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG 326
Query: 244 HMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQH 303
++++SD GL E +
Sbjct: 327 NVRISDLGLAV----------------------ELKAGQTK------------------- 345
Query: 304 WQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTT 363
GTP ++APE+LL + Y D+++LG +YEM+ PF +
Sbjct: 346 --------TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 397
Query: 364 C----RKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHPWFK 416
++++ + +P+ + +P +KD LL D E RLG + ++ HP F+
Sbjct: 398 NKELKQRVLE--QAVTYPD--KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453
Query: 417 DIAWDKLY--EMEAAYKPEVNGVLDTQNFM--KFDEVES 451
DI+W +L + + P+ V F V+
Sbjct: 454 DISWRQLEAGMLTPPFVPDSRTVYAKNIQDVGAFSTVKG 492
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 337 bits (865), Expect = e-109
Identities = 111/478 (23%), Positives = 193/478 (40%), Gaps = 105/478 (21%)
Query: 37 ERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERKETEYM 96
+R A + ++ + R+ V P ++ + ++L R EY+
Sbjct: 97 KRKACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKD---LFQELTRLTHEYL 153
Query: 97 R---------------------LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYA 135
L+R ++ + F ++G+G FGEV CQ + +G +YA
Sbjct: 154 SVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYA 213
Query: 136 MKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMT 195
KKL+K + R E+ +L +V S +V L Y+++ + L L++ + GGD+
Sbjct: 214 CKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKF 273
Query: 196 LL--MREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253
+ M + E A FY A+ +E +H+ ++RD+KP+N+LLD +GH+++SD GL
Sbjct: 274 HIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA 333
Query: 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAY 313
V + +
Sbjct: 334 V-------------HVPEGQ-------------------------------------TIK 343
Query: 314 STVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTC----RKIVH 369
VGT Y+APEV+ + Y DWW+LG ++YEM+ G PF R +
Sbjct: 344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE 403
Query: 370 WKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHPWFKDIAWDKLY-- 424
++ E R +P+A+ L +LLC D RLG + ++K HP FK + + +L
Sbjct: 404 --VPEEYSE--RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAG 459
Query: 425 EMEAAYKPEVNGV--LDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLS-FVGYTY 479
+E +KP+ + D + +F V+ L P D + +
Sbjct: 460 MLEPPFKPDPQAIYCKDVLDIEQFSTVKGVE-------------LEPTDQDFYQKFAT 504
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 336 bits (862), Expect = e-108
Identities = 100/398 (25%), Positives = 173/398 (43%), Gaps = 85/398 (21%)
Query: 99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
++++DF + IIGRG FGEV C++ +G +YAMK L K + + ER
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241
Query: 159 LLAEVASHC---IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQS 215
+L+ V++ IV + Y+F + L I++ + GGD+ L + +E RFY A+
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI 301
Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENL 275
+L +E +H ++RD+KP N+LLD++GH+++SD GL + +
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC-------------DFSKKK-- 346
Query: 276 NESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGM 334
+++VGT Y+APEVL K Y
Sbjct: 347 ------------------------------------PHASVGTHGYMAPEVLQKGVAYDS 370
Query: 335 ECDWWSLGAIMYEMLVGYPPFY---SDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLIC 391
DW+SLG +++++L G+ PF + D R + ++ P+ +PE + L+
Sbjct: 371 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--VELPD--SFSPELRSLLE 426
Query: 392 RLLC-DVEHRLGTL--GSEQIKAHPWFKDIAWDKLY--EMEAAYKPEVNGV-----LDTQ 441
LL DV RLG L G++++K P+F+ + W ++ + P V D
Sbjct: 427 GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIG 486
Query: 442 NFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTY 479
+F + T +L + +
Sbjct: 487 SF---------DEEDTKGIK----LLDSDQELYRNFPL 511
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 295 bits (757), Expect = 2e-97
Identities = 94/325 (28%), Positives = 147/325 (45%), Gaps = 59/325 (18%)
Query: 93 TEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH 152
T + + K ++DDFD+ +G+G FG V L +EK++ I A+K L KS++ G
Sbjct: 1 TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60
Query: 153 VRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYI 212
+R E + + + I+++Y F D + +YL++E+ P G++ L + E + ++
Sbjct: 61 LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120
Query: 213 AQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDD 272
+ A+ H+ IHRDIKP+NLL+ G +K++DFG
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV------------------ 162
Query: 273 ENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY 332
H RR+ + GT DY+ PE++ K +
Sbjct: 163 ------------------------------HAPSLRRR---TMCGTLDYLPPEMIEGKTH 189
Query: 333 GMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICR 392
+ D W G + YE LVG PPF S T R+IV LKFP L+ +KDLI +
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV--NVDLKFPPF--LSDGSKDLISK 245
Query: 393 LLC-DVEHRLGTLGSEQIKAHPWFK 416
LL R L + + HPW K
Sbjct: 246 LLRYHPPQR---LPLKGVMEHPWVK 267
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 292 bits (750), Expect = 2e-96
Identities = 93/319 (29%), Positives = 142/319 (44%), Gaps = 59/319 (18%)
Query: 99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
K+ + +++DF++ +G+G FG V L +EK+S I A+K L K+++ G +R E
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 159 LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLA 218
+ + + I++LY F DA +YLI+EY P G V L + E YI + A
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
+ H IHRDIKP+NLLL G +K++DFG
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-------------------- 161
Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
+RR GT DY+ PE++ + + + D
Sbjct: 162 ----------------------------SRRT---DLCGTLDYLPPEMIEGRMHDEKVDL 190
Query: 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DV 397
WSLG + YE LVG PPF ++ T ++I + FP+ +T A+DLI RLL +
Sbjct: 191 WSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPD--FVTEGARDLISRLLKHNP 246
Query: 398 EHRLGTLGSEQIKAHPWFK 416
R ++ HPW
Sbjct: 247 SQR---PMLREVLEHPWIT 262
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 5e-80
Identities = 86/318 (27%), Positives = 147/318 (46%), Gaps = 60/318 (18%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
++DF + ++G+G+F V + +G A+K + K M G V+ V+ E +
Sbjct: 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHC 66
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM-REETLTETVARFYIAQSVLAIE 220
++ I++LY F+D+ Y+YL++E G++ L R + +E AR ++ Q + +
Sbjct: 67 QLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
+H H +HRD+ NLLL +N ++K++DFG L+ +
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFG---------LATQLKMPH----------- 166
Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTV-GTPDYIAPEVLLKKGYGMECDWW 339
+ T+ GTP+YI+PE+ + +G+E D W
Sbjct: 167 --------------------------EKHY----TLCGTPNYISPEIATRSAHGLESDVW 196
Query: 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVE 398
SLG + Y +L+G PPF +D T K+V + P L+ EAKDLI +LL +
Sbjct: 197 SLGCMFYTLLIGRPPFDTDTVKNTLNKVV--LADYEMPSF--LSIEAKDLIHQLLRRNPA 252
Query: 399 HRLGTLGSEQIKAHPWFK 416
RL +L + HP+
Sbjct: 253 DRL-SL--SSVLDHPFMS 267
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 1e-79
Identities = 73/393 (18%), Positives = 134/393 (34%), Gaps = 102/393 (25%)
Query: 77 PEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAM 136
P +IL + +K ++D+ ++ + +G F ++ LC +K YA+
Sbjct: 2 PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILC--EKDNKFYAL 59
Query: 137 KKLKKSEML--------------SRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182
KK +KS + + + + + E ++ ++ + + + + +Y
Sbjct: 60 KKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVY 119
Query: 183 LIMEYLPGGDVMTLLMREETL--------TETVARFYIAQSVLAIESIHKHNYI-HRDIK 233
+I EY+ ++ L V + I + + IH I HRD+K
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK 179
Query: 234 PDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRR 293
P N+L+D+NG +KLSDFG S ++ +
Sbjct: 180 PSNILMDKNGRVKLSDFG---------ESEYMVDKKI----------------------- 207
Query: 294 WKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG--YGMECDWWSLGAIMYEMLVG 351
+ GT +++ PE + G + D WSLG +Y M
Sbjct: 208 -------------------KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248
Query: 352 YPPFYSD-DPVTTCRKIVHWKNHLKFPEEAR-----------------LTPEAKDLICRL 393
PF V I ++++P + L+ E D +
Sbjct: 249 VVPFSLKISLVELFNNIR--TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLF 306
Query: 394 LC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLYE 425
L + R + SE H W D + L E
Sbjct: 307 LRKNPAER---ITSEDALKHEWLADTNIEDLRE 336
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 249 bits (639), Expect = 3e-79
Identities = 86/314 (27%), Positives = 143/314 (45%), Gaps = 57/314 (18%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
S + +G+G F + + + ++A K + KS +L Q E + E ++ +
Sbjct: 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL 98
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH 223
A +V + F+D +++++++E ++ L R + LTE AR+Y+ Q VL + +H
Sbjct: 99 AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 158
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDG 283
++ IHRD+K NL L+++ +K+ DFG L+ ++ DG
Sbjct: 159 RNRVIHRDLKLGNLFLNEDLEVKIGDFG---------LATK--------------VEYDG 195
Query: 284 RFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 343
+ C GTP+YIAPEVL KKG+ E D WS+G
Sbjct: 196 ERKKVLC--------------------------GTPNYIAPEVLSKKGHSFEVDVWSIGC 229
Query: 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLG 402
IMY +LVG PPF + T +I KN P+ + P A LI ++L D R
Sbjct: 230 IMYTLLVGKPPFETSCLKETYLRIK--KNEYSIPK--HINPVAASLIQKMLQTDPTARP- 284
Query: 403 TLGSEQIKAHPWFK 416
T+ ++ +F
Sbjct: 285 TI--NELLNDEFFT 296
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 4e-79
Identities = 86/314 (27%), Positives = 143/314 (45%), Gaps = 57/314 (18%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
S + +G+G F + + + ++A K + KS +L Q E + E ++ +
Sbjct: 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL 72
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH 223
A +V + F+D +++++++E ++ L R + LTE AR+Y+ Q VL + +H
Sbjct: 73 AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 132
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDG 283
++ IHRD+K NL L+++ +K+ DFG L+ ++ DG
Sbjct: 133 RNRVIHRDLKLGNLFLNEDLEVKIGDFG---------LATK--------------VEYDG 169
Query: 284 RFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 343
+ C GTP+YIAPEVL KKG+ E D WS+G
Sbjct: 170 ERKKVLC--------------------------GTPNYIAPEVLSKKGHSFEVDVWSIGC 203
Query: 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLG 402
IMY +LVG PPF + T +I KN P+ + P A LI ++L D R
Sbjct: 204 IMYTLLVGKPPFETSCLKETYLRIK--KNEYSIPK--HINPVAASLIQKMLQTDPTARP- 258
Query: 403 TLGSEQIKAHPWFK 416
T+ ++ +F
Sbjct: 259 TI--NELLNDEFFT 270
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 5e-79
Identities = 67/329 (20%), Positives = 117/329 (35%), Gaps = 64/329 (19%)
Query: 91 KETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQV 150
+ Y + F L+ +G G++GEV + K+ G +YA+K+ +
Sbjct: 42 QSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK-DR 100
Query: 151 EHVRAERNLLAEVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMRE-ETLTETVA 208
AE +V H C V+L ++++ LYL E G + +L E
Sbjct: 101 ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQV 159
Query: 209 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENE 268
Y+ ++LA+ +H +H D+KP N+ L G KL DFGL
Sbjct: 160 WGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLV-------------- 205
Query: 269 VLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL 328
++ G P Y+APE+ L
Sbjct: 206 ------------------------------------ELGTAGAGEVQEGDPRYMAPEL-L 228
Query: 329 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKD 388
+ YG D +SLG + E+ + + +++ +F L+ E +
Sbjct: 229 QGSYGTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQGYLPPEFTA--GLSSELRS 283
Query: 389 LICRLLC-DVEHRLGTLGSEQIKAHPWFK 416
++ +L D + R E + A P +
Sbjct: 284 VLVMMLEPDPKLRATA---EALLALPVLR 309
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 5e-78
Identities = 74/334 (22%), Positives = 130/334 (38%), Gaps = 60/334 (17%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
DF+ + ++G+GAFG+V + YA+KK++ +E ++ + +E LLA +
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNH 61
Query: 166 HCIVKLYYSFQDAE-------------YLYLIMEYLPGGDVMTLLMREETLT-ETVARFY 211
+V+ Y ++ + L++ MEY G + L+ E
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD 271
Q + A+ IH IHRD+KP N+ +D++ ++K+ DFGL K + + +++ L
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331
+ S +GT Y+A EVL G
Sbjct: 182 GSS-----------------------------------DNLTSAIGTAMYVATEVLDGTG 206
Query: 332 -YGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLI 390
Y + D +SLG I +EM+ YP + V +K+ + K +I
Sbjct: 207 HYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKII 264
Query: 391 CRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKL 423
L+ D R G + W D++
Sbjct: 265 RLLIDHDPNKRPGA---RTLLNSGWLPVKHQDEV 295
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 1e-72
Identities = 83/334 (24%), Positives = 139/334 (41%), Gaps = 71/334 (21%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA- 164
++++ I+GRG VR C K + YA+K + + S E L EV
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 165 -----SH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLA 218
H I++L +++ + +L+ + + G++ L + TL+E R + +
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
I ++HK N +HRD+KP+N+LLD + ++KL+DFG ++ E L +
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC--------QLDPGEKLRE------ 182
Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL------LKKGY 332
GTP Y+APE++ GY
Sbjct: 183 ------------------------------------VCGTPSYLAPEIIECSMNDNHPGY 206
Query: 333 GMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEE--ARLTPEAKDLI 390
G E D WS G IMY +L G PPF+ + R I+ + +F + KDL+
Sbjct: 207 GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM--SGNYQFGSPEWDDYSDTVKDLV 264
Query: 391 CRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKL 423
R L + R E+ AHP+F+ +++
Sbjct: 265 SRFLVVQPQKRYTA---EEALAHPFFQQYVVEEV 295
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 1e-71
Identities = 92/371 (24%), Positives = 155/371 (41%), Gaps = 71/371 (19%)
Query: 61 KQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFG 120
+ + E K + P+ + + + ++ + +D +IGRG
Sbjct: 50 QSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFY-QKYDPKDVIGRGVSS 108
Query: 121 EVRLCQEKKSGNIYAMK-----KLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKLYYS 174
VR C + +G+ +A+K + S E R E ++L +VA H I+ L S
Sbjct: 109 VVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168
Query: 175 FQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKP 234
++ + +++L+ + + G++ L + L+E R + + A+ +H +N +HRD+KP
Sbjct: 169 YESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKP 228
Query: 235 DNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRW 294
+N+LLD N ++LSDFG + E L +
Sbjct: 229 ENILLDDNMQIRLSDFGFSC--------HLEPGEKLRE---------------------- 258
Query: 295 KSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL------LKKGYGMECDWWSLGAIMYEM 348
GTP Y+APE+L GYG E D W+ G I++ +
Sbjct: 259 --------------------LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTL 298
Query: 349 LVGYPPFYSDDPVTTCRKIVHWKNHLKFPEE--ARLTPEAKDLICRLLC-DVEHRLGTLG 405
L G PPF+ + R I+ + +F + KDLI RLL D E RL T
Sbjct: 299 LAGSPPFWHRRQILMLRMIM--EGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARL-T-- 353
Query: 406 SEQIKAHPWFK 416
+EQ HP+F+
Sbjct: 354 AEQALQHPFFE 364
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 1e-71
Identities = 83/318 (26%), Positives = 143/318 (44%), Gaps = 62/318 (19%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
D++D+ +G+GAF VR C K +G +A K + ++ +R + + E + ++
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQH 64
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
IV+L+ S Q+ + YL+ + + GG++ ++ E +E A I Q + +I H +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 226 NYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
+HR++KP+NLLL + +KL+DFGL ++ ++E
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--------DSEAW------------ 164
Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342
+ GTP Y++PEVL K Y D W+ G
Sbjct: 165 ------------------------------HGFAGTPGYLSPEVLKKDPYSKPVDIWACG 194
Query: 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEE--ARLTPEAKDLICRLLC-DVEH 399
I+Y +LVGYPPF+ +D +I +P +TPEAK LI +L + +
Sbjct: 195 VILYILLVGYPPFWDEDQHRLYAQIK--AGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKK 252
Query: 400 RLGTLGSEQIKAHPWFKD 417
R + ++Q PW +
Sbjct: 253 R---ITADQALKVPWICN 267
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 4e-71
Identities = 90/333 (27%), Positives = 150/333 (45%), Gaps = 63/333 (18%)
Query: 91 KETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQV 150
+ +E+M K S D++D+ +G+GAF VR C K +G +A K + + LS
Sbjct: 15 RGSEFMMNASTKFS-DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDF 72
Query: 151 EHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF 210
+ + E + ++ IV+L+ S Q+ + YL+ + + GG++ ++ E +E A
Sbjct: 73 QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH 132
Query: 211 YIAQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAINEN 267
I Q + +I H + +HR++KP+NLLL + +KL+DFGL +N++
Sbjct: 133 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI--------EVNDS 184
Query: 268 EVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL 327
E + GTP Y++PEVL
Sbjct: 185 EAW------------------------------------------HGFAGTPGYLSPEVL 202
Query: 328 LKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEE--ARLTPE 385
K Y D W+ G I+Y +LVGYPPF+ +D +I +P +TPE
Sbjct: 203 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK--AGAYDYPSPEWDTVTPE 260
Query: 386 AKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417
AK LI +L + + R+ T ++Q PW +
Sbjct: 261 AKSLIDSMLTVNPKKRI-T--ADQALKVPWICN 290
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 5e-71
Identities = 81/323 (25%), Positives = 147/323 (45%), Gaps = 63/323 (19%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
+ ++++ ++G+G+FGEV C+++ + YA+K + K+ ++ + E LL ++
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDH 80
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
I+KL+ +D+ Y++ E GG++ +++ + +E A I Q I +HKH
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 226 NYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
N +HRD+KP+N+LL +++ +K+ DFGL +N + D
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLST--------CFQQNTKMKD---------- 182
Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342
+GT YIAPEV L+ Y +CD WS G
Sbjct: 183 --------------------------------RIGTAYYIAPEV-LRGTYDEKCDVWSAG 209
Query: 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEE--ARLTPEAKDLICRLLC-DVEH 399
I+Y +L G PPFY + +++ F ++ +AKDLI ++L
Sbjct: 210 VILYILLSGTPPFYGKNEYDILKRVE--TGKYAFDLPQWRTISDDAKDLIRKMLTFHPSL 267
Query: 400 RLGTLGSEQIKAHPWFKDIAWDK 422
R + + Q HPW + + ++
Sbjct: 268 R---ITATQCLEHPWIQKYSSEE 287
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 2e-70
Identities = 87/318 (27%), Positives = 144/318 (45%), Gaps = 65/318 (20%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
F + ++G GAF EV L +++ +G ++A+K +KKS + + E +L ++
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKS---PAFRDSSLENEIAVLKKIKH 65
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
IV L ++ + YL+M+ + GG++ ++ TE A I Q + A++ +H++
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 226 NYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
+HRD+KP+NLL ++N + ++DFG LS + +N ++
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFG---------LSKMEQNGIM------------ 164
Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342
+ GTP Y+APEVL +K Y D WS+G
Sbjct: 165 ------------------------------STACGTPGYVAPEVLAQKPYSKAVDCWSIG 194
Query: 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEE--ARLTPEAKDLICRLLC-DVEH 399
I Y +L GYPPFY + KI + + +F ++ AKD IC LL D
Sbjct: 195 VITYILLCGYPPFYEETESKLFEKIK--EGYYEFESPFWDDISESAKDFICHLLEKDPNE 252
Query: 400 RLGTLGSEQIKAHPWFKD 417
R T E+ +HPW
Sbjct: 253 RY-T--CEKALSHPWIDG 267
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 2e-70
Identities = 72/320 (22%), Positives = 129/320 (40%), Gaps = 59/320 (18%)
Query: 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLL 160
+ S++ + L IG G+FG+ L + + G Y +K++ S M S + E R E +L
Sbjct: 19 YFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVL 77
Query: 161 AEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLA 218
A + IV+ SF++ LY++M+Y GGD+ + + E + Q LA
Sbjct: 78 ANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA 137
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
++ +H +HRDIK N+ L ++G ++L DFG+ + L+ T
Sbjct: 138 LKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV------------------ 179
Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
+LA + +GTP Y++PE+ K Y + D
Sbjct: 180 -------------------------------ELARACIGTPYYLSPEICENKPYNNKSDI 208
Query: 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DV 397
W+LG ++YE+ F + KI+ + + + + L+ +L +
Sbjct: 209 WALGCVLYELCTLKHAFEAGSMKNLVLKIIS-GSFPPVSL--HYSYDLRSLVSQLFKRNP 265
Query: 398 EHRLGTLGSEQIKAHPWFKD 417
R I +
Sbjct: 266 RDRPSV---NSILEKGFIAK 282
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 3e-70
Identities = 72/342 (21%), Positives = 137/342 (40%), Gaps = 71/342 (20%)
Query: 90 RKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ 149
TE + + + + +L IG G +V + IYA+K + E
Sbjct: 12 DLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQT 69
Query: 150 VEHVRAERNLLAEVASHC--IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETV 207
++ R E L ++ H I++LY +Y+Y++ME D+ + L +++++
Sbjct: 70 LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWE 128
Query: 208 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINEN 267
+ Y + A+ +IH+H +H D+KP N L+ +G +KL DFG+
Sbjct: 129 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN------------- 174
Query: 268 EVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL 327
+ + + D S VGT +Y+ PE +
Sbjct: 175 -QMQPDTTSVVKD---------------------------------SQVGTVNYMPPEAI 200
Query: 328 L-----------KKGYGMECDWWSLGAIMYEMLVGYPPFYS-DDPVTTCRKIVHWKNHLK 375
K + D WSLG I+Y M G PF + ++ I+ + ++
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 260
Query: 376 FPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFK 416
FP+ + +D++ L D + R+ ++ ++ AHP+ +
Sbjct: 261 FPD--IPEKDLQDVLKCCLKRDPKQRI-SI--PELLAHPYVQ 297
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 7e-70
Identities = 89/359 (24%), Positives = 149/359 (41%), Gaps = 73/359 (20%)
Query: 98 LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ---VEHVR 154
K+ K+ D +D+ +G G F V+ C+EK +G YA K +KK + + + E +
Sbjct: 5 FKQQKVE-DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE 63
Query: 155 AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQ 214
E ++L +V H ++ L+ +++ + LI+E + GG++ L ++E+L+E A +I Q
Sbjct: 64 REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 215 SVLAIESIHKHNYIHRDIKPDNLLL----DQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270
+ + +H H D+KP+N++L H+KL DFGL I +
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--------EIEDGVEF 175
Query: 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK 330
+ GTP+++APE++ +
Sbjct: 176 KN------------------------------------------IFGTPEFVAPEIVNYE 193
Query: 331 GYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEA--RLTPEAKD 388
G+E D WS+G I Y +L G PF D T I F EE + AKD
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT--SVSYDFDEEFFSHTSELAKD 251
Query: 389 LICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKF 446
I +LL + R L ++ HPW + V++ +NF K
Sbjct: 252 FIRKLLVKETRKR---LTIQEALRHPWITPVD-------NQQAMVRRESVVNLENFRKQ 300
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 1e-69
Identities = 82/322 (25%), Positives = 134/322 (41%), Gaps = 69/322 (21%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
D F +G GAFG+V L +E+ SG +K + K + +E + AE +L +
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSL-D 78
Query: 166 H-CIVKLYYSFQDAEYLYLIMEYLPGGD----VMTLLMREETLTETVARFYIAQSVLAIE 220
H I+K++ F+D +Y++ME GG+ +++ R + L+E + Q + A+
Sbjct: 79 HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 221 SIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNE 277
H + +H+D+KP+N+L + +K+ DFGL + +E +
Sbjct: 139 YFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE--------LFKSDEHSTN----- 185
Query: 278 SMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
GT Y+APEV K+ +CD
Sbjct: 186 -------------------------------------AAGTALYMAPEV-FKRDVTFKCD 207
Query: 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEE-ARLTPEAKDLICRLLC- 395
WS G +MY +L G PF +K + E LTP+A DL+ ++L
Sbjct: 208 IWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT--YKEPNYAVECRPLTPQAVDLLKQMLTK 265
Query: 396 DVEHRLGTLGSEQIKAHPWFKD 417
D E R + Q+ H WFK
Sbjct: 266 DPERR---PSAAQVLHHEWFKQ 284
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 2e-69
Identities = 88/341 (25%), Positives = 140/341 (41%), Gaps = 72/341 (21%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ---VEHVRAERNLLAE 162
D +++ +G G F VR C++K +G YA K +KK + S + E + E N+L E
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESI 222
+ I+ L+ F++ + LI+E + GG++ L +E+LTE A ++ Q + + +
Sbjct: 65 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124
Query: 223 HKHNYIHRDIKPDNLLL----DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
H H D+KP+N++L N +KL DFG+ I +
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH--------KIEAGNEFKN------ 170
Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
GTP+++APE++ + G+E D
Sbjct: 171 ------------------------------------IFGTPEFVAPEIVNYEPLGLEADM 194
Query: 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEA--RLTPEAKDLICRLLC- 395
WS+G I Y +L G PF + T I + F EE + AKD I RLL
Sbjct: 195 WSIGVITYILLSGASPFLGETKQETLTNIS--AVNYDFDEEYFSNTSELAKDFIRRLLVK 252
Query: 396 DVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNG 436
D + R + Q H W K I + E +G
Sbjct: 253 DPKRR---MTIAQSLEHSWIKAIR-------RRNVRGEDSG 283
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 3e-69
Identities = 84/384 (21%), Positives = 151/384 (39%), Gaps = 97/384 (25%)
Query: 90 RKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM--LSR 147
R+ + ++ + L IG+G++G VR+ E ++ I A+K + K+++ ++
Sbjct: 11 RENLYFQGGSLLELQ-KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINP 69
Query: 148 GQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGD--------------- 192
VE ++ E L+ ++ I +LY ++D +Y+ L+ME GG
Sbjct: 70 KDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGK 129
Query: 193 -------------------------VMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
+ E + + Q A+ +H
Sbjct: 130 CAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGI 189
Query: 228 IHRDIKPDNLLL--DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
HRDIKP+N L +++ +KL DFGL K + + +
Sbjct: 190 CHRDIKPENFLFSTNKSFEIKLVDFGLSK--------EFYKLNNGEYYGMTT-------- 233
Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL--LKKGYGMECDWWSLGA 343
GTP ++APEVL + YG +CD WS G
Sbjct: 234 -----------------------------KAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLG 402
+++ +L+G PF + T ++++ K + P L+P A+DL+ LL +V+ R
Sbjct: 265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDER-- 322
Query: 403 TLGSEQIKAHPWFKDIAWDKLYEM 426
+ + HPW + DK+Y+M
Sbjct: 323 -FDAMRALQHPWISQFS-DKIYKM 344
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 3e-69
Identities = 91/371 (24%), Positives = 159/371 (42%), Gaps = 71/371 (19%)
Query: 83 NILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS 142
+++ L +++ S D + ++G+G+FGEV LC++K +G A+K + K
Sbjct: 4 SMMDHLHATPGMFVQHSTAIFS-DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 62
Query: 143 EMLSRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE 201
++ + E + E LL ++ H I+KLY F+D Y YL+ E GG++ ++ +
Sbjct: 63 QVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK 121
Query: 202 TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDC 258
+E A I Q + I +HK+ +HRD+KP+NLLL ++ ++++ DFGL
Sbjct: 122 RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST---- 177
Query: 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGT 318
++ + D +GT
Sbjct: 178 ----HFEASKKMKD------------------------------------------KIGT 191
Query: 319 PDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPE 378
YIAPEV L Y +CD WS G I+Y +L G PPF + +K+ K F
Sbjct: 192 AYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE--KGKYTFEL 248
Query: 379 E--ARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVN 435
+++ AKDLI ++L R + + H W + ++ + P ++
Sbjct: 249 PQWKKVSESAKDLIRKMLTYVPSMR---ISARDALDHEWIQTYTKEQ----ISVDVPSLD 301
Query: 436 GVLDTQNFMKF 446
+ N +F
Sbjct: 302 NAI--LNIRQF 310
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 6e-69
Identities = 87/318 (27%), Positives = 139/318 (43%), Gaps = 65/318 (20%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
+ L IGRG++GEV++ +K + A KK+ K + V+ + E ++ +
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDH 65
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
I++LY +F+D +YL+ME GG++ ++ + E+ A + + A+ HK
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 226 NYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
N HRD+KP+N L + +KL DFGL +++
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA--------RFKPGKMMRT---------- 167
Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342
VGTP Y++P+V L+ YG ECD WS G
Sbjct: 168 --------------------------------KVGTPYYVSPQV-LEGLYGPECDEWSAG 194
Query: 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEE--ARLTPEAKDLICRLLC-DVEH 399
+MY +L GYPPF + KI + FPE+ ++P+A+ LI RLL +
Sbjct: 195 VMMYVLLCGYPPFSAPTDSEVMLKIR--EGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQ 252
Query: 400 RLGTLGSEQIKAHPWFKD 417
R + S Q H WF+
Sbjct: 253 R---ITSLQALEHEWFEK 267
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 1e-68
Identities = 87/353 (24%), Positives = 146/353 (41%), Gaps = 76/353 (21%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ--VEHVRAERNLLAEV 163
D ++L +IG+G F VR C +++G +A+K + ++ S E ++ E ++ +
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGD----VMTLLMREETLTETVARFYIAQSVLAI 219
IV+L ++ LY++ E++ G D ++ +E VA Y+ Q + A+
Sbjct: 84 KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 220 ESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLN 276
H +N IHRD+KP +LL + + +KL FG+
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI---------------------- 181
Query: 277 ESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336
+ ESG +A VGTP ++APEV+ ++ YG
Sbjct: 182 -------QLGESG--------------------LVAGGRVGTPHFMAPEVVKREPYGKPV 214
Query: 337 DWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEE--ARLTPEAKDLICRLL 394
D W G I++ +L G PFY I+ K K + ++ AKDL+ R+L
Sbjct: 215 DVWGCGVILFILLSGCLPFYGTKE-RLFEGII--KGKYKMNPRQWSHISESAKDLVRRML 271
Query: 395 C-DVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKF 446
D R+ T + HPW K+ AYK + ++ KF
Sbjct: 272 MLDPAERI-T--VYEALNHPWLKERD-------RYAYKIHLPETVE--QLRKF 312
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 2e-68
Identities = 89/359 (24%), Positives = 149/359 (41%), Gaps = 73/359 (20%)
Query: 98 LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ---VEHVR 154
K+ K+ D +D+ +G G F V+ C+EK +G YA K +KK + + + E +
Sbjct: 5 FKQQKVE-DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIE 63
Query: 155 AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQ 214
E ++L +V I+ L+ +++ + LI+E + GG++ L ++E+L+E A +I Q
Sbjct: 64 REVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 215 SVLAIESIHKHNYIHRDIKPDNLLL----DQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270
+ + +H H D+KP+N++L H+KL DFGL I +
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--------EIEDGVEF 175
Query: 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK 330
+ GTP+++APE++ +
Sbjct: 176 KN------------------------------------------IFGTPEFVAPEIVNYE 193
Query: 331 GYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEA--RLTPEAKD 388
G+E D WS+G I Y +L G PF D T I F EE + + AKD
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT--AVSYDFDEEFFSQTSELAKD 251
Query: 389 LICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKF 446
I +LL + R L ++ HPW + V++ +NF K
Sbjct: 252 FIRKLLVKETRKR---LTIQEALRHPWITPVD-------TQQAMVRRESVVNLENFKKQ 300
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 2e-68
Identities = 81/330 (24%), Positives = 138/330 (41%), Gaps = 66/330 (20%)
Query: 98 LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ---VEHVR 154
++ + D +D +G G F V+ C+EK +G YA K +KK S + E +
Sbjct: 4 FRQENVD-DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 155 AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQ 214
E ++L E+ ++ L+ +++ + LI+E + GG++ L +E+LTE A ++ Q
Sbjct: 63 REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 215 SVLAIESIHKHNYIHRDIKPDNLLL----DQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270
+ + +H H D+KP+N++L +K+ DFGL I+
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--------KIDFGNEF 174
Query: 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK 330
+ GTP+++APE++ +
Sbjct: 175 KN------------------------------------------IFGTPEFVAPEIVNYE 192
Query: 331 GYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEA--RLTPEAKD 388
G+E D WS+G I Y +L G PF D T + + +F +E + AKD
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVNYEFEDEYFSNTSALAKD 250
Query: 389 LICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417
I RLL D + R + + HPW K
Sbjct: 251 FIRRLLVKDPKKR---MTIQDSLQHPWIKP 277
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 5e-68
Identities = 85/318 (26%), Positives = 138/318 (43%), Gaps = 61/318 (19%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
+++ L +G+GAF VR C + +G YA + LS + + E + +
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTK-KLSARDHQKLEREARICRLLKH 69
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
IV+L+ S + + YLI + + GG++ ++ E +E A I Q + A+ H+
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 226 NYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
+HR++KP+NLLL + +KL+DFGL ++ E +
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-------GEQQAW------------ 170
Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342
+ GTP Y++PEVL K YG D W+ G
Sbjct: 171 ------------------------------FGFAGTPGYLSPEVLRKDPYGKPVDLWACG 200
Query: 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEE--ARLTPEAKDLICRLLC-DVEH 399
I+Y +LVGYPPF+ +D ++I FP +TPEAKDLI ++L +
Sbjct: 201 VILYILLVGYPPFWDEDQHRLYQQIK--AGAYDFPSPEWDTVTPEAKDLINKMLTINPSK 258
Query: 400 RLGTLGSEQIKAHPWFKD 417
R + + + HPW
Sbjct: 259 R---ITAAEALKHPWISH 273
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 1e-67
Identities = 78/313 (24%), Positives = 128/313 (40%), Gaps = 65/313 (20%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKLY 172
+GRG F VR C K +G YA K LKK + + E +L S ++ L+
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRR-RGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 173 YSFQDAEYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHR 230
+++ + LI+EY GG++ +L + E E ++E I Q + + +H++N +H
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHL 155
Query: 231 DIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
D+KP N+LL G +K+ DFG+ + I L +
Sbjct: 156 DLKPQNILLSSIYPLGDIKIVDFGMSR--------KIGHACELRE--------------- 192
Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 347
+GTP+Y+APE+L D W++G I Y
Sbjct: 193 ---------------------------IMGTPEYLAPEILNYDPITTATDMWNIGIIAYM 225
Query: 348 MLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEA--RLTPEAKDLICRLLC-DVEHRLGTL 404
+L PF +D T I + ++ + EE ++ A D I LL + E R
Sbjct: 226 LLTHTSPFVGEDNQETYLNIS--QVNVDYSEETFSSVSQLATDFIQSLLVKNPEKR---P 280
Query: 405 GSEQIKAHPWFKD 417
+E +H W +
Sbjct: 281 TAEICLSHSWLQQ 293
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 1e-67
Identities = 90/333 (27%), Positives = 147/333 (44%), Gaps = 73/333 (21%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA- 164
D++ + +G GA GEV+L E+K+ A+K + K + E A + E+
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN-VETEIEI 68
Query: 165 ----SH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAI 219
+H CI+K+ F +Y Y+++E + GG++ ++ + L E + Y Q +LA+
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 220 ESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLN 276
+ +H++ IHRD+KP+N+LL +++ +K++DFG K L E ++
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--------ETSLMRT---- 175
Query: 277 ESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL---LKKGYG 333
GTP Y+APEVL GY
Sbjct: 176 --------------------------------------LCGTPTYLAPEVLVSVGTAGYN 197
Query: 334 MECDWWSLGAIMYEMLVGYPPFYSD-DPVTTCRKIVHWKNHLKFPEE--ARLTPEAKDLI 390
D WSLG I++ L GYPPF V+ +I F E A ++ +A DL+
Sbjct: 198 RAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT--SGKYNFIPEVWAEVSEKALDLV 255
Query: 391 CRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDK 422
+LL D + R T E+ HPW +D +
Sbjct: 256 KKLLVVDPKARFTT---EEALRHPWLQDEDMKR 285
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 1e-67
Identities = 93/337 (27%), Positives = 137/337 (40%), Gaps = 78/337 (23%)
Query: 98 LKRHKISVDDFDLLT---IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
+K +DL +G G+F R C KKS +A+K + K + +
Sbjct: 1 MKDSPFY-QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQ 53
Query: 155 AERNLLAEVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIA 213
E L H IVKL+ F D + +L+ME L GG++ + +++ +ET A + +
Sbjct: 54 KEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR 113
Query: 214 QSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270
+ V A+ +H +HRD+KP+NLL + N +K+ DFG + +N+ L
Sbjct: 114 KLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP-------PDNQPL 166
Query: 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK 330
T Y APE+L +
Sbjct: 167 KT------------------------------------------PCFTLHYAAPELLNQN 184
Query: 331 GYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTC-------RKIVHWKNHLKFPEE--AR 381
GY CD WSLG I+Y ML G PF S D TC +KI K F E
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK--KGDFSFEGEAWKN 242
Query: 382 LTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417
++ EAKDLI LL D RL ++ + W +D
Sbjct: 243 VSQEAKDLIQGLLTVDPNKRL-K--MSGLRYNEWLQD 276
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 2e-67
Identities = 74/353 (20%), Positives = 140/353 (39%), Gaps = 72/353 (20%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
+ + +L IG G +V + IYA+K + E ++ R E L
Sbjct: 5 SVKGRIYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLN 62
Query: 162 EVASHC--IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAI 219
++ H I++LY +Y+Y++ME D+ + L +++++ + Y + A+
Sbjct: 63 KLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 121
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESM 279
+IH+H +H D+KP N L+ +G +KL DFG+ + +
Sbjct: 122 HTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN--------QMQPDTT---------- 162
Query: 280 DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL----------- 328
+ S VGT +Y+ PE +
Sbjct: 163 -----------------------------SVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 193
Query: 329 KKGYGMECDWWSLGAIMYEMLVGYPPFYS-DDPVTTCRKIVHWKNHLKFPEEARLTPEAK 387
K + D WSLG I+Y M G PF + ++ I+ + ++FP+ + +
Sbjct: 194 KSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI--PEKDLQ 251
Query: 388 DLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLD 439
D++ L D + R+ ++ ++ AHP+ + I + +M E+ VL
Sbjct: 252 DVLKCCLKRDPKQRI-SI--PELLAHPYVQ-IQTHPVNQMAKGTTEEMKYVLG 300
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 4e-67
Identities = 88/328 (26%), Positives = 146/328 (44%), Gaps = 73/328 (22%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA- 164
D++ + +G GA GEV+L E+K+ A++ + K + E A + E+
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALN-VETEIEI 193
Query: 165 ----SH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAI 219
+H CI+K+ F +Y Y+++E + GG++ ++ + L E + Y Q +LA+
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 252
Query: 220 ESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLN 276
+ +H++ IHRD+KP+N+LL +++ +K++DFG K + E ++
Sbjct: 253 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--------ILGETSLMRT---- 300
Query: 277 ESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL---LKKGYG 333
GTP Y+APEVL GY
Sbjct: 301 --------------------------------------LCGTPTYLAPEVLVSVGTAGYN 322
Query: 334 MECDWWSLGAIMYEMLVGYPPFYSDD-PVTTCRKIVHWKNHLKFPEE--ARLTPEAKDLI 390
D WSLG I++ L GYPPF V+ +I F E A ++ +A DL+
Sbjct: 323 RAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT--SGKYNFIPEVWAEVSEKALDLV 380
Query: 391 CRLLC-DVEHRLGTLGSEQIKAHPWFKD 417
+LL D + R T E+ HPW +D
Sbjct: 381 KKLLVVDPKARFTT---EEALRHPWLQD 405
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 5e-67
Identities = 99/377 (26%), Positives = 163/377 (43%), Gaps = 71/377 (18%)
Query: 77 PEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAM 136
E + DL+ ++ K+ +S + + + +G GA+GEV LC++K + A+
Sbjct: 9 SGRENLYFQGDLQATPGMFITSKKGHLS-EMYQRVKKLGSGAYGEVLLCRDKVTHVERAI 67
Query: 137 KKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMT 195
K ++K+ +S + E +L + H I+KLY F+D YL+ME GG++
Sbjct: 68 KIIRKTS-VSTSSNSKLLEEVAVLKLL-DHPNIMKLYDFFEDKRNYYLVMECYKGGELFD 125
Query: 196 LLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGL 252
++ E A I Q + + +HKHN +HRD+KP+NLLL +++ +K+ DFGL
Sbjct: 126 EIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGL 185
Query: 253 CKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLA 312
+ + +
Sbjct: 186 SA--------VFENQKKMKE---------------------------------------- 197
Query: 313 YSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKN 372
+GT YIAPEV L+K Y +CD WS+G I++ +L GYPPF RK+ K
Sbjct: 198 --RLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE--KG 252
Query: 373 HLKFPEE--ARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAA 429
F ++ AKDLI ++L D + R + ++Q HPW K+ +
Sbjct: 253 KYTFDSPEWKNVSEGAKDLIKQMLQFDSQRR---ISAQQALEHPWIKE---MCSKKESGI 306
Query: 430 YKPEVNGVLDTQNFMKF 446
P + + +N KF
Sbjct: 307 ELPSLANAI--ENMRKF 321
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 8e-67
Identities = 85/348 (24%), Positives = 154/348 (44%), Gaps = 70/348 (20%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
+ ++++ ++G+G+FGEV C+++ + YA+K + K+ ++ + E LL ++
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKL-D 79
Query: 166 H-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK 224
H I+KL+ +D+ Y++ E GG++ +++ + +E A I Q I +HK
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 225 HNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
HN +HRD+KP+N+LL +++ +K+ DFGL +N + D
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLST--------CFQQNTKMKD--------- 182
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341
+GT YIAPEV L+ Y +CD WS
Sbjct: 183 ---------------------------------RIGTAYYIAPEV-LRGTYDEKCDVWSA 208
Query: 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEE--ARLTPEAKDLICRLLC-DVE 398
G I+Y +L G PPFY + +++ F ++ +AKDLI ++L
Sbjct: 209 GVILYILLSGTPPFYGKNEYDILKRVE--TGKYAFDLPQWRTISDDAKDLIRKMLTFHPS 266
Query: 399 HRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKF 446
R + + Q HPW + + + + P + + N +F
Sbjct: 267 LR---ITATQCLEHPWIQKYSSETP---TISDLPSLESAM--TNIRQF 306
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 1e-66
Identities = 81/370 (21%), Positives = 160/370 (43%), Gaps = 66/370 (17%)
Query: 54 MKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTI 113
M+ S + K + + ++ ++ + + +K+ + D +D+L
Sbjct: 1 MRGSHHHHHHGSKVRGKYDGPKINDYDK-FYEDIWKKYVPQPVEVKQGSVY-DYYDILEE 58
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173
+G GAFG V C EK +G ++ K + L + V+ E +++ ++ ++ L+
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHHPKLINLHD 115
Query: 174 SFQDAEYLYLIMEYLPGGDVM-TLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDI 232
+F+D + LI+E+L GG++ + + ++E Y+ Q+ ++ +H+H+ +H DI
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDI 175
Query: 233 KPDNLLL--DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGC 290
KP+N++ + +K+ DFGL +N +E++
Sbjct: 176 KPENIMCETKKASSVKIIDFGLAT--------KLNPDEIVKV------------------ 209
Query: 291 GRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 350
T T ++ APE++ ++ G D W++G + Y +L
Sbjct: 210 ------------------------TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 245
Query: 351 GYPPFYSDDPVTTCRKIVHWKNHLKFPEEA--RLTPEAKDLICRLLC-DVEHRLGTLGSE 407
G PF +D + T + + + +F E+A ++PEAKD I LL + R L
Sbjct: 246 GLSPFAGEDDLETLQNVK--RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKR---LTVH 300
Query: 408 QIKAHPWFKD 417
HPW K
Sbjct: 301 DALEHPWLKG 310
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 2e-66
Identities = 103/384 (26%), Positives = 161/384 (41%), Gaps = 79/384 (20%)
Query: 79 EEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKK 138
+ + + Y+R K KI + + + +G GA+GEV LC+EK + A+K
Sbjct: 10 GRENLYFQGIAINPGMYVRKKEGKIG-ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKV 68
Query: 139 LKKSEMLSRGQVEHVRA----ERNLLAEVA-----SH-CIVKLYYSFQDAEYLYLIMEYL 188
+KKS+ + + + E++ H I+KL+ F+D +Y YL+ E+
Sbjct: 69 IKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFY 128
Query: 189 PGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHM 245
GG++ ++ E A + Q + I +HKHN +HRDIKP+N+LL + ++
Sbjct: 129 EGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNI 188
Query: 246 KLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQ 305
K+ DFGL +++ L D
Sbjct: 189 KIVDFGLSS--------FFSKDYKLRD--------------------------------- 207
Query: 306 INRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCR 365
+GT YIAPEV LKK Y +CD WS G IMY +L GYPPF + +
Sbjct: 208 ---------RLGTAYYIAPEV-LKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK 257
Query: 366 KIVHWKNHLKFPEE--ARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDK 422
K+ K F ++ EAK+LI +L D R +E+ W K A +
Sbjct: 258 KVE--KGKYYFDFNDWKNISDEAKELIKLMLTYDYNKR---CTAEEALNSRWIKKYANNI 312
Query: 423 LYEMEAAYKPEVNGVLDTQNFMKF 446
+ + + G L N KF
Sbjct: 313 ----NKSDQKTLCGAL--SNMRKF 330
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 5e-66
Identities = 83/437 (18%), Positives = 160/437 (36%), Gaps = 85/437 (19%)
Query: 38 RVAAAKQFIESHY-----KAQMKHIQERKQRRSVLERKLASSDVPEEEQIN----ILKDL 88
R+ A + +S + + +++R ++ + N +
Sbjct: 81 RIIAENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIW 140
Query: 89 ERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRG 148
++ + + +K + D +D+ +G GAFG V E+ +GN +A K +
Sbjct: 141 KQYYPQPVEIKHDHVL-DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---S 196
Query: 149 QVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVM-TLLMREETLTETV 207
E VR E ++ + +V L+ +F+D + +I E++ GG++ + ++E
Sbjct: 197 DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDE 256
Query: 208 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL--DQNGHMKLSDFGLCKPLDCTNLSAIN 265
A Y+ Q + +H++NY+H D+KP+N++ ++ +KL DFGL ++
Sbjct: 257 AVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA--------HLD 308
Query: 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPE 325
+ + T GT ++ APE
Sbjct: 309 PKQSVKV------------------------------------------TTGTAEFAAPE 326
Query: 326 VLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEA--RLT 383
V K G D WS+G + Y +L G PF ++ T R + + A ++
Sbjct: 327 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK--SCDWNMDDSAFSGIS 384
Query: 384 PEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQN 442
+ KD I +LL D R + Q HPW P + + +
Sbjct: 385 EDGKDFIRKLLLADPNTR---MTIHQALEHPWLTP-----------GNAPGRDSQIPSSR 430
Query: 443 FMKFDEVESQTPKRTGS 459
+ K +
Sbjct: 431 YTKIRDSIKTKYDAWPE 447
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 5e-66
Identities = 83/401 (20%), Positives = 153/401 (38%), Gaps = 85/401 (21%)
Query: 54 MKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTI 113
MK K R ++ +D ++ + + + K Y LK
Sbjct: 17 MKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILK-------------Q 63
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC--IVKL 171
IG G +V + IYA+K + E ++ R E L ++ H I++L
Sbjct: 64 IGSGGSSKVFQVL-NEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
Y +Y+Y++ME D+ + L +++++ + Y + A+ +IH+H +H D
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSD 180
Query: 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCG 291
+KP N L+ +G +KL DFG+ + + V D
Sbjct: 181 LKPANFLIV-DGMLKLIDFGIAN-----QMQPDTTSVVKD-------------------- 214
Query: 292 RRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----------KKGYGMECDWWS 340
S VG +Y+ PE + K + D WS
Sbjct: 215 ----------------------SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS 252
Query: 341 LGAIMYEMLVGYPPFYS-DDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVE 398
LG I+Y M G PF + ++ I+ + ++FP+ + +D++ L D +
Sbjct: 253 LGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI--PEKDLQDVLKCCLKRDPK 310
Query: 399 HRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLD 439
R+ ++ ++ AHP+ + I + +M E+ VL
Sbjct: 311 QRI-SI--PELLAHPYVQ-IQTHPVNQMAKGTTEEMKYVLG 347
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 2e-65
Identities = 73/318 (22%), Positives = 120/318 (37%), Gaps = 65/318 (20%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
+ + + +GRG FG V C E S Y K +K V+ E ++L
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARH 60
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVM-TLLMREETLTETVARFYIAQSVLAIESIHK 224
I+ L+ SF+ E L +I E++ G D+ + L E Y+ Q A++ +H
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 225 HNYIHRDIKPDNLLL--DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
HN H DI+P+N++ ++ +K+ +FG + + +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR--------QLKPGDNFRL---------- 162
Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342
P+Y APEV D WSLG
Sbjct: 163 --------------------------------LFTAPEYYAPEVHQHDVVSTATDMWSLG 190
Query: 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEA--RLTPEAKDLICRLLC-DVEH 399
++Y +L G PF ++ I+ F EEA ++ EA D + RLL + +
Sbjct: 191 TLVYVLLSGINPFLAETNQQIIENIM--NAEYTFDEEAFKEISIEAMDFVDRLLVKERKS 248
Query: 400 RLGTLGSEQIKAHPWFKD 417
R + + + HPW K
Sbjct: 249 R---MTASEALQHPWLKQ 263
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 2e-65
Identities = 82/374 (21%), Positives = 145/374 (38%), Gaps = 65/374 (17%)
Query: 51 KAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVD-DFD 109
++ +E + ER S ++I + + K+ ++
Sbjct: 33 RSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVS 92
Query: 110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
I+G G FG+V C+E +G A K +K M + E V+ E +++ ++ ++
Sbjct: 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHANLI 149
Query: 170 KLYYSFQDAEYLYLIMEYLPGGDVM-TLLMREETLTETVARFYIAQSVLAIESIHKHNYI 228
+LY +F+ + L+MEY+ GG++ ++ LTE ++ Q I +H+ +
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYIL 209
Query: 229 HRDIKPDNLLL--DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFP 286
H D+KP+N+L +K+ DFGL + E L
Sbjct: 210 HLDLKPENILCVNRDAKQIKIIDFGLAR--------RYKPREKLKV-------------- 247
Query: 287 ESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 346
GTP+++APEV+ D WS+G I Y
Sbjct: 248 ----------------------------NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAY 279
Query: 347 EMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEA--RLTPEAKDLICRLLC-DVEHRLGT 403
+L G PF D+ T I+ +E ++ EAK+ I +LL + R
Sbjct: 280 MLLSGLSPFLGDNDAETLNNIL--ACRWDLEDEEFQDISEEAKEFISKLLIKEKSWR--- 334
Query: 404 LGSEQIKAHPWFKD 417
+ + + HPW D
Sbjct: 335 ISASEALKHPWLSD 348
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-65
Identities = 86/339 (25%), Positives = 148/339 (43%), Gaps = 68/339 (20%)
Query: 89 ERKETEYMRLKRHKISVDDF-DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR 147
+Y ++ ++ DF ++ + +GRGA V C++K + YA+K LKK+
Sbjct: 35 ASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---- 90
Query: 148 GQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETV 207
+ VR E +L ++ I+KL F+ + L++E + GG++ ++ + +E
Sbjct: 91 -DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERD 149
Query: 208 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAI 264
A + Q + A+ +H++ +HRD+KP+NLL + +K++DFGL K ++
Sbjct: 150 AADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE------- 202
Query: 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAP 324
++ + GTP Y AP
Sbjct: 203 -HQVLM------------------------------------------KTVCGTPGYCAP 219
Query: 325 EVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD-DPVTTCRKIVHWKNHLKFPEE--AR 381
E+L YG E D WS+G I Y +L G+ PFY + R+I+ F
Sbjct: 220 EILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL--NCEYYFISPWWDE 277
Query: 382 LTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIA 419
++ AKDL+ +L+ D + RL T + Q HPW A
Sbjct: 278 VSLNAKDLVRKLIVLDPKKRL-T--TFQALQHPWVTGKA 313
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 3e-65
Identities = 77/335 (22%), Positives = 129/335 (38%), Gaps = 73/335 (21%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKL 171
++G GA V+ C + YA+K ++K R V E +L + H +++L
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRVFREVEMLYQCQGHRNVLEL 76
Query: 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRD 231
F++ + YL+ E + GG +++ + + E A + A++ +H HRD
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136
Query: 232 IKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPES 288
+KP+N+L +Q +K+ DF L + + L
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL------------------ 178
Query: 289 GCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-----KGYGMECDWWSLGA 343
+ G+ +Y+APEV+ Y CD WSLG
Sbjct: 179 ------------------------LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGV 214
Query: 344 IMYEMLVGYPPFYSDDPVTTCRKIVHW-------------KNHLKFPEE--ARLTPEAKD 388
I+Y +L GYPPF + +FP++ A ++ AKD
Sbjct: 215 ILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKD 274
Query: 389 LICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDK 422
LI +LL D + RL Q+ HPW + A +
Sbjct: 275 LISKLLVRDAKQRLSA---AQVLQHPWVQGCAPEN 306
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 3e-65
Identities = 79/332 (23%), Positives = 133/332 (40%), Gaps = 73/332 (21%)
Query: 98 LKRHKISV-DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAE 156
L R+ I D +++ IG G++ + C K + +A+K + KS+ E
Sbjct: 13 LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEE 65
Query: 157 RNLLAEVASHC-IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQS 215
+L H I+ L + D +Y+Y++ E + GG+++ ++R++ +E A +
Sbjct: 66 IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTI 125
Query: 216 VLAIESIHKHNYIHRDIKPDNLLL----DQNGHMKLSDFGLCKPLDCTNLSAINENEVLD 271
+E +H +HRD+KP N+L +++ DFG K L EN +L
Sbjct: 126 TKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-------AENGLLM 178
Query: 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331
T +++APEVL ++G
Sbjct: 179 T------------------------------------------PCYTANFVAPEVLERQG 196
Query: 332 YGMECDWWSLGAIMYEMLVGYPPFYS---DDPVTTCRKIVHWKNHLKFPEE--ARLTPEA 386
Y CD WSLG ++Y ML GY PF + D P +I ++ A
Sbjct: 197 YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG--SGKFSLSGGYWNSVSDTA 254
Query: 387 KDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417
KDL+ ++L D R L + + HPW
Sbjct: 255 KDLVSKMLHVDPHQR---LTAALVLRHPWIVH 283
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 2e-64
Identities = 82/324 (25%), Positives = 136/324 (41%), Gaps = 68/324 (20%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
+D+++L IG G++G + + K G I K+L M + + + + +E NLL E+
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKH 64
Query: 166 HCIVKLYYSFQDAE--YLYLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAI 219
IV+ Y D LY++MEY GGD+ +++ + + L E + Q LA+
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 220 ESIHKHNY-----IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDEN 274
+ H+ + +HRD+KP N+ LD ++KL DFGL + L+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-------------- 170
Query: 275 LNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM 334
A + VGTP Y++PE + + Y
Sbjct: 171 -----------------------------------SFAKTFVGTPYYMSPEQMNRMSYNE 195
Query: 335 ECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLL 394
+ D WSLG ++YE+ PPF + KI + P R + E ++I R+L
Sbjct: 196 KSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPY--RYSDELNEIITRML 252
Query: 395 C-DVEHRLGTLGSEQIKAHPWFKD 417
HR E+I +P +
Sbjct: 253 NLKDYHRPSV---EEILENPLILE 273
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 213 bits (543), Expect = 4e-64
Identities = 86/341 (25%), Positives = 136/341 (39%), Gaps = 84/341 (24%)
Query: 96 MRLKRHKISVDDFDLLT-IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
+++K++ I +DD+ + + ++G G G+V K++ +A+K L+ R
Sbjct: 52 LQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR------- 103
Query: 155 AERNLLAEVASH-CIVKLYYSFQDA----EYLYLIMEYLPGGDVMTLLMR-----EETLT 204
E L + IV++ +++ + L ++ME L GG+ L R ++ T
Sbjct: 104 -EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE---LFSRIQDRGDQAFT 159
Query: 205 ETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNL 261
E A + AI+ +H N HRD+KP+NLL N +KL+DFG K
Sbjct: 160 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK------- 212
Query: 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDY 321
+ L TP Y
Sbjct: 213 -ETTSHNSLTT------------------------------------------PCYTPYY 229
Query: 322 IAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVH--WKNHLKFPEE 379
+APEVL + Y CD WSLG IMY +L GYPPFYS+ + + +FP
Sbjct: 230 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289
Query: 380 --ARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417
+ ++ E K LI LL + R + + HPW
Sbjct: 290 EWSEVSEEVKMLIRNLLKTEPTQR---MTITEFMNHPWIMQ 327
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 1e-63
Identities = 87/347 (25%), Positives = 135/347 (38%), Gaps = 85/347 (24%)
Query: 90 RKETEYMRLKRHKISVDDFDLL-TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRG 148
+ K++ ++ DD+ L ++G G G+V C +++G A+K L S +
Sbjct: 13 EVLFQGPEPKKYAVT-DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ- 70
Query: 149 QVEHVRAERNLLAEVASH-CIVKLYYSFQDA----EYLYLIMEYLPGGDVMTLLMR---- 199
E + + + IV + +++ L +IME + GG+ L R
Sbjct: 71 -------EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGE---LFSRIQER 120
Query: 200 -EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKP 255
++ TE A + AI+ +H HN HRD+KP+NLL +++ +KL+DFG
Sbjct: 121 GDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG---- 176
Query: 256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYST 315
+ L +
Sbjct: 177 -----FAKETTQNAL------------------------------------------QTP 189
Query: 316 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVH--WKNH 373
TP Y+APEVL + Y CD WSLG IMY +L G+PPFYS+ +
Sbjct: 190 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ 249
Query: 374 LKFPEE--ARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417
FP + ++ +AK LI LL D RL Q HPW
Sbjct: 250 YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTI---TQFMNHPWINQ 293
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 4e-62
Identities = 68/332 (20%), Positives = 110/332 (33%), Gaps = 89/332 (26%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
DF + +IG G FG+V + + G Y +K++K + E E LA++
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDH 63
Query: 166 HCIVKLYYSFQDAE----------------YLYLIMEYLPGGDVMTLL--MREETLTETV 207
IV + + L++ ME+ G + + R E L + +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 208 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINEN 267
A Q ++ IH I+RD+KP N+ L +K+ DFGL L
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG------- 176
Query: 268 EVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL 327
+ GT Y++PE +
Sbjct: 177 -------------------------------------------KRTRSKGTLRYMSPEQI 193
Query: 328 LKKGYGMECDWWSLGAIMYEML-VGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEA 386
+ YG E D ++LG I+ E+L V F + T R + +
Sbjct: 194 SSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG-------IISD--IFDKKE 244
Query: 387 KDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417
K L+ +LL E R T +I
Sbjct: 245 KTLLQKLLSKKPEDRPNT---SEILRTLTVWK 273
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 6e-62
Identities = 45/413 (10%), Positives = 112/413 (27%), Gaps = 122/413 (29%)
Query: 51 KAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDL 110
Q + +S + +++S + + +L + +R
Sbjct: 31 IPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGT----------- 79
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAER------------- 157
++G+ ++++G + + +E ++ ++ E
Sbjct: 80 --VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 137
Query: 158 ------------NLLAEVASHCIVKLYYSFQD--AEYLYLIME------YLPGGDVMTLL 197
+L+ + ++++ +D + + G +++
Sbjct: 138 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 197
Query: 198 MREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
++L Q + + S+H + +H ++P +++LDQ G + L+ F
Sbjct: 198 STHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR-- 255
Query: 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG 317
DG S
Sbjct: 256 ------------------------DGARVVS-SV-------------------------- 264
Query: 318 TPDYIAPEVLL-----------KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRK 366
+ + PE+ + D W+LG ++Y + P D +
Sbjct: 265 SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEW 324
Query: 367 IVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418
I F + + L+ L E RL Q P ++ +
Sbjct: 325 I--------FRSCKNIPQPVRALLEGFLRYPKEDRLLP---LQAMETPEYEQL 366
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 5e-61
Identities = 71/357 (19%), Positives = 122/357 (34%), Gaps = 98/357 (27%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
S + L I+G+GA V + KK+G+++A+K L V+ E +L
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLK 62
Query: 162 EVASHCIVKLYYSFQD--AEYLYLIMEYLPGGDVMTLLM---REETLTETVARFYIAQSV 216
++ IVKL+ ++ + LIME+ P G + T+L L E+ + V
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 217 LAIESIHKHNYIHRDIKPDNLLL----DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDD 272
+ + ++ +HR+IKP N++ D KL+DFG + L+ DD
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-------------DD 169
Query: 273 ENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL----- 327
E S GT +Y+ P++
Sbjct: 170 EQFV-------------------------------------SLYGTEEYLHPDMYERAVL 192
Query: 328 ---LKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVH--------------- 369
+K YG D WS+G Y G PF + +++++
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQ 252
Query: 370 ------WKNHLKFPEEARLTPEAKD----LICRLLC-DVEHRLGTLGSEQIKAHPWF 415
P L+ + ++ +L D E G +Q A
Sbjct: 253 KAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF---DQFFAETSD 306
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 8e-61
Identities = 76/329 (23%), Positives = 125/329 (37%), Gaps = 75/329 (22%)
Query: 99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH-VRAER 157
K + ++ L ++G+G FG V A+K + ++ +L + V
Sbjct: 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83
Query: 158 -----NLLAEVASH-CIVKLYYSFQDAEYLYLIMEY-LPGGDVMTLLMREETLTETVARF 210
+ H +++L F+ E L++E LP D+ + + L E +R
Sbjct: 84 EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC 143
Query: 211 YIAQSVLAIESIHKHNYIHRDIKPDNLLLD-QNGHMKLSDFGLCKPLDCTNLSAINENEV 269
+ Q V AI+ H +HRDIK +N+L+D + G KL DFG A+ +E
Sbjct: 144 FFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG---------SGALLHDEP 194
Query: 270 LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK 329
D GT Y PE + +
Sbjct: 195 YTD------------------------------------------FDGTRVYSPPEWISR 212
Query: 330 KGY-GMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKD 388
Y + WSLG ++Y+M+ G PF D ++I+ + L FP ++P+
Sbjct: 213 HQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAE--LHFPA--HVSPDCCA 262
Query: 389 LICRLLC-DVEHRLGTLGSEQIKAHPWFK 416
LI R L R +L E+I PW +
Sbjct: 263 LIRRCLAPKPSSRP-SL--EEILLDPWMQ 288
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 1e-60
Identities = 71/297 (23%), Positives = 120/297 (40%), Gaps = 57/297 (19%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
++ +F + IGRG F EV G A+KK++ +++ E +LL ++
Sbjct: 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 89
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL----MREETLTETVARFYIAQSVLAI 219
++K Y SF + L +++E GD+ ++ ++ + E Y Q A+
Sbjct: 90 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESM 279
E +H +HRDIKP N+ + G +KL D GL +
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT------------------- 190
Query: 280 DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339
A+S VGTP Y++PE + + GY + D W
Sbjct: 191 ------------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIW 220
Query: 340 SLGAIMYEMLVGYPPFYSDD--PVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLL 394
SLG ++YEM PFY D + C+KI ++ P + + E + L+ +
Sbjct: 221 SLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDYPPLPSD-HYSEELRQLVNMCI 275
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 1e-60
Identities = 92/347 (26%), Positives = 144/347 (41%), Gaps = 84/347 (24%)
Query: 99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
+ ++ + L IG+G++G V+L + YAMK L K +++ + R
Sbjct: 6 SGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRG 65
Query: 159 LLA-----------------EVA-----SH-CIVKLYYSFQDAE--YLYLIMEYLPGGDV 193
E+A H +VKL D +LY++ E + G V
Sbjct: 66 TRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV 125
Query: 194 MTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253
M + + L+E ARFY + IE +H IHRDIKP NLL+ ++GH+K++DFG+
Sbjct: 126 MEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAY 313
NE D L
Sbjct: 185 ----------------------NEFKGSDA---------------------------LLS 195
Query: 314 STVGTPDYIAPEVL--LKKGY-GMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHW 370
+TVGTP ++APE L +K + G D W++G +Y + G PF + + KI
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIK-- 253
Query: 371 KNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFK 416
L+FP++ + + KDLI R+L + E R+ + +IK HPW
Sbjct: 254 SQALEFPDQPDIAEDLKDLITRMLDKNPESRI-VV--PEIKLHPWVT 297
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 5e-60
Identities = 86/320 (26%), Positives = 140/320 (43%), Gaps = 59/320 (18%)
Query: 99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
++ + + L +G G FG+V++ + + +G+ A+K L + ++ S V ++ E
Sbjct: 4 HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQ 63
Query: 159 LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLA 218
L I+KLY +++MEY+ GG++ + + + E AR Q + A
Sbjct: 64 NLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA 123
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
++ H+H +HRD+KP+N+LLD + + K++DFGL N + D E L S
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS-------------NMMSDGEFLRTS 170
Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECD 337
C G+P+Y APEV+ + Y G E D
Sbjct: 171 -----------C--------------------------GSPNYAAPEVISGRLYAGPEVD 193
Query: 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-D 396
WS G I+Y +L G PF + T +KI PE L L+ +L D
Sbjct: 194 IWSCGVILYALLCGTLPFDDEHVPTLFKKIR--GGVFYIPEY--LNRSVATLLMHMLQVD 249
Query: 397 VEHRLGTLGSEQIKAHPWFK 416
R T+ + I+ H WFK
Sbjct: 250 PLKRA-TI--KDIREHEWFK 266
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 1e-59
Identities = 69/330 (20%), Positives = 119/330 (36%), Gaps = 65/330 (19%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
DF+ + +GRG FG V + K YA+K+++ E V E LA++
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL--AREKVMREVKALAKLEH 62
Query: 166 HCIVKLYYSFQD------------AEYLYLIMEYLPGGDVMTLLMREETLT---ETVARF 210
IV+ + ++ + YLY+ M+ ++ + T+ +V
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 211 YIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270
Q A+E +H +HRD+KP N+ + +K+ DFGL +D +
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK 330
VGT Y++PE +
Sbjct: 183 AYARH-------------------------------------TGQVGTKLYMSPEQIHGN 205
Query: 331 GYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEE-ARLTPEAKDL 389
Y + D +SLG I++E+L YP + V T + +LKFP + P +
Sbjct: 206 SYSHKVDIFSLGLILFELL--YPFSTQMERVRTLTDV----RNLKFPPLFTQKYPCEYVM 259
Query: 390 ICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418
+ +L R I + F+D+
Sbjct: 260 VQDMLSPSPMERPEA---INIIENAVFEDL 286
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 2e-59
Identities = 73/317 (23%), Positives = 130/317 (41%), Gaps = 61/317 (19%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
V+D+DL+ +G GA+GEV+L + + A+K + + E+++ E + +
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK 224
+VK Y ++ YL +EY GG++ + + + E A+ + Q + + +H
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
HRDIKP+NLLLD+ ++K+SDFG L+ +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFG---------LATVFR------------------ 156
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGA 343
NR +L GT Y+APE+L ++ + D WS G
Sbjct: 157 --------------------YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 196
Query: 344 IMYEMLVGYPPFYSDDPVTTC---RKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEH 399
++ ML G P+ D P +C + ++ L+ ++L +
Sbjct: 197 VLTAMLAGELPW--DQPSDSCQEYSDWK--EKKTYLNPWKKIDSAPLALLHKILVENPSA 252
Query: 400 RLGTLGSEQIKAHPWFK 416
R+ T+ IK W+
Sbjct: 253 RI-TI--PDIKKDRWYN 266
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 2e-58
Identities = 86/324 (26%), Positives = 129/324 (39%), Gaps = 63/324 (19%)
Query: 99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
D +D + IG G FG RL ++K + + A+K +++ + E+V+ E
Sbjct: 13 MPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREII 68
Query: 159 LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLA 218
+ IV+ +L +IMEY GG++ + +E ARF+ Q +
Sbjct: 69 NHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSG 128
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHM--KLSDFGLCKPLDCTNLSAINENEVLDDENLN 276
+ H HRD+K +N LLD + K+ DFG K
Sbjct: 129 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK---------------------- 166
Query: 277 ESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GME 335
V P+S GTP YIAPEVLL++ Y G
Sbjct: 167 --SSVLHSQPKSTV--------------------------GTPAYIAPEVLLRQEYDGKI 198
Query: 336 CDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHW--KNHLKFPEEARLTPEAKDLICRL 393
D WS G +Y MLVG PF + RK + P++ R++PE LI R+
Sbjct: 199 ADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRI 258
Query: 394 LC-DVEHRLGTLGSEQIKAHPWFK 416
D R+ ++ +IK H WF
Sbjct: 259 FVADPATRI-SI--PEIKTHSWFL 279
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 2e-58
Identities = 74/325 (22%), Positives = 125/325 (38%), Gaps = 71/325 (21%)
Query: 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE-----HVR 154
+ ++ +G GAFG V +K+ +K +KK ++L +E V
Sbjct: 18 CEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVT 77
Query: 155 AERNLLAEVASHCIVKLYYSFQDAEYLYLIME-YLPGGDVMTLLMREETLTETVARFYIA 213
E +L+ V I+K+ F++ + L+ME + G D+ + R L E +A +
Sbjct: 78 LEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR 137
Query: 214 QSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDE 273
Q V A+ + + IHRDIK +N+++ ++ +KL DFG + +
Sbjct: 138 QLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA-------------AYLERGK 184
Query: 274 NLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY- 332
+ GT +Y APEVL+ Y
Sbjct: 185 LFY-------------------------------------TFCGTIEYCAPEVLMGNPYR 207
Query: 333 GMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICR 392
G E + WSLG +Y ++ PF + V + + P ++ E L+
Sbjct: 208 GPELEMWSLGVTLYTLVFEENPFCEL------EETV--EAAIHPPYL--VSKELMSLVSG 257
Query: 393 LLC-DVEHRLGTLGSEQIKAHPWFK 416
LL E R TL E++ PW
Sbjct: 258 LLQPVPERRT-TL--EKLVTDPWVT 279
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 3e-58
Identities = 81/338 (23%), Positives = 133/338 (39%), Gaps = 73/338 (21%)
Query: 89 ERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRG 148
+ T+ K + + + ++G G FG V A+K ++K + G
Sbjct: 26 DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 85
Query: 149 QVEH---VRAERNLLAEVASHC--IVKLYYSFQDAEYLYLIMEY-LPGGDVMTLLMREET 202
++ + V E LL +V+S +++L F+ + LI+E P D+ +
Sbjct: 86 ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 145
Query: 203 LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPLDCTNL 261
L E +AR + Q + A+ H +HRDIK +N+L+D N G +KL DFG
Sbjct: 146 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG---------S 196
Query: 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDY 321
A+ ++ V D GT Y
Sbjct: 197 GALLKDTVYTD------------------------------------------FDGTRVY 214
Query: 322 IAPEVLLKKGY-GMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEA 380
PE + Y G WSLG ++Y+M+ G PF D +I+ + + F +
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQ--VFFRQ-- 264
Query: 381 RLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417
R++ E + LI L R T E+I+ HPW +D
Sbjct: 265 RVSSECQHLIRWCLALRPSDRP-TF--EEIQNHPWMQD 299
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 197 bits (501), Expect = 6e-58
Identities = 44/386 (11%), Positives = 98/386 (25%), Gaps = 103/386 (26%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH------ 166
++G+ ++++G + + +E ++ ++ E L +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 167 ----------------CIVKLYYSFQDAEYLYLIMEYLP-----------GGDVMTLLMR 199
K+ D ++++ + G +++
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 200 EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259
++L Q + + S+H + +H ++P +++LDQ G + L+ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-- 262
Query: 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTP 319
G P
Sbjct: 263 ----------------------ASAVSPIG------------------------RGFAPP 276
Query: 320 DYIAPEVLL-----KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL 374
+ A +L D W+LG +Y + P D + I
Sbjct: 277 ETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI------- 329
Query: 375 KFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPE 433
F + + L+ L E RL Q P ++ + +A P
Sbjct: 330 -FRSCKNIPQPVRALLEGFLRYPKEDRLLP---LQAMETPEYEQLR-----TELSAALPL 380
Query: 434 VNGVLDTQNFMKFDEVESQTPKRTGS 459
+ + P G+
Sbjct: 381 YQTDGEPTREGGAPPSGTSQPDEAGA 406
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 7e-58
Identities = 73/317 (23%), Positives = 130/317 (41%), Gaps = 61/317 (19%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
V+D+DL+ +G GA+GEV+L + + A+K + + E+++ E + +
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK 224
+VK Y ++ YL +EY GG++ + + + E A+ + Q + + +H
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
HRDIKP+NLLLD+ ++K+SDFG L+ +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFG---------LATVFR------------------ 156
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGA 343
NR +L GT Y+APE+L ++ + D WS G
Sbjct: 157 --------------------YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 196
Query: 344 IMYEMLVGYPPFYSDDPVTTC---RKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEH 399
++ ML G P+ D P +C + ++ L+ ++L +
Sbjct: 197 VLTAMLAGELPW--DQPSDSCQEYSDWK--EKKTYLNPWKKIDSAPLALLHKILVENPSA 252
Query: 400 RLGTLGSEQIKAHPWFK 416
R+ T+ IK W+
Sbjct: 253 RI-TI--PDIKKDRWYN 266
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 9e-58
Identities = 72/356 (20%), Positives = 122/356 (34%), Gaps = 98/356 (27%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
S + L I+G+GA V + KK+G+++A+K L V+ E +L
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLK 62
Query: 162 EVASHCIVKLYYSFQD--AEYLYLIMEYLPGGDVMTLLM---REETLTETVARFYIAQSV 216
++ IVKL+ ++ + LIME+ P G + T+L L E+ + V
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 217 LAIESIHKHNYIHRDIKPDNLLL----DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDD 272
+ + ++ +HR+IKP N++ D KL+DFG + L+ DD
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-------------DD 169
Query: 273 ENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL----- 327
E S GT +Y+ P++
Sbjct: 170 EQFV-------------------------------------SLYGTEEYLHPDMYERAVL 192
Query: 328 ---LKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVH--------------- 369
+K YG D WS+G Y G PF + +++++
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQ 252
Query: 370 ------WKNHLKFPEEARLTPEAKDLICRLL-----CDVEHRLGTLGSEQIKAHPW 414
P L+ + L+ +L D E G +Q A
Sbjct: 253 KAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF---DQFFAETS 305
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 3e-57
Identities = 62/322 (19%), Positives = 104/322 (32%), Gaps = 61/322 (18%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
+ + +G G F V L + G+ YA+K++ E R E + E ++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR---EEAQREADMHRLFNHP 86
Query: 167 CIVKLYYSFQDAE----YLYLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLA 218
I++L +L++ + G + + R LTE + +
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
+E+IH Y HRD+KP N+LL G L D G +
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGS--------------- 191
Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY---GME 335
LQ W + T Y APE+ + +
Sbjct: 192 -----------------RQALTLQDW--------AAQRCTISYRAPELFSVQSHCVIDER 226
Query: 336 CDWWSLGAIMYEMLVGYPPF-YSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLL 394
D WSLG ++Y M+ G P+ + V N L P+ R + L+ ++
Sbjct: 227 TDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ--NQLSIPQSPRHSSALWQLLNSMM 284
Query: 395 C-DVEHRLGTLGSEQIKAHPWF 415
D R + +
Sbjct: 285 TVDPHQRPHI---PLLLSQLEA 303
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 4e-56
Identities = 87/320 (27%), Positives = 141/320 (44%), Gaps = 59/320 (18%)
Query: 99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
++ + + L +G G FG+V++ + + +G+ A+K L + ++ S V +R E
Sbjct: 9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQ 68
Query: 159 LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLA 218
L I+KLY ++++MEY+ GG++ + + L E +R Q +
Sbjct: 69 NLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSG 128
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
++ H+H +HRD+KP+N+LLD + + K++DFGL N + D E L S
Sbjct: 129 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS-------------NMMSDGEFLRTS 175
Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECD 337
C G+P+Y APEV+ + Y G E D
Sbjct: 176 -----------C--------------------------GSPNYAAPEVISGRLYAGPEVD 198
Query: 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-D 396
WS G I+Y +L G PF D T +KI P+ L P L+ +L D
Sbjct: 199 IWSSGVILYALLCGTLPFDDDHVPTLFKKIC--DGIFYTPQY--LNPSVISLLKHMLQVD 254
Query: 397 VEHRLGTLGSEQIKAHPWFK 416
R T+ + I+ H WFK
Sbjct: 255 PMKRA-TI--KDIREHEWFK 271
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 6e-56
Identities = 50/401 (12%), Positives = 96/401 (23%), Gaps = 108/401 (26%)
Query: 58 QERKQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRG 117
+E + + + + ++ P+ + + L + E + ++ + G
Sbjct: 27 EEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVE-------------PLRVG 73
Query: 118 AFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY----- 172
V L ++ + +A+K SR ++E + A + +
Sbjct: 74 DRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRL 133
Query: 173 ---------------------YSFQDAEYLYLIMEYLPG--GDVMTLLMR----EETLTE 205
L+M + + L
Sbjct: 134 LLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGI 193
Query: 206 TVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265
AQ + ++ +H PDNL + +G + L D +
Sbjct: 194 LALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-------- 245
Query: 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPE 325
++ Y E
Sbjct: 246 --------------------------------------------TRGPASSVPVTYAPRE 261
Query: 326 VLLKKG--YGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKI-----VHWKNHLKFPE 378
L + + W LG +Y + + PF P V + L F
Sbjct: 262 FLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGS 321
Query: 379 EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418
L K LI R L D R L + P F +
Sbjct: 322 CTPLPDFVKTLIGRFLNFDRRRR---LLPLEAMETPEFLQL 359
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 6e-56
Identities = 84/317 (26%), Positives = 138/317 (43%), Gaps = 60/317 (18%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
+ + ++ LL IG+G F +V+L + +G A+K + K++ L+ ++ + E ++
Sbjct: 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFREVRIMK 69
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES 221
+ IVKL+ + + LYLIMEY GG+V L+ + E AR Q V A++
Sbjct: 70 ILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQY 129
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
H+ +HRD+K +NLLLD + ++K++DFG NE L+
Sbjct: 130 CHQKRIVHRDLKAENLLLDADMNIKIADFGFS-------------NEFTVGGKLDAF--- 173
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDWWS 340
C G P Y APE+ K Y G E D WS
Sbjct: 174 --------C--------------------------GAPPYAAPELFQGKKYDGPEVDVWS 199
Query: 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEH 399
LG I+Y ++ G PF + +++ K+ ++ + ++L+ R L +
Sbjct: 200 LGVILYTLVSGSLPFDGQNLKELRERVL----RGKYRIPFYMSTDCENLLKRFLVLNPIK 255
Query: 400 RLGTLGSEQIKAHPWFK 416
R TL EQI W
Sbjct: 256 RG-TL--EQIMKDRWIN 269
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 1e-55
Identities = 88/321 (27%), Positives = 144/321 (44%), Gaps = 60/321 (18%)
Query: 98 LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAER 157
+ K + + + +G G+FG+V+L K+ A+K + + + V E
Sbjct: 1 MAISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREI 60
Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL 217
+ L + I+KLY + +++EY GG++ ++ ++ +TE R + Q +
Sbjct: 61 SYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIIC 119
Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNE 277
AIE H+H +HRD+KP+NLLLD N ++K++DFGL N + D L
Sbjct: 120 AIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS-------------NIMTDGNFLKT 166
Query: 278 SMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMEC 336
S C G+P+Y APEV+ K Y G E
Sbjct: 167 S-----------C--------------------------GSPNYAAPEVINGKLYAGPEV 189
Query: 337 DWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC- 395
D WS G ++Y MLVG PF + +K+ P+ L+P A+ LI R++
Sbjct: 190 DVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN--SCVYVMPDF--LSPGAQSLIRRMIVA 245
Query: 396 DVEHRLGTLGSEQIKAHPWFK 416
D R+ T+ ++I+ PWF
Sbjct: 246 DPMQRI-TI--QEIRRDPWFN 263
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 4e-55
Identities = 51/344 (14%), Positives = 102/344 (29%), Gaps = 80/344 (23%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAE 156
++ + ++G GAF +V + K+ + +K K + +
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQL 117
Query: 157 RNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR-----EETLTETVARFY 211
L H +K Y + L+ E G ++ + E+ + + + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 212 IAQSVLAIESIHKHNYIHRDIKPDNLLL-----------DQNGHMKLSDFGLCKPLDCTN 260
+ + IE +H IH DIKPDN +L D + + L D G +
Sbjct: 178 AMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI-----D 232
Query: 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPD 320
+ + + + T
Sbjct: 233 MKLFPKGTIF------------------------------------------TAKCETSG 250
Query: 321 YIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEA 380
+ E+L K + + D++ + A +Y ML G ++ K F
Sbjct: 251 FQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG-------GECKPEGLFRRLP 303
Query: 381 RLTPEAKDLICRLL-CDVEHRLGTLGSEQIKAHPWFKDIAWDKL 423
+ +L H L +L + K F+ +K+
Sbjct: 304 H-LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKI 346
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 8e-55
Identities = 70/348 (20%), Positives = 114/348 (32%), Gaps = 88/348 (25%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
+ +++ +G G FG V + +G A+K+ ++ LS E E ++ ++
Sbjct: 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKL 69
Query: 164 ASHCIVKLYYSFQDAEYL------YLIMEYLPGGDVMTLLMREET---LTETVARFYIAQ 214
+V + L L MEY GGD+ L + E L E R ++
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129
Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGH---MKLSDFGLCKPLDCTNLSAINENEVLD 271
A+ +H++ IHRD+KP+N++L K+ D G K LD
Sbjct: 130 ISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-------------Q 176
Query: 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331
E VGT Y+APE+L +K
Sbjct: 177 GELCT-------------------------------------EFVGTLQYLAPELLEQKK 199
Query: 332 YGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIV----------------HWKNHLK 375
Y + D+WS G + +E + G+ PF + V K
Sbjct: 200 YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSV 259
Query: 376 FPEEARLTPEAKDLICRLL-----CDVEHRLGTLGSEQIKAHPWFKDI 418
P L+ + R L R Q F+ +
Sbjct: 260 LPTPNHLSGILAGKLERWLQCMLMWHQRQR---GTDPQNPNVGCFQAL 304
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 4e-54
Identities = 68/342 (19%), Positives = 114/342 (33%), Gaps = 85/342 (24%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
+ I+G G+ G V G A+K++ + E LL E
Sbjct: 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFC------DIALMEIKLLTESDD 67
Query: 166 H-CIVKLYYSFQDAEYLYLIMEYLPGG--DVM----TLLMREETLTETVARFYIAQSVLA 218
H +++ Y S +LY+ +E D++ + E + Q
Sbjct: 68 HPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 219 IESIHKHNYIHRDIKPDNLLLD-------------QNGHMKLSDFGLCKPLDCTNLSAIN 265
+ +H IHRD+KP N+L+ +N + +SDFGLCK
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK----------- 176
Query: 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPE 325
+L Q + R + GT + APE
Sbjct: 177 ----------------------------------KLDSGQSSFRTNLNNPSGTSGWRAPE 202
Query: 326 VLL-------KKGYGMECDWWSLGAIMYEMLV-GYPPFYSD-DPVTTCRKIVHWKNHLKF 376
+L K+ D +S+G + Y +L G PF + + + + +K
Sbjct: 203 LLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKC 262
Query: 377 PEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417
+ L EA DLI +++ D R ++ HP F
Sbjct: 263 LHDRSLIAEATDLISQMIDHDPLKRPTA---MKVLRHPLFWP 301
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 5e-54
Identities = 59/330 (17%), Positives = 109/330 (33%), Gaps = 70/330 (21%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
+ F ++G GA G + + + A+K++ E LL
Sbjct: 20 IVGKISFCPKDVLGHGAEGTI-VYRGMFDNRDVAVKRILPE------CFSFADREVQLLR 72
Query: 162 EVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIE 220
E H +++ + + +D ++ Y+ +E + ++ + Q+ +
Sbjct: 73 ESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLA 132
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGH-----MKLSDFGLCKPLDCTNLSAINENEVLDDENL 275
+H N +HRD+KP N+L+ +SDFGLCK L +
Sbjct: 133 HLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA-------------VGRHS 179
Query: 276 NESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL---LKKGY 332
GT +IAPE+L K+
Sbjct: 180 FSRR---------------------------------SGVPGTEGWIAPEMLSEDCKENP 206
Query: 333 GMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPE-EARLTPEAKDLI 390
D +S G + Y ++ G PF I+ L E A++LI
Sbjct: 207 TYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA--NILLGACSLDCLHPEKHEDVIARELI 264
Query: 391 CRLLC-DVEHRLGTLGSEQIKAHPWFKDIA 419
+++ D + R + + HP+F +
Sbjct: 265 EKMIAMDPQKRPSA---KHVLKHPFFWSLE 291
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-53
Identities = 69/310 (22%), Positives = 120/310 (38%), Gaps = 61/310 (19%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVE-HVRAERNLLAEVASHCIVKLY 172
+G G++G+V+ + ++ A+K LKK ++ E +V+ E LL + +++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 173 --YSFQDAEYLYLIMEYLPGGDV-MTLLMREETLTETVARFYIAQSVLAIESIHKHNYIH 229
++ + +Y++MEY G M + E+ A Y Q + +E +H +H
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVH 132
Query: 230 RDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESG 289
+DIKP NLLL G +K+S G ++ DD +
Sbjct: 133 KDIKPGNLLLTTGGTLKISALG---------VAEALHPFAADD------------TCRTS 171
Query: 290 CGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGY-GMECDWWSLGAIMYE 347
G+P + PE+ + G + D WS G +Y
Sbjct: 172 Q--------------------------GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYN 205
Query: 348 MLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGS 406
+ G PF D+ I K P + P DL+ +L + R ++
Sbjct: 206 ITTGLYPFEGDNIYKLFENIG--KGSYAIPGD--CGPPLSDLLKGMLEYEPAKRF-SI-- 258
Query: 407 EQIKAHPWFK 416
QI+ H WF+
Sbjct: 259 RQIRQHSWFR 268
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 2e-52
Identities = 75/330 (22%), Positives = 125/330 (37%), Gaps = 61/330 (18%)
Query: 73 SSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGN 132
+ + E + + + L+ + EY + V +GRG+FGEV ++K++G
Sbjct: 31 GPETEDNEGVLLTEKLKPVDYEY------REEVHWMTHQPRVGRGSFGEVHRMKDKQTGF 84
Query: 133 IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGD 192
A+KK++ E A ++S IV LY + ++ ++ + ME L GG
Sbjct: 85 QCAVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136
Query: 193 VMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG-HMKLSDFG 251
+ L+ + L E A +Y+ Q++ +E +H +H D+K DN+LL +G L DFG
Sbjct: 137 LGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFG 196
Query: 252 LCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKL 311
L + L +S+
Sbjct: 197 HAL--------------CLQPDGLGKSLLTGDYI-------------------------- 216
Query: 312 AYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWK 371
GT ++APEV++ K + D WS +M ML G P+ C KI +
Sbjct: 217 ----PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS-E 271
Query: 372 NHLKFPEEARLTPEAKDLICR-LLCDVEHR 400
P I L + HR
Sbjct: 272 PPPIREIPPSCAPLTAQAIQEGLRKEPVHR 301
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-51
Identities = 61/323 (18%), Positives = 111/323 (34%), Gaps = 53/323 (16%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
+F L IG G FG V C ++ G IYA+K+ KK S + +R E A +
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR-EVYAHAVLGQ 69
Query: 166 H-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL----MREETLTETVARFYIAQSVLAIE 220
H +V+ + ++ + +++ + EY GG + + E + + Q +
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
IH + +H DIKP N+ + + + E +D+ + +
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASE-----------------EGDEDDWASNKVM 172
Query: 281 VD-GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECDW 338
G G R SP G ++A EVL + + D
Sbjct: 173 FKIGDL---GHVTRISSP---------------QVEEGDSRFLANEVLQENYTHLPKADI 214
Query: 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DV 397
++L + P + D +I + L L+ E +L+ ++ D
Sbjct: 215 FALALTVVCAAGAEPLPRNGDQW---HEIR--QGRLP-RIPQVLSQEFTELLKVMIHPDP 268
Query: 398 EHRLGTLGSEQIKAHPWFKDIAW 420
E R + H +
Sbjct: 269 ERRPSA---MALVKHSVLLSASR 288
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-45
Identities = 80/319 (25%), Positives = 129/319 (40%), Gaps = 73/319 (22%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMK--KLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK 170
++G+G +G V ++ + A+K + S + + E L + IV+
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY-----SQPLHEEIALHKHLKHKNIVQ 83
Query: 171 LYYSFQDAEYLYLIMEYLPGGDVMTLLMREE---TLTETVARFYIAQSVLAIESIHKHNY 227
SF + ++ + ME +PGG + LL + E FY Q + ++ +H +
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 228 IHRDIKPDNLLLDQ-NGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFP 286
+HRDIK DN+L++ +G +K+SDFG K L N E+
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-------------PCTETF------- 183
Query: 287 ESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAI 344
GT Y+APE++ K +GYG D WSLG
Sbjct: 184 -----------------------------TGTLQYMAPEIIDKGPRGYGKAADIWSLGCT 214
Query: 345 MYEMLVGYPPFYS-DDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC---DVEHR 400
+ EM G PPFY +P K+ +K H + PE ++ EAK I L C D + R
Sbjct: 215 IIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPES--MSAEAKAFI--LKCFEPDPDKR 270
Query: 401 LGTLGSEQIKAHPWFKDIA 419
+ + + K +
Sbjct: 271 ---ACANDLLVDEFLKVSS 286
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 6e-44
Identities = 84/317 (26%), Positives = 141/317 (44%), Gaps = 65/317 (20%)
Query: 92 ETEYMRLKRHKISVDD----FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR 147
++ R + D D IG G+ G V L +EK SG A+K + ++ +
Sbjct: 27 HEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQ 83
Query: 148 GQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETV 207
+ E + E ++ + +V++Y S+ E L+++ME+L GG + T ++ + L E
Sbjct: 84 QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGAL-TDIVSQVRLNEEQ 142
Query: 208 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINEN 267
+ A+ +H IHRDIK D++LL +G +KLSDFG C +
Sbjct: 143 IATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD-------- 194
Query: 268 EVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL 327
+ +RK S VGTP ++APEV+
Sbjct: 195 --------------------------------------VPKRK---SLVGTPYWMAPEVI 213
Query: 328 LKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKN---HLKFPEEARLTP 384
+ Y E D WSLG ++ EM+ G PP++SD PV +++ + LK +++P
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR--DSPPPKLKNSH--KVSP 269
Query: 385 EAKDLICRLLC-DVEHR 400
+D + R+L D + R
Sbjct: 270 VLRDFLERMLVRDPQER 286
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 7e-44
Identities = 64/318 (20%), Positives = 110/318 (34%), Gaps = 66/318 (20%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKLY 172
+ G F V Q+ SG YA+K+L +E + E + +++ H IV+
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN---RAIIQEVCFMKKLSGHPNIVQFC 92
Query: 173 YSF-------QDAEYLYLIMEYLPGGDVMTLLMREET---LTETVARFYIAQSVLAIESI 222
+ + +L++ L G ++ L + E+ L+ Q+ A++ +
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 223 HKHN--YIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
H+ IHRD+K +NLLL G +KL DFG +
Sbjct: 153 HRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS----------------------- 189
Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL---LKKGYGMECD 337
P + + + TP Y PE++ G + D
Sbjct: 190 --------------HYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQD 235
Query: 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-D 396
W+LG I+Y + PF + +IV+ K P LI +L +
Sbjct: 236 IWALGCILYLLCFRQHPFEDGAKL----RIVNGK--YSIPPHDTQYTVFHSLIRAMLQVN 289
Query: 397 VEHRLGTLGSEQIKAHPW 414
E RL ++
Sbjct: 290 PEERLSI---AEVVHQLQ 304
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 6e-43
Identities = 79/316 (25%), Positives = 132/316 (41%), Gaps = 61/316 (19%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
+ F L IG+G+FGEV + ++ + A+K + E + ++E ++ E +L++ S
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDS 79
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
+ K Y S+ L++IMEYL GG + L + L ET + + + ++ +H
Sbjct: 80 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLDYLHSE 138
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
IHRDIK N+LL ++G +KL+DFG+ L T
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-------------------------- 172
Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345
+R + VGTP ++APEV+ + Y + D WSLG
Sbjct: 173 --------------------QIKRN---TFVGTPFWMAPEVIKQSAYDSKADIWSLGITA 209
Query: 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPE-EARLTPEAKDLICRLLC-DVEHRLGT 403
E+ G PP P+ I KN P E + K+ + L + R
Sbjct: 210 IELARGEPPHSELHPMKVLFLIP--KN--NPPTLEGNYSKPLKEFVEACLNKEPSFR--- 262
Query: 404 LGSEQIKAHPWFKDIA 419
++++ H + A
Sbjct: 263 PTAKELLKHKFILRNA 278
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 8e-43
Identities = 60/313 (19%), Positives = 119/313 (38%), Gaps = 65/313 (20%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY 172
IGRG+F V + ++ A +L+ + L++ + + + E +L + IV+ Y
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRK-LTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 173 YSFQDA----EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY- 227
S++ + + L+ E + G + T L R + + V R + Q + ++ +H
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151
Query: 228 -IHRDIKPDNLLLD-QNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
IHRD+K DN+ + G +K+ D GL
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLAT------------------------------- 180
Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345
+ R A + +GTP+++APE+ ++ Y D ++ G M
Sbjct: 181 --------------------LKRASFAKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCM 219
Query: 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL 404
EM P+ + V ++ PE K++I + + + R
Sbjct: 220 LEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV-AIPEVKEIIEGCIRQNKDERYSI- 277
Query: 405 GSEQIKAHPWFKD 417
+ + H +F++
Sbjct: 278 --KDLLNHAFFQE 288
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 8e-43
Identities = 87/321 (27%), Positives = 144/321 (44%), Gaps = 73/321 (22%)
Query: 92 ETEYMRLKRHKISVDD----FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR 147
+ E + R +SV D + IG+GA G V + +G A++++ + +
Sbjct: 2 DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQ 58
Query: 148 GQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETV 207
+ E + E ++ E + IV S+ + L+++MEYL GG + T ++ E + E
Sbjct: 59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEG- 116
Query: 208 ARFYIA----QSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
IA + + A+E +H + IHRDIK DN+LL +G +KL+DFG C +
Sbjct: 117 ---QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---- 169
Query: 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIA 323
++R + VGTP ++A
Sbjct: 170 ------------------------------------------QSKRS---TMVGTPYWMA 184
Query: 324 PEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKN---HLKFPEEA 380
PEV+ +K YG + D WSLG + EM+ G PP+ +++P+ I N L+ PE
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA--TNGTPELQNPE-- 240
Query: 381 RLTPEAKDLICRLLC-DVEHR 400
+L+ +D + R L DVE R
Sbjct: 241 KLSAIFRDFLNRCLEMDVEKR 261
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-42
Identities = 51/299 (17%), Positives = 99/299 (33%), Gaps = 51/299 (17%)
Query: 125 CQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184
+++ I+ + + S ++ + + ++ V YLY+
Sbjct: 80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQ 139
Query: 185 MEYLPGGDVMTLLMREETLT---ETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ 241
M+ ++ + R +L V Q A+E +H +HRD+KP N+
Sbjct: 140 MQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTM 199
Query: 242 NGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQL 301
+ +K+ DFGL +D +
Sbjct: 200 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT------------------------- 234
Query: 302 QHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPV 361
VGT Y++PE + Y + D +SLG I++E+L Y + V
Sbjct: 235 ------------GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL--YSFSTQMERV 280
Query: 362 TTCRKIVHWKNHLKFPEE-ARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418
+ +LKFP + P+ ++ +L R I + F+++
Sbjct: 281 RIITDV----RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEA---TDIIENAIFENL 332
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-41
Identities = 84/344 (24%), Positives = 141/344 (40%), Gaps = 72/344 (20%)
Query: 85 LKDLERKETEYMRLKRHK--ISVDD----FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKK 138
L+ ++ + +LK+ FD+L +G G++G V K++G I A+K+
Sbjct: 2 LETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ 61
Query: 139 LKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL- 197
+ ++ + E +++ + S +VK Y S+ L+++MEY G V ++
Sbjct: 62 VPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR 116
Query: 198 MREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
+R +TLTE + ++ +E +H IHRDIK N+LL+ GH KL+DFG+ L
Sbjct: 117 LRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176
Query: 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG 317
T + +R + +G
Sbjct: 177 DT----------------------------------------------MAKRN---TVIG 187
Query: 318 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKN---HL 374
TP ++APEV+ + GY D WSLG EM G PP+ P+ I N
Sbjct: 188 TPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP--TNPPPTF 245
Query: 375 KFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417
+ PE + D + + L E R Q+ HP+ +
Sbjct: 246 RKPE--LWSDNFTDFVKQCLVKSPEQRATA---TQLLQHPFVRS 284
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 8e-40
Identities = 92/359 (25%), Positives = 151/359 (42%), Gaps = 74/359 (20%)
Query: 89 ERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRG 148
RK EY ++R + ++++ +G GAFG+V + K++G + A K + E S
Sbjct: 2 MRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEE 58
Query: 149 QVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG---DVMTLLMREETLTE 205
++E E +LA IVKL ++ L++++E+ PGG +M L + LTE
Sbjct: 59 ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL--DRGLTE 116
Query: 206 TVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265
+ Q + A+ +H IHRD+K N+L+ G ++L+DFG+ T
Sbjct: 117 PQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT------ 170
Query: 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPE 325
+ +R S +GTP ++APE
Sbjct: 171 ----------------------------------------LQKRD---SFIGTPYWMAPE 187
Query: 326 VLL-----KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKN---HLKFP 377
V++ Y + D WSLG + EM PP + +P+ KI K+ L P
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA--KSDPPTLLTP 245
Query: 378 EEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDK-LYEMEAAYKPEV 434
+ + E +D + L + E R Q+ HP+ I +K L E+ A K EV
Sbjct: 246 S--KWSVEFRDFLKIALDKNPETRPSA---AQLLEHPFVSSITSNKALRELVAEAKAEV 299
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 9e-40
Identities = 73/332 (21%), Positives = 132/332 (39%), Gaps = 69/332 (20%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMK--KLKKSEMLSRGQVEHVRAERNLL 160
I+ DD++L +IG GA V+ A+K L+K + ++ + E +
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ----TSMDELLKEIQAM 67
Query: 161 AEVASHCIVKLYYSFQDAEYLYLIMEYLPGG---DVMTLLMREE-----TLTETVARFYI 212
++ IV Y SF + L+L+M+ L GG D++ ++ + L E+ +
Sbjct: 68 SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 213 AQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDD 272
+ + +E +HK+ IHRD+K N+LL ++G ++++DFG+
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA------------------ 169
Query: 273 ENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KG 331
L D I R K+ + VGTP ++APEV+ + +G
Sbjct: 170 -FLATGGD-------------------------ITRNKVRKTFVGTPCWMAPEVMEQVRG 203
Query: 332 YGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWK------NHLKFPEEARLTPE 385
Y + D WS G E+ G P++ P+ + +
Sbjct: 204 YDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKS 263
Query: 386 AKDLICRLLC-DVEHRLGTLGSEQIKAHPWFK 416
+ +I L D E R ++ H +F+
Sbjct: 264 FRKMISLCLQKDPEKRPTA---AELLRHKFFQ 292
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 9e-40
Identities = 72/315 (22%), Positives = 117/315 (37%), Gaps = 64/315 (20%)
Query: 85 LKDLERKETEYMRL--------KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAM 136
L++LE E + RL K ++ DDF+ ++ +G G G V K SG + A
Sbjct: 4 LEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMAR 63
Query: 137 KKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTL 196
K + + E +L E S IV Y +F + + ME++ GG + +
Sbjct: 64 KLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV 121
Query: 197 LMREETLTETVARFYIAQSVL-AIESIH-KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
L + + E + ++ +V+ + + KH +HRD+KP N+L++ G +KL DFG+
Sbjct: 122 LKKAGRIPEQILG-KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 180
Query: 255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYS 314
L + +A S
Sbjct: 181 QLIDS---------------------------------------------------MANS 189
Query: 315 TVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL 374
VGT Y++PE L Y ++ D WS+G + EM VG P D
Sbjct: 190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 249
Query: 375 KFPEEARLTPEAKDL 389
R + L
Sbjct: 250 AAETPPRPRTPGRPL 264
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-39
Identities = 74/364 (20%), Positives = 132/364 (36%), Gaps = 79/364 (21%)
Query: 48 SHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDD 107
S+Y H + ++ + +P + LKD + E DD
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMDP-MPAGGRAGSLKDPDVAEL---------FFKDD 51
Query: 108 ----FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
F L IG G+FG V ++ ++ + A+KK+ S S + + + E L ++
Sbjct: 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 111
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH 223
++ + +L+MEY G L + ++ L E ++ + +H
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDG 283
HN IHRD+K N+LL + G +KL DFG ++
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGS---------AS-------------------- 202
Query: 284 RFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---KKGYGMECDWWS 340
+ S VGTP ++APEV+L + Y + D WS
Sbjct: 203 ---------------------IMAPAN---SFVGTPYWMAPEVILAMDEGQYDGKVDVWS 238
Query: 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKN---HLKFPEEARLTPEAKDLICRLLC-D 396
LG E+ PP ++ + ++ I +N L+ + ++ + L
Sbjct: 239 LGITCIELAERKPPLFNMNAMSALYHIA--QNESPALQSGH---WSEYFRNFVDSCLQKI 293
Query: 397 VEHR 400
+ R
Sbjct: 294 PQDR 297
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-39
Identities = 64/331 (19%), Positives = 124/331 (37%), Gaps = 71/331 (21%)
Query: 99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLK---KSEMLSRGQVEHVRA 155
+R++ ++D + L +G G G+V + +K+G++ A+K+++ E R ++
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDL--- 74
Query: 156 ERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQS 215
+L IV+ + +F +++ ME + + + E + + +
Sbjct: 75 -DVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-KMTVA 132
Query: 216 VL-AIESIH-KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDE 273
++ A+ + KH IHRD+KP N+LLD+ G +KL DFG +S
Sbjct: 133 IVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFG---------ISG---------- 173
Query: 274 NLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL-----L 328
L + D + G Y+APE +
Sbjct: 174 RLVDDKAKD-------------------------------RSAGCAAYMAPERIDPPDPT 202
Query: 329 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPV-TTCRKIVHWKNHLKFPEEARLTPEAK 387
K Y + D WSLG + E+ G P+ + K++ + P + + +
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ-EEPPLLPGHMGFSGDFQ 261
Query: 388 DLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417
+ L D R ++ H + K
Sbjct: 262 SFVKDCLTKDHRKRPKY---NKLLEHSFIKR 289
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-39
Identities = 70/337 (20%), Positives = 130/337 (38%), Gaps = 86/337 (25%)
Query: 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN-- 158
++ DD + + +GRGA+G V + SG I A+K++ + E+
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI---------RATVNSQEQKRL 52
Query: 159 ------LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG---DVMTLLMREETLTETVAR 209
+ V V Y + +++ ME + ++ + +T+ E +
Sbjct: 53 LMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILG 112
Query: 210 FYIAQSVL-AIESIH-KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINEN 267
IA S++ A+E +H K + IHRD+KP N+L++ G +K+ DFG+
Sbjct: 113 -KIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG------------- 158
Query: 268 EVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYST-VGTPDYIAPEV 326
L + + A G Y+APE
Sbjct: 159 ------YLVDDV--------------------------------AKDIDAGCKPYMAPER 180
Query: 327 LL----KKGYGMECDWWSLGAIMYEMLVGYPPFYSDD-PVTTCRKIVHWKNHLKFPEEAR 381
+ +KGY ++ D WSLG M E+ + P+ S P +++V + + P + +
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS-PQLPAD-K 238
Query: 382 LTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417
+ E D + L + + R ++ HP+F
Sbjct: 239 FSAEFVDFTSQCLKKNSKERPTY---PELMQHPFFTL 272
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 47/282 (16%), Positives = 96/282 (34%), Gaps = 49/282 (17%)
Query: 85 LKDLERKETEYMRLKRHKISVDDFDLLTIIGRGA--FGEVRLCQEKKSGNIYAMKKLKKS 142
+ + + ++LLT+IG+G V L + K +G ++++
Sbjct: 4 HHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN-L 62
Query: 143 EMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL--MRE 200
E S V ++ E ++ IV +F L+++ ++ G L+
Sbjct: 63 EACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFM 122
Query: 201 ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260
+ + E + + + A++ IH Y+HR +K ++L+ +G + LS +
Sbjct: 123 DGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH- 181
Query: 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPD 320
Q +V
Sbjct: 182 -----------------------------------------GQRQRVVHDFPKYSVKVLP 200
Query: 321 YIAPEVL--LKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDP 360
+++PEVL +GY + D +S+G E+ G+ PF
Sbjct: 201 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-38
Identities = 81/330 (24%), Positives = 135/330 (40%), Gaps = 77/330 (23%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
F+L+ ++G G +G+V + K+G + A+K + ++ + E ++ E N+L + +
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 166 HC-IVKLYYSF------QDAEYLYLIMEYLPGGDVMTLLM--REETLTETVARFYIAQSV 216
H I Y +F + L+L+ME+ G V L+ + TL E + + +
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLN 276
+ +H+H IHRDIK N+LL +N +KL DFG+ LD T
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT----------------- 182
Query: 277 ESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-----G 331
+ RR + +GTP ++APEV+
Sbjct: 183 -----------------------------VGRRN---TFIGTPYWMAPEVIACDENPDAT 210
Query: 332 YGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFP--EEARLTPEAKDL 389
Y + D WSLG EM G PP P+ I +N P + + + + +
Sbjct: 211 YDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP--RN--PAPRLKSKKWSKKFQSF 266
Query: 390 ICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418
I L + R T EQ+ HP+ +D
Sbjct: 267 IESCLVKNHSQRPAT---EQLMKHPFIRDQ 293
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-36
Identities = 70/335 (20%), Positives = 126/335 (37%), Gaps = 74/335 (22%)
Query: 99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLK---KSEMLSRGQVEHVRA 155
+ + +D L IGRGA+G V K SG I A+K+++ + + ++
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL--- 71
Query: 156 ERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGG--DVMTLLM--REETLTETVARFY 211
++ IV+ Y + ++ ME + + ++ + E +
Sbjct: 72 -DVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG-K 129
Query: 212 IAQSVL-AIESIH-KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEV 269
I + + A+ + IHRDIKP N+LLD++G++KL DFG+ L +
Sbjct: 130 ITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS---------- 179
Query: 270 LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL-- 327
+ ++ D GC Y+APE +
Sbjct: 180 -----IAKTRDA-------GC----------------------------RPYMAPERIDP 199
Query: 328 --LKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTC-RKIVHWKN-HLKFPEEARLT 383
++GY + D WSLG +YE+ G P+ + V ++V L EE +
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFS 259
Query: 384 PEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417
P + + L D R +++ HP+
Sbjct: 260 PSFINFVNLCLTKDESKRPKY---KELLKHPFILM 291
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-35
Identities = 77/353 (21%), Positives = 132/353 (37%), Gaps = 102/353 (28%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRA----ERNLL 160
++ ++ + IG G++G V C+ + +G I A+KK +SE ++ E +L
Sbjct: 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-----DDPVIKKIALREIRML 56
Query: 161 AEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFYIAQSVLAI 219
++ +V L F+ L+L+ EY V+ L + + E + + Q++ A+
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAV 115
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESM 279
HKHN IHRD+KP+N+L+ ++ +KL DFG
Sbjct: 116 NFCHKHNCIHRDVKPENILITKHSVIKLCDFGF--------------------------- 148
Query: 280 DVDGRFPESGCGRRWKSPLEQLQH-----WQINRRKLAYSTVGTPDYIAPEVLLK-KGYG 333
R P + W Y +PE+L+ YG
Sbjct: 149 -----------ARLLTGPSDYYDDEVATRW----------------YRSPELLVGDTQYG 181
Query: 334 MECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIV---------HW--------KNHLKF 376
D W++G + E+L G P + V I H + +K
Sbjct: 182 PPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKI 241
Query: 377 PEE----------ARLTPEAKDLICRLL-CDVEHRLGTLGSEQIKAHPWFKDI 418
P+ ++ A L+ L D R L EQ+ HP+F++I
Sbjct: 242 PDPEDMEPLELKFPNISYPALGLLKGCLHMDPTER---LTCEQLLHHPYFENI 291
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-35
Identities = 83/367 (22%), Positives = 143/367 (38%), Gaps = 92/367 (25%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRA----ERNL 159
S++ ++ L ++G G++G V C+ K +G I A+KK +S+ + V+ E L
Sbjct: 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-----DDKMVKKIAMREIKL 77
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFYIAQSVLA 218
L ++ +V L + + YL+ E++ ++ L + L V + Y+ Q +
Sbjct: 78 LKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIING 136
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
I H HN IHRDIKP+N+L+ Q+G +KL DFG
Sbjct: 137 IGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGF-------------------------- 170
Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGMECD 337
R +P E V T Y APE+L+ YG D
Sbjct: 171 ------------ARTLAAPGEVYDDE-----------VATRWYRAPELLVGDVKYGKAVD 207
Query: 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIV---------HWK--------NHLKFPEE- 379
W++G ++ EM +G P F D + I+ H + ++ PE
Sbjct: 208 VWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIK 267
Query: 380 ---------ARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAA 429
+L+ DL + L D + R ++ H +F+ + + + E
Sbjct: 268 EREPLERRYPKLSEVVIDLAKKCLHIDPDKR---PFCAELLHHDFFQMDGFAERFSQELQ 324
Query: 430 YKPEVNG 436
K + +
Sbjct: 325 LKVQKDA 331
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 75/366 (20%), Positives = 125/366 (34%), Gaps = 119/366 (32%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH--------VRA 155
S F L +G G + V K +G A+K++K ++ +R
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK---------LDSEEGTPSTAIR- 52
Query: 156 ERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL------MREETLTETVAR 209
E +L+ E+ IV+LY L L+ E++ D+ + L + +
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVK 111
Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEV 269
++ Q + + H++ +HRD+KP NLL+++ G +KL DFGL
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGL----------------- 154
Query: 270 LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQH-----WQINRRKLAYSTVGTPDYIAP 324
R + P+ W Y AP
Sbjct: 155 ---------------------ARAFGIPVNTFSSEVVTLW----------------YRAP 177
Query: 325 EVLL-KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVH---------WKNHL 374
+VL+ + Y D WS G I+ EM+ G P F + + I W +
Sbjct: 178 DVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237
Query: 375 KFPE---------------------EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412
K P+ + L D + LL + + R L ++Q H
Sbjct: 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMR---LSAKQALHH 294
Query: 413 PWFKDI 418
PWF +
Sbjct: 295 PWFAEY 300
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 78/357 (21%), Positives = 126/357 (35%), Gaps = 105/357 (29%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---------VR 154
S+D + +T +G G +GEV + + A+K+++ +EH +R
Sbjct: 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR---------LEHEEEGVPGTAIR 82
Query: 155 AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQ 214
E +LL E+ I++L L+LI EY D+ + + ++ V + ++ Q
Sbjct: 83 -EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQ 140
Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQN-----GHMKLSDFGLCKPLDCTNLSAINENEV 269
+ + H +HRD+KP NLLL + +K+ DFGL
Sbjct: 141 LINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL----------------- 183
Query: 270 LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL- 328
R + P+ Q H + T Y PE+LL
Sbjct: 184 ---------------------ARAFGIPIRQFTH-----------EIITLWYRPPEILLG 211
Query: 329 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVH---------WKNHLKFPE- 378
+ Y D WS+ I EML+ P F D + KI W P+
Sbjct: 212 SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDW 271
Query: 379 ----------------EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418
A L E DL+ +L D R + ++ HP+F
Sbjct: 272 KQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKR---ISAKNALEHPYFSHN 325
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 74/352 (21%), Positives = 127/352 (36%), Gaps = 102/352 (28%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH--------VRAE 156
++ + L +G G + V + K + N+ A+K+++ +EH +R E
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR---------LEHEEGAPCTAIR-E 50
Query: 157 RNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFYIAQS 215
+LL ++ IV L+ + L L+ EYL D+ L + + ++ Q
Sbjct: 51 VSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENL 275
+ + H+ +HRD+KP NLL+++ G +KL+DFGL
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGL----------------------- 146
Query: 276 NESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGM 334
R P + + V T Y P++LL Y
Sbjct: 147 ---------------ARAKSIPTKTYDN-----------EVVTLWYRPPDILLGSTDYST 180
Query: 335 ECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIV------------------HWKNHLKF 376
+ D W +G I YEM G P F I +K +
Sbjct: 181 QIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT-YNY 239
Query: 377 PEEA---------RLTPEAKDLICRLL-CDVEHRLGTLGSEQIKAHPWFKDI 418
P+ RL + DL+ +LL + +R + +E HP+F +
Sbjct: 240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNR---ISAEDAMKHPFFLSL 288
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-33
Identities = 83/351 (23%), Positives = 132/351 (37%), Gaps = 101/351 (28%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---------VRA 155
++ + L IG G +G V Q G +A+KK++ +E +R
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIR---------LEKEDEGIPSTTIR- 49
Query: 156 ERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFYIAQ 214
E ++L E+ IVKLY + L L+ E+L D+ LL + E L A+ ++ Q
Sbjct: 50 EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDEN 274
+ I H +HRD+KP NLL+++ G +K++DFGL
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGL---------------------- 146
Query: 275 LNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYG 333
R + P+ + H + T Y AP+VL+ K Y
Sbjct: 147 ----------------ARAFGIPVRKYTH-----------EIVTLWYRAPDVLMGSKKYS 179
Query: 334 MECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVH---------WKNHLKFPE------ 378
D WS+G I EM+ G P F +I W N + P+
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239
Query: 379 ----------EARLTPEAKDLICRLL-CDVEHRLGTLGSEQIKAHPWFKDI 418
L DL+ ++L D R + ++Q H +FK+
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQR---ITAKQALEHAYFKEN 287
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-32
Identities = 75/352 (21%), Positives = 129/352 (36%), Gaps = 101/352 (28%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---------VRA 155
+ ++ L IG G +G V + +++ I A+K+++ ++ +R
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR---------LDDDDEGVPSSALR- 50
Query: 156 ERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFYIAQ 214
E LL E+ IV+L+ + L L+ E+ D+ L + + ++ Q
Sbjct: 51 EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQ 109
Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDEN 274
+ + H N +HRD+KP NLL+++NG +KL++FGL
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGL---------------------- 147
Query: 275 LNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYG 333
R + P+ V T Y P+VL K Y
Sbjct: 148 ----------------ARAFGIPVRCYSA-----------EVVTLWYRPPDVLFGAKLYS 180
Query: 334 MECDWWSLGAIMYEML-VGYPPFYSDDPVTTCRKIV------------------HWKNHL 374
D WS G I E+ G P F +D ++I +K +
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 375 KFPEE-------ARLTPEAKDLICRLL-CDVEHRLGTLGSEQIKAHPWFKDI 418
+P +L +DL+ LL C+ R + +E+ HP+F D
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQR---ISAEEALQHPYFSDF 289
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 80/354 (22%), Positives = 129/354 (36%), Gaps = 104/354 (29%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---------VR 154
++ + L +G G +G V ++ G I A+K+++ ++ +R
Sbjct: 19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIR---------LDAEDEGIPSTAIR 68
Query: 155 AERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFYIA 213
E +LL E+ IV L L L+ E++ D+ +L + L ++ + Y+
Sbjct: 69 -EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLY 126
Query: 214 QSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDE 273
Q + + H+H +HRD+KP NLL++ +G +KL+DFGL
Sbjct: 127 QLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGL--------------------- 165
Query: 274 NLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGY 332
R + P+ H V T Y AP+VL+ K Y
Sbjct: 166 -----------------ARAFGIPVRSYTH-----------EVVTLWYRAPDVLMGSKKY 197
Query: 333 GMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIV------------------HWKNHL 374
D WS+G I EM+ G P F KI WK
Sbjct: 198 STSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ-R 256
Query: 375 KFPEEAR---------LTPEAKDLICRLL-CDVEHRLGTLGSEQIKAHPWFKDI 418
F + E DL+ +L D R + + HP+FKD+
Sbjct: 257 TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKR---ISARDAMNHPYFKDL 307
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-32
Identities = 75/352 (21%), Positives = 132/352 (37%), Gaps = 100/352 (28%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH------VRAER 157
++ L +G G F V ++K + I A+KK+K + R + + +R E
Sbjct: 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK---LGHRSEAKDGINRTALR-EI 63
Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFYIAQSV 216
LL E++ I+ L +F + L+ +++ D+ ++ LT + + Y+ ++
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLN 276
+E +H+H +HRD+KP+NLLLD+NG +KL+DFGL
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGL------------------------ 158
Query: 277 ESMDVDGRFPESGCGRRWKSPLEQLQH-----WQINRRKLAYSTVGTPDYIAPEVLL-KK 330
+ + SP H W Y APE+L +
Sbjct: 159 --------------AKSFGSPNRAYTHQVVTRW----------------YRAPELLFGAR 188
Query: 331 GYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIV------------------HWKN 372
YG+ D W++G I+ E+L+ P D + +I +
Sbjct: 189 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 248
Query: 373 HLKFPEEA------RLTPEAKDLICRLL-CDVEHRLGTLGSEQIKAHPWFKD 417
FP + DLI L + R + + Q +F +
Sbjct: 249 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCAR---ITATQALKMKYFSN 297
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 70/354 (19%), Positives = 117/354 (33%), Gaps = 96/354 (27%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH----VRAERNL 159
+ ++ + IG GA+G V ++ SG+ A+K ++ G VR E L
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV-PNGGGGGGGLPISTVR-EVAL 64
Query: 160 LAE--VASH-CIVKLY-----YSFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVAR 209
L H +V+L + L+ E++ D+ T L L +
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123
Query: 210 FYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEV 269
+ Q + ++ +H + +HRD+KP+N+L+ G +KL+DF
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF------------------- 164
Query: 270 LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYST-VGTPDYIAPEVLL 328
G R + + A + V T Y APEVLL
Sbjct: 165 -------------------GLARIYSYQM-------------ALTPVVVTLWYRAPEVLL 192
Query: 329 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVH---------WKNHLKFPEE 379
+ Y D WS+G I EM P F + KI W + P
Sbjct: 193 QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRG 252
Query: 380 A--------------RLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418
A + L+ +L + R + + + H +
Sbjct: 253 AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKR---ISAFRALQHSYLHKD 303
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 46/171 (26%), Positives = 81/171 (47%), Gaps = 26/171 (15%)
Query: 96 MRLKRHKISVDDFDLL-TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
+++K++ I +DD+ + ++G G G+V K++ +A+K L+ R
Sbjct: 8 LQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR------- 59
Query: 155 AERNLLAEVASH-CIVKLYYSFQDA----EYLYLIMEYLPGGDVMTLLMR-----EETLT 204
E L + IV++ +++ + L ++ME L GG+ L R ++ T
Sbjct: 60 -EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE---LFSRIQDRGDQAFT 115
Query: 205 ETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGL 252
E A + AI+ +H N HRD+KP+NLL N +KL+DFG
Sbjct: 116 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 4e-23
Identities = 32/101 (31%), Positives = 44/101 (43%), Gaps = 9/101 (8%)
Query: 322 IAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVH--WKNHLKFPEE 379
A E + Y CD WSLG IMY +L GYPPFYS+ + + +FP
Sbjct: 166 FAKETT-GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 224
Query: 380 --ARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417
+ ++ E K LI LL + R + + HPW
Sbjct: 225 EWSEVSEEVKMLIRNLLKTEPTQR---MTITEFMNHPWIMQ 262
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 67/298 (22%), Positives = 105/298 (35%), Gaps = 71/298 (23%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
I + ++ ++GRGAFG V C+ K A+K+++ + E L+
Sbjct: 5 IDYKEIEVEEVVGRGAFGVV--CKAKWRAKDVAIKQIESESER-----KAFIVELRQLSR 57
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVA--RFYIAQSV-LAI 219
V IVKLY + + + L+MEY GG + +L E L A +
Sbjct: 58 VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 220 ESIHKHNY---IHRDIKPDNLLLDQNG-HMKLSDFGLCKPLDCTNLSAINENEVLDDENL 275
+H IHRD+KP NLLL G +K+ DFG ++
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-------------------DI 156
Query: 276 NESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME 335
M + G+ ++APEV Y +
Sbjct: 157 QTHM---------------------------------TNNKGSAAWMAPEVFEGSNYSEK 183
Query: 336 CDWWSLGAIMYEMLVGYPPFYS-DDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICR 392
CD +S G I++E++ PF P VH + L + L+ R
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKN--LPKPIESLMTR 239
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-30
Identities = 56/268 (20%), Positives = 104/268 (38%), Gaps = 53/268 (19%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK-SEMLSRGQVEHVRAERNLLA 161
D ++G+G FG+ +++G + MK+L + E +R L
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE----------TQRTFLK 56
Query: 162 EVA-----SH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQS 215
EV H ++K + L I EY+ GG + ++ ++ R A+
Sbjct: 57 EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116
Query: 216 V-LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDEN 274
+ + +H N IHRD+ N L+ +N ++ ++DFGL + ++ DE
Sbjct: 117 IASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLAR--------------LMVDEK 162
Query: 275 LNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM 334
+ P+ RK Y+ VG P ++APE++ + Y
Sbjct: 163 TQPEGLRSLKKPD---------------------RKKRYTVVGNPYWMAPEMINGRSYDE 201
Query: 335 ECDWWSLGAIMYEMLVGYPPFYSDDPVT 362
+ D +S G ++ E++ P T
Sbjct: 202 KVDVFSFGIVLCEIIGRVNADPDYLPRT 229
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-29
Identities = 57/253 (22%), Positives = 100/253 (39%), Gaps = 48/253 (18%)
Query: 110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
++ +G G V L ++ A+K + ++ E + ++++ IV
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 170 KLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIH 229
+ ++ + YL+MEY+ G + + L+ A + Q + I+ H +H
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVH 134
Query: 230 RDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESG 289
RDIKP N+L+D N +K+ DFG+ K L T+L+ N
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTN------------------------ 170
Query: 290 CGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 349
+GT Y +PE + D +S+G ++YEML
Sbjct: 171 ------------------------HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEML 206
Query: 350 VGYPPFYSDDPVT 362
VG PPF + V+
Sbjct: 207 VGEPPFNGETAVS 219
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 74/375 (19%), Positives = 135/375 (36%), Gaps = 109/375 (29%)
Query: 89 ERKETEYMRLKRHKIS---VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML 145
+ EY + H + DD+ L+ +GRG + EV + +K LK
Sbjct: 16 THRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---- 71
Query: 146 SRGQVEHVRAER--NLLAEVASH-CIVKLYYSFQDAE--YLYLIMEYLPGGDVMTLLMRE 200
V+ + +R +L + I+ L +D L+ E++ D L
Sbjct: 72 ----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--- 124
Query: 201 ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-QNGHMKLSDFGLCKPLDCT 259
+TLT+ RFY+ + + A++ H +HRD+KP N+++D ++ ++L D+GL
Sbjct: 125 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL------- 177
Query: 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTP 319
F P ++ V +
Sbjct: 178 -----------------------AEF---------YHPGQEYNVR-----------VASR 194
Query: 320 DYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPFY-----------------SDDPV 361
+ PE+L+ + Y D WSLG ++ M+ PF+ ++D
Sbjct: 195 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 254
Query: 362 TTCRKI-----------------VHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT 403
K W+ + + ++PEA D + +LL D + RL T
Sbjct: 255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL-T 313
Query: 404 LGSEQIKAHPWFKDI 418
+ + HP+F +
Sbjct: 314 --AREAMEHPYFYTV 326
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 76/376 (20%), Positives = 134/376 (35%), Gaps = 85/376 (22%)
Query: 68 ERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQE 127
++ D+P E + ++ + + I D ++ IG G+FG V +
Sbjct: 7 HHPMSDYDIPTTENLYFQGAMDGDDMD--------IPWCDLNIKEKIGAGSFGTVHRAEW 58
Query: 128 KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY 187
G+ A+K L + + + +V E ++ + IV + L ++ EY
Sbjct: 59 H--GSDVAVKILMEQDFHAE-RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115
Query: 188 LPGGDVMTLLMREETLTE--TVARFYIAQSV-LAIESIHKHNY--IHRDIKPDNLLLDQN 242
L G + LL + + R +A V + +H N +HR++K NLL+D+
Sbjct: 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK 175
Query: 243 GHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQ 302
+K+ DFGL + T LS
Sbjct: 176 YTVKVCDFGLSRLKASTFLS---------------------------------------- 195
Query: 303 HWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVT 362
+ S GTP+++APEVL + + D +S G I++E+ P+ + +P
Sbjct: 196 ---------SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ 246
Query: 363 TCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC---DVEHRLGTLGSEQIKAHPWFKDIA 419
+ L+ P L P+ +I C + R P F I
Sbjct: 247 VVAAVGFKCKRLEIPRN--LNPQVAAIIEG--CWTNEPWKR------------PSFATIM 290
Query: 420 WDKLYEMEAAYKPEVN 435
D L + + P N
Sbjct: 291 -DLLRPLIKSAVPPPN 305
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 54/251 (21%), Positives = 95/251 (37%), Gaps = 52/251 (20%)
Query: 110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ--VEHVRAERNLLAEVASHC 167
L ++GRG G+V ++ I A+K + ++ LS ++ E +
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSET--LSSDPVFRTRMQREARTAGRLQEPH 95
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
+V ++ + LY+ M + G D+ +L R+ L A + Q A+++ H
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGA 155
Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
HRD+KP+N+L+ + L DFG+ L+ +
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLG---------------------- 193
Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 347
+TVGT Y+APE + D ++L ++YE
Sbjct: 194 --------------------------NTVGTLYYMAPERFSESHATYRADIYALTCVLYE 227
Query: 348 MLVGYPPFYSD 358
L G PP+ D
Sbjct: 228 CLTGSPPYQGD 238
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 76/360 (21%), Positives = 131/360 (36%), Gaps = 110/360 (30%)
Query: 104 SVDDFDLLTIIGRGAFGEV-RLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---------V 153
+ ++ + IG GA+G+V + K G A+K+++ V+ +
Sbjct: 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR---------VQTGEEGMPLSTI 59
Query: 154 RAERNLLAE--VASH-CIVKLY-----YSFQDAEYLYLIMEYLPGGDVMTLL--MREETL 203
R E +L H +V+L+ L L+ E++ D+ T L + E +
Sbjct: 60 R-EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV 117
Query: 204 TETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263
+ + Q + ++ +H H +HRD+KP N+L+ +G +KL+DF
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF------------- 164
Query: 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYST-VGTPDYI 322
G R + + A ++ V T Y
Sbjct: 165 -------------------------GLARIYSFQM-------------ALTSVVVTLWYR 186
Query: 323 APEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVH---------WKNH 373
APEVLL+ Y D WS+G I EM P F V KI+ W
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246
Query: 374 LKFPEEA--------------RLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418
+ P +A + KDL+ + L + R + + +HP+F+D+
Sbjct: 247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR---ISAYSALSHPYFQDL 303
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 78/383 (20%), Positives = 128/383 (33%), Gaps = 115/383 (30%)
Query: 84 ILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSE 143
+ K + E + V ++ L IG+G FGEV + +K+G A+KK+
Sbjct: 1 MAKQYDSVECPFCD------EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--- 51
Query: 144 MLSRGQVEH---------VRAERNLLAEVASHCIVKLY--------YSFQDAEYLYLIME 186
+E+ +R E +L + +V L + +YL+ +
Sbjct: 52 ------MENEKEGFPITALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFD 104
Query: 187 YLPGGDVMTLL-MREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHM 245
+ D+ LL T + + + + + IH++ +HRD+K N+L+ ++G +
Sbjct: 105 FCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVL 163
Query: 246 KLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQ 305
KL+DFGL R +
Sbjct: 164 KLADFGL--------------------------------------ARAFSLA-------- 177
Query: 306 INRRKLAY-STVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTT 363
N + Y + V T Y PE+LL ++ YG D W G IM EM P +
Sbjct: 178 KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ 237
Query: 364 CRKIVH---------WKNHLKFPE-------------------EARLTPEAKDLICRLLC 395
I W N + P A DLI +LL
Sbjct: 238 LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLV 297
Query: 396 -DVEHRLGTLGSEQIKAHPWFKD 417
D R + S+ H +F
Sbjct: 298 LDPAQR---IDSDDALNHDFFWS 317
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 60/257 (23%), Positives = 97/257 (37%), Gaps = 50/257 (19%)
Query: 110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
L I+G G EV L ++ + A+K L+ R E A + IV
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 170 KLY----YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
+Y Y++MEY+ G + ++ E +T A IA + A+ H++
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN 135
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
IHRD+KP N+++ +K+ DFG+ + + + S V+
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI--------------- 180
Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345
GT Y++PE D +SLG ++
Sbjct: 181 -------------------------------GTAQYLSPEQARGDSVDARSDVYSLGCVL 209
Query: 346 YEMLVGYPPFYSDDPVT 362
YE+L G PPF D PV+
Sbjct: 210 YEVLTGEPPFTGDSPVS 226
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 58/306 (18%), Positives = 109/306 (35%), Gaps = 72/306 (23%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK----SEMLSRGQVEHVRAERN 158
++ ++ + IG+G FG V + K ++ A+K L E + + + E
Sbjct: 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 159 LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSV-L 217
+++ + IVKLY + ++ME++P GD+ L+ + + + + + L
Sbjct: 76 IMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIAL 133
Query: 218 AIESIHKHNY--IHRDIKPDNLLLDQNG-----HMKLSDFGLCKPLDCTNLSAINENEVL 270
IE + N +HRD++ N+ L K++DFGL +
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ---------------- 177
Query: 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK 330
S+ G ++APE + +
Sbjct: 178 ---QSVHSVS-------GLLG--------------------------NFQWMAPETIGAE 201
Query: 331 G--YGMECDWWSLGAIMYEMLVGYPPF--YSDDPVTTCRKIVHWKNHLKFPEEARLTPEA 386
Y + D +S I+Y +L G PF YS + I PE+ P
Sbjct: 202 EESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPED--CPPRL 259
Query: 387 KDLICR 392
+++I
Sbjct: 260 RNVIEL 265
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 65/302 (21%), Positives = 102/302 (33%), Gaps = 68/302 (22%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ-VEHVRAERNLLA 161
I + L IIG G FG+V G+ A+K + Q +E+VR E L A
Sbjct: 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES 221
+ I+ L L L+ME+ GG + +L + + + + Q +
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL-SGKRIPPDILVNWAVQIARGMNY 120
Query: 222 IHKHNY---IHRDIKPDNLLLDQ--------NGHMKLSDFGLCKPLDCTNLSAINENEVL 270
+H IHRD+K N+L+ Q N +K++DFGL + T
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM-------- 172
Query: 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK 330
S G ++APEV+
Sbjct: 173 -------------------------------------------SAAGAYAWMAPEVIRAS 189
Query: 331 GYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLI 390
+ D WS G +++E+L G PF D + + K L P L+
Sbjct: 190 MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST--CPEPFAKLM 247
Query: 391 CR 392
Sbjct: 248 ED 249
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 45/266 (16%), Positives = 88/266 (33%), Gaps = 65/266 (24%)
Query: 103 ISVDDFDLLTIIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL 159
I + ++ +IG+G FG+V R E A++ + + Q++ + E
Sbjct: 30 IPFEQLEIGELIGKGRFGQVYHGRWHGE------VAIRLIDIERD-NEDQLKAFKREVMA 82
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSV-LA 218
+ +V + +L +I G + +++ + + + IAQ +
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKG 142
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
+ +H +H+D+K N+ D NG + ++DFGL
Sbjct: 143 MGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG---------------- 185
Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL---------LK 329
R G ++APE++ K
Sbjct: 186 ----------------------------RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDK 217
Query: 330 KGYGMECDWWSLGAIMYEMLVGYPPF 355
+ D ++LG I YE+ PF
Sbjct: 218 LPFSKHSDVFALGTIWYELHAREWPF 243
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 60/273 (21%), Positives = 110/273 (40%), Gaps = 41/273 (15%)
Query: 89 ERKETEYMRLKRHKISVDD-FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK---SEM 144
K T M + D +++ +IG G++G V +K + A+KK+ + +
Sbjct: 35 SSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLI 94
Query: 145 LSRGQVEHVRAER--NLLAEVASHCIVKLY-----YSFQDAEYLYLIMEYLPGGDVMTLL 197
+ R R +L + +VK+ + + LY+++E D L
Sbjct: 95 DCK------RILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLF 147
Query: 198 MREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
LTE + + ++ ++ +H +HRD+KP N L++Q+ +K+ DFGL + +D
Sbjct: 148 RTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207
Query: 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG 317
++ N + K+ QL + V
Sbjct: 208 YP-----------ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTG---------H--VV 245
Query: 318 TPDYIAPEVLL-KKGYGMECDWWSLGAIMYEML 349
T Y APE++L ++ Y D WS+G I E+L
Sbjct: 246 TRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-25
Identities = 43/305 (14%), Positives = 91/305 (29%), Gaps = 69/305 (22%)
Query: 98 LKRHK-ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAE 156
+ +H I + LT + GE+ + + GN +K LK + +R + E
Sbjct: 1 MNKHSGIDFKQLNFLTKLNENHSGEL--WKGRWQGNDIVVKVLKVRDWSTR-KSRDFNEE 57
Query: 157 RNLLAEVASHCIVKLY--YSFQDAEYLYLIMEYLPGGDVMTLLMREETLT-ETVARFYIA 213
L + ++ + A + LI ++P G + +L + A
Sbjct: 58 CPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFA 117
Query: 214 QSV-LAIESIHKHNY--IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270
+ + +H + ++++D++ ++S
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMA-------------------- 157
Query: 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK 330
++SP + P ++APE L KK
Sbjct: 158 ------------------DVKFSFQSP----------------GRMYAPAWVAPEALQKK 183
Query: 331 GYGME---CDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAK 387
D WS +++E++ PF + K+ P ++P
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPG--ISPHVS 241
Query: 388 DLICR 392
L+
Sbjct: 242 KLMKI 246
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 49/260 (18%), Positives = 93/260 (35%), Gaps = 62/260 (23%)
Query: 103 ISVDDFDLLTIIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL 159
I + IG G+FG V + + A+K L + + Q++ + E +
Sbjct: 21 IPDGQITVGQRIGSGSFGTVYKGKWHGD------VAVKMLNVTAP-TPQQLQAFKNEVGV 73
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSV-LA 218
L + I+ L ++ ++ G + L ET E IA+
Sbjct: 74 LRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 132
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
++ +H + IHRD+K +N+ L ++ +K+ DFGL + S E
Sbjct: 133 MDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL---------- 182
Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG---YGME 335
G+ ++APEV+ + Y +
Sbjct: 183 -------------------------------------SGSILWMAPEVIRMQDSNPYSFQ 205
Query: 336 CDWWSLGAIMYEMLVGYPPF 355
D ++ G ++YE++ G P+
Sbjct: 206 SDVYAFGIVLYELMTGQLPY 225
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 53/166 (31%), Positives = 80/166 (48%), Gaps = 29/166 (17%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKK-LKKSEMLSRGQVEHVRAERNLLAEVASH 166
+ +IG G+FG V + SG + A+KK L+ +R E ++ ++ H
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL-DH 106
Query: 167 C-IVKLYYSF------QDAEYLYLIMEYLPGGDVMTL--LMRE-----ETLTETVARFYI 212
C IV+L Y F +D YL L+++Y+P T+ + R +TL + Y+
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYM 162
Query: 213 AQSVLAIESIHKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPLD 257
Q ++ IH HRDIKP NLLLD + +KL DFG K L
Sbjct: 163 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 33/125 (26%), Positives = 47/125 (37%), Gaps = 30/125 (24%)
Query: 321 YIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVH---------W 370
Y APE++ Y D WS G ++ E+L+G P F D V +I+
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281
Query: 371 K------NHLKFPE----------EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHP 413
+ KFP+ R PEA L RLL R L + AH
Sbjct: 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR---LTPLEACAHS 338
Query: 414 WFKDI 418
+F ++
Sbjct: 339 FFDEL 343
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 63/266 (23%), Positives = 111/266 (41%), Gaps = 45/266 (16%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK---SEMLSRGQVEHVRAER--NLL 160
D++ + +IGRG++G V L +K + A+KK+ + + + R R +L
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK------RILREITIL 79
Query: 161 AEVASHCIVKLY-----YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQS 215
+ S I++LY + LY+++E D+ L LTE + +
Sbjct: 80 NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNL 138
Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENL 275
+L IH+ IHRD+KP N LL+Q+ +K+ DFGL + ++ + I + ++E
Sbjct: 139 LLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 276 NESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGM 334
+ ++ + + V T Y APE++L + Y
Sbjct: 199 PHNKNLKKQLTS-------------------------H--VVTRWYRAPELILLQENYTK 231
Query: 335 ECDWWSLGAIMYEMLVGYPPFYSDDP 360
D WS G I E+L +D
Sbjct: 232 SIDIWSTGCIFAELLNMLQSHINDPT 257
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 79/349 (22%), Positives = 136/349 (38%), Gaps = 85/349 (24%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAER--NLLAEV 163
DF L +++G GA+G V K +G I A+KK++ + R R +L
Sbjct: 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFAL----RTLREIKILKHF 66
Query: 164 ASHCIVKLY-----YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLA 218
I+ ++ SF++ +Y+I E + D + ++ + L++ +++I Q++ A
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELM-QTD-LHRVISTQMLSDDHIQYFIYQTLRA 124
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
++ +H N IHRD+KP NLL++ N +K+ DFGL + +D +A N + E
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID--ESAADNSEPTGQQSGMVE- 181
Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECD 337
+ V T Y APEV+L Y D
Sbjct: 182 ----------------------------------F--VATRWYRAPEVMLTSAKYSRAMD 205
Query: 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHW------------------KNHLK-FPE 378
WS G I+ E+ + P F D I + ++K P
Sbjct: 206 VWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPM 265
Query: 379 EARL---------TPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417
P+ DL+ R+L D R+ ++ HP+ +
Sbjct: 266 YPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA---KEALEHPYLQT 311
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-23
Identities = 46/257 (17%), Positives = 89/257 (34%), Gaps = 65/257 (25%)
Query: 110 LLTIIGRGAFGEVRLCQEKK-SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCI 168
+ I G G + L ++ +G +K L S AER LAEV I
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSI 141
Query: 169 VKLY-----YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH 223
V+++ Y++MEY+ G + ++ + E +A Y+ + + A+ +H
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA--YLLEILPALSYLH 199
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDG 283
++ D+KP+N++L + +KL D G ++
Sbjct: 200 SIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFG----------------------- 235
Query: 284 RFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 343
Y T G + APE+ ++ G + D +++G
Sbjct: 236 ---------------------------YLYGTPG---FQAPEI-VRTGPTVATDIYTVGR 264
Query: 344 IMYEMLVGYPPFYSDDP 360
+ + + P
Sbjct: 265 TLAALTLDLPTRNGRYV 281
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 8e-23
Identities = 76/394 (19%), Positives = 134/394 (34%), Gaps = 121/394 (30%)
Query: 87 DLERKETEYMRLKRHKISVDDFDLLTI-IGRGAFGEVRLCQEK--KSGNIYAMKKLKKSE 143
D + K +R D F+ +GRG +G V + K K YA+K+++ +
Sbjct: 4 DYDFKVKLSSERER---VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG 60
Query: 144 MLSRGQVEHVRAERNLLAEVASHCIVKLY--YSFQDAEYLYLIMEYLPGGDVMTLL---- 197
+ E LL E+ ++ L + ++L+ +Y D+ ++
Sbjct: 61 ISMSACREI-----ALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHR 114
Query: 198 -----MREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL----DQNGHMKLS 248
+ L + + + Q + I +H + +HRD+KP N+L+ + G +K++
Sbjct: 115 ASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174
Query: 249 DFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINR 308
D G R + SPL+ L
Sbjct: 175 DMGF--------------------------------------ARLFNSPLKPLADLDPV- 195
Query: 309 RKLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCR-- 365
V T Y APE+LL + Y D W++G I E+L P F+
Sbjct: 196 -------VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248
Query: 366 -------KIVH---------WKNHLKFPE-------------------------EARLTP 384
+I + W++ K PE + +
Sbjct: 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDS 308
Query: 385 EAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417
+A L+ +LL D R + SEQ P+F +
Sbjct: 309 KAFHLLQKLLTMDPIKR---ITSEQAMQDPYFLE 339
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 66/264 (25%), Positives = 114/264 (43%), Gaps = 55/264 (20%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK---SEMLSRGQVEHVRAER--NLL 160
++L+ +G+GA+G V ++++G + A+KK+ + ++ R R +L
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ------RTFREIMIL 62
Query: 161 AEVASH-CIVKLY-----YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQ 214
E++ H IV L + +D +YL+ +Y+ D + ++R L ++ + Q
Sbjct: 63 TELSGHENIVNLLNVLRADNDRD---VYLVFDYM-ETD-LHAVIRANILEPVHKQYVVYQ 117
Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDEN 274
+ I+ +H +HRD+KP N+LL+ H+K++DFGL + N +++
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 275 LNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYST--VGTPDYIAPEVLLK-KG 331
N D T V T Y APE+LL
Sbjct: 178 ENFDDDQP------------------------------ILTDYVATRWYRAPEILLGSTK 207
Query: 332 YGMECDWWSLGAIMYEMLVGYPPF 355
Y D WSLG I+ E+L G P F
Sbjct: 208 YTKGIDMWSLGCILGEILCGKPIF 231
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 75/350 (21%), Positives = 132/350 (37%), Gaps = 95/350 (27%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAER--NLLAEV 163
+ L+ IG GA+G V + + A+KK+ E + Q R R +L
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ----RTLREIKILLRF 82
Query: 164 ASHCIVKLY-----YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLA 218
I+ + + + + +Y++ + + D + L++ + L+ +++ Q +
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETD-LYKLLKTQHLSNDHICYFLYQILRG 140
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
++ IH N +HRD+KP NLLL+ +K+ DFGL + D D +
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD-------------PDHDHTGF 187
Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYST--VGTPDYIAPEVLLK-KGYGME 335
+ T V T Y APE++L KGY
Sbjct: 188 L-----------------------------------TEYVATRWYRAPEIMLNSKGYTKS 212
Query: 336 CDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHW-----------------KNHLK-FP 377
D WS+G I+ EML P F + I+ +N+L P
Sbjct: 213 IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLP 272
Query: 378 EEARL---------TPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417
+ ++ +A DL+ ++L + R+ EQ AHP+ +
Sbjct: 273 HKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV---EQALAHPYLEQ 319
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 6e-22
Identities = 54/188 (28%), Positives = 84/188 (44%), Gaps = 43/188 (22%)
Query: 86 KDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK-SEM 144
K E++E Y K +IG G+FG V + +S + A+KK+ +
Sbjct: 33 KTGEQREIAYTNCK-------------VIGNGSFGVVFQAKLVESDEV-AIKKVLQDKRF 78
Query: 145 LSRGQVEHVRAERNLLAEVASHC-IVKLYYSF------QDAEYLYLIMEYLPGGDVMTL- 196
+R E ++ V H +V L F +D +L L++EY+P T+
Sbjct: 79 KNR--------ELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP----ETVY 125
Query: 197 -LMR-----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-GHMKLSD 249
R ++T+ + + Y+ Q + ++ IH HRDIKP NLLLD G +KL D
Sbjct: 126 RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLID 185
Query: 250 FGLCKPLD 257
FG K L
Sbjct: 186 FGSAKILI 193
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 33/126 (26%), Positives = 51/126 (40%), Gaps = 32/126 (25%)
Query: 321 YIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIV----------- 368
Y APE++ Y D WS G +M E++ G P F + + +I+
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266
Query: 369 -----HWKNHLKFPE----------EARLTPEAKDLICRLL-CDVEHRLGTLGSEQIKAH 412
++ H KFP+ R P+A DLI RLL R L + + H
Sbjct: 267 KTMNPNYMEH-KFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSAR---LTAIEALCH 322
Query: 413 PWFKDI 418
P+F ++
Sbjct: 323 PFFDEL 328
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-21
Identities = 58/259 (22%), Positives = 112/259 (43%), Gaps = 61/259 (23%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLK-KSEMLSRGQVEHVRAERNLLAEVA-- 164
+++L +IG+G+FG+V + K A+K ++ + + E +R +L +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE-IRILEHLRKQDKDN 157
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVARFYIAQSVLAIESI 222
+ ++ + +F ++ + E L ++ L+ + + + + R + + ++++
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 223 HKHNYIHRDIKPDNLLLDQNGH--MKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
HK+ IH D+KP+N+LL Q G +K+ DFG S+ E++ +
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFG----------SSCYEHQRV---------- 256
Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340
Y+ + + Y APEV+L YGM D WS
Sbjct: 257 --------------------------------YTYIQSRFYRAPEVILGARYGMPIDMWS 284
Query: 341 LGAIMYEMLVGYPPFYSDD 359
LG I+ E+L GYP +D
Sbjct: 285 LGCILAELLTGYPLLPGED 303
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 59/287 (20%), Positives = 95/287 (33%), Gaps = 81/287 (28%)
Query: 103 ISVDDFDLLTIIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN- 158
+ +D+ LL +IGRG +G V L + A+K + + E+N
Sbjct: 10 LDLDNLKLLELIGRGRYGAVYKGSLDERP-----VAVKVFSFANRQN------FINEKNI 58
Query: 159 -LLAEVASHCIVKLY-----YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYI 212
+ + I + + L+MEY P G + L + + R +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCR--L 116
Query: 213 AQSV----------LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262
A SV L +K HRD+ N+L+ +G +SDFGL L L
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYI 322
E + A S VGT Y+
Sbjct: 177 RPGEEDN-----------------------------------------AAISEVGTIRYM 195
Query: 323 APEVL-------LKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVT 362
APEVL + + D ++LG I +E+ + + + V
Sbjct: 196 APEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 68/357 (19%), Positives = 117/357 (32%), Gaps = 101/357 (28%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEK-KSGNIYAMKKLKKSEMLSRGQV--EHV----RAER- 157
+ + I G++G V C G A+K++ + R R R
Sbjct: 22 SPYTVQRFISSGSYGAV--CAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79
Query: 158 -NLLAEVASHCIVKLY-----YSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARF 210
LL I+ L + LYL+ E + D+ ++ + ++ ++
Sbjct: 80 IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQY 138
Query: 211 YIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL 270
++ +L + +H+ +HRD+ P N+LL N + + DF L +
Sbjct: 139 FMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDT------------- 185
Query: 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK- 329
D N Y V Y APE++++
Sbjct: 186 ADANKTH-----------------------------------Y--VTHRWYRAPELVMQF 208
Query: 330 KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHW-----------------KN 372
KG+ D WS G +M EM F KIV ++
Sbjct: 209 KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARD 268
Query: 373 HLK--FPEEARL---------TPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417
+L+ P A DLI ++L + + R+ T EQ HP+F+
Sbjct: 269 YLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST---EQALRHPYFES 322
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 67/356 (18%), Positives = 121/356 (33%), Gaps = 103/356 (28%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLK-KSEMLSRGQVEHVRAER--NLLAEVA 164
+ L +G G G V + A+KK+ + A R ++ +
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVK------HALREIKIIRRLD 66
Query: 165 SHCIVKLY--------------YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF 210
IVK++ S + +Y++ EY+ D + ++ + L E AR
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETD-LANVLEQGPLLEEHARL 124
Query: 211 YIAQSVLAIESIHKHNYIHRDIKPDNLLLD-QNGHMKLSDFGLCKPLDCTNLSAINENEV 269
++ Q + ++ IH N +HRD+KP NL ++ ++ +K+ DFGL + +D
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD---------PHY 175
Query: 270 LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK 329
+L+E + T Y +P +LL
Sbjct: 176 SHKGHLSE-----------------------------------G--LVTKWYRSPRLLLS 198
Query: 330 -KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVH----------------WKN 372
Y D W+ G I EML G F + + I+
Sbjct: 199 PNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPV 258
Query: 373 HLK-FPEEARL---------TPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417
+++ E + EA D + ++L RL E+ +HP+
Sbjct: 259 YIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA---EEALSHPYMSI 311
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 60/254 (23%), Positives = 92/254 (36%), Gaps = 56/254 (22%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLC----QEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
L +G+G FG V +C + +G + A+KKL+ S + E
Sbjct: 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---EHLRDFEREIE 63
Query: 159 LLAEVASHCIVKLY--YSFQDAEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQS 215
+L + IVK L LIMEYLP G + L + +E + Y +Q
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENL 275
+E + YIHRD+ N+L++ +K+ DFGL K VL +
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--------------VLPQDKE 169
Query: 276 NESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME 335
+ G P W APE L + + +
Sbjct: 170 FFKVKEPGESP-----IFW---------------------------YAPESLTESKFSVA 197
Query: 336 CDWWSLGAIMYEML 349
D WS G ++YE+
Sbjct: 198 SDVWSFGVVLYELF 211
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 60/254 (23%), Positives = 91/254 (35%), Gaps = 56/254 (22%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLC----QEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
L +G+G FG V +C + +G + A+KKL+ S + E
Sbjct: 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---EHLRDFEREIE 94
Query: 159 LLAEVASHCIVKLY--YSFQDAEYLYLIMEYLPGGDVMT-LLMREETLTETVARFYIAQS 215
+L + IVK L LIMEYLP G + L +E + Y +Q
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 154
Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENL 275
+E + YIHRD+ N+L++ +K+ DFGL K VL +
Sbjct: 155 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--------------VLPQDKE 200
Query: 276 NESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME 335
+ G P W APE L + + +
Sbjct: 201 YYKVKEPGESP-----IFW---------------------------YAPESLTESKFSVA 228
Query: 336 CDWWSLGAIMYEML 349
D WS G ++YE+
Sbjct: 229 SDVWSFGVVLYELF 242
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 55/253 (21%), Positives = 88/253 (34%), Gaps = 55/253 (21%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIY----AMKKLKKSEMLSRGQVEHVRAERN 158
+ +G G FG+V L + + A+K LK + E +
Sbjct: 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK--ADAGPQHRSGWKQEID 85
Query: 159 LLAEVASHCIVKLY--YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSV 216
+L + I+K A L L+MEY+P G + L ++ + Q
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQIC 144
Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLN 276
+ +H +YIHRD+ N+LLD + +K+ DFGL K + + +
Sbjct: 145 EGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK--------------AVPEGHEY 190
Query: 277 ESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336
+ DG P W APE L + +
Sbjct: 191 YRVREDGDSP-----VFW---------------------------YAPECLKEYKFYYAS 218
Query: 337 DWWSLGAIMYEML 349
D WS G +YE+L
Sbjct: 219 DVWSFGVTLYELL 231
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 49/288 (17%), Positives = 87/288 (30%), Gaps = 85/288 (29%)
Query: 98 LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKS---------EMLSRG 148
+ LL + RG FG V Q A+K E+ S
Sbjct: 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLP 73
Query: 149 QVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVA 208
++H N+L + + L+LI + G + L + ++
Sbjct: 74 GMKH----ENILQFIGA-EKRGTSVDVD----LWLITAFHEKGSLSDFL-KANVVSWN-E 122
Query: 209 RFYIAQSV-----------LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
+IA+++ ++ HK HRDIK N+LL N ++DFGL +
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG 317
+ + VG
Sbjct: 183 AGKSAGDTHGQ-----------------------------------------------VG 195
Query: 318 TPDYIAPEVL-----LKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDP 360
T Y+APEVL ++ + D +++G +++E+
Sbjct: 196 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 15/148 (10%), Positives = 47/148 (31%), Gaps = 2/148 (1%)
Query: 110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
LL G + + A+ + +L ++ + L+ + +
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 170 KLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIH 229
++ ++ E++ GG + + + + + A + A ++ H+
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRAGVAL 152
Query: 230 RDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
P + + +G + L+ +
Sbjct: 153 SIDHPSRVRVSIDGDVVLAYPATMPDAN 180
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 9e-06
Identities = 10/82 (12%), Positives = 22/82 (26%), Gaps = 10/82 (12%)
Query: 316 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIV-HWKNHL 374
+ P + + D +GA +Y +LV P +
Sbjct: 170 LAYPATMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222
Query: 375 KFPEEAR--LTPEAKDLICRLL 394
P + + + + R +
Sbjct: 223 IEPADIDRDIPFQISAVAARSV 244
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 62/270 (22%), Positives = 107/270 (39%), Gaps = 63/270 (23%)
Query: 95 YMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLK-KSEMLSRGQVEHV 153
+K + +D +++ ++IG+G+FG+V ++ A+K +K K L++ Q+E V
Sbjct: 43 DYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE-V 101
Query: 154 RAERNLLAE--VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVAR 209
R + + IV L F +L L+ E L ++ LL ++ + R
Sbjct: 102 RLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTR 160
Query: 210 FYIAQSVLAIESIH--KHNYIHRDIKPDNLLLDQNGH--MKLSDFGLCKPLDCTNLSAIN 265
+ Q A+ + + + IH D+KP+N+LL +K+ DFG S+
Sbjct: 161 KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG----------SSCQ 210
Query: 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPE 325
+ + Y + + Y +PE
Sbjct: 211 LGQRI------------------------------------------YQYIQSRFYRSPE 228
Query: 326 VLLKKGYGMECDWWSLGAIMYEMLVGYPPF 355
VLL Y + D WSLG I+ EM G P F
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHTGEPLF 258
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 3e-19
Identities = 64/322 (19%), Positives = 115/322 (35%), Gaps = 38/322 (11%)
Query: 68 ERKLASSDVPEEEQINILKDLERKETEYMRLKRHKISVDD-----FDLLTIIGRGAFGEV 122
E ++ SD E+E N +Y + H + + D + ++ +G G F V
Sbjct: 4 EEEILGSDDDEQEDPN----------DYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTV 53
Query: 123 RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS--------HCIVKLYYS 174
L + + AMK +K +E E E LL V + +V+L
Sbjct: 54 WLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD 109
Query: 175 FQ----DAEYLYLIMEYLPGGDVMTLLMR--EETLTETVARFYIAQSVLAIESIHKH-NY 227
F+ + ++ ++ E L G ++ +++ + L + I Q + ++ +H
Sbjct: 110 FKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRI 168
Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
IH DIKP+N+LL N + + + V + V+ P+
Sbjct: 169 IHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPK 228
Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 347
+ + K W + T Y + EVL+ GY D WS + +E
Sbjct: 229 NAEKLKVKIADLGNACWVHKHFT---EDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFE 285
Query: 348 MLVGYPPFYSDDPVTTCRKIVH 369
+ G F R H
Sbjct: 286 LATGDYLFEPHSGEEYTRDEDH 307
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 51/279 (18%), Positives = 104/279 (37%), Gaps = 73/279 (26%)
Query: 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLK-KSEMLSRGQVE-----HVR-AERNLLAEV 163
+ +G G F V L ++ + AMK ++ + E V A+ +
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 164 ASHCIVKLYYSFQ----DAEYLYLIMEYLPGGDVMTLLMR--EETLTETVARFYIAQSVL 217
++ I+KL F + ++ ++ E L G +++ L+ + + + Q +L
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLL 142
Query: 218 AIESIHKH-NYIHRDIKPDNLLLD------QNGHMKLSDFGLCKPLDCTNLSAINENEVL 270
++ +H+ IH DIKP+N+L++ +K++D G +A +E
Sbjct: 143 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG----------NACWYDEHY 192
Query: 271 DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK 330
+++ T +Y +PEVLL
Sbjct: 193 ------------------------------------------TNSIQTREYRSPEVLLGA 210
Query: 331 GYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVH 369
+G D WS +++E++ G F D+ + + H
Sbjct: 211 PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 4e-19
Identities = 39/163 (23%), Positives = 71/163 (43%), Gaps = 31/163 (19%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE----- 162
+ + IG G+FG + + A+K E R++ L +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF------------EPRRSDAPQLRDEYRTY 59
Query: 163 ---VASHCIVKLYYSFQDAEYLYLIMEYLPG---GDVMTLLMREETLTETVARFYIAQSV 216
I +YY Q+ + L+++ L G D++ L R+ ++ +TVA Q +
Sbjct: 60 KLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSV-KTVAMAAK-QML 116
Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMK-----LSDFGLCK 254
++SIH+ + ++RDIKPDN L+ + + DFG+ K
Sbjct: 117 ARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 5e-19
Identities = 54/281 (19%), Positives = 88/281 (31%), Gaps = 76/281 (27%)
Query: 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLL 160
+ ++ IG+G +GEV + + + G A+K +E S + + +
Sbjct: 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLM- 88
Query: 161 AEVASH-CIVKLY----YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQS 215
H I+ LYLI +Y G + L + TL +A S
Sbjct: 89 ----RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKS-MLKLAYS 142
Query: 216 V---------LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL-CKPLDCTNLSAIN 265
+ K HRD+K N+L+ +NG ++D GL K + TN I
Sbjct: 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP 202
Query: 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPE 325
N + VGT Y+ PE
Sbjct: 203 PN----------------------------------------------TRVGTKRYMPPE 216
Query: 326 VL------LKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDP 360
VL + D +S G I++E+ +
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 52/176 (29%), Positives = 81/176 (46%), Gaps = 37/176 (21%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR-AERNL---- 159
+D F + + G+G FG V+L +EK +G A+KK+ ++ R R L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV----------IQDPRFRNRELQIMQ 71
Query: 160 LAEVASHC-IVKLYYSF-------QDAEYLYLIMEYLPGGDVMTL--LMR-----EETLT 204
V H IV+L F + YL ++MEY+P TL R +
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYRRQVAPP 127
Query: 205 ETVARFYIAQSVLAIESIHK--HNYIHRDIKPDNLLLD-QNGHMKLSDFGLCKPLD 257
+ + ++ Q + +I +H N HRDIKP N+L++ +G +KL DFG K L
Sbjct: 128 PILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 29/128 (22%), Positives = 45/128 (35%), Gaps = 33/128 (25%)
Query: 321 YIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPV---------------TTC 364
Y APE++ + Y D WS+G I EM++G P F D+
Sbjct: 197 YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256
Query: 365 RKIVHWKNHLKFP-------------EEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIK 410
RK+ + + EA DL+ LL E R + +
Sbjct: 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEER---MKPYEAL 313
Query: 411 AHPWFKDI 418
HP+F ++
Sbjct: 314 CHPYFDEL 321
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 43/164 (26%), Positives = 72/164 (43%), Gaps = 33/164 (20%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE----- 162
F + IG G FGE+RL + + A+K +E +++ L
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIK------------LEPMKSRAPQLHLEYRFY 58
Query: 163 ---VASHCIVKLYYSFQDAEYLYLIMEYLPGG----DVMTLLMREETLTETVARFYIAQS 215
+ I ++YY +Y +++E L G D+ L R +L +TV I Q
Sbjct: 59 KQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSL-KTVLMIAI-QL 114
Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMK-----LSDFGLCK 254
+ +E +H N I+RD+KP+N L+ + G+ + DF L K
Sbjct: 115 ISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 6e-19
Identities = 45/161 (27%), Positives = 69/161 (42%), Gaps = 29/161 (18%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAER-NLLAEVA-- 164
+ L IG G+FG++ L + +G A+K E V+ + L E
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL------------ECVKTKHPQLHIESKIY 58
Query: 165 -----SHCIVKLYYSFQDAEYLYLIMEYLPG---GDVMTLLMREETLTETVARFYIAQSV 216
I + + + +Y ++ME L G D+ R+ +L +TV Q +
Sbjct: 59 KMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSL-KTVLLLAD-QMI 115
Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMK---LSDFGLCK 254
IE IH N+IHRD+KPDN L+ + DFGL K
Sbjct: 116 SRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 7e-19
Identities = 53/280 (18%), Positives = 85/280 (30%), Gaps = 74/280 (26%)
Query: 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLL 160
+ L IG+G FGEV + + G A+K E S AE
Sbjct: 37 QRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERS----WFREAEIYQT 90
Query: 161 AEVASHCIVKLYYS----FQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSV 216
+ I+ + L+L+ +Y G + L R E + + +A S
Sbjct: 91 VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK--LALST 148
Query: 217 ---------LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD-CTNLSAINE 266
+ + K HRD+K N+L+ +NG ++D GL D T+ I
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 208
Query: 267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEV 326
N VGT Y+APEV
Sbjct: 209 N----------------------------------------------HRVGTKRYMAPEV 222
Query: 327 LLKKG------YGMECDWWSLGAIMYEMLVGYPPFYSDDP 360
L D +++G + +E+ +
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 53/274 (19%), Positives = 81/274 (29%), Gaps = 74/274 (27%)
Query: 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
D LL +G+G +GEV + G A+K + S + + L H
Sbjct: 9 DITLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVML-----RH 61
Query: 167 -CIVKLY----YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSV----- 216
I+ S + L+LI Y G + L + TL I S+
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVS-CLRIVLSIASGLA 119
Query: 217 ----LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDD 272
+ K HRD+K N+L+ +NG ++D GL
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA------------------- 160
Query: 273 ENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL----- 327
S N VGT Y+APEVL
Sbjct: 161 --------------------VMHSQSTNQLDVGNN------PRVGTKRYMAPEVLDETIQ 194
Query: 328 -LKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDP 360
D W+ G +++E+ +
Sbjct: 195 VDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 52/254 (20%), Positives = 91/254 (35%), Gaps = 55/254 (21%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIY----AMKKLKKSEMLSRGQVEHVRAERN 158
+ +G G FG+V LC+ G+ A+K LK + ++ E
Sbjct: 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK--PESGGNHIADLKKEIE 75
Query: 159 LLAEVASHCIVKLY--YSFQDAEYLYLIMEYLPGGDVMT-LLMREETLTETVARFYIAQS 215
+L + IVK + + LIME+LP G + L + + Y Q
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135
Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENL 275
++ + Y+HRD+ N+L++ +K+ DFGL K ++ +
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK--------------AIETDKE 181
Query: 276 NESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME 335
++ D P W APE L++ + +
Sbjct: 182 YYTVKDDRDSP-----VFW---------------------------YAPECLMQSKFYIA 209
Query: 336 CDWWSLGAIMYEML 349
D WS G ++E+L
Sbjct: 210 SDVWSFGVTLHELL 223
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 29/162 (17%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAE-RNLLAEVA-- 164
F L IG G+FGE+ L ++ A+K E+V+ + LL E
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL------------ENVKTKHPQLLYESKIY 56
Query: 165 -----SHCIVKLYYSFQDAEYLYLIMEYLPG---GDVMTLLMREETLTETVARFYIAQSV 216
I + + + +Y L+M+ L G D+ R+ +L +TV Q +
Sbjct: 57 RILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL-KTVLMLAD-QMI 113
Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMK---LSDFGLCKP 255
+E +H +++HRDIKPDN L+ + DFGL K
Sbjct: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 9e-18
Identities = 42/186 (22%), Positives = 68/186 (36%), Gaps = 37/186 (19%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKL---------------------------- 139
+ L +G G+FG V + +SG +A+KK+
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 140 ---KKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDV--- 193
E Q + ++ + + +YL +IMEY+P +
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKV 127
Query: 194 -MTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-GHMKLSDFG 251
+ + ++ + YI Q A+ IH HRDIKP NLL++ +KL DFG
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 252 LCKPLD 257
K L
Sbjct: 188 SAKKLI 193
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 31/160 (19%), Positives = 54/160 (33%), Gaps = 36/160 (22%)
Query: 321 YIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIV----------- 368
Y APE++L Y D WS+G + E+++G P F + + +I+
Sbjct: 207 YRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQM 266
Query: 369 -------------HWKNH---LKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411
K PE A DL+ ++L + + R + + A
Sbjct: 267 IRMNPHYTEVRFPTLKAKDWRKILPE--GTPSLAIDLLEQILRYEPDLR---INPYEAMA 321
Query: 412 HPWFKDIAWDKLYEMEAAYKPEVNGVL-DTQNFMKFDEVE 450
HP+F + + +GV + F E
Sbjct: 322 HPFFDHLR-NSYESEVKNNSNFPHGVNQNIPQLFNFSPYE 360
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 53/255 (20%), Positives = 94/255 (36%), Gaps = 51/255 (20%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
++ +D L IGRG FGEV + + + A+K +++ E +L +
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP--PDLKAKFLQEARILKQ 168
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFYIAQSVLAIES 221
+ IV+L + +Y++ME + GGD +T L L + + +E
Sbjct: 169 YSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEY 228
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
+ IHRD+ N L+ + +K+SDFG+ + + + +
Sbjct: 229 LESKCCIHRDLAARNCLVTEKNVLKISDFGMSREE---------------ADGVYAASGG 273
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341
+ P +W APE L Y E D WS
Sbjct: 274 LRQVP-----VKW---------------------------TAPEALNYGRYSSESDVWSF 301
Query: 342 GAIMYEML-VGYPPF 355
G +++E +G P+
Sbjct: 302 GILLWETFSLGASPY 316
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 57/254 (22%), Positives = 94/254 (37%), Gaps = 56/254 (22%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLC----QEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN 158
++ +G+G FG V LC +G + A+K+L+ S + + E
Sbjct: 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQ 76
Query: 159 LLAEVASHCIVKLY--YSFQDAEYLYLIMEYLPGGDVMT-LLMREETLTETVARFYIAQS 215
+L + S IVK + L L+MEYLP G + L L + Y +Q
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI 136
Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENL 275
+E + +HRD+ N+L++ H+K++DFGL K +L +
Sbjct: 137 CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK--------------LLPLDKD 182
Query: 276 NESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME 335
+ G+ P W APE L + +
Sbjct: 183 YYVVREPGQSP-----IFW---------------------------YAPESLSDNIFSRQ 210
Query: 336 CDWWSLGAIMYEML 349
D WS G ++YE+
Sbjct: 211 SDVWSFGVVLYELF 224
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 50/270 (18%), Positives = 98/270 (36%), Gaps = 70/270 (25%)
Query: 99 KRHKISVDDFDLLTIIGRGAFGEV---RLCQEKKSGNIY-AMKKLKKSEMLSRGQVEHVR 154
+ +F + ++G GAFG V E + I A+K+L+++ +
Sbjct: 8 LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--------PK 59
Query: 155 AERNLLAEVA-----SH-CIVKLY-YSFQDAEYLYLIMEYLPGGDVMT-LLMREETLTET 206
A + +L E + + +L + LI + +P G ++ + ++ +
Sbjct: 60 ANKEILDEAYVMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQ 117
Query: 207 VARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE 266
+ Q + + +HRD+ N+L+ H+K++DFGL K L
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--------- 168
Query: 267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEV 326
+E E G+ P +W +A E
Sbjct: 169 ----AEE--KEYHAEGGKVP-----IKW---------------------------MALES 190
Query: 327 LLKKGYGMECDWWSLGAIMYEML-VGYPPF 355
+L + Y + D WS G ++E++ G P+
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 52/249 (20%), Positives = 94/249 (37%), Gaps = 54/249 (21%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
+ D + +G G +GEV KK A+K LK+ M +VE E ++ E
Sbjct: 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKE 272
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF--YIAQSVLAIE 220
+ +V+L Y+I E++ G+++ L + Q A+E
Sbjct: 273 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 332
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
+ K N+IHR++ N L+ +N +K++DFGL + + D +
Sbjct: 333 YLEKKNFIHRNLAARNCLVGENHLVKVADFGLSR-------------LMTGDTY---TAH 376
Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340
+FP +W APE L + ++ D W+
Sbjct: 377 AGAKFP-----IKW---------------------------TAPESLAYNKFSIKSDVWA 404
Query: 341 LGAIMYEML 349
G +++E+
Sbjct: 405 FGVLLWEIA 413
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 51/263 (19%), Positives = 97/263 (36%), Gaps = 59/263 (22%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGN-IYAMKKLK-KSEMLSRGQVEHVRAERNLLAEVA- 164
++++ +G GAFG+V C + K+G A+K +K + E +L +
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE-----IQVLEHLNT 70
Query: 165 -----SHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM--REETLTETVARFYIAQSVL 217
+ V++ F+ ++ ++ E L G + R Q
Sbjct: 71 TDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICK 129
Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLD-----D 272
++ +H + H D+KP+N+L Q+ + + + + + I +V+D
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI---KVVDFGSATY 186
Query: 273 ENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY 332
++ + S V R Y APEV+L G+
Sbjct: 187 DDEHHSTLVSTRH-----------------------------------YRAPEVILALGW 211
Query: 333 GMECDWWSLGAIMYEMLVGYPPF 355
CD WS+G I+ E +G+ F
Sbjct: 212 SQPCDVWSIGCILIEYYLGFTVF 234
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 5e-17
Identities = 56/256 (21%), Positives = 101/256 (39%), Gaps = 57/256 (22%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
I + L +G+G FGEV + + + A+K LK M E E ++ +
Sbjct: 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKK 318
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF--YIAQSVLAIE 220
+ +V+LY + E +Y++ EY+ G ++ L E + + AQ +
Sbjct: 319 LRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 377
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
+ + NY+HRD++ N+L+ +N K++DFGL + + D+E
Sbjct: 378 YVERMNYVHRDLRAANILVGENLVCKVADFGLAR-------------LIEDNEYTARQ-- 422
Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340
+FP +W APE L + ++ D WS
Sbjct: 423 -GAKFP-----IKW---------------------------TAPEAALYGRFTIKSDVWS 449
Query: 341 LGAIMYEML-VGYPPF 355
G ++ E+ G P+
Sbjct: 450 FGILLTELTTKGRVPY 465
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 7e-17
Identities = 52/266 (19%), Positives = 95/266 (35%), Gaps = 61/266 (22%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLK-KSEMLSRGQVEHVRAERNLLAEVAS- 165
F ++ +G G FG V LCQ + YA+K ++ + ++E ++L ++ +
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE-----ADILKKIQND 91
Query: 166 ----HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR--EETLTETVARFYIAQSVLAI 219
+ IVK + F +++ LI E L G + ++ R + Y + + A+
Sbjct: 92 DINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKAL 150
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVL--------- 270
+ K + H D+KP+N+LLD K ++ +
Sbjct: 151 NYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT 210
Query: 271 -DDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK 329
+ S + T Y APEV+L
Sbjct: 211 FKSDYH-------------------------------------GSIINTRQYRAPEVILN 233
Query: 330 KGYGMECDWWSLGAIMYEMLVGYPPF 355
G+ + D WS G ++ E+ G F
Sbjct: 234 LGWDVSSDMWSFGCVLAELYTGSLLF 259
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 52/258 (20%), Positives = 94/258 (36%), Gaps = 49/258 (18%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIY-AMKKLK-KSEMLSRGQVEHVRAERNLLAEVA- 164
++++ +G G FG+V C + G A+K ++ + ++E N+L ++
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE-----INVLKKIKE 75
Query: 165 -----SHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM--REETLTETVARFYIAQSVL 217
V + F ++ + E L G + L + R Q
Sbjct: 76 KDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCH 134
Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNE 277
A+ +H++ H D+KP+N+L + L + ++I V D
Sbjct: 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI---RVAD------ 185
Query: 278 SMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
F S + H + V T Y PEV+L+ G+ CD
Sbjct: 186 -------F-GSAT-------FDHEHH---------TTIVATRHYRPPEVILELGWAQPCD 221
Query: 338 WWSLGAIMYEMLVGYPPF 355
WS+G I++E G+ F
Sbjct: 222 VWSIGCILFEYYRGFTLF 239
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 40/160 (25%), Positives = 66/160 (41%), Gaps = 22/160 (13%)
Query: 114 IGRGAFGEVRLCQEKKSGNIYAMKKLK---------KSEM--LSRGQVEHVRAERNLLAE 162
IG G FG + L A +K SE+ R + + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 163 VASHCIVKLYYS----FQDAEYLYLIMEYLPGGDVMTLLMREETLTE-TVARFYIA-QSV 216
+ I Y S F+ Y +++ME L G D+ + + T + TV + + + +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQ--LGIRML 161
Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMK--LSDFGLCK 254
+E IH++ Y+H DIK NLLL + L+D+GL
Sbjct: 162 DVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 43/163 (26%), Positives = 82/163 (50%), Gaps = 19/163 (11%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK---SEMLSRGQVEHVRAER--NLL 160
+ + L+ +G GA+G V + K+G A+KKL + S + ++ R R LL
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK------RTYRELRLL 82
Query: 161 AEVASHCIVKLY------YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQ 214
+ ++ L S ++ +YL+ + G D + +++ + LT+ +F I Q
Sbjct: 83 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GAD-LNNIVKCQKLTDDHVQFLIYQ 140
Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
+ ++ IH + IHRD+KP NL ++++ +K+ DFGL +
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 32/131 (24%), Positives = 52/131 (39%), Gaps = 32/131 (24%)
Query: 316 VGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHW---- 370
V T Y APE++L Y D WS+G IM E+L G F D + + I+
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249
Query: 371 -------------KNHLK-FPEEARL---------TPEAKDLICRLLC-DVEHRLGTLGS 406
+N+++ + ++ P A DL+ ++L D + R+
Sbjct: 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA--- 306
Query: 407 EQIKAHPWFKD 417
Q AH +F
Sbjct: 307 AQALAHAYFAQ 317
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 54/249 (21%), Positives = 98/249 (39%), Gaps = 54/249 (21%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
+ D + +G G +GEV KK A+K LK+ M +VE E ++ E
Sbjct: 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKE 65
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVARFYIAQSVLAIE 220
+ +V+L Y+I E++ G+++ L + ++ V + Q A+E
Sbjct: 66 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 125
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
+ K N+IHRD+ N L+ +N +K++DFGL + + D +
Sbjct: 126 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR-------------LMTGDTYTAHA-- 170
Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340
+FP +W APE L + ++ D W+
Sbjct: 171 -GAKFP-----IKW---------------------------TAPESLAYNKFSIKSDVWA 197
Query: 341 LGAIMYEML 349
G +++E+
Sbjct: 198 FGVLLWEIA 206
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 51/256 (19%), Positives = 93/256 (36%), Gaps = 55/256 (21%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
I + + IG G FG V L + A+K +++ M E E ++ +
Sbjct: 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAM----SEEDFIEEAEVMMK 59
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM-REETLTETVARFYIAQSVLAIES 221
++ +V+LY + + L+ E++ G + L + +
Sbjct: 60 LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
+ + IHRD+ N L+ +N +K+SDFG+ + VLDD+ + +
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTR-------------FVLDDQYTSST--- 163
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341
+FP +W +PEV Y + D WS
Sbjct: 164 GTKFP-----VKW---------------------------ASPEVFSFSRYSSKSDVWSF 191
Query: 342 GAIMYEML-VGYPPFY 356
G +M+E+ G P+
Sbjct: 192 GVLMWEVFSEGKIPYE 207
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 56/256 (21%), Positives = 101/256 (39%), Gaps = 57/256 (22%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
I + L +G+G FGEV + + + A+K LK M E E ++ +
Sbjct: 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKK 235
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF--YIAQSVLAIE 220
+ +V+LY + E +Y++ EY+ G ++ L E + + AQ +
Sbjct: 236 LRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 294
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
+ + NY+HRD++ N+L+ +N K++DFGL + + D+E
Sbjct: 295 YVERMNYVHRDLRAANILVGENLVCKVADFGLAR-------------LIEDNEYTARQ-- 339
Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340
+FP +W APE L + ++ D WS
Sbjct: 340 -GAKFP-----IKW---------------------------TAPEAALYGRFTIKSDVWS 366
Query: 341 LGAIMYEML-VGYPPF 355
G ++ E+ G P+
Sbjct: 367 FGILLTELTTKGRVPY 382
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 58/265 (21%), Positives = 93/265 (35%), Gaps = 65/265 (24%)
Query: 103 ISVDDFDLLTIIGRGAFGEVR--LCQEKKSGNIY-AMKKLKKSEMLSRGQVEHVRAERNL 159
I + IIG G GEV + ++ A+K LK R R+
Sbjct: 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE--------RQRRDF 97
Query: 160 LAEVA-----SH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFYI 212
L+E + H I++L ++ EY+ G + T L + T +
Sbjct: 98 LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGML 157
Query: 213 AQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDD 272
+ + Y+HRD+ N+L+D N K+SDFGL + VL+D
Sbjct: 158 RGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR--------------VLED 203
Query: 273 ENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY 332
+ G+ P RW APE + + +
Sbjct: 204 DPDAAYTTTGGKIP-----IRW---------------------------TAPEAIAFRTF 231
Query: 333 GMECDWWSLGAIMYEML-VGYPPFY 356
D WS G +M+E+L G P++
Sbjct: 232 SSASDVWSFGVVMWEVLAYGERPYW 256
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-16
Identities = 52/255 (20%), Positives = 82/255 (32%), Gaps = 59/255 (23%)
Query: 103 ISVDDFDLLTIIGRGAFGEVR--LCQEKKSGNIY-AMKKLKKSEMLSRGQVEHVRAERNL 159
I D LL +G G+FG VR + A+K LK + ++ E N
Sbjct: 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 160 LAEVASHCIVKLYYSFQDA----EYLYLIMEYLPGGDVMT-LLMREETLTETVARFYIAQ 214
+ + +++LY + ++ E P G ++ L + Y Q
Sbjct: 75 MHSLDHRNLIRLY-----GVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDEN 274
+ + +IHRD+ NLLL +K+ DFGL + L DD
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN-----------DDHY 178
Query: 275 LNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM 334
M + P W APE L + +
Sbjct: 179 ---VMQEHRKVP-----FAW---------------------------CAPESLKTRTFSH 203
Query: 335 ECDWWSLGAIMYEML 349
D W G ++EM
Sbjct: 204 ASDTWMFGVTLWEMF 218
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-16
Identities = 60/275 (21%), Positives = 107/275 (38%), Gaps = 58/275 (21%)
Query: 85 LKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVR--LCQEKKSGNIYAMKKLKKS 142
L+++ KE L R ++++D +G G FG V+ Q KK A+K LK
Sbjct: 3 LEEIRPKEVY---LDRKLLTLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE 55
Query: 143 EMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREET 202
+ + AE N++ ++ + IV++ +AE L+ME G + L +
Sbjct: 56 AN-DPALKDELLAEANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRH 113
Query: 203 LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262
+ + + Q + ++ + + N++HRD+ N+LL + K+SDFGL K
Sbjct: 114 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSK-------- 165
Query: 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYI 322
L + G++P +W
Sbjct: 166 ------ALRADENYYKAQTHGKWP-----VKW---------------------------Y 187
Query: 323 APEVLLKKGYGMECDWWSLGAIMYEML-VGYPPFY 356
APE + + + D WS G +M+E G P+
Sbjct: 188 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 222
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 48/163 (29%), Positives = 80/163 (49%), Gaps = 19/163 (11%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK---SEMLSRGQVEHVRAER--NLL 160
+ L +G GA+G V + ++G A+KKL + SE+ ++ RA R LL
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK------RAYRELRLL 78
Query: 161 AEVASHCIVKLY------YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQ 214
+ ++ L + D YL+M ++ G D + LM+ E L E +F + Q
Sbjct: 79 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTD-LGKLMKHEKLGEDRIQFLVYQ 136
Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
+ + IH IHRD+KP NL ++++ +K+ DFGL + D
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 50/264 (18%), Positives = 99/264 (37%), Gaps = 58/264 (21%)
Query: 99 KRHKISVDDFDLLTIIGRGAFGEV---RLCQEKKSGNIY-AMKKLKKSEMLSRGQVEHVR 154
+ +F + ++G GAFG V E + I A+K+L+++ + +
Sbjct: 8 LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEIL 65
Query: 155 AERNLLAEVASHCIVKLY-YSFQDAEYLYLIMEYLPGGDVMT-LLMREETLTETVARFYI 212
E ++A V + + +L + LI + +P G ++ + ++ + +
Sbjct: 66 DEAYVMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123
Query: 213 AQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDD 272
Q + + +HRD+ N+L+ H+K++DFGL K L +
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-------------AE 170
Query: 273 ENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY 332
E E G+ P +W +A E +L + Y
Sbjct: 171 E--KEYHAEGGKVP-----IKW---------------------------MALESILHRIY 196
Query: 333 GMECDWWSLGAIMYEML-VGYPPF 355
+ D WS G ++E++ G P+
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKPY 220
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 8e-16
Identities = 49/259 (18%), Positives = 96/259 (37%), Gaps = 53/259 (20%)
Query: 103 ISVDDFDLLTIIGRGAFGEVR--LCQEKKSGNIY-AMKKLKKSEMLSRGQVEHVRAERNL 159
+ + + ++G G FGEV + I A+K LK Q E ++
Sbjct: 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--QRRDFLGEASI 99
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFYIAQSVLA 218
+ + I++L ++ + ++ EY+ G + + L + T +
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
++ + Y+HRD+ N+L++ N K+SDFGL + VL+D+
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGR--------------VLEDDPEAAY 205
Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
G+ P RW +PE + + + D
Sbjct: 206 TTRGGKIP-----IRW---------------------------TSPEAIAYRKFTSASDV 233
Query: 339 WSLGAIMYEML-VGYPPFY 356
WS G +++E++ G P++
Sbjct: 234 WSYGIVLWEVMSYGERPYW 252
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 8e-16
Identities = 64/329 (19%), Positives = 113/329 (34%), Gaps = 66/329 (20%)
Query: 32 SSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQINILKDLERK 91
S + ++ + S K Q + + +++ +EE +
Sbjct: 326 QSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDY 385
Query: 92 ETEYMRLKRHKISVDDFDLLTIIGRGAFGEVR--LCQEKKSGNIY-AMKKLKKSEMLSRG 148
E I + +L IG G FG+V + ++ + A+K K S
Sbjct: 386 E----------IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS-- 433
Query: 149 QVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMT-LLMREETLTETV 207
E E + + IVKL + +++IME G++ + L +R+ +L
Sbjct: 434 VREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLAS 492
Query: 208 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINEN 267
Y Q A+ + ++HRDI N+L+ N +KL DFGL +
Sbjct: 493 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR------------- 539
Query: 268 EVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL 327
++D G+ P +W +APE +
Sbjct: 540 -YMEDS--TYYKASKGKLP-----IKW---------------------------MAPESI 564
Query: 328 LKKGYGMECDWWSLGAIMYEML-VGYPPF 355
+ + D W G M+E+L G PF
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKPF 593
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 47/263 (17%), Positives = 92/263 (34%), Gaps = 64/263 (24%)
Query: 103 ISVDDFDLLTIIGRGAFGEVR---LCQEKKSGNIY-AMKKLKKSEMLSRGQVEHVRAERN 158
+ L ++G G FG V E +S I +K ++ + R + V
Sbjct: 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE--DKSGRQSFQAVTDHML 67
Query: 159 LLAEVASHCIVKLYYSFQDA----EYLYLIMEYLPGGDVMT-LLMREETLTETVARFYIA 213
+ + IV+L L L+ +YLP G ++ + L + +
Sbjct: 68 AIGSLDHAHIVRLL-----GLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV 122
Query: 214 QSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDE 273
Q + + +H +HR++ N+LL ++++DFG+ L DD+
Sbjct: 123 QIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP------------PDDK 170
Query: 274 NLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG 333
+ + + + P +W +A E + Y
Sbjct: 171 ---QLLYSEAKTP-----IKW---------------------------MALESIHFGKYT 195
Query: 334 MECDWWSLGAIMYEML-VGYPPF 355
+ D WS G ++E++ G P+
Sbjct: 196 HQSDVWSYGVTVWELMTFGAEPY 218
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 59/257 (22%), Positives = 104/257 (40%), Gaps = 60/257 (23%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
I + L +G G FGEV + K + A+K +K M VE AE N++
Sbjct: 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKT 239
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARF--YIAQSVLAIE 220
+ +VKL+ E +Y+I E++ G ++ L +E + + + + AQ +
Sbjct: 240 LQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 298
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
I + NYIHRD++ N+L+ + K++DFGL + + D+E
Sbjct: 299 FIEQRNYIHRDLRAANILVSASLVCKIADFGLAR-------------VIEDNEYTARE-- 343
Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340
+FP +W APE + + ++ D WS
Sbjct: 344 -GAKFP-----IKWT---------------------------APEAINFGSFTIKSDVWS 370
Query: 341 LGAIMYEML----VGYP 353
G ++ E++ + YP
Sbjct: 371 FGILLMEIVTYGRIPYP 387
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 58/283 (20%), Positives = 103/283 (36%), Gaps = 82/283 (28%)
Query: 76 VPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYA 135
E + + R +++ + LL IG+G FG+V L + GN A
Sbjct: 171 KVMEGTVAAQDEFYRSGWA--------LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVA 220
Query: 136 MKKLKKSEMLSRGQVEHVRAERNLLAEVA-----SH-CIVKLY-YSFQDAEYLYLIMEYL 188
+K +K + LAE + H +V+L ++ LY++ EY+
Sbjct: 221 VKCIKNDAT-----------AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269
Query: 189 PGGDVMTLL--MREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMK 246
G ++ L L + A+E + +N++HRD+ N+L+ ++ K
Sbjct: 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAK 329
Query: 247 LSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQI 306
+SDFGL K + + S G+ P +W
Sbjct: 330 VSDFGLTK-----------------EAS---STQDTGKLP-----VKW------------ 352
Query: 307 NRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 349
APE L +K + + D WS G +++E+
Sbjct: 353 ---------------TAPEALREKKFSTKSDVWSFGILLWEIY 380
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 43/163 (26%), Positives = 80/163 (49%), Gaps = 20/163 (12%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK---SEMLSRGQVEHVRAER--NLL 160
+ T +G GA+G V +K+SG A+KKL + SE+ ++ RA R LL
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK------RAYRELLLL 77
Query: 161 AEVASHCIVKLY------YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQ 214
+ ++ L S ++ YL+M ++ D+ ++ +E ++ + Q
Sbjct: 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQ 134
Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
+ ++ IH +HRD+KP NL ++++ +K+ DFGL + D
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 55/260 (21%), Positives = 95/260 (36%), Gaps = 54/260 (20%)
Query: 103 ISVDDFDLLTIIGRGAFGEV---RLCQEKKSGNIY-AMKKLKKSEMLSRGQVEHVRAERN 158
I +IG G FGEV L + A+K LK Q E
Sbjct: 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK--QRVDFLGEAG 98
Query: 159 LLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM-REETLTETVARFYIAQSVL 217
++ + + H I++L + + +I EY+ G + L ++ + +
Sbjct: 99 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 158
Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNE 277
++ + NY+HRD+ N+L++ N K+SDFGL + VL+D+
Sbjct: 159 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR--------------VLEDDPEAT 204
Query: 278 SMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337
G+ P RW APE + + + D
Sbjct: 205 YTTSGGKIP-----IRW---------------------------TAPEAISYRKFTSASD 232
Query: 338 WWSLGAIMYEML-VGYPPFY 356
WS G +M+E++ G P++
Sbjct: 233 VWSFGIVMWEVMTYGERPYW 252
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 3e-15
Identities = 57/255 (22%), Positives = 102/255 (40%), Gaps = 55/255 (21%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
+ ++ LL +G G FG V+L + K ++ A+K +K+ M + E + +
Sbjct: 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSM----SEDEFFQEAQTMMK 59
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSV-LAIES 221
++ +VK Y +Y++ EY+ G ++ L E + V +
Sbjct: 60 LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
+ H +IHRD+ N L+D++ +K+SDFG+ + VLDD+ V
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDFGMTR-------------YVLDDQ---YVSSV 163
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341
+FP +W APEV Y + D W+
Sbjct: 164 GTKFP-----VKW---------------------------SAPEVFHYFKYSSKSDVWAF 191
Query: 342 GAIMYEML-VGYPPF 355
G +M+E+ +G P+
Sbjct: 192 GILMWEVFSLGKMPY 206
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 3e-15
Identities = 58/259 (22%), Positives = 103/259 (39%), Gaps = 61/259 (23%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
I D L +G G FG V+ + + ++ A+K +K+ M + E ++
Sbjct: 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSM----SEDEFIEEAKVMMN 75
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLA---- 218
++ +V+LY +++I EY+ G ++ L +T + + V
Sbjct: 76 LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 135
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
+ES ++HRD+ N L++ G +K+SDFGL + VLDDE +
Sbjct: 136 LES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSR-------------YVLDDEY---T 176
Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
V +FP RW PEVL+ + + D
Sbjct: 177 SSVGSKFP-----VRW---------------------------SPPEVLMYSKFSSKSDI 204
Query: 339 WSLGAIMYEML-VGYPPFY 356
W+ G +M+E+ +G P+
Sbjct: 205 WAFGVLMWEIYSLGKMPYE 223
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 20/163 (12%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK---SEMLSRGQVEHVRAER--NLL 160
+ L IG GA G V + A+KKL + ++ ++ RA R L+
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK------RAYRELVLM 78
Query: 161 AEVASHCIVKLY------YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQ 214
V I+ L S ++ + +Y++ME + ++ ++ E L + + Q
Sbjct: 79 KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQ 135
Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
+ I+ +H IHRD+KP N+++ + +K+ DFGL +
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 5e-15
Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 20/163 (12%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK---SEMLSRGQVEHVRAER--NLL 160
+ L IG GA G V + A+KKL + ++ ++ RA R L+
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK------RAYRELVLM 115
Query: 161 AEVASHCIVKLY------YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQ 214
V I+ L + ++ + +YL+ME + ++ ++ E L + + Q
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQ 172
Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
+ I+ +H IHRD+KP N+++ + +K+ DFGL +
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 61/343 (17%), Positives = 123/343 (35%), Gaps = 58/343 (16%)
Query: 24 LEEEGEIGSSLTMERVAAAKQFIESHYKAQMKHIQERKQRRSVLERKLASSDVPEEEQIN 83
++ G R + A + + I ++ + L +K S ++ +
Sbjct: 4 IDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANT 63
Query: 84 ILKDLERKETEYMRLKRH---KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIY---AMK 137
+ DL E ++ +H S +IGRG FG V + A+K
Sbjct: 64 VHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 123
Query: 138 KLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY-YSFQDAEYLYLIMEYLPGGDVMTL 196
L + G+V E ++ + + ++ L + +++ Y+ GD+
Sbjct: 124 SLN--RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 181
Query: 197 LMREETLTETVARF--YIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
+ R ET TV + Q ++ + ++HRD+ N +LD+ +K++DFGL +
Sbjct: 182 I-RNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240
Query: 255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYS 314
++ D E + + P +W
Sbjct: 241 -------------DMYDKEFDSVHNKTGAKLP-----VKW-------------------- 262
Query: 315 TVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPPFY 356
+A E L + + + D WS G +++E++ G PP+
Sbjct: 263 -------MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 298
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 6e-15
Identities = 27/163 (16%), Positives = 58/163 (35%), Gaps = 25/163 (15%)
Query: 114 IGRGAFGEVRLCQEKKSGNI--------YAMKKLKKSEMLSRGQVEHVRAERNL------ 159
R G + + +++K K L Q RA + L
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 160 -LAEVASHCIVKLYYS-FQDAEYLYLIMEYLPGGDVMTLLM---REETLTETVARFYIA- 213
L I +Y +L++ L G + + L + +V + +A
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQ--VAC 166
Query: 214 QSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMK--LSDFGLCK 254
+ + A+E +H++ Y+H ++ +N+ +D + L+ +G
Sbjct: 167 RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 7e-15
Identities = 63/275 (22%), Positives = 111/275 (40%), Gaps = 59/275 (21%)
Query: 86 KDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVR---LCQEKKSGNIYAMKKLKKS 142
D E + + + LKR + + D +G G FG VR KK ++ A+K LK
Sbjct: 320 SDPEELKDKKLFLKRDNLLIAD----IELGCGNFGSVRQGVYRMRKKQIDV-AIKVLK-- 372
Query: 143 EMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMT-LLMREE 201
+ + E + E ++ ++ + IV+L AE L L+ME GG + L+ + E
Sbjct: 373 QGTEKADTEEMMREAQIMHQLDNPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKRE 431
Query: 202 TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261
+ + + Q + ++ + + N++HR++ N+LL + K+SDFGL K
Sbjct: 432 EIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSK------- 484
Query: 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDY 321
L ++ + G++P +W
Sbjct: 485 -------ALGADDSYYTARSAGKWP-----LKW--------------------------- 505
Query: 322 IAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPPF 355
APE + + + D WS G M+E L G P+
Sbjct: 506 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 35/164 (21%), Positives = 65/164 (39%), Gaps = 27/164 (16%)
Query: 114 IGRGAFGEVRLCQEKKSGNI-----YAMKKLKK--------SEMLSRGQVEHVRAERNLL 160
IG+G FG + L S ++ +K + R +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 161 AEVASHCIVKLYYS----FQDAEYLYLIMEYLPGGDVMTLLM---REETLTETVARFYIA 213
++ + K + S Y ++IM+ G D+ + + + +TV + ++
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSR-KTVLQ--LS 158
Query: 214 -QSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMK--LSDFGLCK 254
+ + +E IH+H Y+H DIK NLLL+ + L D+GL
Sbjct: 159 LRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 9e-15
Identities = 56/256 (21%), Positives = 98/256 (38%), Gaps = 74/256 (28%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
+++ + LL IG+G FG+V L + GN A+K +K + LAE
Sbjct: 18 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT-----------AQAFLAE 64
Query: 163 VA-----SHC-IVKLY-YSFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVARFYIA 213
+ H +V+L ++ LY++ EY+ G ++ L L +
Sbjct: 65 ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 124
Query: 214 QSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDE 273
A+E + +N++HRD+ N+L+ ++ K+SDFGL K +
Sbjct: 125 DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------------EA 167
Query: 274 NLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG 333
S G+ P +W APE L +K +
Sbjct: 168 ---SSTQDTGKLP-----VKW---------------------------TAPEALREKKFS 192
Query: 334 MECDWWSLGAIMYEML 349
+ D WS G +++E+
Sbjct: 193 TKSDVWSFGILLWEIY 208
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 1e-14
Identities = 57/259 (22%), Positives = 95/259 (36%), Gaps = 56/259 (21%)
Query: 103 ISVDDFDLLTIIGRGAFGEVR--LCQEKKSGNIY-AMKKLKKSEMLSRGQVEHVRAERNL 159
I + +L IG G FG+V + ++ + A+K K S E E
Sbjct: 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFLQEALT 69
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMT-LLMREETLTETVARFYIAQSVLA 218
+ + IVKL + +++IME G++ + L +R+ +L Y Q A
Sbjct: 70 MRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 128
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
+ + ++HRDI N+L+ N +KL DFGL + ++ D
Sbjct: 129 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-------------DST---YY 172
Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
G+ P +W +APE + + + D
Sbjct: 173 KASKGKLP-----IKW---------------------------MAPESINFRRFTSASDV 200
Query: 339 WSLGAIMYEML-VGYPPFY 356
W G M+E+L G PF
Sbjct: 201 WMFGVCMWEILMHGVKPFQ 219
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 62/259 (23%), Positives = 98/259 (37%), Gaps = 56/259 (21%)
Query: 103 ISVDDFDLLTIIGRGAFGEVR--LCQEKKSGNIY-AMKKLKKSEMLSRGQVEHVRAERNL 159
I+ +D L I+G G FGEV + K I A+K KK L E +E +
Sbjct: 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD--NKEKFMSEAVI 66
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLA 218
+ + IVKL ++ E ++IME P G++ L R + +L Y Q A
Sbjct: 67 MKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 125
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
+ + N +HRDI N+L+ +KL DFGL + + D++
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSR-------------YIEDED---YY 169
Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
R P +W ++PE + + + D
Sbjct: 170 KASVTRLP-----IKW---------------------------MSPESINFRRFTTASDV 197
Query: 339 WSLGAIMYEML-VGYPPFY 356
W M+E+L G PF+
Sbjct: 198 WMFAVCMWEILSFGKQPFF 216
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-14
Identities = 50/253 (19%), Positives = 93/253 (36%), Gaps = 53/253 (20%)
Query: 110 LLTIIGRGAFGEVRLCQEKKSGNIY---AMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
+IG+G FG V + A+K L + QVE E L+ +
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS--RITEMQQVEAFLREGLLMRGLNHP 82
Query: 167 CIVKLY-YSFQDAEYLYLIMEYLPGGDVMT-LLMREETLTETVARFYIAQSVLAIESIHK 224
++ L ++++ Y+ GD++ + + T + Q +E + +
Sbjct: 83 NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE 142
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
++HRD+ N +LD++ +K++DFGL + ++LD E + R
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLAR-------------DILDREYYSVQQHRHAR 189
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344
P +W A E L + + D WS G +
Sbjct: 190 LP-----VKW---------------------------TALESLQTYRFTTKSDVWSFGVL 217
Query: 345 MYEML-VGYPPFY 356
++E+L G PP+
Sbjct: 218 LWELLTRGAPPYR 230
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 8e-14
Identities = 45/174 (25%), Positives = 76/174 (43%), Gaps = 21/174 (12%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIY--AMKKLKKSEMLSRGQVEHVRAERNLL 160
+ +D +IG G FG+V + KK G A+K++K E S+ E +L
Sbjct: 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVL 79
Query: 161 AEVASHC-IVKLYYSFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVARFYIAQSVL 217
++ H I+ L + + YLYL +EY P G+++ L R A S L
Sbjct: 80 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139
Query: 218 AIESIHK--------------HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
+ + + +IHRD+ N+L+ +N K++DFGL + +
Sbjct: 140 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE 193
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 57/253 (22%), Positives = 100/253 (39%), Gaps = 64/253 (25%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
+ + L+ +G G FGEV + + A+K LK+ M + AE NL+ +
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQ 64
Query: 163 VASHCIVKLYYSFQDA----EYLYLIMEYLPGGDVMTLLMREETLTETVARF--YIAQSV 216
+ +V+LY A E +Y+I EY+ G ++ L + T+ + AQ
Sbjct: 65 LQHQRLVRLY-----AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLN 276
+ I + NYIHRD++ N+L+ K++DFGL + + D+E
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR-------------LIEDNEYTA 166
Query: 277 ESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336
+FP +W APE + + ++
Sbjct: 167 RE---GAKFP-----IKW---------------------------TAPEAINYGTFTIKS 191
Query: 337 DWWSLGAIMYEML 349
D WS G ++ E++
Sbjct: 192 DVWSFGILLTEIV 204
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 44/169 (26%), Positives = 70/169 (41%), Gaps = 40/169 (23%)
Query: 106 DDFDLLTIIGRGAFGEV---RLCQEKKSGNIYAMKKLKKS------------EMLSRGQV 150
++FD +IG G FG+V L + G A+K+ E LS
Sbjct: 39 NNFDHKFLIGHGVFGKVYKGVL----RDGAKVALKRRTPESSQGIEEFETEIETLSF--C 92
Query: 151 EHVRAERNLLAEVASHCIVKLY-YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTET--- 206
H +L V L + + E + LI +Y+ G++ L + T +
Sbjct: 93 RH----PHL---------VSLIGFCDERNEMI-LIYKYMENGNLKRHLYGSDLPTMSMSW 138
Query: 207 VARFYIA-QSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
R I + + +H IHRD+K N+LLD+N K++DFG+ K
Sbjct: 139 EQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 59/262 (22%), Positives = 104/262 (39%), Gaps = 54/262 (20%)
Query: 99 KRHKISVDDFDLLTI-IGRGAFGEVRLCQEKKSGNIY--AMKKLKKSEMLSRGQVEHVRA 155
K+ + D+ + I +G G FG VR + A+K LK + + E +
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK--QGTEKADTEEMMR 59
Query: 156 ERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM-REETLTETVARFYIAQ 214
E ++ ++ + IV+L AE L L+ME GG + L+ + E + + + Q
Sbjct: 60 EAQIMHQLDNPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118
Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDEN 274
+ ++ + + N++HRD+ N+LL + K+SDFGL K L ++
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK--------------ALGADD 164
Query: 275 LNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM 334
+ G++P +W APE + + +
Sbjct: 165 SYYTARSAGKWP-----LKW---------------------------YAPECINFRKFSS 192
Query: 335 ECDWWSLGAIMYEML-VGYPPF 355
D WS G M+E L G P+
Sbjct: 193 RSDVWSYGVTMWEALSYGQKPY 214
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 45/277 (16%), Positives = 91/277 (32%), Gaps = 80/277 (28%)
Query: 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIY-------AMKKLKKSEMLSRGQVEHV 153
HKI +D +G+G F ++ ++ G+ +K L K+ E
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---ESF 59
Query: 154 RAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIA 213
+++++++ +V Y + L+ E++ G + T L + + + + +A
Sbjct: 60 FEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVA 119
Query: 214 QSVLA----IESIHKHNYIHRDIKPDNLLLDQ--------NGHMKLSDFGLCKPLDCTNL 261
+ + A +E + IH ++ N+LL + +KLSD G+
Sbjct: 120 KQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI------- 169
Query: 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDY 321
VL + + W
Sbjct: 170 ------TVLPKDI--------LQER-----IPW--------------------------- 183
Query: 322 IAPEVLL-KKGYGMECDWWSLGAIMYEML-VGYPPFY 356
+ PE + K + D WS G ++E+ G P
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS 220
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 44/173 (25%), Positives = 71/173 (41%), Gaps = 27/173 (15%)
Query: 100 RHKISVDDFDLLTIIGRGAFGEVRLCQ----EKKSGNIY-AMKKLKKSEMLSRGQVEHVR 154
R+ + +G GAFG+V K+ + A+K LK + + E +
Sbjct: 45 RNNLQ-----FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD--EKEALM 97
Query: 155 AERNLLAEVASHC-IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIA 213
+E +++ + H IV L + + +I EY GD++ L R+ + ET F IA
Sbjct: 98 SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 214 QSVLAIESIHK--------------HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
S + + N IHRD+ N+LL K+ DFGL
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL 210
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 51/257 (19%), Positives = 96/257 (37%), Gaps = 61/257 (23%)
Query: 110 LLTIIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH 166
+IGRG FG V L A+K L + G+V E ++ + +
Sbjct: 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--RITDIGEVSQFLTEGIIMKDFSHP 86
Query: 167 CIVKLY-YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFY-----IAQSVLAIE 220
++ L + +++ Y+ GD+ + R ET TV +A+ + +
Sbjct: 87 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLA 145
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
S ++HRD+ N +LD+ +K++DFGL + ++ D E +
Sbjct: 146 S---KKFVHRDLAARNCMLDEKFTVKVADFGLAR-------------DMYDKEYYSVHNK 189
Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340
+ P +W +A E L + + + D WS
Sbjct: 190 TGAKLP-----VKW---------------------------MALESLQTQKFTTKSDVWS 217
Query: 341 LGAIMYEML-VGYPPFY 356
G +++E++ G PP+
Sbjct: 218 FGVLLWELMTRGAPPYP 234
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 39/172 (22%), Positives = 69/172 (40%), Gaps = 18/172 (10%)
Query: 97 RLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIY---AMKKLKKSEMLSRGQVEHV 153
+L+ I F L ++G+G FG VR Q K+ + A+K LK + + +E
Sbjct: 14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEF 72
Query: 154 RAERNLLAEVASHCIVKLY------YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETV 207
E + E + KL + +I+ ++ GD+ L + E
Sbjct: 73 LREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL-LASRIGENP 131
Query: 208 ARFYIAQSVLAIESIHK-------HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
+ V + I N+IHRD+ N +L ++ + ++DFGL
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGL 183
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 6e-13
Identities = 48/206 (23%), Positives = 83/206 (40%), Gaps = 36/206 (17%)
Query: 71 LASSDVPEEEQINIL-KDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQ--- 126
+ ++P +E L D + E R ++ L +GRGAFG+V
Sbjct: 1 MDPDELPLDEHCERLPYDASKWE-----FPRDRLK-----LGKPLGRGAFGQVIEADAFG 50
Query: 127 --EKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKLY-YSFQDAEYLY 182
+ + A+K LK+ S + + +E +L + H +V L + L
Sbjct: 51 IDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 108
Query: 183 LIMEYLPGGDVMTLLM--REETLTETVARFYIAQSVLAIESIHK--------------HN 226
+I+E+ G++ T L R E + VA + + L +E +
Sbjct: 109 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 168
Query: 227 YIHRDIKPDNLLLDQNGHMKLSDFGL 252
IHRD+ N+LL + +K+ DFGL
Sbjct: 169 CIHRDLAARNILLSEKNVVKICDFGL 194
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 45/245 (18%), Positives = 93/245 (37%), Gaps = 43/245 (17%)
Query: 49 HYK-AQMKHIQERKQRRSVLERKL---ASSDVPEEEQINILKDLERKET-----EYMRLK 99
H+ +Q + +R L R++ A S +++ R + +
Sbjct: 7 HHHHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVS 66
Query: 100 RHKISVDD--------FDLLTIIGRGAFGEV------RLCQEKKSGNIY-AMKKLKKSEM 144
+++ D L +G G FG+V + ++K + A+K LK +
Sbjct: 67 EYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DD 124
Query: 145 LSRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM--REE 201
+ + + +E ++ + H I+ L + LY+I+EY G++ L R
Sbjct: 125 ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 184
Query: 202 TLTETVARFYIAQSVLAIESIHK--------------HNYIHRDIKPDNLLLDQNGHMKL 247
+ + + + + + + IHRD+ N+L+ +N MK+
Sbjct: 185 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 244
Query: 248 SDFGL 252
+DFGL
Sbjct: 245 ADFGL 249
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 9e-13
Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 30/158 (18%)
Query: 113 IIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA----- 164
+G G FG V + + A+KKL ++ + ++ E+
Sbjct: 38 KMGEGGFGVVYKGYV-----NNTTVAVKKLAAMVDITTEE-----LKQQFDQEIKVMAKC 87
Query: 165 SH-CIVKLY-YSFQDAEYLYLIMEYLPGGDVMT-LLMREETLT---ETVARFYIAQSVLA 218
H +V+L +S + L+ Y+P G ++ L + T R IAQ A
Sbjct: 88 QHENLVELLGFSSDGDDLC-LVYVYMPNGSLLDRLSCLDGTPPLSWHM--RCKIAQGA-A 143
Query: 219 --IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254
I +H++++IHRDIK N+LLD+ K+SDFGL +
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLAR 181
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 57/208 (27%), Positives = 86/208 (41%), Gaps = 50/208 (24%)
Query: 75 DVPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEV---RLCQEKKSG 131
DVP EE + ++ + L+ +++ D+F I+GRG FG+V RL G
Sbjct: 3 DVPAEEDPEVHLGQLKRFS----LRELQVASDNFSNKNILGRGGFGKVYKGRL----ADG 54
Query: 132 NIYAMKKLKKS-------------EMLSRGQVEHVRAERNLLAEVASHCIVKLY-YSFQD 177
+ A+K+LK+ EM+S H RNL ++L +
Sbjct: 55 TLVAVKRLKEERTQGGELQFQTEVEMISM--AVH----RNL---------LRLRGFCMTP 99
Query: 178 AEYLYLIMEYLPGGDVMTLLMREETLTETV---ARFYIAQSV---LAI--ESIHKHNYIH 229
E L L+ Y+ G V + L + R IA LA + IH
Sbjct: 100 TERL-LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK-IIH 157
Query: 230 RDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
RD+K N+LLD+ + DFGL K +D
Sbjct: 158 RDVKAANILLDEEFEAVVGDFGLAKLMD 185
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 44/177 (24%), Positives = 73/177 (41%), Gaps = 31/177 (17%)
Query: 100 RHKISVDDFDLLTIIGRGAFGEVRLCQ----EKKSGNIY-AMKKLKKSEMLSRGQVEHVR 154
R+++S +G GAFG+V K + A+K LK S L+ + E +
Sbjct: 22 RNRLS-----FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALM 74
Query: 155 AERNLLAEVASHC-IVKLYYSFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVARFY 211
+E +L+ + +H IV L + +I EY GD++ L R+ + +
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 212 IAQSVLAIES----------------IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
+ LA++ + N IHRD+ N+LL K+ DFGL
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL 191
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 38/191 (19%), Positives = 74/191 (38%), Gaps = 34/191 (17%)
Query: 94 EYMRLKRHKISVDD--------FDLLTIIGRGAFGEV------RLCQEKKSGNIY-AMKK 138
+ +++ D L +G GAFG+V + ++K + A+K
Sbjct: 15 MLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM 74
Query: 139 LKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDAEYLYLIMEYLPGGDVMTLL 197
LK + + +E ++ + H I+ L + LY+I+EY G++ L
Sbjct: 75 LKDDATEK--DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
Query: 198 --MREETLTETVARFYIAQSVLAIESIHK--------------HNYIHRDIKPDNLLLDQ 241
R + + + + + + + IHRD+ N+L+ +
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 242 NGHMKLSDFGL 252
N MK++DFGL
Sbjct: 193 NNVMKIADFGL 203
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 48/211 (22%), Positives = 81/211 (38%), Gaps = 39/211 (18%)
Query: 79 EEQINILKDLERKETEYMRLKRHKISVDD---FD-----LLTIIGRGAFGEVRLCQ---- 126
E Q+ +++ + EY + + D F ++G GAFG+V
Sbjct: 10 ESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGI 69
Query: 127 EKKSGNIY-AMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDAEYLYLI 184
K +I A+K LK+ S + E + +E ++ ++ SH IV L + + +YLI
Sbjct: 70 SKTGVSIQVAVKMLKEKADSS--EREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 127
Query: 185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK-------------------- 224
EY GD++ L + Y Q L E
Sbjct: 128 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 187
Query: 225 ---HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
+ +HRD+ N+L+ +K+ DFGL
Sbjct: 188 LEFKSCVHRDLAARNVLVTHGKVVKICDFGL 218
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 5e-12
Identities = 35/164 (21%), Positives = 71/164 (43%), Gaps = 15/164 (9%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIY---AMKKLKKSEMLSRGQVEHVRAERNL 159
I + L I+G G FG V K+ A+K +K + S+ ++E +E
Sbjct: 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKL-DNSSQREIEEFLSEAAC 89
Query: 160 LAEVASHCIVKLY-----YSFQDAEYLYLIMEYLPGGDVMTLLMR------EETLTETVA 208
+ + + +++L S Q +I+ ++ GD+ T L+ + +
Sbjct: 90 MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL 149
Query: 209 RFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
++ L +E + N++HRD+ N +L + + ++DFGL
Sbjct: 150 LKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGL 193
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 8e-12
Identities = 40/179 (22%), Positives = 71/179 (39%), Gaps = 31/179 (17%)
Query: 98 LKRHKISVDDFDLLTIIGRGAFGEVRLC-------QEKKSGNIYAMKKLKKSEMLSRGQV 150
L R ++ L +G GAFG+V L + A+K LK +
Sbjct: 66 LPRDRLV-----LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DL 118
Query: 151 EHVRAERNLLAEVASHC-IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM--REETLTETV 207
+ +E ++ + H I+ L + LY+I+EY G++ L R L +
Sbjct: 119 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 178
Query: 208 ARFYIAQSVLAIESIHK--------------HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
+ + L+ + + IHRD+ N+L+ ++ MK++DFGL
Sbjct: 179 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL 237
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 39/175 (22%), Positives = 70/175 (40%), Gaps = 28/175 (16%)
Query: 98 LKRHKISVDDFDLLTIIGRGAFGEVRLCQ----EKKSGNIY-AMKKLKKSEMLSRGQVEH 152
+KR I L +G GAFG+V L + + + A+K LK++ +R +
Sbjct: 38 IKRRDIV-----LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR---QD 89
Query: 153 VRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL-MREETLTETVARFY 211
+ E LL + IV+ + + L ++ EY+ GD+ L
Sbjct: 90 FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 149
Query: 212 IAQSVLAIESIHK--------------HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
+A L + + +++HRD+ N L+ Q +K+ DFG+
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGM 204
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 42/176 (23%), Positives = 72/176 (40%), Gaps = 29/176 (16%)
Query: 98 LKRHKISVDDFDLLTIIGRGAFGEVRLCQ----EKKSGNIY-AMKKLKKSEMLSRGQVEH 152
+KR I L +G GAFG+V L + + A+K LK + +R +
Sbjct: 12 IKRRDIV-----LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR---KD 63
Query: 153 VRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM--REETLTETVARF 210
+ E LL + IVK Y D + L ++ EY+ GD+ L + + +
Sbjct: 64 FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 123
Query: 211 YIAQSVLAIESIHK--------------HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
A+ L + + +++HRD+ N L+ N +K+ DFG+
Sbjct: 124 RQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGM 179
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 48/275 (17%), Positives = 96/275 (34%), Gaps = 70/275 (25%)
Query: 98 LKRHKISVDDFDLLTIIGRGAFGEVRLCQ-----EKKSGNIYAMKKLKKSEMLSRGQVEH 152
+ R KI+ + +G+G+FG V + + A+K + E S +
Sbjct: 22 VAREKIT-----MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIE 74
Query: 153 VRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM--REETLTETVARF 210
E +++ E H +V+L + +IME + GD+ + L R V
Sbjct: 75 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134
Query: 211 YIAQSVLAI--------ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262
++ + ++ + ++HRD+ N ++ ++ +K+ DFG+ +
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD------- 187
Query: 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYI 322
I E + G P RW +
Sbjct: 188 -IYETDY-------YRKGGKGLLP-----VRW---------------------------M 207
Query: 323 APEVLLKKGYGMECDWWSLGAIMYEML-VGYPPFY 356
+PE L + D WS G +++E+ + P+
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 242
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 42/184 (22%), Positives = 70/184 (38%), Gaps = 36/184 (19%)
Query: 98 LKRHKISVDDFDLLTIIGRGAFGEVRLCQ----EKKSGNIY-AMKKLKKSEMLSRGQVEH 152
R + L +G G FG+V + ++G A+K LK++ S ++
Sbjct: 20 FPRKNLV-----LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS--ELRD 72
Query: 153 VRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM--REETLTETVARF 210
+ +E N+L +V ++KLY + L LI+EY G + L R+ +
Sbjct: 73 LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 211 YIAQSVLAIESIHK----------------------HNYIHRDIKPDNLLLDQNGHMKLS 248
S L +HRD+ N+L+ + MK+S
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKIS 192
Query: 249 DFGL 252
DFGL
Sbjct: 193 DFGL 196
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 51/271 (18%), Positives = 95/271 (35%), Gaps = 67/271 (24%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQ----EKKSGNIY-AMKKLKKSEMLSRGQVEHVRAER 157
+ + L+ +G GAFGEV Q + A+K L E+ S E
Sbjct: 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP--EVCSEQDELDFLMEA 125
Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL 217
++++ IV+ + ++++E + GGD+ + L RE + +L
Sbjct: 126 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLL 184
Query: 218 AI--------ESIHKHNYIHRDIKPDNLLLDQNGH---MKLSDFGLCKPLDCTNLSAINE 266
+ + + ++++IHRDI N LL G K+ DFG+ + I
Sbjct: 185 HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--------IYR 236
Query: 267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEV 326
P +W + PE
Sbjct: 237 AGY-------YRKGGCAMLP-----VKW---------------------------MPPEA 257
Query: 327 LLKKGYGMECDWWSLGAIMYEML-VGYPPFY 356
++ + + D WS G +++E+ +GY P+
Sbjct: 258 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 288
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 52/271 (19%), Positives = 95/271 (35%), Gaps = 67/271 (24%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQ----EKKSGNIY-AMKKLKKSEMLSRGQVEHVRAER 157
+ + L+ +G GAFGEV Q + A+K L E+ S E
Sbjct: 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP--EVCSEQDELDFLMEA 84
Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL 217
++++ IV+ + +++ME + GGD+ + L RE + +L
Sbjct: 85 LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAMLDLL 143
Query: 218 AI--------ESIHKHNYIHRDIKPDNLLLDQNGH---MKLSDFGLCKPLDCTNLSAINE 266
+ + + ++++IHRDI N LL G K+ DFG+ + I
Sbjct: 144 HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--------IYR 195
Query: 267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEV 326
P +W + PE
Sbjct: 196 ASY-------YRKGGCAMLP-----VKW---------------------------MPPEA 216
Query: 327 LLKKGYGMECDWWSLGAIMYEML-VGYPPFY 356
++ + + D WS G +++E+ +GY P+
Sbjct: 217 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 247
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 35/171 (20%), Positives = 57/171 (33%), Gaps = 23/171 (13%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQ----EKKSGNIY-AMKKLKKSEMLSRGQVEHVRAER 157
IS+ + +G FG+V A+K LK E R E
Sbjct: 6 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP--LREEFRHEA 63
Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLL--MREETLTETVARFYIAQS 215
L A + +V L + L +I Y GD+ L + + +S
Sbjct: 64 MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 216 VLAIESIHK--------------HNYIHRDIKPDNLLLDQNGHMKLSDFGL 252
L H+ +H+D+ N+L+ ++K+SD GL
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL 174
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 42/184 (22%), Positives = 64/184 (34%), Gaps = 36/184 (19%)
Query: 98 LKRHKISVDDFDLLTIIGRGAFGEVRLCQ----EKKSGNIY-AMKKLKKSEMLSRGQVEH 152
R+ I + IG GAFG V + A+K LK E S
Sbjct: 44 YPRNNIE-----YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK--EEASADMQAD 96
Query: 153 VRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYI 212
+ E L+AE + IVKL + + L+ EY+ GD+ L T
Sbjct: 97 FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156
Query: 213 AQSVLAIESIHK------------------------HNYIHRDIKPDNLLLDQNGHMKLS 248
+ + S ++HRD+ N L+ +N +K++
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 216
Query: 249 DFGL 252
DFGL
Sbjct: 217 DFGL 220
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 55.7 bits (133), Expect = 1e-08
Identities = 33/200 (16%), Positives = 60/200 (30%), Gaps = 48/200 (24%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKL-----KKSEMLSRGQVEHVRAER 157
+ + IG G FGEV A+K + + E + E
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 158 NLLAEVA-----------------SHCIVKLYY----------------------SFQDA 178
+ E++ S V+ Y F
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNL 237
+ L++++E+ GG + MR + + A+ + Q ++ + HRD+ N+
Sbjct: 135 DQLFIVLEFEFGGIDL-EQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNV 193
Query: 238 LLDQNGHMKLSDFGLCKPLD 257
LL + KL K
Sbjct: 194 LLKKTSLKKLHYTLNGKSST 213
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 5e-08
Identities = 38/192 (19%), Positives = 67/192 (34%), Gaps = 22/192 (11%)
Query: 76 VPEEEQINILKDLERKETEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQ-----EKKS 130
+P +E L + + E+ R D L +GRGAFG+V + +
Sbjct: 1 LPLDEHCERL-PYDASKWEFPR--------DRLKLGKPLGRGAFGQVIEADAFGIDKTAT 51
Query: 131 GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKLY-YSFQDAEYLYLIMEYL 188
A+K LK+ S + + +E +L + H +V L + L +I+E+
Sbjct: 52 CRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFC 109
Query: 189 PGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLS 248
G++ T L + Y + + I D+K + + S
Sbjct: 110 KFGNLSTYLRSKRNEFVP----YKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASS 165
Query: 249 DFGLCKPLDCTN 260
F K L
Sbjct: 166 GFVEEKSLSDVE 177
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 30/147 (20%), Positives = 56/147 (38%), Gaps = 17/147 (11%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKK-LKKS----EMLSRGQVEHVRAERNLLAEVASHC 167
+IG+GA E + ++ +K+ +KK + + E LA V
Sbjct: 343 LIGKGA--EADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFG 400
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
I Y D + ++M Y+ G ++ + + + +HK++
Sbjct: 401 IPAPYIFDVDLDNKRIMMSYINGKLAKDVIEDNLDIAYKIGE--------IVGKLHKNDV 452
Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCK 254
IH D+ N + D + + DFGL K
Sbjct: 453 IHNDLTTSNFIFD--KDLYIIDFGLGK 477
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 514 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.95 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.78 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.44 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.22 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.18 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.89 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.71 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.61 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.56 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.51 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.37 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.35 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.25 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.04 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.91 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.73 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.53 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.53 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.51 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.51 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.47 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.43 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.42 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.17 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.04 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.89 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.5 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.96 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.39 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-74 Score=576.28 Aligned_cols=276 Identities=36% Similarity=0.682 Sum_probs=252.5
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 181 (514)
+...+||++++.||+|+||+||+|+++.||+.||||++.+..+...+..+.+.+|+++|+.++|||||+++++|++++++
T Consensus 28 ~~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 107 (311)
T 4aw0_A 28 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 107 (311)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 34568999999999999999999999999999999999988776677788999999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
|||||||+||||.++|.+.+.++|..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+.....
T Consensus 108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999987642210
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
...+.++||||.|||||++.+.+|+.++|||||
T Consensus 188 -----------------------------------------------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSl 220 (311)
T 4aw0_A 188 -----------------------------------------------QARANSFVGTAQYVSPELLTEKSACKSSDLWAL 220 (311)
T ss_dssp -----------------------------------------------CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHH
T ss_pred -----------------------------------------------cccccCcccCcccCCHHHHcCCCCCcHHHHHHH
Confidence 112347899999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhH------HhcCCc
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQ------IKAHPW 414 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~e------il~Hpf 414 (514)
||+||||++|.+||.+.+..+++.+|+. ..+.+|. .+|++++|||.+||+ ||.+|+ |++| |++|||
T Consensus 221 Gvilyeml~G~~PF~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~dli~~lL~~dp~~R~---t~~e~~~~~~i~~Hp~ 293 (311)
T 4aw0_A 221 GCIIYQLVAGLPPFRAGNEGLIFAKIIK--LEYDFPE--KFFPKARDLVEKLLVLDATKRL---GCEEMEGYGPLKAHPF 293 (311)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCCCCCT--TCCHHHHHHHHHHSCSSGGGST---TSGGGTCHHHHHTSGG
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCc--ccCHHHHHHHHHHccCCHhHCc---ChHHHcCCHHHHCCCC
Confidence 9999999999999999999999999987 4567775 689999999999999 999999 5555 799999
Q ss_pred cccCCccccccccCCCC
Q 010266 415 FKDIAWDKLYEMEAAYK 431 (514)
Q Consensus 415 f~~i~w~~l~~~~~p~~ 431 (514)
|+++||+.|++..||.+
T Consensus 294 F~~idw~~l~~~~pP~l 310 (311)
T 4aw0_A 294 FESVTWENLHQQTPPKL 310 (311)
T ss_dssp GTTCCCTTGGGSCCCCC
T ss_pred cCCCCHHHhcCCCCCCC
Confidence 99999999998877753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-72 Score=609.93 Aligned_cols=317 Identities=31% Similarity=0.593 Sum_probs=268.5
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHH---HcCCCceeeEEEEEE
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA---EVASHCIVKLYYSFQ 176 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~---~l~hp~Iv~l~~~f~ 176 (514)
...++++||+++++||+|+||+||+|+++.||+.||||++.|..+........+.+|+.++. .++|||||+++++|+
T Consensus 183 ~~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~ 262 (689)
T 3v5w_A 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH 262 (689)
T ss_dssp TCCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred CCCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence 34788999999999999999999999999999999999999887766666777777766655 457999999999999
Q ss_pred cCCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccC
Q 010266 177 DAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256 (514)
Q Consensus 177 ~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~ 256 (514)
+.+++|||||||+||||..+|.+.+.|++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcc
Q 010266 257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGME 335 (514)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~ 335 (514)
... .+.+.||||.|||||++.+ .+|+.+
T Consensus 343 ~~~---------------------------------------------------~~~t~~GTp~YmAPEvl~~~~~y~~~ 371 (689)
T 3v5w_A 343 SKK---------------------------------------------------KPHASVGTHGYMAPEVLQKGVAYDSS 371 (689)
T ss_dssp SSC---------------------------------------------------CCCSCCSCGGGCCHHHHSTTCCCCTH
T ss_pred CCC---------------------------------------------------CCCCccCCcCccCHHHHhCCCCCCcH
Confidence 321 1337899999999999974 689999
Q ss_pred cchhhhhHHHHHHhhCCCCCCCCC---hhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCC--CCHhHH
Q 010266 336 CDWWSLGAIMYEMLVGYPPFYSDD---PVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT--LGSEQI 409 (514)
Q Consensus 336 ~DiWSlGvilyemltG~~PF~~~~---~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~ei 409 (514)
+|||||||+||||++|.+||.+.+ ..++...+.. ..+.+|. .+|++++|||.+||+ ||.+|+|. .+++||
T Consensus 372 vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~--~~~~~p~--~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei 447 (689)
T 3v5w_A 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 447 (689)
T ss_dssp HHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC--CCCCCCc--cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHH
Confidence 999999999999999999998643 3445556655 4556665 699999999999999 99999985 369999
Q ss_pred hcCCccccCCccccc--cccCCCCCcCCCCCCCCCCCC--CCcccCCCCCCCCCCccccccCCCCCCcccCeeeec
Q 010266 410 KAHPWFKDIAWDKLY--EMEAAYKPEVNGVLDTQNFMK--FDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKN 481 (514)
Q Consensus 410 l~Hpff~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~ 481 (514)
++||||++|||+.|. ++.|||+|.+.+..++++||. |+++..... +. ....+..|.||+|..
T Consensus 448 ~~HpfF~~idW~~l~~~~~~pP~~P~~~~~~~~~~fD~~~fd~e~~~~~------~~----~~~d~~~f~~Fs~~~ 513 (689)
T 3v5w_A 448 KESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGI------KL----LDSDQELYRNFPLTI 513 (689)
T ss_dssp TTSGGGTTCCHHHHHTTCSCCSCCCCTTCSSTTBCCC---------CCC------CC----CHHHHTTTTTCCEEC
T ss_pred hcCccccCCCHHHHHcCCCCcCccCCCCCCCcCCCCCCccCCccccCCC------CC----CchHHHHHhCCCccC
Confidence 999999999999985 689999999998888888873 333321111 00 112356789999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-72 Score=560.68 Aligned_cols=279 Identities=43% Similarity=0.761 Sum_probs=243.8
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEc---cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEK---KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 176 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~---~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 176 (514)
..++.+++|++++.||+|+||+||+|++. .+++.||||++++...... ....+.+|+.+|+.++|||||+++++|+
T Consensus 18 ~~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~ 96 (304)
T 3ubd_A 18 HEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQ 96 (304)
T ss_dssp CCCCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEE
T ss_pred cccCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 45566789999999999999999999984 4788999999987654332 3345788999999999999999999999
Q ss_pred cCCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccC
Q 010266 177 DAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256 (514)
Q Consensus 177 ~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~ 256 (514)
+++.+|||||||+||||.++|.+.+.+++..++.|++||+.||+|||++|||||||||+|||++.+|++||+|||+|+..
T Consensus 97 ~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 97 TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp ETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred ECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999864
Q ss_pred CCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCccc
Q 010266 257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336 (514)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 336 (514)
... .....+.+|||.|||||++.+.+|+.++
T Consensus 177 ~~~-------------------------------------------------~~~~~~~~GT~~YmAPE~~~~~~y~~~~ 207 (304)
T 3ubd_A 177 IDH-------------------------------------------------EKKAYSFCGTVEYMAPEVVNRRGHTQSA 207 (304)
T ss_dssp -----------------------------------------------------CCCCSCCCCGGGCCHHHHHTSCCCTHH
T ss_pred cCC-------------------------------------------------CccccccccCcccCCHHHhccCCCCCCC
Confidence 321 0123367999999999999999999999
Q ss_pred chhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CHhHHhcCC
Q 010266 337 DWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHP 413 (514)
Q Consensus 337 DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~Hp 413 (514)
|||||||+||||++|.+||.+.+..+++.+|.+ ..+.+|. .+|+++++||.+||+ ||.+|+++. +++||++||
T Consensus 208 DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp 283 (304)
T 3ubd_A 208 DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK--AKLGMPQ--FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHS 283 (304)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSG
T ss_pred cccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc--CCCCCCC--cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCc
Confidence 999999999999999999999999999999987 4456665 699999999999999 999999642 478999999
Q ss_pred ccccCCccccc--cccCCCCC
Q 010266 414 WFKDIAWDKLY--EMEAAYKP 432 (514)
Q Consensus 414 ff~~i~w~~l~--~~~~p~~p 432 (514)
||+++||+.+. +++|||+|
T Consensus 284 ~f~~idw~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 284 FFSTIDWNKLYRREIHPPFKP 304 (304)
T ss_dssp GGTTCCHHHHHTTCSCCSSCC
T ss_pred cccCCCHHHHHhCCCCcCcCC
Confidence 99999999995 68899998
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-68 Score=558.48 Aligned_cols=344 Identities=43% Similarity=0.805 Sum_probs=283.8
Q ss_pred HHHHhhcCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEE
Q 010266 94 EYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173 (514)
Q Consensus 94 ~~~~~~~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~ 173 (514)
...++.+..+..++|++++.||+|+||+||+|+++.+|+.||||++++.......+..++.+|+.+|..++|||||++++
T Consensus 49 ~~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~ 128 (412)
T 2vd5_A 49 IVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128 (412)
T ss_dssp HHHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred hhhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence 34455667788899999999999999999999999999999999998876656666777899999999999999999999
Q ss_pred EEEcCCeEEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccc
Q 010266 174 SFQDAEYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252 (514)
Q Consensus 174 ~f~~~~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGl 252 (514)
+|++.+++|+||||++||+|.+++.+. ..+++..+++|++||+.||+|||++|||||||||+|||++.+|++||+|||+
T Consensus 129 ~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 129 AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechh
Confidence 999999999999999999999999875 4899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc----
Q 010266 253 CKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---- 328 (514)
Q Consensus 253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---- 328 (514)
|+....... ....+.+||+.|+|||++.
T Consensus 209 a~~~~~~~~------------------------------------------------~~~~~~~Gt~~Y~APE~l~~~~~ 240 (412)
T 2vd5_A 209 CLKLRADGT------------------------------------------------VRSLVAVGTPDYLSPEILQAVGG 240 (412)
T ss_dssp CEECCTTSC------------------------------------------------EECSSCCSCGGGCCHHHHHHHHT
T ss_pred heeccCCCc------------------------------------------------cccceeccccCcCCHHHHhhccc
Confidence 986542210 0122568999999999998
Q ss_pred ---cCCCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCc-CcCCChhHHHHHhhhccCccccCCCC
Q 010266 329 ---KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPE-EARLTPEAKDLICRLLCDVEHRLGTL 404 (514)
Q Consensus 329 ---~~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~dLI~~lL~dp~~Rl~~~ 404 (514)
+..|+.++|||||||++|||++|.+||.+.+..+++.+|+.+...+.+|. ...+|+++++||++||++|.+|+|+.
T Consensus 241 ~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~~p~~Rlgr~ 320 (412)
T 2vd5_A 241 GPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRG 320 (412)
T ss_dssp CTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSSCGGGCTTTT
T ss_pred CcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcCChhhcCCCC
Confidence 35789999999999999999999999999999999999998766666664 24799999999999999999999999
Q ss_pred CHhHHhcCCccccCCccccccccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCC--CCccccccCCCCCCcccCeeeecC
Q 010266 405 GSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTG--SGPMRKMMLTPKDLSFVGYTYKNF 482 (514)
Q Consensus 405 ~~~eil~Hpff~~i~w~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~f~~f~~~~~ 482 (514)
+++||++||||+++||+.+++..|||+|.+.++.|++|||.+.+.......... ............+..|.||||.+.
T Consensus 321 ~~~ei~~Hpff~~i~w~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~ 400 (412)
T 2vd5_A 321 GAGDFRTHPFFFGLDWDGLRDSVPPFTPDFEGATDTCNFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVGYSYSCM 400 (412)
T ss_dssp THHHHHTSGGGTTCCSTTSTTSCCSCCCC-----CCSSCC--CCCCCTTSSSSSCCTTTC-----CCTTGGGTTCCBSCC
T ss_pred CHHHHhcCCCcCCCCHHHHhhcCCCCCCcCCCcccccccCcccccccccccccCCCcccccCCCccccCCCCCCCcccCc
Confidence 999999999999999999999999999999999999999976543221110000 000000001235678999999976
Q ss_pred ccc
Q 010266 483 EAV 485 (514)
Q Consensus 483 ~~~ 485 (514)
...
T Consensus 401 ~~~ 403 (412)
T 2vd5_A 401 ALR 403 (412)
T ss_dssp CCC
T ss_pred ccc
Confidence 543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-68 Score=557.49 Aligned_cols=334 Identities=44% Similarity=0.826 Sum_probs=288.3
Q ss_pred HhhcCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE
Q 010266 97 RLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 176 (514)
Q Consensus 97 ~~~~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 176 (514)
.+....+..++|++++.||+|+||+||+|+++.+++.||||++.+..........++.+|+.+|..++|||||+++++|+
T Consensus 60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34556778899999999999999999999999999999999998866555556667889999999999999999999999
Q ss_pred cCCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccC
Q 010266 177 DAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256 (514)
Q Consensus 177 ~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~ 256 (514)
+..++|+|||||+||+|.+++.. ..+++..+++|++||+.||.|||++|||||||||+|||++.+|++||+|||+|+..
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence 99999999999999999999865 57999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCC----C
Q 010266 257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG----Y 332 (514)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~----y 332 (514)
..... ..+.+.+||+.|+|||++.+.+ |
T Consensus 219 ~~~~~------------------------------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~ 250 (410)
T 3v8s_A 219 NKEGM------------------------------------------------VRCDTAVGTPDYISPEVLKSQGGDGYY 250 (410)
T ss_dssp CTTSE------------------------------------------------EECCSCCSCGGGCCHHHHHTTTTTCEE
T ss_pred ccCCc------------------------------------------------ccccCCcCCccccCHHHhhccCCCcCC
Confidence 42210 1123678999999999998766 8
Q ss_pred CcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhccCccccCCCCCHhHHhcC
Q 010266 333 GMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 333 ~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~H 412 (514)
+.++|||||||++|||++|.+||.+.+..+++.+|+.+...+.+|....+|+++++||.+||+++..|+||.+++||++|
T Consensus 251 ~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 251 GRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred CCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 89999999999999999999999999999999999987777888887789999999999999977778888899999999
Q ss_pred CccccCCcccc--ccccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeeecCcc
Q 010266 413 PWFKDIAWDKL--YEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFEA 484 (514)
Q Consensus 413 pff~~i~w~~l--~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~ 484 (514)
|||++++|+.+ +++.|||+|.+.++.|++|||.+++.+........ +.. ....+..|.||||.+...
T Consensus 331 p~f~~~~w~~~~~~~~~~p~~p~~~~~~d~~~fd~~~~~~~~~~~~~~--~~~---~~~~~~~f~~f~~~~~~~ 399 (410)
T 3v8s_A 331 LFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPI--PKA---FVGNQLPFVGFTYYSNRR 399 (410)
T ss_dssp GGGCCSSCCSTTGGGSCCSCCCCCSSTTCCTTSCCCCSCCSCCCCCCC--CSS---CCCTTGGGTTCCEECC--
T ss_pred ccccCCCHHHHhhcccCCCCCCcCCCccchhhcCCccccccccccCCC--chh---hcccccccccceEeCccc
Confidence 99999999865 57899999999999999999987665432211111 101 123578999999998654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-67 Score=557.49 Aligned_cols=339 Identities=45% Similarity=0.818 Sum_probs=286.4
Q ss_pred HhhcCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE
Q 010266 97 RLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 176 (514)
Q Consensus 97 ~~~~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 176 (514)
.+....+..++|+++++||+|+||+||+|+++.+++.||||++.+...........+.+|+.+|..++|||||+++++|+
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34455677899999999999999999999999999999999998866555555666889999999999999999999999
Q ss_pred cCCeEEEEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 177 DAEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 177 ~~~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
+.+.+|||||||+||+|.+++.+ .+.+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+.
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence 99999999999999999999987 57899999999999999999999999999999999999999999999999999976
Q ss_pred CCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc-----cC
Q 010266 256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----KK 330 (514)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~ 330 (514)
...... ....+.+||+.|+|||++. +.
T Consensus 225 ~~~~~~------------------------------------------------~~~~~~~GT~~Y~APE~l~~~~~~~~ 256 (437)
T 4aw2_A 225 LMEDGT------------------------------------------------VQSSVAVGTPDYISPEILQAMEGGKG 256 (437)
T ss_dssp CCTTSC------------------------------------------------EECCSCCSCGGGCCHHHHHHHHTSCC
T ss_pred cccCCC------------------------------------------------cccccccCCcCeeChHHHhhcccCCC
Confidence 532210 0122568999999999997 56
Q ss_pred CCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcC-cCCChhHHHHHhhhccCccccCCCCCHhHH
Q 010266 331 GYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEE-ARLTPEAKDLICRLLCDVEHRLGTLGSEQI 409 (514)
Q Consensus 331 ~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~-~~~s~~~~dLI~~lL~dp~~Rl~~~~~~ei 409 (514)
.|+.++|||||||++|||++|.+||.+.+..+++.+|+.+...+.+|.. ..+|+++++||++||+.+.+|+++.+++||
T Consensus 257 ~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~ei 336 (437)
T 4aw2_A 257 RYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDF 336 (437)
T ss_dssp EECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHH
T ss_pred CCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHH
Confidence 7899999999999999999999999999999999999987666777764 458999999999999966778788899999
Q ss_pred hcCCccccCCccccccccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeeecCcccc
Q 010266 410 KAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFEAVK 486 (514)
Q Consensus 410 l~Hpff~~i~w~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~~~ 486 (514)
++||||+++||+.+++++|||+|.+.++.|++|||..++............. ......+..|.||||.++....
T Consensus 337 l~Hpff~~i~w~~l~~~~~p~~P~~~~~~d~~~fd~~~~~~~~~~~~~~~~~---~~~~~~~~~f~~~~~~~~~~~~ 410 (437)
T 4aw2_A 337 KKHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPPPTH---TAFSGHHLPFVGFTYTSSCVLS 410 (437)
T ss_dssp HTSGGGTTCCTTTGGGSCCSCCCCCSSTTCCTTSCCC---------------------CCTTGGGTTCCEESSCTTS
T ss_pred hCCCccCCCCHHHHhhCCCCCCCcCCCccchhhcCCcccccccccCCCCCcc---ccccccCccccCCCcCCchhhc
Confidence 9999999999999999999999999999999999875433221111111000 1123457799999999887653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-66 Score=536.27 Aligned_cols=327 Identities=33% Similarity=0.652 Sum_probs=276.5
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCC
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAE 179 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~ 179 (514)
..+..++|++++.||+|+||+||+|+++.+|+.||||++++..........++..|+.+|..+ +|||||+++++|++.+
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 456789999999999999999999999999999999999987666677788899999999988 7999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
.+|+||||++||+|..++.+.+.+++..+++|++||+.||.|||++||+||||||+||||+.+|++||+|||+|+.....
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999853211
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
. ..+.+.+||+.|+|||++.+..|+.++|||
T Consensus 178 ~-------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 208 (353)
T 3txo_A 178 G-------------------------------------------------VTTATFCGTPDYIAPEILQEMLYGPAVDWW 208 (353)
T ss_dssp ---------------------------------------------------------CCGGGCCHHHHHHHHCTTHHHHH
T ss_pred C-------------------------------------------------ccccccCCCcCeEChhhcCCCCcCCccCCC
Confidence 0 112367899999999999999999999999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCC---CCHhHHhcCCcc
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT---LGSEQIKAHPWF 415 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~---~~~~eil~Hpff 415 (514)
||||++|||++|.+||.+.+..+++.+|.. ..+.+|. .+++++++||.+||+ ||.+|++. .+++||++||||
T Consensus 209 slG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f 284 (353)
T 3txo_A 209 AMGVLLYEMLCGHAPFEAENEDDLFEAILN--DEVVYPT--WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284 (353)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGG
T ss_pred cchHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcc
Confidence 999999999999999999999999999987 4566675 689999999999999 99999964 245999999999
Q ss_pred ccCCccccc--cccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeeecCcc
Q 010266 416 KDIAWDKLY--EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFEA 484 (514)
Q Consensus 416 ~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~ 484 (514)
++++|+.+. ++.|||+|.+.+..|++|||.....+.+..++....... ...+..|.||||.+.+.
T Consensus 285 ~~~~w~~l~~~~~~~p~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~----~~~~~~f~~f~~~~~~~ 351 (353)
T 3txo_A 285 KEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPDFIKEEPVLTPIDEGHLP----MINQDEFRNFEYVSPEL 351 (353)
T ss_dssp TTCCHHHHHTTCSCCSCCCCCCSTTCCTTSCHHHHTSCCCCCCCCTTSGG----GSCGGGGTTCCEECC--
T ss_pred cCCCHHHHhcCcCCCCccCCCCCcccccccCcccccCCCcCCCccccccC----cccccccCCceeeCccc
Confidence 999999985 689999999999999999997444333322222221111 12356899999998653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-66 Score=528.46 Aligned_cols=327 Identities=36% Similarity=0.667 Sum_probs=278.3
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
+..++|++++.||+|+||+||+|+++.+|+.||||++++..........++.+|+.+|..++||||++++++|++.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 56789999999999999999999999999999999998876656667888999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
+||||++||+|..++.+.+.+++..++++++||+.||+|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-- 159 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-- 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC--
Confidence 999999999999999988999999999999999999999999999999999999999999999999999998532110
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
....+.+||+.|+|||++.+..|+.++||||||
T Consensus 160 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 192 (337)
T 1o6l_A 160 -----------------------------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 192 (337)
T ss_dssp -----------------------------------------------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHH
T ss_pred -----------------------------------------------CcccccccChhhCChhhhcCCCCCchhhcccch
Confidence 012367899999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CHhHHhcCCccccCC
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHPWFKDIA 419 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~Hpff~~i~ 419 (514)
|++|||++|.+||.+.+....+..|.. ..+.+|. .+|+++++||.+||. ||.+|+|.. +++||++||||++++
T Consensus 193 ~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 193 VVMYEMMCGRLPFYNQDHERLFELILM--EEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred hHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence 999999999999999999999888886 4566775 689999999999998 999999753 899999999999999
Q ss_pred ccccc--cccCCCCCcCCCCCCCCCCCC-CCcccCCCCCCCCCCcccccc--CCCCCCcccCeeeecC
Q 010266 420 WDKLY--EMEAAYKPEVNGVLDTQNFMK-FDEVESQTPKRTGSGPMRKMM--LTPKDLSFVGYTYKNF 482 (514)
Q Consensus 420 w~~l~--~~~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~--~~~~~~~f~~f~~~~~ 482 (514)
|+.+. ++.|||+|.+.++.|++||+. |+.+.....+.........+. ....+..|.||||.+.
T Consensus 269 ~~~~~~~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~ 336 (337)
T 1o6l_A 269 WQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQEMFEDFDYIAD 336 (337)
T ss_dssp HHHHHTTCSCCSCCCCCSSTTCCTTSCHHHHTSCCC--------------------CCTTTTCCEECC
T ss_pred HHHHHhCCCCCCCCCCCCCcchhhcccchhccCccCcCCCcccccccccccccccccccCCCceecCC
Confidence 99985 588999999999999999985 443322211111111111110 1124578999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-66 Score=542.64 Aligned_cols=328 Identities=33% Similarity=0.629 Sum_probs=273.8
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCC
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAE 179 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~ 179 (514)
..+..++|+++++||+|+||+||+|+++.+++.||||++++...........+..|+.+|..+ +|||||+++++|++.+
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 456778999999999999999999999999999999999988776666777899999999887 8999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
.+|+||||++||+|..++.+.+.+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 99999999999999999999899999999999999999999999999999999999999999999999999999853211
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
. ..+.+.+||+.|+|||++.+..|+.++|||
T Consensus 207 ~-------------------------------------------------~~~~~~~gt~~Y~aPE~l~~~~~~~~~Diw 237 (396)
T 4dc2_A 207 G-------------------------------------------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWW 237 (396)
T ss_dssp T-------------------------------------------------CCBCCCCBCGGGCCHHHHTTCCBCTHHHHH
T ss_pred C-------------------------------------------------CccccccCCcccCCchhhcCCCCChHHHHH
Confidence 0 112367999999999999999999999999
Q ss_pred hhhHHHHHHhhCCCCCCCC---------ChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC---CH
Q 010266 340 SLGAIMYEMLVGYPPFYSD---------DPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL---GS 406 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~---------~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~---~~ 406 (514)
||||++|||++|.+||.+. .....+..|.. ..+.+|. .+|+++++||++||+ ||.+|++.. ++
T Consensus 238 slGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ 313 (396)
T 4dc2_A 238 ALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGF 313 (396)
T ss_dssp HHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSCTTTSTTCSTTTHH
T ss_pred HHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc--cccCCCC--cCCHHHHHHHHHHhcCCHhHcCCCCCCCCH
Confidence 9999999999999999643 22335566665 4566775 689999999999999 999999752 57
Q ss_pred hHHhcCCccccCCccccc--cccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeeecCcc
Q 010266 407 EQIKAHPWFKDIAWDKLY--EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFEA 484 (514)
Q Consensus 407 ~eil~Hpff~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~ 484 (514)
+||++||||+++||+.+. ++.|||+|.+.++.|++|||..++.+....++.... ......+..|.||||.++..
T Consensus 314 ~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~~~~~d~~~fd~~~~~~~~~~~~~~~~----~~~~~~~~~f~~f~~~~~~~ 389 (396)
T 4dc2_A 314 ADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQLTPDDDD----IVRKIDQSEFEGFEYINPLL 389 (396)
T ss_dssp HHHHHSTTTTTCCHHHHHTTCSCCSCCCCCCSSTTGGGSCHHHHTSCCCCCCCCHH----HHTTSCGGGGTTCCEECC--
T ss_pred HHHhcCccccCCCHHHHHcCCCCCCCcCCCCCccchhhcChhhccCCCccCCCcch----hhccccccccCCcEeECccc
Confidence 999999999999999985 578999999999999999997444432222221111 11223456899999998765
Q ss_pred c
Q 010266 485 V 485 (514)
Q Consensus 485 ~ 485 (514)
+
T Consensus 390 ~ 390 (396)
T 4dc2_A 390 M 390 (396)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-66 Score=526.43 Aligned_cols=256 Identities=29% Similarity=0.531 Sum_probs=230.0
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
..|++++.||+|+||+||+|+++.||+.||||++.+.... ..+.+.+|+.+|+.++|||||+++++|++.+.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 5799999999999999999999999999999999876433 3345788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
|||+||+|.+++.+ +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+....
T Consensus 151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~----- 224 (346)
T 4fih_A 151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV----- 224 (346)
T ss_dssp CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-----
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-----
Confidence 99999999998865 679999999999999999999999999999999999999999999999999998754221
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 345 (514)
....+.||||.|||||++.+.+|+.++|||||||++
T Consensus 225 --------------------------------------------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvil 260 (346)
T 4fih_A 225 --------------------------------------------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMV 260 (346)
T ss_dssp --------------------------------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred --------------------------------------------CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHH
Confidence 112368999999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 346 yemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
|||++|.+||.+.+..+++..|... ....++.+..+|++++|||.+||+ ||.+|+ |++|+++||||+..
T Consensus 261 yeml~G~~PF~~~~~~~~~~~i~~~-~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~---ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 261 IEMVDGEPPYFNEPPLKAMKMIRDN-LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA---TAAELLKHPFLAKA 330 (346)
T ss_dssp HHHHHSSCTTTTSCHHHHHHHHHHS-SCCCCSCGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCGGGGGC
T ss_pred HHHHHCCCCCCCcCHHHHHHHHHcC-CCCCCCccccCCHHHHHHHHHHcCCChhHCc---CHHHHhcCHhhcCC
Confidence 9999999999999999998888763 223444445799999999999999 999999 99999999999853
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-66 Score=514.23 Aligned_cols=254 Identities=30% Similarity=0.587 Sum_probs=217.7
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
+++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|+.++|||||+++++|++.+.+|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 47999999999999999999999999999999999988766666778899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
|||| +|+|.+++.+.+.+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----- 165 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG----- 165 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC-----
Confidence 9999 7899999999999999999999999999999999999999999999999999999999999999754321
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCC-CcccchhhhhH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGA 343 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWSlGv 343 (514)
....+.+|||.|||||++.+.+| +.++|||||||
T Consensus 166 ---------------------------------------------~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGv 200 (275)
T 3hyh_A 166 ---------------------------------------------NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGV 200 (275)
T ss_dssp ------------------------------------------------------CTTSCHHHHSSSSCCCTHHHHHHHHH
T ss_pred ---------------------------------------------CccCCeeECcccCChhhhcCCCCCCChhhhHHHHH
Confidence 01226799999999999999887 68999999999
Q ss_pred HHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccc
Q 010266 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFK 416 (514)
Q Consensus 344 ilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~ 416 (514)
++|||++|.+||.+.+..+++.+|.. ....+|. .+|+++++||.+||+ ||.+|+ |++|+++||||+
T Consensus 201 ily~lltg~~PF~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L~~dP~~R~---s~~eil~hpw~k 267 (275)
T 3hyh_A 201 ILYVMLCRRLPFDDESIPVLFKNISN--GVYTLPK--FLSPGAAGLIKRMLIVNPLNRI---SIHEIMQDDWFK 267 (275)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHH--TCCCCCT--TSCHHHHHHHHHHSCSSGGGSC---CHHHHHHCHHHH
T ss_pred HHHHHHHCCCCCCCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHccCChhHCc---CHHHHHcCcccc
Confidence 99999999999999999999999887 4456664 689999999999999 999999 999999999996
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-66 Score=532.80 Aligned_cols=327 Identities=32% Similarity=0.631 Sum_probs=279.1
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCC
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAE 179 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~ 179 (514)
..+..++|++++.||+|+||+||+|+++.+|+.||||++++.........+++..|+.+|..+ +||+|++++++|++.+
T Consensus 15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp ----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred CCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence 456789999999999999999999999999999999999987665666778899999999987 7999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
.+|+||||++||+|..++...+.+++..+++|++||+.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 99999999999999999998899999999999999999999999999999999999999999999999999999853211
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
. ..+.+.+||+.|+|||++.+.+|+.++|||
T Consensus 175 ~-------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 205 (353)
T 2i0e_A 175 G-------------------------------------------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWW 205 (353)
T ss_dssp T-------------------------------------------------CCBCCCCSCGGGCCHHHHTTCCBSTHHHHH
T ss_pred C-------------------------------------------------cccccccCCccccChhhhcCCCcCCccccc
Confidence 0 012367899999999999999999999999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CHhHHhcCCccc
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHPWFK 416 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~Hpff~ 416 (514)
||||++|||++|.+||.+.+..+++.+|.. ..+.+|. .+|+++++||.+||+ ||.+|++.. ++++|++||||+
T Consensus 206 slG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~ 281 (353)
T 2i0e_A 206 AFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281 (353)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGT
T ss_pred chHHHHHHHHcCCCCCCCCCHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcccc
Confidence 999999999999999999999999999987 4566775 689999999999999 999999753 689999999999
Q ss_pred cCCccccc--cccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeeecCccc
Q 010266 417 DIAWDKLY--EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFEAV 485 (514)
Q Consensus 417 ~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~~ 485 (514)
++||+.+. ++.|||+|.+.+. |++|||.+...+........ . ....+..+..|.||||.+++..
T Consensus 282 ~~~w~~l~~~~~~~p~~p~~~~~-~~~~f~~~~~~~~~~~~~~~--~--~~~~~~~~~~f~~f~~~~~~~~ 347 (353)
T 2i0e_A 282 YIDWEKLERKEIQPPYKPKACGR-NAENFDRFFTRHPPVLTPPD--Q--EVIRNIDQSEFEGFSFVNSEFL 347 (353)
T ss_dssp TCCHHHHHTTCSCCSCCCCCCCC---CHHHHHHHHSCCCCCCCC--H--HHHHHSCTTTTCSCCEECTTCC
T ss_pred CCCHHHHHhCCCCCCcCCCCCCc-chhhccchhccCCcccCCcc--c--cccccccccccCCCeeeCcccc
Confidence 99999994 6899999999998 99999975444332221111 0 0001124568999999987653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-66 Score=526.13 Aligned_cols=258 Identities=28% Similarity=0.496 Sum_probs=226.6
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 183 (514)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||+++++|++++.+||
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 46899999999999999999999999999999999987754 45567889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 184 IMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
|||||+||+|.++|... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-- 178 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-- 178 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH--
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC--
Confidence 99999999999999654 46799999999999999999999999999999999999999999999999999865311
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
...+.+.||||.|||||++.+.+|+.++|||||
T Consensus 179 -----------------------------------------------~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSl 211 (350)
T 4b9d_A 179 -----------------------------------------------VELARACIGTPYYLSPEICENKPYNNKSDIWAL 211 (350)
T ss_dssp -----------------------------------------------HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHH
T ss_pred -----------------------------------------------cccccccCCCccccCHHHHCCCCCCcHHHHHHH
Confidence 011236789999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
||+||||++|.+||.+.+..+++.+|+.... ..+ +..+|+++++||.+||+ ||.+|+ |++|+++||||+.
T Consensus 212 GvilyemltG~~PF~~~~~~~~~~~i~~~~~-~~~--~~~~s~~~~~li~~~L~~dP~~R~---s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 212 GCVLYELCTLKHAFEAGSMKNLVLKIISGSF-PPV--SLHYSYDLRSLVSQLFKRNPRDRP---SVNSILEKGFIAK 282 (350)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-CCC--CTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHTSHHHHT
T ss_pred HHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCC--CccCCHHHHHHHHHHccCChhHCc---CHHHHhcCHHhhc
Confidence 9999999999999999999999999987432 122 34789999999999999 999999 9999999999975
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-65 Score=526.39 Aligned_cols=325 Identities=34% Similarity=0.643 Sum_probs=252.9
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCC
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAE 179 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~ 179 (514)
..+..++|++++.||+|+||+||+|+++.+|+.||||++++...........+..|+.+|..+ +||||++++++|++.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 456789999999999999999999999999999999999987665566778889999999987 8999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
.+|+||||++||+|..++.+.+.+++..+++|++||+.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 99999999999999999998899999999999999999999999999999999999999999999999999999754211
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
. ..+.+.+||+.|+|||++.+.+|+.++|||
T Consensus 172 ~-------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 202 (345)
T 1xjd_A 172 D-------------------------------------------------AKTNTFCGTPDYIAPEILLGQKYNHSVDWW 202 (345)
T ss_dssp T-------------------------------------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHH
T ss_pred C-------------------------------------------------CcccCCCCCcccCChhhhcCCCCCChhhhH
Confidence 0 012367899999999999999999999999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHh-HHhcCCcccc
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSE-QIKAHPWFKD 417 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~-eil~Hpff~~ 417 (514)
||||++|||++|.+||.+.+..+++.+|.. ....+|. .+|+++++||.+||+ ||.+|+ ++. +|++||||++
T Consensus 203 slG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dp~~R~---~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 203 SFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNPFYPR--WLEKEAKDLLVKLFVREPEKRL---GVRGDIRQHPLFRE 275 (345)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHSCSSGGGSB---TTBSCGGGSGGGTT
T ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHHHHHh--CCCCCCc--ccCHHHHHHHHHHhcCCHhHcC---CChHHHHcCccccC
Confidence 999999999999999999999999999886 3455664 689999999999999 999999 666 9999999999
Q ss_pred CCccccc--cccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeeecCccc
Q 010266 418 IAWDKLY--EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFEAV 485 (514)
Q Consensus 418 i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~~ 485 (514)
++|+.+. ++.|||+|.+.++.|++|||.....+.+..+..... ......+..|.||+|.+....
T Consensus 276 ~~w~~l~~~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~----~~~~~~~~~f~~f~~~~~~~~ 341 (345)
T 1xjd_A 276 INWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRA----LINSMDQNMFRNFSFMNPGME 341 (345)
T ss_dssp CCHHHHHTTCSCC------------------------------------------CCTTTTCCC------
T ss_pred CCHHHHhhCCCCCCcCCCCCCcchhhhcchhhcccCccCCccccc----ccccccccccCCCeeeChhhh
Confidence 9999995 689999999999999999996333322211111111 111234678999999876543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-65 Score=527.26 Aligned_cols=330 Identities=36% Similarity=0.665 Sum_probs=246.5
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHH-HHHcCCCceeeEEEEEEcCC
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL-LAEVASHCIVKLYYSFQDAE 179 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~i-L~~l~hp~Iv~l~~~f~~~~ 179 (514)
..+..++|++++.||+|+||+||+|+++.+++.||||++.+..........++..|+.+ ++.++|||||+++++|++.+
T Consensus 33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 45677899999999999999999999999999999999999887777777888888887 46789999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
.+|+||||++||+|..++.+.+.+++..+++|++||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999999999999899999999999999999999999999999999999999999999999999999753211
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
. ..+.+.+||+.|+|||++.+..|+.++|||
T Consensus 193 ~-------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 223 (373)
T 2r5t_A 193 N-------------------------------------------------STTSTFCGTPEYLAPEVLHKQPYDRTVDWW 223 (373)
T ss_dssp C-------------------------------------------------CCCCSBSCCCCCCCHHHHTTCCCCTHHHHH
T ss_pred C-------------------------------------------------CccccccCCccccCHHHhCCCCCCchhhhH
Confidence 0 112367999999999999999999999999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC-CHhHHhcCCcccc
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL-GSEQIKAHPWFKD 417 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~-~~~eil~Hpff~~ 417 (514)
||||++|||++|.+||.+.+..+++.+|+. ..+.+|. .+++++++||.+||+ ||.+|++.. ++++|++||||++
T Consensus 224 slG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~~~--~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 224 CLGAVLYEMLYGLPPFYSRNTAEMYDNILN--KPLQLKP--NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp HHHHHHHHHHHSSCTTCCSBHHHHHHHHHH--SCCCCCS--SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--cccCCCC--CCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 999999999999999999999999999987 3456664 689999999999999 999999753 5689999999999
Q ss_pred CCccccc--cccCCCCCcCCCCCCCCCCCC-CCcccCCCCCCCCCC-ccccccCCCCCCcccCeeeecCc
Q 010266 418 IAWDKLY--EMEAAYKPEVNGVLDTQNFMK-FDEVESQTPKRTGSG-PMRKMMLTPKDLSFVGYTYKNFE 483 (514)
Q Consensus 418 i~w~~l~--~~~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~f~~f~~~~~~ 483 (514)
+||+.+. ++.|||+|.+.++.|++|||. |.++........... ..........+..|.||||.+..
T Consensus 300 ~~w~~l~~~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~ 369 (373)
T 2r5t_A 300 INWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNAIGKAPDSVLVTASVKEAAEAFLGFSYAPPT 369 (373)
T ss_dssp CCHHHHHTTCSCCSCCCSCCC-------------------------------------------------
T ss_pred CCHHHHHhCCCCCCCCCCCCCcchhhhcCcccccccccccccCCccccccccccccccccCCCCcccCch
Confidence 9999995 689999999999999999996 444332211100000 00000011245679999998754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-64 Score=527.10 Aligned_cols=257 Identities=29% Similarity=0.527 Sum_probs=230.3
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.+.|++++.||+|+||+||+|+++.||+.||||++.+.... ..+.+.+|+.+|+.++|||||+++++|++.+.+|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 35799999999999999999999999999999999876432 334588999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
||||+||+|.+++. .+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+....
T Consensus 227 mEy~~gG~L~~~i~-~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~---- 301 (423)
T 4fie_A 227 MEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV---- 301 (423)
T ss_dssp EECCTTEEHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC----
T ss_pred EeCCCCCcHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC----
Confidence 99999999999885 4679999999999999999999999999999999999999999999999999998754221
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 344 (514)
....+.||||.|||||++.+..|+.++|||||||+
T Consensus 302 ---------------------------------------------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvi 336 (423)
T 4fie_A 302 ---------------------------------------------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIM 336 (423)
T ss_dssp ---------------------------------------------CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHH
T ss_pred ---------------------------------------------ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHH
Confidence 11237899999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 345 MYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 345 lyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
+|||++|.+||.+.+..+.+..|... ....++....+|++++|||.+||+ ||.+|+ |++|+++||||+..
T Consensus 337 lyeml~G~~PF~~~~~~~~~~~i~~~-~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~---ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 337 VIEMVDGEPPYFNEPPLKAMKMIRDN-LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA---TAAELLKHPFLAKA 407 (423)
T ss_dssp HHHHHHSSCTTTTSCHHHHHHHHHHS-CCCCCSCTTSSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCGGGGGC
T ss_pred HHHHHHCCCCCCCcCHHHHHHHHHcC-CCCCCcccccCCHHHHHHHHHHcCCChhHCc---CHHHHhcCHHhcCC
Confidence 99999999999999999998888763 223344445799999999999999 999999 99999999999863
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-64 Score=514.51 Aligned_cols=324 Identities=34% Similarity=0.659 Sum_probs=275.4
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCC
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAE 179 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~ 179 (514)
..+..++|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|+.+|..+ +|||||+++++|++..
T Consensus 4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 83 (345)
T 3a8x_A 4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 83 (345)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence 356778999999999999999999999999999999999988777777888899999999988 8999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
.+|+||||++||+|..++.+.+.+++..+++|++||+.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999999853211
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
. ....+.+||+.|+|||++.+..|+.++|||
T Consensus 164 ~-------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 194 (345)
T 3a8x_A 164 G-------------------------------------------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWW 194 (345)
T ss_dssp T-------------------------------------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHH
T ss_pred C-------------------------------------------------CcccccCCCccccCccccCCCCCChHHhHH
Confidence 0 012367899999999999999999999999
Q ss_pred hhhHHHHHHhhCCCCCCC---------CChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCC---CCH
Q 010266 340 SLGAIMYEMLVGYPPFYS---------DDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT---LGS 406 (514)
Q Consensus 340 SlGvilyemltG~~PF~~---------~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~---~~~ 406 (514)
||||++|||++|.+||.. .+....+..|.. ..+.+|. .+|+++++||.+||+ ||.+|++. .++
T Consensus 195 slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ 270 (345)
T 3a8x_A 195 ALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGF 270 (345)
T ss_dssp HHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCCTTTHH
T ss_pred HHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhcCCHhHCCCCCCcCCH
Confidence 999999999999999975 233445566665 4456665 689999999999999 99999964 246
Q ss_pred hHHhcCCccccCCccccc--cccCCCCCcCCCCCCCCCCCC-CCcccCCCCCCCCCCccccccCCCCCCcccCeeeecC
Q 010266 407 EQIKAHPWFKDIAWDKLY--EMEAAYKPEVNGVLDTQNFMK-FDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNF 482 (514)
Q Consensus 407 ~eil~Hpff~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~ 482 (514)
+||++||||++++|+.+. ++.|||+|.+.+..|++||+. +..+... ..... . .......+..|.||||.++
T Consensus 271 ~~i~~hp~f~~~~w~~~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~--~--~~~~~~~~~~f~~f~~~~~ 344 (345)
T 3a8x_A 271 ADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQ-LTPDD--D--DIVRKIDQSEFEGFEYINP 344 (345)
T ss_dssp HHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCTTTCGGGSCHHHHTSCSS-CCCCC--H--HHHTTSCGGGGTTCCEECC
T ss_pred HHHhcCCccCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCccc-CCCcc--c--cccccccccccCCCEeeCC
Confidence 899999999999999985 588999999999999999996 4333221 11111 1 0111234568999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-63 Score=506.42 Aligned_cols=292 Identities=43% Similarity=0.875 Sum_probs=254.8
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
+..++|++++.||+|+||+||+|+++.+|+.||||++++.........+++.+|+.+|..++|||||+++++|++...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 56789999999999999999999999999999999998876555567788999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
+||||++||+|.+++...+.+++..+++++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--- 159 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 159 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence 99999999999999999899999999999999999999999999999999999999999999999999999754311
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
..+.+||+.|+|||++.+..|+.++||||||
T Consensus 160 -------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 190 (318)
T 1fot_A 160 -------------------------------------------------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFG 190 (318)
T ss_dssp -------------------------------------------------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHH
T ss_pred -------------------------------------------------cccccCCccccCHhHhcCCCCCcccchhhhH
Confidence 2256899999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CHhHHhcCCccccCC
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHPWFKDIA 419 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~Hpff~~i~ 419 (514)
|++|||++|.+||.+.+..+++.+|+. ..+.+|. .+++++++||.+||+ ||.+|++.. ++++|++||||++++
T Consensus 191 ~il~ell~g~~pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 191 ILIYEMLAGYTPFYDSNTMKTYEKILN--AELRFPP--FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp HHHHHHHHSSCTTCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence 999999999999999999999999987 4456665 689999999999999 999999754 889999999999999
Q ss_pred ccccc--cccCCCCCcCC-CCCCCCCCCCCCccc
Q 010266 420 WDKLY--EMEAAYKPEVN-GVLDTQNFMKFDEVE 450 (514)
Q Consensus 420 w~~l~--~~~~p~~p~~~-~~~d~~~f~~~~~~~ 450 (514)
|+.+. ++.|||+|.+. +..|+++||.+++..
T Consensus 267 ~~~~~~~~~~~p~~p~~~~~~~d~~~f~~~~~~~ 300 (318)
T 1fot_A 267 WEKLLSRNIETPYEPPIQQGQGDTSQFDKYPEED 300 (318)
T ss_dssp HHHHHTTCSCCSCCCCC----------------C
T ss_pred HHHHHhCCCCCCCCCCcCCCccchhhcCCCCccc
Confidence 99985 57899999998 589999999886654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-63 Score=507.88 Aligned_cols=295 Identities=41% Similarity=0.811 Sum_probs=269.9
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE 179 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 179 (514)
......++|++++.||+|+||+||+|+++.+|+.||||++.+.........+++.+|+.+|..++||||++++++|++..
T Consensus 35 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 114 (350)
T 1rdq_E 35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114 (350)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 44567899999999999999999999999999999999998876656667788999999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
.+|+||||++||+|.+++.+.+.+++..+++++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999999864311
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
..+.+||+.|+|||++.+..|+.++|||
T Consensus 195 ----------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Diw 222 (350)
T 1rdq_E 195 ----------------------------------------------------TWTLCGTPEALAPEIILSKGYNKAVDWW 222 (350)
T ss_dssp ----------------------------------------------------BCCCEECGGGCCHHHHTTCCBCTHHHHH
T ss_pred ----------------------------------------------------cccccCCccccCHHHhcCCCCCCcCCEe
Confidence 1256899999999999999999999999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCC--CCHhHHhcCCccc
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT--LGSEQIKAHPWFK 416 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~Hpff~ 416 (514)
||||++|||++|.+||.+.+..+.+.+|.. ..+.+|. .+|+++++||.+||+ ||.+|++. .++++|++||||+
T Consensus 223 slG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~ 298 (350)
T 1rdq_E 223 ALGVLIYEMAAGYPPFFADQPIQIYEKIVS--GKVRFPS--HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298 (350)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred cccHhHhHHhhCCCCCCCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcC
Confidence 999999999999999999999999999987 3456665 689999999999999 99999963 2589999999999
Q ss_pred cCCccccc--cccCCCCCcCCCCCCCCCCCCCCccc
Q 010266 417 DIAWDKLY--EMEAAYKPEVNGVLDTQNFMKFDEVE 450 (514)
Q Consensus 417 ~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~ 450 (514)
++||+.+. ++.|||+|.+.++.|++|||.+++++
T Consensus 299 ~~~w~~~~~~~~~~p~~p~~~~~~~~~~f~~~~~~~ 334 (350)
T 1rdq_E 299 TTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEE 334 (350)
T ss_dssp TCCHHHHHTTCSCCSCCCCCCSTTCCTTSCCCCCCC
T ss_pred CCCHHHHhhccCCCCCCCCCCCcccccccccccccc
Confidence 99999985 68999999999999999999776654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-63 Score=494.99 Aligned_cols=254 Identities=24% Similarity=0.430 Sum_probs=220.0
Q ss_pred CCe-eEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc----CCe
Q 010266 106 DDF-DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD----AEY 180 (514)
Q Consensus 106 ~~f-~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~----~~~ 180 (514)
.+| ++.+.||+|+||+||+|+++.++..||+|++.+... .....+.+.+|+.+|+.++|||||+++++|++ ...
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 455 778889999999999999999999999999987654 45566789999999999999999999999975 467
Q ss_pred EEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eEEcCCCCCCccccC-CCcEEEccccccccCC
Q 010266 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLDQ-NGHMKLSDFGLCKPLD 257 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKpeNILld~-~g~iKL~DFGla~~~~ 257 (514)
+|||||||+||+|.++|.+.+.+++..++.|+.||+.||+|||++| ||||||||+||||+. +|++||+|||+|+...
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999999999999999999999999999999999999998 999999999999984 8999999999997532
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
.. .+.+.+|||.|||||++.+ +|+.++|
T Consensus 184 ~~---------------------------------------------------~~~~~~GTp~YmAPE~~~~-~y~~~~D 211 (290)
T 3fpq_A 184 AS---------------------------------------------------FAKAVIGTPEFMAPEMYEE-KYDESVD 211 (290)
T ss_dssp TT---------------------------------------------------SBEESCSSCCCCCGGGGGT-CCCTHHH
T ss_pred CC---------------------------------------------------ccCCcccCccccCHHHcCC-CCCcHHH
Confidence 11 1236799999999999865 6999999
Q ss_pred hhhhhHHHHHHhhCCCCCCCCCh-hHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 338 WWSLGAIMYEMLVGYPPFYSDDP-VTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 338 iWSlGvilyemltG~~PF~~~~~-~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
||||||+||||+||.+||.+.+. ...+..+........+| ..+|+++++||.+||. ||.+|+ |++|+++||||
T Consensus 212 iwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~R~---s~~e~l~Hp~~ 286 (290)
T 3fpq_A 212 VYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD--KVAIPEVKEIIEGCIRQNKDERY---SIKDLLNHAFF 286 (290)
T ss_dssp HHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG--GCCCHHHHHHHHHHSCSSGGGSC---CHHHHHTSGGG
T ss_pred HHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCC--ccCCHHHHHHHHHHccCChhHCc---CHHHHhcCccc
Confidence 99999999999999999986544 45555665533333333 3678999999999999 999999 99999999999
Q ss_pred cc
Q 010266 416 KD 417 (514)
Q Consensus 416 ~~ 417 (514)
++
T Consensus 287 ~~ 288 (290)
T 3fpq_A 287 QE 288 (290)
T ss_dssp C-
T ss_pred cC
Confidence 74
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-64 Score=556.91 Aligned_cols=329 Identities=33% Similarity=0.639 Sum_probs=284.5
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcC
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDA 178 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~ 178 (514)
...+..++|+++++||+|+||+||+|+++.+++.||||++++.........+.+..|+.+|..+ +||+|+.++++|++.
T Consensus 335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~ 414 (674)
T 3pfq_A 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 414 (674)
T ss_dssp -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence 3456789999999999999999999999999999999999987665666778889999999987 799999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
+.+||||||++||+|..++...+.+++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 99999999999999999999989999999999999999999999999999999999999999999999999999985321
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
.. ..+.+.+||+.|+|||++.+..|+.++||
T Consensus 495 ~~-------------------------------------------------~~~~~~~GT~~Y~APE~l~~~~~~~~~Dv 525 (674)
T 3pfq_A 495 DG-------------------------------------------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDW 525 (674)
T ss_dssp TT-------------------------------------------------CCBCCCCSCSSSCCHHHHTCCCBSTHHHH
T ss_pred CC-------------------------------------------------cccccccCCCcccCHhhhcCCCCCccceE
Confidence 10 01236799999999999999999999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCC--CCHhHHhcCCcc
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT--LGSEQIKAHPWF 415 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~Hpff 415 (514)
|||||+||||++|.+||.+.+..+++.+|+. ..+.+|. .+|+++++||.+||+ ||.+|++. .+++||++||||
T Consensus 526 wSlGvilyelltG~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff 601 (674)
T 3pfq_A 526 WAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601 (674)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS--SCCCCCT--TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGG
T ss_pred echHHHHHHHHcCCCCCCCCCHHHHHHHHHh--CCCCCCc--cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccc
Confidence 9999999999999999999999999999987 4567775 699999999999999 99999964 256999999999
Q ss_pred ccCCccccc--cccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeeeecCcccc
Q 010266 416 KDIAWDKLY--EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTYKNFEAVK 486 (514)
Q Consensus 416 ~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~~~ 486 (514)
+++||+.+. ++.|||+|.+.+ .|++|||.++..+.+..++.+. ....+..+..|.||||.+++.+.
T Consensus 602 ~~i~w~~l~~~~~~pp~~p~~~~-~~~~~f~~~~~~~~~~~~~~~~----~~~~~~~~~~f~~f~~~~~~~~~ 669 (674)
T 3pfq_A 602 RYIDWEKLERKEIQPPYKPKASG-RNAENFDRFFTRHPPVLTPPDQ----EVIRNIDQSEFEGFSFVNSEFLK 669 (674)
T ss_dssp SSCCHHHHTTTCSCCSCCCBCCG-GGHHHHTTTTTSSCSSCCCCCH----HHHTTCCGGGGTTCCEECSSCCC
T ss_pred cCCCHHHHHhCCCCCCCCCcCCC-CchhhcCchhccCCCccCCCch----hhhhcccccccCCCcccChhhhc
Confidence 999999995 689999999988 9999999876665443322221 11122346789999999887753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-63 Score=506.32 Aligned_cols=252 Identities=28% Similarity=0.404 Sum_probs=219.8
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
...++|++.+.||+|+||+||+|+++.+|+.||||++++.... .+|+.+|+.++|||||+++++|++++.+|
T Consensus 55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ 126 (336)
T 4g3f_A 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVN 126 (336)
T ss_dssp BTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 3457899999999999999999999999999999999876432 35999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC-cEEEccccccccCCCCCc
Q 010266 183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG-HMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g-~iKL~DFGla~~~~~~~~ 261 (514)
||||||+||+|.++|.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.+.....
T Consensus 127 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999999999999999999999999999999999999999999999999999999998 699999999987643210
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
.. ......++||||.|||||++.+.+|+.++|||||
T Consensus 207 ~~--------------------------------------------~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSl 242 (336)
T 4g3f_A 207 GK--------------------------------------------SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSS 242 (336)
T ss_dssp ---------------------------------------------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred cc--------------------------------------------ceecCCccccCccccCHHHHCCCCCCcHHHHHHH
Confidence 00 0001235789999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcc-cCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL-KFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~~-~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
||+||||++|.+||.+.+..+++.+|......+ .+| ..+|+++++||.+||+ ||.+|+ |+.||++
T Consensus 243 GvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~R~---sa~el~~ 309 (336)
T 4g3f_A 243 CCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP--PSCAPLTAQAIQEGLRKEPVHRA---SAMELRR 309 (336)
T ss_dssp HHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcC--ccCCHHHHHHHHHHccCCHhHCc---CHHHHHH
Confidence 999999999999999998888899988743322 234 3689999999999999 999999 9999853
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-61 Score=504.07 Aligned_cols=265 Identities=24% Similarity=0.410 Sum_probs=227.0
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc------CC
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------AE 179 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~------~~ 179 (514)
++|++++.||+|+||+||+|+++.||+.||||++++.. ......+.+.+|+.+|+.++|||||+++++|.+ .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 67999999999999999999999999999999997654 344556778899999999999999999998764 46
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
++|||||||+ |+|.+++.+.+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+...
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 8999999995 689999999999999999999999999999999999999999999999999999999999999865422
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-CCCcccch
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDW 338 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~Di 338 (514)
... ......+.|||+.|||||++.+. .|+.++||
T Consensus 212 ~~~---------------------------------------------~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~Di 246 (398)
T 4b99_A 212 PAE---------------------------------------------HQYFMTEYVATRWYRAPELMLSLHEYTQAIDL 246 (398)
T ss_dssp -------------------------------------------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHH
T ss_pred ccc---------------------------------------------cccccccceeChHhcCHHHhcCCCCCCChhhe
Confidence 100 01123478999999999999875 56999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCccc------------------CCc---------CcCCChhHHHHHh
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLK------------------FPE---------EARLTPEAKDLIC 391 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~------------------~p~---------~~~~s~~~~dLI~ 391 (514)
||||||+|||++|.+||.+.+..+++..|........ +|. ...+|++++|||.
T Consensus 247 WSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~ 326 (398)
T 4b99_A 247 WSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLG 326 (398)
T ss_dssp HHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHH
T ss_pred ehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHH
Confidence 9999999999999999999999999988875332211 111 1247899999999
Q ss_pred hhcc-CccccCCCCCHhHHhcCCccccCCc
Q 010266 392 RLLC-DVEHRLGTLGSEQIKAHPWFKDIAW 420 (514)
Q Consensus 392 ~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w 420 (514)
+||+ ||.+|+ |++|+++||||+...+
T Consensus 327 ~mL~~dP~~R~---ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 327 RMLRFEPSARI---SAAAALRHPFLAKYHD 353 (398)
T ss_dssp HHSCSSTTTSC---CHHHHTTSGGGTTTCC
T ss_pred HHCcCChhHCc---CHHHHhcCHhhCcCCC
Confidence 9999 999999 9999999999997653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-61 Score=485.82 Aligned_cols=268 Identities=26% Similarity=0.421 Sum_probs=205.3
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC------
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE------ 179 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~------ 179 (514)
+||++++.||+|+||+||+|+++.+|+.||||++++.. .....+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 47999999999999999999999999999999997653 3445567899999999999999999999997544
Q ss_pred ------eEEEEEeecCCCCHHHHHhhccCC---CHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccc
Q 010266 180 ------YLYLIMEYLPGGDVMTLLMREETL---TETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDF 250 (514)
Q Consensus 180 ------~l~lVmEy~~gg~L~~~l~~~~~l---~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DF 250 (514)
++|+|||||+||+|.+++.....+ ++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 489999999999999999876554 44668899999999999999999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC
Q 010266 251 GLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK 330 (514)
Q Consensus 251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~ 330 (514)
|+|+.+.......... . .........+.||||.|||||++.+.
T Consensus 163 Gla~~~~~~~~~~~~~--------------------~-----------------~~~~~~~~~~~~GT~~YmAPE~~~~~ 205 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVL--------------------T-----------------PMPAYARHTGQVGTKLYMSPEQIHGN 205 (299)
T ss_dssp CCC---------------------------------------------------------------CCCTTSCHHHHTTC
T ss_pred ccceecCCCccccccc--------------------c-----------------ccccccccCCcccCccccCHHHHcCC
Confidence 9998765321100000 0 00001122367999999999999999
Q ss_pred CCCcccchhhhhHHHHHHhhCCCCCCCCCh-hHHHHHHhhhcCcccCCc-CcCCChhHHHHHhhhcc-CccccCCCCCHh
Q 010266 331 GYGMECDWWSLGAIMYEMLVGYPPFYSDDP-VTTCRKIVHWKNHLKFPE-EARLTPEAKDLICRLLC-DVEHRLGTLGSE 407 (514)
Q Consensus 331 ~y~~~~DiWSlGvilyemltG~~PF~~~~~-~~~~~~i~~~~~~~~~p~-~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ 407 (514)
+|+.++|||||||++|||++ ||.+... ......+.. ..+|+ ....++++.+||.+||+ ||.+|+ |+.
T Consensus 206 ~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~----~~~p~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~ 275 (299)
T 4g31_A 206 SYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRN----LKFPPLFTQKYPCEYVMVQDMLSPSPMERP---EAI 275 (299)
T ss_dssp CCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHT----TCCCHHHHHHCHHHHHHHHHHTCSSGGGSC---CHH
T ss_pred CCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhc----CCCCCCCcccCHHHHHHHHHHcCCChhHCc---CHH
Confidence 99999999999999999996 8865432 222333332 33443 22467889999999999 999999 999
Q ss_pred HHhcCCccccCCccc
Q 010266 408 QIKAHPWFKDIAWDK 422 (514)
Q Consensus 408 eil~Hpff~~i~w~~ 422 (514)
||++||||+++||..
T Consensus 276 eil~h~~~~~~~~p~ 290 (299)
T 4g31_A 276 NIIENAVFEDLDFPG 290 (299)
T ss_dssp HHHTSGGGCCC----
T ss_pred HHhcCHhhCCCCCCC
Confidence 999999999999954
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-60 Score=517.30 Aligned_cols=264 Identities=29% Similarity=0.494 Sum_probs=237.5
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+.+.+|+.+|+.++|||||+|+++|++...+|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 478999999999999999999999999999999997653 34557788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCC--CcEEEccccccccCCCCCc
Q 010266 185 MEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN--GHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 185 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~--g~iKL~DFGla~~~~~~~~ 261 (514)
||||+||+|.++|.. .+.+++..+++|++||+.||.|||++||+||||||+|||++.+ |++||+|||+|+.+....
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~- 311 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 311 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence 999999999999864 4689999999999999999999999999999999999999854 899999999998764221
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
...+.|||+.|||||++.+.+|+.++|||||
T Consensus 312 -------------------------------------------------~~~~~~GT~~y~APEv~~~~~y~~~~DiWSl 342 (573)
T 3uto_A 312 -------------------------------------------------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSV 342 (573)
T ss_dssp -------------------------------------------------EEEEECSSGGGCCHHHHTTCCBCHHHHHHHH
T ss_pred -------------------------------------------------ceeeeEECccccCHHHhCCCCCCcHHHHHHH
Confidence 1236799999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCc
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAW 420 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w 420 (514)
||+||||++|.+||.+.+..+++.+|......+..+....+|++++|||.+||+ ||.+|+ |++|+++||||+..+|
T Consensus 343 Gvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~---t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 343 GVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM---TIHQALEHPWLTPGNA 419 (573)
T ss_dssp HHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSTTTSCCCC
T ss_pred HHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCc---CHHHHhcCcCcCCCCC
Confidence 999999999999999999999999998754433333345799999999999999 999999 9999999999999998
Q ss_pred cccc
Q 010266 421 DKLY 424 (514)
Q Consensus 421 ~~l~ 424 (514)
....
T Consensus 420 ~~~~ 423 (573)
T 3uto_A 420 PGRD 423 (573)
T ss_dssp TTTT
T ss_pred CCch
Confidence 7643
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-60 Score=488.47 Aligned_cols=282 Identities=28% Similarity=0.468 Sum_probs=214.1
Q ss_pred CCeeEEeeeeecCceEEEEEEEc---cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCeE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEK---KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~---~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l 181 (514)
++|++++.||+|+||+||+|+++ .+++.||||++.+.. ....+.+|+.+|..+ +|||||+++++|++.+++
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 67999999999999999999986 467899999986542 345678899999988 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCC-CcEEEccccccccCCCCC
Q 010266 182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~-g~iKL~DFGla~~~~~~~ 260 (514)
|+|||||+||+|.+++ +.+++..++.|+.||+.||+|||++|||||||||+|||++.+ |++||+|||+|+......
T Consensus 96 ~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 96 VIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp EEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred EEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 9999999999999998 359999999999999999999999999999999999999977 899999999998765432
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-CCCcccchh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWW 339 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiW 339 (514)
........ ... ...+.....+ ..-..+.....+.||||.|||||++.+. .|+.++|||
T Consensus 173 ~~~~~~~~---~~~------~~~~~~~~~~------------~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiW 231 (361)
T 4f9c_A 173 IELLKFVQ---SEA------QQERCSQNKC------------SICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMW 231 (361)
T ss_dssp CGGGGGC-----------------------------------------------CCCCGGGCCHHHHTTCSCCCTHHHHH
T ss_pred cccccccc---ccc------cccccccccc------------cccccccccccccccCccccCHHHHcCCCCCCCccchh
Confidence 11110000 000 0000000000 0001112234578999999999999875 589999999
Q ss_pred hhhHHHHHHhhCCCCCCC-CChhHHHHHHhhhcCc---------------------------------------------
Q 010266 340 SLGAIMYEMLVGYPPFYS-DDPVTTCRKIVHWKNH--------------------------------------------- 373 (514)
Q Consensus 340 SlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~~--------------------------------------------- 373 (514)
|+||++|||++|++||.+ .+..+....|....+.
T Consensus 232 SlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~ 311 (361)
T 4f9c_A 232 SAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSD 311 (361)
T ss_dssp HHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC------------
T ss_pred hhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccc
Confidence 999999999999999964 4455555554321000
Q ss_pred -----ccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCC
Q 010266 374 -----LKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIA 419 (514)
Q Consensus 374 -----~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~ 419 (514)
...+.+..+|++++|||.+||+ ||.+|+ |++|+++||||++++
T Consensus 312 ~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~---ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 312 IQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRI---TAEEALLHPFFKDMS 360 (361)
T ss_dssp ----------CTTCCHHHHHHHHHHTCSCTTTSC---CHHHHHTSGGGTTC-
T ss_pred cccccccccccccCCHHHHHHHHHHCcCChhHCc---CHHHHhcCcccCCCC
Confidence 0011234689999999999999 999999 999999999999875
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-59 Score=496.76 Aligned_cols=296 Identities=39% Similarity=0.733 Sum_probs=252.4
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE 179 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 179 (514)
...+..++|++++.||+|+||.||+|+++.+|+.||||++.+..........++.+|..+|..++||||++++++|.+.+
T Consensus 142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 221 (446)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT
T ss_pred ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC
Confidence 45667789999999999999999999999999999999998876666667778889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
.+|+||||++||+|..++...+.+++..++.++.||+.||.|||+ .|||||||||+||||+.+|++||+|||+|+....
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 999999999999999999998999999999999999999999998 9999999999999999999999999999975321
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
.. ....+.+||+.|+|||++.+..|+.++||
T Consensus 302 ~~-------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 332 (446)
T 4ejn_A 302 DG-------------------------------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDW 332 (446)
T ss_dssp ------------------------------------------------------CCSSSCGGGCCHHHHHTSCCCTHHHH
T ss_pred CC-------------------------------------------------cccccccCCccccCHhhcCCCCCCCccch
Confidence 10 01225789999999999999999999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CHhHHhcCCcc
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHPWF 415 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~Hpff 415 (514)
|||||++|||++|.+||.+.+.......+.. ..+.+|. .+++++++||.+||. ||.+|++.. +++|+++||||
T Consensus 333 wslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f 408 (446)
T 4ejn_A 333 WGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEIRFPR--TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408 (446)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred hhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh--CCCCCCc--cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccc
Confidence 9999999999999999999999888888876 4556665 689999999999999 999999653 89999999999
Q ss_pred ccCCccccc--cccCCCCCcCCCCCCCCCCCCCCc
Q 010266 416 KDIAWDKLY--EMEAAYKPEVNGVLDTQNFMKFDE 448 (514)
Q Consensus 416 ~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~ 448 (514)
++++|+.+. .+.|||+|.+.+..|+++||+.++
T Consensus 409 ~~~~~~~~~~~~~~pp~~p~~~~~~~~~~~~~~~~ 443 (446)
T 4ejn_A 409 AGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFT 443 (446)
T ss_dssp TTCCHHHHHTTCSCCSCCCSCSSTTCCTTC-----
T ss_pred cCCCHHHHhhCcCCCCccCCCCCccchhhcchhhh
Confidence 999999985 588999999999999999997543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-58 Score=479.02 Aligned_cols=281 Identities=30% Similarity=0.642 Sum_probs=248.1
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE 179 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 179 (514)
...+..++|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|+.+|..++|||||+++++|++.+
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 45677899999999999999999999999999999999998877666677888999999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
.+|+||||++||+|..++.....+++..+++|++||+.||.|||++||+||||||+||||+.+|++||+|||+|+.....
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999999865321
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc---CCCCccc
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK---KGYGMEC 336 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~y~~~~ 336 (514)
....+.+||+.|+|||++.+ .+|+.++
T Consensus 169 --------------------------------------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~ 198 (384)
T 4fr4_A 169 --------------------------------------------------TQITTMAGTKPYMAPEMFSSRKGAGYSFAV 198 (384)
T ss_dssp --------------------------------------------------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTH
T ss_pred --------------------------------------------------CceeccCCCccccCCeeeccCCCCCCCccc
Confidence 01236789999999999974 4689999
Q ss_pred chhhhhHHHHHHhhCCCCCCCCCh---hHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 337 DWWSLGAIMYEMLVGYPPFYSDDP---VTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 337 DiWSlGvilyemltG~~PF~~~~~---~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
|||||||++|||++|.+||.+.+. .+....+.. ....+|. .+|+++.+||.+||+ ||.+|++ ++++|++|
T Consensus 199 DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~s--~~~~l~~h 272 (384)
T 4fr4_A 199 DWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET--TVVTYPS--AWSQEMVSLLKKLLEPNPDQRFS--QLSDVQNF 272 (384)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHSCSSGGGSCC--SHHHHHTS
T ss_pred eeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh--cccCCCC--cCCHHHHHHHHHHhcCCHhHhcc--cHHHHHcC
Confidence 999999999999999999985433 344444443 3445554 689999999999999 9999994 48999999
Q ss_pred CccccCCccccc--cccCCCCCcCCC
Q 010266 413 PWFKDIAWDKLY--EMEAAYKPEVNG 436 (514)
Q Consensus 413 pff~~i~w~~l~--~~~~p~~p~~~~ 436 (514)
|||++++|+.+. ++.|||+|....
T Consensus 273 p~f~~~~w~~~~~~~~~p~~~p~~~~ 298 (384)
T 4fr4_A 273 PYMNDINWDAVFQKRLIPGFIPNKGR 298 (384)
T ss_dssp GGGTTCCHHHHHTTCSCCCCCCSCCS
T ss_pred hhhhcCCHHHHHhCCCCCCCCCCCCC
Confidence 999999999986 588999998643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-58 Score=498.37 Aligned_cols=285 Identities=34% Similarity=0.635 Sum_probs=252.4
Q ss_pred hcCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC
Q 010266 99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA 178 (514)
Q Consensus 99 ~~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 178 (514)
....+..++|+++++||+|+||+||+|+++.+|+.||||++.+..........++..|+.+|..++|||||+++++|++.
T Consensus 178 ~~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 257 (543)
T 3c4z_A 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK 257 (543)
T ss_dssp HTSCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC
Confidence 34678889999999999999999999999999999999999887665556678899999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccc
Q 010266 179 EYLYLIMEYLPGGDVMTLLMRE----ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~ 254 (514)
..+|+||||++||+|..++... ..+++..+++|++||+.||.|||++||+||||||+||||+.+|++||+|||+|+
T Consensus 258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337 (543)
T ss_dssp SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceee
Confidence 9999999999999999998763 469999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCc
Q 010266 255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM 334 (514)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~ 334 (514)
...... ..+.+.+||+.|+|||++.+.+|+.
T Consensus 338 ~~~~~~-------------------------------------------------~~~~~~~GT~~Y~APE~l~~~~~~~ 368 (543)
T 3c4z_A 338 ELKAGQ-------------------------------------------------TKTKGYAGTPGFMAPELLLGEEYDF 368 (543)
T ss_dssp ECCTTC-------------------------------------------------CCBCCCCSCTTTSCHHHHTTCCBCT
T ss_pred eccCCC-------------------------------------------------cccccccCCccccChhhhcCCCCCh
Confidence 653211 0122568999999999999999999
Q ss_pred ccchhhhhHHHHHHhhCCCCCCCCC----hhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CHh
Q 010266 335 ECDWWSLGAIMYEMLVGYPPFYSDD----PVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSE 407 (514)
Q Consensus 335 ~~DiWSlGvilyemltG~~PF~~~~----~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~ 407 (514)
++|||||||++|||++|.+||.+.+ ..+....+.. ....+|. .+|+++++||.+||+ ||.+|++.. +++
T Consensus 369 ~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ 444 (543)
T 3c4z_A 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE--QAVTYPD--KFSPASKDFCEALLQKDPEKRLGFRDGSCD 444 (543)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHSCSSGGGSCCCBTTBSH
T ss_pred HHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh--cccCCCc--ccCHHHHHHHHHhccCCHhHCCCCcccCHH
Confidence 9999999999999999999998763 4556666665 4455664 689999999999999 999999753 579
Q ss_pred HHhcCCccccCCccccc--cccCCCCCcCCC
Q 010266 408 QIKAHPWFKDIAWDKLY--EMEAAYKPEVNG 436 (514)
Q Consensus 408 eil~Hpff~~i~w~~l~--~~~~p~~p~~~~ 436 (514)
+|++||||++++|+.+. .+.|||+|.+..
T Consensus 445 ei~~Hpff~~i~w~~l~~~~~~pp~~P~~~~ 475 (543)
T 3c4z_A 445 GLRTHPLFRDISWRQLEAGMLTPPFVPDSRT 475 (543)
T ss_dssp HHHTSGGGTTCCHHHHHTTCSCCSCCCCSSS
T ss_pred HHHcCccccCCCHHHHHcCCCCCCCCCCccc
Confidence 99999999999999996 578999998753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-58 Score=469.59 Aligned_cols=293 Identities=40% Similarity=0.758 Sum_probs=239.6
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEc---cCCCEEEEEEeecccccC-hhhHHHHHHHHHHHHHcCCCceeeEEEEEE
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEK---KSGNIYAMKKLKKSEMLS-RGQVEHVRAERNLLAEVASHCIVKLYYSFQ 176 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~---~t~~~~AiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 176 (514)
..+..++|++++.||+|+||.||+|++. .+|+.||||++++..... ......+.+|+.+|..++|||||+++++|.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 4567789999999999999999999985 689999999998765432 234566888999999999999999999999
Q ss_pred cCCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccC
Q 010266 177 DAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256 (514)
Q Consensus 177 ~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~ 256 (514)
+.+.+|+||||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+..
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999999999998899999999999999999999999999999999999999999999999999998753
Q ss_pred CCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCccc
Q 010266 257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336 (514)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 336 (514)
.... ....+.+||+.|+|||++.+..++.++
T Consensus 172 ~~~~-------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~ 202 (327)
T 3a62_A 172 IHDG-------------------------------------------------TVTHTFCGTIEYMAPEILMRSGHNRAV 202 (327)
T ss_dssp --------------------------------------------------------CTTSSCCTTSCHHHHTTSCCCTHH
T ss_pred ccCC-------------------------------------------------ccccccCCCcCccCHhhCcCCCCCCcc
Confidence 2110 012256899999999999999999999
Q ss_pred chhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CHhHHhcCC
Q 010266 337 DWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHP 413 (514)
Q Consensus 337 DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~Hp 413 (514)
|||||||++|+|++|.+||.+.+..+...++.. ..+.+|. .+++++++||.+||. ||.+|++.. +++|+++||
T Consensus 203 DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 203 DWWSLGALMYDMLTGAPPFTGENRKKTIDKILK--CKLNLPP--YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--TCCCCCT--TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred cchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 999999999999999999999999888888886 3455664 689999999999999 999999764 899999999
Q ss_pred ccccCCccccc--cccCCCCCcCCCCCCCCCCCCC
Q 010266 414 WFKDIAWDKLY--EMEAAYKPEVNGVLDTQNFMKF 446 (514)
Q Consensus 414 ff~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~ 446 (514)
||++++|+.+. ...|||.|.+.+..|.++|+..
T Consensus 279 ~f~~~~~~~~~~~~~~~p~~p~~~~~~~~~~~~~~ 313 (327)
T 3a62_A 279 FFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSK 313 (327)
T ss_dssp GGSSCCHHHHHTTCSCCSCCCC-------------
T ss_pred cccCCCHHHHhhccCCCCCCCCcCChhhhhhcchh
Confidence 99999999885 5789999999999999999853
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-58 Score=500.55 Aligned_cols=294 Identities=33% Similarity=0.659 Sum_probs=252.5
Q ss_pred HhhcCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE
Q 010266 97 RLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 176 (514)
Q Consensus 97 ~~~~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 176 (514)
.+.+..+..++|+++++||+|+||+||+|+++.+|+.||||++.+..+........+.+|+.+|..++|||||+++++|+
T Consensus 175 ~l~~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 254 (576)
T 2acx_A 175 WLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE 254 (576)
T ss_dssp HHHTSCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhcCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe
Confidence 34566788999999999999999999999999999999999998876655666788899999999999999999999999
Q ss_pred cCCeEEEEEeecCCCCHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccc
Q 010266 177 DAEYLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254 (514)
Q Consensus 177 ~~~~l~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~ 254 (514)
+.+.+|+||||++||+|..++...+ .+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+
T Consensus 255 ~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~ 334 (576)
T 2acx_A 255 TKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAV 334 (576)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccce
Confidence 9999999999999999999997754 49999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCc
Q 010266 255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM 334 (514)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~ 334 (514)
...... ...+.+||+.|+|||++.+..|+.
T Consensus 335 ~~~~~~--------------------------------------------------~~~~~~GT~~Y~APEvl~~~~~~~ 364 (576)
T 2acx_A 335 HVPEGQ--------------------------------------------------TIKGRVGTVGYMAPEVVKNERYTF 364 (576)
T ss_dssp ECCTTC--------------------------------------------------CEECCCSCGGGCCHHHHTTCEESS
T ss_pred ecccCc--------------------------------------------------cccccCCCccccCHHHHcCCCCCc
Confidence 653210 112568999999999999999999
Q ss_pred ccchhhhhHHHHHHhhCCCCCCCCC----hhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CHh
Q 010266 335 ECDWWSLGAIMYEMLVGYPPFYSDD----PVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSE 407 (514)
Q Consensus 335 ~~DiWSlGvilyemltG~~PF~~~~----~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~ 407 (514)
++|||||||++|||++|.+||.+.+ .......+.. ....+|. .+|+++++||.+||+ ||.+|+|.. +++
T Consensus 365 ~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~--~~~~~p~--~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~ 440 (576)
T 2acx_A 365 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--VPEEYSE--RFSPQARSLCSQLLCKDPAERLGCRGGSAR 440 (576)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSGGGSTTCSSSHHH
T ss_pred cchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc--ccccCCc--cCCHHHHHHHHHhccCCHHHcCCCCCCCHH
Confidence 9999999999999999999998764 3445555554 3345553 689999999999999 999999764 789
Q ss_pred HHhcCCccccCCccccc--cccCCCCCcCCC-----CCCCCCCC
Q 010266 408 QIKAHPWFKDIAWDKLY--EMEAAYKPEVNG-----VLDTQNFM 444 (514)
Q Consensus 408 eil~Hpff~~i~w~~l~--~~~~p~~p~~~~-----~~d~~~f~ 444 (514)
||++||||++++|+.+. .+.|||+|.+.. ..|.++|+
T Consensus 441 eil~HpfF~~i~w~~l~~~~~~pp~~p~~~~~~~~~~~d~~~f~ 484 (576)
T 2acx_A 441 EVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFS 484 (576)
T ss_dssp HHHTSGGGTTCCHHHHHTTCSCCSCCCCCCCCCC----------
T ss_pred HHHhChhhccCCHHHHhcCCCCCCCCCCccccccCCcccHhhcc
Confidence 99999999999999996 578999998753 34445554
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-59 Score=465.86 Aligned_cols=258 Identities=24% Similarity=0.407 Sum_probs=222.9
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEc-----cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 176 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 176 (514)
.+..++|.+.+.||+|+||+||+|++. .++..||||++++. .....+.+.+|+.+|+.++|||||+++++|.
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 466689999999999999999999875 36789999999754 3456678999999999999999999999999
Q ss_pred cCCeEEEEEeecCCCCHHHHHhhc-------------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC
Q 010266 177 DAEYLYLIMEYLPGGDVMTLLMRE-------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG 243 (514)
Q Consensus 177 ~~~~l~lVmEy~~gg~L~~~l~~~-------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g 243 (514)
+.+.+|||||||+||+|.++|.+. ..+++..+..++.|++.||.|||++|||||||||+||||+.++
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 999999999999999999999764 3699999999999999999999999999999999999999999
Q ss_pred cEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCC
Q 010266 244 HMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIA 323 (514)
Q Consensus 244 ~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~A 323 (514)
++||+|||+|+....... ...+...+||+.|||
T Consensus 166 ~~Ki~DFGla~~~~~~~~-----------------------------------------------~~~~~~~~gt~~ymA 198 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDY-----------------------------------------------YRVGGHTMLPIRWMP 198 (299)
T ss_dssp CEEECCCSCHHHHTGGGC-----------------------------------------------EEETTTEEECGGGCC
T ss_pred cEEECCcccceecCCCCc-----------------------------------------------eeecCceecChhhcC
Confidence 999999999985432110 011225679999999
Q ss_pred ccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccC
Q 010266 324 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRL 401 (514)
Q Consensus 324 PEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl 401 (514)
||++.+..|+.++|||||||+||||+| |.+||.+.+..+....|.... .+..|. .+|+++.+||.+||. ||.+|+
T Consensus 199 PE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~-~~~~p~--~~~~~~~~li~~cl~~dP~~RP 275 (299)
T 4asz_A 199 PESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR-VLQRPR--TCPQEVYELMLGCWQREPHMRK 275 (299)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC-CCCCCT--TCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCCc--cchHHHHHHHHHHcCCChhHCc
Confidence 999999999999999999999999998 999999999999988887643 344454 689999999999999 999999
Q ss_pred CCCCHhHHhcCCcccc
Q 010266 402 GTLGSEQIKAHPWFKD 417 (514)
Q Consensus 402 ~~~~~~eil~Hpff~~ 417 (514)
+++|| |+|+++
T Consensus 276 ---s~~~i--~~~L~~ 286 (299)
T 4asz_A 276 ---NIKGI--HTLLQN 286 (299)
T ss_dssp ---CHHHH--HHHHHH
T ss_pred ---CHHHH--HHHHHH
Confidence 99999 567764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-57 Score=459.51 Aligned_cols=256 Identities=23% Similarity=0.394 Sum_probs=217.0
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEc-----cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEE
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSF 175 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 175 (514)
..+..++|.+.+.||+|+||+||+|+.+ .+++.||||++++. .....+.+.+|+.+|+.++|||||+++++|
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 112 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVC 112 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 4466789999999999999999999865 36889999999754 355667899999999999999999999999
Q ss_pred EcCCeEEEEEeecCCCCHHHHHhhc---------------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCcccc
Q 010266 176 QDAEYLYLIMEYLPGGDVMTLLMRE---------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD 240 (514)
Q Consensus 176 ~~~~~l~lVmEy~~gg~L~~~l~~~---------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld 240 (514)
.+.+.+|||||||+||+|.++|.+. +++++..+..++.|++.||.|||++|||||||||+||||+
T Consensus 113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192 (329)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence 9999999999999999999999753 3589999999999999999999999999999999999999
Q ss_pred CCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCC
Q 010266 241 QNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPD 320 (514)
Q Consensus 241 ~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~ 320 (514)
.++++||+|||+|+....... .....+.+||+.
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~-----------------------------------------------~~~~~~~~gt~~ 225 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDY-----------------------------------------------YRVGGRTMLPIR 225 (329)
T ss_dssp TTTEEEECCCC---------------------------------------------------------------CCCCGG
T ss_pred CCCcEEEcccccceeccCCCc-----------------------------------------------ceecCccccccc
Confidence 999999999999986532210 011225689999
Q ss_pred cCCccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-Ccc
Q 010266 321 YIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVE 398 (514)
Q Consensus 321 Y~APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~ 398 (514)
|||||++.+..|+.++|||||||+||||+| |.+||.+.+..+....|... ..+..|. .+++++.+||.+||. ||.
T Consensus 226 ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g-~~~~~p~--~~~~~~~~li~~cl~~dP~ 302 (329)
T 4aoj_A 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG-RELERPR--ACPPEVYAIMRGCWQREPQ 302 (329)
T ss_dssp GCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT-CCCCCCT--TCCHHHHHHHHHHCCSSTT
T ss_pred ccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CCCCCcc--cccHHHHHHHHHHcCcChh
Confidence 999999999999999999999999999999 99999999998888888764 3345554 689999999999999 999
Q ss_pred ccCCCCCHhHHhcC
Q 010266 399 HRLGTLGSEQIKAH 412 (514)
Q Consensus 399 ~Rl~~~~~~eil~H 412 (514)
+|+ +++||+.+
T Consensus 303 ~RP---s~~ei~~~ 313 (329)
T 4aoj_A 303 QRH---SIKDVHAR 313 (329)
T ss_dssp TSC---CHHHHHHH
T ss_pred HCc---CHHHHHHH
Confidence 999 99999763
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-57 Score=453.07 Aligned_cols=257 Identities=21% Similarity=0.324 Sum_probs=220.8
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEc-----cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEE
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSF 175 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 175 (514)
..+..+++++++.||+|+||+||+|+.. .+++.||||+++... .....+.+.+|+.+|+.++|||||++++++
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 3567789999999999999999999853 467899999997542 334457799999999999999999999999
Q ss_pred EcCCeEEEEEeecCCCCHHHHHhhc----------------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccc
Q 010266 176 QDAEYLYLIMEYLPGGDVMTLLMRE----------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL 239 (514)
Q Consensus 176 ~~~~~l~lVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILl 239 (514)
.+++.+|||||||+||+|.++|... ..+++..+..++.||+.||+|||+++||||||||+||||
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 9999999999999999999999643 358999999999999999999999999999999999999
Q ss_pred cCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCC
Q 010266 240 DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTP 319 (514)
Q Consensus 240 d~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~ 319 (514)
+.++++||+|||+|+....... .....+.+||+
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~-----------------------------------------------~~~~~~~~gt~ 211 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADY-----------------------------------------------YKLLGNSLLPI 211 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGC-----------------------------------------------BCSSSSSCBCG
T ss_pred CCCCCEEECCcccceeccCCCc-----------------------------------------------eeEecccccCC
Confidence 9999999999999986532110 01123568999
Q ss_pred CcCCccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-Cc
Q 010266 320 DYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DV 397 (514)
Q Consensus 320 ~Y~APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp 397 (514)
.|||||++.+..|+.++|||||||+||||+| |.+||.+.+..+....|.... .+..| ..+++++.+||.+|+. ||
T Consensus 212 ~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~-~~~~p--~~~~~~~~~li~~C~~~dP 288 (308)
T 4gt4_A 212 RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQ-VLPCP--DDCPAWVYALMIECWNEFP 288 (308)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSG
T ss_pred cccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCc--ccchHHHHHHHHHHcCCCh
Confidence 9999999999999999999999999999998 899999999988888887632 23344 4689999999999998 99
Q ss_pred cccCCCCCHhHHhcC
Q 010266 398 EHRLGTLGSEQIKAH 412 (514)
Q Consensus 398 ~~Rl~~~~~~eil~H 412 (514)
.+|| ++.||+++
T Consensus 289 ~~RP---s~~ei~~~ 300 (308)
T 4gt4_A 289 SRRP---RFKDIHSR 300 (308)
T ss_dssp GGSC---CHHHHHHH
T ss_pred hHCc---CHHHHHHH
Confidence 9999 99999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=451.41 Aligned_cols=257 Identities=21% Similarity=0.269 Sum_probs=210.5
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE 179 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 179 (514)
.+++..+++++.+.||+|+||+||+|+.+ ..||||+++... ......+.+.+|+.+|+.++|||||++++++. ++
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~ 104 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KD 104 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CC
Confidence 35788899999999999999999999754 359999987543 34556788999999999999999999999775 56
Q ss_pred eEEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
.+|||||||+||+|.++|... ..+++..+..++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 789999999999999999764 6799999999999999999999999999999999999999999999999999986532
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc---CCCCcc
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK---KGYGME 335 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~y~~~ 335 (514)
... ...+.+.+||+.|||||++.+ .+|+.+
T Consensus 185 ~~~-----------------------------------------------~~~~~~~~GT~~ymAPE~l~~~~~~~y~~k 217 (307)
T 3omv_A 185 WSG-----------------------------------------------SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQ 217 (307)
T ss_dssp --------------------------------------------------------CCCCTTSCCHHHHHCCSSCCCCHH
T ss_pred CCc-----------------------------------------------ceeecccccCCCccCHHHhhccCCCCCCcH
Confidence 110 011236789999999999974 358999
Q ss_pred cchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhc-CcccCCc-CcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 336 CDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWK-NHLKFPE-EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 336 ~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~~~p~-~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
+|||||||+||||+||.+||.+.+.......++... .....+. ...+++++++||.+||. ||.+|+ |+.||++
T Consensus 218 sDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~ei~~ 293 (307)
T 3omv_A 218 SDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERP---LFPQILS 293 (307)
T ss_dssp HHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSC---CHHHHHH
T ss_pred HHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCc---CHHHHHH
Confidence 999999999999999999999877665555554321 1111221 23678999999999999 999999 8888754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-56 Score=456.85 Aligned_cols=259 Identities=22% Similarity=0.334 Sum_probs=220.7
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCC-----CEEEEEEeecccccChhhHHHHHHHHHHHHHcCC-CceeeEEE
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSG-----NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS-HCIVKLYY 173 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~-----~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~ 173 (514)
++.+..++|++.+.||+|+||+||+|++..++ +.||||++.... .....+.+.+|..+|..+.| ||||++++
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 35677899999999999999999999987543 689999997653 34556778999999999965 89999999
Q ss_pred EEEc-CCeEEEEEeecCCCCHHHHHhhc----------------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCC
Q 010266 174 SFQD-AEYLYLIMEYLPGGDVMTLLMRE----------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDN 236 (514)
Q Consensus 174 ~f~~-~~~l~lVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeN 236 (514)
+|.+ .+.+|||||||+||+|.++|... ..+++..+..|+.||+.||+|||+++||||||||+|
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N 215 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 215 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence 9865 56799999999999999999753 348899999999999999999999999999999999
Q ss_pred ccccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccc
Q 010266 237 LLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTV 316 (514)
Q Consensus 237 ILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 316 (514)
||++.+|++||+|||+|+.+...... ..+.+.+
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~~-----------------------------------------------~~~~~~~ 248 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPDY-----------------------------------------------VRKGDAR 248 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTS-----------------------------------------------EEETTEE
T ss_pred eeeCCCCCEEECcchhhhhcccCCCc-----------------------------------------------eeecccc
Confidence 99999999999999999865432110 1123578
Q ss_pred cCCCcCCccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc
Q 010266 317 GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC 395 (514)
Q Consensus 317 GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~ 395 (514)
||+.|||||++.+..|+.++|||||||+||||+| |.+||.+.+..+.+.+++.....+..|+ .+|+++.+||.+||.
T Consensus 249 gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~--~~~~~~~~li~~c~~ 326 (353)
T 4ase_A 249 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD--YTTPEMYQTMLDCWH 326 (353)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCT--TCCHHHHHHHHHHTC
T ss_pred ccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCc--cCCHHHHHHHHHHcC
Confidence 9999999999999999999999999999999998 9999998776555555554334455554 689999999999999
Q ss_pred -CccccCCCCCHhHHhcC
Q 010266 396 -DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 396 -dp~~Rl~~~~~~eil~H 412 (514)
||.+|+ |+.||++|
T Consensus 327 ~dP~~RP---t~~eil~~ 341 (353)
T 4ase_A 327 GEPSQRP---TFSELVEH 341 (353)
T ss_dssp SSGGGSC---CHHHHHHH
T ss_pred cChhHCc---CHHHHHHH
Confidence 999999 99999987
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-55 Score=450.54 Aligned_cols=265 Identities=31% Similarity=0.526 Sum_probs=236.8
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccCh---hhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR---GQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 181 (514)
.++|++++.||+|+||+||+|+++.+|+.||+|++.+...... ...+.+.+|+.+|..++|||||+++++|.+...+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 4679999999999999999999999999999999987654322 1356788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC----cEEEccccccccCC
Q 010266 182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG----HMKLSDFGLCKPLD 257 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g----~iKL~DFGla~~~~ 257 (514)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+|+...
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 99999999999999998888999999999999999999999999999999999999998877 89999999998653
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
... ...+.+||+.|+|||++.+..|+.++|
T Consensus 171 ~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~D 200 (361)
T 2yab_A 171 DGV--------------------------------------------------EFKNIFGTPEFVAPEIVNYEPLGLEAD 200 (361)
T ss_dssp TTC--------------------------------------------------CCCCCCSCGGGCCHHHHTTCCCCTHHH
T ss_pred CCC--------------------------------------------------ccccCCCCccEECchHHcCCCCCcccc
Confidence 210 112568999999999999999999999
Q ss_pred hhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCc--CcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCc
Q 010266 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPE--EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPW 414 (514)
Q Consensus 338 iWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpf 414 (514)
||||||++|+|++|.+||.+.+..+.+.+|.... ..++. +..+|+++++||.+||+ ||.+|+ +++|+++|||
T Consensus 201 iwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~e~l~hp~ 275 (361)
T 2yab_A 201 MWSIGVITYILLSGASPFLGDTKQETLANITAVS--YDFDEEFFSQTSELAKDFIRKLLVKETRKRL---TIQEALRHPW 275 (361)
T ss_dssp HHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHTSTT
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--CCCCchhccCCCHHHHHHHHHHCCCChhHCc---CHHHHhcCcC
Confidence 9999999999999999999999999999988743 33332 34689999999999999 999999 9999999999
Q ss_pred cccCCccccc
Q 010266 415 FKDIAWDKLY 424 (514)
Q Consensus 415 f~~i~w~~l~ 424 (514)
|++++|....
T Consensus 276 ~~~~~~~~~~ 285 (361)
T 2yab_A 276 ITPVDTQQAM 285 (361)
T ss_dssp TSCSSHHHHH
T ss_pred cCCCchhhhh
Confidence 9999997653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-54 Score=438.22 Aligned_cols=261 Identities=29% Similarity=0.526 Sum_probs=234.6
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
.....++|++++.||+|+||.||+|++..+|+.||||++.+... .....+.+.+|..+|+.++||||+++++++.+.+.
T Consensus 10 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 88 (328)
T 3fe3_A 10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT 88 (328)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence 34456899999999999999999999999999999999987643 45566778899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
+|+||||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|.......
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 99999999999999999988999999999999999999999999999999999999999999999999999987543210
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCC-cccchh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG-MECDWW 339 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~-~~~DiW 339 (514)
...+.+||+.|+|||++.+..+. .++|||
T Consensus 169 --------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw 198 (328)
T 3fe3_A 169 --------------------------------------------------KLDAFCGAPPYAAPELFQGKKYDGPEVDVW 198 (328)
T ss_dssp --------------------------------------------------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHH
T ss_pred --------------------------------------------------ccccccCCcceeCcccccCCCcCCchhhhh
Confidence 11256899999999999988874 899999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
||||++|+|++|.+||.+.+..+...++.. ....+|. .+|+++.+||.+||. ||.+|+ |++||++||||+..
T Consensus 199 slG~il~ell~g~~pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L~~dP~~R~---t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 199 SLGVILYTLVSGSLPFDGQNLKELRERVLR--GKYRIPF--YMSTDCENLLKRFLVLNPIKRG---TLEQIMKDRWINAG 271 (328)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHCCSSTTTSC---CHHHHTTCTTTTTT
T ss_pred hhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHHHCCCChhHCc---CHHHHhcCHhhcCC
Confidence 999999999999999999999998888886 3445554 689999999999999 999999 99999999999865
Q ss_pred C
Q 010266 419 A 419 (514)
Q Consensus 419 ~ 419 (514)
.
T Consensus 272 ~ 272 (328)
T 3fe3_A 272 H 272 (328)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-55 Score=447.52 Aligned_cols=291 Identities=41% Similarity=0.754 Sum_probs=241.8
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEc---cCCCEEEEEEeecccccC-hhhHHHHHHHHHHHHHc-CCCceeeEEEEE
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEK---KSGNIYAMKKLKKSEMLS-RGQVEHVRAERNLLAEV-ASHCIVKLYYSF 175 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~---~t~~~~AiK~l~k~~~~~-~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f 175 (514)
..+..++|++++.||+|+||.||+|++. .+++.||||++++..... ......+.+|+.+|..+ +||||++++++|
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 3456689999999999999999999984 589999999997654321 22334567899999999 699999999999
Q ss_pred EcCCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 176 QDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 176 ~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
.+...+|+||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999999999999999888999999999999999999999999999999999999999999999999999976
Q ss_pred CCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc--CCCC
Q 010266 256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK--KGYG 333 (514)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~ 333 (514)
..... .......+||+.|+|||++.+ ..++
T Consensus 209 ~~~~~------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~ 240 (355)
T 1vzo_A 209 FVADE------------------------------------------------TERAYDFCGTIEYMAPDIVRGGDSGHD 240 (355)
T ss_dssp CCGGG------------------------------------------------GGGGCGGGSCCTTCCHHHHTTCC---C
T ss_pred cccCC------------------------------------------------CCcccCcccCcCccChhhhcCCCCCCC
Confidence 43210 011235689999999999985 4578
Q ss_pred cccchhhhhHHHHHHhhCCCCCCCCCh----hHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CH
Q 010266 334 MECDWWSLGAIMYEMLVGYPPFYSDDP----VTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GS 406 (514)
Q Consensus 334 ~~~DiWSlGvilyemltG~~PF~~~~~----~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~ 406 (514)
.++|||||||++|||++|..||...+. ......+.. ....+|. .+++.+++||.+||. ||.+|++.. ++
T Consensus 241 ~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~L~~dP~~R~~~~~~s~ 316 (355)
T 1vzo_A 241 KAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--SEPPYPQ--EMSALAKDLIQRLLMKDPKKRLGCGPRDA 316 (355)
T ss_dssp THHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSGGGSTTSSTTTH
T ss_pred chhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc--cCCCCCc--ccCHHHHHHHHHHhhhCHHHhcCCCCCCH
Confidence 999999999999999999999975433 333334433 2333443 689999999999999 999999754 89
Q ss_pred hHHhcCCccccCCccccc--cccCCCCCcCCCCCCCCCC
Q 010266 407 EQIKAHPWFKDIAWDKLY--EMEAAYKPEVNGVLDTQNF 443 (514)
Q Consensus 407 ~eil~Hpff~~i~w~~l~--~~~~p~~p~~~~~~d~~~f 443 (514)
+|+++||||..++|+.+. ..+|||.|.+.+..|.+||
T Consensus 317 ~ell~h~~f~~~~~~~l~~~~~~~p~~p~~~~~~d~~~~ 355 (355)
T 1vzo_A 317 DEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDVSNF 355 (355)
T ss_dssp HHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC-CCC---
T ss_pred HHHHcCcchhcCChhHhhhccCCCCCCCccccccccccC
Confidence 999999999999999986 5779999999999999987
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-54 Score=441.99 Aligned_cols=279 Identities=29% Similarity=0.542 Sum_probs=233.4
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCeEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lV 184 (514)
++|++++.||+|+||+||+|+++.+|+.||||++.+.... ..+|.++|..+ +|||||+++++|++...+|+|
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 5799999999999999999999999999999999876421 34578888877 799999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC-C---CcEEEccccccccCCCCC
Q 010266 185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ-N---GHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~-~---g~iKL~DFGla~~~~~~~ 260 (514)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+.. + +++||+|||+|+......
T Consensus 95 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 95 TELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp ECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 999999999999999899999999999999999999999999999999999999843 3 359999999998653211
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 340 (514)
....+.+||+.|+|||++.+.+|+.++||||
T Consensus 175 -------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 205 (342)
T 2qr7_A 175 -------------------------------------------------GLLMTPCYTANFVAPEVLERQGYDAACDIWS 205 (342)
T ss_dssp -------------------------------------------------CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHH
T ss_pred -------------------------------------------------CceeccCCCccccCHHHhcCCCCCCccCeee
Confidence 0122568999999999999988999999999
Q ss_pred hhHHHHHHhhCCCCCCC---CChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccc
Q 010266 341 LGAIMYEMLVGYPPFYS---DDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFK 416 (514)
Q Consensus 341 lGvilyemltG~~PF~~---~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~ 416 (514)
|||++|||++|.+||.+ .+..+....|......+..+.+..+|+++++||.+||. ||.+|+ +++++++||||.
T Consensus 206 lG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~~il~hp~~~ 282 (342)
T 2qr7_A 206 LGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRL---TAALVLRHPWIV 282 (342)
T ss_dssp HHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSC---CHHHHTTSHHHH
T ss_pred HhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCc---CHHHHhcCCeec
Confidence 99999999999999986 45566777776633332222335789999999999999 999999 999999999994
Q ss_pred cCCccccc--cccCCCCCcCCCCCCCCCCCC
Q 010266 417 DIAWDKLY--EMEAAYKPEVNGVLDTQNFMK 445 (514)
Q Consensus 417 ~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~ 445 (514)
+|+.+. ++.+|+.|......+..+|+.
T Consensus 283 --~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 311 (342)
T 2qr7_A 283 --HWDQLPQYQLNRQDAPHLVKGAMAATYSA 311 (342)
T ss_dssp --TGGGSCCSCCCCCCCHHHHHHHHHHHHHH
T ss_pred --CccccccccCCCccchhhhhhHHHHHHhh
Confidence 588775 466777776443333334443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=425.90 Aligned_cols=264 Identities=31% Similarity=0.527 Sum_probs=233.7
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccCh---hhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR---GQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
++|++.+.||+|+||.||+|+++.+|+.||+|++.+...... ...+.+.+|..+|..++|||||+++++|.+...+|
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 569999999999999999999999999999999987643321 13567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC----cEEEccccccccCCC
Q 010266 183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG----HMKLSDFGLCKPLDC 258 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g----~iKL~DFGla~~~~~ 258 (514)
+||||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++ ++||+|||+|+....
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~ 170 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence 9999999999999998888999999999999999999999999999999999999999888 899999999986532
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
.. .....+||+.|+|||++.+..|+.++||
T Consensus 171 ~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di 200 (326)
T 2y0a_A 171 GN--------------------------------------------------EFKNIFGTPEFVAPEIVNYEPLGLEADM 200 (326)
T ss_dssp TS--------------------------------------------------CCCCCCSCTTTCCHHHHTTCCCCTHHHH
T ss_pred CC--------------------------------------------------ccccccCCcCcCCceeecCCCCCcHHHH
Confidence 10 0124679999999999999999999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCc--CcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPE--EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
|||||++|+|++|.+||.+.+..+....+.... ..++. ...+|+.+++||.+||. ||.+|+ +++|+++||||
T Consensus 201 wslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~e~l~hp~~ 275 (326)
T 2y0a_A 201 WSIGVITYILLSGASPFLGDTKQETLANVSAVN--YEFEDEYFSNTSALAKDFIRRLLVKDPKKRM---TIQDSLQHPWI 275 (326)
T ss_dssp HHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTC--CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSC---CHHHHHHSTTT
T ss_pred HHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcC--CCcCccccccCCHHHHHHHHHHccCChhhCC---CHHHHhcCCCc
Confidence 999999999999999999998888888877633 23332 24689999999999999 999999 99999999999
Q ss_pred ccCCccccc
Q 010266 416 KDIAWDKLY 424 (514)
Q Consensus 416 ~~i~w~~l~ 424 (514)
++.+|....
T Consensus 276 ~~~~~~~~~ 284 (326)
T 2y0a_A 276 KPKDTQQAL 284 (326)
T ss_dssp SCCSHHHHH
T ss_pred cCCcchhhh
Confidence 998886543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=431.89 Aligned_cols=258 Identities=32% Similarity=0.580 Sum_probs=231.0
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++++.||+|+||.||+|.++.+|+.||+|++.+... .....+.+.+|..+|..++|||||+++++|.+.+..|+||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 579999999999999999999999999999999987643 4456678899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCC---CcEEEccccccccCCCCCcc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN---GHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~---g~iKL~DFGla~~~~~~~~~ 262 (514)
||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~-- 185 (362)
T 2bdw_A 108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-- 185 (362)
T ss_dssp CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC--
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc--
Confidence 999999999999888899999999999999999999999999999999999999865 459999999997653210
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
.....+||+.|+|||++.+..|+.++||||||
T Consensus 186 ------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 217 (362)
T 2bdw_A 186 ------------------------------------------------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG 217 (362)
T ss_dssp ------------------------------------------------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHH
T ss_pred ------------------------------------------------ccccCCCCccccCHHHHccCCCCchhhHHHHH
Confidence 11256899999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
|++|+|++|.+||.+.+..+.+..|......+..+.+..+|+++++||.+||. ||.+|+ +++|+++||||.+
T Consensus 218 ~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 218 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI---TADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSC---CHHHHTTSHHHHT
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCc---CHHHHhcCcccCC
Confidence 99999999999999999988888888754433344445789999999999999 999999 9999999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=443.48 Aligned_cols=259 Identities=32% Similarity=0.593 Sum_probs=231.2
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++++.||+|+||.||+|.++.+|+.||+|++.+... .....+.+.+|..+|+.++|||||+++++|.+.+.+|+||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 579999999999999999999999999999999987653 3445667889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCcccc---CCCcEEEccccccccCCCCCcc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD---QNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld---~~g~iKL~DFGla~~~~~~~~~ 262 (514)
||++||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+......
T Consensus 90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~-- 167 (444)
T 3soa_A 90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-- 167 (444)
T ss_dssp CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC--
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC--
Confidence 9999999999999999999999999999999999999999999999999999998 46899999999997654211
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
....+.+||+.|+|||++.+..|+.++||||||
T Consensus 168 -----------------------------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlG 200 (444)
T 3soa_A 168 -----------------------------------------------QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACG 200 (444)
T ss_dssp -----------------------------------------------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHH
T ss_pred -----------------------------------------------ceeecccCCcccCCHHHhcCCCCCCccccHHHH
Confidence 011256899999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
|++|+|++|.+||.+.+..+.+..+......+..|.+..+|+++++||.+||. ||.+|+ ++.|+++||||++
T Consensus 201 vilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---ta~e~L~hp~~~~ 273 (444)
T 3soa_A 201 VILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRI---TAAEALKHPWISH 273 (444)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHHSCTTHH
T ss_pred HHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCC---CHHHHhcCccccC
Confidence 99999999999999999999999998755444445556789999999999999 999999 9999999999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=423.63 Aligned_cols=257 Identities=27% Similarity=0.449 Sum_probs=227.6
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.++|++++.||+|+||.||+|.++.+++.||+|++... ......+.+|..+|..++||||++++++|.+.+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 47899999999999999999999999999999998743 33456688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC--CCcEEEccccccccCCCCCc
Q 010266 185 MEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ--NGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~--~g~iKL~DFGla~~~~~~~~ 261 (514)
|||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+++......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~- 158 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence 9999999999999765 47999999999999999999999999999999999999997 7999999999998654211
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
.....+||+.|+|||++.+..++.++|||||
T Consensus 159 -------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 189 (321)
T 1tki_A 159 -------------------------------------------------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSL 189 (321)
T ss_dssp -------------------------------------------------EEEEEESCGGGSCHHHHTTCEECHHHHHHHH
T ss_pred -------------------------------------------------ccccccCChhhcCcHHhcCCCCCchhhHHHH
Confidence 1125679999999999999989999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
||++|+|++|.+||.+.+..+....+......+..+....+|+++++||.+||. ||.+|+ +++|+++||||+..
T Consensus 190 G~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp---t~~e~l~hp~~~~~ 264 (321)
T 1tki_A 190 GTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM---TASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSHHHHSC
T ss_pred HHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCc---CHHHHhcChhhccC
Confidence 999999999999999999998888888743322222234689999999999999 999999 99999999999753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-52 Score=415.51 Aligned_cols=258 Identities=29% Similarity=0.505 Sum_probs=226.0
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 183 (514)
..++|++++.||+|+||+||+|++..+++.||+|++..... ...+.+.+|..+++.++|||||+++++|.+.+.+|+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 34689999999999999999999999999999999976543 234568889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
||||++||+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|........
T Consensus 95 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 171 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 171 (297)
T ss_dssp EEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred EEECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--
Confidence 9999999999999865 4699999999999999999999999999999999999999999999999999876542210
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhH
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 343 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 343 (514)
...+.+||+.|+|||++.+..|+.++|||||||
T Consensus 172 -----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 204 (297)
T 3fxz_A 172 -----------------------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204 (297)
T ss_dssp -----------------------------------------------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHH
T ss_pred -----------------------------------------------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHH
Confidence 112568999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 344 ilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
++|||++|.+||.+.+.......+.... ...++....+++.+++||.+||. ||.+|+ +++|+++||||+..
T Consensus 205 il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~ell~h~~~~~~ 276 (297)
T 3fxz_A 205 MAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDFLNRCLEMDVEKRG---SAKELLQHQFLKIA 276 (297)
T ss_dssp HHHHHHHSSCTTTTSCHHHHHHHHHHHC-SCCCSCGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCGGGGGC
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCccccCHHHHHHHHHHccCChhHCc---CHHHHhhChhhccc
Confidence 9999999999999988877766665432 22333334789999999999999 999999 99999999999854
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=428.71 Aligned_cols=257 Identities=32% Similarity=0.570 Sum_probs=225.5
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
...++|.+++.||+|+||+||+|++..+++.||+|++.+...........+.+|..+|+.++||||++++++|.+...+|
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 44689999999999999999999999999999999998764433344567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
+||||+ +|+|.+++...+.+++..++.++.|++.||.|||+.||+||||||+|||++.+|++||+|||+|.......
T Consensus 86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~-- 162 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-- 162 (336)
T ss_dssp EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--
T ss_pred EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--
Confidence 999999 78999999888999999999999999999999999999999999999999999999999999987543210
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCC-Ccccchhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSL 341 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWSl 341 (514)
...+.+||+.|+|||++.+..+ +.++|||||
T Consensus 163 ------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 194 (336)
T 3h4j_B 163 ------------------------------------------------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSC 194 (336)
T ss_dssp ------------------------------------------------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHH
T ss_pred ------------------------------------------------ccccccCCcCcCCHHHHcCCCCCCCccchhHH
Confidence 1125689999999999998887 789999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
||++|+|++|.+||.+.+.......+.. ....+|. .+|+++++||.+||. ||.+|+ |++||++||||+.
T Consensus 195 G~il~~ll~g~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L~~dP~~Rp---t~~eil~hp~~~~ 264 (336)
T 3h4j_B 195 GIVLYVMLVGRLPFDDEFIPNLFKKVNS--CVYVMPD--FLSPGAQSLIRRMIVADPMQRI---TIQEIRRDPWFNV 264 (336)
T ss_dssp HHHHHHHHHSSCSSBCSSSTTCBCCCCS--SCCCCCT--TSCHHHHHHHHTTSCSSGGGSC---CHHHHTTCHHHHT
T ss_pred HHHHHHHHhCCCCCCCccHHHHHHHHHc--CCCCCcc--cCCHHHHHHHHHHcCCChhHCc---CHHHHHhChhhcc
Confidence 9999999999999988766655544432 2234443 689999999999999 999999 9999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-52 Score=431.62 Aligned_cols=280 Identities=25% Similarity=0.450 Sum_probs=213.9
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEEEcCC--eE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAE--YL 181 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~--~l 181 (514)
.++|++++.||+|+||.||+|.++.+|+.||||++.+. .........+.+|..+|..+. |||||+++++|.+.+ .+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 37899999999999999999999999999999999754 334556677889999999997 999999999998544 79
Q ss_pred EEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
|+|||||+ |+|..++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+|+.+.....
T Consensus 87 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred EEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 99999997 689988865 6799999999999999999999999999999999999999999999999999987643211
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWS 340 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWS 340 (514)
....... ..... . ... ........+.+||+.|+|||++.+ ..|+.++||||
T Consensus 165 ~~~~~~~-----------~~~~~------~----------~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS 216 (388)
T 3oz6_A 165 VTNNIPL-----------SINEN------T----------ENF-DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWS 216 (388)
T ss_dssp CCCCGGG-----------CCC--------------------------------CCCGGGGCCHHHHTTCCCCCTHHHHHH
T ss_pred ccccccc-----------ccccc------c----------ccc-ccccccccCCcccCCcCCHHHhcCCCCCCChhhHHH
Confidence 1000000 00000 0 000 000112336799999999999987 67999999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCccc-------------------------------------------CC
Q 010266 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLK-------------------------------------------FP 377 (514)
Q Consensus 341 lGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~-------------------------------------------~p 377 (514)
|||++|||++|.+||.+.+....+..|+....... .+
T Consensus 217 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (388)
T 3oz6_A 217 LGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKIN 296 (388)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhccccc
Confidence 99999999999999999998888888764211100 00
Q ss_pred cCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 378 EEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 378 ~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
....+++++.+||.+||+ ||.+|+ |++|+++||||+.+
T Consensus 297 ~~~~~~~~~~dll~~~L~~dP~~R~---t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 297 PKADCNEEALDLLDKLLQFNPNKRI---SANDALKHPFVSIF 335 (388)
T ss_dssp TTCCCCHHHHHHHHHHCCSSGGGSC---CHHHHTTSTTTTTT
T ss_pred ccccCCHHHHHHHHHhhccCcccCC---CHHHHhCCHHHHHh
Confidence 112578999999999999 999999 99999999998764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=409.62 Aligned_cols=260 Identities=27% Similarity=0.469 Sum_probs=217.9
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
+++|++++.||+|+||+||+|+++.+++.||+|++..... .......+.+|..+|+.++||||++++++|.+.+.+|+|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 3689999999999999999999999999999999987643 444557788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHH-hhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 185 MEYLPGGDVMTLL-MREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 185 mEy~~gg~L~~~l-~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
|||++| +|...+ ...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 155 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--- 155 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC---
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc---
Confidence 999976 555554 446789999999999999999999999999999999999999999999999999998653211
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCC-CCcccchhhhh
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLG 342 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~-y~~~~DiWSlG 342 (514)
......+||+.|+|||++.+.. |+.++||||||
T Consensus 156 ----------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 189 (292)
T 3o0g_A 156 ----------------------------------------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAG 189 (292)
T ss_dssp ----------------------------------------------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHH
T ss_pred ----------------------------------------------ccccCCccccCCcChHHHcCCCCcCchHHHHHHH
Confidence 0112457999999999998766 89999999999
Q ss_pred HHHHHHhhCCCC-CCCCChhHHHHHHhhhcCccc---------------CC----------cCcCCChhHHHHHhhhcc-
Q 010266 343 AIMYEMLVGYPP-FYSDDPVTTCRKIVHWKNHLK---------------FP----------EEARLTPEAKDLICRLLC- 395 (514)
Q Consensus 343 vilyemltG~~P-F~~~~~~~~~~~i~~~~~~~~---------------~p----------~~~~~s~~~~dLI~~lL~- 395 (514)
|++|+|++|..| |.+.+..+....+........ +| ....+++++++||.+||+
T Consensus 190 ~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 269 (292)
T 3o0g_A 190 CIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKC 269 (292)
T ss_dssp HHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCS
T ss_pred HHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhcc
Confidence 999999987776 566666666666654211100 00 012478999999999999
Q ss_pred CccccCCCCCHhHHhcCCccccC
Q 010266 396 DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 396 dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
||.+|+ |++|+++||||+++
T Consensus 270 dP~~R~---t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 270 NPVQRI---SAEEALQHPYFSDF 289 (292)
T ss_dssp SGGGSC---CHHHHHTSGGGTTC
T ss_pred ChhhCC---CHHHHhcCcccccC
Confidence 999999 99999999999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=415.98 Aligned_cols=266 Identities=29% Similarity=0.483 Sum_probs=221.0
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
.+...++|++++.||+|+||+||+|++. +|+.||+|++.... ........+.+|..+|+.++|||||+++++|.+...
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 93 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC 93 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence 3455689999999999999999999985 58999999997653 233445678899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
+|+||||++| +|..++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9999999975 788777654 46999999999999999999999999999999999999999999999999999865321
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccch
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDW 338 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~Di 338 (514)
.. .....+||+.|+|||++.+ ..|+.++||
T Consensus 173 ~~-------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 203 (311)
T 3niz_A 173 VR-------------------------------------------------SYTHEVVTLWYRAPDVLMGSKKYSTSVDI 203 (311)
T ss_dssp CC----------------------------------------------------CCCCCCTTCCHHHHTTCCSCCTHHHH
T ss_pred cc-------------------------------------------------cccCCcccCCcCCHHHhcCCCCCCchHHh
Confidence 10 0114579999999999986 568999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccC---C-----------------------cCcCCChhHHHHHhh
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKF---P-----------------------EEARLTPEAKDLICR 392 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~---p-----------------------~~~~~s~~~~dLI~~ 392 (514)
|||||++|+|++|.+||.+.+..+....+......... + ....+++++++||.+
T Consensus 204 wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 283 (311)
T 3niz_A 204 WSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSN 283 (311)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHH
Confidence 99999999999999999988887777776542111100 0 012468899999999
Q ss_pred hcc-CccccCCCCCHhHHhcCCccccCCcc
Q 010266 393 LLC-DVEHRLGTLGSEQIKAHPWFKDIAWD 421 (514)
Q Consensus 393 lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~ 421 (514)
||+ ||.+|+ |++|+++||||++++++
T Consensus 284 ~L~~dP~~Rp---t~~ell~hp~f~~~~~~ 310 (311)
T 3niz_A 284 MLCFDPNKRI---SARDAMNHPYFKDLDPQ 310 (311)
T ss_dssp HSCSCTTTSC---CHHHHHTSGGGTTSCTT
T ss_pred HcCCChhHCC---CHHHHhcCcccccCCcc
Confidence 999 999999 99999999999998864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=428.50 Aligned_cols=276 Identities=19% Similarity=0.323 Sum_probs=226.3
Q ss_pred CCCCCeeEEeeeeec--CceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 103 ISVDDFDLLTIIGRG--AFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G--~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
...++|++++.||+| +||+||+|+++.+|+.||||++.+... .......+.+|..+|+.++|||||+++++|.+.+.
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 456789999999999 999999999999999999999987643 45567788899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
+|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999999775 7799999999999999999999999999999999999999999999999999875432
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc--CCCCccc
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK--KGYGMEC 336 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~ 336 (514)
....... ........+||+.|+|||++.+ ..|+.++
T Consensus 181 ~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 218 (389)
T 3gni_B 181 HGQRQRV------------------------------------------VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKS 218 (389)
T ss_dssp TTEECSC------------------------------------------BCCCCTTCTTTGGGSCHHHHSTTSSCBCTHH
T ss_pred ccccccc------------------------------------------cccccccccccccccCHHHHhccCCCCCcHh
Confidence 2100000 0001124589999999999987 6799999
Q ss_pred chhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCc------------------------------------------c
Q 010266 337 DWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNH------------------------------------------L 374 (514)
Q Consensus 337 DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~------------------------------------------~ 374 (514)
|||||||++|||++|.+||.+.+.......++..... .
T Consensus 219 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (389)
T 3gni_B 219 DIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP 298 (389)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------------------------------------------
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCC
Confidence 9999999999999999999987766665554321100 0
Q ss_pred cCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCccccc
Q 010266 375 KFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLY 424 (514)
Q Consensus 375 ~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~l~ 424 (514)
..|....+|+++++||.+||. ||.+|+ +++|+++||||+.+.|....
T Consensus 299 ~~~~~~~~s~~~~~li~~~L~~dP~~Rp---ta~ell~hp~f~~~~~~~~~ 346 (389)
T 3gni_B 299 SHPYHRTFSPHFHHFVEQCLQRNPDARP---SASTLLNHSFFKQIKRRASE 346 (389)
T ss_dssp -------CCHHHHHHHHHHTCSCTTTSC---CHHHHTTSGGGGGC---CCS
T ss_pred CCccccccCHHHHHHHHHHhhcCcccCC---CHHHHhcCHHHHHHhhcchh
Confidence 111223578999999999999 999999 99999999999999886544
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=427.50 Aligned_cols=262 Identities=30% Similarity=0.561 Sum_probs=223.6
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccCh--hhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR--GQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~--~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 183 (514)
++|++++.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|..+|..++|||||+++++|.+.+.+|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 579999999999999999999999999999999976543221 245678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCc---EEEccccccccC
Q 010266 184 IMEYLPGGDVMTLLMRE----ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH---MKLSDFGLCKPL 256 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~---iKL~DFGla~~~ 256 (514)
|||||+||+|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 99999999999887653 35899999999999999999999999999999999999987655 999999999865
Q ss_pred CCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCccc
Q 010266 257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336 (514)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 336 (514)
..... ...+.+||+.|+|||++.+..|+.++
T Consensus 184 ~~~~~-------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~ 214 (351)
T 3c0i_A 184 GESGL-------------------------------------------------VAGGRVGTPHFMAPEVVKREPYGKPV 214 (351)
T ss_dssp CTTSC-------------------------------------------------BCCCCCSCGGGCCHHHHTTCCBCTHH
T ss_pred cCCCe-------------------------------------------------eecCCcCCcCccCHHHHcCCCCCchH
Confidence 42210 11256899999999999999999999
Q ss_pred chhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 337 DWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 337 DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
|||||||++|+|++|.+||.+. ..+.+..+.........+.+..+|+++++||.+||. ||.+|+ ++.|+++||||
T Consensus 215 DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~e~l~hp~~ 290 (351)
T 3c0i_A 215 DVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERI---TVYEALNHPWL 290 (351)
T ss_dssp HHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSC---CHHHHHTSHHH
T ss_pred hhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCc---CHHHHhcChhh
Confidence 9999999999999999999885 455666666533222212224689999999999999 999999 99999999999
Q ss_pred ccCCc
Q 010266 416 KDIAW 420 (514)
Q Consensus 416 ~~i~w 420 (514)
++.+|
T Consensus 291 ~~~~~ 295 (351)
T 3c0i_A 291 KERDR 295 (351)
T ss_dssp HTHHH
T ss_pred cCCcc
Confidence 98665
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-52 Score=440.83 Aligned_cols=261 Identities=31% Similarity=0.565 Sum_probs=235.1
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE 179 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 179 (514)
...+..++|.+.+.||+|+||+||+|+++.+|+.||||++.+...........+.+|..+|+.++||||+++++++.+.+
T Consensus 10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 89 (476)
T 2y94_A 10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89 (476)
T ss_dssp CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 45667899999999999999999999999999999999998765544455678999999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999999865321
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCC-Ccccch
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDW 338 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~Di 338 (514)
. ...+.+||+.|+|||++.+..| +.++||
T Consensus 170 ~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 199 (476)
T 2y94_A 170 E--------------------------------------------------FLRTSCGSPNYAAPEVISGRLYAGPEVDI 199 (476)
T ss_dssp C--------------------------------------------------CBCCCCSCSTTCCHHHHTTCCBCSHHHHH
T ss_pred c--------------------------------------------------cccccCCCcCeEChhhccCCCCCCCccee
Confidence 0 1125689999999999998876 789999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
|||||++|+|++|.+||.+.+....+.+|.. .....|. .+++++++||.+||. ||.+|+ +++||++||||+.
T Consensus 200 wSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~Li~~~L~~dP~~Rp---t~~eil~hp~~~~ 272 (476)
T 2y94_A 200 WSSGVILYALLCGTLPFDDDHVPTLFKKICD--GIFYTPQ--YLNPSVISLLKHMLQVDPMKRA---TIKDIREHEWFKQ 272 (476)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSSHHHHHHHHT--TCCCCCT--TCCHHHHHHHHHHTCSSTTTSC---CHHHHHTCHHHHT
T ss_pred hhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc--CCcCCCc--cCCHHHHHHHHHHcCCCchhCc---CHHHHHhCHHhhh
Confidence 9999999999999999999988888888876 3344453 689999999999999 999999 9999999999975
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=426.05 Aligned_cols=261 Identities=28% Similarity=0.534 Sum_probs=228.9
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.++|++++.||+|+||.||+|.++.+|+.||+|++.+.. ......+.+|+.+|..++|||||+++++|.+...+|+|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 368999999999999999999999999999999997653 33445788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC--CCcEEEccccccccCCCCCc
Q 010266 185 MEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ--NGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~--~g~iKL~DFGla~~~~~~~~ 261 (514)
|||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++++||+|||+|+......
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 205 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 205 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence 99999999999997654 7999999999999999999999999999999999999974 5789999999998653211
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
.....+||+.|+|||++.+..++.++|||||
T Consensus 206 -------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 236 (387)
T 1kob_A 206 -------------------------------------------------IVKVTTATAEFAAPEIVDREPVGFYTDMWAI 236 (387)
T ss_dssp -------------------------------------------------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHH
T ss_pred -------------------------------------------------ceeeeccCCCccCchhccCCCCCCcccEeeH
Confidence 1124579999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCc
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAW 420 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w 420 (514)
||++|||++|.+||.+.+..+...++......+..+....+|+++++||.+||+ ||.+|+ +++|+++||||++..+
T Consensus 237 G~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 237 GVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL---TVHDALEHPWLKGDHS 313 (387)
T ss_dssp HHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHTSTTTSSCCT
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCc---CHHHHhhCccccCCcc
Confidence 999999999999999999888888887643333322334689999999999999 999999 9999999999987654
Q ss_pred c
Q 010266 421 D 421 (514)
Q Consensus 421 ~ 421 (514)
.
T Consensus 314 ~ 314 (387)
T 1kob_A 314 N 314 (387)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=438.00 Aligned_cols=295 Identities=24% Similarity=0.378 Sum_probs=210.3
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE-----cC
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ-----DA 178 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~-----~~ 178 (514)
..++|++++.||+|+||+||+|+++.+++.||||++.+. .......+.+.+|+.+|..++|||||+++++|. +.
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 347899999999999999999999999999999999764 334556678899999999999999999999994 34
Q ss_pred CeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
..+|+||||+ +|+|..++.....+++..++.++.||+.||.|||+.|||||||||+||||+.+|++||+|||+|+....
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 130 DELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp CCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred ceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 6799999998 579999998888999999999999999999999999999999999999999999999999999987653
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccc-ccCCCCcccc
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL-LKKGYGMECD 337 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl-~~~~y~~~~D 337 (514)
......... ...+... ........ ..+......+.+||+.|+|||++ .+..|+.++|
T Consensus 209 ~~~~~~~~~-------------~~~~~~~--------~~~~~~~~-~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~D 266 (458)
T 3rp9_A 209 PENGNSQLP-------------ISPREDD--------MNLVTFPH-TKNLKRQLTGHVVTRWYRAPELILLQENYTEAID 266 (458)
T ss_dssp CTTCCCCCC-------------------------------------------------CCCTTCCHHHHTTCCCCCTHHH
T ss_pred ccccccccc-------------cCccccc--------cccccccc-cccccccccCCcccccccChHHhhCCCCCCcHhH
Confidence 221100000 0000000 00000000 00011123467999999999986 4567999999
Q ss_pred hhhhhHHHHHHhh-----------CCCCCCCCCh--------------------hHHHHHHhhhcCcc------------
Q 010266 338 WWSLGAIMYEMLV-----------GYPPFYSDDP--------------------VTTCRKIVHWKNHL------------ 374 (514)
Q Consensus 338 iWSlGvilyemlt-----------G~~PF~~~~~--------------------~~~~~~i~~~~~~~------------ 374 (514)
|||||||||||++ |.+||.+.+. ......|...-+..
T Consensus 267 iwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 346 (458)
T 3rp9_A 267 VWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKED 346 (458)
T ss_dssp HHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHH
T ss_pred HHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHH
Confidence 9999999999999 7888877542 22222222110000
Q ss_pred ------cCC---------cCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCcccccc
Q 010266 375 ------KFP---------EEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLYE 425 (514)
Q Consensus 375 ------~~p---------~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~l~~ 425 (514)
.+| ....+|+++.|||.+||+ ||.+|+ |++|+++||||++++|..+..
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~---t~~e~L~Hp~f~~~~~~~~e~ 410 (458)
T 3rp9_A 347 AKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRI---TINECLAHPFFKEVRIAEVET 410 (458)
T ss_dssp HHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHHSGGGTTTCCGGGCC
T ss_pred HHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccC---CHHHHhcCHhhhhcCCCccCC
Confidence 001 012468999999999999 999999 999999999999999988753
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-52 Score=443.69 Aligned_cols=266 Identities=32% Similarity=0.595 Sum_probs=238.1
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 183 (514)
..++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|..+|..++|||||+++++|.+...+|+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 34679999999999999999999999999999999988766556667889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccc---cCCCcEEEccccccccCCCCC
Q 010266 184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILl---d~~g~iKL~DFGla~~~~~~~ 260 (514)
||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++++||+|||+|+......
T Consensus 104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 183 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183 (484)
T ss_dssp EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence 99999999999999998999999999999999999999999999999999999999 567899999999997653221
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 340 (514)
...+.+||+.|+|||++.+ .|+.++||||
T Consensus 184 --------------------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~Diws 212 (484)
T 3nyv_A 184 --------------------------------------------------KMKDKIGTAYYIAPEVLHG-TYDEKCDVWS 212 (484)
T ss_dssp --------------------------------------------------SHHHHTTGGGTCCHHHHHT-CCCTHHHHHH
T ss_pred --------------------------------------------------ccccCCCCccccCceeecC-CCCCcceeHH
Confidence 0124679999999999976 6999999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCC
Q 010266 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIA 419 (514)
Q Consensus 341 lGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~ 419 (514)
|||++|+|++|.+||.+.+..+....+......+..|.+..+|+++++||.+||. ||.+|+ +++|+++||||+...
T Consensus 213 lG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 213 TGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRI---SARDALDHEWIQTYT 289 (484)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSC---CHHHHHTSHHHHHHT
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCc---CHHHHhhChhhcccc
Confidence 9999999999999999999999999998765555666666899999999999999 999999 999999999999877
Q ss_pred cccc
Q 010266 420 WDKL 423 (514)
Q Consensus 420 w~~l 423 (514)
++.+
T Consensus 290 ~~~~ 293 (484)
T 3nyv_A 290 KEQI 293 (484)
T ss_dssp C---
T ss_pred cccc
Confidence 6543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-52 Score=417.05 Aligned_cols=249 Identities=21% Similarity=0.244 Sum_probs=190.9
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHH--HHHHHHcCCCceeeEEEEEEcCC----
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAE--RNLLAEVASHCIVKLYYSFQDAE---- 179 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E--~~iL~~l~hp~Iv~l~~~f~~~~---- 179 (514)
.+|.+.+.||+|+||+||+|++ +|+.||||++.... ......| +.++..++|||||++++++.+++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~------~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc------hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence 4688999999999999999976 58899999986542 2223334 44456789999999999997653
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC--------CeEEcCCCCCCccccCCCcEEEcccc
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH--------NYIHRDIKPDNLLLDQNGHMKLSDFG 251 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~--------giiHrDLKpeNILld~~g~iKL~DFG 251 (514)
.+|||||||+||+|.++|.. ..+++..+..++.|++.||.|||+. |||||||||+||||+.+|++||+|||
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 68999999999999999965 5688999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-
Q 010266 252 LCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK- 330 (514)
Q Consensus 252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~- 330 (514)
+|+......... .....+.+||+.|||||++.+.
T Consensus 154 la~~~~~~~~~~---------------------------------------------~~~~~~~~GT~~ymAPE~l~~~~ 188 (303)
T 3hmm_A 154 LAVRHDSATDTI---------------------------------------------DIAPNHRVGTKRYMAPEVLDDSI 188 (303)
T ss_dssp TCEEEETTTTEE---------------------------------------------SCC-----CCGGGCCHHHHTTCS
T ss_pred CCccccCCCCce---------------------------------------------eeecccccccccccCHHHhcccc
Confidence 998654221100 0012256899999999999764
Q ss_pred -----CCCcccchhhhhHHHHHHhhCCCCCCCCC---------------hhHHHHHHhhhcCcccCCcCc---CCChhHH
Q 010266 331 -----GYGMECDWWSLGAIMYEMLVGYPPFYSDD---------------PVTTCRKIVHWKNHLKFPEEA---RLTPEAK 387 (514)
Q Consensus 331 -----~y~~~~DiWSlGvilyemltG~~PF~~~~---------------~~~~~~~i~~~~~~~~~p~~~---~~s~~~~ 387 (514)
.|+.++|||||||+||||+||.+||.... .......+......+.+|... ..++.+.
T Consensus 189 ~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~ 268 (303)
T 3hmm_A 189 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMA 268 (303)
T ss_dssp CTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHH
T ss_pred cccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHH
Confidence 46789999999999999999988764321 122333333322233444321 1234678
Q ss_pred HHHhhhcc-CccccCCCCCHhHHhc
Q 010266 388 DLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 388 dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
+||.+||. ||.+|+ |+.||++
T Consensus 269 ~li~~cl~~dP~~RP---t~~ei~~ 290 (303)
T 3hmm_A 269 KIMRECWYANGAARL---TALRIKK 290 (303)
T ss_dssp HHHHTTCCSSGGGSC---CHHHHHH
T ss_pred HHHHHHcccCHhHCc---CHHHHHH
Confidence 99999998 999999 9999876
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=411.82 Aligned_cols=259 Identities=34% Similarity=0.648 Sum_probs=220.5
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccCh-----------------------hhHHHHHHHHHH
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR-----------------------GQVEHVRAERNL 159 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~-----------------------~~~~~~~~E~~i 159 (514)
+..++|++.+.||+|+||.||+|+++.+++.||||++.+...... ...+.+.+|..+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 456899999999999999999999999999999999987643221 224568899999
Q ss_pred HHHcCCCceeeEEEEEEc--CCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCc
Q 010266 160 LAEVASHCIVKLYYSFQD--AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNL 237 (514)
Q Consensus 160 L~~l~hp~Iv~l~~~f~~--~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNI 237 (514)
|+.++||||+++++++.+ ...+|+||||++||+|..++ ....+++..++.++.|++.||.|||++||+||||||+||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 999999999999999987 67899999999999998865 456799999999999999999999999999999999999
Q ss_pred cccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhcccccccccc
Q 010266 238 LLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG 317 (514)
Q Consensus 238 Lld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~G 317 (514)
|++.+|++||+|||+++....... .....+|
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~-------------------------------------------------~~~~~~g 199 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDA-------------------------------------------------LLSNTVG 199 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSC-------------------------------------------------EECCCCS
T ss_pred EECCCCCEEEecCCCccccccccc-------------------------------------------------cccCCcC
Confidence 999999999999999986542210 1124579
Q ss_pred CCCcCCccccccCC---CCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhc
Q 010266 318 TPDYIAPEVLLKKG---YGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLL 394 (514)
Q Consensus 318 T~~Y~APEvl~~~~---y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL 394 (514)
|+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+.......+.. ..+.+|....+++++++||.+||
T Consensus 200 t~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l 277 (298)
T 2zv2_A 200 TPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKS--QALEFPDQPDIAEDLKDLITRML 277 (298)
T ss_dssp CGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCSSSCCCHHHHHHHHHHT
T ss_pred CccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhc--ccCCCCCccccCHHHHHHHHHHh
Confidence 99999999998765 47889999999999999999999999888777777765 34556665679999999999999
Q ss_pred c-CccccCCCCCHhHHhcCCccc
Q 010266 395 C-DVEHRLGTLGSEQIKAHPWFK 416 (514)
Q Consensus 395 ~-dp~~Rl~~~~~~eil~Hpff~ 416 (514)
. ||.+|+ +++||++||||+
T Consensus 278 ~~dp~~R~---s~~e~l~hp~~~ 297 (298)
T 2zv2_A 278 DKNPESRI---VVPEIKLHPWVT 297 (298)
T ss_dssp CSCTTTSC---CHHHHTTCHHHH
T ss_pred hcChhhCC---CHHHHhcCcccc
Confidence 9 999999 999999999996
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=416.68 Aligned_cols=261 Identities=26% Similarity=0.467 Sum_probs=221.2
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.++|++++.||+|+||+||+|+++.+++.||||++..... ....+.+.+|..+++.++|||||++++++.+.+..|+|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 5899999999999999999999999999999999975532 22335678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
|||++||+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--- 160 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--- 160 (323)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE---
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc---
Confidence 99999999999998888899999999999999999999999999999999999999999999999999976532110
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCC-CcccchhhhhH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGA 343 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWSlGv 343 (514)
.......+||+.|+|||++.+..+ +.++|||||||
T Consensus 161 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 196 (323)
T 3tki_A 161 --------------------------------------------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 196 (323)
T ss_dssp --------------------------------------------ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHH
T ss_pred --------------------------------------------ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHH
Confidence 011225689999999999988776 78999999999
Q ss_pred HHHHHhhCCCCCCCCChhHH-HHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCC
Q 010266 344 IMYEMLVGYPPFYSDDPVTT-CRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIA 419 (514)
Q Consensus 344 ilyemltG~~PF~~~~~~~~-~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~ 419 (514)
++|+|++|.+||.+.+.... +..+.. .....+....+++++.+||.+||. ||.+|+ +++|+++||||+..-
T Consensus 197 il~~ll~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 197 VLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYNKPL 269 (323)
T ss_dssp HHHHHHHSSCSCSSSCTTSHHHHHHHT--TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCTTTTCCC
T ss_pred HHHHHHhCCCCCCCCchHHHHHHHHhc--ccccCCccccCCHHHHHHHHHHccCChhhCc---CHHHHhhChhhcccc
Confidence 99999999999987655432 333332 222333345789999999999999 999999 999999999998643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=405.64 Aligned_cols=260 Identities=35% Similarity=0.581 Sum_probs=231.5
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
..+..++|++++.||+|+||.||+|+++.++..||+|++.+...........+.+|..++..++||||++++++|.+...
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 83 (279)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence 45677999999999999999999999999999999999987654444456778899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
.|+||||++||+|..++.....+++..+..++.|++.||.|||+.||+||||||+|||++.+|++||+|||++......
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~- 162 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 162 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence 9999999999999999998889999999999999999999999999999999999999999999999999998643211
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 340 (514)
.....+||+.|+|||++.+..++.++|+||
T Consensus 163 --------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 192 (279)
T 3fdn_A 163 --------------------------------------------------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWS 192 (279)
T ss_dssp -------------------------------------------------------CCCCTTCCHHHHTTCCCCTTHHHHH
T ss_pred --------------------------------------------------cccccCCCCCccCHhHhccCCCCccchhHh
Confidence 011457999999999999999999999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 341 lGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
|||++|+|++|.+||.+.+..+....+.. ....+|. .+++++++||.+||. ||.+|+ +++||++||||++.
T Consensus 193 lG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp---s~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 193 LGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPD--FVTEGARDLISRLLKHNPSQRP---MLREVLEHPWITAN 264 (279)
T ss_dssp HHHHHHHHHHSSCTTCCSSHHHHHHHHHH--TCCCCCT--TSCHHHHHHHHHHCCSSGGGSC---CHHHHHHCHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCcHHHHHHHHHh--CCCCCCC--cCCHHHHHHHHHHhccChhhCC---CHHHHhhCccccCC
Confidence 99999999999999999988888888765 3344554 689999999999999 999999 99999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=400.57 Aligned_cols=264 Identities=31% Similarity=0.558 Sum_probs=234.6
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.++|++++.||+|+||.||+|.++.+|+.||+|++..... .......+.+|..++..++||||+++++++.+....|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 5789999999999999999999999999999999987643 455567788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCc---EEEccccccccCCCCCc
Q 010266 185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH---MKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~---iKL~DFGla~~~~~~~~ 261 (514)
|||++||+|...+.....+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||++.......
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~- 162 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE- 162 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC-
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc-
Confidence 999999999999998899999999999999999999999999999999999999987665 9999999987543210
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
.....+||+.|+|||++.+..++.++|||||
T Consensus 163 -------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 193 (284)
T 3kk8_A 163 -------------------------------------------------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWAC 193 (284)
T ss_dssp -------------------------------------------------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred -------------------------------------------------cccCCCCCcCCcCchhhcCCCCCcccchHHH
Confidence 0124679999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCc
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAW 420 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w 420 (514)
||++|+|++|.+||.+.+.......+.........|....+++++.+||.+||. ||.+|+ +++|+++||||++..+
T Consensus 194 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 194 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI---TADQALKVPWICNRER 270 (284)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSC---CHHHHTTSHHHHSCCC
T ss_pred HHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCC---CHHHHhcCccccCChh
Confidence 999999999999999999888888887644444444445789999999999999 999999 9999999999988665
Q ss_pred cc
Q 010266 421 DK 422 (514)
Q Consensus 421 ~~ 422 (514)
..
T Consensus 271 ~~ 272 (284)
T 3kk8_A 271 VA 272 (284)
T ss_dssp GG
T ss_pred HH
Confidence 43
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=418.25 Aligned_cols=267 Identities=27% Similarity=0.439 Sum_probs=218.1
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
.....++|++++.||+|+||+||+|++..+++.||||++..... .......+.+|..+|+.++||||+++++++.+...
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 34556899999999999999999999999999999999976532 33344567789999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCcccc-----CCCcEEEcccccccc
Q 010266 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-----QNGHMKLSDFGLCKP 255 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld-----~~g~iKL~DFGla~~ 255 (514)
+|+||||++ |+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+.
T Consensus 108 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 108 LHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 999999997 59999999888999999999999999999999999999999999999994 555699999999975
Q ss_pred CCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-CCCc
Q 010266 256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGM 334 (514)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~ 334 (514)
..... ......+||+.|+|||++.+. .|+.
T Consensus 187 ~~~~~-------------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~ 217 (329)
T 3gbz_A 187 FGIPI-------------------------------------------------RQFTHEIITLWYRPPEILLGSRHYST 217 (329)
T ss_dssp HC------------------------------------------------------------CCTTCCHHHHTTCCCCCT
T ss_pred cCCcc-------------------------------------------------cccCCCcCCccccCHHHhcCCCCCCc
Confidence 43210 011245799999999999874 4899
Q ss_pred ccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCccc---------CCc-----------------CcCCChhHHH
Q 010266 335 ECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLK---------FPE-----------------EARLTPEAKD 388 (514)
Q Consensus 335 ~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~---------~p~-----------------~~~~s~~~~d 388 (514)
++|||||||++|||++|.+||.+.+..+....+........ .|. ...+++++++
T Consensus 218 ~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (329)
T 3gbz_A 218 SVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLD 297 (329)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHH
Confidence 99999999999999999999999988888777764211110 000 0127899999
Q ss_pred HHhhhcc-CccccCCCCCHhHHhcCCccccCCcc
Q 010266 389 LICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWD 421 (514)
Q Consensus 389 LI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~ 421 (514)
||.+||. ||.+|+ +++|+++||||++++|+
T Consensus 298 li~~~L~~dP~~R~---t~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 298 LLTAMLEMDPVKRI---SAKNALEHPYFSHNDFD 328 (329)
T ss_dssp HHHHHTCSSGGGSC---CHHHHHTSGGGSSSCSC
T ss_pred HHHHHccCChhhCC---CHHHHhCCcccCCCCCC
Confidence 9999999 999999 99999999999999997
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-51 Score=404.67 Aligned_cols=262 Identities=34% Similarity=0.607 Sum_probs=233.2
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE 179 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 179 (514)
...+..++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|..++..++||||+++++++.+.+
T Consensus 8 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 87 (284)
T 2vgo_A 8 KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK 87 (284)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred ccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC
Confidence 45667789999999999999999999999999999999998765433444567889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
.+|+||||++||+|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||+++.+|++||+|||++......
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999998654311
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
.....+||+.|+|||++.+..++.++|+|
T Consensus 168 ---------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 196 (284)
T 2vgo_A 168 ---------------------------------------------------RRRTMCGTLDYLPPEMIEGKTHDEKVDLW 196 (284)
T ss_dssp ---------------------------------------------------CBCCCCSCGGGCCHHHHTTCCBCTTHHHH
T ss_pred ---------------------------------------------------ccccccCCCCcCCHHHhccCCCCcccchh
Confidence 01145799999999999999999999999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
||||++|+|++|.+||.+.+..+....+.. ....+|. .+++++++||.+||. ||.+|+ +++++++||||+..
T Consensus 197 slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp---s~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 197 CAGVLCYEFLVGMPPFDSPSHTETHRRIVN--VDLKFPP--FLSDGSKDLISKLLRYHPPQRL---PLKGVMEHPWVKAN 269 (284)
T ss_dssp HHHHHHHHHHHSSCTTCCSSHHHHHHHHHT--TCCCCCT--TSCHHHHHHHHHHSCSSGGGSC---CHHHHHTCHHHHHH
T ss_pred hHHHHHHHHHHCCCCCCCCCHhHHHHHHhc--cccCCCC--cCCHHHHHHHHHHhhcCHhhCC---CHHHHhhCHHHHhh
Confidence 999999999999999999888888877775 3345554 689999999999999 999999 99999999999864
Q ss_pred C
Q 010266 419 A 419 (514)
Q Consensus 419 ~ 419 (514)
.
T Consensus 270 ~ 270 (284)
T 2vgo_A 270 S 270 (284)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=413.26 Aligned_cols=264 Identities=31% Similarity=0.541 Sum_probs=233.6
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccCh---hhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR---GQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
++|++.+.||+|+||.||+|+++.+|+.||+|++.+...... ...+.+.+|..+|..++||||++++++|.+...+|
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 579999999999999999999999999999999987643322 13567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC----cEEEccccccccCCC
Q 010266 183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG----HMKLSDFGLCKPLDC 258 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g----~iKL~DFGla~~~~~ 258 (514)
+||||++||+|.+++...+.+++..++.++.|++.||.|||+.||+||||||+|||++.+| ++||+|||+++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~ 171 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171 (321)
T ss_dssp EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCc
Confidence 9999999999999998888999999999999999999999999999999999999999888 899999999976532
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
.. .....+||+.|+|||++.+..++.++|+
T Consensus 172 ~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di 201 (321)
T 2a2a_A 172 GV--------------------------------------------------EFKNIFGTPEFVAPEIVNYEPLGLEADM 201 (321)
T ss_dssp TC--------------------------------------------------CCCCCCSCGGGCCHHHHTTCCCCTHHHH
T ss_pred cc--------------------------------------------------cccccCCCCCccCcccccCCCCCCcccc
Confidence 10 0124579999999999999999999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCc--CcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPE--EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
|||||++|+|++|..||.+.+..+....+.... ..+|. ...+++.+++||.+||. ||.+|+ +++|+++||||
T Consensus 202 ~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~e~l~hp~~ 276 (321)
T 2a2a_A 202 WSIGVITYILLSGASPFLGDTKQETLANITSVS--YDFDEEFFSHTSELAKDFIRKLLVKETRKRL---TIQEALRHPWI 276 (321)
T ss_dssp HHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC--CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSC---CHHHHHHSTTT
T ss_pred HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc--cccChhhhcccCHHHHHHHHHHcCCChhhCc---CHHHHhcCccc
Confidence 999999999999999999998888888887632 23332 23689999999999999 999999 99999999999
Q ss_pred ccCCccccc
Q 010266 416 KDIAWDKLY 424 (514)
Q Consensus 416 ~~i~w~~l~ 424 (514)
.+++|....
T Consensus 277 ~~~~~~~~~ 285 (321)
T 2a2a_A 277 TPVDNQQAM 285 (321)
T ss_dssp SCSSHHHHH
T ss_pred cCCCccccc
Confidence 999987653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=413.28 Aligned_cols=264 Identities=28% Similarity=0.465 Sum_probs=209.2
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.++|++++.||+|+||.||+|+++.+|+.||+|+++... .......+.+|..+|+.++|||||+++++|.+.+.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 478999999999999999999999999999999997653 233345678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 185 MEYLPGGDVMTLLMRE------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
|||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99998 5999988654 3589999999999999999999999999999999999999999999999999986532
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccc
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECD 337 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~D 337 (514)
... .....+||+.|+|||++.+ ..|+.++|
T Consensus 161 ~~~-------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~D 191 (317)
T 2pmi_A 161 PVN-------------------------------------------------TFSSEVVTLWYRAPDVLMGSRTYSTSID 191 (317)
T ss_dssp CCC-------------------------------------------------CCCCCCSCCTTCCHHHHTTCCCCCTHHH
T ss_pred Ccc-------------------------------------------------cCCCCcccccccCchHhhCCCCCCcHHH
Confidence 100 0124579999999999986 46899999
Q ss_pred hhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcc---------cCC---------------------cCcCCChhHH
Q 010266 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL---------KFP---------------------EEARLTPEAK 387 (514)
Q Consensus 338 iWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---------~~p---------------------~~~~~s~~~~ 387 (514)
||||||++|||++|.+||.+.+..+....+....... ..| ....++++++
T Consensus 192 iwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 271 (317)
T 2pmi_A 192 IWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLM 271 (317)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHH
Confidence 9999999999999999999998888877775421110 000 0125788999
Q ss_pred HHHhhhcc-CccccCCCCCHhHHhcCCccccCCcccc
Q 010266 388 DLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKL 423 (514)
Q Consensus 388 dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~l 423 (514)
+||.+||+ ||.+|+ +++|+++||||++..|...
T Consensus 272 ~li~~~L~~dP~~Rp---t~~e~l~hp~f~~~~~~~~ 305 (317)
T 2pmi_A 272 DFLHGLLQLNPDMRL---SAKQALHHPWFAEYYHHAS 305 (317)
T ss_dssp HHHHHHSCSSGGGSC---CHHHHTTSGGGGGGCC---
T ss_pred HHHHHHCCCCcccCC---CHHHHhCChhhhcccchhh
Confidence 99999999 999999 9999999999998776543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=420.77 Aligned_cols=256 Identities=33% Similarity=0.557 Sum_probs=213.3
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
...++|++++.||+|+||+||+|+++.+++.||||++.+.... .+.+.+|..+++.++|||||+++++|.+...+|
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 3468999999999999999999999999999999999865432 245778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCc--EEEccccccccCCCCC
Q 010266 183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH--MKLSDFGLCKPLDCTN 260 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~--iKL~DFGla~~~~~~~ 260 (514)
+||||++||+|..++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+|+.....
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~- 171 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 171 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence 99999999999999988889999999999999999999999999999999999999987765 999999998743211
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcc-cchh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME-CDWW 339 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~-~DiW 339 (514)
....+.+||+.|+|||++.+..++.+ +|||
T Consensus 172 -------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw 202 (361)
T 3uc3_A 172 -------------------------------------------------SQPKSTVGTPAYIAPEVLLRQEYDGKIADVW 202 (361)
T ss_dssp ----------------------------------------------------------CTTSCHHHHHCSSCCHHHHHHH
T ss_pred -------------------------------------------------CCCCCCcCCCCcCChhhhcCCCCCCCeeeee
Confidence 01125689999999999998888655 8999
Q ss_pred hhhHHHHHHhhCCCCCCCCChh----HHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCc
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPV----TTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPW 414 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~----~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpf 414 (514)
||||++|+|++|.+||.+.+.. .....+.. ....+|....+|+++++||.+||. ||.+|+ |++||++|||
T Consensus 203 slG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---s~~ell~hp~ 277 (361)
T 3uc3_A 203 SCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS--VKYSIPDDIRISPECCHLISRIFVADPATRI---SIPEIKTHSW 277 (361)
T ss_dssp HHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT--TCCCCCTTSCCCHHHHHHHHHHSCSCTTTSC---CHHHHHTSHH
T ss_pred hhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc--CCCCCCCcCCCCHHHHHHHHHHccCChhHCc---CHHHHHhCcc
Confidence 9999999999999999876543 33344443 345666666789999999999999 999999 9999999999
Q ss_pred ccc
Q 010266 415 FKD 417 (514)
Q Consensus 415 f~~ 417 (514)
|..
T Consensus 278 f~~ 280 (361)
T 3uc3_A 278 FLK 280 (361)
T ss_dssp HHT
T ss_pred hhc
Confidence 953
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=438.26 Aligned_cols=261 Identities=31% Similarity=0.610 Sum_probs=232.8
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++++.||+|+||+||+|+++.+++.||||++.+... .......+.+|..+|+.++|||||++++++.+...+|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHH-BCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 579999999999999999999999999999999976543 2334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCcccc---CCCcEEEccccccccCCCCCcc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD---QNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld---~~g~iKL~DFGla~~~~~~~~~ 262 (514)
||++||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++++||+|||+|+......
T Consensus 101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-- 178 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-- 178 (486)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC--
Confidence 9999999999999889999999999999999999999999999999999999995 45689999999997643210
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
.....+||+.|+|||++.+ .|+.++||||||
T Consensus 179 ------------------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG 209 (486)
T 3mwu_A 179 ------------------------------------------------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAG 209 (486)
T ss_dssp ---------------------------------------------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHH
T ss_pred ------------------------------------------------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHH
Confidence 1124689999999999976 599999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCcc
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWD 421 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~ 421 (514)
|++|+|++|.+||.+.+..+....+......+..|.+..+|+++++||.+||+ ||.+|+ |+.|+++||||+.....
T Consensus 210 ~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---t~~~~l~hp~~~~~~~~ 286 (486)
T 3mwu_A 210 VILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI---TATQCLEHPWIQKYSSE 286 (486)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSC---CHHHHHHCHHHHHTCCC
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCc---CHHHHhcCHhhccCccc
Confidence 99999999999999999999999998866666666667899999999999999 999999 99999999999876543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-51 Score=416.55 Aligned_cols=261 Identities=33% Similarity=0.540 Sum_probs=213.6
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
...++|++.+.||+|+||.||+|+++.+++.||||++.+.. ..+.+.+|..+|..++||||++++++|.+...+|
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 33467999999999999999999999999999999998642 2345778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC---CCcEEEccccccccCCCC
Q 010266 183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ---NGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~---~g~iKL~DFGla~~~~~~ 259 (514)
+||||++||+|.+++...+.+++..++.++.|++.||.|||+.||+||||||+|||++. ++.+||+|||+++.....
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 99999999999999988889999999999999999999999999999999999999975 899999999998754311
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
. ...+.+||+.|+|||++.+..++.++|||
T Consensus 205 ~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 234 (349)
T 2w4o_A 205 V--------------------------------------------------LMKTVCGTPGYCAPEILRGCAYGPEVDMW 234 (349)
T ss_dssp ----------------------------------------------------------CGGGSCHHHHTTCCCCTHHHHH
T ss_pred c--------------------------------------------------ccccccCCCCccCHHHhcCCCCCcccchH
Confidence 0 11256899999999999999999999999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhH-HHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPVT-TCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~~-~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
||||++|||++|..||.+.+... .+..+.........|....+++++++||.+||+ ||.+|+ ++.|+++||||.+
T Consensus 235 slG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~e~l~hp~~~~ 311 (349)
T 2w4o_A 235 SVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRL---TTFQALQHPWVTG 311 (349)
T ss_dssp HHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSTTTTS
T ss_pred HHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCc---CHHHHhcCcccCC
Confidence 99999999999999998765544 666676643333333345789999999999999 999999 9999999999987
Q ss_pred CCcc
Q 010266 418 IAWD 421 (514)
Q Consensus 418 i~w~ 421 (514)
..++
T Consensus 312 ~~~~ 315 (349)
T 2w4o_A 312 KAAN 315 (349)
T ss_dssp TTCC
T ss_pred Cccc
Confidence 6543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-51 Score=405.32 Aligned_cols=260 Identities=29% Similarity=0.470 Sum_probs=215.8
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.++|++++.||+|+||+||+|++ .+|+.||+|++..... .......+.+|..+|+.++||||+++++++.+.+.+|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 36899999999999999999998 6789999999976532 223345678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 185 MEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
|||++| +|.+++... +.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 154 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--- 154 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc---
Confidence 999975 899888764 679999999999999999999999999999999999999999999999999987543110
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchhhhh
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 342 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlG 342 (514)
......+||+.|+|||++.+ ..++.++||||||
T Consensus 155 ----------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 188 (288)
T 1ob3_A 155 ----------------------------------------------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVG 188 (288)
T ss_dssp -----------------------------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHH
T ss_pred ----------------------------------------------cccccccccccccCchheeCCCCCCcHHHHHHHH
Confidence 00114579999999999976 4589999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcCcc---------cCCc----------------CcCCChhHHHHHhhhcc-C
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL---------KFPE----------------EARLTPEAKDLICRLLC-D 396 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~~~---------~~p~----------------~~~~s~~~~dLI~~lL~-d 396 (514)
|++|||++|.+||.+.+..+....+....... ..|. ...+++++++||.+||. |
T Consensus 189 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 268 (288)
T 1ob3_A 189 CIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLD 268 (288)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSS
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCC
Confidence 99999999999999988877777765421110 0000 12478999999999999 9
Q ss_pred ccccCCCCCHhHHhcCCccccCC
Q 010266 397 VEHRLGTLGSEQIKAHPWFKDIA 419 (514)
Q Consensus 397 p~~Rl~~~~~~eil~Hpff~~i~ 419 (514)
|.+|+ +++|+++||||++.|
T Consensus 269 P~~Rp---t~~e~l~hp~f~~~n 288 (288)
T 1ob3_A 269 PNQRI---TAKQALEHAYFKENN 288 (288)
T ss_dssp TTTSC---CHHHHHTSGGGGC--
T ss_pred cccCC---CHHHHhcCcchhhcC
Confidence 99999 999999999998753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=425.88 Aligned_cols=289 Identities=28% Similarity=0.424 Sum_probs=219.3
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC-----C
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA-----E 179 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~-----~ 179 (514)
.++|++++.||+|+||.||+|+++.+++.||||++.+. .......+.+.+|+.+|+.++|||||++++++.+. .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 57899999999999999999999999999999999764 23445567889999999999999999999999876 6
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
.+|+||||+. |+|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+|+.....
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred eEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 7999999985 699999988888999999999999999999999999999999999999999999999999999876433
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccc-ccCCCCcccch
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL-LKKGYGMECDW 338 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl-~~~~y~~~~Di 338 (514)
......... .. ...+ + ....+......+.+||+.|+|||++ .+..|+.++||
T Consensus 183 ~~~~~~~~~-------~~-----~~~~----~-----------~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~Di 235 (432)
T 3n9x_A 183 KDTNIVNDL-------EE-----NEEP----G-----------PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDI 235 (432)
T ss_dssp -------------------------------------------------------CCCCCTTCCHHHHTTCSCCCTHHHH
T ss_pred ccccccccc-------cc-----cccc----c-----------ccccchhccccCCCCCccccCHHHHhcCCCCCccccc
Confidence 211000000 00 0000 0 0000011123478999999999986 45679999999
Q ss_pred hhhhHHHHHHhh-----------CCCCCCCCCh-----------------hHHHHHHhhhcCc-----------------
Q 010266 339 WSLGAIMYEMLV-----------GYPPFYSDDP-----------------VTTCRKIVHWKNH----------------- 373 (514)
Q Consensus 339 WSlGvilyemlt-----------G~~PF~~~~~-----------------~~~~~~i~~~~~~----------------- 373 (514)
|||||++|||++ |.++|.+.+. ......|...-+.
T Consensus 236 wSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~ 315 (432)
T 3n9x_A 236 WSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKY 315 (432)
T ss_dssp HHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHH
T ss_pred chHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHH
Confidence 999999999998 5566655431 1222222210000
Q ss_pred -----ccCCc-----CcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCcccccc
Q 010266 374 -----LKFPE-----EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLYE 425 (514)
Q Consensus 374 -----~~~p~-----~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~l~~ 425 (514)
...+. ...+|+++.+||.+||+ ||.+|+ |++|+++||||++++|.....
T Consensus 316 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~---ta~e~L~Hp~f~~~~~~~~e~ 375 (432)
T 3n9x_A 316 IKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRI---TIDQALDHPYLKDVRKKKLEN 375 (432)
T ss_dssp HHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHTCGGGTTTCCTTTC-
T ss_pred HHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCC---CHHHHhcChhhhhccCcccCc
Confidence 00000 13589999999999999 999999 999999999999999988753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=410.17 Aligned_cols=265 Identities=28% Similarity=0.483 Sum_probs=230.0
Q ss_pred CCeeEE-eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEEEcCCeEEE
Q 010266 106 DDFDLL-TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 106 ~~f~~~-~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l~l 183 (514)
+.|.+. +.||+|+||.||+|+++.+++.||+|++.+... .......+.+|..++..+. ||+|++++++|.+...+|+
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 457777 899999999999999999999999999987643 3344567889999999984 6999999999999999999
Q ss_pred EEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC---CCcEEEccccccccCCC
Q 010266 184 IMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ---NGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~---~g~iKL~DFGla~~~~~ 258 (514)
||||++||+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++. +|.+||+|||+++....
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 99999999999998653 67999999999999999999999999999999999999997 79999999999986532
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
.. .....+||+.|+|||++.+..++.++||
T Consensus 187 ~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di 216 (327)
T 3lm5_A 187 AC--------------------------------------------------ELREIMGTPEYLAPEILNYDPITTATDM 216 (327)
T ss_dssp ---------------------------------------------------------CCCGGGCCHHHHTTCCCCTHHHH
T ss_pred cc--------------------------------------------------ccccccCCcCccCCeeecCCCCCchhhH
Confidence 10 1124679999999999999999999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
|||||++|+|++|.+||.+.+..+....+.........+....+++.+++||.+||. ||.+|+ +++++++||||++
T Consensus 217 wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~~ll~h~~~~~ 293 (327)
T 3lm5_A 217 WNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRP---TAEICLSHSWLQQ 293 (327)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSC---CHHHHTTCGGGCC
T ss_pred HHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCc---CHHHHhCCHhhcc
Confidence 999999999999999999999888888887644444333345789999999999999 999999 9999999999999
Q ss_pred CCccccc
Q 010266 418 IAWDKLY 424 (514)
Q Consensus 418 i~w~~l~ 424 (514)
++|+.+.
T Consensus 294 ~~~~~~~ 300 (327)
T 3lm5_A 294 WDFENLF 300 (327)
T ss_dssp CCTTCC-
T ss_pred ccccccc
Confidence 9999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=435.03 Aligned_cols=256 Identities=27% Similarity=0.438 Sum_probs=213.2
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC------
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA------ 178 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~------ 178 (514)
.++|++++.||+|+||+||+|+++.+|+.||||++.+. .........+.+|+.+|+.++|||||+++++|.+.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG-GGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc-ccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 47899999999999999999999999999999999865 33455667888999999999999999999999755
Q ss_pred CeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
..+|+||||++| +|...+. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 467999999976 5666664 3589999999999999999999999999999999999999999999999999976432
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
.. ...+.+||+.|+|||++.+.+|+.++||
T Consensus 217 ~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di 246 (464)
T 3ttj_A 217 SF--------------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDI 246 (464)
T ss_dssp CC--------------------------------------------------CC----CCCTTCCHHHHTTCCCCTTHHH
T ss_pred Cc--------------------------------------------------ccCCCcccccccCHHHHcCCCCCHHHHH
Confidence 10 1125689999999999999999999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcc-------------------------c----CCcC---------c
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL-------------------------K----FPEE---------A 380 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~-------------------------~----~p~~---------~ 380 (514)
|||||++|||++|.+||.+.+..+.+.+|+...... . +|.. .
T Consensus 247 wSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (464)
T 3ttj_A 247 WSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 326 (464)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCccccccccccccc
Confidence 999999999999999999999888888876522110 0 0100 0
Q ss_pred CCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 381 RLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 381 ~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
..+++++|||.+||. ||.+|+ |++|+++||||+.
T Consensus 327 ~~s~~~~dLl~~mL~~dP~~R~---ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 327 LKASQARDLLSKMLVIDPAKRI---SVDDALQHPYINV 361 (464)
T ss_dssp HHHHHHHHHHHHHSCSSTTTSC---CHHHHHTSTTTGG
T ss_pred ccCHHHHHHHHHHcCCChhhCC---CHHHHhcChhhhh
Confidence 015679999999999 999999 9999999999984
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=416.60 Aligned_cols=268 Identities=31% Similarity=0.535 Sum_probs=227.0
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeeccccc--ChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML--SRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 183 (514)
++|++++.||+|+||.||+|+++.+++.||+|++.+.... .....+.+.+|..+|+.++|||||+++++|.+.+.+|+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 5799999999999999999999999999999999876432 34566789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhh----------------------------------------ccCCCHHHHHHHHHHHHHHHHHHH
Q 010266 184 IMEYLPGGDVMTLLMR----------------------------------------EETLTETVARFYIAQSVLAIESIH 223 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~----------------------------------------~~~l~e~~~~~~~~qi~~aL~~LH 223 (514)
||||++||+|.+++.. ...+++..++.++.||+.||.|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999852 112467788899999999999999
Q ss_pred hCCeEEcCCCCCCccccCCC--cEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHH
Q 010266 224 KHNYIHRDIKPDNLLLDQNG--HMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQL 301 (514)
Q Consensus 224 ~~giiHrDLKpeNILld~~g--~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (514)
+.||+||||||+|||++.++ .+||+|||+|+.+.......
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~-------------------------------------- 227 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE-------------------------------------- 227 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC---------------------------------------
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccc--------------------------------------
Confidence 99999999999999998777 89999999998643211000
Q ss_pred HHHhhhccccccccccCCCcCCcccccc--CCCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcC
Q 010266 302 QHWQINRRKLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEE 379 (514)
Q Consensus 302 ~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~ 379 (514)
.....+.+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+....+......+..|..
T Consensus 228 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 300 (345)
T 3hko_A 228 -------YYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNY 300 (345)
T ss_dssp --------------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGG
T ss_pred -------cccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCccc
Confidence 001125679999999999975 67899999999999999999999999999998888888875544455554
Q ss_pred cCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCcc
Q 010266 380 ARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWD 421 (514)
Q Consensus 380 ~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~ 421 (514)
..+++++++||.+||. ||.+|+ ++.++++||||+++.|.
T Consensus 301 ~~~~~~~~~li~~~l~~~p~~Rp---s~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 301 NVLSPLARDLLSNLLNRNVDERF---DAMRALQHPWISQFSDK 340 (345)
T ss_dssp GGSCHHHHHHHHHHSCSCTTTSC---CHHHHHHSHHHHTTSSC
T ss_pred ccCCHHHHHHHHHHcCCChhHCC---CHHHHhcChhhccChHh
Confidence 5689999999999999 999999 99999999999987654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=436.37 Aligned_cols=262 Identities=35% Similarity=0.587 Sum_probs=227.8
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccCh----------hhHHHHHHHHHHHHHcCCCceeeEEE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR----------GQVEHVRAERNLLAEVASHCIVKLYY 173 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~----------~~~~~~~~E~~iL~~l~hp~Iv~l~~ 173 (514)
..++|++++.||+|+||+||+|+++.+++.||+|++.+...... ...+.+.+|..+|+.++|||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 34789999999999999999999999999999999987654321 34567889999999999999999999
Q ss_pred EEEcCCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC---cEEEccc
Q 010266 174 SFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG---HMKLSDF 250 (514)
Q Consensus 174 ~f~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g---~iKL~DF 250 (514)
+|.+...+|+|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+| ++||+||
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 9999999999999999999999999889999999999999999999999999999999999999999876 6999999
Q ss_pred cccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC
Q 010266 251 GLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK 330 (514)
Q Consensus 251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~ 330 (514)
|+|+...... .....+||+.|+|||++. .
T Consensus 194 g~a~~~~~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~-~ 222 (504)
T 3q5i_A 194 GLSSFFSKDY--------------------------------------------------KLRDRLGTAYYIAPEVLK-K 222 (504)
T ss_dssp TTCEECCTTS--------------------------------------------------CBCCCCSCTTTCCHHHHT-T
T ss_pred CCCEEcCCCC--------------------------------------------------ccccccCCcCCCCHHHhc-c
Confidence 9998653210 112567999999999986 4
Q ss_pred CCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHH
Q 010266 331 GYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQI 409 (514)
Q Consensus 331 ~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ei 409 (514)
.|+.++|||||||++|+|++|.+||.+.+..+....+......+..+.+..+|+++++||.+||+ ||.+|+ |++|+
T Consensus 223 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---t~~e~ 299 (504)
T 3q5i_A 223 KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRC---TAEEA 299 (504)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSC---CHHHH
T ss_pred CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCC---CHHHH
Confidence 69999999999999999999999999999999999988754444444445799999999999999 999999 99999
Q ss_pred hcCCccccCC
Q 010266 410 KAHPWFKDIA 419 (514)
Q Consensus 410 l~Hpff~~i~ 419 (514)
++||||+...
T Consensus 300 l~h~~~~~~~ 309 (504)
T 3q5i_A 300 LNSRWIKKYA 309 (504)
T ss_dssp HTSHHHHHTC
T ss_pred hcCHhhhhch
Confidence 9999998653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=423.64 Aligned_cols=253 Identities=33% Similarity=0.550 Sum_probs=210.2
Q ss_pred CCCCeeEE-eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHH-HcCCCceeeEEEEEEc----
Q 010266 104 SVDDFDLL-TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA-EVASHCIVKLYYSFQD---- 177 (514)
Q Consensus 104 ~~~~f~~~-~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~-~l~hp~Iv~l~~~f~~---- 177 (514)
..++|.++ +.||+|+||+||+|+++.+|+.||||++.+. ..+.+|..++. ..+|||||+++++|.+
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 35788887 7899999999999999999999999999643 23667888874 4589999999999875
Q ss_pred CCeEEEEEeecCCCCHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC---CCcEEEccccc
Q 010266 178 AEYLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ---NGHMKLSDFGL 252 (514)
Q Consensus 178 ~~~l~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~---~g~iKL~DFGl 252 (514)
..++|+|||||+||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. +|++||+|||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 678999999999999999997653 5999999999999999999999999999999999999997 79999999999
Q ss_pred cccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCC
Q 010266 253 CKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY 332 (514)
Q Consensus 253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y 332 (514)
|+...... ...+.+||+.|+|||++.+..|
T Consensus 211 a~~~~~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~ 240 (400)
T 1nxk_A 211 AKETTSHN--------------------------------------------------SLTTPCYTPYYVAPEVLGPEKY 240 (400)
T ss_dssp CEECC-------------------------------------------------------------CTTCCGGGSCCCCS
T ss_pred ccccCCCC--------------------------------------------------ccccCCCCCCccCHhhcCCCCC
Confidence 98543210 1125689999999999999999
Q ss_pred CcccchhhhhHHHHHHhhCCCCCCCCChhH----HHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHh
Q 010266 333 GMECDWWSLGAIMYEMLVGYPPFYSDDPVT----TCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSE 407 (514)
Q Consensus 333 ~~~~DiWSlGvilyemltG~~PF~~~~~~~----~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ 407 (514)
+.++|||||||++|||++|.+||.+.+... ....+......+..|.+..+|+++++||.+||+ ||.+|+ +++
T Consensus 241 ~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~ 317 (400)
T 1nxk_A 241 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM---TIT 317 (400)
T ss_dssp SSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSC---CHH
T ss_pred CCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCc---CHH
Confidence 999999999999999999999998765432 445555533333334445789999999999999 999999 999
Q ss_pred HHhcCCcccc
Q 010266 408 QIKAHPWFKD 417 (514)
Q Consensus 408 eil~Hpff~~ 417 (514)
||++||||.+
T Consensus 318 eil~hp~~~~ 327 (400)
T 1nxk_A 318 EFMNHPWIMQ 327 (400)
T ss_dssp HHHHSHHHHT
T ss_pred HHhcCccccC
Confidence 9999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-51 Score=435.97 Aligned_cols=260 Identities=34% Similarity=0.607 Sum_probs=225.8
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++++.||+|+||+||+|+++.++..||+|++.+.... ......+.+|..+|+.++|||||+++++|.+...+|+||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4699999999999999999999999999999999876532 233566889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC---CCcEEEccccccccCCCCCcc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ---NGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~---~g~iKL~DFGla~~~~~~~~~ 262 (514)
|||+||+|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+......
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~-- 193 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-- 193 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB--
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc--
Confidence 99999999999998899999999999999999999999999999999999999976 4569999999997653210
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
...+.+||+.|+|||++. ..|+.++||||||
T Consensus 194 ------------------------------------------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG 224 (494)
T 3lij_A 194 ------------------------------------------------KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIG 224 (494)
T ss_dssp ------------------------------------------------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHH
T ss_pred ------------------------------------------------cccccCCCcCeeCHHHHc-ccCCCchhHHHHH
Confidence 112568999999999986 5699999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCc
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAW 420 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w 420 (514)
|++|+|++|.+||.+.+..+....+......+..|.+..+|+++++||.+||+ ||.+|+ |++|+++||||+...+
T Consensus 225 ~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~e~l~hp~~~~~~~ 300 (494)
T 3lij_A 225 VILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRI---SAQQALEHPWIKEMCS 300 (494)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSC---CHHHHHTCHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCc---cHHHHhcCcccccCcc
Confidence 99999999999999999999999988755555555556799999999999999 999999 9999999999987544
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=403.87 Aligned_cols=262 Identities=24% Similarity=0.396 Sum_probs=215.5
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccC--hhhHHHHHHHHHHHHHc---CCCceeeEEEEEEc
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS--RGQVEHVRAERNLLAEV---ASHCIVKLYYSFQD 177 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~--~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~~ 177 (514)
+..++|++++.||+|+||+||+|+++.+++.||||++....... ......+.+|..+++.+ +||||++++++|.+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 44689999999999999999999999999999999997543211 11223466777777766 49999999999987
Q ss_pred CC-----eEEEEEeecCCCCHHHHHhhccC--CCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccc
Q 010266 178 AE-----YLYLIMEYLPGGDVMTLLMREET--LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDF 250 (514)
Q Consensus 178 ~~-----~l~lVmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DF 250 (514)
.. .+|+||||+. |+|.+++..... +++..++.++.|++.||.|||++||+||||||+|||++.+|++||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 65 6899999996 599999987654 999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC
Q 010266 251 GLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK 330 (514)
Q Consensus 251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~ 330 (514)
|+|+...... .....+||+.|+|||++.+.
T Consensus 165 g~a~~~~~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~ 194 (308)
T 3g33_A 165 GLARIYSYQM--------------------------------------------------ALTPVVVTLWYRAPEVLLQS 194 (308)
T ss_dssp SCTTTSTTCC--------------------------------------------------CSGGGGCCCSSCCHHHHHTS
T ss_pred ccccccCCCc--------------------------------------------------ccCCccccccccCchHHcCC
Confidence 9997643210 11256899999999999999
Q ss_pred CCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCc---------ccCCc--------------CcCCChhHH
Q 010266 331 GYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNH---------LKFPE--------------EARLTPEAK 387 (514)
Q Consensus 331 ~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~---------~~~p~--------------~~~~s~~~~ 387 (514)
.|+.++|||||||++|+|++|.+||.+.+..+...++...... ..+|. ...+++++.
T Consensus 195 ~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (308)
T 3g33_A 195 TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGA 274 (308)
T ss_dssp CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHH
T ss_pred CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHH
Confidence 9999999999999999999999999999988888887652111 11110 125789999
Q ss_pred HHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 388 DLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 388 dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
+||.+||. ||.+|+ |++|+++||||+..
T Consensus 275 ~li~~~L~~dP~~R~---t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 275 QLLLEMLTFNPHKRI---SAFRALQHSYLHKD 303 (308)
T ss_dssp HHHHHHTCSSTTTSC---CHHHHHTSTTC---
T ss_pred HHHHHHhcCCCccCC---CHHHHhcCccccCC
Confidence 99999999 999999 99999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=419.37 Aligned_cols=260 Identities=29% Similarity=0.537 Sum_probs=222.0
Q ss_pred CeeE--EeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 107 DFDL--LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 107 ~f~~--~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.|.+ .+.||+|+||.||+|+++.+|+.||+|+++... ....+.+.+|..+|..++|||||+++++|.+.+.+|+|
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 3444 678999999999999999999999999998653 24556788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccc--cCCCcEEEccccccccCCCCCc
Q 010266 185 MEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL--DQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILl--d~~g~iKL~DFGla~~~~~~~~ 261 (514)
|||++||+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++++||+|||+++......
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~- 243 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE- 243 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-
Confidence 9999999999988654 579999999999999999999999999999999999999 567899999999998654211
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
.....+||+.|+|||++.+..++.++|||||
T Consensus 244 -------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 274 (373)
T 2x4f_A 244 -------------------------------------------------KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSV 274 (373)
T ss_dssp -------------------------------------------------BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHH
T ss_pred -------------------------------------------------ccccccCCCcEeChhhccCCCCCcHHhHHHH
Confidence 1124579999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCc
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAW 420 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w 420 (514)
||++|||++|.+||.+.+..+...+|......+..+....+++++++||.+||+ ||.+|+ +++|+++||||++..|
T Consensus 275 G~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---s~~e~l~hp~~~~~~~ 351 (373)
T 2x4f_A 275 GVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRI---SASEALKHPWLSDHKL 351 (373)
T ss_dssp HHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSHHHHCHHH
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCC---CHHHHhcCcCcCCCch
Confidence 999999999999999999998888888743333322334689999999999999 999999 9999999999998776
Q ss_pred cc
Q 010266 421 DK 422 (514)
Q Consensus 421 ~~ 422 (514)
..
T Consensus 352 ~~ 353 (373)
T 2x4f_A 352 HS 353 (373)
T ss_dssp HH
T ss_pred hh
Confidence 43
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=402.77 Aligned_cols=265 Identities=28% Similarity=0.442 Sum_probs=220.8
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.++|++++.||+|+||+||+|++..+|+.||+|++.+.. ......+.+.+|..++..++||||++++++|.+.+.+|+|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 478999999999999999999999999999999987653 2344456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
|||++|++|..++...+.+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+|.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 156 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS---- 156 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc----
Confidence 9999999999999888889999999999999999999999999999999999999999999999999997653210
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchhhhhH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 343 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGv 343 (514)
......+||+.|+|||++.+ ..++.++|+|||||
T Consensus 157 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 191 (311)
T 4agu_A 157 ---------------------------------------------DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGC 191 (311)
T ss_dssp ------------------------------------------------------GGGCCHHHHHTCSCCCTHHHHHHHHH
T ss_pred ---------------------------------------------cccCCCcCCccccChHHHhcCCCCCcchhhHHHHH
Confidence 01124579999999999986 67899999999999
Q ss_pred HHHHHhhCCCCCCCCChhHHHHHHhhhcC-----------------cccCCc----------CcCCChhHHHHHhhhcc-
Q 010266 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKN-----------------HLKFPE----------EARLTPEAKDLICRLLC- 395 (514)
Q Consensus 344 ilyemltG~~PF~~~~~~~~~~~i~~~~~-----------------~~~~p~----------~~~~s~~~~dLI~~lL~- 395 (514)
++|+|++|.+||.+.+..+....+..... ....|. ...+|+++.+||.+||.
T Consensus 192 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 271 (311)
T 4agu_A 192 VFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHM 271 (311)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccC
Confidence 99999999999999888777665543211 111111 13578999999999999
Q ss_pred CccccCCCCCHhHHhcCCccccCCccc
Q 010266 396 DVEHRLGTLGSEQIKAHPWFKDIAWDK 422 (514)
Q Consensus 396 dp~~Rl~~~~~~eil~Hpff~~i~w~~ 422 (514)
||.+|+ |++|+++||||+++.|..
T Consensus 272 dP~~Rp---t~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 272 DPTERL---TCEQLLHHPYFENIREIE 295 (311)
T ss_dssp STTTSC---CHHHHHTSGGGTTCC---
T ss_pred ChhhcC---CHHHHhcChHHHhccCHH
Confidence 999999 999999999999987654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=411.63 Aligned_cols=251 Identities=34% Similarity=0.567 Sum_probs=198.7
Q ss_pred CeeEE---eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEEEcCCeEE
Q 010266 107 DFDLL---TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 107 ~f~~~---~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l~ 182 (514)
+|++. +.||+|+||.||+|+++.+++.||||++.+. ....+.+|..+|..+. |||||+++++|.+....|
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 46664 7899999999999999999999999999754 3456778999999997 999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC---cEEEccccccccCCCC
Q 010266 183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG---HMKLSDFGLCKPLDCT 259 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g---~iKL~DFGla~~~~~~ 259 (514)
+||||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 83 LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp EEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred EEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 9999999999999999999999999999999999999999999999999999999998766 8999999999754321
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
. ....+.+||+.|+|||++.+..|+.++|||
T Consensus 163 ~-------------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Diw 193 (325)
T 3kn6_A 163 N-------------------------------------------------QPLKTPCFTLHYAAPELLNQNGYDESCDLW 193 (325)
T ss_dssp ----------------------------------------------------------------------CCCCHHHHHH
T ss_pred C-------------------------------------------------CcccccCCCcCccCHHHhcCCCCCCccchH
Confidence 0 011256899999999999999999999999
Q ss_pred hhhHHHHHHhhCCCCCCCCCh-------hHHHHHHhhhcCcccCCc--CcCCChhHHHHHhhhcc-CccccCCCCCHhHH
Q 010266 340 SLGAIMYEMLVGYPPFYSDDP-------VTTCRKIVHWKNHLKFPE--EARLTPEAKDLICRLLC-DVEHRLGTLGSEQI 409 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~-------~~~~~~i~~~~~~~~~p~--~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ei 409 (514)
||||++|+|++|.+||.+.+. .+....+... ...++. +..+|+++++||.+||+ ||.+|+ +++|+
T Consensus 194 slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~el 268 (325)
T 3kn6_A 194 SLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG--DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRL---KMSGL 268 (325)
T ss_dssp HHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT--CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCC---CTTTS
T ss_pred HHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC--CCCCCcccccCCCHHHHHHHHHHCCCChhHCC---CHHHH
Confidence 999999999999999986543 4556666553 233332 24689999999999999 999999 99999
Q ss_pred hcCCcccc
Q 010266 410 KAHPWFKD 417 (514)
Q Consensus 410 l~Hpff~~ 417 (514)
+.||||++
T Consensus 269 l~h~w~~~ 276 (325)
T 3kn6_A 269 RYNEWLQD 276 (325)
T ss_dssp TTCGGGCT
T ss_pred hcChhhcc
Confidence 99999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-50 Score=398.10 Aligned_cols=268 Identities=31% Similarity=0.554 Sum_probs=230.8
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeeccccc--C----hhhHHHHHHHHHHHHHcC-CCceeeEEEEEE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML--S----RGQVEHVRAERNLLAEVA-SHCIVKLYYSFQ 176 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~--~----~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~ 176 (514)
..++|++++.||+|+||.||+|+++.+|+.||||++...... . ....+.+.+|..+|..+. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 358999999999999999999999999999999999765311 1 223456788999999995 999999999999
Q ss_pred cCCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccC
Q 010266 177 DAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256 (514)
Q Consensus 177 ~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~ 256 (514)
+...+|+||||++||+|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||++...
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 99999999999999999999988889999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc------cC
Q 010266 257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL------KK 330 (514)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~------~~ 330 (514)
.... .....+||+.|+|||++. ..
T Consensus 175 ~~~~--------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~ 204 (298)
T 1phk_A 175 DPGE--------------------------------------------------KLREVCGTPSYLAPEIIECSMNDNHP 204 (298)
T ss_dssp CTTC--------------------------------------------------CBCCCCSCGGGCCHHHHHHHHCTTSC
T ss_pred CCCc--------------------------------------------------ccccccCCccccCHHHhccccccccc
Confidence 3210 012457999999999985 45
Q ss_pred CCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHH
Q 010266 331 GYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQI 409 (514)
Q Consensus 331 ~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ei 409 (514)
.++.++|+|||||++|+|++|..||.+.+.......+.........|....+++++.+||.+||. ||.+|+ +++|+
T Consensus 205 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~l 281 (298)
T 1phk_A 205 GYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY---TAEEA 281 (298)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSC---CHHHH
T ss_pred cCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCC---CHHHH
Confidence 68999999999999999999999999988888888887644444444445789999999999999 999999 99999
Q ss_pred hcCCccccCCccccc
Q 010266 410 KAHPWFKDIAWDKLY 424 (514)
Q Consensus 410 l~Hpff~~i~w~~l~ 424 (514)
++||||++..|+.++
T Consensus 282 l~h~~~~~~~~~~~~ 296 (298)
T 1phk_A 282 LAHPFFQQYVVEEVR 296 (298)
T ss_dssp TTSGGGCTTC-----
T ss_pred HhChHhhhccchhhc
Confidence 999999999988765
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=414.75 Aligned_cols=260 Identities=30% Similarity=0.481 Sum_probs=216.3
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC-----
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE----- 179 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~----- 179 (514)
.++|++++.||+|+||.||+|.++.+|+.||||++.+.. ........+.+|..+|+.++||||++++++|....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 478999999999999999999999999999999996542 34455677889999999999999999999998763
Q ss_pred -eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 180 -YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 180 -~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
.+|+||||+ |++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 469999999 8899999865 6799999999999999999999999999999999999999999999999999986431
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccc
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECD 337 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~D 337 (514)
. ....+||+.|+|||++.+ ..|+.++|
T Consensus 181 ~----------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~D 208 (367)
T 1cm8_A 181 E----------------------------------------------------MTGYVVTRWYRAPEVILNWMRYTQTVD 208 (367)
T ss_dssp S----------------------------------------------------CCSSCSCGGGCCTHHHHTTTCCCTTHH
T ss_pred c----------------------------------------------------cCcCcCCCCcCCHHHHhCCCCCChhhh
Confidence 1 114689999999999987 78999999
Q ss_pred hhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcc------------------cCCc---------CcCCChhHHHHH
Q 010266 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL------------------KFPE---------EARLTPEAKDLI 390 (514)
Q Consensus 338 iWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~------------------~~p~---------~~~~s~~~~dLI 390 (514)
||||||++|||++|.+||.+.+..+....|....... .+|. ...+++++.+||
T Consensus 209 iwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 288 (367)
T 1cm8_A 209 IWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLL 288 (367)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHH
Confidence 9999999999999999999998888877776421110 0000 125689999999
Q ss_pred hhhcc-CccccCCCCCHhHHhcCCccccCCccc
Q 010266 391 CRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDK 422 (514)
Q Consensus 391 ~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~ 422 (514)
.+||+ ||.+|+ |++|+++||||+.+.+..
T Consensus 289 ~~mL~~dP~~R~---t~~e~l~hp~f~~~~~~~ 318 (367)
T 1cm8_A 289 EKMLVLDAEQRV---TAGEALAHPYFESLHDTE 318 (367)
T ss_dssp HHHSCSSTTTSC---CHHHHHHSGGGTTTC---
T ss_pred HHHccCChhHCC---CHHHHhcChHHHhhcCCc
Confidence 99999 999999 999999999999876543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=407.60 Aligned_cols=268 Identities=28% Similarity=0.533 Sum_probs=215.8
Q ss_pred CCCeeEE-eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCeEE
Q 010266 105 VDDFDLL-TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 105 ~~~f~~~-~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~ 182 (514)
.+.|++. +.||+|+||.||+|+++.+++.||||++.+.. ......+.+|..+|..+ +||||++++++|.+.+.+|
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 4679886 78999999999999999999999999997653 33456788999999885 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCc---EEEccccccccCCCC
Q 010266 183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH---MKLSDFGLCKPLDCT 259 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~---iKL~DFGla~~~~~~ 259 (514)
+||||++||+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||++......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999999999998889999999999999999999999999999999999999998776 999999998765321
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-----CCCCc
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-----KGYGM 334 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-----~~y~~ 334 (514)
...... ......+.+||+.|+|||++.+ ..|+.
T Consensus 168 ~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 205 (316)
T 2ac3_A 168 GDCSPI------------------------------------------STPELLTPCGSAEYMAPEVVEAFSEEASIYDK 205 (316)
T ss_dssp --------------------------------------------------------CCSGGGCCHHHHHHTSHHHHHHTT
T ss_pred Cccccc------------------------------------------cccccccccCCcCccChHHhhcccccccCCCc
Confidence 100000 0001225679999999999975 56899
Q ss_pred ccchhhhhHHHHHHhhCCCCCCCCCh---------------hHHHHHHhhhcCcccCCc--CcCCChhHHHHHhhhcc-C
Q 010266 335 ECDWWSLGAIMYEMLVGYPPFYSDDP---------------VTTCRKIVHWKNHLKFPE--EARLTPEAKDLICRLLC-D 396 (514)
Q Consensus 335 ~~DiWSlGvilyemltG~~PF~~~~~---------------~~~~~~i~~~~~~~~~p~--~~~~s~~~~dLI~~lL~-d 396 (514)
++|||||||++|||++|.+||.+.+. ......+.. ....+|. ...+++++++||.+||. |
T Consensus 206 ~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~~~~~li~~~L~~d 283 (316)
T 2ac3_A 206 RCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQE--GKYEFPDKDWAHISCAAKDLISKLLVRD 283 (316)
T ss_dssp THHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHH--CCCCCCHHHHTTSCHHHHHHHHHHSCSS
T ss_pred ccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhc--cCcccCchhcccCCHHHHHHHHHHhhCC
Confidence 99999999999999999999987642 334555554 3344443 24689999999999999 9
Q ss_pred ccccCCCCCHhHHhcCCccccCCccc
Q 010266 397 VEHRLGTLGSEQIKAHPWFKDIAWDK 422 (514)
Q Consensus 397 p~~Rl~~~~~~eil~Hpff~~i~w~~ 422 (514)
|.+|+ +++|+++||||++..|+.
T Consensus 284 P~~Rp---s~~e~l~hp~~~~~~~~~ 306 (316)
T 2ac3_A 284 AKQRL---SAAQVLQHPWVQGCAPEN 306 (316)
T ss_dssp TTTSC---CHHHHHHSTTCC------
T ss_pred hhhCC---CHHHHhcChhhcCCCCcc
Confidence 99999 999999999999877654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=409.20 Aligned_cols=262 Identities=27% Similarity=0.461 Sum_probs=214.5
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
+++|++++.||+|+||+||+|+++.+++.||+|++..... ......+.+|..+|+.++||||++++++|.+.+.+|+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 3689999999999999999999999999999999975431 11112345689999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 185 MEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
|||++ |+|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.+|++||+|||+|+......
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--- 154 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--- 154 (324)
T ss_dssp EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc---
Confidence 99997 5888888764 469999999999999999999999999999999999999999999999999997543210
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchhhhh
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 342 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlG 342 (514)
......+||+.|+|||++.+ ..|+.++||||||
T Consensus 155 ----------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 188 (324)
T 3mtl_A 155 ----------------------------------------------KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVG 188 (324)
T ss_dssp ------------------------------------------------------CGGGCCHHHHTTCCCCCTHHHHHHHH
T ss_pred ----------------------------------------------cccccccCcccccChhhhcCCCCCCcHHHHHHHH
Confidence 01124579999999999987 6689999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcCccc-----------------CC---------cCcCCChhHHHHHhhhcc-
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLK-----------------FP---------EEARLTPEAKDLICRLLC- 395 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~~~~-----------------~p---------~~~~~s~~~~dLI~~lL~- 395 (514)
|++|+|++|.+||.+.+..+....+........ +| ....+++++++||.+||.
T Consensus 189 ~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 268 (324)
T 3mtl_A 189 CIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQF 268 (324)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCS
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCc
Confidence 999999999999999988888777764221110 11 012478999999999999
Q ss_pred CccccCCCCCHhHHhcCCccccCCcc
Q 010266 396 DVEHRLGTLGSEQIKAHPWFKDIAWD 421 (514)
Q Consensus 396 dp~~Rl~~~~~~eil~Hpff~~i~w~ 421 (514)
||.+|+ |++|+++||||.++.+.
T Consensus 269 dP~~R~---t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 269 EGRNRI---SAEDAMKHPFFLSLGER 291 (324)
T ss_dssp SGGGSC---CHHHHTTSGGGGGGCST
T ss_pred CcccCC---CHHHHhcChhhhhcccc
Confidence 999999 99999999999987543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=396.23 Aligned_cols=254 Identities=34% Similarity=0.608 Sum_probs=226.0
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++.+.||+|+||.||+|.++.++..||+|++.+... ...+.+.+|..+|..++||||++++++|.+...+|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 579999999999999999999999999999999987543 33567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccc---cCCCcEEEccccccccCCCCCcc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILl---d~~g~iKL~DFGla~~~~~~~~~ 262 (514)
||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~-- 163 (277)
T 3f3z_A 86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-- 163 (277)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS--
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc--
Confidence 999999999999988999999999999999999999999999999999999999 788999999999987653211
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
...+.+||+.|+|||++.+. ++.++|+||||
T Consensus 164 ------------------------------------------------~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG 194 (277)
T 3f3z_A 164 ------------------------------------------------MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAG 194 (277)
T ss_dssp ------------------------------------------------CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHH
T ss_pred ------------------------------------------------chhccCCCCCccChHHhccc-CCchhhehhHH
Confidence 11245799999999998665 99999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCc--CcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPE--EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
|++|+|++|.+||.+.+..+....+... ...+|. ...+++++.+||.+||. ||.+|+ ++.++++||||++.
T Consensus 195 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~---s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 195 VMMYVLLCGYPPFSAPTDSEVMLKIREG--TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRI---TSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSC---CHHHHTTSHHHHHH
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHHhC--CCCCCchhhhcCCHHHHHHHHHHccCChhhCc---CHHHHhcCHHHhcc
Confidence 9999999999999999888888888763 334443 23689999999999999 999999 99999999999764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=394.51 Aligned_cols=261 Identities=31% Similarity=0.511 Sum_probs=234.4
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
...++|.+.+.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|..+++.++||||+++++++.+.+.+|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 34578999999999999999999999999999999998877666777788999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
+||||++|++|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.+|++||+|||++........
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 170 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 170 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc-
Confidence 9999999999999998888999999999999999999999999999999999999999999999999999876532110
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
.....+||+.|+|||++.+..++.++|+||||
T Consensus 171 ------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 202 (294)
T 2rku_A 171 ------------------------------------------------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 202 (294)
T ss_dssp ------------------------------------------------CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHH
T ss_pred ------------------------------------------------ccccccCCCCcCCcchhccCCCCchhhHHHHH
Confidence 01245799999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCC
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIA 419 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~ 419 (514)
|++|+|++|..||.+.+..+....+.. ....+|. .+++++.+||.+||. ||.+|+ +++|+++||||....
T Consensus 203 ~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp---s~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 203 CIMYTLLVGKPPFETSCLKETYLRIKK--NEYSIPK--HINPVAASLIQKMLQTDPTARP---TINELLNDEFFTSGY 273 (294)
T ss_dssp HHHHHHHHSSCTTCCSSHHHHHHHHHT--TCCCCCT--TSCHHHHHHHHHHTCSSGGGSC---CGGGGGGSHHHHTSC
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHhh--ccCCCcc--ccCHHHHHHHHHHcccChhhCc---CHHHHhhChheecCC
Confidence 999999999999999888887777765 3344554 689999999999999 999999 999999999998643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=397.45 Aligned_cols=265 Identities=31% Similarity=0.530 Sum_probs=229.5
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccCh---hhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR---GQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
++|++++.||+|+||.||+|+++.+++.||+|++.+...... ...+.+.+|..+|..++||||+++++++.+...+|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 569999999999999999999999999999999987654322 13577889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC----cEEEccccccccCCC
Q 010266 183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG----HMKLSDFGLCKPLDC 258 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g----~iKL~DFGla~~~~~ 258 (514)
+||||++|++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++ ++||+|||++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 9999999999999998888999999999999999999999999999999999999999877 899999999876432
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
.. .....+||+.|+|||++.+..++.++|+
T Consensus 165 ~~--------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di 194 (283)
T 3bhy_A 165 GN--------------------------------------------------EFKNIFGTPEFVAPEIVNYEPLGLEADM 194 (283)
T ss_dssp ---------------------------------------------------------CCCGGGCCHHHHTTCCCCTHHHH
T ss_pred CC--------------------------------------------------cccccCCCcCccCcceecCCCCCcchhh
Confidence 10 0114579999999999999999999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
|||||++|+|++|..||.+.+..+....+.........+....+++.+.+||.+||. ||.+|+ ++.++++||||+.
T Consensus 195 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~~l~h~~~~~ 271 (283)
T 3bhy_A 195 WSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRM---TIAQSLEHSWIKA 271 (283)
T ss_dssp HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSC---CHHHHHHCHHHHH
T ss_pred hhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCc---CHHHHHhCHHHHH
Confidence 999999999999999999998888887776533222111124678999999999999 999999 9999999999998
Q ss_pred CCcccc
Q 010266 418 IAWDKL 423 (514)
Q Consensus 418 i~w~~l 423 (514)
+.|...
T Consensus 272 ~~~~~~ 277 (283)
T 3bhy_A 272 IRRRNV 277 (283)
T ss_dssp HHHCCC
T ss_pred HHHHhh
Confidence 876654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=400.09 Aligned_cols=256 Identities=33% Similarity=0.612 Sum_probs=225.2
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|.+++.||+|+||.||+|+++.+|+.||+|++.+... .....+.+|..+|..++||||++++++|.+...+|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 579999999999999999999999999999999986532 23345788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccc---cCCCcEEEccccccccCCCCCcc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILl---d~~g~iKL~DFGla~~~~~~~~~ 262 (514)
||++||+|.+++...+.+++..+..++.|++.||.|||+.||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~--- 162 (304)
T 2jam_A 86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--- 162 (304)
T ss_dssp CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB---
T ss_pred EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC---
Confidence 999999999999888899999999999999999999999999999999999999 78899999999998743211
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
.....+||+.|+|||++.+..++.++|+||||
T Consensus 163 ------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 194 (304)
T 2jam_A 163 ------------------------------------------------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIG 194 (304)
T ss_dssp ------------------------------------------------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHH
T ss_pred ------------------------------------------------ccccccCCCCccChHHhccCCCCchhhHHHHH
Confidence 01145799999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
|++|+|++|.+||.+.+.......+......+..+....+++++++||.+||. ||.+|+ +++|+++||||.+.
T Consensus 195 ~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~~l~h~~~~~~ 268 (304)
T 2jam_A 195 VITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERY---TCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSC---CHHHHHTSHHHHSS
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCc---CHHHHhcCccccCC
Confidence 99999999999999998888888887643333333335689999999999999 999999 99999999999863
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=402.12 Aligned_cols=261 Identities=31% Similarity=0.511 Sum_probs=234.8
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
...++|.+.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|..++..++||||++++++|.+.+.+|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 34578999999999999999999999999999999998877666777888999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
+||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++........
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~- 196 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 196 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-
Confidence 9999999999999998888999999999999999999999999999999999999999999999999999986532110
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
.....+||+.|+|||++.+..++.++||||||
T Consensus 197 ------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 228 (335)
T 2owb_A 197 ------------------------------------------------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 228 (335)
T ss_dssp ------------------------------------------------CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHH
T ss_pred ------------------------------------------------cccccCCCccccCHHHhccCCCCchhhHHHHH
Confidence 01245799999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCC
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIA 419 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~ 419 (514)
|++|+|++|..||.+.+..+.+..+.. ....+|. .+++++.+||.+||. ||.+|+ +++|+++||||....
T Consensus 229 ~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~dp~~Rp---s~~ell~~~~~~~~~ 299 (335)
T 2owb_A 229 CIMYTLLVGKPPFETSCLKETYLRIKK--NEYSIPK--HINPVAASLIQKMLQTDPTARP---TINELLNDEFFTSGY 299 (335)
T ss_dssp HHHHHHHHSSCTTCCSSHHHHHHHHHH--TCCCCCT--TSCHHHHHHHHHHTCSSGGGSC---CGGGGGGSHHHHTSC
T ss_pred HHHHHHHHCcCCCCCCCHHHHHHHHhc--CCCCCCc--cCCHHHHHHHHHHccCChhHCc---CHHHHhcCccccCCC
Confidence 999999999999999888887777765 3345554 689999999999999 999999 999999999998643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=396.52 Aligned_cols=259 Identities=33% Similarity=0.623 Sum_probs=202.8
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 183 (514)
..++|++.+.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|..++..++||||+++++++.+.+.+|+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 34789999999999999999999999999999999987654444456778999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 184 IMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
||||+++|+|.+++... ..+++..++.++.|++.||.|||+.||+||||||+||+++.+|++||+|||++.......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-- 166 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH-- 166 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC--
Confidence 99999999999999765 679999999999999999999999999999999999999999999999999987653210
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
......+||+.|+|||++.+..++.++|+||||
T Consensus 167 -----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 199 (278)
T 3cok_A 167 -----------------------------------------------EKHYTLCGTPNYISPEIATRSAHGLESDVWSLG 199 (278)
T ss_dssp ------------------------------------------------------------------------CTHHHHHH
T ss_pred -----------------------------------------------CcceeccCCCCcCCcchhcCCCCCchhhHHHHH
Confidence 011245799999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
|++|+|++|.+||...+.......+.. .....|. .+++++++||.+||. ||.+|+ +++++++||||.+.
T Consensus 200 ~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~dp~~Rp---s~~~~l~h~~~~~~ 269 (278)
T 3cok_A 200 CMFYTLLIGRPPFDTDTVKNTLNKVVL--ADYEMPS--FLSIEAKDLIHQLLRRNPADRL---SLSSVLDHPFMSRN 269 (278)
T ss_dssp HHHHHHHHSSCSSCCCSCC-----CCS--SCCCCCT--TSCHHHHHHHHHHSCSSGGGSC---CHHHHTTSTTTC--
T ss_pred HHHHHHHhCCCCCCChhHHHHHHHHhh--cccCCcc--ccCHHHHHHHHHHcccCHhhCC---CHHHHhcCccccCC
Confidence 999999999999998776666655543 2234443 689999999999999 999999 99999999999763
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=400.66 Aligned_cols=256 Identities=31% Similarity=0.546 Sum_probs=224.1
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
.|...+.||+|+||.||+|+++.+|+.||||++.... ....+.+.+|..+|..++||||++++++|.+.+.+|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4888899999999999999999999999999997653 3345668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccc
Q 010266 187 YLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE 266 (514)
Q Consensus 187 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~ 266 (514)
|++||+|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++........
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~----- 196 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP----- 196 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-----
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-----
Confidence 9999999998854 5799999999999999999999999999999999999999999999999999876532100
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHH
Q 010266 267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 346 (514)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 346 (514)
.....+||+.|+|||++.+..++.++|||||||++|
T Consensus 197 --------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~ 232 (321)
T 2c30_A 197 --------------------------------------------KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVI 232 (321)
T ss_dssp --------------------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHH
T ss_pred --------------------------------------------ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHH
Confidence 012568999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCC
Q 010266 347 EMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIA 419 (514)
Q Consensus 347 emltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~ 419 (514)
||++|.+||.+.+..+....+.... ...++....+++++++||.+||. ||.+|+ +++|+++||||....
T Consensus 233 el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~hp~~~~~~ 302 (321)
T 2c30_A 233 EMVDGEPPYFSDSPVQAMKRLRDSP-PPKLKNSHKVSPVLRDFLERMLVRDPQERA---TAQELLDHPFLLQTG 302 (321)
T ss_dssp HHHHSSCTTTTSCHHHHHHHHHHSS-CCCCTTGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHHTSGGGGGCC
T ss_pred HHHhCCCCCCCCCHHHHHHHHhcCC-CCCcCccccCCHHHHHHHHHHccCChhhCc---CHHHHhcChhhccCC
Confidence 9999999999988888777776532 22233334689999999999999 999999 999999999998643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=410.94 Aligned_cols=258 Identities=33% Similarity=0.604 Sum_probs=226.0
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeeccccc-C----hhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCC
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML-S----RGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAE 179 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~-~----~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~ 179 (514)
++|++.+.||+|+||.||+|+++.+|+.||||++...... . ....+.+.+|..++..+ +||||++++++|.+..
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5799999999999999999999999999999999765321 1 12245678899999999 7999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
..|+||||++||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++..+...
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999998765421
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc------CCCC
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK------KGYG 333 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~------~~y~ 333 (514)
. .....+||+.|+|||++.+ ..|+
T Consensus 254 ~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 283 (365)
T 2y7j_A 254 E--------------------------------------------------KLRELCGTPGYLAPEILKCSMDETHPGYG 283 (365)
T ss_dssp C--------------------------------------------------CBCCCCSCGGGCCHHHHHHTTCTTSCCBC
T ss_pred c--------------------------------------------------ccccCCCCCCccChhhccccccccCcCCC
Confidence 0 1125689999999999863 3689
Q ss_pred cccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 334 MECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 334 ~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
.++|||||||++|+|++|.+||.+.+.......+.........|.+..+++++.+||.+||. ||.+|+ +++++++|
T Consensus 284 ~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~ell~h 360 (365)
T 2y7j_A 284 KEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARL---TAEQALQH 360 (365)
T ss_dssp TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSC---CHHHHHHS
T ss_pred chhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCc---CHHHHhcC
Confidence 99999999999999999999999988888888887644433334445789999999999999 999999 99999999
Q ss_pred Cccc
Q 010266 413 PWFK 416 (514)
Q Consensus 413 pff~ 416 (514)
|||+
T Consensus 361 p~f~ 364 (365)
T 2y7j_A 361 PFFE 364 (365)
T ss_dssp GGGC
T ss_pred cccC
Confidence 9996
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-50 Score=413.04 Aligned_cols=272 Identities=26% Similarity=0.407 Sum_probs=217.1
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC-----
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE----- 179 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~----- 179 (514)
.++|++++.||+|+||.||+|.++.+++.||||++.+.. ........+.+|..+++.++||||++++++|.+..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 478999999999999999999999999999999997643 34455677889999999999999999999998765
Q ss_pred -eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 180 -YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 180 -~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
.+|+||||++| +|.+.+. ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred cceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 78999999974 7888875 4689999999999999999999999999999999999999999999999999875431
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
.. ...+.+||+.|+|||++.+..|+.++||
T Consensus 180 ~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di 209 (371)
T 2xrw_A 180 SF--------------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDI 209 (371)
T ss_dssp ------------------------------------------------------------CTTCCHHHHTTCCCCTTHHH
T ss_pred cc--------------------------------------------------ccCCceecCCccCHHHhcCCCCCchHhH
Confidence 10 1124689999999999999999999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcc----------------------------------cCCcC----c
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL----------------------------------KFPEE----A 380 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~----------------------------------~~p~~----~ 380 (514)
|||||++|+|++|.+||.+.+..+.+..++...... .+|.. .
T Consensus 210 wslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (371)
T 2xrw_A 210 WSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNK 289 (371)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccc
Confidence 999999999999999999998888877776421100 01100 0
Q ss_pred CCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCccccccccCCCCCc
Q 010266 381 RLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPE 433 (514)
Q Consensus 381 ~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~l~~~~~p~~p~ 433 (514)
..++++++||.+||+ ||.+|+ |++|+++||||+...........||..|.
T Consensus 290 ~~~~~~~~li~~mL~~dP~~R~---t~~e~l~hp~~~~~~~~~~~~~~~~~~~~ 340 (371)
T 2xrw_A 290 LKASQARDLLSKMLVIDASKRI---SVDEALQHPYINVWYDPSEAEAPPPKIPD 340 (371)
T ss_dssp HHHHHHHHHHHHHSCSSGGGSC---CHHHHHHSHHHHTTCCHHHHTCCCCCCCT
T ss_pred cccHHHHHHHHHHCcCChhhCC---CHHHHhCCcchhhhcCccccCCCCCCCCC
Confidence 125789999999999 999999 99999999999853322223445556554
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-50 Score=410.09 Aligned_cols=268 Identities=27% Similarity=0.400 Sum_probs=229.8
Q ss_pred hcCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC
Q 010266 99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA 178 (514)
Q Consensus 99 ~~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 178 (514)
....+..++|++++.||+|+||.||+|+++.+++.||+|++.... .......+.+|..+|..++||||++++++|.+.
T Consensus 26 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 103 (360)
T 3eqc_A 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 103 (360)
T ss_dssp TCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET
T ss_pred cccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC
Confidence 446677889999999999999999999999999999999998652 455567789999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC-CeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
+.+|+||||++||+|.+++...+.+++..+..++.|++.||.|||+. ||+||||||+|||++.+|++||+|||++....
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred CEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 99999999999999999999888999999999999999999999986 99999999999999999999999999986432
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
.. .....+||+.|+|||++.+..++.++|
T Consensus 184 ~~---------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~D 212 (360)
T 3eqc_A 184 DS---------------------------------------------------MANSFVGTRSYMSPERLQGTHYSVQSD 212 (360)
T ss_dssp HH---------------------------------------------------C----CCCCTTCCHHHHTTCCCSHHHH
T ss_pred cc---------------------------------------------------cccCCCCCCCeECHHHHcCCCCCchhh
Confidence 10 112568999999999999999999999
Q ss_pred hhhhhHHHHHHhhCCCCCCCCChhHHHHH------------------------------------------HhhhcCccc
Q 010266 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRK------------------------------------------IVHWKNHLK 375 (514)
Q Consensus 338 iWSlGvilyemltG~~PF~~~~~~~~~~~------------------------------------------i~~~~~~~~ 375 (514)
||||||++|+|++|..||.+.+..+.... +... ....
T Consensus 213 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 291 (360)
T 3eqc_A 213 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNE-PPPK 291 (360)
T ss_dssp HHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHS-CCCC
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhcc-CCCC
Confidence 99999999999999999987765443222 1111 1111
Q ss_pred CCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCccccc
Q 010266 376 FPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLY 424 (514)
Q Consensus 376 ~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~l~ 424 (514)
.| ...+|+++++||.+||. ||.+|+ |++|+++||||++.+|+.+.
T Consensus 292 ~~-~~~~~~~~~~li~~~L~~dP~~Rp---t~~ell~hp~~~~~~~~~~~ 337 (360)
T 3eqc_A 292 LP-SGVFSLEFQDFVNKCLIKNPAERA---DLKQLMVHAFIKRSDAEEVD 337 (360)
T ss_dssp CC-TTTSCHHHHHHHHHHHCSSTTTSC---CHHHHHTSHHHHHHHHSCCC
T ss_pred CC-cccccHHHHHHHHHHhhcChhhCC---CHHHHhhChHhhcchHhhhh
Confidence 22 23578999999999999 999999 99999999999998887763
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=411.04 Aligned_cols=260 Identities=29% Similarity=0.517 Sum_probs=220.8
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccCh-----hhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR-----GQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~-----~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
++|++++.||+|+||.||+|+++.+++.||||++.+...... .....+.+|..+|..++||||++++++|.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 579999999999999999999999999999999987654322 133456789999999999999999999999999
Q ss_pred EEEEEeecCCC-CHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 181 LYLIMEYLPGG-DVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 181 l~lVmEy~~gg-~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
+|+||||+.+| +|..++.....+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 183 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCC
Confidence 99999999777 99999998889999999999999999999999999999999999999999999999999999765321
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCC-Ccccch
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDW 338 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~Di 338 (514)
. ...+.+||+.|+|||++.+..+ +.++||
T Consensus 184 ~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 213 (335)
T 3dls_A 184 K--------------------------------------------------LFYTFCGTIEYCAPEVLMGNPYRGPELEM 213 (335)
T ss_dssp C--------------------------------------------------CBCEECSCGGGCCHHHHTTCCBCSHHHHH
T ss_pred C--------------------------------------------------ceeccCCCccccChhhhcCCCCCCCcccc
Confidence 1 1125689999999999998887 889999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
|||||++|+|++|..||..... +.. .....| ..+|+++++||.+||. ||.+|+ +++++++||||+.
T Consensus 214 wslG~il~el~~g~~pf~~~~~------~~~--~~~~~~--~~~~~~l~~li~~~L~~dP~~Rp---s~~ell~hp~~~~ 280 (335)
T 3dls_A 214 WSLGVTLYTLVFEENPFCELEE------TVE--AAIHPP--YLVSKELMSLVSGLLQPVPERRT---TLEKLVTDPWVTQ 280 (335)
T ss_dssp HHHHHHHHHHHHSSCSCSSGGG------GTT--TCCCCS--SCCCHHHHHHHHHHTCSSGGGSC---CHHHHHHCTTTTC
T ss_pred hhHHHHHHHHHhCCCchhhHHH------HHh--hccCCC--cccCHHHHHHHHHHccCChhhCc---CHHHHhcCccccC
Confidence 9999999999999999976321 111 122223 3689999999999999 999999 9999999999965
Q ss_pred ------CCccccccccC
Q 010266 418 ------IAWDKLYEMEA 428 (514)
Q Consensus 418 ------i~w~~l~~~~~ 428 (514)
.+|+.+.....
T Consensus 281 ~~~~~~~~~~~~~~~~~ 297 (335)
T 3dls_A 281 PVNLADYTWEEVFRVNK 297 (335)
T ss_dssp CCCGGGCCHHHHC----
T ss_pred CccccccCHHHHhhhcC
Confidence 56666654433
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=394.02 Aligned_cols=255 Identities=31% Similarity=0.557 Sum_probs=217.7
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|.+.+.||+|+||.||+|+++.++..||+|++.+.. .....+.+.+|..+|+.++||||++++++|.+...+|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 67999999999999999999999999999999998764 2334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccc---cCCCcEEEccccccccCCC
Q 010266 186 EYLPGGDVMTLLMRE----ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILl---d~~g~iKL~DFGla~~~~~ 258 (514)
||++||+|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||+ +.++.+||+|||++.....
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 999999999998543 679999999999999999999999999999999999999 4568999999999975432
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
.. .....+||+.|+|||++. ..++.++|+
T Consensus 180 ~~--------------------------------------------------~~~~~~~t~~y~aPE~~~-~~~~~~~Di 208 (285)
T 3is5_A 180 DE--------------------------------------------------HSTNAAGTALYMAPEVFK-RDVTFKCDI 208 (285)
T ss_dssp ---------------------------------------------------------CTTGGGCCHHHHT-TCCCHHHHH
T ss_pred cc--------------------------------------------------cCcCcccccCcCChHHhc-cCCCcccCe
Confidence 10 012457999999999985 568999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
|||||++|+|++|..||.+.+..+....+......... ....+++++.+||.+||. ||.+|+ +++||++||||+.
T Consensus 209 ~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rp---s~~e~l~hp~f~~ 284 (285)
T 3is5_A 209 WSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAV-ECRPLTPQAVDLLKQMLTKDPERRP---SAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCCCHHHHHHHHHHTCSCTTTSC---CHHHHHTSGGGGC
T ss_pred ehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccc-ccCcCCHHHHHHHHHHccCChhhCc---CHHHHhcCHHhhc
Confidence 99999999999999999998887777766543222221 223589999999999999 999999 9999999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=407.21 Aligned_cols=267 Identities=27% Similarity=0.379 Sum_probs=220.4
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc-------
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------- 177 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~------- 177 (514)
.++|++++.||+|+||.||+|+++.+|+.||||++..... .......+.+|..+|..++||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 4789999999999999999999999999999999976543 23334557789999999999999999999987
Q ss_pred -CCeEEEEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 178 -AEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 178 -~~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
.+.+|+||||++| +|...+.. ...+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+.
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 4579999999975 77776655 46799999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCc
Q 010266 256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGM 334 (514)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~ 334 (514)
........ .......+||+.|+|||++.+ ..|+.
T Consensus 174 ~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~ 208 (351)
T 3mi9_A 174 FSLAKNSQ---------------------------------------------PNRYTNRVVTLWYRPPELLLGERDYGP 208 (351)
T ss_dssp CCCCSSSS---------------------------------------------CCCCCSSCSCGGGCCHHHHTTCCSCCT
T ss_pred cccccccc---------------------------------------------ccccCCcccccCccCchhhcCCCCCCc
Confidence 54221100 001125689999999999986 55899
Q ss_pred ccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcC----------------------------CChhH
Q 010266 335 ECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEAR----------------------------LTPEA 386 (514)
Q Consensus 335 ~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~----------------------------~s~~~ 386 (514)
++|||||||++|+|++|.+||.+.+.......+......+....... .++++
T Consensus 209 ~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (351)
T 3mi9_A 209 PIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYA 288 (351)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHH
T ss_pred HhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHH
Confidence 99999999999999999999999988888777765322221111001 27789
Q ss_pred HHHHhhhcc-CccccCCCCCHhHHhcCCccccCCcc
Q 010266 387 KDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWD 421 (514)
Q Consensus 387 ~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~ 421 (514)
++||.+||+ ||.+|+ +++|+++||||.+..+.
T Consensus 289 ~~li~~~L~~dP~~R~---t~~e~l~hp~f~~~~~~ 321 (351)
T 3mi9_A 289 LDLIDKLLVLDPAQRI---DSDDALNHDFFWSDPMP 321 (351)
T ss_dssp HHHHHHHSCSSGGGSC---CHHHHHTSGGGGSSSCC
T ss_pred HHHHHHHhcCChhhCC---CHHHHhCCCCcCCCCCc
Confidence 999999999 999999 99999999999876544
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=408.82 Aligned_cols=261 Identities=25% Similarity=0.421 Sum_probs=221.8
Q ss_pred HHhhcCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-----CCceee
Q 010266 96 MRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-----SHCIVK 170 (514)
Q Consensus 96 ~~~~~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-----hp~Iv~ 170 (514)
.......+..++|++++.||+|+||+||+|++..+++.||||++.+. .........|..+|..+. |||||+
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 34455666678999999999999999999999999999999999743 344556778999999986 999999
Q ss_pred EEEEEEcCCeEEEEEeecCCCCHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC-------
Q 010266 171 LYYSFQDAEYLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ------- 241 (514)
Q Consensus 171 l~~~f~~~~~l~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~------- 241 (514)
++++|.+.+.+|+||||+ ||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEE
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccc
Confidence 999999999999999999 999999997654 5999999999999999999999999999999999999975
Q ss_pred ------------------CCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHH
Q 010266 242 ------------------NGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQH 303 (514)
Q Consensus 242 ------------------~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (514)
++.+||+|||+|+.....
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-------------------------------------------- 215 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-------------------------------------------- 215 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--------------------------------------------
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCCC--------------------------------------------
Confidence 889999999998753211
Q ss_pred HhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcc---------
Q 010266 304 WQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL--------- 374 (514)
Q Consensus 304 ~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~--------- 374 (514)
..+.+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+....+......+
T Consensus 216 --------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 287 (360)
T 3llt_A 216 --------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEAT 287 (360)
T ss_dssp --------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHT
T ss_pred --------CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhh
Confidence 115679999999999999999999999999999999999999999988877776665421111
Q ss_pred ---------------cCCcC------------------cCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccc
Q 010266 375 ---------------KFPEE------------------ARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFK 416 (514)
Q Consensus 375 ---------------~~p~~------------------~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~ 416 (514)
.+|.. ...++.+.+||.+||+ ||.+|+ |++|+++||||+
T Consensus 288 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp---ta~elL~hp~f~ 360 (360)
T 3llt_A 288 KTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRP---SPAELLKHKFLE 360 (360)
T ss_dssp TSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSC---CHHHHTTSGGGC
T ss_pred hccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCC---CHHHHhcCcccC
Confidence 01110 0124778899999999 999999 999999999995
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=422.87 Aligned_cols=262 Identities=33% Similarity=0.613 Sum_probs=213.9
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccC-----hhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS-----RGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~-----~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
++|.+.+.||+|+||+||+|.++.+++.||||++.+..... ......+.+|..+|..++|||||+++++|.+ +.
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~ 213 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-ED 213 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cc
Confidence 68999999999999999999999999999999998764322 1223357889999999999999999999865 55
Q ss_pred EEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC---cEEEccccccccCC
Q 010266 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG---HMKLSDFGLCKPLD 257 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g---~iKL~DFGla~~~~ 257 (514)
+|+||||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 214 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~ 293 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293 (419)
T ss_dssp EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC
T ss_pred eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecC
Confidence 899999999999999998888999999999999999999999999999999999999997554 59999999998653
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc---CCCCc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK---KGYGM 334 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~y~~ 334 (514)
... ...+.+||+.|+|||++.+ ..|+.
T Consensus 294 ~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~ 323 (419)
T 3i6u_A 294 ETS--------------------------------------------------LMRTLCGTPTYLAPEVLVSVGTAGYNR 323 (419)
T ss_dssp -------------------------------------------------------------CTTCCTTTTC----CTTHH
T ss_pred CCc--------------------------------------------------cccccCCCCCccCceeeecCCCCCCCc
Confidence 210 1125689999999999864 67889
Q ss_pred ccchhhhhHHHHHHhhCCCCCCCCChhHH-HHHHhhhcCcccCCc--CcCCChhHHHHHhhhcc-CccccCCCCCHhHHh
Q 010266 335 ECDWWSLGAIMYEMLVGYPPFYSDDPVTT-CRKIVHWKNHLKFPE--EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIK 410 (514)
Q Consensus 335 ~~DiWSlGvilyemltG~~PF~~~~~~~~-~~~i~~~~~~~~~p~--~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 410 (514)
++|||||||++|+|++|.+||.+...... ...+... ...+++ ...+++++.+||.+||. ||.+|+ +++|++
T Consensus 324 ~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~e~l 398 (419)
T 3i6u_A 324 AVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG--KYNFIPEVWAEVSEKALDLVKKLLVVDPKARF---TTEEAL 398 (419)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTT--CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC---CHHHHH
T ss_pred hhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcC--CCCCCchhhcccCHHHHHHHHHHccCChhHCc---CHHHHh
Confidence 99999999999999999999987654433 3344332 222221 24689999999999999 999999 999999
Q ss_pred cCCccccCCcccc
Q 010266 411 AHPWFKDIAWDKL 423 (514)
Q Consensus 411 ~Hpff~~i~w~~l 423 (514)
+||||++.+|...
T Consensus 399 ~hp~~~~~~~~~~ 411 (419)
T 3i6u_A 399 RHPWLQDEDMKRK 411 (419)
T ss_dssp HSGGGCCHHHHHH
T ss_pred CCcccCChhHHHH
Confidence 9999999887653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=406.66 Aligned_cols=265 Identities=25% Similarity=0.387 Sum_probs=221.8
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC----
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE---- 179 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~---- 179 (514)
..++|++++.||+|+||.||+|+++.+++.||||++.............+.+|..++..++||||+++++++.+..
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 3578999999999999999999999999999999998766555666778899999999999999999999987654
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
..|+||||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 35999999999999999998889999999999999999999999999999999999999999999999999999865422
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
... .......+||+.|+|||++.+..++.++|||
T Consensus 170 ~~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 203 (311)
T 3ork_A 170 GNS----------------------------------------------VTQTAAVIGTAQYLSPEQARGDSVDARSDVY 203 (311)
T ss_dssp ----------------------------------------------------------CCTTCCHHHHHTCCCCHHHHHH
T ss_pred ccc----------------------------------------------cccccccCcCcccCCHHHhcCCCCCchHhHH
Confidence 100 0012256899999999999999999999999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
||||++|+|++|..||.+.+..+....+..............+|+++.+||.+||. ||.+|+ ++.+++.|+|++.
T Consensus 204 slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~---~~~~~l~~~l~~~ 279 (311)
T 3ork_A 204 SLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRY---QTAAEMRADLVRV 279 (311)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSC---SSHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhCh---hhHHHHHHHHHHH
Confidence 99999999999999999998887776666532221111224689999999999999 999999 8899999999974
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=391.78 Aligned_cols=261 Identities=30% Similarity=0.556 Sum_probs=223.1
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE 179 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 179 (514)
...+..++|++.+.||+|+||.||+|+++.+|+.||+|++.............+.+|..++..++||||+++++++.+.+
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34566789999999999999999999999999999999998765444455677889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
.+|+||||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999998765321
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCC-Ccccch
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDW 338 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~Di 338 (514)
. .....+||+.|+|||++.+..+ +.++|+
T Consensus 165 ~--------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 194 (276)
T 2h6d_A 165 E--------------------------------------------------FLRTSCGSPNYAAPEVISGRLYAGPEVDI 194 (276)
T ss_dssp --------------------------------------------------------------CCTGGGTTSCCCHHHHHH
T ss_pred c--------------------------------------------------ceecccCCccccCHHHHcCCCCCCccchH
Confidence 0 0114579999999999988776 689999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
|||||++|+|++|..||.+.+.......+.. ....+|. .+++++.+||.+||. ||.+|+ ++++|++||||+.
T Consensus 195 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~--~~~~~l~~li~~~l~~~p~~Rp---s~~~~l~h~~~~~ 267 (276)
T 2h6d_A 195 WSCGVILYALLCGTLPFDDEHVPTLFKKIRG--GVFYIPE--YLNRSVATLLMHMLQVDPLKRA---TIKDIREHEWFKQ 267 (276)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSGGGSC---CHHHHHHSHHHHT
T ss_pred HHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc--CcccCch--hcCHHHHHHHHHHccCChhhCC---CHHHHHhChhhcc
Confidence 9999999999999999999888877777765 3334453 688999999999999 999999 9999999999975
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=405.14 Aligned_cols=267 Identities=27% Similarity=0.440 Sum_probs=218.2
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccC--hhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS--RGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~--~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
.++|++++.||+|+||.||+|+++.+|+.||||++....... ......+.+|..+|..++||||++++++|.+...+|
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 478999999999999999999999999999999997643221 112245778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 183 LIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
+||||++| +|..++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 167 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence 99999976 888888654 4799999999999999999999999999999999999999999999999999986532210
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWS 340 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWS 340 (514)
.....+||+.|+|||++.+ ..|+.++||||
T Consensus 168 -------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 198 (346)
T 1ua2_A 168 -------------------------------------------------AYTHQVVTRWYRAPELLFGARMYGVGVDMWA 198 (346)
T ss_dssp -------------------------------------------------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHH
T ss_pred -------------------------------------------------cCCcccccccccCchHhhCCCCCCchhhhHh
Confidence 1124679999999999976 45899999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcc---------cCCc---------------CcCCChhHHHHHhhhcc-
Q 010266 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL---------KFPE---------------EARLTPEAKDLICRLLC- 395 (514)
Q Consensus 341 lGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---------~~p~---------------~~~~s~~~~dLI~~lL~- 395 (514)
|||++|||++|.+||.+.+..+.+.++....... ..|. ...+++++++||.+||.
T Consensus 199 lG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 278 (346)
T 1ua2_A 199 VGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLF 278 (346)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCS
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhcc
Confidence 9999999999999999999888888876521111 1110 03467899999999999
Q ss_pred CccccCCCCCHhHHhcCCccccCCccccc
Q 010266 396 DVEHRLGTLGSEQIKAHPWFKDIAWDKLY 424 (514)
Q Consensus 396 dp~~Rl~~~~~~eil~Hpff~~i~w~~l~ 424 (514)
||.+|+ +++|+++||||++..|....
T Consensus 279 dP~~Rp---t~~ell~h~~f~~~~~~~~~ 304 (346)
T 1ua2_A 279 NPCARI---TATQALKMKYFSNRPGPTPG 304 (346)
T ss_dssp STTTSC---CHHHHHTSGGGTSSSCCCCS
T ss_pred ChhhCC---CHHHHhcChhhhcCCCCCCc
Confidence 999999 99999999999987766543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=411.45 Aligned_cols=259 Identities=30% Similarity=0.454 Sum_probs=212.9
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc------C
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------A 178 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~------~ 178 (514)
..+|++++.||+|+||+||+|++..+++ ||+|++.+.... ..+|..+|+.++|||||+++++|.+ .
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence 3579999999999999999999887776 888877654322 2369999999999999999999954 3
Q ss_pred CeEEEEEeecCCCCHHHHH---hhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCcccc-CCCcEEEccccccc
Q 010266 179 EYLYLIMEYLPGGDVMTLL---MREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-QNGHMKLSDFGLCK 254 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l---~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld-~~g~iKL~DFGla~ 254 (514)
.++|+||||++++.+..+. .....+++..++.++.||+.||.|||++||+||||||+|||++ .+|++||+|||+|+
T Consensus 111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 3489999999875443332 2356899999999999999999999999999999999999999 79999999999998
Q ss_pred cCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-CCC
Q 010266 255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYG 333 (514)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~ 333 (514)
...... ...+.+||+.|+|||++.+. .|+
T Consensus 191 ~~~~~~--------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~ 220 (394)
T 4e7w_A 191 ILIAGE--------------------------------------------------PNVSYICSRYYRAPELIFGATNYT 220 (394)
T ss_dssp ECCTTC--------------------------------------------------CCCSSCSCGGGCCHHHHTTCSSCC
T ss_pred cccCCC--------------------------------------------------CCcccccCcCccCHHHHcCCCCCC
Confidence 653211 11256899999999999765 589
Q ss_pred cccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCc---------------ccCCc----------CcCCChhHHH
Q 010266 334 MECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNH---------------LKFPE----------EARLTPEAKD 388 (514)
Q Consensus 334 ~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~s~~~~d 388 (514)
.++|||||||++|||++|.+||.+.+..+....|+..... ..+|. ...+++++++
T Consensus 221 ~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (394)
T 4e7w_A 221 TNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAID 300 (394)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHH
Confidence 9999999999999999999999999888877777642111 11111 1247899999
Q ss_pred HHhhhcc-CccccCCCCCHhHHhcCCccccCCccccc
Q 010266 389 LICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLY 424 (514)
Q Consensus 389 LI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~l~ 424 (514)
||.+||. ||.+|+ ++.|+++||||+++.|....
T Consensus 301 li~~~L~~dP~~R~---t~~e~l~hp~f~~~~~~~~~ 334 (394)
T 4e7w_A 301 LISRLLEYTPSARL---TAIEALCHPFFDELRTGEAR 334 (394)
T ss_dssp HHHHHCCSSGGGSC---CHHHHHTSGGGSTTTSSCCC
T ss_pred HHHHHhCCChhhCC---CHHHHhcChhhhhhcccccc
Confidence 9999999 999999 99999999999999887654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=410.40 Aligned_cols=257 Identities=28% Similarity=0.484 Sum_probs=213.4
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE------
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ------ 176 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~------ 176 (514)
...++|++++.||+|+||+||+|++..+|+.||||++...... ..+|..+|+.++|||||+++++|.
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 3457899999999999999999999999999999998765321 236999999999999999999984
Q ss_pred --------------------------------cCCeEEEEEeecCCCCHHHHHh----hccCCCHHHHHHHHHHHHHHHH
Q 010266 177 --------------------------------DAEYLYLIMEYLPGGDVMTLLM----REETLTETVARFYIAQSVLAIE 220 (514)
Q Consensus 177 --------------------------------~~~~l~lVmEy~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ 220 (514)
+..++|+||||++| +|.+.+. ....+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 34459999999984 7766654 4578999999999999999999
Q ss_pred HHHhCCeEEcCCCCCCcccc-CCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchH
Q 010266 221 SIHKHNYIHRDIKPDNLLLD-QNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLE 299 (514)
Q Consensus 221 ~LH~~giiHrDLKpeNILld-~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (514)
|||++||+||||||+|||++ .+|.+||+|||+|+......
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--------------------------------------- 196 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--------------------------------------- 196 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---------------------------------------
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---------------------------------------
Confidence 99999999999999999998 68999999999998653221
Q ss_pred HHHHHhhhccccccccccCCCcCCccccccC-CCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCc-----
Q 010266 300 QLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNH----- 373 (514)
Q Consensus 300 ~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~----- 373 (514)
...+.+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+....|+.....
T Consensus 197 -----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~ 265 (383)
T 3eb0_A 197 -----------PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQ 265 (383)
T ss_dssp -----------CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred -----------CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 11256799999999999875 4899999999999999999999999999888888777642111
Q ss_pred ----------ccCCc----------CcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCc
Q 010266 374 ----------LKFPE----------EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAW 420 (514)
Q Consensus 374 ----------~~~p~----------~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w 420 (514)
..+|. ...+++++.+||.+||. ||.+|+ |+.|+++||||+.+.+
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 266 MIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI---NPYEAMAHPFFDHLRN 330 (383)
T ss_dssp HHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC---CHHHHHTSGGGHHHHH
T ss_pred HHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC---CHHHHhcCHHHHHHHh
Confidence 11221 12478999999999999 999999 9999999999987643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-49 Score=396.98 Aligned_cols=255 Identities=26% Similarity=0.448 Sum_probs=212.4
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEEEc--CCeE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQD--AEYL 181 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~--~~~l 181 (514)
.++|++++.||+|+||+||+|++..+++.||||++... ..+.+.+|..+|..+. ||||+++++++.+ ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 47899999999999999999999999999999998743 2356889999999997 9999999999998 6789
Q ss_pred EEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC-cEEEccccccccCCCCC
Q 010266 182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG-HMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g-~iKL~DFGla~~~~~~~ 260 (514)
|+||||++|++|..++. .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus 109 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999999999999884 489999999999999999999999999999999999999777 89999999997653211
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWW 339 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiW 339 (514)
.....+||+.|+|||++.+ ..++.++|||
T Consensus 186 --------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Diw 215 (330)
T 3nsz_A 186 --------------------------------------------------EYNVRVASRYFKGPELLVDYQMYDYSLDMW 215 (330)
T ss_dssp --------------------------------------------------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHH
T ss_pred --------------------------------------------------ccccccccccccChhhhcCCCcCCchhhHH
Confidence 0124579999999999987 6789999999
Q ss_pred hhhHHHHHHhhCCCCCCCC-ChhHHHHHHhhhc---------------------------------CcccCCcCcCCChh
Q 010266 340 SLGAIMYEMLVGYPPFYSD-DPVTTCRKIVHWK---------------------------------NHLKFPEEARLTPE 385 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~-~~~~~~~~i~~~~---------------------------------~~~~~p~~~~~s~~ 385 (514)
||||++|+|++|..||... +..+....+.... ..........++++
T Consensus 216 slG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (330)
T 3nsz_A 216 SLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPE 295 (330)
T ss_dssp HHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHH
T ss_pred HHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHH
Confidence 9999999999999999543 3333333222100 00011112237999
Q ss_pred HHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCcc
Q 010266 386 AKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWD 421 (514)
Q Consensus 386 ~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~ 421 (514)
+++||.+||. ||.+|+ |++|+++||||+++.|+
T Consensus 296 ~~~li~~~L~~dP~~Rp---ta~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 296 ALDFLDKLLRYDHQSRL---TAREAMEHPYFYTVVKD 329 (330)
T ss_dssp HHHHHHTTSCSSGGGSC---CHHHHHTSGGGTTCC--
T ss_pred HHHHHHHHhcCCcccCC---CHHHHhcCccHhhhccC
Confidence 9999999999 999999 99999999999999876
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=397.79 Aligned_cols=251 Identities=27% Similarity=0.415 Sum_probs=206.2
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCeEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lV 184 (514)
++|++++.||+|+||+||+|+++.+|+.||||++...... .........|...+..+ .|||||+++++|.+...+|+|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG-PKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCS-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccC-hHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 5799999999999999999999999999999998765332 23333344455555444 899999999999999999999
Q ss_pred EeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 185 MEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
|||+ +|+|..++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.+|++||+|||++.......
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~--- 211 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG--- 211 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC---
Confidence 9999 67898888664 469999999999999999999999999999999999999999999999999987653210
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhH
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 343 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 343 (514)
.....+||+.|+|||++.+ .++.++|||||||
T Consensus 212 -----------------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~ 243 (311)
T 3p1a_A 212 -----------------------------------------------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGL 243 (311)
T ss_dssp --------------------------------------------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHH
T ss_pred -----------------------------------------------CCcccCCCccccCHhHhcC-CCCchhhHHHHHH
Confidence 1124579999999999876 7999999999999
Q ss_pred HHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 344 ilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
++|||++|..||.+.+ ....+........++ ..+++++.+||.+||+ ||.+|+ +++|+++||||+.
T Consensus 244 il~el~~g~~~~~~~~---~~~~~~~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~Rp---t~~ell~hp~~~~ 310 (311)
T 3p1a_A 244 TILEVACNMELPHGGE---GWQQLRQGYLPPEFT--AGLSSELRSVLVMMLEPDPKLRA---TAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHTCCCCSSHH---HHHHHTTTCCCHHHH--TTSCHHHHHHHHHHSCSSTTTSC---CHHHHHTSGGGSC
T ss_pred HHHHHHhCCCCCCCcc---HHHHHhccCCCcccc--cCCCHHHHHHHHHHcCCChhhCc---CHHHHHhCccccC
Confidence 9999999987776543 233343322112222 3689999999999999 999999 9999999999975
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=404.13 Aligned_cols=255 Identities=26% Similarity=0.400 Sum_probs=222.8
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
+.|++++.||+|+||+||+|++..+|+.||||++...........+.+.+|..+|..++|||||+++++|.+.+.+|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45999999999999999999999999999999998765444555677899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 186 EYLPGGDVMTLLM-REETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 186 Ey~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
||+. |+|.+++. ....+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~----- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-----
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-----
Confidence 9997 57877775 4568999999999999999999999999999999999999999999999999998754311
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc---cCCCCcccchhhh
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSL 341 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiWSl 341 (514)
.+.+||+.|+|||++. +..++.++|||||
T Consensus 208 ------------------------------------------------~~~~gt~~y~aPE~~~~~~~~~~~~~~Diwsl 239 (348)
T 1u5q_A 208 ------------------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 239 (348)
T ss_dssp ------------------------------------------------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHH
T ss_pred ------------------------------------------------CcccCCcceeCHhhhccccCCCCCcHHHHHHH
Confidence 1457999999999985 5678999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCC
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIA 419 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~ 419 (514)
||++|||++|.+||.+.+.......+........ ....+++.+++||.+||. ||.+|+ +++++++||||....
T Consensus 240 G~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rp---s~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 240 GITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVLRER 313 (348)
T ss_dssp HHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--CCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHTTCHHHHSCC
T ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHcccChhhCc---CHHHHhhChhhhccC
Confidence 9999999999999999888777777765332221 223689999999999999 999999 999999999997643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=412.92 Aligned_cols=257 Identities=32% Similarity=0.503 Sum_probs=213.4
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc------CC
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------AE 179 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~------~~ 179 (514)
.+|++++.||+|+||.||+|+++.+|+.||||++.+.... ..+|+.+|+.++|||||+++++|.. ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh-------HHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 4699999999999999999999999999999999764321 2369999999999999999998843 33
Q ss_pred eEEEEEeecCCCCHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCC-CcEEEccccccc
Q 010266 180 YLYLIMEYLPGGDVMTLLM----REETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCK 254 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~-g~iKL~DFGla~ 254 (514)
++++||||+++ +|..++. ....+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||+|+
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 58899999975 6666554 35689999999999999999999999999999999999999965 678999999998
Q ss_pred cCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-CCC
Q 010266 255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYG 333 (514)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~ 333 (514)
.+.... ...+.+||+.|+|||++.+. .|+
T Consensus 206 ~~~~~~--------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~ 235 (420)
T 1j1b_A 206 QLVRGE--------------------------------------------------PNVSYICSRYYRAPELIFGATDYT 235 (420)
T ss_dssp ECCTTC--------------------------------------------------CCCSCCSCTTSCCHHHHTTCSSCC
T ss_pred hcccCC--------------------------------------------------CceeeeeCCCcCCHHHHcCCCCCC
Confidence 653210 01256899999999999764 799
Q ss_pred cccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcC---------------cccCCc----------CcCCChhHHH
Q 010266 334 MECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKN---------------HLKFPE----------EARLTPEAKD 388 (514)
Q Consensus 334 ~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~d 388 (514)
.++|||||||++|||++|.+||.+.+..+.+..|+.... .+.+|. ...+++++++
T Consensus 236 ~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 315 (420)
T 1j1b_A 236 SSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIA 315 (420)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHH
T ss_pred chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHH
Confidence 999999999999999999999999988777777654211 122221 1246899999
Q ss_pred HHhhhcc-CccccCCCCCHhHHhcCCccccCCcccc
Q 010266 389 LICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKL 423 (514)
Q Consensus 389 LI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~l 423 (514)
||.+||. ||.+|+ ++.|+++||||+++.|...
T Consensus 316 Li~~~L~~dP~~R~---t~~e~l~hp~f~~~~~~~~ 348 (420)
T 1j1b_A 316 LCSRLLEYTPTARL---TPLEACAHSFFDELRDPNV 348 (420)
T ss_dssp HHHHHSCSSGGGSC---CHHHHHTSGGGGGGGCTTC
T ss_pred HHHHhccCChhHCC---CHHHHhCCHhhcccccccc
Confidence 9999999 999999 9999999999998876543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=408.93 Aligned_cols=260 Identities=29% Similarity=0.458 Sum_probs=206.3
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC------
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA------ 178 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~------ 178 (514)
.++|++++.||+|+||.||+|.+..+|+.||||++.+.. ........+.+|..+|+.++||||++++++|...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 378999999999999999999999999999999997542 3445567788999999999999999999999754
Q ss_pred CeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
..+|+||||+ |++|..++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+|+....
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 5689999999 7899998865 6799999999999999999999999999999999999999999999999999875321
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccc
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECD 337 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~D 337 (514)
. ....+||+.|+|||++.+ ..|+.++|
T Consensus 185 ~----------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~D 212 (367)
T 2fst_X 185 E----------------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVD 212 (367)
T ss_dssp ----------------------------------------------------------CCCTTCCHHHHTTCCSCCTTHH
T ss_pred c----------------------------------------------------CCCcCcCcCccChHHHcCCcCCCchhh
Confidence 1 114689999999999987 67899999
Q ss_pred hhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcc---------------------cCCc------CcCCChhHHHHH
Q 010266 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL---------------------KFPE------EARLTPEAKDLI 390 (514)
Q Consensus 338 iWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---------------------~~p~------~~~~s~~~~dLI 390 (514)
||||||++|||++|.+||.+.+.......|....... ..|. ....++++.+||
T Consensus 213 iwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl 292 (367)
T 2fst_X 213 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 292 (367)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHH
Confidence 9999999999999999999998888777776421110 0010 124689999999
Q ss_pred hhhcc-CccccCCCCCHhHHhcCCccccCCccc
Q 010266 391 CRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDK 422 (514)
Q Consensus 391 ~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~ 422 (514)
.+||+ ||.+|+ +++|+++||||+......
T Consensus 293 ~~mL~~dP~~R~---t~~e~L~hp~~~~~~~~~ 322 (367)
T 2fst_X 293 EKMLVLDSDKRI---TAAQALAHAYFAQYHDPD 322 (367)
T ss_dssp HHHSCSSGGGSC---CHHHHHTSGGGTTTCCGG
T ss_pred HHhCCCCcccCc---CHHHHhcChhhhhccCCC
Confidence 99999 999999 999999999999765433
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=387.38 Aligned_cols=256 Identities=23% Similarity=0.411 Sum_probs=219.2
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc----CC
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD----AE 179 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~----~~ 179 (514)
....|.+.+.||+|+||.||+|.+..++..||+|++..... .....+.+.+|..+|+.++||||++++++|.+ ..
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence 34568999999999999999999999999999999986543 45567788999999999999999999999875 56
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eEEcCCCCCCcccc-CCCcEEEccccccccC
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLD-QNGHMKLSDFGLCKPL 256 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKpeNILld-~~g~iKL~DFGla~~~ 256 (514)
.+|+||||++||+|.+++...+.+++..++.++.|++.||.|||+.| |+||||||+|||++ .+|.+||+|||++...
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 79999999999999999998889999999999999999999999999 99999999999998 7899999999998643
Q ss_pred CCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCccc
Q 010266 257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336 (514)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 336 (514)
... .....+||+.|+|||++.+ .++.++
T Consensus 183 ~~~---------------------------------------------------~~~~~~~t~~y~aPE~~~~-~~~~~~ 210 (290)
T 1t4h_A 183 RAS---------------------------------------------------FAKAVIGTPEFMAPEMYEE-KYDESV 210 (290)
T ss_dssp CTT---------------------------------------------------SBEESCSSCCCCCGGGGGT-CCCTHH
T ss_pred ccc---------------------------------------------------ccccccCCcCcCCHHHHhc-cCCCcc
Confidence 211 1124579999999998864 599999
Q ss_pred chhhhhHHHHHHhhCCCCCCCCCh-hHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCc
Q 010266 337 DWWSLGAIMYEMLVGYPPFYSDDP-VTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPW 414 (514)
Q Consensus 337 DiWSlGvilyemltG~~PF~~~~~-~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpf 414 (514)
|+|||||++|+|++|..||.+... ......+........++ ...++++.+||.+||. ||.+|+ +++|+++|||
T Consensus 211 Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~h~~ 285 (290)
T 1t4h_A 211 DVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD--KVAIPEVKEIIEGCIRQNKDERY---SIKDLLNHAF 285 (290)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG--GCCCHHHHHHHHHHSCSSGGGSC---CHHHHHTSGG
T ss_pred hHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccC--CCCCHHHHHHHHHHccCChhhCC---CHHHHhhCcc
Confidence 999999999999999999987544 44444454432222333 3578999999999999 999999 9999999999
Q ss_pred ccc
Q 010266 415 FKD 417 (514)
Q Consensus 415 f~~ 417 (514)
|++
T Consensus 286 f~~ 288 (290)
T 1t4h_A 286 FQE 288 (290)
T ss_dssp GC-
T ss_pred ccc
Confidence 986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=416.76 Aligned_cols=262 Identities=19% Similarity=0.204 Sum_probs=203.6
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc--CCCceeeEEE-------EE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV--ASHCIVKLYY-------SF 175 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l--~hp~Iv~l~~-------~f 175 (514)
..+|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+++|..++..+ +||||++++. .+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 45699999999999999999999999999999999987655566777888886655555 6999888663 33
Q ss_pred EcC-----------------CeEEEEEeecCCCCHHHHHhhccCCCHHHHH-------HHHHHHHHHHHHHHhCCeEEcC
Q 010266 176 QDA-----------------EYLYLIMEYLPGGDVMTLLMREETLTETVAR-------FYIAQSVLAIESIHKHNYIHRD 231 (514)
Q Consensus 176 ~~~-----------------~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~-------~~~~qi~~aL~~LH~~giiHrD 231 (514)
... .++|+||||++ |+|.+++...+...+..++ .++.||+.||.|||++||||||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 322 45899999998 8999999874333333444 5559999999999999999999
Q ss_pred CCCCCccccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhcccc
Q 010266 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKL 311 (514)
Q Consensus 232 LKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (514)
|||+|||++.+|++||+|||+|+.....
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~---------------------------------------------------- 247 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTR---------------------------------------------------- 247 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCE----------------------------------------------------
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCC----------------------------------------------------
Confidence 9999999999999999999999854311
Q ss_pred ccccccCCCcCCcccccc--CCCCcccchhhhhHHHHHHhhCCCCCCCCChhHH--HHH---HhhhcCcccCCcCcCCCh
Q 010266 312 AYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTT--CRK---IVHWKNHLKFPEEARLTP 384 (514)
Q Consensus 312 ~~s~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~--~~~---i~~~~~~~~~p~~~~~s~ 384 (514)
.....||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+..+... +.. .......+.+|....+++
T Consensus 248 ~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (371)
T 3q60_A 248 GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPD 327 (371)
T ss_dssp EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCH
T ss_pred ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCH
Confidence 113467799999999987 7899999999999999999999999987744311 111 111123445555567899
Q ss_pred hHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCccc
Q 010266 385 EAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDK 422 (514)
Q Consensus 385 ~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~ 422 (514)
++++||.+||. ||.+|+ +++++++||||++++|..
T Consensus 328 ~~~~li~~~L~~dP~~Rp---t~~e~l~hp~f~~~~~~~ 363 (371)
T 3q60_A 328 FVKTLIGRFLNFDRRRRL---LPLEAMETPEFLQLQNEI 363 (371)
T ss_dssp HHHHHHHHHTCSSTTTCC---CHHHHTTSHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCC---CHHHHhcCHHHHHHHHHH
Confidence 99999999999 999999 999999999999988764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=387.15 Aligned_cols=259 Identities=26% Similarity=0.463 Sum_probs=222.0
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++++.||+|+||.||+|+++.+++.||+|++..... ....+.+.+|..++..++||||+++++++.+.+..|+||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 579999999999999999999999999999999976542 344567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
||++||+|.+++.....+++..+..++.|++.||.|||+.||+||||||+||+++.+|++||+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---- 160 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR---- 160 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE----
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc----
Confidence 9999999999998888899999999999999999999999999999999999999999999999999875432110
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCC-CcccchhhhhHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAI 344 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWSlGvi 344 (514)
.......+||+.|+|||++.+..+ +.++|+|||||+
T Consensus 161 -------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~i 197 (276)
T 2yex_A 161 -------------------------------------------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 197 (276)
T ss_dssp -------------------------------------------ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHH
T ss_pred -------------------------------------------hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHH
Confidence 001225679999999999988776 789999999999
Q ss_pred HHHHhhCCCCCCCCChh-HHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 345 MYEMLVGYPPFYSDDPV-TTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 345 lyemltG~~PF~~~~~~-~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
+|+|++|..||.+.+.. ..+..+... ....+....+++++.+||.+||. ||.+|+ +++||++||||++.
T Consensus 198 l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~~~~~~ 268 (276)
T 2yex_A 198 LTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYNKP 268 (276)
T ss_dssp HHHHHHSSCCCSCSCTTSHHHHHHHTT--CTTSTTGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCTTTTCC
T ss_pred HHHHHhCCCCCCCCchHHHHHHHhhhc--ccccCchhhcCHHHHHHHHHHCCCCchhCC---CHHHHhcCccccCh
Confidence 99999999999876543 233333331 22233345789999999999999 999999 99999999999764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=401.84 Aligned_cols=259 Identities=26% Similarity=0.460 Sum_probs=215.4
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCC--CceeeEEEEEEcCCe
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS--HCIVKLYYSFQDAEY 180 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~f~~~~~ 180 (514)
+..++|++++.||+|+||.||+|.+ .+++.||||++.... ......+.+.+|..+|..+.| |||+++++++.+...
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 4567899999999999999999987 568999999998654 344556778999999999976 999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
+|+||| +.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ +|.+||+|||+|+......
T Consensus 84 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 84 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 999999 56889999999999999999999999999999999999999999999999996 7899999999998654221
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-----------
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK----------- 329 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~----------- 329 (514)
.. ....+.+||+.|+|||++.+
T Consensus 162 ~~-----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 194 (343)
T 3dbq_A 162 TS-----------------------------------------------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSK 194 (343)
T ss_dssp -------------------------------------------------------CCCCSSCCHHHHHHCC---------
T ss_pred cc-----------------------------------------------ccCCCCcCCcCcCCHHHHhhccccccccccc
Confidence 00 01125689999999999975
Q ss_pred CCCCcccchhhhhHHHHHHhhCCCCCCCCC-hhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHh
Q 010266 330 KGYGMECDWWSLGAIMYEMLVGYPPFYSDD-PVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSE 407 (514)
Q Consensus 330 ~~y~~~~DiWSlGvilyemltG~~PF~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ 407 (514)
..|+.++|||||||++|||++|.+||.+.. .......++.......+|. ..++++.+||.+||. ||.+|+ ++.
T Consensus 195 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~L~~dp~~Rp---t~~ 269 (343)
T 3dbq_A 195 SKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQRI---SIP 269 (343)
T ss_dssp --CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCC--CSCHHHHHHHHHHTCSSTTTSC---CHH
T ss_pred cCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcc--cCCHHHHHHHHHHcCCChhHCC---CHH
Confidence 678999999999999999999999998743 3344555554334445554 567899999999999 999999 999
Q ss_pred HHhcCCcccc
Q 010266 408 QIKAHPWFKD 417 (514)
Q Consensus 408 eil~Hpff~~ 417 (514)
|+++||||+.
T Consensus 270 e~l~hp~~~~ 279 (343)
T 3dbq_A 270 ELLAHPYVQI 279 (343)
T ss_dssp HHHTSHHHHS
T ss_pred HHHhCccccc
Confidence 9999999974
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=402.01 Aligned_cols=265 Identities=25% Similarity=0.416 Sum_probs=210.6
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC------
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE------ 179 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~------ 179 (514)
++|++++.||+|+||.||+|+++.+|+.||||+++... .....+.+.+|..+|+.++|||||+++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 57999999999999999999999999999999998653 3445677899999999999999999999986543
Q ss_pred ---------------------------------------------------eEEEEEeecCCCCHHHHHhhccC---CCH
Q 010266 180 ---------------------------------------------------YLYLIMEYLPGGDVMTLLMREET---LTE 205 (514)
Q Consensus 180 ---------------------------------------------------~l~lVmEy~~gg~L~~~l~~~~~---l~e 205 (514)
++|+|||||+||+|.+++..... .++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 48999999999999999987543 455
Q ss_pred HHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCC
Q 010266 206 TVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285 (514)
Q Consensus 206 ~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (514)
..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+............
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~------------------- 224 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL------------------- 224 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------------------
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccc-------------------
Confidence 5688999999999999999999999999999999999999999999998765331100000
Q ss_pred CCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHH
Q 010266 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCR 365 (514)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~ 365 (514)
. ...........+||+.|+|||++.+..++.++|||||||++|||++|..|+.. ......
T Consensus 225 ~------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~ 284 (332)
T 3qd2_B 225 T------------------PMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIIT 284 (332)
T ss_dssp -------------------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHH
T ss_pred c------------------cccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHH
Confidence 0 00000112356899999999999999999999999999999999999887632 122222
Q ss_pred HHhhhcCcccCCc-CcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 366 KIVHWKNHLKFPE-EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 366 ~i~~~~~~~~~p~-~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
.+.. ..+|. ....++++++||.+||. ||.+|+ +++|+++||||+++
T Consensus 285 ~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 285 DVRN----LKFPLLFTQKYPQEHMMVQDMLSPSPTERP---EATDIIENAIFENL 332 (332)
T ss_dssp HHHT----TCCCHHHHHHCHHHHHHHHHHHCSSGGGSC---CHHHHHHSTTCCCC
T ss_pred Hhhc----cCCCcccccCChhHHHHHHHHccCCCCcCC---CHHHHhhchhhhcC
Confidence 2322 23332 12467889999999999 999999 99999999999875
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=392.76 Aligned_cols=264 Identities=24% Similarity=0.363 Sum_probs=220.3
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 181 (514)
.+..++|++++.||+|+||.||+|++..+++.||+|++...........+.+.+|..++..++||||+++++++.+.+.+
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 34457899999999999999999999999999999999876655666678899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
|+||||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 99999999999999999888999999999999999999999999999999999999999999999999999986532110
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
......+||+.|+|||++.+..++.++|||||
T Consensus 167 ------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 198 (294)
T 4eqm_A 167 ------------------------------------------------TQTNHVLGTVQYFSPEQAKGEATDECTDIYSI 198 (294)
T ss_dssp --------------------------------------------------------CCSSCCHHHHHTCCCCTTHHHHHH
T ss_pred ------------------------------------------------cccCccccCccccCHhHhcCCCCCchHhHHHH
Confidence 01124679999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCc-ccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccc
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNH-LKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFK 416 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~-~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~ 416 (514)
||++|+|++|.+||.+.+......+....... +..+....+++.+.++|.+||. ||.+|+. + .+.+.++|..
T Consensus 199 G~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~--~-~~~l~~~l~~ 272 (294)
T 4eqm_A 199 GIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYK--T-IQEMKDDLSS 272 (294)
T ss_dssp HHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCS--S-HHHHHHHHHT
T ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccc--c-HHHHHHHHHH
Confidence 99999999999999998887766555542111 1011123688999999999999 9999983 3 4444555543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=408.68 Aligned_cols=259 Identities=27% Similarity=0.458 Sum_probs=217.5
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC--CCceeeEEEEEEcCCeE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA--SHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~--hp~Iv~l~~~f~~~~~l 181 (514)
...+|++++.||+|+||+||+|.+.. ++.||||++.+... .....+.+.+|+.+|..+. |||||++++++.+.+.+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 34569999999999999999998765 89999999987643 4556678899999999996 59999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
|+||| +.+|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ +|.+||+|||+|+.+.....
T Consensus 132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 99999 56899999999988999999999999999999999999999999999999995 68999999999986542210
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-----------C
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-----------K 330 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-----------~ 330 (514)
. ....+.+||+.|+|||++.+ .
T Consensus 210 ~-----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 242 (390)
T 2zmd_A 210 S-----------------------------------------------VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKS 242 (390)
T ss_dssp ---------------------------------------------------CCSCCCGGGCCHHHHHCC-----------
T ss_pred c-----------------------------------------------ccCCCCCcCCCccChHHhhhcccccccccccc
Confidence 0 01125689999999999975 4
Q ss_pred CCCcccchhhhhHHHHHHhhCCCCCCCCC-hhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhH
Q 010266 331 GYGMECDWWSLGAIMYEMLVGYPPFYSDD-PVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQ 408 (514)
Q Consensus 331 ~y~~~~DiWSlGvilyemltG~~PF~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~e 408 (514)
.|+.++|||||||++|||++|.+||.+.. .......++.....+.+|. ..++++++||.+||. ||.+|+ ++.|
T Consensus 243 ~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rp---s~~e 317 (390)
T 2zmd_A 243 KISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQRI---SIPE 317 (390)
T ss_dssp -CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCC--CSCHHHHHHHHHHTCSSTTTSC---CHHH
T ss_pred CCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCc--cchHHHHHHHHHHcccChhhCC---CHHH
Confidence 68999999999999999999999998753 3455566665444445554 568899999999999 999999 9999
Q ss_pred HhcCCccccC
Q 010266 409 IKAHPWFKDI 418 (514)
Q Consensus 409 il~Hpff~~i 418 (514)
+++||||+..
T Consensus 318 ll~hp~~~~~ 327 (390)
T 2zmd_A 318 LLAHPYVQIQ 327 (390)
T ss_dssp HHTSHHHHSC
T ss_pred HhhCcCcccc
Confidence 9999999753
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-49 Score=390.11 Aligned_cols=261 Identities=31% Similarity=0.608 Sum_probs=230.1
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
++|++++.||+|+||.||+|+++.+++.||+|++.+... .......+.+|..+++.++||||+++++++.+...+|+||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 579999999999999999999999999999999986543 3345677889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCC---CcEEEccccccccCCCCCcc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN---GHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~---g~iKL~DFGla~~~~~~~~~ 262 (514)
||++|++|.+.+.....+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++.......
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~-- 178 (287)
T 2wei_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-- 178 (287)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS--
T ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC--
Confidence 999999999999888899999999999999999999999999999999999999764 479999999987543210
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
......||+.|+|||++.+. ++.++|+||||
T Consensus 179 ------------------------------------------------~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG 209 (287)
T 2wei_A 179 ------------------------------------------------KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAG 209 (287)
T ss_dssp ------------------------------------------------SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHH
T ss_pred ------------------------------------------------ccccccCcccccChHHhcCC-CCCchhhHhHH
Confidence 01145699999999998764 89999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCcc
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWD 421 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~ 421 (514)
|++|+|++|.+||.+.+..+....+.........|....+|+++.+||.+||. ||.+|+ +++|+++||||++.+|+
T Consensus 210 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~ell~hp~~~~~~~~ 286 (287)
T 2wei_A 210 VILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI---TATQCLEHPWIQKYSSE 286 (287)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHSHHHHHHCCC
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCc---CHHHHhcCHHHhccccC
Confidence 99999999999999998888888887654444555555789999999999999 999999 99999999999987764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=396.73 Aligned_cols=281 Identities=26% Similarity=0.420 Sum_probs=224.5
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC-----
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA----- 178 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~----- 178 (514)
..++|++.+.||+|+||.||+|+++.+|+.||||++.... .......+.+|..+|+.++||||+++++++.+.
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 4579999999999999999999999999999999996532 344556788999999999999999999987654
Q ss_pred CeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
..+|+||||+. |+|..++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 78999999996 689998865 5799999999999999999999999999999999999999999999999999987543
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccc
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECD 337 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~D 337 (514)
........ . .........+||+.|+|||++.+ ..++.++|
T Consensus 165 ~~~~~~~~-----------------------~----------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D 205 (353)
T 2b9h_A 165 SAADNSEP-----------------------T----------------GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMD 205 (353)
T ss_dssp ------------------------------------------------------CCCCCCGGGCCHHHHHSCCCCCHHHH
T ss_pred ccccccCc-----------------------c----------------ccccchhhccccccccCCeeeccCCCccchhh
Confidence 21100000 0 00001225689999999999865 67899999
Q ss_pred hhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcc----------------------cCCc------CcCCChhHHHH
Q 010266 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL----------------------KFPE------EARLTPEAKDL 389 (514)
Q Consensus 338 iWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~----------------------~~p~------~~~~s~~~~dL 389 (514)
||||||++|+|++|.+||.+.+.......+....... ..|. ...+++++++|
T Consensus 206 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 285 (353)
T 2b9h_A 206 VWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDL 285 (353)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHH
Confidence 9999999999999999999988766665554311110 0110 12578999999
Q ss_pred Hhhhcc-CccccCCCCCHhHHhcCCccccCCccccccccCCC
Q 010266 390 ICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAY 430 (514)
Q Consensus 390 I~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~l~~~~~p~ 430 (514)
|.+||. ||.+|+ +++|+++||||+.+.|........|.
T Consensus 286 i~~~L~~dP~~Rp---t~~ell~hp~~~~~~~~~~~~~~~~~ 324 (353)
T 2b9h_A 286 LQRMLVFDPAKRI---TAKEALEHPYLQTYHDPNDEPEGEPI 324 (353)
T ss_dssp HHHHSCSSGGGSC---CHHHHHTSGGGTTTCCTTSSCCCCCC
T ss_pred HHHhcCcCcccCC---CHHHHhcCccccccCCcccccccCCC
Confidence 999999 999999 99999999999998876544333333
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=401.88 Aligned_cols=267 Identities=29% Similarity=0.482 Sum_probs=224.9
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
...++|++++.||+|+||.||+|++..+|+.||+|++.... ........+.+|..+|..++||||+++++++.+...+|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence 35689999999999999999999999999999999997653 23444566789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
+||||++|++|..++...+.+++..++.++.|++.||.|||+.||+||||||+|||++.+|++||+|||+++......
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 178 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-- 178 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc--
Confidence 999999999999988888889999999999999999999999999999999999999999999999999997543210
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-CCCcccchhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSL 341 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSl 341 (514)
......+||+.|+|||++.+. .++.++|||||
T Consensus 179 -----------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~sl 211 (331)
T 4aaa_A 179 -----------------------------------------------EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAI 211 (331)
T ss_dssp ----------------------------------------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHH
T ss_pred -----------------------------------------------cccCCCcCCccccCcccccCCCCcchHHHHHHH
Confidence 011245799999999999875 78999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCc-----------------ccCCc----------CcCCChhHHHHHhhhc
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNH-----------------LKFPE----------EARLTPEAKDLICRLL 394 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~-----------------~~~p~----------~~~~s~~~~dLI~~lL 394 (514)
||++|+|++|.+||.+.+..+....+...... ...|. ...+++++.+||.+||
T Consensus 212 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 291 (331)
T 4aaa_A 212 GCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCL 291 (331)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHT
T ss_pred HHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHh
Confidence 99999999999999998887776666532111 11111 1257899999999999
Q ss_pred c-CccccCCCCCHhHHhcCCccccCCccc
Q 010266 395 C-DVEHRLGTLGSEQIKAHPWFKDIAWDK 422 (514)
Q Consensus 395 ~-dp~~Rl~~~~~~eil~Hpff~~i~w~~ 422 (514)
. ||.+|+ +++|+++||||+..+|..
T Consensus 292 ~~dP~~Rp---t~~ell~hp~f~~~~~~~ 317 (331)
T 4aaa_A 292 HIDPDKRP---FCAELLHHDFFQMDGFAE 317 (331)
T ss_dssp CSSGGGSC---CGGGGGGSHHHHGGGHHH
T ss_pred ccCcccCC---CHHHHhcCchhccCChhh
Confidence 9 999999 999999999999876654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=401.52 Aligned_cols=260 Identities=27% Similarity=0.434 Sum_probs=219.3
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC-----Ce
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA-----EY 180 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~-----~~ 180 (514)
++|++++.||+|+||.||+|++..+++.||||++.+.. .......+.+|..+|..++||||+++++++.+. ..
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 68999999999999999999999999999999997532 344557788999999999999999999999765 47
Q ss_pred EEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
+|+||||+. |+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 105 ~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 999999996 599998854 579999999999999999999999999999999999999999999999999998653211
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWW 339 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiW 339 (514)
.. .......+||+.|+|||++.+ ..++.++|||
T Consensus 183 ~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw 216 (364)
T 3qyz_A 183 DH----------------------------------------------TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 216 (364)
T ss_dssp CB----------------------------------------------CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHH
T ss_pred Cc----------------------------------------------cccccccccccCCCCCHHhcCCCCCCcchhHH
Confidence 00 001225689999999998765 5589999999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcc------------------cCCc---------CcCCChhHHHHHhh
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL------------------KFPE---------EARLTPEAKDLICR 392 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~------------------~~p~---------~~~~s~~~~dLI~~ 392 (514)
||||++|+|++|.+||.+.+..+....+....... ..|. ...+++++.+||.+
T Consensus 217 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 296 (364)
T 3qyz_A 217 SVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDK 296 (364)
T ss_dssp HHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHH
Confidence 99999999999999999998888877775321110 0110 12578999999999
Q ss_pred hcc-CccccCCCCCHhHHhcCCccccC
Q 010266 393 LLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 393 lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
||. ||.+|+ +++|+++||||+..
T Consensus 297 ~L~~dP~~R~---t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 297 MLTFNPHKRI---EVEQALAHPYLEQY 320 (364)
T ss_dssp HTCSSTTTSC---CHHHHHTSGGGTTT
T ss_pred HcCCChhhCC---CHHHHhcCcchhhc
Confidence 999 999999 99999999999876
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-49 Score=392.18 Aligned_cols=271 Identities=28% Similarity=0.457 Sum_probs=226.3
Q ss_pred HhhcCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE
Q 010266 97 RLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 176 (514)
Q Consensus 97 ~~~~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 176 (514)
...+.....++|++++.||+|+||.||+|+++.+++.||+|++.... ....+.+.+|..++..++||||+++++++.
T Consensus 10 ~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 86 (302)
T 2j7t_A 10 HVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYY 86 (302)
T ss_dssp CCBSSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccccccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeee
Confidence 33444445678999999999999999999999999999999987542 345667889999999999999999999999
Q ss_pred cCCeEEEEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 177 DAEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 177 ~~~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
+.+.+|+||||++||+|..++.. ...+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++..
T Consensus 87 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 87 HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp CC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred eCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 99999999999999999998876 46799999999999999999999999999999999999999999999999998753
Q ss_pred CCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc-----cC
Q 010266 256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----KK 330 (514)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~ 330 (514)
.... .......+||+.|+|||++. +.
T Consensus 167 ~~~~-------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~ 197 (302)
T 2j7t_A 167 NLKT-------------------------------------------------LQKRDSFIGTPYWMAPEVVMCETMKDT 197 (302)
T ss_dssp HHHH-------------------------------------------------HHC-----CCGGGCCHHHHHHHHTTST
T ss_pred cccc-------------------------------------------------ccccccccCChhhcCCeeeccccCCCC
Confidence 2100 00112467999999999984 67
Q ss_pred CCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHH
Q 010266 331 GYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQI 409 (514)
Q Consensus 331 ~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ei 409 (514)
.++.++|+|||||++|+|++|.+||.+.+.......+..... ...+....+++++.+||.+||. ||.+|+ +++++
T Consensus 198 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~l 273 (302)
T 2j7t_A 198 PYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP-PTLLTPSKWSVEFRDFLKIALDKNPETRP---SAAQL 273 (302)
T ss_dssp TTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSSGGGSCHHHHHHHHHHSCSCTTTSC---CHHHH
T ss_pred CCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCC-cccCCccccCHHHHHHHHHHcccChhhCC---CHHHH
Confidence 789999999999999999999999999888777777665322 2222234689999999999999 999999 99999
Q ss_pred hcCCccccCCcccc
Q 010266 410 KAHPWFKDIAWDKL 423 (514)
Q Consensus 410 l~Hpff~~i~w~~l 423 (514)
++||||+++.|...
T Consensus 274 l~h~~~~~~~~~~~ 287 (302)
T 2j7t_A 274 LEHPFVSSITSNKA 287 (302)
T ss_dssp TTSTTTTTCCCCHH
T ss_pred hcChHHhhhccchh
Confidence 99999999988753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=417.20 Aligned_cols=250 Identities=16% Similarity=0.214 Sum_probs=208.3
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHH---HHHHcCCCceeeEE-------E
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN---LLAEVASHCIVKLY-------Y 173 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~---iL~~l~hp~Iv~l~-------~ 173 (514)
..++|++.+.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|.. +|+.++|||||+++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 3578999999999999999999999999999999998776666667788999995 45556899999998 6
Q ss_pred EEEcCC-----------------eEEEEEeecCCCCHHHHHhhccCCCH-------HHHHHHHHHHHHHHHHHHhCCeEE
Q 010266 174 SFQDAE-----------------YLYLIMEYLPGGDVMTLLMREETLTE-------TVARFYIAQSVLAIESIHKHNYIH 229 (514)
Q Consensus 174 ~f~~~~-----------------~l~lVmEy~~gg~L~~~l~~~~~l~e-------~~~~~~~~qi~~aL~~LH~~giiH 229 (514)
++.+.+ ..|+||||+ +|+|.+++...+.+++ ..+..++.||+.||.|||++||+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 229 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 229 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 666553 389999999 6899999987766766 677779999999999999999999
Q ss_pred cCCCCCCccccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhcc
Q 010266 230 RDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRR 309 (514)
Q Consensus 230 rDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (514)
|||||+|||++.+|++||+|||+|+....
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~~~--------------------------------------------------- 258 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA--------------------------------------------------- 258 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTC---------------------------------------------------
T ss_pred CCCCHHHEEEcCCCCEEEEechhheecCC---------------------------------------------------
Confidence 99999999999999999999999975321
Q ss_pred ccccccccCCCcCCccccccC-----------CCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCc
Q 010266 310 KLAYSTVGTPDYIAPEVLLKK-----------GYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPE 378 (514)
Q Consensus 310 ~~~~s~~GT~~Y~APEvl~~~-----------~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~ 378 (514)
...+.+| +.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+.......+.. .
T Consensus 259 -~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~--------~ 328 (377)
T 3byv_A 259 -RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFR--------S 328 (377)
T ss_dssp -EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGS--------S
T ss_pred -cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhh--------h
Confidence 1125678 999999999988 899999999999999999999999987765544433332 1
Q ss_pred CcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 379 EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 379 ~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
...+++++++||.+||+ ||.+|+ ++.|+++||||+++
T Consensus 329 ~~~~~~~~~~li~~~L~~dp~~Rp---t~~e~l~hp~f~~~ 366 (377)
T 3byv_A 329 CKNIPQPVRALLEGFLRYPKEDRL---LPLQAMETPEYEQL 366 (377)
T ss_dssp CCCCCHHHHHHHHHHTCSSGGGCC---CHHHHHTSHHHHHH
T ss_pred ccCCCHHHHHHHHHHcCCCchhCC---CHHHHhhChHHHHH
Confidence 23689999999999999 999999 99999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=403.91 Aligned_cols=267 Identities=25% Similarity=0.485 Sum_probs=230.8
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhh--------------HHHHHHHHHHHHHcCCC
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ--------------VEHVRAERNLLAEVASH 166 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~--------------~~~~~~E~~iL~~l~hp 166 (514)
..+..++|++++.||+|+||.||+|++ +|+.||||++.......... .+.+.+|..++..++||
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 103 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE 103 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence 445568999999999999999999998 89999999998664432221 26788999999999999
Q ss_pred ceeeEEEEEEcCCeEEEEEeecCCCCHHHH------Hhh--ccCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCCc
Q 010266 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTL------LMR--EETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNL 237 (514)
Q Consensus 167 ~Iv~l~~~f~~~~~l~lVmEy~~gg~L~~~------l~~--~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKpeNI 237 (514)
||+++++++.+.+.+|+||||++||+|.++ +.. ...+++..++.++.|++.||.|||+ .||+||||||+||
T Consensus 104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 999999999999999999999999999998 665 5789999999999999999999999 9999999999999
Q ss_pred cccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhcccccccccc
Q 010266 238 LLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG 317 (514)
Q Consensus 238 Lld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~G 317 (514)
|++.+|++||+|||++...... .....+|
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---------------------------------------------------~~~~~~~ 212 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---------------------------------------------------KIKGSRG 212 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---------------------------------------------------EECSSCS
T ss_pred EEcCCCcEEEeccccccccccc---------------------------------------------------cccCCCC
Confidence 9999999999999998764321 0114579
Q ss_pred CCCcCCccccccC-CCCc-ccchhhhhHHHHHHhhCCCCCCCCCh-hHHHHHHhhhcCcccCCcC---------------
Q 010266 318 TPDYIAPEVLLKK-GYGM-ECDWWSLGAIMYEMLVGYPPFYSDDP-VTTCRKIVHWKNHLKFPEE--------------- 379 (514)
Q Consensus 318 T~~Y~APEvl~~~-~y~~-~~DiWSlGvilyemltG~~PF~~~~~-~~~~~~i~~~~~~~~~p~~--------------- 379 (514)
|+.|+|||++.+. .++. ++|||||||++|+|++|.+||.+.+. .+....+.. ....+|..
T Consensus 213 ~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~~~~~~~~~ 290 (348)
T 2pml_X 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT--KNIEYPLDRNHFLYPLTNKKSTC 290 (348)
T ss_dssp CGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTS--CCCCCCCSSSSSTTTTCC-----
T ss_pred CcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc--cCcCCccchhhhhcccccccccc
Confidence 9999999999887 6766 99999999999999999999998776 667777765 23344421
Q ss_pred --cCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCcccccc
Q 010266 380 --ARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLYE 425 (514)
Q Consensus 380 --~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~l~~ 425 (514)
..+++++.+||.+||+ ||.+|+ +++|+++||||++++|..+.+
T Consensus 291 ~~~~~~~~l~~li~~~L~~dP~~Rp---s~~e~l~hp~f~~~~~~~~~~ 336 (348)
T 2pml_X 291 SNNFLSNEDIDFLKLFLRKNPAERI---TSEDALKHEWLADTNIEDLRE 336 (348)
T ss_dssp ---CCCHHHHHHHHHHCCSSGGGSC---CHHHHHTSGGGTTCCHHHHHH
T ss_pred chhhcCHHHHHHHHHHccCChhhCC---CHHHHhcCccccCCCHHHHHH
Confidence 4689999999999999 999999 999999999999999988754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=409.76 Aligned_cols=254 Identities=26% Similarity=0.469 Sum_probs=215.5
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc------CCCceeeEEEEEEcC
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV------ASHCIVKLYYSFQDA 178 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l------~hp~Iv~l~~~f~~~ 178 (514)
..+|++++.||+|+||+||+|++..+++.||||++... ......+.+|..++..+ +||||++++++|...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 46799999999999999999999999999999999754 23445677888888877 577999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCc--EEEccccccc
Q 010266 179 EYLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH--MKLSDFGLCK 254 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~--iKL~DFGla~ 254 (514)
..+|+||||+. |+|.+++.... .+++..++.++.||+.||.|||+.|||||||||+||||+.+|. +||+|||+|.
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999999995 68999987653 5999999999999999999999999999999999999999988 9999999986
Q ss_pred cCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCc
Q 010266 255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM 334 (514)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~ 334 (514)
..... ..+.+||+.|+|||++.+..|+.
T Consensus 251 ~~~~~----------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~ 278 (429)
T 3kvw_A 251 YEHQR----------------------------------------------------VYTYIQSRFYRAPEVILGARYGM 278 (429)
T ss_dssp ETTCC----------------------------------------------------CCSSCSCGGGCCHHHHHTBCCCT
T ss_pred ecCCc----------------------------------------------------ccccCCCCCccChHHHhCCCCCc
Confidence 53211 12568999999999999999999
Q ss_pred ccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcc------------------cCC-------------------
Q 010266 335 ECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL------------------KFP------------------- 377 (514)
Q Consensus 335 ~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~------------------~~p------------------- 377 (514)
++|||||||++|||++|.+||.+.+..+....++...... .+|
T Consensus 279 ~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (429)
T 3kvw_A 279 PIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGR 358 (429)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEE
T ss_pred hHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccc
Confidence 9999999999999999999999998887777665421100 000
Q ss_pred ---------c---------CcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 378 ---------E---------EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 378 ---------~---------~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
. ....++++.+||.+||+ ||.+|+ |++|+++||||+..
T Consensus 359 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp---ta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 359 SRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM---TPGQALRHPWLRRR 415 (429)
T ss_dssp CTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC---CHHHHHTSTTTC--
T ss_pred cchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC---CHHHHhCChhhccC
Confidence 0 01237889999999999 999999 99999999999863
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=401.47 Aligned_cols=259 Identities=31% Similarity=0.471 Sum_probs=218.9
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeE---
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL--- 181 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l--- 181 (514)
.++|.+.+.||+|+||.||+|+++.+|+.||||++.+.. ........+.+|..+|+.++||||++++++|.+.+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 378999999999999999999999999999999997643 3445567788999999999999999999999887765
Q ss_pred ---EEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 182 ---YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 182 ---~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
|+||||+. |+|..++. ..+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred eeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 99999997 68888873 4599999999999999999999999999999999999999999999999999875431
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccc
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECD 337 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~D 337 (514)
. ....+||+.|+|||++.+ ..++.++|
T Consensus 197 ~----------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~D 224 (371)
T 4exu_A 197 E----------------------------------------------------MTGYVVTRWYRAPEVILSWMHYNQTVD 224 (371)
T ss_dssp -------------------------------------------------------CTTCCCTTSCHHHHSCCSCCCTTHH
T ss_pred C----------------------------------------------------cCCcccCccccCHHHhcCCCCCCcHHh
Confidence 1 114679999999999987 78899999
Q ss_pred hhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcc---------------------cCCc------CcCCChhHHHHH
Q 010266 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL---------------------KFPE------EARLTPEAKDLI 390 (514)
Q Consensus 338 iWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---------------------~~p~------~~~~s~~~~dLI 390 (514)
||||||++|+|++|.+||.+.+..+....+....... ..+. ...+++++++||
T Consensus 225 iwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 304 (371)
T 4exu_A 225 IWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLL 304 (371)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHH
Confidence 9999999999999999999998888777775421110 0000 124689999999
Q ss_pred hhhcc-CccccCCCCCHhHHhcCCccccCCccc
Q 010266 391 CRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDK 422 (514)
Q Consensus 391 ~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~ 422 (514)
.+||+ ||.+|+ +++|+++||||+.+.+..
T Consensus 305 ~~~L~~dP~~Rp---t~~ell~hp~f~~~~~~~ 334 (371)
T 4exu_A 305 EKMLELDVDKRL---TAAQALTHPFFEPFRDPE 334 (371)
T ss_dssp HHHSCSCTTTSC---CHHHHHTSGGGTTTCCGG
T ss_pred HHHCCCChhhcC---CHHHHhcCcccccCCCcc
Confidence 99999 999999 999999999999876543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=383.67 Aligned_cols=250 Identities=22% Similarity=0.328 Sum_probs=210.7
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCeEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lV 184 (514)
++|++++.||+|+||.||+|+++.+++.||+|++.+... .......+.+|..++..+ +||||++++++|.+.+.+|+|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 579999999999999999999999999999999986543 333456677899999988 999999999999999999999
Q ss_pred EeecCCCCHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC-----------------
Q 010266 185 MEYLPGGDVMTLLMRE----ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG----------------- 243 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g----------------- 243 (514)
|||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 9999999999999765 6799999999999999999999999999999999999998544
Q ss_pred --cEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCc
Q 010266 244 --HMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDY 321 (514)
Q Consensus 244 --~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y 321 (514)
.+||+|||++...... ...+||+.|
T Consensus 170 ~~~~kl~Dfg~~~~~~~~-----------------------------------------------------~~~~gt~~y 196 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSP-----------------------------------------------------QVEEGDSRF 196 (289)
T ss_dssp CCCEEECCCTTCEETTCS-----------------------------------------------------CCCCCCGGG
T ss_pred ceEEEEcccccccccCCc-----------------------------------------------------cccCCCccc
Confidence 7999999998764321 134699999
Q ss_pred CCccccccC-CCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-Cccc
Q 010266 322 IAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEH 399 (514)
Q Consensus 322 ~APEvl~~~-~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~ 399 (514)
+|||++.+. .++.++|||||||++|+|++|.+|+...+ ....+... ....+| ..+++++.+||.+||. ||.+
T Consensus 197 ~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~dp~~ 270 (289)
T 1x8b_A 197 LANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQG-RLPRIP--QVLSQEFTELLKVMIHPDPER 270 (289)
T ss_dssp CCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHHTT-CCCCCS--SCCCHHHHHHHHHHTCSSGGG
T ss_pred cChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHHHcC-CCCCCC--cccCHHHHHHHHHHhCCCccc
Confidence 999999876 56789999999999999999998886543 23344332 122333 3689999999999999 9999
Q ss_pred cCCCCCHhHHhcCCccccC
Q 010266 400 RLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 400 Rl~~~~~~eil~Hpff~~i 418 (514)
|+ ++.|+++||||.+.
T Consensus 271 Rp---s~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 271 RP---SAMALVKHSVLLSA 286 (289)
T ss_dssp SC---CHHHHHTCTTC---
T ss_pred CC---CHHHHhhChHhhhh
Confidence 99 99999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=397.82 Aligned_cols=261 Identities=33% Similarity=0.624 Sum_probs=215.9
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeeccccc-----ChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML-----SRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~-----~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
++|++++.||+|+||.||+|+++.+++.||||++.+.... .......+.+|..+|..++||||+++++++.+..
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5799999999999999999999999999999999765432 1223345788999999999999999999998765
Q ss_pred EEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCc---EEEccccccccCC
Q 010266 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH---MKLSDFGLCKPLD 257 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~---iKL~DFGla~~~~ 257 (514)
.|+||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 168 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence 8999999999999999988889999999999999999999999999999999999999987665 9999999987653
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc---cCCCCc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---KKGYGM 334 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~~ 334 (514)
... .....+||+.|+|||++. ...++.
T Consensus 169 ~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~ 198 (322)
T 2ycf_A 169 ETS--------------------------------------------------LMRTLCGTPTYLAPEVLVSVGTAGYNR 198 (322)
T ss_dssp CCH--------------------------------------------------HHHHHHSCCTTCCHHHHHHTTTTTCTT
T ss_pred ccc--------------------------------------------------ccccccCCcCccCchhhccCCCCCCCc
Confidence 210 011457999999999974 567899
Q ss_pred ccchhhhhHHHHHHhhCCCCCCCCChh-HHHHHHhhhcCcccCCc--CcCCChhHHHHHhhhcc-CccccCCCCCHhHHh
Q 010266 335 ECDWWSLGAIMYEMLVGYPPFYSDDPV-TTCRKIVHWKNHLKFPE--EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIK 410 (514)
Q Consensus 335 ~~DiWSlGvilyemltG~~PF~~~~~~-~~~~~i~~~~~~~~~p~--~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 410 (514)
++|||||||++|+|++|.+||.+.... .....+... ...+++ ...+++++.+||.+||. ||.+|+ ++++++
T Consensus 199 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp---s~~~~l 273 (322)
T 2ycf_A 199 AVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG--KYNFIPEVWAEVSEKALDLVKKLLVVDPKARF---TTEEAL 273 (322)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHT--CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC---CHHHHH
T ss_pred hhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhC--ccccCchhhhhcCHHHHHHHHHHcccCHhhCC---CHHHHh
Confidence 999999999999999999999876544 333344332 222221 23689999999999999 999999 999999
Q ss_pred cCCccccCCccc
Q 010266 411 AHPWFKDIAWDK 422 (514)
Q Consensus 411 ~Hpff~~i~w~~ 422 (514)
+||||++.+|..
T Consensus 274 ~h~~~~~~~~~~ 285 (322)
T 2ycf_A 274 RHPWLQDEDMKR 285 (322)
T ss_dssp TSGGGCCHHHHH
T ss_pred hCcCcCCHHHHH
Confidence 999999988754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=388.47 Aligned_cols=262 Identities=25% Similarity=0.458 Sum_probs=221.1
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccC-hhhHHHHHHHHHHHHHcCCCceeeEEEEEE--cCCeE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS-RGQVEHVRAERNLLAEVASHCIVKLYYSFQ--DAEYL 181 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~--~~~~l 181 (514)
.++|++++.||+|+||.||+|.++.+++.||+|++.+..... ......+.+|..++..++||||+++++++. +...+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999999999999999998654321 345677899999999999999999999984 55689
Q ss_pred EEEEeecCCCCHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 182 YLIMEYLPGGDVMTLLMR--EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
|+||||+++| |.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999877 7777755 467999999999999999999999999999999999999999999999999999765321
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCC--CCcccc
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG--YGMECD 337 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~--y~~~~D 337 (514)
... .......||+.|+|||++.+.. ++.++|
T Consensus 163 ~~~-----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~D 195 (305)
T 2wtk_C 163 AAD-----------------------------------------------DTCRTSQGSPAFQPPEIANGLDTFSGFKVD 195 (305)
T ss_dssp CSS-----------------------------------------------CEECCCCSCGGGCCHHHHTCCSCEESHHHH
T ss_pred ccc-----------------------------------------------cccccCCCCCCCcChhhccCcccCCcchhh
Confidence 100 0112457999999999998654 378999
Q ss_pred hhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccc
Q 010266 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFK 416 (514)
Q Consensus 338 iWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~ 416 (514)
+|||||++|+|++|..||.+.+..+....+.. ....+|. .+++++.+||.+||. ||.+|+ +++|+++||||+
T Consensus 196 i~slG~il~~l~~g~~p~~~~~~~~~~~~i~~--~~~~~~~--~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~~~~~ 268 (305)
T 2wtk_C 196 IWSAGVTLYNITTGLYPFEGDNIYKLFENIGK--GSYAIPG--DCGPPLSDLLKGMLEYEPAKRF---SIRQIRQHSWFR 268 (305)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--CCCCCCS--SSCHHHHHHHHHHTCSSTTTSC---CHHHHHHSHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc--CCCCCCC--ccCHHHHHHHHHHccCChhhCC---CHHHHhcCcccc
Confidence 99999999999999999999988888888776 3344453 689999999999999 999999 999999999998
Q ss_pred cCCcc
Q 010266 417 DIAWD 421 (514)
Q Consensus 417 ~i~w~ 421 (514)
.....
T Consensus 269 ~~~~~ 273 (305)
T 2wtk_C 269 KKHPP 273 (305)
T ss_dssp SCCCC
T ss_pred cCCCC
Confidence 76543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=386.10 Aligned_cols=260 Identities=26% Similarity=0.429 Sum_probs=204.9
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 181 (514)
.+..++|++++.||+|+||+||+|++..+|+.||+|++.... ........+..+...++.++||||+++++++.+.+..
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc-CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 466789999999999999999999999999999999997653 2233334445555567788999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC-CeEEcCCCCCCccccCCCcEEEccccccccC
Q 010266 182 YLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHrDLKpeNILld~~g~iKL~DFGla~~~ 256 (514)
|+||||++ |+|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.+|++||+|||+|+..
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99999997 487776643 56899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccc----ccCCC
Q 010266 257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL----LKKGY 332 (514)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl----~~~~y 332 (514)
.... .....+||+.|+|||++ .+..+
T Consensus 161 ~~~~--------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~ 190 (290)
T 3fme_A 161 VDDV--------------------------------------------------AKDIDAGCKPYMAPERINPELNQKGY 190 (290)
T ss_dssp -----------------------------------------------------------CCCCCCSCHHHHSCCTTC--C
T ss_pred cccc--------------------------------------------------cccccCCCccccChhhcChhhcCcCC
Confidence 3210 01134799999999996 56678
Q ss_pred CcccchhhhhHHHHHHhhCCCCCCC-CChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHh
Q 010266 333 GMECDWWSLGAIMYEMLVGYPPFYS-DDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIK 410 (514)
Q Consensus 333 ~~~~DiWSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 410 (514)
+.++|+|||||++|+|++|..||.. .........+... .....+ ...+++++.+||.+||. ||.+|+ +++|++
T Consensus 191 ~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp---t~~e~l 265 (290)
T 3fme_A 191 SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE-PSPQLP-ADKFSAEFVDFTSQCLKKNSKERP---TYPELM 265 (290)
T ss_dssp CHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS-CCCCCC-TTTSCHHHHHHHHHHTCSSGGGSC---CHHHHT
T ss_pred CcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhcc-CCCCcc-cccCCHHHHHHHHHHhhcChhhCc---CHHHHH
Confidence 9999999999999999999999986 3444444444432 222233 23689999999999999 999999 999999
Q ss_pred cCCccccC
Q 010266 411 AHPWFKDI 418 (514)
Q Consensus 411 ~Hpff~~i 418 (514)
+||||+..
T Consensus 266 ~hp~f~~~ 273 (290)
T 3fme_A 266 QHPFFTLH 273 (290)
T ss_dssp TSHHHHHH
T ss_pred hCcccccC
Confidence 99999753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-48 Score=389.68 Aligned_cols=265 Identities=28% Similarity=0.488 Sum_probs=220.2
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEc-
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQD- 177 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~- 177 (514)
......++|++++.||+|+||.||+|++..+|+.||+|++.... .....+.+|..++..+ +||||++++++|.+
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 34456789999999999999999999999999999999997543 2345688899999998 79999999999986
Q ss_pred -----CCeEEEEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccc
Q 010266 178 -----AEYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDF 250 (514)
Q Consensus 178 -----~~~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DF 250 (514)
...+|+||||++||+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeC
Confidence 56899999999999999999764 57999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc--
Q 010266 251 GLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-- 328 (514)
Q Consensus 251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-- 328 (514)
|++....... ......+||+.|+|||++.
T Consensus 174 g~~~~~~~~~-------------------------------------------------~~~~~~~~~~~y~aPE~~~~~ 204 (326)
T 2x7f_A 174 GVSAQLDRTV-------------------------------------------------GRRNTFIGTPYWMAPEVIACD 204 (326)
T ss_dssp TTTC--------------------------------------------------------------CCGGGCCHHHHC--
T ss_pred cCceecCcCc-------------------------------------------------cccccccCCccccChhhhccc
Confidence 9987543210 0012457999999999997
Q ss_pred ---cCCCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC
Q 010266 329 ---KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL 404 (514)
Q Consensus 329 ---~~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~ 404 (514)
+..++.++|||||||++|+|++|.+||.+.+.......+..... .......+++.+++||.+||. ||.+|+
T Consensus 205 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rp--- 279 (326)
T 2x7f_A 205 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA--PRLKSKKWSKKFQSFIESCLVKNHSQRP--- 279 (326)
T ss_dssp ------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--CCCSCSCSCHHHHHHHHHHCCSSGGGSC---
T ss_pred cccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc--ccCCccccCHHHHHHHHHHhccChhhCC---
Confidence 56789999999999999999999999998887777666654222 111224689999999999998 999999
Q ss_pred CHhHHhcCCccccCCccc
Q 010266 405 GSEQIKAHPWFKDIAWDK 422 (514)
Q Consensus 405 ~~~eil~Hpff~~i~w~~ 422 (514)
+++++++||||++..+..
T Consensus 280 s~~~ll~hp~~~~~~~~~ 297 (326)
T 2x7f_A 280 ATEQLMKHPFIRDQPNER 297 (326)
T ss_dssp CHHHHHTSHHHHCCTTHH
T ss_pred CHHHHhhChHHhhCcccc
Confidence 999999999999877654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=388.21 Aligned_cols=255 Identities=25% Similarity=0.366 Sum_probs=215.6
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE 179 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 179 (514)
...+..++|++.+.||+|+||+||+|++ +|+.||||++.+... .....+.+.+|..+|..++|||||+++++|.+..
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 4456778999999999999999999975 588999999976543 4556677899999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhccC---CCHHHHHHHHHHHHHHHHHHHhCC--eEEcCCCCCCccccCCCcEEEccccccc
Q 010266 180 YLYLIMEYLPGGDVMTLLMREET---LTETVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLDQNGHMKLSDFGLCK 254 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKpeNILld~~g~iKL~DFGla~ 254 (514)
.+|+||||++||+|.+++...+. +++..+..++.|++.||.|||+.| |+||||||+|||++.+|.+||+|||+|+
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 99999999999999999977543 999999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCc
Q 010266 255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM 334 (514)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~ 334 (514)
...... ....+.+||+.|+|||++.+..++.
T Consensus 188 ~~~~~~-------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ 218 (309)
T 3p86_A 188 LKASTF-------------------------------------------------LSSKSAAGTPEWMAPEVLRDEPSNE 218 (309)
T ss_dssp ---------------------------------------------------------------CCTTSCHHHHTTCCCCT
T ss_pred cccccc-------------------------------------------------cccccCCCCccccChhhhcCCCCCc
Confidence 532110 0112567999999999999999999
Q ss_pred ccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 335 ECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 335 ~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
++|||||||++|+|++|..||.+.+..+....+........+|. .+++++.+||.+||. ||.+|+ ++++|++
T Consensus 219 ~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dP~~Rp---s~~~ll~ 291 (309)
T 3p86_A 219 KSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPR--NLNPQVAAIIEGCWTNEPWKRP---SFATIMD 291 (309)
T ss_dssp THHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCT--TSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCc--cCCHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 99999999999999999999999988888777765444555554 789999999999999 999999 9999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=407.35 Aligned_cols=264 Identities=25% Similarity=0.391 Sum_probs=198.5
Q ss_pred CCeeE-EeeeeecCceEEEEEEEc--cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE--cCCe
Q 010266 106 DDFDL-LTIIGRGAFGEVRLCQEK--KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ--DAEY 180 (514)
Q Consensus 106 ~~f~~-~~~LG~G~fG~V~l~~~~--~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~--~~~~ 180 (514)
+.|++ .++||+|+||+||+|+++ .+++.||||++.+... ...+.+|+.+|+.++|||||+++++|. +...
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 34666 347999999999999976 4688999999975532 235778999999999999999999994 5789
Q ss_pred EEEEEeecCCCCHHHHHhhc---------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccc----cCCCcEEE
Q 010266 181 LYLIMEYLPGGDVMTLLMRE---------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL----DQNGHMKL 247 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~---------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILl----d~~g~iKL 247 (514)
+|+||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||| +.+|++||
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999999996 5888887532 249999999999999999999999999999999999999 77899999
Q ss_pred ccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccc
Q 010266 248 SDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL 327 (514)
Q Consensus 248 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl 327 (514)
+|||+|+........ .....+.+||+.|+|||++
T Consensus 174 ~Dfg~a~~~~~~~~~----------------------------------------------~~~~~~~~gt~~y~aPE~~ 207 (405)
T 3rgf_A 174 ADMGFARLFNSPLKP----------------------------------------------LADLDPVVVTFWYRAPELL 207 (405)
T ss_dssp CCTTCCC--------------------------------------------------------------CCCTTCCHHHH
T ss_pred EECCCceecCCCCcc----------------------------------------------cccCCCceecCcccCchhh
Confidence 999999865421100 0012256899999999999
Q ss_pred ccC-CCCcccchhhhhHHHHHHhhCCCCCCCCChh---------HHHHHHhhhcCccc---------CCc----------
Q 010266 328 LKK-GYGMECDWWSLGAIMYEMLVGYPPFYSDDPV---------TTCRKIVHWKNHLK---------FPE---------- 378 (514)
Q Consensus 328 ~~~-~y~~~~DiWSlGvilyemltG~~PF~~~~~~---------~~~~~i~~~~~~~~---------~p~---------- 378 (514)
.+. .|+.++|||||||++|||++|.+||.+.+.. +....|........ .|.
T Consensus 208 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 287 (405)
T 3rgf_A 208 LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRR 287 (405)
T ss_dssp TTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCG
T ss_pred cCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccc
Confidence 874 5899999999999999999999999876542 34444433111100 000
Q ss_pred ---------------CcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCccccc
Q 010266 379 ---------------EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLY 424 (514)
Q Consensus 379 ---------------~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~l~ 424 (514)
....++++.+||.+||+ ||.+|+ |++|+++||||.+..|....
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~---ta~e~L~hp~f~~~~~~~~~ 346 (405)
T 3rgf_A 288 NTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI---TSEQAMQDPYFLEDPLPTSD 346 (405)
T ss_dssp GGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSC---CHHHHHTSGGGTSSSCCCSS
T ss_pred cCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCC---CHHHHhcChhhccCCCCccc
Confidence 01237899999999999 999999 99999999999987776543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=391.92 Aligned_cols=272 Identities=23% Similarity=0.366 Sum_probs=205.5
Q ss_pred hcCCCCCCCeeEEeeeeecCceEEEEEEEccCCC---EEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEE
Q 010266 99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGN---IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSF 175 (514)
Q Consensus 99 ~~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~---~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 175 (514)
....+..++|++++.||+|+||.||+|+++.++. .||||++..... .....+.+.+|..+++.++||||+++++++
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 3455677899999999999999999999887765 899999976533 345567889999999999999999999999
Q ss_pred EcCCeE------EEEEeecCCCCHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC
Q 010266 176 QDAEYL------YLIMEYLPGGDVMTLLMREE------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG 243 (514)
Q Consensus 176 ~~~~~l------~lVmEy~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g 243 (514)
.+.... |+||||++||+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.+|
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC
Confidence 887665 99999999999999996543 699999999999999999999999999999999999999999
Q ss_pred cEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCC
Q 010266 244 HMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIA 323 (514)
Q Consensus 244 ~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~A 323 (514)
.+||+|||+|+........ .......||+.|+|
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y~a 207 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYY-----------------------------------------------RQGCASKLPVKWLA 207 (323)
T ss_dssp CEEECCCCC----------------------------------------------------------------CCGGGCC
T ss_pred CEEEeeccccccccccccc-----------------------------------------------cccccccCcccccC
Confidence 9999999999865322100 00113457899999
Q ss_pred ccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccC
Q 010266 324 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRL 401 (514)
Q Consensus 324 PEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl 401 (514)
||++.+..++.++|||||||++|||++ |.+||.+.+..+....+.... ....| ..+++++.+||.+||. ||.+|+
T Consensus 208 PE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rp 284 (323)
T 3qup_A 208 LESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN-RLKQP--PECMEEVYDLMYQCWSADPKQRP 284 (323)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCC--TTCCHHHHHHHHHTTCSSGGGSC
T ss_pred chhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC-CCCCC--CccCHHHHHHHHHHccCChhhCc
Confidence 999999999999999999999999999 999999998888888877532 22333 4689999999999999 999999
Q ss_pred CCCC-------HhHHhcCCccccCCccccc
Q 010266 402 GTLG-------SEQIKAHPWFKDIAWDKLY 424 (514)
Q Consensus 402 ~~~~-------~~eil~Hpff~~i~w~~l~ 424 (514)
+ +++++.|||+....++.+.
T Consensus 285 ---s~~~l~~~l~~~l~~~~~~~~~~~pl~ 311 (323)
T 3qup_A 285 ---SFTCLRMELENILGHLSVLSTSQDPLY 311 (323)
T ss_dssp ---CHHHHHHHHHHHHHC------------
T ss_pred ---CHHHHHHHHHHHHHHhhhcCCCCCCCC
Confidence 7 7889999999987766654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=386.11 Aligned_cols=263 Identities=30% Similarity=0.488 Sum_probs=222.0
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 183 (514)
..++|++++.||+|+||.||+|.++.+|+.||+|++.... ....+.+|..++..++||||+++++++.+...+|+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 3578999999999999999999999999999999997642 23568889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 184 IMEYLPGGDVMTLLM-REETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 184 VmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
||||++||+|.+++. ....+++..+..++.|++.||.|||+.||+||||||+||+++.+|++||+|||++.......
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-- 179 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-- 179 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--
Confidence 999999999999986 45689999999999999999999999999999999999999999999999999987643210
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
.......||+.|+|||++.+..++.++|+||||
T Consensus 180 -----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 212 (314)
T 3com_A 180 -----------------------------------------------AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLG 212 (314)
T ss_dssp -----------------------------------------------SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHH
T ss_pred -----------------------------------------------cccCccCCCCCccChhhcCCCCCCccccHHHHH
Confidence 001245799999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCcc
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWD 421 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~ 421 (514)
|++|+|++|..||.+.+.......+... ....++....+++++.+||.+||. ||.+|+ +++++++||||++..+.
T Consensus 213 ~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---t~~~ll~~~~~~~~~~~ 288 (314)
T 3com_A 213 ITAIEMAEGKPPYADIHPMRAIFMIPTN-PPPTFRKPELWSDNFTDFVKQCLVKSPEQRA---TATQLLQHPFVRSAKGV 288 (314)
T ss_dssp HHHHHHHHSSCTTTTSCHHHHHHHHHHS-CCCCCSSGGGSCHHHHHHHHHHTCSCTTTSC---CHHHHTTSHHHHTCCCG
T ss_pred HHHHHHHhCCCCCCCCChHHHHHHHhcC-CCcccCCcccCCHHHHHHHHHHccCChhhCc---CHHHHHhCHHHhcCCcc
Confidence 9999999999999988776665554432 222233334679999999999999 999999 99999999999988776
Q ss_pred ccc
Q 010266 422 KLY 424 (514)
Q Consensus 422 ~l~ 424 (514)
.+.
T Consensus 289 ~~~ 291 (314)
T 3com_A 289 SIL 291 (314)
T ss_dssp GGG
T ss_pred hHH
Confidence 653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=402.49 Aligned_cols=260 Identities=23% Similarity=0.378 Sum_probs=211.6
Q ss_pred hhcCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC--------CCcee
Q 010266 98 LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA--------SHCIV 169 (514)
Q Consensus 98 ~~~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~--------hp~Iv 169 (514)
.....+..++|++++.||+|+||+||+|++..+++.||||++.+. ....+.+.+|..+|..+. ||||+
T Consensus 29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv 104 (397)
T 1wak_A 29 VKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVV 104 (397)
T ss_dssp SCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBC
T ss_pred EehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceee
Confidence 333444568899999999999999999999999999999999754 344567889999999885 78899
Q ss_pred eEEEEEE----cCCeEEEEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC-CeEEcCCCCCCccccCC
Q 010266 170 KLYYSFQ----DAEYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDQN 242 (514)
Q Consensus 170 ~l~~~f~----~~~~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~-giiHrDLKpeNILld~~ 242 (514)
+++++|. +...+|+||||+ +|+|...+... ..+++..++.++.||+.||.|||++ ||+||||||+||||+.+
T Consensus 105 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~ 183 (397)
T 1wak_A 105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN 183 (397)
T ss_dssp CEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCC
T ss_pred eeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEecc
Confidence 9999998 667899999999 66777766554 5799999999999999999999998 99999999999999987
Q ss_pred C-------------------------------------------------cEEEccccccccCCCCCccccccccccccc
Q 010266 243 G-------------------------------------------------HMKLSDFGLCKPLDCTNLSAINENEVLDDE 273 (514)
Q Consensus 243 g-------------------------------------------------~iKL~DFGla~~~~~~~~~~~~~~~~~~~~ 273 (514)
| .+||+|||+|......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-------------- 249 (397)
T 1wak_A 184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-------------- 249 (397)
T ss_dssp HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--------------
T ss_pred chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--------------
Confidence 6 7999999998764311
Q ss_pred cccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhhCCC
Q 010266 274 NLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 353 (514)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemltG~~ 353 (514)
....+||+.|+|||++.+..|+.++|||||||++|||++|.+
T Consensus 250 --------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 291 (397)
T 1wak_A 250 --------------------------------------FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDY 291 (397)
T ss_dssp --------------------------------------SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred --------------------------------------CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCC
Confidence 114579999999999999999999999999999999999999
Q ss_pred CCCCCCh------hHHHHHHhhhcCccc--------------------------------------CCcCcCCChhHHHH
Q 010266 354 PFYSDDP------VTTCRKIVHWKNHLK--------------------------------------FPEEARLTPEAKDL 389 (514)
Q Consensus 354 PF~~~~~------~~~~~~i~~~~~~~~--------------------------------------~p~~~~~s~~~~dL 389 (514)
||.+.+. ......+......+. ++.....++++++|
T Consensus 292 pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 371 (397)
T 1wak_A 292 LFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDF 371 (397)
T ss_dssp SCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHH
T ss_pred CCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHH
Confidence 9986552 222333322111100 00011235678999
Q ss_pred Hhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 390 ICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 390 I~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
|.+||+ ||.+|+ +++||++||||++
T Consensus 372 i~~~L~~dP~~Rp---t~~e~l~hp~~~~ 397 (397)
T 1wak_A 372 LLPMLELIPEKRA---TAAECLRHPWLNS 397 (397)
T ss_dssp HGGGGCSSGGGSC---CHHHHHTSGGGGC
T ss_pred HHHHhccChhhcC---CHHHHhhCccccC
Confidence 999999 999999 9999999999974
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=396.13 Aligned_cols=260 Identities=30% Similarity=0.473 Sum_probs=203.0
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC-----
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE----- 179 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~----- 179 (514)
.++|++++.||+|+||+||+|+++.+|+.||||++.+..... .....+...+..++||||++++++|.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 378999999999999999999999999999999987653322 23456777888899999999999996533
Q ss_pred --eEEEEEeecCCCCHHHH----HhhccCCCHHHHHHHHHHHHHHHHHHH--hCCeEEcCCCCCCccccC-CCcEEEccc
Q 010266 180 --YLYLIMEYLPGGDVMTL----LMREETLTETVARFYIAQSVLAIESIH--KHNYIHRDIKPDNLLLDQ-NGHMKLSDF 250 (514)
Q Consensus 180 --~l~lVmEy~~gg~L~~~----l~~~~~l~e~~~~~~~~qi~~aL~~LH--~~giiHrDLKpeNILld~-~g~iKL~DF 250 (514)
++|+||||++|+ |... +.....+++..++.++.|++.||.||| +.||+||||||+|||++. +|++||+||
T Consensus 98 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Df 176 (360)
T 3e3p_A 98 DIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176 (360)
T ss_dssp CEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred ceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeC
Confidence 389999999875 4433 335678999999999999999999999 999999999999999996 899999999
Q ss_pred cccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC
Q 010266 251 GLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK 330 (514)
Q Consensus 251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~ 330 (514)
|+|+...... .....+||+.|+|||++.+.
T Consensus 177 g~a~~~~~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~ 206 (360)
T 3e3p_A 177 GSAKKLSPSE--------------------------------------------------PNVAYICSRYYRAPELIFGN 206 (360)
T ss_dssp TTCBCCCTTS--------------------------------------------------CCCSTTSCGGGCCHHHHTTC
T ss_pred CCceecCCCC--------------------------------------------------CcccccCCcceeCHHHHcCC
Confidence 9998654221 01245799999999999765
Q ss_pred C-CCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcc---------------c------------CC-cCcC
Q 010266 331 G-YGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL---------------K------------FP-EEAR 381 (514)
Q Consensus 331 ~-y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---------------~------------~p-~~~~ 381 (514)
. ++.++|||||||++|+|++|.+||.+.+.......+....... . ++ ....
T Consensus 207 ~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (360)
T 3e3p_A 207 QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLK 286 (360)
T ss_dssp SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCT
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhcc
Confidence 4 8999999999999999999999999998888877776421110 0 00 0112
Q ss_pred CChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCccc
Q 010266 382 LTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDK 422 (514)
Q Consensus 382 ~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~ 422 (514)
.++++++||.+||+ ||.+|+ ++.|+++||||+++.+..
T Consensus 287 ~~~~~~~li~~~L~~dP~~Rp---t~~e~l~hp~f~~~~~~~ 325 (360)
T 3e3p_A 287 DAKEAYDLLSALLQYLPEERM---KPYEALCHPYFDELHDPA 325 (360)
T ss_dssp THHHHHHHHHHHTCSSGGGSC---CHHHHTTSGGGGGGGCTT
T ss_pred ccHHHHHHHHHHhccCccccC---CHHHHhcCccccccCCcc
Confidence 56899999999999 999999 999999999999876543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=392.84 Aligned_cols=259 Identities=30% Similarity=0.470 Sum_probs=217.6
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe----
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY---- 180 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~---- 180 (514)
.++|.+.+.||+|+||.||+|+++.+|+.||||++.+.. ........+.+|..+|..++||||++++++|.+...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 378999999999999999999999999999999997643 344556778899999999999999999999987764
Q ss_pred --EEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 181 --LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 181 --l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
+|+||||+. |+|..++. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 499999997 68888774 3599999999999999999999999999999999999999999999999999875321
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccc
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECD 337 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~D 337 (514)
. ....+||+.|+|||++.+ ..++.++|
T Consensus 179 ~----------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~D 206 (353)
T 3coi_A 179 E----------------------------------------------------MTGYVVTRWYRAPEVILSWMHYNQTVD 206 (353)
T ss_dssp ---------------------------------------------------------CCSBCCSCHHHHSCCSCCCTTHH
T ss_pred C----------------------------------------------------ccccccCcCcCCHHHHhCcCCCCchhh
Confidence 1 114579999999999987 67899999
Q ss_pred hhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCc--------------------------ccCCc-CcCCChhHHHHH
Q 010266 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNH--------------------------LKFPE-EARLTPEAKDLI 390 (514)
Q Consensus 338 iWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~--------------------------~~~p~-~~~~s~~~~dLI 390 (514)
+|||||++|+|++|.+||.+.+..+....+...... ..++. ...+++++++||
T Consensus 207 i~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 286 (353)
T 3coi_A 207 IWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLL 286 (353)
T ss_dssp HHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHH
Confidence 999999999999999999998887777666542110 00110 125789999999
Q ss_pred hhhcc-CccccCCCCCHhHHhcCCccccCCccc
Q 010266 391 CRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDK 422 (514)
Q Consensus 391 ~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~ 422 (514)
.+||+ ||.+|+ +++|+++||||+.+.+..
T Consensus 287 ~~~L~~dp~~Rp---t~~e~l~hp~f~~~~~~~ 316 (353)
T 3coi_A 287 EKMLELDVDKRL---TAAQALTHPFFEPFRDPE 316 (353)
T ss_dssp HHHSCSCTTTSC---CHHHHHTSGGGTTTCCGG
T ss_pred HHHcCCCcccCC---CHHHHhcCcchhhccCcc
Confidence 99999 999999 999999999998765443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=394.09 Aligned_cols=256 Identities=18% Similarity=0.279 Sum_probs=211.9
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCE----EEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNI----YAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 176 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~----~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 176 (514)
..+..++|++++.||+|+||+||+|++..+++. ||+|++.... .......+.+|..++..++|||||++++++.
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (325)
T 3kex_A 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP 85 (325)
T ss_dssp CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 345678999999999999999999999888876 5666654332 1222344677999999999999999999886
Q ss_pred cCCeEEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 177 DAEYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 177 ~~~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
....|+||||++||+|.+++... +.+++..+..++.|++.||.|||+.||+||||||+|||++.+|++||+|||+|+.
T Consensus 86 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 86 -GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp -BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred -CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 46789999999999999999764 6899999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcc
Q 010266 256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME 335 (514)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~ 335 (514)
....... .......||+.|+|||++.+..++.+
T Consensus 165 ~~~~~~~-----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~ 197 (325)
T 3kex_A 165 LPPDDKQ-----------------------------------------------LLYSEAKTPIKWMALESIHFGKYTHQ 197 (325)
T ss_dssp SCCCTTC-----------------------------------------------CC-----CCTTTSCHHHHHHCCCCHH
T ss_pred cCccccc-----------------------------------------------ccccCCCCcccccChHHhccCCCChh
Confidence 5432110 01124568899999999999999999
Q ss_pred cchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 336 CDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 336 ~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
+|||||||++|+|++ |..||.+.+..+....+... .....| ..+++++.+||.+||. ||.+|+ ++.++++|
T Consensus 198 ~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~dp~~Rp---s~~el~~~ 270 (325)
T 3kex_A 198 SDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-ERLAQP--QICTIDVYMVMVKCWMIDENIRP---TFKELANE 270 (325)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT-CBCCCC--TTBCTTTTHHHHHHTCSCTTTSC---CHHHHHHH
T ss_pred hHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC-CCCCCC--CcCcHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 999999999999999 99999998877777666542 233344 3578999999999999 999999 88888765
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-48 Score=398.82 Aligned_cols=260 Identities=29% Similarity=0.428 Sum_probs=215.5
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CC-----ceeeEEEE
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SH-----CIVKLYYS 174 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp-----~Iv~l~~~ 174 (514)
.....++|++++.||+|+||+||+|+++.+++.||||++++. ......+..|..++..+. |+ +|++++++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 344468999999999999999999999999999999999754 234566778888988875 44 49999999
Q ss_pred EEcCCeEEEEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH--hCCeEEcCCCCCCcccc--CCCcEEEc
Q 010266 175 FQDAEYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIH--KHNYIHRDIKPDNLLLD--QNGHMKLS 248 (514)
Q Consensus 175 f~~~~~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH--~~giiHrDLKpeNILld--~~g~iKL~ 248 (514)
|.+.+.+|+||||++ |+|.+++... ..+++..++.++.|++.||.||| +.|||||||||+|||++ .++.+||+
T Consensus 125 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp EEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred eccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 999999999999996 5999999765 46999999999999999999999 57999999999999994 57889999
Q ss_pred cccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc
Q 010266 249 DFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL 328 (514)
Q Consensus 249 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~ 328 (514)
|||+|+..... ....+||+.|+|||++.
T Consensus 204 DFG~a~~~~~~----------------------------------------------------~~~~~~t~~y~aPE~~~ 231 (382)
T 2vx3_A 204 DFGSSCQLGQR----------------------------------------------------IYQYIQSRFYRSPEVLL 231 (382)
T ss_dssp CCTTCEETTCC----------------------------------------------------CCSSCSCGGGCCHHHHT
T ss_pred eccCceecccc----------------------------------------------------cccccCCccccChHHHc
Confidence 99999765311 12568999999999999
Q ss_pred cCCCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcc----------------cCCcC-------------
Q 010266 329 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL----------------KFPEE------------- 379 (514)
Q Consensus 329 ~~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~----------------~~p~~------------- 379 (514)
+..|+.++|||||||++|||++|.+||.+.+..+....|....... .+|..
T Consensus 232 ~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (382)
T 2vx3_A 232 GMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKRE 311 (382)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccc
Confidence 9999999999999999999999999999998888887776421110 00000
Q ss_pred ------cC-------------------------CChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCc
Q 010266 380 ------AR-------------------------LTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAW 420 (514)
Q Consensus 380 ------~~-------------------------~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w 420 (514)
.. .++++++||.+||+ ||.+|+ |++|+++||||++..|
T Consensus 312 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rp---ta~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 312 YKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRI---QPYYALQHSFFKKTAD 381 (382)
T ss_dssp SCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSC---CHHHHTTSGGGCC---
T ss_pred cCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCC---CHHHHhcCcccccCCC
Confidence 00 01378999999999 999999 9999999999987654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=388.80 Aligned_cols=260 Identities=25% Similarity=0.422 Sum_probs=217.0
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEE-ccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCC------ceeeEE
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQE-KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH------CIVKLY 172 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~-~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp------~Iv~l~ 172 (514)
...+..++|++++.||+|+||+||+|.+ +.+++.||+|+++.. ....+.+.+|..++..++|+ +|++++
T Consensus 8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred cCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 3445568999999999999999999998 568899999999754 34456788899999988655 499999
Q ss_pred EEEEcCCeEEEEEeecCCCCHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC---------
Q 010266 173 YSFQDAEYLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ--------- 241 (514)
Q Consensus 173 ~~f~~~~~l~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~--------- 241 (514)
++|.+.+.+|+||||+ +++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.
T Consensus 84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence 9999999999999999 889999997765 6899999999999999999999999999999999999987
Q ss_pred ----------CCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhcccc
Q 010266 242 ----------NGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKL 311 (514)
Q Consensus 242 ----------~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (514)
++.+||+|||+++.....
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---------------------------------------------------- 190 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEH---------------------------------------------------- 190 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSC----------------------------------------------------
T ss_pred ccccccccccCCCceEeeCcccccCccc----------------------------------------------------
Confidence 678999999998753211
Q ss_pred ccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCccc----------------
Q 010266 312 AYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLK---------------- 375 (514)
Q Consensus 312 ~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~---------------- 375 (514)
..+.+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+....+......+.
T Consensus 191 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 270 (339)
T 1z57_A 191 HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHD 270 (339)
T ss_dssp CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETT
T ss_pred cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhc
Confidence 1146799999999999999999999999999999999999999998887666554432111000
Q ss_pred ---CC---------------------cCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCC
Q 010266 376 ---FP---------------------EEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIA 419 (514)
Q Consensus 376 ---~p---------------------~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~ 419 (514)
++ .....++++.+||.+||. ||.+|+ +++|+++||||+.+.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp---t~~ell~hp~f~~~~ 336 (339)
T 1z57_A 271 RLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI---TLREALKHPFFDLLK 336 (339)
T ss_dssp EECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC---CHHHHTTSGGGGGGG
T ss_pred cccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc---CHHHHhcCHHHHHHh
Confidence 00 001235678999999999 999999 999999999998754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=389.98 Aligned_cols=273 Identities=21% Similarity=0.273 Sum_probs=219.9
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCeEE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~ 182 (514)
..++|++++.||+|+||+||+|+++.+|+.||||++..... ...+..|..++..+ +||||+++++++.+....|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 34789999999999999999999999999999999876532 12477899999999 9999999999999999999
Q ss_pred EEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCc-----EEEccccccccC
Q 010266 183 LIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH-----MKLSDFGLCKPL 256 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~-----iKL~DFGla~~~ 256 (514)
+||||+ ||+|.+++.. .+.+++..++.++.|++.||.|||+.||+||||||+|||++.+|+ +||+|||+|+..
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999999 9999999976 478999999999999999999999999999999999999999988 999999999865
Q ss_pred CCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCccc
Q 010266 257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336 (514)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 336 (514)
......... ......+.+||+.|+|||++.+..++.++
T Consensus 161 ~~~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 198 (330)
T 2izr_A 161 IDPETKKHI------------------------------------------PYREHKSLTGTARYMSINTHLGKEQSRRD 198 (330)
T ss_dssp BCTTTCCBC------------------------------------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHH
T ss_pred ecCCCCccc------------------------------------------cccccCCcCCCccccChHHHcCCCCCchh
Confidence 432110000 00012367899999999999999999999
Q ss_pred chhhhhHHHHHHhhCCCCCCCCC---hhHHHHHHhhhcCcccCCcC--cCCChhHHHHHhhhcc-CccccCCCCCHhHHh
Q 010266 337 DWWSLGAIMYEMLVGYPPFYSDD---PVTTCRKIVHWKNHLKFPEE--ARLTPEAKDLICRLLC-DVEHRLGTLGSEQIK 410 (514)
Q Consensus 337 DiWSlGvilyemltG~~PF~~~~---~~~~~~~i~~~~~~~~~p~~--~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 410 (514)
|||||||++|||++|.+||.+.+ ..+.+..+..... ..|.. ....+++.+||.+||. ||.+|+ ++++|.
T Consensus 199 Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~p~~~~li~~~l~~~p~~RP---~~~~l~ 273 (330)
T 2izr_A 199 DLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR--ATPIEVLCENFPEMATYLRYVRRLDFFEKP---DYDYLR 273 (330)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH--HSCHHHHTTTCHHHHHHHHHHHHCCTTCCC---CHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc--cCCHHHHhccChHHHHHHHHHHhCCCCCCC---CHHHHH
Confidence 99999999999999999998843 3445555544222 22211 1123499999999998 999999 777766
Q ss_pred c----------CCccccCCccccccccCCC
Q 010266 411 A----------HPWFKDIAWDKLYEMEAAY 430 (514)
Q Consensus 411 ~----------Hpff~~i~w~~l~~~~~p~ 430 (514)
+ .++...+||+. ..+.+|+
T Consensus 274 ~~l~~~~~~~~~~~~~~~dw~~-~~~~~p~ 302 (330)
T 2izr_A 274 KLFTDLFDRKGYMFDYEYDWIG-KQLPTPV 302 (330)
T ss_dssp HHHHHHHHHTTCCCSCCCTTTT-SCCCCCC
T ss_pred HHHHHHHHHcCCCCCCCccCCC-CCcCCCC
Confidence 4 34555688883 3445555
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=387.12 Aligned_cols=263 Identities=27% Similarity=0.433 Sum_probs=219.5
Q ss_pred CCCeeEEeeeeecCceEEEEEEEc-cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc---CCCceeeEEEEEE----
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEK-KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV---ASHCIVKLYYSFQ---- 176 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~-~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~---- 176 (514)
.++|++++.||+|+||.||+|++. .+|+.||+|++...... ......+.+|..++..+ .||||++++++|.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 378999999999999999999995 67899999999765422 22223455677777766 8999999999987
Q ss_pred -cCCeEEEEEeecCCCCHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccc
Q 010266 177 -DAEYLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253 (514)
Q Consensus 177 -~~~~l~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla 253 (514)
+...+|+||||+. |+|.+++.... .+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 6678999999997 69999997643 4999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCC
Q 010266 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG 333 (514)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 333 (514)
+...... .....+||+.|+|||++.+..++
T Consensus 168 ~~~~~~~--------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~ 197 (326)
T 1blx_A 168 RIYSFQM--------------------------------------------------ALTSVVVTLWYRAPEVLLQSSYA 197 (326)
T ss_dssp CCCCGGG--------------------------------------------------GGCCCCCCCTTCCHHHHTTCCCC
T ss_pred ccccCCC--------------------------------------------------CccccccccceeCHHHHhcCCCC
Confidence 7543110 11256799999999999999999
Q ss_pred cccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcC---------cccCC--------------cCcCCChhHHHHH
Q 010266 334 MECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKN---------HLKFP--------------EEARLTPEAKDLI 390 (514)
Q Consensus 334 ~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~---------~~~~p--------------~~~~~s~~~~dLI 390 (514)
.++|||||||++|+|++|.+||.+.+.......++.... ....| ....+++++++||
T Consensus 198 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 277 (326)
T 1blx_A 198 TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLL 277 (326)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHH
T ss_pred cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHH
Confidence 999999999999999999999999988888777764211 11100 0135789999999
Q ss_pred hhhcc-CccccCCCCCHhHHhcCCccccCCccc
Q 010266 391 CRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDK 422 (514)
Q Consensus 391 ~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~ 422 (514)
.+||. ||.+|+ ++.|+++||||++++|..
T Consensus 278 ~~~L~~dP~~Rp---t~~e~l~hp~~~~~~~~~ 307 (326)
T 1blx_A 278 LKCLTFNPAKRI---SAYSALSHPYFQDLERCK 307 (326)
T ss_dssp HHHSCSSTTTSC---CHHHHHTSGGGTTCCCCC
T ss_pred HHHcCCCcccCC---CHHHHhcCccccccchhh
Confidence 99999 999999 999999999999987653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=388.17 Aligned_cols=273 Identities=25% Similarity=0.441 Sum_probs=200.6
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
..+..++|++++.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|..++..++||||++++++|.+.+.
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 45677999999999999999999999988999999999875432 2345667889999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhh--------ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccc
Q 010266 181 LYLIMEYLPGGDVMTLLMR--------EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~--------~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGl 252 (514)
.|+||||++||+|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999999864 45699999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CC
Q 010266 253 CKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KG 331 (514)
Q Consensus 253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~ 331 (514)
+.......... ........+||+.|+|||++.+ ..
T Consensus 168 ~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~ 203 (303)
T 2vwi_A 168 SAFLATGGDIT--------------------------------------------RNKVRKTFVGTPCWMAPEVMEQVRG 203 (303)
T ss_dssp HHHCC-----------------------------------------------------------CCCTTCCHHHHHHHHC
T ss_pred hheeccCCCcc--------------------------------------------chhhhcccCCCccccCHHHhccccC
Confidence 87654221000 0011225689999999999976 56
Q ss_pred CCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCC-------cCcCCChhHHHHHhhhcc-CccccCCC
Q 010266 332 YGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFP-------EEARLTPEAKDLICRLLC-DVEHRLGT 403 (514)
Q Consensus 332 y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p-------~~~~~s~~~~dLI~~lL~-dp~~Rl~~ 403 (514)
++.++|+|||||++|+|++|..||.+.+............. ...+ ....+++++++||.+||. ||.+|+
T Consensus 204 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-- 280 (303)
T 2vwi_A 204 YDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP-PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP-- 280 (303)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC-CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSC--
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC-CccccccccchhhhhhhHHHHHHHHHHccCChhhCc--
Confidence 89999999999999999999999998877666655543211 1111 113578999999999999 999999
Q ss_pred CCHhHHhcCCccccCCcccc
Q 010266 404 LGSEQIKAHPWFKDIAWDKL 423 (514)
Q Consensus 404 ~~~~eil~Hpff~~i~w~~l 423 (514)
+++++++||||+...+..+
T Consensus 281 -s~~~ll~h~~~~~~~~~~~ 299 (303)
T 2vwi_A 281 -TAAELLRHKFFQKAKNKEF 299 (303)
T ss_dssp -CHHHHHTSTTC--------
T ss_pred -CHHHHhhChhhhcCCCCcc
Confidence 9999999999998776544
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=395.23 Aligned_cols=256 Identities=23% Similarity=0.349 Sum_probs=219.3
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEc-------cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEK-------KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYY 173 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~-------~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 173 (514)
.+..++|++.+.||+|+||.||+|++. .++..||||++++.. .....+.+.+|..+|..+ +|||||++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 456689999999999999999999875 345679999997652 445667899999999999 8999999999
Q ss_pred EEEcCCeEEEEEeecCCCCHHHHHhhcc----------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCc
Q 010266 174 SFQDAEYLYLIMEYLPGGDVMTLLMREE----------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNL 237 (514)
Q Consensus 174 ~f~~~~~l~lVmEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNI 237 (514)
+|.+.+.+|+||||++||+|.+++.... .++...+..++.||+.||.|||++||+||||||+||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 9999999999999999999999997643 478899999999999999999999999999999999
Q ss_pred cccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhcccccccccc
Q 010266 238 LLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG 317 (514)
Q Consensus 238 Lld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~G 317 (514)
|++.+|++||+|||+|+........ .......|
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~-----------------------------------------------~~~~~~~~ 267 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYY-----------------------------------------------KKTTNGRL 267 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTT-----------------------------------------------CTTTTTTS
T ss_pred EECCCCCEEEccccCCcccCcccce-----------------------------------------------ecccCCCc
Confidence 9999999999999999865422100 01124468
Q ss_pred CCCcCCccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-
Q 010266 318 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC- 395 (514)
Q Consensus 318 T~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~- 395 (514)
|+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..+....+... .....| ..+++++.+||.+||.
T Consensus 268 t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~ 344 (370)
T 2psq_A 268 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG-HRMDKP--ANCTNELYMMMRDCWHA 344 (370)
T ss_dssp CGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-CCCCCC--TTSCHHHHHHHHHHTCS
T ss_pred ccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-CCCCCC--CCCCHHHHHHHHHHcCC
Confidence 899999999999999999999999999999999 99999998888877776653 223334 3689999999999999
Q ss_pred CccccCCCCCHhHHhcC
Q 010266 396 DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 396 dp~~Rl~~~~~~eil~H 412 (514)
||.+|+ ++.|++++
T Consensus 345 dP~~Rp---t~~ell~~ 358 (370)
T 2psq_A 345 VPSQRP---TFKQLVED 358 (370)
T ss_dssp SGGGSC---CHHHHHHH
T ss_pred ChhhCc---CHHHHHHH
Confidence 999999 99998863
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=390.42 Aligned_cols=263 Identities=23% Similarity=0.398 Sum_probs=218.1
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCC-CEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCc------eeeEEE
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSG-NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC------IVKLYY 173 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~-~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~------Iv~l~~ 173 (514)
.....++|++++.||+|+||+||+|.+..++ +.||+|++++. ....+.+.+|..+|..+.|++ ++.+++
T Consensus 14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 89 (355)
T 2eu9_A 14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSD 89 (355)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEE
T ss_pred CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeee
Confidence 3445689999999999999999999998777 68999999753 234566788999999887655 999999
Q ss_pred EEEcCCeEEEEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccc------------
Q 010266 174 SFQDAEYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL------------ 239 (514)
Q Consensus 174 ~f~~~~~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILl------------ 239 (514)
+|.....+|+||||+ +|+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 90 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 90 WFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred eeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc
Confidence 999999999999999 66777777654 379999999999999999999999999999999999999
Q ss_pred -------cCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccc
Q 010266 240 -------DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLA 312 (514)
Q Consensus 240 -------d~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (514)
+.++.+||+|||+++..... .
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~----------------------------------------------------~ 196 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH----------------------------------------------------H 196 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC----------------------------------------------------C
T ss_pred ccccccccCCCcEEEeecCcccccccc----------------------------------------------------c
Confidence 67899999999998753211 1
Q ss_pred cccccCCCcCCccccccCCCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCccc-----------------
Q 010266 313 YSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLK----------------- 375 (514)
Q Consensus 313 ~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~----------------- 375 (514)
.+.+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+....+......+.
T Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 276 (355)
T 2eu9_A 197 TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGG 276 (355)
T ss_dssp CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTE
T ss_pred cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccc
Confidence 145799999999999999999999999999999999999999998877666555433111100
Q ss_pred --C---------------------CcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCcccc
Q 010266 376 --F---------------------PEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKL 423 (514)
Q Consensus 376 --~---------------------p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~l 423 (514)
+ ......++++.+||.+||. ||.+|+ +++|+++||||++++|+..
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp---t~~e~l~hp~f~~~~~~~~ 345 (355)
T 2eu9_A 277 LVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI---TLAEALLHPFFAGLTPEER 345 (355)
T ss_dssp ECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC---CHHHHTTSGGGGGCCHHHH
T ss_pred cccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc---CHHHHhcChhhcCCChhhc
Confidence 0 0011124578999999999 999999 9999999999999988754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=385.93 Aligned_cols=264 Identities=25% Similarity=0.400 Sum_probs=214.7
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE--------
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ-------- 176 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~-------- 176 (514)
.++|++++.||+|+||.||+|.++.+++.||+|++... .....+.+.+|..+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 47899999999999999999999999999999998754 3456678899999999999999999998874
Q ss_pred ------cCCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCcccc-CCCcEEEcc
Q 010266 177 ------DAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-QNGHMKLSD 249 (514)
Q Consensus 177 ------~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld-~~g~iKL~D 249 (514)
+...+|+||||++ |+|.+++. .+.+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 4578999999997 69999885 46799999999999999999999999999999999999997 567999999
Q ss_pred ccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc
Q 010266 250 FGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK 329 (514)
Q Consensus 250 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~ 329 (514)
||+++........ ........||+.|+|||++.+
T Consensus 165 fg~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~ 198 (320)
T 2i6l_A 165 FGLARIMDPHYSH----------------------------------------------KGHLSEGLVTKWYRSPRLLLS 198 (320)
T ss_dssp CTTCBCC------------------------------------------------------CCCGGGSCCTTCCHHHHHC
T ss_pred CccccccCCCccc----------------------------------------------ccccccccccccccCcHHhcC
Confidence 9999865321000 001124578999999999876
Q ss_pred -CCCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcc--------------------cCCc------CcCC
Q 010266 330 -KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL--------------------KFPE------EARL 382 (514)
Q Consensus 330 -~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~--------------------~~p~------~~~~ 382 (514)
..++.++|+|||||++|||++|.+||.+.+..+....+....... ..|. ...+
T Consensus 199 ~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (320)
T 2i6l_A 199 PNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGI 278 (320)
T ss_dssp TTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTC
T ss_pred cccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchh
Confidence 678999999999999999999999999998887777765421100 0010 1257
Q ss_pred ChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCccc
Q 010266 383 TPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDK 422 (514)
Q Consensus 383 s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~ 422 (514)
++++++||.+||. ||.+|+ +++|+++||||+.++|..
T Consensus 279 ~~~~~~li~~~L~~dP~~Rp---t~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 279 SREAVDFLEQILTFSPMDRL---TAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp CHHHHHHHHTTSCSSGGGSC---CHHHHHTSHHHHTTCC--
T ss_pred hHHHHHHHHHHcCCCccccC---CHHHHhCCcccccccCcc
Confidence 9999999999999 999999 999999999999988764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=379.91 Aligned_cols=255 Identities=29% Similarity=0.481 Sum_probs=223.9
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
+.|++++.||+|+||.||+|++..+++.||+|++..... ....+.+.+|..++..++||||++++++|.+...+|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 569999999999999999999999999999999986542 345677899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
||++||+|.+++.. +.+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++........
T Consensus 100 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~---- 174 (303)
T 3a7i_A 100 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI---- 174 (303)
T ss_dssp ECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC----
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc----
Confidence 99999999999854 6799999999999999999999999999999999999999999999999999876532110
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 345 (514)
.....+||+.|+|||++.+..++.++|+|||||++
T Consensus 175 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 209 (303)
T 3a7i_A 175 ---------------------------------------------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITA 209 (303)
T ss_dssp ---------------------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred ---------------------------------------------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHH
Confidence 01246799999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 346 yemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
|+|++|.+||...+.......+... ....++ ..+++++.+||.+||. ||.+|+ ++++|++||||...
T Consensus 210 ~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 210 IELARGEPPHSELHPMKVLFLIPKN-NPPTLE--GNYSKPLKEFVEACLNKEPSFRP---TAKELLKHKFILRN 277 (303)
T ss_dssp HHHHHSSCTTTTSCHHHHHHHHHHS-CCCCCC--SSCCHHHHHHHHHHCCSSGGGSC---CHHHHTTCHHHHHH
T ss_pred HHHccCCCCCCCcCHHHHHHHhhcC-CCCCCc--cccCHHHHHHHHHHcCCChhhCc---CHHHHhhChhhhcC
Confidence 9999999999988877766666542 222233 3689999999999999 999999 99999999999653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=387.77 Aligned_cols=257 Identities=27% Similarity=0.406 Sum_probs=212.8
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC--e
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE--Y 180 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~--~ 180 (514)
+..++|++.+.||+|+||+||+|+++.+++.||||++.+... ....+.+.+|..+|..++||||+++++++.+.. .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 445789999999999999999999999999999999986543 233566789999999999999999999998665 8
Q ss_pred EEEEEeecCCCCHHHHHhhccC---CCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccc----cCCCcEEEcccccc
Q 010266 181 LYLIMEYLPGGDVMTLLMREET---LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL----DQNGHMKLSDFGLC 253 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILl----d~~g~iKL~DFGla 253 (514)
+|+||||++||+|.+++..... +++..++.++.|++.||.|||+.||+||||||+|||+ +.++.+||+|||+|
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 8999999999999999976543 9999999999999999999999999999999999999 88889999999999
Q ss_pred ccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc-----
Q 010266 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL----- 328 (514)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~----- 328 (514)
+...... ...+.+||+.|+|||++.
T Consensus 164 ~~~~~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~ 193 (319)
T 4euu_A 164 RELEDDE--------------------------------------------------QFVSLYGTEEYLHPDMYERAVLR 193 (319)
T ss_dssp EECCTTC--------------------------------------------------CBCCCCSCGGGCCHHHHHHHTSC
T ss_pred eecCCCC--------------------------------------------------ceeecccCCCccCHHHhhhcccc
Confidence 8654221 112567999999999987
Q ss_pred ---cCCCCcccchhhhhHHHHHHhhCCCCCCCCC----hhHHHHHHhhhcCcc-----------------cCCcC----c
Q 010266 329 ---KKGYGMECDWWSLGAIMYEMLVGYPPFYSDD----PVTTCRKIVHWKNHL-----------------KFPEE----A 380 (514)
Q Consensus 329 ---~~~y~~~~DiWSlGvilyemltG~~PF~~~~----~~~~~~~i~~~~~~~-----------------~~p~~----~ 380 (514)
+..++.++|||||||++|||++|.+||...+ ..+...+++...... .+|.. .
T Consensus 194 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (319)
T 4euu_A 194 KDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSR 273 (319)
T ss_dssp CCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCH
T ss_pred ccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccch
Confidence 5778999999999999999999999997533 234444554321100 11211 1
Q ss_pred CCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCc
Q 010266 381 RLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPW 414 (514)
Q Consensus 381 ~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpf 414 (514)
.+++.+.+||.+||. ||.+|+ +++|+++||=
T Consensus 274 ~~~~~l~~ll~~~L~~dP~~R~---s~~ell~h~~ 305 (319)
T 4euu_A 274 GLQVLLTPVLANILEADQEKCW---GFDQFFAETS 305 (319)
T ss_dssp HHHHHHHHHHHHHSCCCTTTSC---CHHHHHHHHH
T ss_pred hHHHHhHHHHHHhccCChhhhc---cHHHhhhccH
Confidence 345688999999999 999999 9999999874
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-48 Score=394.09 Aligned_cols=258 Identities=22% Similarity=0.335 Sum_probs=218.4
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEE-----EccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEE
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQ-----EKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYS 174 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~-----~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 174 (514)
..+..++|++++.||+|+||.||+|+ +..+++.||||++++.. .....+.+.+|..+|..+ +|||||+++++
T Consensus 17 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 94 (359)
T 3vhe_A 17 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 94 (359)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence 45677899999999999999999998 45677899999997652 345567789999999999 78999999999
Q ss_pred EEcCC-eEEEEEeecCCCCHHHHHhhccC---------------------------------------------------
Q 010266 175 FQDAE-YLYLIMEYLPGGDVMTLLMREET--------------------------------------------------- 202 (514)
Q Consensus 175 f~~~~-~l~lVmEy~~gg~L~~~l~~~~~--------------------------------------------------- 202 (514)
+.+.+ .+|+||||++||+|.+++.....
T Consensus 95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 98755 49999999999999999976543
Q ss_pred ---------------CCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccccc
Q 010266 203 ---------------LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINEN 267 (514)
Q Consensus 203 ---------------l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~ 267 (514)
+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+........
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~----- 249 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----- 249 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC-----
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc-----
Confidence 899999999999999999999999999999999999999999999999999865322100
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHH
Q 010266 268 EVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 347 (514)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilye 347 (514)
.......||+.|+|||++.+..|+.++|||||||++||
T Consensus 250 ------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~e 287 (359)
T 3vhe_A 250 ------------------------------------------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 287 (359)
T ss_dssp ------------------------------------------EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred ------------------------------------------hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHH
Confidence 01124679999999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 348 MLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 348 mlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
|++ |.+||.+.+..+.....+........| ..+++++.+||.+||. ||.+|+ +++||++|
T Consensus 288 llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rp---s~~ell~~ 349 (359)
T 3vhe_A 288 IFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRP---TFSELVEH 349 (359)
T ss_dssp HTTTSCCSSTTCCCSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHhcCCCCCCccchhHHHHHHHHcCCCCCCC--CCCCHHHHHHHHHHccCChhhCC---CHHHHHHH
Confidence 998 999999877665555555433444444 3689999999999999 999999 99999875
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=378.67 Aligned_cols=258 Identities=32% Similarity=0.562 Sum_probs=222.4
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE--cCCeE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ--DAEYL 181 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~--~~~~l 181 (514)
..++|++++.||+|+||.||+|+++.+++.||+|++..... .....+.+.+|..+++.++||||+++++++. +...+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 35789999999999999999999999999999999987543 4456678899999999999999999999884 46789
Q ss_pred EEEEeecCCCCHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhCC-----eEEcCCCCCCccccCCCcEEEccccc
Q 010266 182 YLIMEYLPGGDVMTLLMREE----TLTETVARFYIAQSVLAIESIHKHN-----YIHRDIKPDNLLLDQNGHMKLSDFGL 252 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~~LH~~g-----iiHrDLKpeNILld~~g~iKL~DFGl 252 (514)
|+||||++||+|.+++.... .+++..+..++.|++.||.|||+.| |+||||||+|||++.+|++||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 99999999999999997643 4999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCC
Q 010266 253 CKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY 332 (514)
Q Consensus 253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y 332 (514)
++...... ......+||+.|+|||++.+..+
T Consensus 163 ~~~~~~~~-------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~ 193 (279)
T 2w5a_A 163 ARILNHDT-------------------------------------------------SFAKTFVGTPYYMSPEQMNRMSY 193 (279)
T ss_dssp HHHC---C-------------------------------------------------HHHHHHHSCCTTCCHHHHHCC-C
T ss_pred heeecccc-------------------------------------------------ccccccCCCccccChHHhccCCC
Confidence 87643210 00114579999999999999999
Q ss_pred CcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 333 GMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 333 ~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
+.++|+|||||++|+|++|.+||.+.+..+....+.... ...+|. .+++++.+||.+||. ||.+|+ +++||++
T Consensus 194 ~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~--~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~ 267 (279)
T 2w5a_A 194 NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-FRRIPY--RYSDELNEIITRMLNLKDYHRP---SVEEILE 267 (279)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCCT--TSCHHHHHHHHHHTCSSGGGSC---CHHHHHT
T ss_pred CchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc-cccCCc--ccCHHHHHHHHHHcCCCcccCC---CHHHHHh
Confidence 999999999999999999999999988887777776532 223343 689999999999999 999999 9999999
Q ss_pred CCcccc
Q 010266 412 HPWFKD 417 (514)
Q Consensus 412 Hpff~~ 417 (514)
|||+.+
T Consensus 268 ~~~~~~ 273 (279)
T 2w5a_A 268 NPLILE 273 (279)
T ss_dssp STTCCG
T ss_pred Chhhhh
Confidence 999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=401.10 Aligned_cols=266 Identities=20% Similarity=0.287 Sum_probs=223.9
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEE-----EccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEE
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQ-----EKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSF 175 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~-----~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 175 (514)
..+..++|++++.||+|+||+||+|+ +..+++.||||+++.. ........+.+|..+|..++|||||+++++|
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 143 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVS 143 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 35667899999999999999999999 4457789999999643 2445556788899999999999999999999
Q ss_pred EcCCeEEEEEeecCCCCHHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC---cE
Q 010266 176 QDAEYLYLIMEYLPGGDVMTLLMREE-------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG---HM 245 (514)
Q Consensus 176 ~~~~~l~lVmEy~~gg~L~~~l~~~~-------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g---~i 245 (514)
.+....|+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999999997653 589999999999999999999999999999999999999665 49
Q ss_pred EEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcc
Q 010266 246 KLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPE 325 (514)
Q Consensus 246 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APE 325 (514)
||+|||+|+....... .......+||+.|+|||
T Consensus 224 kL~DFG~a~~~~~~~~-----------------------------------------------~~~~~~~~~t~~y~aPE 256 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGY-----------------------------------------------YRKGGCAMLPVKWMPPE 256 (367)
T ss_dssp EECCCHHHHHHHHHSS-----------------------------------------------CTTCCGGGSCGGGCCHH
T ss_pred EECCCccccccccccc-----------------------------------------------cccCCCcCCcccEECHH
Confidence 9999999975321100 00112567999999999
Q ss_pred ccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCC
Q 010266 326 VLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT 403 (514)
Q Consensus 326 vl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~ 403 (514)
++.+..|+.++|||||||++|||++ |.+||.+.+..+....+.... ....| ..+++++.+||.+||. ||.+|+
T Consensus 257 ~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~~l~~dP~~Rp-- 331 (367)
T 3l9p_A 257 AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-RMDPP--KNCPGPVYRIMTQCWQHQPEDRP-- 331 (367)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC--
T ss_pred HhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCC--ccCCHHHHHHHHHHcCCCHhHCc--
Confidence 9999999999999999999999998 999999999888888777532 22233 4689999999999999 999999
Q ss_pred CCHhHHhcCCccccCCcc
Q 010266 404 LGSEQIKAHPWFKDIAWD 421 (514)
Q Consensus 404 ~~~~eil~Hpff~~i~w~ 421 (514)
++++|++|.++-.-+.+
T Consensus 332 -s~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 332 -NFAIILERIEYCTQDPD 348 (367)
T ss_dssp -CHHHHHHHHHHHHHCHH
T ss_pred -CHHHHHHHHHHHhhChh
Confidence 99999999888654433
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=385.53 Aligned_cols=257 Identities=22% Similarity=0.320 Sum_probs=219.8
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCC---EEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGN---IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 177 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~---~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 177 (514)
..+..++|++.+.||+|+||.||+|+++.+++ .||||+++... .....+.+.+|..+|..++||||++++++|.+
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 45677899999999999999999999986655 49999997542 44556778999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccC
Q 010266 178 AEYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256 (514)
Q Consensus 178 ~~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~ 256 (514)
.+.+|+||||++||+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999999999654 68999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCccc
Q 010266 257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336 (514)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 336 (514)
....... .......||+.|+|||++.+..++.++
T Consensus 202 ~~~~~~~----------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~ 235 (325)
T 3kul_A 202 EDDPDAA----------------------------------------------YTTTGGKIPIRWTAPEAIAFRTFSSAS 235 (325)
T ss_dssp C----CC----------------------------------------------EECC---CCGGGSCHHHHHHCEECHHH
T ss_pred ccCccce----------------------------------------------eeccCCCCcccccCHhHhcCCCCCcHH
Confidence 4321000 011134578899999999999999999
Q ss_pred chhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 337 DWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 337 DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|||||||++|||++ |..||.+.+..+....+... ...|....+++++.+||.+||. ||.+|+ ++.+|++
T Consensus 236 Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~eil~ 306 (325)
T 3kul_A 236 DVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG---YRLPAPMGCPHALHQLMLDCWHKDRAQRP---RFSQIVS 306 (325)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC---CCCCCCCCcCHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 99999999999999 99999999888888777653 2333344789999999999999 999999 8999876
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=392.05 Aligned_cols=259 Identities=25% Similarity=0.401 Sum_probs=210.2
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeeccccc--------ChhhHHHHHHHHHHHHHcCCCceeeEEEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML--------SRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 176 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~--------~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 176 (514)
.++|++++.||+|+||.||+|.+.. |+.||||++.+.... .....+.+.+|..+|..++||||++++++|.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 4789999999999999999998754 899999999654321 2223477899999999999999999999984
Q ss_pred -----cCCeEEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccc
Q 010266 177 -----DAEYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDF 250 (514)
Q Consensus 177 -----~~~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DF 250 (514)
....+|+||||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+||
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence 3457999999997 5888877654 47999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-
Q 010266 251 GLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK- 329 (514)
Q Consensus 251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~- 329 (514)
|+|+...... .....+||+.|+|||++.+
T Consensus 179 g~~~~~~~~~--------------------------------------------------~~~~~~~t~~y~aPE~~~~~ 208 (362)
T 3pg1_A 179 NLAREDTADA--------------------------------------------------NKTHYVTHRWYRAPELVMQF 208 (362)
T ss_dssp TC-----------------------------------------------------------------CGGGCCHHHHTTC
T ss_pred Cccccccccc--------------------------------------------------ccceecccceecCcHHhcCC
Confidence 9987432110 1124579999999999987
Q ss_pred CCCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCccc----------------------CCc------CcC
Q 010266 330 KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLK----------------------FPE------EAR 381 (514)
Q Consensus 330 ~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~----------------------~p~------~~~ 381 (514)
..++.++|+|||||++|+|++|.+||.+.+..+....+........ .|. ...
T Consensus 209 ~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (362)
T 3pg1_A 209 KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT 288 (362)
T ss_dssp TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTT
T ss_pred CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCC
Confidence 6789999999999999999999999999988877777754221110 110 124
Q ss_pred CChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 382 LTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 382 ~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
.++.+.+||.+||. ||.+|+ +++|+++||||+.+
T Consensus 289 ~~~~~~~li~~~L~~dP~~Rp---t~~ell~hp~f~~~ 323 (362)
T 3pg1_A 289 ADPVALDLIAKMLEFNPQRRI---STEQALRHPYFESL 323 (362)
T ss_dssp SCHHHHHHHHHHTCSSGGGSC---CHHHHHTSGGGTTT
T ss_pred CCHHHHHHHHHHhcCChhhCC---CHHHHHcCchhhhc
Confidence 68899999999999 999999 99999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=388.62 Aligned_cols=253 Identities=34% Similarity=0.557 Sum_probs=186.1
Q ss_pred CCCCeeEEe-eeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc----C
Q 010266 104 SVDDFDLLT-IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD----A 178 (514)
Q Consensus 104 ~~~~f~~~~-~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~----~ 178 (514)
..++|.+++ +||+|+||+||+|+++.+|+.||||++.+.. . ........+..+.||||++++++|.+ .
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----K---ARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 457899976 6999999999999999999999999997532 1 12223334567799999999999976 5
Q ss_pred CeEEEEEeecCCCCHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC---CCcEEEcccccc
Q 010266 179 EYLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ---NGHMKLSDFGLC 253 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~---~g~iKL~DFGla 253 (514)
..+|+||||++||+|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 66999999999999999998754 6999999999999999999999999999999999999986 456999999998
Q ss_pred ccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCC
Q 010266 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG 333 (514)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 333 (514)
+..... .....+||+.|+|||++.+..++
T Consensus 179 ~~~~~~---------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~ 207 (336)
T 3fhr_A 179 KETTQN---------------------------------------------------ALQTPCYTPYYVAPEVLGPEKYD 207 (336)
T ss_dssp EEC-------------------------------------------------------------------------CHHH
T ss_pred eecccc---------------------------------------------------ccccCCCCcCccChhhhCCCCCC
Confidence 754311 01245799999999999999999
Q ss_pred cccchhhhhHHHHHHhhCCCCCCCCChhHHH----HHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhH
Q 010266 334 MECDWWSLGAIMYEMLVGYPPFYSDDPVTTC----RKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQ 408 (514)
Q Consensus 334 ~~~DiWSlGvilyemltG~~PF~~~~~~~~~----~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~e 408 (514)
.++|||||||++|+|++|.+||.+.+..... ..+......+..|....+++++++||.+||. ||.+|+ +++|
T Consensus 208 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~e 284 (336)
T 3fhr_A 208 KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERL---TITQ 284 (336)
T ss_dssp HHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSC---CHHH
T ss_pred chhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCc---CHHH
Confidence 9999999999999999999999876654432 2222222223333445789999999999999 999999 9999
Q ss_pred HhcCCcccc
Q 010266 409 IKAHPWFKD 417 (514)
Q Consensus 409 il~Hpff~~ 417 (514)
+++||||++
T Consensus 285 ll~hp~~~~ 293 (336)
T 3fhr_A 285 FMNHPWINQ 293 (336)
T ss_dssp HHHSHHHHT
T ss_pred HhcCccccc
Confidence 999999976
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=379.48 Aligned_cols=259 Identities=22% Similarity=0.310 Sum_probs=222.0
Q ss_pred hcCCCCCCCeeEEeeeeecCceEEEEEEEc-----cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEE
Q 010266 99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYY 173 (514)
Q Consensus 99 ~~~~~~~~~f~~~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~ 173 (514)
....+..++|.+.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|..+|..++||||+++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 93 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYG 93 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence 345667789999999999999999999983 456899999997542 4556778899999999999999999999
Q ss_pred EEEcCCeEEEEEeecCCCCHHHHHhhccC------------------------CCHHHHHHHHHHHHHHHHHHHhCCeEE
Q 010266 174 SFQDAEYLYLIMEYLPGGDVMTLLMREET------------------------LTETVARFYIAQSVLAIESIHKHNYIH 229 (514)
Q Consensus 174 ~f~~~~~l~lVmEy~~gg~L~~~l~~~~~------------------------l~e~~~~~~~~qi~~aL~~LH~~giiH 229 (514)
++.+.+.+|+||||++||+|.+++..... +++..+..++.|++.||.|||++||+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 173 (314)
T 2ivs_A 94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH 173 (314)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 99999999999999999999999976543 899999999999999999999999999
Q ss_pred cCCCCCCccccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhcc
Q 010266 230 RDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRR 309 (514)
Q Consensus 230 rDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (514)
|||||+|||++.+|++||+|||+++........
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~----------------------------------------------- 206 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSY----------------------------------------------- 206 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCE-----------------------------------------------
T ss_pred cccchheEEEcCCCCEEEccccccccccccccc-----------------------------------------------
Confidence 999999999999999999999999865422100
Q ss_pred ccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHH
Q 010266 310 KLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKD 388 (514)
Q Consensus 310 ~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~d 388 (514)
.......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+.......+.... ....| ..+++++.+
T Consensus 207 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~ 283 (314)
T 2ivs_A 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGH-RMERP--DNCSEEMYR 283 (314)
T ss_dssp ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CCCCC--TTCCHHHHH
T ss_pred eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCC-cCCCC--ccCCHHHHH
Confidence 01114468899999999999999999999999999999999 999999988887777765432 23333 368999999
Q ss_pred HHhhhcc-CccccCCCCCHhHHhcC
Q 010266 389 LICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 389 LI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
||.+||. ||.+|+ ++++|++|
T Consensus 284 li~~~l~~dp~~Rp---s~~~l~~~ 305 (314)
T 2ivs_A 284 LMLQCWKQEPDKRP---VFADISKD 305 (314)
T ss_dssp HHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHccCChhhCc---CHHHHHHH
Confidence 9999999 999999 99999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=371.61 Aligned_cols=253 Identities=20% Similarity=0.285 Sum_probs=218.6
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
..+..++|++++.||+|+||.||+|++. +++.||+|++.+... ..+.+.+|..++..++||||+++++++.+...
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence 3566789999999999999999999986 567899999986532 23568899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
+|+||||++||+|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.+|++||+|||+++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 9999999999999999965 456899999999999999999999999999999999999999999999999999754321
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
. ........||+.|+|||++.+..++.++|+|
T Consensus 160 ~------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 191 (269)
T 4hcu_A 160 Q------------------------------------------------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 191 (269)
T ss_dssp H------------------------------------------------HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHH
T ss_pred c------------------------------------------------cccccCcccccccCCHHHhcCCCCCchhhhH
Confidence 0 0011245688999999999999999999999
Q ss_pred hhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 340 SLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 340 SlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
||||++|+|++ |.+||.+.+..+....+.... ....| ..+++++.+||.+||. ||.+|+ ++.++++|
T Consensus 192 slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~ll~~ 260 (269)
T 4hcu_A 192 SFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-RLYKP--RLASTHVYQIMNHCWRERPEDRP---AFSRLLRQ 260 (269)
T ss_dssp HHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc-cCCCC--CcCCHHHHHHHHHHccCCcccCc---CHHHHHHH
Confidence 99999999999 999999998888888876531 22223 4679999999999999 999999 99999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=384.70 Aligned_cols=260 Identities=21% Similarity=0.322 Sum_probs=217.8
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEc-----cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEE
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYY 173 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 173 (514)
...+..++|++.+.||+|+||.||+|++. .++..||+|++.+.. .....+.+.+|..+|..+ +||||+++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 34567789999999999999999999973 356789999997543 233456788999999999 8999999999
Q ss_pred EEEcCCeEEEEEeecCCCCHHHHHhhcc-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEc
Q 010266 174 SFQDAEYLYLIMEYLPGGDVMTLLMREE-----------------------TLTETVARFYIAQSVLAIESIHKHNYIHR 230 (514)
Q Consensus 174 ~f~~~~~l~lVmEy~~gg~L~~~l~~~~-----------------------~l~e~~~~~~~~qi~~aL~~LH~~giiHr 230 (514)
++.+.+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||+.||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 9999999999999999999999997643 37899999999999999999999999999
Q ss_pred CCCCCCccccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccc
Q 010266 231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRK 310 (514)
Q Consensus 231 DLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (514)
||||+|||++.+|++||+|||++......... .
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-----------------------------------------------~ 229 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNY-----------------------------------------------V 229 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTS-----------------------------------------------E
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccc-----------------------------------------------e
Confidence 99999999999999999999999865322100 0
Q ss_pred cccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHH
Q 010266 311 LAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDL 389 (514)
Q Consensus 311 ~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dL 389 (514)
......||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+.......++........| ..+++++.+|
T Consensus 230 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l 307 (344)
T 1rjb_A 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQP--FYATEEIYII 307 (344)
T ss_dssp EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCC--TTCCHHHHHH
T ss_pred eccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCC--CCCCHHHHHH
Confidence 1124578999999999999999999999999999999998 999999887766666666533333333 4689999999
Q ss_pred Hhhhcc-CccccCCCCCHhHHhcCC
Q 010266 390 ICRLLC-DVEHRLGTLGSEQIKAHP 413 (514)
Q Consensus 390 I~~lL~-dp~~Rl~~~~~~eil~Hp 413 (514)
|.+||. ||.+|+ ++.+|++|.
T Consensus 308 i~~~l~~dp~~Rp---s~~~l~~~l 329 (344)
T 1rjb_A 308 MQSCWAFDSRKRP---SFPNLTSFL 329 (344)
T ss_dssp HHHHTCSSGGGSC---CHHHHHHHH
T ss_pred HHHHcCCCchhCc---CHHHHHHHH
Confidence 999999 999999 999998853
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=380.76 Aligned_cols=266 Identities=20% Similarity=0.342 Sum_probs=215.8
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
+..++|.+.+.||+|+||+||+|.++.+++.||+|++.+. .....+.+.+|..+|..++||||+++++++.+...+|
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 4568999999999999999999999999999999998653 4556678899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 183 LIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
+||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+++.......
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999999999987 57899999999999999999999999999999999999999999999999999987543211
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
..... ............+.+||+.|+|||++.+..++.++|||||
T Consensus 164 ~~~~~-----------------------------------~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 208 (310)
T 3s95_A 164 QPEGL-----------------------------------RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSF 208 (310)
T ss_dssp ---------------------------------------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred ccccc-----------------------------------ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHH
Confidence 10000 0000001122336789999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHH-----HHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTT-----CRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~-----~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
||++|||++|..||........ ...... ...| ..+++++.+||.+||. ||.+|+ +++++++ |+
T Consensus 209 G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~----~~~~--~~~~~~l~~li~~~l~~dP~~Rp---s~~~l~~--~L 277 (310)
T 3s95_A 209 GIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD----RYCP--PNCPPSFFPITVRCCDLDPEKRP---SFVKLEH--WL 277 (310)
T ss_dssp HHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH----HTCC--TTCCTTHHHHHHHHTCSSGGGSC---CHHHHHH--HH
T ss_pred HHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc----ccCC--CCCCHHHHHHHHHHccCChhhCc---CHHHHHH--HH
Confidence 9999999999999976433211 111111 1123 3678999999999999 999999 9999986 55
Q ss_pred cc
Q 010266 416 KD 417 (514)
Q Consensus 416 ~~ 417 (514)
+.
T Consensus 278 ~~ 279 (310)
T 3s95_A 278 ET 279 (310)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=387.84 Aligned_cols=254 Identities=26% Similarity=0.436 Sum_probs=207.9
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-----------CCceeeE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-----------SHCIVKL 171 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-----------hp~Iv~l 171 (514)
+..++|++++.||+|+||+||+|+++.+++.||||++.+. ......+.+|..++..+. ||||+++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 4568999999999999999999999999999999999754 234456788999998876 8999999
Q ss_pred EEEEEcCC----eEEEEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC-CeEEcCCCCCCcccc----
Q 010266 172 YYSFQDAE----YLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLD---- 240 (514)
Q Consensus 172 ~~~f~~~~----~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~-giiHrDLKpeNILld---- 240 (514)
+++|.+.. .+++||||+ |++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence 99998654 899999999 89999999763 5699999999999999999999998 999999999999995
Q ss_pred --CCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccC
Q 010266 241 --QNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGT 318 (514)
Q Consensus 241 --~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT 318 (514)
..+.+||+|||+|+..... ....+||
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~----------------------------------------------------~~~~~~t 198 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH----------------------------------------------------YTNSIQT 198 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC----------------------------------------------------CCSCCSC
T ss_pred CcCcceEEEcccccccccCCC----------------------------------------------------CCCCCCC
Confidence 4458999999998764321 1145799
Q ss_pred CCcCCccccccCCCCcccchhhhhHHHHHHhhCCCCCCCCCh------hHHHHHHhhhcC--------------------
Q 010266 319 PDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDP------VTTCRKIVHWKN-------------------- 372 (514)
Q Consensus 319 ~~Y~APEvl~~~~y~~~~DiWSlGvilyemltG~~PF~~~~~------~~~~~~i~~~~~-------------------- 372 (514)
+.|+|||++.+..++.++|||||||++|||++|.+||.+.+. ......+.....
T Consensus 199 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 278 (373)
T 1q8y_A 199 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSR 278 (373)
T ss_dssp GGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC-
T ss_pred ccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCc
Confidence 999999999999999999999999999999999999986542 222233322111
Q ss_pred --------------------cccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 373 --------------------HLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 373 --------------------~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
...+| ..+++++.+||.+||+ ||.+|+ +++||++||||++.
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rp---t~~ell~hp~f~~~ 340 (373)
T 1q8y_A 279 GLLRNISKLKFWPLEDVLTEKYKFS--KDEAKEISDFLSPMLQLDPRKRA---DAGGLVNHPWLKDT 340 (373)
T ss_dssp -CBSSCCCCCBCCHHHHHHHTTCCC--HHHHHHHHHHHGGGGCSSTTTCB---CHHHHHTCGGGTTC
T ss_pred chhcccccccccchhhhhhhcccCC--cchHHHHHHHHHHHhccCccccC---CHHHHhhChhhhcc
Confidence 01111 2356789999999999 999999 99999999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=367.65 Aligned_cols=252 Identities=22% Similarity=0.318 Sum_probs=217.2
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 181 (514)
.+..++|++++.||+|+||.||+|+++ ++..||+|++..... ..+.+.+|..++..++||||+++++++.+...+
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 456789999999999999999999775 566799999976532 235588999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 182 YLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
|+||||++||+|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999999999999997754 59999999999999999999999999999999999999999999999999998654221
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 340 (514)
. .......||+.|+|||++.+..++.++|+||
T Consensus 159 ~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 190 (268)
T 3sxs_A 159 Y------------------------------------------------VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWA 190 (268)
T ss_dssp E------------------------------------------------EECCSCCCCGGGCCHHHHHHSEEETTHHHHH
T ss_pred h------------------------------------------------hcccCCCcCcccCCHHHHhccCCchhhhhHH
Confidence 0 0111446788999999999999999999999
Q ss_pred hhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 341 LGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 341 lGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
|||++|+|++ |.+||.+.+.......+.... ....| ...++++.+||.+||. ||.+|+ ++.++++|
T Consensus 191 lG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~~ 258 (268)
T 3sxs_A 191 FGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH-RLYRP--HLASDTIYQIMYSCWHELPEKRP---TFQQLLSS 258 (268)
T ss_dssp HHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-CCCCC--TTSCHHHHHHHHHTTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHHHcCCCCCccccChHHHHHHHHcCC-CCCCC--CcChHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 9999999999 999999988888777776532 22223 3678999999999999 999999 99999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=371.23 Aligned_cols=259 Identities=19% Similarity=0.213 Sum_probs=212.3
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCe
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~ 180 (514)
.+..++|++++.||+|+||.||+|++..+|+.||+|++..... ...+.+|..++..+ +||+|+++++++.+...
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 80 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence 4556889999999999999999999999999999999875432 23477899999999 79999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCc-----EEEccccccc
Q 010266 181 LYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH-----MKLSDFGLCK 254 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~-----iKL~DFGla~ 254 (514)
.|+||||+ ||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|. +||+|||+|+
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99999999 99999999865 46999999999999999999999999999999999999988776 9999999998
Q ss_pred cCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCc
Q 010266 255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM 334 (514)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~ 334 (514)
........... ........+||+.|+|||++.+..++.
T Consensus 160 ~~~~~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ 197 (298)
T 1csn_A 160 FYRDPVTKQHI------------------------------------------PYREKKNLSGTARYMSINTHLGREQSR 197 (298)
T ss_dssp ESBCTTTCCBC------------------------------------------CCCCCCCCCSCTTTCCHHHHTTCCCCH
T ss_pred ccccccccccc------------------------------------------cccCccCCCCCcccCCchhhcCCCCCh
Confidence 65432110000 000123568999999999999999999
Q ss_pred ccchhhhhHHHHHHhhCCCCCCCCC---hhHHHHHHhhhcCcccCCc-CcCCChhHHHHHhhhcc-CccccCCCCCHhHH
Q 010266 335 ECDWWSLGAIMYEMLVGYPPFYSDD---PVTTCRKIVHWKNHLKFPE-EARLTPEAKDLICRLLC-DVEHRLGTLGSEQI 409 (514)
Q Consensus 335 ~~DiWSlGvilyemltG~~PF~~~~---~~~~~~~i~~~~~~~~~p~-~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ei 409 (514)
++|||||||++|||++|..||.+.+ ..+.+..+.........+. ...+++++.+||.+||. ||.+|+ ++++|
T Consensus 198 ~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP---~~~~l 274 (298)
T 1csn_A 198 RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATP---DYDYL 274 (298)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCC---CHHHH
T ss_pred HHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCC---CHHHH
Confidence 9999999999999999999998743 3444444443221111111 12678999999999998 999999 88877
Q ss_pred hc
Q 010266 410 KA 411 (514)
Q Consensus 410 l~ 411 (514)
++
T Consensus 275 ~~ 276 (298)
T 1csn_A 275 QG 276 (298)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=381.23 Aligned_cols=270 Identities=17% Similarity=0.265 Sum_probs=228.4
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEc-----cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEE
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYS 174 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 174 (514)
...+..++|++.+.||+|+||.||+|.++ .+++.||+|++.+.. .......+.+|..+|+.++||||++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 34566688999999999999999999877 467889999997543 34455678899999999999999999999
Q ss_pred EEcCCeEEEEEeecCCCCHHHHHhhc----------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCc
Q 010266 175 FQDAEYLYLIMEYLPGGDVMTLLMRE----------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH 244 (514)
Q Consensus 175 f~~~~~l~lVmEy~~gg~L~~~l~~~----------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~ 244 (514)
+.+.+..|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|+
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe
Confidence 99999999999999999999998753 35689999999999999999999999999999999999999999
Q ss_pred EEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCc
Q 010266 245 MKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAP 324 (514)
Q Consensus 245 iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~AP 324 (514)
+||+|||+++....... ........||+.|+||
T Consensus 177 ~kl~Dfg~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~y~aP 209 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDY-----------------------------------------------YRKGGKGLLPVRWMSP 209 (322)
T ss_dssp EEECCTTCCCGGGGGGC-----------------------------------------------EEGGGSSEECGGGCCH
T ss_pred EEECcCccccccccccc-----------------------------------------------cccccCCCCCCCccCh
Confidence 99999999875432100 0011245789999999
Q ss_pred cccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCC
Q 010266 325 EVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLG 402 (514)
Q Consensus 325 Evl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~ 402 (514)
|++.+..++.++|||||||++|+|++ |.+||.+.+..+....+.... ....| ..+++++.+||.+||. ||.+|+
T Consensus 210 E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rp- 285 (322)
T 1p4o_A 210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-LLDKP--DNCPDMLFELMRMCWQYNPKMRP- 285 (322)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC-
T ss_pred hhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHcCCCcccCc-
Confidence 99999999999999999999999999 899999988888777776532 22233 4689999999999999 999999
Q ss_pred CCCHhHHhcC------CccccCCccccc
Q 010266 403 TLGSEQIKAH------PWFKDIAWDKLY 424 (514)
Q Consensus 403 ~~~~~eil~H------pff~~i~w~~l~ 424 (514)
++.|+++| |+|+.++|....
T Consensus 286 --s~~e~l~~L~~~~~~~~~~~~~~~~~ 311 (322)
T 1p4o_A 286 --SFLEIISSIKEEMEPGFREVSFYYSE 311 (322)
T ss_dssp --CHHHHHHHHGGGSCTTHHHHCSTTST
T ss_pred --CHHHHHHHHHHhhccCCccccccccc
Confidence 99999876 888877766544
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=373.46 Aligned_cols=259 Identities=29% Similarity=0.479 Sum_probs=213.1
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
...++|.....||+|+||.||+|++..+++.||+|++.... ....+.+.+|..++..++||||++++++|.+.+.+|
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 95 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK 95 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEE
Confidence 34455666669999999999999999999999999997653 334567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC-CCcEEEccccccccCCC
Q 010266 183 LIMEYLPGGDVMTLLMRE---ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ-NGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~-~g~iKL~DFGla~~~~~ 258 (514)
+||||++||+|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++. +|.+||+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 999999999999999764 25678899999999999999999999999999999999997 89999999999876532
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCC--CCccc
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG--YGMEC 336 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~--y~~~~ 336 (514)
... ......||+.|+|||++.+.. ++.++
T Consensus 176 ~~~-------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 206 (295)
T 2clq_A 176 INP-------------------------------------------------CTETFTGTLQYMAPEIIDKGPRGYGKAA 206 (295)
T ss_dssp ------------------------------------------------------CCCCCCGGGCCHHHHHHGGGGCSHHH
T ss_pred CCC-------------------------------------------------cccccCCCccccChhhhcCCCCCCCcHH
Confidence 100 012457999999999997654 89999
Q ss_pred chhhhhHHHHHHhhCCCCCCCCChh-HHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCc
Q 010266 337 DWWSLGAIMYEMLVGYPPFYSDDPV-TTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPW 414 (514)
Q Consensus 337 DiWSlGvilyemltG~~PF~~~~~~-~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpf 414 (514)
|+|||||++|+|++|..||...+.. ..............+|. .+++++.+||.+||. ||.+|+ ++++++.|||
T Consensus 207 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~~~~ 281 (295)
T 2clq_A 207 DIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPE--SMSAEAKAFILKCFEPDPDKRA---CANDLLVDEF 281 (295)
T ss_dssp HHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCT--TSCHHHHHHHHHTTCSSTTTSC---CHHHHHTSGG
T ss_pred HHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccc--cCCHHHHHHHHHHccCChhhCC---CHHHHhcChh
Confidence 9999999999999999999764332 22222222222333443 689999999999999 999999 9999999999
Q ss_pred cccC
Q 010266 415 FKDI 418 (514)
Q Consensus 415 f~~i 418 (514)
|+..
T Consensus 282 ~~~~ 285 (295)
T 2clq_A 282 LKVS 285 (295)
T ss_dssp GCC-
T ss_pred hhhc
Confidence 9864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=382.93 Aligned_cols=260 Identities=29% Similarity=0.474 Sum_probs=219.2
Q ss_pred hcCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChh---hHHHHHHHHHHHHHcC--CCceeeEEE
Q 010266 99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRG---QVEHVRAERNLLAEVA--SHCIVKLYY 173 (514)
Q Consensus 99 ~~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~---~~~~~~~E~~iL~~l~--hp~Iv~l~~ 173 (514)
.......++|++++.||+|+||.||+|+++.+++.||||++.+....... ....+..|..++..+. ||+|+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 34455678999999999999999999999999999999999876543211 1234667999999996 599999999
Q ss_pred EEEcCCeEEEEEeecCC-CCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCcccc-CCCcEEEcccc
Q 010266 174 SFQDAEYLYLIMEYLPG-GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-QNGHMKLSDFG 251 (514)
Q Consensus 174 ~f~~~~~l~lVmEy~~g-g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld-~~g~iKL~DFG 251 (514)
+|.+.+..|+|||++.+ ++|.+++...+.+++..++.++.|++.||.|||+.||+||||||+|||++ .+|.+||+|||
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 99999999999999976 89999999889999999999999999999999999999999999999999 78999999999
Q ss_pred ccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCC
Q 010266 252 LCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331 (514)
Q Consensus 252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~ 331 (514)
+++..... .....+||+.|+|||++.+..
T Consensus 196 ~~~~~~~~---------------------------------------------------~~~~~~gt~~y~aPE~~~~~~ 224 (320)
T 3a99_A 196 SGALLKDT---------------------------------------------------VYTDFDGTRVYSPPEWIRYHR 224 (320)
T ss_dssp TCEECCSS---------------------------------------------------CBCCCCSCGGGSCHHHHHHSC
T ss_pred cccccccc---------------------------------------------------cccCCCCCccCCChHHhccCC
Confidence 98765321 011457999999999998777
Q ss_pred C-CcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHH
Q 010266 332 Y-GMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQI 409 (514)
Q Consensus 332 y-~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ei 409 (514)
+ +.++|||||||++|||++|..||...+ .+.. ....++. .+++++.+||.+||. ||.+|+ ++++|
T Consensus 225 ~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~--~~~~~~~--~~~~~~~~li~~~l~~dp~~Rp---s~~~l 291 (320)
T 3a99_A 225 YHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR--GQVFFRQ--RVSSECQHLIRWCLALRPSDRP---TFEEI 291 (320)
T ss_dssp BCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH--CCCCCSS--CCCHHHHHHHHHHTCSSGGGSC---CHHHH
T ss_pred CCCccchHHhHHHHHHHHHHCCCCCCChh------hhhc--ccccccc--cCCHHHHHHHHHHccCChhhCc---CHHHH
Confidence 6 788999999999999999999997532 2222 2233443 689999999999999 999999 99999
Q ss_pred hcCCccccCCccc
Q 010266 410 KAHPWFKDIAWDK 422 (514)
Q Consensus 410 l~Hpff~~i~w~~ 422 (514)
++||||+++.+..
T Consensus 292 l~hp~~~~~~~~~ 304 (320)
T 3a99_A 292 QNHPWMQDVLLPQ 304 (320)
T ss_dssp HTSGGGSSCCCHH
T ss_pred hcCHhhcCccCcc
Confidence 9999999876543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=386.27 Aligned_cols=258 Identities=22% Similarity=0.337 Sum_probs=221.8
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccC-------CCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeE
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKS-------GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKL 171 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t-------~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l 171 (514)
...+..++|.+.+.||+|+||.||+|++..+ +..||+|+++.. ........+.+|..++..+ +|||||++
T Consensus 63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~ 140 (382)
T 3tt0_A 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINL 140 (382)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence 3456678999999999999999999997543 357999999765 2455667889999999999 89999999
Q ss_pred EEEEEcCCeEEEEEeecCCCCHHHHHhhcc----------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCC
Q 010266 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREE----------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPD 235 (514)
Q Consensus 172 ~~~f~~~~~l~lVmEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpe 235 (514)
+++|.+.+.+|+||||++||+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+
T Consensus 141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 220 (382)
T 3tt0_A 141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 220 (382)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence 999999999999999999999999997653 4999999999999999999999999999999999
Q ss_pred CccccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhcccccccc
Q 010266 236 NLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYST 315 (514)
Q Consensus 236 NILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 315 (514)
|||++.+|.+||+|||+|+........ ......
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~-----------------------------------------------~~~~~~ 253 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYY-----------------------------------------------KKTTNG 253 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTT-----------------------------------------------CCCTTC
T ss_pred eEEEcCCCcEEEcccCccccccccccc-----------------------------------------------ccccCC
Confidence 999999999999999999865422100 011245
Q ss_pred ccCCCcCCccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhc
Q 010266 316 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLL 394 (514)
Q Consensus 316 ~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL 394 (514)
.||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.... ....| ..+++++.+||.+||
T Consensus 254 ~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l 330 (382)
T 3tt0_A 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH-RMDKP--SNCTNELYMMMRDCW 330 (382)
T ss_dssp CCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCCC--SSCCHHHHHHHHHHT
T ss_pred CCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCC--ccCCHHHHHHHHHHc
Confidence 68999999999999999999999999999999999 999999988888777776532 23333 478999999999999
Q ss_pred c-CccccCCCCCHhHHhcC
Q 010266 395 C-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 395 ~-dp~~Rl~~~~~~eil~H 412 (514)
. ||.+|+ +++||++|
T Consensus 331 ~~dP~~Rp---s~~ell~~ 346 (382)
T 3tt0_A 331 HAVPSQRP---TFKQLVED 346 (382)
T ss_dssp CSSGGGSC---CHHHHHHH
T ss_pred CCChhhCc---CHHHHHHH
Confidence 9 999999 99999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=374.01 Aligned_cols=271 Identities=27% Similarity=0.473 Sum_probs=209.9
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc--------
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-------- 177 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~-------- 177 (514)
++|++++.||+|+||.||+|++..+++.||||++... ....+.+.+|..++..++||||++++++|.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 5799999999999999999999999999999999653 3456778899999999999999999998865
Q ss_pred -----CCeEEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccc
Q 010266 178 -----AEYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFG 251 (514)
Q Consensus 178 -----~~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFG 251 (514)
...+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 46789999999999999999754 467889999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-
Q 010266 252 LCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK- 330 (514)
Q Consensus 252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~- 330 (514)
++............. ....+ .......+.+||+.|+|||++.+.
T Consensus 162 ~~~~~~~~~~~~~~~---------------~~~~~--------------------~~~~~~~~~~~~~~y~aPE~~~~~~ 206 (303)
T 1zy4_A 162 LAKNVHRSLDILKLD---------------SQNLP--------------------GSSDNLTSAIGTAMYVATEVLDGTG 206 (303)
T ss_dssp CCSCTTC------------------------------------------------------------CTTSCHHHHTSCS
T ss_pred chhhcccccchhccc---------------ccccc--------------------ccccccccCCCcccccCcccccCCC
Confidence 998654221000000 00000 000112356899999999999865
Q ss_pred CCCcccchhhhhHHHHHHhhCCCCCCC-CChhHHHHHHhhhcCcccCCc--CcCCChhHHHHHhhhcc-CccccCCCCCH
Q 010266 331 GYGMECDWWSLGAIMYEMLVGYPPFYS-DDPVTTCRKIVHWKNHLKFPE--EARLTPEAKDLICRLLC-DVEHRLGTLGS 406 (514)
Q Consensus 331 ~y~~~~DiWSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~ 406 (514)
.++.++|+|||||++|+|++ ||.. .+.......+.. ....+|. ....++.+++||.+||. ||.+|+ ++
T Consensus 207 ~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~ 278 (303)
T 1zy4_A 207 HYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRS--VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP---GA 278 (303)
T ss_dssp CCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHS--TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSC---CH
T ss_pred CCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccc--cccccCccccccchHHHHHHHHHHHhcCcccCc---CH
Confidence 68999999999999999998 5543 233344444443 2233333 23467789999999999 999999 99
Q ss_pred hHHhcCCccccCCcccc
Q 010266 407 EQIKAHPWFKDIAWDKL 423 (514)
Q Consensus 407 ~eil~Hpff~~i~w~~l 423 (514)
+++++||||....++..
T Consensus 279 ~~ll~h~~~~~~~~~~~ 295 (303)
T 1zy4_A 279 RTLLNSGWLPVKHQDEV 295 (303)
T ss_dssp HHHHHSSCSCCCCHHHH
T ss_pred HHHhCCCCcCCCChHHH
Confidence 99999999987766543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=368.11 Aligned_cols=252 Identities=27% Similarity=0.388 Sum_probs=206.5
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccC-hhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS-RGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
.+..++|++.+.||+|+||.||+|.+. ++.||+|++.+..... ....+.+.+|..+++.++||||+++++++.+.+.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 356789999999999999999999864 8899999987653322 2345778899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eEEcCCCCCCccccC--------CCcEEEcc
Q 010266 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHN---YIHRDIKPDNLLLDQ--------NGHMKLSD 249 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKpeNILld~--------~g~iKL~D 249 (514)
+|+||||++||+|.+++. .+.+++..+..++.|++.||.|||+.| |+||||||+|||++. ++.+||+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999999884 568999999999999999999999999 999999999999986 78899999
Q ss_pred ccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc
Q 010266 250 FGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK 329 (514)
Q Consensus 250 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~ 329 (514)
||+++..... ......||+.|+|||++.+
T Consensus 160 fg~~~~~~~~---------------------------------------------------~~~~~~~~~~y~aPE~~~~ 188 (271)
T 3dtc_A 160 FGLAREWHRT---------------------------------------------------TKMSAAGAYAWMAPEVIRA 188 (271)
T ss_dssp CCC----------------------------------------------------------------CCGGGSCHHHHHH
T ss_pred CCcccccccc---------------------------------------------------cccCCCCccceeCHHHhcc
Confidence 9998754321 0114579999999999999
Q ss_pred CCCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhH
Q 010266 330 KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQ 408 (514)
Q Consensus 330 ~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~e 408 (514)
..++.++|+|||||++|+|++|..||.+.+.......+.........| ..+++++.+||.+||. ||.+|+ ++.|
T Consensus 189 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~e 263 (271)
T 3dtc_A 189 SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP--STCPEPFAKLMEDCWNPDPHSRP---SFTN 263 (271)
T ss_dssp CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHH
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC--cccCHHHHHHHHHHhcCCcccCc---CHHH
Confidence 999999999999999999999999999988877777766533333333 4789999999999999 999999 9999
Q ss_pred HhcC
Q 010266 409 IKAH 412 (514)
Q Consensus 409 il~H 412 (514)
+++|
T Consensus 264 ~l~~ 267 (271)
T 3dtc_A 264 ILDQ 267 (271)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=390.36 Aligned_cols=256 Identities=23% Similarity=0.329 Sum_probs=218.9
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
..+..++|.+.+.||+|+||.||+|+++.+++.||||+++.. ........+.+|..+|+.++|||||++++++.+.+.
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP 186 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence 345678999999999999999999999999999999998754 234455668899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999999999765 46999999999999999999999999999999999999999999999999999754321
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
... .......+|+.|+|||++.+..++.++|||
T Consensus 267 ~~~-----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 299 (377)
T 3cbl_A 267 VYA-----------------------------------------------ASGGLRQVPVKWTAPEALNYGRYSSESDVW 299 (377)
T ss_dssp EEE-----------------------------------------------CCSSCCEEEGGGSCHHHHHHCEEEHHHHHH
T ss_pred cee-----------------------------------------------ecCCCCCCCcCcCCHhHhccCCCCchhhHH
Confidence 000 000123467889999999999999999999
Q ss_pred hhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 340 SLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 340 SlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
||||++|||++ |.+||.+.+..+....+... ..+..| ..+++++.+||.+||. ||.+|+ ++++|++
T Consensus 300 slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~cl~~dP~~Rp---s~~~i~~ 367 (377)
T 3cbl_A 300 SFGILLWETFSLGASPYPNLSNQQTREFVEKG-GRLPCP--ELCPDAVFRLMEQCWAYEPGQRP---SFSTIYQ 367 (377)
T ss_dssp HHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcCCCchhCc---CHHHHHH
Confidence 99999999998 99999998887776666542 233334 4688999999999999 999999 8998874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=370.93 Aligned_cols=255 Identities=19% Similarity=0.336 Sum_probs=217.5
Q ss_pred hcCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC
Q 010266 99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA 178 (514)
Q Consensus 99 ~~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 178 (514)
....+..++|++++.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|..++..++||||+++++++.+.
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 91 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence 445677889999999999999999999875 577899999986532 235588999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
..+|+||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 999999999999999999976 5679999999999999999999999999999999999999999999999999997643
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
.... .......||+.|+|||++.+..++.++|
T Consensus 172 ~~~~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~D 203 (283)
T 3gen_A 172 DDEY------------------------------------------------TSSVGSKFPVRWSPPEVLMYSKFSSKSD 203 (283)
T ss_dssp CHHH------------------------------------------------HSTTSTTSCGGGCCHHHHHHCCCSHHHH
T ss_pred cccc------------------------------------------------ccccCCccCcccCCHHHhccCCCCchhh
Confidence 2100 0112446889999999999999999999
Q ss_pred hhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 338 WWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 338 iWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
+|||||++|+|++ |.+||.+.+..+....+.... ..+.....++.+.+||.+||. ||.+|+ +++++++|
T Consensus 204 v~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~~ 274 (283)
T 3gen_A 204 IWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL---RLYRPHLASEKVYTIMYSCWHEKADERP---TFKILLSN 274 (283)
T ss_dssp HHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC---CCCCCTTCCHHHHHHHHHTTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCccccChhHHHHHHhccc---CCCCCCcCCHHHHHHHHHHccCChhHCc---CHHHHHHH
Confidence 9999999999998 999999988888888877532 222224678999999999999 999999 99999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=382.27 Aligned_cols=257 Identities=22% Similarity=0.327 Sum_probs=221.0
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEc-----cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEE
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYS 174 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 174 (514)
...+..++|++++.||+|+||.||+|++. .+++.||+|++++.. .....+.+.+|..+|..++||||++++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 34567789999999999999999999987 455899999997653 34556778999999999999999999999
Q ss_pred EEcCCeEEEEEeecCCCCHHHHHhhc------------------------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEc
Q 010266 175 FQDAEYLYLIMEYLPGGDVMTLLMRE------------------------ETLTETVARFYIAQSVLAIESIHKHNYIHR 230 (514)
Q Consensus 175 f~~~~~l~lVmEy~~gg~L~~~l~~~------------------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHr 230 (514)
|.+.+.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 99999999999999999999999763 578999999999999999999999999999
Q ss_pred CCCCCCccccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccc
Q 010266 231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRK 310 (514)
Q Consensus 231 DLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (514)
||||+|||++.+|++||+|||+++........ .
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-----------------------------------------------~ 231 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYY-----------------------------------------------K 231 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCB-----------------------------------------------C
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccc-----------------------------------------------c
Confidence 99999999999999999999998754321000 0
Q ss_pred cccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHH
Q 010266 311 LAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDL 389 (514)
Q Consensus 311 ~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dL 389 (514)
......||+.|+|||++.+..++.++|+|||||++|||++ |..||.+.+..+....+.... ....| ..+++++.+|
T Consensus 232 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~l 308 (343)
T 1luf_A 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-ILACP--ENCPLELYNL 308 (343)
T ss_dssp ----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHHH
T ss_pred ccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCC-cCCCC--CCCCHHHHHH
Confidence 1124578999999999999999999999999999999999 999999998888887776532 22334 3689999999
Q ss_pred Hhhhcc-CccccCCCCCHhHHhc
Q 010266 390 ICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 390 I~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|.+||. ||.+|+ ++.+|++
T Consensus 309 i~~~l~~~p~~Rp---s~~~~~~ 328 (343)
T 1luf_A 309 MRLCWSKLPADRP---SFCSIHR 328 (343)
T ss_dssp HHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHcccCcccCC---CHHHHHH
Confidence 999999 999999 8999876
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=375.50 Aligned_cols=258 Identities=22% Similarity=0.285 Sum_probs=219.3
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEE-----ccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEE
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQE-----KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYS 174 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~-----~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 174 (514)
..+..++|++.+.||+|+||.||+|.+ ..+++.||+|++.... .....+.+.+|..+|..+ +||||++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 356678999999999999999999985 4577899999997653 334567789999999999 99999999999
Q ss_pred EEcCCeEEEEEeecCCCCHHHHHhhcc------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCC
Q 010266 175 FQDAEYLYLIMEYLPGGDVMTLLMREE------------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDN 236 (514)
Q Consensus 175 f~~~~~l~lVmEy~~gg~L~~~l~~~~------------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeN 236 (514)
+.+.+..|+||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 999999999999999999999997654 48999999999999999999999999999999999
Q ss_pred ccccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccc
Q 010266 237 LLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTV 316 (514)
Q Consensus 237 ILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 316 (514)
||++.+|.+||+|||++......... .......
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~ 208 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNY-----------------------------------------------VVKGNAR 208 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTS-----------------------------------------------EECSSSE
T ss_pred EEEcCCCCEEEccccccccccccccc-----------------------------------------------eeccCCC
Confidence 99999999999999999865432100 0112456
Q ss_pred cCCCcCCccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc
Q 010266 317 GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC 395 (514)
Q Consensus 317 GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~ 395 (514)
||+.|+|||++.+..++.++|+|||||++|+|++ |.+||.+.+.......++..... .+....+++++.+||.+||.
T Consensus 209 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~ 286 (313)
T 1t46_A 209 LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR--MLSPEHAPAEMYDIMKTCWD 286 (313)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCC--CCCCTTSCHHHHHHHHHHTC
T ss_pred CcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCC--CCCcccCCHHHHHHHHHHcC
Confidence 8999999999999999999999999999999999 99999987766666555543222 22234689999999999999
Q ss_pred -CccccCCCCCHhHHhcC
Q 010266 396 -DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 396 -dp~~Rl~~~~~~eil~H 412 (514)
||.+|+ +++||+++
T Consensus 287 ~dp~~Rp---s~~ell~~ 301 (313)
T 1t46_A 287 ADPLKRP---TFKQIVQL 301 (313)
T ss_dssp SSGGGSC---CHHHHHHH
T ss_pred CCchhCc---CHHHHHHH
Confidence 999999 99999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=376.30 Aligned_cols=263 Identities=26% Similarity=0.456 Sum_probs=216.0
Q ss_pred hcCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC--CCceeeEEEEEE
Q 010266 99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA--SHCIVKLYYSFQ 176 (514)
Q Consensus 99 ~~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~--hp~Iv~l~~~f~ 176 (514)
....+..++|++++.||+|+||.||+|.+. +++.||+|++..... .......+.+|..+|..+. ||+|+++++++.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 98 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence 344556678999999999999999999875 588999999976542 4456678899999999997 599999999999
Q ss_pred cCCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccC
Q 010266 177 DAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256 (514)
Q Consensus 177 ~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~ 256 (514)
+...+|+||| +.+|+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++ +|.+||+|||+++..
T Consensus 99 ~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 99 TDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 176 (313)
T ss_dssp CSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-
T ss_pred cCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccc
Confidence 9999999999 56889999999888999999999999999999999999999999999999996 599999999999865
Q ss_pred CCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-------
Q 010266 257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK------- 329 (514)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~------- 329 (514)
...... ......+||+.|+|||++.+
T Consensus 177 ~~~~~~-----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~ 209 (313)
T 3cek_A 177 QPDTTS-----------------------------------------------VVKDSQVGTVNYMPPEAIKDMSSSREN 209 (313)
T ss_dssp ------------------------------------------------------------CCGGGCCHHHHTTCC-----
T ss_pred cCcccc-----------------------------------------------ccccCCCCCCCcCCHHHHhhccccccc
Confidence 321100 01124579999999999976
Q ss_pred ----CCCCcccchhhhhHHHHHHhhCCCCCCCCC-hhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCC
Q 010266 330 ----KGYGMECDWWSLGAIMYEMLVGYPPFYSDD-PVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT 403 (514)
Q Consensus 330 ----~~y~~~~DiWSlGvilyemltG~~PF~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~ 403 (514)
..++.++|||||||++|+|++|..||.... .......+........+|. ..++++.+||.+||. ||.+|+
T Consensus 210 ~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rp-- 285 (313)
T 3cek_A 210 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQRI-- 285 (313)
T ss_dssp -----CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCC--CSCHHHHHHHHHHTCSSTTTSC--
T ss_pred ccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcc--cchHHHHHHHHHHccCCcccCc--
Confidence 468899999999999999999999998653 3344444544333344453 568899999999999 999999
Q ss_pred CCHhHHhcCCcccc
Q 010266 404 LGSEQIKAHPWFKD 417 (514)
Q Consensus 404 ~~~~eil~Hpff~~ 417 (514)
+++|+++||||+.
T Consensus 286 -s~~ell~h~~~~~ 298 (313)
T 3cek_A 286 -SIPELLAHPYVQI 298 (313)
T ss_dssp -CHHHHHTSHHHHC
T ss_pred -CHHHHhcCccccC
Confidence 9999999999975
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=373.57 Aligned_cols=258 Identities=22% Similarity=0.308 Sum_probs=208.6
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
...++|++++.||+|+||.||+|++..+++.||+|++.+.........+.+.+|..++..++||||+++++++.+.+.+|
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 34689999999999999999999999999999999998765555555678899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
+||||++|++|.+++...+.+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++........
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~- 189 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL- 189 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc-
Confidence 9999999999999999888999999999999999999999999999999999999999999999999999875432100
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
......+||+.|+|||++.+..++.++|+||||
T Consensus 190 -----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 222 (309)
T 2h34_A 190 -----------------------------------------------TQLGNTVGTLYYMAPERFSESHATYRADIYALT 222 (309)
T ss_dssp ------------------------------------------------------CCGGGCCGGGTCC----CCCHHHHHH
T ss_pred -----------------------------------------------ccccccCCCcCccCHHHHcCCCCCchHhHHHHH
Confidence 011245799999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|++|+|++|..||.+.+.......+... ..........+++++.+||.+||. ||.+|+. ++++++.
T Consensus 223 ~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~--s~~~l~~ 289 (309)
T 2h34_A 223 CVLYECLTGSPPYQGDQLSVMGAHINQA-IPRPSTVRPGIPVAFDAVIARGMAKNPEDRYV--TCGDLSA 289 (309)
T ss_dssp HHHHHHHHSSCSSCSCHHHHHHHHHHSC-CCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCS--SHHHHHH
T ss_pred HHHHHHHHCCCCCCCchHHHHHHHhccC-CCCccccCCCCCHHHHHHHHHhccCCHHHHHH--hHHHHHH
Confidence 9999999999999987665444433321 111111123689999999999999 9999984 5677664
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=375.98 Aligned_cols=263 Identities=24% Similarity=0.391 Sum_probs=204.4
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
.....++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+..+..++..++||||+++++++.+.+.
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~ 98 (318)
T 2dyl_A 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD 98 (318)
T ss_dssp EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Confidence 34567899999999999999999999999999999999986532 22233444555567888899999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC-CeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
+|+||||+ ++.+..++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.+|++||+|||++.....
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 99999999 5666666544 56899999999999999999999995 999999999999999999999999999875432
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc-----cCCCC
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----KKGYG 333 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~y~ 333 (514)
.. .....+||+.|+|||++. +..++
T Consensus 178 ~~--------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 207 (318)
T 2dyl_A 178 DK--------------------------------------------------AKDRSAGCAAYMAPERIDPPDPTKPDYD 207 (318)
T ss_dssp -----------------------------------------------------------CCTTCCHHHHC--------CC
T ss_pred Cc--------------------------------------------------cccccCCCccccChhhcccccccccCCc
Confidence 10 011457999999999995 56689
Q ss_pred cccchhhhhHHHHHHhhCCCCCCCC-ChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 334 MECDWWSLGAIMYEMLVGYPPFYSD-DPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 334 ~~~DiWSlGvilyemltG~~PF~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
.++|||||||++|+|++|..||... +..+....+... ....+|....+++++.+||.+||. ||.+|+ ++++|++
T Consensus 208 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~ 283 (318)
T 2dyl_A 208 IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE-EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRP---KYNKLLE 283 (318)
T ss_dssp THHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS-CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSC---CHHHHTT
T ss_pred cccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc-CCCCCCccCCCCHHHHHHHHHHccCChhHCc---CHHHHhh
Confidence 9999999999999999999999873 445555666543 233455545689999999999999 999999 9999999
Q ss_pred CCccccCC
Q 010266 412 HPWFKDIA 419 (514)
Q Consensus 412 Hpff~~i~ 419 (514)
||||++.+
T Consensus 284 h~~~~~~~ 291 (318)
T 2dyl_A 284 HSFIKRYE 291 (318)
T ss_dssp SHHHHHHH
T ss_pred CHHHHhcc
Confidence 99998754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=372.33 Aligned_cols=247 Identities=20% Similarity=0.285 Sum_probs=209.7
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCC-------CEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSG-------NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYS 174 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~-------~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 174 (514)
++..++|++.+.||+|+||+||+|+++.++ ..||+|++.+.. ....+.+.+|..+|..++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 456789999999999999999999998877 469999997643 4456778899999999999999999999
Q ss_pred EEcCCeEEEEEeecCCCCHHHHHhhccC-CCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCc--------E
Q 010266 175 FQDAEYLYLIMEYLPGGDVMTLLMREET-LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH--------M 245 (514)
Q Consensus 175 f~~~~~l~lVmEy~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~--------i 245 (514)
+.+.+..|+||||++||+|.+++..... +++..+..++.|++.||.|||++||+||||||+|||++.++. +
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999999999987654 999999999999999999999999999999999999999887 9
Q ss_pred EEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcc
Q 010266 246 KLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPE 325 (514)
Q Consensus 246 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APE 325 (514)
||+|||++...... ....||+.|+|||
T Consensus 161 kl~Dfg~~~~~~~~-----------------------------------------------------~~~~~~~~y~aPE 187 (289)
T 4fvq_A 161 KLSDPGISITVLPK-----------------------------------------------------DILQERIPWVPPE 187 (289)
T ss_dssp EECCCCSCTTTSCH-----------------------------------------------------HHHHHTTTTSCHH
T ss_pred eeccCcccccccCc-----------------------------------------------------cccCCcCcccCHH
Confidence 99999998653210 1356899999999
Q ss_pred cccc-CCCCcccchhhhhHHHHHHhhC-CCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCC
Q 010266 326 VLLK-KGYGMECDWWSLGAIMYEMLVG-YPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLG 402 (514)
Q Consensus 326 vl~~-~~y~~~~DiWSlGvilyemltG-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~ 402 (514)
++.+ ..++.++|||||||++|||++| .+||...+..... .+.. ....+|. ..++++.+||.+||. ||.+|+
T Consensus 188 ~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~--~~~~~~~--~~~~~l~~li~~~l~~dp~~Rp- 261 (289)
T 4fvq_A 188 CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYE--DRHQLPA--PKAAELANLINNCMDYEPDHRP- 261 (289)
T ss_dssp HHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHH--TTCCCCC--CSSCTTHHHHHHHSCSSGGGSC-
T ss_pred HhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhh--ccCCCCC--CCCHHHHHHHHHHcCCChhHCc-
Confidence 9988 7799999999999999999995 5555554444333 3333 2334443 568899999999999 999999
Q ss_pred CCCHhHHhcC
Q 010266 403 TLGSEQIKAH 412 (514)
Q Consensus 403 ~~~~~eil~H 412 (514)
+++++++|
T Consensus 262 --s~~~ll~~ 269 (289)
T 4fvq_A 262 --SFRAIIRD 269 (289)
T ss_dssp --CHHHHHHH
T ss_pred --CHHHHHHH
Confidence 99999874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=381.31 Aligned_cols=267 Identities=25% Similarity=0.440 Sum_probs=198.8
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHH-HHHHcCCCceeeEEEEEEcC
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERN-LLAEVASHCIVKLYYSFQDA 178 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~-iL~~l~hp~Iv~l~~~f~~~ 178 (514)
...+..++|++++.||+|+||.||+|.++.+|+.||||++.... .......+..|.. +++.++||||+++++++.+.
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~ 93 (327)
T 3aln_A 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE 93 (327)
T ss_dssp EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence 45677899999999999999999999999999999999997653 2333344555555 66778999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHhC-CeEEcCCCCCCccccCCCcEEEccccc
Q 010266 179 EYLYLIMEYLPGGDVMTLLMR-----EETLTETVARFYIAQSVLAIESIHKH-NYIHRDIKPDNLLLDQNGHMKLSDFGL 252 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHrDLKpeNILld~~g~iKL~DFGl 252 (514)
+.+|+||||++| +|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.+|++||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 172 (327)
T 3aln_A 94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI 172 (327)
T ss_dssp SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCC
Confidence 999999999975 78777753 57899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccc----c
Q 010266 253 CKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL----L 328 (514)
Q Consensus 253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl----~ 328 (514)
++...... .....+||+.|+|||++ .
T Consensus 173 ~~~~~~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~ 202 (327)
T 3aln_A 173 SGQLVDSI--------------------------------------------------AKTRDAGCRPYMAPERIDPSAS 202 (327)
T ss_dssp SCC-----------------------------------------------------------------------------
T ss_pred ceeccccc--------------------------------------------------ccccCCCCccccCceeeccccC
Confidence 87643210 01134799999999999 4
Q ss_pred cCCCCcccchhhhhHHHHHHhhCCCCCCCCChh-HHHHHHhhhcCcccCCc--CcCCChhHHHHHhhhcc-CccccCCCC
Q 010266 329 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPV-TTCRKIVHWKNHLKFPE--EARLTPEAKDLICRLLC-DVEHRLGTL 404 (514)
Q Consensus 329 ~~~y~~~~DiWSlGvilyemltG~~PF~~~~~~-~~~~~i~~~~~~~~~p~--~~~~s~~~~dLI~~lL~-dp~~Rl~~~ 404 (514)
+..++.++|||||||++|+|++|..||.+.+.. +....+... ....++. ...+++++.+||.+||. ||.+|+
T Consensus 203 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp--- 278 (327)
T 3aln_A 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG-DPPQLSNSEEREFSPSFINFVNLCLTKDESKRP--- 278 (327)
T ss_dssp ---CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCS-CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSC---
T ss_pred cCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcC-CCCCCCCcccccCCHHHHHHHHHHhhCChhhCc---
Confidence 667899999999999999999999999875432 222222221 1112221 23589999999999999 999999
Q ss_pred CHhHHhcCCccccCCcccc
Q 010266 405 GSEQIKAHPWFKDIAWDKL 423 (514)
Q Consensus 405 ~~~eil~Hpff~~i~w~~l 423 (514)
++.+|++||||...++..+
T Consensus 279 s~~ell~hp~~~~~~~~~~ 297 (327)
T 3aln_A 279 KYKELLKHPFILMYEERAV 297 (327)
T ss_dssp CHHHHTTSHHHHHHHHSCC
T ss_pred CHHHHHhChHHHHhHhhHH
Confidence 9999999999998776654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=365.51 Aligned_cols=250 Identities=17% Similarity=0.246 Sum_probs=217.4
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC-
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA- 178 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~- 178 (514)
...+..++|++++.||+|+||.||+|++. ++.||+|++..... .....+.+.+|..+|..++||||+++++++.+.
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP 80 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence 34677889999999999999999999874 88999999986532 345567789999999999999999999999987
Q ss_pred -CeEEEEEeecCCCCHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC--eEEcCCCCCCccccCCCcEEEcccccc
Q 010266 179 -EYLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLDQNGHMKLSDFGLC 253 (514)
Q Consensus 179 -~~l~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKpeNILld~~g~iKL~DFGla 253 (514)
..+|+||||++||+|.+++.... .+++..+..++.|++.||.|||++| |+||||||+|||++.+|.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK 160 (271)
T ss_dssp SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccce
Confidence 78999999999999999998765 4899999999999999999999999 999999999999999999999999986
Q ss_pred ccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCC
Q 010266 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG 333 (514)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 333 (514)
..... ...+||+.|+|||++.+..++
T Consensus 161 ~~~~~------------------------------------------------------~~~~~t~~y~aPE~~~~~~~~ 186 (271)
T 3kmu_A 161 FSFQS------------------------------------------------------PGRMYAPAWVAPEALQKKPED 186 (271)
T ss_dssp CTTSC------------------------------------------------------TTCBSCGGGSCHHHHHSCGGG
T ss_pred eeecc------------------------------------------------------cCccCCccccChhhhccCCCC
Confidence 53221 145799999999999876665
Q ss_pred c---ccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHH
Q 010266 334 M---ECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQI 409 (514)
Q Consensus 334 ~---~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ei 409 (514)
. ++|||||||++|||++|..||.+.+.......+........+|. .+++++.+||.+||. ||.+|+ +++++
T Consensus 187 ~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp---s~~~i 261 (271)
T 3kmu_A 187 TNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPP--GISPHVSKLMKICMNEDPAKRP---KFDMI 261 (271)
T ss_dssp SCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCT--TCCHHHHHHHHHHTCSSGGGSC---CHHHH
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCC--CCCHHHHHHHHHHcCCChhhCc---CHHHH
Confidence 4 79999999999999999999999888888777765444444443 689999999999999 999999 89998
Q ss_pred hc
Q 010266 410 KA 411 (514)
Q Consensus 410 l~ 411 (514)
++
T Consensus 262 l~ 263 (271)
T 3kmu_A 262 VP 263 (271)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=370.07 Aligned_cols=255 Identities=24% Similarity=0.353 Sum_probs=208.1
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccC---CCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKS---GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 177 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t---~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 177 (514)
..+..++|++.+.||+|+||.||+|++..+ +..||+|++.... .....+.+.+|..++..++||||+++++++.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 456678999999999999999999998654 4579999987542 3455677889999999999999999999985
Q ss_pred CCeEEEEEeecCCCCHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccC
Q 010266 178 AEYLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256 (514)
Q Consensus 178 ~~~l~lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~ 256 (514)
++..|+||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+++..
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence 567899999999999999997654 7999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCccc
Q 010266 257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336 (514)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 336 (514)
..... .......||+.|+|||++.+..++.++
T Consensus 167 ~~~~~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~ 198 (281)
T 1mp8_A 167 EDSTY------------------------------------------------YKASKGKLPIKWMAPESINFRRFTSAS 198 (281)
T ss_dssp ------------------------------------------------------------CCGGGCCHHHHHHCCCSHHH
T ss_pred Ccccc------------------------------------------------cccccCCCcccccChhhcccCCCCCcc
Confidence 32110 001134678999999999999999999
Q ss_pred chhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 337 DWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 337 DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
|||||||++|||++ |.+||.+.+..+....+.... ...+| ..+++++.+||.+||. ||.+|+ ++.+++++
T Consensus 199 Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~~ 270 (281)
T 1mp8_A 199 DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMP--PNCPPTLYSLMTKCWAYDPSRRP---RFTELKAQ 270 (281)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred CchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 99999999999997 999999988888887776532 23333 4789999999999999 999999 89998763
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=370.59 Aligned_cols=254 Identities=22% Similarity=0.348 Sum_probs=221.6
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE 179 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 179 (514)
...+..++|++.+.||+|+||.||+|.++.++..||+|++... ....+.+.+|..+++.++||||+++++++.+..
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 4566778999999999999999999999999999999999754 335677889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
.+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||++....
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999999999999999764 459999999999999999999999999999999999999999999999999998654
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
..... ......||+.|+|||++.+..++.++|
T Consensus 163 ~~~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~D 194 (288)
T 3kfa_A 163 GDTYT------------------------------------------------AHAGAKFPIKWTAPESLAYNKFSIKSD 194 (288)
T ss_dssp SSSSE------------------------------------------------EETTEEECGGGCCHHHHHHCCCCHHHH
T ss_pred CCccc------------------------------------------------cccCCccccCcCChhhhccCCCCchhh
Confidence 22100 112456899999999999999999999
Q ss_pred hhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 338 WWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 338 iWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
+|||||++|+|++ |.+||.+.+.......+... ...+....+++++.+||.+||. ||.+|+ +++++++
T Consensus 195 i~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~~~~ 264 (288)
T 3kfa_A 195 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD---YRMERPEGCPEKVYELMRACWQWNPSDRP---SFAEIHQ 264 (288)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc---CCCCCCCCCCHHHHHHHHHHhCCChhhCc---CHHHHHH
Confidence 9999999999999 99999998887777766542 2223334789999999999999 999999 8999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=376.16 Aligned_cols=258 Identities=22% Similarity=0.326 Sum_probs=219.7
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCC-----EEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEE
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGN-----IYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYY 173 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~-----~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 173 (514)
...+..++|++.+.||+|+||.||+|.+..+++ .||+|++.... .....+.+.+|..+|..+ +||||+++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 345677899999999999999999999877664 79999997653 344567789999999999 8999999999
Q ss_pred EEEcCCeEEEEEeecCCCCHHHHHhhc--------------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccc
Q 010266 174 SFQDAEYLYLIMEYLPGGDVMTLLMRE--------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL 239 (514)
Q Consensus 174 ~f~~~~~l~lVmEy~~gg~L~~~l~~~--------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILl 239 (514)
+|.+.+.+|+||||++||+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||+
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 999999999999999999999999753 357999999999999999999999999999999999999
Q ss_pred cCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCC
Q 010266 240 DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTP 319 (514)
Q Consensus 240 d~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~ 319 (514)
+.+|++||+|||+++........ .......||+
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~ 230 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNY-----------------------------------------------IVKGNARLPV 230 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTS-----------------------------------------------EECSSCEECG
T ss_pred CCCCeEEECccccccccccccce-----------------------------------------------eecCCCCCCc
Confidence 99999999999999754321100 0112456899
Q ss_pred CcCCccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-Cc
Q 010266 320 DYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DV 397 (514)
Q Consensus 320 ~Y~APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp 397 (514)
.|+|||++.+..++.++|||||||++|||++ |.+||.+.........+.........| ...++++.+||.+||. ||
T Consensus 231 ~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p 308 (333)
T 2i1m_A 231 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQP--AFAPKNIYSIMQACWALEP 308 (333)
T ss_dssp GGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHTCSSG
T ss_pred cccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCC--CCCCHHHHHHHHHHhccCh
Confidence 9999999999999999999999999999998 999999877766666665533333333 4678999999999999 99
Q ss_pred cccCCCCCHhHHhc
Q 010266 398 EHRLGTLGSEQIKA 411 (514)
Q Consensus 398 ~~Rl~~~~~~eil~ 411 (514)
.+|+ ++++|++
T Consensus 309 ~~Rp---s~~~l~~ 319 (333)
T 2i1m_A 309 THRP---TFQQICS 319 (333)
T ss_dssp GGSC---CHHHHHH
T ss_pred hhCc---CHHHHHH
Confidence 9999 9999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=378.42 Aligned_cols=254 Identities=20% Similarity=0.329 Sum_probs=207.2
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEE----EEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIY----AMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA 178 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~----AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 178 (514)
+..++|++++.||+|+||+||+|++..+++.+ |+|.+.... .......+.+|..+|+.++|||||+++++|.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 45678999999999999999999998888765 666664332 334557788999999999999999999999876
Q ss_pred CeEEEEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
. .++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 5 7899999999999999977 4679999999999999999999999999999999999999999999999999998653
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
..... .......||+.|+|||++.+..|+.++|
T Consensus 169 ~~~~~-----------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~D 201 (327)
T 3poz_A 169 AEEKE-----------------------------------------------YHAEGGKVPIKWMALESILHRIYTHQSD 201 (327)
T ss_dssp TTCC------------------------------------------------------CCCGGGSCHHHHHHCCCCHHHH
T ss_pred CCccc-----------------------------------------------ccccCCCccccccChHHhccCCCCchhh
Confidence 22100 0111346889999999999999999999
Q ss_pred hhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 338 WWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 338 iWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
||||||++|||++ |.+||.+.+..+....+... . ..+.....+.++.+||.+||. ||.+|+ ++.+++.|
T Consensus 202 i~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~ell~~ 272 (327)
T 3poz_A 202 VWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-E--RLPQPPICTIDVYMIMVKCWMIDADSRP---KFRELIIE 272 (327)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-C--CCCCCTTBCHHHHHHHHHHTCSCGGGSC---CHHHHHHH
T ss_pred hhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC-C--CCCCCccCCHHHHHHHHHHcCCChhhCC---CHHHHHHH
Confidence 9999999999999 99999988877766655532 2 233334688999999999999 999999 99999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=374.86 Aligned_cols=257 Identities=22% Similarity=0.336 Sum_probs=216.4
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEE-----ccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQE-----KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSF 175 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~-----~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f 175 (514)
.+..++|++.+.||+|+||.||+|++ ..+++.||+|++.+.. .......+.+|..+|..+ +||||+++++++
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 45678999999999999999999985 3567899999997653 344556788999999999 799999999998
Q ss_pred EcCC-eEEEEEeecCCCCHHHHHhhccC----------------CCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCcc
Q 010266 176 QDAE-YLYLIMEYLPGGDVMTLLMREET----------------LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLL 238 (514)
Q Consensus 176 ~~~~-~l~lVmEy~~gg~L~~~l~~~~~----------------l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNIL 238 (514)
.+.+ .+|+||||++||+|.+++..... +++..+..++.|++.||.|||+.||+||||||+|||
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 180 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 7654 59999999999999999977543 899999999999999999999999999999999999
Q ss_pred ccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccC
Q 010266 239 LDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGT 318 (514)
Q Consensus 239 ld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT 318 (514)
++.+|++||+|||+++........ .......||
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~t 213 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPDY-----------------------------------------------VRKGDARLP 213 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTS-----------------------------------------------EEETTEEEC
T ss_pred ECCCCCEEECCCccccccccCccc-----------------------------------------------eeccCCCcc
Confidence 999999999999999865422100 011245789
Q ss_pred CCcCCccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-C
Q 010266 319 PDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-D 396 (514)
Q Consensus 319 ~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-d 396 (514)
+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+........+........| ..+++++.+||.+||. |
T Consensus 214 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~d 291 (316)
T 2xir_A 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGE 291 (316)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHTCSS
T ss_pred eeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCC--CCCCHHHHHHHHHHcCCC
Confidence 99999999999999999999999999999998 999998876555544444333333444 3689999999999999 9
Q ss_pred ccccCCCCCHhHHhcC
Q 010266 397 VEHRLGTLGSEQIKAH 412 (514)
Q Consensus 397 p~~Rl~~~~~~eil~H 412 (514)
|.+|+ ++.+|++|
T Consensus 292 p~~Rp---s~~ell~~ 304 (316)
T 2xir_A 292 PSQRP---TFSELVEH 304 (316)
T ss_dssp GGGSC---CHHHHHHH
T ss_pred hhhCc---CHHHHHHH
Confidence 99999 99999876
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=365.78 Aligned_cols=253 Identities=23% Similarity=0.356 Sum_probs=211.4
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhh----HHHHHHHHHHHHHcCCCceeeEEEEE
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ----VEHVRAERNLLAEVASHCIVKLYYSF 175 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~----~~~~~~E~~iL~~l~hp~Iv~l~~~f 175 (514)
...+..++|++.+.||+|+||+||+|++..+++.||+|++.......... .+.+.+|..++..++||||+++++++
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (287)
T 4f0f_A 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92 (287)
T ss_dssp CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence 34567789999999999999999999999999999999997654333222 16788999999999999999999999
Q ss_pred EcCCeEEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eEEcCCCCCCccccCCCc-----EEE
Q 010266 176 QDAEYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLDQNGH-----MKL 247 (514)
Q Consensus 176 ~~~~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKpeNILld~~g~-----iKL 247 (514)
.+.. ++||||++||+|.+.+... ..+++..+..++.|++.||.|||+.| |+||||||+|||++.++. +||
T Consensus 93 ~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 93 HNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp TTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred cCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 8766 6999999999998888654 57999999999999999999999999 999999999999998887 999
Q ss_pred ccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccc
Q 010266 248 SDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL 327 (514)
Q Consensus 248 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl 327 (514)
+|||+|+..... ....+||+.|+|||++
T Consensus 171 ~Dfg~~~~~~~~----------------------------------------------------~~~~~g~~~y~aPE~~ 198 (287)
T 4f0f_A 171 ADFGLSQQSVHS----------------------------------------------------VSGLLGNFQWMAPETI 198 (287)
T ss_dssp CCCTTCBCCSSC----------------------------------------------------EECCCCCCTTSCGGGS
T ss_pred CCCCcccccccc----------------------------------------------------ccccCCCccccCchhh
Confidence 999998743211 1146799999999999
Q ss_pred c--cCCCCcccchhhhhHHHHHHhhCCCCCCCCChhHH--HHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCC
Q 010266 328 L--KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTT--CRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLG 402 (514)
Q Consensus 328 ~--~~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~--~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~ 402 (514)
. ...++.++|||||||++|+|++|..||.+.+.... ...+........+| ..+++++.+||.+||. ||.+|+
T Consensus 199 ~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rp- 275 (287)
T 4f0f_A 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP--EDCPPRLRNVIELCWSGDPKKRP- 275 (287)
T ss_dssp SCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCC--TTSCHHHHHHHHHHTCSSGGGSC-
T ss_pred ccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCC--cccCHHHHHHHHHHhcCChhhCc-
Confidence 4 45678999999999999999999999987654433 33343322233344 3689999999999999 999999
Q ss_pred CCCHhHHhc
Q 010266 403 TLGSEQIKA 411 (514)
Q Consensus 403 ~~~~~eil~ 411 (514)
++++|++
T Consensus 276 --s~~~ll~ 282 (287)
T 4f0f_A 276 --HFSYIVK 282 (287)
T ss_dssp --CHHHHHH
T ss_pred --CHHHHHH
Confidence 9999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=398.53 Aligned_cols=260 Identities=22% Similarity=0.341 Sum_probs=202.3
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCeE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l 181 (514)
+...+|.+.++||+|+||+|+. ....+|+.||||++.+... ..+.+|..+|..+ +|||||++++++.+...+
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 93 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQ 93 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred EccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence 4456799999999999999874 4567899999999976432 1245799999999 799999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC---C--CcEEEcccccccc
Q 010266 182 YLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ---N--GHMKLSDFGLCKP 255 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~---~--g~iKL~DFGla~~ 255 (514)
|+|||||. |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. + ..+||+|||+|+.
T Consensus 94 ~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 99999996 69999987653 4666677889999999999999999999999999999953 3 3578999999986
Q ss_pred CCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc---cCCC
Q 010266 256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---KKGY 332 (514)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y 332 (514)
....... .......+||+.|+|||++. ...+
T Consensus 173 ~~~~~~~----------------------------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~ 206 (432)
T 3p23_A 173 LAVGRHS----------------------------------------------FSRRSGVPGTEGWIAPEMLSEDCKENP 206 (432)
T ss_dssp C----------------------------------------------------------CCSCTTSCCGGGTSCC---CC
T ss_pred ccCCCcc----------------------------------------------eeeccccCCCcCccChhhhhcccccCC
Confidence 5422100 00122568999999999998 4567
Q ss_pred CcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHh
Q 010266 333 GMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIK 410 (514)
Q Consensus 333 ~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 410 (514)
+.++|||||||++|||++ |.+||...........+... .....+.....+..+++||.+||. ||.+|+ ++++|+
T Consensus 207 t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~evl 282 (432)
T 3p23_A 207 TYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGAC-SLDCLHPEKHEDVIARELIEKMIAMDPQKRP---SAKHVL 282 (432)
T ss_dssp CTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCC-CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSC---CHHHHH
T ss_pred CcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccC-CccccCccccccHHHHHHHHHHHhCCHhhCC---CHHHHH
Confidence 889999999999999999 99999765544333222211 111111222446779999999999 999999 999999
Q ss_pred cCCccccCCc
Q 010266 411 AHPWFKDIAW 420 (514)
Q Consensus 411 ~Hpff~~i~w 420 (514)
+||||.+++|
T Consensus 283 ~hp~f~~~~~ 292 (432)
T 3p23_A 283 KHPFFWSLEK 292 (432)
T ss_dssp TSTTTCCHHH
T ss_pred hCccccChHH
Confidence 9999999988
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=376.33 Aligned_cols=252 Identities=25% Similarity=0.390 Sum_probs=214.2
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEE--EEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCC
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIY--AMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAE 179 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~--AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~ 179 (514)
+..++|++.+.||+|+||.||+|+++.++..+ |+|.+... ........+.+|..+|..+ +||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 55689999999999999999999999998865 99998753 2344556688999999999 8999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhcc----------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMREE----------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG 243 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g 243 (514)
.+|+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999997654 799999999999999999999999999999999999999999
Q ss_pred cEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCC
Q 010266 244 HMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIA 323 (514)
Q Consensus 244 ~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~A 323 (514)
.+||+|||+++...... ......||+.|+|
T Consensus 180 ~~kL~Dfg~~~~~~~~~--------------------------------------------------~~~~~~~~~~y~a 209 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYV--------------------------------------------------KKTMGRLPVRWMA 209 (327)
T ss_dssp CEEECCTTCEESSCEEC--------------------------------------------------CC----CCTTTCC
T ss_pred eEEEcccCcCccccccc--------------------------------------------------cccCCCCCccccC
Confidence 99999999987432100 0113467899999
Q ss_pred ccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccC
Q 010266 324 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRL 401 (514)
Q Consensus 324 PEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl 401 (514)
||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+.... ....| ..+++++.+||.+||. ||.+|+
T Consensus 210 PE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rp 286 (327)
T 1fvr_A 210 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RLEKP--LNCDDEVYDLMRQCWREKPYERP 286 (327)
T ss_dssp HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC-CCCCC--TTBCHHHHHHHHHHTCSSGGGSC
T ss_pred hhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC-CCCCC--CCCCHHHHHHHHHHccCChhhCc
Confidence 999999999999999999999999998 999999998888877776531 22233 4689999999999999 999999
Q ss_pred CCCCHhHHhcC
Q 010266 402 GTLGSEQIKAH 412 (514)
Q Consensus 402 ~~~~~~eil~H 412 (514)
++++++.|
T Consensus 287 ---s~~ell~~ 294 (327)
T 1fvr_A 287 ---SFAQILVS 294 (327)
T ss_dssp ---CHHHHHHH
T ss_pred ---CHHHHHHH
Confidence 99999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=370.68 Aligned_cols=256 Identities=24% Similarity=0.398 Sum_probs=207.9
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEE----EccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQ----EKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 176 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~----~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 176 (514)
..+..++|++++.||+|+||+||+|+ +..+++.||||++... .....+.+.+|..+|..++||||+++++++.
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY 81 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 35667899999999999999999998 5678999999999754 3455677899999999999999999999985
Q ss_pred c--CCeEEEEEeecCCCCHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccc
Q 010266 177 D--AEYLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253 (514)
Q Consensus 177 ~--~~~l~lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla 253 (514)
+ ...+|+||||++||+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.+|++||+|||++
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 4 456999999999999999997754 5999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCC
Q 010266 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG 333 (514)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 333 (514)
+........ ........||+.|+|||++.+..++
T Consensus 162 ~~~~~~~~~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~ 195 (295)
T 3ugc_A 162 KVLPQDKEF----------------------------------------------FKVKEPGESPIFWYAPESLTESKFS 195 (295)
T ss_dssp C-----------------------------------------------------------CTTCGGGGCCHHHHHHCCCC
T ss_pred ccccCCcce----------------------------------------------eeeccCCCCccceeCcHHhcCCCCC
Confidence 865422100 0011134688899999999999999
Q ss_pred cccchhhhhHHHHHHhhCCCCCCCCChh----------------HHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-C
Q 010266 334 MECDWWSLGAIMYEMLVGYPPFYSDDPV----------------TTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-D 396 (514)
Q Consensus 334 ~~~DiWSlGvilyemltG~~PF~~~~~~----------------~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-d 396 (514)
.++|||||||++|||++|..||...... .....+. .....|....+++++.+||.+||. |
T Consensus 196 ~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~d 272 (295)
T 3ugc_A 196 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK---NNGRLPRPDGCPDEIYMIMTECWNNN 272 (295)
T ss_dssp HHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH---TTCCCCCCTTCCHHHHHHHHHHSCSS
T ss_pred hHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh---ccCcCCCCcCcCHHHHHHHHHHcCCC
Confidence 9999999999999999999998653211 1111111 222333344789999999999999 9
Q ss_pred ccccCCCCCHhHHhc
Q 010266 397 VEHRLGTLGSEQIKA 411 (514)
Q Consensus 397 p~~Rl~~~~~~eil~ 411 (514)
|.+|+ +++||++
T Consensus 273 p~~Rp---s~~el~~ 284 (295)
T 3ugc_A 273 VNQRP---SFRDLAL 284 (295)
T ss_dssp GGGSC---CHHHHHH
T ss_pred hhhCC---CHHHHHH
Confidence 99999 8999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=373.65 Aligned_cols=258 Identities=23% Similarity=0.351 Sum_probs=219.2
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEc-------cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeE
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEK-------KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKL 171 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~-------~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l 171 (514)
...+..++|++.+.||+|+||.||+|++. .++..||+|++.... .......+.+|..+|..+ +||||+++
T Consensus 29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence 34566789999999999999999999975 467789999997653 445567789999999999 89999999
Q ss_pred EEEEEcCCeEEEEEeecCCCCHHHHHhhcc----------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCC
Q 010266 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMREE----------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPD 235 (514)
Q Consensus 172 ~~~f~~~~~l~lVmEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpe 235 (514)
++++.+.+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 186 (334)
T ss_dssp EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence 999999999999999999999999997654 3889999999999999999999999999999999
Q ss_pred CccccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhcccccccc
Q 010266 236 NLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYST 315 (514)
Q Consensus 236 NILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 315 (514)
|||++.+|++||+|||+++........ ......
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~-----------------------------------------------~~~~~~ 219 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYY-----------------------------------------------KKTTNG 219 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSE-----------------------------------------------ECCSCC
T ss_pred eEEEcCCCCEEEccccccccccccccc-----------------------------------------------cccCCC
Confidence 999999999999999999865422100 011134
Q ss_pred ccCCCcCCccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhc
Q 010266 316 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLL 394 (514)
Q Consensus 316 ~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL 394 (514)
.||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.... ....| ..+++++.+||.+||
T Consensus 220 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l 296 (334)
T 2pvf_A 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH-RMDKP--ANCTNELYMMMRDCW 296 (334)
T ss_dssp CCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC-CCCCC--TTCCHHHHHHHHHHT
T ss_pred CcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCC-CCCCC--ccCCHHHHHHHHHHc
Confidence 68899999999999999999999999999999999 999999988887777766532 22333 368999999999999
Q ss_pred c-CccccCCCCCHhHHhcC
Q 010266 395 C-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 395 ~-dp~~Rl~~~~~~eil~H 412 (514)
. ||.+|+ ++++|+++
T Consensus 297 ~~dp~~Rp---s~~ell~~ 312 (334)
T 2pvf_A 297 HAVPSQRP---TFKQLVED 312 (334)
T ss_dssp CSSGGGSC---CHHHHHHH
T ss_pred cCChhhCc---CHHHHHHH
Confidence 9 999999 99999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=374.34 Aligned_cols=253 Identities=30% Similarity=0.490 Sum_probs=206.7
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChh---hHHHHHHHHHHHHHc----CCCceeeEEEEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRG---QVEHVRAERNLLAEV----ASHCIVKLYYSF 175 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~---~~~~~~~E~~iL~~l----~hp~Iv~l~~~f 175 (514)
...++|++.+.||+|+||.||+|+++.+++.||+|++.+....... ....+..|..++..+ +||||++++++|
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 3357899999999999999999999999999999999766433221 223355788999888 899999999999
Q ss_pred EcCCeEEEEEee-cCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCcccc-CCCcEEEcccccc
Q 010266 176 QDAEYLYLIMEY-LPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-QNGHMKLSDFGLC 253 (514)
Q Consensus 176 ~~~~~l~lVmEy-~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld-~~g~iKL~DFGla 253 (514)
.+.+..|+|||| +.|++|.+++...+.+++..++.++.|++.||.|||+.||+||||||+|||++ .+|.+||+|||++
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 999999999999 78999999999888999999999999999999999999999999999999999 8999999999998
Q ss_pred ccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCC-
Q 010266 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY- 332 (514)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y- 332 (514)
....... .....||+.|+|||++.+..+
T Consensus 188 ~~~~~~~---------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~ 216 (312)
T 2iwi_A 188 ALLHDEP---------------------------------------------------YTDFDGTRVYSPPEWISRHQYH 216 (312)
T ss_dssp EECCSSC---------------------------------------------------BCCCCSCTTTSCHHHHHHSCBC
T ss_pred hhcccCc---------------------------------------------------ccccCCcccccCceeeecCCCC
Confidence 7653210 114579999999999987776
Q ss_pred CcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 333 GMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 333 ~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
+.++|||||||++|+|++|..||.+.. .+.. ....+|. .+++++++||.+||. ||.+|+ +++|+++
T Consensus 217 ~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp---s~~e~l~ 283 (312)
T 2iwi_A 217 ALPATVWSLGILLYDMVCGDIPFERDQ------EILE--AELHFPA--HVSPDCCALIRRCLAPKPSSRP---SLEEILL 283 (312)
T ss_dssp HHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH--TCCCCCT--TSCHHHHHHHHHHTCSSTTTSC---CHHHHHH
T ss_pred CccchHHHHHHHHHHHHHCCCCCCChH------HHhh--hccCCcc--cCCHHHHHHHHHHccCChhhCc---CHHHHhc
Confidence 458999999999999999999997532 2322 2344554 689999999999999 999999 9999999
Q ss_pred CCccccCC
Q 010266 412 HPWFKDIA 419 (514)
Q Consensus 412 Hpff~~i~ 419 (514)
||||+...
T Consensus 284 ~~~~~~~~ 291 (312)
T 2iwi_A 284 DPWMQTPA 291 (312)
T ss_dssp STTTCC--
T ss_pred ChhhcCch
Confidence 99998653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=361.66 Aligned_cols=253 Identities=20% Similarity=0.284 Sum_probs=217.8
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
..+..++|++++.||+|+||.||+|.+. +++.||+|++.+... ..+.+.+|..++..++||||+++++++.+.+.
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 77 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 77 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred eEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3456789999999999999999999986 677899999986542 23568899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
+|+||||++||+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.+|++||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 99999999999999999765 56899999999999999999999999999999999999999999999999998754311
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
. ........||+.|+|||++.+..++.++|+|
T Consensus 158 ~------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 189 (267)
T 3t9t_A 158 Q------------------------------------------------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 189 (267)
T ss_dssp H------------------------------------------------HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHH
T ss_pred c------------------------------------------------ccccccccccccccChhhhcCCCccchhchh
Confidence 0 0011245688999999999999999999999
Q ss_pred hhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 340 SLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 340 SlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
||||++|+|++ |.+||.+.+..+....+.... ....| ...++++.+||.+||. ||.+|+ ++.+++++
T Consensus 190 slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~~ 258 (267)
T 3t9t_A 190 SFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-RLYKP--RLASTHVYQIMNHCWRERPEDRP---AFSRLLRQ 258 (267)
T ss_dssp HHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred hhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC-cCCCC--ccCcHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 99999999999 999999988888887776532 22223 3678999999999999 999999 99998863
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=374.67 Aligned_cols=253 Identities=20% Similarity=0.325 Sum_probs=208.6
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEE----EEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIY----AMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA 178 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~----AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 178 (514)
+..++|++++.||+|+||.||+|++..+++.+ |+|.+... ........+.+|..+|..++||||++++++|.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC--SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc--cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 55689999999999999999999998888766 55544332 2344567788999999999999999999999876
Q ss_pred CeEEEEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
. .++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 5 8899999999999999976 4679999999999999999999999999999999999999999999999999998653
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
..... .......||+.|+|||++.+..|+.++|
T Consensus 169 ~~~~~-----------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~D 201 (327)
T 3lzb_A 169 AEEKE-----------------------------------------------YHAEGGKVPIKWMALESILHRIYTHQSD 201 (327)
T ss_dssp ----------------------------------------------------------CCCGGGSCHHHHHHCCCCHHHH
T ss_pred Ccccc-----------------------------------------------ccccCCCccccccCHHHHcCCCCChHHH
Confidence 22100 0111346889999999999999999999
Q ss_pred hhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 338 WWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 338 iWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
||||||++|||++ |.+||.+.+..+....+... . ..|....+++++.+||.+||. ||.+|+ ++.|+++
T Consensus 202 i~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~ 271 (327)
T 3lzb_A 202 VWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-E--RLPQPPICTIDVYMIMRKCWMIDADSRP---KFRELII 271 (327)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-C--CCCCCTTBCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-C--CCCCCccCCHHHHHHHHHHcCCChhHCc---CHHHHHH
Confidence 9999999999999 99999998887776666542 2 233334689999999999999 999999 9999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=382.85 Aligned_cols=275 Identities=17% Similarity=0.187 Sum_probs=206.0
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccC-----CCEEEEEEeecccccChhhH--------HHHHHHHHHHHHcCCCcee
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKS-----GNIYAMKKLKKSEMLSRGQV--------EHVRAERNLLAEVASHCIV 169 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t-----~~~~AiK~l~k~~~~~~~~~--------~~~~~E~~iL~~l~hp~Iv 169 (514)
+..++|++++.||+|+||.||+|.++.+ ++.||||++.........+. .....|...+..++|||||
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 4456999999999999999999998765 57899999876531111111 1223345556677899999
Q ss_pred eEEEEEEcC----CeEEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCcccc--CC
Q 010266 170 KLYYSFQDA----EYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD--QN 242 (514)
Q Consensus 170 ~l~~~f~~~----~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld--~~ 242 (514)
++++++.+. .++|+||||+ ||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 999998764 5699999999 99999999775 6899999999999999999999999999999999999999 88
Q ss_pred CcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcC
Q 010266 243 GHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYI 322 (514)
Q Consensus 243 g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~ 322 (514)
|++||+|||+|+.+......... ........+||+.|+
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~------------------------------------------~~~~~~~~~gt~~y~ 228 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAY------------------------------------------AADPKRCHDGTIEFT 228 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCS------------------------------------------SCCSSCCCCCCTTTC
T ss_pred CeEEEEECCcceecccCCccccc------------------------------------------ccCcccccCCCCCcc
Confidence 99999999999865422110000 000112567999999
Q ss_pred CccccccCCCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhh--cCcc------cCCcCcCCChhHHHHHhhhc
Q 010266 323 APEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHW--KNHL------KFPEEARLTPEAKDLICRLL 394 (514)
Q Consensus 323 APEvl~~~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~------~~p~~~~~s~~~~dLI~~lL 394 (514)
|||++.+..++.++|||||||++|||++|..||.+............. ...+ .++ ...+++++.+||..||
T Consensus 229 aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl 307 (364)
T 3op5_A 229 SIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFP-AANAPGEIAKYMETVK 307 (364)
T ss_dssp CHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSC-TTCCCHHHHHHHHHHH
T ss_pred CHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcc-cccCHHHHHHHHHHHh
Confidence 999999999999999999999999999999999864333332222110 0000 111 1367899999999999
Q ss_pred c-CccccCCCCCHhHHhc----------CCccccCCccccc
Q 010266 395 C-DVEHRLGTLGSEQIKA----------HPWFKDIAWDKLY 424 (514)
Q Consensus 395 ~-dp~~Rl~~~~~~eil~----------Hpff~~i~w~~l~ 424 (514)
. ||.+|+ ++++|++ .++-..+||..+.
T Consensus 308 ~~~p~~RP---~~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 345 (364)
T 3op5_A 308 LLDYTEKP---LYENLRDILLQGLKAIGSKDDGKLDLSVVE 345 (364)
T ss_dssp TCCTTCCC---CHHHHHHHHHHHHHHTTCCCCCCCCC----
T ss_pred cCCCCCCC---CHHHHHHHHHHHHHHcCCCcCCccceEecc
Confidence 9 999999 8877764 3444455665443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=366.27 Aligned_cols=256 Identities=29% Similarity=0.494 Sum_probs=206.7
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 181 (514)
....++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|..++..++||||++++++|.+.+.+
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 34567899999999999999999999999999999999876665666778899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 182 YLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
|+||||++||+|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++....
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999999864 4568999999999999999999999999999999999999999999999999987543
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
... .......||+.|+|||++.+..++.++|
T Consensus 188 ~~~-------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~D 218 (310)
T 2wqm_A 188 SKT-------------------------------------------------TAAHSLVGTPYYMSPERIHENGYNFKSD 218 (310)
T ss_dssp ------------------------------------------------------------CCSSCCHHHHTTCCCCHHHH
T ss_pred CCC-------------------------------------------------ccccccCCCeeEeChHHhCCCCCCchhh
Confidence 210 0112457999999999999999999999
Q ss_pred hhhhhHHHHHHhhCCCCCCCCCh--hHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 338 WWSLGAIMYEMLVGYPPFYSDDP--VTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 338 iWSlGvilyemltG~~PF~~~~~--~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
+|||||++|+|++|..||.+... ......+.... ....+ ...+++++.+||.+||. ||.+|+ ++++|++
T Consensus 219 v~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~l~~li~~~l~~dp~~Rp---s~~~il~ 290 (310)
T 2wqm_A 219 IWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD-YPPLP-SDHYSEELRQLVNMCINPDPEKRP---DVTYVYD 290 (310)
T ss_dssp HHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC-SCCCC-TTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc-CCCCc-ccccCHHHHHHHHHHcCCChhhCC---CHHHHHH
Confidence 99999999999999999986532 33444443321 11122 23689999999999999 999999 9999886
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=382.92 Aligned_cols=257 Identities=20% Similarity=0.326 Sum_probs=208.8
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEc---cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEK---KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 177 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~---~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 177 (514)
..+..++|++.+.||+|+||.||+|+++ .++..||||+++... .....+.+.+|..+|..++|||||++++++.+
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 3566789999999999999999999877 467789999997642 44566778999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccC
Q 010266 178 AEYLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256 (514)
Q Consensus 178 ~~~l~lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~ 256 (514)
...+|+||||++||+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+++..
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999999999997654 7999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCccc
Q 010266 257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336 (514)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 336 (514)
....... .......||+.|+|||++.+..++.++
T Consensus 198 ~~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~ 231 (373)
T 2qol_A 198 EDDPEAA----------------------------------------------YTTRGGKIPIRWTSPEAIAYRKFTSAS 231 (373)
T ss_dssp --------------------------------------------------------------CTTSCHHHHHHCCCCHHH
T ss_pred ccCCccc----------------------------------------------eeccCCCcCCCccChhhhccCCcCchh
Confidence 4211000 001123578899999999999999999
Q ss_pred chhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 337 DWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 337 DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|||||||++|||++ |..||.+.+..+....+... ...|....+++++.+||.+||. ||.+|+ ++++|++
T Consensus 232 Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~RP---s~~~i~~ 302 (373)
T 2qol_A 232 DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG---YRLPPPMDCPAALYQLMLDCWQKDRNNRP---KFEQIVS 302 (373)
T ss_dssp HHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTT---EECCCCTTCBHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCccccHHHHHHHHHHhCcChhhCc---CHHHHHH
Confidence 99999999999998 99999998888777776542 3344445788999999999999 999999 8888875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=373.20 Aligned_cols=253 Identities=21% Similarity=0.232 Sum_probs=200.7
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC--
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE-- 179 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~-- 179 (514)
.+..++|++++.||+|+||+||+|++. ++.||||++.... ........|..+|..++|||||++++++.+..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV 93 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred ccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence 356789999999999999999999865 7899999996542 33344556888899999999999999998743
Q ss_pred --eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC----------CeEEcCCCCCCccccCCCcEEE
Q 010266 180 --YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH----------NYIHRDIKPDNLLLDQNGHMKL 247 (514)
Q Consensus 180 --~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~----------giiHrDLKpeNILld~~g~iKL 247 (514)
.+|+||||++||+|.+++.. ..+++..+..++.|++.||.|||+. ||+||||||+|||++.+|++||
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred CceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 47999999999999999965 5699999999999999999999999 9999999999999999999999
Q ss_pred ccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccc
Q 010266 248 SDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL 327 (514)
Q Consensus 248 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl 327 (514)
+|||+|+........ ......+||+.|+|||++
T Consensus 173 ~DFg~a~~~~~~~~~-----------------------------------------------~~~~~~~gt~~y~aPE~~ 205 (322)
T 3soc_A 173 ADFGLALKFEAGKSA-----------------------------------------------GDTHGQVGTRRYMAPEVL 205 (322)
T ss_dssp CCCTTCEEECTTSCC-----------------------------------------------CCCTTCCCCGGGCCHHHH
T ss_pred ccCCcccccccccCc-----------------------------------------------cccccCccCccccCHhhc
Confidence 999999765422100 011246899999999999
Q ss_pred cc-----CCCCcccchhhhhHHHHHHhhCCCCCCCCCh----------------hHHHHHHhhhcCcccCCcC---cCCC
Q 010266 328 LK-----KGYGMECDWWSLGAIMYEMLVGYPPFYSDDP----------------VTTCRKIVHWKNHLKFPEE---ARLT 383 (514)
Q Consensus 328 ~~-----~~y~~~~DiWSlGvilyemltG~~PF~~~~~----------------~~~~~~i~~~~~~~~~p~~---~~~s 383 (514)
.+ ..++.++|||||||++|||++|.+||.+... ......+........++.. ...+
T Consensus 206 ~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (322)
T 3soc_A 206 EGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGM 285 (322)
T ss_dssp TTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHH
T ss_pred ccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchH
Confidence 87 4567789999999999999999999976432 1222222221111112210 1123
Q ss_pred hhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 384 PEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 384 ~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
+++.+||.+||. ||.+|+ ++.||++
T Consensus 286 ~~l~~li~~cl~~dP~~Rp---s~~ell~ 311 (322)
T 3soc_A 286 AMLCETIEECWDHDAEARL---SAGCVGE 311 (322)
T ss_dssp HHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 459999999999 999999 8999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=362.47 Aligned_cols=257 Identities=25% Similarity=0.354 Sum_probs=217.8
Q ss_pred CCCCCCeeEEe-eeeecCceEEEEEEEc--cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC
Q 010266 102 KISVDDFDLLT-IIGRGAFGEVRLCQEK--KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA 178 (514)
Q Consensus 102 ~~~~~~f~~~~-~LG~G~fG~V~l~~~~--~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 178 (514)
.+..++|.++. .||+|+||.||+|.++ .++..||+|+++... .....+.+.+|..+|..++||||+++++++. .
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 81 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-A 81 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-S
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-C
Confidence 34567898988 9999999999999854 467889999998652 4556778999999999999999999999995 5
Q ss_pred CeEEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
+.+|+||||++||+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++....
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 6699999999999999998654 569999999999999999999999999999999999999999999999999998654
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
..... ........||+.|+|||++.+..++.++|
T Consensus 162 ~~~~~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 195 (287)
T 1u59_A 162 ADDSY----------------------------------------------YTARSAGKWPLKWYAPECINFRKFSSRSD 195 (287)
T ss_dssp TCSCE----------------------------------------------ECCCCSSCCCGGGCCHHHHHHCEECHHHH
T ss_pred cCcce----------------------------------------------eeccccccccccccCHHHhccCCCCchhh
Confidence 22110 00111346899999999999899999999
Q ss_pred hhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCC
Q 010266 338 WWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHP 413 (514)
Q Consensus 338 iWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hp 413 (514)
+|||||++|+|++ |.+||.+.+..+....+.... ...+| ..+++++.+||.+||. ||.+|+ ++.++++|.
T Consensus 196 i~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~~l 267 (287)
T 1u59_A 196 VWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RMECP--PECPPELYALMSDCWIYKWEDRP---DFLTVEQRM 267 (287)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHTTCSSGGGSC---CHHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC-cCCCC--CCcCHHHHHHHHHHcCCChhhCc---CHHHHHHHH
Confidence 9999999999998 999999988877777776532 23444 3689999999999999 999999 999999863
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=364.77 Aligned_cols=256 Identities=22% Similarity=0.358 Sum_probs=207.9
Q ss_pred CCCCCeeEEeeeeecCceEEEEEE----EccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQ----EKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA 178 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~----~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 178 (514)
+....|++++.||+|+||.||+|+ +..+++.||+|++.... .......+.+|..+|..++||||+++++++.+.
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 445679999999999999999998 56789999999997653 344567789999999999999999999999877
Q ss_pred --CeEEEEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 179 --EYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 179 --~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
..+|+||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||++..
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence 679999999999999999954 46799999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcc
Q 010266 256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME 335 (514)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~ 335 (514)
....... ........||+.|+|||++.+..++.+
T Consensus 176 ~~~~~~~----------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~ 209 (302)
T 4e5w_A 176 IETDKEY----------------------------------------------YTVKDDRDSPVFWYAPECLMQSKFYIA 209 (302)
T ss_dssp CCTTCCE----------------------------------------------EECCCCTTCCGGGCCHHHHHHCEEEHH
T ss_pred ccCCCcc----------------------------------------------eeccCCCCCCccccCCeeecCCCCCcc
Confidence 5432110 001124578999999999999999999
Q ss_pred cchhhhhHHHHHHhhCCCCCCCC--------------ChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-Ccccc
Q 010266 336 CDWWSLGAIMYEMLVGYPPFYSD--------------DPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHR 400 (514)
Q Consensus 336 ~DiWSlGvilyemltG~~PF~~~--------------~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R 400 (514)
+|+|||||++|+|++|..|+... .........+. .....+....+++++.+||.+||. ||.+|
T Consensus 210 ~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 287 (302)
T 4e5w_A 210 SDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK--EGKRLPCPPNCPDEVYQLMRKCWEFQPSNR 287 (302)
T ss_dssp HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH--TTCCCCCCTTCCHHHHHHHHHTTCSSGGGS
T ss_pred hhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh--ccCCCCCCCCCCHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999986422 11112222222 222333334789999999999999 99999
Q ss_pred CCCCCHhHHhc
Q 010266 401 LGTLGSEQIKA 411 (514)
Q Consensus 401 l~~~~~~eil~ 411 (514)
+ +++++++
T Consensus 288 p---s~~~ll~ 295 (302)
T 4e5w_A 288 T---SFQNLIE 295 (302)
T ss_dssp C---CHHHHHH
T ss_pred C---CHHHHHH
Confidence 9 8998875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=385.75 Aligned_cols=248 Identities=24% Similarity=0.408 Sum_probs=213.6
Q ss_pred hcCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC
Q 010266 99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA 178 (514)
Q Consensus 99 ~~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 178 (514)
....+..++|++++.||+|+||.||++..+ |+.||||+++... ..+.+.+|..+|+.++|||||++++++.+.
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 258 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence 345678899999999999999999999864 7799999997643 345688999999999999999999998765
Q ss_pred C-eEEEEEeecCCCCHHHHHhhccC--CCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 179 E-YLYLIMEYLPGGDVMTLLMREET--LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 179 ~-~l~lVmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
. .+|+||||++||+|.+++...+. +++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+.
T Consensus 259 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 4 79999999999999999987643 79999999999999999999999999999999999999999999999999874
Q ss_pred CCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcc
Q 010266 256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME 335 (514)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~ 335 (514)
.... .....+|+.|+|||++.+..++.+
T Consensus 339 ~~~~----------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~ 366 (450)
T 1k9a_A 339 ASST----------------------------------------------------QDTGKLPVKWTAPEALREKKFSTK 366 (450)
T ss_dssp CC----------------------------------------------------------CCCTTTSCHHHHHSSCCCHH
T ss_pred cccc----------------------------------------------------ccCCCCCcceeCHHHhcCCCCCcH
Confidence 3211 012367899999999999999999
Q ss_pred cchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 336 CDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 336 ~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
+|||||||+||||++ |..||.+.+..+....+... ..+..| ..+++++.+||.+||. ||.+|+ ++.+|+.
T Consensus 367 sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~p--~~~~~~l~~li~~cl~~dp~~Rp---t~~~l~~ 438 (450)
T 1k9a_A 367 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAP--DGCPPAVYDVMKNCWHLDAATRP---TFLQLRE 438 (450)
T ss_dssp HHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CcCCHHHHHHHHHHcCCChhHCc---CHHHHHH
Confidence 999999999999998 99999988887777777643 223344 4789999999999999 999999 8888874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=361.37 Aligned_cols=266 Identities=20% Similarity=0.281 Sum_probs=210.2
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEE-EEEEcCCeEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLY-YSFQDAEYLYL 183 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~-~~f~~~~~l~l 183 (514)
.++|++.+.||+|+||+||+|++..+++.||||++...... ..+..|..++..+.|++++..+ .++.+.+..|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 37899999999999999999999999999999987655322 2377899999999887755554 55578889999
Q ss_pred EEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccc---cCCCcEEEccccccccCCCC
Q 010266 184 IMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILl---d~~g~iKL~DFGla~~~~~~ 259 (514)
||||+ ||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+|+.....
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99999 9999999974 5679999999999999999999999999999999999999 78999999999999865432
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
...... + .......+||+.|+|||++.+..++.++|||
T Consensus 162 ~~~~~~--------------------~----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 199 (296)
T 4hgt_A 162 RTHQHI--------------------P----------------------YRENKNLTGTARYASINTHLGIEQSRRDDLE 199 (296)
T ss_dssp TTCCBC--------------------C----------------------CCCSCCCCSCGGGCCHHHHTTCCCCHHHHHH
T ss_pred ccCccC--------------------C----------------------CCcccccCCCccccchHHhcCCCCCchhHHH
Confidence 110000 0 0012256899999999999999999999999
Q ss_pred hhhHHHHHHhhCCCCCCCCChh---HHHHHHhhhcCcccCCc---CcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc-
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPV---TTCRKIVHWKNHLKFPE---EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA- 411 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~---~~~~~i~~~~~~~~~p~---~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~- 411 (514)
||||++|+|++|.+||.+.+.. .....+... ....|. ...+++++.+||.+||. ||.+|+ ++++|++
T Consensus 200 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~l~~~ 274 (296)
T 4hgt_A 200 SLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK--KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKP---DYSYLRQL 274 (296)
T ss_dssp HHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH--HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCC---CHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc--cccchhhhhhccCCHHHHHHHHHHHhcCCCCCC---CHHHHHHH
Confidence 9999999999999999875432 333444331 122221 13578999999999999 999999 8888775
Q ss_pred ---------CCccccCCcccc
Q 010266 412 ---------HPWFKDIAWDKL 423 (514)
Q Consensus 412 ---------Hpff~~i~w~~l 423 (514)
.+|-..+||+.+
T Consensus 275 l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 4hgt_A 275 FRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp HHHHHHHHTCCTTCCCGGGGC
T ss_pred HHHHHHHhCCCccCccchhhc
Confidence 456666778765
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=393.89 Aligned_cols=253 Identities=22% Similarity=0.348 Sum_probs=219.5
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
..+..++|++.+.||+|+||.||+|.++.++..||||+++... ...+.+.+|..+|..++|||||+++++|.+...
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 290 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 4556678999999999999999999999999999999997653 235678899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 99999999999999999763 4689999999999999999999999999999999999999999999999999986532
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
.... ......||+.|+|||++.+..|+.++||
T Consensus 371 ~~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDv 402 (495)
T 1opk_A 371 DTYT------------------------------------------------AHAGAKFPIKWTAPESLAYNKFSIKSDV 402 (495)
T ss_dssp CCEE------------------------------------------------CCTTCCCCGGGCCHHHHHHCEECHHHHH
T ss_pred Ccee------------------------------------------------ecCCCcCCcceeCHhHHhcCCCCcHHhH
Confidence 1100 0113457889999999999999999999
Q ss_pred hhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 339 WSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 339 WSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|||||+||||++ |.+||.+.+..+....+... ..+..| ..+++++.+||.+||. ||.+|+ ++.+|++
T Consensus 403 wSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~cl~~dP~~RP---s~~el~~ 471 (495)
T 1opk_A 403 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMERP--EGCPEKVYELMRACWQWNPSDRP---SFAEIHQ 471 (495)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcCcChhHCc---CHHHHHH
Confidence 999999999999 99999998887777666542 223333 4789999999999999 999999 9999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=373.62 Aligned_cols=261 Identities=20% Similarity=0.287 Sum_probs=217.0
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEE-----EccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQ-----EKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 176 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~-----~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 176 (514)
.+..++|++++.||+|+||.||+|+ +..++..||+|++... ........+.+|..++..++||||+++++++.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 4667899999999999999999998 5567889999999643 24455667889999999999999999999999
Q ss_pred cCCeEEEEEeecCCCCHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCC---CcEE
Q 010266 177 DAEYLYLIMEYLPGGDVMTLLMRE-------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN---GHMK 246 (514)
Q Consensus 177 ~~~~l~lVmEy~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~---g~iK 246 (514)
+...+|+||||++||+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.+ +.+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 999999999999999999999765 348899999999999999999999999999999999999954 4699
Q ss_pred EccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccc
Q 010266 247 LSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEV 326 (514)
Q Consensus 247 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEv 326 (514)
|+|||++........ ........||+.|+|||+
T Consensus 184 l~Dfg~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~y~aPE~ 216 (327)
T 2yfx_A 184 IGDFGMARDIYRASY-----------------------------------------------YRKGGCAMLPVKWMPPEA 216 (327)
T ss_dssp ECCCHHHHHHHC-----------------------------------------------------CCGGGSCGGGCCHHH
T ss_pred ECccccccccccccc-----------------------------------------------cccCCCcCCCcceeCHhH
Confidence 999999875321100 001124578999999999
Q ss_pred cccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC
Q 010266 327 LLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL 404 (514)
Q Consensus 327 l~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~ 404 (514)
+.+..++.++|||||||++|+|++ |.+||.+.+..+....+.... ....| ..+++.+.+||.+||. ||.+|+
T Consensus 217 ~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rp--- 290 (327)
T 2yfx_A 217 FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-RMDPP--KNCPGPVYRIMTQCWQHQPEDRP--- 290 (327)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---
T ss_pred hcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC-CCCCC--CCCCHHHHHHHHHHhcCChhhCc---
Confidence 999999999999999999999998 999999988877777776532 22233 4689999999999999 999999
Q ss_pred CHhHHhcCCcccc
Q 010266 405 GSEQIKAHPWFKD 417 (514)
Q Consensus 405 ~~~eil~Hpff~~ 417 (514)
++.+|++|+|+-.
T Consensus 291 s~~~ll~~l~~~~ 303 (327)
T 2yfx_A 291 NFAIILERIEYCT 303 (327)
T ss_dssp CHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHh
Confidence 9999999988753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=363.14 Aligned_cols=257 Identities=24% Similarity=0.324 Sum_probs=215.3
Q ss_pred CCCCCCCeeEEe-eeeecCceEEEEEEE--ccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc
Q 010266 101 HKISVDDFDLLT-IIGRGAFGEVRLCQE--KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 177 (514)
Q Consensus 101 ~~~~~~~f~~~~-~LG~G~fG~V~l~~~--~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 177 (514)
..+..++|.+.+ .||+|+||.||+|.. +.+++.||+|++.... ......+.+.+|..++..++||||+++++++ +
T Consensus 11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 445667899998 999999999999954 5677899999997653 2344467789999999999999999999999 5
Q ss_pred CCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 178 AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 178 ~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
.+.+|+||||++||+|.+++...+.+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++....
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 67789999999999999999988889999999999999999999999999999999999999999999999999998654
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
...... .......||+.|+|||++.+..++.++|
T Consensus 169 ~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~D 202 (291)
T 1xbb_A 169 ADENYY----------------------------------------------KAQTHGKWPVKWYAPECINYYKFSSKSD 202 (291)
T ss_dssp TTCSEE----------------------------------------------EC----CCCGGGCCHHHHHHCEEEHHHH
T ss_pred cCCCcc----------------------------------------------cccccCCCCceeeChHHhccCCCChhhh
Confidence 221100 0011345789999999999989999999
Q ss_pred hhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 338 WWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 338 iWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
+|||||++|+|++ |..||.+.+..+....+... ....+| ..+++++.+||.+||. ||.+|+ ++.+|++
T Consensus 203 i~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~~l~~ 272 (291)
T 1xbb_A 203 VWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGCP--AGCPREMYDLMNLCWTYDVENRP---GFAAVEL 272 (291)
T ss_dssp HHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSTTTSC---CHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 9999999999999 99999998887777766543 223344 3689999999999999 999999 8888875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=361.77 Aligned_cols=255 Identities=25% Similarity=0.317 Sum_probs=214.0
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEcc---CCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKK---SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 177 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~---t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 177 (514)
..+..++|++.+.||+|+||+||+|++.. ++..||+|++.+.. .....+.+.+|..+++.++||||+++++++.+
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 45667899999999999999999998754 34569999997653 34556778999999999999999999999875
Q ss_pred CCeEEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccC
Q 010266 178 AEYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256 (514)
Q Consensus 178 ~~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~ 256 (514)
. ..|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||++...
T Consensus 85 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 85 E-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred C-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 4 578999999999999999765 46999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCccc
Q 010266 257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336 (514)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 336 (514)
..... .......||+.|+|||++.+..++.++
T Consensus 164 ~~~~~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~ 195 (281)
T 3cc6_A 164 EDEDY------------------------------------------------YKASVTRLPIKWMSPESINFRRFTTAS 195 (281)
T ss_dssp ---------------------------------------------------------CCCCCGGGCCHHHHHHCCCCHHH
T ss_pred ccccc------------------------------------------------cccccCCCCcceeCchhhccCCCCchh
Confidence 32110 001134688999999999999999999
Q ss_pred chhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 337 DWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 337 DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
|+|||||++|+|++ |..||...+.......+... .....| ..+++.+.+||.+||. ||.+|+ ++.|+++|
T Consensus 196 Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~ell~~ 267 (281)
T 3cc6_A 196 DVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-DRLPKP--DLCPPVLYTLMTRCWDYDPSDRP---RFTELVCS 267 (281)
T ss_dssp HHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred ccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC-CCCCCC--CCCCHHHHHHHHHHccCCchhCc---CHHHHHHH
Confidence 99999999999998 99999988777776666542 222333 4689999999999999 999999 99999864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=370.89 Aligned_cols=256 Identities=24% Similarity=0.397 Sum_probs=212.4
Q ss_pred CCCCCeeEEeeeeecCceEEEEEE----EccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE--
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQ----EKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ-- 176 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~----~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~-- 176 (514)
+..++|++++.||+|+||.||+|+ +..+++.||+|++.+. .....+.+.+|..+|..++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 456899999999999999999998 4678999999999765 3455677899999999999999999999886
Q ss_pred cCCeEEEEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 177 DAEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 177 ~~~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
+...+|+||||++||+|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++..
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence 56779999999999999999977 45699999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcc
Q 010266 256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME 335 (514)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~ 335 (514)
........ .......||+.|+|||++.+..++.+
T Consensus 177 ~~~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~ 210 (327)
T 3lxl_A 177 LPLDKDYY----------------------------------------------VVREPGQSPIFWYAPESLSDNIFSRQ 210 (327)
T ss_dssp CCTTCSEE----------------------------------------------ECSSCCCSCGGGSCHHHHHHCEEEHH
T ss_pred cccCCccc----------------------------------------------eeeccCCccccccCHHHhccCCCChH
Confidence 54321100 01124568999999999999999999
Q ss_pred cchhhhhHHHHHHhhCCCCCCCCChh--------------HHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-Ccccc
Q 010266 336 CDWWSLGAIMYEMLVGYPPFYSDDPV--------------TTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHR 400 (514)
Q Consensus 336 ~DiWSlGvilyemltG~~PF~~~~~~--------------~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R 400 (514)
+|||||||++|+|++|..||...... ......+. .....+....+++++.+||.+||. ||.+|
T Consensus 211 ~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 288 (327)
T 3lxl_A 211 SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE--EGQRLPAPPACPAEVHELMKLCWAPSPQDR 288 (327)
T ss_dssp HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH--TTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh--cccCCCCCCcccHHHHHHHHHHcCCChhhC
Confidence 99999999999999999999754322 11111122 122333334789999999999999 99999
Q ss_pred CCCCCHhHHhcC
Q 010266 401 LGTLGSEQIKAH 412 (514)
Q Consensus 401 l~~~~~~eil~H 412 (514)
+ +++++++|
T Consensus 289 p---s~~ell~~ 297 (327)
T 3lxl_A 289 P---SFSALGPQ 297 (327)
T ss_dssp C---CHHHHHHH
T ss_pred c---CHHHHHHH
Confidence 9 89999653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=369.98 Aligned_cols=258 Identities=21% Similarity=0.309 Sum_probs=214.2
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCC----CEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSG----NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 176 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~----~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 176 (514)
..+..++|.+.+.||+|+||.||+|..+.++ ..||+|++.... .......+.+|..++..++||||+++++++.
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 4577889999999999999999999987653 359999997542 3445667889999999999999999999999
Q ss_pred cCCeEEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 177 DAEYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 177 ~~~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
+.+.+|+||||++||+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|++||+|||+++.
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999999999764 6799999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcc
Q 010266 256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME 335 (514)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~ 335 (514)
........ .......||+.|+|||++.+..++.+
T Consensus 197 ~~~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~ 230 (333)
T 1mqb_A 197 LEDDPEAT----------------------------------------------YTTSGGKIPIRWTAPEAISYRKFTSA 230 (333)
T ss_dssp ------------------------------------------------------------CCCGGGSCHHHHHSCCCCHH
T ss_pred hccccccc----------------------------------------------cccCCCCccccccCchhcccCCCCch
Confidence 54221000 00113457889999999999999999
Q ss_pred cchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 336 CDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 336 ~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
+|+|||||++|||++ |..||.+.+..+....+... ...|....+++++.+||.+||. ||.+|+ ++.+|+++
T Consensus 231 ~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~~ 303 (333)
T 1mqb_A 231 SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG---FRLPTPMDCPSAIYQLMMQCWQQERARRP---KFADIVSI 303 (333)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT---CCCCCCTTCBHHHHHHHHHHTCSSTTTSC---CHHHHHHH
T ss_pred hhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC---CcCCCcccCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 999999999999998 99999998888887777653 2333334789999999999999 999999 89998864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=364.31 Aligned_cols=258 Identities=22% Similarity=0.338 Sum_probs=209.1
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEcc-CCC--EEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKK-SGN--IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA 178 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~-t~~--~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 178 (514)
.+..++|++++.||+|+||.||+|++.. +++ .||+|+++..........+.+.+|..++..++||||+++++++.+.
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 3456789999999999999999998653 333 6899999876555556678899999999999999999999999876
Q ss_pred CeEEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
. .++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||++....
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 5 89999999999999999764 679999999999999999999999999999999999999999999999999998654
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
...... .......||+.|+|||++.+..++.++|
T Consensus 173 ~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~D 206 (291)
T 1u46_A 173 QNDDHY----------------------------------------------VMQEHRKVPFAWCAPESLKTRTFSHASD 206 (291)
T ss_dssp C-CCEE----------------------------------------------EC-----CCGGGCCHHHHHHCEEEHHHH
T ss_pred ccccch----------------------------------------------hhhccCCCCceeeCchhhcCCCCCchhh
Confidence 321100 0112456889999999999999999999
Q ss_pred hhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 338 WWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 338 iWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
+|||||++|+|++ |.+||.+.+..+....+..... ..|....+++++.+||.+||. ||.+|+ ++.++++
T Consensus 207 i~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~ 277 (291)
T 1u46_A 207 TWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE--RLPRPEDCPQDIYNVMVQCWAHKPEDRP---TFVALRD 277 (291)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC--CCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCC--CCCCCcCcCHHHHHHHHHHccCCcccCc---CHHHHHH
Confidence 9999999999999 9999999988888888776333 334344789999999999999 999999 9999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=357.34 Aligned_cols=252 Identities=23% Similarity=0.371 Sum_probs=214.5
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE 179 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 179 (514)
...+..++|++++.||+|+||.||+|... ++..||+|++..... ..+.+.+|..+|..++||||+++++++. .+
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 80 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVT-QE 80 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEc-CC
Confidence 34567789999999999999999999865 567899999976532 3456889999999999999999999886 45
Q ss_pred eEEEEEeecCCCCHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
..|+||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||++....
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 6899999999999999997643 79999999999999999999999999999999999999999999999999998654
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
..... ......||+.|+|||++.+..++.++|
T Consensus 161 ~~~~~------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~D 192 (279)
T 1qpc_A 161 DNEYT------------------------------------------------AREGAKFPIKWTAPEAINYGTFTIKSD 192 (279)
T ss_dssp SSCEE------------------------------------------------CCTTCCCCTTTSCHHHHHHCEECHHHH
T ss_pred Ccccc------------------------------------------------cccCCCCccCccChhhhccCCCCchhh
Confidence 22100 011346889999999999889999999
Q ss_pred hhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 338 WWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 338 iWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
+|||||++|||++ |.+||.+.+..+....+.... ....| ..+++++.+||.+||. ||.+|+ ++++|++
T Consensus 193 i~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~ 262 (279)
T 1qpc_A 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY-RMVRP--DNCPEELYQLMRLCWKERPEDRP---TFDYLRS 262 (279)
T ss_dssp HHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred hHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc-CCCCc--ccccHHHHHHHHHHhccChhhCC---CHHHHHH
Confidence 9999999999999 999999988888777776421 22233 4689999999999999 999999 8888875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=366.01 Aligned_cols=260 Identities=20% Similarity=0.313 Sum_probs=210.3
Q ss_pred hcCCCCCCCeeEEeeeeecCceEEEEEEEcc---CCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEE
Q 010266 99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKK---SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSF 175 (514)
Q Consensus 99 ~~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~---t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 175 (514)
....+..++|.+.+.||+|+||.||+|.... ++..||+|++.... ......+.+.+|..++..++||||+++++++
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN-SSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc-cchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 3445667899999999999999999998765 55689999997653 2445567789999999999999999999999
Q ss_pred EcCC-----eEEEEEeecCCCCHHHHHh------hccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCc
Q 010266 176 QDAE-----YLYLIMEYLPGGDVMTLLM------REETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH 244 (514)
Q Consensus 176 ~~~~-----~l~lVmEy~~gg~L~~~l~------~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~ 244 (514)
.+.. ..|+||||+++|+|..++. ....+++..+..++.|++.||.|||+.||+||||||+|||++.+|+
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence 8755 4599999999999999984 3357999999999999999999999999999999999999999999
Q ss_pred EEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCc
Q 010266 245 MKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAP 324 (514)
Q Consensus 245 iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~AP 324 (514)
+||+|||+++........ .......||+.|+||
T Consensus 186 ~kl~Dfg~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y~aP 218 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYY-----------------------------------------------RQGRIAKMPVKWIAI 218 (313)
T ss_dssp EEECSCSCC---------------------------------------------------------------CCGGGSCH
T ss_pred EEEeecCcceeccccccc-----------------------------------------------CcccccCCCccccCc
Confidence 999999998765322100 001134688999999
Q ss_pred cccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCC
Q 010266 325 EVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLG 402 (514)
Q Consensus 325 Evl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~ 402 (514)
|++.+..++.++|+|||||++|+|++ |.+||.+.+..+....+.... ....| ..+++++.+||.+||. ||.+|+
T Consensus 219 E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rp- 294 (313)
T 3brb_A 219 ESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH-RLKQP--EDCLDELYEIMYSCWRTDPLDRP- 294 (313)
T ss_dssp HHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CCCCB--TTCCHHHHHHHHHTTCSSGGGSC-
T ss_pred hhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC-CCCCC--ccccHHHHHHHHHHcCCChhhCc-
Confidence 99999999999999999999999999 999999988888887776532 22333 4689999999999998 999999
Q ss_pred CCCHhHHhcC
Q 010266 403 TLGSEQIKAH 412 (514)
Q Consensus 403 ~~~~~eil~H 412 (514)
++.+++.|
T Consensus 295 --s~~~l~~~ 302 (313)
T 3brb_A 295 --TFSVLRLQ 302 (313)
T ss_dssp --CHHHHHHH
T ss_pred --CHHHHHHH
Confidence 99999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=382.65 Aligned_cols=253 Identities=26% Similarity=0.384 Sum_probs=195.0
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCeEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lV 184 (514)
+.|.+.+.||+|+||+||.+ ...+|+.||||++... ..+.+.+|+.+|..+ +|||||++++++.+...+|+|
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred heeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 44566789999999999875 4578999999998653 234567899999876 899999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCC-------HHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCC-------------Cc
Q 010266 185 MEYLPGGDVMTLLMREETLT-------ETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-------------GH 244 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~~l~-------e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~-------------g~ 244 (514)
||||. |+|.+++....... +..+..++.||+.||.|||++||+||||||+|||++.+ ++
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 99995 69999997654432 23456799999999999999999999999999999754 48
Q ss_pred EEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCc
Q 010266 245 MKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAP 324 (514)
Q Consensus 245 iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~AP 324 (514)
+||+|||+|+......... .......+||+.|+||
T Consensus 167 ~kL~DFG~a~~~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aP 201 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSF---------------------------------------------RTNLNNPSGTSGWRAP 201 (434)
T ss_dssp EEECCCTTCEECCC-----------------------------------------------------------CCTTSCH
T ss_pred EEEcccccceecCCCCccc---------------------------------------------eeeecCCCCCCCccCH
Confidence 9999999998754321000 0011256899999999
Q ss_pred ccccc-------CCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCc-----CcCCChhHHHHHh
Q 010266 325 EVLLK-------KGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPE-----EARLTPEAKDLIC 391 (514)
Q Consensus 325 Evl~~-------~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~-----~~~~s~~~~dLI~ 391 (514)
|++.+ ..++.++|||||||++|||++ |.+||.+....+ ..++... ..++. ...+++++++||.
T Consensus 202 E~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~--~~~~~~~~~~~~~~~~~~~~li~ 277 (434)
T 2rio_A 202 ELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGI--FSLDEMKCLHDRSLIAEATDLIS 277 (434)
T ss_dssp HHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTC--CCCCCCTTCCCHHHHHHHHHHHH
T ss_pred HHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCC--CCcccccccccccchHHHHHHHH
Confidence 99976 678999999999999999999 999997655433 3444322 22221 1235689999999
Q ss_pred hhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 392 RLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 392 ~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
+||+ ||.+|+ ++.+|++||||...
T Consensus 278 ~~L~~dP~~Rp---s~~eil~hp~f~~~ 302 (434)
T 2rio_A 278 QMIDHDPLKRP---TAMKVLRHPLFWPK 302 (434)
T ss_dssp HHTCSSGGGSC---CHHHHHTSGGGSCH
T ss_pred HHhhCChhhCC---CHHHHHhCCccCCc
Confidence 9999 999999 99999999999653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=376.33 Aligned_cols=261 Identities=19% Similarity=0.202 Sum_probs=202.8
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEcc---CCCEEEEEEeecccccChh--------hHHHHHHHHHHHHHcCCCceeeE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKK---SGNIYAMKKLKKSEMLSRG--------QVEHVRAERNLLAEVASHCIVKL 171 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~---t~~~~AiK~l~k~~~~~~~--------~~~~~~~E~~iL~~l~hp~Iv~l 171 (514)
+..++|++.+.||+|+||.||+|++.. ++..||+|++.+....... ....+.+|..++..++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 445789999999999999999999987 7889999999865321111 11235567888899999999999
Q ss_pred EEEEEc----CCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC--cE
Q 010266 172 YYSFQD----AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG--HM 245 (514)
Q Consensus 172 ~~~f~~----~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g--~i 245 (514)
++++.+ ...+|+||||+ ||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 999987 78999999999 999999998888999999999999999999999999999999999999999887 99
Q ss_pred EEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcc
Q 010266 246 KLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPE 325 (514)
Q Consensus 246 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APE 325 (514)
||+|||+|+.+......... ........+||+.|+|||
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE 230 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQY------------------------------------------QENPRKGHNGTIEFTSLD 230 (345)
T ss_dssp EECCCTTCEESSGGGCCCCC------------------------------------------CCCGGGCSCSCTTTCCHH
T ss_pred EEEeCCCceecccccccccc------------------------------------------hhccccccCCCccccCHH
Confidence 99999999865422100000 000112568999999999
Q ss_pred ccccCCCCcccchhhhhHHHHHHhhCCCCCCCC--ChhHHHHHHhhhcCcccCCc-------CcCCChhHHHHHhhhcc-
Q 010266 326 VLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD--DPVTTCRKIVHWKNHLKFPE-------EARLTPEAKDLICRLLC- 395 (514)
Q Consensus 326 vl~~~~y~~~~DiWSlGvilyemltG~~PF~~~--~~~~~~~~i~~~~~~~~~p~-------~~~~s~~~~dLI~~lL~- 395 (514)
++.+..++.++|||||||++|||++|..||.+. +........... ...+|. ...+++++++||.+||.
T Consensus 231 ~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 308 (345)
T 2v62_A 231 AHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNL--LDELPQSVLKWAPSGSSCCEIAQFLVCAHSL 308 (345)
T ss_dssp HHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHH--HHTTTHHHHHHSCTTSCCHHHHHHHHHHHTC
T ss_pred HhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhh--cccccHHHHhhccccccHHHHHHHHHHHhhc
Confidence 999999999999999999999999999999653 222222221111 112221 12688999999999999
Q ss_pred CccccCCCCCHhHHhc
Q 010266 396 DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 396 dp~~Rl~~~~~~eil~ 411 (514)
||.+|+ ++++|++
T Consensus 309 dp~~Rp---s~~~l~~ 321 (345)
T 2v62_A 309 AYDEKP---NYQALKK 321 (345)
T ss_dssp CTTCCC---CHHHHHH
T ss_pred CcccCC---CHHHHHH
Confidence 999999 8999886
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=386.93 Aligned_cols=252 Identities=23% Similarity=0.365 Sum_probs=216.1
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE 179 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 179 (514)
...+..++|++.+.||+|+||+||+|..+ ++..||||+++... ...+.+.+|..+|+.++|||||++++++. .+
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 34567789999999999999999999875 46789999998653 23567899999999999999999999986 66
Q ss_pred eEEEEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 799999999999999999754 378999999999999999999999999999999999999999999999999998653
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
.... .......||+.|+|||++.+..|+.++|
T Consensus 336 ~~~~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~D 367 (454)
T 1qcf_A 336 DNEY------------------------------------------------TAREGAKFPIKWTAPEAINFGSFTIKSD 367 (454)
T ss_dssp CHHH------------------------------------------------HTTCSSSSCGGGSCHHHHHHCCCCHHHH
T ss_pred CCce------------------------------------------------eccCCCcccccccCHHHhccCCCCcHHH
Confidence 2100 0011345788999999999999999999
Q ss_pred hhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 338 WWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 338 iWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
||||||+||||++ |.+||.+.+..+....+... ...|.+..+++++.+||.+||. ||.+|+ ++++|+.
T Consensus 368 vwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~RP---t~~~i~~ 437 (454)
T 1qcf_A 368 VWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG---YRMPRPENCPEELYNIMMRCWKNRPEERP---TFEYIQS 437 (454)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT---CCCCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHccCChhHCc---CHHHHHH
Confidence 9999999999999 99999998888888777653 2334344789999999999999 999999 8998875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=388.46 Aligned_cols=248 Identities=16% Similarity=0.200 Sum_probs=195.5
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeeccccc-----ChhhHHHHHHHHHHHHHcC---------CCcee
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML-----SRGQVEHVRAERNLLAEVA---------SHCIV 169 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~-----~~~~~~~~~~E~~iL~~l~---------hp~Iv 169 (514)
..++|++++.||+|+||+||+|++ +|+.||||++.+.... .....+.+.+|+.+|+.++ |||||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 346799999999999999999987 7899999999876432 2334577889999999886 66666
Q ss_pred eEEEEE-----------------Ec-------------CCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHH
Q 010266 170 KLYYSF-----------------QD-------------AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAI 219 (514)
Q Consensus 170 ~l~~~f-----------------~~-------------~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL 219 (514)
++.+.+ .+ ...+|+|||||+||++.+.+.+ +.+++..++.++.||+.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence 666553 33 7899999999999987777744 6789999999999999999
Q ss_pred HHHH-hCCeEEcCCCCCCccccCCC--------------------cEEEccccccccCCCCCcccccccccccccccccc
Q 010266 220 ESIH-KHNYIHRDIKPDNLLLDQNG--------------------HMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278 (514)
Q Consensus 220 ~~LH-~~giiHrDLKpeNILld~~g--------------------~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (514)
.||| ++|||||||||+||||+.+| ++||+|||+|+....
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------------------- 234 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------------------- 234 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET--------------------
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC--------------------
Confidence 9999 99999999999999999987 999999999985431
Q ss_pred CCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHH-HHHHhhCCCCCCC
Q 010266 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI-MYEMLVGYPPFYS 357 (514)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi-lyemltG~~PF~~ 357 (514)
...+||+.|+|||++.+.. +.++||||||++ .++++.|..||.+
T Consensus 235 ----------------------------------~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 235 ----------------------------------GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp ----------------------------------TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred ----------------------------------CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 1458999999999998776 899999998777 8889999999954
Q ss_pred CCh-hHHHHHHhhh---cCcccCCcCcCCChhHHHHHhhhccCccccCCCCCHhHHh-cCCccc
Q 010266 358 DDP-VTTCRKIVHW---KNHLKFPEEARLTPEAKDLICRLLCDVEHRLGTLGSEQIK-AHPWFK 416 (514)
Q Consensus 358 ~~~-~~~~~~i~~~---~~~~~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil-~Hpff~ 416 (514)
... ......+... ......+....+|+++++||.+||+ +. |++|++ +||||+
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~----~d---sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 280 VLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLN----FS---SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGG----SS---SHHHHHHHCGGGC
T ss_pred hhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhc----cC---CHHHHHhcCCCcC
Confidence 211 1122333321 1111111122578999999999997 11 899999 999995
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=358.48 Aligned_cols=252 Identities=20% Similarity=0.286 Sum_probs=210.1
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCC---EEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeE-E
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGN---IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL-Y 182 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~---~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l-~ 182 (514)
.|.+.+.||+|+||+||+|.+..+++ .||+|++.+. ......+.+.+|..+|+.++||||+++++++.+.+.. |
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 46677999999999999999766555 7999998753 3455667889999999999999999999999877665 9
Q ss_pred EEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 183 LIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
+||||+.||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999999976 46789999999999999999999999999999999999999999999999999986532210
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
.. ........||+.|+|||++.+..++.++|+|||
T Consensus 180 ~~---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 214 (298)
T 3pls_A 180 YS---------------------------------------------VQQHRHARLPVKWTALESLQTYRFTTKSDVWSF 214 (298)
T ss_dssp GC---------------------------------------------SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHH
T ss_pred cc---------------------------------------------cccCcCCCCCccccChhhhccCCCChhhchhhH
Confidence 00 001124578999999999999999999999999
Q ss_pred hHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 342 GAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 342 Gvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
||++|+|++ |.+||.+.+..+....+... . ..+....+++++.+||.+||. ||.+|+ +++++++
T Consensus 215 G~il~~l~~g~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~ 280 (298)
T 3pls_A 215 GVLLWELLTRGAPPYRHIDPFDLTHFLAQG-R--RLPQPEYCPDSLYQVMQQCWEADPAVRP---TFRVLVG 280 (298)
T ss_dssp HHHHHHHHHTSCCTTTTSCGGGHHHHHHTT-C--CCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHhhCCCCCCccCCHHHHHHHhhcC-C--CCCCCccchHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 999999999 56666666666666666542 2 233334689999999999999 999999 8998876
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=382.25 Aligned_cols=254 Identities=28% Similarity=0.412 Sum_probs=208.5
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC--e
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE--Y 180 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~--~ 180 (514)
+..++|++.+.||+|+||+||+|+++.+|+.||||++.+... ....+.+.+|..+|..++|||||++++++.+.. .
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 445789999999999999999999999999999999986543 233566788999999999999999999998765 7
Q ss_pred EEEEEeecCCCCHHHHHhhccC---CCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccc----cCCCcEEEcccccc
Q 010266 181 LYLIMEYLPGGDVMTLLMREET---LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL----DQNGHMKLSDFGLC 253 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILl----d~~g~iKL~DFGla 253 (514)
+|+||||++||+|.+++..... +++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 8999999999999999976543 9999999999999999999999999999999999999 78889999999999
Q ss_pred ccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc----
Q 010266 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK---- 329 (514)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---- 329 (514)
+...... ...+.+||+.|+|||++.+
T Consensus 164 ~~~~~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~ 193 (396)
T 4eut_A 164 RELEDDE--------------------------------------------------QFVSLYGTEEYLHPDMYERAVLR 193 (396)
T ss_dssp EECCCGG--------------------------------------------------GSSCSSSCCTTCCHHHHHHHCC-
T ss_pred eEccCCC--------------------------------------------------ccccccCCccccCHHHhhccccc
Confidence 8653210 1125679999999999875
Q ss_pred ----CCCCcccchhhhhHHHHHHhhCCCCCCCC----ChhHHHHHHhhhcCcc-----------------cCCcC----c
Q 010266 330 ----KGYGMECDWWSLGAIMYEMLVGYPPFYSD----DPVTTCRKIVHWKNHL-----------------KFPEE----A 380 (514)
Q Consensus 330 ----~~y~~~~DiWSlGvilyemltG~~PF~~~----~~~~~~~~i~~~~~~~-----------------~~p~~----~ 380 (514)
..|+.++|||||||++|||++|..||... ...+...+++...... .+|.. .
T Consensus 194 ~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 273 (396)
T 4eut_A 194 KDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSR 273 (396)
T ss_dssp -CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCH
T ss_pred cccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccch
Confidence 56889999999999999999999999742 3344555555421110 11211 1
Q ss_pred CCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 381 RLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 381 ~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
.+++.+.+||.+||. ||.+|+ +++|+++
T Consensus 274 ~~~~~l~~ll~~~L~~dP~~R~---s~~e~l~ 302 (396)
T 4eut_A 274 GLQVLLTPVLANILEADQEKCW---GFDQFFA 302 (396)
T ss_dssp HHHHHHHHHHHHHSCCCTTTSC---CHHHHHH
T ss_pred HHHhhchHHHHHhhccChhhhc---cHHHHHH
Confidence 245678899999999 999999 8888754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=376.16 Aligned_cols=246 Identities=19% Similarity=0.268 Sum_probs=199.0
Q ss_pred CCCCCCeeEEeeeeecCceEEEEE-----EEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC---CCceeeEEE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLC-----QEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA---SHCIVKLYY 173 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~-----~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~~ 173 (514)
.+..++|.+.+.||+|+||+||+| .+..+++.||||++.+. ....+..|..++..+. ||+|+.+++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 355678999999999999999999 46778999999998754 2345677888888876 899999999
Q ss_pred EEEcCCeEEEEEeecCCCCHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC-------
Q 010266 174 SFQDAEYLYLIMEYLPGGDVMTLLMR-----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ------- 241 (514)
Q Consensus 174 ~f~~~~~l~lVmEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~------- 241 (514)
++.+.+..|+|||||+||+|.+++.. ...+++..++.++.||+.||+|||++|||||||||+||||+.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence 99999999999999999999999974 467999999999999999999999999999999999999998
Q ss_pred ----CCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhcccccccccc
Q 010266 242 ----NGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG 317 (514)
Q Consensus 242 ----~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~G 317 (514)
++++||+|||+|+.+..... .....+.+|
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~-----------------------------------------------~~~~~~~~g 247 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPK-----------------------------------------------GTIFTAKCE 247 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCT-----------------------------------------------TEEECCSSC
T ss_pred cccccCCEEEeeCchhhhhhccCC-----------------------------------------------CceeeeecC
Confidence 89999999999975431100 011225689
Q ss_pred CCCcCCccccccCCCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-C
Q 010266 318 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-D 396 (514)
Q Consensus 318 T~~Y~APEvl~~~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-d 396 (514)
|+.|+|||++.+..|+.++|||||||++|||++|..||...+... +.....++. ...++...+++.+||. +
T Consensus 248 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------~~~~~~~~~-~~~~~~~~~~~~~~l~~~ 319 (365)
T 3e7e_A 248 TSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-------CKPEGLFRR-LPHLDMWNEFFHVMLNIP 319 (365)
T ss_dssp TTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-------EEECSCCTT-CSSHHHHHHHHHHHHCCC
T ss_pred CCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-------eeechhccc-cCcHHHHHHHHHHHcCCC
Confidence 999999999999999999999999999999999999997543311 111111221 1346789999999998 9
Q ss_pred ccccCCCCCHhHHh
Q 010266 397 VEHRLGTLGSEQIK 410 (514)
Q Consensus 397 p~~Rl~~~~~~eil 410 (514)
|.+|+. +++++.
T Consensus 320 p~~r~~--~~~~l~ 331 (365)
T 3e7e_A 320 DCHHLP--SLDLLR 331 (365)
T ss_dssp CTTCCC--CHHHHH
T ss_pred CCCcch--HHHHHH
Confidence 998873 444444
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=361.97 Aligned_cols=253 Identities=25% Similarity=0.353 Sum_probs=200.3
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHH--cCCCceeeEEEEEEc--
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE--VASHCIVKLYYSFQD-- 177 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~--l~hp~Iv~l~~~f~~-- 177 (514)
.+..++|++++.||+|+||+||+|++ +++.||||++... .......|.+++.. ++||||+++++++.+
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 34568999999999999999999976 6889999998653 33456678888877 789999999988653
Q ss_pred --CCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH--------hCCeEEcCCCCCCccccCCCcEEE
Q 010266 178 --AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH--------KHNYIHRDIKPDNLLLDQNGHMKL 247 (514)
Q Consensus 178 --~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH--------~~giiHrDLKpeNILld~~g~iKL 247 (514)
...+|+||||++||+|.+++. ...+++..+..++.|++.||.||| +.||+||||||+|||++.+|++||
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CCCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 467999999999999999994 457999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccc
Q 010266 248 SDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL 327 (514)
Q Consensus 248 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl 327 (514)
+|||+|+......... .....+.+||+.|+|||++
T Consensus 155 ~Dfg~a~~~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~ 189 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQL---------------------------------------------DVGNNPRVGTKRYMAPEVL 189 (301)
T ss_dssp CCCTTCEEEETTTTEE---------------------------------------------ECCCCCCCCCGGGCCHHHH
T ss_pred eeCCCeeecccccccc---------------------------------------------cccccccccccceeChhhh
Confidence 9999997543221000 0011245899999999999
Q ss_pred ccC------CCCcccchhhhhHHHHHHhhC----------CCCCCCCCh----hHHHHHHhh-hcCcccCCcC---cCCC
Q 010266 328 LKK------GYGMECDWWSLGAIMYEMLVG----------YPPFYSDDP----VTTCRKIVH-WKNHLKFPEE---ARLT 383 (514)
Q Consensus 328 ~~~------~y~~~~DiWSlGvilyemltG----------~~PF~~~~~----~~~~~~i~~-~~~~~~~p~~---~~~s 383 (514)
.+. .++.++|||||||++|||++| .+||..... ......+.. ......+|.. ...+
T Consensus 190 ~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (301)
T 3q4u_A 190 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTL 269 (301)
T ss_dssp TTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHH
T ss_pred cCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccH
Confidence 876 566799999999999999999 899965322 222333322 1122223321 1245
Q ss_pred hhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 384 PEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 384 ~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
+++.+||.+||. ||.+|+ ++++|++
T Consensus 270 ~~l~~li~~cl~~dP~~Rp---s~~~i~~ 295 (301)
T 3q4u_A 270 TSLAKLMKECWYQNPSARL---TALRIKK 295 (301)
T ss_dssp HHHHHHHHHHCCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHHHhhcChhhCC---CHHHHHH
Confidence 789999999999 999999 9999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=356.22 Aligned_cols=254 Identities=20% Similarity=0.264 Sum_probs=206.1
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceee-EEEEEEcCCeEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK-LYYSFQDAEYLYL 183 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~-l~~~f~~~~~l~l 183 (514)
.++|++.+.||+|+||.||+|++..+|+.||||++..... ...+.+|..++..+.|++++. +..++.+....|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 4789999999999999999999999999999999876532 234788999999999877554 4455577889999
Q ss_pred EEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccc---cCCCcEEEccccccccCCCC
Q 010266 184 IMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILl---d~~g~iKL~DFGla~~~~~~ 259 (514)
||||+ ||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+|+.....
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99999 9999999974 5679999999999999999999999999999999999999 58899999999999865432
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
...... ........+||+.|+|||++.+..++.++|||
T Consensus 162 ~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 199 (296)
T 3uzp_A 162 RTHQHI------------------------------------------PYRENKNLTGTARYASINTHLGIEQSRRDDLE 199 (296)
T ss_dssp TTCCBC------------------------------------------CCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHH
T ss_pred cccccc------------------------------------------ccccccccccccccCChhhhcCCCCCcchhhH
Confidence 110000 00012256899999999999999999999999
Q ss_pred hhhHHHHHHhhCCCCCCCCC---hhHHHHHHhhhcCcccCCc---CcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 340 SLGAIMYEMLVGYPPFYSDD---PVTTCRKIVHWKNHLKFPE---EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~---~~~~~~~i~~~~~~~~~p~---~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
||||++|||++|..||.+.+ ..+.+..+... ....|. ...+++++.+||.+||. ||.+|+ ++++|++
T Consensus 200 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~l~~ 273 (296)
T 3uzp_A 200 SLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK--KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKP---DYSYLRQ 273 (296)
T ss_dssp HHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH--HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCC---CHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc--ccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCC---CHHHHHH
Confidence 99999999999999998743 33444554432 122221 13678999999999999 999999 8888775
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=371.77 Aligned_cols=259 Identities=22% Similarity=0.307 Sum_probs=210.4
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
.....++|++.+.||+|+||.||+|++ .+++.||+|++... .....+.+.+|..+|..++||||+++++++.+.+.
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPE---SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSC---CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred HHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEeccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 344668999999999999999999985 46899999988754 23456778899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccC
Q 010266 181 LYLIMEYLPGGDVMTLLMREE----TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~ 256 (514)
+|+||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+++..
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999999999986543 5899999999999999999999999999999999999999999999999999754
Q ss_pred CCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCccc
Q 010266 257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336 (514)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 336 (514)
...... ......+||+.|+|||++.+..++.++
T Consensus 190 ~~~~~~-----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~ 222 (321)
T 2qkw_B 190 TELDQT-----------------------------------------------HLSTVVKGTLGYIDPEYFIKGRLTEKS 222 (321)
T ss_dssp SSSSCC-----------------------------------------------CCBCCCEEETTTCCHHHHHHCBCCTHH
T ss_pred cccccc-----------------------------------------------ccccccCCCccccCHHHhcCCCCCccc
Confidence 321100 011245799999999999999999999
Q ss_pred chhhhhHHHHHHhhCCCCCCCCChhHHHHHHh-----hhcCcc------cCC--cCcCCChhHHHHHhhhcc-CccccCC
Q 010266 337 DWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIV-----HWKNHL------KFP--EEARLTPEAKDLICRLLC-DVEHRLG 402 (514)
Q Consensus 337 DiWSlGvilyemltG~~PF~~~~~~~~~~~i~-----~~~~~~------~~p--~~~~~s~~~~dLI~~lL~-dp~~Rl~ 402 (514)
|||||||++|||++|.+||.+..+.+....+. .....+ ..+ .....+..+.+||.+||. ||.+|+
T Consensus 223 Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp- 301 (321)
T 2qkw_B 223 DVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRP- 301 (321)
T ss_dssp HHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSC-
T ss_pred chHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCc-
Confidence 99999999999999999998765433211110 000000 000 011245678999999999 999999
Q ss_pred CCCHhHHhcCC
Q 010266 403 TLGSEQIKAHP 413 (514)
Q Consensus 403 ~~~~~eil~Hp 413 (514)
++.|+++|.
T Consensus 302 --s~~ell~~L 310 (321)
T 2qkw_B 302 --SMGDVLWKL 310 (321)
T ss_dssp --CHHHHHHHH
T ss_pred --CHHHHHHHH
Confidence 999998753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=359.11 Aligned_cols=259 Identities=20% Similarity=0.292 Sum_probs=201.8
Q ss_pred hhcCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc
Q 010266 98 LKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 177 (514)
Q Consensus 98 ~~~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 177 (514)
....++..++|++.+.||+|+||.||+|+.. ..||+|+++... ......+.+.+|..+|+.++||||++++++ ..
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~ 90 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 90 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE-EC
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEee-cc
Confidence 3456788899999999999999999999753 359999997653 345567788999999999999999999985 56
Q ss_pred CCeEEEEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccC
Q 010266 178 AEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256 (514)
Q Consensus 178 ~~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~ 256 (514)
...+++||||++||+|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++...
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 91 APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccc
Confidence 6779999999999999999964 467999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc---cCCCC
Q 010266 257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---KKGYG 333 (514)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~---~~~y~ 333 (514)
..... .......+||+.|+|||++. +..++
T Consensus 171 ~~~~~-----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 203 (289)
T 3og7_A 171 SRWSG-----------------------------------------------SHQFEQLSGSILWMAPEVIRMQDSNPYS 203 (289)
T ss_dssp ------------------------------------------------------------CCCTTCCHHHHC----CCSC
T ss_pred ccccc-----------------------------------------------cccccccCCCccccCchhhcccCCCCCC
Confidence 32100 00112457999999999997 56788
Q ss_pred cccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcC-cccCCc-CcCCChhHHHHHhhhcc-CccccCCCCCHhHHh
Q 010266 334 MECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKN-HLKFPE-EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIK 410 (514)
Q Consensus 334 ~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-~~~~p~-~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 410 (514)
.++|+|||||++|+|++|..||.+.+.......++.... ....+. ...+++++.+||.+||. ||.+|+ ++++++
T Consensus 204 ~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~ell 280 (289)
T 3og7_A 204 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERP---SFPRIL 280 (289)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHH
T ss_pred cccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCC---CHHHHH
Confidence 999999999999999999999988666555544443211 111111 13578999999999999 999999 899987
Q ss_pred c
Q 010266 411 A 411 (514)
Q Consensus 411 ~ 411 (514)
+
T Consensus 281 ~ 281 (289)
T 3og7_A 281 A 281 (289)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=364.30 Aligned_cols=261 Identities=22% Similarity=0.348 Sum_probs=209.2
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE----cC
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ----DA 178 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~----~~ 178 (514)
+..++|++++.||+|+||.||+|+++.+|+.||||++... .....+.+.+|..+++.++||||+++++++. ..
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 4567899999999999999999999999999999998654 3456677889999999999999999999987 44
Q ss_pred CeEEEEEeecCCCCHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccc
Q 010266 179 EYLYLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~ 254 (514)
..+|+||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 589999999999999999875 4679999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCC---
Q 010266 255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG--- 331 (514)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~--- 331 (514)
........ ...... ........||+.|+|||++.+..
T Consensus 183 ~~~~~~~~----------------------------------~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~ 222 (317)
T 2buj_A 183 QACIHVEG----------------------------------SRQALT------LQDWAAQRCTISYRAPELFSVQSHCV 222 (317)
T ss_dssp ESCEEEES----------------------------------HHHHHH------HHHHHHHHSCGGGCCGGGSSCCSEEE
T ss_pred hccccccc----------------------------------cccccc------ccccccccCCcccCCHhHhccCCCcC
Confidence 54311000 000000 00012457899999999997654
Q ss_pred CCcccchhhhhHHHHHHhhCCCCCCCCC--hhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhH
Q 010266 332 YGMECDWWSLGAIMYEMLVGYPPFYSDD--PVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQ 408 (514)
Q Consensus 332 y~~~~DiWSlGvilyemltG~~PF~~~~--~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~e 408 (514)
++.++|||||||++|+|++|..||.... .......+. ....+|....+++++.+||.+||. ||.+|+ ++++
T Consensus 223 ~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ 296 (317)
T 2buj_A 223 IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ---NQLSIPQSPRHSSALWQLLNSMMTVDPHQRP---HIPL 296 (317)
T ss_dssp ECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH---CC--CCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHH
T ss_pred CCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh---ccCCCCccccCCHHHHHHHHHHhhcChhhCC---CHHH
Confidence 6899999999999999999999995421 111222222 234455555789999999999999 999999 9999
Q ss_pred HhcC
Q 010266 409 IKAH 412 (514)
Q Consensus 409 il~H 412 (514)
+++|
T Consensus 297 ll~~ 300 (317)
T 2buj_A 297 LLSQ 300 (317)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=357.44 Aligned_cols=243 Identities=26% Similarity=0.416 Sum_probs=207.9
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc--------
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-------- 177 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~-------- 177 (514)
++|++++.||+|+||.||+|++..+++.||+|++.... ..+.+|..++..++||||++++++|.+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 57999999999999999999999999999999997642 236689999999999999999998865
Q ss_pred --------CCeEEEEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEE
Q 010266 178 --------AEYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKL 247 (514)
Q Consensus 178 --------~~~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL 247 (514)
...+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|++||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 45689999999999999999754 57999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccc
Q 010266 248 SDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL 327 (514)
Q Consensus 248 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl 327 (514)
+|||++....... ......||+.|+|||++
T Consensus 164 ~Dfg~~~~~~~~~--------------------------------------------------~~~~~~~~~~y~aPE~~ 193 (284)
T 2a19_B 164 GDFGLVTSLKNDG--------------------------------------------------KRTRSKGTLRYMSPEQI 193 (284)
T ss_dssp CCCTTCEESSCCS--------------------------------------------------CCCCCCSCCTTSCHHHH
T ss_pred Ccchhheeccccc--------------------------------------------------cccccCCcccccChhhh
Confidence 9999987654221 01145799999999999
Q ss_pred ccCCCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCH
Q 010266 328 LKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGS 406 (514)
Q Consensus 328 ~~~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~ 406 (514)
.+..++.++|+|||||++|+|++|..||... ......+.. ..++ ..+++++++||.+||. ||.+|+ ++
T Consensus 194 ~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~----~~~~--~~~~~~~~~li~~~l~~dp~~Rp---s~ 262 (284)
T 2a19_B 194 SSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRD----GIIS--DIFDKKEKTLLQKLLSKKPEDRP---NT 262 (284)
T ss_dssp HCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHT----TCCC--TTSCHHHHHHHHHHTCSSGGGSC---CH
T ss_pred ccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhc----cccc--ccCCHHHHHHHHHHccCChhhCc---CH
Confidence 9999999999999999999999999998532 222333322 1233 2578999999999999 999999 99
Q ss_pred hHHhcCCccc
Q 010266 407 EQIKAHPWFK 416 (514)
Q Consensus 407 ~eil~Hpff~ 416 (514)
.|+++|++.-
T Consensus 263 ~e~l~~l~~~ 272 (284)
T 2a19_B 263 SEILRTLTVW 272 (284)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999998763
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=358.52 Aligned_cols=254 Identities=18% Similarity=0.281 Sum_probs=209.8
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCC---CEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEE-EcCCe
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSG---NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSF-QDAEY 180 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~---~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f-~~~~~ 180 (514)
..+|++.+.||+|+||.||+|++..++ ..||+|.+.+. ......+.+.+|..+++.++||||+++++++ .++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 357999999999999999999975433 36899998753 3455667889999999999999999999985 56678
Q ss_pred EEEEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
.|+||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 9999999999999999976 456899999999999999999999999999999999999999999999999999865422
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
.... ........||+.|+|||++.+..++.++|+|
T Consensus 182 ~~~~---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 216 (298)
T 3f66_A 182 EYYS---------------------------------------------VHNKTGAKLPVKWMALESLQTQKFTTKSDVW 216 (298)
T ss_dssp GGCB---------------------------------------------C-----CCBCGGGSCHHHHHHCCCCHHHHHH
T ss_pred chhc---------------------------------------------cccccCCCCCccccChHHhcCCCCChHHHHH
Confidence 1000 0011245789999999999999999999999
Q ss_pred hhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 340 SLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 340 SlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
||||++|+|++ |.+||.+.+..+....+..... ...| ..+++++.+||.+||. ||.+|+ +++++++
T Consensus 217 slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~ell~ 284 (298)
T 3f66_A 217 SFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-LLQP--EYCPDPLYEVMLKCWHPKAEMRP---SFSELVS 284 (298)
T ss_dssp HHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC-CCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC-CCCC--ccCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 99999999999 7788888777777777665322 2223 3688999999999999 999999 8998876
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=357.15 Aligned_cols=247 Identities=23% Similarity=0.400 Sum_probs=206.4
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC-
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA- 178 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~- 178 (514)
...+..++|++++.||+|+||.||+|.+ +|+.||+|++.... ..+.+.+|..++..++||||+++++++.+.
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 87 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred cccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 3456778999999999999999999976 48899999987542 446688999999999999999999987544
Q ss_pred CeEEEEEeecCCCCHHHHHhhccC--CCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMREET--LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~ 256 (514)
..+|+||||++||+|.+++...+. +++..+..++.|++.||.|||++||+||||||+||+++.+|++||+|||++...
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 88 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccc
Confidence 579999999999999999976543 899999999999999999999999999999999999999999999999998753
Q ss_pred CCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCccc
Q 010266 257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336 (514)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 336 (514)
... .....||+.|+|||++.+..++.++
T Consensus 168 ~~~----------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~ 195 (278)
T 1byg_A 168 SST----------------------------------------------------QDTGKLPVKWTAPEALREKKFSTKS 195 (278)
T ss_dssp ------------------------------------------------------------CCTTTSCHHHHHHCCCCHHH
T ss_pred ccc----------------------------------------------------ccCCCccccccCHHHhCCCCCCchh
Confidence 211 0134688999999999999999999
Q ss_pred chhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 337 DWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 337 DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|+|||||++|+|++ |.+||.+.+..+....+... .....| ..+++++.+||.+||. ||.+|+ ++.++++
T Consensus 196 Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~ 266 (278)
T 1byg_A 196 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAP--DGCPPAVYEVMKNCWHLDAAMRP---SFLQLRE 266 (278)
T ss_dssp HHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CCCCCc--ccCCHHHHHHHHHHhcCChhhCC---CHHHHHH
Confidence 99999999999998 99999988887777777542 122333 4689999999999999 999999 8888875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=358.07 Aligned_cols=243 Identities=27% Similarity=0.421 Sum_probs=198.2
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 181 (514)
.+..++|++.+.||+|+||+||+|++. ++.||+|++... ...+.+.+|..+|+.++||||+++++++.+ ..
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~ 74 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PV 74 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TT
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--Cc
Confidence 356689999999999999999999864 788999998643 345678899999999999999999998874 48
Q ss_pred EEEEeecCCCCHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHh---CCeEEcCCCCCCccccCCCc-EEEccccccc
Q 010266 182 YLIMEYLPGGDVMTLLMREE---TLTETVARFYIAQSVLAIESIHK---HNYIHRDIKPDNLLLDQNGH-MKLSDFGLCK 254 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKpeNILld~~g~-iKL~DFGla~ 254 (514)
|+||||++||+|.+++.... .+++..+..++.|++.||.|||+ +||+||||||+|||++.+|. +||+|||++.
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence 99999999999999997654 47888999999999999999999 89999999999999998887 7999999987
Q ss_pred cCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCc
Q 010266 255 PLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM 334 (514)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~ 334 (514)
..... .....||+.|+|||++.+..++.
T Consensus 155 ~~~~~----------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~ 182 (307)
T 2eva_A 155 DIQTH----------------------------------------------------MTNNKGSAAWMAPEVFEGSNYSE 182 (307)
T ss_dssp --------------------------------------------------------------CCTTSSCHHHHTCCCCCT
T ss_pred ccccc----------------------------------------------------cccCCCCCceEChhhhCCCCCCc
Confidence 54211 01346999999999999999999
Q ss_pred ccchhhhhHHHHHHhhCCCCCCCCChh--HHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 335 ECDWWSLGAIMYEMLVGYPPFYSDDPV--TTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 335 ~~DiWSlGvilyemltG~~PF~~~~~~--~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
++|||||||++|||++|..||...... .....+... ..... ...+++.+.+||.+||. ||.+|+ +++++++
T Consensus 183 ~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~ 256 (307)
T 2eva_A 183 KCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG-TRPPL--IKNLPKPIESLMTRCWSKDPSQRP---SMEEIVK 256 (307)
T ss_dssp HHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT-CCCCC--BTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC-CCCCc--ccccCHHHHHHHHHHhcCChhhCc---CHHHHHH
Confidence 999999999999999999999754332 222233221 12222 24689999999999999 999999 9999987
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=359.24 Aligned_cols=233 Identities=31% Similarity=0.565 Sum_probs=192.0
Q ss_pred CCCCeeEE-eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHH-HHcCCCceeeEEEEEEc----
Q 010266 104 SVDDFDLL-TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLL-AEVASHCIVKLYYSFQD---- 177 (514)
Q Consensus 104 ~~~~f~~~-~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL-~~l~hp~Iv~l~~~f~~---- 177 (514)
..++|.++ +.||+|+||.||+|.++.+++.||+|++... ....+|..++ +..+||||++++++|.+
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 34788888 7899999999999999999999999999643 2366788887 55689999999999987
Q ss_pred CCeEEEEEeecCCCCHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC---CCcEEEccccc
Q 010266 178 AEYLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ---NGHMKLSDFGL 252 (514)
Q Consensus 178 ~~~l~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~---~g~iKL~DFGl 252 (514)
...+|+||||++||+|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 788999999999999999998754 6999999999999999999999999999999999999998 78999999999
Q ss_pred cccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCC
Q 010266 253 CKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY 332 (514)
Q Consensus 253 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y 332 (514)
|.... +..|
T Consensus 167 a~~~~-----------------------------------------------------------------------~~~~ 175 (299)
T 3m2w_A 167 AKETT-----------------------------------------------------------------------GEKY 175 (299)
T ss_dssp CEECT-----------------------------------------------------------------------TCGG
T ss_pred ccccc-----------------------------------------------------------------------cccC
Confidence 76421 2346
Q ss_pred CcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhh--cCcccCCc--CcCCChhHHHHHhhhcc-CccccCCCCCHh
Q 010266 333 GMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHW--KNHLKFPE--EARLTPEAKDLICRLLC-DVEHRLGTLGSE 407 (514)
Q Consensus 333 ~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~~~p~--~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ 407 (514)
+.++|||||||++|||++|.+||.+.+.......+... .....+|. ...+++++++||.+||. ||.+|+ +++
T Consensus 176 ~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp---s~~ 252 (299)
T 3m2w_A 176 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM---TIT 252 (299)
T ss_dssp GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSC---CHH
T ss_pred CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCC---CHH
Confidence 78999999999999999999999876554432222111 11122231 14689999999999999 999999 999
Q ss_pred HHhcCCccccC
Q 010266 408 QIKAHPWFKDI 418 (514)
Q Consensus 408 eil~Hpff~~i 418 (514)
|+++||||++.
T Consensus 253 e~l~hp~~~~~ 263 (299)
T 3m2w_A 253 EFMNHPWIMQS 263 (299)
T ss_dssp HHHTSHHHHTG
T ss_pred HHhcChhhccc
Confidence 99999999763
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=383.22 Aligned_cols=269 Identities=21% Similarity=0.254 Sum_probs=217.9
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCC-CceeeEEEEEEcCCeEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS-HCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~f~~~~~l~l 183 (514)
.++|++++.||+|+||.||+|++..+++.||||++...... ..+..|..++..+.| ++|+.+..++.+.+..||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 47899999999999999999999999999999998765322 236789999999976 566677777788999999
Q ss_pred EEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccc---cCCCcEEEccccccccCCCC
Q 010266 184 IMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILl---d~~g~iKL~DFGla~~~~~~ 259 (514)
||||+ ||+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||| +.++++||+|||+|+.....
T Consensus 81 vme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99999 9999999975 5689999999999999999999999999999999999999 68899999999999875432
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
...... ........+||+.|+|||++.+..++.++|||
T Consensus 160 ~~~~~~------------------------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvw 197 (483)
T 3sv0_A 160 STHQHI------------------------------------------PYRENKNLTGTARYASVNTHLGIEQSRRDDLE 197 (483)
T ss_dssp TTCCBC------------------------------------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHH
T ss_pred cccccc------------------------------------------ccccccccCCCccccCHHHhcCCCCChHHHHH
Confidence 110000 00012256899999999999999999999999
Q ss_pred hhhHHHHHHhhCCCCCCCCCh---hHHHHHHhhhcCcccCCc-CcCCChhHHHHHhhhcc-CccccCCCCCHhHHh----
Q 010266 340 SLGAIMYEMLVGYPPFYSDDP---VTTCRKIVHWKNHLKFPE-EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIK---- 410 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~---~~~~~~i~~~~~~~~~p~-~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil---- 410 (514)
||||+||||++|..||.+... .+.+..+.........+. ...+++++.+||.+||. +|.+|+ ++++|+
T Consensus 198 SlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RP---s~~el~~~L~ 274 (483)
T 3sv0_A 198 SLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKP---DYSYLKRLFR 274 (483)
T ss_dssp HHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCC---CHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCc---CHHHHHHHHH
Confidence 999999999999999987543 344444433211111100 13578999999999999 999999 776655
Q ss_pred ------cCCccccCCccccc
Q 010266 411 ------AHPWFKDIAWDKLY 424 (514)
Q Consensus 411 ------~Hpff~~i~w~~l~ 424 (514)
.|+|+..+||+.+.
T Consensus 275 ~l~~~~~~~~~~~~dW~~~~ 294 (483)
T 3sv0_A 275 DLFIREGFQFDYVFDWTILK 294 (483)
T ss_dssp HHHHHTTCCCSSCCHHHHHT
T ss_pred HHHHHcCCCccCCcCchhhc
Confidence 48999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=362.33 Aligned_cols=261 Identities=22% Similarity=0.338 Sum_probs=192.1
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEE------
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSF------ 175 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f------ 175 (514)
+...+|++.+.||+|+||.||+|+++.+++.||||++.+. .......+.+|..++..+. ||||+++++++
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 4456899999999999999999999999999999998654 3445667889999999996 99999999998
Q ss_pred --EcCCeEEEEEeecCCCCHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC--eEEcCCCCCCccccCCCcEEEc
Q 010266 176 --QDAEYLYLIMEYLPGGDVMTLLMR---EETLTETVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLDQNGHMKLS 248 (514)
Q Consensus 176 --~~~~~l~lVmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKpeNILld~~g~iKL~ 248 (514)
.+...+|+||||+. |+|.+++.. .+.+++..+..++.||+.||.|||+.| |+||||||+|||++.+|++||+
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEe
Confidence 34556899999995 789888865 467999999999999999999999999 9999999999999999999999
Q ss_pred cccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccc-
Q 010266 249 DFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL- 327 (514)
Q Consensus 249 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl- 327 (514)
|||+++............. .........+.+||+.|+|||++
T Consensus 181 Dfg~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~~~~~t~~y~aPE~~~ 223 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQ-------------------------------------RRALVEEEITRNTTPMYRTPEIID 223 (337)
T ss_dssp CCTTCBCCSSCC--------------------------------------------------------------------
T ss_pred cCccceeccccCccccccc-------------------------------------ccccchhhccccCCCCcCChhhhh
Confidence 9999987643211100000 00000011256799999999999
Q ss_pred --ccCCCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC
Q 010266 328 --LKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL 404 (514)
Q Consensus 328 --~~~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~ 404 (514)
.+..++.++|||||||++|+|++|..||.+.+...... .....+.....++.+.+||.+||. ||.+|+
T Consensus 224 ~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp--- 294 (337)
T 3ll6_A 224 LYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN------GKYSIPPHDTQYTVFHSLIRAMLQVNPEERL--- 294 (337)
T ss_dssp CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSC---
T ss_pred ccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc------CcccCCcccccchHHHHHHHHHccCChhhCc---
Confidence 56778999999999999999999999997655433322 223344445678899999999999 999999
Q ss_pred CHhHHhcCC
Q 010266 405 GSEQIKAHP 413 (514)
Q Consensus 405 ~~~eil~Hp 413 (514)
+++|+++|-
T Consensus 295 s~~e~l~~l 303 (337)
T 3ll6_A 295 SIAEVVHQL 303 (337)
T ss_dssp CHHHHHHHH
T ss_pred CHHHHHHHH
Confidence 999999873
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=367.77 Aligned_cols=253 Identities=15% Similarity=0.199 Sum_probs=203.1
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccC--------CCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceee------
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKS--------GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVK------ 170 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t--------~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~------ 170 (514)
.++|++.+.||+|+||.||+|+++.+ ++.||+|++.+. ..+.+|..++..++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 47899999999999999999999874 889999999765 24778999999999999887
Q ss_pred ---------EEEEEEc-CCeEEEEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCcc
Q 010266 171 ---------LYYSFQD-AEYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLL 238 (514)
Q Consensus 171 ---------l~~~f~~-~~~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNIL 238 (514)
+++++.. ...+|+||||+ ||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 5666654 78999999999 99999999876 78999999999999999999999999999999999999
Q ss_pred ccCCC--cEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccc
Q 010266 239 LDQNG--HMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTV 316 (514)
Q Consensus 239 ld~~g--~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 316 (514)
++.+| .+||+|||+|+........... ........+
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~------------------------------------------~~~~~~~~~ 229 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAY------------------------------------------VEGSRSPHE 229 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCC------------------------------------------CTTSSCTTC
T ss_pred EcCCCCceEEEecCcceeeccCCCccccc------------------------------------------ccccccccc
Confidence 99998 9999999999865422100000 000112458
Q ss_pred cCCCcCCccccccCCCCcccchhhhhHHHHHHhhCCCCCCCCC--hhHHHHHHhhhc-CcccCCc----CcCCChhHHHH
Q 010266 317 GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD--PVTTCRKIVHWK-NHLKFPE----EARLTPEAKDL 389 (514)
Q Consensus 317 GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemltG~~PF~~~~--~~~~~~~i~~~~-~~~~~p~----~~~~s~~~~dL 389 (514)
||+.|+|||++.+..++.++|||||||++|||++|..||.+.. .......+.... ....++. +..+++++.+|
T Consensus 230 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 309 (352)
T 2jii_A 230 GDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKY 309 (352)
T ss_dssp SCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHH
T ss_pred CCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHH
Confidence 9999999999999999999999999999999999999998754 333332222111 1111111 12578999999
Q ss_pred Hhhhcc-CccccCCCCCHhHHhc
Q 010266 390 ICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 390 I~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|.+||. ||.+|+ ++++|++
T Consensus 310 i~~~l~~dp~~Rp---s~~~l~~ 329 (352)
T 2jii_A 310 LKVVMALTYEEKP---PYAMLRN 329 (352)
T ss_dssp HHHHHTCCTTCCC---CHHHHHH
T ss_pred HHHHHhCChhhCC---CHHHHHH
Confidence 999999 999999 8888875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=365.50 Aligned_cols=261 Identities=22% Similarity=0.282 Sum_probs=206.6
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
..+..++|++.+.||+|+||.||+|+. .+|+.||||++...... .....+.+|..++..++||||++++++|.+...
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (326)
T 3uim_A 25 LQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 101 (326)
T ss_dssp HHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC
T ss_pred HHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEEecCCc
Confidence 345678999999999999999999974 46899999999765422 222357889999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhC---CeEEcCCCCCCccccCCCcEEEcccccc
Q 010266 181 LYLIMEYLPGGDVMTLLMREE----TLTETVARFYIAQSVLAIESIHKH---NYIHRDIKPDNLLLDQNGHMKLSDFGLC 253 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKpeNILld~~g~iKL~DFGla 253 (514)
.|+||||++||+|.+++.... .+++..+..++.|++.||.|||+. ||+||||||+|||++.+|++||+|||+|
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~ 181 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSC
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccc
Confidence 999999999999999997643 489999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCC
Q 010266 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG 333 (514)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 333 (514)
+....... ......+||+.|+|||++.+..++
T Consensus 182 ~~~~~~~~------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~ 213 (326)
T 3uim_A 182 KLMDYKDT------------------------------------------------HVTTAVRGTIGHIAPEYLSTGKSS 213 (326)
T ss_dssp EECCSSSS------------------------------------------------CEECCCCSCGGGCCHHHHHHSEEC
T ss_pred cccCcccc------------------------------------------------cccccccCCcCccCHHHhccCCCC
Confidence 86542210 011245699999999999999999
Q ss_pred cccchhhhhHHHHHHhhCCCCCCCC----ChhHHHHHHhh-hcCcccCC----------cCcCCChhHHHHHhhhcc-Cc
Q 010266 334 MECDWWSLGAIMYEMLVGYPPFYSD----DPVTTCRKIVH-WKNHLKFP----------EEARLTPEAKDLICRLLC-DV 397 (514)
Q Consensus 334 ~~~DiWSlGvilyemltG~~PF~~~----~~~~~~~~i~~-~~~~~~~p----------~~~~~s~~~~dLI~~lL~-dp 397 (514)
.++|||||||++|+|++|.+||... .........+. .......+ .....++++.+||.+||. ||
T Consensus 214 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 293 (326)
T 3uim_A 214 EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSP 293 (326)
T ss_dssp HHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCG
T ss_pred ccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCC
Confidence 9999999999999999999999521 11111111111 00000000 011234789999999999 99
Q ss_pred cccCCCCCHhHHhcCCcc
Q 010266 398 EHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 398 ~~Rl~~~~~~eil~Hpff 415 (514)
.+|+ ++.||++|-.-
T Consensus 294 ~~Rp---s~~ell~~L~~ 308 (326)
T 3uim_A 294 MERP---KMSEVVRMLEG 308 (326)
T ss_dssp GGSC---CHHHHHHHHHT
T ss_pred ccCC---CHHHHHHHhcC
Confidence 9999 99999987543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=379.64 Aligned_cols=251 Identities=24% Similarity=0.392 Sum_probs=210.9
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
..+..++|++.+.||+|+||.||+|.++. +..||||+++.... ..+.+.+|..+|+.++|||||++++++.+ +.
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~ 252 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 252 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence 45667889999999999999999999865 45699999976532 24568899999999999999999999876 77
Q ss_pred EEEEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 99999999999999999753 5699999999999999999999999999999999999999999999999999986532
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
... .......||+.|+|||++.+..++.++||
T Consensus 333 ~~~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDv 364 (452)
T 1fmk_A 333 NEY------------------------------------------------TARQGAKFPIKWTAPEAALYGRFTIKSDV 364 (452)
T ss_dssp ----------------------------------------------------------CCGGGSCHHHHHHCCCCHHHHH
T ss_pred Cce------------------------------------------------ecccCCcccccccCHhHHhcCCCCccccH
Confidence 100 00113457889999999999999999999
Q ss_pred hhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 339 WSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 339 WSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|||||++|||++ |.+||.+.+..+....+... ...|.+..+++++.+||.+||. ||.+|+ ++++|++
T Consensus 365 wslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---t~~~l~~ 433 (452)
T 1fmk_A 365 WSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLHDLMCQCWRKEPEERP---TFEYLQA 433 (452)
T ss_dssp HHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT---CCCCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 999999999999 99999998888887777642 2233334789999999999999 999999 9999886
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=359.64 Aligned_cols=254 Identities=24% Similarity=0.346 Sum_probs=206.5
Q ss_pred CCCC-eeEEeeeeecCceEEEEEEE----ccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc-
Q 010266 104 SVDD-FDLLTIIGRGAFGEVRLCQE----KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD- 177 (514)
Q Consensus 104 ~~~~-f~~~~~LG~G~fG~V~l~~~----~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~- 177 (514)
..++ |++++.||+|+||+||++.. ..+++.||||++.+. ........+.+|..+|+.++||||+++++++.+
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 3344 49999999999999988754 357899999999865 244556778999999999999999999999987
Q ss_pred -CCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccC
Q 010266 178 -AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256 (514)
Q Consensus 178 -~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~ 256 (514)
...+|+||||++||+|.+++... .+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++...
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 47899999999999999999654 5999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCccc
Q 010266 257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336 (514)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 336 (514)
....... .......||+.|+|||++.+..++.++
T Consensus 185 ~~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~ 218 (318)
T 3lxp_A 185 PEGHEYY----------------------------------------------RVREDGDSPVFWYAPECLKEYKFYYAS 218 (318)
T ss_dssp CTTCSEE----------------------------------------------EC---CCCCGGGCCHHHHHHCEEEHHH
T ss_pred ccccccc----------------------------------------------ccccCCCCCceeeChHHhcCCCCCcHH
Confidence 4321100 011245689999999999999999999
Q ss_pred chhhhhHHHHHHhhCCCCCCCCChhH--------------HHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccC
Q 010266 337 DWWSLGAIMYEMLVGYPPFYSDDPVT--------------TCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRL 401 (514)
Q Consensus 337 DiWSlGvilyemltG~~PF~~~~~~~--------------~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl 401 (514)
|||||||++|+|++|..||....... .....+. .....+....+++++.+||.+||. ||.+|+
T Consensus 219 Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 296 (318)
T 3lxp_A 219 DVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE--RGERLPRPDKCPAEVYHLMKNCWETEASFRP 296 (318)
T ss_dssp HHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH--TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh--cccCCCCCccccHHHHHHHHHHcCCCcccCc
Confidence 99999999999999999997542210 1111222 122333334789999999999999 999999
Q ss_pred CCCCHhHHhc
Q 010266 402 GTLGSEQIKA 411 (514)
Q Consensus 402 ~~~~~~eil~ 411 (514)
+++|+++
T Consensus 297 ---s~~ell~ 303 (318)
T 3lxp_A 297 ---TFENLIP 303 (318)
T ss_dssp ---CHHHHHH
T ss_pred ---CHHHHHH
Confidence 9999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=392.42 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=209.7
Q ss_pred CeeEE-eeeeecCceEEEEEEE--ccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEE
Q 010266 107 DFDLL-TIIGRGAFGEVRLCQE--KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 107 ~f~~~-~~LG~G~fG~V~l~~~--~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 183 (514)
.+.+. +.||+|+||.||+|.. +.+++.||||+++... ......+.+.+|+.+|..++|||||++++++.+ +.+|+
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 446 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 34443 4899999999999954 4567899999997653 344556789999999999999999999999975 55899
Q ss_pred EEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
|||||+||+|.+++.....+++..+..++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+......
T Consensus 447 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~- 525 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY- 525 (635)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred EEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc-
Confidence 9999999999999998889999999999999999999999999999999999999999999999999999865422100
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhH
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 343 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 343 (514)
........||+.|+|||++.+..|+.++|||||||
T Consensus 526 ---------------------------------------------~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv 560 (635)
T 4fl3_A 526 ---------------------------------------------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGV 560 (635)
T ss_dssp ------------------------------------------------------CGGGSCHHHHHHCCCCHHHHHHHHHH
T ss_pred ---------------------------------------------cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHH
Confidence 00011346889999999999999999999999999
Q ss_pred HHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 344 IMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 344 ilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
++|||++ |.+||.+.+..+....+... .....| ..+++++.+||.+||. ||.+|+ ++++|+.
T Consensus 561 ~l~ellt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p--~~~~~~l~~li~~cl~~dP~~RP---s~~~l~~ 624 (635)
T 4fl3_A 561 LMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGCP--AGCPREMYDLMNLCWTYDVENRP---GFAAVEL 624 (635)
T ss_dssp HHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSTTTSC---CHHHHHH
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcCCCHhHCc---CHHHHHH
Confidence 9999998 99999999888888777653 233444 3689999999999999 999999 8888864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=389.19 Aligned_cols=254 Identities=24% Similarity=0.351 Sum_probs=211.1
Q ss_pred CCCCCeeEEe-eeeecCceEEEEEEEcc--CCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC
Q 010266 103 ISVDDFDLLT-IIGRGAFGEVRLCQEKK--SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE 179 (514)
Q Consensus 103 ~~~~~f~~~~-~LG~G~fG~V~l~~~~~--t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 179 (514)
+..+++.+.+ .||+|+||.||+|..+. ++..||||++++.. .....+.+.+|+.+|..++|||||++++++.+ +
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 408 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence 4456777777 89999999999998763 55679999997652 34456789999999999999999999999987 5
Q ss_pred eEEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
.+|+|||||+||+|.+++... ..+++..+..++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+..
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 699999999999999999754 5699999999999999999999999999999999999999999999999999986542
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
.... ........||+.|+|||++.+..|+.++||
T Consensus 489 ~~~~----------------------------------------------~~~~~~~~~~~~y~APE~~~~~~~~~~sDv 522 (613)
T 2ozo_A 489 DDSY----------------------------------------------YTARSAGKWPLKWYAPECINFRKFSSRSDV 522 (613)
T ss_dssp -----------------------------------------------------------CCTTSCHHHHHHCCCCHHHHH
T ss_pred CCce----------------------------------------------eeeccCCCCccceeCHhhhcCCCCCcHHHH
Confidence 2100 000113357899999999999999999999
Q ss_pred hhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 339 WSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 339 WSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|||||+||||++ |..||.+.+..+....+.... .+.+|. .+++++.+||.+||. ||.+|+ ++++|++
T Consensus 523 wSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~-~~~~p~--~~~~~l~~li~~cl~~dP~~RP---s~~~l~~ 591 (613)
T 2ozo_A 523 WSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RMECPP--ECPPELYALMSDCWIYKWEDRP---DFLTVEQ 591 (613)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC-CCCCCT--TCCHHHHHHHHHTTCSSTTTSC---CHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CCCCCC--cCCHHHHHHHHHHcCCChhHCc---CHHHHHH
Confidence 999999999998 999999988888888776532 334443 689999999999999 999999 8888753
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=371.02 Aligned_cols=254 Identities=18% Similarity=0.289 Sum_probs=203.2
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCC---CEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE-cCCeE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSG---NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ-DAEYL 181 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~---~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~-~~~~l 181 (514)
..|++.+.||+|+||+||+|....++ ..||+|.+++. ......+.+.+|..+|+.++|||||++++++. +.+..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 35889999999999999999876543 46899998653 34456778999999999999999999999864 55688
Q ss_pred EEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 182 YLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999999764 468889999999999999999999999999999999999999999999999998653211
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 340 (514)
... ........||+.|+|||++.+..++.++||||
T Consensus 247 ~~~---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS 281 (373)
T 3c1x_A 247 FDS---------------------------------------------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 281 (373)
T ss_dssp --------------------------------------------------------CCGGGSCHHHHHHCCCCHHHHHHH
T ss_pred ccc---------------------------------------------ccccCCCCCcccccChHHhcCCCCCcHHHHHH
Confidence 000 00011456889999999999999999999999
Q ss_pred hhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 341 LGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 341 lGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
|||++|||++ |.+||.+.+..+....+.... ....| ..+++++.+||.+||. ||.+|+ ++++++++
T Consensus 282 lG~il~ellt~~~~p~~~~~~~~~~~~~~~~~-~~~~p--~~~~~~l~~li~~cl~~dp~~RP---s~~ell~~ 349 (373)
T 3c1x_A 282 FGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQP--EYCPDPLYEVMLKCWHPKAEMRP---SFSELVSR 349 (373)
T ss_dssp HHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 9999999999 788998887777776666532 22333 3689999999999999 999999 99998863
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=358.76 Aligned_cols=258 Identities=25% Similarity=0.362 Sum_probs=193.6
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHH--HcCCCceeeEEEEEE--
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA--EVASHCIVKLYYSFQ-- 176 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~--~l~hp~Iv~l~~~f~-- 176 (514)
..+..++|++++.||+|+||.||+|+. +++.||||++.... ......|.+++. .++||||+++++.+.
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 457789999999999999999999965 68999999997542 233445555544 579999999997553
Q ss_pred ---cCCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---------CeEEcCCCCCCccccCCCc
Q 010266 177 ---DAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH---------NYIHRDIKPDNLLLDQNGH 244 (514)
Q Consensus 177 ---~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~---------giiHrDLKpeNILld~~g~ 244 (514)
+...+|+||||++||+|.+++... .+++..+..++.|++.||.|||+. ||+||||||+|||++.+|+
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence 344789999999999999999654 458889999999999999999999 9999999999999999999
Q ss_pred EEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCc
Q 010266 245 MKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAP 324 (514)
Q Consensus 245 iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~AP 324 (514)
+||+|||+|+.+......... .......+.+||+.|+||
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~gt~~y~aP 197 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPG-----------------------------------------EEDNAAISEVGTIRYMAP 197 (336)
T ss_dssp EEECCCTTCEECSSSSCC--------------------------------------------------CCTTSCGGGCCH
T ss_pred EEEeeccceeecccccccCcc-----------------------------------------ccccccccCCCccceeCc
Confidence 999999999876432110000 000112256899999999
Q ss_pred ccccc-------CCCCcccchhhhhHHHHHHhhCCCCCCCCChh-----------------HHHHH-HhhhcCcccCCcC
Q 010266 325 EVLLK-------KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPV-----------------TTCRK-IVHWKNHLKFPEE 379 (514)
Q Consensus 325 Evl~~-------~~y~~~~DiWSlGvilyemltG~~PF~~~~~~-----------------~~~~~-i~~~~~~~~~p~~ 379 (514)
|++.+ ..++.++|||||||++|||++|..||...... ..... +........+|..
T Consensus 198 E~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (336)
T 3g2f_A 198 EVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA 277 (336)
T ss_dssp HHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT
T ss_pred hhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc
Confidence 99987 46778999999999999999997776432211 11111 1111122233321
Q ss_pred ----cCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 380 ----ARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 380 ----~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
...++++.+||.+||. ||.+|+ +++|+++
T Consensus 278 ~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~e~l~ 311 (336)
T 3g2f_A 278 WKENSLAVRSLKETIEDCWDQDAEARL---TAQXAEE 311 (336)
T ss_dssp CCCCSHHHHHHHHHHHHHSCSSGGGSC---CHHHHHH
T ss_pred cccccchHHHHHHHHHHHhcCChhhCc---chHHHHH
Confidence 1234579999999999 999999 9999854
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=356.68 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=196.9
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc--CCCceeeEEEEEEcC----
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV--ASHCIVKLYYSFQDA---- 178 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l--~hp~Iv~l~~~f~~~---- 178 (514)
.++|++++.||+|+||.||+|++. ++.||||++.... ......|.+++... +||||+++++++.+.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 368999999999999999999864 8899999986442 23445566776654 899999999999877
Q ss_pred CeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC--------CeEEcCCCCCCccccCCCcEEEccc
Q 010266 179 EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH--------NYIHRDIKPDNLLLDQNGHMKLSDF 250 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~--------giiHrDLKpeNILld~~g~iKL~DF 250 (514)
..+|+||||++||+|.+++.. ..+++..+..++.|++.||.|||+. ||+||||||+|||++.+|++||+||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 789999999999999999955 4799999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC
Q 010266 251 GLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK 330 (514)
Q Consensus 251 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~ 330 (514)
|+|+......... .....+.+||+.|+|||++.+.
T Consensus 187 g~a~~~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~ 221 (337)
T 3mdy_A 187 GLAVKFISDTNEV---------------------------------------------DIPPNTRVGTKRYMPPEVLDES 221 (337)
T ss_dssp TTCEECC------------------------------------------------------CCSSCSCGGGCCHHHHTTC
T ss_pred CCceeeccccccc---------------------------------------------cCCCCCCccCcceeChhhcccc
Confidence 9997654221000 0011256899999999999887
Q ss_pred CCCcc------cchhhhhHHHHHHhhC----------CCCCCCCCh----hHHHHHHhh-hcCcccCCc---CcCCChhH
Q 010266 331 GYGME------CDWWSLGAIMYEMLVG----------YPPFYSDDP----VTTCRKIVH-WKNHLKFPE---EARLTPEA 386 (514)
Q Consensus 331 ~y~~~------~DiWSlGvilyemltG----------~~PF~~~~~----~~~~~~i~~-~~~~~~~p~---~~~~s~~~ 386 (514)
.++.. +|||||||++|||++| ..||..... ......+.. ......+|. ...+++++
T Consensus 222 ~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 301 (337)
T 3mdy_A 222 LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQM 301 (337)
T ss_dssp CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHH
T ss_pred cCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHH
Confidence 77665 9999999999999999 777764321 222222222 111223332 11345679
Q ss_pred HHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 387 KDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 387 ~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
.+||.+||. ||.+|+ ++++|++|
T Consensus 302 ~~li~~~l~~dP~~Rp---s~~ell~~ 325 (337)
T 3mdy_A 302 GKLMTECWAHNPASRL---TALRVKKT 325 (337)
T ss_dssp HHHHHHHSCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHhhhhChhhCC---CHHHHHHH
Confidence 999999999 999999 99999875
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=377.40 Aligned_cols=251 Identities=17% Similarity=0.210 Sum_probs=198.3
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCC-Cc----------ee---
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS-HC----------IV--- 169 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~----------Iv--- 169 (514)
....|...+.||+|+||+||+|++..+|+.||||++...........+.+++|..++..+.| ++ ++
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 44568899999999999999999999999999999985544444456778899999998876 21 11
Q ss_pred --------eEEEEEEc-----CCeEEEEEeecCCCCHHHHHhh-------ccCCCHHHHHHHHHHHHHHHHHHHhCCeEE
Q 010266 170 --------KLYYSFQD-----AEYLYLIMEYLPGGDVMTLLMR-------EETLTETVARFYIAQSVLAIESIHKHNYIH 229 (514)
Q Consensus 170 --------~l~~~f~~-----~~~l~lVmEy~~gg~L~~~l~~-------~~~l~e~~~~~~~~qi~~aL~~LH~~giiH 229 (514)
.+...+.. ...+|++|+++ +|+|.+++.. ...+++..+..++.||+.||.|||++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 11111222 23467888866 6899998842 345777788888899999999999999999
Q ss_pred cCCCCCCccccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhcc
Q 010266 230 RDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRR 309 (514)
Q Consensus 230 rDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (514)
|||||+||||+.+|++||+|||+|+.....
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~-------------------------------------------------- 264 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-------------------------------------------------- 264 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE--------------------------------------------------
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc--------------------------------------------------
Confidence 999999999999999999999998754311
Q ss_pred ccccccccCCCcCCcccc----------ccCCCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcC
Q 010266 310 KLAYSTVGTPDYIAPEVL----------LKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEE 379 (514)
Q Consensus 310 ~~~~s~~GT~~Y~APEvl----------~~~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~ 379 (514)
..+.+| +.|+|||++ .+..|+.++|||||||++|||++|..||.+.+..+....+. +..
T Consensus 265 --~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~--------~~~ 333 (413)
T 3dzo_A 265 --AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIF--------RSC 333 (413)
T ss_dssp --ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGG--------SSC
T ss_pred --cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHH--------hhc
Confidence 125678 999999999 56668999999999999999999999998876655444332 222
Q ss_pred cCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCC
Q 010266 380 ARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIA 419 (514)
Q Consensus 380 ~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~ 419 (514)
..+++++++||.+||. ||.+|+ ++.++++||||+.+.
T Consensus 334 ~~~~~~~~~li~~~l~~dP~~Rp---t~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 334 KNIPQPVRALLEGFLRYPKEDRL---LPLQAMETPEYEQLR 371 (413)
T ss_dssp CCCCHHHHHHHHHHTCSSGGGSC---CHHHHTTSHHHHHHH
T ss_pred ccCCHHHHHHHHHHccCChhhCc---CHHHHHhCHHHHHHH
Confidence 3678999999999999 999999 999999999998764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=399.22 Aligned_cols=260 Identities=27% Similarity=0.430 Sum_probs=209.7
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc------
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------ 177 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~------ 177 (514)
..++|++.+.||+|+||.||+|.++.+|+.||||++... ......+.+.+|..+|..++|||||++++++.+
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 357899999999999999999999999999999998764 245566778999999999999999999998765
Q ss_pred CCeEEEEEeecCCCCHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCc---EEEcccc
Q 010266 178 AEYLYLIMEYLPGGDVMTLLMREE---TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGH---MKLSDFG 251 (514)
Q Consensus 178 ~~~l~lVmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~---iKL~DFG 251 (514)
.+..|+||||++||+|.+++.... .+++..++.++.|++.||.|||+.||+||||||+|||++.+|. +||+|||
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 778899999999999999997654 6999999999999999999999999999999999999997775 9999999
Q ss_pred ccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCC
Q 010266 252 LCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331 (514)
Q Consensus 252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~ 331 (514)
++....... .....+||+.|+|||++.+..
T Consensus 170 ~a~~~~~~~--------------------------------------------------~~~~~~gt~~Y~APE~l~~~~ 199 (676)
T 3qa8_A 170 YAKELDQGE--------------------------------------------------LCTEFVGTLQYLAPELLEQKK 199 (676)
T ss_dssp CCCBTTSCC--------------------------------------------------CCCCCCSCCTTCSSCSSCCSC
T ss_pred ccccccccc--------------------------------------------------ccccccCCcccCChHHhccCC
Confidence 998653221 112468999999999999999
Q ss_pred CCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHH---------Hh---------hhcCcccCCc--CcCCChhHHHHHh
Q 010266 332 YGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRK---------IV---------HWKNHLKFPE--EARLTPEAKDLIC 391 (514)
Q Consensus 332 y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~---------i~---------~~~~~~~~p~--~~~~s~~~~dLI~ 391 (514)
++.++|+|||||++|+|++|..||.+......+.. +. .+...+..|. ...+++.+.+||.
T Consensus 200 ~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~ 279 (676)
T 3qa8_A 200 YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQ 279 (676)
T ss_dssp CSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHH
Confidence 99999999999999999999999976543222110 00 0111111111 1235688999999
Q ss_pred hhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 392 RLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 392 ~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
+||. ||.+|+ +++|++.||||+.+
T Consensus 280 ~mL~~DP~kRP---Ta~elL~hp~F~~l 304 (676)
T 3qa8_A 280 CMLMWHQRQRG---TDPQNPNVGCFQAL 304 (676)
T ss_dssp HHSCSSCC------CCTTCCCCTTHHHH
T ss_pred HHccCCHhhCc---CHHHHhcCHHHHHH
Confidence 9999 999999 89999999999874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=355.78 Aligned_cols=257 Identities=25% Similarity=0.410 Sum_probs=208.8
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEE----EccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQ----EKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 176 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~----~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 176 (514)
..+..++|++++.||+|+||.||+|+ +..+++.||+|++... .....+.+.+|..+|+.++||||+++++++.
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY 112 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 45566789999999999999999998 4568999999999764 3455677899999999999999999999987
Q ss_pred cCC--eEEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccc
Q 010266 177 DAE--YLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLC 253 (514)
Q Consensus 177 ~~~--~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla 253 (514)
+.+ .+|+||||++||+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 654 789999999999999999775 46999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCC
Q 010266 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG 333 (514)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 333 (514)
.......... .......||+.|+|||++.+..++
T Consensus 193 ~~~~~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~ 226 (326)
T 2w1i_A 193 KVLPQDKEYY----------------------------------------------KVKEPGESPIFWYAPESLTESKFS 226 (326)
T ss_dssp EECCSSCSEE----------------------------------------------ECSSCCSCCGGGCCHHHHHHCEEE
T ss_pred hhcccccccc----------------------------------------------ccccCCCCceeEECchhhcCCCCC
Confidence 8654221000 001134688899999999999999
Q ss_pred cccchhhhhHHHHHHhhCCCCCCCCChh------------HH---HHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-Cc
Q 010266 334 MECDWWSLGAIMYEMLVGYPPFYSDDPV------------TT---CRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DV 397 (514)
Q Consensus 334 ~~~DiWSlGvilyemltG~~PF~~~~~~------------~~---~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp 397 (514)
.++|||||||++|||++|..||...... .. ....+. .....|....+++++.+||.+||. ||
T Consensus 227 ~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP 304 (326)
T 2w1i_A 227 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK--NNGRLPRPDGCPDEIYMIMTECWNNNV 304 (326)
T ss_dssp HHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH--TTCCCCCCTTCCHHHHHHHHHHSCSSG
T ss_pred chhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh--cCCCCCCCCcccHHHHHHHHHHcCCCh
Confidence 9999999999999999999998643110 00 111111 112233334789999999999999 99
Q ss_pred cccCCCCCHhHHhc
Q 010266 398 EHRLGTLGSEQIKA 411 (514)
Q Consensus 398 ~~Rl~~~~~~eil~ 411 (514)
.+|+ ++.+|++
T Consensus 305 ~~Rp---s~~el~~ 315 (326)
T 2w1i_A 305 NQRP---SFRDLAL 315 (326)
T ss_dssp GGSC---CHHHHHH
T ss_pred hhCc---CHHHHHH
Confidence 9999 8998875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=381.82 Aligned_cols=252 Identities=24% Similarity=0.390 Sum_probs=215.0
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE 179 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 179 (514)
...+..++|++.+.||+|+||.||++.++. +..||||+++.... ..+.+.+|..+|+.++|||||++++++.+ +
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 345667889999999999999999999865 45799999986542 24568899999999999999999999876 7
Q ss_pred eEEEEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
.+|+||||++||+|.++|... ..+++..+..++.||+.||.|||++|||||||||+||||+.++++||+|||+++...
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 799999999999999999753 568999999999999999999999999999999999999999999999999998653
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
.... .......||+.|+|||++.+..|+.++|
T Consensus 415 ~~~~------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sD 446 (535)
T 2h8h_A 415 DNEY------------------------------------------------TARQGAKFPIKWTAPEAALYGRFTIKSD 446 (535)
T ss_dssp CHHH------------------------------------------------HTTCSTTSCGGGSCHHHHHHCCCCHHHH
T ss_pred CCce------------------------------------------------ecccCCcCcccccCHHHhccCCCCchhh
Confidence 1100 0011345788999999999999999999
Q ss_pred hhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 338 WWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 338 iWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
||||||+||||++ |..||.+.+..+....+... ...|....+++++.+||.+||. ||.+|+ ++++|+.
T Consensus 447 vwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~~l~~ 516 (535)
T 2h8h_A 447 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLHDLMCQCWRKEPEERP---TFEYLQA 516 (535)
T ss_dssp HHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHcCCChhHCc---CHHHHHH
Confidence 9999999999999 99999998888887777642 2233334789999999999999 999999 8999886
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=352.68 Aligned_cols=252 Identities=23% Similarity=0.300 Sum_probs=202.1
Q ss_pred eeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccc-cChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM-LSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~-~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
|...+.||+|+||.||+|.. +++.||+|++..... ......+.+.+|..++..++||||+++++++.+.+..|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 33448999999999999974 688999999976432 233456778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 187 YLPGGDVMTLLMR---EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 187 y~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
|++||+|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~- 189 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT- 189 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC-
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc-
Confidence 9999999999864 346899999999999999999999999999999999999999999999999998765321100
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhH
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 343 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 343 (514)
......+||+.|+|||++.+ .++.++|+|||||
T Consensus 190 ----------------------------------------------~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~ 222 (307)
T 2nru_A 190 ----------------------------------------------VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGV 222 (307)
T ss_dssp ----------------------------------------------EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHH
T ss_pred ----------------------------------------------ccccccCCCcCcCChHHhcC-CCCccchhHHHHH
Confidence 01124579999999999865 5899999999999
Q ss_pred HHHHHhhCCCCCCCCChhHHHHHHhh----hcCcc------cCC-cCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 344 IMYEMLVGYPPFYSDDPVTTCRKIVH----WKNHL------KFP-EEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 344 ilyemltG~~PF~~~~~~~~~~~i~~----~~~~~------~~p-~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
++|+|++|.+||.+.+.......+.. ....+ .++ .....++.+.+||.+||. ||.+|+ ++++|++
T Consensus 223 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp---s~~~l~~ 299 (307)
T 2nru_A 223 VLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRP---DIKKVQQ 299 (307)
T ss_dssp HHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSC---CHHHHHH
T ss_pred HHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCc---CHHHHHH
Confidence 99999999999987654433222221 00000 011 112345778999999999 999999 9999886
Q ss_pred C
Q 010266 412 H 412 (514)
Q Consensus 412 H 412 (514)
|
T Consensus 300 ~ 300 (307)
T 2nru_A 300 L 300 (307)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=358.71 Aligned_cols=261 Identities=18% Similarity=0.256 Sum_probs=212.1
Q ss_pred HhhcCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE
Q 010266 97 RLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 176 (514)
Q Consensus 97 ~~~~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 176 (514)
......+..++|++.+.||+|+||.||+|++.. .+|+|++..... .....+.+.+|..++..++||||+++++++.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 99 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACM 99 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence 345677889999999999999999999998754 499999876532 2233345678999999999999999999999
Q ss_pred cCCeEEEEEeecCCCCHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 177 DAEYLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 177 ~~~~l~lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
+...+|+||||++||+|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+|||++ +|.+||+|||++..
T Consensus 100 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 100 SPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp CSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred cCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 9999999999999999999997754 799999999999999999999999999999999999998 78999999999875
Q ss_pred CCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc------
Q 010266 256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK------ 329 (514)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~------ 329 (514)
........ .........||+.|+|||++.+
T Consensus 179 ~~~~~~~~--------------------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 214 (319)
T 2y4i_B 179 SGVLQAGR--------------------------------------------REDKLRIQNGWLCHLAPEIIRQLSPDTE 214 (319)
T ss_dssp -----------------------------------------------------CCSCBCCSGGGGTSCHHHHSCBSCC--
T ss_pred cccccccc--------------------------------------------cccccccCCCcccccChHHhhhcccccc
Confidence 43210000 0011224579999999999975
Q ss_pred ---CCCCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCC
Q 010266 330 ---KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLG 405 (514)
Q Consensus 330 ---~~y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~ 405 (514)
..++.++|||||||++|||++|..||.+.+.......+...... ......+++++.+||.+||. ||.+|+ +
T Consensus 215 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp---t 289 (319)
T 2y4i_B 215 EDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP--NLSQIGMGKEISDILLFCWAFEQEERP---T 289 (319)
T ss_dssp CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC--CCCCSSCCTTHHHHHHHHHCSSTTTSC---C
T ss_pred ccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC--CCCcCCCCHHHHHHHHHHhcCChhhCc---C
Confidence 45789999999999999999999999998888777777653221 11223688999999999999 999999 9
Q ss_pred HhHHhc
Q 010266 406 SEQIKA 411 (514)
Q Consensus 406 ~~eil~ 411 (514)
+.++++
T Consensus 290 ~~~l~~ 295 (319)
T 2y4i_B 290 FTKLMD 295 (319)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=385.62 Aligned_cols=254 Identities=24% Similarity=0.352 Sum_probs=214.0
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccC---CCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKS---GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD 177 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t---~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~ 177 (514)
..+..++|++.+.||+|+||+||+|.+..+ +..||+|++... ......+.+.+|..+|..++|||||++++++.
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 345667899999999999999999998654 457999988653 23445577899999999999999999999985
Q ss_pred CCeEEEEEeecCCCCHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccC
Q 010266 178 AEYLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256 (514)
Q Consensus 178 ~~~l~lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~ 256 (514)
++.+|+||||++||+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+..
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 567899999999999999997653 6899999999999999999999999999999999999999999999999999865
Q ss_pred CCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCccc
Q 010266 257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336 (514)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 336 (514)
..... .......||+.|+|||++.+..|+.++
T Consensus 542 ~~~~~------------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~ 573 (656)
T 2j0j_A 542 EDSTY------------------------------------------------YKASKGKLPIKWMAPESINFRRFTSAS 573 (656)
T ss_dssp CC----------------------------------------------------------CCGGGCCHHHHHHCCCCHHH
T ss_pred CCCcc------------------------------------------------eeccCCCCCcceeCHHHhcCCCCCchh
Confidence 32110 001134688999999999999999999
Q ss_pred chhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 337 DWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 337 DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|||||||++|||++ |.+||.+.+..+....+.... .+.+| ..+++++.+||.+||. ||.+|+ ++.+|++
T Consensus 574 DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~~l~~dP~~RP---s~~el~~ 644 (656)
T 2j0j_A 574 DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMP--PNCPPTLYSLMTKCWAYDPSRRP---RFTELKA 644 (656)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred hHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-CCCCC--ccccHHHHHHHHHHcCCChhHCc---CHHHHHH
Confidence 99999999999997 999999998888888876532 23344 3689999999999999 999999 8999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=352.71 Aligned_cols=250 Identities=22% Similarity=0.293 Sum_probs=201.1
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHH--cCCCceeeEEEEEEcCC----
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE--VASHCIVKLYYSFQDAE---- 179 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~--l~hp~Iv~l~~~f~~~~---- 179 (514)
++|++.+.||+|+||.||+|++ +|+.||||++.+. ....+..|.+++.. ++||||+++++++.+..
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 5799999999999999999986 5899999998643 23557789999988 78999999999998876
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH--------hCCeEEcCCCCCCccccCCCcEEEcccc
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH--------KHNYIHRDIKPDNLLLDQNGHMKLSDFG 251 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH--------~~giiHrDLKpeNILld~~g~iKL~DFG 251 (514)
.+|+||||++||+|.+++.+ ..+++..+..++.|++.||.||| +.||+||||||+|||++.+|++||+|||
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred eeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 89999999999999999965 57899999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-
Q 010266 252 LCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK- 330 (514)
Q Consensus 252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~- 330 (514)
++.......... .......+||+.|+|||++.+.
T Consensus 193 ~~~~~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~ 227 (342)
T 1b6c_B 193 LAVRHDSATDTI---------------------------------------------DIAPNHRVGTKRYMAPEVLDDSI 227 (342)
T ss_dssp TCEEEETTTTEE---------------------------------------------EECCCSCCCCGGGCCHHHHTSCC
T ss_pred Cceecccccccc---------------------------------------------ccccccCCcCcccCCHhhhcccc
Confidence 997643221000 0011255799999999999875
Q ss_pred -----CCCcccchhhhhHHHHHHhhC----------CCCCCCCC-----hhHHHHHHhhhcCcccCCcC---cCCChhHH
Q 010266 331 -----GYGMECDWWSLGAIMYEMLVG----------YPPFYSDD-----PVTTCRKIVHWKNHLKFPEE---ARLTPEAK 387 (514)
Q Consensus 331 -----~y~~~~DiWSlGvilyemltG----------~~PF~~~~-----~~~~~~~i~~~~~~~~~p~~---~~~s~~~~ 387 (514)
.++.++|||||||++|||++| ..||.... .......+........+|.. ...++.+.
T Consensus 228 ~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 307 (342)
T 1b6c_B 228 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMA 307 (342)
T ss_dssp CTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHH
T ss_pred cccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHH
Confidence 344789999999999999999 78997643 23333334332222333321 12345788
Q ss_pred HHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 388 DLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 388 dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
+||.+||. ||.+|+ ++++|++|
T Consensus 308 ~li~~cl~~dp~~Rp---s~~~i~~~ 330 (342)
T 1b6c_B 308 KIMRECWYANGAARL---TALRIKKT 330 (342)
T ss_dssp HHHHHHCCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHhccChhhCC---CHHHHHHH
Confidence 99999998 999999 99999875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=381.29 Aligned_cols=244 Identities=20% Similarity=0.308 Sum_probs=201.0
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEcc-CCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKK-SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~-t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
.+..++|++++.||+|+||+||+|.+.. +|+.||||++.... .......+.+|+.+|..++|||||+++++|.+.+.
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 153 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR 153 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECT
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCC
Confidence 3445899999999999999999999976 78999999987542 34455678899999999999999999999987655
Q ss_pred -----EEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 181 -----LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 181 -----l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
.||||||++|++|.+++.. .+++..+..++.||+.||.|||++|||||||||+|||++.+ ++||+|||+++.
T Consensus 154 ~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 154 HGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp TSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 7999999999999988754 79999999999999999999999999999999999999875 999999999876
Q ss_pred CCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcc
Q 010266 256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME 335 (514)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~ 335 (514)
.... ...+||+.|+|||++.+. ++.+
T Consensus 231 ~~~~-----------------------------------------------------~~~~gt~~y~aPE~~~~~-~~~~ 256 (681)
T 2pzi_A 231 INSF-----------------------------------------------------GYLYGTPGFQAPEIVRTG-PTVA 256 (681)
T ss_dssp TTCC-----------------------------------------------------SCCCCCTTTSCTTHHHHC-SCHH
T ss_pred cccC-----------------------------------------------------CccCCCccccCHHHHcCC-CCCc
Confidence 4311 145799999999998764 5899
Q ss_pred cchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCc
Q 010266 336 CDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPW 414 (514)
Q Consensus 336 ~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpf 414 (514)
+|||||||++|+|++|.+||.+...... .........++.+.+||.+||. ||.+|+ +..+.+.|+|
T Consensus 257 sDi~slG~~l~~l~~g~~~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~R~---~~~~~l~~~l 323 (681)
T 2pzi_A 257 TDIYTVGRTLAALTLDLPTRNGRYVDGL----------PEDDPVLKTYDSYGRLLRRAIDPDPRQRF---TTAEEMSAQL 323 (681)
T ss_dssp HHHHHHHHHHHHHHSCCCEETTEECSSC----------CTTCHHHHHCHHHHHHHHHHTCSSGGGSC---SSHHHHHHHH
T ss_pred eehhhhHHHHHHHHhCCCCCcccccccc----------cccccccccCHHHHHHHhhhccCChhhCC---CHHHHHHHHH
Confidence 9999999999999999999976321100 0001111346889999999999 999999 7778888998
Q ss_pred ccc
Q 010266 415 FKD 417 (514)
Q Consensus 415 f~~ 417 (514)
+.-
T Consensus 324 ~~~ 326 (681)
T 2pzi_A 324 TGV 326 (681)
T ss_dssp HHH
T ss_pred HHH
Confidence 853
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=337.82 Aligned_cols=225 Identities=12% Similarity=0.110 Sum_probs=189.1
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
+..++|++++.||+|+||.||+|++..+++.||||++.............+.+|..++..++||||+++++++.+.+.+|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 44578999999999999999999999999999999998776555666788999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
+||||++|++|.+++.. + ..+..+..++.|++.||.|||++||+||||||+|||++.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 99999999999999854 3 3566778899999999999999999999999999999999999997544
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
|++ .++.++||||||
T Consensus 175 ----------------------------------------------------------~~~-------~~~~~~Di~slG 189 (286)
T 3uqc_A 175 ----------------------------------------------------------TMP-------DANPQDDIRGIG 189 (286)
T ss_dssp ----------------------------------------------------------CCT-------TCCHHHHHHHHH
T ss_pred ----------------------------------------------------------ccC-------CCCchhHHHHHH
Confidence 233 278899999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHH---HHhhhcCcccCC--cCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCR---KIVHWKNHLKFP--EEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~---~i~~~~~~~~~p--~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|++|||++|..||.+.+...... ++.. .....+ ....+++++++||.+||. ||.+| ++.|+++
T Consensus 190 ~il~elltg~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R----s~~el~~ 258 (286)
T 3uqc_A 190 ASLYALLVNRWPLPEAGVRSGLAPAERDTA--GQPIEPADIDRDIPFQISAVAARSVQGDGGIR----SASTLLN 258 (286)
T ss_dssp HHHHHHHHSEECSCCCSBCCCSEECCBCTT--SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC----CHHHHHH
T ss_pred HHHHHHHHCCCCCCcCCcchhhHHHHHHhc--cCCCChhhcccCCCHHHHHHHHHHcccCCccC----CHHHHHH
Confidence 99999999999999876543221 1111 111111 123689999999999999 99999 7888876
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=331.84 Aligned_cols=190 Identities=17% Similarity=0.179 Sum_probs=139.8
Q ss_pred eeeecCceEEEEEEEccCCCEEEEEEeecccccC-------hhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCCeEEEE
Q 010266 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS-------RGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 113 ~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~-------~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.++.|++|.+..++...+|+.||+|++.+..... ....+.+.+|+++|+++ .|+||++++++|+++..+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 3567888888888888899999999998764322 22345689999999999 699999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
||||+||+|.++|.+.+++++. .++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~---- 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC---- 393 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-------
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC----
Confidence 9999999999999998888765 478999999999999999999999999999999999999999998654211
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 344 (514)
....+.+|||.|||||++.+. +..++|+||+|++
T Consensus 394 ---------------------------------------------~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~ 427 (569)
T 4azs_A 394 ---------------------------------------------SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVH 427 (569)
T ss_dssp ---------------------------------------------CCSHHHHHHHHHHHHHHC-----------------
T ss_pred ---------------------------------------------ccccCceechhhccHHHhCCC-CCCcccccccccc
Confidence 112367999999999999764 6778999999999
Q ss_pred HHHHhhCCCCC
Q 010266 345 MYEMLVGYPPF 355 (514)
Q Consensus 345 lyemltG~~PF 355 (514)
+|+|++|..||
T Consensus 428 ~~~l~~~~~~~ 438 (569)
T 4azs_A 428 PFNLPQPWSNW 438 (569)
T ss_dssp -CCCCTTHHHH
T ss_pred hhhhccccchh
Confidence 99888776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.9e-31 Score=283.63 Aligned_cols=192 Identities=18% Similarity=0.206 Sum_probs=148.8
Q ss_pred EeeeeecCceEEEEEEEccCCCEEEEEEeecccccCh-----hhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR-----GQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 111 ~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~-----~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
.+.||+|+||+||++ ...++.+|+|+......... ...+.+.+|..+|..++||||+++..++.+.+..||||
T Consensus 341 ~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 341 EHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp -------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 468999999999999 45678899998765433222 12455789999999999999996555555777889999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
||++||+|.+++.. +..++.|++.||.|||++||+||||||+|||++. ++||+|||+|+.........
T Consensus 419 E~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~-- 486 (540)
T 3en9_A 419 SYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA-- 486 (540)
T ss_dssp ECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH--
T ss_pred ECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc--
Confidence 99999999999865 5688999999999999999999999999999998 99999999998754210000
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc--CCCCcccchhhhhH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGA 343 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiWSlGv 343 (514)
.+......+.+||+.|||||++.. .+|+..+|+||.++
T Consensus 487 ----------------------------------------~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl 526 (540)
T 3en9_A 487 ----------------------------------------VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIIL 526 (540)
T ss_dssp ----------------------------------------HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHH
T ss_pred ----------------------------------------cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHH
Confidence 000001236789999999999987 78999999999999
Q ss_pred HHHHHhhCCCCCC
Q 010266 344 IMYEMLVGYPPFY 356 (514)
Q Consensus 344 ilyemltG~~PF~ 356 (514)
-..+.+.++.+|.
T Consensus 527 ~~l~~v~~r~rY~ 539 (540)
T 3en9_A 527 ELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHTCSCCC
T ss_pred HHHHHHHhccccC
Confidence 9999888877763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-28 Score=241.07 Aligned_cols=132 Identities=14% Similarity=0.140 Sum_probs=107.6
Q ss_pred EEeeeeecCceEEEEEEEccCCCEEEEEEeecccccCh---------------hhHHHHHHHHHHHHHcCCCceeeEEEE
Q 010266 110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR---------------GQVEHVRAERNLLAEVASHCIVKLYYS 174 (514)
Q Consensus 110 ~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~---------------~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 174 (514)
+.+.||+|+||.||+|++ .+|+.||||+++....... .....+.+|..+|..++| ++++.+
T Consensus 94 ~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~ 169 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKV 169 (282)
T ss_dssp EEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCE
T ss_pred ecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeE
Confidence 339999999999999999 8899999999975432111 235668899999999984 555555
Q ss_pred EEcCCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccc
Q 010266 175 FQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254 (514)
Q Consensus 175 f~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~ 254 (514)
+.. +..|+||||++||+|.+ +. ...+..++.|++.||.|||++||+||||||+|||++ +|++||+|||+|+
T Consensus 170 ~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~ 240 (282)
T 1zar_A 170 YAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 240 (282)
T ss_dssp EEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE
T ss_pred Eec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe
Confidence 543 56799999999999988 42 133557899999999999999999999999999999 9999999999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-22 Score=199.22 Aligned_cols=142 Identities=15% Similarity=0.120 Sum_probs=110.8
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCE--EEEEEeecccccCh---------------------hhHHHHHHHHHHHHHc
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNI--YAMKKLKKSEMLSR---------------------GQVEHVRAERNLLAEV 163 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~--~AiK~l~k~~~~~~---------------------~~~~~~~~E~~iL~~l 163 (514)
-|++.+.||+|+||.||+|.+..+|+. ||||+++....... .....+.+|..+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378999999999999999998788999 99999865421110 1123678899999999
Q ss_pred CCCce--eeEEEEEEcCCeEEEEEeecCC-C----CHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH-hCCeEEcCCCCC
Q 010266 164 ASHCI--VKLYYSFQDAEYLYLIMEYLPG-G----DVMTLLMREETLTETVARFYIAQSVLAIESIH-KHNYIHRDIKPD 235 (514)
Q Consensus 164 ~hp~I--v~l~~~f~~~~~l~lVmEy~~g-g----~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH-~~giiHrDLKpe 235 (514)
.|+++ +.++.. ...||||||+.+ | +|.++... .++..+..++.|++.||.||| +.|||||||||+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 88753 444432 356899999942 3 66665432 345677889999999999999 999999999999
Q ss_pred CccccCCCcEEEccccccccCC
Q 010266 236 NLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 236 NILld~~g~iKL~DFGla~~~~ 257 (514)
|||++. +++|+|||+|....
T Consensus 201 NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 201 NIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SEEESS--SEEECCCTTCEETT
T ss_pred HEEEcC--cEEEEECcccccCC
Confidence 999988 99999999998654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.78 E-value=5.3e-20 Score=188.99 Aligned_cols=138 Identities=12% Similarity=0.134 Sum_probs=101.5
Q ss_pred eeEEeeeeecCceEEEEEEEccCCCEEEEEEeeccccc-----------ChhhH--------HHHHHHHHHHHHcCCCce
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML-----------SRGQV--------EHVRAERNLLAEVASHCI 168 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~-----------~~~~~--------~~~~~E~~iL~~l~hp~I 168 (514)
|.+...||.|+||.||+|.+ .+|+.||||+++..... ..... -....|...|.++.++++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 89999999999999999987 46999999998643211 00000 112356677777755443
Q ss_pred e--eEEEEEEcCCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC---
Q 010266 169 V--KLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG--- 243 (514)
Q Consensus 169 v--~l~~~f~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g--- 243 (514)
. ..+.. . ..+|||||++|++|..+.. ...++.++.|++.||.+||+.|||||||||.|||++.+|
T Consensus 176 ~vp~p~~~--~--~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 PVPEPIAQ--S--RHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp SCCCEEEE--E--TTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCeeeec--c--CceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 2 22222 1 2379999999988865532 234456789999999999999999999999999999877
Q ss_pred -------cEEEccccccccC
Q 010266 244 -------HMKLSDFGLCKPL 256 (514)
Q Consensus 244 -------~iKL~DFGla~~~ 256 (514)
.+.|+||+-+...
T Consensus 246 d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CTTSEEEEEEECCCTTCEET
T ss_pred cccccccceEEEEeCCcccC
Confidence 4899999987643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=5.3e-13 Score=129.90 Aligned_cols=140 Identities=12% Similarity=0.062 Sum_probs=111.2
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEEEcCCeEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l~lV 184 (514)
..|++...+|.|+.+.||.+.. .+..|++|+........ ...+.+|..+|..+. +..++++++++.+.+..|+|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 4689999999999999998863 36789999987532111 234788999999885 66788999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 010266 185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK---------------------------------------- 224 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~---------------------------------------- 224 (514)
|||++|.+|...+. +......++.++..+|..||+
T Consensus 89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999999877631 122334567888899999998
Q ss_pred -------------------CCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 225 -------------------HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 225 -------------------~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
.+++|+|++|.|||++.++.+.|+||+.|..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4599999999999998765667999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.33 E-value=2.3e-12 Score=124.51 Aligned_cols=136 Identities=14% Similarity=0.131 Sum_probs=100.0
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCc--eeeEEEEEEcCCeEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC--IVKLYYSFQDAEYLY 182 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~--Iv~l~~~f~~~~~l~ 182 (514)
..++.+..+.+.|+.+.||++.. .+|..|++|+..... ...+..|..+|+.+.+.. ++++++++.+.+..|
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~ 91 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 91 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence 35676655555667799999853 567789999876431 134678999998885443 667888888888899
Q ss_pred EEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 010266 183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHN------------------------------------ 226 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~g------------------------------------ 226 (514)
+||||++|.+|. .. ..+ ...++.++..+|..||+..
T Consensus 92 ~v~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 92 LLLGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EEEECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEEEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999999998874 21 111 1245566777777777643
Q ss_pred ----------------------eEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 227 ----------------------YIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 227 ----------------------iiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
++|+|++|.|||++.++.+.|+|||.|..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999998763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.22 E-value=2.9e-11 Score=123.30 Aligned_cols=142 Identities=18% Similarity=0.246 Sum_probs=106.6
Q ss_pred eeEEeeeeecCceEEEEEEEccCCCEEEEEEee--cccccChhhHHHHHHHHHHHHHcC--CCceeeEEEEEEcC---Ce
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLK--KSEMLSRGQVEHVRAERNLLAEVA--SHCIVKLYYSFQDA---EY 180 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~--k~~~~~~~~~~~~~~E~~iL~~l~--hp~Iv~l~~~f~~~---~~ 180 (514)
...++.|+.|.++.||++... +..+++|+.. ..... .....+.+|..+|+.+. +..+++++..+.+. +.
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~ 115 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR 115 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence 345788999999999998743 4678999775 33211 12245778999999987 45588899888776 45
Q ss_pred EEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 010266 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK------------------------------------ 224 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~------------------------------------ 224 (514)
.|+||||++|..+.+.. ...+++.....++.+++.+|..||+
T Consensus 116 ~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp CEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred eEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 89999999998775421 2346777888888999999999996
Q ss_pred ----------------------CCeEEcCCCCCCccccCCCc--EEEcccccccc
Q 010266 225 ----------------------HNYIHRDIKPDNLLLDQNGH--MKLSDFGLCKP 255 (514)
Q Consensus 225 ----------------------~giiHrDLKpeNILld~~g~--iKL~DFGla~~ 255 (514)
.+++|+|++|+|||++.++. +.|+||+.|..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 46999999999999997763 69999999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.18 E-value=2.5e-11 Score=120.98 Aligned_cols=134 Identities=19% Similarity=0.217 Sum_probs=96.7
Q ss_pred EeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CC--ceeeEEEEEEcCC---eEEEE
Q 010266 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SH--CIVKLYYSFQDAE---YLYLI 184 (514)
Q Consensus 111 ~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp--~Iv~l~~~f~~~~---~l~lV 184 (514)
++.++.|....||++. ..+++|+.... .....+.+|..+|..+. +. .++..+....+.. ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4569999999999763 45889985432 33566889999998873 32 2455555544333 35899
Q ss_pred EeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 010266 185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK---------------------------------------- 224 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~---------------------------------------- 224 (514)
|++++|..|..... ..++......++.+++..|..||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999988765332 345666666777777777777774
Q ss_pred ------------------CCeEEcCCCCCCccccC--CCcEEEccccccccC
Q 010266 225 ------------------HNYIHRDIKPDNLLLDQ--NGHMKLSDFGLCKPL 256 (514)
Q Consensus 225 ------------------~giiHrDLKpeNILld~--~g~iKL~DFGla~~~ 256 (514)
..++|+|++|.|||++. ++.+.|+||+.+...
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 24899999999999998 456789999988653
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.71 E-value=1.7e-07 Score=93.43 Aligned_cols=133 Identities=17% Similarity=0.186 Sum_probs=89.2
Q ss_pred EeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCC---ceeeEEEEEE-cCCeEEEEEe
Q 010266 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH---CIVKLYYSFQ-DAEYLYLIME 186 (514)
Q Consensus 111 ~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp---~Iv~l~~~f~-~~~~l~lVmE 186 (514)
++.++.|....||.+ |..+++|+-.. ......+..|..+|..+.+. .+++.+.+.. ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456899999999987 46688997432 23456788999999998642 3566666664 4566789999
Q ss_pred ecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 010266 187 YLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH------------------------------------------- 223 (514)
Q Consensus 187 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH------------------------------------------- 223 (514)
|++|..+..... ..++......++.++...|..||
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999987765311 11222222222333333333333
Q ss_pred -----------------hCCeEEcCCCCCCccccC---CCcE-EEcccccccc
Q 010266 224 -----------------KHNYIHRDIKPDNLLLDQ---NGHM-KLSDFGLCKP 255 (514)
Q Consensus 224 -----------------~~giiHrDLKpeNILld~---~g~i-KL~DFGla~~ 255 (514)
...++|+|++|.|||++. +|.+ .|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 235799999999999987 4665 8999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.61 E-value=5.2e-07 Score=87.54 Aligned_cols=133 Identities=17% Similarity=0.150 Sum_probs=92.2
Q ss_pred eeeecCce-EEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEEEcCCeEEEEEeecCC
Q 010266 113 IIGRGAFG-EVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYLYLIMEYLPG 190 (514)
Q Consensus 113 ~LG~G~fG-~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l~lVmEy~~g 190 (514)
.+..|..| .||.+.....+..+.+|+-... ....+.+|..+|+.+. +--+++++.++.+.+..|+|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 34455555 7998877667778999986533 3455788999998874 33477888889999999999999999
Q ss_pred CCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 010266 191 GDVMTLLMREETLTETVARFYIAQSVLAIESIHK---------------------------------------------- 224 (514)
Q Consensus 191 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~---------------------------------------------- 224 (514)
.++....... ......+..++...|.-||+
T Consensus 105 ~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 105 KTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 8776654221 11111223333333333332
Q ss_pred ------------CCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 225 ------------HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 225 ------------~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
..++|+|+.|.|||++.++.+-|+||+.|..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1279999999999999877778999998864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=2.6e-07 Score=95.28 Aligned_cols=81 Identities=19% Similarity=0.213 Sum_probs=51.8
Q ss_pred eEEeeeeecCceEEEEEEEccCCCEEEEEEeecccc-cCh---hhHHHHHHHHHHHHHcCC--C-ceeeEEEEEEcCCeE
Q 010266 109 DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM-LSR---GQVEHVRAERNLLAEVAS--H-CIVKLYYSFQDAEYL 181 (514)
Q Consensus 109 ~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~-~~~---~~~~~~~~E~~iL~~l~h--p-~Iv~l~~~f~~~~~l 181 (514)
..++.||.|..+.||.+....+++.|++|....... ... .....+..|.++|..+.. | .+++++++ +.+..
T Consensus 33 ~~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~ 110 (397)
T 2olc_A 33 LTCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMA 110 (397)
T ss_dssp CEEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTT
T ss_pred eEEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCcc
Confidence 346789999999999997655678899998753211 111 123456779999987742 3 34556543 34556
Q ss_pred EEEEeecCCC
Q 010266 182 YLIMEYLPGG 191 (514)
Q Consensus 182 ~lVmEy~~gg 191 (514)
++||||++|.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 8999999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.37 E-value=3.7e-06 Score=84.01 Aligned_cols=137 Identities=11% Similarity=0.152 Sum_probs=79.7
Q ss_pred EEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC--CCceeeEEE------EEEcCCeE
Q 010266 110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA--SHCIVKLYY------SFQDAEYL 181 (514)
Q Consensus 110 ~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~--hp~Iv~l~~------~f~~~~~l 181 (514)
-++.|+.|..+.||++... +..|++|+.... . ..+..|..++..+. .-.+++++. +..+.+..
T Consensus 36 ~~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~ 106 (346)
T 2q83_A 36 KIDVIQGNQMALVWKVHTD--SGAVCLKRIHRP----E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFL 106 (346)
T ss_dssp EEEECC----CEEEEEEET--TEEEEEEEECSC----H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEE
T ss_pred EeeeccccccCcEEEEEeC--CCCEEEEecCCC----H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEE
Confidence 4456777889999998753 335999988752 1 23344555555442 112334433 12356778
Q ss_pred EEEEeecCCCCHH--------------HHHhhc-cCC--C----------HH---------H------------------
Q 010266 182 YLIMEYLPGGDVM--------------TLLMRE-ETL--T----------ET---------V------------------ 207 (514)
Q Consensus 182 ~lVmEy~~gg~L~--------------~~l~~~-~~l--~----------e~---------~------------------ 207 (514)
|+||+|++|..+. ..++.. ..+ + .. .
T Consensus 107 ~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 186 (346)
T 2q83_A 107 FVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQ 186 (346)
T ss_dssp EEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHH
T ss_pred EEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHH
Confidence 9999999986542 111110 111 1 00 0
Q ss_pred -----HHHHHHHHHHHHHHHH-------------hCCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 208 -----ARFYIAQSVLAIESIH-------------KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 208 -----~~~~~~qi~~aL~~LH-------------~~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
...+..++..++.+|+ ..+++|+|++|.|||++.++.+.|+||+.|..
T Consensus 187 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 187 LYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111122334556664 36899999999999998889999999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=1e-05 Score=81.85 Aligned_cols=84 Identities=8% Similarity=0.114 Sum_probs=57.0
Q ss_pred eeEEeee-eecCceEEEEEEEc--c----CCCEEEEEEeeccc---ccChhhHHHHHHHHHHHHHcC-C--CceeeEEEE
Q 010266 108 FDLLTII-GRGAFGEVRLCQEK--K----SGNIYAMKKLKKSE---MLSRGQVEHVRAERNLLAEVA-S--HCIVKLYYS 174 (514)
Q Consensus 108 f~~~~~L-G~G~fG~V~l~~~~--~----t~~~~AiK~l~k~~---~~~~~~~~~~~~E~~iL~~l~-h--p~Iv~l~~~ 174 (514)
...++.| +.|..+.||++... . ++..+++|+-.... .... ..+..|..+|..+. + -.+++++.+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~---~~~~~E~~~l~~L~~~~~vpvP~v~~~ 98 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPT---YRLDHQFEVIRLVGELTDVPVPRVRWI 98 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSC---CCHHHHHHHHHHHHHHCCSCCCCEEEE
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCch---hHHHHHHHHHHHHhhcCCCCCCcEEEE
Confidence 3456778 88999999988653 1 25678999865432 1111 23667888888774 2 357778877
Q ss_pred EEcC---CeEEEEEeecCCCCHH
Q 010266 175 FQDA---EYLYLIMEYLPGGDVM 194 (514)
Q Consensus 175 f~~~---~~l~lVmEy~~gg~L~ 194 (514)
..+. ...|+||||++|..+.
T Consensus 99 ~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 99 ETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp ECSSTTTSSCEEEEECCCCBCCC
T ss_pred ccCCCccCCceEEEEecCCCChh
Confidence 7655 3568999999986653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.04 E-value=2.3e-05 Score=81.35 Aligned_cols=77 Identities=17% Similarity=0.193 Sum_probs=47.0
Q ss_pred EEeeeeecCceEEEEEEEccCCCEEEEEEeecccc-cChh---hHHHHHHHHHHHHHc---CCCceeeEEEEEEcCCeEE
Q 010266 110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM-LSRG---QVEHVRAERNLLAEV---ASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 110 ~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~-~~~~---~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~~~~~l~ 182 (514)
-++.||.|..+.||++. .++..|+||......- .... .......|.+++... ....+++++++. ....+
T Consensus 38 ~i~~l~~G~~n~vyrv~--~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVV--GSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEE--CSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEE--cCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 46789999999999985 3567899995432111 1111 011223344444332 334677777665 56678
Q ss_pred EEEeec-CC
Q 010266 183 LIMEYL-PG 190 (514)
Q Consensus 183 lVmEy~-~g 190 (514)
+||||+ +|
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 87
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.91 E-value=7.3e-05 Score=74.50 Aligned_cols=133 Identities=17% Similarity=0.177 Sum_probs=90.8
Q ss_pred EEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC---CCceeeEEEEEEcCCeEEEEEe
Q 010266 110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA---SHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 110 ~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
-++.|+.|....||++.. ++..|++|+-... ....+..|..+|+.+. ...+++++....+.+..|+|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 467899999999999863 5678999987643 2456788999988773 3568888888888889999999
Q ss_pred ecCCCCHH--------HH---Hhhcc---CC-----------------CHHHHHHHHH---------------------H
Q 010266 187 YLPGGDVM--------TL---LMREE---TL-----------------TETVARFYIA---------------------Q 214 (514)
Q Consensus 187 y~~gg~L~--------~~---l~~~~---~l-----------------~e~~~~~~~~---------------------q 214 (514)
|++|..+. .. |+... .| ......++.. +
T Consensus 112 ~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~ 191 (312)
T 3jr1_A 112 ALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDL 191 (312)
T ss_dssp CCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHH
T ss_pred eccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHH
Confidence 99997642 11 22211 11 1122222221 1
Q ss_pred HHHHH-HHHH----hCCeEEcCCCCCCccccCCCcEEEcccc
Q 010266 215 SVLAI-ESIH----KHNYIHRDIKPDNLLLDQNGHMKLSDFG 251 (514)
Q Consensus 215 i~~aL-~~LH----~~giiHrDLKpeNILld~~g~iKL~DFG 251 (514)
++..+ ..|. ...+||+|+.+.|++++.+| +.|+||+
T Consensus 192 l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 192 IVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 22222 2342 24699999999999999888 8999985
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00011 Score=72.43 Aligned_cols=132 Identities=12% Similarity=0.004 Sum_probs=75.1
Q ss_pred EeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEEEcCCeEEEEEeec-
Q 010266 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYLYLIMEYL- 188 (514)
Q Consensus 111 ~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l~lVmEy~- 188 (514)
++.|+.|....+|++ ..|++|+....... ......|..++..+. +...+++++.+ .+.-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 788999999999998 45889987643110 011245777777664 22225666554 33457899999
Q ss_pred CCCCHHHH---------------H---hhcc-CCC-----HHHHHHHHH--------------HHHHHHHHH----H---
Q 010266 189 PGGDVMTL---------------L---MREE-TLT-----ETVARFYIA--------------QSVLAIESI----H--- 223 (514)
Q Consensus 189 ~gg~L~~~---------------l---~~~~-~l~-----e~~~~~~~~--------------qi~~aL~~L----H--- 223 (514)
+|..+... | +... .++ ...+..+.. .+...+..| .
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 66443210 1 1111 011 111111111 111111111 1
Q ss_pred -hCCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 224 -KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 224 -~~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
...++|+|+.|.||| ..+|.+.|+||..|..
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 135899999999999 6678899999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00038 Score=69.10 Aligned_cols=136 Identities=10% Similarity=0.154 Sum_probs=78.7
Q ss_pred eeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCC--ceeeEEEE-----EEcCCeEEEE
Q 010266 112 TIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH--CIVKLYYS-----FQDAEYLYLI 184 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~-----f~~~~~l~lV 184 (514)
..|+ |.-..||++.. .+|+.|++|+...... ....+..|..++..+... .+++++.. ....+..++|
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 88899998753 3466799999864321 234566788888776421 24444433 1234566899
Q ss_pred EeecCCCCHH-----H------H---Hhh---cc------CCCHHH----HH------------------HHHHHHHHHH
Q 010266 185 MEYLPGGDVM-----T------L---LMR---EE------TLTETV----AR------------------FYIAQSVLAI 219 (514)
Q Consensus 185 mEy~~gg~L~-----~------~---l~~---~~------~l~e~~----~~------------------~~~~qi~~aL 219 (514)
|+|++|..+. . . ++. .. .++... .+ ..+.+++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999885421 0 1 111 00 111110 00 0111222222
Q ss_pred HHH----HhCCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 220 ESI----HKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 220 ~~L----H~~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
.-+ ...+++|+|++|.|||++ + .+.|+||+.|..
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 222 235689999999999998 4 899999998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00034 Score=71.59 Aligned_cols=144 Identities=17% Similarity=0.221 Sum_probs=85.5
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEcc-------CCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKK-------SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYS 174 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~-------t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~ 174 (514)
+..++.+ ++.|..|-...+|++.... +++.|.+|+.-.. . .....+.+|..+++.+. +...+++++.
T Consensus 48 ~~~~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~ 122 (379)
T 3feg_A 48 VQPEELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--L--QGVDSLVLESVMFAILAERSLGPQLYGV 122 (379)
T ss_dssp CCGGGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEE
T ss_pred CCcCceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--c--chHHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence 3334454 3567778889999987642 3578999985321 1 12345668999998774 3344677777
Q ss_pred EEcCCeEEEEEeecCCCCHHH--------------HH---hhcc-----CCC--HHHHHHHHHHHHH-------------
Q 010266 175 FQDAEYLYLIMEYLPGGDVMT--------------LL---MREE-----TLT--ETVARFYIAQSVL------------- 217 (514)
Q Consensus 175 f~~~~~l~lVmEy~~gg~L~~--------------~l---~~~~-----~l~--e~~~~~~~~qi~~------------- 217 (514)
+.+. +||||++|..|.. .| +... ... ...+..|..++-.
T Consensus 123 ~~~g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~ 198 (379)
T 3feg_A 123 FPEG----RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLE 198 (379)
T ss_dssp ETTE----EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHH
T ss_pred cCCc----cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhh
Confidence 7542 9999999854421 11 1110 111 2344445543321
Q ss_pred ------HHHHHH----h----CCeEEcCCCCCCccccCC----CcEEEcccccccc
Q 010266 218 ------AIESIH----K----HNYIHRDIKPDNLLLDQN----GHMKLSDFGLCKP 255 (514)
Q Consensus 218 ------aL~~LH----~----~giiHrDLKpeNILld~~----g~iKL~DFGla~~ 255 (514)
.+..|. . ..++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 199 ~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 199 MYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred hHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 223332 2 369999999999999876 7899999998864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00023 Score=70.51 Aligned_cols=143 Identities=13% Similarity=0.035 Sum_probs=80.6
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCc--eeeEEEE------EEc
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC--IVKLYYS------FQD 177 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~--Iv~l~~~------f~~ 177 (514)
....-++.|+.|....||++... +| .|++|+..... .. ..+..|..++..+.... +++++.. ...
T Consensus 22 ~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~--~~---~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~ 94 (322)
T 2ppq_A 22 GSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--EK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL 94 (322)
T ss_dssp CCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred CcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC--CH---HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE
Confidence 44556778888999999998743 33 68899887531 11 23556777777663211 3333321 123
Q ss_pred CCeEEEEEeecCCCCHHH--------------HHhhc-cCCC--------HH-HHH--------------HHHHHHHHHH
Q 010266 178 AEYLYLIMEYLPGGDVMT--------------LLMRE-ETLT--------ET-VAR--------------FYIAQSVLAI 219 (514)
Q Consensus 178 ~~~l~lVmEy~~gg~L~~--------------~l~~~-~~l~--------e~-~~~--------------~~~~qi~~aL 219 (514)
.+..++||+|++|..+.. .++.. ..++ .. ... .....+...+
T Consensus 95 ~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~ 174 (322)
T 2ppq_A 95 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI 174 (322)
T ss_dssp TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHH
Confidence 456799999999865311 01110 0110 00 000 0001133344
Q ss_pred HHHH-------hCCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 220 ESIH-------KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 220 ~~LH-------~~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
+.++ ..+++|+|+.|.|||++.++.+.|+||+.|..
T Consensus 175 ~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 175 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 5554 24799999999999998776668999998753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00033 Score=72.90 Aligned_cols=74 Identities=23% Similarity=0.287 Sum_probs=51.0
Q ss_pred EEeeeeecCceEEEEEEEcc-------CCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEEEcCCeE
Q 010266 110 LLTIIGRGAFGEVRLCQEKK-------SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 110 ~~~~LG~G~fG~V~l~~~~~-------t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l 181 (514)
-++.|+.|....||++.... ++..|++|+..... ...++..|..++..+. +...+++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-----cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 45678889999999997643 25789999874311 1134557888888774 3334677777653
Q ss_pred EEEEeecCCCC
Q 010266 182 YLIMEYLPGGD 192 (514)
Q Consensus 182 ~lVmEy~~gg~ 192 (514)
.+||||++|..
T Consensus 148 g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 GRLEEYIPSRP 158 (429)
T ss_dssp EEEECCCCEEE
T ss_pred CEEEEEeCCcc
Confidence 28999998743
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.0021 Score=62.64 Aligned_cols=79 Identities=15% Similarity=0.021 Sum_probs=55.2
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCC--C-ceeeEEEEEEcCCeEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS--H-CIVKLYYSFQDAEYLY 182 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h--p-~Iv~l~~~f~~~~~l~ 182 (514)
....-++.+|.|..+.||.+.. .+|+.|.+|+-...... ....+..|...|+.+.. + .+++.+.. +. -+
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~ 86 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPA---LDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RT 86 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCC---CTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TE
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcc---hhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ce
Confidence 4566788999999999999874 57889999986543221 12336789999988742 2 34555543 22 37
Q ss_pred EEEeecCCCC
Q 010266 183 LIMEYLPGGD 192 (514)
Q Consensus 183 lVmEy~~gg~ 192 (514)
+||||+.++.
T Consensus 87 lv~e~l~~~~ 96 (288)
T 3f7w_A 87 LAMEWVDERP 96 (288)
T ss_dssp EEEECCCCCC
T ss_pred EEEEeecccC
Confidence 8999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00028 Score=71.56 Aligned_cols=75 Identities=15% Similarity=0.063 Sum_probs=45.4
Q ss_pred EEeeeeecCceEEEEEEEcc--------CCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCC-ceeeEEEEEEcCCe
Q 010266 110 LLTIIGRGAFGEVRLCQEKK--------SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDAEY 180 (514)
Q Consensus 110 ~~~~LG~G~fG~V~l~~~~~--------t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp-~Iv~l~~~f~~~~~ 180 (514)
-++.|+.|....||++.... .+..|++|+..... ........|..++..+... .++++++.+.
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~---- 108 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV----DELYNTISEFEVYKTMSKYKIAPQLLNTFN---- 108 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG----GGTSCHHHHHHHHHHHHHTTSSCCEEEEET----
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc----cceecHHHHHHHHHHHHhcCCCCceEEecC----
Confidence 35678889899999997643 13688999875431 1111235688888877432 3557776652
Q ss_pred EEEEEeecCCCC
Q 010266 181 LYLIMEYLPGGD 192 (514)
Q Consensus 181 l~lVmEy~~gg~ 192 (514)
-++||||++|..
T Consensus 109 ~~~v~e~i~G~~ 120 (369)
T 3c5i_A 109 GGRIEEWLYGDP 120 (369)
T ss_dssp TEEEEECCCSEE
T ss_pred CcEEEEEecCCc
Confidence 268999999854
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00043 Score=69.09 Aligned_cols=137 Identities=15% Similarity=0.141 Sum_probs=72.4
Q ss_pred EeeeeecCceE-EEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCC--CceeeEEEEEEcCCeEEEEEee
Q 010266 111 LTIIGRGAFGE-VRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS--HCIVKLYYSFQDAEYLYLIMEY 187 (514)
Q Consensus 111 ~~~LG~G~fG~-V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~f~~~~~l~lVmEy 187 (514)
++.|+.|+... +|.+.. .+|..|++|...... . ..+..|..++..+.. -.+++++.+..+.. ++|||+
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~---~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~ 93 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE---G---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED 93 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTT---T---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCC---C---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence 45676665555 666642 236677777654321 0 224557777776632 23556666533333 789999
Q ss_pred cCCCCHHHHHhhc--------------------------cCCCHHHHH--------HHH------------HHHHHHHHH
Q 010266 188 LPGGDVMTLLMRE--------------------------ETLTETVAR--------FYI------------AQSVLAIES 221 (514)
Q Consensus 188 ~~gg~L~~~l~~~--------------------------~~l~e~~~~--------~~~------------~qi~~aL~~ 221 (514)
+.|..+...+... ..++..... .+. ..+..++..
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 9776665433210 012221110 011 011112222
Q ss_pred H------HhCCeEEcCCCCCCccccCC----CcEEEccccccccC
Q 010266 222 I------HKHNYIHRDIKPDNLLLDQN----GHMKLSDFGLCKPL 256 (514)
Q Consensus 222 L------H~~giiHrDLKpeNILld~~----g~iKL~DFGla~~~ 256 (514)
+ +...++|+|+.|.|||++.+ +.+.|+||+.|...
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3 23579999999999999875 78999999988753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0016 Score=65.37 Aligned_cols=31 Identities=19% Similarity=0.241 Sum_probs=27.9
Q ss_pred CCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 225 ~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
.+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888999999988764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0087 Score=62.62 Aligned_cols=75 Identities=15% Similarity=0.184 Sum_probs=48.9
Q ss_pred EEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCc-eeeEEEEEEcCCeEEEEEeec
Q 010266 110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDAEYLYLIMEYL 188 (514)
Q Consensus 110 ~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~-Iv~l~~~f~~~~~l~lVmEy~ 188 (514)
-++.|+.|-...+|++.....+..|++|+..... ...+ ....|..+|..+...+ .+++++.|. + .+||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence 4567888999999999865445789999875421 1111 1247888998886443 467887773 2 2599999
Q ss_pred CCCC
Q 010266 189 PGGD 192 (514)
Q Consensus 189 ~gg~ 192 (514)
+|..
T Consensus 184 ~G~~ 187 (458)
T 2qg7_A 184 DGYA 187 (458)
T ss_dssp CSEE
T ss_pred CCcc
Confidence 9843
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.50 E-value=0.017 Score=53.87 Aligned_cols=120 Identities=19% Similarity=0.150 Sum_probs=79.1
Q ss_pred CHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHH-hCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccccccc
Q 010266 192 DVMTLLMR-EETLTETVARFYIAQSVLAIESIH-KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEV 269 (514)
Q Consensus 192 ~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH-~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~ 269 (514)
+|.++|.. ..+++|++++.++.|.+.+|.-+- +..-..+=+-|..|+|..+|.|-+.+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------------
Confidence 68888875 569999999999999999987762 11111333457899999999998874 2110
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHh
Q 010266 270 LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 349 (514)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 349 (514)
.....+.|||... .+.+.+.=|+|||+++|.-+
T Consensus 98 ----------------------------------------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~AL 130 (229)
T 2yle_A 98 ----------------------------------------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKAL 130 (229)
T ss_dssp -------------------------------------------------------CCSS-SSSCHHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHh
Confidence 0112345777763 34466778999999999887
Q ss_pred hCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc
Q 010266 350 VGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC 395 (514)
Q Consensus 350 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~ 395 (514)
--..|= ..+..+|+++..||..|..
T Consensus 131 DygL~e---------------------~eE~eLS~~LE~LL~~Mt~ 155 (229)
T 2yle_A 131 DYGLKE---------------------NEERELSPPLEQLIDHMAN 155 (229)
T ss_dssp TTTCCT---------------------TEEECCCHHHHHHHHHHTT
T ss_pred hcCCCc---------------------ccchhhCHHHHHHHHHHHh
Confidence 432221 1124699999999999975
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.96 E-value=0.053 Score=56.02 Aligned_cols=75 Identities=11% Similarity=0.087 Sum_probs=49.3
Q ss_pred EEeeeeecCceEEEEEEEccC-------CCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEEEcCCeE
Q 010266 110 LLTIIGRGAFGEVRLCQEKKS-------GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 110 ~~~~LG~G~fG~V~l~~~~~t-------~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l 181 (514)
-++.|..|-...+|++..... ++.|++++..... . ..-...+|..+++.+. +...+++++.+..
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~~---- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---G-KFYDSKVELDVFRYLSNINIAPNIIADFPE---- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEETT----
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---c-hhcCHHHHHHHHHHHHhcCCCCCEEEEcCC----
Confidence 456777788999999986521 5789999864421 1 1111346888887774 3345667765532
Q ss_pred EEEEeecCCCC
Q 010266 182 YLIMEYLPGGD 192 (514)
Q Consensus 182 ~lVmEy~~gg~ 192 (514)
++||||++|..
T Consensus 146 ~~I~efI~G~~ 156 (424)
T 3mes_A 146 GRIEEFIDGEP 156 (424)
T ss_dssp EEEEECCCSEE
T ss_pred CEEEEEeCCcc
Confidence 68999999864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.39 E-value=0.28 Score=50.05 Aligned_cols=30 Identities=27% Similarity=0.463 Sum_probs=25.8
Q ss_pred CeEEcCCCCCCccc------cCCCcEEEcccccccc
Q 010266 226 NYIHRDIKPDNLLL------DQNGHMKLSDFGLCKP 255 (514)
Q Consensus 226 giiHrDLKpeNILl------d~~g~iKL~DFGla~~ 255 (514)
.++|+|+.+.|||+ +.++.+.++||-.|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 37899999999999 4567899999999864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 514 | ||||
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-84 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-84 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-82 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-80 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-76 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-75 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-73 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-71 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-70 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-70 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-69 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-69 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-68 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-67 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-67 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-66 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-65 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-65 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-63 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-62 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-61 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-58 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-58 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-56 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-53 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-52 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-52 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-52 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-50 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-50 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-50 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-49 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-49 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-49 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-49 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-48 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-47 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-47 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-47 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-46 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-45 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-45 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-45 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-45 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-45 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-44 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-44 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-43 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-43 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-42 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-41 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-38 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-31 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-14 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 262 bits (669), Expect = 4e-84
Identities = 123/386 (31%), Positives = 188/386 (48%), Gaps = 61/386 (15%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
K++++DFD L ++G+G FG+V L +EK +G YAMK L+K ++++ +V H E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES 221
+ L Y+FQ + L +MEY GG++ L RE TE ARFY A+ V A+E
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
+H + ++RDIK +NL+LD++GH+K++DFGLCK
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--------------------- 159
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341
+ GTP+Y+APEVL YG DWW L
Sbjct: 160 ----------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHR 400
G +MYEM+ G PFY+ D I+ ++FP L+PEAK L+ LL D + R
Sbjct: 192 GVVMYEMMCGRLPFYNQDHERLFELIL--MEEIRFPRT--LSPEAKSLLAGLLKKDPKQR 247
Query: 401 LGTLGS--EQIKAHPWFKDIAWDKLY--EMEAAYKPEVNGVLDTQNFMKFDEVESQT--- 453
LG S +++ H +F I W + ++ +KP+V +DT+ F +S T
Sbjct: 248 LGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITP 307
Query: 454 PKRTGSGPMRKMMLTPKDLSFVGYTY 479
P R S + ++ + F + Y
Sbjct: 308 PDRYDSLGLLELDQREEQEMFEDFDY 333
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 260 bits (665), Expect = 4e-84
Identities = 98/335 (29%), Positives = 165/335 (49%), Gaps = 55/335 (16%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
K +DF I+G G+F V L +E + YA+K L+K ++ +V +V ER++++
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES 221
+ VKLY++FQD E LY + Y G+++ + + + ET RFY A+ V A+E
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
+H IHRD+KP+N+LL+++ H++++DFG K
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAK--------------------------- 156
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341
+++ A S VGT Y++PE+L +K D W+L
Sbjct: 157 --------------------VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWAL 196
Query: 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHR 400
G I+Y+++ G PPF + + +KI+ + FPE + P+A+DL+ +LL D R
Sbjct: 197 GCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--YDFPE--KFFPKARDLVEKLLVLDATKR 252
Query: 401 LG---TLGSEQIKAHPWFKDIAWDKLYEMEAAYKP 432
LG G +KAHP+F+ + W+ L++
Sbjct: 253 LGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 257 bits (658), Expect = 1e-82
Identities = 112/380 (29%), Positives = 185/380 (48%), Gaps = 65/380 (17%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
++DF L ++G+G+FG+V L + KK+ +A+K LKK +L VE E+ +L+
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 165 SH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH 223
H + ++ +FQ E L+ +MEYL GGD+M + + A FY A+ +L ++ +H
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDG 283
++RD+K DN+LLD++GH+K++DFG+CK +
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD----------------------- 157
Query: 284 RFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 343
+ GTPDYIAPE+LL + Y DWWS G
Sbjct: 158 --------------------------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGV 191
Query: 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLG 402
++YEML+G PF+ D I ++ +P L EAKDL+ +L + E RLG
Sbjct: 192 LLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRW--LEKEAKDLLVKLFVREPEKRLG 247
Query: 403 TLGSEQIKAHPWFKDIAWDKLY--EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSG 460
I+ HP F++I W++L E++ ++P+V D NF K E ++ P+ +
Sbjct: 248 V--RGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDK--EFLNEKPRLS--- 300
Query: 461 PMRKMMLTPKD-LSFVGYTY 479
+ ++ D F +++
Sbjct: 301 FADRALINSMDQNMFRNFSF 320
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 250 bits (640), Expect = 5e-80
Identities = 127/351 (36%), Positives = 191/351 (54%), Gaps = 62/351 (17%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
S+ DF +L +G G+FG V L + + +G YAMK LKK ++ QVEH ER +L+ V
Sbjct: 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61
Query: 164 ASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH 223
I++++ +FQDA+ +++IM+Y+ GG++ +LL + + VA+FY A+ LA+E +H
Sbjct: 62 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 121
Query: 224 KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDG 283
+ I+RD+KP+N+LLD+NGH+K++DFG K +
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----------------------- 158
Query: 284 RFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 343
Y+ GTPDYIAPEV+ K Y DWWS G
Sbjct: 159 -----------------------------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGI 189
Query: 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLG 402
++YEML GY PFY + + T KI++ + L+FP + KDL+ RL+ D+ RLG
Sbjct: 190 LIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPF--FNEDVKDLLSRLITRDLSQRLG 245
Query: 403 TL--GSEQIKAHPWFKDIAWDKLY--EMEAAYKPEV-NGVLDTQNFMKFDE 448
L G+E +K HPWFK++ W+KL +E Y+P + G DT F K+ E
Sbjct: 246 NLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKYPE 296
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (612), Expect = 1e-76
Identities = 90/316 (28%), Positives = 139/316 (43%), Gaps = 59/316 (18%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
+ +++DF++ +G+G FG V L +EK+S I A+K L K+++ G +R E + +
Sbjct: 2 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES 221
+ I++LY F DA +YLI+EY P G V L + E YI + A+
Sbjct: 62 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 121
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
H IHRDIKP+NLLL G +K++DFG +
Sbjct: 122 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-------------------- 161
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341
+ GT DY+ PE++ + + + D WSL
Sbjct: 162 -------------------------------TTLCGTLDYLPPEMIEGRMHDEKVDLWSL 190
Query: 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHR 400
G + YE LVG PPF ++ T ++I + FP+ +T A+DLI RLL + R
Sbjct: 191 GVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPD--FVTEGARDLISRLLKHNPSQR 246
Query: 401 LGTLGSEQIKAHPWFK 416
++ HPW
Sbjct: 247 ---PMLREVLEHPWIT 259
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 238 bits (609), Expect = 4e-75
Identities = 126/390 (32%), Positives = 199/390 (51%), Gaps = 65/390 (16%)
Query: 72 ASSDVPEEEQINILKDLERKETEYMR----LKRHKISVDDFDLLTIIGRGAFGEVRLCQE 127
A++ EQ ++ + L + + ++++ ++ +D FD + +G G+FG V L +
Sbjct: 3 AAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKH 62
Query: 128 KKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEY 187
K+SGN YAMK L K +++ Q+EH E+ +L V +VKL +SF+D LY++MEY
Sbjct: 63 KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 188 LPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKL 247
+ GG++ + L R +E ARFY AQ VL E +H + I+RD+KP+NLL+DQ G++++
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQV 182
Query: 248 SDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQIN 307
+DFG K +
Sbjct: 183 TDFGFAKRVKGRT----------------------------------------------- 195
Query: 308 RRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKI 367
++ GTP+ +APE++L KGY DWW+LG ++YEM GYPPF++D P+ KI
Sbjct: 196 -----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250
Query: 368 VHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHPWFKDIAWDKLY 424
++FP + + KDL+ LL D+ R G L G IK H WF W +Y
Sbjct: 251 --VSGKVRFPSH--FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306
Query: 425 --EMEAAYKPEVNGVLDTQNFMKFDEVESQ 452
++EA + P+ G DT NF ++E E +
Sbjct: 307 QRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 235 bits (599), Expect = 2e-73
Identities = 100/364 (27%), Positives = 167/364 (45%), Gaps = 63/364 (17%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
++++DF + IIGRG FGEV C++ +G +YAMK L K + + ER +L+
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 163 VASHC---IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAI 219
V++ IV + Y+F + L I++ + GGD+ L + +E RFY A+ +L +
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 120
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESM 279
E +H ++RD+KP N+LLD++GH+++SD GL
Sbjct: 121 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---------------------- 158
Query: 280 DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDW 338
+K +++VGT Y+APEVL K Y DW
Sbjct: 159 -----------------------------KKKPHASVGTHGYMAPEVLQKGVAYDSSADW 189
Query: 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DV 397
+SLG +++++L G+ PF +I + +PE + L+ LL DV
Sbjct: 190 FSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDV 248
Query: 398 EHRLGTL--GSEQIKAHPWFKDIAWDKLY--EMEAAYKPEVNGVLDTQNF--MKFDEVES 451
RLG L G++++K P+F+ + W ++ + P V F FDE ++
Sbjct: 249 NRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDT 308
Query: 452 QTPK 455
+ K
Sbjct: 309 KGIK 312
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 228 bits (581), Expect = 6e-71
Identities = 79/369 (21%), Positives = 145/369 (39%), Gaps = 60/369 (16%)
Query: 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL 159
+H +D +D+ +G GAFG V E+ +GN +A K + + E VR E
Sbjct: 20 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQT 76
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLA 218
++ + +V L+ +F+D + +I E++ GG++ + E ++E A Y+ Q
Sbjct: 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136
Query: 219 IESIHKHNYIHRDIKPDNLLL--DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLN 276
+ +H++NY+H D+KP+N++ ++ +KL DFGL
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---------------------- 174
Query: 277 ESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336
++ ++ T GT ++ APEV K G
Sbjct: 175 ----------------------------HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT 206
Query: 337 DWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC- 395
D WS+G + Y +L G PF ++ T R + ++ + ++ + KD I +LL
Sbjct: 207 DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLA 266
Query: 396 DVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKFDEVESQTPK 455
D R + Q HPW + + + + E +
Sbjct: 267 DPNTR---MTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGR 323
Query: 456 RTGSGPMRK 464
+ +RK
Sbjct: 324 ISNYSSLRK 332
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 224 bits (572), Expect = 2e-70
Identities = 83/325 (25%), Positives = 140/325 (43%), Gaps = 67/325 (20%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS------RGQVEHVRAERNL 159
++++ I+GRG VR C K + YA+K + + S + E E ++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 160 LAEVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLA 218
L +V+ H I++L +++ + +L+ + + G++ L + TL+E R + +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
I ++HK N +HRD+KP+N+LLD + ++KL+DFG
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC------------------------ 158
Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL------KKGY 332
Q++ + GTP Y+APE++ GY
Sbjct: 159 --------------------------QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGY 192
Query: 333 GMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICR 392
G E D WS G IMY +L G PPF+ + R I+ PE + KDL+ R
Sbjct: 193 GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSR 252
Query: 393 LLC-DVEHRLGTLGSEQIKAHPWFK 416
L + R +E+ AHP+F+
Sbjct: 253 FLVVQPQKR---YTAEEALAHPFFQ 274
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 2e-70
Identities = 79/333 (23%), Positives = 140/333 (42%), Gaps = 63/333 (18%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
D ++++ +G GAFG+V Q K++ + A K + S ++E E ++LA
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDH 68
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHK 224
IVKL +F L++++E+ GG V +++ E LTE+ + Q++ A+ +H
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
+ IHRD+K N+L +G +KL+DFG+
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--------------------------- 161
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----KKGYGMECDWW 339
+ S +GTP ++APEV++ + Y + D W
Sbjct: 162 ----------------------RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVW 199
Query: 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVE 398
SLG + EM PP + +P+ KI + +R + KD + + L +V+
Sbjct: 200 SLGITLIEMAEIEPPHHELNPMRVLLKIAK-SEPPTLAQPSRWSSNFKDFLKKCLEKNVD 258
Query: 399 HRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYK 431
R + Q+ HP+ + + E+ A K
Sbjct: 259 AR---WTTSQLLQHPFVTVDSNKPIRELIAEAK 288
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 2e-69
Identities = 69/314 (21%), Positives = 122/314 (38%), Gaps = 55/314 (17%)
Query: 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA 164
V+D+DL+ +G GA+GEV+L + + A+K + + E+++ E + +
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 61
Query: 165 SHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK 224
+VK Y ++ YL +EY GG++ + + + E A+ + Q + + +H
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
HRDIKP+NLLLD+ ++K+SDFGL
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN------------------------- 156
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGA 343
NR +L GT Y+APE+L ++ + D WS G
Sbjct: 157 ----------------------NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 194
Query: 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLG 402
++ ML G P+ + ++ L+ ++L + R
Sbjct: 195 VLTAMLAGELPWDQPSDSCQEYSDWK-EKKTYLNPWKKIDSAPLALLHKILVENPSAR-- 251
Query: 403 TLGSEQIKAHPWFK 416
+ IK W+
Sbjct: 252 -ITIPDIKKDRWYN 264
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 223 bits (568), Expect = 5e-69
Identities = 79/388 (20%), Positives = 165/388 (42%), Gaps = 63/388 (16%)
Query: 83 NILKDLERKET-EYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK 141
+D+ +K + + +K+ + D +D+L +G GAFG V C EK +G ++ K +
Sbjct: 6 KFYEDIWKKYVPQPVEVKQGSV-YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT 64
Query: 142 SEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE 201
L + V+ E +++ ++ ++ L+ +F+D + LI+E+L GG++ + E+
Sbjct: 65 PYPLDK---YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED 121
Query: 202 -TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD--QNGHMKLSDFGLCKPLDC 258
++E Y+ Q+ ++ +H+H+ +H DIKP+N++ + + +K+ DFGL
Sbjct: 122 YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT---- 177
Query: 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGT 318
++N ++ T T
Sbjct: 178 ----------------------------------------------KLNPDEIVKVTTAT 191
Query: 319 PDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPE 378
++ APE++ ++ G D W++G + Y +L G PF +D + T + +
Sbjct: 192 AEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA 251
Query: 379 EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGV 437
+ ++PEAKD I LL + R L HPW K + + ++ ++
Sbjct: 252 FSSVSPEAKDFIKNLLQKEPRKR---LTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQK 308
Query: 438 LDTQNFMKFDEVESQTPKRTGSGPMRKM 465
+ + + + + + +RK
Sbjct: 309 IK-EKYADWPAPQPAIGRIANFSSLRKH 335
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 220 bits (562), Expect = 1e-68
Identities = 91/345 (26%), Positives = 149/345 (43%), Gaps = 62/345 (17%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
D +D ++G GAF EV L ++K++ + A+K + K + G+ + E +L ++
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKH 66
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
IV L ++ +LYLIM+ + GG++ ++ + TE A I Q + A++ +H
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 226 NYIHRDIKPDNLLL---DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
+HRD+KP+NLL D++ + +SDFGL K
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---------------------------- 158
Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342
+ + + GTP Y+APEVL +K Y D WS+G
Sbjct: 159 ----------------------MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIG 196
Query: 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRL 401
I Y +L GYPPFY ++ +I+ + P ++ AKD I L+ D E R
Sbjct: 197 VIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKR- 255
Query: 402 GTLGSEQIKAHPWFK-DIAWDKLYEMEAAYKPEVNGVLDTQNFMK 445
EQ HPW D A DK + + ++ + +
Sbjct: 256 --FTCEQALQHPWIAGDTALDK--NIHQSVSEQIKKNFAKSKWKQ 296
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 1e-67
Identities = 80/331 (24%), Positives = 138/331 (41%), Gaps = 62/331 (18%)
Query: 92 ETEYMRLKRHKISVDD----FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR 147
+ E + R +SV D + IG+GA G V + +G A++++ +
Sbjct: 2 DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--- 58
Query: 148 GQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETV 207
+ E + E ++ E + IV S+ + L+++MEYL GG + ++ E
Sbjct: 59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQ 117
Query: 208 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINEN 267
+ + A+E +H + IHRDIK DN+LL +G +KL+DFG C +
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ------- 170
Query: 268 EVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL 327
+ VGTP ++APEV+
Sbjct: 171 ------------------------------------------SKRSTMVGTPYWMAPEVV 188
Query: 328 LKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAK 387
+K YG + D WSLG + EM+ G PP+ +++P+ I + +L+ +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLSAIFR 247
Query: 388 DLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417
D + R L DVE R ++++ H + K
Sbjct: 248 DFLNRCLDMDVEKR---GSAKELLQHQFLKI 275
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 3e-67
Identities = 113/350 (32%), Positives = 180/350 (51%), Gaps = 60/350 (17%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQE---KKSGNIYAMKKLKKSEMLSRGQ-VEHVRAER 157
K+ +++F+LL ++G GA+G+V L ++ +G +YAMK LKK+ ++ + + EH R ER
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79
Query: 158 NLLAEVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSV 216
+L + +V L+Y+FQ L+LI++Y+ GG++ T L + E TE + Y+ + V
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 139
Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLN 276
LA+E +HK I+RDIK +N+LLD NGH+ L+DFGL
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS----------------------- 176
Query: 277 ESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL--KKGYGM 334
+ + + + AY GT +Y+AP+++ G+
Sbjct: 177 -------------------------KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDK 211
Query: 335 ECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLL 394
DWWSLG +MYE+L G PF D + +I + P ++ AKDLI RLL
Sbjct: 212 AVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLL 271
Query: 395 C-DVEHRLGTL--GSEQIKAHPWFKDIAWDKLY--EMEAAYKPEVNGVLD 439
D + RLG +++IK H +F+ I WD L ++ A +KP + LD
Sbjct: 272 MKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELD 321
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 4e-66
Identities = 71/362 (19%), Positives = 125/362 (34%), Gaps = 98/362 (27%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
+ DDF+ ++ +G G G V K SG + A K + + + E +L E
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHE 60
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESI 222
S IV Y +F + + ME++ GG + +L + + E + + + +
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 223 H-KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
KH +HRD+KP N+L++ G +KL DFG+ L +
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---------------------- 158
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341
+A S VGT Y++PE L Y ++ D WS+
Sbjct: 159 -----------------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSM 189
Query: 342 GAIMYEMLVGYPPFYSDD--------------------------------------PVTT 363
G + EM VG P D P
Sbjct: 190 GLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMA 249
Query: 364 CRKIVHWKNHLKFPE--EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAW 420
+++ + + P+ + E +D + + L + R +Q+ H + K
Sbjct: 250 IFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER---ADLKQLMVHAFIKRSDA 306
Query: 421 DK 422
++
Sbjct: 307 EE 308
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 212 bits (540), Expect = 2e-65
Identities = 67/315 (21%), Positives = 117/315 (37%), Gaps = 62/315 (19%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
F L IG G+FG V ++ ++ + A+KK+ S S + + + E L ++
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
++ + +L+MEY G L + ++ L E ++ + +H H
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
N IHRD+K N+LL + G +KL DFG + N
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------------------------- 169
Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLG 342
S VGTP ++APEV+L + Y + D WSLG
Sbjct: 170 ----------------------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 201
Query: 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRL 401
E+ PP ++ + ++ I +N + + ++ + L + R
Sbjct: 202 ITCIELAERKPPLFNMNAMSALYHIA--QNESPALQSGHWSEYFRNFVDSCLQKIPQDR- 258
Query: 402 GTLGSEQIKAHPWFK 416
SE + H +
Sbjct: 259 --PTSEVLLKHRFVL 271
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 3e-65
Identities = 84/321 (26%), Positives = 137/321 (42%), Gaps = 68/321 (21%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
+D+++L IG G++G + + K G I K+L M + + + + +E NLL E+
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKH 62
Query: 166 HCIVKLYYSFQDAE--YLYLIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAI 219
IV+ Y D LY++MEY GGD+ +++ + + L E + Q LA+
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 220 ESIHK-----HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDEN 274
+ H+ H +HRD+KP N+ LD ++KL DFGL + L+
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN----------------- 165
Query: 275 LNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM 334
+ A + VGTP Y++PE + + Y
Sbjct: 166 --------------------------------HDTSFAKAFVGTPYYMSPEQMNRMSYNE 193
Query: 335 ECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLL 394
+ D WSLG ++YE+ PPF + KI K + P R + E ++I R+L
Sbjct: 194 KSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-FRRIPY--RYSDELNEIITRML 250
Query: 395 C-DVEHRLGTLGSEQIKAHPW 414
HR E+I +P
Sbjct: 251 NLKDYHR---PSVEEILENPL 268
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 2e-63
Identities = 81/342 (23%), Positives = 141/342 (41%), Gaps = 64/342 (18%)
Query: 99 KRHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ---VEHVRA 155
++ + D +D +G G F V+ C+EK +G YA K +KK S + E +
Sbjct: 4 RQENVD-DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 156 ERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQS 215
E ++L E+ ++ L+ +++ + LI+E + GG++ L +E+LTE A ++ Q
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122
Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNG----HMKLSDFGLCKPLDCTNLSAINENEVLD 271
+ + +H H D+KP+N++L +K+ DFGL +D N
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--------- 173
Query: 272 DENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331
+ GTP+++APE++ +
Sbjct: 174 -----------------------------------------KNIFGTPEFVAPEIVNYEP 192
Query: 332 YGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLIC 391
G+E D WS+G I Y +L G PF D T + + + + AKD I
Sbjct: 193 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 252
Query: 392 RLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKP 432
RLL D + R + + HPW K + + +A+
Sbjct: 253 RLLVKDPKKR---MTIQDSLQHPWIKPKDTQQA--LSSAWSH 289
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 3e-62
Identities = 70/315 (22%), Positives = 117/315 (37%), Gaps = 61/315 (19%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
+ + + +GRG FG V C E S Y K +K V+ E ++L
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARH 60
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHK 224
I+ L+ SF+ E L +I E++ G D+ + L E Y+ Q A++ +H
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 225 HNYIHRDIKPDNLLLDQ--NGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVD 282
HN H DI+P+N++ + +K+ +FG + L +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---------------------- 158
Query: 283 GRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342
P+Y APEV D WSLG
Sbjct: 159 ----------------------------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLG 190
Query: 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRL 401
++Y +L G PF ++ I++ + ++ EA D + RLL + + R
Sbjct: 191 TLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSR- 249
Query: 402 GTLGSEQIKAHPWFK 416
+ + + HPW K
Sbjct: 250 --MTASEALQHPWLK 262
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (511), Expect = 1e-61
Identities = 60/318 (18%), Positives = 120/318 (37%), Gaps = 67/318 (21%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC 167
IGRG+F V + ++ A +L+ ++ ++ + + + E +L +
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPN 69
Query: 168 IVKLYYSFQDA----EYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIH 223
IV+ Y S++ + + L+ E + G + T L R + + V R + Q + ++ +H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 224 KHNY--IHRDIKPDNLLL-DQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
IHRD+K DN+ + G +K+ D GL
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-------------------------- 163
Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340
+ R A + +GTP+++APE+ ++ Y D ++
Sbjct: 164 -------------------------LKRASFAKAVIGTPEFMAPEM-YEEKYDESVDVYA 197
Query: 341 LGAIMYEMLVGYPPFY-SDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVE 398
G M EM P+ + R++ F + PE K++I + + +
Sbjct: 198 FGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV--AIPEVKEIIEGCIRQNKD 255
Query: 399 HRLGTLGSEQIKAHPWFK 416
R + + H +F+
Sbjct: 256 ER---YSIKDLLNHAFFQ 270
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-58
Identities = 84/338 (24%), Positives = 138/338 (40%), Gaps = 78/338 (23%)
Query: 96 MRLKRHKISVDDFDLLT-IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVR 154
+++K++ I +DD+ + + ++G G G+V K++ +A+K L+ R
Sbjct: 2 LQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR------- 53
Query: 155 AERNLLAEVASH-CIVKLYYSFQDA----EYLYLIMEYLPGGDVMTLLMR--EETLTETV 207
E L + IV++ +++ + L ++ME L GG++ + + ++ TE
Sbjct: 54 -EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 112
Query: 208 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD---QNGHMKLSDFGLCKPLDCTNLSAI 264
A + AI+ +H N HRD+KP+NLL N +KL+DFG K
Sbjct: 113 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---------- 162
Query: 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAP 324
+ + TP Y+AP
Sbjct: 163 ----------------------------------------ETTSHNSLTTPCYTPYYVAP 182
Query: 325 EVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTC----RKIVHWKNHLKFPEEA 380
EVL + Y CD WSLG IMY +L GYPPFYS+ + +I + PE +
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242
Query: 381 RLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417
++ E K LI LL + R + + HPW
Sbjct: 243 EVSEEVKMLIRNLLKTEPTQR---MTITEFMNHPWIMQ 277
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 192 bits (488), Expect = 4e-58
Identities = 66/303 (21%), Positives = 115/303 (37%), Gaps = 51/303 (16%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
D ++L I+G G EV L ++ + A+K L+ R E A +
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 166 HCIVKLYYSFQD----AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES 221
IV +Y + + Y++MEY+ G + ++ E +T A IA + A+
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
H++ IHRD+KP N+++ +K+ DFG+ + +
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI------------------------- 161
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341
N + +GT Y++PE D +SL
Sbjct: 162 ---------------------ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 200
Query: 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHR 400
G ++YE+L G PPF D PV+ + V L+ + ++ + L + E+R
Sbjct: 201 GCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 260
Query: 401 LGT 403
T
Sbjct: 261 YQT 263
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 1e-56
Identities = 76/322 (23%), Positives = 124/322 (38%), Gaps = 73/322 (22%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEH---VRAERNLLAE 162
+ + ++G G FG V A+K ++K + G++ + V E LL +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 163 VASHC--IVKLYYSFQDAEYLYLIMEYL-PGGDVMTLLMREETLTETVARFYIAQSVLAI 219
V+S +++L F+ + LI+E P D+ + L E +AR + Q + A+
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 220 ESIHKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
H +HRDIK +N+L+D N G +KL DFG L T +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT---------------- 167
Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECD 337
GT Y PE + Y G
Sbjct: 168 -----------------------------------DFDGTRVYSPPEWIRYHRYHGRSAA 192
Query: 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-D 396
WSLG ++Y+M+ G PF D+ + + + F + R++ E + LI L
Sbjct: 193 VWSLGILLYDMVCGDIPFEHDEEII--------RGQVFFRQ--RVSSECQHLIRWCLALR 242
Query: 397 VEHRLGTLGSEQIKAHPWFKDI 418
R E+I+ HPW +D+
Sbjct: 243 PSDR---PTFEEIQNHPWMQDV 261
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 5e-53
Identities = 73/336 (21%), Positives = 123/336 (36%), Gaps = 80/336 (23%)
Query: 110 LLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEM--LSRGQVEHVRAERNLLAEVASHC 167
L +G G F V ++K + I A+KK+K G E LL E++
Sbjct: 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61
Query: 168 IVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNY 227
I+ L +F + L+ +++ + + LT + + Y+ ++ +E +H+H
Sbjct: 62 IIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI 121
Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
+HRD+KP+NLLLD+NG +KL+DFGL K N
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--------------------------- 154
Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 346
+ V T Y APE+L + YG+ D W++G I+
Sbjct: 155 ----------------------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILA 192
Query: 347 EMLVGYPPFYSDDPVTTCRKIVH---------WKNHLKFPEEA---------------RL 382
E+L+ P D + +I W + P+
Sbjct: 193 ELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAA 252
Query: 383 TPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417
+ DLI L + R + + Q +F +
Sbjct: 253 GDDLLDLIQGLFLFNPCAR---ITATQALKMKYFSN 285
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 3e-52
Identities = 73/352 (20%), Positives = 116/352 (32%), Gaps = 87/352 (24%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV 163
V ++ L IG+G FGEV + +K+G A+KK+ G E +L +
Sbjct: 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLL 66
Query: 164 ASHCIVKLYYSFQDAE--------YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQS 215
+V L + +YL+ ++ L T + + +
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126
Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENL 275
+ + IH++ +HRD+K N+L+ ++G +KL+DFGL + S N
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY-------- 178
Query: 276 NESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-KKGYGM 334
+ V T Y PE+LL ++ YG
Sbjct: 179 -------------------------------------TNRVVTLWYRPPELLLGERDYGP 201
Query: 335 ECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVH---------WKNHLKFPEEARLT-- 383
D W G IM EM P + I W N + +L
Sbjct: 202 PIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELV 261
Query: 384 -----------------PEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417
P A DLI +LL D R + S+ H +F
Sbjct: 262 KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR---IDSDDALNHDFFWS 310
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 3e-52
Identities = 53/305 (17%), Positives = 104/305 (34%), Gaps = 59/305 (19%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
I + IG G+FG V + A+K L + + Q++ + E +L +
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAP-TPQQLQAFKNEVGVLRK 60
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREET-LTETVARFYIAQSVLAIES 221
I+ + + A L ++ ++ G + L ET Q+ ++
Sbjct: 61 TRHVNILL-FMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
+H + IHRD+K +N+ L ++ +K+ DFGL
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS------------------------ 155
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL---KKGYGMECDW 338
+ + G+ ++APEV+ K Y + D
Sbjct: 156 -----------------------RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDV 192
Query: 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEAR--LTPEAKDLICRLLC- 395
++ G ++YE++ G P+ + + +V + R K L+ L
Sbjct: 193 YAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKK 252
Query: 396 DVEHR 400
+ R
Sbjct: 253 KRDER 257
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 3e-52
Identities = 77/341 (22%), Positives = 124/341 (36%), Gaps = 81/341 (23%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
++F + IG G +G V + K +G + A+KK++ + + G E +LL E+
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNH 60
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREET-LTETVARFYIAQSVLAIESIHK 224
IVKL LYL+ E+L + T + + + Y+ Q + + H
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 225 HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGR 284
H +HRD+KP NLL++ G +KL+DFGL +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV------------------------ 156
Query: 285 FPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGA 343
+ V T Y APE+LL Y D WSLG
Sbjct: 157 -------------------------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGC 191
Query: 344 IMYEMLVGYPPFYSDDPVTTCRKIVH---------WKNHLKFPEE--------------- 379
I EM+ F D + +I W P+
Sbjct: 192 IFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKV 251
Query: 380 -ARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418
L + + L+ ++L D R + ++ AHP+F+D+
Sbjct: 252 VPPLDEDGRSLLSQMLHYDPNKR---ISAKAALAHPFFQDV 289
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 7e-52
Identities = 82/355 (23%), Positives = 127/355 (35%), Gaps = 97/355 (27%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
+ +IG G+FG V + SG + A+KK+ + + E ++ ++
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDH 72
Query: 166 HCIVKLYYSF------QDAEYLYLIMEYLPGGDVMTLL---MREETLTETVARFYIAQSV 216
IV+L Y F +D YL L+++Y+P ++TL + Y+ Q
Sbjct: 73 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNG-HMKLSDFGLCKPLDCTNLSAINENEVLDDENL 275
++ IH HRDIKP NLLLD + +KL DFG K
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--------------------- 171
Query: 276 NESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGM 334
Q+ R + S + + Y APE++ Y
Sbjct: 172 -----------------------------QLVRGEPNVSYICSRYYRAPELIFGATDYTS 202
Query: 335 ECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVH---------------WKNHLKFPE- 378
D WS G ++ E+L+G P F D V +I+ KFP+
Sbjct: 203 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 262
Query: 379 ---------EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKL 423
R PEA L RLL R L + AH +F ++ +
Sbjct: 263 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR---LTPLEACAHSFFDELRDPNV 314
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 9e-51
Identities = 69/326 (21%), Positives = 117/326 (35%), Gaps = 61/326 (18%)
Query: 96 MRLKRHKISVDDFDLLTIIGRGAFGEVRLCQEK--KSGNIYAMKKLKKSEMLSRGQVEHV 153
+ LKR + + D + +G G FG VR + K A+K LK+ + E +
Sbjct: 3 LFLKRDNLLIADIE----LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEM 56
Query: 154 RAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM-REETLTETVARFYI 212
E ++ ++ + IV+L Q L L+ME GG + L+ + E + + +
Sbjct: 57 MREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 115
Query: 213 AQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDD 272
Q + ++ + + N++HRD+ N+LL + K+SDFGL K L +
Sbjct: 116 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD------------ 163
Query: 273 ENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY 332
+ + + APE + + +
Sbjct: 164 ----------------------------------SYYTARSAGKWPLKWYAPECINFRKF 189
Query: 333 GMECDWWSLGAIMYEML-VGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLIC 391
D WS G M+E L G P+ I K ++ P E PE L+
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RMECPPE--CPPELYALMS 246
Query: 392 RLLC-DVEHRLGTLGSEQIKAHPWFK 416
E R L EQ ++
Sbjct: 247 DCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-50
Identities = 65/331 (19%), Positives = 120/331 (36%), Gaps = 60/331 (18%)
Query: 98 LKRHKISVDDFDLLTIIGRGAFGEVRLC--QEKKSGNIYAMKKLKKSEMLSRGQVEHVRA 155
L R ++++D +G G FG V+ Q KK A+K LK E + + A
Sbjct: 3 LDRKLLTLEDK----ELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLA 57
Query: 156 ERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQS 215
E N++ ++ + IV++ + E L+ME G + L + + + + Q
Sbjct: 58 EANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 116
Query: 216 VLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENL 275
+ ++ + + N++HRD+ N+LL + K+SDFGL K L
Sbjct: 117 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--------------- 161
Query: 276 NESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME 335
N K + APE + + +
Sbjct: 162 -------------------------------NYYKAQTHGKWPVKWYAPECINYYKFSSK 190
Query: 336 CDWWSLGAIMYEML-VGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLL 394
D WS G +M+E G P+ + + + P E DL+
Sbjct: 191 SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RMGCPAG--CPREMYDLMNLCW 247
Query: 395 C-DVEHRLGTLGSEQIKAHPWFKDIAWDKLY 424
DVE+R + +++ ++ D+ + +
Sbjct: 248 TYDVENRP-GFAAVELRLRNYYYDVVNEGHH 277
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 172 bits (436), Expect = 5e-50
Identities = 71/376 (18%), Positives = 134/376 (35%), Gaps = 105/376 (27%)
Query: 89 ERKETEYMRLKRHKI---SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML 145
+ EY + H + + DD+ L+ +GRG + EV + +K LK
Sbjct: 15 THRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--- 71
Query: 146 SRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDA--EYLYLIMEYLPGGDVMTLLMREET 202
+ + ++ E +L + I+ L +D L+ E++ D L +T
Sbjct: 72 ---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QT 125
Query: 203 LTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD-QNGHMKLSDFGLCKPLDCTNL 261
LT+ RFY+ + + A++ H +HRD+KP N+++D ++ ++L D+GL +
Sbjct: 126 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE------- 178
Query: 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDY 321
+ + V + +
Sbjct: 179 -------------------------------------------FYHPGQEYNVRVASRYF 195
Query: 322 IAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPFY-SDDPVTTCRKIV----------- 368
PE+L+ + Y D WSLG ++ M+ PF+ D +I
Sbjct: 196 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255
Query: 369 ----------------------HWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLG 405
W+ + + ++PEA D + +LL D + R L
Sbjct: 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR---LT 312
Query: 406 SEQIKAHPWFKDIAWD 421
+ + HP+F + D
Sbjct: 313 AREAMEHPYFYTVVKD 328
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 170 bits (432), Expect = 6e-50
Identities = 77/339 (22%), Positives = 121/339 (35%), Gaps = 81/339 (23%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
+ + L IG G +G V Q G +A+KK++ E G E ++L E+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRL-EKEDEGIPSTTIREISILKELKH 59
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
IVKLY + L L+ E+L L + E L A+ ++ Q + I H
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
+HRD+KP NLL+++ G +K++DFGL +
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV------------------------- 154
Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAI 344
+ + T Y AP+VL+ Y D WS+G I
Sbjct: 155 ------------------------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCI 190
Query: 345 MYEMLVGYPPFYSDDPVTTCRKIVH---------WKNHLKFPEE---------------- 379
EM+ G P F +I W N + P+
Sbjct: 191 FAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFL 250
Query: 380 ARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417
L DL+ ++L D R + ++Q H +FK+
Sbjct: 251 KGLDESGIDLLSKMLKLDPNQR---ITAKQALEHAYFKE 286
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 8e-50
Identities = 61/361 (16%), Positives = 120/361 (33%), Gaps = 90/361 (24%)
Query: 79 EEQINILKDLERKETEYMRLKRHK--------ISVDDFDLLTIIGRGAFGEVRLCQEKKS 130
E Q+ +++ + EY + + ++ + ++G GAFG+V
Sbjct: 2 ESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGI 61
Query: 131 GNI-----YAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH-CIVKLYYSFQDAEYLYLI 184
A+K LK+ + E + +E ++ ++ SH IV L + + +YLI
Sbjct: 62 SKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 119
Query: 185 MEYLPGGDVMTLLMREE-----------------------TLTETVARFYIAQSVLAIES 221
EY GD++ L + LT + Q +E
Sbjct: 120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 179
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
+ + +HRD+ N+L+ +K+ DFGL + +
Sbjct: 180 LEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM------------------------ 215
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341
+ + + ++APE L + Y ++ D WS
Sbjct: 216 -----------------------SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 252
Query: 342 GAIMYEML-VGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEH 399
G +++E+ +G P+ K++ + P T E ++ D
Sbjct: 253 GILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFY--ATEEIYIIMQSCWAFDSRK 310
Query: 400 R 400
R
Sbjct: 311 R 311
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-49
Identities = 56/304 (18%), Positives = 98/304 (32%), Gaps = 55/304 (18%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGN---IYAMKKLKKSEMLSRGQVEHVRAERNL 159
I D LL +G G+FG VR + A+K LK + ++ E N
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 160 LAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLA 218
+ + +++LY + ++ E P G ++ L + + Y Q
Sbjct: 65 MHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 219 IESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNES 278
+ + +IHRD+ NLLL +K+ DFGL + L +
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND------------------ 165
Query: 279 MDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338
+ + + APE L + + D
Sbjct: 166 ----------------------------DHYVMQEHRKVPFAWCAPESLKTRTFSHASDT 197
Query: 339 WSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-D 396
W G ++EM G P+ + KI L PE+ + +++ +
Sbjct: 198 WMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED--CPQDIYNVMVQCWAHK 255
Query: 397 VEHR 400
E R
Sbjct: 256 PEDR 259
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 1e-49
Identities = 73/352 (20%), Positives = 127/352 (36%), Gaps = 86/352 (24%)
Query: 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGN-IYAMKKLKKSEMLSRGQVEHVR--AERNLL 160
+ ++ + IG GA+G+V ++ K+G A+K+++ + +R A L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 161 AEVASHCIVKLYYSFQDAE-----YLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQ 214
+V+L+ + L L+ E++ L E + + + Q
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDEN 274
+ ++ +H H +HRD+KP N+L+ +G +KL+DFGL +
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-------------------- 164
Query: 275 LNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGM 334
+ + S V T Y APEVLL+ Y
Sbjct: 165 ------------------------------IYSFQMALTSVVVTLWYRAPEVLLQSSYAT 194
Query: 335 ECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVH---------WKNHLKFPEEA----- 380
D WS+G I EM P F V KI+ W + P +A
Sbjct: 195 PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKS 254
Query: 381 ---------RLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDK 422
+ KDL+ + L + R + + +HP+F+D+ K
Sbjct: 255 AQPIEKFVTDIDELGKDLLLKCLTFNPAKR---ISAYSALSHPYFQDLERCK 303
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (428), Expect = 3e-49
Identities = 56/301 (18%), Positives = 110/301 (36%), Gaps = 57/301 (18%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
+ D + +G G +GEV KK A+K LK+ M +VE E ++ E
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKE 69
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM--REETLTETVARFYIAQSVLAIE 220
+ +V+L Y+I E++ G+++ L + ++ V + Q A+E
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
+ K N+IHRD+ N L+ +N +K++DFGL + + +A
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA--------------- 174
Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340
+ APE L + ++ D W+
Sbjct: 175 ---------------------------------GAKFPIKWTAPESLAYNKFSIKSDVWA 201
Query: 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEH 399
G +++E+ Y ++ +++ ++ PE + +L+ +
Sbjct: 202 FGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG--CPEKVYELMRACWQWNPSD 259
Query: 400 R 400
R
Sbjct: 260 R 260
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 9e-49
Identities = 57/303 (18%), Positives = 109/303 (35%), Gaps = 67/303 (22%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
+++ + LL IG+G FG+V L + GN A+K +K + AE +++ +
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT-----AQAFLAEASVMTQ 56
Query: 163 VASHCIVKLY-YSFQDAEYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAI 219
+ +V+L ++ LY++ EY+ G ++ L L + A+
Sbjct: 57 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESM 279
E + +N++HRD+ N+L+ ++ K+SDFGL K T
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ------------------- 157
Query: 280 DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339
+ + APE L +K + + D W
Sbjct: 158 ---------------------------------DTGKLPVKWTAPEALREKKFSTKSDVW 184
Query: 340 SLGAIMYEML-VGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DV 397
S G +++E+ G P+ ++ + K P +++ D
Sbjct: 185 SFGILLWEIYSFGRVPYPRIPLKDVVPRV---EKGYKMDAPDGCPPAVYEVMKNCWHLDA 241
Query: 398 EHR 400
R
Sbjct: 242 AMR 244
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-48
Identities = 79/387 (20%), Positives = 134/387 (34%), Gaps = 91/387 (23%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
+ L+ IG GA+G V + + A+KK+ E + + E +L
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRH 65
Query: 166 HCIVKLYYSFQDAEY----LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIES 221
I+ + + ++ +L G D+ LL + + L+ +++ Q + ++
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKY 124
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
IH N +HRD+KP NLLL+ +K+ DFGL + D +
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH--------------------- 163
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWWS 340
+ V T Y APE++L GY D WS
Sbjct: 164 -------------------------DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 198
Query: 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVH------------------WKNHLKFPEEAR- 381
+G I+ EML P F + I+ L P + +
Sbjct: 199 VGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 258
Query: 382 --------LTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKP 432
+A DL+ ++L + R + EQ AHP+ + +D E A
Sbjct: 259 PWNRLFPNADSKALDLLDKMLTFNPHKR---IEVEQALAHPYLEQY-YDPSDEPIAEAPF 314
Query: 433 EVNGVLDTQNF-----MKFDEVESQTP 454
+ + LD + F+E P
Sbjct: 315 KFDMELDDLPKEKLKELIFEETARFQP 341
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 164 bits (415), Expect = 3e-47
Identities = 57/323 (17%), Positives = 110/323 (34%), Gaps = 59/323 (18%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK-SEMLSRGQVEHVRAERNLL 160
+I + + +IG G FGEV K G +K + Q +E +++
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 81
Query: 161 AEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAI 219
+ ++ L + + +I E++ G + + L + + T + +
Sbjct: 82 GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGM 141
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESM 279
+ + NY+HRD+ N+L++ N K+SDFGL + L+ DD +
Sbjct: 142 KYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE-------------DDTSDPTYT 188
Query: 280 DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339
G + APE + + + D W
Sbjct: 189 SALGG-------------------------------KIPIRWTAPEAIQYRKFTSASDVW 217
Query: 340 SLGAIMYEML-VGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DV 397
S G +M+E++ G P++ I + + P L+ D
Sbjct: 218 SYGIVMWEVMSYGERPYWDMTNQDVINAI---EQDYRLPPPMDCPSALHQLMLDCWQKDR 274
Query: 398 EHR------LGTLGSEQIKAHPW 414
HR + TL +++ +P
Sbjct: 275 NHRPKFGQIVNTL--DKMIRNPN 295
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 4e-47
Identities = 50/301 (16%), Positives = 100/301 (33%), Gaps = 59/301 (19%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
I D L +G G FG V+ + + A+K +K+ M + E ++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMN 55
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM-REETLTETVARFYIAQSVLAIES 221
++ +V+LY +++I EY+ G ++ L A+E
Sbjct: 56 LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 115
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
+ ++HRD+ N L++ G +K+SDFGL +
Sbjct: 116 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR--------------------------- 148
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341
+ + + + + PEVL+ + + D W+
Sbjct: 149 ---------------------YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 187
Query: 342 GAIMYEML-VGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEH 399
G +M+E+ +G P+ T I L+ + + ++ +
Sbjct: 188 GVLMWEIYSLGKMPYERFTNSETAEHIAQG---LRLYRPHLASEKVYTIMYSCWHEKADE 244
Query: 400 R 400
R
Sbjct: 245 R 245
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 4e-47
Identities = 87/387 (22%), Positives = 139/387 (35%), Gaps = 96/387 (24%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
+ L +G GA+G V + ++G A+KKL + S + E LL +
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMRH 76
Query: 166 HCIVKLYYSFQDAE------YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAI 219
++ L F E YL+M ++ G + LM+ E L E +F + Q + +
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGL 134
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESM 279
IH IHRD+KP NL ++++ +K+ DFGL + D
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-------------------- 174
Query: 280 DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDW 338
V T Y APEV+L Y D
Sbjct: 175 --------------------------------MTGYVVTRWYRAPEVILNWMRYTQTVDI 202
Query: 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVH------------------WKNHLKFPEEA 380
WS+G IM EM+ G F D + ++I+ PE
Sbjct: 203 WSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELE 262
Query: 381 R---------LTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAY 430
+ +P A +L+ ++L D E R + + + AHP+F+ + + Y
Sbjct: 263 KKDFASILTNASPLAVNLLEKMLVLDAEQR---VTAGEALAHPYFESLHDTEDEPQVQKY 319
Query: 431 KPEVNGVLDTQNFMK---FDEVESQTP 454
+ V T + K + EV S P
Sbjct: 320 DDSFDDVDRTLDEWKRVTYKEVLSFKP 346
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-46
Identities = 63/319 (19%), Positives = 110/319 (34%), Gaps = 64/319 (20%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
I + L +G+G FGEV + A+K LK M E E ++ +
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM----SPEAFLQEAQVMKK 68
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIE 220
+ +V+LY + E +Y++ EY+ G ++ L E L AQ +
Sbjct: 69 LRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 127
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
+ + NY+HRD++ N+L+ +N K++DFGL + ++ +A
Sbjct: 128 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ--------------- 172
Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340
+ APE L + ++ D WS
Sbjct: 173 ---------------------------------GAKFPIKWTAPEAALYGRFTIKSDVWS 199
Query: 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEH 399
G ++ E+ Y V + P E DL+C+ + E
Sbjct: 200 FGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE--CPESLHDLMCQCWRKEPEE 257
Query: 400 RLGTLGSEQIKA--HPWFK 416
R E ++A +F
Sbjct: 258 RPTF---EYLQAFLEDYFT 273
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-45
Identities = 57/318 (17%), Positives = 103/318 (32%), Gaps = 72/318 (22%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA 161
+ +D +IG G FG+V + KK G + E S+ E +L
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 65
Query: 162 EVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMRE----------------ETLT 204
++ H I+ L + + YLYL +EY P G+++ L + TL+
Sbjct: 66 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 205 ETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264
+ A ++ + + +IHRD+ N+L+ +N K++DFGL + +
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK-- 183
Query: 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAP 324
++A
Sbjct: 184 ------------------------------------------------TMGRLPVRWMAI 195
Query: 325 EVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLT 383
E L Y D WS G +++E++ G P+ K+ + +
Sbjct: 196 ESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL---PQGYRLEKPLNCD 252
Query: 384 PEAKDLICRLLC-DVEHR 400
E DL+ + R
Sbjct: 253 DEVYDLMRQCWREKPYER 270
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 1e-45
Identities = 50/300 (16%), Positives = 100/300 (33%), Gaps = 57/300 (19%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
I + + IG G FG V L + + A+K +++ M E E ++ +
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAM----SEEDFIEEAEVMMK 56
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL-AIES 221
++ +V+LY + + L+ E++ G + L + L + V +
Sbjct: 57 LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 116
Query: 222 IHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
+ + IHRD+ N L+ +N +K+SDFG+ + +
Sbjct: 117 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD----------------------- 153
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341
++ + T + +PEV Y + D WS
Sbjct: 154 -------------------------DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 188
Query: 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHR 400
G +M+E+ Y + + + + L P + ++ E R
Sbjct: 189 GVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRL--ASTHVYQIMNHCWKERPEDR 246
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-45
Identities = 59/301 (19%), Positives = 102/301 (33%), Gaps = 59/301 (19%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAE 162
+ + L+ +G G FGEV + A+K LK+ M + AE NL+ +
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQ 64
Query: 163 VASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE--TLTETVARFYIAQSVLAIE 220
+ +V+LY E +Y+I EY+ G ++ L LT AQ +
Sbjct: 65 LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
I + NYIHRD++ N+L+ K++DFGL + ++
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED---------------------- 161
Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340
N + APE + + ++ D WS
Sbjct: 162 --------------------------NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEH 399
G ++ E++ Y + + + P+ E L+ E
Sbjct: 196 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN--CPEELYQLMRLCWKERPED 253
Query: 400 R 400
R
Sbjct: 254 R 254
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 3e-45
Identities = 70/340 (20%), Positives = 120/340 (35%), Gaps = 81/340 (23%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
++ L IG G +G V + +++ I A+K+++ + G E LL E+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKH 60
Query: 166 HCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKH 225
IV+L+ + L L+ E+ L + + ++ Q + + H
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 226 NYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRF 285
N +HRD+KP NLL+++NG +KL++FGL +
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV------------------------- 155
Query: 286 PESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAI 344
+ + V T Y P+VL Y D WS G I
Sbjct: 156 ------------------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCI 191
Query: 345 MYEMLVG-YPPFYSDDPVTTCRKIVH---------WKNHLKFPEEA-------------- 380
E+ P F +D ++I W + K P+
Sbjct: 192 FAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNV 251
Query: 381 --RLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417
+L +DL+ LL + R + +E+ HP+F D
Sbjct: 252 VPKLNATGRDLLQNLLKCNPVQR---ISAEEALQHPYFSD 288
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 7e-45
Identities = 83/386 (21%), Positives = 139/386 (36%), Gaps = 94/386 (24%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
+ + L+ +G GA+G V + K+G A+KKL + S + E LL +
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 76
Query: 166 HCIVKLYYSFQDAEYL-----YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIE 220
++ L F A L ++ +L G D+ + ++ + LT+ +F I Q + ++
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 135
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
IH + IHRD+KP NL ++++ +K+ DFGL + D
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------------------- 175
Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG-YGMECDWW 339
V T Y APE++L Y D W
Sbjct: 176 --------------------------------TGYVATRWYRAPEIMLNWMHYNQTVDIW 203
Query: 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVH---------------------WKNHLKFPE 378
S+G IM E+L G F D + + I+ ++ + P+
Sbjct: 204 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 263
Query: 379 E------ARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYK 431
P A DL+ ++L D + R + + Q AH +F + Y
Sbjct: 264 MNFANVFIGANPLAVDLLEKMLVLDSDKR---ITAAQALAHAYFAQYHDPDDEPVADPYD 320
Query: 432 PEVNGVLDTQNFMK---FDEVESQTP 454
+ K +DEV S P
Sbjct: 321 QSFESRDLLIDEWKSLTYDEVISFVP 346
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (397), Expect = 9e-45
Identities = 55/333 (16%), Positives = 99/333 (29%), Gaps = 57/333 (17%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
+ + L IG G+FG++ L + +G A+K + E + +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQG 61
Query: 166 H-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK 224
I + + + +Y ++ME L + Q + IE IH
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 225 HNYIHRDIKPDNLLLDQNGHMKL---SDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
N+IHRD+KPDN L+ L DFGL K
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA---------------------- 159
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341
+ Q + + GT Y + L D SL
Sbjct: 160 --------------------RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESL 199
Query: 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNH-LKFPEEA---RLTPEAKDLICRLLC-D 396
G ++ +G P+ T +K + P E E +
Sbjct: 200 GYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLR 259
Query: 397 VEHRLGTLGSEQIKAHPWFKD-IAWDKLYEMEA 428
+ + Q+ + + + ++D +++
Sbjct: 260 FDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 292
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (394), Expect = 3e-44
Identities = 59/335 (17%), Positives = 106/335 (31%), Gaps = 83/335 (24%)
Query: 97 RLKRHKISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVE 151
+L + ++ + + IG GAFG V + + + A+K LK+ S
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQA 61
Query: 152 HVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMRE----------- 200
+ E L+AE + IVKL + + L+ EY+ GD+ L
Sbjct: 62 DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121
Query: 201 -------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKL 247
L+ Q + + + ++HRD+ N L+ +N +K+
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKI 181
Query: 248 SDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQIN 307
+DFGL + + +
Sbjct: 182 ADFGLSRNIYSA-----------------------------------------------D 194
Query: 308 RRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRK 366
K + ++ PE + Y E D W+ G +++E+ G P+Y
Sbjct: 195 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY 254
Query: 367 IVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHR 400
+ N L PE E +L+ R
Sbjct: 255 VRD-GNILACPEN--CPLELYNLMRLCWSKLPADR 286
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 7e-44
Identities = 48/301 (15%), Positives = 95/301 (31%), Gaps = 52/301 (17%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK--SEMLSRGQVEHVRAERNLL 160
+ +F + ++G GAFG V G + K E S + + E ++
Sbjct: 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 161 AEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIE 220
A V + + +L + + G + + ++ + + Q +
Sbjct: 66 ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
+ +HRD+ N+L+ H+K++DFGL K L
Sbjct: 126 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE--------------------- 164
Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340
+ A ++A E +L + Y + D WS
Sbjct: 165 --------------------------EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWS 198
Query: 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEH 399
G ++E++ Y P + I+ L P T + ++ + D +
Sbjct: 199 YGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI--CTIDVYMIMVKCWMIDADS 256
Query: 400 R 400
R
Sbjct: 257 R 257
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 4e-43
Identities = 62/334 (18%), Positives = 107/334 (32%), Gaps = 77/334 (23%)
Query: 93 TEYMRLKRHKISVDDFDLLTIIGRGAFGEVRLCQ-----EKKSGNIYAMKKLKKSEMLSR 147
T+ + + + +G GAFG+V + + A+K LK S L
Sbjct: 10 TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-- 67
Query: 148 GQVEHVRAERNLLAEVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR------- 199
+ E + +E +L+ + +H IV L + +I EY GD++ L R
Sbjct: 68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127
Query: 200 -----------EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLS 248
E L + Q + + N IHRD+ N+LL K+
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKIC 187
Query: 249 DFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINR 308
DFGL + + +
Sbjct: 188 DFGLARDIK-----------------------------------------------NDSN 200
Query: 309 RKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPPFYSDDPVTTCRKI 367
+ + ++APE + Y E D WS G ++E+ +G P+ + K+
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 368 VHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHR 400
+ + PE E D++ D R
Sbjct: 261 IKEGFRMLSPEH--APAEMYDIMKTCWDADPLKR 292
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 152 bits (384), Expect = 7e-43
Identities = 48/293 (16%), Positives = 89/293 (30%), Gaps = 53/293 (18%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASH- 166
+ + IG G+FG + + A+K + R +R E +A
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGCT 61
Query: 167 CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHN 226
I +YY Q+ + L+++ L L + + Q + ++SIH+ +
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 227 YIHRDIKPDNLLLD-----QNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDV 281
++RDIKPDN L+ + + DFG+ K
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK------------------- 162
Query: 282 DGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341
Q + + GT Y++ L + D +L
Sbjct: 163 -----------------------QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEAL 199
Query: 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLL 394
G + L G P+ T +K + L + + +
Sbjct: 200 GHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYM 252
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 9e-43
Identities = 59/302 (19%), Positives = 98/302 (32%), Gaps = 56/302 (18%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKK-SEMLSRGQVEHVRAERNLLA 161
I + +L IG G FG+V N +K S E E +
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 63
Query: 162 EVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIE 220
+ IVKL + +++IME G++ + L + +L Y Q A+
Sbjct: 64 QFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122
Query: 221 SIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMD 280
+ ++HRDI N+L+ N +KL DFGL + ++ +
Sbjct: 123 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-------------------- 162
Query: 281 VDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340
A ++APE + + + D W
Sbjct: 163 ----------------------------YYKASKGKLPIKWMAPESINFRRFTSASDVWM 194
Query: 341 LGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVE 398
G M+E+L+ G PF +I +N + P P L+ + D
Sbjct: 195 FGVCMWEILMHGVKPFQGVKNNDVIGRI---ENGERLPMPPNCPPTLYSLMTKCWAYDPS 251
Query: 399 HR 400
R
Sbjct: 252 RR 253
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-42
Identities = 54/305 (17%), Positives = 99/305 (32%), Gaps = 56/305 (18%)
Query: 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGN----IYAMKKLKKSEMLSRGQVEHVRAER 157
+I +IG G FGEV K S A+K LK + Q E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEA 60
Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREE-TLTETVARFYIAQSV 216
++ + + H I++L + + +I EY+ G + L ++ + +
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 217 LAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLN 276
++ + NY+HRD+ N+L++ N K+SDFGL + L+
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP---------------- 164
Query: 277 ESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMEC 336
+ APE + + +
Sbjct: 165 ------------------------------EATYTTSGGKIPIRWTAPEAISYRKFTSAS 194
Query: 337 DWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC- 395
D WS G +M+E++ Y + K ++ L P + L+ +
Sbjct: 195 DVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD--CPSAIYQLMMQCWQQ 252
Query: 396 DVEHR 400
+ R
Sbjct: 253 ERARR 257
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (383), Expect = 4e-42
Identities = 75/383 (19%), Positives = 124/383 (32%), Gaps = 104/383 (27%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
+ L IG GA G V + A+KKL + ++ + E L+ V
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 75
Query: 166 HCIVKLYYSF------QDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAI 219
I+ L F ++ + +YL+ME + + M + + Q + I
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGI 132
Query: 220 ESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESM 279
+ +H IHRD+KP N+++ + +K+ DFGL + + +
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM----------------- 175
Query: 280 DVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339
V T Y APEV+L GY D W
Sbjct: 176 ---------------------------------TPYVVTRYYRAPEVILGMGYKENVDIW 202
Query: 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHW-------------------------KNHL 374
S+G IM EM+ F D + K++ L
Sbjct: 203 SVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGL 262
Query: 375 KFPE-------------EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAW 420
FP+ +A+DL+ ++L D R + + HP+ W
Sbjct: 263 TFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR---ISVDDALQHPYINV--W 317
Query: 421 DKLYEMEAAYKPEVNGVLDTQNF 443
E+EA + LD +
Sbjct: 318 YDPAEVEAPPPQIYDKQLDEREH 340
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 3e-41
Identities = 61/323 (18%), Positives = 107/323 (33%), Gaps = 76/323 (23%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEKK-------SGNIYAMKKLKKSEMLSRGQVEHVRA 155
+ D L +G GAFG+V L + A+K LK + + + +
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLIS 67
Query: 156 ERNLLAEVASH-CIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMR--------------- 199
E ++ + H I+ L + LY+I+EY G++ L
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127
Query: 200 -EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258
EE L+ Q +E + IHRD+ N+L+ ++ MK++DFGL + +
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH- 186
Query: 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGT 318
I+ K +
Sbjct: 187 ----------------------------------------------HIDYYKKTTNGRLP 200
Query: 319 PDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPE 378
++APE L + Y + D WS G +++E+ Y PV K++ + + P
Sbjct: 201 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS 260
Query: 379 EARLTPEAKDLICRLLC-DVEHR 400
T E ++ R
Sbjct: 261 N--CTNELYMMMRDCWHAVPSQR 281
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 8e-41
Identities = 46/336 (13%), Positives = 111/336 (33%), Gaps = 70/336 (20%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAER 157
++ + + +G+G+FG V K + A+K + ++ S + E
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEA 74
Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLM----------REETLTETV 207
+++ E H +V+L + +IME + GD+ + L + +
Sbjct: 75 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 208 ARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINEN 267
+ + ++ + ++HRD+ N ++ ++ +K+ DFG+ + + T+
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG-- 192
Query: 268 EVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVL 327
+ +++PE L
Sbjct: 193 ---------------------------------------------GKGLLPVRWMSPESL 207
Query: 328 LKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAK 387
+ D WS G +++E+ Y + V L P+
Sbjct: 208 KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDN--CPDMLF 265
Query: 388 DLICRLLC-DVEHRLGT---LGSEQIKAHPWFKDIA 419
+L+ + + R + S + + P F++++
Sbjct: 266 ELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 301
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 6e-40
Identities = 47/294 (15%), Positives = 96/294 (32%), Gaps = 55/294 (18%)
Query: 113 IIGRGAFGEV---RLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIV 169
+IGRG FG V L A+K L + G+V E ++ + + ++
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 170 KLY-YSFQDAEYLYLIMEYLPGGDVMTLLM-REETLTETVARFYIAQSVLAIESIHKHNY 227
L + +++ Y+ GD+ + T + Q ++ + +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 151
Query: 228 IHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPE 287
+HRD+ N +LD+ +K++DFGL + + +++
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT------------------- 192
Query: 288 SGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 347
++A E L + + + D WS G +++E
Sbjct: 193 --------------------------GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 226
Query: 348 MLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHR 400
++ P Y D + L PE +++ + E R
Sbjct: 227 LMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY--CPDPLYEVMLKCWHPKAEMR 278
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 7e-38
Identities = 55/323 (17%), Positives = 103/323 (31%), Gaps = 76/323 (23%)
Query: 103 ISVDDFDLLTIIGRGAFGEVRLCQ-----EKKSGNIYAMKKLKKSEMLSRGQVEHVRAER 157
D L +GRGAFG+V + + A+K LK+ + + +E
Sbjct: 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSEL 67
Query: 158 NLLAEVASHCIVKLY--YSFQDAEYLYLIMEYLPGGDVMTLL----------------MR 199
+L + H V + L +I+E+ G++ T L +
Sbjct: 68 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 127
Query: 200 EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259
++ LT Y Q +E + IHRD+ N+LL + +K+ DFGL + +
Sbjct: 128 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY-- 185
Query: 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTP 319
+
Sbjct: 186 ---------------------------------------------KDPDYVRKGDARLPL 200
Query: 320 DYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY-PPFYSDDPVTTCRKIVHWKNHLKFPE 378
++APE + + Y ++ D WS G +++E+ P+ + + ++ P+
Sbjct: 201 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD 260
Query: 379 EARLTPEAKDLICRLLC-DVEHR 400
TPE + + R
Sbjct: 261 Y--TTPEMYQTMLDCWHGEPSQR 281
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 4e-32
Identities = 48/282 (17%), Positives = 81/282 (28%), Gaps = 68/282 (24%)
Query: 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS 165
L IG+G FGEV K G A+K E + AE +
Sbjct: 3 RTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREE----RSWFREAEIYQTVMLRH 56
Query: 166 HCIVKLYYSFQDAE----YLYLIMEYLPGGDVMTLLMREETLTETVARFYIA-------Q 214
I+ + L+L+ +Y G + L R E + + ++
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 116
Query: 215 SVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDEN 274
+ + + K HRD+K N+L+ +NG ++D GL D +
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT------------ 164
Query: 275 LNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL------ 328
VGT Y+APEVL
Sbjct: 165 ---------------------------------IDIAPNHRVGTKRYMAPEVLDDSINMK 191
Query: 329 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHW 370
D +++G + +E+ + +
Sbjct: 192 HFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 121 bits (304), Expect = 4e-31
Identities = 59/401 (14%), Positives = 128/401 (31%), Gaps = 113/401 (28%)
Query: 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNL-------L 160
+ L+ +G G F V L ++ + AMK ++ ++ + + ++ + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 161 AEVASHCIVKLYYSFQD--AEYLYLIMEYLPGGDVMTLLMREE---TLTETVARFYIAQS 215
+ ++ I+KL F ++++M + G+ + L+++ + + Q
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 216 VLAIESI-HKHNYIHRDIKPDNLLLDQNGHM-KLSDFGLCKPLDCTNLSAINENEVLDDE 273
+L ++ + + IH DIKP+N+L++ L + +
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY------------ 182
Query: 274 NLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG 333
+ +++ T +Y +PEVLL +G
Sbjct: 183 -----------------------------------DEHYTNSIQTREYRSPEVLLGAPWG 207
Query: 334 MECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL------------------- 374
D WS +++E++ G F D+ + + H +
Sbjct: 208 CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRT 267
Query: 375 -------------------------KFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQ 408
K+ E D + +L D R +
Sbjct: 268 FFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR---ADAGG 324
Query: 409 IKAHPWFKDIAWDKLYEMEAAYKPEVNGVLDTQNFMKFDEV 449
+ HPW KD + E+ + D + F+EV
Sbjct: 325 LVNHPWLKDTLGME--EIRVPDRELYGSGSDIPGW--FEEV 361
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 68.7 bits (167), Expect = 4e-14
Identities = 21/160 (13%), Positives = 48/160 (30%), Gaps = 28/160 (17%)
Query: 113 IIGRGAFGEVRLCQEKKSGNIYAMKKLKKS---------------EMLSRGQVEHVRAER 157
++G G V C + +K K S + R E
Sbjct: 7 LMGEGKESAVFNC-YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 158 NLLAEVASHCIVKLYYSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVL 217
L ++ + K+Y + ++ME + ++ + + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRV-------RVENPDEVLDMILE 114
Query: 218 AIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257
+ + +H D+ N+L+ + G + DF +
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVG 153
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 514 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.56 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.21 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.99 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.22 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.21 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.93 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-73 Score=579.59 Aligned_cols=327 Identities=37% Similarity=0.666 Sum_probs=280.2
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 181 (514)
++++++|++++.||+|+||+||+|+++.||+.||||++++..+......+++.+|+.+|+.++|||||+++++|++.+++
T Consensus 1 ~i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 80 (337)
T d1o6la_ 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred CCchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence 46789999999999999999999999999999999999988776677788899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
|+|||||+||+|..++.+.+.+++..+++|++||+.||+|||++|||||||||+|||++.+|++||+|||+|+......
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~- 159 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998653211
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
....+.+|||.|||||++.+.+|+.++|||||
T Consensus 160 ------------------------------------------------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSl 191 (337)
T d1o6la_ 160 ------------------------------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 191 (337)
T ss_dssp ------------------------------------------------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHH
T ss_pred ------------------------------------------------cccccceeCHHHhhhhhccCCCCChhhcccch
Confidence 11236799999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CHhHHhcCCccccC
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHPWFKDI 418 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~Hpff~~i 418 (514)
||++|||++|.+||.+.+..+++.++.. ..+.+|. .+|++++|||.+||+ ||.+|++.. +++||++||||+++
T Consensus 192 Gvilyeml~G~~pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 192 GVVMYEMMCGRLPFYNQDHERLFELILM--EEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred hhHHHHHHHCCCCCCCcCHHHHHHHHhc--CCCCCCc--cCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 9999999999999999999999999887 4567775 699999999999999 999999642 68999999999999
Q ss_pred Cccccc--cccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCC---CCccccccCCCCCCcccCeeeec
Q 010266 419 AWDKLY--EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTG---SGPMRKMMLTPKDLSFVGYTYKN 481 (514)
Q Consensus 419 ~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~f~~f~~~~ 481 (514)
+|+.+. ++.|||+|.+.+..|+++|+..........++.. ............+..|.||+|..
T Consensus 268 ~~~~l~~~~~~~p~~P~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~v~ 335 (337)
T d1o6la_ 268 NWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQEMFEDFDYIA 335 (337)
T ss_dssp CHHHHHTTCSCCSCCCCCSSTTCCTTSCHHHHTSCCC--------------------CCTTTTCCEEC
T ss_pred CHHHHHhCCCCCCCCCCCCChhhhhhcCchhhhccCCCCCCccccccccccccchhhhhccCCCEeeC
Confidence 999985 5789999999999999999864333222111111 11111111233567899999964
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-69 Score=545.92 Aligned_cols=292 Identities=43% Similarity=0.866 Sum_probs=254.5
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~l 183 (514)
+++||++++.||+|+||+||+|+++.+|+.||||++++.........+++.+|+.+|+.++|||||+++++|++.+.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 46799999999999999999999999999999999988766566677889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
|||||+||+|..++.....+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---- 157 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 157 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999865321
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhH
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 343 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 343 (514)
..+.+||+.|||||++.+.+|+.++|||||||
T Consensus 158 ------------------------------------------------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGv 189 (316)
T d1fota_ 158 ------------------------------------------------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGI 189 (316)
T ss_dssp ------------------------------------------------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHH
T ss_pred ------------------------------------------------cccccCcccccCHHHHcCCCCCchhhccccch
Confidence 12578999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCC--CCHhHHhcCCccccCCc
Q 010266 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT--LGSEQIKAHPWFKDIAW 420 (514)
Q Consensus 344 ilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~Hpff~~i~w 420 (514)
++|||++|.+||.+.+..+.+.+|.. ....+|. .+|+++++||.+||. ||.+|++. .++++|++||||++++|
T Consensus 190 ilyemltG~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~ 265 (316)
T d1fota_ 190 LIYEMLAGYTPFYDSNTMKTYEKILN--AELRFPP--FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 265 (316)
T ss_dssp HHHHHHHSSCTTCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred hHHHHHhCCCCCCCcCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence 99999999999999999999999987 3456664 689999999999998 99999864 48999999999999999
Q ss_pred cccc--cccCCCCCcCC-CCCCCCCCCCCCcccC
Q 010266 421 DKLY--EMEAAYKPEVN-GVLDTQNFMKFDEVES 451 (514)
Q Consensus 421 ~~l~--~~~~p~~p~~~-~~~d~~~f~~~~~~~~ 451 (514)
+.+. +++|||+|.+. +..|+++|++++++..
T Consensus 266 ~~l~~~~~~~p~~p~~~~~~~d~~~f~~~~~~~~ 299 (316)
T d1fota_ 266 EKLLSRNIETPYEPPIQQGQGDTSQFDKYPEEDI 299 (316)
T ss_dssp HHHHTTCSCCSCCCCC----------------CC
T ss_pred HHHHhCCCCcCCCCCcCCCcchhhhcCCCccccc
Confidence 9985 68899999864 4579999998777644
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-69 Score=548.55 Aligned_cols=315 Identities=35% Similarity=0.664 Sum_probs=250.6
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHH-HcCCCceeeEEEEEEcCCeEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLA-EVASHCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~-~l~hp~Iv~l~~~f~~~~~l~l 183 (514)
+++|++++.||+|+||+||+|+++.+|+.||||++++.........+++..|..++. .++|||||+++++|++++++|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 478999999999999999999999999999999998876655666777888888776 6899999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
|||||+||+|..++.....+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+......
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~--- 157 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--- 157 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT---
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998653211
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhH
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 343 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 343 (514)
......+||+.|+|||++.+.+|+.++|||||||
T Consensus 158 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 191 (320)
T d1xjda_ 158 ----------------------------------------------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGV 191 (320)
T ss_dssp ----------------------------------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHH
T ss_pred ----------------------------------------------ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhH
Confidence 0112568999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHh-HHhcCCccccCCcc
Q 010266 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSE-QIKAHPWFKDIAWD 421 (514)
Q Consensus 344 ilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~-eil~Hpff~~i~w~ 421 (514)
++|||++|.+||.+.+..+++.+|.. ..+.+|. .+|+++++||.+||+ ||.+|+ ++. ++++||||++++|+
T Consensus 192 ilyemltG~~PF~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~dli~~~L~~dP~~R~---s~~~~l~~hpff~~~~~~ 264 (320)
T d1xjda_ 192 LLYEMLIGQSPFHGQDEEELFHSIRM--DNPFYPR--WLEKEAKDLLVKLFVREPEKRL---GVRGDIRQHPLFREINWE 264 (320)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHSCSSGGGSB---TTBSCGGGSGGGTTCCHH
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCc--cCCHHHHHHHHHhcccCCCCCc---CHHHHHHhCchhccCCHH
Confidence 99999999999999999999999886 4456664 689999999999999 999999 774 89999999999999
Q ss_pred ccc--cccCCCCCcCCCCCCCCCCCCCCcccCCCCCCCCCCccccccCCCCCCcccCeee
Q 010266 422 KLY--EMEAAYKPEVNGVLDTQNFMKFDEVESQTPKRTGSGPMRKMMLTPKDLSFVGYTY 479 (514)
Q Consensus 422 ~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~ 479 (514)
.+. ++.||++|.+.++.|++||+.....+.+....... .+..+..+..|.||||
T Consensus 265 ~l~~~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~----~~~~~~~~~~f~~f~~ 320 (320)
T d1xjda_ 265 ELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADR----ALINSMDQNMFRNFSF 320 (320)
T ss_dssp HHHTTCSCC------------------------------------------CCTTTTCCC
T ss_pred HHHhcCCCCCCCCCCCCccchhhcChHhhhCCccCCCCcc----cccCchhhcccCcCcC
Confidence 885 57899999999999999998654433332222211 1223345678999998
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-68 Score=547.41 Aligned_cols=295 Identities=41% Similarity=0.808 Sum_probs=269.4
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
....+++|++++.||+|+||+||+|+++.||+.||||++.+.........+.+.+|+.+|+.++|||||+++++|.+...
T Consensus 36 ~~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 115 (350)
T d1rdqe_ 36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115 (350)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccc
Confidence 34556899999999999999999999999999999999988766566677889999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
+|+||||+.||+|..++.+.+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999865421
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 340 (514)
..+.+||+.|||||++.+.+|+.++||||
T Consensus 195 ---------------------------------------------------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwS 223 (350)
T d1rdqe_ 195 ---------------------------------------------------TWTLCGTPEALAPEIILSKGYNKAVDWWA 223 (350)
T ss_dssp ---------------------------------------------------BCCCEECGGGCCHHHHTTCCBCTHHHHHH
T ss_pred ---------------------------------------------------cccccCccccCCHHHHcCCCCCccccccc
Confidence 12568999999999999999999999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCC--CCHhHHhcCCcccc
Q 010266 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT--LGSEQIKAHPWFKD 417 (514)
Q Consensus 341 lGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~Hpff~~ 417 (514)
|||++|||++|.+||.+.+....+.+|.. ..+.+|. .+|+++.+||++||+ ||.+|++. .++++|++||||++
T Consensus 224 lGvilyemltG~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 224 LGVLIYEMAAGYPPFFADQPIQIYEKIVS--GKVRFPS--HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred hhHHHHHHHhCCCCCCCcCHHHHHHHHhc--CCCCCCc--cCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence 99999999999999999999999999987 3455554 799999999999999 99999753 48999999999999
Q ss_pred CCccccc--cccCCCCCcCCCCCCCCCCCCCCcccC
Q 010266 418 IAWDKLY--EMEAAYKPEVNGVLDTQNFMKFDEVES 451 (514)
Q Consensus 418 i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~ 451 (514)
+||+.+. +++|||+|.+.++.|++||+.+.+++.
T Consensus 300 ~~~~~~~~~~~~~p~~p~~~~~~d~s~~~~~~~~~~ 335 (350)
T d1rdqe_ 300 TDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEI 335 (350)
T ss_dssp CCHHHHHTTCSCCSCCCCCCSTTCCTTSCCCCCCCC
T ss_pred CCHHHHHhcCCCcCccCCCCCcchhhhcCCCCcccc
Confidence 9999986 578999999999999999998765543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-68 Score=533.02 Aligned_cols=277 Identities=36% Similarity=0.685 Sum_probs=249.1
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 181 (514)
+...++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|++++.+
T Consensus 4 ~~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred CCCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEE
Confidence 34568999999999999999999999999999999999887666666778899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
|+|||||+||+|.+++...+.+++..++.++.|++.||+|||++|||||||||+|||++.+|++||+|||+|+.+.....
T Consensus 84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999987542210
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
.....+.+||+.|||||++.+..|+.++|||||
T Consensus 164 -----------------------------------------------~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSl 196 (288)
T d1uu3a_ 164 -----------------------------------------------QARANSFVGTAQYVSPELLTEKSACKSSDLWAL 196 (288)
T ss_dssp -----------------------------------------------------CCCCGGGCCHHHHHTCCCCHHHHHHHH
T ss_pred -----------------------------------------------ccccccccCCccccCceeeccCCCCcccceehh
Confidence 011236789999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhH------HhcCCc
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQ------IKAHPW 414 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~e------il~Hpf 414 (514)
||++|||++|.+||.+.+..+++.+|.+ ..+.+|. .+|+++++||.+||+ ||.+|+ |++| |++|||
T Consensus 197 Gvilyell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L~~dP~~R~---t~~e~~~~~~i~~Hpf 269 (288)
T d1uu3a_ 197 GCIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPE--KFFPKARDLVEKLLVLDATKRL---GCEEMEGYGPLKAHPF 269 (288)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHT--TCCCCCT--TCCHHHHHHHHTTSCSSGGGST---TSGGGTCHHHHHTSGG
T ss_pred hHHHHHHhhCCCCCCCcCHHHHHHHHHc--CCCCCCc--cCCHHHHHHHHHHccCCHhHCc---CHHHHcCCHHHHcCCc
Confidence 9999999999999999999999999987 3456665 689999999999999 999999 6665 699999
Q ss_pred cccCCccccccccCCCCC
Q 010266 415 FKDIAWDKLYEMEAAYKP 432 (514)
Q Consensus 415 f~~i~w~~l~~~~~p~~p 432 (514)
|+++||+.|.+..||-.|
T Consensus 270 f~~i~w~~l~~~~pP~l~ 287 (288)
T d1uu3a_ 270 FESVTWENLHQQTPPKLT 287 (288)
T ss_dssp GTTCCCTTGGGSCCCCCC
T ss_pred cCCCCHHHhhcCCCCCCC
Confidence 999999999988888655
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.5e-66 Score=529.56 Aligned_cols=289 Identities=32% Similarity=0.613 Sum_probs=238.4
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHH---HHHHHHcCCCceeeEEEEEEcCC
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAE---RNLLAEVASHCIVKLYYSFQDAE 179 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E---~~iL~~l~hp~Iv~l~~~f~~~~ 179 (514)
+++++|+++++||+|+||+||+|+++.||+.||||++.+..+........+.+| ..+++.++|||||+++++|.+.+
T Consensus 1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~ 80 (364)
T d1omwa3 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 80 (364)
T ss_dssp CCSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CCHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC
Confidence 467899999999999999999999999999999999987665444444445555 44555667999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
.+|+|||||+||+|.++|.+...+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999865421
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccch
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDW 338 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~Di 338 (514)
...+.+||+.|||||++.+ ..|+.++||
T Consensus 161 ---------------------------------------------------~~~~~~GT~~y~APE~~~~~~~~~~~~Di 189 (364)
T d1omwa3 161 ---------------------------------------------------KPHASVGTHGYMAPEVLQKGVAYDSSADW 189 (364)
T ss_dssp ---------------------------------------------------CCCSCCSCGGGCCHHHHSTTCCCCTHHHH
T ss_pred ---------------------------------------------------cccccccccccchhHHhhcCCCCCcccch
Confidence 1225689999999999974 679999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhh-hcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CHhHHhcCCc
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVH-WKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQIKAHPW 414 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~-~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~Hpf 414 (514)
|||||+||||++|.+||.+.+.......+.. ......+| ..+|+++++||.+||. ||.+|++.. +++||++|||
T Consensus 190 wSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~ 267 (364)
T d1omwa3 190 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP--DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 267 (364)
T ss_dssp HHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCC--SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGG
T ss_pred hHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCC--CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCcc
Confidence 9999999999999999987655433322211 11333444 3799999999999999 999999532 4899999999
Q ss_pred cccCCccccc--cccCCCCCcCCCCCCCCCCC
Q 010266 415 FKDIAWDKLY--EMEAAYKPEVNGVLDTQNFM 444 (514)
Q Consensus 415 f~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~ 444 (514)
|+++||+.+. +++||++|......+.+.||
T Consensus 268 f~~i~~~~~~~~~~~~p~~p~~~~~~~~~~~d 299 (364)
T d1omwa3 268 FRSLDWQMVFLQKYPPPLIPPRGEVNAADAFD 299 (364)
T ss_dssp GTTCCHHHHHTTCSCCSCCCCCC---------
T ss_pred ccCCCHHHHhcCCCCcCcCCCCCCCCcCCccc
Confidence 9999999885 57899999887766666665
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-65 Score=501.74 Aligned_cols=257 Identities=35% Similarity=0.590 Sum_probs=236.3
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
.++++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+|+.++|||||+++++|.+++.+|
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence 45689999999999999999999999999999999998876655566778899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcc
Q 010266 183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~ 262 (514)
+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--- 159 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 159 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999764321
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
...+.+||+.|||||++.+..|+.++||||||
T Consensus 160 ------------------------------------------------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlG 191 (263)
T d2j4za1 160 ------------------------------------------------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 191 (263)
T ss_dssp ------------------------------------------------CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHH
T ss_pred ------------------------------------------------cccccCCCCcccCHHHHcCCCCCchhhhhhHh
Confidence 11256899999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
|+||||++|.+||.+.+..+++.+|.. ..+.+|+ .+|+++++||.+||+ ||.+|+ |++|+++||||..
T Consensus 192 vilyell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L~~dp~~R~---t~~eil~hp~~~~ 260 (263)
T d2j4za1 192 VLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPD--FVTEGARDLISRLLKHNPSQRP---MLREVLEHPWITA 260 (263)
T ss_dssp HHHHHHHHSSCTTCCSSHHHHHHHHHT--TCCCCCT--TSCHHHHHHHHHHTCSSGGGSC---CHHHHHTCHHHHH
T ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCc--cCCHHHHHHHHHHccCCHhHCc---CHHHHHcCcCcCC
Confidence 999999999999999999999998876 4456665 689999999999999 999999 9999999999964
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-64 Score=493.52 Aligned_cols=260 Identities=26% Similarity=0.459 Sum_probs=222.0
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .+..+.+.+|..+|+.++|||||+++++|.+++.+|+|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 5789999999999999999999999999999999987642 23345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
||||+||+|.++|.+.+.+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.......
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~--- 158 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--- 158 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE---
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc---
Confidence 99999999999998888999999999999999999999999999999999999999999999999999986542210
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCC-CcccchhhhhH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGA 343 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWSlGv 343 (514)
.....+.+||+.|||||++.+..| +.++|||||||
T Consensus 159 --------------------------------------------~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGv 194 (271)
T d1nvra_ 159 --------------------------------------------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 194 (271)
T ss_dssp --------------------------------------------ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHH
T ss_pred --------------------------------------------cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHH
Confidence 112236789999999999998876 67899999999
Q ss_pred HHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 344 ilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
++|||++|.+||.+.+........... .....+....+|+++++||.+||+ ||.+|+ |++||++||||+.
T Consensus 195 ilyeml~G~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~eil~hpwf~~ 265 (271)
T d1nvra_ 195 VLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHHHSSCSCSSSSTTSHHHHHHHT-TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCTTTTC
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHhc-CCCCCCccccCCHHHHHHHHHHcCCChhHCc---CHHHHhcCHhhCc
Confidence 999999999999876554433333322 222333345789999999999999 999999 9999999999963
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-63 Score=491.97 Aligned_cols=266 Identities=30% Similarity=0.503 Sum_probs=232.3
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccCh---hhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR---GQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
++|++++.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+.+|+.++|||||+++++|++.+.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 569999999999999999999999999999999987654332 23677899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC----cEEEccccccccCCC
Q 010266 183 LIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG----HMKLSDFGLCKPLDC 258 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g----~iKL~DFGla~~~~~ 258 (514)
+|||||+||+|.+++...+.+++..++.++.|++.||+|||++|||||||||+|||++.+| ++||+|||+|+....
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~ 169 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence 9999999999999999989999999999999999999999999999999999999999776 599999999986542
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
.. ...+.+||+.|+|||++.+..|+.++||
T Consensus 170 ~~--------------------------------------------------~~~~~~~t~~y~APE~~~~~~~~~~~Di 199 (293)
T d1jksa_ 170 GN--------------------------------------------------EFKNIFGTPEFVAPEIVNYEPLGLEADM 199 (293)
T ss_dssp SC--------------------------------------------------BCSCCCCCGGGCCHHHHTTCCBCTHHHH
T ss_pred Cc--------------------------------------------------cccccCCCCcccCHHHHcCCCCCCcccc
Confidence 21 1125689999999999999999999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
|||||++|||++|.+||.+.+..+++.+|......+..+....+|+++++||.+||+ ||.+|+ |++||++||||++
T Consensus 200 wSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~eil~hp~~~~ 276 (293)
T d1jksa_ 200 WSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM---TIQDSLQHPWIKP 276 (293)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSTTTCC
T ss_pred hhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCc---CHHHHhcCcccCC
Confidence 999999999999999999999999999998744333222234689999999999999 999999 9999999999999
Q ss_pred CCccccc
Q 010266 418 IAWDKLY 424 (514)
Q Consensus 418 i~w~~l~ 424 (514)
.+|....
T Consensus 277 ~~~~~~l 283 (293)
T d1jksa_ 277 KDTQQAL 283 (293)
T ss_dssp -------
T ss_pred CChhHhh
Confidence 9998765
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.1e-63 Score=495.51 Aligned_cols=257 Identities=34% Similarity=0.591 Sum_probs=217.5
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
+.|++++.||+|+||+||+|+++.+|+.||||++.+.... .....+.+|+.+|+.++|||||+++++|++++++|+||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 6699999999999999999999999999999999876542 23456789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCcccc---CCCcEEEccccccccCCCCCcc
Q 010266 186 EYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD---QNGHMKLSDFGLCKPLDCTNLS 262 (514)
Q Consensus 186 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld---~~g~iKL~DFGla~~~~~~~~~ 262 (514)
|||+||+|.++|...+.+++..++.++.||+.||+|||++|||||||||+|||+. .+|++||+|||+|+.....
T Consensus 87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~--- 163 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--- 163 (307)
T ss_dssp CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC---
Confidence 9999999999999999999999999999999999999999999999999999995 5799999999999854321
Q ss_pred ccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhh
Q 010266 263 AINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 342 (514)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 342 (514)
....+.+||+.|||||++.+..|+.++||||||
T Consensus 164 -----------------------------------------------~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlG 196 (307)
T d1a06a_ 164 -----------------------------------------------SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIG 196 (307)
T ss_dssp --------------------------------------------------------CTTSCHHHHTTCCCCTHHHHHHHH
T ss_pred -----------------------------------------------CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhh
Confidence 012267899999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
|++|||++|.+||.+.+..++..+|......+..|....+|+++++||.+||. ||.+|+ |++|+++||||++
T Consensus 197 vilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~eil~hp~~~~ 269 (307)
T d1a06a_ 197 VIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF---TCEQALQHPWIAG 269 (307)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSC---CHHHHHHSTTTTS
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCc---CHHHHhcCHhhCC
Confidence 99999999999999999999999998865555555556799999999999999 999999 9999999999986
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-62 Score=489.56 Aligned_cols=256 Identities=29% Similarity=0.512 Sum_probs=227.2
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|+.++|||||+++++|.+.+++|+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 3579999999999999999999999999999999987643 2346688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
||||+||+|..++.+ +.+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+....
T Consensus 96 mEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~---- 170 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---- 170 (293)
T ss_dssp EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT----
T ss_pred EEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc----
Confidence 999999999998754 579999999999999999999999999999999999999999999999999998654221
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 344 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 344 (514)
....+.+||+.|||||++.+..|+.++|||||||+
T Consensus 171 ---------------------------------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 205 (293)
T d1yhwa1 171 ---------------------------------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM 205 (293)
T ss_dssp ---------------------------------------------CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHH
T ss_pred ---------------------------------------------ccccccccCCCccChhhhcCCCCCchhceehHhHH
Confidence 01225689999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 345 MYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 345 lyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
+|+|++|.+||.+.+..+....+.... ...++.+..+|+++++||.+||. ||.+|+ |++|+++||||+.
T Consensus 206 lyemltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 206 AIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDFLNRCLDMDVEKRG---SAKELLQHQFLKI 275 (293)
T ss_dssp HHHHHHSSCTTTTSCHHHHHHHHHHHC-SCCCSSGGGSCHHHHHHHHHHTCSSTTTSC---CHHHHTTCGGGGG
T ss_pred HHHHhhCCCCCCCCCHHHHHHHHHhCC-CCCCCCcccCCHHHHHHHHHHccCChhHCc---CHHHHhcCHhhCC
Confidence 999999999999988888777776532 22333335799999999999999 999999 9999999999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.7e-62 Score=498.03 Aligned_cols=264 Identities=29% Similarity=0.496 Sum_probs=235.4
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
+++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+.+.+|+.+|+.++|||||+++++|++++.+|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 468999999999999999999999999999999997653 34557789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCcccc--CCCcEEEccccccccCCCCCc
Q 010266 185 MEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD--QNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 185 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld--~~g~iKL~DFGla~~~~~~~~ 261 (514)
||||+||+|.+++.. .+.+++..++.++.||+.||.|||++|||||||||+|||++ .+|++||+|||+|+.+....
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 180 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 180 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence 999999999999854 56899999999999999999999999999999999999996 46899999999998654221
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
...+.+||+.|||||++.+.+|+.++|||||
T Consensus 181 -------------------------------------------------~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSl 211 (350)
T d1koaa2 181 -------------------------------------------------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSV 211 (350)
T ss_dssp -------------------------------------------------CEEEECSCTTTCCHHHHHTCCBCHHHHHHHH
T ss_pred -------------------------------------------------ccceecCcccccCHHHHcCCCCChhHhhhhh
Confidence 1225789999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCc
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAW 420 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w 420 (514)
||++|||++|.+||.+.+..+++.+|......+..+....+|+++++||.+||+ ||.+|+ |++||++||||+..+|
T Consensus 212 Gvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 212 GVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM---TIHQALEHPWLTPGNA 288 (350)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSC---CHHHHHHSTTTSCTTC
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCc---CHHHHhcCcccCCCCC
Confidence 999999999999999999999999998754433333334789999999999999 999999 9999999999999888
Q ss_pred cccc
Q 010266 421 DKLY 424 (514)
Q Consensus 421 ~~l~ 424 (514)
....
T Consensus 289 ~~~~ 292 (350)
T d1koaa2 289 PGRD 292 (350)
T ss_dssp CSCC
T ss_pred CCch
Confidence 6554
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-63 Score=498.67 Aligned_cols=264 Identities=27% Similarity=0.422 Sum_probs=225.9
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeE
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYL 181 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l 181 (514)
++..++|++++.||+|+||+||+|+++.+|+.||+|++++.. .......+.+|+.+|+.++|||||+++++|.+.+++
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 79 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 79 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 355689999999999999999999999999999999998652 344557789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 182 YLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 182 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
|+|||||+||+|.+++.+.+.+++..++.++.|++.||.|||+ +|||||||||+||||+.+|++||+|||+|+....
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-- 157 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 157 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC--
Confidence 9999999999999999999999999999999999999999997 5999999999999999999999999999975321
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 340 (514)
....+.+||+.|||||++.+..|+.++||||
T Consensus 158 -------------------------------------------------~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWS 188 (322)
T d1s9ja_ 158 -------------------------------------------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWS 188 (322)
T ss_dssp -------------------------------------------------HTC---CCSSCCCCHHHHHCSCCCTTHHHHH
T ss_pred -------------------------------------------------CccccccCCccccCchHHcCCCCCcHHHHHH
Confidence 1123679999999999999999999999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhHHHHH------------------------------------------HhhhcCcccCCc
Q 010266 341 LGAIMYEMLVGYPPFYSDDPVTTCRK------------------------------------------IVHWKNHLKFPE 378 (514)
Q Consensus 341 lGvilyemltG~~PF~~~~~~~~~~~------------------------------------------i~~~~~~~~~p~ 378 (514)
|||++|||++|+.||.+.+..+.... +.. .....+|.
T Consensus 189 lGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 267 (322)
T d1s9ja_ 189 MGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVN-EPPPKLPS 267 (322)
T ss_dssp HHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHT-SCCCCCCB
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhc-cCCccCcc
Confidence 99999999999999987654322111 000 01111221
Q ss_pred CcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCcccc
Q 010266 379 EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKL 423 (514)
Q Consensus 379 ~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~l 423 (514)
..+|++++|||.+||+ ||.+|+ |++|+++||||++.+|+.+
T Consensus 268 -~~~s~~~~dli~~~L~~dP~~R~---ta~e~L~Hpf~~~~~~~~~ 309 (322)
T d1s9ja_ 268 -GVFSLEFQDFVNKCLIKNPAERA---DLKQLMVHAFIKRSDAEEV 309 (322)
T ss_dssp -TTBCHHHHHHHHHHTCSSTTTSC---CHHHHHTSHHHHHHHHSCC
T ss_pred -ccCCHHHHHHHHHHcCCChhHCc---CHHHHhhCHhhCcCCcccc
Confidence 2468999999999999 999999 9999999999999888754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-62 Score=483.82 Aligned_cols=256 Identities=30% Similarity=0.499 Sum_probs=226.5
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIM 185 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVm 185 (514)
+.|++++.||+|+||+||+|+++.+|+.||||++.+. .....+.+.+|+.+|+.++|||||+++++|.+++.+|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 4689999999999999999999999999999999865 3345567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 186 EYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 186 Ey~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
|||+||+|..++.+ .+.+++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~----- 163 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT----- 163 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-----
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC-----
Confidence 99999999999765 467999999999999999999999999999999999999999999999999998754211
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccc-----cCCCCcccchh
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLL-----KKGYGMECDWW 339 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~DiW 339 (514)
.....+.+||+.|||||++. +.+|+.++|||
T Consensus 164 --------------------------------------------~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~Diw 199 (288)
T d2jfla1 164 --------------------------------------------IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVW 199 (288)
T ss_dssp --------------------------------------------HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHH
T ss_pred --------------------------------------------cccccccccccccCCHHHHhhcccCCCCCChhhhHH
Confidence 00123678999999999984 56689999999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
||||++|||++|.+||.+.+..+.+.+|..... ..++.+..+|+++++||.+||+ ||.+|+ |++|+++||||+.
T Consensus 200 SlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~---t~~ell~hp~~~~ 274 (288)
T d2jfla1 200 SLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP-PTLAQPSRWSSNFKDFLKKCLEKNVDARW---TTSQLLQHPFVTV 274 (288)
T ss_dssp HHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCC-CCCSSGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTSGGGCC
T ss_pred HHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-CCCCccccCCHHHHHHHHHHccCChhHCc---CHHHHhcCcccCC
Confidence 999999999999999999999999988887432 2333335789999999999999 999999 9999999999974
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-61 Score=485.51 Aligned_cols=253 Identities=26% Similarity=0.396 Sum_probs=228.8
Q ss_pred CeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 107 DFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 107 ~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
.|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999999999999999999988766666677889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccc
Q 010266 187 YLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE 266 (514)
Q Consensus 187 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~ 266 (514)
||+||+|..++...+.+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-------- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------- 167 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--------
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--------
Confidence 999999988888888999999999999999999999999999999999999999999999999999975431
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc---CCCCcccchhhhhH
Q 010266 267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGA 343 (514)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~y~~~~DiWSlGv 343 (514)
..+.+||+.|||||++.+ ..|+.++|||||||
T Consensus 168 ---------------------------------------------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGv 202 (309)
T d1u5ra_ 168 ---------------------------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 202 (309)
T ss_dssp ---------------------------------------------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHH
T ss_pred ---------------------------------------------CCccccCccccCHHHHhccCCCCcCchhhhhhHHH
Confidence 125689999999999964 45899999999999
Q ss_pred HHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 344 ilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
++|||++|.+||.+.+..+...++..... ..+....+|+++++||.+||+ ||.+|+ |++|+++||||..
T Consensus 203 ilyel~~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 203 TCIELAERKPPLFNMNAMSALYHIAQNES--PALQSGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVLR 272 (309)
T ss_dssp HHHHHHHSSCTTTTSCHHHHHHHHHHSCC--CCCSCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHTTCHHHHS
T ss_pred HHHHHHHCCCCCCCCCHHHHHHHHHhCCC--CCCCCCCCCHHHHHHHHHHCcCChhHCc---CHHHHHhCHHhcC
Confidence 99999999999999998888888876432 222334689999999999999 999999 9999999999964
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.4e-61 Score=488.71 Aligned_cols=258 Identities=28% Similarity=0.537 Sum_probs=229.5
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. ......+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 367999999999999999999999999999999998753 23445688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCcccc--CCCcEEEccccccccCCCCCc
Q 010266 185 MEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD--QNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld--~~g~iKL~DFGla~~~~~~~~ 261 (514)
||||+||+|.+++... ..+++..++.++.||+.||.|||++|||||||||+||||+ .+|++||+|||+|+.+....
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 9999999999887665 4799999999999999999999999999999999999998 67999999999998764221
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
...+.+||+.|||||++.+..|+.++|||||
T Consensus 184 -------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 214 (352)
T d1koba_ 184 -------------------------------------------------IVKVTTATAEFAAPEIVDREPVGFYTDMWAI 214 (352)
T ss_dssp -------------------------------------------------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHH
T ss_pred -------------------------------------------------ceeeccCcccccCHHHHcCCCCCCccchHHH
Confidence 1235789999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
||++|||++|.+||.+.+..+++.+|......+..+....+|+++++||.+||+ ||.+|+ |++|+++||||++.
T Consensus 215 GvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 215 GVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL---TVHDALEHPWLKGD 289 (352)
T ss_dssp HHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHTSTTTSSC
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCc---CHHHHhcCHhhCCC
Confidence 999999999999999999999999988743332222334789999999999999 999999 99999999999874
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.5e-60 Score=470.15 Aligned_cols=260 Identities=32% Similarity=0.564 Sum_probs=232.8
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccCh------hhHHHHHHHHHHHHHcC-CCceeeEEEEEEc
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSR------GQVEHVRAERNLLAEVA-SHCIVKLYYSFQD 177 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~------~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~ 177 (514)
.++|++++.||+|+||+||+|+++.+|+.||||++++...... ...+.+.+|+.+|+.++ |||||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 3789999999999999999999999999999999987654322 23356888999999997 9999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 178 AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 178 ~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
.+++|||||||+||||.++|...+.+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.+.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998654
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc------CC
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK------KG 331 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~------~~ 331 (514)
... .....+||+.|+|||++.+ ..
T Consensus 162 ~~~--------------------------------------------------~~~~~~gt~~y~~PE~~~~~~~~~~~~ 191 (277)
T d1phka_ 162 PGE--------------------------------------------------KLREVCGTPSYLAPEIIECSMNDNHPG 191 (277)
T ss_dssp TTC--------------------------------------------------CBCCCCSCGGGCCHHHHHHHHCTTSCC
T ss_pred CCC--------------------------------------------------ceeeeeccCCCCCHHHhhccccccCCC
Confidence 221 1124689999999999863 45
Q ss_pred CCcccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHh
Q 010266 332 YGMECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIK 410 (514)
Q Consensus 332 y~~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 410 (514)
|+.++||||+||++|||++|.+||.+.+......+|......+..|....+|+++++||.+||. ||.+|+ +++||+
T Consensus 192 ~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~---s~~eil 268 (277)
T d1phka_ 192 YGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY---TAEEAL 268 (277)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSC---CHHHHT
T ss_pred CCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCc---CHHHHH
Confidence 7889999999999999999999999999999999998865555555556899999999999999 999999 999999
Q ss_pred cCCcccc
Q 010266 411 AHPWFKD 417 (514)
Q Consensus 411 ~Hpff~~ 417 (514)
+||||+.
T Consensus 269 ~h~~~~~ 275 (277)
T d1phka_ 269 AHPFFQQ 275 (277)
T ss_dssp TSGGGCT
T ss_pred cCHHHHH
Confidence 9999985
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-61 Score=474.30 Aligned_cols=255 Identities=33% Similarity=0.574 Sum_probs=216.6
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc--CCeEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD--AEYLY 182 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~--~~~l~ 182 (514)
.+||++++.||+|+||+||+|+++.||+.||+|++.+... .+...+.+.+|..+|+.++|||||+++++|.+ ...+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 4789999999999999999999999999999999987654 45567788999999999999999999999965 56799
Q ss_pred EEEeecCCCCHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC-----eEEcCCCCCCccccCCCcEEEcccccc
Q 010266 183 LIMEYLPGGDVMTLLMR----EETLTETVARFYIAQSVLAIESIHKHN-----YIHRDIKPDNLLLDQNGHMKLSDFGLC 253 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~g-----iiHrDLKpeNILld~~g~iKL~DFGla 253 (514)
+|||||+||+|.+++.+ ...+++..++.++.||+.||.|||+.| ||||||||+||||+.+|++||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999999864 357999999999999999999999876 999999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCC
Q 010266 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG 333 (514)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 333 (514)
+.+.... ....+.+|||.|||||++.+..|+
T Consensus 162 ~~~~~~~-------------------------------------------------~~~~~~~gt~~Y~APE~l~~~~~~ 192 (269)
T d2java1 162 RILNHDT-------------------------------------------------SFAKAFVGTPYYMSPEQMNRMSYN 192 (269)
T ss_dssp HHC------------------------------------------------------------CCCSCCCHHHHTTCCCC
T ss_pred eecccCC-------------------------------------------------CccccCCCCcccCCHHHHcCCCCC
Confidence 8754210 012367899999999999999999
Q ss_pred cccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 334 MECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 334 ~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
.++|||||||++|||++|.+||.+.+..++..+|..... ..+| ..+|+++++||.+||. ||.+|+ |++||++|
T Consensus 193 ~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~-~~~~--~~~s~~l~~li~~~L~~dp~~Rp---s~~ell~h 266 (269)
T d2java1 193 EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-RRIP--YRYSDELNEIITRMLNLKDYHRP---SVEEILEN 266 (269)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-CCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHTS
T ss_pred hHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-CCCC--cccCHHHHHHHHHHcCCChhHCc---CHHHHHhC
Confidence 999999999999999999999999999999888876432 2344 3689999999999999 999999 99999999
Q ss_pred Ccc
Q 010266 413 PWF 415 (514)
Q Consensus 413 pff 415 (514)
||.
T Consensus 267 p~i 269 (269)
T d2java1 267 PLI 269 (269)
T ss_dssp TTC
T ss_pred CcC
Confidence 995
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-60 Score=466.61 Aligned_cols=251 Identities=24% Similarity=0.428 Sum_probs=218.7
Q ss_pred eeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc----CCeEEE
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD----AEYLYL 183 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~----~~~l~l 183 (514)
|++.+.||+|+||+||+|+++.+++.||+|++.+... .....+.+.+|.++|+.++|||||+++++|.+ ...+|+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 4777899999999999999999999999999987654 45567789999999999999999999999875 467999
Q ss_pred EEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eEEcCCCCCCcccc-CCCcEEEccccccccCCCCC
Q 010266 184 IMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHN--YIHRDIKPDNLLLD-QNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKpeNILld-~~g~iKL~DFGla~~~~~~~ 260 (514)
|||||+||+|.+++.+...+++..++.++.||+.||+|||++| ||||||||+||||+ .+|++||+|||+|+.....
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~- 168 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 168 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence 9999999999999999899999999999999999999999998 99999999999997 5899999999999753211
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 340 (514)
.+.+.+|||.|||||++.+ +|+.++||||
T Consensus 169 --------------------------------------------------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwS 197 (270)
T d1t4ha_ 169 --------------------------------------------------FAKAVIGTPEFMAPEMYEE-KYDESVDVYA 197 (270)
T ss_dssp --------------------------------------------------SBEESCSSCCCCCGGGGGT-CCCTHHHHHH
T ss_pred --------------------------------------------------ccCCcccCccccCHHHhCC-CCCCcCchhh
Confidence 1236789999999999865 6999999999
Q ss_pred hhHHHHHHhhCCCCCCCCC-hhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccc
Q 010266 341 LGAIMYEMLVGYPPFYSDD-PVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFK 416 (514)
Q Consensus 341 lGvilyemltG~~PF~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~ 416 (514)
|||++|||++|.+||.+.+ ..+.+..+........++ ...++++++||.+||. ||++|+ |++|+++||||+
T Consensus 198 lGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~---s~~ell~Hp~fk 270 (270)
T d1t4ha_ 198 FGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD--KVAIPEVKEIIEGCIRQNKDERY---SIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG--GCCCHHHHHHHHHHSCSSGGGSC---CHHHHHTSGGGC
T ss_pred HHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccC--ccCCHHHHHHHHHHccCCHhHCc---CHHHHhCCcccC
Confidence 9999999999999998654 455566666543333333 3678999999999999 999999 999999999996
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-61 Score=485.47 Aligned_cols=290 Identities=39% Similarity=0.722 Sum_probs=247.1
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEE---ccCCCEEEEEEeecccccC-hhhHHHHHHHHHHHHHcCC-CceeeEEEEE
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQE---KKSGNIYAMKKLKKSEMLS-RGQVEHVRAERNLLAEVAS-HCIVKLYYSF 175 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~---~~t~~~~AiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~f 175 (514)
.++.+++|++++.||+|+||+||+|++ +.+|+.||||++++..... ....+.+.+|+.+|++++| |||++++++|
T Consensus 19 ~~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~ 98 (322)
T d1vzoa_ 19 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 98 (322)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred cccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee
Confidence 456779999999999999999999997 3478999999998765432 2334567889999999976 7999999999
Q ss_pred EcCCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 176 QDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 176 ~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
.+...+|+||||+.||+|..++...+.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC--CCC
Q 010266 256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK--GYG 333 (514)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~--~y~ 333 (514)
...... ....+..||+.|+|||++.+. .++
T Consensus 179 ~~~~~~------------------------------------------------~~~~~~~g~~~~~~pe~~~~~~~~~~ 210 (322)
T d1vzoa_ 179 FVADET------------------------------------------------ERAYDFCGTIEYMAPDIVRGGDSGHD 210 (322)
T ss_dssp CCGGGG------------------------------------------------GGGCGGGSCCTTCCHHHHTTCC---C
T ss_pred hccccc------------------------------------------------ccccccccccccchhHHhhcCCcCCC
Confidence 542210 112356899999999999764 468
Q ss_pred cccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhc--CcccCCcCcCCChhHHHHHhhhcc-CccccCCCC--CHhH
Q 010266 334 MECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWK--NHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTL--GSEQ 408 (514)
Q Consensus 334 ~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~e 408 (514)
.++|||||||+||||++|.+||.+.+.......+.... ..+.+| ..+|+++++||.+||. ||.+|++.. +++|
T Consensus 211 ~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~--~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~e 288 (322)
T d1vzoa_ 211 KAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--QEMSALAKDLIQRLLMKDPKKRLGCGPRDADE 288 (322)
T ss_dssp THHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHH
T ss_pred chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCc--ccCCHHHHHHHHHHcccCHHHcCCCCcccHHH
Confidence 89999999999999999999999877666666655422 233444 3689999999999999 999999642 6999
Q ss_pred HhcCCccccCCccccc--cccCCCCCcCCCCCCC
Q 010266 409 IKAHPWFKDIAWDKLY--EMEAAYKPEVNGVLDT 440 (514)
Q Consensus 409 il~Hpff~~i~w~~l~--~~~~p~~p~~~~~~d~ 440 (514)
+++||||++++|+.+. +++|||+|.+.++.|.
T Consensus 289 il~Hpff~~i~~~~l~~~~~~~p~~p~~~~~~~~ 322 (322)
T d1vzoa_ 289 IKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDV 322 (322)
T ss_dssp HHTSGGGTTCCHHHHHTTCSCCSCCCCCCC-CCC
T ss_pred HHcCHhhcCCCHHHHHhCCCCcCCCCCCCCCCCC
Confidence 9999999999999985 6899999999988773
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-60 Score=475.91 Aligned_cols=256 Identities=27% Similarity=0.458 Sum_probs=228.0
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.++|++++.||+|+||+||+|+++.||+.||||++++.. .....+.+|+.+|+.++|||||+++++|++++++|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 478999999999999999999999999999999997653 3345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCC--CcEEEccccccccCCCCCc
Q 010266 185 MEYLPGGDVMTLLMREE-TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN--GHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~--g~iKL~DFGla~~~~~~~~ 261 (514)
||||+||+|.+++...+ .+++..++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+......
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~- 158 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence 99999999999997665 79999999999999999999999999999999999999854 589999999998653221
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
...+.+||+.|+|||++.+..|+.++|||||
T Consensus 159 -------------------------------------------------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSl 189 (321)
T d1tkia_ 159 -------------------------------------------------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSL 189 (321)
T ss_dssp -------------------------------------------------EEEEEESCGGGSCHHHHTTCEECHHHHHHHH
T ss_pred -------------------------------------------------cccccccccccccchhccCCCCCchhhcccH
Confidence 1235789999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 342 GAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 342 GvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
||++|+|++|.+||.+.+..+.+.+|......+..+....+|+++++||.+||. ||.+|+ |++|+++||||+.
T Consensus 190 Gvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~eil~hp~~~~ 263 (321)
T d1tkia_ 190 GTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM---TASEALQHPWLKQ 263 (321)
T ss_dssp HHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSHHHHS
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCc---CHHHHhcCHhhcc
Confidence 999999999999999999999999998744333222234689999999999999 999999 9999999999974
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-59 Score=465.35 Aligned_cols=259 Identities=28% Similarity=0.438 Sum_probs=217.7
Q ss_pred eEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChh--hHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEe
Q 010266 109 DLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRG--QVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIME 186 (514)
Q Consensus 109 ~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~--~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmE 186 (514)
+.+++||+|+||+||+|+++.+|+.||||++++....... ....+.+|+.+|+.++|||||+++++|.+.+++|+|||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 3578999999999999999999999999999766433221 23468899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccccc
Q 010266 187 YLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINE 266 (514)
Q Consensus 187 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~ 266 (514)
|+.||++..++.....+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+......
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~------ 154 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN------ 154 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC------
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc------
Confidence 99999888888778899999999999999999999999999999999999999999999999999998654321
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchhhhhHHH
Q 010266 267 NEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 345 (514)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil 345 (514)
....+.+||+.|+|||++.+ ..|+.++|||||||++
T Consensus 155 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil 191 (299)
T d1ua2a_ 155 -------------------------------------------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCIL 191 (299)
T ss_dssp -------------------------------------------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHH
T ss_pred -------------------------------------------ccccceecChhhccHHHHccCCCCChhhhhhhcchHH
Confidence 01225689999999999875 4689999999999999
Q ss_pred HHHhhCCCCCCCCChhHHHHHHhhhcCcc---------c---------CCc------CcCCChhHHHHHhhhcc-Ccccc
Q 010266 346 YEMLVGYPPFYSDDPVTTCRKIVHWKNHL---------K---------FPE------EARLTPEAKDLICRLLC-DVEHR 400 (514)
Q Consensus 346 yemltG~~PF~~~~~~~~~~~i~~~~~~~---------~---------~p~------~~~~s~~~~dLI~~lL~-dp~~R 400 (514)
|||++|.+||.+.+..++..+|....... . +|. ...+|++++|||.+||+ ||.+|
T Consensus 192 ~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R 271 (299)
T d1ua2a_ 192 AELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCAR 271 (299)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTS
T ss_pred HHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhC
Confidence 99999999999999988888876421110 0 010 12468999999999999 99999
Q ss_pred CCCCCHhHHhcCCccccCC
Q 010266 401 LGTLGSEQIKAHPWFKDIA 419 (514)
Q Consensus 401 l~~~~~~eil~Hpff~~i~ 419 (514)
+ |++|+++||||++..
T Consensus 272 ~---sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 272 I---TATQALKMKYFSNRP 287 (299)
T ss_dssp C---CHHHHHTSGGGTSSS
T ss_pred c---CHHHHhCCHhhCCCC
Confidence 9 999999999998754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-59 Score=471.18 Aligned_cols=252 Identities=33% Similarity=0.572 Sum_probs=211.8
Q ss_pred CCCeeEEe-eeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEc----C
Q 010266 105 VDDFDLLT-IIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQD----A 178 (514)
Q Consensus 105 ~~~f~~~~-~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~----~ 178 (514)
.++|.++. +||+|+||+||+|+++.||+.||||++++. ..+.+|..++.++ +|||||+++++|++ .
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 57899985 699999999999999999999999999754 2367799887654 89999999999976 5
Q ss_pred CeEEEEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC---CCcEEEcccccc
Q 010266 179 EYLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ---NGHMKLSDFGLC 253 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~---~g~iKL~DFGla 253 (514)
.++|+|||||+||+|.++|.+. ..+++..++.|+.||+.||+|||++||+||||||+|||++. ++++||+|||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 7799999999999999999764 47999999999999999999999999999999999999985 578999999999
Q ss_pred ccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCC
Q 010266 254 KPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYG 333 (514)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~ 333 (514)
+...... ...+.+|||.|||||++.+..|+
T Consensus 162 ~~~~~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~y~ 191 (335)
T d2ozaa1 162 KETTSHN--------------------------------------------------SLTTPCYTPYYVAPEVLGPEKYD 191 (335)
T ss_dssp EECCCCC--------------------------------------------------CCCCCSCCCSSCCCCCCCGGGGS
T ss_pred eeccCCC--------------------------------------------------ccccccCCcccCCcHHHcCCCCC
Confidence 8654221 11256899999999999999999
Q ss_pred cccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhh--cCcccCCc--CcCCChhHHHHHhhhcc-CccccCCCCCHhH
Q 010266 334 MECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHW--KNHLKFPE--EARLTPEAKDLICRLLC-DVEHRLGTLGSEQ 408 (514)
Q Consensus 334 ~~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~~~p~--~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~e 408 (514)
.++|||||||+||+|+||.+||.+.+..+....+... .....+|. ...+|+++++||++||+ ||.+|+ |++|
T Consensus 192 ~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~e 268 (335)
T d2ozaa1 192 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM---TITE 268 (335)
T ss_dssp HHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSC---CHHH
T ss_pred HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCc---CHHH
Confidence 9999999999999999999999887765555444321 12233443 34689999999999999 999999 9999
Q ss_pred HhcCCcccc
Q 010266 409 IKAHPWFKD 417 (514)
Q Consensus 409 il~Hpff~~ 417 (514)
|++||||..
T Consensus 269 il~hp~~~~ 277 (335)
T d2ozaa1 269 FMNHPWIMQ 277 (335)
T ss_dssp HHHSHHHHT
T ss_pred HHcCHHhhC
Confidence 999999964
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-58 Score=456.20 Aligned_cols=262 Identities=29% Similarity=0.482 Sum_probs=217.7
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
+++|++++.||+|+||+||+|+++.+|+.||||++++.. ......+.+.+|+.+|+.++|||||+++++|++..++|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 479999999999999999999999999999999997653 2334456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccc
Q 010266 185 MEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSA 263 (514)
Q Consensus 185 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~ 263 (514)
|||+.|+.+...... ...+++..++.++.|++.||+|||++|||||||||+|||++.++++||+|||+|+......
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--- 156 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--- 156 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS---
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc---
Confidence 999976544433333 4679999999999999999999999999999999999999999999999999997643211
Q ss_pred cccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCC-Ccccchhhhh
Q 010266 264 INENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLG 342 (514)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWSlG 342 (514)
......+||+.|+|||++....+ +.++|+||||
T Consensus 157 ----------------------------------------------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlG 190 (298)
T d1gz8a_ 157 ----------------------------------------------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 190 (298)
T ss_dssp ----------------------------------------------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHH
T ss_pred ----------------------------------------------ccceeecccceeeehhhhccccCCCccccccccc
Confidence 01225689999999999887665 8899999999
Q ss_pred HHHHHHhhCCCCCCCCChhHHHHHHhhhcCc----------------ccCCc---------CcCCChhHHHHHhhhcc-C
Q 010266 343 AIMYEMLVGYPPFYSDDPVTTCRKIVHWKNH----------------LKFPE---------EARLTPEAKDLICRLLC-D 396 (514)
Q Consensus 343 vilyemltG~~PF~~~~~~~~~~~i~~~~~~----------------~~~p~---------~~~~s~~~~dLI~~lL~-d 396 (514)
|++|+|++|++||.+.+..+...++...... ..+|. ...+|++++|||.+||+ |
T Consensus 191 vily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~d 270 (298)
T d1gz8a_ 191 CIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYD 270 (298)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSS
T ss_pred hhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCC
Confidence 9999999999999999888877776531110 00110 12568999999999999 9
Q ss_pred ccccCCCCCHhHHhcCCccccCC
Q 010266 397 VEHRLGTLGSEQIKAHPWFKDIA 419 (514)
Q Consensus 397 p~~Rl~~~~~~eil~Hpff~~i~ 419 (514)
|.+|+ |++||++||||++++
T Consensus 271 P~~R~---t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 271 PNKRI---SAKAALAHPFFQDVT 290 (298)
T ss_dssp TTTSC---CHHHHHTSGGGTTCC
T ss_pred hhHCc---CHHHHhCCHhhccCC
Confidence 99999 999999999998763
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-58 Score=452.22 Aligned_cols=250 Identities=30% Similarity=0.497 Sum_probs=216.6
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhh---HHHHHHHHHHHHHcC--CCceeeEEEEEEcCCe
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQ---VEHVRAERNLLAEVA--SHCIVKLYYSFQDAEY 180 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~---~~~~~~E~~iL~~l~--hp~Iv~l~~~f~~~~~ 180 (514)
++|++.+.||+|+||+||+|+++.+|+.||||++.+........ ...+.+|..+|+.++ |||||+++++|.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 68999999999999999999999999999999998765443222 223567999999986 8999999999999999
Q ss_pred EEEEEeecCC-CCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCC-CcEEEccccccccCCC
Q 010266 181 LYLIMEYLPG-GDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQN-GHMKLSDFGLCKPLDC 258 (514)
Q Consensus 181 l~lVmEy~~g-g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~-g~iKL~DFGla~~~~~ 258 (514)
+|+||||+.| +++..++.....+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+....
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~ 163 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc
Confidence 9999999976 6888899888999999999999999999999999999999999999999854 8999999999975432
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCC-Ccccc
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGY-GMECD 337 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y-~~~~D 337 (514)
. ...+.+||+.|+|||++.+..| +.++|
T Consensus 164 ~---------------------------------------------------~~~~~~GT~~y~aPE~~~~~~~~~~~~D 192 (273)
T d1xwsa_ 164 T---------------------------------------------------VYTDFDGTRVYSPPEWIRYHRYHGRSAA 192 (273)
T ss_dssp S---------------------------------------------------CBCCCCSCGGGSCHHHHHHSCBCHHHHH
T ss_pred c---------------------------------------------------cccccccCCCcCCHHHHcCCCCCCcccc
Confidence 1 1125789999999999987765 67899
Q ss_pred hhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccc
Q 010266 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFK 416 (514)
Q Consensus 338 iWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~ 416 (514)
||||||++|||++|.+||.+.+ .+.. ....+|. .+|+++++||.+||. ||.+|+ |++|+++||||+
T Consensus 193 iwSlGvilyell~g~~Pf~~~~------~i~~--~~~~~~~--~~s~~~~~li~~~L~~dp~~R~---s~~eil~hp~~~ 259 (273)
T d1xwsa_ 193 VWSLGILLYDMVCGDIPFEHDE------EIIR--GQVFFRQ--RVSSECQHLIRWCLALRPSDRP---TFEEIQNHPWMQ 259 (273)
T ss_dssp HHHHHHHHHHHHHSSCSCCSHH------HHHH--CCCCCSS--CCCHHHHHHHHHHTCSSGGGSC---CHHHHHTSGGGS
T ss_pred cccceeeehhHhhCCCCCCCch------HHhh--cccCCCC--CCCHHHHHHHHHHccCCHhHCc---CHHHHhcCHhhC
Confidence 9999999999999999997632 3443 3445554 789999999999999 999999 999999999998
Q ss_pred cCC
Q 010266 417 DIA 419 (514)
Q Consensus 417 ~i~ 419 (514)
++-
T Consensus 260 ~~~ 262 (273)
T d1xwsa_ 260 DVL 262 (273)
T ss_dssp SCC
T ss_pred CCC
Confidence 764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-57 Score=453.66 Aligned_cols=262 Identities=27% Similarity=0.417 Sum_probs=217.4
Q ss_pred CCeeEEeeeeecCceEEEEEEEccC-CCEEEEEEeecccccChhhHHHHHHHHHHHHHc---CCCceeeEEEEEEc----
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKS-GNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV---ASHCIVKLYYSFQD---- 177 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t-~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~~---- 177 (514)
++|++++.||+|+||+||+|++..+ ++.||||++++.... ......+.+|..+|+.+ +|||||+++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 6899999999999999999999765 678999999765432 22233455677777665 79999999999853
Q ss_pred -CCeEEEEEeecCCCCHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 178 -AEYLYLIMEYLPGGDVMTLLM-REETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 178 -~~~l~lVmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
..++|+||||+.||++..... ....+++..++.++.|++.||+|||++|||||||||+|||++.+|++||+|||+++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 457999999999887765443 346799999999999999999999999999999999999999999999999999875
Q ss_pred CCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcc
Q 010266 256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME 335 (514)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~ 335 (514)
.... ....+.+||+.|+|||++.+.+|+.+
T Consensus 166 ~~~~--------------------------------------------------~~~~~~~gT~~Y~APE~~~~~~y~~~ 195 (305)
T d1blxa_ 166 YSFQ--------------------------------------------------MALTSVVVTLWYRAPEVLLQSSYATP 195 (305)
T ss_dssp CCGG--------------------------------------------------GGGCCCCCCCTTCCHHHHTTCCCCTH
T ss_pred hccc--------------------------------------------------ccCCCcccChhhcCcchhcCCCCChh
Confidence 4311 01226789999999999999999999
Q ss_pred cchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcC---------cccCC--------------cCcCCChhHHHHHhh
Q 010266 336 CDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKN---------HLKFP--------------EEARLTPEAKDLICR 392 (514)
Q Consensus 336 ~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~---------~~~~p--------------~~~~~s~~~~dLI~~ 392 (514)
+|||||||++|||++|.+||.+.+..++..+|+.... ....+ ....+|++++|||.+
T Consensus 196 ~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~ 275 (305)
T d1blxa_ 196 VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLK 275 (305)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHH
T ss_pred ehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHH
Confidence 9999999999999999999999999888888764211 00000 013578999999999
Q ss_pred hcc-CccccCCCCCHhHHhcCCccccCCcc
Q 010266 393 LLC-DVEHRLGTLGSEQIKAHPWFKDIAWD 421 (514)
Q Consensus 393 lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~ 421 (514)
||+ ||.+|+ |++|+++||||+++++.
T Consensus 276 mL~~dP~~R~---sa~e~L~Hpff~~i~~~ 302 (305)
T d1blxa_ 276 CLTFNPAKRI---SAYSALSHPYFQDLERC 302 (305)
T ss_dssp HSCSSTTTSC---CHHHHHTSGGGTTCCCC
T ss_pred HCcCChhHCc---CHHHHhcChhhcCchhh
Confidence 999 999999 99999999999998763
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.3e-57 Score=446.87 Aligned_cols=263 Identities=24% Similarity=0.403 Sum_probs=220.8
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC----e
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE----Y 180 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~----~ 180 (514)
.++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|..+|+.++|||||++++++.+.+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 367999999999999999999999999999999998876666667788999999999999999999999998654 4
Q ss_pred EEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
+|||||||+||+|..++...+.+++..++.++.||+.||+|||++|||||||||+|||++.++.++|+|||+++......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999987653221
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 340 (514)
. ......+.+||+.|||||++.+..|+.++||||
T Consensus 166 ~----------------------------------------------~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwS 199 (277)
T d1o6ya_ 166 N----------------------------------------------SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYS 199 (277)
T ss_dssp -----------------------------------------------------------TTCCHHHHTTCCCCHHHHHHH
T ss_pred c----------------------------------------------cccccccccCcccccCHHHHcCCCCCcceeccc
Confidence 0 001123678999999999999999999999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccc
Q 010266 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFK 416 (514)
Q Consensus 341 lGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~ 416 (514)
|||++|||+||.+||.+.+..+...+++.............+|+++++||.+||. ||.+|+. ++++++ |+|.+
T Consensus 200 lGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~--sa~~l~-~~l~r 273 (277)
T d1o6ya_ 200 LGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ--TAAEMR-ADLVR 273 (277)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCS--SHHHHH-HHHHH
T ss_pred chHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHh--HHHHHH-HHHHH
Confidence 9999999999999999999988888887643332222335789999999999999 9999984 555554 66653
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2e-56 Score=443.90 Aligned_cols=259 Identities=29% Similarity=0.446 Sum_probs=219.6
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.++|++++.||+|+||+||+|+++ +|+.||||++++... .....+.+.+|+.+|+.++|||||+++++|.+.+.+|+|
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 378999999999999999999985 789999999976543 344457788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
|||+.|+++..+....+.+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|........
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--- 155 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--- 155 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc---
Confidence 99999888888887789999999999999999999999999999999999999999999999999999986532210
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-CCCcccchhhhhH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGA 343 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGv 343 (514)
.....+||+.|+|||++.+. .++.++|+|||||
T Consensus 156 ----------------------------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv 189 (286)
T d1ob3a_ 156 ----------------------------------------------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGC 189 (286)
T ss_dssp ----------------------------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHH
T ss_pred ----------------------------------------------ccceecccchhhhHHHHhCCCCCCcceeehhcCc
Confidence 11255799999999999764 5699999999999
Q ss_pred HHHHHhhCCCCCCCCChhHHHHHHhhhcCcc---------cCC----------------cCcCCChhHHHHHhhhcc-Cc
Q 010266 344 IMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL---------KFP----------------EEARLTPEAKDLICRLLC-DV 397 (514)
Q Consensus 344 ilyemltG~~PF~~~~~~~~~~~i~~~~~~~---------~~p----------------~~~~~s~~~~dLI~~lL~-dp 397 (514)
++|||++|++||.+.+..+++.++....... ..+ ....+|++++|||++||. ||
T Consensus 190 ~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP 269 (286)
T d1ob3a_ 190 IFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDP 269 (286)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSST
T ss_pred HHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCCh
Confidence 9999999999999998888877765311110 000 013578999999999999 99
Q ss_pred cccCCCCCHhHHhcCCcccc
Q 010266 398 EHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 398 ~~Rl~~~~~~eil~Hpff~~ 417 (514)
++|+ |++|+++||||+.
T Consensus 270 ~~R~---s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 270 NQRI---TAKQALEHAYFKE 286 (286)
T ss_dssp TTSC---CHHHHHTSGGGGC
T ss_pred hHCc---CHHHHhcCcccCc
Confidence 9999 9999999999974
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-56 Score=450.99 Aligned_cols=258 Identities=21% Similarity=0.328 Sum_probs=218.8
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCC-----EEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEE
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGN-----IYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYS 174 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~-----~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 174 (514)
+.+..++|++.++||+|+||+||+|+++.+++ .||+|++.+.. .......+.+|..+|..+ +|||||+++++
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence 34677899999999999999999999876654 69999987543 233456688999999998 89999999999
Q ss_pred EEcCCeEEEEEeecCCCCHHHHHhhc-----------------------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcC
Q 010266 175 FQDAEYLYLIMEYLPGGDVMTLLMRE-----------------------ETLTETVARFYIAQSVLAIESIHKHNYIHRD 231 (514)
Q Consensus 175 f~~~~~l~lVmEy~~gg~L~~~l~~~-----------------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrD 231 (514)
|.+.+.+|+|||||+||+|.++|... ..+++..++.|+.||+.||.|||++||||||
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD 189 (325)
T d1rjba_ 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189 (325)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 99999999999999999999999654 3488999999999999999999999999999
Q ss_pred CCCCCccccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhcccc
Q 010266 232 IKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKL 311 (514)
Q Consensus 232 LKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (514)
|||+|||++.+|++||+|||+|+....... ...
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~-----------------------------------------------~~~ 222 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSN-----------------------------------------------YVV 222 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTT-----------------------------------------------SEE
T ss_pred CchhccccccCCeEEEeeccccccccCCCc-----------------------------------------------eee
Confidence 999999999999999999999986532210 011
Q ss_pred ccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHH
Q 010266 312 AYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLI 390 (514)
Q Consensus 312 ~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI 390 (514)
..+.+||+.|||||++.+..|+.++|||||||+||||++ |.+||.+.+..+.+.+++.....+..| ..+|+++++||
T Consensus 223 ~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p--~~~~~~l~~li 300 (325)
T d1rjba_ 223 RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQP--FYATEEIYIIM 300 (325)
T ss_dssp ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCC--TTCCHHHHHHH
T ss_pred eccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCCHHHHHHH
Confidence 225679999999999999999999999999999999997 899999988777777777644444444 47899999999
Q ss_pred hhhcc-CccccCCCCCHhHHhcC
Q 010266 391 CRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 391 ~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
.+||. ||.+|+ |++||++|
T Consensus 301 ~~cl~~dP~~RP---t~~ei~~~ 320 (325)
T d1rjba_ 301 QSCWAFDSRKRP---SFPNLTSF 320 (325)
T ss_dssp HHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHcCCChhHCc---CHHHHHHH
Confidence 99999 999999 99999875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-55 Score=444.55 Aligned_cols=264 Identities=26% Similarity=0.354 Sum_probs=218.2
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc-------
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD------- 177 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~------- 177 (514)
+++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||++++++|.+
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 4789999999999999999999999999999999977643 34445668899999999999999999999865
Q ss_pred -CCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccC
Q 010266 178 -AEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPL 256 (514)
Q Consensus 178 -~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~ 256 (514)
..++|+||||+.++.+.........+++..++.++.|++.||.|||++|||||||||+|||++.+|.+||+|||+|+..
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 4568999999998887777777789999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-CCCcc
Q 010266 257 DCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGME 335 (514)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~ 335 (514)
....... .....+.+||+.|+|||++.+. .|+.+
T Consensus 168 ~~~~~~~---------------------------------------------~~~~~~~~gT~~Y~aPE~~~~~~~~~~k 202 (318)
T d3blha1 168 SLAKNSQ---------------------------------------------PNRYTNRVVTLWYRPPELLLGERDYGPP 202 (318)
T ss_dssp CC--------------------------------------------------CCCCCSCCSCGGGCCHHHHTTCSSCCTH
T ss_pred ccccccc---------------------------------------------cccccceecCHHHhhHHHHcCCCCCCcH
Confidence 4321110 0112356899999999999865 68999
Q ss_pred cchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcccCCcC----------------------------cCCChhHH
Q 010266 336 CDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHLKFPEE----------------------------ARLTPEAK 387 (514)
Q Consensus 336 ~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~----------------------------~~~s~~~~ 387 (514)
+|||||||++|||++|.+||.+.+.......+......+.-... ...+++++
T Consensus 203 ~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (318)
T d3blha1 203 IDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYAL 282 (318)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHH
T ss_pred HHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHH
Confidence 99999999999999999999998888887777553221111000 11378899
Q ss_pred HHHhhhcc-CccccCCCCCHhHHhcCCcccc
Q 010266 388 DLICRLLC-DVEHRLGTLGSEQIKAHPWFKD 417 (514)
Q Consensus 388 dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~ 417 (514)
|||.+||. ||.+|+ |++|+++||||+.
T Consensus 283 dLl~~mL~~dP~~R~---sa~elL~Hpff~~ 310 (318)
T d3blha1 283 DLIDKLLVLDPAQRI---DSDDALNHDFFWS 310 (318)
T ss_dssp HHHHHHSCSSTTTSC---CHHHHHHSGGGSS
T ss_pred HHHHHHCcCChhHCc---CHHHHHcChhhcc
Confidence 99999999 999999 9999999999974
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.5e-55 Score=444.42 Aligned_cols=256 Identities=26% Similarity=0.445 Sum_probs=213.1
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEEEc--CCe
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQD--AEY 180 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~--~~~ 180 (514)
..++|++++.||+|+||+||+|+++.+|+.||||++++. ..+.+.+|+++|..+. ||||++++++|.+ ...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 347899999999999999999999999999999998754 2356889999999995 9999999999984 467
Q ss_pred EEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC-cEEEccccccccCCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG-HMKLSDFGLCKPLDCT 259 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g-~iKL~DFGla~~~~~~ 259 (514)
+|+|||||.+|+|..+. +.+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.....
T Consensus 107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999999999997764 5799999999999999999999999999999999999999765 6999999999865422
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-CCCcccch
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECDW 338 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~Di 338 (514)
. .....+||+.|+|||++.+. .|+.++|+
T Consensus 184 ~--------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 213 (328)
T d3bqca1 184 Q--------------------------------------------------EYNVRVASRYFKGPELLVDYQMYDYSLDM 213 (328)
T ss_dssp C--------------------------------------------------CCCSCCSCGGGCCHHHHTTCCCCCTHHHH
T ss_pred C--------------------------------------------------cccccccCccccCcccccCCCCCCcccch
Confidence 1 11256899999999998865 57999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCCh-hHHHHHHhhh---------------------------------cCcccCCcCcCCCh
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDP-VTTCRKIVHW---------------------------------KNHLKFPEEARLTP 384 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~-~~~~~~i~~~---------------------------------~~~~~~p~~~~~s~ 384 (514)
|||||++|||++|..||..... ......+... ......+....+|+
T Consensus 214 wslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 293 (328)
T d3bqca1 214 WSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 293 (328)
T ss_dssp HHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCH
T ss_pred hhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCH
Confidence 9999999999999999976543 2222222210 00011112235789
Q ss_pred hHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCcc
Q 010266 385 EAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWD 421 (514)
Q Consensus 385 ~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~ 421 (514)
+++|||++||+ ||.+|+ |++|+++||||+++.|+
T Consensus 294 ~~~dli~~mL~~dP~~R~---ta~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 294 EALDFLDKLLRYDHQSRL---TAREAMEHPYFYTVVKD 328 (328)
T ss_dssp HHHHHHHHHSCSSGGGSC---CHHHHHTSGGGTTSCCC
T ss_pred HHHHHHHHHccCChhHCc---CHHHHhcCcccCCCCCC
Confidence 99999999999 999999 99999999999999996
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.8e-56 Score=441.01 Aligned_cols=254 Identities=21% Similarity=0.315 Sum_probs=217.6
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE 179 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 179 (514)
++++..++|++.+.||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 86 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence 45677889999999999999999999999999999999997653 24567889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
.+|+|||||++|+|..++... ..+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecC
Confidence 999999999999999999754 578999999999999999999999999999999999999999999999999998654
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
.... .......||+.|||||++.+..|+.++|
T Consensus 167 ~~~~------------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~k~D 198 (287)
T d1opja_ 167 GDTY------------------------------------------------TAHAGAKFPIKWTAPESLAYNKFSIKSD 198 (287)
T ss_dssp SSSS------------------------------------------------EEETTEEECGGGCCHHHHHHCCCSHHHH
T ss_pred CCCc------------------------------------------------eeeccccccccccChHHHcCCCCCchhh
Confidence 2210 0112456999999999999999999999
Q ss_pred hhhhhHHHHHHhhCCCCC-CCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 338 WWSLGAIMYEMLVGYPPF-YSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 338 iWSlGvilyemltG~~PF-~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
||||||++|||++|..|| .+.+..+....+.. ...+.+| ..+|+++++||.+||. ||.+|+ |++||++
T Consensus 199 iwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~-~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rp---s~~ei~~ 268 (287)
T d1opja_ 199 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-DYRMERP--EGCPEKVYELMRACWQWNPSDRP---SFAEIHQ 268 (287)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-TCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred hhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc-CCCCCCC--ccchHHHHHHHHHHcCCCHhHCc---CHHHHHH
Confidence 999999999999966555 45555555544433 2334444 4789999999999999 999999 9999965
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-55 Score=447.71 Aligned_cols=259 Identities=30% Similarity=0.468 Sum_probs=214.3
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC-----
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE----- 179 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~----- 179 (514)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. ......+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 578999999999999999999999999999999997653 35566778999999999999999999999998665
Q ss_pred -eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 180 -YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 180 -~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
++|+||||+ |++|..++ +.+.+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+....
T Consensus 96 ~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp CCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence 579999999 66777765 556899999999999999999999999999999999999999999999999999986432
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccC-CCCcccc
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKK-GYGMECD 337 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~-~y~~~~D 337 (514)
. ..+.+||+.|+|||++.+. .++.++|
T Consensus 174 ~----------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~D 201 (346)
T d1cm8a_ 174 E----------------------------------------------------MTGYVVTRWYRAPEVILNWMRYTQTVD 201 (346)
T ss_dssp S----------------------------------------------------CCSSCSCGGGCCTHHHHTTTCCCTTHH
T ss_pred c----------------------------------------------------cccccccccccCHHHHcCCCCCCccch
Confidence 1 1256899999999999874 5689999
Q ss_pred hhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcc---------------------cCC------cCcCCChhHHHHH
Q 010266 338 WWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL---------------------KFP------EEARLTPEAKDLI 390 (514)
Q Consensus 338 iWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---------------------~~p------~~~~~s~~~~dLI 390 (514)
||||||++|||++|.+||.+.+.......+....... ..+ ....+|++++|||
T Consensus 202 iwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli 281 (346)
T d1cm8a_ 202 IWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLL 281 (346)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHH
T ss_pred hhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHH
Confidence 9999999999999999999988777665554311110 000 0135789999999
Q ss_pred hhhcc-CccccCCCCCHhHHhcCCccccCCcc
Q 010266 391 CRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWD 421 (514)
Q Consensus 391 ~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~ 421 (514)
.+||+ ||.+|+ |++||++||||+++.+.
T Consensus 282 ~~mL~~dP~~R~---ta~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 282 EKMLVLDAEQRV---TAGEALAHPYFESLHDT 310 (346)
T ss_dssp HHHSCSSTTTSC---CHHHHHHSGGGTTTC--
T ss_pred HHHCcCChhHCc---CHHHHhcChhhCcCCCc
Confidence 99999 999999 99999999999987643
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-55 Score=445.57 Aligned_cols=254 Identities=32% Similarity=0.499 Sum_probs=212.1
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE------cCC
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ------DAE 179 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~------~~~ 179 (514)
-+|+.+++||+|+||+||+|+++.+|+.||||++.+.... ..+|+.+|+.++|||||+++++|. +..
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 3699999999999999999999999999999999876432 236999999999999999999984 345
Q ss_pred eEEEEEeecCCCCHHHHH---hhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC-cEEEcccccccc
Q 010266 180 YLYLIMEYLPGGDVMTLL---MREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG-HMKLSDFGLCKP 255 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l---~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g-~iKL~DFGla~~ 255 (514)
++|||||||++|.+..+. .....+++..++.++.||+.||+|||++|||||||||+|||++.+| .+||+|||+|+.
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence 689999999876443333 3456799999999999999999999999999999999999999876 899999999986
Q ss_pred CCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCc
Q 010266 256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGM 334 (514)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~ 334 (514)
..... ...+.+||+.|+|||++.+ ..|+.
T Consensus 173 ~~~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~ 202 (350)
T d1q5ka_ 173 LVRGE--------------------------------------------------PNVSYICSRYYRAPELIFGATDYTS 202 (350)
T ss_dssp CCTTS--------------------------------------------------CCCSCCSCTTSCCHHHHTTCSSCCT
T ss_pred ccCCc--------------------------------------------------ccccccccccccChHHhhcccCCCc
Confidence 53211 1225689999999999875 57899
Q ss_pred ccchhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcC---------------cccCCc----------CcCCChhHHHH
Q 010266 335 ECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKN---------------HLKFPE----------EARLTPEAKDL 389 (514)
Q Consensus 335 ~~DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~dL 389 (514)
++|||||||++|||++|.+||.+.+..+.+.+|..... ...+|. ...+|+++.||
T Consensus 203 ~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 282 (350)
T d1q5ka_ 203 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 282 (350)
T ss_dssp HHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHH
T ss_pred ceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHH
Confidence 99999999999999999999999888888777653110 111111 12478999999
Q ss_pred Hhhhcc-CccccCCCCCHhHHhcCCccccCC
Q 010266 390 ICRLLC-DVEHRLGTLGSEQIKAHPWFKDIA 419 (514)
Q Consensus 390 I~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~ 419 (514)
|.+||+ ||.+|+ |+.|+++||||+++.
T Consensus 283 l~~mL~~dP~~R~---ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 283 CSRLLEYTPTARL---TPLEACAHSFFDELR 310 (350)
T ss_dssp HHHHSCSSGGGSC---CHHHHHTSGGGGGGG
T ss_pred HHHHccCChhHCc---CHHHHhcCHhhcccc
Confidence 999999 999999 999999999998763
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.1e-55 Score=436.10 Aligned_cols=259 Identities=22% Similarity=0.335 Sum_probs=210.5
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCCC---EEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSGN---IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA 178 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~---~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 178 (514)
.+..++|++.+.||+|+||+||+|+++.+++ .||||.+.... .....+.+.+|+.+|+.++|||||+++++|.+.
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 4667899999999999999999999987765 58888876542 455667899999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
+.+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999999999988764 579999999999999999999999999999999999999999999999999998654
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
...... .........||+.|||||++.+..|+.++|
T Consensus 180 ~~~~~~--------------------------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~sD 215 (299)
T d1jpaa_ 180 DDTSDP--------------------------------------------TYTSALGGKIPIRWTAPEAIQYRKFTSASD 215 (299)
T ss_dssp ------------------------------------------------------------CGGGSCHHHHHSCCCCHHHH
T ss_pred CCCCcc--------------------------------------------eeeecccccCCccccCHHHHhcCCCCcccc
Confidence 321000 000112356899999999999999999999
Q ss_pred hhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 338 WWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 338 iWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
||||||+||||+| |.+||.+.+..+....+... ...|.+..+++++.+||.+||. ||.+|+ ++.||+++
T Consensus 216 vwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~~P~~RP---s~~ei~~~ 286 (299)
T d1jpaa_ 216 VWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD---YRLPPPMDCPSALHQLMLDCWQKDRNHRP---KFGQIVNT 286 (299)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSTTTSC---CHHHHHHH
T ss_pred cccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCccchHHHHHHHHHHcCCCHhHCc---CHHHHHHH
Confidence 9999999999998 89999999988888887652 2333345789999999999998 999999 88888764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-55 Score=433.96 Aligned_cols=254 Identities=22% Similarity=0.324 Sum_probs=213.2
Q ss_pred eeeeecCceEEEEEEEc--cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEEEeecC
Q 010266 112 TIIGRGAFGEVRLCQEK--KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLIMEYLP 189 (514)
Q Consensus 112 ~~LG~G~fG~V~l~~~~--~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lVmEy~~ 189 (514)
+.||+|+||+||+|..+ .+++.||||+++... ......+.+.+|..+|++++|||||+++++|.++ ..|||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 47999999999999865 456789999997653 3445567899999999999999999999999754 5789999999
Q ss_pred CCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccccccc
Q 010266 190 GGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEV 269 (514)
Q Consensus 190 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~ 269 (514)
||+|.+++.....+++..+..++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.+......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~------- 163 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY------- 163 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE-------
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccc-------
Confidence 9999999999899999999999999999999999999999999999999999999999999999865432110
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHHHHHh
Q 010266 270 LDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 349 (514)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 349 (514)
........||+.|||||++.+..|+.++|||||||++|||+
T Consensus 164 ---------------------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ell 204 (277)
T d1xbba_ 164 ---------------------------------------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 204 (277)
T ss_dssp ---------------------------------------EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred ---------------------------------------cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHh
Confidence 01112457999999999999999999999999999999999
Q ss_pred h-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHH---hcCCccccCC
Q 010266 350 V-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQI---KAHPWFKDIA 419 (514)
Q Consensus 350 t-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ei---l~Hpff~~i~ 419 (514)
+ |.+||.+.+..+....|... ..+.+|. .+|+++++||.+||. ||.+|| ++++| ++|+|+.-++
T Consensus 205 t~g~~Pf~~~~~~~~~~~i~~~-~~~~~p~--~~~~~~~~li~~cl~~dp~~RP---s~~~i~~~L~~~~~~~~~ 273 (277)
T d1xbba_ 205 SYGQKPYRGMKGSEVTAMLEKG-ERMGCPA--GCPREMYDLMNLCWTYDVENRP---GFAAVELRLRNYYYDVVN 273 (277)
T ss_dssp TTTCCSSTTCCHHHHHHHHHTT-CCCCCCT--TCCHHHHHHHHHHTCSSTTTSC---CHHHHHHHHHHHHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHHHcC-CCCCCCc--ccCHHHHHHHHHHcCCCHhHCc---CHHHHHHHhhCHHhhcCC
Confidence 8 99999998888887777653 3344553 789999999999999 999999 88887 5677776544
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-55 Score=429.39 Aligned_cols=258 Identities=23% Similarity=0.371 Sum_probs=219.1
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE 179 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 179 (514)
.+.+..++|++++.||+|+||+||+|+.+ +++.||||++++... ..+.+.+|..+|+.++|||||++++++. ++
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~ 80 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVT-QE 80 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeec-cC
Confidence 34567789999999999999999999975 577899999976532 3456899999999999999999999875 46
Q ss_pred eEEEEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
.+|+|||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.+|++||+|||+|+...
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence 689999999999999987543 369999999999999999999999999999999999999999999999999998754
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
.... ....+..||+.|||||++.+..|+.++|
T Consensus 161 ~~~~------------------------------------------------~~~~~~~gt~~y~APE~~~~~~~~~~sD 192 (272)
T d1qpca_ 161 DNEY------------------------------------------------TAREGAKFPIKWTAPEAINYGTFTIKSD 192 (272)
T ss_dssp SSCE------------------------------------------------ECCTTCCCCTTTSCHHHHHHCEECHHHH
T ss_pred CCcc------------------------------------------------ccccccCCcccccChHHHhCCCCCchhh
Confidence 3210 0112467999999999999999999999
Q ss_pred hhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc--CC
Q 010266 338 WWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA--HP 413 (514)
Q Consensus 338 iWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~--Hp 413 (514)
||||||++|||+| |.+||...+..+....+... ..+..| ..+++++++||.+||. ||.+|+ |+++|++ |+
T Consensus 193 vwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~-~~~~~p--~~~~~~l~~li~~cl~~~P~~Rp---t~~ei~~~L~~ 266 (272)
T d1qpca_ 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMVRP--DNCPEELYQLMRLCWKERPEDRP---TFDYLRSVLED 266 (272)
T ss_dssp HHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHHHHH
T ss_pred hhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-CCCCCc--ccChHHHHHHHHHHcCCCHhHCc---CHHHHHHHhhh
Confidence 9999999999999 56667777777777777653 223344 4789999999999999 999999 9999988 88
Q ss_pred cccc
Q 010266 414 WFKD 417 (514)
Q Consensus 414 ff~~ 417 (514)
||..
T Consensus 267 ~fts 270 (272)
T d1qpca_ 267 FFTA 270 (272)
T ss_dssp HHHH
T ss_pred hhhc
Confidence 8853
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-55 Score=431.69 Aligned_cols=257 Identities=20% Similarity=0.251 Sum_probs=210.2
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCe
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEY 180 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~ 180 (514)
+++..++|++.+.||+|+||+||+|+.+ ..||||+++.... .....+.+.+|..+|+.++|||||++++++ +...
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~-~~~~ 77 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQ 77 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSS
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEE-eccE
Confidence 4577899999999999999999999743 3599999976543 455678899999999999999999999876 4567
Q ss_pred EEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
+|+|||||+||+|.+++... ..+++..+..++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 89999999999999999754 57999999999999999999999999999999999999999999999999999865321
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc---CCCCccc
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK---KGYGMEC 336 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~---~~y~~~~ 336 (514)
.. .....+.+||+.|||||++.+ ..|+.++
T Consensus 158 ~~-----------------------------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~~s 190 (276)
T d1uwha_ 158 SG-----------------------------------------------SHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190 (276)
T ss_dssp -------------------------------------------------------CCCCGGGCCHHHHTTCSSCCCCHHH
T ss_pred CC-----------------------------------------------cccccccccCcccCCHHHHhcccCCCCCchh
Confidence 10 001225689999999999974 3589999
Q ss_pred chhhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhc-CcccCC-cCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 337 DWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWK-NHLKFP-EEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 337 DiWSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~~~p-~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
|||||||+||||+||..||.+.+.......++... .....+ ....+++++++||.+||. ||.+|+ |++||++|
T Consensus 191 DiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RP---t~~~il~~ 266 (276)
T d1uwha_ 191 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERP---LFPQILAS 266 (276)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred hhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCc---CHHHHHHH
Confidence 99999999999999999999877665554444322 111111 123678999999999999 999999 99999876
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=426.28 Aligned_cols=251 Identities=20% Similarity=0.294 Sum_probs=209.1
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
+..++|++++.||+|+||+||+|+++ +++.||||++++... ..+.+.+|..+|+.++|||||++++++.+.+.+|
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 76 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceeccCCceE
Confidence 45689999999999999999999975 567899999976532 2356889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 183 LIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
+|||||++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus 77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 999999999999998654 5688999999999999999999999999999999999999999999999999986542210
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
......+||+.|||||++.+..|+.++|||||
T Consensus 157 ------------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~ 188 (263)
T d1sm2a_ 157 ------------------------------------------------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 188 (263)
T ss_dssp --------------------------------------------------------CTTSCCHHHHTTCCCCHHHHHHHH
T ss_pred ------------------------------------------------eeecceecCcccCChHHhcCCCCCchhhhcch
Confidence 01124579999999999999999999999999
Q ss_pred hHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 342 GAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 342 Gvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
||++|||+| |.+||.+.+..+....+... .....| ...++++.+||.+||. ||.+|+ +++||++|
T Consensus 189 Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-~~~~~p--~~~~~~l~~li~~cl~~~p~~Rp---s~~~il~~ 255 (263)
T d1sm2a_ 189 GVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKP--RLASTHVYQIMNHCWKERPEDRP---AFSRLLRQ 255 (263)
T ss_dssp HHHHHHHHTTSCCTTCSCCHHHHHHHHHHT-CCCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHHHCCCCCCCCCCHHHHHHHHHhc-CCCCCc--cccCHHHHHHHHHHccCCHhHCc---CHHHHHHH
Confidence 999999999 67788888888888887763 223344 3678999999999999 999999 99999886
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-54 Score=430.35 Aligned_cols=259 Identities=24% Similarity=0.355 Sum_probs=219.4
Q ss_pred CCCCCeeEEee-eeecCceEEEEEEEcc--CCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC
Q 010266 103 ISVDDFDLLTI-IGRGAFGEVRLCQEKK--SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE 179 (514)
Q Consensus 103 ~~~~~f~~~~~-LG~G~fG~V~l~~~~~--t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 179 (514)
+..++|.+... ||+|+||+||+|.++. ++..||||++++.. .....+.+.+|..+|+.++|||||++++++.+ +
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 81 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C
Confidence 34567888885 9999999999998764 44579999997652 45567789999999999999999999999975 4
Q ss_pred eEEEEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
.+|+|||||+||+|.+++.. ...+++..+..++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+..
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 68999999999999999765 46799999999999999999999999999999999999999999999999999987643
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
.... .......+||+.|||||++.+..|+.++||
T Consensus 162 ~~~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV 195 (285)
T d1u59a_ 162 DDSY----------------------------------------------YTARSAGKWPLKWYAPECINFRKFSSRSDV 195 (285)
T ss_dssp CSCE----------------------------------------------ECCCCSSCCCGGGCCHHHHHHCEECHHHHH
T ss_pred cccc----------------------------------------------cccccccccCccccChHHHhCCCCCccchh
Confidence 2110 001124579999999999999999999999
Q ss_pred hhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHH---hcCC
Q 010266 339 WSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQI---KAHP 413 (514)
Q Consensus 339 WSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ei---l~Hp 413 (514)
|||||++|||+| |.+||.+.+..+....|... ..+.+|+ .+|+++.+||.+||. ||.+|| ++.+| ++|+
T Consensus 196 wS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p~--~~~~~l~~li~~cl~~~p~~RP---s~~~i~~~L~~~ 269 (285)
T d1u59a_ 196 WSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMECPP--ECPPELYALMSDCWIYKWEDRP---DFLTVEQRMRAC 269 (285)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT-CCCCCCT--TCCHHHHHHHHHTTCSSGGGSC---CHHHHHHHHHHH
T ss_pred hcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCC--cCCHHHHHHHHHHcCCCHhHCc---CHHHHHHHHHHH
Confidence 999999999998 99999998888888887753 2344554 689999999999999 999999 66666 6788
Q ss_pred ccc
Q 010266 414 WFK 416 (514)
Q Consensus 414 ff~ 416 (514)
|+.
T Consensus 270 ~~~ 272 (285)
T d1u59a_ 270 YYS 272 (285)
T ss_dssp HHH
T ss_pred HHH
Confidence 874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-54 Score=425.79 Aligned_cols=261 Identities=26% Similarity=0.431 Sum_probs=223.8
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~lV 184 (514)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|..+|+.++|||||+++.+|.+..++++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 368999999999999999999999999999999997764 3455678899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCcccc
Q 010266 185 MEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAI 264 (514)
Q Consensus 185 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~ 264 (514)
||++.|++|..++...+.+++..++.++.|++.||+|||++|||||||||+|||++.++++||+|||.|+.......
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~--- 156 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--- 156 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS---
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc---
Confidence 99999999999998889999999999999999999999999999999999999999999999999999986542210
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCC-CCcccchhhhhH
Q 010266 265 NENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGA 343 (514)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~-y~~~~DiWSlGv 343 (514)
......+++.|+|||++.+.. ++.++|+|||||
T Consensus 157 ----------------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~ 190 (292)
T d1unla_ 157 ----------------------------------------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGC 190 (292)
T ss_dssp ----------------------------------------------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHH
T ss_pred ----------------------------------------------cceeeccccchhhhhHhccCCCCCchhhccccch
Confidence 111346889999999998765 699999999999
Q ss_pred HHHHHhhCCCCC-CCCChhHHHHHHhhhcCcc---------cCC----------------cCcCCChhHHHHHhhhcc-C
Q 010266 344 IMYEMLVGYPPF-YSDDPVTTCRKIVHWKNHL---------KFP----------------EEARLTPEAKDLICRLLC-D 396 (514)
Q Consensus 344 ilyemltG~~PF-~~~~~~~~~~~i~~~~~~~---------~~p----------------~~~~~s~~~~dLI~~lL~-d 396 (514)
++|||++|..|| .+.+..+...++....... ..+ ....+|++++|||.+||+ |
T Consensus 191 il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~d 270 (292)
T d1unla_ 191 IFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCN 270 (292)
T ss_dssp HHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSS
T ss_pred HHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCC
Confidence 999999999885 5566666666664321110 000 013468999999999999 9
Q ss_pred ccccCCCCCHhHHhcCCccccC
Q 010266 397 VEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 397 p~~Rl~~~~~~eil~Hpff~~i 418 (514)
|.+|+ |++||++||||+++
T Consensus 271 P~~R~---sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 271 PVQRI---SAEEALQHPYFSDF 289 (292)
T ss_dssp GGGSC---CHHHHTTSGGGSSC
T ss_pred hhHCc---CHHHHhcChhhcCC
Confidence 99999 99999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-54 Score=420.78 Aligned_cols=251 Identities=20% Similarity=0.352 Sum_probs=220.7
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCCeEE
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAEYLY 182 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~~l~ 182 (514)
+..++|++++.||+|+||+||+|+++ +++.||||++++... ..+.+.+|..+++.++|||||+++++|.+++.+|
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~ 75 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 75 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEE
T ss_pred CChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC----CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceE
Confidence 35689999999999999999999975 778899999987643 2356889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCc
Q 010266 183 LIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNL 261 (514)
Q Consensus 183 lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~ 261 (514)
+||||+++|+|..++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++++||+|||+|+.......
T Consensus 76 iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp EEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred EEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 99999999999999655 56789999999999999999999999999999999999999999999999999986543211
Q ss_pred cccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhh
Q 010266 262 SAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 341 (514)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 341 (514)
. .....+||+.|+|||++.+..|+.++|||||
T Consensus 156 ~------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~ 187 (258)
T d1k2pa_ 156 T------------------------------------------------SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 187 (258)
T ss_dssp C------------------------------------------------CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred e------------------------------------------------eecccCCCCCcCCcHHhcCCCCCcceeeccc
Confidence 0 1114579999999999999999999999999
Q ss_pred hHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 342 GAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 342 Gvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
||++|||+| |..||.+.+..++..+|.... .+..| ...++++++||.+||. ||.+|+ |+++|++|
T Consensus 188 G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~-~~~~p--~~~~~~l~~li~~cl~~dP~~RP---t~~eil~~ 254 (258)
T d1k2pa_ 188 GVLMWEIYSLGKMPYERFTNSETAEHIAQGL-RLYRP--HLASEKVYTIMYSCWHEKADERP---TFKILLSN 254 (258)
T ss_dssp HHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHTTCSSGGGSC---CHHHHHHH
T ss_pred chhhHhHHhcCCCCCCCCCHHHHHHHHHhCC-CCCCc--ccccHHHHHHHHHHccCCHhHCc---CHHHHHHH
Confidence 999999998 899999999999988887632 33444 4788999999999999 999999 99999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-54 Score=436.28 Aligned_cols=260 Identities=28% Similarity=0.447 Sum_probs=212.5
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC-----e
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE-----Y 180 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~-----~ 180 (514)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. .....+.+.+|+.+|+.++||+||++++++.+.. +
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 56999999999999999999999999999999997653 3455677899999999999999999999997653 3
Q ss_pred EEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCC
Q 010266 181 LYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 181 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~ 260 (514)
+|+| +|+.||+|.+++.. +.+++..++.++.|++.||+|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 86 ~~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 86 VYLV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EEEE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 4555 55679999999865 579999999999999999999999999999999999999999999999999998654221
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcccccc-CCCCcccchh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLK-KGYGMECDWW 339 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiW 339 (514)
.. .......+||+.|+|||++.. ..|+.++|+|
T Consensus 164 ~~----------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~Diw 197 (345)
T d1pmea_ 164 DH----------------------------------------------TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 197 (345)
T ss_dssp CB----------------------------------------------CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHH
T ss_pred cc----------------------------------------------ceeeccccccceechHHHhhcCCCCCchhhhh
Confidence 00 011235689999999999854 5679999999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCc------------------ccCCc---------CcCCChhHHHHHhh
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNH------------------LKFPE---------EARLTPEAKDLICR 392 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~------------------~~~p~---------~~~~s~~~~dLI~~ 392 (514)
|+||++|||++|.+||.+.+...+...+...... ...|. ...+|+++++||.+
T Consensus 198 SlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 277 (345)
T d1pmea_ 198 SVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDK 277 (345)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHH
T ss_pred ccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHH
Confidence 9999999999999999998876666555321000 00110 13578999999999
Q ss_pred hcc-CccccCCCCCHhHHhcCCccccC
Q 010266 393 LLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 393 lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
||+ ||.+|+ +++|+++||||+..
T Consensus 278 ~L~~dP~~R~---ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 278 MLTFNPHKRI---EVEQALAHPYLEQY 301 (345)
T ss_dssp HSCSSTTTSC---CHHHHHTSGGGTTT
T ss_pred HccCChhHCc---CHHHHhcCHhhccC
Confidence 999 999999 99999999999854
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-54 Score=442.40 Aligned_cols=269 Identities=26% Similarity=0.390 Sum_probs=213.3
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE------cCC
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ------DAE 179 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~------~~~ 179 (514)
++|++++.||+|+||+||+|+++.||+.||||++.+.. ........+.+|..+|+.++|||||+++++|. +..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh-cCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 68999999999999999999999999999999998764 35666778899999999999999999999996 347
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
++|+|||||.|+ +...+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++.....
T Consensus 96 ~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 899999999765 44444 356899999999999999999999999999999999999999999999999998754321
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchh
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWW 339 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 339 (514)
. .....+||+.|+|||++.+..|+.++|+|
T Consensus 173 ~--------------------------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~Diw 202 (355)
T d2b1pa1 173 F--------------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIW 202 (355)
T ss_dssp ----------------------------------------------------------CCTTCCHHHHTTCCCCTTHHHH
T ss_pred c--------------------------------------------------ccccccccccccChhhhcCCCCCCCcccc
Confidence 0 11256899999999999999999999999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCc--------------------c---------cCCc---------CcC
Q 010266 340 SLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNH--------------------L---------KFPE---------EAR 381 (514)
Q Consensus 340 SlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~--------------------~---------~~p~---------~~~ 381 (514)
|+||++|||++|.+||.+.+......+++..... . .++. ...
T Consensus 203 SlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (355)
T d2b1pa1 203 SVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKL 282 (355)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHH
T ss_pred cccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcccccccccccccccccccccccccc
Confidence 9999999999999999998887777666531110 0 0000 012
Q ss_pred CChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCccccccccCCCC
Q 010266 382 LTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYK 431 (514)
Q Consensus 382 ~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~l~~~~~p~~ 431 (514)
.|++++|||++||+ ||.+|+ ||+||++||||+..-|..-....+|..
T Consensus 283 ~s~~~~dll~~mL~~dP~~R~---ta~elL~Hpw~~~~~~~~~~~~~~~~~ 330 (355)
T d2b1pa1 283 KASQARDLLSKMLVIDPAKRI---SVDDALQHPYINVWYDPAEVEAPPPQI 330 (355)
T ss_dssp HHHHHHHHHHHHSCSSTTTSC---CHHHHHTSTTTGGGCCHHHHTCCCC--
T ss_pred CCHHHHHHHHHHCcCChhHCc---CHHHHhcCcccCCCCCcccccCCCCCC
Confidence 46889999999999 999999 999999999999754433334444433
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-54 Score=438.94 Aligned_cols=257 Identities=29% Similarity=0.440 Sum_probs=215.9
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC-----C
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA-----E 179 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~-----~ 179 (514)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ......+.+.+|+.+|+.++|||||+++++|... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 478999999999999999999999999999999998653 3445567788999999999999999999999743 3
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCT 259 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~ 259 (514)
..++||+|+.||+|.+++. .+.+++..++.++.||+.||+|||++|||||||||+|||++.+|++|++|||+|......
T Consensus 96 ~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~ 174 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174 (348)
T ss_dssp CCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred ceEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcc
Confidence 3466677788999999885 457999999999999999999999999999999999999999999999999998754311
Q ss_pred CccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCC-CCcccch
Q 010266 260 NLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG-YGMECDW 338 (514)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~-y~~~~Di 338 (514)
..+.+||+.|+|||++.+.. ++.++|+
T Consensus 175 ----------------------------------------------------~~~~~g~~~y~apE~~~~~~~~~~~~Di 202 (348)
T d2gfsa1 175 ----------------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDI 202 (348)
T ss_dssp ----------------------------------------------------GSSSCHHHHTSCHHHHTTCSCCCTTHHH
T ss_pred ----------------------------------------------------cccccccccccCchhhcCCccCCcccch
Confidence 12568999999999987755 5899999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhHHHHHHhhhcCcc---------------------cCCc------CcCCChhHHHHHh
Q 010266 339 WSLGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKNHL---------------------KFPE------EARLTPEAKDLIC 391 (514)
Q Consensus 339 WSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---------------------~~p~------~~~~s~~~~dLI~ 391 (514)
|||||++|+|++|.+||.+.+.......|....... ..+. ...+|++++|||.
T Consensus 203 wSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~ 282 (348)
T d2gfsa1 203 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 282 (348)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHH
T ss_pred hhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHH
Confidence 999999999999999999999888887776432111 0110 1257999999999
Q ss_pred hhcc-CccccCCCCCHhHHhcCCccccC
Q 010266 392 RLLC-DVEHRLGTLGSEQIKAHPWFKDI 418 (514)
Q Consensus 392 ~lL~-dp~~Rl~~~~~~eil~Hpff~~i 418 (514)
+||+ ||.+|+ |++|+++||||+.+
T Consensus 283 ~mL~~dP~~R~---ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 283 KMLVLDSDKRI---TAAQALAHAYFAQY 307 (348)
T ss_dssp HHSCSSGGGSC---CHHHHHTSGGGTTT
T ss_pred HHCcCChhhCc---CHHHHhcCHhhCCC
Confidence 9999 999999 99999999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=421.09 Aligned_cols=254 Identities=24% Similarity=0.350 Sum_probs=209.8
Q ss_pred CCCCCCeeEEeeeeecCceEEEEEEEccCC---CEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcC
Q 010266 102 KISVDDFDLLTIIGRGAFGEVRLCQEKKSG---NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDA 178 (514)
Q Consensus 102 ~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~---~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~ 178 (514)
++..++|++.+.||+|+||+||+|++..++ ..||||+++.. ......+.+.+|..+|+.++|||||+++++|. +
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 79 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 466689999999999999999999987543 46888887643 34556678999999999999999999999996 5
Q ss_pred CeEEEEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 179 EYLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 179 ~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
+.+|+||||++||+|..++.. ...+++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+.
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 679999999999999998765 4579999999999999999999999999999999999999999999999999998654
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
.... ..+...+||+.|+|||++.+..|+.++|
T Consensus 160 ~~~~------------------------------------------------~~~~~~~gt~~y~apE~l~~~~~~~~~D 191 (273)
T d1mp8a_ 160 DSTY------------------------------------------------YKASKGKLPIKWMAPESINFRRFTSASD 191 (273)
T ss_dssp -----------------------------------------------------------CCGGGCCHHHHHHCCCSHHHH
T ss_pred CCcc------------------------------------------------eeccceecCcccchhhHhccCCCCCccc
Confidence 2210 0122457999999999999999999999
Q ss_pred hhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 338 WWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 338 iWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
||||||++|||++ |.+||.+.+..+...++.... .+.+| ..+|+++++||.+||. ||.+|+ |++||++|
T Consensus 192 iwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~~~~li~~cl~~dp~~Rp---s~~ei~~~ 262 (273)
T d1mp8a_ 192 VWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMP--PNCPPTLYSLMTKCWAYDPSRRP---RFTELKAQ 262 (273)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred cccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHcCCCHhHCc---CHHHHHHH
Confidence 9999999999998 899999999999998887643 23444 4789999999999999 999999 99999876
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=422.35 Aligned_cols=259 Identities=23% Similarity=0.381 Sum_probs=214.6
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE 179 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 179 (514)
.+.+..++|++.+.||+|+||+||+|+++.+ +.||||++++... ..+.+.+|..+|+.++|||||++++++.+ +
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~ 84 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 84 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEec-C
Confidence 4567779999999999999999999998765 5699999976532 23568899999999999999999999865 5
Q ss_pred eEEEEEeecCCCCHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMR--EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
.+|+|||||++|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.+|++||+|||+|+...
T Consensus 85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 164 (285)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhcc
Confidence 68999999999999998865 3579999999999999999999999999999999999999999999999999998653
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
.... ....+.+||+.|+|||++.+..++.++|
T Consensus 165 ~~~~------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksD 196 (285)
T d1fmka3 165 DNEY------------------------------------------------TARQGAKFPIKWTAPEAALYGRFTIKSD 196 (285)
T ss_dssp -----------------------------------------------------------CCGGGSCHHHHHHCCCCHHHH
T ss_pred CCCc------------------------------------------------eeeccccccccccChHHHhCCCCCcHHh
Confidence 2210 0112457999999999999999999999
Q ss_pred hhhhhHHHHHHhhC-CCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc--CC
Q 010266 338 WWSLGAIMYEMLVG-YPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA--HP 413 (514)
Q Consensus 338 iWSlGvilyemltG-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~--Hp 413 (514)
||||||++|||++| .+||.+.+..+....+... .....| ..+|+++++||.+||. ||++|+ ++++|++ |+
T Consensus 197 I~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~l~~li~~cl~~dP~~Rp---s~~~i~~~L~~ 270 (285)
T d1fmka3 197 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCP--PECPESLHDLMCQCWRKEPEERP---TFEYLQAFLED 270 (285)
T ss_dssp HHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHHHHT
T ss_pred hhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-CCCCCC--cccCHHHHHHHHHHcccCHhHCc---CHHHHHHHHhh
Confidence 99999999999995 5666677777777777642 223333 4789999999999999 999999 9999988 88
Q ss_pred ccccC
Q 010266 414 WFKDI 418 (514)
Q Consensus 414 ff~~i 418 (514)
||...
T Consensus 271 ~~~~~ 275 (285)
T d1fmka3 271 YFTST 275 (285)
T ss_dssp TTSCS
T ss_pred hhcCC
Confidence 88753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-53 Score=424.35 Aligned_cols=258 Identities=22% Similarity=0.317 Sum_probs=207.3
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEcc-----CCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEE
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKK-----SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYS 174 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~-----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 174 (514)
+.+..++|++++.||+|+||+||+|++.. +++.||||++++.. .....+.+..|..++.++ +||+||.++++
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 34666899999999999999999999764 44689999987543 344556677788888776 68899999998
Q ss_pred EEc-CCeEEEEEeecCCCCHHHHHhhc----------------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCc
Q 010266 175 FQD-AEYLYLIMEYLPGGDVMTLLMRE----------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNL 237 (514)
Q Consensus 175 f~~-~~~l~lVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNI 237 (514)
+.+ ...+|+|||||+||+|.++|... ..+++..+..|+.||+.||.|||++|||||||||+||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NI 165 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 165 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccce
Confidence 765 45799999999999999999653 3488999999999999999999999999999999999
Q ss_pred cccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhcccccccccc
Q 010266 238 LLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVG 317 (514)
Q Consensus 238 Lld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~G 317 (514)
||+.+|++||+|||+|+........ ....+.+|
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~-----------------------------------------------~~~~~~~g 198 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDY-----------------------------------------------VRKGDARL 198 (299)
T ss_dssp EECGGGCEEECC------CCSCTTS-----------------------------------------------CCTTSCCC
T ss_pred eECCCCcEEEccCcchhhccccccc-----------------------------------------------cccCceee
Confidence 9999999999999999865422100 01225689
Q ss_pred CCCcCCccccccCCCCcccchhhhhHHHHHHhhC-CCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-
Q 010266 318 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG-YPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC- 395 (514)
Q Consensus 318 T~~Y~APEvl~~~~y~~~~DiWSlGvilyemltG-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~- 395 (514)
|+.|||||++.+..|+.++|||||||++|||++| .+||.+.+..+.+..++.....+..|+ .+|+++++||.+||+
T Consensus 199 t~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~ 276 (299)
T d1ywna1 199 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD--YTTPEMYQTMLDCWHG 276 (299)
T ss_dssp GGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCT--TCCHHHHHHHHHHTCS
T ss_pred CccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCc--cCCHHHHHHHHHHcCC
Confidence 9999999999999999999999999999999986 678888776666666655444455554 689999999999999
Q ss_pred CccccCCCCCHhHHhcC
Q 010266 396 DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 396 dp~~Rl~~~~~~eil~H 412 (514)
||.+|+ |++||++|
T Consensus 277 dP~~Rp---t~~eil~~ 290 (299)
T d1ywna1 277 EPSQRP---TFSELVEH 290 (299)
T ss_dssp SGGGSC---CHHHHHHH
T ss_pred ChhHCc---CHHHHHHH
Confidence 999999 99999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-53 Score=425.86 Aligned_cols=255 Identities=20% Similarity=0.306 Sum_probs=210.7
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCC----EEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGN----IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE 179 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~----~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 179 (514)
..+||+++++||+|+||+||+|++..+|+ .||+|.++... .....+.+.+|..+|+.++|||||+++++|.+.
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~- 83 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 83 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 44789999999999999999999988887 47777775432 344567799999999999999999999999875
Q ss_pred eEEEEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
..++||||+.+|+|.+.+.. ...+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 56788999999999988766 46899999999999999999999999999999999999999999999999999987543
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
.... ..+...+||+.|||||++.+..|+.++||
T Consensus 164 ~~~~-----------------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~sDv 196 (317)
T d1xkka_ 164 EEKE-----------------------------------------------YHAEGGKVPIKWMALESILHRIYTHQSDV 196 (317)
T ss_dssp TCC-------------------------------------------------------CCTTTSCHHHHHHCCCCHHHHH
T ss_pred cccc-----------------------------------------------ccccccccCccccChHHHhcCCCChhhhh
Confidence 2110 01224579999999999999999999999
Q ss_pred hhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCc
Q 010266 339 WSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPW 414 (514)
Q Consensus 339 WSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpf 414 (514)
|||||++|||+| |.+||.+.+..+....+... ..+..| ..+++++++||.+||. ||.+|+ ++.||+.|..
T Consensus 197 wS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~-~~~~~p--~~~~~~~~~li~~cl~~dP~~RP---s~~eil~~l~ 268 (317)
T d1xkka_ 197 WSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQP--PICTIDVYMIMVKCWMIDADSRP---KFRELIIEFS 268 (317)
T ss_dssp HHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT-CCCCCC--TTBCHHHHHHHHHHTCSSGGGSC---CHHHHHHHHH
T ss_pred hhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCC--cccCHHHHHHHHHhCCCChhhCc---CHHHHHHHHH
Confidence 999999999998 89999988888777666553 334444 3689999999999999 999999 9999999843
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=415.20 Aligned_cols=257 Identities=21% Similarity=0.289 Sum_probs=209.9
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCC----CEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSG----NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ 176 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~----~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 176 (514)
.++.++.|++.++||+|+||+||+|..+.++ ..||||+++... .......+.+|..+|+.++|||||++++++.
T Consensus 2 ~ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~ 79 (283)
T d1mqba_ 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 79 (283)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CcCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe
Confidence 3567789999999999999999999987655 479999997542 3455667889999999999999999999999
Q ss_pred cCCeEEEEEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 177 DAEYLYLIMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 177 ~~~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
+.+.+|+|||||.+|++..++... ..+++..+..++.|++.||+|||++|||||||||+||||+.+|++||+|||+|+.
T Consensus 80 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 80 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred cCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 999999999999999999987654 6799999999999999999999999999999999999999999999999999986
Q ss_pred CCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcc
Q 010266 256 LDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGME 335 (514)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~ 335 (514)
....... ........||+.|||||++.+..|+.+
T Consensus 160 ~~~~~~~----------------------------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~ 193 (283)
T d1mqba_ 160 LEDDPEA----------------------------------------------TYTTSGGKIPIRWTAPEAISYRKFTSA 193 (283)
T ss_dssp ------------------------------------------------------------CCCGGGSCHHHHHSCCCCHH
T ss_pred ccCCCcc----------------------------------------------ceEeccCCCCccccCHHHHccCCCCCc
Confidence 5422100 001124579999999999999999999
Q ss_pred cchhhhhHHHHHHhhC-CCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 336 CDWWSLGAIMYEMLVG-YPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 336 ~DiWSlGvilyemltG-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
+|||||||++|||++| .+||.+.+..+....+... ..+..| ..+++++++||.+||. ||.+|| ++.||++
T Consensus 194 sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~l~~li~~cl~~~p~~RP---t~~eil~ 265 (283)
T d1mqba_ 194 SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLPTP--MDCPSAIYQLMMQCWQQERARRP---KFADIVS 265 (283)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCC--TTCBHHHHHHHHHHTCSSTTTSC---CHHHHHH
T ss_pred ccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc-CCCCCc--hhhHHHHHHHHHHHCcCCHhHCc---CHHHHHH
Confidence 9999999999999995 5556666666676666542 233333 4689999999999998 999999 8999876
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=414.41 Aligned_cols=257 Identities=22% Similarity=0.335 Sum_probs=209.0
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEcc-CCC--EEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEcCC
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKK-SGN--IYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQDAE 179 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~-t~~--~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~~~ 179 (514)
+..+||++++.||+|+||+||+|+... +++ .||||++++.........+.+.+|+.+|+.++|||||+++++|.+ .
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 345789999999999999999998653 333 689999988766666667889999999999999999999999976 5
Q ss_pred eEEEEEeecCCCCHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMR-EETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDC 258 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~ 258 (514)
.+|+||||+++|++.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 78999999999999988765 45799999999999999999999999999999999999999999999999999987643
Q ss_pred CCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccch
Q 010266 259 TNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDW 338 (514)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 338 (514)
.... .......+||+.|+|||++.+..|+.++||
T Consensus 164 ~~~~----------------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 197 (273)
T d1u46a_ 164 NDDH----------------------------------------------YVMQEHRKVPFAWCAPESLKTRTFSHASDT 197 (273)
T ss_dssp -CCE----------------------------------------------EEC-----CCGGGCCHHHHHHCEEEHHHHH
T ss_pred CCCc----------------------------------------------ceecCccccCcccCCHHHHhCCCCCcchhh
Confidence 2111 011224568889999999999999999999
Q ss_pred hhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhc
Q 010266 339 WSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 339 WSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|||||++|||++ |.+||.+.+..+...++......+..| ..+|+++++||.+||. ||.+|+ |++||.+
T Consensus 198 ~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~RP---t~~ei~~ 267 (273)
T d1u46a_ 198 WMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP--EDCPQDIYNVMVQCWAHKPEDRP---TFVALRD 267 (273)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred hhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCc--ccccHHHHHHHHHHcCCChhHCc---CHHHHHH
Confidence 999999999998 899999999999999988754433333 4789999999999999 999999 9999863
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-52 Score=418.13 Aligned_cols=257 Identities=22% Similarity=0.312 Sum_probs=220.1
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEc-----cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEE
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYS 174 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 174 (514)
..++..++|++++.||+|+||+||+|+.+ .+++.||||++++.. .....+.+.+|..+|+.++||||++++++
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 34566789999999999999999999976 356789999987543 44556789999999999999999999999
Q ss_pred EEcCCeEEEEEeecCCCCHHHHHhhcc------------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEc
Q 010266 175 FQDAEYLYLIMEYLPGGDVMTLLMREE------------------------TLTETVARFYIAQSVLAIESIHKHNYIHR 230 (514)
Q Consensus 175 f~~~~~l~lVmEy~~gg~L~~~l~~~~------------------------~l~e~~~~~~~~qi~~aL~~LH~~giiHr 230 (514)
+.+.+.+++||||+++|+|.+++.... .+++..+..++.|++.||+|||++|||||
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHr 164 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 164 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEee
Confidence 999999999999999999999996532 38889999999999999999999999999
Q ss_pred CCCCCCccccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccc
Q 010266 231 DIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRK 310 (514)
Q Consensus 231 DLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (514)
||||+|||||.++++||+|||+|+...... ...
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~-----------------------------------------------~~~ 197 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSAD-----------------------------------------------YYK 197 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGG-----------------------------------------------CBC
T ss_pred EEcccceEECCCCcEEEccchhheeccCCc-----------------------------------------------ccc
Confidence 999999999999999999999997543211 011
Q ss_pred cccccccCCCcCCccccccCCCCcccchhhhhHHHHHHhhC-CCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHH
Q 010266 311 LAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG-YPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDL 389 (514)
Q Consensus 311 ~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemltG-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dL 389 (514)
...+.+||+.|+|||++.+..|+.++|||||||++|||++| .+||.+.+..+....+.... ....| ..+++++.+|
T Consensus 198 ~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~-~~~~p--~~~~~~~~~l 274 (301)
T d1lufa_ 198 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-ILACP--ENCPLELYNL 274 (301)
T ss_dssp ----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHHH
T ss_pred ccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCC-CCCCC--ccchHHHHHH
Confidence 12356899999999999999999999999999999999998 47899999999888887643 23344 3689999999
Q ss_pred Hhhhcc-CccccCCCCCHhHHhc
Q 010266 390 ICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 390 I~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
|.+||+ ||.+|| |+.||.+
T Consensus 275 i~~cl~~~P~~RP---t~~ev~~ 294 (301)
T d1lufa_ 275 MRLCWSKLPADRP---SFCSIHR 294 (301)
T ss_dssp HHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHcCCChhHCc---CHHHHHH
Confidence 999999 999999 9999854
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-52 Score=418.30 Aligned_cols=252 Identities=24% Similarity=0.373 Sum_probs=214.8
Q ss_pred CCCCCeeEEeeeeecCceEEEEEEEccCCCE--EEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEEEEcCC
Q 010266 103 ISVDDFDLLTIIGRGAFGEVRLCQEKKSGNI--YAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYSFQDAE 179 (514)
Q Consensus 103 ~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~--~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~~~~ 179 (514)
+..++|++.++||+|+||+||+|+++.+|.. ||||.+++. ......+.+.+|..+|..+ +|||||+++++|.+.+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 5668999999999999999999999988875 566766533 2344566789999999998 7999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHhhc----------------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMRE----------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNG 243 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g 243 (514)
.+|+||||++||+|.++|... ..+++..+..++.||+.||.|||++|||||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999999654 5789999999999999999999999999999999999999999
Q ss_pred cEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCC
Q 010266 244 HMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIA 323 (514)
Q Consensus 244 ~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~A 323 (514)
.+||+|||+|+...... .....+||+.|+|
T Consensus 165 ~~kl~DfG~a~~~~~~~--------------------------------------------------~~~~~~gt~~y~a 194 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYV--------------------------------------------------KKTMGRLPVRWMA 194 (309)
T ss_dssp CEEECCTTCEESSCEEC--------------------------------------------------CC----CCTTTCC
T ss_pred ceEEccccccccccccc--------------------------------------------------cccceecCCcccc
Confidence 99999999997543210 1124579999999
Q ss_pred ccccccCCCCcccchhhhhHHHHHHhhC-CCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccC
Q 010266 324 PEVLLKKGYGMECDWWSLGAIMYEMLVG-YPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRL 401 (514)
Q Consensus 324 PEvl~~~~y~~~~DiWSlGvilyemltG-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl 401 (514)
||++.+..|+.++|||||||++|||++| .+||.+.+..+....|..+. .+..| ..+++++++||.+||. ||++|+
T Consensus 195 PE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~~~~li~~cl~~dP~~RP 271 (309)
T d1fvra_ 195 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RLEKP--LNCDDEVYDLMRQCWREKPYERP 271 (309)
T ss_dssp HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC-CCCCC--TTBCHHHHHHHHHHTCSSGGGSC
T ss_pred hHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-CCCCC--ccCCHHHHHHHHHHcCCChhHCc
Confidence 9999999999999999999999999996 56898989888888887642 33444 4789999999999999 999999
Q ss_pred CCCCHhHHhcC
Q 010266 402 GTLGSEQIKAH 412 (514)
Q Consensus 402 ~~~~~~eil~H 412 (514)
+++||++|
T Consensus 272 ---s~~eil~~ 279 (309)
T d1fvra_ 272 ---SFAQILVS 279 (309)
T ss_dssp ---CHHHHHHH
T ss_pred ---CHHHHHHH
Confidence 99999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-52 Score=407.08 Aligned_cols=247 Identities=23% Similarity=0.412 Sum_probs=208.7
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEE-cCC
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQ-DAE 179 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~-~~~ 179 (514)
+.+..++|++++.||+|+||.||+|+.+ |+.||||+++++. ..+.+.+|+.+|+.++|||||++++++. +.+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 3567889999999999999999999874 7789999997643 3456889999999999999999999885 456
Q ss_pred eEEEEEeecCCCCHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCC
Q 010266 180 YLYLIMEYLPGGDVMTLLMRE--ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLD 257 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~ 257 (514)
.+|+||||+++|+|.++|.+. ..+++..++.++.||+.||.|||+.+||||||||+|||++.+|++||+|||+++...
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence 789999999999999999664 358999999999999999999999999999999999999999999999999987543
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
.. .....||+.|+|||++.+..|+.++|
T Consensus 155 ~~----------------------------------------------------~~~~~~~~~y~aPE~l~~~~~t~~sD 182 (262)
T d1byga_ 155 ST----------------------------------------------------QDTGKLPVKWTAPEALREKKFSTKSD 182 (262)
T ss_dssp -----------------------------------------------------------CCTTTSCHHHHHHCCCCHHHH
T ss_pred CC----------------------------------------------------CccccccccCCChHHHhCCCCChHHH
Confidence 21 11457899999999999999999999
Q ss_pred hhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 338 WWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 338 iWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
||||||++|||++ |.+||.+.+..+....|.+. ..+.+|. .+++++++||.+||. ||.+|+ ++.+|++|
T Consensus 183 IwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~-~~~~~~~--~~~~~~~~li~~cl~~dP~~Rp---s~~~l~~~ 253 (262)
T d1byga_ 183 VWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPD--GCPPAVYEVMKNCWHLDAAMRP---SFLQLREQ 253 (262)
T ss_dssp HHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-CCCCCCT--TCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCCc--cCCHHHHHHHHHHcccCHhHCc---CHHHHHHH
Confidence 9999999999998 79999999888888888753 2344554 689999999999999 999999 99988763
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=411.25 Aligned_cols=257 Identities=23% Similarity=0.348 Sum_probs=216.2
Q ss_pred cCCCCCCCeeEEeeeeecCceEEEEEEEccCC-------CEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeE
Q 010266 100 RHKISVDDFDLLTIIGRGAFGEVRLCQEKKSG-------NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKL 171 (514)
Q Consensus 100 ~~~~~~~~f~~~~~LG~G~fG~V~l~~~~~t~-------~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l 171 (514)
+..+..++|++++.||+|+||.||+|+...++ ..||||++++.. .......+.+|..++..+ +|||||++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~ 84 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINL 84 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEec
Confidence 35577799999999999999999999987654 379999997653 445567788899999888 79999999
Q ss_pred EEEEEcCCeEEEEEeecCCCCHHHHHhhc----------------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCC
Q 010266 172 YYSFQDAEYLYLIMEYLPGGDVMTLLMRE----------------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPD 235 (514)
Q Consensus 172 ~~~f~~~~~l~lVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpe 235 (514)
+++|.++..+|+|||||.||+|.++|... ..+++..+..++.||+.||+|||+.|||||||||+
T Consensus 85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence 99999999999999999999999999654 35899999999999999999999999999999999
Q ss_pred CccccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhcccccccc
Q 010266 236 NLLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYST 315 (514)
Q Consensus 236 NILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 315 (514)
|||++.+|.+||+|||+++....... .......
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~-----------------------------------------------~~~~~~~ 197 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDY-----------------------------------------------YKKTTNG 197 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCT-----------------------------------------------TCCCTTS
T ss_pred ceeecCCCCeEeccchhhcccccccc-----------------------------------------------ccccccC
Confidence 99999999999999999986542210 0112256
Q ss_pred ccCCCcCCccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhc
Q 010266 316 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLL 394 (514)
Q Consensus 316 ~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL 394 (514)
+||+.|+|||++.++.|+.++|||||||++|||++ |.+||.+.+..+.+..+.+. ..+.+| ..+|+++++||.+||
T Consensus 198 ~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~-~~~~~p--~~~~~~l~~li~~cl 274 (299)
T d1fgka_ 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG-HRMDKP--SNCTNELYMMMRDCW 274 (299)
T ss_dssp CCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCCCCC--SSCCHHHHHHHHHHT
T ss_pred CCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcC-CCCCCC--ccchHHHHHHHHHHc
Confidence 89999999999999999999999999999999998 79999988888887777653 344455 478999999999999
Q ss_pred c-CccccCCCCCHhHHhc
Q 010266 395 C-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 395 ~-dp~~Rl~~~~~~eil~ 411 (514)
. ||.+|+ |+.||++
T Consensus 275 ~~dP~~Rp---s~~eil~ 289 (299)
T d1fgka_ 275 HAVPSQRP---TFKQLVE 289 (299)
T ss_dssp CSSGGGSC---CHHHHHH
T ss_pred cCCHhHCc---CHHHHHH
Confidence 9 999999 9999976
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-51 Score=412.13 Aligned_cols=257 Identities=23% Similarity=0.299 Sum_probs=222.1
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEc-----cCCCEEEEEEeecccccChhhHHHHHHHHHHHHHc-CCCceeeEEEE
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEK-----KSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEV-ASHCIVKLYYS 174 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 174 (514)
+.+..++|++.++||+|+||.||+|+.+ .+++.||||++++.. .......+.+|..+++.+ +|||||+++++
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 4567789999999999999999999864 466789999998653 345566789999999999 69999999999
Q ss_pred EEcCCeEEEEEeecCCCCHHHHHhhcc------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCC
Q 010266 175 FQDAEYLYLIMEYLPGGDVMTLLMREE------------------TLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDN 236 (514)
Q Consensus 175 f~~~~~l~lVmEy~~gg~L~~~l~~~~------------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeN 236 (514)
+.+...+|+|||||+||+|..++.... .+++..+..++.||+.||.|||++|||||||||+|
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N 175 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence 999999999999999999999997543 58999999999999999999999999999999999
Q ss_pred ccccCCCcEEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccc
Q 010266 237 LLLDQNGHMKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTV 316 (514)
Q Consensus 237 ILld~~g~iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 316 (514)
||++.++++||+|||+++........ ......+
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~-----------------------------------------------~~~~~~~ 208 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNY-----------------------------------------------VVKGNAR 208 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTS-----------------------------------------------EECSSSE
T ss_pred ccccccCcccccccchheeccCCCcc-----------------------------------------------eEeeecc
Confidence 99999999999999999865432110 0122568
Q ss_pred cCCCcCCccccccCCCCcccchhhhhHHHHHHhh-CCCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc
Q 010266 317 GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC 395 (514)
Q Consensus 317 GT~~Y~APEvl~~~~y~~~~DiWSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~ 395 (514)
||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..+.+.+++.....+..|. .+|+++.+||.+||.
T Consensus 209 gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~l~~Li~~cl~ 286 (311)
T d1t46a_ 209 LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPE--HAPAEMYDIMKTCWD 286 (311)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCT--TSCHHHHHHHHHHTC
T ss_pred cChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcc--cccHHHHHHHHHHcC
Confidence 9999999999999999999999999999999998 7777878777777777777555455553 689999999999999
Q ss_pred -CccccCCCCCHhHHhc
Q 010266 396 -DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 396 -dp~~Rl~~~~~~eil~ 411 (514)
||.+|+ +++||++
T Consensus 287 ~dP~~RP---s~~~il~ 300 (311)
T d1t46a_ 287 ADPLKRP---TFKQIVQ 300 (311)
T ss_dssp SSGGGSC---CHHHHHH
T ss_pred CChhHCc---CHHHHHH
Confidence 999999 9999885
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=411.72 Aligned_cols=264 Identities=17% Similarity=0.269 Sum_probs=226.0
Q ss_pred CCCCCCCeeEEeeeeecCceEEEEEEEcc-----CCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEE
Q 010266 101 HKISVDDFDLLTIIGRGAFGEVRLCQEKK-----SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSF 175 (514)
Q Consensus 101 ~~~~~~~f~~~~~LG~G~fG~V~l~~~~~-----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 175 (514)
+.+..++|++.+.||+|+||+||+|.++. ++..||||++++.. .......+.+|+.+++.++|||||++++++
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 45777999999999999999999998763 35789999997643 445566789999999999999999999999
Q ss_pred EcCCeEEEEEeecCCCCHHHHHhhc----------cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcE
Q 010266 176 QDAEYLYLIMEYLPGGDVMTLLMRE----------ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHM 245 (514)
Q Consensus 176 ~~~~~l~lVmEy~~gg~L~~~l~~~----------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~i 245 (514)
.....+++|||||++|+|.+++... ..++...+..++.|++.||.|||+++||||||||+||||+.++++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence 9999999999999999999998643 246888899999999999999999999999999999999999999
Q ss_pred EEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCcc
Q 010266 246 KLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPE 325 (514)
Q Consensus 246 KL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APE 325 (514)
||+|||+|+....... .......+||+.|+|||
T Consensus 173 Kl~DFGla~~~~~~~~-----------------------------------------------~~~~~~~~~t~~y~aPe 205 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDY-----------------------------------------------YRKGGKGLLPVRWMSPE 205 (308)
T ss_dssp EECCTTCCCGGGGGGC-----------------------------------------------EEGGGSSEECGGGCCHH
T ss_pred EEeecccceeccCCcc-----------------------------------------------eeeccceecccccCCHH
Confidence 9999999986532110 01122457999999999
Q ss_pred ccccCCCCcccchhhhhHHHHHHhhC-CCCCCCCChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCC
Q 010266 326 VLLKKGYGMECDWWSLGAIMYEMLVG-YPPFYSDDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGT 403 (514)
Q Consensus 326 vl~~~~y~~~~DiWSlGvilyemltG-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~ 403 (514)
++.+..|+.++|||||||++|||+|| .+||.+.+..+.+..+.... .+..| ..+++++.+||.+||. +|.+|+
T Consensus 206 ~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~-~~~~p--~~~~~~l~~li~~cl~~~P~~RP-- 280 (308)
T d1p4oa_ 206 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-LLDKP--DNCPDMLFELMRMCWQYNPKMRP-- 280 (308)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC--
T ss_pred HHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC-CCCCc--ccchHHHHHHHHHHcCCChhHCc--
Confidence 99999999999999999999999998 58999999999988887643 23334 3789999999999999 999999
Q ss_pred CCHhHHhc------CCccccCC
Q 010266 404 LGSEQIKA------HPWFKDIA 419 (514)
Q Consensus 404 ~~~~eil~------Hpff~~i~ 419 (514)
|+++|++ +|+|+.++
T Consensus 281 -s~~~il~~L~~~~~~~~~~~~ 301 (308)
T d1p4oa_ 281 -SFLEIISSIKEEMEPGFREVS 301 (308)
T ss_dssp -CHHHHHHHHGGGSCTTHHHHC
T ss_pred -CHHHHHHHHHHhcCCCCcCCC
Confidence 9999987 77776544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.1e-50 Score=399.48 Aligned_cols=263 Identities=20% Similarity=0.257 Sum_probs=201.9
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCc-eeeEEEEEEcCCeEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC-IVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~-Iv~l~~~f~~~~~l~lV 184 (514)
++|++++.||+|+||+||+|+++.+|+.||||++...... ..+..|.++++.++|++ |+.+++++.+.+..|+|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 5699999999999999999999999999999998765321 23678999999997665 55666777889999999
Q ss_pred EeecCCCCHHHHH-hhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCcccc---CCCcEEEccccccccCCCCC
Q 010266 185 MEYLPGGDVMTLL-MREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLD---QNGHMKLSDFGLCKPLDCTN 260 (514)
Q Consensus 185 mEy~~gg~L~~~l-~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld---~~g~iKL~DFGla~~~~~~~ 260 (514)
|||+. |+|...+ ...+.+++..+..++.|++.||+|||++|||||||||+|||++ .++.+||+|||+|+.+....
T Consensus 82 me~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 82 MELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 99995 4555554 4467899999999999999999999999999999999999875 45679999999998764321
Q ss_pred ccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhh
Q 010266 261 LSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 340 (514)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 340 (514)
..... ......+.+||+.|||||++.+.+|+.++||||
T Consensus 161 ~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 198 (299)
T d1ckia_ 161 THQHI------------------------------------------PYRENKNLTGTARYASINTHLGIEQSRRDDLES 198 (299)
T ss_dssp TCCBC------------------------------------------CCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHH
T ss_pred cccce------------------------------------------eccccCCcCCCccccCHHHHhCCCCCChhhEEe
Confidence 11000 001123678999999999999999999999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhHHHHHHhhhcC-cccCCc---CcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCcc
Q 010266 341 LGAIMYEMLVGYPPFYSDDPVTTCRKIVHWKN-HLKFPE---EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWF 415 (514)
Q Consensus 341 lGvilyemltG~~PF~~~~~~~~~~~i~~~~~-~~~~p~---~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff 415 (514)
|||++|||++|.+||.+.........+..... ....|. ...+|+++.+||.+||. +|.+||....+.++++|+|.
T Consensus 199 lG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 199 LGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred cCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 99999999999999987665544443322111 111221 13688999999999998 99999922223456778876
Q ss_pred c
Q 010266 416 K 416 (514)
Q Consensus 416 ~ 416 (514)
+
T Consensus 279 ~ 279 (299)
T d1ckia_ 279 R 279 (299)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2e-48 Score=387.67 Aligned_cols=255 Identities=20% Similarity=0.216 Sum_probs=205.7
Q ss_pred CCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCC-CceeeEEEEEEcCCeEEE
Q 010266 105 VDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS-HCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 105 ~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~f~~~~~l~l 183 (514)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+++|.+++..+.| ++|+.+++++.+....|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 4689999999999999999999999999999999876432 1236778899999875 899999999999999999
Q ss_pred EEeecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccC-----CCcEEEccccccccCC
Q 010266 184 IMEYLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQ-----NGHMKLSDFGLCKPLD 257 (514)
Q Consensus 184 VmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~-----~g~iKL~DFGla~~~~ 257 (514)
||||+ ||+|.+++... ..+++..+..++.|++.||+|||++|||||||||+|||++. ++++||+|||+|+...
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999 78999988765 47999999999999999999999999999999999999974 6889999999998764
Q ss_pred CCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccc
Q 010266 258 CTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECD 337 (514)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 337 (514)
........ ......+.+|||.|||||++.+..|+.++|
T Consensus 158 ~~~~~~~~------------------------------------------~~~~~~~~~GT~~y~aPE~~~~~~~~~~~D 195 (293)
T d1csna_ 158 DPVTKQHI------------------------------------------PYREKKNLSGTARYMSINTHLGREQSRRDD 195 (293)
T ss_dssp CTTTCCBC------------------------------------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHH
T ss_pred cCccccce------------------------------------------eecccCceEEchhhcCHHHhcCCCCChHHH
Confidence 32110000 001123678999999999999999999999
Q ss_pred hhhhhHHHHHHhhCCCCCCCCCh---hHHHHHHhhhcCcccCCc-CcCCChhHHHHHhhhcc-CccccCCCCCHhHHh
Q 010266 338 WWSLGAIMYEMLVGYPPFYSDDP---VTTCRKIVHWKNHLKFPE-EARLTPEAKDLICRLLC-DVEHRLGTLGSEQIK 410 (514)
Q Consensus 338 iWSlGvilyemltG~~PF~~~~~---~~~~~~i~~~~~~~~~p~-~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 410 (514)
||||||++|||++|.+||.+.+. .....++.........+. ...+++++.+++..|+. +|.+|| +.+.+.
T Consensus 196 iwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP---~y~~l~ 270 (293)
T d1csna_ 196 LEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATP---DYDYLQ 270 (293)
T ss_dssp HHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCC---CHHHHH
T ss_pred HHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCc---CHHHHH
Confidence 99999999999999999986543 333444443222111111 13578999999999998 999998 555443
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=392.62 Aligned_cols=249 Identities=18% Similarity=0.281 Sum_probs=203.6
Q ss_pred EeeeeecCceEEEEEEEccCC---CEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCceeeEEEEEEc-CCeEEEEEe
Q 010266 111 LTIIGRGAFGEVRLCQEKKSG---NIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHCIVKLYYSFQD-AEYLYLIME 186 (514)
Q Consensus 111 ~~~LG~G~fG~V~l~~~~~t~---~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~~-~~~l~lVmE 186 (514)
-++||+|+||+||+|+...++ ..||||++++. ......+.+.+|+++|++++|||||++++++.+ +..+|+|||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 578999999999999986643 36999999753 356677889999999999999999999998764 568999999
Q ss_pred ecCCCCHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccccccCCCCCccccc
Q 010266 187 YLPGGDVMTLLMRE-ETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGLCKPLDCTNLSAIN 265 (514)
Q Consensus 187 y~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGla~~~~~~~~~~~~ 265 (514)
||++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||||++++++||+|||+++.........
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~-- 187 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS-- 187 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC--
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc--
Confidence 99999999988754 457778888999999999999999999999999999999999999999999998764321110
Q ss_pred cccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCCCCcccchhhhhHHH
Q 010266 266 ENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 345 (514)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 345 (514)
........||+.|+|||++.+..|+.++|||||||++
T Consensus 188 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl 224 (311)
T d1r0pa_ 188 -------------------------------------------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 224 (311)
T ss_dssp -------------------------------------------TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred -------------------------------------------ceecccccccccccChHHHhcCCCCChhHhhhhHHHH
Confidence 0011245799999999999999999999999999999
Q ss_pred HHHhhCCCCCCC-CChhHHHHHHhhhcCcccCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcC
Q 010266 346 YEMLVGYPPFYS-DDPVTTCRKIVHWKNHLKFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAH 412 (514)
Q Consensus 346 yemltG~~PF~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 412 (514)
|||++|..||.. .+..+....+.... .+..| ..+++++.+||.+||. ||.+|+ ++.||++|
T Consensus 225 ~El~t~~~p~~~~~~~~~~~~~i~~g~-~~~~p--~~~~~~l~~li~~cl~~dP~~RP---s~~ei~~~ 287 (311)
T d1r0pa_ 225 WELMTRGAPPYPDVNTFDITVYLLQGR-RLLQP--EYCPDPLYEVMLKCWHPKAEMRP---SFSELVSR 287 (311)
T ss_dssp HHHHTTSCCSCC------CHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHcCC-CCCCc--ccCcHHHHHHHHHHcCCCHhHCc---CHHHHHHH
Confidence 999997777654 34445556665532 33344 3688999999999999 999999 99999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3e-47 Score=389.36 Aligned_cols=273 Identities=24% Similarity=0.381 Sum_probs=207.3
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-----------CCceeeEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-----------SHCIVKLYYS 174 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-----------hp~Iv~l~~~ 174 (514)
++|+++++||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.+|+.++ |||||+++.+
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 46999999999999999999999999999999998653 23345677888887765 5789999888
Q ss_pred EE--cCCeEEEEEeecCCCCHHHHH---hhccCCCHHHHHHHHHHHHHHHHHHHh-CCeEEcCCCCCCccccCCCc----
Q 010266 175 FQ--DAEYLYLIMEYLPGGDVMTLL---MREETLTETVARFYIAQSVLAIESIHK-HNYIHRDIKPDNLLLDQNGH---- 244 (514)
Q Consensus 175 f~--~~~~l~lVmEy~~gg~L~~~l---~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKpeNILld~~g~---- 244 (514)
+. .....++||+++.++...... .....+++..++.++.||+.||+|||+ .||+||||||+||||+.+|.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 75 456788888887665443332 234688999999999999999999997 89999999999999987764
Q ss_pred --EEEccccccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcC
Q 010266 245 --MKLSDFGLCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYI 322 (514)
Q Consensus 245 --iKL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~ 322 (514)
+||+|||.|...... ..+.+||+.|+
T Consensus 169 ~~~kl~dfg~s~~~~~~----------------------------------------------------~~~~~gt~~y~ 196 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH----------------------------------------------------YTNSIQTREYR 196 (362)
T ss_dssp EEEEECCCTTCEETTBC----------------------------------------------------CCSCCSCGGGC
T ss_pred ceeeEeecccccccccc----------------------------------------------------ccccccccccc
Confidence 999999998754311 12568999999
Q ss_pred CccccccCCCCcccchhhhhHHHHHHhhCCCCCCCCChh------HHHHHHhhhcC------------------------
Q 010266 323 APEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPV------TTCRKIVHWKN------------------------ 372 (514)
Q Consensus 323 APEvl~~~~y~~~~DiWSlGvilyemltG~~PF~~~~~~------~~~~~i~~~~~------------------------ 372 (514)
|||++.+.+|+.++|+|||||++++|++|++||...+.. .....++..-.
T Consensus 197 aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~ 276 (362)
T d1q8ya_ 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLR 276 (362)
T ss_dssp CHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBS
T ss_pred ChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhh
Confidence 999999999999999999999999999999999754321 11111110000
Q ss_pred ---cc-----------cCCcCcCCChhHHHHHhhhcc-CccccCCCCCHhHHhcCCccccCCccccccccCCCCCcCCCC
Q 010266 373 ---HL-----------KFPEEARLTPEAKDLICRLLC-DVEHRLGTLGSEQIKAHPWFKDIAWDKLYEMEAAYKPEVNGV 437 (514)
Q Consensus 373 ---~~-----------~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpff~~i~w~~l~~~~~p~~p~~~~~ 437 (514)
.. ........+++++|||.+||+ ||.+|+ |++|+++||||+++.+ ..++..|..|...+.
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp---ta~e~L~Hp~f~~~~~--~~~~~~p~~~~~~~~ 351 (362)
T d1q8ya_ 277 NISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA---DAGGLVNHPWLKDTLG--MEEIRVPDRELYGSG 351 (362)
T ss_dssp SCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB---CHHHHHTCGGGTTCTT--CTTCCCTTSCTTCBS
T ss_pred ccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc---CHHHHhcCcccCCCCC--cccCCCCCcccCCCC
Confidence 00 000011346889999999999 999999 9999999999996653 334556666665544
Q ss_pred CC
Q 010266 438 LD 439 (514)
Q Consensus 438 ~d 439 (514)
.|
T Consensus 352 ~~ 353 (362)
T d1q8ya_ 352 SD 353 (362)
T ss_dssp TT
T ss_pred CC
Confidence 44
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=381.64 Aligned_cols=249 Identities=21% Similarity=0.250 Sum_probs=190.4
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHH--HHcCCCceeeEEEEEEcCC----
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLL--AEVASHCIVKLYYSFQDAE---- 179 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL--~~l~hp~Iv~l~~~f~~~~---- 179 (514)
.+|.+.+.||+|+||.||+|+. +|+.||||+++... ......|++++ ..++|||||++++++.+.+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc------hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 4788999999999999999975 68899999986432 23344455555 5678999999999997653
Q ss_pred eEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh--------CCeEEcCCCCCCccccCCCcEEEcccc
Q 010266 180 YLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHK--------HNYIHRDIKPDNLLLDQNGHMKLSDFG 251 (514)
Q Consensus 180 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~--------~giiHrDLKpeNILld~~g~iKL~DFG 251 (514)
.+|+|||||++|+|..+|.+ ..++......++.|++.||.|||+ +|||||||||+||||+.+|++||+|||
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 68999999999999999965 468899999999999999999996 599999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccCCCCCCCCCCCCCCCCCCchHHHHHHhhhccccccccccCCCcCCccccccCC
Q 010266 252 LCKPLDCTNLSAINENEVLDDENLNESMDVDGRFPESGCGRRWKSPLEQLQHWQINRRKLAYSTVGTPDYIAPEVLLKKG 331 (514)
Q Consensus 252 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~GT~~Y~APEvl~~~~ 331 (514)
+|+......... .......+||+.|||||++.+..
T Consensus 154 l~~~~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~ 188 (303)
T d1vjya_ 154 LAVRHDSATDTI---------------------------------------------DIAPNHRVGTKRYMAPEVLDDSI 188 (303)
T ss_dssp TCEEEETTTTEE---------------------------------------------CC----CCSCGGGCCHHHHTTCS
T ss_pred ccccccCCCcce---------------------------------------------eccccceecccCcCChhhccccc
Confidence 998654321100 00122568999999999987642
Q ss_pred ------CCcccchhhhhHHHHHHhhCCCCCCCCC---------------hhHHHHHHhhhcCcccCCcCc---CCChhHH
Q 010266 332 ------YGMECDWWSLGAIMYEMLVGYPPFYSDD---------------PVTTCRKIVHWKNHLKFPEEA---RLTPEAK 387 (514)
Q Consensus 332 ------y~~~~DiWSlGvilyemltG~~PF~~~~---------------~~~~~~~i~~~~~~~~~p~~~---~~s~~~~ 387 (514)
++.++|||||||+||||+||.+||.... .......+........+|... .....+.
T Consensus 189 ~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~ 268 (303)
T d1vjya_ 189 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMA 268 (303)
T ss_dssp CTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHH
T ss_pred cccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHH
Confidence 6789999999999999999998874321 112222222211122233211 1224588
Q ss_pred HHHhhhcc-CccccCCCCCHhHHhc
Q 010266 388 DLICRLLC-DVEHRLGTLGSEQIKA 411 (514)
Q Consensus 388 dLI~~lL~-dp~~Rl~~~~~~eil~ 411 (514)
+|+.+||. ||.+|+ |+.||++
T Consensus 269 ~li~~cl~~dp~~Rp---s~~ei~~ 290 (303)
T d1vjya_ 269 KIMRECWYANGAARL---TALRIKK 290 (303)
T ss_dssp HHHHTTCCSSGGGSC---CHHHHHH
T ss_pred HHHHHHcccCHhHCc---CHHHHHH
Confidence 99999999 999999 9999876
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=1e-26 Score=215.37 Aligned_cols=137 Identities=14% Similarity=0.140 Sum_probs=107.6
Q ss_pred eeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccC---------------hhhHHHHHHHHHHHHHcCCCceeeEE
Q 010266 108 FDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLS---------------RGQVEHVRAERNLLAEVASHCIVKLY 172 (514)
Q Consensus 108 f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~---------------~~~~~~~~~E~~iL~~l~hp~Iv~l~ 172 (514)
+.+.+.||+|+||+||+|++. +|+.||||+++...... .........|...|..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 357889999999999999874 78999999876432110 01123445688889999999999988
Q ss_pred EEEEcCCeEEEEEeecCCCCHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeEEcCCCCCCccccCCCcEEEccccc
Q 010266 173 YSFQDAEYLYLIMEYLPGGDVMTLLMREETLTETVARFYIAQSVLAIESIHKHNYIHRDIKPDNLLLDQNGHMKLSDFGL 252 (514)
Q Consensus 173 ~~f~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKpeNILld~~g~iKL~DFGl 252 (514)
++.. .++||||++++.+. .+++..+..++.|++.||.|||++||+||||||+|||++.+ .++|+|||+
T Consensus 81 ~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred EecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 6532 37999999886543 24566677899999999999999999999999999999865 589999999
Q ss_pred cccCC
Q 010266 253 CKPLD 257 (514)
Q Consensus 253 a~~~~ 257 (514)
|....
T Consensus 149 a~~~~ 153 (191)
T d1zara2 149 SVEVG 153 (191)
T ss_dssp CEETT
T ss_pred cccCC
Confidence 87643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.56 E-value=3.3e-07 Score=86.15 Aligned_cols=86 Identities=9% Similarity=-0.029 Sum_probs=62.1
Q ss_pred CCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEEEcCCeEEEE
Q 010266 106 DDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSFQDAEYLYLI 184 (514)
Q Consensus 106 ~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~~~~~l~lV 184 (514)
..|++++..+.|+.+.||.+. ..++.+.+|+....... ....+.+|..+|..+. +--+++++++..+++..|+|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~---~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc---chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 467777776666678999874 45667888987654322 2234677888888774 33467888888888999999
Q ss_pred EeecCCCCHHHH
Q 010266 185 MEYLPGGDVMTL 196 (514)
Q Consensus 185 mEy~~gg~L~~~ 196 (514)
|++++|..+...
T Consensus 89 ~~~l~G~~~~~~ 100 (263)
T d1j7la_ 89 MSEADGVLCSEE 100 (263)
T ss_dssp EECCSSEEHHHH
T ss_pred EEeccccccccc
Confidence 999999877544
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.21 E-value=1.7e-06 Score=86.77 Aligned_cols=80 Identities=20% Similarity=0.259 Sum_probs=50.5
Q ss_pred EeeeeecCceEEEEEEEccCCCEEEEEEeeccccc-C---hhhHHHHHHHHHHHHHcC--C-CceeeEEEEEEcCCeEEE
Q 010266 111 LTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEML-S---RGQVEHVRAERNLLAEVA--S-HCIVKLYYSFQDAEYLYL 183 (514)
Q Consensus 111 ~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~-~---~~~~~~~~~E~~iL~~l~--h-p~Iv~l~~~f~~~~~l~l 183 (514)
.+.||.|....||.+....+++.|++|.-...... . .....+...|..+|..+. - ..+++++++ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 56799999999999987777888999965432111 1 112344667888887663 2 346666654 3455678
Q ss_pred EEeecCCCC
Q 010266 184 IMEYLPGGD 192 (514)
Q Consensus 184 VmEy~~gg~ 192 (514)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.99 E-value=1.8e-05 Score=73.39 Aligned_cols=136 Identities=13% Similarity=0.102 Sum_probs=82.6
Q ss_pred eeeecC-ceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCC--CceeeEEEEEEcCCeEEEEEeecC
Q 010266 113 IIGRGA-FGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVAS--HCIVKLYYSFQDAEYLYLIMEYLP 189 (514)
Q Consensus 113 ~LG~G~-fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~f~~~~~l~lVmEy~~ 189 (514)
.+..|. -+.||.+.. ..+..+.+|.-.... ...+..|..+|+.+.. -.+++++....+.+..++||++++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 344454 368998764 456678889765432 1236678888876642 236778888888889999999999
Q ss_pred CCCHHHH--------------Hhhcc-------CCCHHHH-------HHHH---------------HHHHHHHHHHHh--
Q 010266 190 GGDVMTL--------------LMREE-------TLTETVA-------RFYI---------------AQSVLAIESIHK-- 224 (514)
Q Consensus 190 gg~L~~~--------------l~~~~-------~l~e~~~-------~~~~---------------~qi~~aL~~LH~-- 224 (514)
|-++... +.+-. .+..... ..+. ......+..+..
T Consensus 90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (255)
T d1nd4a_ 90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM 169 (255)
T ss_dssp SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred ccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhC
Confidence 8654321 11100 0000000 0000 001112233332
Q ss_pred -----CCeEEcCCCCCCccccCCCcEEEcccccccc
Q 010266 225 -----HNYIHRDIKPDNLLLDQNGHMKLSDFGLCKP 255 (514)
Q Consensus 225 -----~giiHrDLKpeNILld~~g~iKL~DFGla~~ 255 (514)
..++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 2489999999999999876678999998763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.22 E-value=0.00086 Score=66.34 Aligned_cols=79 Identities=22% Similarity=0.318 Sum_probs=53.9
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEcc-------CCCEEEEEEeecccccChhhHHHHHHHHHHHHHcC-CCceeeEEEEE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKK-------SGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVA-SHCIVKLYYSF 175 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~-------t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f 175 (514)
..+++++ +.|+.|---.+|++.... ..+.|.+++.-... .. ....+|..+++.+. +...++++++|
T Consensus 41 ~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~~-idr~~E~~i~~~ls~~gl~Pkll~~~ 114 (395)
T d1nw1a_ 41 PLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----TE-SHLVAESVIFTLLSERHLGPKLYGIF 114 (395)
T ss_dssp CGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----CH-HHHHHHHHHHHHHHHTTSSSCEEEEE
T ss_pred CccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----hh-hHHHHHHHHHHHHHhCCCCCeEEEEc
Confidence 3455554 678889999999998653 24567777765321 12 23557888888774 54556788887
Q ss_pred EcCCeEEEEEeecCCCC
Q 010266 176 QDAEYLYLIMEYLPGGD 192 (514)
Q Consensus 176 ~~~~~l~lVmEy~~gg~ 192 (514)
.+ .+||||++|..
T Consensus 115 ~~----g~I~efi~g~~ 127 (395)
T d1nw1a_ 115 SG----GRLEEYIPSRP 127 (395)
T ss_dssp TT----EEEECCCCEEE
T ss_pred CC----ceEEEEecccc
Confidence 54 58999998753
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.21 E-value=0.00049 Score=66.30 Aligned_cols=68 Identities=7% Similarity=0.156 Sum_probs=44.0
Q ss_pred ceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCc--eeeEE-----EEEEcCCeEEEEEeecCCC
Q 010266 119 FGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC--IVKLY-----YSFQDAEYLYLIMEYLPGG 191 (514)
Q Consensus 119 fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~--Iv~l~-----~~f~~~~~l~lVmEy~~gg 191 (514)
--.||++.. .+|..|++|+.+... ...+.+..|..+|..+.... ++... ..+......+.|+++++|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~----~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCC----CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 468999874 578889999987542 22345777888887764211 11111 2234567789999999874
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.93 E-value=0.0014 Score=62.24 Aligned_cols=144 Identities=15% Similarity=0.072 Sum_probs=78.6
Q ss_pred CCCCeeEEeeeeecCceEEEEEEEccCCCEEEEEEeecccccChhhHHHHHHHHHHHHHcCCCc--eeeEE------EEE
Q 010266 104 SVDDFDLLTIIGRGAFGEVRLCQEKKSGNIYAMKKLKKSEMLSRGQVEHVRAERNLLAEVASHC--IVKLY------YSF 175 (514)
Q Consensus 104 ~~~~f~~~~~LG~G~fG~V~l~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~--Iv~l~------~~f 175 (514)
..+...-++.|..|.--+.|++... +| .|++|+..+.. .. ..+..|..+|..+.... ++... ...
T Consensus 16 ~lg~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~--~~---~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~ 88 (316)
T d2ppqa1 16 DVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--EK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLG 88 (316)
T ss_dssp CCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCE
T ss_pred CCCCceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCCC--CH---HHHHHHHHHHHhhhhccccccccceecCCCcce
Confidence 4456666777888888999998743 34 59999986532 22 23455666666653221 11111 011
Q ss_pred EcCCeEEEEEeecCCCCHHHH--------------Hhh---c------cCC------------------CHHHHHHHHHH
Q 010266 176 QDAEYLYLIMEYLPGGDVMTL--------------LMR---E------ETL------------------TETVARFYIAQ 214 (514)
Q Consensus 176 ~~~~~l~lVmEy~~gg~L~~~--------------l~~---~------~~l------------------~e~~~~~~~~q 214 (514)
.-......++.++.|...... +.. . ... ........+..
T Consensus 89 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 168 (316)
T d2ppqa1 89 ELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRP 168 (316)
T ss_dssp EETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHH
T ss_pred eeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHH
Confidence 224556777777777533210 000 0 000 01111122333
Q ss_pred HHHHHHHHH----hCCeEEcCCCCCCccccCCCcEEEccccccc
Q 010266 215 SVLAIESIH----KHNYIHRDIKPDNLLLDQNGHMKLSDFGLCK 254 (514)
Q Consensus 215 i~~aL~~LH----~~giiHrDLKpeNILld~~g~iKL~DFGla~ 254 (514)
+...+...+ ..|+||+|+.++||+++.++..-|.||+.|.
T Consensus 169 ~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 169 EIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 333333333 2489999999999999988777899999886
|